PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hu, YS; Young, AJ; Ehli, EA; Nowotny, D; Davies, PS; Droke, EA; Soundy, TJ; Davies, GE				Hu, Yueshan; Young, Alan J.; Ehli, Erik A.; Nowotny, Dustin; Davies, Paige S.; Droke, Elizabeth A.; Soundy, Timothy J.; Davies, Gareth E.			Metformin and Berberine Prevent Olanzapine-Induced Weight Gain in Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MESSENGER-RNA EXPRESSION; FATTY LIVER-DISEASE; DOUBLE-BLIND; BODY-WEIGHT; INSULIN-RESISTANCE; METABOLIC SYNDROME; SCHIZOPHRENIA; CLOZAPINE; GLUCOSE	Olanzapine is a first line medication for the treatment of schizophrenia, but it is also one of the atypical antipsychotics carrying the highest risk of weight gain. Metformin was reported to produce significant attenuation of antipsychotic-induced weight gain in patients, while the study of preventing olanzapine-induced weight gain in an animal model is absent. Berberine, an herbal alkaloid, was shown in our previous studies to prevent fat accumulation in vitro and in vivo. Utilizing a well-replicated rat model of olanzapine-induced weight gain, here we demonstrated that two weeks of metformin or berberine treatment significantly prevented the olanzapine-induced weight gain and white fat accumulation. Neither metformin nor berberine treatment demonstrated a significant inhibition of olanzapine-increased food intake. But interestingly, a significant loss of brown adipose tissue caused by olanzapine treatment was prevented by the addition of metformin or berberine. Our gene expression analysis also demonstrated that the weight gain prevention efficacy of metformin or berberine treatment was associated with changes in the expression of multiple key genes controlling energy expenditure. This study not only demonstrates a significant preventive efficacy of metformin and berberine treatment on olanzapine-induced weight gain in rats, but also suggests a potential mechanism of action for preventing olanzapine-reduced energy expenditure.	[Hu, Yueshan; Ehli, Erik A.; Nowotny, Dustin; Davies, Paige S.; Davies, Gareth E.] Avera McKennan Hosp, Avera Inst Human Genet, Sioux Falls, SD 57117 USA; [Hu, Yueshan; Ehli, Erik A.; Nowotny, Dustin; Davies, Paige S.; Davies, Gareth E.] Univ Hlth Ctr, Sioux Falls, SD USA; [Hu, Yueshan; Ehli, Erik A.; Soundy, Timothy J.; Davies, Gareth E.] Univ S Dakota, Dept Psychiat, Sanford Sch Med, Sioux Falls, SD USA; [Young, Alan J.] S Dakota State Univ, Dept Vet & Biomed Sci, Coll Agr & Biol Sci, Brookings, SD 57007 USA; [Droke, Elizabeth A.] S Dakota State Univ, Dept Hlth & Nutr Sci, Coll Educ & Human Sci, Brookings, SD 57007 USA; [Davies, Gareth E.] S Dakota State Univ, Coll Pharm, Dept Pharm Practice, Brookings, SD 57007 USA	University of South Dakota; South Dakota State University; South Dakota State University; South Dakota State University	Hu, YS (corresponding author), Avera McKennan Hosp, Avera Inst Human Genet, Sioux Falls, SD 57117 USA.	Yueshan.Hu@avera.org		Xiang, Zou/0000-0003-3925-0296	Avera Research Institute	Avera Research Institute	Avera Research Institute sponsored this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh VL, 2006, OBESITY, V14, P36, DOI 10.1038/oby.2006.6; Blouin M, 2008, OBESITY, V16, P1780, DOI 10.1038/oby.2008.277; Boyda HN, 2014, PROG NEURO-PSYCHOPH, V48, P170, DOI 10.1016/j.pnpbp.2013.10.006; Boyda HN, 2012, J PSYCHIATR NEUROSCI, V37, P407, DOI 10.1503/jpn.110140; Case M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-72; Chen CH, 2008, PROG NEURO-PSYCHOPH, V32, P925, DOI 10.1016/j.pnpbp.2007.11.013; Citrome L, 2011, CLIN DRUG INVEST, V31, P455, DOI 10.2165/11589060-000000000-00000; D'Agostino G, 2007, J PHARMACOL EXP THER, V322, P1137, DOI 10.1124/jpet.107.123265; De Hert MA, 2006, SCHIZOPHR RES, V83, P87, DOI 10.1016/j.schres.2005.12.855; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; Dessalle K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050878; Faulkner G, 2006, CAN J PSYCHIAT, V51, P502, DOI 10.1177/070674370605100805; Fell MJ, 2007, PSYCHOPHARMACOLOGY, V194, P221, DOI 10.1007/s00213-007-0833-9; Feng S, 2012, NEUROENDOCRINOL LETT, V33, P493; Gilles M, 2010, CLIN NEUROPHARMACOL, V33, P248, DOI 10.1097/WNF.0b013e3181f0ec33; Goudie AJ, 2002, J PSYCHOPHARMACOL, V16, P291, DOI 10.1177/026988110201600402; Haupt DW, 2006, EUR NEUROPSYCHOPHARM, V16, pS149, DOI 10.1016/j.euroneuro.2006.06.003; Hu Y, 2012, PHARMACOGENOMICS J, V12, P372, DOI 10.1038/tpj.2011.24; Hu Y, 2009, PHYTOMEDICINE, V16, P864, DOI 10.1016/j.phymed.2009.03.002; Hu YS, 2012, PHYTOMEDICINE, V19, P861, DOI 10.1016/j.phymed.2012.05.009; Hu YS, 2010, PHYTOTHER RES, V24, P1831, DOI 10.1002/ptr.3204; Hu YS, 2010, FITOTERAPIA, V81, P358, DOI 10.1016/j.fitote.2009.10.010; Hu YS, 2010, FITOTERAPIA, V81, P259, DOI 10.1016/j.fitote.2009.09.012; Ikegami M, 2013, EUR J PHARM; Jarskog LF, 2007, ANNU REV MED, V58, P49, DOI 10.1146/annurev.med.58.060904.084114; Jassim G, 2012, PSYCHOPHARMACOLOGY, V219, P783, DOI 10.1007/s00213-011-2397-y; Kluge M, 2007, J CLIN PSYCHOPHARM, V27, P662, DOI 10.1097/jcp.0b013e31815a8872; Kreuzer P, 2012, NERVENARZT, V83, P630, DOI 10.1007/s00115-011-3310-y; Kudoh A, 2004, ANESTH ANALG, V98, P111, DOI 10.1213/01.ANE.0000093313.16711.5E; Kulkarni SK, 2010, PHYTOTHER RES, V24, P317, DOI 10.1002/ptr.2968; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Lee MS, 2011, J NUTR, V141, P1947, DOI 10.3945/jn.111.146050; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Liebig M, 2010, OBESITY, V18, P1952, DOI 10.1038/oby.2010.17; Lindenmayer JP, 2003, AM J PSYCHIAT, V160, P290, DOI 10.1176/appi.ajp.160.2.290; Maayan L, 2010, NEUROPSYCHOPHARMACOL, V35, P1520, DOI 10.1038/npp.2010.21; Makino T, 2009, BIOL PHARM BULL, V32, P1741, DOI 10.1248/bpb.32.1741; de Morentin PBM, 2012, DIABETES, V61, P807, DOI 10.2337/db11-1079; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Muench J, 2010, AM FAM PHYSICIAN, V81, P617; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Newcomer JW, 2006, CAN J PSYCHIAT, V51, P480, DOI 10.1177/070674370605100803; Newcomer JW, 2004, CLIN THER, V26, P1936, DOI 10.1016/j.clinthera.2004.12.003; Oh JE, 2012, EXP MOL MED, V44, P545, DOI 10.3858/emm.2012.44.9.062; Praharaj SK, 2011, BRIT J CLIN PHARMACO, V71, P377, DOI 10.1111/j.1365-2125.2010.03783.x; Russo GL, 2013, BIOCHEM PHARMACOL, V86, P339, DOI 10.1016/j.bcp.2013.05.023; Saddichha S, 2008, SCHIZOPHR RES, V101, P266, DOI 10.1016/j.schres.2008.01.004; Schreiner A, 2012, J CLIN PSYCHOPHARM, V32, P449, DOI 10.1097/JCP.0b013e31825cccad; Sejima E, 2011, CELL MOL NEUROBIOL, V31, P985, DOI 10.1007/s10571-011-9663-8; Shirzadi AA, 2006, HARVARD REV PSYCHIAT, V14, P152, DOI 10.1080/10673220600748486; Skrede S, 2012, INT J NEUROPSYCHOPH, V15, P163, DOI 10.1017/S1461145711001271; Smith G. C., 2011, Archives of Physiology and Biochemistry, V117, P241, DOI 10.3109/13813455.2011.576681; Stefanidis A, 2009, OBESITY, V17, P16, DOI 10.1038/oby.2008.468; Thakore JH, 2004, BRIT J PSYCHIAT, V184, pS76, DOI 10.1192/bjp.184.47.s76; Toalson Patrick, 2004, Prim Care Companion J Clin Psychiatry, V6, P152; Tschoner A, 2007, INT J CLIN PRACT, V61, P1356, DOI 10.1111/j.1742-1241.2007.01416.x; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Vuddanda PR, 2010, EXPERT OPIN INV DRUG, V19, P1297, DOI 10.1517/13543784.2010.517745; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wang YW, 2011, METABOLISM, V60, P298, DOI 10.1016/j.metabol.2010.02.005; Wu RR, 2008, AM J PSYCHIAT, V165, P352, DOI 10.1176/appi.ajp.2007.07010079; Xing LJ, 2011, EUR J PHARMACOL, V668, P467, DOI 10.1016/j.ejphar.2011.07.036; Yang QH, 2011, CHIN J INTEGR MED, V17, P205, DOI 10.1007/s11655-011-0668-4; Zhang M, 2012, MOL CELL ENDOCRINOL, V363, P122, DOI 10.1016/j.mce.2012.08.006; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhang YF, 2008, J CLIN ENDOCR METAB, V93, P2559, DOI 10.1210/jc.2007-2404	66	150	161	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93310	10.1371/journal.pone.0093310	http://dx.doi.org/10.1371/journal.pone.0093310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24676355	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600170
J	Hu, Y; Zhu, Q; Tang, LL				Hu, Yu; Zhu, Qin; Tang, Lili			MiR-99a Antitumor Activity in Human Breast Cancer Cells through Targeting of mTOR Expression	PLOS ONE			English	Article							DOWN-REGULATION; HEPATOCELLULAR-CARCINOMA; LUNG-CANCER; S6 KINASE; MICRORNA; PATHWAY; GROWTH; AKT; TRANSLATION; APOPTOSIS	MicroRNAs (miRNAs) play an important role in human tumorigenesis as oncogenes or tumor suppressors. miR-99a has been reported as a tumor suppressor gene in various cancers in humans. However, only limited information about the function of miR-99a in human breast cancers is available. Here we investigated the expression of miR-99a in breast cancer tissue specimens and its antitumor activity in breast cancer cells. We initially identified that the expression of miR-99a was significantly reduced in four breast cancer cell lines. More importantly, we found downregulation of miR-99a in breast cancer specimens from ten different patients. We then analyzed the mechanism of miR-99a in inhibiting tumorigenesis. Cell-based assays that showed overexpression of miR-99a not only reduced breast cancer cell viability by inducing accumulation of cells at sub-G1 phase and cell apoptosis, but also inhibited tumorigenicity in vivo. As a critical miR-99a target, we have shown that the function of mammalian target of rapamycin (mTOR) was greatly inhibited by miR-99a-based Luciferase report assay; overexpression of miR-99a reduced the expression of mTOR and its downstream phosphorylated proteins (p-4E-BP1 and p-S6K1). Similar to restoring miR-99a expression, mTOR downregulation suppressed cell viability and increased cell apoptosis, whereas restoration of mTOR expression significantly reversed the inhibitory effects of miR-99a on the mTOR/p-4E-BP1/p-S6K1 signal pathway and the miR-99a antitumor activity. In clinical specimens and cell lines, mTOR was commonly overexpressed and its protein levels were statistically inversely correlated with miR-99a expression. Taken together, these results have demonstrated that miR-99a antitumor activity is achieved by targeting the mTOR/p-4E-BP1/p-S6K1 pathway in human breast cancer cells. This study suggests a potential therapeutic strategy to effectively control breast cancer development.	[Hu, Yu; Tang, Lili] Cent S Univ, Xiangya Hosp, Dept Breast Surg, Changsha, Hunan, Peoples R China; [Zhu, Qin] Cent S Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Hunan, Peoples R China	Central South University; Central South University	Tang, LL (corresponding author), Cent S Univ, Xiangya Hosp, Dept Breast Surg, Changsha, Hunan, Peoples R China.	lilitangxy@126.com		Xiang, Zou/0000-0003-3925-0296				Bose S, 2006, MODERN PATHOL, V19, P238, DOI 10.1038/modpathol.3800525; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Cui L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-546; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Ekman S, 2012, J THORAC ONCOL, V7, P947, DOI 10.1097/JTO.0b013e31825581bd; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Grabinski N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-85; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Heinonen H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-348; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kajstura M, 2007, CYTOM PART A, V71A, P125, DOI 10.1002/cyto.a.20357; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kremer CL, 2006, PROSTATE, V66, P1203, DOI 10.1002/pros.20410; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Li M, 2012, ONCOL LETT, V4, P1213, DOI 10.3892/ol.2012.930; Li XH, 2011, MOL CANCER RES, V9, P824, DOI 10.1158/1541-7786.MCR-10-0529; Lin HJ, 2005, BRIT J CANCER, V93, P1372, DOI 10.1038/sj.bjc.6602862; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martelli AM, 2009, EXPERT OPIN INV DRUG, V18, P1333, DOI 10.1517/14728220903136775; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Mueller AC, 2013, ONCOGENE, V32, P1164, DOI 10.1038/onc.2012.131; Nagayama K, 2007, GENE CHROMOSOME CANC, V46, P1000, DOI 10.1002/gcc.20485; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Noh WC, 2004, CLIN CANCER RES, V10, P1013, DOI 10.1158/1078-0432.CCR-03-0043; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Oneyama C, 2011, ONCOGENE, V30, P3489, DOI 10.1038/onc.2011.63; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Rojo F, 2007, CLIN CANCER RES, V13, P81, DOI 10.1158/1078-0432.CCR-06-1560; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Soni A, 2008, MOL CANCER THER, V7, P1782, DOI 10.1158/1535-7163.MCT-07-2357; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Sun J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0411-9; TELFORD WG, 1992, CYTOMETRY, V13, P137, DOI 10.1002/cyto.990130205; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang BY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047053; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Zhou J, 2010, MOL MED REP, V3, P387, DOI 10.3892/mmr_00000269	45	150	161	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e92099	10.1371/journal.pone.0092099	http://dx.doi.org/10.1371/journal.pone.0092099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24676355	Green Submitted, gold, Green Published			2022-12-25	WOS:000333254100111
J	Santini, R; Pietrobono, S; Pandolfi, S; Montagnani, V; D'Amico, M; Penachioni, JY; Vinci, MC; Borgognoni, L; Stecca, B				Santini, R.; Pietrobono, S.; Pandolfi, S.; Montagnani, V.; D'Amico, M.; Penachioni, J. Y.; Vinci, M. C.; Borgognoni, L.; Stecca, B.			SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells	ONCOGENE			English	Article							TRANSCRIPTION FACTOR SOX2; NEURAL STEM-CELL; SONIC HEDGEHOG; IN-VITRO; PROGENITOR; EXPRESSION; PROLIFERATION; SURVIVAL; LUNG; GLI1	Melanoma is one of the most aggressive types of human cancer, characterized by enhanced heterogeneity and resistance to conventional therapy at advanced stages. We and others have previously shown that HEDGEHOG-GLI (HH-GLI) signaling is required for melanoma growth and for survival and expansion of melanoma-initiating cells (MICs). Recent reports indicate that HH-GLI signaling regulates a set of genes typically expressed in embryonic stem cells, including SOX2 (sex-determining region Y (SRY)-Box2). Here we address the function of SOX2 in human melanomas and MICs and its interaction with HH-GLI signaling. We find that SOX2 is highly expressed in melanoma stem cells. Knockdown of SOX2 sharply decreases self-renewal in melanoma spheres and in putative melanoma stem cells with high aldehyde dehydrogenase activity (ALDH(high)). Conversely, ectopic expression of SOX2 in melanoma cells enhances their self-renewal in vitro. SOX2 silencing also inhibits cell growth and induces apoptosis in melanoma cells. In addition, depletion of SOX2 progressively abrogates tumor growth and leads to a significant decrease in tumor-initiating capability of ALDH(high) MICs upon xenotransplantation, suggesting that SOX2 is required for tumor initiation and for continuous tumor growth. We show that SOX2 is regulated by HH signaling and that the transcription factors GLI1 and GLI2, the downstream effectors of HH-GLI signaling, bind to the proximal promoter region of SOX2 in primary melanoma cells. In functional studies, we find that SOX2 function is required for HH-induced melanoma cell growth and MIC self-renewal in vitro. Thus SOX2 is a critical factor for self-renewal and tumorigenicity of MICs and an important mediator of HH-GLI signaling in melanoma. These findings could provide the basis for novel therapeutic strategies based on the inhibition of SOX2 for the treatment of a subset of human melanomas.	[Santini, R.; Pietrobono, S.; Pandolfi, S.; Montagnani, V.; Penachioni, J. Y.; Vinci, M. C.; Stecca, B.] Ist Toscano Tumori, Corp Res Lab, Tumor Cell Biol Lab, I-50139 Florence, Italy; [D'Amico, M.] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Borgognoni, L.] Ist Toscano Tumori, Reg Melanoma Referral Ctr, SM Annunziata Hosp, Plast Surg Unit, I-50139 Florence, Italy	ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Stecca, B (corresponding author), Ist Toscano Tumori, Corp Res Lab, Tumor Cell Biol Lab, Viale Pieraccini 6, I-50139 Florence, Italy.	barbara.stecca@ittumori.it	Stecca, Barbara/J-7209-2016; Borgognoni, Lorenzo/X-1981-2019; Vinci, Maria Cristina/E-7401-2016; Pietrobono, Silvia S/K-3932-2016	Borgognoni, Lorenzo/0000-0002-3571-0366; Vinci, Maria Cristina/0000-0001-6323-147X; Pietrobono, Silvia S/0000-0002-5544-7286; Stecca, Barbara/0000-0003-1197-1622	AIRC (Associazione Italiana per la Ricerca sul Cancro) [IG-9566]; Regional Health Research Program; Fondazione Cassa di Risparmio di Firenze (FiorGen Foundation) [2011.1072]; AIRC fellowship	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Regional Health Research Program; Fondazione Cassa di Risparmio di Firenze (FiorGen Foundation)(Fondazione Cassa Risparmio Firenze); AIRC fellowship(Fondazione AIRC per la ricerca sul cancro)	We thank Gianni Gerlini (S Maria Annunziata Hospital, Florence, Italy), Nicola Pimpinelli (Department of Dermatology, University of Florence, Florence, Italy) and Riccardo Gattai (Department of Medical-Surgical Critical Area, General and Oncological Surgery, University of Florence, Florence, Italy) for providing samples. We also thank Alessio Zippo (INGM, Milan, Italy) and Lucio Luzzatto (Istituto Toscano Tumori, Florence, Italy) for helpful comments on the paper and Elisabetta Rovida and Eugenio Torre (Department of Biomedical and Clinical Sciences, University of Florence, Italy) for assistance with confocal microscopy and histology. This work was supported by grants from AIRC (Associazione Italiana per la Ricerca sul Cancro, IG-9566), Regional Health Research Program 2009 and Fondazione Cassa di Risparmio di Firenze (2011.1072, FiorGen Foundation) to BS. SP was supported by an AIRC fellowship.	Adameyko I, 2012, DEVELOPMENT, V139, P397, DOI 10.1242/dev.065581; Ahlfeld J, 2013, CANCER RES, V73, P3796, DOI 10.1158/0008-5472.CAN-13-0238; Alexaki VI, 2010, JNCI-J NATL CANCER I, V102, P1148, DOI 10.1093/jnci/djq257; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Bareiss PM, 2013, CANCER RES, V73, P5544, DOI 10.1158/0008-5472.CAN-12-4177; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Basu-Roy U, 2010, CELL DEATH DIFFER, V17, P1345, DOI 10.1038/cdd.2010.57; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Boonyaratanakornkit JB, 2010, J INVEST DERMATOL, V130, P2799, DOI 10.1038/jid.2010.237; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Calloni GW, 2007, P NATL ACAD SCI USA, V104, P19879, DOI 10.1073/pnas.0708806104; Chartrain M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036762; Chen PL, 2013, MODERN PATHOL, V26, P44, DOI 10.1038/modpathol.2012.132; Chou YT, 2013, STEM CELLS, V31, P2607, DOI 10.1002/stem.1518; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Eberl M, 2012, EMBO MOL MED, V4, P218, DOI 10.1002/emmm.201100201; Engelen E, 2011, NAT GENET, V43, P607, DOI 10.1038/ng.825; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fang XF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-11; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Freier K, 2010, GENE CHROMOSOME CANC, V49, P9, DOI 10.1002/gcc.20714; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Girouard SD, 2012, LAB INVEST, V92, P362, DOI 10.1038/labinvest.2011.188; Girouard SD, 2011, LAB INVEST, V91, P647, DOI 10.1038/labinvest.2011.50; Gopinath S, 2013, CARCINOGENESIS, V34, P550, DOI 10.1093/carcin/bgs375; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Herreros-Villanueva M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.23; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hu YP, 2012, AM J CANCER RES, V2, P340; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hutz K, 2014, CARCINOGENESIS, V35, P942, DOI 10.1093/carcin/bgt410; Hutchin ME, 2005, GENE DEV, V19, P214, DOI 10.1101/gad.1258705; Jalili A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069064; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Laga AC, 2011, EXP DERMATOL, V20, P339, DOI 10.1111/j.1600-0625.2011.01247.x; Laga AC, 2010, AM J PATHOL, V176, P903, DOI 10.2353/ajpath.2010.090495; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lee J, 1997, DEVELOPMENT, V124, P2537; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Luo YC, 2012, STEM CELLS, V30, P2100, DOI 10.1002/stem.1193; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Miyagi S, 2006, J BIOL CHEM, V281, P13374, DOI 10.1074/jbc.M512669200; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Murphy GF, 2014, MOL ASPECTS MED, V39, P33, DOI 10.1016/j.mam.2013.10.003; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Narasimhan K, 2011, ACS CHEM BIOL, V6, P573, DOI 10.1021/cb100432x; O'Reilly KE, 2013, PHARMACEUTICALS, V6, P1429, DOI 10.3390/ph6111429; Pandolfi S, 2013, ONCOGENE, V32, P4737, DOI 10.1038/onc.2012.502; Perego M, 2010, J INVEST DERMATOL, V130, P1877, DOI 10.1038/jid.2010.69; Pinc A, 2012, MOL THER, V20, P1056, DOI 10.1038/mt.2012.27; Piva M, 2014, EMBO MOL MED, V6, P66, DOI 10.1002/emmm.201303411; Po A, 2010, EMBO J, V29, P2646, DOI 10.1038/emboj.2010.131; Ramgolam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018784; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Rybak AP, 2013, CELL SIGNAL, V25, P2734, DOI 10.1016/j.cellsig.2013.08.041; Santini R, 2012, STEM CELLS, V30, P1808, DOI 10.1002/stem.1160; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schlaak M, 2012, ONCOTARGET, V3, P22; Schmidt P, 2011, P NATL ACAD SCI USA, V108, P2474, DOI 10.1073/pnas.1009069108; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Stolzenburg S, 2012, NUCLEIC ACIDS RES, V40, P6725, DOI 10.1093/nar/gks360; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137	74	146	152	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 18	2014	33	38					4697	4708		10.1038/onc.2014.71	http://dx.doi.org/10.1038/onc.2014.71			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AP3VX	24681955	hybrid, Green Published			2022-12-25	WOS:000342007200008
J	Slominski, AT; Kim, TK; Takeda, Y; Janjetovic, Z; Brozyna, AA; Skobowiat, C; Wang, J; Postlethwaite, A; Li, W; Tuckey, RC; Jetten, AM				Slominski, Andrzej T.; Kim, Tae-Kang; Takeda, Yukimasa; Janjetovic, Zorica; Brozyna, Anna A.; Skobowiat, Cezary; Wang, Jin; Postlethwaite, Arnold; Li, Wei; Tuckey, Robert C.; Jetten, Anton M.			ROR alpha and ROR gamma are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D	FASEB JOURNAL			English	Article						keratinocytes; melanoma cells; retinoic acid-related nuclear receptors; CYP11A1	VITAMIN-D; CYTOCHROME P450SCC; TRANSCRIPTIONAL ACTIVATION; INHIBITS PROLIFERATION; CHOLESTEROL SULFATE; NUCLEAR RECEPTORS; TH17 CELLS; METABOLISM; MELATONIN; PATHWAY	ROR alpha and ROR gamma are expressed in human skin cells that produce the noncalcemic 20-hydroxyvitamin D-3 [20(OH)D-3] and 20,23-dihydroxyvitamin D-3 [20,23(OH)(2)D-3]. Chinese hamster ovary (CHO) cells stably expressing a Tet-on ROR alpha or ROR gamma expression vector and a ROR-responsive element (RORE)-LUC reporter, and a mammalian 2-hybrid model examining the interaction between the ligand binding domain (LBD) of ROR alpha or ROR gamma with an LBD-interacting LXXLL-peptide, were used to study ROR-antagonist activities. These assays revealed that 20(OH)D-3 and 20,23(OH)(2)D-3 function as antagonists of ROR alpha and ROR gamma. Moreover, 20(OH)D-3 inhibited the activation of the promoter of the Bmal1 and G6pase genes, targets of ROR alpha, and 20(OH)D-3 and 20,23(OH)(2)D-3 inhibited Il17 promoter activity in Jurkat cells overexpressing ROR alpha or ROR gamma. Molecular modeling using crystal structures of the LBDs of ROR alpha and ROR gamma revealed docking scores for 20(OH)D-3, 20, 23(OH)(2)D-3 and 1,25(OH)(2)D-3 similar to those of the natural ligands, predicting good binding to the receptor. Notably, 20(OH)D-3, 20,23(OH)(2)D-3, and 1,25(OH)(2)D-3 inhibited RORE-mediated activation of a reporter in keratinocytes and melanoma cells and inhibited IL-17 production by immune cells. Our study identifies a novel signaling pathway, in which 20(OH)D-3 and 20,23(OH)(2)D-3 act as antagonists or inverse agonists of ROR alpha and ROR gamma, that opens new possibilities for local (skin) or systemic regulation.	[Slominski, Andrzej T.; Kim, Tae-Kang; Janjetovic, Zorica; Skobowiat, Cezary] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Slominski, Andrzej T.; Postlethwaite, Arnold] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA; [Wang, Jin; Li, Wei] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Takeda, Yukimasa; Jetten, Anton M.] NIEHS, Cell Biol Sect, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA; [Brozyna, Anna A.] Nicolaus Copernicus Univ, Dept Tumor Pathol & Pathomorphol, Prof Franciszek Lukaszczyk Mem Hosp, Oncol Ctr,Ludwik Rydygier Coll Med, Bydgoszcz, Poland; [Postlethwaite, Arnold] Dept Vet Affairs Med Ctr, Memphis, TN USA; [Tuckey, Robert C.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Nicolaus Copernicus University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Western Australia	Slominski, AT (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pathol, 930 Madison Ave,RM525, Memphis, TN 38163 USA.	aslominski@uthsc.edu; jetten@niehs.nih.gov	Brożyna, Anna A/D-4902-2014; Skobowiat, Cezary/J-5007-2012; Jetten, Anton/C-3736-2019	Brożyna, Anna A/0000-0002-3195-9965; Skobowiat, Cezary/0000-0002-3881-0231; Jetten, Anton/0000-0003-0954-4445; Slominski, Andrzej/0000-0001-8963-3995; Li, Wei/0000-0002-9522-4474; Wang, Jin/0000-0001-5420-5704	U.S. National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases [2R06AR052190, 1R01AR056666-01A2]; West Clinic Cancer Foundation; Department of Veterans Affairs Program [1IPIBX00107-01, 1R21AR063242-01A1, 1S10OD010678-01]; National Institute of Environmental Health Sciences, NIH [Z01-ES-101586]; Japanese Society for the Promotion of Science (JSPS); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056666, R21AR063242, R01AR052190, R21AR066505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101586, ZIAES101586] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010678] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); West Clinic Cancer Foundation; Department of Veterans Affairs Program; National Institute of Environmental Health Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The project was supported by grants from the U.S. National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (2R06AR052190 and 1R01AR056666-01A2) and the West Clinic Cancer Foundation to A. T. S.; Department of Veterans Affairs Program Project grant 1IPIBX00107-01 to A. P. and grants 1R21AR063242-01A1 and 1S10OD010678-01 to W. L.; and by grants from the Intramural Research Program of the National Institute of Environmental Health Sciences, NIH (Z01-ES-101586), and the Japanese Society for the Promotion of Science (JSPS) to A.M.J. and Y.T.	Antonov J, 2005, LAB INVEST, V85, P1040, DOI 10.1038/labinvest.3700303; Bikle DD, 2011, EXP DERMATOL, V20, P7, DOI 10.1111/j.1600-0625.2010.01202.x; Bikle DD, 2011, DISCOV MED, V11, P7; Brand DD, 2002, J IMMUNOL, V168, P490, DOI 10.4049/jimmunol.168.1.490; Brozyna AA, 2013, HUM PATHOL, V44, P374, DOI 10.1016/j.humpath.2012.03.031; Brozyna AA, 2011, HUM PATHOL, V42, P618, DOI 10.1016/j.humpath.2010.09.014; Carlberg C, 2000, ANN NY ACAD SCI, V917, P387; Chen JJ, 2011, BIOORGAN MED CHEM, V19, P4782, DOI 10.1016/j.bmc.2011.06.084; Dai J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070392; Elias PM, 2014, BBA-MOL CELL BIOL L, V1841, P353, DOI 10.1016/j.bbalip.2013.11.009; Elias PM, 2012, J INVEST DERMATOL, V132, P2131, DOI 10.1038/jid.2012.246; Fischer TW, 2006, INT J ONCOL, V29, P665; Guryev O, 2003, P NATL ACAD SCI USA, V100, P14754, DOI 10.1073/pnas.2336107100; Hill SM, 2009, INTEGR CANCER THER, V8, P337, DOI 10.1177/1534735409353332; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Huh JR, 2012, EUR J IMMUNOL, V42, P2232, DOI 10.1002/eji.201242740; Hyter S, 2013, FEBS LETT, V587, P529, DOI 10.1016/j.febslet.2013.01.041; Janjetovic Z, 2010, J CELL PHYSIOL, V223, P36, DOI 10.1002/jcp.21992; Jetten AM, 2001, PROG NUCLEIC ACID RE, V69, P205, DOI 10.1016/S0079-6603(01)69048-2; Jetten Anton M, 2013, Front Endocrinol (Lausanne), V4, P1, DOI 10.3389/fendo.2013.00001; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Kallen J, 2004, J BIOL CHEM, V279, P14033, DOI 10.1074/jbc.M400302200; Kallen JA, 2002, STRUCTURE, V10, P1697, DOI 10.1016/S0969-2126(02)00912-7; Kim TK, 2013, FASEB J, V27, P2742, DOI 10.1096/fj.12-224691; Kobayashi H, 2005, FASEB J, V19, P1710, DOI 10.1096/fj.04-2293fje; Kurebayashi S, 2004, BIOCHEM BIOPH RES CO, V315, P919, DOI 10.1016/j.bbrc.2004.01.131; Marciano DP, 2014, CELL METAB, V19, P193, DOI 10.1016/j.cmet.2013.12.009; Mohan V, 2005, CURR PHARM DESIGN, V11, P323, DOI 10.2174/1381612053382106; Myers LK, 1997, LIFE SCI, V61, P1861, DOI 10.1016/S0024-3205(97)00480-3; Nguyen MN, 2009, DRUG METAB DISPOS, V37, P761, DOI 10.1124/dmd.108.025619; Palmer MT, 2011, J BIOL CHEM, V286, P997, DOI 10.1074/jbc.M110.163790; Peiser M, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/261037; Pike JW, 2014, J STEROID BIOCHEM, V144, P5, DOI 10.1016/j.jsbmb.2013.11.004; Plum LA, 2010, NAT REV DRUG DISCOV, V9, P941, DOI 10.1038/nrd3318; Schmuth M, 2008, J LIPID RES, V49, P499, DOI 10.1194/jlr.R800001-JLR200; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2005, ENDOCRINE, V27, P137, DOI 10.1385/ENDO:27:2:137; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski A, 2005, FEBS J, V272, P4080, DOI 10.1111/j.1742-4658.2005.04819.x; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski A, 2006, FEBS J, V273, P2891, DOI 10.1111/j.1742-4658.2006.05302.x; Slominski A, 2013, J CLIN ENDOCR METAB, V98, pE298, DOI 10.1210/jc.2012-3074; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2014, J STEROID BIOCHEM, V144, P28, DOI 10.1016/j.jsbmb.2013.10.012; Slominski AT, 2014, MOL CELL ENDOCRINOL, V383, P181, DOI 10.1016/j.mce.2013.12.012; Slominski AT, 2012, INT J BIOCHEM CELL B, V44, P2003, DOI 10.1016/j.biocel.2012.07.027; Slominski AT, 2012, ANTICANCER RES, V32, P3733; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Slominski AT, 2011, J INVEST DERMATOL, V131, P1167, DOI 10.1038/jid.2010.425; Slominski AT, 2011, AM J PHYSIOL-CELL PH, V300, pC526, DOI 10.1152/ajpcell.00203.2010; Slominski AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009907; SLOMINSKI AT, 2014, ANTI-CANCER AGENT ME, V14, P77, DOI DOI 10.2174/18715206113139990308; Slominski RM, 2012, MOL CELL ENDOCRINOL, V351, P152, DOI 10.1016/j.mce.2012.01.004; Solt LA, 2012, TRENDS ENDOCRIN MET, V23, P619, DOI 10.1016/j.tem.2012.05.012; Steinmayr M, 1998, P NATL ACAD SCI USA, V95, P3960, DOI 10.1073/pnas.95.7.3960; Takeda Y, 2013, NUCLEIC ACIDS RES, V41, P6992, DOI 10.1093/nar/gkt447; Takeda Y, 2012, NUCLEIC ACIDS RES, V40, P8519, DOI 10.1093/nar/gks630; Takeda Y, 2011, NUCLEIC ACIDS RES, V39, P4769, DOI 10.1093/nar/gkq1335; Tuckey RC, 2008, FEBS J, V275, P2585, DOI 10.1111/j.1742-4658.2008.06406.x; Tuckey RC, 2011, DRUG METAB DISPOS, V39, P1577, DOI 10.1124/dmd.111.040071; Van Belle TL, 2013, TRENDS ENDOCRIN MET, V24, P561, DOI 10.1016/j.tem.2013.07.002; Wang J, 2012, ANTICANCER RES, V32, P739; Wang YJ, 2010, BBA-MOL CELL BIOL L, V1801, P917, DOI 10.1016/j.bbalip.2010.02.012; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; WIESENBERG I, 1995, NUCLEIC ACIDS RES, V23, P327, DOI 10.1093/nar/23.3.327; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zbytek B, 2008, J INVEST DERMATOL, V128, P2271, DOI 10.1038/jid.2008.62	70	192	194	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2775	2789		10.1096/fj.13-242040	http://dx.doi.org/10.1096/fj.13-242040			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24668754	Green Published, Bronze			2022-12-25	WOS:000337949400005
J	Heisey, DM; Jennelle, CS; Russell, RE; Walsh, DP				Heisey, Dennis M.; Jennelle, Christopher S.; Russell, Robin E.; Walsh, Daniel P.			Using Auxiliary Information to Improve Wildlife Disease Surveillance When Infected Animals Are Not Detected: A Bayesian Approach	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; WHITE-TAILED DEER; SUBSTANTIATE FREEDOM; STRATEGIES; MANAGEMENT; WISCONSIN; ECOLOGY	There are numerous situations in which it is important to determine whether a particular disease of interest is present in a free-ranging wildlife population. However adequate disease surveillance can be labor-intensive and expensive and thus there is substantial motivation to conduct it as efficiently as possible. Surveillance is often based on the assumption of a simple random sample, but this can almost always be improved upon if there is auxiliary information available about disease risk factors. We present a Bayesian approach to disease surveillance when auxiliary risk information is available which will usually allow for substantial improvements over simple random sampling. Others have employed risk weights in surveillance, but this can result in overly optimistic statements regarding freedom from disease due to not accounting for the uncertainty in the auxiliary information; our approach remedies this. We compare our Bayesian approach to a published example of risk weights applied to chronic wasting disease in deer in Colorado, and we also present calculations to examine when uncertainty in the auxiliary information has a serious impact on the risk weights approach. Our approach allows "apples-to-apples" comparisons of surveillance efficiencies between units where heterogeneous samples were collected.	[Heisey, Dennis M.; Russell, Robin E.; Walsh, Daniel P.] Natl Wildlife Hlth Ctr, United States Geol Survey, Madison, WI 53711 USA; [Jennelle, Christopher S.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA	United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison	Heisey, DM (corresponding author), Natl Wildlife Hlth Ctr, United States Geol Survey, Madison, WI 53711 USA.	dheisey@usgs.gov		Walsh, Daniel/0000-0002-7772-2445; Jennelle, Christopher/0000-0003-4133-814X; Russell, Robin/0000-0001-8726-7303	United States Geological Survey-National Wildlife Health Center	United States Geological Survey-National Wildlife Health Center	The support for this study was provided by the United States Geological Survey-National Wildlife Health Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, ORDONNANCE EPIZOOTIE; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Cai TT, 2005, J STAT PLAN INFER, V131, P63, DOI 10.1016/j.jspi.2004.01.005; Cameron A., 2003, Animal disease surveillance and survey systems: methods and applications, P47, DOI 10.1002/9780470344866.ch4; Cameron AR, 1998, PREV VET MED, V34, P1, DOI 10.1016/S0167-5877(97)00081-0; Cannon RM, 2002, PREV VET MED, V52, P227, DOI 10.1016/S0167-5877(01)00262-8; Casella G, 2001, STAT SCI, V16, P121; Centers for Disease Control and Prevention, CHRON WAST DIS; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dayton PK, 1998, SCIENCE, V279, P821, DOI 10.1126/science.279.5352.821; Diefenbach DB, 2004, WILDLIFE SOC B, V32, P267, DOI 10.2193/0091-7648(2004)32[267:FTFEOD]2.0.CO;2; Doherr M. G., 2003, Animal disease surveillance and survey systems: methods and applications, P135, DOI 10.1002/9780470344866.ch9; Dufour B, 2001, VET RES, V32, P545, DOI 10.1051/vetres:2001102; Fienberg SE, 2006, BAYESIAN ANAL, V1, P1; Gelman A., 2004, BAYESIAN DATA ANAL; Ghosh M, 2001, STAT SCI, V16, P124; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Joly DO, 2009, J WILDLIFE DIS, V45, P989, DOI 10.7589/0090-3558-45.4.989; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Nusser SM, 2008, J WILDLIFE MANAGE, V72, P52, DOI 10.2193/2007-317; Osnas EE, 2009, ECOL APPL, V19, P1311, DOI 10.1890/08-0578.1; Reid N, 2003, MATH STAT APPL, P31; Salman M.D., 2003, ANIMAL DIS SURVEILLA, V1st; Samuel MD, 2003, SURV STRAT DET CHRON; Tuyl F, 2009, BAYESIAN ANAL, V4, P151, DOI 10.1214/09-BA405; Walsh DP, 2010, J WILDLIFE DIS, V46, P118, DOI 10.7589/0090-3558-46.1.118; Wobeser G, 2002, REV SCI TECH OIE, V21, P159, DOI 10.20506/rst.21.1.1326; World Organisation for Animal Health (OIE), 2010, TERR AN HLTH COD; Ziller M, 2002, PREV VET MED, V52, P333, DOI 10.1016/S0167-5877(01)00245-8	29	13	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e89843	10.1371/journal.pone.0089843	http://dx.doi.org/10.1371/journal.pone.0089843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676479	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500005
J	Kim, MY; Eiby, YA; Lumbers, ER; Wright, LL; Gibson, KJ; Barnett, AC; Lingwood, BE				Kim, Min Young; Eiby, Yvonne A.; Lumbers, Eugenie R.; Wright, Layne L.; Gibson, Karen J.; Barnett, Amanda C.; Lingwood, Barbara E.			Effects of Glucocorticoid Exposure on Growth and Structural Maturation of the Heart of the Preterm Piglet	PLOS ONE			English	Article							VENA-CAVA FLOW; CARDIAC MYOCYTES; DEXAMETHASONE TREATMENT; SINGLE COURSE; NEONATAL RAT; FETAL SHEEP; BIRTH; PROLIFERATION; CARDIOMYOCYTE; INFANTS	Inadequate maintenance of systemic blood flow in neonates following preterm birth is associated with increased morbidity and mortality, and may be due in part to structural immaturity of the myocardium. Maternal glucocorticoid administration is associated with improved cardiovascular function, and possibly promotes structural maturation of the myocardium. This study assessed the structural maturity of the myocardium in male and female preterm and term piglets, and preterm piglets exposed to a regimen of maternal glucocorticoids as used clinically. In preterm, term and glucocorticoid exposed preterm piglets cardiomyocyte maturity was examined by measuring the proportion of binucleated myocytes and the volumes of single living ventricular cardiomyocytes with fluorescence microscopy. Ventricular apoptosis and proliferation were measured by immunohistochemistry. Preterm piglet hearts had fewer binucleated myocytes, smaller myocytes, and more proliferative and fewer apoptotic nuclei than term hearts. Maternal glucocorticoid treatment resulted in increased binucleation with no increase in myocyte volume, and levels of proliferation and apoptosis that were more similar to the term heart. Atrial weights were increased and in female piglets there was an increase in the ratio of left to right ventricular weight. The observed changes in atrial mass and myocyte structural maturation correlated with changes in cardiac function of isolated hearts of littermates. In conclusion, the association between increased myocardial maturation following glucocorticoid exposure, improved cardiac function in littermates, and clinical improvement in human neonatal cardiac function exposed to antenatal glucocorticoids, suggests that glucocorticoid exposure contributes to improved cardiovascular function in preterm infants by promoting myocardial structural maturity.	[Kim, Min Young; Eiby, Yvonne A.; Lumbers, Eugenie R.; Wright, Layne L.; Barnett, Amanda C.; Lingwood, Barbara E.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Lumbers, Eugenie R.; Gibson, Karen J.] Univ New S Wales, Sch Med Sci, Dept Physiol, Sydney, NSW, Australia; [Lumbers, Eugenie R.] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia	University of Queensland; University of New South Wales Sydney; University of Newcastle	Lingwood, BE (corresponding author), Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia.	b.lingwood@uq.edu.au	Lingwood, Barbara E/F-1398-2010; Eiby, Yvonne/F-2772-2010; Lumbers, Eugenie/AAS-4930-2020	Eiby, Yvonne/0000-0003-0079-7796; 	National Health and Medical Research Council of Australia [569635]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (grant number 569635) (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani M, 2011, MOL CELL BIOL, V31, P163, DOI 10.1128/MCB.01539-09; ANVERSA P, 1980, CIRC RES, V46, P495, DOI 10.1161/01.RES.46.4.495; Bal MP, 2009, PEDIATR RES, V66, P74, DOI 10.1203/PDR.0b013e3181a283a0; Barbera A, 2000, AM J PHYSIOL-REG I, V279, pR1157, DOI 10.1152/ajpregu.2000.279.4.R1157; BEINLICH CJ, 1993, MOL CELL BIOCHEM, V119, P3, DOI 10.1007/BF00926846; Bensley JG, 2010, EUR HEART J, V31, P2058, DOI 10.1093/eurheartj/ehq104; Bruel A, 2007, CARDIOVASC RES, V76, P400, DOI 10.1016/j.cardiores.2007.06.026; Burrell JH, 2003, ANAT REC PART A, V274A, P952, DOI 10.1002/ar.a.10110; Burrell JH, 2001, EXP PHYSIOL, V86, P71, DOI 10.1113/eph8602075; Choi JH, 2002, PEDIATR RES, V52, P325, DOI 10.1203/01.PDR.0000025654.32501.3D; CLUBB FJ, 1984, LAB INVEST, V50, P571; De Matteo R, 2010, REPROD SCI, V17, P724, DOI 10.1177/1933719110369182; de Vries WB, 2006, BASIC RES CARDIOL, V101, P36, DOI 10.1007/s00395-005-0557-0; Eiby YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068763; Eiby YA, 2012, AM J PHYSIOL-REG I, V303, pR769, DOI 10.1152/ajpregu.00010.2012; Elsmen E, 2004, ACTA PAEDIATR, V93, P529, DOI 10.1080/08035250410024998; French NP, 1999, AM J OBSTET GYNECOL, V180, P114, DOI 10.1016/S0002-9378(99)70160-2; Giraud GD, 2006, ENDOCRINOLOGY, V147, P3643, DOI 10.1210/en.2006-0061; GOTOH T, 1983, ACTA ANAT, V115, P168; Gregorio CC, 2000, TRENDS CELL BIOL, V10, P355, DOI 10.1016/S0962-8924(00)01793-1; Groves AM, 2012, PEDIATR RES, V71, P380, DOI 10.1038/pr.2011.77; Ikegami M, 1997, AM J RESP CRIT CARE, V156, P178, DOI 10.1164/ajrccm.156.1.9612036; ISRAEL BA, 1993, AM J PERINAT, V10, P307, DOI 10.1055/s-2007-994747; Jobe AH, 1998, AM J OBSTET GYNECOL, V178, P880, DOI 10.1016/S0002-9378(98)70518-6; Jobe AH, 2010, PEDIATR NEONATOL, V51, P7, DOI 10.1016/S1875-9572(10)60003-4; Jonker SS, 2007, J APPL PHYSIOL, V102, P1130, DOI 10.1152/japplphysiol.00937.2006; KHOURY MJ, 1985, AM J OBSTET GYNECOL, V151, P777, DOI 10.1016/0002-9378(85)90518-6; Kluckow M, 2000, ARCH DIS CHILD-FETAL, V82, pF188, DOI 10.1136/fn.82.3.F188; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Lumbers ER, 2005, AM J PHYSIOL-REG I, V288, pR567, DOI 10.1152/ajpregu.00556.2004; Lumbers ER, 2009, AM J PHYSIOL-ENDOC M, V296, pE513, DOI 10.1152/ajpendo.90497.2008; Miller DR, 2009, J ANIM SCI, V87, P3167, DOI 10.2527/jas.2009-1825; Miller SL, 2012, REPROD FERT DEVELOP, V24, P753, DOI 10.1071/RD11143; Mizuno M, 2010, CIRC J, V74, P171, DOI 10.1253/circj.CJ-09-0311; MOISE AA, 1995, PEDIATRICS, V95, P845; Newnham J P, 2001, Semin Neonatol, V6, P285, DOI 10.1053/siny.2001.0064; Osborn DA, 2003, PEDIATRICS, V112, P33, DOI 10.1542/peds.112.1.33; Osborn DA, 2007, PEDIATRICS, V120, P372, DOI 10.1542/peds.2006-3398; Quaedackers JS, 2005, BJOG-INT J OBSTET GY, V112, P182, DOI 10.1111/j.1471-0528.2004.00344.x; Rodriguez AG, 2013, INTEGR BIOL-UK, V5, P1366, DOI 10.1039/c3ib40135a; Rudolph AM, 2000, ACTA PAEDIATR, V89, P129, DOI 10.1080/080352500750028681; Rudy DE, 2001, DEV DYNAM, V221, P61, DOI 10.1002/dvdy.1125; SCHMID G, 1985, VIRCHOWS ARCH B, V48, P59, DOI 10.1007/BF02890115; Seri I, 2001, Semin Neonatol, V6, P85, DOI 10.1053/siny.2000.0034; Skelton R, 1998, ARCH DIS CHILD-FETAL, V78, pF133, DOI 10.1136/fn.78.2.F133; SMOLICH JJ, 1995, REPROD FERT DEVELOP, V7, P451, DOI 10.1071/RD9950451; Stark MJ, 2009, AM J PHYSIOL-REG I, V297, pR510, DOI 10.1152/ajpregu.00175.2009; Stevenson DK, 2000, ARCH DIS CHILD-FETAL, V83, pF182, DOI 10.1136/fn.83.3.F182; Tracy RE, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/658958; Vural M, 2006, ARCH DIS CHILD-FETAL, V91, pF118, DOI 10.1136/adc.2005.084525; ZAK R, 1974, CIRC RES, V35, P17; Zecca E, 2001, J CLIN PHARMACOL, V41, P1075, DOI 10.1177/00912700122012670	53	39	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93407	10.1371/journal.pone.0093407	http://dx.doi.org/10.1371/journal.pone.0093407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676209	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500119
J	Kraft, CE; Gordon, ERL; Angert, ER				Kraft, Clifford E.; Gordon, Eric R. L.; Angert, Esther R.			A Rapid Method for Assaying Thiaminase I Activity in Diverse Biological Samples	PLOS ONE			English	Article							DEFICIENCY; FISH; THIAMINOLYTICUS; IDENTIFICATION; INACTIVATION; SALVAGE; SHEEP; CARP	Vitamin B-1 (thiamine) deficiencies can lead to neurological disorders, reproductive failure and death in wild and domestic animal populations. In some cases, disease is brought about by the consumption of foods high in thiaminase I activity. Levels of thiaminase activity in these foods are highly variable and the factors leading to production of this enzyme are poorly understood. Here we describe improvements in a spectrophotometric thiaminase I activity assay that measures the disappearance of 4-nitrothiophenol, a favored nucleophile co-substrate that replaces the thiazole portion of thiamine during the inactivation of thiamine by the enzyme. Scalable sample processing protocols and a 96-well microtiter plate format are presented that allow the rapid evaluation of multiple, replicated samples in the course of only a few hours. Observed levels of activity in bacterial culture supernatant, fish, ferns and molluscs using this colorimetric assay were similar to previously published reports that employed a radiometric method. Organisms devoid of thiaminase I, based upon previous work, showed no activity with this assay. In addition, activity was found in a variety of fishes and one fern species from which this enzyme had not previously been reported. Overall, we demonstrate the suitability of this technique for measuring thiaminase I activity within small amounts of tissue and environmental samples with replication levels that were heretofore prohibitive. The assay provides a considerable improvement in the ability to examine and understand the properties of an enzyme that has a substantial influence on organism and ecosystem health.	[Kraft, Clifford E.] Cornell Univ, Dept Nat Resources, Ithaca, NY 14853 USA; [Gordon, Eric R. L.; Angert, Esther R.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Gordon, Eric R. L.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	Cornell University; Cornell University; University of California System; University of California Riverside	Kraft, CE (corresponding author), Cornell Univ, Dept Nat Resources, Fernow Hall, Ithaca, NY 14853 USA.	cek7@cornell.edu	Gordon, Eric/B-6154-2016	Gordon, Eric/0000-0002-5547-0953	Cornell University Agricultural Experiment Station federal formula funds [NYC-102400]	Cornell University Agricultural Experiment Station federal formula funds	This research was supported in part by the Cornell University Agricultural Experiment Station federal formula funds, Project No. NYC-102400). http://cuaes.cornell.edu/cals/cuaes/support/index.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arsan O. M, 1969, Gidrobiol. Zh., V5, P79; Balk L, 2009, P NATL ACAD SCI USA, V106, P12001, DOI 10.1073/pnas.0902903106; Bos M, 2000, J PROTEIN CHEM, V19, P75, DOI 10.1023/A:1007043530616; Brown SB, 2005, J AQUAT ANIM HEALTH, V17, P113, DOI 10.1577/H04-015.1; Campobasso N, 1998, BIOCHEMISTRY-US, V37, P15981, DOI 10.1021/bi981673l; Costello CA, 1996, J BIOL CHEM, V271, P3445, DOI 10.1074/jbc.271.7.3445; DEOLALKAR ST, 1954, NATURE, V173, P489, DOI 10.1038/173489a0; DOUTHIT HA, 1966, ARCH BIOCHEM BIOPHYS, V113, P331, DOI 10.1016/0003-9861(66)90194-9; EDWIN EE, 1970, NATURE, V228, P772, DOI 10.1038/228772a0; Evans W C, 1975, Vitam Horm, V33, P467; EVANS WC, 1976, BOT J LINN SOC, V73, P113, DOI 10.1111/j.1095-8339.1976.tb02017.x; Fisher Jeffrey P., 1995, Journal of Aquatic Animal Health, V7, P269, DOI 10.1577/1548-8667(1995)007&lt;0269:PABMOT&gt;2.3.CO;2; Fitzsimons JD, 2005, J AQUAT ANIM HEALTH, V17, P26, DOI 10.1577/H04-002.1; FUJITA A, 1954, ADV ENZYMOL REL S BI, V15, P389; FUJITA AKIJI, 1954, JOUR VITAMINOL, V1, P1; GREEN R. G., 1940, SCIENCE, V92, P154, DOI 10.1126/science.92.2381.154; Hanes JW, 2007, ANAL BIOCHEM, V368, P33, DOI 10.1016/j.ab.2007.06.001; Honeyfield DC, 2010, J GREAT LAKES RES, V36, P641, DOI 10.1016/j.jglr.2010.07.005; Honeyfield DC, 2005, J AQUAT ANIM HEALTH, V17, P1, DOI 10.1577/H04-012.1; Honeyfield DC, 2002, T AM FISH SOC, V131, P171, DOI 10.1577/1548-8659(2002)131&lt;0171:IOTPBF&gt;2.0.CO;2; Jenkins AH, 2007, NAT CHEM BIOL, V3, P492, DOI 10.1038/nchembio.2007.13; KENTEN RH, 1958, BIOCHEM J, V69, P439, DOI 10.1042/bj0690439; KIMURA R., 1953, Proceedings of the Japan Academy, V29, P132; Kimura R., 1965, REV JAPANESE LIT BER, P255; Krampitz LO, 1944, J BIOL CHEM, V152, P9; Kuno Y, 1951, P JPN ACAD, V27, P362, DOI [10.2183/pjab1945.27.362, DOI 10.2183/PJAB1945.27.362]; Lepak JM, 2008, J AQUAT ANIM HEALTH, V20, P63, DOI 10.1577/H07-026.1; MCCLEARY BV, 1977, PHYTOCHEMISTRY, V16, P207, DOI 10.1016/S0031-9422(00)86787-4; MOORE W. E. C., 1966, INT J SYST BACTERIOL, V16, P173; Newton AC, 2010, TRENDS MICROBIOL, V18, P365, DOI 10.1016/j.tim.2010.06.002; Onozuka M, 2008, FEMS YEAST RES, V8, P266, DOI 10.1111/j.1567-1364.2007.00333.x; OTTOSSON JG, 1983, BIOL J LINN SOC, V19, P305, DOI 10.1111/j.1095-8312.1983.tb00789.x; Ramos JJ, 2003, VET RES COMMUN, V27, P111, DOI 10.1023/A:1022807119539; Richter CA, 2012, CAN J FISH AQUAT SCI, V69, P1056, DOI [10.1139/F2012-043, 10.1139/f2012-043]; SATO M, 1994, COMP BIOCHEM PHYS A, V108, P31; Sealock RR, 1943, J AM CHEM SOC, V65, P935, DOI 10.1021/ja01245a046; Shimazono N, 1965, REV JAPANESE LIT BER; SHREEVE JE, 1974, VET REC, V94, P330, DOI 10.1136/vr.94.15.330; STOUT FM, 1963, NATURE, V197, P810, DOI 10.1038/197810a0; THOMAS KW, 1987, AUST VET J, V64, P126, DOI 10.1111/j.1751-0813.1987.tb09654.x; Tillitt DE, 2009, J GREAT LAKES RES, V35, P309, DOI 10.1016/j.jglr.2009.01.007; Toms AV, 2005, BIOCHEMISTRY-US, V44, P2319, DOI 10.1021/bi0478648; Wistbacka S, 2002, J FISH BIOL, V60, P1031, DOI 10.1006/jfbi.2002.1912; YUDKIN WH, 1949, PHYSIOL REV, V29, P389, DOI 10.1152/physrev.1949.29.4.389; Zajicek JL, 2005, J AQUAT ANIM HEALTH, V17, P82, DOI 10.1577/H03-083.1	45	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92688	10.1371/journal.pone.0092688	http://dx.doi.org/10.1371/journal.pone.0092688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675843	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500033
J	Perkins, MJ; McDonald, RA; van Veen, FJF; Kelly, SD; Rees, G; Bearhop, S				Perkins, Matthew J.; McDonald, Robbie A.; van Veen, F. J. Frank; Kelly, Simon D.; Rees, Gareth; Bearhop, Stuart			Application of Nitrogen and Carbon Stable Isotopes (delta N-15 and delta C-13) to Quantify Food Chain Length and Trophic Structure	PLOS ONE			English	Article							ECOSYSTEM SIZE; DIET; ENRICHMENT; POSITION; RATIOS; DISCRIMINATION; FRACTIONATION; DISTURBANCE; QUALITY; STRESS	Increasingly, stable isotope ratios of nitrogen (delta N-15) and carbon (delta C-13) are used to quantify trophic structure, though relatively few studies have tested accuracy of isotopic structural measures. For laboratory-raised and wild-collected plant-invertebrate food chains spanning four trophic levels we estimated nitrogen range (NR) using delta N-15, and carbon range (CR) using delta C-13, which are used to quantify food chain length and breadth of trophic resources respectively. Across a range of known food chain lengths we examined how NR and CR changed within and between food chains. Our isotopic estimates of structure are robust because they were calculated using resampling procedures that propagate variance in sample means through to quantified uncertainty in final estimates. To identify origins of uncertainty in estimates of NR and CR, we additionally examined variation in discrimination (which is change in delta N-15 or delta C-13 from source to consumer) between trophic levels and among food chains. delta N-15 discrimination showed significant enrichment, while variation in enrichment was species and system specific, ranged broadly (1.4% to 3.3%), and importantly, propagated variation to subsequent estimates of NR. However, NR proved robust to such variation and distinguished food chain length well, though some overlap between longer food chains infers a need for awareness of such limitations. delta C-13 discrimination was inconsistent; generally no change or small significant enrichment was observed. Consequently, estimates of CR changed little with increasing food chain length, showing the potential utility of delta C-13 as a tracer of energy pathways. This study serves as a robust test of isotopic quantification of food chain structure, and given global estimates of aquatic food chains approximate four trophic levels while many food chains include invertebrates, our use of four trophic level plant-invertebrate food chains makes our findings relevant for a majority of ecological systems.	[Perkins, Matthew J.; van Veen, F. J. Frank; Bearhop, Stuart] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England; [McDonald, Robbie A.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Kelly, Simon D.; Rees, Gareth] Food & Environm Res Agcy, York, Yorkshire, England	University of Exeter; University of Exeter; Food & Environment Research Agency	Perkins, MJ (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England.	matthewjperkins@outlook.com	Bearhop, Stuart/G-3105-2012; van Veen, Franciscus JF/H-2101-2013; McDonald, Robbie A/A-2931-2012; McDonald, Robbie/AAK-2718-2020	Bearhop, Stuart/0000-0002-5864-0129; McDonald, Robbie A/0000-0002-6922-3195; McDonald, Robbie/0000-0002-6922-3195; van Veen, Frank/0000-0003-0708-5492; Kelly, Simon/0000-0003-1034-1442	Food and Environment Research Agency, United Kingdom, under their Seedcorn Programme	Food and Environment Research Agency, United Kingdom, under their Seedcorn Programme	This research was funded by The Food and Environment Research Agency, United Kingdom, under their Seedcorn Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bunn SE, 2013, LIMNOL OCEANOGR, V58, P765, DOI 10.4319/lo.2013.58.3.0765; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Doi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037856; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jardine TD, 2006, ENVIRON SCI TECHNOL, V40, P7501, DOI 10.1021/es061263h; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Matthews B, 2004, OECOLOGIA, V140, P361, DOI 10.1007/s00442-004-1579-2; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McHugh PA, 2010, ECOL LETT, V13, P881, DOI 10.1111/j.1461-0248.2010.01484.x; Oelbermann K, 2002, OECOLOGIA, V130, P337, DOI 10.1007/s004420100813; Parnell A., 2008, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Perkins MJ, 2013, METHODS ECOL EVOL, V4, P944, DOI 10.1111/2041-210X.12098; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Price SA, 2012, P NATL ACAD SCI USA, V109, P7008, DOI 10.1073/pnas.1117133109; R Development Core Team, 2011, R LANG ENV STAT COMP; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Rooney N, 2012, TRENDS ECOL EVOL, V27, P40, DOI 10.1016/j.tree.2011.09.001; Schmidt SN, 2007, ECOLOGY, V88, P2793, DOI 10.1890/07-0121.1; Srivastava DS, 2009, ECOL LETT, V12, P1016, DOI 10.1111/j.1461-0248.2009.01357.x; Takimoto G, 2008, ECOLOGY, V89, P3001, DOI 10.1890/07-1990.1; Thompson RM, 2005, OIKOS, V108, P137, DOI 10.1111/j.0030-1299.2005.11600.x; Thompson RM, 2012, TRENDS ECOL EVOL, V27, P689, DOI 10.1016/j.tree.2012.08.005; Vander Zanden MJ, 2007, OIKOS, V116, P1378, DOI 10.1111/j.2007.0030-1299.16036.x; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Vander Zanden MJ, 1997, CAN J FISH AQUAT SCI, V54, P1142, DOI 10.1139/cjfas-54-5-1142; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Voigt CC, 2004, J EXP BIOL, V207, P1741, DOI 10.1242/jeb.00929; Wilson ACC, 2011, P NATL ACAD SCI USA, V108, P10220, DOI 10.1073/pnas.1007065108	40	75	75	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93281	10.1371/journal.pone.0093281	http://dx.doi.org/10.1371/journal.pone.0093281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676331	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000333677500102
J	Sargeant, DP; Hedden, MW; Deverasetty, S; Strong, CL; Alaniz, IJ; Bartlett, AN; Brandon, NR; Brooks, SB; Brown, FA; Bufi, F; Chakarova, M; David, RP; Dobritch, KM; Guerra, HP; Levit, KS; Mathew, KR; Matti, R; Maza, DQ; Mistry, S; Novakovic, N; Pomerantz, A; Rafalski, TF; Rathnayake, V; Rezapour, N; Ross, CA; Schooler, SG; Songao, S; Tuggle, SL; Wing, HJ; Yousif, S; Schiller, MR				Sargeant, David P.; Hedden, Michael W.; Deverasetty, Sandeep; Strong, Christy L.; Alaniz, Izua J.; Bartlett, Alexandria N.; Brandon, Nicholas R.; Brooks, Steven B.; Brown, Frederick A.; Bufi, Flaviona; Chakarova, Monika; David, Roxanne P.; Dobritch, Karlyn M.; Guerra, Horacio P.; Levit, Kelvy S.; Mathew, Kiran R.; Matti, Ray; Maza, Dorothea Q.; Mistry, Sabyasachy; Novakovic, Nemanja; Pomerantz, Austin; Rafalski, Timothy F.; Rathnayake, Viraj; Rezapour, Noura; Ross, Christian A.; Schooler, Steve G.; Songao, Sarah; Tuggle, Sean L.; Wing, Helen J.; Yousif, Sandy; Schiller, Martin R.			The Geogenomic Mutational Atlas of Pathogens (GoMAP) Web System	PLOS ONE			English	Article							DRUG-RESISTANCE; HIV-1 PROTEASE; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL DRUGS; CROSS-RESISTANCE; NORTH-AMERICA; AMPRENAVIR; SUSCEPTIBILITY; ATAZANAVIR; PREVALENCE	We present a new approach for pathogen surveillance we call Geogenomics. Geogenomics examines the geographic distribution of the genomes of pathogens, with a particular emphasis on those mutations that give rise to drug resistance. We engineered a new web system called Geogenomic Mutational Atlas of Pathogens (GoMAP) that enables investigation of the global distribution of individual drug resistance mutations. As a test case we examined mutations associated with HIV resistance to FDA-approved antiretroviral drugs. GoMAP-HIV makes use of existing public drug resistance and HIV protein sequence data to examine the distribution of 872 drug resistance mutations in similar to 502,000 sequences for many countries in the world. We also implemented a broadened classification scheme for HIV drug resistance mutations. Several patterns for geographic distributions of resistance mutations were identified by visual mining using this web tool. GoMAP-HIV is an open access web application available at http://www.bio-toolkit.com/GoMap/project/	[Sargeant, David P.; Hedden, Michael W.; Deverasetty, Sandeep; Strong, Christy L.; Alaniz, Izua J.; Bartlett, Alexandria N.; Brandon, Nicholas R.; Brooks, Steven B.; Brown, Frederick A.; Bufi, Flaviona; Chakarova, Monika; David, Roxanne P.; Dobritch, Karlyn M.; Guerra, Horacio P.; Levit, Kelvy S.; Mathew, Kiran R.; Matti, Ray; Maza, Dorothea Q.; Mistry, Sabyasachy; Novakovic, Nemanja; Pomerantz, Austin; Rafalski, Timothy F.; Rathnayake, Viraj; Rezapour, Noura; Ross, Christian A.; Schooler, Steve G.; Songao, Sarah; Tuggle, Sean L.; Wing, Helen J.; Yousif, Sandy; Schiller, Martin R.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Schiller, MR (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	martin.schiller@unlv.edu		Wing, Helen J./0000-0003-0123-5568; Novakovic, Nemanja/0000-0002-1681-7715; Schiller, Martin R/0000-0003-1671-6823	National Institutes of Health [AI078708, DK078735, RR027140, GM07689]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health [AI078708, DK078735, RR027140, and GM07689]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvieux C, 2005, DRUGS, V65, P633, DOI 10.2165/00003495-200565050-00005; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Bandaranayake RM, 2010, J VIROL, V84, P9995, DOI 10.1128/JVI.00505-10; Blaise P, 2002, ACTA CLIN BELG, V57, P191, DOI 10.1179/acb.2002.041; Brownstein JS, 2010, NEW ENGL J MED, V362, P1731, DOI 10.1056/NEJMsr1002707; CBN: IUPAC-IUB Commission on Biochemical Nomenclature (CBN), 1970, BIOCHEM J, V120, P449; Chan Philip A., 2009, HIV Therapy, V3, P447, DOI [10.2217/hiv.09.30, 10.2217/HIV.09.30]; Colonno R, 2004, J INFECT DIS, V189, P1802, DOI 10.1086/386291; Cunyat F, 2010, ANTIVIR THER, V15, P431, DOI 10.3851/IMP1543; de Mendoza C, 2006, AIDS, V20, P1071, DOI 10.1097/01.aids.0000222084.44411.cc; Diallo K, 2003, ANTIMICROB AGENTS CH, V47, P2376, DOI 10.1128/AAC.47.7.2376-2379.2003; Gatanaga H, 2002, J BIOL CHEM, V277, P5952, DOI 10.1074/jbc.M108005200; Geretti AM, 2007, CURR OPIN INFECT DIS, V20, P22, DOI 10.1097/QCO.0b013e328013caff; Jain R, 2006, CURR PHARM DESIGN, V12, P1065, DOI 10.2174/138161206776055813; Janies DA, 2011, CLADISTICS, V27, P61, DOI 10.1111/j.1096-0031.2010.00314.x; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Kagan R, 2004, AIDS RES HUM RETROV, V20, P1, DOI 10.1089/088922204322749440; Lam E, 2003, CLIN INFECT DIS, V37, P1273, DOI 10.1086/378894; LEITNER T, 2005, HIV SEQUENCE COMPEND; Maguire M, 2002, ANTIMICROB AGENTS CH, V46, P731, DOI 10.1128/AAC.46.3.731-738.2002; Marcelin AG, 2004, J MED VIROL, V74, P16, DOI 10.1002/jmv.20140; Masquelier B, 2005, J MED VIROL, V76, P441, DOI 10.1002/jmv.20380; Menzo S, 2004, ANTIMICROB AGENTS CH, V48, P3253, DOI 10.1128/AAC.48.9.3253-3259.2004; PARKER MT, 1964, POSTGRAD MED J, VS 40, P170, DOI 10.1136/pgmj.40.Suppl.170; PARTALEDIS JA, 1995, J VIROL, V69, P5228, DOI 10.1128/JVI.69.9.5228-5235.1995; Pillay D, 2004, ANTIVIR THER, V9, P695; Prado JG, 2002, AIDS, V16, P1009, DOI 10.1097/00002030-200205030-00007; Rahim S, 2009, HIV CLIN TRIALS, V10, P94, DOI 10.1310/hct1002-94; Sargeant D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020122; Schmidt B, 2000, ANTIMICROB AGENTS CH, V44, P3213, DOI 10.1128/AAC.44.11.3213-3216.2000; Shafer RW, 2002, CLIN MICROBIOL REV, V15, P247, DOI 10.1128/CMR.15.2.247-277.2002; Shekelle Paul, 2007, Evid Rep Technol Assess (Full Rep), P1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sista P, 2008, J CLIN VIROL, V42, P405, DOI 10.1016/j.jcv.2008.03.023; Spira S, 2003, J ANTIMICROB CHEMOTH, V51, P229, DOI 10.1093/jac/dkg079; Tanne JH, 2006, BRIT MED J, V332, P1289, DOI 10.1136/bmj.332.7553.1289; Vyas J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp616; Yanchunas J, 2005, ANTIMICROB AGENTS CH, V49, P3825, DOI 10.1128/AAC.49.9.3825-3832.2005; Young TP, 2010, ANTIMICROB AGENTS CH, V54, P4903, DOI 10.1128/AAC.00906-10	39	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92877	10.1371/journal.pone.0092877	http://dx.doi.org/10.1371/journal.pone.0092877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675726	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500048
J	Katikireddi, SV; Hilton, S; Bonell, C; Bond, L				Katikireddi, Srinivasa Vittal; Hilton, Shona; Bonell, Chris; Bond, Lyndal			Understanding the Development of Minimum Unit Pricing of Alcohol in Scotland: A Qualitative Study of the Policy Process	PLOS ONE			English	Article							PUBLIC-HEALTH; KNOWLEDGE TRANSFER; DRINKING; IDEAS; INEQUALITIES; DEVOLUTION; DRINKERS; BRITAIN; ENGLAND; WORLD	Background: Minimum unit pricing of alcohol is a novel public health policy with the potential to improve population health and reduce health inequalities. Theories of the policy process may help to understand the development of policy innovation and in turn identify lessons for future public health research and practice. This study aims to explain minimum unit pricing's development by taking a 'multiple-lenses' approach to understanding the policy process. In particular, we apply three perspectives of the policy process (Kingdon's multiple streams, Punctuated-Equilibrium Theory, Multi-Level Governance) to understand how and why minimum unit pricing has developed in Scotland and describe implications for efforts to develop evidence-informed policymaking. Methods: Semi-structured interviews were conducted with policy actors (politicians, civil servants, academics, advocates, industry representatives) involved in the development of MUP (n = 36). Interviewees were asked about the policy process and the role of evidence in policy development. Data from two other sources (a review of policy documents and an analysis of evidence submission documents to the Scottish Parliament) were used for triangulation. Findings: The three perspectives provide complementary understandings of the policy process. Evidence has played an important role in presenting the policy issue of alcohol as a problem requiring action. Scotland-specific data and a change in the policy 'image' to a population-based problem contributed to making alcohol-related harms a priority for action. The limited powers of Scottish Government help explain the type of price intervention pursued while distinct aspects of the Scottish political climate favoured the pursuit of price-based interventions. Conclusions: Evidence has played a crucial but complex role in the development of an innovative policy. Utilising different political science theories helps explain different aspects of the policy process, with Multi-Level Governance particularly useful for highlighting important lessons for the future of public health policy.	[Katikireddi, Srinivasa Vittal; Hilton, Shona; Bond, Lyndal] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Katikireddi, Srinivasa Vittal] NHS Lothian, Dept Publ Hlth & Policy, Edinburgh, Midlothian, Scotland; [Bonell, Chris] Univ Oxford, Dept Social Policy & Intervent, Oxford, England; [Bond, Lyndal] Ctr Excellence Intervent & Prevent Sci, Melbourne, Vic, Australia	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Oxford	Katikireddi, SV (corresponding author), Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.	srinivasa.katikireddi@glasgow.ac.uk		BOND, LYNDAL/0000-0003-1693-5508; Katikireddi, Srinivasa/0000-0001-6593-9092; Hilton, Shona/0000-0003-0633-8152	Chief Scientist Office at the Scottish Health Directorates as part of the Evaluating Social Interventions programme at the MRC/CSO Social and Public Health Sciences Unit [25605200 68093]; Medical Research Council as part of the Understandings and Uses of Public Health Research programme [25605200 68096]; MRC [MC_UU_12017/6, MC_U130085862, MC_UU_12017/4] Funding Source: UKRI; Medical Research Council [MC_U130085862, MC_UU_12017/4, MC_UU_12017/6] Funding Source: researchfish; Chief Scientist Office [SPHSU1] Funding Source: researchfish	Chief Scientist Office at the Scottish Health Directorates as part of the Evaluating Social Interventions programme at the MRC/CSO Social and Public Health Sciences Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council as part of the Understandings and Uses of Public Health Research programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This study received no specific funding. At the time of the research SVK and LB were funded by the Chief Scientist Office at the Scottish Health Directorates as part of the Evaluating Social Interventions programme at the MRC/CSO Social and Public Health Sciences Unit (25605200 68093). SH is funded by the Medical Research Council as part of the Understandings and Uses of Public Health Research programme (25605200 68096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Academy of Medical Sciences (AMS), 2004, CALL TIM NAT DRINK M; B, 2011, BBC NEWS; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Baggott R, 2011, PUBLIC HLTH POLICY P, V2nd; Bambra C, 2010, J PUBLIC HEALTH-UK, V32, P496, DOI 10.1093/pubmed/fdq028; Banche I., 2004, PUBLIC POLICY ADMIN, V19, P31, DOI [DOI 10.1177/095207670401900103, 10.1177/095207670401900103]; Baumgartner FR, 2006, J EUR PUBLIC POLICY, V13, P959, DOI 10.1080/13501760600923805; Baumgartner FrankR., 1993, AGENDAS INSTABILITY; BBC News, 2013, BBC NEWS; Beeston C, 2011, MONITORING EVALUATIN; Bennetts R., 2008, IAS BRIEFING PAPER U; Berridge V., 2005, TEMPERANCE ITS HIST; Black H, 2011, ADDICTION, V106, P729, DOI 10.1111/j.1360-0443.2010.03225.x; Black J, 2008, REGUL GOV, V2, P137, DOI 10.1111/j.1748-5991.2008.00034.x; Bloor M, 2013, SCI PUBLIC POLICY; Blyth M, 2001, WORLD POLIT, V54, P1, DOI 10.1353/wp.2001.0020; Booth A., 2008, INDEPENDENT REV EFFE; Brennan A., 2008, INDEPENDENT REV EFFE; Cabinet Office, 2003, GREEN BOOK APPR EV C; Cabinet Office, 1999, PROF POL 21 CENT REP; Cairney P., 2007, BRIT POLIT, V2, P45, DOI DOI 10.1057/PALGRAVE.BP.4200061; Cairney P., 2011, ALL POINTS N SCOTTIS; Cairney P, 2008, BRIT POLIT, V3, P350, DOI 10.1057/bp.2008.15; Cairney Paul., 2007, BRIT J POLIT INT REL, V9, P73, DOI DOI 10.1111/J.1467-856X.2007.00259.X; CAPLAN N, 1979, AM BEHAV SCI, V22, P459, DOI 10.1177/000276427902200308; Chief Medical Officer, 2008, HLTH SCOTL 2007 ANN; Davies H, 2008, J HEALTH SERV RES PO, V13, P188, DOI 10.1258/jhsrp.2008.008055; Exworthy M, 2002, POLICY POLIT, V30, P79, DOI 10.1332/0305573022501584; Gillan E, 2007, ALCOHOL PRICE POLICY; Gillan E, 2008, INFLUENCING FAMILY P; Glaser B. G., 2009, DISCOVERY GROUNDED T; Greer SL, 2009, STATE NATIONS 2008 3, P167; Hajer M, 2003, POLICY SCI, V36, P175, DOI 10.1023/A:1024834510939; Health and Sport Committee, 2010, 5 HLTH SPORT COMM SC; Hexagon Research and Consulting, 2009, AN RESP CONS SCOTT G; Hill M., 2013, PUBLIC POLICY PROCES, Vsixth; Hilton S, 2014, SOC SCI MED, V102, P157, DOI 10.1016/j.socscimed.2013.11.041; HM Government, 2012, GOV ALC STRAT; Hogwood B., 1984, POLICY ANAL REAL WOR; Holden C., 2012, PUBLIC POLICY ADMIN, V28, P253, DOI DOI 10.1177/0952076712452290; Holloway SL, 2008, T I BRIT GEOGR, V33, P532, DOI 10.1111/j.1475-5661.2008.00322.x; Hooghe L, 2003, AM POLIT SCI REV, V97, P233; House of Commons Health Committee, 2009, 1 HOUS COMM HLTH COM, V1; Innvaer Simon, 2002, J Health Serv Res Policy, V7, P239, DOI 10.1258/135581902320432778; ISD, 2009, ALC STAT SCOTL 2009; Katikireddi S. V., 2013, RELATIONSHIP EVIDENC; Katikireddi SV, 2014, EUR J PUBLIC HEALTH, V24, P490, DOI 10.1093/eurpub/ckt206; Katikireddi SV, 2012, EUR J PUBLIC HEALTH, V22, P457, DOI 10.1093/eurpub/cks091; Katikireddi SV, 2014, STUDYING PUBLIC POLICY: AN INTERNATIONAL APPROACH, P240; Katikireddi SV, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7310; Katikireddi SV, 2014, MILBANK Q IN PRESS; Keating M, 2009, CAMB J REG ECON SOC, V2, P51, DOI 10.1093/cjres/rsn024; Kingdon J.W., 2010, AGENDAS ALTERNATIVES; Kouri D., 2009, EVID POLICY, V5, P71; Latour Bruno, 1987, SCI ACTION FOLLOW SC; Lavis JN, 2003, MILBANK Q, V81, P221, DOI 10.1111/1468-0009.t01-1-00052; Lavis JN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000141; Leon DA, 2006, LANCET, V367, P52, DOI 10.1016/S0140-6736(06)67924-5; Lomas J, 2007, BRIT MED J, V334, P129, DOI 10.1136/bmj.39038.593380.AE; LUDBROOK A, 2001, EFFECTIVE COST EFFEC; Ludbrook A, 2008, MINIMUM PRICING ALCO; Marsh D, 2009, POLICY STUD-UK, V30, P269, DOI 10.1080/01442870902863851; Mason J., 2018, QUALITATIVE RES; Mitton C, 2007, MILBANK Q, V85, P729, DOI 10.1111/j.1468-0009.2007.00506.x; Moore SC, 2010, ALCOHOL ALCOHOLISM, V45, P403, DOI 10.1093/alcalc/agq048; NHS Health Scotland, 2012, ALC TOOLS BACKGR; NHS Health Scotland, 2008, ALC LOG MOD 1 STRAT; O'Donnell BA, 2006, INT J DRUG POLICY, V17, P367, DOI 10.1016/j.drugpo.2006.01.006; Ogilvie D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-116; Osborne T, 2004, ECON SOC, V33, P430, DOI 10.1080/0308514042000285224; Pollack MA, 2005, ANNU REV POLIT SCI, V8, P357, DOI 10.1146/annurev.polisci.8.082103.104858; Purshouse R, 2009, MODEL BASED APPRAISA; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Read B, 2008, ALC026 U SHEFF; Record C, 2009, CLIN MED, V9, P421, DOI 10.7861/clinmedicine.9-5-421; Rice P, 2012, BRIT J PSYCHIAT, V201, P169, DOI 10.1192/bjp.bp.111.105601; ROBINSON M, 2010, MONITORING EVALUATIN; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Sabatier PA, 2007, THEORIES POLICY PROC; Sanderson I, 2009, POLIT STUD-LONDON, V57, P699, DOI 10.1111/j.1467-9248.2009.00791.x; Scotch Whisky Association, 2012, SCOTCH WHISK IND CHA; Scottish Executive, 2002, PLAN ACT ALC PROBL; Scottish Government, 2008, CHANG SCOTL REL ALC; Scottish National Party, 2007, MAN 2007; Scottish National Party, 2011, MAN 2011 REEL SCOTT; SHAAP, 2012, SCOTT HLTH ACT ALC P; Smith K., 2008, HLTH INEQUALITIES SC; Smith KE, 2007, SOC SCI MED, V64, P1438, DOI 10.1016/j.socscimed.2006.11.008; Smith KE, 2013, J EPIDEMIOL COMMUN H, V67, P198, DOI 10.1136/jech-2012-200990; Stockwell T, 2006, ALCOHOL PRICING PUBL; Stockwell T, 2012, AM J PUBLIC HLTH, V102, P10; Stockwell T, 2012, ADDICTION, V107, P912, DOI 10.1111/j.1360-0443.2011.03763.x; The Scottish Government, 2009, CHANG SCOTL REL ALC; True JL, 2007, THEORIES POLICY PROC, P144; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; WEISS CH, 1979, PUBLIC ADMIN REV, V39, P426, DOI 10.2307/3109916; Wells S, 2009, ADDICTION, V104, P4, DOI 10.1111/j.1360-0443.2008.02393.x; Wood K, 2014, ADDICTION, V109, P578, DOI 10.1111/add.12427; Yin RK, 2014, CASE STUDY RES DESIG, P133	99	47	47	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91185	10.1371/journal.pone.0091185	http://dx.doi.org/10.1371/journal.pone.0091185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24670519	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000333677000017
J	Wen, P; Ji, BZ; Sillam-Dusses, D				Wen, Ping; Ji, Bao-Zhong; Sillam-Dusses, David			Trail Communication Regulated by Two Trail Pheromone Components in the Fungus-Growing Termite Odontotermes formosanus (Shiraki)	PLOS ONE			English	Article							SUBTERRANEAN TERMITE; NASUTITERMES-COSTALIS; TRINERVITERMES-TRINERVOIDES; RETICULITERMES-SANTONENSIS; HARVESTER TERMITE; VIBRATION SIGNALS; FEYTAUD ISOPTERA; SEX-PHEROMONES; RHINOTERMITIDAE; ORIENTATION	The eusocial termites are well accomplished in chemical communication, but how they achieve the communication using trace amount of no more than two pheromone components is mostly unknown. In this study, the foraging process and trail pheromones of the fungus-growing termite Odontotermes formosanus (Shiraki) were systematically studied and monitored in real-time using a combination of techniques, including video analysis, solid-phase microextraction, gas chromatography coupled with either mass spectrometry or an electroantennographic detector, and bioassays. The trail pheromone components in foraging workers were (3Z)-dodec-3-en-1-ol and (3Z,6Z)-dodeca-3,6-dien-1-ol secreted by their sternal glands. Interestingly, ratio of the two components changed according to the behaviors that the termites were displaying. This situation only occurs in termites whereas ratios of pheromone components are fixed and species-specific for other insect cuticular glands. Moreover, in bioassays, the active thresholds of the two components ranged from 1 fg/cm to 10 pg/cm according to the behavioral contexts or the pheromonal exposure of tested workers. The two components did not act in synergy. (3Z)-Dodec-3-en-1-ol induced orientation behavior of termites that explore their environment, whereas (3Z,6Z)dodeca-3,6-dien-1-ol had both an orientation effect and a recruitment effect when food was discovered. The trail pheromone of O. formosanus was regulated both quantitatively by the increasing number of workers involved in the early phases of foraging process, and qualitatively by the change in ratio of the two pheromone components on sternal glandular cuticle in the food-collecting workers. In bioassays, the responses of workers to the pheromone were also affected by the variation in pheromone concentration and component ratio in the microenvironment. Thus, this termite could exchange more information with nestmates using the traces of the two trail pheromone components that can be easily regulated within a limited microenvironment formed by the tunnels or chambers.	[Wen, Ping; Ji, Bao-Zhong] Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China; [Sillam-Dusses, David] IRD, UMR BIOEMCO IBIOS 211, Bondy, France; [Sillam-Dusses, David] Univ Paris 13, Sorbonne Paris Cite, LEEC, EA4443, F-93430 Villetaneuse, France; [Wen, Ping] Jiangsu Agrochem Lab, Changzhou, Peoples R China; [Wen, Ping] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Nanjing Forestry University; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paris 13; Zhejiang University	Ji, BZ (corresponding author), Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing, Jiangsu, Peoples R China.	jbz9885@njfu.edu.cn	Wen, Ping/V-6685-2019; Sillam-Dussès, David/AAI-5942-2021	Wen, Ping/0000-0002-6759-7097; Sillam-Dusses, David/0000-0001-5027-8703	Specialized Research Fund for the Doctoral Program of Higher Education [20123204110001]; Natural Science Foundation of Jiangsu Province, China [BK2012816]; Natural Science Foundation for Young Scientists of Jiangsu Province, China [BK20130257]; Priority Academic Program Development of Jiangsu Higher Education Institutions [PAPD 164010641]; Funding Project of Nanjing Municipal Construction Bureau; Management Office of Dr. Sun Yat-Sen's Mausoleum [200409]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Natural Science Foundation for Young Scientists of Jiangsu Province, China; Priority Academic Program Development of Jiangsu Higher Education Institutions; Funding Project of Nanjing Municipal Construction Bureau; Management Office of Dr. Sun Yat-Sen's Mausoleum	This work was supported by the Specialized Research Fund for the Doctoral Program of Higher Education (grant 20123204110001) in China, the Natural Science Foundation of Jiangsu Province, China (grant BK2012816), the Natural Science Foundation for Young Scientists of Jiangsu Province, China (grant BK20130257), the Priority Academic Program Development of Jiangsu Higher Education Institutions (grant PAPD 164010641), and the Funding Project of Nanjing Municipal Construction Bureau & the Management Office of Dr. Sun Yat-Sen's Mausoleum (grant 200409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T., 1987, P125; Adam RA, 2008, AFR ENTOMOL, V16, P153, DOI 10.4001/1021-3589-16.2.153; Affolter J, 2000, INSECT SOC, V47, P256, DOI 10.1007/PL00001712; Arab Alberto, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/806782; Bordereau C, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P279, DOI 10.1007/978-90-481-3977-4_11; Bordereau C, 2010, BIOL J LINN SOC, V100, P519, DOI 10.1111/j.1095-8312.2010.01446.x; Casarin FE, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.0201; Cheng ML, 2007, SOCIOBIOLOGY, V50, P45; CORK A, 1992, J CHEM ECOL, V18, P403, DOI 10.1007/BF00994240; Deng Xiao-Jun, 2002, Acta Entomologica Sinica, V45, P739; DU TY, 1982, ACTA ENTOMOL SINICA, V25, P172; DUNKELBLUM E, 1980, PHYTOPARASITICA, V8, P209, DOI 10.1007/BF03158319; Evans TA, 2007, INSECT SOC, V54, P374, DOI 10.1007/s00040-007-0958-1; Evans TA, 2005, P NATL ACAD SCI USA, V102, P3732, DOI 10.1073/pnas.0408649102; Gessner S, 2001, INSECT SOC, V48, P238, DOI 10.1007/PL00001772; GRACE JK, 1988, J CHEM ECOL, V14, P653, DOI 10.1007/BF01013913; GRACE JK, 1989, SOCIOBIOLOGY, V16, P175; HALL P, 1985, J CHEM ECOL, V11, P1503, DOI 10.1007/BF01012196; HOLLDOBLER B, 1995, P NATL ACAD SCI USA, V92, P19, DOI 10.1073/pnas.92.1.19; Hu J, 2006, SOCIOBIOLOGY, V48, P661; Hu J, 2012, COMP BIOCHEM PHYS A, V161, P201, DOI 10.1016/j.cbpa.2011.10.028; Huang QY, 2006, STUDY FORAGING BEHAV; Inta R, 2009, J ECON ENTOMOL, V102, P121, DOI 10.1603/029.102.0117; KLUN JA, 1975, ENVIRON ENTOMOL, V4, P891, DOI 10.1093/ee/4.6.891; Lee SH, 2007, BIOSYSTEMS, V90, P802, DOI 10.1016/j.biosystems.2007.04.004; LEUTHOLD RH, 1976, BEHAV ECOL SOCIOBIOL, V1, P127, DOI 10.1007/BF00299194; LEUTHOLD RH, 1974, INSECT SOC, V21, P335, DOI 10.1007/BF02331563; Miura T, 1998, INSECT SOC, V45, P17, DOI 10.1007/s000400050065; Miura T, 1998, J INSECT BEHAV, V11, P179, DOI 10.1023/A:1021039722402; Peppuy A, 2001, INSECT SOC, V48, P245, DOI 10.1007/PL00001773; Reinhard J, 1997, INSECT SOC, V44, P147, DOI 10.1007/s000400050037; Reinhard J, 2001, J INSECT BEHAV, V14, P157, DOI 10.1023/A:1007881510237; Roonwal ML, 1975, J APPL ENTOMOL, V78, P424; RUNCIE CD, 1987, J CHEM ECOL, V13, P1967, DOI 10.1007/BF01014679; Saran RK, 2007, J CHEM ECOL, V33, P369, DOI 10.1007/s10886-006-9229-2; Sillam-Dusses D, 2005, CHEMOECOLOGY, V15, P1, DOI 10.1007/s00049-005-0285-9; Sillam-Dusses D, 2011, J CHEM ECOL, V37, P179, DOI 10.1007/s10886-011-9910-y; Sillam-Dusses D, 2010, BIOL J LINN SOC, V99, P20, DOI 10.1111/j.1095-8312.2009.01348.x; TRANIELLO JFA, 1985, J CHEM ECOL, V11, P319, DOI 10.1007/BF01411418; TRANIELLO JFA, 1982, NATURWISSENSCHAFTEN, V69, P343, DOI 10.1007/BF00480461; TRANIELLO JFA, 1981, P NATL ACAD SCI-BIOL, V78, P1976, DOI 10.1073/pnas.78.3.1976; TSCHINKE.WR, 1973, J INSECT PHYSIOL, V19, P707, DOI 10.1016/0022-1910(73)90079-6; Tschinkel WR, 2010, J INSECT SCI, V10; Wang J, 1999, BAI YI KE JI, V16, P26; Wen P, 2012, J CHEM ECOL, V38, P566, DOI 10.1007/s10886-012-0111-0	45	15	17	50	1662	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e90906	10.1371/journal.pone.0090906	http://dx.doi.org/10.1371/journal.pone.0090906			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670407	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000013
J	Gordon, O; He, ZH; Gilon, D; Gruener, S; Pietranico-Cole, S; Oppenheim, A; Keshet, E				Gordon, Oren; He, Zhiheng; Gilon, Dan; Gruener, Sabine; Pietranico-Cole, Sherrie; Oppenheim, Amit; Keshet, Eli			A Transgenic Platform for Testing Drugs Intended for Reversal of Cardiac Remodeling Identifies a Novel 11 beta HSD1 Inhibitor Rescuing Hypertrophy Independently of Re-Vascularization	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITION; ACTIVATED RECEPTOR-GAMMA; MYOCARDIAL-INFARCTION; HEART-FAILURE; DEHYDROGENASE TYPE-1; ANGIOGENESIS; DYSFUNCTION; MICE; EXPRESSION; AGONIST	Rationale: Rescuing adverse myocardial remodeling is an unmet clinical goal and, correspondingly, pharmacological means for its intended reversal are urgently needed. Objectives: To harness a newly-developed experimental model recapitulating progressive heart failure development for the discovery of new drugs capable of reversing adverse remodeling. Methods and Results: A VEGF-based conditional transgenic system was employed in which an induced perfusion deficit and a resultant compromised cardiac function lead to progressive remodeling and eventually heart failure. Ability of candidate drugs administered at sequential remodeling stages to reverse hypertrophy, enlarged LV size and improve cardiac function was monitored. Arguing for clinical relevance of the experimental system, clinically-used drugs operating on the Renin-Angiotensin-Aldosterone-System (RAAS), namely, the ACE inhibitor Enalapril and the direct renin inhibitor Aliskerin fully reversed remodeling. Remodeling reversal by these drugs was not accompanied by neovascularization and reached a point-of-no-return. Similarly, the PPAR gamma agonist Pioglitazone was proven capable of reversing all aspects of cardiac remodeling without affecting the vasculature. Extending the arsenal of remodeling-reversing drugs to pathways other than RAAS, a specific inhibitor of 11 beta-hydroxy-steroid dehydrogenase type 1 (11 beta HSD1), a key enzyme required for generating active glucocorticoids, fully rescued myocardial hypertrophy. This was associated with mitigating the hypertrophy-associated gene signature, including reversing the myosin heavy chain isoform switch but in a pattern distinguishable from that associated with neovascularization-induced reversal. Conclusions: A system was developed suitable for identifying novel remodeling-reversing drugs operating in different pathways and for gaining insights into their mechanisms of action, exemplified here by uncoupling their vascular affects.	[Gordon, Oren; He, Zhiheng; Keshet, Eli] Hebrew Univ Jerusalem, Hadassah Univ Hosp, Dept Dev Biol, Jerusalem, Israel; [Gordon, Oren; He, Zhiheng; Keshet, Eli] Hebrew Univ Jerusalem, Dept Canc Res, Hadassah Univ Hosp, Jerusalem, Israel; [Gilon, Dan; Oppenheim, Amit] Hebrew Univ Jerusalem, Dept Cardiol, Hadassah Univ Hosp, Jerusalem, Israel; [Gruener, Sabine; Pietranico-Cole, Sherrie] Hoffmann La Roche Pharmaceut, Dept Metab & Vasc Dis, Basel, Switzerland	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Roche Holding	Keshet, E (corresponding author), Hebrew Univ Jerusalem, Hadassah Univ Hosp, Dept Dev Biol, Jerusalem, Israel.	keshet@cc.huji.ac.il	Gordon, Oren/AAS-1246-2021; Gordon, Oren/GRJ-4372-2022; Keshet, Eli/GQR-0445-2022	Gordon, Oren/0000-0002-3159-8426; 	Israel Science Foundation (ISF); Hoffmann-La Roche Pharmaceuticals	Israel Science Foundation (ISF)(Israel Science Foundation); Hoffmann-La Roche Pharmaceuticals(Hoffmann-La Roche)	This study was supported by Israel Science Foundation (ISF) and partly funded by Hoffmann-La Roche Pharmaceuticals. Sabine Gruener, Sherrie Pietranico-Cole and Jacques Himber of Hoffmann-La Roche pharmaceuticals have contributed to the design and interpretation of some of the experiments detailed in this study, in particular for the novel 11HSD1 inhibitor. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Balakumar Pitchai, 2007, Journal of Pharmacological and Toxicological Methods, V56, P1, DOI 10.1016/j.vascn.2007.01.003; Brooks WW, 2009, COMPARATIVE MED, V59, P339; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Fedak PWM, 2005, CARDIOVASC PATHOL, V14, P1, DOI 10.1016/j.carpath.2004.12.002; Finck BN, 2007, CARDIOVASC RES, V73, P269, DOI 10.1016/j.cardiores.2006.08.023; Gordon O, 2012, VEGF INDUCED NEOVASC; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Koitabashi N, 2012, NAT REV CARDIOL, V9, P147, DOI 10.1038/nrcardio.2011.172; Li L, 2011, CARDIOVASC RES, V91, P80, DOI 10.1093/cvr/cvr067; Lister K, 2006, CARDIOVASC RES, V70, P555, DOI 10.1016/j.cardiores.2006.02.010; Lopez-Sendon J, 2004, EUR HEART J, V25, P1454, DOI 10.1016/j.ehj.2004.06.003; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; May D, 2008, P NATL ACAD SCI USA, V105, P282, DOI 10.1073/pnas.0707778105; McSweeney SJ, 2010, CARDIOVASC RES, V88, P159, DOI 10.1093/cvr/cvq149; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; PFEFFER JM, 1995, ANNU REV PHYSIOL, V57, P805, DOI 10.1146/annurev.ph.57.030195.004105; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiomi T, 2002, CIRCULATION, V106, P3126, DOI 10.1161/01.CIR.0000039346.31538.2C; Small GR, 2005, P NATL ACAD SCI USA, V102, P12165, DOI 10.1073/pnas.0500641102; Solomon SD, 2011, EUR HEART J, V32, P1227, DOI 10.1093/eurheartj/ehq522; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Tamargo J, 2011, NAT REV DRUG DISCOV, V10, P536, DOI 10.1038/nrd3431; Wamil M, 2007, DRUG DISCOV TODAY, V12, P504, DOI 10.1016/j.drudis.2007.06.001; Westermann D, 2008, HYPERTENSION, V52, P1068, DOI 10.1161/HYPERTENSIONAHA.108.116350; Yazawa H, 2011, J CARD FAIL, V17, P1041, DOI 10.1016/j.cardfail.2011.09.002; Yu ZH, 1996, CIRC RES, V79, P691, DOI 10.1161/01.RES.79.4.691; Zaragoza C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/497841; ZBINDEN G., 1963, REV CANADIENNE BIOL, V22, P257	33	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92869	10.1371/journal.pone.0092869	http://dx.doi.org/10.1371/journal.pone.0092869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667808	Green Submitted, gold, Green Published			2022-12-25	WOS:000333675600094
J	Taboas, M; Acuna, LG; Scaia, MF; Bruque, CD; Buzzalino, N; Stivel, M; Ceballos, NR; Dain, L				Taboas, Melisa; Gomez Acuna, Luciana; Florencia Scaia, Maria; Bruque, Carlos D.; Buzzalino, Noemi; Stivel, Mirta; Ceballos, Nora R.; Dain, Liliana			Functional Studies of p.R132C, p.R149C, p.M283V, p.E431K, and a Novel c.652-2A > G Mutations of the CYP21A2 Gene	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; STEROID 21-HYDROXYLASE DEFICIENCY; ENZYME-ACTIVITY; GENOTYPE; PHENOTYPE; IDENTIFICATION; ASSOCIATION; POPULATION; CONVERSION; DISEASE	Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is the most frequent inborn error of metabolism and accounts for 90-95% of CAH cases. In the present work, we analyzed the functional consequence of four novel previously reported point CYP21A2 mutations p.R132C, p.R149C, p.M283V, p.E431K-found in Argentinean 21-hydroxylase deficient patients. In addition, we report an acceptor splice site novel point mutation, c.652-2A>G, found in a classical patient in compound heterozygosity with the rare p.R483Q mutation. We performed bioinformatic and functional assays to evaluate the biological implication of the novel mutation. Our analyses revealed that the residual enzymatic activity of the isolated mutants coding for CYP21A2 aminoacidic substitutions was reduced to a lesser than 50% of the wild type with both progesterone and 17-OH progesterone as substrates. Accordingly, all the variants would predict mild non-classical alleles. In one non-classical patient, the p.E431K mutation was found in cis with the p.D322G one. The highest decrease in enzyme activity was obtained when both mutations were assayed in the same construction, with a residual activity most likely related to the simple virilizing form of the disease. For the c.652-2A>G mutation, bioinformatic tools predicted the putative use of two different cryptic splicing sites. Nevertheless, functional analyses revealed the use of only one cryptic splice acceptor site located within exon 6, leading to the appearance of an mRNA with a 16 nt deletion. A severe allele is strongly suggested due to the presence of a premature stop codon in the protein only 12 nt downstream.	[Taboas, Melisa; Bruque, Carlos D.; Buzzalino, Noemi; Dain, Liliana] ANLIS, Ctr Nacl Genet Med, Buenos Aires, DF, Argentina; [Taboas, Melisa; Bruque, Carlos D.; Dain, Liliana] Consejo Nacl Invest Cient & Tecn IBYME CONICET, Inst Biol & Med Expt, Buenos Aires, DF, Argentina; [Gomez Acuna, Luciana] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Fisiol Biol Mol & Neurociencias IFIBYNE, Buenos Aires, DF, Argentina; [Gomez Acuna, Luciana; Florencia Scaia, Maria; Ceballos, Nora R.] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Florencia Scaia, Maria; Ceballos, Nora R.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina; [Stivel, Mirta] Hosp Durand, Div Endocrinol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Dain, L (corresponding author), ANLIS, Ctr Nacl Genet Med, Buenos Aires, DF, Argentina.	ldain@fbmc.fcen.uba.ar	Scaia, Maria Florencia/L-2769-2015	Bruque, Carlos David/0000-0003-0726-5418; Scaia, Maria Florencia/0000-0003-4069-5567; DAIN, Liliana/0000-0002-2155-4999	ANPCYT [PICT 00208]; UBACYT [X059]; FOCANLIS	ANPCYT(ANPCyT); UBACYT; FOCANLIS	This work was supported by: ANPCYT, PICT 00208 (LD, www.foncyt.gov.ar), UBACYT X059 (LD, www.uba.ar) and FOCANLIS 2010 (LD www.anlis.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admoni O, 2006, CLIN ENDOCRINOL, V64, P645, DOI 10.1111/j.1365-2265.2006.02521.x; Bleicken C, 2009, HUM MUTAT, V30, pE443, DOI 10.1002/humu.20926; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chu XJ, 2014, CLIN ENDOCRINOL, V80, P927, DOI 10.1111/cen.12309; Dain LB, 2002, CLIN ENDOCRINOL, V56, P237; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dolzan V, 2005, EUR J ENDOCRINOL, V153, P99, DOI 10.1530/eje.1.01944; Dolzan V, 1999, EUR J ENDOCRINOL, V141, P132, DOI 10.1530/eje.0.1410132; DONOHOUE PA, 1986, J CLIN ENDOCR METAB, V62, P995, DOI 10.1210/jcem-62-5-995; Elisa A, 2002, J CLIN ENDOCR METAB, V87, P4314, DOI 10.1210/jc.2001-011939; Ezquieta B, 2002, ACTA PAEDIATR, V91, P892, DOI 10.1080/080352502760148595; Ghayee HK, 2011, J CLIN ENDOCR METAB, V96, pE243, DOI 10.1210/jc.2010-1222; Gomes LG, 2008, J CLIN ENDOCR METAB, V93, P2913, DOI 10.1210/jc.2008-0304; Haider S, 2013, P NATL ACAD SCI USA, V110, P2605, DOI 10.1073/pnas.1221133110; HIGASHI Y, 1988, AM J HUM GENET, V42, P17; Jaaskelainen J, 1997, J CLIN ENDOCR METAB, V82, P3293, DOI 10.1210/jc.82.10.3293; Krone N, 2000, J CLIN ENDOCR METAB, V85, P1059, DOI 10.1210/jc.85.3.1059; Krone N, 2005, J CLIN ENDOCR METAB, V90, P445, DOI 10.1210/jc.2004-0813; Lajic S, 1996, HUM GENET, V98, P182, DOI 10.1007/s004390050186; Lee HH, 1998, HUM GENET, V103, P304, DOI 10.1007/s004390050821; Lee HH, 2001, J ENDOCRINOL, V171, P397, DOI 10.1677/joe.0.1710397; Menassa R, 2008, J CLIN ENDOCR METAB, V93, P1901, DOI 10.1210/jc.2007-2701; Merke DP, 2005, LANCET, V365, P2125, DOI 10.1016/S0140-6736(05)66736-0; MILLER WL, 1994, J CLIN ENDOCR METAB, V78, P241, DOI 10.1210/jc.78.2.241; Minutolo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015899; Muro AF, 1999, MOL CELL BIOL, V19, P2657; New MI, 2013, P NATL ACAD SCI USA, V110, P2611, DOI 10.1073/pnas.1300057110; NEW MI, 1989, METABOLIC BASIS INHE, P1881; Nikoshkov A, 1997, J CLIN ENDOCR METAB, V82, P194, DOI 10.1210/jc.82.1.194; Nikoshkov A, 1998, J BIOL CHEM, V273, P6163, DOI 10.1074/jbc.273.11.6163; Nimkarn S, 1999, J CLIN ENDOCR METAB, V84, P378, DOI 10.1210/jc.84.1.378; Ono Makoto, 2008, Clin Pediatr Endocrinol, V17, P49, DOI 10.1297/cpe.17.49; Ordonez-Sanchez ML, 1998, HUM GENET, V102, P170, DOI 10.1007/s004390050672; OWERBACH D, 1992, J CLIN ENDOCR METAB, V74, P553, DOI 10.1210/jc.74.3.553; Pang Songya, 1997, Current Opinion in Pediatrics, V9, P419, DOI 10.1097/00008480-199708000-00018; Pasqualini T, 2007, MEDICINA-BUENOS AIRE, V67, P253; Robins T, 2007, J MOL MED, V85, P243, DOI 10.1007/s00109-006-0121-x; Robins T, 2006, MOL ENDOCRINOL, V20, P2946, DOI 10.1210/me.2006-0172; Soardi FC, 2008, J CLIN ENDOCR METAB, V93, P2416, DOI 10.1210/jc.2007-2594; Solari JJF, 2002, J COMP PHYSIOL B, V172, P685, DOI 10.1007/s00360-002-0296-6; Speiser PW, 2010, J CLIN ENDOCR METAB, V95, P4133, DOI 10.1210/jc.2009-2631; SPEISER PW, 1985, AM J HUM GENET, V37, P650; Stikkelbroeck NMML, 2003, J CLIN ENDOCR METAB, V88, P3852, DOI 10.1210/jc.2002-021681; Tardy V, 2010, J CLIN ENDOCR METAB, V95, P1288, DOI 10.1210/jc.2009-1202; Therrell BL, 2001, ENDOCRIN METAB CLIN, V30, P15, DOI 10.1016/S0889-8529(08)70017-3; TUSIELUNA MT, 1990, J BIOL CHEM, V265, P20916; van der Kamp HJ, 2004, EUR J ENDOCRINOL, V151, pU71, DOI 10.1530/eje.0.151U071; WEDELL A, 1993, HUM MOL GENET, V2, P499, DOI 10.1093/hmg/2.5.499; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111; WILSON RC, 1995, J CLIN ENDOCR METAB, V80, P2322, DOI 10.1210/jc.80.8.2322	52	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92181	10.1371/journal.pone.0092181	http://dx.doi.org/10.1371/journal.pone.0092181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667412	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600027
J	Vaccaro, A; Despas, F; Delmas, C; Lairez, O; Lambert, E; Lambert, G; Labrunee, M; Guiraud, T; Esler, M; Galinier, M; Senard, JM; Pathak, A				Vaccaro, Angelica; Despas, Fabien; Delmas, Clement; Lairez, Olivier; Lambert, Elisabeth; Lambert, Gavin; Labrunee, Marc; Guiraud, Thibaut; Esler, Murray; Galinier, Michel; Senard, Jean Michel; Pathak, Atul			Direct Evidences for Sympathetic Hyperactivity and Baroreflex Impairment in Tako Tsubo Cardiopathy	PLOS ONE			English	Article							APICAL BALLOONING SYNDROME; LEFT-VENTRICULAR DYSFUNCTION; CHRONIC HEART-FAILURE; TAKOTSUBO CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; CHEMOREFLEX ACTIVATION; CLINICAL-FEATURES; STRESS; CATECHOLAMINES; WOMEN	Background: The exact pathophysiology of Tako-Tsubo cardiomyopathy (TTC) remains unknown but a role for sympathetic hyperactivity has been suggested. Up to now, no direct evidence of sympathetic nerve hyperactivity has been established nor involvement of sympathetic baroreflex identified. The aim of our study was to determine, by direct sympathetic nerve activity (SNS) recording if sympathetic nervous system activity is increased and spontaneous baroreflex control of sympathetic activity reduced in patients with TTC. Methods: We included 13 patients who presented with TTC and compared their SNS activity and spontaneous baroreflex control of sympathetic activity with that of 13 control patients with acutely decompensated chronic heart failure. SNS activity was evaluated by microneurography, a technique assessing muscle sympathetic nerve activity (MSNA). Spontaneous baroreflex control of sympathetic activity was evaluated as the absolute value of the slope of the regression line representing the relationship between spontaneous diastolic blood pressure values and concomitant SNS activity. Control patients were matched for age, sex, left ventricular ejection fraction and creatinine clearance. Results: The mean age of the patients with TTC was 80 years, all patients were women. There were no significant differences between the two groups of patients for blood pressure, heart rate or oxygen saturation level. TTC patients presented a significant increase in sympathetic nerve activity (MSNA median 63.3 bursts/min [interquartile range 61.3 to 66.0] vs median 55.7 bursts/min [interquartile range 51.0 to 61.7]; p = 0.0089) and a decrease in spontaneous baroreflex control of sympathetic activity compared to matched control patients (spontaneous baroreflex control of sympathetic activity median 0.7%burst/mmHg [interquartile range 0.4 to 1.9] vs median 2.4%burst/mmHg [interquartile range 1.8 to 2.9]; p = 0.005). Conclusions: We report for the first time, through direct measurement of sympathetic nerve activity, that patients with TTC exhibit elevated SNS activity associated with a decrease in spontaneous baroreflex control of sympathetic activity. These data may explain the pathophysiology and clinical presentation of patient with TTC.	[Vaccaro, Angelica; Despas, Fabien; Delmas, Clement; Lairez, Olivier; Labrunee, Marc; Guiraud, Thibaut; Galinier, Michel; Senard, Jean Michel; Pathak, Atul] Inst Metab & Cardiovasc Dis, INSERM, UMR 1048, Toulouse, France; [Despas, Fabien; Lairez, Olivier; Labrunee, Marc; Guiraud, Thibaut; Galinier, Michel; Senard, Jean Michel; Pathak, Atul] Univ Toulouse 3, F-31062 Toulouse, France; [Despas, Fabien; Senard, Jean Michel; Pathak, Atul] Univ Hosp Toulouse, Dept Clin Pharmacol, Toulouse, France; [Delmas, Clement; Lairez, Olivier; Labrunee, Marc; Galinier, Michel; Senard, Jean Michel; Pathak, Atul] Univ Hosp Toulouse, Dept Cardiol, Toulouse, France; [Lambert, Elisabeth; Lambert, Gavin; Esler, Murray; Pathak, Atul] Monash Univ, Human Neurotransmitter Lab, Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Lambert, Elisabeth; Lambert, Gavin; Esler, Murray; Pathak, Atul] Monash Univ, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia; [Pathak, Atul] Univ Hosp Toulouse, CIC, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse; Baker Heart and Diabetes Institute; Monash University; Monash University; CHU de Toulouse	Pathak, A (corresponding author), Inst Metab & Cardiovasc Dis, INSERM, UMR 1048, Toulouse, France.	atul.pathak@univ-tlse3.fr	O, Lairez/B-7152-2016; Lambert, Gavin/Q-4869-2017; Pathak, Atul/ABC-5223-2020; Lambert, Gavin W/E-7384-2010	O, Lairez/0000-0001-8141-6582; Lambert, Gavin/0000-0003-0315-645X; Pathak, Atul/0000-0001-6151-0096; Lambert, Gavin W/0000-0003-0315-645X; Senard, Jean-Michel/0000-0001-7679-1281; LABRUNEE, MARC/0000-0001-7782-5703; GALINIER, Michel/0000-0003-1735-3390; Delmas, Clement/0000-0001-9180-9128; Guiraud, Thibaut/0000-0002-9525-5422; Lambert, Elisabeth/0000-0002-2232-9048				Abraham J, 2009, J AM COLL CARDIOL, V53, P1320, DOI 10.1016/j.jacc.2009.02.020; Akashi YJ, 2004, J NUCL MED, V45, P1121; Akashi YJ, 2003, QJM-INT J MED, V96, P563, DOI 10.1093/qjmed/hcg096; Azzarelli S, 2006, AM J CARDIOL, V98, P1273, DOI 10.1016/j.amjcard.2006.05.065; Barton DA, 2007, J HYPERTENS, V25, P2117, DOI 10.1097/HJH.0b013e32829baae7; Berganzo K, 2011, CLIN AUTON RES, V21, P65, DOI 10.1007/s10286-010-0088-0; Bielecka-Dabrowa A, 2010, INT J CARDIOL, V142, P120, DOI 10.1016/j.ijcard.2009.11.040; Brydon L, 2010, J PSYCHOSOM RES, V68, P109, DOI 10.1016/j.jpsychores.2009.06.007; Burgdorf C, 2008, EUR J HEART FAIL, V10, P1015, DOI 10.1016/j.ejheart.2008.07.008; Bybee KA, 2004, AM J CARDIOL, V94, P343, DOI 10.1016/j.amjcard.2004.04.030; Bybee KA, 2004, ANN INTERN MED, V141, P858, DOI 10.7326/0003-4819-141-11-200412070-00010; Chua TP, 1996, HEART, V76, P483, DOI 10.1136/hrt.76.6.483; Despas F, 2012, J HYPERTENS, V30, P753, DOI 10.1097/HJH.0b013e328350136c; Despas F, 2010, J HEART LUNG TRANSPL, V29, P591, DOI 10.1016/j.healun.2009.10.017; Despas F, 2009, J HYPERTENS, V27, P1849, DOI 10.1097/HJH.0b013e32832e8d0f; Eisenhofer G, 2001, PHARMACOL THERAPEUT, V91, P35, DOI 10.1016/S0163-7258(01)00144-9; Elesber AA, 2007, J AM COLL CARDIOL, V50, P448, DOI 10.1016/j.jacc.2007.03.050; Elian D, 2006, CLIN CARDIOL, V29, P9, DOI 10.1002/clc.4960290104; Franchitto N, 2013, INT J CARDIOL; Gianni M, 2006, EUR HEART J, V27, P1523, DOI 10.1093/eurheartj/ehl032; Grassi G, 2008, EUR J HEART FAIL, V10, P1186, DOI 10.1016/j.ejheart.2008.09.013; KINGWELL BA, 1994, CIRCULATION, V90, P234, DOI 10.1161/01.CIR.90.1.234; Kume T, 2008, CIRC J, V72, P106, DOI 10.1253/circj.72.106; Lavi S, 2007, AM J PHYSIOL-REG I, V292, pR788, DOI 10.1152/ajpregu.00352.2006; LEIMBACH WN, 1986, CIRCULATION, V73, P913, DOI 10.1161/01.CIR.73.5.913; Litvinov IV, 2009, CLIN RES CARDIOL, V98, P457, DOI 10.1007/s00392-009-0028-y; Lyon AR, 2008, NAT CLIN PRACT CARD, V5, P22, DOI 10.1038/ncpcardio1066; Macefield VG, 1999, CIRCULATION, V100, P1708, DOI 10.1161/01.CIR.100.16.1708; MADHAVAN M, 2010, HERZ; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Meyer T, 2010, PSYCHOSOM MED, V72, P9, DOI 10.1097/PSY.0b013e3181c64fc0; Nef HM, 2009, EUR HEART J, V30, P2155, DOI 10.1093/eurheartj/ehp240; Nigmatullina RR, 2009, CARDIOLOGY, V113, P277, DOI 10.1159/000205962; Norcliffe-Kaufmann LJ, 2011, CLIN AUTON RES, V21, P1, DOI 10.1007/s10286-010-0113-3; Parodi G, 2007, AM J CARDIOL, V99, P182, DOI 10.1016/j.amjcard.2006.07.080; Pilgrim TM, 2008, INT J CARDIOL, V124, P283, DOI 10.1016/j.ijcard.2007.07.002; Pilliere R, 2006, AM J CARDIOL, V98, P662, DOI 10.1016/j.amjcard.2006.03.048; Sato H., 1990, CLIN ASPECT MYOCARDI, P56; Scheitz JF, 2011, J NEUROL; Schneider B, 2013, INT J CARDIOL, V166, P584, DOI 10.1016/j.ijcard.2011.11.027; Sharkey SW, 2010, J AM COLL CARDIOL, V55, P333, DOI 10.1016/j.jacc.2009.08.057; SPYER KM, 1994, J PHYSIOL-LONDON, V474, P1; Vizzardi E, 2010, INT J CLIN PRACT, V64, P67, DOI 10.1111/j.1742-1241.2008.01833.x; Volz HC, 2009, CAN J CARDIOL, V25, pE261, DOI 10.1016/S0828-282X(09)70517-3; Waldenborg M, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-14; WALLIN BG, 1992, J PHYSIOL-LONDON, V453, P45, DOI 10.1113/jphysiol.1992.sp019217; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; Yoshimura S, 2008, ANN NEUROL, V64, P547, DOI 10.1002/ana.21459	48	40	40	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93278	10.1371/journal.pone.0093278	http://dx.doi.org/10.1371/journal.pone.0093278			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667435	Green Submitted, gold, Green Published			2022-12-25	WOS:000333675600162
J	Abrams, JL; Verghese, J; Gibney, PA; Morano, KA				Abrams, Jennifer L.; Verghese, Jacob; Gibney, Patrick A.; Morano, Kevin A.			Hierarchical Functional Specificity of Cytosolic Heat Shock Protein 70 ( Hsp70) Nucleotide Exchange Factors in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Molecular Chaperone; Protein Degradation; Protein Folding; Protein Misfolding; Protein Stability; Yeast; Hsp70; Nucleotide Exchange Factor; Protein Homeostasis; Saccharomyces cerevisiae	HEAT-SHOCK RESPONSE; RIBOSOME-ASSOCIATED HSP70; PROTEIN-QUALITY CONTROL; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONES; HSP110 CHAPERONES; TRANSCRIPTION FACTOR; PRION PROPAGATION; STRUCTURAL BASIS; PEPTIDE-BINDING	Background: Several conserved families of nucleotide exchange factor interact with heat shock protein 70 (Hsp70) with unknown functional preferences. Results: Multiple assays for Hsp70-dependent cellular activities reveal major functional defects primarily in cells lacking heat shock protein 110 (Hsp110). Conclusion: The Hsp110 NEF plays a dominant role in Hsp70-mediated processes. Significance: Hsp110 may be a high value target for therapies to treat protein misfolding diseases. Heat shock protein 70 (Hsp70) molecular chaperones play critical roles in protein homeostasis. In the budding yeast Saccharomyces cerevisiae, cytosolic Hsp70 interacts with up to three types of nucleotide exchange factors (NEFs) homologous to human counterparts: Sse1/Sse2 (Heat shock protein 110 (Hsp110)), Fes1 (HspBP1), and Snl1 (Bag-1). All three NEFs stimulate ADP release; however, it is unclear why multiple distinct families have been maintained throughout eukaryotic evolution. In this study we investigate NEF roles in Hsp70 cell biology using an isogenic combinatorial collection of NEF deletion mutants. Utilizing well characterized model substrates, we find that Sse1 participates in most Hsp70-mediated processes and is of particular importance in protein biogenesis and degradation, whereas Fes1 contributes to a minimal extent. Surprisingly, disaggregation and resolubilization of thermally denatured firefly luciferase occurred independently of NEF activity. Simultaneous deletion of SSE1 and FES1 resulted in constitutive activation of heat shock protein expression mediated by the transcription factor Hsf1, suggesting that these two factors are important for modulating stress response. Fes1 was found to interact in vivo preferentially with the Ssa family of cytosolic Hsp70 and not the co-translational Ssb homolog, consistent with the lack of cold sensitivity and protein biogenesis phenotypes for fes1 cells. No significant consequence could be attributed to deletion of the minor Hsp110 SSE2 or the Bag homolog SNL1. Together, these lines of investigation provide a comparative analysis of NEF function in yeast that implies Hsp110 is the principal NEF for cytosolic Hsp70, making it an ideal candidate for therapeutic intervention in human protein folding disorders.	[Abrams, Jennifer L.; Verghese, Jacob; Gibney, Patrick A.; Morano, Kevin A.] Univ Texas Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Morano, KA (corresponding author), Univ Texas Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	kevin.a.morano@uth.tmc.edu		Morano, Kevin/0000-0002-5992-0253	National Institutes of Health [GM074696]; American Society of Microbiology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074696] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Microbiology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074696 (to K. A. M.).; Supported by a Robert D. Watkins Graduate Research Fellowship from the American Society of Microbiology.	Abrams JL, 2013, JOVE-J VIS EXP, DOI 10.3791/50432; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; CRAIG EA, 1991, TRENDS BIOCHEM SCI, V16, P135, DOI 10.1016/0968-0004(91)90055-Z; Cyr DM, 2008, CELL, V133, P945, DOI 10.1016/j.cell.2008.05.036; Dragovic Z, 2006, BIOL CHEM, V387, P1593, DOI 10.1515/BC.2006.198; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; Eroglu B, 2010, MOL CELL BIOL, V30, P4626, DOI 10.1128/MCB.01493-09; Fan Q, 2007, GENETICS, V177, P1583, DOI 10.1534/genetics.107.077982; Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goeckeler JL, 2008, FEBS LETT, V582, P2393, DOI 10.1016/j.febslet.2008.05.047; Gowda NKC, 2013, P NATL ACAD SCI USA, V110, P5975, DOI 10.1073/pnas.1216778110; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hundley H, 2002, P NATL ACAD SCI USA, V99, P4203, DOI 10.1073/pnas.062048399; James P, 1997, SCIENCE, V275, P387, DOI 10.1126/science.275.5298.387; Kabani M, 2002, MOL CELL BIOL, V22, P4677, DOI 10.1128/MCB.22.13.4677-4689.2002; Kabani M, 2009, PROTEIN PEPTIDE LETT, V16, P623, DOI 10.2174/092986609788490186; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Kryndushkin D, 2007, MOL BIOL CELL, V18, P2149, DOI 10.1091/mbc.E07-02-0128; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; Liu XD, 1997, EMBO J, V16, P6466, DOI 10.1093/emboj/16.21.6466; Mandal AK, 2010, MOL BIOL CELL, V21, P1439, DOI 10.1091/mbc.E09-09-0779; Martineau CN, 2007, GENETICS, V177, P1679, DOI 10.1534/genetics.107.081141; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Meyer AE, 2007, P NATL ACAD SCI USA, V104, P1558, DOI 10.1073/pnas.0610704104; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Morano KA, 1998, CURR OPIN MICROBIOL, V1, P197, DOI 10.1016/S1369-5274(98)80011-8; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; MUKAI H, 1993, GENE, V132, P57; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Polier S, 2010, J MOL BIOL, V401, P696, DOI 10.1016/j.jmb.2010.07.004; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Reimann B, 1999, YEAST, V15, P397, DOI 10.1002/(SICI)1097-0061(19990330)15:5<397::AID-YEA384>3.3.CO;2-L; Sadlish H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001763; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Saxena A, 2012, J BIOL CHEM, V287, P19158, DOI 10.1074/jbc.M111.297580; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Senderek J, 2005, NAT GENET, V37, P1312, DOI 10.1038/ng1678; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Shaner L, 2006, BIOCHEMISTRY-US, V45, P15075, DOI 10.1021/bi061279k; Sharma D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006644; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; SIKORSKI RS, 1989, GENETICS, V122, P19; Sondermann H, 2002, J BIOL CHEM, V277, P33220, DOI 10.1074/jbc.M204624200; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Tkach JM, 2008, TRAFFIC, V9, P39, DOI 10.1111/j.1600-0854.2007.00666.x; Trott A, 2005, GENETICS, V170, P1009, DOI 10.1534/genetics.105.043109; Trotter EW, 2002, J BIOL CHEM, V277, P44817, DOI 10.1074/jbc.M204686200; Trotter EW, 2001, P NATL ACAD SCI USA, V98, P7313, DOI 10.1073/pnas.121172998; Verghese J, 2012, EUKARYOT CELL, V11, P1003, DOI 10.1128/EC.00146-12; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Wang YY, 2012, MOL BIOL CELL, V23, P3290, DOI 10.1091/mbc.E12-06-0447; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Xiao J, 2006, MOL BIOL CELL, V17, P3281, DOI 10.1091/mbc.E06-02-0106; Xu XP, 2012, J BIOL CHEM, V287, P5661, DOI 10.1074/jbc.M111.275057; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P1309, DOI 10.1038/nsmb.1518; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200; Zhang S, 2010, GENETICS, V184, P1165, DOI 10.1534/genetics.109.112516; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	78	39	39	0	68	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13155	13167		10.1074/jbc.M113.530014	http://dx.doi.org/10.1074/jbc.M113.530014			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24671421	hybrid, Green Published			2022-12-25	WOS:000335522800017
J	Du, HS; Li, WH; Wang, YQ; Yang, WC				Du, Heshan; Li, Wenhui; Wang, Yuqing; Yang, Wencai			Identification of Genes Differentially Expressed between Resistant and Susceptible Tomato Lines during Time-Course Interactions with Xanthomonas perforans Race T3	PLOS ONE			English	Article							CAMPESTRIS PV. VESICATORIA; BACTERIAL SPOT; CDNA-AFLP; DISEASE RESISTANCE; ANALYSIS REVEALS; PLANT; ETHYLENE; INFECTION; PEPPER; INHERITANCE	Bacterial spot caused by several Xanthomonas sp. is one of the most devastating diseases in tomato (Solanum lycopersicum L.). The genetics of hypersensitive resistance to X. perforans race T3 has been intensively investigated and regulatory genes during the infection of race T3 have been identified through transcriptional profiling. However, no work on isolating regulatory genes for field resistance has been reported. In this study, cDNA-amplified fragment length polymorphism technique was used to identify differentially expressed transcripts between resistant tomato accession PI 114490 and susceptible variety OH 88119 at 3, 4 and 5 days post-inoculation of the pathogen. Using 256 selective primer combinations, a total of 79 differentially expressed transcript-derived fragments (TDFs) representing 71 genes were obtained. Of which, 60 were up-regulated and 4 were down-regulated in both tomato lines, 4 were uniquely up-regulated and 2 were uniquely down-regulated in PI 114490, and 1 was specifically up-regulated in OH 88119. The expression patterns of 19 representative TDFs were further confirmed by semi-quantitative and/or quantitative real time RT-PCR. These results suggested that the two tomato lines activated partly similar defensive mechanism in response to race T3 infection. The data obtained here will provide some fundamental information for elucidating the molecular mechanism of response to race T3 infection in tomato plants with field resistance.	[Du, Heshan; Li, Wenhui; Wang, Yuqing; Yang, Wencai] China Agr Univ, Beijing Key Lab Growth & Dev Regulat Protected Ve, Dept Vegetable Sci, Beijing 100094, Peoples R China	China Agricultural University	Yang, WC (corresponding author), China Agr Univ, Beijing Key Lab Growth & Dev Regulat Protected Ve, Dept Vegetable Sci, Beijing 100094, Peoples R China.	yangwencai@cau.edu.cn	Yang, Wencai/G-6517-2011	Yang, Wencai/0000-0001-5369-2555	National Natural Science Foundation of China [31372073]; Specialized Research Fund for the Doctoral Program of Higher Education [20110008110019]; Beijing Modern Agro-industry Technology Research System	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Beijing Modern Agro-industry Technology Research System	The work was partly supported by National Natural Science Foundation of China (31372073), Specialized Research Fund for the Doctoral Program of Higher Education (20110008110019) and Beijing Modern Agro-industry Technology Research System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles F, 1992, ETHYLENE PLANT BIOL; Astua-Monge G, 2000, MOL PLANT MICROBE IN, V13, P911, DOI 10.1094/MPMI.2000.13.9.911; Bachem CWB, 1998, PLANT MOL BIOL REP, V16, P157, DOI 10.1023/A:1007468801806; Balaji V, 2008, PLANT PHYSIOL, V146, P1797, DOI 10.1104/pp.107.115188; Balaji V, 2007, FUNCT INTEGR GENOMIC, V7, P305, DOI 10.1007/s10142-007-0050-y; BENT AF, 1992, MOL PLANT MICROBE IN, V5, P372, DOI 10.1094/MPMI-5-372; Broekaert WF, 2006, ANNU REV PHYTOPATHOL, V44, P393, DOI 10.1146/annurev.phyto.44.070505.143440; Chen J, 2009, SCI HORTIC-AMSTERDAM, V122, P6, DOI 10.1016/j.scienta.2009.03.025; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Chung HS, 2010, PLANT J, V63, P613, DOI 10.1111/j.1365-313X.2010.04265.x; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Daurelio LD, 2011, J PLANT PHYSIOL, V168, P382, DOI 10.1016/j.jplph.2010.07.014; Demianski AJ, 2012, MOL PLANT PATHOL, V13, P46, DOI 10.1111/j.1364-3703.2011.00727.x; Dinari A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052757; Froehlich JE, 2001, PLANT PHYSIOL, V125, P306, DOI 10.1104/pp.125.1.306; Gabriels SHEJ, 2006, MOL PLANT MICROBE IN, V19, P567, DOI 10.1094/MPMI-19-0567; Gibly A, 2004, MOL PLANT MICROBE IN, V17, P1212, DOI 10.1094/MPMI.2004.17.11.1212; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; Gu YQ, 2000, PLANT CELL, V12, P771, DOI 10.1105/tpc.12.5.771; Gu YQ, 2002, PLANT CELL, V14, P817, DOI 10.1105/tpc.000794; Gu YQ, 1998, PHILOS T R SOC B, V353, P1455, DOI 10.1098/rstb.1998.0301; Hoffman T, 1999, PLANT PHYSIOL, V119, P935, DOI 10.1104/pp.119.3.935; Hutton SF, 2010, THEOR APPL GENET, V121, P1275, DOI 10.1007/s00122-010-1387-5; Jones JB, 2005, ACTA HORTIC, P27, DOI 10.17660/ActaHortic.2005.695.1; Jones JB, 2000, INT J SYST EVOL MICR, V50, P1211, DOI 10.1099/00207713-50-3-1211; Lelliot R.A., 1987, METHODS DIAGNOSIS BA; Lin YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068749; Melech-Bonfil S, 2011, PLANT SIGNAL BEHAV, V6, P154, DOI 10.4161/psb.6.1.14311; Melech-Bonfil S, 2010, PLANT J, V64, P379, DOI 10.1111/j.1365-313X.2010.04333.x; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; O'Donnell PJ, 2003, PLANT J, V33, P245, DOI 10.1046/j.1365-313X.2003.01619.x; Orlowska E, 2012, PLANT CELL REP, V31, P187, DOI 10.1007/s00299-011-1155-2; Panstruga R, 2009, CELL, V136, P978, DOI 10.1016/j.cell.2009.02.020; Pei CC, 2012, THEOR APPL GENET, V124, P533, DOI 10.1007/s00122-011-1726-1; Polesani M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-142; Potnis N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-146; Reijans M, 2003, GENOMICS, V82, P606, DOI 10.1016/S0888-7543(03)00179-4; Robbins MD, 2009, PHYTOPATHOLOGY, V99, P1037, DOI 10.1094/PHYTO-99-9-1037; Santaella M, 2004, MOL PLANT PATHOL, V5, P549, DOI [10.1111/j.1364-3703.2004.00254.x, 10.1111/J.1364-3703.2004.00254.X]; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott JW, 2003, J AM SOC HORTIC SCI, V128, P698, DOI 10.21273/JASHS.128.5.0698; Scott JW, 2001, J AM SOC HORTIC SCI, V126, P436, DOI 10.21273/JASHS.126.4.436; Scott JW., 1996, RPT TOMATO GENET COO, V46, P23; SHENG JS, 1993, PLANT PHYSIOL, V101, P1409, DOI 10.1104/pp.101.4.1409; Shi C, 2011, MOL BIOL REP, V38, P75, DOI 10.1007/s11033-010-0079-1; Stall RE, 2009, ANNU REV PHYTOPATHOL, V47, P265, DOI 10.1146/annurev-phyto-080508-081752; Sun HJ, 2014, EUR J PLANT PATHOL, V139, P125, DOI 10.1007/s10658-013-0371-8; [孙会军 Sun Huijun], 2011, [河北农业大学学报, Journal of Agricultural University of Hebei], V34, P65; Sun HuiJun, 2011, Acta Horticulturae Sinica, V38, P2297; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Vuylsteke M, 2007, NAT PROTOC, V2, P1399, DOI 10.1038/nprot.2007.174; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; [杨文才 Yang Wencai], 2013, [园艺学报, Acta Horticulturae Sinica], V40, P1731; Yang WenCai, 2007, Scientia Agricultura Sinica, V40, P283; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhou JM, 1997, EMBO J, V16, P3207, DOI 10.1093/emboj/16.11.3207	56	9	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93476	10.1371/journal.pone.0093476	http://dx.doi.org/10.1371/journal.pone.0093476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686403	Green Published, Green Submitted, gold			2022-12-25	WOS:000340842300012
J	Kim, HA; Lim, CJ; Kim, S; Choe, JK; Jo, SH; Baek, N; Kwon, SY				Kim, Hyun A.; Lim, Chan Ju; Kim, Sangmi; Choe, Jun Kyoung; Jo, Sung-Hwan; Baek, Namkwon; Kwon, Suk-Yoon			High-Throughput Sequencing and De Novo Assembly of Brassica oleracea var. Capitata L. for Transcriptome Analysis	PLOS ONE			English	Article							NUCLEAR-DNA AMOUNTS; FULL-LENGTH CDNAS; ARABIDOPSIS-THALIANA; MOLECULAR CHARACTERIZATION; EXPRESSION ANALYSIS; NITRATE TRANSPORT; GENE-EXPRESSION; FAMILY; CONSTRUCTION; ANNOTATION	Background: The cabbage, Brassica oleracea var. capitata L., has a distinguishable phenotype within the genus Brassica. Despite the economic and genetic importance of cabbage, there is little genomic data for cabbage, and most studies of Brassica are focused on other species or other B. oleracea subspecies. The lack of genomic data for cabbage, a non-model organism, hinders research on its molecular biology. Hence, the construction of reliable transcriptomic data based on highthroughput sequencing technologies is needed to enhance our understanding of cabbage and provide genomic information for future work. Methodology/Principal Findings: We constructed cDNAs from total RNA isolated from the roots, leaves, flowers, seedlings, and calcium-limited seedling tissues of two cabbage genotypes: 102043 and 107140. We sequenced a total of six different samples using the Illumina HiSeq platform, producing 40.5 Gbp of sequence data comprising 401,454,986 short reads. We assembled 205,046 transcripts (>= 200 bp) using the Velvet and Oases assembler and predicted 53,562 loci from the transcripts. We annotated 35,274 of the loci with 55,916 plant peptides in the Phytozome database. The average length of the annotated loci was 1,419 bp. We confirmed the reliability of the sequencing assembly using reverse-transcriptase PCR to identify tissue-specific gene candidates among the annotated loci. Conclusion: Our study provides valuable transcriptome sequence data for B. oleracea var. capitata L., offering a new resource for studying B. oleracea and closely related species. Our transcriptomic sequences will enhance the quality of gene annotation and functional analysis of the cabbage genome and serve as a material basis for future genomic research on cabbage. The sequencing data from this study can be used to develop molecular markers and to identify the extreme differences among the phenotypes of different species in the genus Brassica.	[Kim, Hyun A.; Lim, Chan Ju; Kwon, Suk-Yoon] Korea Res Inst Biosci & Biotechnol KRIBB, Green Bio Res Ctr, Taejon, South Korea; [Kim, Sangmi; Choe, Jun Kyoung; Jo, Sung-Hwan] SEEDERS, Taejon, South Korea; [Baek, Namkwon] Samsung Seed Co Ltd, Pyongtaek, Kyeonggi, South Korea; [Kim, Hyun A.; Kwon, Suk-Yoon] Univ Sci & Technol, Biosyst & Bioengn Program, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kwon, SY (corresponding author), Korea Res Inst Biosci & Biotechnol KRIBB, Green Bio Res Ctr, Taejon, South Korea.	sykwon@kribb.re.kr		Kwon, Suk-Yoon/0000-0002-5787-4898	Technology Development Program for Agriculture and Forestry, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; KRIBB Research Initiative Program	Technology Development Program for Agriculture and Forestry, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; KRIBB Research Initiative Program	This work was supported by grants from the Technology Development Program for Agriculture and Forestry, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea, and the KRIBB Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NU, 2012, PLANT PHYSIOL BIOCH, V58, P106, DOI 10.1016/j.plaphy.2012.06.015; Amarasinghe BHRR, 1998, PLANTA, V206, P44, DOI 10.1007/s004250050372; Aoki K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-210; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayele M, 2005, GENOME RES, V15, P487, DOI 10.1101/gr.3176505; BENNETT MD, 1991, PHILOS T R SOC B, V334, P309, DOI 10.1098/rstb.1991.0120; BENNETT MD, 1976, PHILOS T R SOC B, V274, P227, DOI 10.1098/rstb.1976.0044; Blair MW, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-171; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Cao BH, 2010, PLANT CELL TISS ORG, V103, P217, DOI 10.1007/s11240-010-9769-6; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; Chang SX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-497; Chen G, 2011, SCI CHINA LIFE SCI, V54, P1129, DOI 10.1007/s11427-011-4256-9; Chen ZY, 2006, PLANT MOL BIOL, V60, P583, DOI 10.1007/s11103-005-5082-x; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; Cho SK, 2008, PLANT CELL, V20, P1899, DOI 10.1105/tpc.108.060699; Clepet C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018445; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Daniel-Vedele F, 1998, CURR OPIN PLANT BIOL, V1, P235, DOI 10.1016/S1369-5266(98)80110-6; EDERY I, 1995, MOL CELL BIOL, V15, P3363; Faltusova Z, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue3-fulltext-4; Filleur S, 1999, PLANTA, V207, P461, DOI 10.1007/s004250050505; Fowler TJ, 1999, PLANT PHYSIOL, V121, P1081, DOI 10.1104/pp.121.4.1081; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; GOLDMAN MHS, 1994, EMBO J, V13, P2976, DOI 10.1002/j.1460-2075.1994.tb06596.x; Haas BJ, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-6-RESEARCH0029; Hatey F, 1998, GENET SEL EVOL, V30, P521, DOI 10.1051/gse:19980601; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Johnston JS, 2005, ANN BOT-LONDON, V95, P229, DOI 10.1093/aob/mci016; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Liu GQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-700; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Mei J, 2012, THEOR APPL GENET; Obulareddy N, 2013, MOL PLANT MICROBE IN, V26, P844, DOI 10.1094/MPMI-03-13-0081-TA; Orsel M, 2002, PLANT PHYSIOL, V129, P886, DOI 10.1104/pp.005280; Paterson AH, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-3-reviews1011; Quesada A, 1997, PLANT MOL BIOL, V34, P265, DOI 10.1023/A:1005872816881; Reintanz B, 2002, P NATL ACAD SCI USA, V99, P4079, DOI 10.1073/pnas.052677799; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Seki M, 2009, J PLANT RES, V122, P355, DOI 10.1007/s10265-009-0239-3; Sze H, 2004, PLANT PHYSIOL, V136, P2532, DOI 10.1104/pp.104.046003; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; U. N., 1935, Japanese Journal of Botany, V7, P389; Umezawa T, 2008, DNA RES, V15, P333, DOI 10.1093/dnares/dsn024; Wang QB, 2012, MOL BREEDING, V30, P709, DOI 10.1007/s11032-011-9656-9; Wang WX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-523; Wang XJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-716; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Xiao SJ, 2010, BIOINFORMATICS, V26, P1273, DOI 10.1093/bioinformatics/btq109; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang L, 2007, 18 INT C AR RES; Zheng SJ, 2011, J CHEM ECOL, V37, P818, DOI 10.1007/s10886-011-9984-6; Zhuo DG, 1999, PLANT J, V17, P563, DOI 10.1046/j.1365-313X.1999.00396.x	62	30	31	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92087	10.1371/journal.pone.0092087	http://dx.doi.org/10.1371/journal.pone.0092087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682075	Green Submitted, Green Published, gold			2022-12-25	WOS:000333678100005
J	Kusaka, T; Nakayama, M; Nakamura, K; Ishimiya, M; Furusawa, E; Ogasawara, K				Kusaka, Toshimasa; Nakayama, Masafumi; Nakamura, Kyohei; Ishimiya, Mai; Furusawa, Emi; Ogasawara, Kouetsu			Effect of Silica Particle Size on Macrophage Inflammatory Responses	PLOS ONE			English	Article							ULTRAFINE AMORPHOUS SILICA; NALP3 INFLAMMASOME; INTRATRACHEAL INSTILLATION; PULMONARY INFLAMMATION; SURFACE MODIFICATION; NLRP3 INFLAMMASOME; NANOPARTICLES; MICE; ACTIVATION; IL-1-BETA	Amorphous silica particles, such as nanoparticles (<100 nm diameter particles), are used in a wide variety of products, including pharmaceuticals, paints, cosmetics, and food. Nevertheless, the immunotoxicity of these particles and the relationship between silica particle size and pro-inflammatory activity are not fully understood. In this study, we addressed the relationship between the size of amorphous silica (particle dose, diameter, number, and surface area) and the inflammatory activity (macrophage phagocytosis, inflammasome activation, IL-1 beta secretion, cell death and lung inflammation). Irrespective of diameter size, silica particles were efficiently internalized by mouse bone marrow-derived macrophages via an actin cytoskeleton-dependent pathway, and induced caspase-1, but not caspase-11, activation. Of note, 30 nm-1000 nm diameter silica particles induced lysosomal destabilization, cell death, and IL-1 beta secretion at markedly higher levels than did 3000 nm-10000 nm silica particles. Consistent with in vitro results, intra-tracheal administration of 30 nm silica particles into mice caused more severe lung inflammation than that of 3000 nm silica particles, as assessed by measurement of pro-inflammatory cytokines and neutrophil infiltration in bronchoalveolar lavage fluid of mice, and by the micro-computed tomography analysis. Taken together, these results suggest that silica particle size impacts immune responses, with submicron amorphous silica particles inducing higher inflammatory responses than silica particles over 1000 nm in size, which is ascribed not only to their ability to induce caspase-1 activation but also to their cytotoxicity.	[Kusaka, Toshimasa; Nakayama, Masafumi; Nakamura, Kyohei; Ishimiya, Mai; Furusawa, Emi; Ogasawara, Kouetsu] Tohoku Univ, Dept Immunobiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Nakayama, Masafumi] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 980, Japan; [Nakamura, Kyohei] Tohoku Univ, Dept Hematol & Rheumatol, Grad Sch Med, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Ogasawara, K (corresponding author), Tohoku Univ, Dept Immunobiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	ogasawara@idac.tohoku.ac.jp	Nakamura, Kyohei/AAH-4823-2019; Ogasawara, Kouetsu/G-9892-2011	Nakamura, Kyohei/0000-0002-6631-9028; Nakayama, Masafumi/0000-0002-9839-7143	Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI); Takeda Science Foundation; Japan Society for the Promotion of Science (JSPS); Ministry of Health, Labour, and Welfare of Japan [H22-meneki-ippan-004]; Grants-in-Aid for Scientific Research [25118703] Funding Source: KAKEN	Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by a grant from the Japan Chemical Industry Association (JCIA) Long-range Research Initiative (LRI), by a grant from the Takeda Science Foundation, by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), and by Grants-in-Aid for Scientific Research from the Ministry of Health, Labour, and Welfare of Japan (H22-meneki-ippan-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Bowman DM, 2010, NAT NANOTECHNOL, V5, P92, DOI 10.1038/nnano.2010.12; Brown JM, 2007, AM J RESP CELL MOL, V36, P43, DOI 10.1165/rcmb.2006-0197OC; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Cho WS, 2007, TOXICOL LETT, V175, P24, DOI 10.1016/j.toxlet.2007.09.008; Choi M, 2008, TOXICOL LETT, V182, P97, DOI 10.1016/j.toxlet.2008.08.019; Costantini LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014647; De Jong WH, 2008, BIOMATERIALS, V29, P1912, DOI 10.1016/j.biomaterials.2007.12.037; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Hamilton RF, 2006, J BIOL CHEM, V281, P34218, DOI 10.1074/jbc.M605229200; Hirai T, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-3; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kaewamatawong T, 2005, TOXICOL PATHOL, V33, P743, DOI 10.1080/01926230500416302; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Morishige T, 2012, ARCH TOXICOL, V86, P1297, DOI 10.1007/s00204-012-0823-5; Morishige T, 2010, BIOMATERIALS, V31, P6833, DOI 10.1016/j.biomaterials.2010.05.036; Mukhopadhyay S, 2011, BLOOD, V117, P1319, DOI 10.1182/blood-2010-03-276733; Nabeshi H, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/4/045101; Nabeshi H, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-1; Nabeshi H, 2011, BIOMATERIALS, V32, P2713, DOI 10.1016/j.biomaterials.2010.12.042; Nakayama M, 2007, J IMMUNOL, V178, P4250, DOI 10.4049/jimmunol.178.7.4250; Nakayama M, 2012, J IMMUNOL, V189, P5903, DOI 10.4049/jimmunol.1201940; Sandberg WJ, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-32; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Srivastava KD, 2002, AM J RESP CRIT CARE, V165, P527, DOI 10.1164/ajrccm.165.4.2106009; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Waters KM, 2009, TOXICOL SCI, V107, P553, DOI 10.1093/toxsci/kfn250; World Health Organization, 2007, GLOB OCC HLTH NETW N; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107	35	152	155	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92634	10.1371/journal.pone.0092634	http://dx.doi.org/10.1371/journal.pone.0092634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681489	gold, Green Published, Green Submitted			2022-12-25	WOS:000333678100011
J	Wang, SQ; Zhou, MN; Lin, FQ; Liu, DY; Hong, WS; Lu, LJ; Zhu, YP; Xu, A				Wang, Suiquan; Zhou, Miaoni; Lin, Fuquan; Liu, Dongyin; Hong, Weisong; Lu, Liangjun; Zhu, Yiping; Xu, Aie			Interferon-gamma Induces Senescence in Normal Human Melanocytes	PLOS ONE			English	Article							IFN-GAMMA; T-CELLS; CELLULAR SENESCENCE; AUTOIMMUNE-DISEASE; OXIDATIVE STRESS; IMMUNE-RESPONSE; MOUSE MODEL; VITILIGO; SKIN; EXPRESSION	Background: Interferon-gamma (IFN-gamma) plays an important role in the proceedings of vitiligo through recruiting lymphocytes to the lesional skin. However, the potential effects of IFN-gamma on skin melanocytes and the subsequent contribution to the vitiligo pathogenesis are still unclear. Objective: To investigate the effects of IFN-gamma on viability and cellular functions of melanocytes. Methods: Primary human melanocytes were treated with IFN-gamma. Cell viability, apoptosis, cell cycle melanin content and intracellular reactive oxygen species (ROS) level were measured. mRNA expression was examined by real-time PCR. The release of interleukin 6 (IL-6) and heat shock protein 70 (HSP-70) was monitored by ELISA. beta-galactosidase staining was utilized to evaluate melanocyte senescence. Results: Persistent IFN-gamma treatment induced viability loss, apoptosis, cell cycle arrest and senescence in melanocytes. Melanocyte senescence was characterized as the changes in pigmentation and morphology, as well as the increase of beta-galactosidase activity. Increase of p21(Cip1/Waf1) protein was evident in melanocytes after IFN-gamma treatment. IFN-gamma induction of senescence was attenuated by siRNAs against p21, Janus kinase 2 (JAK2) or signal transducer and activator of transcription 1 (STAT1), but not by JAK1 siRNA nor by p53 inhibitor pifithrin-alpha. IFN-gamma treatment increased the accumulation of intracellular ROS in melanocytes, while ROS scavenger N-acetyl cysteine (NAC) effectively inhibited IFN-gamma induced p21 expression and melanocyte senescence. IL-6 and HSP-70 release was significantly induced by IFN-gamma treatment, which was largely inhibited by NAC. The increase of IL-6 and HSP-70 release could also be observed in senescent melanocytes. Conclusion: IFN-gamma can induce senescence in melanocytes and consequently enhance their immuno-competency, leading to a vitiligo-prone milieu.	[Wang, Suiquan; Zhou, Miaoni; Lin, Fuquan; Liu, Dongyin; Hong, Weisong; Lu, Liangjun; Zhu, Yiping; Xu, Aie] Third Peoples Hosp Hangzhou, Hangzhou Inst Dermatol & Venereol, Dept Dermatol, Hangzhou, Zhejiang Provin, Peoples R China; [Lu, Liangjun; Zhu, Yiping] Zhejiang Chinese Med Univ, Hangzhou, Zhejiang Provin, Peoples R China	Zhejiang Chinese Medical University	Xu, A (corresponding author), Third Peoples Hosp Hangzhou, Hangzhou Inst Dermatol & Venereol, Dept Dermatol, Hangzhou, Zhejiang Provin, Peoples R China.	xuaiehz@msn.com	Zhou, Linjie/E-7874-2013	Zhou, Linjie/0000-0002-2792-2959	Natural Science Foundation of Zhejiang, China [LY13H110001, Z2100973]; National Natural Science Foundation of China [81071294, 81271758]; Co-construction Project of Ministry of Health and Zhejiang Province [WKJ2012-2-036]; National key clinical specialty construction project of China	Natural Science Foundation of Zhejiang, China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Co-construction Project of Ministry of Health and Zhejiang Province; National key clinical specialty construction project of China	This research was supported by grants from the Natural Science Foundation of Zhejiang, China (grant no. LY13H110001 and Z2100973), the National Natural Science Foundation of China (grant no. 81071294 and 81271758), and the Co-construction Project of Ministry of Health and Zhejiang Province (grant no. WKJ2012-2-036). This research was also supported by the National key clinical specialty construction project of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwa E, 2012, ARCH DERMATOL RES, V304, P823, DOI 10.1007/s00403-012-1269-6; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Bandyopadhyay D, 2001, EXP GERONTOL, V36, P1265, DOI 10.1016/S0531-5565(01)00098-5; Bansal R, 2010, CELL CYCLE, V9, P2782, DOI 10.4161/cc.9.14.12251; Basak PY, 2009, J AM ACAD DERMATOL, V60, P256, DOI 10.1016/j.jaad.2008.09.048; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bellei B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059782; Biedermann T, 2006, J IMMUNOL, V177, P3763, DOI 10.4049/jimmunol.177.6.3763; Carnaud C, 1999, J IMMUNOL, V163, P4647; Catalano A, 2005, EMBO J, V24, P170, DOI 10.1038/sj.emboj.7600502; Costin GE, 2005, BIOCHEM J, V391, P249, DOI 10.1042/BJ20042070; Dell'Anna ML, 2012, EXP DERMATOL, V21, P490, DOI 10.1111/j.1600-0625.2012.01506.x; Denman CJ, 2008, J INVEST DERMATOL, V128, P2041, DOI 10.1038/jid.2008.45; El Nasr HS, 2013, J EUR ACAD DERMATOL, V27, P103, DOI 10.1111/j.1468-3083.2011.04368.x; Ezzedine K, 2012, PIGM CELL MELANOMA R, V25, pE1, DOI 10.1111/j.1755-148X.2012.00997.x; Flaishon L, 2000, J EXP MED, V192, P1381, DOI 10.1084/jem.192.9.1381; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; Gauthier Y, 2003, BRIT J DERMATOL, V148, P95, DOI 10.1046/j.1365-2133.2003.05024.x; Gregg RK, 2010, J IMMUNOL, V184, P1909, DOI 10.4049/jimmunol.0902778; Harris JE, 2012, J INVEST DERMATOL, V132, P1869, DOI 10.1038/jid.2011.463; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hirobe T, 2005, PIGM CELL RES, V18, P2, DOI 10.1111/j.1600-0749.2004.00198.x; Hoffmann A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031298; Hong WS, 2011, BRIT J DERMATOL, V165, P520, DOI 10.1111/j.1365-2133.2011.10398.x; Imokawa G, 2004, PIGM CELL RES, V17, P96, DOI 10.1111/j.1600-0749.2003.00126.x; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; KIRNBAUER R, 1992, J INVEST DERMATOL, V98, P320, DOI 10.1111/1523-1747.ep12499793; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Klarquist J, 2010, PIGM CELL MELANOMA R, V23, P276, DOI 10.1111/j.1755-148X.2010.00688.x; Kroll TM, 2005, J INVEST DERMATOL, V124, P798, DOI 10.1111/j.0022-202X.2005.23653.x; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Laddha NC, 2013, EXP DERMATOL, V22, P245, DOI 10.1111/exd.12103; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; McCully ML, 2012, BLOOD, V120, P4591, DOI 10.1182/blood-2012-05-433037; Moretti S, 2002, PIGM CELL RES, V15, P87, DOI 10.1034/j.1600-0749.2002.1o049.x; Mosenson JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005127; Mosenson JA, 2012, PIGM CELL MELANOMA R, V25, P88, DOI 10.1111/j.1755-148X.2011.00916.x; Mycko MA, 2008, EUR J IMMUNOL, V38, P1999, DOI 10.1002/eji.200737661; Mycko MP, 2004, J IMMUNOL, V177, P4168; NOROSE K, 1994, INVEST OPHTH VIS SCI, V35, P33; Roy N, 2010, MOL CELL BIOL, V30, P2681, DOI 10.1128/MCB.01480-09; Sayama K, 1999, J CELL PHYSIOL, V179, P40, DOI 10.1002/(SICI)1097-4652(199904)179:1<40::AID-JCP5>3.0.CO;2-Z; Schallreuter KU, 2008, EXP DERMATOL, V17, P139, DOI [10.1111/j.1600-0625.2007.00666_1.x, 10.1111/j.1600-0625.2007.00666.x]; Schallreuter KU, 1999, J INVEST DERM SYMP P, V4, P91, DOI 10.1038/sj.jidsp.5640189; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Steitz J, 2004, EUR J CELL BIOL, V83, P797, DOI 10.1078/0171-9335-00423; Sviderskaya EV, 2003, J NATL CANCER I, V95, P723, DOI 10.1093/jnci/95.10.723; Sviderskaya EV, 2002, JNCI-J NATL CANCER I, V94, P446; Taieb A, 2009, NEW ENGL J MED, V360, P160, DOI 10.1056/NEJMcp0804388; Toosi S, 2012, J INVEST DERMATOL, V132, P2601, DOI 10.1038/jid.2012.181; van den Boorn JG, 2009, J INVEST DERMATOL, V129, P2220, DOI 10.1038/jid.2009.32; Zhou Z, 2009, BRIT J DERMATOL, V161, P504, DOI 10.1111/j.1365-2133.2009.09288.x; Zuo SG, 2012, J CANCER RES CLIN, V138, P1045, DOI 10.1007/s00432-012-1153-y	55	29	34	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93232	10.1371/journal.pone.0093232	http://dx.doi.org/10.1371/journal.pone.0093232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681574	Green Published, gold, Green Submitted			2022-12-25	WOS:000333678100034
J	Ayres, MP; Pena, R; Lombardo, JA; Lombardero, MJ				Ayres, Matthew P.; Pena, Rebeca; Lombardo, Jeffrey A.; Lombardero, Maria J.			Host Use Patterns by the European Woodwasp, Sirex noctilio, in Its Native and Invaded Range	PLOS ONE			English	Article							ASIAN LONGHORNED BEETLE; PINE SHOOT BEETLE; HYMENOPTERA-SIRICIDAE; BIOLOGICAL-CONTROL; FABRICIUS HYMENOPTERA; UNITED-STATES; NORTH-AMERICA; POPULATION-DYNAMICS; TOMICUS-PINIPERDA; FOREST INSECT	Accelerating introductions of forest insects challenge decision-makers who might or might not respond with surveillance programs, quarantines, eradication efforts, or biological control programs. Comparing ecological controls on indigenous vs. introduced populations could inform responses to new introductions. We studied the European woodwasp, Sirex noctilio, which is not a pest in its native forests, is a serious invasive pest in the southern hemisphere, and now has an uncertain future in North America after its introduction there. Indigenous populations of S. noctilio (in Galicia, Spain) resembled those in New York in that S. noctilio were largely restricted to suppressed trees that were also dying for other reasons, and still only some dying trees showed evidence of S. noctilio: 20-40% and 35-51% in Galicia and New York, respectively. In both areas, P. sylvestris (native to Europe) was the species most likely to have attacks in non-suppressed trees. P. resinosa, native to North America, does not appear dangerously susceptible to S. noctilio. P. radiata, which sustains high damage in the southern hemisphere, is apparently not innately susceptible because in Galicia it was less often used by native S. noctilio than either native pine (P. pinaster and P. sylvestris). Silvicultural practices in Galicia that maintain basal area at 25-40 m(2)/ha limit S. noctilio abundance. More than 25 species of other xylophagous insects feed on pine in Galicia, but co-occurrences with S. noctilio were infrequent, so strong interspecific competition seemed unlikely. Evidently, S. noctilio in northeastern North America will be more similar to indigenous populations in Europe, where it is not a pest, than to introduced populations in the southern hemisphere, where it is. However, S. noctilio populations could behave differently when they reach forests of the southeastern U.S., where tree species, soils, climate, ecology, management, and landscape configurations of pine stands are different.	[Ayres, Matthew P.; Lombardo, Jeffrey A.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Pena, Rebeca; Lombardero, Maria J.] Univ Santiago, Dept Prod Vegetal, Lugo, Spain	Dartmouth College; Universidade de Santiago de Compostela	Ayres, MP (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	Matthew.P.Ayres@Dartmouth.edu	Ayres, Matthew/AAI-6873-2020; Lombardero, María J/H-1629-2015	Ayres, Matthew/0000-0001-6120-9068; Lombardero, María J/0000-0002-3245-896X	Dartmouth College; USDA APHIS; USDA Forest Service International Programs	Dartmouth College; USDA APHIS(United States Department of Agriculture (USDA)); USDA Forest Service International Programs(United States Department of Agriculture (USDA)United States Forest Service)	Support was provided by a cooperative agreement between Dartmouth College and USDA APHIS, and by a grant from USDA Forest Service International Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez P., 2004, THESIS U SANTIAGO SA; [Anonymous], PEST TRACK SIR NOCT; Bain J, 2005, P 16 USDA INT RES FO; Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; BILLINGS RF, 1972, TURRIALBA, V22, P105; Boroczky K, 2012, J CHEM ECOL, V38, P213, DOI 10.1007/s10886-012-0077-y; Boissin E, 2012, MOL ECOL, V21, P5728, DOI 10.1111/mec.12065; Botto E, 1998, P C TRAIN CONTR SIR, P89; Bruzzone OA, 2009, J EXP BIOL, V212, P731, DOI 10.1242/jeb.022517; BURKE HE, 1917, USDA B, V437; Carnegie AJ, 2006, ANN FOREST SCI, V63, P119, DOI 10.1051/forest:2005104; Carnegie Angus J., 2005, New Zealand Journal of Forestry Science, V35, P3; Cavey JF, 1998, P ENTOMOL SOC WASH, V100, P373; Ceballos Jimenez P., 1963, Graellsia Madrid, V20, P55; Ciesla WM., COLOBURA ALBOPLAGIAT; Collett NG, 2009, AGR FOREST ENTOMOL, V11, P283, DOI 10.1111/j.1461-9563.2008.00422.x; COPPEL HC, 1965, ANNU REV ENTOMOL, V10, P69, DOI 10.1146/annurev.en.10.010165.000441; Corley JC, 2007, ENTOMOL EXP APPL, V125, P231, DOI 10.1111/j.1570-7458.2007.00623.x; Corley JC, 2012, SIREX WOODWASP AND ITS FUNGAL SYMBIONT: RESEARCH AND MANAGEMENT OF A WORLDWIDE INVASIVE PEST, P51, DOI 10.1007/978-94-007-1960-6_4; Coyle DR, 2012, ENVIRON ENTOMOL, V41, P731, DOI 10.1603/EN11280; Czokajlo D, 1997, CAN J FOREST RES, V27, P1394, DOI 10.1139/cjfr-27-9-1394; Dajoz R., 1980, ECOLOGIE INSECTES FO, P489; Dans de Valle F, 1999, MANUAL SELVICULTURA; Dodds KI, 2007, NORTH J APPL FOR, V24, P165, DOI 10.1093/njaf/24.3.165; Dodds KJ, 2012, ENVIRON ENTOMOL, V41, P1350, DOI 10.1603/EN12180; Dodds KJ, 2012, SIREX WOODWASP AND ITS FUNGAL SYMBIONT: RESEARCH AND MANAGEMENT OF A WORLDWIDE INVASIVE PEST, P265, DOI 10.1007/978-94-007-1960-6_19; Dodds KJ, 2011, CAN J FOREST RES, V41, P1729, DOI [10.1139/X11-097, 10.1139/x11-097]; Dodds KJ, 2010, CAN J FOREST RES, V40, P212, DOI 10.1139/X09-181; Eager PT, 2011, ENVIRON ENTOMOL, V40, P1266, DOI 10.1603/EN10322; Eaton E.R., 2007, KAUFMAN FIELD GUIDE; Edmonds RL, 2000, FOREST HLTH PROTECTI; ELKINTON JS, 1990, ANNU REV ENTOMOL, V35, P571, DOI 10.1146/annurev.en.35.010190.003035; Fernandez I, 2006, ENVIRON SCI TECHNOL, V40, P2552, DOI 10.1021/es0519841; Fettig CJ, BUPRESTIS NOVEMMACUL; Gandhi KJK, 2010, BIOL INVASIONS, V12, P1839, DOI 10.1007/s10530-009-9594-1; Garnas JR, 2012, INT J PEST MANAGE, V58, P211, DOI 10.1080/09670874.2012.698764; Haack RA, 2006, CAN J FOREST RES, V36, P269, DOI 10.1139/x05-249; Haack Robert A., 1993, P503; Haack Robert A., 2001, Biological Invasions, V3, P307, DOI 10.1023/A:1015298114837; Hajek AE, 2013, MICROB ECOL, V65, P753, DOI 10.1007/s00248-013-0218-z; HALL M. J., 1968, Australian Forestry, V32, P155; Haugen DA, 2005, PEST ALERT SIREX WOO; Hawkeswood Trevor J., 1992, Giornale Italiano di Entomologia, V6, P207; Hawkeswood Trevor J., 1993, Giornale Italiano di Entomologia, V6, P313; Hoebeke E. R., 2005, Newsletter of the Michigan Entomological Society, V50, P24; Hofstetter RW, 2006, OECOLOGIA, V147, P679, DOI 10.1007/s00442-005-0312-0; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; Hurley BP, 2007, AGR FOREST ENTOMOL, V9, P159, DOI 10.1111/j.1461-9563.2007.00340.x; JACKSON D. S., 1955, NEW ZEALAND JOUR FOREST, V7, P26; Kaitaniemi P, 2007, SILVA FENN, V41, P259, DOI 10.14214/sf.295; Kausrud K, 2012, BIOL REV, V87, P34, DOI 10.1111/j.1469-185X.2011.00183.x; Klapwijk Maartje J., 2012, P429; KLITSCHER J A, 1987, New Zealand Forestry, V31, P23; Kovacs KF, 2010, ECOL ECON, V69, P569, DOI 10.1016/j.ecolecon.2009.09.004; Langor D, 2009, BIOL INVASIONS, V11, P5, DOI 10.1007/s10530-008-9327-x; Lavery Peter B., 1998, P432; Leal I, 2012, CAN J FOREST RES, V42, P1173, DOI [10.1139/X2012-058, 10.1139/x2012-058]; Lede ET, 1988, 201 EMBRAPACNPF, V20, P1; Letourneau DK, 2009, ANNU REV ECOL EVOL S, V40, P573, DOI 10.1146/annurev.ecolsys.110308.120320; Lewis NB, 1976, YIELD REGULATION S A; LIEBHOLD AM, 1995, FOREST SCI, V41, P1; Liebhold AM, 2012, FRONT ECOL ENVIRON, V10, P135, DOI 10.1890/110198; Linsley E. G., 1997, University of California Publications in Entomology, V117; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lombardero MJ, 2012, FOREST ECOL MANAG, V281, P121, DOI 10.1016/j.foreco.2012.06.036; Long SJ, 2009, CAN ENTOMOL, V141, P153, DOI 10.4039/n08-068; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Madden J.L., 1988, P407; MADDEN JL, 1975, B ENTOMOL RES, V65, P491, DOI 10.1017/S0007485300006155; Marini L, 2012, CLIMATIC CHANGE, V115, P327, DOI 10.1007/s10584-012-0463-z; MARM, 2011, CUART INV FOR NAC; MILLER D., 1935, BULL ENT RES, V26, P149, DOI 10.1017/S000748530003813X; MORGAN F D, 1989, New Zealand Journal of Forestry Science, V19, P198; Morgan F.D., 1960, NZ ENTOMOL, V2, P26, DOI DOI 10.1080/00779962.1960.9722791; Morgan RE, 2004, CAN J FOREST RES, V34, P2528, DOI 10.1139/X04-135; Neumann F. G., 1981, Australian Forestry, V44, P46; Nielsen C, 2009, MYCOL RES, V113, P1242, DOI 10.1016/j.mycres.2009.08.012; Nielson RM, 2004, ENVIRONMETRICS, V15, P119, DOI 10.1002/env.627; Orwig DA, 1998, J TORREY BOT SOC, V125, P60, DOI 10.2307/2997232; Pimentel C, 2011, AGR FOREST ENTOMOL, V13, P273, DOI 10.1111/j.1461-9563.2011.00520.x; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Poland TM, 2006, J FOREST, V104, P118; RA Ek, 2007, N CENTRAL REGION RED; Rebuffo S, 1988, AVISPA MADERA SIREX, VMinisterio de Ganaderi'a Agricultura y Pesca; Rodriguez-Soalleiro R. J., 1997, MANUAL SELVICULTURA; Ryan K, 2012, J INSECT BEHAV, V25, P453, DOI 10.1007/s10905-011-9313-5; Ryan K, 2012, ENVIRON ENTOMOL, V41, P289, DOI 10.1603/EN11275; Ryan K, 2013, CAN ENTOMOL, V145, P117, DOI 10.4039/tce.2012.96; Ryan K, 2012, AGR FOREST ENTOMOL, V14, P187, DOI 10.1111/j.1461-9563.2011.00558.x; Ryan K, 2011, CAN ENTOMOL, V143, P224, DOI 10.4039/n11-001; SAG, 2001, 6 SAG DEP PROT AGR, V6; SCION, PESTS DIS FOR NZ SQU; Seppala R, 2009, IUFRO WORLD SERIES, V22, P224; Slippers B, 2012, SIREX WOODWASP AND ITS FUNGAL SYMBIONT: RESEARCH AND MANAGEMENT OF A WORLDWIDE INVASIVE PEST, P1, DOI 10.1007/978-94-007-1960-6; SPRADBERY JP, 1978, B ENTOMOL RES, V68, P341, DOI 10.1017/S0007485300009330; Standley CR, 2012, P ENTOMOL SOC WASH, V114, P238, DOI 10.4289/0013-8797.114.2.238; Sun JH, 2013, ANNU REV ENTOMOL, V58, P293, DOI 10.1146/annurev-ento-120811-153624; Tribe GD, 1995, AFR ENTOMOL, V3, P215; Tribe GD, 2004, AFR ENTOMOL, V12, P9; USDA-APHIS, 2008, SIR WOODW; Verdugo A, 2005, FAUNA BUPRESTIDAE PE; Vicente C, 2012, EUR J PLANT PATHOL, V133, P89, DOI 10.1007/s10658-011-9924-x; Vives E, 2001, ATLAS FOTOGRAFICO CE; Wainhouse D, 2005, ECOLOGICAL METHODS F, P288; Weed AS, 2013, ECOL MONOGR, V83, P441, DOI 10.1890/13-0160.1; Wermelinger B, 2008, ECOL ENTOMOL, V33, P239, DOI 10.1111/j.1365-2311.2007.00960.x; Williamson M., 1996, BIOL INVASIONS; Wingfield MJ, 2006, INVASIVE FOREST INSE, P53; Wolf F., 1969, Bulletin de la Societe Royale Forestiere de Belgique, V76, P281; Wolf F., 1969, Bull Annls Soc r ent Belg, V105, P202; Wooding AL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0342; Work TT, 2005, BIOL INVASIONS, V7, P323, DOI 10.1007/s10530-004-1663-x; Xunta de Galicia, 1992, PLAN FOR GAL; Xunta de Galicia, 2001, MONT GAL CIFR DIR XE; Yemshanov D, 2012, BIOL INVASIONS, V14, P797, DOI 10.1007/s10530-011-0117-5; Yemshanov D, 2011, J ENVIRON MANAGE, V92, P205, DOI 10.1016/j.jenvman.2010.09.002; Yemshanov D, 2009, CAN J FOREST RES, V39, P154, DOI 10.1139/X08-164; Yemshanova D, 2010, J ENVIRON MANAGE, V91, P2535, DOI 10.1016/j.jenvman.2010.07.009; Zylstra KE, 2012, J INSECT SCI, V12, P1, DOI 10.1673/031.012.8301; Zylstra KE, 2010, AGR FOREST ENTOMOL, V12, P243, DOI 10.1111/j.1461-9563.2010.00476.x	120	24	24	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e90321	10.1371/journal.pone.0090321	http://dx.doi.org/10.1371/journal.pone.0090321			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675574	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500007
J	DiRenzo, GV; Langhammer, PF; Zamudio, KR; Lips, KR				DiRenzo, Graziella V.; Langhammer, Penny F.; Zamudio, Kelly R.; Lips, Karen R.			Fungal Infection Intensity and Zoospore Output of Atelopus zeteki, a Potential Acute Chytrid Supershedder	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; POPULATION DECLINES; DISEASE; CHYTRIDIOMYCOSIS; TEMPERATURE; DYNAMICS; SUSCEPTIBILITY; HETEROGENEITY; TRANSMISSION; SURVIVAL	Amphibians vary in their response to infection by the amphibian-killing chytrid fungus, Batrachochytrium dendrobatidis (Bd). Highly susceptible species are the first to decline and/or disappear once Bd arrives at a site. These competent hosts likely facilitate Bd proliferation because of ineffective innate and/or acquired immune defenses. We show that Atelopus zeteki, a highly susceptible species that has undergone substantial population declines throughout its range, rapidly and exponentially increases skin Bd infection intensity, achieving intensities that are several orders of magnitude greater than most other species reported. We experimentally infected individuals that were never exposed to Bd (n = 5) or previously exposed to an attenuated Bd strain (JEL427-P39; n = 3). Within seven days post-inoculation, the average Bd infection intensity was 18,213 zoospores (SE: 9,010; range: 0 to 66,928). Both average Bd infection intensity and zoospore output (i.e., the number of zoospores released per minute by an infected individual) increased exponentially until time of death (t(50) = 7.018, p, 0.001, t(46) = 3.164, p = 0.001, respectively). Mean Bd infection intensity and zoospore output at death were 4,334,422 zoospores (SE: 1,236,431) and 23.55 zoospores per minute (SE: 22.78), respectively, with as many as 9,584,158 zoospores on a single individual. The daily percent increases in Bd infection intensity and zoospore output were 35.4% (SE: 0.05) and 13.1% (SE: 0.04), respectively. We also found that Bd infection intensity and zoospore output were positively correlated (t(43) = 3.926, p<0.001). All animals died between 22 and 33 days post-inoculation (mean: 28.88; SE: 1.58). Prior Bd infection had no effect on survival, Bd infection intensity, or zoospore output. We conclude that A. zeteki, a highly susceptible amphibian species, may be an acute supershedder. Our results can inform epidemiological models to estimate Bd outbreak probability, especially as they relate to reintroduction programs.	[DiRenzo, Graziella V.; Lips, Karen R.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Langhammer, Penny F.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Zamudio, Kelly R.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	University System of Maryland; University of Maryland College Park; Arizona State University; Arizona State University-Tempe; Cornell University	DiRenzo, GV (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	gdirenzo@umd.edu	Zamudio, Kelly/R-3533-2016	Zamudio, Kelly/0000-0001-5107-6206; Lips, Karen/0000-0002-2719-1551; DiRenzo, Graziella/0000-0001-5264-4762	National Science Foundation [DEB 1120161]; National Science Foundation Graduate Research Fellowship Program; Direct For Biological Sciences [1120161] Funding Source: National Science Foundation; Division Of Environmental Biology [1120249] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank the Maryland Baltimore Zoo for permission to use A. zeteki, the National Science Foundation who funded the research (DEB 1120161), and the National Science Foundation Graduate Research Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2010, FRONT ECOL ENVIRON, V8, P522, DOI 10.1890/090057; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Becker MH, 2011, ECOHEALTH, V8, P501, DOI 10.1007/s10393-012-0743-0; Berger L., 1999, ZOOS PRINT J, V15, P184, DOI DOI 10.11609/JOTT.ZPJ.15.1.184-90; Bishop PJ, 2009, DIS AQUAT ORGAN, V84, P9, DOI 10.3354/dao02028; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Bustamante HM, 2010, INTEGR ZOOL, V5, P143, DOI 10.1111/j.1749-4877.2010.00197.x; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Cashins SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056747; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Daszak P, 2004, HERPETOL J, V14, P201; Dwyer G, 1997, AM NAT, V150, P685, DOI 10.1086/286089; Fites JS, 2013, SCIENCE, V342, P366, DOI 10.1126/science.1243316; Galvani AP, 2005, NATURE, V438, P293, DOI 10.1038/438293a; Gervasi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054490; Gopinath S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003408; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Jankowski MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072611; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; KEMPER JT, 1980, MATH BIOSCI, V48, P111, DOI 10.1016/0025-5564(80)90018-8; Kriger KM, 2006, DIS AQUAT ORGAN, V71, P149, DOI 10.3354/dao071149; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; Lampo M, 2011, BIOTROPICA, V0, P1; Langhammer PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077630; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; McCaig C, 2011, B MATH BIOL, V73, P777, DOI 10.1007/s11538-010-9603-7; Muths E, 2003, BIOL CONSERV, V110, P357, DOI 10.1016/S0006-3207(02)00239-2; Pilliod DS, 2010, CONSERV BIOL, V24, P1259, DOI 10.1111/j.1523-1739.2010.01506.x; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; R Core Team, 2012, R LANG ENV STAT COMP; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rosenblum EB, 2012, MOL ECOL, V21, P3110, DOI 10.1111/j.1365-294X.2012.05481.x; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Sarkar D., 2019, NLME LINEAR NONLINEA; Scherer RD, 2005, ECOL APPL, V15, P2150, DOI 10.1890/05-0431; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Small M, 2006, PHYSICA D, V215, P146, DOI 10.1016/j.physd.2006.01.021; Stice MJ, 2010, J WILDLIFE DIS, V46, P70, DOI 10.7589/0090-3558-46.1.70; Streicker DG, 2013, ECOL LETT, V16, P975, DOI 10.1111/ele.12122; Therneau T, 2012, PACKAGE SURVIVAL ANA; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107	48	49	49	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93356	10.1371/journal.pone.0093356	http://dx.doi.org/10.1371/journal.pone.0093356			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675899	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500113
J	Allison, JD; Bhandari, BD; McKenney, JL; Millar, JG				Allison, Jeremy D.; Bhandari, Basu D.; McKenney, Jessica L.; Millar, Jocelyn G.			Design Factors That Influence the Performance of Flight Intercept Traps for the Capture of Longhorned Beetles (Coleoptera: Cerambycidae) from the Subfamilies Lamiinae and Cerambycinae	PLOS ONE			English	Article							MULTIPLE-FUNNEL TRAPS; HOST-PLANT VOLATILES; TETROPIUM-FUSCUM F; UNITED-STATES; SCUTELLATUS COLEOPTERA; PHEROMONE COMPONENTS; ECONOMIC COSTS; PANEL TRAPS; GYPSY-MOTH; ECOLOGY	In North America, cerambycid beetles can have significant ecological and economic effects on forest ecosystems, and the rate of introduction and/or detection of exotic species is increasing. Detection and survey programs rely on semiochemical-baited intercept traps which are often ineffective for large woodborers like cerambycid beetles. This study examined the effects of flight intercept trap design on the capture of cerambycid beetles in the subfamilies Lamiinae and Cerambycinae. These subfamilies are the two largest in the Cerambycidae and they include many of the most damaging cerambycid pests and species on regulatory watch lists in North America. This study demonstrates that intercept trap design, treatment of trap surfaces with a lubricant, and the type of collection cup all influence the capture of beetles from the subfamilies Lamiinae and Cerambycinae. It also demonstrates that the addition of a large lubricant-treated collar to the bottom funnel of a multiple-funnel trap significantly increases the capture of some Lamiinae. The best trap design for both subfamilies was a lubricant treated multiple-funnel [MF] trap equipped with a wet cup and lubricant treated large collar on the bottom funnel. This design captured between 4 and 14 times more Lamiinae and Cerambycinae than commercially-available MF and panel traps.	[Allison, Jeremy D.; Bhandari, Basu D.; McKenney, Jessica L.] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA; [Millar, Jocelyn G.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	Louisiana State University System; Louisiana State University; University of California System; University of California Riverside	Allison, JD (corresponding author), Nat Resources Canada, Great Lakes Forestry Ctr, Sault Ste Marie, ON, Canada.	Jeremy.Allison@NRCan.gc.ca	Allison, Jeremy/AAQ-1461-2020	Allison, Jeremy/0000-0002-0765-3149	USDA-APHIS-PPQ [11-8130-1422]; LSU AgCenter; Canadian Forest Service	USDA-APHIS-PPQ(United States Department of Agriculture (USDA)); LSU AgCenter; Canadian Forest Service(Natural Resources CanadaCanadian Forest Service)	This work was supported by Canadian Forest Service, USDA-APHIS-PPQ award 11-8130-1422 and the LSU AgCenter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JD, 2004, CHEMOECOLOGY, V14, P123, DOI 10.1007/s00049-004-0277-1; Allison JD, 2003, ENVIRON ENTOMOL, V32, P23, DOI 10.1603/0046-225X-32.1.23; Allison JD, 2001, J CHEM ECOL, V27, P633, DOI 10.1023/A:1010353315939; Allison JD, 2012, ENVIRON ENTOMOL, V41, P1587, DOI 10.1603/EN12185; Allison JD, 2013, J INSECT BEHAV, V26, P321, DOI 10.1007/s10905-012-9349-1; Allison JD, 2011, J ECON ENTOMOL, V104, P1258, DOI 10.1603/EC11044; [Anonymous], 1995, AGR HDB; (APHIS) Animal and Plant Health Inspection Service, 2006, EX WOORD BOR BARK BE; Aukema JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024587; Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borden J.H., 1982, P74; Brockerhoff EG, 2006, CAN J FOREST RES, V36, P289, DOI [10.1139/x05-250, 10.1139/X05-250]; CHENIER JVR, 1989, CAN ENTOMOL, V121, P159, DOI 10.4039/Ent121159-2; Czokajlo D., 2001, Journal of Forest Science (Prague), V47, P34; de Groot P, 2003, J APPL ENTOMOL, V127, P548, DOI 10.1046/j.1439-0418.2003.00799.x; de Groot P, 2001, AGR FOREST ENTOMOL, V3, P107, DOI 10.1046/j.1461-9563.2001.00087.x; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Graham EE, 2010, J ECON ENTOMOL, V103, P641, DOI 10.1603/EC10013; Haack Robert A., 2003, Integrated Pest Management Reviews, V6, P253, DOI 10.1023/A:1025715200538; Hanks LM, 2013, CHEMOECOLOGY, V23, P21, DOI 10.1007/s00049-012-0116-8; Hanks LM, 2012, CAN J FOREST RES, V42, P1050, DOI [10.1139/x2012-062, 10.1139/X2012-062]; Holland JD, 2006, ENVIRON ENTOMOL, V35, P1647, DOI 10.1603/0046-225X(2006)35[1647:CLHCPT]2.0.CO;2; Imrei Z, 2013, Z NATURFORSCH C, V68, P236; Kovacs KF, 2010, ECOL ECON, V69, P569, DOI 10.1016/j.ecolecon.2009.09.004; Lacey ES, 2004, J CHEM ECOL, V30, P1493, DOI 10.1023/B:JOEC.0000042064.25363.42; Liebhold A, 2003, ECOL LETT, V6, P133, DOI 10.1046/j.1461-0248.2003.00405.x; Liebhold A. M., 1995, FOREST SCI MONOGR, V30, P1; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; LINDGREN BS, 1983, CAN ENTOMOL, V115, P299, DOI 10.4039/Ent115299-3; Lingafelter S.W., 2007, SPECIAL PUBLICATION, V3; LINSLEY EG, 1959, ANNU REV ENTOMOL, V4, P99, DOI 10.1146/annurev.en.04.010159.000531; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McIntosh RL, 2001, AGR FOREST ENTOMOL, V3, P113, DOI 10.1046/j.1461-9563.2001.00095.x; Miller DR, 2008, J ECON ENTOMOL, V101, P107, DOI 10.1603/0022-0493(2008)101[107:COABCI]2.0.CO;2; Miller DR, 2013, J ECON ENTOMOL, V106, P206, DOI 10.1603/EC12254; Mitchell RF, 2011, ENTOMOL EXP APPL, V141, P71, DOI 10.1111/j.1570-7458.2011.01167.x; Morewood WD, 2002, CAN J FOREST RES, V32, P519, DOI 10.1139/X01-224; Myers JH, 2000, TRENDS ECOL EVOL, V15, P316, DOI 10.1016/S0169-5347(00)01914-5; Nakamura K, 1999, JPN J APPL ENTOMOL Z, V43, P55, DOI 10.1303/jjaez.43.55; Nowak DJ, 2001, J ECON ENTOMOL, V94, P116, DOI 10.1603/0022-0493-94.1.116; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Rabaglia R, 2008, EARLY DETECTION RAPI; Sharov AA, 1998, ECOL APPL, V8, P1170, DOI 10.1890/1051-0761(1998)008[1170:MOSTSO]2.0.CO;2; Sharov AA, 2002, J FOREST, V100, P30; Sweeney J, 2004, ENVIRON ENTOMOL, V33, P844, DOI 10.1603/0046-225X-33.4.844; Sweeney J, 2006, ENVIRON ENTOMOL, V35, P645, DOI 10.1603/0046-225X-35.3.645; Tobin Patrick C., 2004, American Entomologist, V50, P200; Wardlaw T, 2007, BOR ROT C PERTH W AU; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; YANEGA D, 1996, ILLINOIS NATURAL HIS, V6; Yemshanov D, 2009, CAN J FOREST RES, V39, P154, DOI 10.1139/X08-164	55	29	29	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93203	10.1371/journal.pone.0093203	http://dx.doi.org/10.1371/journal.pone.0093203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671147	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000127
J	Kennedy, J; Flemer, B; Jackson, SA; Morrissey, JP; O'Gara, F; Dobson, ADW				Kennedy, Jonathan; Flemer, Burkhardt; Jackson, Stephen A.; Morrissey, John P.; O'Gara, Ferghal; Dobson, Alan D. W.			Evidence of a Putative Deep Sea Specific Microbiome in Marine Sponges	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; ANTIMICROBIAL ACTIVITIES; PHYLOGENETIC ANALYSIS; SPATIAL-DISTRIBUTION; HALICLONA-SIMULANS; SP-NOV.; DIVERSITY; COMMUNITY; BACTERIA; ARCHAEA	The microbiota of four individual deep water sponges, Lissodendoryx diversichela, Poecillastra compressa, Inflatella pellicula, and Stelletta normani, together with surrounding seawater were analysed by pyrosequencing of a region of the 16S rRNA gene common to Bacteria and Archaea. Due to sampling constraints at depths below 700 m duplicate samples were not collected. The microbial communities of L. diversichela, P. compressa and I. pellicula were typical of low microbial abundance (LMA) sponges while S. normani had a community more typical of high microbial abundance (HMA) sponges. Analysis of the deep sea sponge microbiota revealed that the three LMA-like sponges shared a set of abundant OTUs that were distinct from those associated with sponges from shallow waters. Comparison of the pyrosequencing data with that from shallow water sponges revealed that the microbial communities of all sponges analysed have similar archaeal populations but that the bacterial populations of the deep sea sponges were distinct. Further analysis of the common and abundant OTUs from the three LMA-like sponges placed them within the groups of ammonia oxidising Archaea (Thaumarchaeota) and sulphur oxidising gamma-Proteobacteria (Chromatiales). Reads from these two groups made up over 70% of all 16S rRNA genes detected from the three LMA-like sponge samples, providing evidence of a putative common microbial assemblage associated with deep sea LMA sponges.	[Kennedy, Jonathan; Flemer, Burkhardt; Jackson, Stephen A.; Morrissey, John P.; O'Gara, Ferghal; Dobson, Alan D. W.] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Ctr Marine Biotechnol, Lee Rd, Cork, Ireland; [Flemer, Burkhardt; Morrissey, John P.; O'Gara, Ferghal; Dobson, Alan D. W.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [O'Gara, Ferghal] Natl Univ Ireland Univ Coll Cork, BIOMERIT Res Ctr, Cork, Ireland; [O'Gara, Ferghal] Curtin Univ, Sch Biomed Sci, Perth, WA 6845, Australia	University College Cork; University College Cork; University College Cork; Curtin University	Dobson, ADW (corresponding author), Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Ctr Marine Biotechnol, Lee Rd, Cork, Ireland.	a.dobson@ucc.ie	Morrissey, John/AAD-2255-2019; Jackson, Stephen/J-4368-2019; Dobson, Alan D W/M-7844-2017	Jackson, Stephen/0000-0001-7869-9032; Dobson, Alan D W/0000-0002-7713-5574; Flemer, Burkhardt/0000-0003-4614-4432; Morrissey, John/0000-0001-7960-2001; O'Gara, Fergal/0000-0002-2659-0673	PharmaSea project; EU Seventh Framework Programme [312184]; Beuafort Marine Research Award; Marine Institute under the Marine Research Sub-Programme of the National Development Plan	PharmaSea project; EU Seventh Framework Programme; Beuafort Marine Research Award; Marine Institute under the Marine Research Sub-Programme of the National Development Plan	This work was supported by the PharmaSea project (www.pharma-sea.eu) funded by the EU Seventh Framework Programme (contract no. 312184) and by the Beuafort Marine Research Award, part of the Sea Change Strategy and the Strategy for Science Technology and Innovation (2006-2012), with the support of The Marine Institute under the Marine Research Sub-Programme of the National Development Plan 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano SM, 2013, MICROB ECOL, V65, P450, DOI 10.1007/s00248-012-0130-y; Brady SF, 2007, NAT PROTOC, V2, P1297, DOI 10.1038/nprot.2007.195; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Bruck WM, 2008, ISME J, V2, P335, DOI 10.1038/ismej.2007.91; Bruck WM, 2010, ISME J, V4, P686, DOI 10.1038/ismej.2009.149; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Flemer B, 2012, J APPL MICROBIOL, V112, P289, DOI 10.1111/j.1365-2672.2011.05211.x; Giles EC, 2013, FEMS MICROBIOL ECOL, V83, P232, DOI 10.1111/j.1574-6941.2012.01467.x; Gunasekera SP, 2003, J NAT PROD, V66, P1615, DOI 10.1021/np030292s; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Hentschel U, 2003, MAR MOL BIOTECHNOL, P59; Hentschel U, 2001, FEMS MICROBIOL ECOL, V35, P305, DOI 10.1111/j.1574-6941.2001.tb00816.x; Hickford SJH, 2009, BIOORGAN MED CHEM, V17, P2199, DOI 10.1016/j.bmc.2008.10.093; Jackson SA, 2012, MICROB ECOL, V64, P105, DOI 10.1007/s00248-011-0002-x; Kennedy J, 2008, ENVIRON MICROBIOL, V10, P1888, DOI 10.1111/j.1462-2920.2008.01614.x; Kennedy J, 2009, MAR BIOTECHNOL, V11, P384, DOI 10.1007/s10126-008-9154-1; Kubota N, 2007, MICROBES ENVIRONMENT, V22, P136, DOI 10.1264/jsme2.22.136; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Meyer B, 2008, MICROB ECOL, V56, P306, DOI 10.1007/s00248-007-9348-5; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moitinho-Silva L, 2014, MOL ECOL, V23, P1348, DOI 10.1111/mec.12365; Muller F, 2010, ENVIRON MICROBIOL, V12, P2371, DOI 10.1111/j.1462-2920.2010.02309.x; Nishijima M, 2010, MAR BIOTECHNOL, V12, P253, DOI 10.1007/s10126-009-9253-7; Pape T, 2006, POLAR BIOL, V29, P662, DOI 10.1007/s00300-005-0103-4; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; Radax R, 2012, ENVIRON MICROBIOL, V14, P1308, DOI 10.1111/j.1462-2920.2012.02714.x; Radax R, 2012, ENVIRON MICROBIOL, V14, P909, DOI 10.1111/j.1462-2920.2011.02661.x; Raggi L, 2013, ENVIRON MICROBIOL, V15, P1969, DOI 10.1111/1462-2920.12051; Romanenko LA, 2005, INT J SYST EVOL MICR, V55, P919, DOI 10.1099/ijs.0.63176-0; Romanenko LA, 2008, INT J SYST EVOL MICR, V58, P370, DOI 10.1099/ijs.0.65391-0; Schlappy ML, 2010, MAR BIOL, V157, P593, DOI 10.1007/s00227-009-1344-5; Schmitt S, 2012, HYDROBIOLOGIA, V687, P341, DOI 10.1007/s10750-011-0799-9; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Schmitt S, 2011, FEMS MICROBIOL ECOL, V78, P497, DOI 10.1111/j.1574-6941.2011.01179.x; Simister RL, 2012, ENVIRON MICROBIOL, V14, P517, DOI 10.1111/j.1462-2920.2011.02664.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Thiel V, 2007, MICROB ECOL, V54, P101, DOI 10.1007/s00248-006-9177-y; Thiel V, 2007, FEMS MICROBIOL ECOL, V59, P47, DOI 10.1111/j.1574-6941.2006.00217.x; Trindade-Silva AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039905; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Webster NS, 2001, MAR BIOL, V138, P843, DOI 10.1007/s002270000503; Webster NS, 2001, MAR BIOTECHNOL, V3, P600, DOI 10.1007/s10126-001-0065-7; Weisz JB, 2008, OECOLOGIA, V155, P367, DOI 10.1007/s00442-007-0910-0; White JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038204	54	43	43	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91092	10.1371/journal.pone.0091092	http://dx.doi.org/10.1371/journal.pone.0091092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670421	Green Published, gold			2022-12-25	WOS:000333677000015
J	Sun, WY; Zheng, Y; Lu, ZY; Cui, Y; Tian, Q; Xiao, SX; Liu, F; Liu, JK				Sun, Wenyan; Zheng, Yan; Lu, Zhuoyang; Cui, Yang; Tian, Qiong; Xiao, Shengxiang; Liu, Feng; Liu, Jiankang			Overexpression of S100A7 Protects LPS-Induced Mitochondrial Dysfunction and Stimulates IL-6 and IL-8 in HaCaT Cells	PLOS ONE			English	Article							EF-HAND TYPE; PSORIASIN INTERACTS; HUMAN KERATINOCYTES; OXIDATIVE STRESS; FUNCTIONAL ROLES; EPITHELIAL-CELLS; BREAST-CANCER; EXPRESSION; AUTOPHAGY; CALCIUM	Background: S100A7 (or psoriasin) is distributed in the cytoplasm of keratinocytes of normal human epidermis, and it is overexpressed in many epidermal inflammatory diseases. Lipopolysaccharide (LPS) induces mitochondrial function changes, which play important roles in multiple cellular mechanisms including inflammation. Although S100A7 expression is regulated by various factors in the human epidermis during inflammation, whether S100A7 interacts with mitochondria in keratinocytes is not clear. Objectives: Our study was designed to investigate whether S100A7 could prohibit mitochondrial dysfunction and stimulate cytokines in cultured normal HaCaT cells treated with LPS. Results: We generated HaCaT cells that constitutively express enhanced green fluorescence protein (EGFP)-S100A7 (S100A7-EGFP) or EGFP alone, as a control. Here, we show that S100A7-EGFP HaCaT cells exhibit an increase in mitochondrial DNA (mtDNA) copy number and mitochondrial membrane potential (MMP). qRT-PCR revealed that expression of three main mitochondrial biogenesis-associated genes was significantly increased: PPAR-coactivator-1alpha (PGC-1 alpha), the mitochondrial transcription factor A (Tfam) and nuclear respiratory factor-1 (NRF1). S100A7 overexpression increased mtDNA content and effectively increased intracellular adenosine 5'-triphosphate (ATP) production, while decreasing reactive oxygen species (ROS) generation. S100A7 overexpression also significantly decreased the expression of Mfn2 and increased DRP1 expression compared with control EGFP cells. S100A7 down-regulated the expression of the autophagy-related proteins Beclin-1 and LC3B. S100A7 also increased expression of IL-6 and IL-8 cytokines. Knockdown of S100A7 decreased MMP and disrupted mitochondrial homeostasis. Conclusions: These findings demonstrate that S100A7 stimulates mitochondrial biogenesis and increases mitochondrial function in HaCaT cells treated with LPS; and S100A7 also promotes secretion of IL-6 and IL-8.	[Sun, Wenyan; Lu, Zhuoyang; Cui, Yang; Liu, Jiankang] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Ctr Mitochondrial Biol & Med, Sch Life Sci & Technol,Minist Educ, Xian 710049, Peoples R China; [Sun, Wenyan; Lu, Zhuoyang; Cui, Yang; Liu, Jiankang] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Peoples R China; [Zheng, Yan; Tian, Qiong; Xiao, Shengxiang] Xi An Jiao Tong Univ, Dept Dermatol, Affiliated Hosp 2, Xian 710049, Peoples R China; [Liu, Feng] Univ Calif Irvine, Sch Med, Dept Med, Irvine, CA 92717 USA; [Liu, Feng] Univ Calif Irvine, Sch Med, Chao Family Comprehens Canc Ctr, Irvine, CA 92717 USA; [Liu, Jiankang] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Southern California	Zheng, Y (corresponding author), Xi An Jiao Tong Univ, Dept Dermatol, Affiliated Hosp 2, Xian 710049, Peoples R China.	zenyan66@126.com	Liu-Smith, Feng/AAX-7508-2020; Liu, Jiankang/A-1610-2011	Liu-Smith, Feng/0000-0003-3963-0651; Zheng, Yan/0000-0002-1380-3211; Sun, Wenyan/0000-0002-3186-5002	National Natural Science Foundation of China [81371732]; Xi'an Jiaotong University [985, 211]; New Century Excellent Talents in University; Fundamental Research Funds for the Central Universities; Changjiang Scholars and Innovative Research Team in University [PCSIRT:1171]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xi'an Jiaotong University(Xi'an Jiaotong University); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (81371732) and by projects 985 and 211 of Xi'an Jiaotong University, and was partially supported by New Century Excellent Talents in University and the Fundamental Research Funds for the Central Universities and for Changjiang Scholars and Innovative Research Team in University (PCSIRT:1171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alowami Salem, 2003, BMC Dermatol, V3, P1, DOI 10.1186/1471-5945-3-1; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Bo H, 2010, ANN NY ACAD SCI, V1201, P121, DOI 10.1111/j.1749-6632.2010.05618.x; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Broome AM, 2003, J HISTOCHEM CYTOCHEM, V51, P675, DOI 10.1177/002215540305100513; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Emberley ED, 2003, CANCER RES, V63, P1954; Enerback C, 2002, CANCER RES, V62, P43; Feng ZH, 2011, FREE RADICAL BIO MED, V50, P1437, DOI 10.1016/j.freeradbiomed.2011.03.001; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Hao JJ, 2010, J NUTR BIOCHEM, V21, P634, DOI 10.1016/j.jnutbio.2009.03.012; HOFFMANN HJ, 1994, J INVEST DERMATOL, V103, P370, DOI 10.1111/1523-1747.ep12395202; Hulse KE, 2012, J ALLERGY CLIN IMMUN, V129, pAB68, DOI 10.1016/j.jaci.2011.12.747; Kang Z, 2012, J INVEST DERMATOL, V132, pS25; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lee KC, 2007, J INVEST DERMATOL, V127, P945, DOI 10.1038/sj.jid.5700663; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li XQ, 2005, BIOCHEMISTRY-US, V44, P14688, DOI 10.1021/bi051519g; Liu JK, 2008, NEUROCHEM RES, V33, P194, DOI 10.1007/s11064-007-9403-0; Luo C, 2013, J CELL BIOCHEM, V114, P212, DOI 10.1002/jcb.24356; MADSEN P, 1991, J INVEST DERMATOL, V97, P701, DOI 10.1111/1523-1747.ep12484041; Niyonsaba F, 2008, J DERMATOL SCI, V52, P216, DOI 10.1016/j.jdermsci.2008.07.003; Perrier S, 2009, FEBS LETT, V583, P259, DOI 10.1016/j.febslet.2008.12.030; Ranger JJ, 2009, CANCER RES, V69, P6823, DOI 10.1158/0008-5472.CAN-09-1684; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Ruse M, 2003, J INVEST DERMATOL, V121, P132, DOI 10.1046/j.1523-1747.2003.12309.x; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Smart N, 2006, CARDIOVASC RES, V69, P164, DOI 10.1016/j.cardiores.2005.08.017; Takeichi T, 2010, J INVEST DERMATOL, V130, P2760, DOI 10.1038/jid.2010.203; Tan JQ, 1996, J INVEST DERMATOL, V107, P5, DOI 10.1111/1523-1747.ep12294284; Nguyen TT, 2012, J DERMATOL SCI, V68, P63, DOI 10.1016/j.jdermsci.2012.07.010; Waxman AB, 2009, AM J RESP CELL MOL, V41, P385, DOI 10.1165/rcmb.2008-0302OC; West NR, 2010, ONCOGENE, V29, P2083, DOI 10.1038/onc.2009.488; Wolf R, 2008, J IMMUNOL, V181, P1499, DOI 10.4049/jimmunol.181.2.1499; Zaccagnino P, 2012, INT J BIOCHEM CELL B, V44, P1962, DOI 10.1016/j.biocel.2012.07.024; Zheng Y, 2008, IMMUNOLOGY, V124, P357, DOI 10.1111/j.1365-2567.2007.02782.x	42	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92927	10.1371/journal.pone.0092927	http://dx.doi.org/10.1371/journal.pone.0092927			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671027	Green Published, gold			2022-12-25	WOS:000333677000092
J	Jubair, M; Atanasova, KR; Rahman, M; Klose, KE; Yasmin, M; Yilmaz, O; Morris, JG; Ali, A				Jubair, Mohammad; Atanasova, Kalina R.; Rahman, Mustafizur; Klose, Karl E.; Yasmin, Mahmuda; Yilmaz, Oezlem; Morris, J. Glenn, Jr.; Ali, Afsar			Vibrio cholerae Persisted in Microcosm for 700 Days Inhibits Motility but Promotes Biofilm Formation in Nutrient-Poor Lake Water Microcosms	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; VPS BIOSYNTHESIS GENES; O1 EL-TOR; EXOPOLYSACCHARIDE PRODUCTION; PSEUDOMONAS-AERUGINOSA; COLONY MORPHOLOGY; EXPRESSION; EVOLUTION; RESISTANCE; PHENOTYPE	Toxigenic Vibrio cholerae, ubiquitous in aquatic environments, is responsible for cholera; humans can become infected after consuming food and/or water contaminated with the bacterium. The underlying basis of persistence of V. cholerae in the aquatic environment remains poorly understood despite decades of research. We recently described a "persister" phenotype of V. cholerae that survived in nutrient-poor "filter sterilized" lake water (FSLW) in excess of 700-days. Previous reports suggest that microorganisms can assume a growth advantage in stationary phase (GASP) phenotype in response to long-term survival during stationary phase of growth. Here we report a V. cholerae GASP phenotype (GASP-700D) that appeared to result from 700 day-old persister cells stored in glycerol broth at -80 degrees C. The GASP-700D, compared to its wildtype N16961, was defective in motility, produced increased biofilm that was independent of vps (p<0.005) and resistant to oxidative stress when grown specifically in FSLW (p<0.005). We propose that V. cholerae GASP-700D represents cell populations that may better fit and adapt to stressful survival conditions while serving as a critical link in the cycle of cholera transmission.	[Jubair, Mohammad; Rahman, Mustafizur; Ali, Afsar] Univ Florida, Sch Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL 32611 USA; [Atanasova, Kalina R.; Yilmaz, Oezlem] Univ Florida, Dept Periodontol, Gainesville, FL USA; [Klose, Karl E.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Yasmin, Mahmuda] Univ Dhaka, Dept Microbiol, Dhaka 1000, Bangladesh; [Yilmaz, Oezlem; Morris, J. Glenn, Jr.; Ali, Afsar] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Texas System; University of Texas at San Antonio (UTSA); University of Dhaka; State University System of Florida; University of Florida	Ali, A (corresponding author), Univ Florida, Sch Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL 32611 USA.	aali@epi.ufl.edu	Atanasova, Kalina/V-6497-2018; Yilmaz, Ozlem/ABG-5367-2021	Atanasova, Kalina/0000-0002-2396-6196; Yilmaz, Ozlem/0000-0003-3487-7217	Department of Defense [C0654_12_UN]; National Institute of Health (NIH) [R01 AI097405, R01 AI039129]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039129, R01AI097405] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a Department of Defense grant (C0654_12_UN) awarded to Afsar Ali, and National Institute of Health (NIH) grants R01 AI097405 awarded to J. Glenn Morris Jr. and R01 AI039129 awarded to R. Bradley Sack at Johns Hopkins University. Afsar Ali is the subcontract PI of R01 AI039129 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2005, J CLIN MICROBIOL, V43, P1426, DOI 10.1128/JCM.43.3.1426-1429.2005; Ali A, 2000, INFECT IMMUN, V68, P1967, DOI 10.1128/IAI.68.4.1967-1974.2000; Ali A, 2002, APPL ENVIRON MICROB, V68, P5773, DOI 10.1128/AEM.68.11.5773-5778.2002; Ali A, 2000, INFECT IMMUN, V68, P6857, DOI 10.1128/IAI.68.12.6857-6864.2000; Balaban NQ, 2011, CURR OPIN GENET DEV, V21, P768, DOI 10.1016/j.gde.2011.10.001; Banning N, 2003, MICROBIOL-SGM, V149, P47, DOI 10.1099/mic.0.25938-0; Beyenal H, 2004, J MICROBIOL METH, V59, P395, DOI 10.1016/j.mimet.2004.08.003; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Casper-Lindley C, 2004, J BACTERIOL, V186, P1574, DOI 10.1128/JB.186.5.1574-1578.2004; COLWELL RR, 1985, BIO-TECHNOL, V3, P817, DOI 10.1038/nbt0985-817; Colwell RR, 1994, VIBRIO CHOLERAE CHOL; Correa NE, 2005, J BACTERIOL, V187, P6324, DOI 10.1128/JB.187.18.6324-6332.2005; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; DONNENBERG MS, 1993, J CLIN INVEST, V92, P1412, DOI 10.1172/JCI116717; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Finkel SE, 1999, P NATL ACAD SCI USA, V96, P4023, DOI 10.1073/pnas.96.7.4023; Fong JCN, 2010, MICROBIOL-SGM, V156, P2757, DOI 10.1099/mic.0.040196-0; Harrison JJ, 2005, ENVIRON MICROBIOL, V7, P981, DOI 10.1111/j.1462-2920.2005.00777.x; Jubair M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045187; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Klose KE, 1998, J BACTERIOL, V180, P303, DOI 10.1128/JB.180.2.303-316.1998; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Moker N, 2010, J BACTERIOL, V192, P1946, DOI 10.1128/JB.01231-09; Morris JG, 2011, EMERG INFECT DIS, V17, P2099, DOI 10.3201/eid1711.111109; Nelson EJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000187; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Prouty MG, 2001, MOL MICROBIOL, V39, P1595, DOI 10.1046/j.1365-2958.2001.02348.x; Pruzzo C, 2003, ENVIRON MICROBIOL, V5, P850, DOI 10.1046/j.1462-2920.2003.00498.x; Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1111/j.1574-6976.2002.tb00605.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Wai SN, 1998, APPL ENVIRON MICROB, V64, P3648; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x; Watnick PI, 2001, MOL MICROBIOL, V39, P223, DOI 10.1046/j.1365-2958.2001.02195.x; Yildiz FH, 2004, MOL MICROBIOL, V53, P497, DOI 10.1111/j.1365-2958.2004.04154.x; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yildiz FH, 2001, J BACTERIOL, V183, P1716, DOI 10.1128/JB.183.5.1716-1726.2001; Zinser ER, 2004, RES MICROBIOL, V155, P328, DOI 10.1016/j.resmic.2004.01.014	42	9	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92883	10.1371/journal.pone.0092883	http://dx.doi.org/10.1371/journal.pone.0092883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667909	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600098
J	Lacoste, S; Bhatia, R; Bhatia, S; O'Connor, TR				Lacoste, Sandrine; Bhatia, Ravi; Bhatia, Smita; O'Connor, Timothy R.			Granulocytes Affect Double-Strand Break Repair Assays in Primary Human Lymphocytes	PLOS ONE			English	Article							T-CELL FUNCTION; DNA-REPAIR; ADAPTIVE RESPONSE; RADIATION; BLOOD; EXPRESSION; VALIDATION; EFFICIENCY; ELISPOT	Patients who develop therapy-related myelodysplasia/acute myeloid leukemia after autologous-hematopoietic stem cell (aHCT) transplant show lower expression levels of DNA repair genes in their pre-aHCT CD34(+) cells. To investigate whether this leads to functional differences in DNA repair abilities measurable in patients, we adapted two plasmid-based host-cell reactivation assays for use in primary lymphocytes. Prior to applying these assays to patients who underwent aHCT, we wanted first to verify whether sample preparation affected repair measurements, as patient samples were simply depleted of erythrocytes (with hetastarch) prior to freezing, which is not the classical way to prepare lymphocytes prior to DNA repair experiments (with a density gradient). We show here that lymphocytes from healthy donors freshly prepared with hetastarch show systematically a higher level of double-strand break repair as compared to when prepared with a density gradient, but that most of this difference disappears after samples were frozen. Several observations points to granulocytes as the source for this effect of sample preparation on repair: 1) removal of granulocytes makes the effect disappear, 2) DSB repair measurements for the same individual correlate to the percentage of granulocytes in the sample and 3) nucleofection in presence of granulocytes increases the level of reactive oxygen species (ROS) in neighboring lymphocytes in a dose-dependent manner (R 2 of 0.95). These results indicate that co-purified granulocytes, possibly through the release of ROS at time of transfection, can lead to an enhanced repair in lymphocytes that obfuscates any evaluation of inter individual differences in repair as measured by host-cell reactivation. As a result, hetastarch-prepared samples are likely unsuitable for the assessment of DSB repair in primary cells with that type of assay. Granulocyte contamination that exists after a density gradient preparation, although much more limited, could have similar effects, but might be circumvented by freezing cells prior to analysis.	[Lacoste, Sandrine; O'Connor, Timothy R.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Bhatia, Ravi] City Hope Natl Med Ctr, Div Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA; [Bhatia, Smita] City Hope Natl Med Ctr, Dept Populat Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope	Lacoste, S (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA.	slacoste@coh.org		O'Connor, Timothy/0000-0001-5848-3592	NIH SPORE grant [5P50CA107399]; City of Hope Comprehensive Cancer Center Grant [NCI 5P30CA033572-27]; NATIONAL CANCER INSTITUTE [P30CA033572, P50CA107399] Funding Source: NIH RePORTER	NIH SPORE grant; City of Hope Comprehensive Cancer Center Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by the NIH SPORE grant (5P50CA107399, S. Forman, http://www.nih.gov/index.html) and by the City of Hope Comprehensive Cancer Center Grant (NCI 5P30CA033572-27, S. Rosen, http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso G, 2010, J IMMUNOL METHODS, V359, P28, DOI 10.1016/j.jim.2010.05.005; ATHAS WF, 1991, CANCER RES, V51, P5786; Bhatia R, 2005, J CLIN ONCOL, V23, P6699, DOI 10.1200/JCO.2005.10.330; Chakraborty S, 2009, J CLIN ONCOL, V27, P791, DOI 10.1200/JCO.2008.17.1033; Cherng JY, 1999, J CONTROL RELEASE, V60, P343, DOI 10.1016/S0168-3659(99)00089-9; De Rose R, 2005, J IMMUNOL METHODS, V297, P177, DOI 10.1016/j.jim.2004.12.009; Decordier I, 2010, MUTAT RES-REV MUTAT, V705, P107, DOI 10.1016/j.mrrev.2010.05.002; Gafter-Gvili A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068341; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Li L, 2011, CANCER CELL, V20, P591, DOI 10.1016/j.ccr.2011.09.011; Manning G, 2013, INT J RADIAT BIOL, V89, P512, DOI 10.3109/09553002.2013.769694; McKenna KC, 2009, J IMMUNOL METHODS, V341, P68, DOI 10.1016/j.jim.2008.10.019; Mendez P, 2011, DNA REPAIR, V10, P603, DOI 10.1016/j.dnarep.2011.04.001; Modi H, 2011, LEUKEMIA, V25, P305, DOI 10.1038/leu.2010.257; NICKOLOFF JA, 1992, ANAL BIOCHEM, V205, P237, DOI 10.1016/0003-2697(92)90429-B; Nose I, 2013, DNA REPAIR, V12, P508, DOI 10.1016/j.dnarep.2013.04.021; Olemukan RE, 2010, CLIN VACCINE IMMUNOL, V17, P910, DOI 10.1128/CVI.00492-09; Saini D, 2012, MOL CELL BIOCHEM, V364, P271, DOI 10.1007/s11010-012-1227-9; Schmielau J, 2001, CANCER RES, V61, P4756; Secretan MB, 2004, MUTAT RES-FUND MOL M, V554, P351, DOI 10.1016/j.mrfmmm.2004.05.016; Singh S, 2009, DOSE-RESPONSE, V7, P193, DOI 10.2203/dose-response.09-001.Singh; WOLFF S, 1988, INT J RADIAT BIOL, V53, P39, DOI 10.1080/09553008814550401; Wolff S, 1998, ENVIRON HEALTH PERSP, V106, P277, DOI 10.2307/3433927; Wolff S, 1996, MUTAT RES-FUND MOL M, V358, P135, DOI 10.1016/S0027-5107(96)00114-5; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558	25	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93185	10.1371/journal.pone.0093185	http://dx.doi.org/10.1371/journal.pone.0093185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667872	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600155
J	Xu, ZW; Zhang, XY; Xie, J; Yuan, GF; Tang, XZ; Sun, XM; Yu, GR				Xu, Zhiwei; Zhang, Xinyu; Xie, Juan; Yuan, Guofu; Tang, Xinzhai; Sun, Xiaomin; Yu, Guirui			Total Nitrogen Concentrations in Surface Water of Typical Agro- and Forest Ecosystems in China, 2004-2009	PLOS ONE			English	Article							TAIHU LAKE REGION; LAND-USE; RIVER-BASIN; NEW-ZEALAND; ACID-RAIN; MANAGEMENT; STREAMS; AGRICULTURE; CATCHMENT; POLLUTION	We assessed the total nitrogen (N) concentrations of 28 still surface water (lake and pond), and 42 flowing surface water (river), monitoring sites under 29 typical terrestrial ecosystems of the Chinese Ecosystem Research Network (CERN) using monitoring data collected between 2004 and 2009. The results showed that the median total N concentrations of still surface water were significantly higher in the agro- (1.5 mg.L-1) and oasis agro- ecosystems (1.8 mg.L-1) than in the forest ecosystems (1.0 mg.L-1). This was also the case for flowing surface water, with total N concentrations of 2.4 mg.L-1, 1.8 mg.L-1 and 0.5 mg.L-1 for the agro-, oasis agro- and forest ecosystems, respectively. In addition, more than 50% of the samples in agro- and oasis agro- ecosystems were seriously polluted (>1.0 mg.L-1) by N. Spatial analysis showed that the total N concentrations in northern and northwestern regions were higher than those in the southern region for both still and flowing surface waters under agro- and oasis agro- ecosystems, with more than 50% of samples exceeding 1.0 mg.L-1 (the Class III limit of the Chinese National Quality Standards for Surface Waters) in surface water in the northern region. Nitrogen pollution in agro- ecosystems is mainly due to fertilizer applications, while the combination of fertilizer and irrigation exacerbates nitrogen pollution in oasis agro- ecosystems.	[Xu, Zhiwei; Zhang, Xinyu; Xie, Juan; Yuan, Guofu; Tang, Xinzhai; Sun, Xiaomin; Yu, Guirui] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Zhang, XY (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.	zhangxy@igsnrr.ac.cn	于, 贵瑞/C-1768-2014; yuan, guo fu/Q-1554-2016	于, 贵瑞/0000-0002-1859-8966; Tang, Xinzhai/0000-0003-1072-9172; yuan, guo fu/0000-0002-6945-5017; Xie, Juan/0000-0002-4170-9273	Key Direction in Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-EW-310]; National Natural Science Foundation of China [41171153]	Key Direction in Knowledge Innovation Program of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the Key Direction in Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-EW-310) and the National Natural Science Foundation of China (No. 41171153). The authors declare that no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Cobelas M, 2008, ENVIRON POLLUT, V156, P261, DOI 10.1016/j.envpol.2008.02.016; [Anonymous], 2001, ACTA ECOL SIN, DOI DOI 10.3321/J.ISSN:1000-0933.2001.12.006; BAO QS, 1996, GEOGRAPHICAL SCI, V16, P66; Barton L, 2006, AGR WATER MANAGE, V80, P160, DOI 10.1016/j.agwat.2005.07.011; Beaudoin N, 2005, AGR ECOSYST ENVIRON, V111, P292, DOI 10.1016/j.agee.2005.06.006; Bergstrom AK, 2006, GLOBAL CHANGE BIOL, V12, P635, DOI 10.1111/j.1365-2486.2006.01129.x; Boers PCM, 1996, WATER SCI TECHNOL, V33, P183, DOI 10.1016/0273-1223(96)00229-6; Boesch DF, 2001, J ENVIRON QUAL, V30, P303, DOI 10.2134/jeq2001.302303x; [蔡龙炎 Cai Longyan], 2010, [地球与环境, Earth and Environment], V38, P235; Cang HJ, 2004, TROPICAL GEOGRAPHY, V24, P332; Chen LD, 2005, J ENVIRON SCI, V17, P224; Davies JM, 2003, J ENVIRON MANAGE, V68, P273, DOI 10.1016/S0301-4797(03)00070-7; Dayyani S, 2012, T ASABE, V55, P389; Dodds WK, 2000, J N AM BENTHOL SOC, V19, P186, DOI 10.2307/1468291; Duggan IC, 2002, NEW ZEAL J MAR FRESH, V36, P831, DOI 10.1080/00288330.2002.9517136; GALLOWAY JN, 1995, GLOBAL BIOGEOCHEM CY, V9, P235, DOI 10.1029/95GB00158; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; General Administration of Quality Supervision and Quarantine of China, 2002, 186682002 GB; Gorham E., 1998, ENVIRON SCI POLICY, V1, P153, DOI [DOI 10.1016/S1462-9011(98)00025-2), 10.1016/S1462-9011(98)00025-2, DOI 10.1016/S1462-9011(98)00025-2]; He B, 2009, WATER SCI TECHNOL, V60, P2009, DOI 10.2166/wst.2009.596; He B, 2009, ECOL MODEL, V220, P2325, DOI 10.1016/j.ecolmodel.2009.05.018; [胡玉婷 Hu Yuting], 2011, [土壤, Soils], V43, P19; Huang Z. L, 1994, ACTA PHYTOECOLOGICA, V18, P194; ISERMANN K, 1990, FERT RES, V26, P253, DOI 10.1007/BF01048764; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kaushal SS, 2011, ENVIRON SCI TECHNOL, V45, P8225, DOI 10.1021/es200779e; Kemp MJ, 2001, BIOGEOCHEMISTRY, V53, P125, DOI 10.1023/A:1010707632340; Kronvang B, 1996, WATER SCI TECHNOL, V33, P81, DOI 10.1016/0273-1223(96)00217-X; Krusche AV, 2003, ENVIRON POLLUT, V121, P389, DOI 10.1016/S0269-7491(02)00235-X; Kvitek T, 2009, PHYS CHEM EARTH, V34, P541, DOI 10.1016/j.pce.2008.07.003; Larned ST, 2004, NEW ZEAL J MAR FRESH, V38, P347, DOI 10.1080/00288330.2004.9517243; Lassaletta L, 2009, SCI TOTAL ENVIRON, V407, P6034, DOI 10.1016/j.scitotenv.2009.08.002; Letcher RA, 2005, ENVIRON MODELL SOFTW, V20, P93, DOI 10.1016/j.envsoft.2004.01.003; Lewis WM, 2011, INLAND WATERS, V1, P1, DOI 10.5268/IW-1.1.384; Li J, 2010, ENVIRON MONIT ASSESS, V169, P335, DOI 10.1007/s10661-009-1174-4; Likens GE, 2006, BIOGEOCHEMISTRY, V78, P1, DOI 10.1007/s10533-005-2024-2; Liu ZD, 2003, J NATURAL RESOURCES, V16, P467; McKee LJ, 2001, MAR FRESHWATER RES, V52, P235, DOI 10.1071/MF99025; [孟令尧 MENG Ling-yao], 2009, [地理与地理信息科学, Geography and Geo-information Science], V25, P95; Mian IA, 2010, SCI TOTAL ENVIRON, V408, P702, DOI 10.1016/j.scitotenv.2009.11.020; Mouri G, 2011, J ENVIRON MANAGE, V92, P1837, DOI 10.1016/j.jenvman.2011.03.005; Mueller-Warrant GW, 2012, J SOIL WATER CONSERV, V67, P183, DOI 10.2489/jswc.67.3.183; National Research Council, 1993, SOIL WAT QUAL AG AGR; Nie SW, 2009, AGR SCI CHINA, V8, P843, DOI 10.1016/S1671-2927(08)60286-2; Novotny V., 2005, P INT WORKSH DO FERT; OECD, 1982, EUTR WAT MON ASS CON, DOI DOI 10.1002/IROH.19840690206; Ometo JPHB, 2000, FRESHWATER BIOL, V44, P327, DOI 10.1046/j.1365-2427.2000.00557.x; Ren YF, 2014, FRONT ENV SCI ENG, V8, P106, DOI 10.1007/s11783-012-0474-z; Roche LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068127; SCHINDLER DW, 1988, SCIENCE, V239, P149, DOI 10.1126/science.239.4836.149; Shepard R, 2000, J SOIL WATER CONSERV, V55, P63; Smil V, 1999, GLOBAL BIOGEOCHEM CY, V13, P647, DOI 10.1029/1999GB900015; STODDARD JL, 1994, ADV CHEM SER, V237, P223; The Central People's Government of the People's Republic of China, 2012, GAZETTE STAT COUNCIL, V11, P51; Tian YH, 2007, PEDOSPHERE, V17, P445, DOI 10.1016/S1002-0160(07)60054-X; U.S. EPA, 2002, NAT REC WAT QUAL CRI; USEPA, 2000, EPA822B00002; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; [王丽香 WANG Li-xiang], 2009, [土壤, Soils], V41, P402; Xie J, 2014, FRONT ENV SCI ENG, V8, P561, DOI 10.1007/s11783-013-0601-5; Xie YX, 2007, PEDOSPHERE, V17, P200, DOI 10.1016/S1002-0160(07)60026-5; Xu Hai, 2008, Shengtaixue Zazhi, V27, P43; Yang A. L., 1999, TECHNIQUES EQUIPMENT, V7, P60; Yuan G. F., 2007, WATER MONITORING PRO; Zhang D, 2009, HYDROLOG SCI J, V54, P316, DOI 10.1623/hysj.54.2.316; Zhang FuSuo, 2008, Acta Pedologica Sinica, V45, P915; Zhang XY, 2013, J ENVIRON SCI-CHINA, V25, P1007, DOI 10.1016/S1001-0742(12)60139-9; [张颖 ZHANG Ying], 2006, [生态学报, Acta Ecologica Sinica], V26, P1633, DOI 10.1016/S1872-2032(06)60026-7; Zhang Z, 2008, SCI TOTAL ENVIRON, V402, P113, DOI 10.1016/j.scitotenv.2008.04.045; Zhao SZ, 2003, NW GEOLOGY, V36, P92; [朱波 ZHU Bo], 2006, [山地学报, Journal of Mountain Science], V24, P601; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	72	15	18	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92850	10.1371/journal.pone.0092850	http://dx.doi.org/10.1371/journal.pone.0092850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667701	Green Published, gold			2022-12-25	WOS:000333675600091
J	Jia, YJ; Peng, LW; Rao, Q; Xing, HY; Huai, L; Yu, P; Chen, YR; Wang, CC; Wang, M; Mi, YC; Wang, JX				Jia, Yujiao; Peng, Leiwen; Rao, Qing; Xing, Haiyan; Huai, Lei; Yu, Pei; Chen, Yirui; Wang, Cuicui; Wang, Min; Mi, Yingchang; Wang, Jianxiang			Oncogene iASPP enhances self-renewal of hematopoietic stem cells and facilitates their resistance to chemotherapy and irradiation	FASEB JOURNAL			English	Article						transgenic; self-renewal; HSC; antiapoptosis	ACUTE MYELOID-LEUKEMIA; CANCER CELLS; P53; EXPRESSION; APOPTOSIS; ASPP; GENE; FAMILY; DEATH; MICE	iASPP is a member of the apoptosisstimulating proteins of p53 (ASPP) family and negatively regulates the apoptotic function of p53. In a hematopoietic system, overexpression of iASPP results in blockage of apoptosis, which may play a role in regulating hematopoietic stem cell (HSC) numbers. To address this, we first analyzed the expression of iASPP in patients with acute leukemia (AL) and found it was highly expressed in patients with AL. We further established a transgenic mouse model in which human iASPP was specifically expressed in hematopoietic cells. Overexpression of iASPP led to an increase in the proportion of long-term HSCs, short-term HSCs, multipotent progenitors, and common myeloid progenitor. HSCs from iASPP transgenic mice had an advantage in long-term reconstitution potential. In addition, the hematopoietic cells from iASPP transgenic mice exhibited a significantly lower level of p53 dependent apoptosis. After irradiation damage, hematopoietic cells of iASPP transgenic mice had a higher level of gamma-H2AX expression, which lasted for a longer time. These results provide the first evidence that the iASPP can increase HSC populations and reconstitution capacity. Interestingly, in response to cell damage stimuli, hematopoietic cells can be protected against apoptosis by iASPP; meanwhile these apoptosis-resistant cells would have more mutation accumulation, which might be the potential risk for malignant transformation.	[Jia, Yujiao; Peng, Leiwen; Rao, Qing; Xing, Haiyan; Huai, Lei; Yu, Pei; Chen, Yirui; Wang, Cuicui; Wang, Min; Mi, Yingchang; Wang, Jianxiang] Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, 288 Nanjing Rd, Tianjin 300020, Peoples R China; [Jia, Yujiao; Peng, Leiwen; Rao, Qing; Xing, Haiyan; Huai, Lei; Yu, Pei; Chen, Yirui; Wang, Cuicui; Wang, Min; Mi, Yingchang; Wang, Jianxiang] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin 300020, Peoples R China; [Jia, Yujiao; Peng, Leiwen; Rao, Qing; Xing, Haiyan; Huai, Lei; Yu, Pei; Chen, Yirui; Wang, Cuicui; Wang, Min; Mi, Yingchang; Wang, Jianxiang] Peking Union Med Coll, Tianjin 300020, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, JX (corresponding author), Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, 288 Nanjing Rd, Tianjin 300020, Peoples R China.	wangjx@ihcams.ac.cn	CHEN, YIRUI/R-5720-2019		National Natural Science Foundation of China [81270635, 81090412]; National Basic Research Program of China [2011CB964801]; Tianjin Applied Fundamental Research Planning Key Project [13JCZDJC29900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Tianjin Applied Fundamental Research Planning Key Project	This work is supported by the National Natural Science Foundation of China (81270635, 81090412), the National Basic Research Program of China (2011CB964801), and the Tianjin Applied Fundamental Research Planning Key Project (13JCZDJC29900). The authors declare no conflicts of interest. The authors thank Dr. Lu Xin, professor at the Ludwig Institute for Cancer Research (Oxford, UK), for providing pcDNA3.1-WT-iASPP-V5. The authors also thank Prof. J. M. Adams (Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia), who kindly provided the HS21/45-vav vector.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Chen JF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-694; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Domen J, 1999, MOL MED TODAY, V5, P201, DOI 10.1016/S1357-4310(99)01464-1; FENAUX P, 1992, BRIT J HAEMATOL, V80, P178, DOI 10.1111/j.1365-2141.1992.tb08897.x; Hasty P, 2005, MECH AGEING DEV, V126, P71, DOI 10.1016/j.mad.2004.09.036; Jiang LL, 2011, CLIN CANCER RES, V17, P6924, DOI 10.1158/1078-0432.CCR-11-0588; Jude CD, 2008, CELL CYCLE, V7, P586, DOI 10.4161/cc.7.5.5549; Laska MJ, 2007, EXP CELL RES, V313, P2611, DOI 10.1016/j.yexcr.2007.05.006; Liu H, 2009, LEUKEMIA RES, V33, P1243, DOI 10.1016/j.leukres.2009.02.016; Liu WK, 2010, ONKOLOGIE, V33, P500, DOI 10.1159/000319692; LOCOCO F, 1995, EUR J HAEMATOL, V55, P1; Lu B, 2010, GASTROENTEROLOGY, V139, P2183, DOI 10.1053/j.gastro.2010.06.049; Meng AM, 2003, CANCER RES, V63, P5414; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Ogilvy S, 1998, BLOOD, V91, P419, DOI 10.1182/blood.V91.2.419.419_419_430; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Schnell MA, 2002, HUM GENE THER, V13, P155, DOI 10.1089/10430340152712700; Sgroi DC, 1999, CANCER RES, V59, P5656; Slee EA, 2004, ONCOGENE, V23, P9007, DOI 10.1038/sj.onc.1208088; Sullivan A, 2007, BRIT J CANCER, V96, P196, DOI 10.1038/sj.bjc.6603525; TRECCA D, 1994, AM J HEMATOL, V46, P304, DOI 10.1002/ajh.2830460409; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Vilasova Z, 2008, ACTA BIOCHIM POL, V55, P381, DOI 10.18388/abp.2008_3086; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662; Zhang B, 2011, PROSTATE CANCER P D, V14, P219, DOI 10.1038/pcan.2011.25; Zhang XW, 2007, J MOL BIOL, V368, P1162, DOI 10.1016/j.jmb.2007.03.001; Zhang XW, 2005, LEUKEMIA RES, V29, P179, DOI 10.1016/j.leukres.2004.07.001	33	21	24	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2816	2827		10.1096/fj.13-244632	http://dx.doi.org/10.1096/fj.13-244632			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24668753				2022-12-25	WOS:000337949400008
J	Jonas, JB; Holbach, L; Panda-Jonas, S				Jonas, Jost B.; Holbach, Leonard; Panda-Jonas, Songhomitra			Scleral Cross Section Area and Volume and Axial Length	PLOS ONE			English	Article							FORM-DEPRIVATION MYOPIA; TREE SHREW SCLERA; INTRAOCULAR SPACE; REFRACTIVE-ERROR; GENE-EXPRESSION; LAMINA-CRIBROSA; GROWTH; CHICK; EYE; PREVALENCE	Purpose: To examine whether the scleral cross sectional area and estimated scleral volume are associated with a longer axial length in human eyes. Methods: Histologic anterior-posterior sections running through the pupil and the optic nerve head were examined. Using a light microscope, we measured the thickness of the sclera at the limbus, ora serrata, equator, midpoint between equator and posterior pole (MPEPP), peripapillary region and posterior pole. Additionally we determined the length and the cross section area of the sclera. Results: The histomorphometric study included 214 human globes of 214 subjects (mean age: 62.5 +/- 13.9 years) (147 eyes enucleated due to malignant choroidal melanoma or due to other non-glaucomatous reasons; 67 eyes enucleated due to secondary angle-closure glaucoma). Mean axial length was 25.1 +/- 1.8 mm (median: 24.0 mm; range: 20-35 mm). Scleral thickness measurements decreased with increasing axial length for values taken at the equator (P = 0.008; correlation coefficient r = -0.18), MPEPP (P<0.001; r: -0.47), optic nerve head border (P<0.001; r = -0.47) and posterior pole (P<0.001; r = -0.54). Scleral cross section area decreased significantly with increasing axial lengths for the regions at or behind the equator (P = 0.002; r = -0.21), at or behind the MPEPP (P = 0.001; r = -0.25), and at or behind the optic nerve head border (P = 0.001; r = -0.24). Scleral volume measurements were not significantly associated with axial length Conclusions: Despite an associated increase in surface area, eyes with longer axial length do not have an increase in scleral volume. It may point against a scleral volume enlargement to play a role in the process of axial elongation.	[Jonas, Jost B.; Panda-Jonas, Songhomitra] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Mannheim, Germany; [Holbach, Leonard] Univ Erlangen Nurnberg, Dept Ophthalmol, Erlangen, Germany	Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg	Jonas, JB (corresponding author), Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Mannheim, Germany.	Jost.Jonas@medma.uni-heidelberg.de			Open-Access-Publikationsfonds of the University Heidelberg	Open-Access-Publikationsfonds of the University Heidelberg	Open-Access-Publikationsfonds of the University Heidelberg provided the publication funds for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVETISOV ES, 1983, METAB PEDIATR SYST O, V7, P183; Bryant MR, 1998, J THEOR BIOL, V193, P613, DOI 10.1006/jtbi.1998.0727; Congdon N, 2008, INVEST OPHTH VIS SCI, V49, P2888, DOI 10.1167/iovs.07-1160; Cui W, 2004, EXP EYE RES, V78, P275, DOI 10.1016/j.exer.2003.10.007; CURTIN BJ, 1979, ARCH OPHTHALMOL-CHIC, V97, P912, DOI 10.1001/archopht.1979.01020010470017; Fang F, 2013, INVEST OPHTH VIS SCI, V54, P7887, DOI 10.1167/iovs.13-11999; Frost MR, 2012, INVEST OPHTH VIS SCI, V53, P322, DOI 10.1167/iovs.11-8354; Guggenheim JA, 1996, INVEST OPHTH VIS SCI, V37, P1380; Guo L, 2013, INVEST OPHTH VIS SCI, V54, P6806, DOI 10.1167/iovs.13-12551; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; Heine, 1899, ARCH AUGENHEILKD, V38, P277; Jonas JB, 2004, INVEST OPHTH VIS SCI, V45, P2660, DOI 10.1167/iovs.03-1363; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; Jones BE, 1996, EXP EYE RES, V63, P369, DOI 10.1006/exer.1996.0127; Lin Z, 2008, J OCUL PHARMACOL TH, V24, P543, DOI 10.1089/jop.2008.0041; Mathis U, 2010, EXP EYE RES, V90, P780, DOI 10.1016/j.exer.2010.03.014; McBrien NA, 2000, INVEST OPHTH VIS SCI, V41, P3713; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; McBrien NA, 2001, INVEST OPHTH VIS SCI, V42, P2179; McBrien NA, 2009, OPTOMETRY VISION SCI, V86, P23, DOI 10.1097/OPX.0b013e3181940669; Metlapally R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078984; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Nangia V, 2010, OPHTHALMOLOGY, V117, P705, DOI 10.1016/j.ophtha.2009.09.003; Norman RE, 2010, EXP EYE RES, V90, P277, DOI 10.1016/j.exer.2009.11.001; Olsen TW, 1998, AM J OPHTHALMOL, V125, P237, DOI 10.1016/S0002-9394(99)80096-8; Penha AM, 2011, MOL VIS, V17, P1436; Phillips JR, 2000, INVEST OPHTH VIS SCI, V41, P2028; Rada JA, 2000, INVEST OPHTH VIS SCI, V41, P2050; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Seet B, 2001, BRIT J OPHTHALMOL, V85, P521, DOI 10.1136/bjo.85.5.521; Siegwart JT, 2002, INVEST OPHTH VIS SCI, V43, P2067; Tse DY, 2007, INVEST OPHTH VIS SCI, V48, P5352, DOI 10.1167/iovs.07-0383; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Wang YX, 2006, AM J OPHTHALMOL, V141, P1078, DOI 10.1016/j.ajo.2006.01.023; Wildsoet CF, 2000, VISION RES, V40, P3273, DOI 10.1016/S0042-6989(00)00138-3; Wildsoet CF, 1997, OPHTHAL PHYSL OPT, V17, P279, DOI 10.1111/j.1475-1313.1997.tb00059.x; Wong TY, 2000, INVEST OPHTH VIS SCI, V41, P2486; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035	38	25	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93551	10.1371/journal.pone.0093551	http://dx.doi.org/10.1371/journal.pone.0093551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681550	Green Submitted, Green Published, gold			2022-12-25	WOS:000333678100052
J	Lerche, S; Hobert, M; Brockmann, K; Wurster, I; Gaenslen, A; Hasmann, S; Eschweiler, GW; Maetzler, W; Berg, D				Lerche, Stefanie; Hobert, Markus; Brockmann, Kathrin; Wurster, Isabel; Gaenslen, Alexandra; Hasmann, Sandra; Eschweiler, Gerhard W.; Maetzler, Walter; Berg, Daniela			Mild Parkinsonian Signs in the Elderly - Is There an Association with PD? Crossectional Findings in 992 Individuals	PLOS ONE			English	Article							SLEEP BEHAVIOR DISORDER; OLDER-PEOPLE; DISEASE; RISK; POPULATION; PREVALENCE; PATHOLOGY; DEMENTIA; WALKING	Background: Mild parkinsonian signs (MPS) are common in the elderly population, and have been associated with vascular diseases, mild cognitive impairment and dementia; however their relation to Parkinson's disease (PD) is unclear. Hypothesizing that individuals with MPS may reflect a pre-stage of PD, i.e. a stage in which the nigrostriatal system is already affected although to a milder degree than at the time of PD diagnosis, aim of this study was to evaluate the similarities between MPS and PD. Methods: The TREND study is a prospective cross-sectional cohort study in individuals >50 years with biennial assessments designed to identify markers for an earlier diagnosis of Parkinson's and Alzheimer's disease. For this substudy 992 individuals were included for analyses (892 controls, 73 MPS individuals, 27 PD patients). Parameters defining risk of PD (sex, age, positive family history), prodromal markers (hyposmia, REM sleep behavior disorder, depression and autonomic failure) as well as quantitative fine motor, axial motor and cognitive parameters were compared between the three cohorts. Results: As expected, PD patients differed from controls with regard to 12 of 15 of the assessed parameters. MPS individuals differed significantly from controls in 12 of the PD-associated parameters, but differed from PD only in 5 parameters. Conclusion: This study shows that individuals with MPS share many prodromal and clinical markers of PD with PD patients, implying that either a common dynamic process or similar constitutional factors occur in MPS individuals and PD patients.	[Lerche, Stefanie; Hobert, Markus; Brockmann, Kathrin; Wurster, Isabel; Gaenslen, Alexandra; Hasmann, Sandra; Maetzler, Walter; Berg, Daniela] Univ Tubingen, Ctr Neurol, Dept Neurodegenerat, Tubingen, Germany; [Lerche, Stefanie; Hobert, Markus; Brockmann, Kathrin; Wurster, Isabel; Gaenslen, Alexandra; Hasmann, Sandra; Maetzler, Walter; Berg, Daniela] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Lerche, Stefanie; Hobert, Markus; Brockmann, Kathrin; Wurster, Isabel; Gaenslen, Alexandra; Hasmann, Sandra; Maetzler, Walter; Berg, Daniela] Univ Tubingen, German Ctr Neurodegenerat Dis, Tubingen, Germany; [Eschweiler, Gerhard W.] Univ Tubingen Hosp, Geriatr Ctr, Tubingen, Germany; [Eschweiler, Gerhard W.] Univ Tubingen Hosp, Dept Psychiat & Psychotherapy, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Lerche, S (corresponding author), Univ Tubingen, Ctr Neurol, Dept Neurodegenerat, Tubingen, Germany.	Stefanie.lerche@uni-tuebingen.de	Berg, Daniela/A-8728-2019; Maetzler, Walter/AAE-5831-2020; Hobert, Markus A./AAR-3234-2020; Maetzler, Walter/A-6796-2011	Berg, Daniela/0000-0001-5796-5442; Maetzler, Walter/0000-0002-5945-4694; Hobert, Markus A./0000-0002-7558-8107; Maetzler, Walter/0000-0002-5945-4694	UCB	UCB(UCB Pharma SA)	This analysis of the TREND study was financially supported by a grant of UCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bennett DA, 1996, NEW ENGL J MED, V334, P71, DOI 10.1056/NEJM199601113340202; Berg Daniela, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS195, DOI 10.1016/S1353-8020(11)70061-X; Ble A, 2005, J AM GERIATR SOC, V53, P410, DOI 10.1111/j.1532-5415.2005.53157.x; Bleom BR, 2006, J NEUROL SCI, V248, P196, DOI 10.1016/j.jns.2006.05.010; Bock O, 2008, IEEE ENG MED BIOL, V27, P23, DOI 10.1109/MEMB.2008.919497; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Drane DL, 2002, NEUROPSY NEUROPSY BE, V15, P39; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hobert MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027831; Hummel T, 2001, ANN OTO RHINOL LARYN, V110, P976, DOI 10.1177/000348940111001015; Iranzo A, 2013, LANCET NEUROL, V12, P443, DOI 10.1016/S1474-4422(13)70056-5; Lezak M, 1995, ORIENTATION ATTENTIO, P335; Lindemann U, 2010, MOVEMENT DISORD, V25, P1040, DOI 10.1002/mds.23023; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Louis ED, 2004, ARCH NEUROL-CHICAGO, V61, P1273, DOI 10.1001/archneur.61.8.1273; Louis ED, 2004, MOVEMENT DISORD, V19, P268, DOI 10.1002/mds.20013; Louis ED, 2003, NEUROLOGY, V61, P24, DOI 10.1212/01.WNL.0000072330.07328.D6; Louis ED, 2005, NEUROLOGY, V64, P1157, DOI 10.1212/01.WNL.0000156157.97411.5E; Louis ED, 2008, MOVEMENT DISORD, V23, P524, DOI 10.1002/mds.21777; Louis ED, 2007, MOVEMENT DISORD, V22, P1681, DOI 10.1002/mds.21433; Louis ED, 2010, MOVEMENT DISORD, V25, P172, DOI 10.1002/mds.22943; LundinOlsson L, 1997, LANCET, V349, P617, DOI 10.1016/S0140-6736(97)24009-2; Maetzler W, 2012, MOVEMENT DISORD, V27, P627, DOI 10.1002/mds.24973; Marder K, 1996, NEUROLOGY, V47, P155, DOI 10.1212/WNL.47.1.155; Postuma RB, 2012, BRAIN, V135, P1860, DOI 10.1093/brain/aws093; Postuma RB, 2010, J NEUROL NEUROSUR PS, V81, P1008, DOI 10.1136/jnnp.2009.174748; Postuma RB, 2012, MOVEMENT DISORD, V27, P617, DOI 10.1002/mds.24996; RICHARDS M, 1993, NEUROLOGY, V43, P2184, DOI 10.1212/WNL.43.11.2184; Ross G Webster, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS199, DOI 10.1016/S1353-8020(11)70062-1; Ross GW, 2004, ANN NEUROL, V56, P532, DOI 10.1002/ana.20226; Schrodt LA, 2004, GAIT POSTURE, V19, P279, DOI 10.1016/S0966-6362(03)00067-5; Stiasny-Kolster K, 2007, MOVEMENT DISORD, V22, P2386, DOI 10.1002/mds.21740; Uemura Y, 2013, ACTA NEUROL SCAND; Wenning GK, 2004, MOVEMENT DISORD, V19, P1391, DOI 10.1002/mds.20255; Wilson RS, 2003, ARCH NEUROL-CHICAGO, V60, P539, DOI 10.1001/archneur.60.4.539; Zhou GQ, 2010, J CLIN NEUROSCI, V17, P173, DOI 10.1016/j.jocn.2009.07.102	37	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92878	10.1371/journal.pone.0092878	http://dx.doi.org/10.1371/journal.pone.0092878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675747	gold, Green Submitted, Green Published			2022-12-25	WOS:000333677500049
J	Waite, IR; Kennen, JG; May, JT; Brown, LR; Cuffney, TF; Jones, KA; Orlando, JL				Waite, Ian R.; Kennen, Jonathan G.; May, Jason T.; Brown, Larry R.; Cuffney, Thomas F.; Jones, Kimberly A.; Orlando, James L.			Stream Macroinvertebrate Response Models for Bioassessment Metrics: Addressing the Issue of Spatial Scale	PLOS ONE			English	Article							FISH ASSEMBLAGE STRUCTURE; ALTERED FLOW REGIMES; PREDICTIVE MODELS; BENTHIC MACROINVERTEBRATES; BIOLOGICAL CONDITION; LAND-USE; URBANIZATION; INVERTEBRATE; HABITAT; CLASSIFICATION	We developed independent predictive disturbance models for a full regional data set and four individual ecoregions (Full Region vs. Individual Ecoregion models) to evaluate effects of spatial scale on the assessment of human landscape modification, on predicted response of stream biota, and the effect of other possible confounding factors, such as watershed size and elevation, on model performance. We selected macroinvertebrate sampling sites for model development (n = 591) and validation (n = 467) that met strict screening criteria from four proximal ecoregions in the northeastern U.S.: North Central Appalachians, Ridge and Valley, Northeastern Highlands, and Northern Piedmont. Models were developed using boosted regression tree (BRT) techniques for four macroinvertebrate metrics; results were compared among ecoregions and metrics. Comparing within a region but across the four macroinvertebrate metrics, the average richness of tolerant taxa (RichTOL) had the highest R-2 for BRT models. Across the four metrics, final BRT models had between four and seven explanatory variables and always included a variable related to urbanization (e. g., population density, percent urban, or percent manmade channels), and either a measure of hydrologic runoff (e. g., minimum April, average December, or maximum monthly runoff) and(or) a natural landscape factor (e. g., riparian slope, precipitation, and elevation), or a measure of riparian disturbance. Contrary to our expectations, Full Region models explained nearly as much variance in the macroinvertebrate data as Individual Ecoregion models, and taking into account watershed size or elevation did not appear to improve model performance. As a result, it may be advantageous for bioassessment programs to develop large regional models as a preliminary assessment of overall disturbance conditions as long as the range in natural landscape variability is not excessive.	[Waite, Ian R.] US Geol Survey, Portland, OR 97201 USA; [Kennen, Jonathan G.] US Geol Survey, West Trenton, NJ USA; [May, Jason T.; Brown, Larry R.; Orlando, James L.] US Geol Survey, Sacramento, CA USA; [Cuffney, Thomas F.] US Geol Survey, Raleigh, NC USA; [Jones, Kimberly A.] US Geol Survey, Salt Lake City, UT USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Waite, IR (corresponding author), US Geol Survey, Portland, OR 97201 USA.	iwaite@usgs.gov		Kennen, Jonathan/0000-0002-5426-4445	US Federal, National Water Quality Assessment Program (NAWQA) of the US Geological Survey; NAWQA	US Federal, National Water Quality Assessment Program (NAWQA) of the US Geological Survey(United States Geological Survey); NAWQA	This work received US Federal funding - part of the National Water Quality Assessment Program (NAWQA) of the US Geological Survey. NAWQA funded and supported all labor involved, but the authors are responsible for all design, data collection and analysis and all aspects of publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertsen W, 2010, ECOL MODEL, V221, P1119, DOI 10.1016/j.ecolmodel.2010.01.007; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; [Anonymous], 2002, US GEOLOGICAL SURVEY; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Barbour M.T., 1999, RAPID BIOASSESSMENT, V339; Bellucci CJ, 2011, NORTHEAST NAT, V18, P411, DOI 10.1656/045.018.0402; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Boulton AJ, 2003, FRESHWATER BIOL, V48, P1173, DOI 10.1046/j.1365-2427.2003.01084.x; Brakebill JW, 2011, J AM WATER RESOUR AS, V47, P916, DOI 10.1111/j.1752-1688.2011.00578.x; Brenden TO, 2006, AM FISH S S, V48, P49; Brown LR, 2012, LANDSCAPE URBAN PLAN, V108, P17, DOI 10.1016/j.landurbplan.2012.07.009; Brown LR, 2009, J N AM BENTHOL SOC, V28, P1051, DOI 10.1899/08-153.1; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Cabecinha E, 2007, ECOL MODEL, V207, P109, DOI 10.1016/j.ecolmodel.2007.04.009; Cao Y, 2011, J N AM BENTHOL SOC, V30, P680, DOI 10.1899/10-067.1; Carlisle D. M., 2008, ENVIRON MONIT ASSESS, V151, P143; Chessman BC, 2010, FRESHWATER BIOL, V55, P1780, DOI 10.1111/j.1365-2427.2010.02403.x; Clapcott J., 2011, DOC RES DEV SERIES, V365; Clausen B, 1997, FRESHWATER BIOL, V38, P327, DOI 10.1046/j.1365-2427.1997.00230.x; Connecticut Department of Environmental Protection (CTDEP), 1999, AMB MON STRAT RIV ST; Cuffney TE, 2007, J N AM BENTHOL SOC, V26, P286, DOI 10.1899/0887-3593(2007)26[286:ATEOTC]2.0.CO;2; Cuffney TF, 2005, AM FISH S S, V47, P361; CUFFNEY TF, 2003, 03172 US GEOL SURV; Cuffney TF, 2011, J N AM BENTHOL SOC, V30, P797, DOI 10.1899/10-140.1; Cuffney TF, 2010, ECOL APPL, V20, P1384, DOI 10.1890/08-1311.1; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Dodds WK, 2010, J N AM BENTHOL SOC, V29, P988, DOI 10.1899/09-148.1; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Freeman MC, 2013, RIVER RES APPL, V29, P906, DOI 10.1002/rra.2575; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Hilderbrand RH, 2010, J N AM BENTHOL SOC, V29, P1009, DOI 10.1899/09-138.1; HILSENHOFF WL, 1987, GREAT LAKES ENTOMOL, V20, P31; Kennen JG, 2005, AM FISH S S, V47, P39; Kennen JG, 2010, ECOHYDROLOGY, V3, P88, DOI 10.1002/eco.99; Leathwick JR, 2005, FRESHWATER BIOL, V50, P2034, DOI 10.1111/j.1365-2427.2005.01448.x; Leclere J, 2011, ECOL INFORM, V6, P276, DOI 10.1016/j.ecoinf.2011.05.001; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Lytle DA, 2002, ECOLOGY, V83, P370; Maloney KO, 2009, J N AM BENTHOL SOC, V28, P869, DOI 10.1899/08-142.1; Morgan RP, 2005, J N AM BENTHOL SOC, V24, P643, DOI 10.1899/0887-3593(2005)024\\[0643:UEOSFA\\]2.0.CO;2; Munn MD, 2009, ENVIRON MONIT ASSESS, V154, P1, DOI 10.1007/s10661-008-0372-9; New Jersey Department of Environmental Protection (NJDEP), 2007, STAND OP PROC AMB BI; New York State Department of Environmental Conservation (NYDEC), 2012, STAND OP PROC BIOL M; Oberdorff T, 2001, FRESHWATER BIOL, V46, P399, DOI 10.1046/j.1365-2427.2001.00669.x; Ode PR, 2008, J N AM BENTHOL SOC, V27, P967, DOI 10.1899/08-051.1; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Pennsylvania Department of Environmental Protection (PADEP), 2002, BENTH IND BIOT INT W; Pennsylvania Department of Environmental Protection (PADEP), 2012, PENNS SURF WAT QUAL; Phelps MG, 2002, NAFR0203 USDA FOR SE; Pineiro G, 2008, ECOL MODEL, V216, P316, DOI 10.1016/j.ecolmodel.2008.05.006; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; POFF NL, 1995, ECOLOGY, V76, P606, DOI 10.2307/1941217; Potapova M, 2007, ECOL INDIC, V7, P48, DOI 10.1016/j.ecolind.2005.10.001; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Pusey BJ, 2000, ECOL FRESHW FISH, V9, P30, DOI 10.1034/j.1600-0633.2000.90105.x; Qian SS, 2012, ECOL INDIC, V15, P1, DOI 10.1016/j.ecolind.2011.08.019; R Core Development Team, 2010, R LANG ENV STAT COMP; Riseng CM, 2011, ECOL APPL, V21, P3128, DOI 10.1890/11-0077.1; Roy AH, 2005, J N AM BENTHOL SOC, V24, P656, DOI 10.1899/0887-3593(2005)024\\[0656:IHAAAM\\]2.0.CO;2; Roy AH, 2003, FRESHWATER BIOL, V48, P329, DOI 10.1046/j.1365-2427.2003.00979.x; Seelbach P.W., 2011, 2095 MICH DEP NAT RE; Stevenson RJ, 2006, HYDROBIOLOGIA, V561, P149, DOI 10.1007/s10750-005-1611-5; Turak E, 2011, FRESHWATER BIOL, V56, P39, DOI 10.1111/j.1365-2427.2009.02394.x; U.S. Environmental Protection Agency, 1997, DESCR LEV 3 EC REG C; U.S. Geological Survey, 2007, NAT HYDR DAT HIGH RE; Van Sickle J, 2004, ECOL APPL, V14, P368, DOI 10.1890/02-5009; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Waite IR, 2013, J AM WATER RESOUR AS, V49, P431, DOI 10.1111/jawr.12032; Waite IR, 2012, J AM WATER RESOUR AS, V48, P570, DOI 10.1111/j.1752-1688.2011.00632.x; Waite IR, 2010, ECOL INDIC, V10, P1125, DOI 10.1016/j.ecolind.2010.03.011; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI [10.1899/04-020.1, 10.1899/04-028.1]; Wang LZ, 2008, ENVIRON MONIT ASSESS, V141, P1, DOI 10.1007/s10661-006-9510-4; Wang LZ, 2001, ENVIRON MANAGE, V28, P255, DOI 10.1007/s0026702409; WOODS AJ, 1996, EPA600R96077 NAT HLT	78	16	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e90944	10.1371/journal.pone.0090944	http://dx.doi.org/10.1371/journal.pone.0090944			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675770	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677500011
J	Faverani, LP; Assuncao, WG; de Carvalho, PSP; Yuan, JCC; Sukotjo, C; Mathew, MT; Barao, VA				Faverani, Leonardo P.; Assuncao, Wirley G.; de Carvalho, Paulo Sergio P.; Yuan, Judy Chia-Chun; Sukotjo, Cortino; Mathew, Mathew T.; Barao, Valentim A.			Effects of Dextrose and Lipopolysaccharide on the Corrosion Behavior of a Ti-6Al-4V Alloy with a Smooth Surface or Treated with Double-Acid-Etching	PLOS ONE			English	Article							GINGIVALIS ENDOTOXIN AFFINITY; COMMERCIALLY PURE TITANIUM; FINITE-ELEMENT-ANALYSIS; DENTAL IMPLANTS; DIABETES-MELLITUS; ORAL-DISEASES; BONE; PH; PERIODONTITIS; PANCREATITIS	Diabetes and infections are associated with a high risk of implant failure. However, the effects of such conditions on the electrochemical stability of titanium materials remain unclear. This study evaluated the corrosion behavior of a Ti-6Al-4V alloy, with a smooth surface or conditioned by double-acid-etching, in simulated body fluid with different concentrations of dextrose and lipopolysaccharide. For the electrochemical assay, the open-circuit-potential, electrochemical impedance spectroscopy, and potentiodynamic test were used. The disc surfaces were characterized by scanning electron microscopy and atomic force microscopy. Their surface roughness and Vickers microhardness were also tested. The quantitative data were analyzed by Pearson's correlation and independent t-tests (alpha = 0.05). In the corrosion parameters, there was a strong lipopolysaccharide correlation with the I-pass (passivation current density), C-dl (double-layer capacitance), and R-p (polarization resistance) values (p<0.05) for the Ti-6Al-4V alloy with surface treatment by double-acid-etching. The combination of dextrose and lipopolysaccharide was correlated with the I-corr (corrosion current density) and I-pass (p<0.05). The acid-treated groups showed a significant increase in C-dl values and reduced R-p values (p<0.05, t-test). According to the topography, there was an increase in surface roughness (R-2 = 0.726, p<0.0001 for the smooth surface; R-2 = 0.405, p = 0.036 for the double-acid-etching-treated surface). The microhardness of the smooth Ti-6Al-4V alloy decreased (p<0.05) and that of the treated Ti-6Al-4V alloy increased (p<0.0001). Atomic force microscopy showed changes in the microstructure of the Ti-6Al-4V alloy by increasing the surface thickness mainly in the group associated with dextrose and lipopolysaccharide. The combination of dextrose and lipopolysaccharide affected the corrosion behavior of the Ti-6Al-4V alloy surface treated with double-acid-etching. However, no dose-response corrosion behavior could be observed. These results suggest a greater susceptibility to corrosion of titanium implants in diabetic patients with associated infections.	[Faverani, Leonardo P.; Assuncao, Wirley G.] Univ Estadual Paulista UNESP, Aracatuba Dent Sch, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil; [Faverani, Leonardo P.; de Carvalho, Paulo Sergio P.] Univ Estadual Paulista UNESP, Dept Surg, Sao Paulo, Brazil; [Faverani, Leonardo P.; de Carvalho, Paulo Sergio P.] Univ Estadual Paulista UNESP, Integrated Clin, Aracatuba Dent Sch, Sao Paulo, Brazil; [Yuan, Judy Chia-Chun; Sukotjo, Cortino; Mathew, Mathew T.] Univ Illinois, Coll Dent, Dept Restorat Dent, Chicago, IL USA; [Mathew, Mathew T.] Rush Univ, Dept Orthoped Surg, Med Ctr, Chicago, IL 60612 USA; [Barao, Valentim A.] Univ Campinas UNICAMP, Piracicaba Dent Sch, Dept Prosthodont & Periodontol, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; Universidade Estadual de Campinas	Barao, VA (corresponding author), Univ Campinas UNICAMP, Piracicaba Dent Sch, Dept Prosthodont & Periodontol, Sao Paulo, Brazil.	barao@fop.unicamp.br	Faverani, Leonardo P./E-5876-2012; Assunção, Wirley G/E-5931-2012; de Carvalho, Paulo Sergio Perri/H-4279-2012; Barão, Valentim/B-8156-2012; Carvalho, Paulo/AAQ-5563-2020	Faverani, Leonardo P./0000-0003-2249-3048; Assunção, Wirley G/0000-0002-8903-0737; Barão, Valentim/0000-0002-6391-9917; Mathew, Mathew/0000-0003-3604-7938	Sao Paulo State Research Foundation (FAPESP) [2012/14282-5, 2011/20021-7]	Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors would like to thank Sao Paulo State Research Foundation (FAPESP) for the financial support (#2012/14282-5 and #2011/20021-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082; Affronti J, 2011, PRIMARY CARE, V38, P515, DOI 10.1016/j.pop.2011.05.007; AKCA K, 2007, HEAD FACE MED, V16, P3; Al Jabbari Youssef, 2008, J Prosthodont, V17, P181; [Anonymous], J BACTERIOL, V185, P5591; Assuncao WG, 2011, J PROSTHODONT, V20, P523, DOI 10.1111/j.1532-849X.2011.00753.x; Baker P, 2012, J CLIN ENDOCR METAB, V97, pE1573, DOI 10.1210/jc.2011-2824; Barao VA, 2011, J DENT RES, V90, P613, DOI 10.1177/0022034510396880; Barao VA, 2014, J PERIODONT IN PRESS; Barao VAR, 2012, CLIN ORAL IMPLAN RES, V23, P1055, DOI 10.1111/j.1600-0501.2011.02265.x; Bollen CML, 1996, CLIN ORAL IMPLAN RES, V7, P201, DOI 10.1034/j.1600-0501.1996.070302.x; BUNDY KJ, 1994, CRIT REV BIOMED ENG, V22, P139; Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704; Chaturvedi T P, 2009, Indian J Dent Res, V20, P91; Colucci R, 2012, J AM OSTEOPATH ASSOC, V112, P374; Correa CB, 2009, J PROSTHODONT, V18, P382, DOI 10.1111/j.1532-849X.2009.00463.x; Cortada M, 2000, J MATER SCI-MATER M, V11, P287, DOI 10.1023/A:1008905229522; Darnell J A, 1990, Tex Dent J, V107, P23; Deshpande Kalyani, 2010, J Indian Soc Periodontol, V14, P207, DOI 10.4103/0972-124X.76917; Engebretson S, 2013, CONTEMP CLIN TRIALS, V36, P515, DOI 10.1016/j.cct.2013.09.010; Faverani LP, 2014, J BIOMED MATER RES B, V102, P22, DOI 10.1002/jbm.b.32949; GEORGE K, 1994, J PERIODONTOL, V65, P766, DOI 10.1902/jop.1994.65.8.766; Gittens RA, 2011, J DENT RES, V90, P1389, DOI 10.1177/0022034511408428; Gotfredsen K, 2001, CLIN ORAL IMPLAN RES, V12, P552, DOI 10.1034/j.1600-0501.2001.120602.x; Hwang AL, 2013, PANCREAS, V42, P1054, DOI 10.1097/MPA.0b013e3182965a3c; Klokkevold PR, 2007, INT J ORAL MAX IMPL, V22, P173; Knoernschild KL, 2001, J PROSTHET DENT, V86, P644, DOI 10.1067/mpr.2001.120842; Knoernschild KL, 1996, INT J PROSTHODONT, V9, P239; LAMEY PJ, 1992, DIABETIC MED, V9, P410, DOI 10.1111/j.1464-5491.1992.tb01809.x; Li B, 2013, REGUL PEPTIDES, V186, P83, DOI 10.1016/j.regpep.2013.07.005; Li JL, 2006, WEAR, V261, P1247, DOI 10.1016/j.wear.2006.03.010; Lin A, 2009, INT J ORAL MAX IMPL, V24, P808; Mabilleau G, 2006, ACTA BIOMATER, V2, P121, DOI 10.1016/j.actbio.2005.09.004; Manfredi M, 2004, ORAL DIS, V10, P187, DOI 10.1111/j.1601-0825.2004.01019.x; Mareci D, 2009, ACTA BIOMATER, V5, P3625, DOI 10.1016/j.actbio.2009.05.037; Mathew MT, 2012, J MECH BEHAV BIOMED, V8, P71, DOI 10.1016/j.jmbbm.2011.11.004; Messer RLW, 2010, J BIOMED MATER RES B, V92B, P525, DOI 10.1002/jbm.b.31548; Messer RLW, 2009, J BIOMED MATER RES B, V88B, P474, DOI 10.1002/jbm.b.31162; Meyer G, 2013, HORM METAB RES, V45, P92, DOI 10.1055/s-0032-1331766; Morgan TD, 2001, J APPL MICROBIOL, V91, P47, DOI 10.1046/j.1365-2672.2001.01338.x; NELSON RG, 1990, DIABETES CARE, V13, P836, DOI 10.2337/diacare.13.8.836; Nikolopoulou Fotoula, 2006, Implant Dent, V15, P372, DOI 10.1097/01.id.0000239320.57403.8d; Oates TW, 2013, CLIN ORAL IMPLAN RES, V24, P117, DOI 10.1111/j.1600-0501.2011.02374.x; Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010; Olmedo DG, 2010, INT J ORAL MAX SURG, V39, P503, DOI 10.1016/j.ijom.2009.11.007; Olmedo DG, 2012, J PERIODONTOL, V83, P973, DOI 10.1902/jop.2011.110392; Pai PS, 2008, TRIBOL INT, V41, P672, DOI 10.1016/j.triboint.2007.11.015; Barao VAR, 2013, J PROSTHET DENT, V110, P462, DOI 10.1016/j.prosdent.2013.04.004; Robinson FG, 1996, J PROSTHET DENT, V75, P217, DOI 10.1016/S0022-3913(96)90102-X; Savari O, 2013, ISLETS, V5, P226, DOI 10.4161/isl.26432; Skamagas M, 2008, ORAL DIS, V14, P105, DOI 10.1111/j.1601-0825.2007.01425.x; Tada S, 2003, INT J ORAL MAX IMPL, V18, P357; Tamam E, 2012, J ORAL IMPL IN PRESS, DOI [http://dx.doi.org/10.1563/AAID-JOI-D-11-00083.1., DOI 10.1563/AAID-J0I-D-11-00083.1]; Tavares MG, 2007, CLIN ORAL IMPLAN RES, V18, P452, DOI 10.1111/j.1600-0501.2007.01344.x; Tawil G, 2008, INT J ORAL MAX IMPL, V23, P744; Trisi P, 2003, J PERIODONTOL, V74, P945, DOI 10.1902/jop.2003.74.7.945; Udupa A, 2013, ANN MED HEALTH SCI R, V3, P442, DOI 10.4103/2141-9248.117954; Vieira AC, 2006, WEAR, V261, P994, DOI 10.1016/j.wear.2006.03.031; Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x; Winter W, 2013, J ORAL IMPLANTOL, V39, P23, DOI 10.1563/AAID-JOI-D-11-00221; Xavier SP, 2003, J DENT, V31, P173, DOI 10.1016/S0300-5712(03)00027-7; Yang CH, 2011, CLIN ORAL IMPLAN RES, V22, P1426, DOI 10.1111/j.1600-0501.2010.02132.x; Zhang SM, 2013, J MATER SCI-MATER M, V24, P1229, DOI 10.1007/s10856-013-4888-3; Zhoua LY, 2007, MATERIALS, V48, P380	64	20	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93377	10.1371/journal.pone.0093377	http://dx.doi.org/10.1371/journal.pone.0093377			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671257	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000136
J	Jiang, PH; Josue-Almqvist, J; Jin, XL; Li, X; Brand, JG; Margolskee, RF; Reed, DR; Beauchamp, GK				Jiang, Peihua; Josue-Almqvist, Jesusa; Jin, Xuelin; Li, Xia; Brand, Joseph G.; Margolskee, Robert F.; Reed, Danielle R.; Beauchamp, Gary K.			The Bamboo-Eating Giant Panda (Ailuropoda melanoleuca) Has a Sweet Tooth: Behavioral and Molecular Responses to Compounds That Taste Sweet to Humans	PLOS ONE			English	Article							RECEPTOR GENE TAS1R2; NEW-WORLD MONKEY; UMAMI TASTE; TRANSMEMBRANE DOMAIN; GUSTATORY RESPONSES; T1R3; PREFERENCE; EVOLUTION; PSEUDOGENIZATION; SECRETION	A growing body of behavioral and genetic information indicates that taste perception and food sources are highly coordinated across many animal species. For example, sweet taste perception is thought to serve to detect and motivate consumption of simple sugars in plants that provide calories. Supporting this is the observation that most plant-eating mammals examined exhibit functional sweet perception, whereas many obligate carnivores have independently lost function of their sweet taste receptors and exhibit no avidity for simple sugars that humans describe as tasting sweet. As part of a larger effort to compare taste structure/function among species, we examined both the behavioral and the molecular nature of sweet taste in a plant-eating animal that does not consume plants with abundant simple sugars, the giant panda (Ailuropoda melanoleuca). We evaluated two competing hypotheses: as plant-eating mammals, they should have a well-developed sweet taste system; however, as animals that do not normally consume plants with simple sugars, they may have lost sweet taste function, as has occurred in strict carnivores. In behavioral tests, giant pandas avidly consumed most natural sugars and some but not all artificial sweeteners. Cell-based assays revealed similar patterns of sweet receptor responses toward many of the sweeteners. Using mixed pairs of human and giant panda sweet taste receptor units (hT1R2+gpT1R3 and gpT1R2+hT1R3) we identified regions of the sweet receptor that may account for behavioral differences in giant pandas versus humans toward various sugars and artificial sweeteners. Thus, despite the fact that the giant panda's main food, bamboo, is very low in simple sugars, the species has a marked preference for several compounds that taste sweet to humans. We consider possible explanations for retained sweet perception in this species, including the potential extra-oral functions of sweet taste receptors that may be required for animals that consume plants.	[Jiang, Peihua; Josue-Almqvist, Jesusa; Li, Xia; Brand, Joseph G.; Margolskee, Robert F.; Reed, Danielle R.; Beauchamp, Gary K.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Jin, Xuelin] Shaanxi Wild Anim Rescue & Res Ctr, Louguantai, Peoples R China	Monell Chemical Senses Center	Jiang, PH (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	pjiang@monell.org		Margolskee, Robert/0000-0002-9572-2887; Reed, Danielle/0000-0002-4374-6107	NIH-NIDCD grant [DC0101842]; Monell Chemical Senses Center; NIH-NIDCD [1P30DC011735]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014105, P30DC011735, R01DC010842] Funding Source: NIH RePORTER	NIH-NIDCD grant; Monell Chemical Senses Center; NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by NIH-NIDCD grant DC0101842 (P.J.) and institutional funds from the Monell Chemical Senses Center; DNA analysis and calcium mobilization assays were performed at the Monell Genotyping and DNA/RNA Analysis Core and the Chemosensory Receptor Signaling Core, respectively, which are supported in part by funding from NIH-NIDCD core grant 1P30DC011735. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmanov AA, 2001, CHEM SENSES, V26, P905, DOI 10.1093/chemse/26.7.905; Breslin PAS, 2013, CURR BIOL, V23, pR409, DOI 10.1016/j.cub.2013.04.010; Danilova V, 2002, J NEUROPHYSIOL, V88, P579, DOI 10.1152/jn.2002.88.2.579; Danilova V, 1998, J NEUROPHYSIOL, V80, P2102, DOI 10.1152/jn.1998.80.4.2102; Glaser D, 1998, ANN NY ACAD SCI, V855, P169, DOI 10.1111/j.1749-6632.1998.tb10561.x; GLASER D, 1995, CHEM SENSES, V20, P573, DOI 10.1093/chemse/20.5.573; Hall J. E., 2010, GUYTON HALL TXB MED; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Jiang P, 2005, CHEM SENSES, V30, pI17, DOI 10.1093/chemse/bjh091; Jiang PH, 2012, P NATL ACAD SCI USA, V109, pE1465, DOI 10.1073/pnas.1205581109; Jiang PH, 2012, P NATL ACAD SCI USA, V109, P4956, DOI 10.1073/pnas.1118360109; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; KOZUKUE E, 1983, J FOOD SCI, V48, P935, DOI 10.1111/j.1365-2621.1983.tb14934.x; Li DY, 2014, MOL BIOL EVOL, V31, P303, DOI 10.1093/molbev/mst219; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li X, 2005, PLOS GENET, V1, P27, DOI 10.1371/journal.pgen.0010003; Li X, 2009, J HERED, V100, pS90, DOI 10.1093/jhered/esp015; Liu B, 2012, BIOCHEM BIOPH RES CO, V427, P431, DOI 10.1016/j.bbrc.2012.09.083; Liu B, 2011, J NEUROSCI, V31, P11070, DOI 10.1523/JNEUROSCI.0791-11.2011; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Nofre C, 2002, J ANIM PHYSIOL AN N, V86, P90, DOI 10.1046/j.1439-0396.2002.00361.x; Sato JJ, 2012, NATURWISSENSCHAFTEN, V99, P655, DOI 10.1007/s00114-012-0939-8; Schaller G.B., 1985, GIANT PANDAS WOLONG; Winnig M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-22; Winnig M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-66; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Yee KK, 2011, P NATL ACAD SCI USA, V108, P5431, DOI 10.1073/pnas.1100495108; Zhang F, 2010, P NATL ACAD SCI USA, V107, P4752, DOI 10.1073/pnas.0911660107; Zhao HB, 2012, GENOME BIOL EVOL, V4, P73, DOI 10.1093/gbe/evr126; Zhao HB, 2010, MOL BIOL EVOL, V27, P2669, DOI 10.1093/molbev/msq153; Zhao HB, 2010, MOL BIOL EVOL, V27, P2642, DOI 10.1093/molbev/msq152; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108	34	7	8	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93043	10.1371/journal.pone.0093043	http://dx.doi.org/10.1371/journal.pone.0093043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671207	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677000105
J	Li, G; Wang, HQ; Wang, LH; Chen, RP; Liu, JP				Li, Guo; Wang, Hui-qian; Wang, Li-hui; Chen, Ru-ping; Liu, Jun-ping			Distinct Pathways of ERK1/2 Activation by Hydroxy-Carboxylic Acid Receptor-1	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; SIGNAL-REGULATED KINASES; FACTOR-I RECEPTOR; MEDIATED ACTIVATION; GROWTH; GAMMA; SRC; G(I); TRANSACTIVATION; MECHANISMS	Mechanistic investigations have shown that, upon agonist activation, hydroxy-carboxylic acid receptor-1(HCA(1)) couples to a G(i) protein and inhibits adenylate cyclase activity, leading to inhibition of liberation of free fatty acid. However, the underlying molecular mechanisms for HCA(1) signaling remain largely unknown. Using CHO-K1 cells stably expressing HCA(1), and L6 cells, which endogenously express rat HCA(1) receptors, we found that activation of ERK1/2 by HCA(1) was rapid, peaking at 5 min, and was significantly blocked by pertussis toxin. Furthermore, time course experiments with different kinase inhibitors demonstrated that HCA(1) induced ERK1/2 activation via the extracellular Ca2+, PKC and IGF-I receptor transactivation-dependent pathways. In addition, we observed that pretreated the cells with M119K, an inhibitor of G(beta gamma) subunit-dependent signaling, effectively attenuated the ERK1/2 activation triggered by HCA(1), suggesting a critical role for bc-subunits in HCA(1)-activated ERK1/2 phosphorylation. Furthermore, the present results also indicated that the arrestin2/3 were not required for ERK1/2 activation. In conclusion, our findings demonstrate that upon binding to agonist, HCA(1) receptors initially activate G(i), leading to dissociation of the G(beta gamma) subunit from activated G(i), and subsequently induce ERK1/2 activation via two distinct pathways: one PKC-dependent pathway and the other IGF-IR transactivation-dependent pathway. Our results provide the first in-depth evidence that defines the molecular mechanism of HCA(1)-mediated ERK1/2 activation.	[Li, Guo; Wang, Hui-qian; Wang, Li-hui; Chen, Ru-ping; Liu, Jun-ping] Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University	Li, G (corresponding author), Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China.	liguo2000@aliyun.com; jun-ping.liu@monash.edu		Liu, Jun-Ping/0000-0001-7442-2116	National Natural Science Foundation of China [31201067, 81000955]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 31201067, No. 81000955). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; Ahmed K, 2009, TRENDS PHARMACOL SCI, V30, P557, DOI 10.1016/j.tips.2009.09.001; Ahmed K, 2009, J BIOL CHEM, V284, P21928, DOI 10.1074/jbc.M109.019455; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ahn S, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M808463200; Beom SR, 2004, J BIOL CHEM, V279, P28304, DOI 10.1074/jbc.M403899200; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Dickenson JM, 1998, EUR J PHARMACOL, V355, P85, DOI 10.1016/S0014-2999(98)00468-3; Dorn GW, 1997, BIOCHEMISTRY-US, V36, P6415, DOI 10.1021/bi970080s; Du J, 2001, CIRC RES, V88, P1044, DOI 10.1161/hh1001.090840; Ge H, 2008, J LIPID RES, V49, P797, DOI 10.1194/jlr.M700513-JLR200; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gripentrog JM, 2008, CELL SIGNAL, V20, P424, DOI 10.1016/j.cellsig.2007.11.002; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; Kirui JK, 2010, J PHARMACOL EXP THER, V333, P393, DOI 10.1124/jpet.109.164814; Kranenburg O, 1997, EMBO J, V16, P3097, DOI 10.1093/emboj/16.11.3097; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li G, 2011, J BIOL CHEM, V286, P31199, DOI 10.1074/jbc.M111.241372; Li G, 2010, J BIOL CHEM, V285, P22605, DOI 10.1074/jbc.M109.087213; Lin AL, 2008, AM J PHYSIOL-CELL PH, V294, pC1454, DOI 10.1152/ajpcell.00151.2007; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Lopez-Ilasaca M, 1998, J BIOL CHEM, V273, P2505, DOI 10.1074/jbc.273.5.2505; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Luttrell LM, 2002, J CELL SCI, V115, P455; Peterson JE, 1996, J BIOL CHEM, V271, P31562, DOI 10.1074/jbc.271.49.31562; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Pu J, 2011, J LIPID RES, V52, P1319, DOI 10.1194/jlr.M011254; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; vanBiesen T, 1996, J BIOL CHEM, V271, P1266, DOI 10.1074/jbc.271.3.1266; Zahradka P, 2004, ENDOCRINOLOGY, V145, P2978, DOI 10.1210/en.2004-0029; Zhou Q, 2012, BR J PHARM	40	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93041	10.1371/journal.pone.0093041	http://dx.doi.org/10.1371/journal.pone.0093041			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671202	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677000104
J	Otero-Losada, M; Cao, G; Mc Loughlin, S; Rodriguez-Granillo, G; Ottaviano, G; Milei, J				Otero-Losada, Matilde; Cao, Gabriel; Mc Loughlin, Santiago; Rodriguez-Granillo, Gaston; Ottaviano, Graciela; Milei, Jose			Rate of Atherosclerosis Progression in ApoE(-/-) Mice Long After Discontinuation of Cola Beverage Drinking	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; ENDOTHELIAL DYSFUNCTION; PREVENTION; INFLAMMATION; CHILDHOOD; ADULTHOOD; LIVER	This study was conducted in order to evaluate the effect of cola beverages drinking on atherosclerosisand test the hypothesis whether cola beverages consumption at early life stages might affect the development and progression of atherosclerosis later in life. ApoE(-/-) C57BL/6J mice (8 week-old) were randomized in 3 groups (n = 20 each) according to free accessto water (W), sucrose sweetened carbonated cola drink(C) or aspartame-acesulfame K sweetened carbonated 'light' cola drink (L) for the next 8 weeks. Drinking treatment was ended by switching C and L groups to drinking water. Four mice per group and time were sequentially euthanized: before treatment (8weeks-old), at the end of treatment (16 weeks-old) and after treatment discontinuation (20 weeks-old, 24 weeks-old, 30 week-old mice). Aortic roots and livers were harvested, processed for histology and serial cross-sections were stained. Aortic plaque area was analyzed and plaque/media-ratio was calculated. Early consumption of cola drinks accelerated atherosclerotic plaque progression favoring the interaction between macrophages and myofibroblasts, without the participation of either T lymphocytes or proliferative activity. Plaque/media-ratio varied according to drink treatment (F-2,F-54 = 3.433, p<0.04) and mice age (F-4,F-54 = 5.009, p<0.03) and was higher in C and L groups compared with age-matched W group (p<0.05 at 16 weeks and 20 weeks, p<0.01 at 24 weeks and 30 weeks). Natural evolution of atherosclerosis in ApoE(-/-) mice (W group) evidenced atherosclerosis acceleration in parallel with a rapid increase in liver inflammation around the 20 weeks of age. Cola drinking within the 8-16 weeks of age accelerated atherosclerosis progression in ApoE(-/-) mice favoring aortic plaque enlargement (inward remodeling) over media thinning all over the study time. Data suggest that cola drinking at early life stages may predispose to atherosclerosis progression later in life in ApoE(-/-) mice.	[Otero-Losada, Matilde; Cao, Gabriel; Mc Loughlin, Santiago; Rodriguez-Granillo, Gaston; Ottaviano, Graciela; Milei, Jose] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Invest Cardiol, ININCA,CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Milei, J (corresponding author), Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Invest Cardiol, ININCA,CONICET, Buenos Aires, DF, Argentina.	ininca@fmed.uba.ar	Rodriguez-Granillo, Gaston/ABG-2534-2021; Otero-Losada, Matilde/J-3050-2019; Rodriguez-Granillo, Gaston A/A-6279-2010	Rodriguez-Granillo, Gaston/0000-0003-0820-2611; Otero-Losada, Matilde/0000-0001-6650-1033; MILEI, JOSE/0000-0003-4029-5993	Fundacion Florencio Fiorini; Instituto de Investigaciones Cardiologicas, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Cientificas y Tecnicas (ININCA.UBA.CONICET)	Fundacion Florencio Fiorini; Instituto de Investigaciones Cardiologicas, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Cientificas y Tecnicas (ININCA.UBA.CONICET)	This work was partially supported by an educational grant of the Fundacion Florencio Fiorini and by funds from Instituto de Investigaciones Cardiologicas, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Cientificas y Tecnicas (ININCA.UBA.CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Auclair Sylvain, 2009, Atherosclerosis, V204, pe21, DOI 10.1016/j.atherosclerosis.2008.12.007; Cornier MA, 2011, CIRCULATION, V124, P840, DOI 10.1161/CIRCULATIONAHA.110.968461; d'Uscio LV, 2001, ARTERIOSCL THROM VAS, V21, P1017, DOI 10.1161/01.ATV.21.6.1017; Fenyo IM, 2013, IMMUNOBIOLOGY, V218, P1376, DOI 10.1016/j.imbio.2013.06.005; Gaspari T, 2011, DIAB VASC DIS RES; Green D, 2009, ATHEROSCLEROSIS, V202, P623, DOI 10.1016/j.atherosclerosis.2008.05.039; Iwata H, 2013, CIRCULATION, V127, P1173, DOI 10.1161/CIRCULATIONAHA.113.001461; Kressel G, 2009, ATHEROSCLEROSIS, V202, P263, DOI 10.1016/j.atherosclerosis.2008.04.012; Lennartz MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021803; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; Maersk M, 2012, AM J CLIN NUTR, V95, P283, DOI 10.3945/ajcn.111.022533; Mahe G, 2011, PUBLIC HEALTH NUTR, V14, P319, DOI 10.1017/S1368980010001862; Meyrelles SS, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-211; Milei J, 2011, WORLD J CARDIOL, V3, P111, DOI 10.4330/wjc.v3.i4.111; Otero-Losada ME, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-57; Otero-Losada ME, 2011, INT J CARDIOL, V146, P106, DOI 10.1016/j.ijcard.2010.09.066; Pham NA, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-8; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Rasanen M, 2002, J AM DIET ASSOC, V102, P518, DOI 10.1016/S0002-8223(02)90118-5; Reddick RL, 1998, ATHEROSCLEROSIS, V140, P297, DOI 10.1016/S0021-9150(98)00133-6; Report of Sir David Weatherall's working group, 2006, US NONH PRIM RES; Sun CX, 2011, CIRCULATION, V124, P48, DOI 10.1161/CIRCULATIONAHA.110.988915; Tesanovic S, 2010, ARTERIOSCL THROM VAS, V30, P1606, DOI 10.1161/ATVBAHA.110.204453; Verhagen SN, 2012, ATHEROSCLEROSIS, V225, P99, DOI 10.1016/j.atherosclerosis.2012.08.031; Watson AMD, 2011, DIABETOLOGIA, V54, P681, DOI 10.1007/s00125-010-2000-9; Xu ZY, 2009, ATHEROSCLEROSIS, V206, P427, DOI 10.1016/j.atherosclerosis.2009.03.023	27	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e89838	10.1371/journal.pone.0089838	http://dx.doi.org/10.1371/journal.pone.0089838			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670925	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000004
J	Rodriguez-Ramilo, ST; Garcia-Cortes, LA; Gonzalez-Recio, O				Teresa Rodriguez-Ramilo, Silvia; Alberto Garcia-Cortes, Luis; Gonzalez-Recio, Oscar			Combining Genomic and Genealogical Information in a Reproducing Kernel Hilbert Spaces Regression Model for Genome-Enabled Predictions in Dairy Cattle	PLOS ONE			English	Article							ASSISTED PREDICTION; GENETIC VALUE; FULL PEDIGREE; SELECTION	Genome-enhanced genotypic evaluations are becoming popular in several livestock species. For this purpose, the combination of the pedigree-based relationship matrix with a genomic similarities matrix between individuals is a common approach. However, the weight placed on each matrix has been so far established with ad hoc procedures, without formal estimation thereof. In addition, when using marker-and pedigree-based relationship matrices together, the resulting combined relationship matrix needs to be adjusted to the same scale in reference to the base population. This study proposes a semi-parametric Bayesian method for combining marker-and pedigree-based information on genome-enabled predictions. A kernel matrix from a reproducing kernel Hilbert spaces regression model was used to combine genomic and genealogical information in a semi-parametric scenario, avoiding inversion and adjustment complications. In addition, the weights on marker-versus pedigree-based information were inferred from a Bayesian model with Markov chain Monte Carlo. The proposed method was assessed involving a large number of SNPs and a large reference population. Five phenotypes, including production and type traits of dairy cattle were evaluated. The reliability of the genome-based predictions was assessed using the correlation, regression coefficient and mean squared error between the predicted and observed values. The results indicated that when a larger weight was given to the pedigree-based relationship matrix the correlation coefficient was lower than in situations where more weight was given to genomic information. Importantly, the posterior means of the inferred weight were near the maximum of 1. The behavior of the regression coefficient and the mean squared error was similar to the performance of the correlation, that is, more weight to the genomic information provided a regression coefficient closer to one and a smaller mean squared error. Our results also indicated a greater accuracy of genomic predictions when using a large reference population.	[Teresa Rodriguez-Ramilo, Silvia; Alberto Garcia-Cortes, Luis; Gonzalez-Recio, Oscar] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Mejora Genet Anim, Madrid, Spain; [Teresa Rodriguez-Ramilo, Silvia] Dept Tecn Conafe, Madrid, Spain; [Gonzalez-Recio, Oscar] Dept Environm & Primary Ind, Biosci Res Div, Melbourne, Vic, Australia; [Gonzalez-Recio, Oscar] Dairy Futures Cooperat Res Ctr, Melbourne, Vic, Australia	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Gonzalez-Recio, O (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Mejora Genet Anim, Madrid, Spain.	oscar.gonzalez-recio@depi.vic.gov.au	garcia, luis/C-5971-2008; Ramilo, Silvia Teresa Rodriguez/AAC-2843-2021; Gonzalez-Recio, Oscar/C-8553-2016	garcia, luis/0000-0003-1116-7271; Ramilo, Silvia Teresa Rodriguez/0000-0001-7150-0692; Gonzalez-Recio, Oscar/0000-0002-9106-4063	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria; Conafe [CC12-038]	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria(Instituto de Investigacion Agropecuaria (INIA)); Conafe	This work was funded by the agreement between Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria and Conafe (CC12-038). Conafe has been involved on data collection as a partner in the EuroGenomics Consortium.	Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; [Anonymous], 2010, INTERBULL B; Boichard D, 2002, P 7 WORLD C GEN APPL; Christensen OF, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-2; de los Campos G, 2009, J ANIM SCI, V87, P1883, DOI 10.2527/jas.2008-1259; de los Campos G, 2010, GENET RES, V92, P295, DOI 10.1017/S0016672310000285; Forni S, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-1; Gao HD, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-8; Garcia-Cortes LA, 2006, GENET SEL EVOL, V38, P601, DOI 10.1051/gse:2006024; Gianola D, 2003, GENETICS, V163, P347; Gianola D, 2008, GENETICS, V178, P2289, DOI 10.1534/genetics.107.084285; Gianola D, 2006, GENETICS, V173, P1761, DOI 10.1534/genetics.105.049510; Gonzalez-Recio O, 2008, GENETICS, V178, P2305, DOI 10.1534/genetics.107.084293; Gonzalez-Recio O, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-3; Haile-Mariam M, 2013, J ANIM BREED GENET, V130, P20, DOI 10.1111/j.1439-0388.2013.01001.x; HARRIS B. L., 2008, P INT M NIAG FALLS N; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Jimenez-Montero JA, 2013, J DAIRY SCI, V96, P625, DOI 10.3168/jds.2012-5631; KIMELDORF G, 1971, J MATH ANAL APPL, V33, P82, DOI 10.1016/0022-247X(71)90184-3; Liu ZT, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-19; Mallick BK, 2005, J R STAT SOC B, V67, P219, DOI 10.1111/j.1467-9868.2005.00498.x; MEUWISSEN THE, 1992, GENET SEL EVOL, V24, P305, DOI 10.1051/gse:19920402; Meuwissen THE, 2001, GENETICS, V157, P1819; Misztal I, 2009, J DAIRY SCI, V92, P4648, DOI 10.3168/jds.2009-2064; Nakaya A, 2012, ANN BOT-LONDON, V110, P1303, DOI 10.1093/aob/mcs109; Neves HHR, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-100; Rutkoski J, 2012, PLANT GENOME-US, V5, P51, DOI 10.3835/plantgenome2012.02.0001; Stranden I, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-25; Toro MA, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-27; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Vitezica ZG, 2011, GENET RES, V93, P357, DOI 10.1017/S001667231100022X; Wahba G, 1999, ADVANCES IN KERNEL METHODS, P69; Wahba G., 1990, SPLINE MODELS OBSERV; WOOTTERS WK, 1981, PHYS REV D, V23, P357, DOI 10.1103/PhysRevD.23.357; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	36	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93424	10.1371/journal.pone.0093424	http://dx.doi.org/10.1371/journal.pone.0093424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671175	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000144
J	La Scaleia, B; Zago, M; Moscatelli, A; Lacquaniti, F; Viviani, P				La Scaleia, Barbara; Zago, Myrka; Moscatelli, Alessandro; Lacquaniti, Francesco; Viviani, Paolo			Implied Dynamics Biases the Visual Perception of Velocity	PLOS ONE			English	Article							TRAJECTORY FORMS; MOTION; SPEED; DISCRIMINATION; MODEL; LAW; INFORMATION; ACCELERATION; ORIENTATION; ADAPTATION	We expand the anecdotic report by Johansson that back-and-forth linear harmonic motions appear uniform. Six experiments explore the role of shape and spatial orientation of the trajectory of a point-light target in the perceptual judgment of uniform motion. In Experiment 1, the target oscillated back-and-forth along a circular arc around an invisible pivot. The imaginary segment from the pivot to the midpoint of the trajectory could be oriented vertically downward (consistent with an upright pendulum), horizontally leftward, or vertically upward (upside-down). In Experiments 2 to 5, the target moved uni-directionally. The effect of suppressing the alternation of movement directions was tested with curvilinear (Experiment 2 and 3) or rectilinear (Experiment 4 and 5) paths. Experiment 6 replicated the upright condition of Experiment 1, but participants were asked to hold the gaze on a fixation point. When some features of the trajectory evoked the motion of either a simple pendulum or a mass-spring system, observers identified as uniform the kinematic profiles close to harmonic motion. The bias towards harmonic motion was most consistent in the upright orientation of Experiment 1 and 6. The bias disappeared when the stimuli were incompatible with both pendulum and mass-spring models (Experiments 3 to 5). The results are compatible with the hypothesis that the perception of dynamic stimuli is biased by the laws of motion obeyed by natural events, so that only natural motions appear uniform.	[La Scaleia, Barbara; Zago, Myrka; Lacquaniti, Francesco] IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy; [Moscatelli, Alessandro] Univ Bielefeld, Dept Cognit Neurosci, D-33615 Bielefeld, Germany; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Lacquaniti, Francesco; Viviani, Paolo] Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy	IRCCS Santa Lucia; University of Bielefeld; University of Rome Tor Vergata; University of Rome Tor Vergata	Lacquaniti, F (corresponding author), IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy.	lacquaniti@med.uniroma2.it	Zago, Myrka/B-3669-2012; La Scaleia, Barbara/AAB-2190-2019; Lacquaniti, Francesco/J-9842-2016; La Scaleia, Barbara/A-5981-2015; Moscatelli, Alessandro/L-1391-2018	Zago, Myrka/0000-0001-7100-7582; Lacquaniti, Francesco/0000-0003-0896-7315; La Scaleia, Barbara/0000-0003-2050-2641; Moscatelli, Alessandro/0000-0001-6269-4536	Italian Health Ministry; Italian University Ministry; Italian Space Agency	Italian Health Ministry(Ministry of Health, Italy); Italian University Ministry(Ministry of Education, Universities and Research (MIUR)); Italian Space Agency(Agenzia Spaziale Italiana (ASI))	The work was supported by the Italian Health Ministry, Italian University Ministry (PRIN project), and Italian Space Agency (CRUSOE, COREA and ARIANNA grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Barlow H B, 1959, P S MECH THOUGHT PRO, V2, P537; Bates D, 2011, IME4 LIN MIX EFF MOD; Bex PJ, 1999, J OPT SOC AM A, V16, P2817, DOI 10.1364/JOSAA.16.002817; Bingham G. P., 2008, UNDERSTANDING EVENTS, P255; BINGHAM GP, 1995, J EXP PSYCHOL HUMAN, V21, P1473, DOI 10.1037/0096-1523.21.6.1473; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Bozzi P., 1958, RIV PSICOLOGIA, V52, P281; Brouwer AM, 2002, EXP BRAIN RES, V143, P198, DOI 10.1007/s00221-001-0980-x; Burr D, 2011, VISION RES, V51, P1431, DOI 10.1016/j.visres.2011.02.008; CALDERONE JB, 1989, PERCEPT PSYCHOPHYS, V45, P391, DOI 10.3758/BF03210711; Casella G., 2002, STAT INFERENCE, V2nd; Cohen RL, 1964, PROBLEMS MOTOR PERCE; COLLEWIJN H, 1988, J PHYSIOL-LONDON, V404, P157, DOI 10.1113/jphysiol.1988.sp017284; CUTTING JE, 1982, COGNITION, V12, P25, DOI 10.1016/0010-0277(82)90028-2; DEBRUYN B, 1988, VISION RES, V28, P1323, DOI 10.1016/0042-6989(88)90064-8; deSperati C, 1997, J NEUROSCI, V17, P3932; Eagleman DM, 2001, NAT REV NEUROSCI, V2, P920, DOI 10.1038/35104092; Flash T, 2007, BIOL CYBERN, V96, P577, DOI 10.1007/s00422-007-0145-5; Freeman TCA, 2010, CURR BIOL, V20, P757, DOI 10.1016/j.cub.2010.02.059; Frick A, 2005, SWISS J PSYCHOL, V64, P103, DOI 10.1024/1421-0185.64.2.103; Gibson JJ., 1966, SENSES CONSIDERED PE; GOLDSTEIN J, 1963, J PSYCHOL, V55, P3, DOI 10.1080/00223980.1963.9916594; GOTTSDANKER RM, 1956, PSYCHOL BULL, V53, P477, DOI 10.1037/h0045160; Hammett ST, 2005, P ROY SOC B-BIOL SCI, V272, P2351, DOI 10.1098/rspb.2005.3239; JOHANSSON G, 1975, SCI AM, V232, P76, DOI 10.1038/scientificamerican0675-76; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; JOHANSSON G, 1980, ANNU REV PSYCHOL, V31, P27, DOI 10.1146/annurev.ps.31.020180.000331; Johansson G, 1950, CONFIGURATIONS EVENT, P25; Klemm O, 1907, PSYCHOL STUD, V2, P324; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; Levit-Binnun N, 2006, EXP BRAIN RES, V172, P533, DOI 10.1007/s00221-006-0355-4; Maoz U, 2014, J NEUROPHYSIOL, V111, P336, DOI 10.1152/jn.01071.2012; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; MCKEE SP, 1984, VISION RES, V24, P25, DOI 10.1016/0042-6989(84)90140-8; MCKEE SP, 1986, VISION RES, V26, P609, DOI 10.1016/0042-6989(86)90009-X; Miller WL, 2008, J NEUROPHYSIOL, V99, P1969, DOI 10.1152/jn.00889.2007; Moscatelli A, 2012, J VISION, V12, DOI 10.1167/12.11.26; Moscatelli A, 2011, J VISION, V11, DOI 10.1167/11.4.5; Muchisky MM, 2002, PERCEPT PSYCHOPHYS, V64, P15, DOI 10.3758/BF03194554; ORBAN GA, 1985, J OPT SOC AM A, V2, P1836, DOI 10.1364/JOSAA.2.001836; PIAGET J, 1958, AM J PSYCHOL, V71, P277, DOI 10.2307/1419216; Pittenger J.B., 1990, ECOL PSYCHOL, V2, P55, DOI [10.1207/s15326969eco0201_3, DOI 10.1207/S15326969ECO0201_3, DOI 10.1207/S15326969EC00201_]; PITTENGER JB, 1985, PERCEPTION, V14, P247, DOI 10.1068/p140247; Pollick FE, 1997, VISION RES, V37, P347, DOI 10.1016/S0042-6989(96)00116-2; Radvansky GA, 2011, WIRES COGN SCI, V2, P608, DOI 10.1002/wcs.133; Regan D, 1986, HDB PERCEPTION HUMAN, V1, P19; RUNESON S, 1974, PSYCHOL RES-PSYCH FO, V37, P3, DOI 10.1007/BF00309076; SHEPARD RN, 1984, PSYCHOL REV, V91, P417, DOI 10.1037/0033-295X.91.4.417; Shipley TF, 2003, PSYCHOL SCI, V14, P377, DOI 10.1111/1467-9280.24471; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SMITH AT, 1994, VISION RES, V34, P253, DOI 10.1016/0042-6989(94)90337-9; Souto D, 2013, J VISION, V13, DOI 10.1167/13.2.9; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; THOMPSON P, 1981, VISION RES, V21, P337, DOI 10.1016/0042-6989(81)90161-9; Traschutz A, 2012, VISION RES, V72, P1, DOI 10.1016/j.visres.2012.08.019; VIVIANI P, 1992, J EXP PSYCHOL HUMAN, V18, P603, DOI 10.1037/0096-1523.18.3.603; Viviani P, 2002, ATTENTION PERFORM, V19, P406; WERKHOVEN P, 1992, VISION RES, V32, P2313, DOI 10.1016/0042-6989(92)90095-Z; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wickelgren EA, 2008, PERCEPT PSYCHOPHYS, V70, P266, DOI 10.3758/PP.70.2.266; Zago M, 2004, J NEUROPHYSIOL, V91, P1620, DOI 10.1152/jn.00862.2003; Zago M, 2011, J VISION, V11, DOI 10.1167/11.10.13	63	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93020	10.1371/journal.pone.0093020	http://dx.doi.org/10.1371/journal.pone.0093020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SD	24667578	gold, Green Submitted, Green Published			2022-12-25	WOS:000333675600128
J	Liu, B; Zhang, YH; Zhang, W				Liu, Bo; Zhang, Yuhong; Zhang, Wei			RNA-Seq-Based Analysis of Cold Shock Response in Thermoanaerobacter tengcongensis, a Bacterium Harboring a Single Cold Shock Protein Encoding Gene	PLOS ONE			English	Article							BACILLUS-SUBTILIS; LOW-TEMPERATURE; ESCHERICHIA-COLI; THERMOPHILIC BACTERIUM; FATTY-ACID; DNA UPTAKE; ADAPTATION; GROWTH; STRESS; IDENTIFICATION	Background: Although cold shock responses and the roles of cold shock proteins in microorganisms containing multiple cold shock protein genes have been well characterized, related studies on bacteria possessing a single cold shock protein gene have not been reported. Thermoanaerobacter tengcongensis MB4, a thermophile harboring only one known cold shock protein gene (TtescpC), can survive from 50 degrees to 80 degrees C, but has poor natural competence under cold shock at 50 degrees C. We therefore examined cold shock responses and their effect on natural competence in this bacterium. Results: The transcriptomes of T. tengcongensis before and after cold shock were analyzed by RNA-seq and over 1200 differentially expressed genes were successfully identified. These genes were involved in a wide range of biological processes, including modulation of DNA replication, recombination, and repair; energy metabolism; production of cold shock protein; synthesis of branched amino acids and branched-chain fatty acids; and sporulation. RNA-seq analysis also suggested that T. tengcongensis initiates cell wall and membrane remodeling processes, flagellar assembly, and sporulation in response to low temperature. Expression profiles of TtecspC and failed attempts to produce a TtecspC knockout strain confirmed the essential role of TteCspC in the cold shock response, and also suggested a role of this protein in survival at optimum growth temperature. Repression of genes encoding ComEA and ComEC and low energy metabolism levels in cold-shocked cells are the likely basis of poor natural competence at low temperature. Conclusion: Our study demonstrated changes in global gene expression under cold shock and identified several candidate genes related to cold shock in T. tengcongensis. At the same time, the relationship between cold shock response and poor natural competence at low temperature was preliminarily elucidated. These findings provide a foundation for future studies on genetic and molecular mechanisms associated with cold shock and acclimation at low temperature.	[Liu, Bo; Zhang, Yuhong; Zhang, Wei] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Zhang, W (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	zhangwei02@caas.cn			National Science Foundation for Young Scientists of China [31200072]	National Science Foundation for Young Scientists of China	This work was supported by the National Science Foundation for Young Scientists of China (Grant no. 31200072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Annous BA, 1997, APPL ENVIRON MICROB, V63, P3887, DOI 10.1128/AEM.63.10.3887-3894.1997; Atlung T, 1999, J BACTERIOL, V181, P5557, DOI 10.1128/JB.181.18.5557-5562.1999; Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; Balhesteros H, 2010, ARCH MICROBIOL, V192, P747, DOI 10.1007/s00203-010-0602-8; Bao QY, 2002, GENOME RES, V12, P689, DOI 10.1101/gr.219302; Breaker RR, 2010, MOL CELL, V37, P1, DOI 10.1016/j.molcel.2009.12.032; Bresolin G, 2006, J BACTERIOL, V188, P2945, DOI 10.1128/JB.188.8.2945-2958.2006; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Budde I, 2006, MICROBIOL-SGM, V152, P831, DOI 10.1099/mic.0.28530-0; Carty SM, 1999, J BIOL CHEM, V274, P9677, DOI 10.1074/jbc.274.14.9677; Chanda PK, 2010, J BASIC MICROB, V50, P519, DOI 10.1002/jobm.200900264; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Chen Z, 2013, MOL CELL PROTEOMICS, V12, P2266, DOI 10.1074/mcp.M112.025817; Claverys JP, 2009, FEMS MICROBIOL REV, V33, P643, DOI 10.1111/j.1574-6976.2009.00164.x; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; GOLDSTEIN J, 1990, P NATL ACAD SCI USA, V87, P283, DOI 10.1073/pnas.87.1.283; GRAU R, 1993, MOL MICROBIOL, V8, P535, DOI 10.1111/j.1365-2958.1993.tb01598.x; Graumann P, 1996, J BACTERIOL, V178, P4611, DOI 10.1128/jb.178.15.4611-4619.1996; Graumann Peter L., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P203; Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; JONES PG, 1987, J BACTERIOL, V169, P2092, DOI 10.1128/jb.169.5.2092-2095.1987; Jung YH, 2010, PROTEIN J, V29, P136, DOI 10.1007/s10930-010-9233-9; Kaan T, 2002, MICROBIOL-SGM, V148, P3441, DOI 10.1099/00221287-148-11-3441; Kamp HD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002153; Klein HL, 2002, MOL CELL, V9, P471, DOI 10.1016/S1097-2765(02)00493-8; Klein W, 1999, J BACTERIOL, V181, P5341, DOI 10.1128/JB.181.17.5341-5349.1999; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Laxman S, 2013, CELL, V154, P416, DOI 10.1016/j.cell.2013.06.043; Liu B, 2012, J GENET GENOMICS, V39, P561, DOI 10.1016/j.jgg.2012.07.003; Arvizu-Gomez JL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-81; Lopez-Garcia P, 2000, BIOESSAYS, V22, P738; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Matityahu I, 2006, AMINO ACIDS, V30, P185, DOI 10.1007/s00726-005-0250-5; Mega R, 2010, BIOCHEM BIOPH RES CO, V399, P336, DOI 10.1016/j.bbrc.2010.07.065; Movahedi S, 2002, J BACTERIOL, V184, P5275, DOI 10.1128/JB.184.19.5275-5281.2002; Phadtare S, 2003, GENES CELLS, V8, P801, DOI 10.1046/j.1365-2443.2003.00675.x; Phadtare S, 2010, RNA BIOL, V7, P788, DOI 10.4161/rna.7.6.13482; Phadtare S, 2009, J MOL MICROB BIOTECH, V17, P110, DOI 10.1159/000226587; Pierce A, 2011, ARCH MICROBIOL, V193, P373, DOI 10.1007/s00203-011-0682-0; Piette F, 2012, EXTREMOPHILES, V16, P681, DOI 10.1007/s00792-012-0456-x; Schaerer K, 2013, FOODBORNE PATHOG DIS, V10, P1023, DOI 10.1089/fpd.2013.1562; Shaw AJ, 2010, APPL ENVIRON MICROB, V76, P4713, DOI 10.1128/AEM.00402-10; SHI WY, 1993, J BACTERIOL, V175, P2236, DOI 10.1128/JB.175.8.2236-2240.1993; Spaniol V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068298; STRAUCH MA, 1989, EMBO J, V8, P1615, DOI 10.1002/j.1460-2075.1989.tb03546.x; Stubs D, 2005, MICROBIOL-SGM, V151, P1895, DOI 10.1099/mic.0.27785-0; Tanaka T, 2012, FEBS J, V279, P1014, DOI 10.1111/j.1742-4658.2012.08492.x; Tribble GD, 2012, MBIO, V3, DOI 10.1128/mBio.00231-11; VANBOGELEN RA, 1990, P NATL ACAD SCI USA, V87, P5589, DOI 10.1073/pnas.87.15.5589; Wang JQ, 2007, PROTEOMICS, V7, P1409, DOI 10.1002/pmic.200500226; Wang JQ, 2004, PROTEOMICS, V4, P136, DOI 10.1002/pmic.200300504; Weber Michael H. W., 2003, Science Progress, V86, P9, DOI 10.3184/003685003783238707; Wiegeshoff F, 2006, J BACTERIOL, V188, P3130, DOI 10.1128/JB.188.8.3130-3133.2006; Xue YF, 2001, INT J SYST EVOL MICR, V51, P1335, DOI 10.1099/00207713-51-4-1335; Yousefi-Nejad M, 2011, J PROTEOMICS, V74, P2100, DOI 10.1016/j.jprot.2011.05.037; Zhong WH, 2011, BEHAV ECOL SOCIOBIOL, V65, P493, DOI 10.1007/s00265-010-1117-7	58	17	19	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93289	10.1371/journal.pone.0093289	http://dx.doi.org/10.1371/journal.pone.0093289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667527	gold, Green Published, Green Submitted			2022-12-25	WOS:000333675600164
J	Trias, M; Arbona, A; Masso, J; Minano, B; Bona, C				Trias, Miquel; Arbona, Antonio; Masso, Joan; Minano, Borja; Bona, Carles			FDA's Nozzle Numerical Simulation Challenge: Non-Newtonian Fluid Effects and Blood Damage	PLOS ONE			English	Article							CAROTID BIFURCATION MODEL; BOUNDARY-CONDITIONS; FLOW; HEMODYNAMICS; PREDICTION; DYNAMICS; ARTERIES; MRI	Data from FDA's nozzle challenge-a study to assess the suitability of simulating fluid flow in an idealized medical device-is used to validate the simulations obtained from a numerical, finite-differences code. Various physiological indicators are computed and compared with experimental data from three different laboratories, getting a very good agreement. Special care is taken with the derivation of blood damage (hemolysis). The paper is focused on the laminar regime, in order to investigate non-Newtonian effects (non-constant fluid viscosity). The code can deal with these effects with just a small extra computational cost, improving Newtonian estimations up to a ten percent. The relevance of non-Newtonian effects for hemolysis parameters is discussed.	[Trias, Miquel; Arbona, Antonio; Masso, Joan; Minano, Borja; Bona, Carles] Univ Balearic Isl, IAC3, Palma De Mallorca, Spain	Universitat de les Illes Balears	Arbona, A (corresponding author), Univ Balearic Isl, IAC3, Palma De Mallorca, Spain.	aarbona@iac3.eu	Bona, Carles/Q-5133-2019; Marti Masso, Jose Felix/D-8619-2013	Bona, Carles/0000-0003-3139-4260; Marti Masso, Jose Felix/0000-0001-8428-4386; Masso, Joan/0000-0001-5816-4874	European Commission [TSI-020400-2010-84]; Ministerio de Educacion y Ciencia [CSD2007-00042, PI12/02565]; Balearic Islands government [53/2011]	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Educacion y Ciencia(Spanish Government); Balearic Islands government	This research has been partially funded by the European Commission (TSI-020400-2010-84), the Ministerio de Educacion y Ciencia (CSD2007-00042, PI12/02565), and the Balearic Islands government (53/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Feby, 2005, Computer Methods in Biomechanics and Biomedical Engineering, V8, P127, DOI 10.1080/10255840500180799; Arbona A, 2013, COMPUT PHYS COMMUN, V184, P2321, DOI 10.1016/j.cpc.2013.04.012; Arora D, 2004, ARTIF ORGANS, V28, P1002, DOI 10.1111/j.1525-1594.2004.00072.x; Bona C, 2009, J COMPUT PHYS, V228, P2266, DOI 10.1016/j.jcp.2008.12.010; Boyd J, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2772250; Cebral JR, 2005, IEEE T MED IMAGING, V24, P457, DOI 10.1109/TMI.2005.844159; Cole RH, 1948, UNDERWATER EXPLOSION, V41; Faber T. E., 1995, FLUID DYNAMICS PHYS; Ferziger J.H., 2002, COMPUTATIONAL METHOD; Garon A, 2004, ARTIF ORGANS, V28, P1016, DOI 10.1111/j.1525-1594.2004.00026.x; Giersiepen M, 1990, INT J ARTIFICIAL ORG; Gijsen FJH, 1999, J BIOMECH, V32, P601, DOI 10.1016/S0021-9290(99)00015-9; Grigioni M, 2005, BIOMECH MODEL MECHAN, V4, P249, DOI 10.1007/s10237-005-0005-y; Heys Jeffrey J, 2010, Open Biomed Eng J, V4, P123, DOI 10.2174/1874120701004010123; HIRT CW, 1981, J COMPUT PHYS, V39, P201, DOI 10.1016/0021-9991(81)90145-5; ISSA RI, 1986, J COMPUT PHYS, V62, P40, DOI 10.1016/0021-9991(86)90099-9; Johnston BM, 2004, J BIOMECH, V37, P709, DOI 10.1016/j.jbiomech.2003.09.016; Lee S, 2007, J BIOMECHANICAL ENG, P1; LIMA CO, 1983, CIRCULATION, V67, P866, DOI 10.1161/01.CIR.67.4.866; Miller GH, 2002, J COMPUT PHYS, V183, P26, DOI 10.1006/jcph.2002.7158; Monaghan JJ, 2005, REP PROG PHYS, V68, P1703, DOI 10.1088/0034-4885/68/8/R01; Nixon AM, 2010, J NEUROSURG, V112, P1240, DOI 10.3171/2009.10.JNS09759; PATANKAR SV, 1972, INT J HEAT MASS TRAN, V15, P1787, DOI 10.1016/0017-9310(72)90054-3; PERKTOLD K, 1991, J BIOMECH ENG-T ASME, V113, P464, DOI 10.1115/1.2895428; POINSOT TJ, 1992, J COMPUT PHYS, V101, P104, DOI 10.1016/0021-9991(92)90046-2; Razavi A, 2011, J BIOMECH, V44, P2021, DOI 10.1016/j.jbiomech.2011.04.023; SECOMB TW, 1987, MICROVASC RES, V34, P46, DOI 10.1016/0026-2862(87)90078-1; Segalova PA, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005850; SHU CW, 1988, J COMPUT PHYS, V77, P439, DOI 10.1016/0021-9991(88)90177-5; Stalder AF, 2008, MAGN RESON MED, V60, P1218, DOI 10.1002/mrm.21778; Steinman DA, 2002, MAGN RESON MED, V47, P149, DOI 10.1002/mrm.10025; Stewart S., 2012, CARDIOVASCULAR ENG T, V3, P139, DOI [DOI 10.1007/S13239-012-0087-5, 10.1007/s13239-012-0087-5]; SUSSMAN M, 1994, J COMPUT PHYS, V114, P146, DOI 10.1006/jcph.1994.1155; Tritton D. J., 1988, PHYS FLUID DYNAMICS; Wissink AM, 2001, P 2001 ACM IEEE C SU, P6; Yoo CS, 2005, COMBUST THEOR MODEL, V9, P617, DOI 10.1080/13647830500307378	36	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92638	10.1371/journal.pone.0092638	http://dx.doi.org/10.1371/journal.pone.0092638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667931	Green Submitted, Green Published, gold			2022-12-25	WOS:000333675600058
J	Williams, PS; Hoffman, RL; Clark, BC				Williams, Petra S.; Hoffman, Richard L.; Clark, Brian C.			Cortical and Spinal Mechanisms of Task Failure of Sustained Submaximal Fatiguing Contractions	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; INTERVAL INTRACORTICAL INHIBITION; ELBOW FLEXOR MUSCLES; LOAD TYPE; MOTOR CORTEX; CORTICOCORTICAL INHIBITION; CORTICOMOTOR EXCITABILITY; VISUAL INFORMATION; ENDURANCE TIME; BICEPS-BRACHII	In this and the subsequent companion paper, results are presented that collectively seek to delineate the contribution that supraspinal circuits have in determining the time to task failure (TTF) of sustained submaximal contractions. The purpose of this study was to compare adjustments in supraspinal and spinal excitability taken concurrently throughout the performance of two different fatigue tasks with identical mechanical demands but different TTF (i.e., force-matching and position-matching tasks). On separate visits, ten healthy volunteers performed the force-matching or position-matching task at 15% of maximum strength with the elbow flexors to task failure. Single-pulse transcranial magnetic stimulation (TMS), paired-pulse TMS, paired cortico-cervicomedullary stimulation, and brachial plexus electrical stimulation were delivered in a 6-stimuli sequence at baseline and every 2-3 minutes throughout fatigue-task performance. Contrary to expectations, the force-matching task TTF was 42% shorter (17.567.9 min) than the position-matching task (26.9615.11 min; p < 0.01); however, both tasks caused the same amount of muscle fatigue (p = 0.59). There were no task-specific differences for the total amount or rate of change in the neurophysiologic outcome variables over time (p > 0.05). Therefore, failure occurred after a similar mean decline in motorneuron excitability developed (p < 0.02, ES = 0.35-0.52) coupled with a similar mean increase in measures of corticospinal excitability (p < 0.03, ES = 0.30-0.41). Additionally, the amount of intracortical inhibition decreased (p < 0.03, ES = 0.32) and the amount of intracortical facilitation (p > 0.10) and an index of upstream excitation of the motor cortex remained constant (p > 0.40). Together, these results suggest that as fatigue develops prior to task failure, the increase in corticospinal excitability observed in relationship to the decrease in spinal excitability results from a combination of decreasing intracortical inhibition with constant levels of intracortical facilitation and upstream excitability that together eventually fail to provide the input to the motor cortex necessary for descending drive to overcome the spinal cord resistance, thereby contributing to task failure.	[Williams, Petra S.; Hoffman, Richard L.; Clark, Brian C.] Ohio Univ, OMNI, Athens, OH 45701 USA; [Williams, Petra S.] No Arizona Univ, Dept Phys Therapy & Athlet Training, Flagstaff, AZ 86011 USA; [Clark, Brian C.] Ohio Univ, Dept Biomed Sci, Athens, OH 45701 USA; [Clark, Brian C.] Ohio Univ, Dept Geriatr Med & Gerontol, Athens, OH 45701 USA	University System of Ohio; Ohio University; Northern Arizona University; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Williams, PS (corresponding author), Ohio Univ, OMNI, Athens, OH 45701 USA.	petra.williams@nau.edu			National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development [R15HD065552]; Research and Scholarly Affairs Committee at the Ohio University Heritage College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD065552] Funding Source: NIH RePORTER	National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Research and Scholarly Affairs Committee at the Ohio University Heritage College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by grant R15HD065552 from the National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development to B. C. Clark. Additionally, internal support for this work was provided by a grant from the Research and Scholarly Affairs Committee at the Ohio University Heritage College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2003, J NEUROPHYSIOL, V90, P2919, DOI 10.1152/jn.00179.2003; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Barry BK, 2007, INTEGR COMP BIOL, V47, P465, DOI 10.1093/icb/icm047; Baudry S, 2011, J NEUROPHYSIOL, V106, P265, DOI 10.1152/jn.00954.2010; Baudry S, 2009, J NEUROPHYSIOL, V102, P1725, DOI 10.1152/jn.00382.2009; Benwell NM, 2006, EXP BRAIN RES, V170, P191, DOI 10.1007/s00221-005-0195-7; Bigland-Ritchie B, 1981, Exerc Sport Sci Rev, V9, P75; Bigland-Ritchie B, 1981, Ciba Found Symp, V82, P130; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; BIGLANDRITCHIE B, 1986, ACTA PHYSIOL SCAND, V128, P137; Bojsen-Moller J, 2011, SCAND J MED SCI SPOR, V21, pE48, DOI 10.1111/j.1600-0838.2010.01148.x; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Chen R, 2004, EXP BRAIN RES, V154, P1, DOI 10.1007/s00221-003-1684-1; Chen R, 1999, EXP BRAIN RES, V128, P539, DOI 10.1007/s002210050878; Damron LA, 2008, J NEUROSCI METH, V173, P121, DOI 10.1016/j.jneumeth.2008.06.001; Dearth DJ, 2010, EUR J APPL PHYSIOL, V108, P1089, DOI 10.1007/s00421-009-1323-z; Di Lazzaro V, 2006, J NEUROPHYSIOL, V96, P1765, DOI 10.1152/jn.00360.2006; Di Lazzaro V, 1998, ELECTROMYOGR MOTOR C, V109, P397, DOI 10.1016/S0924-980X(98)00038-1; Duchateau J, 2002, J PHYSIOL-LONDON, V541, P959, DOI 10.1113/jphysiol.2002.016790; ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631, DOI 10.1152/jappl.1992.72.5.1631; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Enoka RM, 2012, J BIOMECH, V45, P427, DOI 10.1016/j.jbiomech.2011.11.047; Enoka RM, 2011, J ELECTROMYOGR KINES, V21, P208, DOI 10.1016/j.jelekin.2010.10.006; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gandevia SC, 2008, EXP PHYSIOL, V93, P1030, DOI 10.1113/expphysiol.2007.039032; Goss DA, 2012, J VISUALIZED EXPT JO, V20; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Harrison DD, 1999, J MANIP PHYSIOL THER, V22, P594, DOI 10.1016/S0161-4754(99)70020-5; Hong SL, 2008, PERCEPT PSYCHOPHYS, V70, P306, DOI 10.3758/PP.70.2.306; Hong SL, 2008, EXP BRAIN RES, V189, P61, DOI 10.1007/s00221-008-1403-z; Hunter SK, 2008, J APPL PHYSIOL, V105, P463, DOI 10.1152/japplphysiol.90398.2008; Hunter SK, 2003, J APPL PHYSIOL, V94, P108, DOI 10.1152/japplphysiol.00635.2002; Hunter SK, 2004, J APPL PHYSIOL, V96, P195, DOI 10.1152/japplphysiol.00893.2003; Hunter SK, 2003, J APPL PHYSIOL, V94, P2439, DOI 10.1152/japplphysiol.01038.2002; Hunter SK, 2002, J NEUROPHYSIOL, V88, P3087, DOI 10.1152/jn.00232.2002; Hunter SK, 2001, J APPL PHYSIOL, V91, P2686, DOI 10.1152/jappl.2001.91.6.2686; Keenan KG, 2006, J APPL PHYSIOL, V100, P1928, DOI 10.1152/japplphysiol.01282.2005; Klass M, 2008, J NEUROPHYSIOL, V99, P1096, DOI 10.1152/jn.01252.2007; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lauber B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032433; Le Bozec S, 2004, NEUROSCI LETT, V356, P61, DOI 10.1016/j.neulet.2003.09.052; Levenez M, 2008, J NEUROPHYSIOL, V99, P554, DOI 10.1152/jn.00963.2007; Maluf KS, 2005, EXP BRAIN RES, V167, P165, DOI 10.1007/s00221-005-0017-y; Maluf KS, 2005, J APPL PHYSIOL, V99, P389, DOI 10.1152/japplphysiol.00207.2005; Martin PG, 2008, J PHYSIOL-LONDON, V586, P1277, DOI 10.1113/jphysiol.2007.140426; Martin PG, 2009, J NEUROPHYSIOL, V102, P606, DOI 10.1152/jn.91348.2008; Maruyama A, 2006, CLIN NEUROPHYSIOL, V117, P864, DOI 10.1016/j.clinph.2005.12.019; McNeil CJ, 2011, J PHYSIOL-LONDON, V589, P3731, DOI 10.1113/jphysiol.2011.210252; McNeil CJ, 2011, J PHYSIOL-LONDON, V589, P3533, DOI 10.1113/jphysiol.2011.207191; McNeil CJ, 2009, J PHYSIOL-LONDON, V587, P5601, DOI 10.1113/jphysiol.2009.180968; McNeil CJ., 2011, PHYSL NEWS, V82, P29; Mottram CJ, 2006, EXP BRAIN RES, V174, P575, DOI 10.1007/s00221-006-0498-3; Mottram CJ, 2005, J NEUROPHYSIOL, V94, P2878, DOI 10.1152/jn.00390.2005; Mottram CJ, 2005, J NEUROPHYSIOL, V93, P1381, DOI 10.1152/jn.00837.2004; Nakamura H, 1997, J PHYSIOL-LONDON, V498, P817, DOI 10.1113/jphysiol.1997.sp021905; Nordstrom MA, 2007, MUSCLE NERVE, V35, P135, DOI 10.1002/mus.20712; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ortu E, 2008, J PHYSIOL-LONDON, V586, P5147, DOI 10.1113/jphysiol.2008.158956; Petersen NC, 2010, ACTA PHYSIOL, V198, P403, DOI 10.1111/j.1748-1716.2009.02066.x; Place N, 2009, CLIN EXP PHARMACOL P, V36, P334, DOI 10.1111/j.1440-1681.2008.05021.x; Poortvliet PC, 2013, CLIN NEUROPHYSIOL, V124, P732, DOI 10.1016/j.clinph.2012.09.025; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Reis J, 2008, BRAIN STIMUL, V1, P363, DOI 10.1016/j.brs.2008.08.001; RIDDING MC, 1995, J PHYSIOL-LONDON, V487, P541, DOI 10.1113/jphysiol.1995.sp020898; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothwell JC, 2012, CLIN NEUROL NEUROSUR, V114, P432, DOI 10.1016/j.clineuro.2011.12.053; Rothwell JC, 2009, J PHYSIOL-LONDON, V587, P5517, DOI 10.1113/jphysiol.2009.183475; Rothwell JC, 2009, J PHYSIOL-LONDON, V587, P11, DOI 10.1113/jphysiol.2008.162461; Rothwell J. C, 2008, OXFORD HDB TRANSCRAN, P171; Rudroff T, 2005, MUSCLE NERVE, V31, P78, DOI 10.1002/mus.20241; Rudroff T, 2007, J APPL PHYSIOL, V102, P1000, DOI 10.1152/japplphysiol.00564.2006; Rudroff T, 2007, MUSCLE NERVE, V35, P657, DOI 10.1002/mus.20752; Rudroff T, 2011, J APPL PHYSIOL, V110, P125, DOI 10.1152/japplphysiol.00605.2010; Rudroff T, 2010, EXP BRAIN RES, V203, P307, DOI 10.1007/s00221-010-2233-3; Sacco P, 2000, MUSCLE NERVE, V23, P1840, DOI 10.1002/1097-4598(200012)23:12<1840::AID-MUS7>3.0.CO;2-H; Shemmell J, 2010, CLIN NEUROPHYSIOL, V121, P1680, DOI 10.1016/j.clinph.2010.02.166; Sidhu SK, 2012, J APPL PHYSIOL, V113, P401, DOI 10.1152/japplphysiol.00486.2012; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Taylor JL, 2006, J ELECTROMYOGR KINES, V16, P215, DOI 10.1016/j.jelekin.2005.07.001; Taylor JL, 2006, CLIN EXP PHARMACOL P, V33, P400, DOI 10.1111/j.1440-1681.2006.04363.x; Taylor JL, 2004, J APPL PHYSIOL, V96, P1496, DOI 10.1152/japplphysiol.01116.2003; Taylor JL, 1996, J PHYSIOL-LONDON, V490, P519, DOI 10.1113/jphysiol.1996.sp021163; Thomas JS, 2011, J MOTOR BEHAV, V43, P27, DOI 10.1080/00222895.2010.530305; UGAWA Y, 1991, ANN NEUROL, V29, P418, DOI 10.1002/ana.410290413; Vucic S, 2011, CEREB CORTEX, V21, P1639, DOI 10.1093/cercor/bhq235; Yoon T, 2009, J MOTOR BEHAV, V41, P393, DOI 10.3200/35-09-003; Zijdewind I, 2006, EXP BRAIN RES, V175, P526, DOI 10.1007/s00221-006-0570-z	90	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93284	10.1371/journal.pone.0093284	http://dx.doi.org/10.1371/journal.pone.0093284			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667484	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600163
J	Sato, T; Takahashi, H; Hatakeyama, S; Iguchi, A; Ariga, T				Sato, T.; Takahashi, H.; Hatakeyama, S.; Iguchi, A.; Ariga, T.			The TRIM-FLMN protein TRIM45 directly interacts with RACK1 and negatively regulates PKC-mediated signaling pathway	ONCOGENE			English	Article							KINASE-C; CANCER-CELLS; MAP KINASES; TRANSCRIPTION; ACTIVATION; RECEPTOR; SITE; MECHANISMS; STRESS; FAMILY	The receptor for activated C-kinase (RACK1), a scaffolding protein that participates in the protein kinase C (PKC) signaling pathway, has an important role in shuttling active PKCs to its substrate. Indeed, recent studies have revealed that RACK1 has an important role in tumorigenesis and that enhancement of the feed-forward mechanism of the c-Jun N-terminal kinase (JNK)-Jun pathway via RACK1 is associated with constitutive activation of MEK (MAPK-ERK kinase)-ERK (extracellular signal-regulated kinase) signaling in human melanoma cells. Taken together, RACK1 additionally has a very important role in the mitogen-activated protein kinase (MAPK) signaling pathway. Here, we show that one of the tripartite motif-containing (TRIM) family ubiquitin ligases, TRIM45, is a novel RACK1-interacting protein and downregulates MAPK signal transduction. Importantly, the expression of TRIM45 is induced when growth-promoting extracellular stimuli activate the MAPK signaling pathway, resulting in attenuation of activation of the MAPK pathway. These findings suggest that TRIM45 functions as a member of the negative feedback loop of the MAPK pathway.	[Sato, T.; Iguchi, A.; Ariga, T.] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido 0608638, Japan; [Sato, T.; Takahashi, H.; Hatakeyama, S.] Hokkaido Univ, Grad Sch Med, Dept Biochem, Sapporo, Hokkaido 0608638, Japan	Hokkaido University; Hokkaido University	Sato, T (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Pediat, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	tomsato@med.hokudai.ac.jp	Hatakeyama, Shigetsugu/C-8333-2012	Hatakeyama, Shigetsugu/0000-0002-2150-9979	Ministry of Education, Culture, Sports, Science and Technology in Japan; Japan Foundation for Applied Enzymology; Children's Cancer Association of Japan; Grants-in-Aid for Scientific Research [24112006, 24390065] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology; Children's Cancer Association of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr Toshio Kitamura (Tokyo University) for the plasmid and cell lines. This work was supported in part by a research grant from Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan, Japan Foundation for Applied Enzymology, and Children's Cancer Association of Japan.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Al-Reefy S, 2010, ONCOGENE, V29, P5651, DOI 10.1038/onc.2010.291; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Bauman AL, 2002, NAT CELL BIOL, V4, pE203, DOI 10.1038/ncb0802-e203; Bourd-Boittin K, 2008, J BIOL CHEM, V283, P26000, DOI 10.1074/jbc.M709829200; Calvo F, 2010, BIOESSAYS, V32, P412, DOI 10.1002/bies.200900155; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Chou YC, 1999, BBA-GENE STRUCT EXPR, V1489, P315, DOI 10.1016/S0167-4781(99)00213-4; Dorn GW, 2002, ANNU REV PHYSIOL, V64, P407, DOI 10.1146/annurev.physiol.64.081501.155903; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; He DY, 2010, J BIOL CHEM, V285, P19043, DOI 10.1074/jbc.M110.100693; Imajo M, 2006, IUBMB LIFE, V58, P312, DOI 10.1080/15216540600746393; Kano S, 2008, CANCER RES, V68, P5572, DOI 10.1158/0008-5472.CAN-07-6231; Kondoh K, 2007, BBA-MOL CELL RES, V1773, P1227, DOI 10.1016/j.bbamcr.2006.12.002; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Lopez-Bergami P, 2008, INT J BIOCHEM CELL B, V40, P1055, DOI 10.1016/j.biocel.2007.11.011; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Maurer G, 2011, ONCOGENE, V30, P3477, DOI 10.1038/onc.2011.160; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Miyajima N, 2008, CANCER RES, V68, P3486, DOI 10.1158/0008-5472.CAN-07-6059; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Noguchi K, 2011, CARCINOGENESIS, V32, P995, DOI 10.1093/carcin/bgr068; Prusty BK, 2005, INT J CANCER, V113, P951, DOI 10.1002/ijc.20668; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; RON D, 1995, P NATL ACAD SCI USA, V92, P492, DOI 10.1073/pnas.92.2.492; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Rotenberg SA, 1998, J BIOL CHEM, V273, P2390, DOI 10.1074/jbc.273.4.2390; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sato T, 2012, J CELL SCI, V125, P1544, DOI 10.1242/jcs.095273; Sato T, 2011, J CELL SCI, V124, P3492, DOI 10.1242/jcs.088799; Shi S, 2012, J BIOL CHEM, V287, P7845, DOI 10.1074/jbc.M111.315416; Shibata M, 2012, BIOCHEM BIOPH RES CO, V423, P104, DOI 10.1016/j.bbrc.2012.05.090; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Wang YQ, 2004, BIOCHEM BIOPH RES CO, V323, P9, DOI 10.1016/j.bbrc.2004.08.048; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Zhang WZ, 2008, J BIOL CHEM, V283, P16416, DOI 10.1074/jbc.M802360200	47	25	26	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2015	34	10					1280	1291		10.1038/onc.2014.68	http://dx.doi.org/10.1038/onc.2014.68			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC9JX	24681954				2022-12-25	WOS:000350687100008
J	Smith, IJ; Godinez, GL; Singh, BK; McCaughey, KM; Alcantara, RR; Gururaja, T; Ho, MS; Nguyen, HN; Friera, AM; White, KA; McLaughlin, JR; Hansen, D; Romero, JM; Baltgalvis, KA; Claypool, MD; Li, W; Lang, W; Yam, GC; Gelman, MS; Ding, RX; Yung, SL; Creger, DP; Chen, Y; Singh, R; Smuder, AJ; Wiggs, MP; Kwon, OS; Sollanek, KJ; Powers, SK; Masuda, ES; Taylor, VC; Payan, DG; Kinoshita, T; Kinsella, TM				Smith, Ira J.; Godinez, Guillermo L.; Singh, Baljit K.; McCaughey, Kelly M.; Alcantara, Raniel R.; Gururaja, Tarikere; Ho, Melissa S.; Nguyen, Henry N.; Friera, Annabelle M.; White, Kathy A.; McLaughlin, John R.; Hansen, Derek; Romero, Jason M.; Baltgalvis, Kristen A.; Claypool, Mark D.; Li, Wei; Lang, Wayne; Yam, George C.; Gelman, Marina S.; Ding, Rongxian; Yung, Stephanie L.; Creger, Daniel P.; Chen, Yan; Singh, Rajinder; Smuder, Ashley J.; Wiggs, Michael P.; Kwon, Oh-Sung; Sollanek, Kurt J.; Powers, Scott K.; Masuda, Esteban S.; Taylor, Vanessa C.; Payan, Donald G.; Kinoshita, Taisei; Kinsella, Todd M.			Inhibition of Janus kinase signaling during controlled mechanical ventilation prevents ventilation-induced diaphragm dysfunction	FASEB JOURNAL			English	Article						muscle wasting; mitochondria; oxidative stress; STAT3	INTENSIVE-CARE-UNIT; SERINE PHOSPHORYLATION; MITOCHONDRIAL STAT3; OXIDATIVE STRESS; MUSCLE ATROPHY; DEGRADATION; ACTIVATION; WEAKNESS; P38	Controlled mechanical ventilation (CMV) is associated with the development of diaphragm atrophy and contractile dysfunction, and respiratory muscle weakness is thought to contribute significantly to delayed weaning of patients. Therefore, therapeutic strategies for preventing these processes may have clinical benefit. The aim of the current study was to investigate the role of the Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) signaling pathway in CMV-mediated diaphragm wasting and weakness in rats. CMV-induced diaphragm atrophy and contractile dysfunction coincided with marked increases in STAT3 phosphorylation on both tyrosine 705 (Tyr705) and serine 727 (Ser727). STAT3 activation was accompanied by its translocation into mitochondria within diaphragm muscle and mitochondrial dysfunction. Inhibition of JAK signaling during CMV prevented phosphorylation of both target sites on STAT3, eliminated the accumulation of phosphorylated STAT3 within the mitochondria, and reversed the pathologic alterations in mitochondrial function, reduced oxidative stress in the diaphragm, and maintained normal diaphragm contractility. In addition, JAK inhibition during CMV blunted the activation of key proteolytic pathways in the diaphragm, as well as diaphragm atrophy. These findings implicate JAK/STAT3 signaling in the development of diaphragm muscle atrophy and dysfunction during CMV and suggest that the delayed extubation times associated with CMV can be prevented by inhibition of Janus kinase signaling.	[Smith, Ira J.; Godinez, Guillermo L.; Singh, Baljit K.; McCaughey, Kelly M.; Alcantara, Raniel R.; Gururaja, Tarikere; Ho, Melissa S.; Nguyen, Henry N.; Friera, Annabelle M.; White, Kathy A.; McLaughlin, John R.; Hansen, Derek; Romero, Jason M.; Baltgalvis, Kristen A.; Claypool, Mark D.; Li, Wei; Lang, Wayne; Yam, George C.; Gelman, Marina S.; Ding, Rongxian; Yung, Stephanie L.; Creger, Daniel P.; Chen, Yan; Singh, Rajinder; Masuda, Esteban S.; Taylor, Vanessa C.; Payan, Donald G.; Kinoshita, Taisei; Kinsella, Todd M.] Rigel Pharmaceut Inc, San Francisco, CA 94080 USA; [Smuder, Ashley J.; Wiggs, Michael P.; Kwon, Oh-Sung; Sollanek, Kurt J.; Powers, Scott K.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA	State University System of Florida; University of Florida	Kinsella, TM (corresponding author), Rigel Pharmaceut Inc, 1180 Vet Blvd, San Francisco, CA 94080 USA.	tkinsella@rigel.com	Kwon, Oh Sung/AAL-4116-2021	Masuda, Esteban/0000-0002-3175-2868; Chen, Yan/0000-0002-5690-5381	Rigel Pharmaceuticals; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043730] Funding Source: NIH RePORTER	Rigel Pharmaceuticals; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Joseph B. Shrager and H. Tang (Stanford University, Stanford, CA, USA) for useful insights, and Vadim Markovtsov (Rigel Pharmaceuticals) for helpful discussions and reading of the manuscript. I.J.S., G. L. G., B. K. S., K. M. M., R. R. A., T. G., M. S. H., H.N.N., A. M. F., K. A. W., J.R.M., D. H., J.M.R., K. A. B., M. D. C., W. Li, W. Lang, G.C.Y., M. S. G., R. D., S.L.Y., D. P. C., Y.C., R. S., E. S. M., V. C. T., D. G. P., T. K., and T. M. K. are employees and/or stockholders of Rigel Pharmaceuticals, Inc. Experiments conducted at the University of Florida were supported by funding from Rigel Pharmaceuticals (to S.K.P.).	Betters JL, 2004, AM J RESP CRIT CARE, V170, P1179, DOI 10.1164/rccm.200407-939OC; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; De Jonghe B, 2007, CRIT CARE MED, V35, P2007, DOI 10.1097/01.ccm.0000281450.01881.d8; Deuse T, 2012, TRANSPLANTATION, V94, P695, DOI 10.1097/TP.0b013e3182660496; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Esteban A, 2000, AM J RESP CRIT CARE, V161, P1450, DOI 10.1164/ajrccm.161.5.9902018; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Hermans G, 2010, CRIT CARE, V14, DOI 10.1186/cc9094; Jaber S, 2011, AM J RESP CRIT CARE, V183, P364, DOI 10.1164/rccm.201004-0670OC; Jain N, 1999, J BIOL CHEM, V274, P24392, DOI 10.1074/jbc.274.34.24392; Kavazis AN, 2009, FREE RADICAL BIO MED, V46, P842, DOI 10.1016/j.freeradbiomed.2009.01.002; Kim J, 2009, KOREAN J PHYSIOL PHA, V13, P491, DOI 10.4196/kjpp.2009.13.6.491; Kurdi M, 2009, AM J PHYSIOL-HEART C, V297, pH1545, DOI 10.1152/ajpheart.00032.2009; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Lokireddy S, 2011, MOL ENDOCRINOL, V25, P1936, DOI 10.1210/me.2011-1124; Maes K, 2007, AM J RESP CRIT CARE, V175, P1134, DOI 10.1164/rccm.200609-1342OC; McClung JM, 2007, J PHYSIOL-LONDON, V585, P203, DOI 10.1113/jphysiol.2007.141119; McClung JM, 2007, AM J RESP CRIT CARE, V175, P150, DOI 10.1164/rccm.200601-142OC; Meyer DM, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-41; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Ochala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020558; Polge C, 2011, FASEB J, V25, P3790, DOI 10.1096/fj.11-180968; Powers SK, 2011, CRIT CARE MED, V39, P1749, DOI 10.1097/CCM.0b013e3182190b62; Reid MB, 2011, J PHYSIOL-LONDON, V589, P2171, DOI 10.1113/jphysiol.2010.203356; Shulga N, 2012, J CELL SCI, V125, P2995, DOI 10.1242/jcs.103093; Smuder AJ, 2010, FREE RADICAL BIO MED, V49, P1152, DOI 10.1016/j.freeradbiomed.2010.06.025; Song B, 2013, REGUL PEPTIDES, V185, P44, DOI 10.1016/j.regpep.2013.06.007; Szczepanek K, 2011, J BIOL CHEM, V286, P29610, DOI 10.1074/jbc.M111.226209; Tammineni P, 2013, J BIOL CHEM, V288, P4723, DOI 10.1074/jbc.M112.378984; Tang HB, 2011, FASEB J, V25, P2921, DOI 10.1096/fj.11-183798; Turkson J, 1999, MOL CELL BIOL, V19, P7519; Vassilakopoulos T, 2004, AM J RESP CRIT CARE, V169, P336, DOI 10.1164/rccm.200304-489CP; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Whidden MA, 2010, J APPL PHYSIOL, V108, P1376, DOI 10.1152/japplphysiol.00098.2010; White JP, 2011, AM J PHYSIOL-REG I, V300, pR201, DOI 10.1152/ajpregu.00300.2010; Wunsch H, 2010, CRIT CARE MED, V38, P1947, DOI 10.1097/CCM.0b013e3181ef4460; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Zhang QF, 2013, J BIOL CHEM, V288, P31280, DOI 10.1074/jbc.M113.505057; Zhou LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021680	42	37	40	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2790	2803		10.1096/fj.13-244210	http://dx.doi.org/10.1096/fj.13-244210			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24671708	Green Published, hybrid			2022-12-25	WOS:000337949400006
J	Birsa, N; Norkett, R; Wauer, T; Mevissen, TET; Wu, HC; Foltynie, T; Bhatia, K; Hirst, WD; Komander, D; Plun-Favreau, H; Kittler, JT				Birsa, Nicol; Norkett, Rosalind; Wauer, Tobias; Mevissen, Tycho E. T.; Wu, Hsiu-Chuan; Foltynie, Thomas; Bhatia, Kailash; Hirst, Warren D.; Komander, David; Plun-Favreau, Helene; Kittler, Josef T.			Lysine 27 Ubiquitination of the Mitochondrial Transport Protein Miro Is Dependent on Serine 65 of the Parkin Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGED MITOCHONDRIA; MITOPHAGY; PINK1; DEGRADATION; MITOFUSIN; DOMAIN; TRANSLOCATION; PROTEASOME; MEMBRANE; RECEPTOR	Mitochondrial transport plays an important role in matching mitochondrial distribution to localized energy production and calcium buffering requirements. Here, we demonstrate that Miro1, an outer mitochondrial membrane (OMM) protein crucial for the regulation of mitochondrial trafficking and distribution, is a substrate of the PINK1/Parkin mitochondrial quality control system in human dopaminergic neuroblastoma cells. Moreover, Miro1 turnover on damaged mitochondria is altered in Parkinson disease (PD) patient-derived fibroblasts containing a pathogenic mutation in the PARK2 gene (encoding Parkin). By analyzing the kinetics of Miro1 ubiquitination, we further demonstrate that mitochondrial damage triggers rapid (within minutes) and persistent Lys-27-type ubiquitination of Miro1 on the OMM, dependent on PINK1 and Parkin. Proteasomal degradation of Miro1 is then seen on a slower time scale, within 2-3 h of the onset of ubiquitination. We find Miro ubiquitination in dopaminergic neuroblastoma cells is independent of Miro1 phosphorylation at Ser-156 but is dependent on the recently identified Ser-65 residue within Parkin that is phosphorylated by PINK1. Interestingly, we find that Miro1 can stabilize phospho-mutant versions of Parkin on the OMM, suggesting that Miro is also part of a Parkin receptor complex. Moreover, we demonstrate that Ser-65 in Parkin is critical for regulating Miro levels upon mitochondrial damage in rodent cortical neurons. Our results provide new insights into the ubiquitination-dependent regulation of the Miro-mediated mitochondrial transport machinery by PINK1/Parkin and also suggest that disruption of this regulation may be implicated in Parkinson disease pathogenesis.	[Birsa, Nicol; Norkett, Rosalind; Kittler, Josef T.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Wauer, Tobias; Mevissen, Tycho E. T.; Komander, David] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Wu, Hsiu-Chuan; Foltynie, Thomas; Bhatia, Kailash; Plun-Favreau, Helene] UCL, Inst Neurol, London WC1N 3BG, England; [Hirst, Warren D.] Pfizer, Neurosci Res Unit, Cambridge, MA 02139 USA	University of London; University College London; MRC Laboratory Molecular Biology; University of London; University College London; Pfizer	Kittler, JT (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	j.kittler@ucl.ac.uk	Plun-Favreau, Helene/Q-4111-2016; Mevissen, Tycho E.T./AAX-4366-2020; Kittler, Josef/N-7589-2019; Kittler, Josef T/E-9113-2010	Plun-Favreau, Helene/0000-0002-1401-9656; Mevissen, Tycho E.T./0000-0002-2324-5292; Kittler, Josef/0000-0002-3437-9456; Kittler, Josef T/0000-0002-3437-9456; Hirst, Warren/0000-0003-0389-8891; Norkett, Rosalind/0000-0001-9460-9973; Bhatia, Kailash/0000-0001-8185-286X; Birsa, Nicol/0000-0002-8271-540X	European Research Council (ERC) [282430]; Lister Institute for Preventive Medicine; University College London; Medical Research Council; Marie Curie Initial Training Network (UPStream); National Institute for Health Research University College London Hospitals Biomedical Research Centre; Medical Research Council [U105192732]; European Research Council [309756]; Wellcome/Medical Research Council Parkinson's Disease Consortium Grant; University of Sheffield; MRC Protein Phosphorylation Unit at the University of Dundee [WT089698]; Medical Research Council Career Development Award [G0700183]; Medical Research Council [G0700183, G0802377, MC_U105192732, 1069309, MC_G1000735] Funding Source: researchfish; Parkinson&quot;s UK [H-1006] Funding Source: researchfish; MRC [MC_U105192732, G0700183, G0802377, MC_G1000735] Funding Source: UKRI	European Research Council (ERC)(European Research Council (ERC)European Commission); Lister Institute for Preventive Medicine; University College London(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Initial Training Network (UPStream); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Wellcome/Medical Research Council Parkinson's Disease Consortium Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Sheffield; MRC Protein Phosphorylation Unit at the University of Dundee(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by European Research Council (ERC) Starting Grant (282430) and the Lister Institute for Preventive Medicine.; Recipient of a University College London Impact Ph.D. award.; Recipient of a Medical Research Council Case award.; Supported by the Marie Curie Initial Training Network (UPStream).; Supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre.; Supported by the Medical Research Council (U105192732), the European Research Council (309756), and the Lister Institute for Preventive Medicine.; Supported by a Wellcome/Medical Research Council Parkinson's Disease Consortium Grant (to University College London/Institute of Neurology), the University of Sheffield, and MRC Protein Phosphorylation Unit at the University of Dundee Grant WT089698, and Medical Research Council Career Development Award G0700183.	Ardley HC, 2003, MOL BIOL CELL, V14, P4541, DOI 10.1091/mbc.E03-02-0078; Brickley K, 2005, J BIOL CHEM, V280, P14723, DOI 10.1074/jbc.M409095200; Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Licchesi JDF, 2012, NAT STRUCT MOL BIOL, V19, P62, DOI 10.1038/nsmb.2169; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; Livingston CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000619; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; MacAskill AF, 2009, MOL CELL NEUROSCI, V40, P301, DOI 10.1016/j.mcn.2008.10.016; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Russo GJ, 2009, J NEUROSCI, V29, P5443, DOI 10.1523/JNEUROSCI.5417-08.2009; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Twelvetrees AE, 2010, NEURON, V65, P53, DOI 10.1016/j.neuron.2009.12.007; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Weihofen A, 2009, BIOCHEMISTRY-US, V48, P2045, DOI 10.1021/bi8019178; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	49	121	124	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14569	14582		10.1074/jbc.M114.563031	http://dx.doi.org/10.1074/jbc.M114.563031			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24671417	Green Published, hybrid			2022-12-25	WOS:000337248100015
J	Gross, TJ; Powers, LS; Boudreau, RL; Brink, B; Reisetter, A; Goel, K; Gerke, AK; Hassan, IH; Monick, MM				Gross, Thomas J.; Powers, Linda S.; Boudreau, Ryan L.; Brink, Brandi; Reisetter, Anna; Goel, Khushboo; Gerke, Alicia K.; Hassan, Ihab H.; Monick, Martha M.			A MicroRNA Processing Defect in Smokers' Macrophages Is Linked to SUMOylation of the Endonuclease DICER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chronic Obstructive Pulmonary Disease (COPD); Cigarette Smoke; DICER; Epigenetics; Macrophage; MicroRNA (miRNA); Small Ubiquitin-like Modifier (SUMO); SUMOylation	GENE-EXPRESSION CHANGES; CIGARETTE-SMOKE; PATHOGENESIS; IMPACT; RELEASE; SUMO; RNA; IDENTIFICATION; EMPHYSEMA; MEDIATORS	Background: Smoking causes a global down-regulation in alveolar macrophage miRNA expression. Results: Cigarette smoke exposure modifies the RNA endonuclease DICER, resulting in a microRNA processing defect. Conclusion: Cigarette smoke alters alveolar macrophage microRNA expression, in part, by SUMOylation of DICER. Significance: This is the first description of an environmental exposure causing changes in microRNA expression via post-translational modification of DICER. Despite the fact that alveolar macrophages play an important role in smoking-related disease, little is known about what regulates their pathophysiologic phenotype. Evaluating smoker macrophages, we found significant down-regulation of multiple microRNAs (miRNAs). This work investigates the hypothesis that cigarette smoke alters mature miRNA expression in lung macrophages by inhibiting processing of primary miRNA transcripts. Studies on smoker alveolar macrophages showed a defect in miRNA maturation. Studies on the miRNA biogenesis machinery led us to focus on the cytosolic RNA endonuclease, DICER. DICER cleaves the stem-loop structure from pre-miRNAs, allowing them to dissociate into their mature 20-22-nucleotide single-stranded form. DICER activity assays confirmed impaired DICER activity following cigarette smoke exposure. Further protein studies demonstrated a decreased expression of the native 217-kDa form of DICER and an accumulation of high molecular weight forms with cigarette smoke exposure. This molecular mass shift was shown to contain SUMO moieties and could be blocked by silencing RNA directed at the primary SUMOylating ligase, Ubc9. In determining the cigarette smoke components responsible for changes in DICER, we found that N-acetylcysteine, an antioxidant and anti-aldehyde, protected DICER protein and activity from cigarette smoke extract. This massive down-regulation of miRNAs (driven in part by alterations in DICER) may be an important regulator of the disease-promoting macrophage phenotype found in the lungs of smokers.	[Gross, Thomas J.; Powers, Linda S.; Boudreau, Ryan L.; Brink, Brandi; Reisetter, Anna; Goel, Khushboo; Gerke, Alicia K.; Hassan, Ihab H.; Monick, Martha M.] Univ Iowa, Carver Coll Med, Dept Med, Iowa City, IA 52242 USA	University of Iowa	Gross, TJ (corresponding author), Univ Iowa, Div Pulm Crit Care & Occupat Med, Iowa City, IA 52242 USA.	thomas-gross@uiowa.edu	Gross, Thomas/AAO-9404-2021	Gross, Thomas/0000-0001-9617-6606; Boudreau, Ryan/0000-0002-9800-5349	National Institutes of Health [R01 HL079901, RO1 HL096625, R21 HL109589]; NIEHS, National Institutes of Health, through the University of Iowa Environmental Health Sciences Research Center; NIEHS/National Institutes of Health [P30 ES005605]; NCRR/National Institutes of Health [UL1RR024979]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096625, T32HL007121, R01HL079901, R21HL109589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, National Institutes of Health, through the University of Iowa Environmental Health Sciences Research Center; NIEHS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCRR/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL079901, RO1 HL096625, and R21 HL109589 ( to M. M.). This research was also supported in part by the NIEHS, National Institutes of Health, through the University of Iowa Environmental Health Sciences Research Center, NIEHS/National Institutes of Health Grant P30 ES005605, and NCRR/National Institutes of Health Grant UL1RR024979.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BELAAOUAJ A, 1995, J BIOL CHEM, V270, P14568, DOI 10.1074/jbc.270.24.14568; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Birrell MA, 2008, J CELL PHYSIOL, V214, P27, DOI 10.1002/jcp.21158; BLUE ML, 1978, AM REV RESPIR DIS, V117, P317; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Carnevali S, 2003, AM J PHYSIOL-LUNG C, V284, pL955, DOI 10.1152/ajplung.00466.2001; Chaudhuri AA, 2011, J IMMUNOL, V187, P5062, DOI 10.4049/jimmunol.1102001; EISERICH JP, 1995, AM J CLIN NUTR, V62, P1490, DOI 10.1093/ajcn/62.6.1490S; Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-0130OC; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Gibbings D, 2012, NAT CELL BIOL, V14, P1314, DOI 10.1038/ncb2611; Graff JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044066; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; JANOFF A, 1968, J EXP MED, V128, P1137, DOI 10.1084/jem.128.5.1137; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Manzel LJ, 2009, AM J RESP CELL MOL, V40, P200, DOI 10.1165/rcmb.2008-0104OC; MARTIN TR, 1985, AM REV RESPIR DIS, V132, P254; Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485; Monick MM, 2006, J IMMUNOL, V177, P1636, DOI 10.4049/jimmunol.177.3.1636; Monick MM, 2010, J IMMUNOL, V185, P5425, DOI 10.4049/jimmunol.1001603; Monick MM, 1998, AM J PHYSIOL-LUNG C, V275, pL389, DOI 10.1152/ajplung.1998.275.2.L389; Nyunoya T, 2006, AM J RESP CELL MOL, V35, P681, DOI 10.1165/rcmb.2006-0169OC; Nyunoya T, 2009, AM J RESP CRIT CARE, V179, P279, DOI 10.1164/rccm.200802-320OC; Panayiotidis MI, 2004, CHEM-BIOL INTERACT, V147, P87, DOI 10.1016/j.cbi.2003.10.009; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Philibert RA, 2012, J LEUKOCYTE BIOL, V92, P621, DOI 10.1189/jlb.1211632; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Reisetter AC, 2011, J BIOL CHEM, V286, P21844, DOI 10.1074/jbc.M111.238519; Robbins CS, 2006, AM J RESP CRIT CARE, V174, P1342, DOI 10.1164/rccm.200604-561OC; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shapiro SD, 2005, AM J RESP CELL MOL, V32, P367, DOI 10.1165/rcmb.F296; Shapiro SD, 1999, AM J RESP CRIT CARE, V160, pS29, DOI 10.1164/ajrccm.160.supplement_1.9; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Spira A, 2004, CHEST, V125, p115S, DOI 10.1378/chest.125.5_suppl.115S; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Talbot P, 1998, BIOL REPROD, V58, P1047, DOI 10.1095/biolreprod58.4.1047; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Teng SL, 2012, AMINO ACIDS, V43, P447, DOI 10.1007/s00726-011-1100-2; Tetley TD, 2002, CHEST, V121, p156S, DOI 10.1378/chest.121.5_suppl.156S; Van Pottelberge GR, 2011, AM J RESP CRIT CARE, V183, P898, DOI 10.1164/rccm.201002-0304OC; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Zeskind Julie E, 2008, Proc Am Thorac Soc, V5, P834, DOI 10.1513/pats.200807-074TH	53	50	50	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12823	12834		10.1074/jbc.M114.565473	http://dx.doi.org/10.1074/jbc.M114.565473			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24668803	Green Published, hybrid			2022-12-25	WOS:000335581400051
J	Bucek, A; Matouskova, P; Sychrova, H; Pichova, I; Hruskova-Heidingsfeldova, O				Bucek, Ales; Matouskova, Petra; Sychrova, Hana; Pichova, Iva; Hruskova-Heidingsfeldova, Olga			Delta 12-Fatty Acid Desaturase from Candida parapsilosis Is a Multifunctional Desaturase Producing a Range of Polyunsaturated and Hydroxylated Fatty Acids	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; HETEROLOGOUS EXPRESSION; MASS-SPECTROMETRY; 4,4-DIMETHYLOXAZOLINE DERIVATIVES; SUBSTRATE-SPECIFICITY; MORTIERELLA-ALPINA; GENE; IDENTIFICATION; BIOSYNTHESIS; REGIOSELECTIVITY	Numerous Delta 12-, Delta 15- and multifunctional membrane fatty acid desaturases (FADs) have been identified in fungi, revealing great variability in the enzymatic specificities of FADs involved in biosynthesis of polyunsaturated fatty acids (PUFAs). Here, we report gene isolation and characterization of novel Delta 12/Delta 15- and Delta 15-FADs named CpFad2 and CpFad3, respectively, from the opportunistic pathogenic yeast Candida parapsilosis. Overexpression of CpFad3 in Saccharomyces cerevisiae strains supplemented with linoleic acid (Delta 9,Delta 12-18:2) and hexadecadienoic acid (Delta 9,Delta 12-16:2) leads to accumulation of Delta 15-PUFAs, i.e., alpha-linolenic acid (Delta 9,Delta 12,Delta 15-18:3) and hexadecatrienoic acid with an unusual terminal double bond (Delta 9,Delta 12,Delta 15-16:3). CpFad2 produces a range of Delta 12- and Delta 15-PUFAs. The major products of CpFad2 are linoleic and hexadecadienoic acid (Delta 9,Delta 12-16:2), accompanied by alpha-linolenic acid and hexadecatrienoic acid (Delta 9,Delta 12,Delta 15-16:3). Using GC/MS analysis of trimethylsilyl derivatives, we identified ricinoleic acid (12-hydroxy-9-octadecenoic acid) as an additional product of CpFad2. These results demonstrate that CpFAD2 is a multifunctional FAD and indicate that detailed analysis of fatty acid derivatives might uncover a range of enzymatic selectivities in other Delta 12-FADs from budding yeasts (Ascomycota: Saccharomycotina).	[Bucek, Ales; Matouskova, Petra; Pichova, Iva; Hruskova-Heidingsfeldova, Olga] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Sychrova, Hana] Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Pichova, I (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic.	iva.pichova@uochb.cas.cz; olga-hh@uochb.cas.cz	HruskovaHeidingsfeld, Olga/B-2429-2009; Bucek, Ales/G-8444-2014; Matoušková, Petra/AAL-1360-2021; Matoušková, Petra/S-5687-2017; Pichova, Iva/G-7917-2014; Sychrova, Hana/B-1350-2012	HruskovaHeidingsfeld, Olga/0000-0001-9881-8473; Matoušková, Petra/0000-0002-9421-5744; Matoušková, Petra/0000-0002-9421-5744; Sychrova, Hana/0000-0001-5967-5019	Technology Agency of the Czech Republic [TA01011461];  [RVO 613 88 963]	Technology Agency of the Czech Republic; 	This study was funded by project TA01011461 from Technology Agency of the Czech Republic and by the research project RVO 613 88 963. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PS, 2006, MOL MICROBIOL, V62, P1507, DOI 10.1111/j.1365-2958.2006.05484.x; Broadwater JA, 2002, J BIOL CHEM, V277, P15613, DOI 10.1074/jbc.M200231200; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; Bucek A, 2013, INSECT BIOCHEM MOLEC, V43, P724, DOI 10.1016/j.ibmb.2013.05.003; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Calvo AM, 2001, J BIOL CHEM, V276, P25766, DOI 10.1074/jbc.M100732200; Carvalho F, 2005, ORG BIOMOL CHEM, V3, P3979, DOI 10.1039/b509612j; Certik M, 1999, J BIOSCI BIOENG, V87, P1, DOI 10.1016/S1389-1723(99)80001-2; Christie WW, 2000, EUR J LIPID SCI TECH, V102, P23, DOI 10.1002/(SICI)1438-9312(200001)102:1<23::AID-EJLT23>3.3.CO;2-I; Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; Diaz AR, 2002, J BIOL CHEM, V277, P48099, DOI 10.1074/jbc.M208960200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAY L, 1991, J CHROMATOGR, V541, P89, DOI 10.1016/S0021-9673(01)95986-2; GHANNOUM MA, 1986, J GEN MICROBIOL, V132, P2367; Hoffmann M, 2007, J BIOL CHEM, V282, P26666, DOI 10.1074/jbc.M705068200; Huang YS, 1999, LIPIDS, V34, P649, DOI 10.1007/s11745-999-0410-8; Kainou K, 2006, YEAST, V23, P605, DOI 10.1002/yea.1378; Kajiwara S, 1996, APPL ENVIRON MICROB, V62, P4309, DOI 10.1128/AEM.62.12.4309-4313.1996; Kikukawa H, 2013, J BIOSCI BIOENG; Krishnamurthy S, 2004, MICROBIOL-SGM, V150, P1991, DOI 10.1099/mic.0.27029-0; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Matouskova P, 2008, CHEMBIOCHEM, V9, P2534, DOI 10.1002/cbic.200800374; Meesapyodsuk D, 2000, BIOCHEMISTRY-US, V39, P11948, DOI 10.1021/bi000756a; Meesapyodsuk D, 2007, J BIOL CHEM, V282, P20191, DOI 10.1074/jbc.M702196200; MOSS CW, 1982, J CLIN MICROBIOL, V16, P1073, DOI 10.1128/JCM.16.6.1073-1079.1982; Murayama SY, 2006, MICROBIOL-SGM, V152, P1551, DOI 10.1099/mic.0.28751-0; Nguyen LN, 2011, INFECT IMMUN, V79, P136, DOI 10.1128/IAI.00753-10; NICOLAIDES N, 1983, BIOMED MASS SPECTROM, V10, P441, DOI 10.1002/bms.1200100802; Oura T, 2004, MICROBIOL-SGM, V150, P1983, DOI 10.1099/mic.0.27049-0; Oura T, 2008, BIOSCI BIOTECH BIOCH, V72, P3174, DOI 10.1271/bbb.80361; Pan ZQ, 2007, J BIOL CHEM, V282, P4326, DOI 10.1074/jbc.M606343200; Pereira SL, 2004, BIOCHEM J, V378, P665, DOI 10.1042/BJ20031319; Peyou-Ndi MM, 2000, ARCH BIOCHEM BIOPHYS, V376, P399, DOI 10.1006/abbi.2000.1733; RENUKAPRASAD M, 1980, J BIOL CHEM, V255, P2583; Rodriguez-Vargas S, 2007, APPL ENVIRON MICROB, V73, P110, DOI 10.1128/AEM.01360-06; Sakuradani E, 2005, APPL MICROBIOL BIOT, V66, P648, DOI 10.1007/s00253-004-1760-x; Sakuradani E, 1999, EUR J BIOCHEM, V261, P812, DOI 10.1046/j.1432-1327.1999.00333.x; Sayanova O, 2006, J BIOL CHEM, V281, P36533, DOI 10.1074/jbc.M605158200; Serra M, 2006, INSECT BIOCHEM MOLEC, V36, P822, DOI 10.1016/j.ibmb.2006.07.008; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; Spitzer V, 1996, PROG LIPID RES, V35, P387, DOI 10.1016/S0163-7827(96)00011-2; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trofa D, 2008, CLIN MICROBIOL REV, V21, P606, DOI 10.1128/CMR.00013-08; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Uemura H, 2012, APPL MICROBIOL BIOT, V95, P1, DOI 10.1007/s00253-012-4105-1; Watanabe K, 2004, BIOSCI BIOTECH BIOCH, V68, P721, DOI 10.1271/bbb.68.721; Wei DS, 2006, ACTA BIOCHIM POL, V53, P753, DOI 10.18388/abp.2006_3303; Wilson RA, 2004, MICROBIOL-SGM, V150, P2881, DOI 10.1099/mic.0.27207-0; Yan Z, 2013, FOOD SCI BIOTECHNOL, V22, P573, DOI DOI 10.1007/S10068-013-0116-7; Yazawa H, 2009, YEAST, V26, P167, DOI 10.1002/yea.1659; Zhan XX, 2008, YEAST, V25, P21, DOI 10.1002/yea.1546; Zhou XR, 2011, J BIOL CHEM, V286, P43644, DOI 10.1074/jbc.M111.266114	54	17	21	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93322	10.1371/journal.pone.0093322	http://dx.doi.org/10.1371/journal.pone.0093322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681902	Green Published, Green Submitted, gold			2022-12-25	WOS:000333678100043
J	Todorovic, Z; Medic, B; Basta-Jovanovic, G; Skodric, SR; Stojanovic, R; Rovcanin, B; Prostran, M				Todorovic, Zoran; Medic, Branislava; Basta-Jovanovic, Gordana; Skodric, Sanja Radojevic; Stojanovic, Radan; Rovcanin, Branislav; Prostran, Milica			Acute Pretreatment with Chloroquine Attenuates Renal I/R Injury in Rats	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ACUTE KIDNEY INJURY; NITRIC-OXIDE; PROXIMAL TUBULE; MODEL; HYDROXYCHLOROQUINE; BIOMARKERS; VASOPRESSIN; MOLECULE-1; INFLAMMATION	Background: Acute kidney injury (AKI) still remains an unresolved problem in pharmacotherapy and renal inflammation is a major factor in its development. Chloroquine, a well-known antimalarial drug, posses pleitropic effects as well: antiinflammatory, anticoagulant and vascular actions. The effects of chloroquine on renal function may involve significant increase in urine flow rate, glomerular filtration rate and sodium excretion, as well as stimulation of nitric oxide synthase. However, its role in experimental models of renal I/R injury is unknown. We aimed to analyze the acute effects of a single-dose intravenous chloroquine administered at three different times in the experimental model of I/R injury in rat. Methods: Rats were subjected to bilateral renal ischemia (45 min) followed by reperfusion with saline lasting 4 hours. Chloroquine was administered in doses of 0.3 mg/kg i.v. and 3 mg/kg i.v. 30 min before ischemia, 30 min before reperfusion and 5 min before reperfusion. Selected a hemodynamic, biochemical and morphological parameters were followed in the Sham-operated animals and rats subjected to I/R injury and pretreated with saline or chloroquine. Results: Chloroquine (0.3 and 3 mg/kg, i.v.) protected the I/R injured kidney in an U-shaped manner. Both doses were protective regarding biochemical and histological markers of the I/R injury (serum urea, creatinine and fractional excretion of sodium, as well as total histological score, tubular necrosis score and KIM-1 staining score) (P<0.05 vs. corresponding controls, i.e. rats subjected to I/R injury and treated with saline only). The protective effects of the lower dose of chloroquine were more profound. Time-related differences between pretreatments were not observed (P>0.05, all). Conclusion: Our study shows for the first time that a single dose of chloroquine (0.3 mg/kg i.v.) could afford significant protection of the injured rat kidney.	[Todorovic, Zoran; Medic, Branislava; Stojanovic, Radan; Prostran, Milica] Univ Belgrade, Dept Pharmacol Clin Pharmacol & Toxicol, Fac Med, Belgrade, Serbia; [Basta-Jovanovic, Gordana; Skodric, Sanja Radojevic] Univ Belgrade, Dept Pathol, Fac Med, Belgrade, Serbia; [Rovcanin, Branislav] Univ Belgrade, Fac Med, Dept Human Genet, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade	Prostran, M (corresponding author), Univ Belgrade, Dept Pharmacol Clin Pharmacol & Toxicol, Fac Med, Belgrade, Serbia.	mprostran@doctor.com	Rovcanin, Branislav/L-2345-2019	Rovcanin, Branislav/0000-0002-8099-3764; Todorovic, Zoran/0000-0001-8869-9976	Ministry of Education, Science and Technological Development of the Republic of Serbia [175023]	Ministry of Education, Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Project No. 175023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MH, 2003, J PHARMACOL EXP THER, V305, P123, DOI 10.1124/jpet.102.047233; Ahmed MH, 2003, J PHARMACOL EXP THER, V304, P156, DOI 10.1124/jpet.102.042523; Ahmed MH, 2007, MED HYPOTHESES, V68, P140, DOI 10.1016/j.mehy.2006.06.012; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bevan AP, 1997, J BIOL CHEM, V272, P26833, DOI 10.1074/jbc.272.43.26833; Bonventre JV, 2009, NEPHROL DIAL TRANSPL, V24, P3265, DOI 10.1093/ndt/gfp010; Chatterjee PK, 1999, EXP NEPHROL, V7, P438; Chatterjee PK, 2007, N-S ARCH PHARMACOL, V376, P1, DOI 10.1007/s00210-007-0183-5; Chatterjee Prabal K, 2003, Methods Mol Biol, V225, P223; Chiodini P, 2009, GUIDELINES MALARIA P; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Cooper RG, 2008, INDIAN J MED RES, V127, P305; Couser WG, 1998, NEPHROL DIAL TRANSPL, V13, P10, DOI 10.1093/ndt/13.suppl_1.10; Dong X, 2007, KIDNEY INT, V71, P619, DOI 10.1038/sj.ki.5002132; Edelstein CL, 2008, ADV CHRONIC KIDNEY D, V15, P222, DOI 10.1053/j.ackd.2008.04.003; Fang H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.225; Garcia-Criado FJ, 1998, TRANSPLANTATION, V66, P982, DOI 10.1097/00007890-199810270-00003; Gerstein HC, 2002, DIABETES RES CLIN PR, V55, P209, DOI 10.1016/S0168-8227(01)00325-4; Ghigo D, 1998, J CLIN INVEST, V102, P595, DOI 10.1172/JCI1052; GUSTAFSSON LL, 1983, BRIT J CLIN PHARMACO, V15, P471, DOI 10.1111/j.1365-2125.1983.tb01532.x; Harhaji-Trajkovic L, 2012, PHARM RES-DORDR, V29, P2249, DOI 10.1007/s11095-012-0753-1; Holschermann H, 2006, ATHEROSCLEROSIS, V185, P240, DOI 10.1016/j.atherosclerosis.2005.06.019; Ichimura T, 2004, AM J PHYSIOL-RENAL, V286, pF552, DOI 10.1152/ajprenal.00285.2002; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Jiang M, 2012, KIDNEY INT, V82, P1271, DOI 10.1038/ki.2012.261; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Kalia S, 2007, DERMATOL THER, V20, P160, DOI 10.1111/j.1529-8019.2007.00131.x; Kunzendorf U, 2010, DRUGS, V70, P1099, DOI 10.2165/11535890-000000000-00000; Lameire N, 2005, LANCET, V365, P417; Magwere T, 1997, FREE RADICAL BIO MED, V22, P321; Martensson J, 2012, BRIT J ANAESTH, V109, P843, DOI 10.1093/bja/aes357; McDuffie JE, 2013, INT J TOXICOL, V32, P251, DOI 10.1177/1091581813493013; MUSABAYANE CT, 1993, J TROP MED HYG, V96, P305; Musabayane CT, 1996, TROP MED INT HEALTH, V1, P542, DOI 10.1046/j.1365-3156.1996.d01-81.x; Nesic Z, 2006, J PHARMACOL SCI, V102, P413, DOI 10.1254/jphs.SCE06002X; Nujic K, 2012, CELL IMMUNOL, V279, P78, DOI 10.1016/j.cellimm.2012.09.007; Petri M, 1996, LUPUS, V5, pS16, DOI 10.1177/096120339600500105; Petri M, 1996, SCAND J RHEUMATOL, V25, P191, DOI 10.3109/03009749609069986; Rouschop KMA, 2008, KIDNEY INT, V73, P1333, DOI 10.1038/ki.2008.156; Slocum JL, 2012, TRANSL RES, V159, P277, DOI 10.1016/j.trsl.2012.01.014; SOFOLA OA, 1981, J TROP MED HYG, V84, P249; SOLEZ K, 1979, MEDICINE, V58, P362, DOI 10.1097/00005792-197909000-00003; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; SPERBER K, 1993, J RHEUMATOL, V20, P803; Thome R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065913; Thurman JM, 2007, CLIN IMMUNOL, V123, P7, DOI 10.1016/j.clim.2006.09.008; Todorovic Z, 2009, ANAL PHARM ACTIVE CO, P217; Todorovic Z, 2008, J PHARMACOL SCI, V107, P465, DOI 10.1254/jphs.SC0070374; Tsigou E, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/361078; Urbschat A, 2011, BIOMARKERS, V16, pS22, DOI 10.3109/1354750X.2011.587129; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Vaidya VS, 2009, KIDNEY INT, V76, P108, DOI 10.1038/ki.2009.96; vandenBorne BEEM, 1997, J RHEUMATOL, V24, P55; WALLACE DJ, 1987, ARTHRITIS RHEUM, V30, P1435, DOI 10.1002/art.1780301219; Weber SM, 2000, J IMMUNOL, V165, P1534, DOI 10.4049/jimmunol.165.3.1534; Wozniacka A, 2007, LUPUS, V16, P89, DOI 10.1177/0961203306075384; Yasuda H, 2008, AM J PHYSIOL-RENAL, V294, pF1050, DOI 10.1152/ajprenal.00461.2007; Zhang PL, 2008, KIDNEY INT, V73, P608, DOI 10.1038/sj.ki.5002697; Zorica N, 2008, ACTA VET-BEOGRAD, V58, P413, DOI 10.2298/AVB0806413N	62	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92673	10.1371/journal.pone.0092673	http://dx.doi.org/10.1371/journal.pone.0092673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681567	gold, Green Published, Green Submitted			2022-12-25	WOS:000333678100014
J	Engert, V; Merla, A; Grant, JA; Cardone, D; Tusche, A; Singer, T				Engert, Veronika; Merla, Arcangelo; Grant, Joshua A.; Cardone, Daniela; Tusche, Anita; Singer, Tania			Exploring the Use of Thermal Infrared Imaging in Human Stress Research	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; SYMPATHETIC-NERVOUS-SYSTEM; PSYCHOSOCIAL STRESS; RESPONSES; CORTISOL; TEMPERATURE; ENDOCRINE; AXIS; ACTIVATION; HEMORRHAGE	High resolution thermal infrared imaging is a pioneering method giving indices of sympathetic activity via the contact-free recording of facial tissues (thermal imprints). Compared to established stress markers, the great advantage of this method is its non-invasiveness. The goal of our study was to pilot the use of thermal infrared imaging in the classical setting of human stress research. Thermal imprints were compared to established stress markers (heart rate, heart rate variability, finger temperature, alpha-amylase and cortisol) in 15 participants undergoing anticipation, stress and recovery phases of two laboratory stress tests, the Cold Pressor Test and the Trier Social Stress Test. The majority of the thermal imprints proved to be change-sensitive in both tests. While correlations between the thermal imprints and established stress markers were mostly non-significant, the thermal imprints (but not the established stress makers) did correlate with stress-induced mood changes. Multivariate pattern analysis revealed that in contrast to the established stress markers the thermal imprints could not disambiguate anticipation, stress and recovery phases of both tests. Overall, these results suggest that thermal infrared imaging is a valuable method for the estimation of sympathetic activity in the stress laboratory setting. The use of this non-invasive method may be particularly beneficial for covert recordings, in the study of special populations showing difficulties in complying with the standard instruments of data collection and in the domain of psychophysiological covariance research. Meanwhile, the established stress markers seem to be superior when it comes to the characterization of complex physiological states during the different phases of the stress cycle.	[Engert, Veronika; Grant, Joshua A.; Tusche, Anita; Singer, Tania] Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany; [Merla, Arcangelo; Cardone, Daniela] G Dannunzio Fdn, Inst Adv Biomed Technol ITAB, Chieti, Italy; [Merla, Arcangelo; Cardone, Daniela] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy	Max Planck Society; G d'Annunzio University of Chieti-Pescara	Engert, V (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany.	engert@cbs.mpg.de	Tusche, Anita/ABB-3952-2021; Engert, Veronika/N-1572-2017; Cardone, Daniela/AAJ-2288-2021; Grant, Joshua/I-2615-2014	Engert, Veronika/0000-0001-5317-933X; Cardone, Daniela/0000-0002-1506-1995; Tusche, Anita/0000-0003-4180-8447; Grant, Joshua/0000-0003-3142-4044	Max Planck Gesellschaft	Max Planck Gesellschaft(Max Planck Society)	This work was supported by Max Planck Gesellschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	al'Absi M, 2002, PAIN, V96, P197, DOI 10.1016/S0304-3959(01)00447-X; Anbar M, 2002, ANN NY ACAD SCI, V972, P111, DOI 10.1111/j.1749-6632.2002.tb04560.x; [Anonymous], 2000, HDB PSYCHOPHYSIOLOGY; Buchanan TW, 1999, PSYCHONEUROENDOCRINO, V24, P227, DOI 10.1016/S0306-4530(98)00078-X; Camm AJ, 1996, CIRCULATION, V93, P1043; Camm AJ, 1995, GEOMETRICAL METHODS; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; CHIEN S, 1967, PHYSIOL REV, V47, P214, DOI 10.1152/physrev.1967.47.2.214; Cohen S, 2000, ANN BEHAV MED, V22, P171, DOI 10.1007/BF02895111; Dallman M. F., 2000, ENCY STRESS; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Dowdall J, 2007, COMPUT VIS IMAGE UND, V106, P205, DOI 10.1016/j.cviu.2006.08.011; DRESSENDORFER RA, 1992, J STEROID BIOCHEM, V43, P683, DOI 10.1016/0960-0760(92)90294-S; Ebisch SJ, 2012, BIOL PSYCHOL, V89, P123, DOI 10.1016/j.biopsycho.2011.09.018; Engert V, 2011, PSYCHONEUROENDOCRINO, V36, P1294, DOI 10.1016/j.psyneuen.2011.02.018; Foley P, 2010, NEUROSCI BIOBEHAV R, V35, P91, DOI 10.1016/j.neubiorev.2010.01.010; Fries E, 2009, INT J PSYCHOPHYSIOL, V72, P67, DOI 10.1016/j.ijpsycho.2008.03.014; Gleeson M, 1998, INT J SPORTS MED, V19, pS96, DOI 10.1055/s-2007-971967; HADDY FJ, 1968, ANNU REV MED, V19, P167, DOI 10.1146/annurev.me.19.020168.001123; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; Hines EA, 1932, P STAFF M MAYO CLIN, P332; Iriarte J, 2003, J CLIN NEUROPHYSIOL, V20, P249, DOI 10.1097/00004691-200307000-00004; Ivanciuc O, 2007, PROTEIN PEPTIDE LETT, V14, P903, DOI 10.2174/092986607782110257; Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kistler A, 1998, INT J PSYCHOPHYSIOL, V29, P35, DOI 10.1016/S0167-8760(97)00087-1; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P983, DOI 10.1016/j.psyneuen.2003.08.009; Kuraoka K, 2011, PHYSIOL BEHAV, V102, P347, DOI 10.1016/j.physbeh.2010.11.029; Lorentz K, 1999, CLIN CHEM LAB MED, V37, P1053, DOI 10.1515/CCLM.1999.154; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Merla A, 2007, P ANN INT IEEE EMBS, P247, DOI 10.1109/IEMBS.2007.4352270; Miller R, 2013, PSYCHONEUROENDOCRINO, V38, P941, DOI 10.1016/j.psyneuen.2012.09.013; Misaki M, 2010, NEUROIMAGE, V53, P103, DOI 10.1016/j.neuroimage.2010.05.051; Mourot L, 2009, PHYSIOL RES, V58, P83, DOI 10.33549/physiolres.931360; Mur M, 2009, SOC COGN AFFECT NEUR, V4, P101, DOI 10.1093/scan/nsn044; Nakanishi R, 2008, INFANT BEHAV DEV, V31, P137, DOI 10.1016/j.infbeh.2007.09.001; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nhan BR, 2010, IEEE T BIO-MED ENG, V57, P979, DOI 10.1109/TBME.2009.2035926; Or Calvin K. L., 2007, Occupational Ergonomics, V7, P83; Pavlidis I, 2012, SCI REP-UK, V2, DOI 10.1038/srep00305; Pavlidis I, 2002, NATURE, V415, P35, DOI 10.1038/415035a; PEARCE WJ, 1980, STROKE, V11, P190, DOI 10.1161/01.STR.11.2.190; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Rohleder N, 2004, ANN NY ACAD SCI, V1032, P258, DOI 10.1196/annals.1314.033; Rohleder N, 2009, PSYCHONEUROENDOCRINO, V34, P469, DOI 10.1016/j.psyneuen.2008.12.004; Schlotz W, 2008, PSYCHOSOM MED, V70, P787, DOI 10.1097/PSY.0b013e3181810658; Schommer NC, 2003, PSYCHOSOM MED, V65, P450, DOI 10.1097/01.PSY.0000035721.12441.17; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Shastri D, 2009, IEEE T BIO-MED ENG, V56, P477, DOI 10.1109/TBME.2008.2003265; van Stegeren A, 2006, PSYCHONEUROENDOCRINO, V31, P137, DOI 10.1016/j.psyneuen.2005.05.012; VATNER SF, 1974, J CLIN INVEST, V54, P225, DOI 10.1172/JCI107757; von Baeyer CL, 2005, J PAIN, V6, P218, DOI 10.1016/j.jpain.2005.01.349; WINNDEEN ES, 1988, CLIN CHEM, V34, P2005	54	71	72	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e90782	10.1371/journal.pone.0090782	http://dx.doi.org/10.1371/journal.pone.0090782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675709	Green Published, gold			2022-12-25	WOS:000333677500009
J	Henson, CA; Duke, SH; Livingston, DP				Henson, Cynthia A.; Duke, Stanley H.; Livingston, David P., III			Metabolic Changes in Avena sativa Crowns Recovering from Freezing	PLOS ONE			English	Article							LOW-TEMPERATURE TOLERANCE; QUANTITATIVE TRAIT LOCI; COLD-ACCLIMATION; FROST-TOLERANCE; INTRACELLULAR SUBSTANCES; AMINO-ACID; ARABIDOPSIS-THALIANA; WINTER HARDINESS; LYSINE CATABOLISM; ENZYME-ACTIVITIES	Extensive research has been conducted on cold acclimation and freezing tolerance of fall-sown cereal plants due to their economic importance; however, little has been reported on the biochemical changes occurring over time after the freezing conditions are replaced by conditions favorable for recovery and growth such as would occur during spring. In this study, GC-MS was used to detect metabolic changes in the overwintering crown tissue of oat (Avena sativa L.) during a fourteen day time-course after freezing. Metabolomic analysis revealed increases in most amino acids, particularly proline, 5-oxoproline and arginine, which increased greatly in crowns that were frozen compared to controls and correlated very significantly with days after freezing. In contrast, sugar and sugar related metabolites were little changed by freezing, except sucrose and fructose which decreased dramatically. In frozen tissue all TCA cycle metabolites, especially citrate and malate, decreased in relation to unfrozen tissue. Alterations in some amino acid pools after freezing were similar to those observed in cold acclimation whereas most changes in sugar pools after freezing were not. These similarities and differences suggest that there are common as well as unique genetic mechanisms between these two environmental conditions that are crucial to the winter survival of plants.	[Henson, Cynthia A.] USDA ARS, Cereal Crops Res Unit, Madison, WI 53706 USA; [Henson, Cynthia A.; Duke, Stanley H.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Livingston, David P., III] N Carolina State Univ, USDA ARS, Raleigh, NC 27695 USA; [Livingston, David P., III] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA	United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Henson, CA (corresponding author), USDA ARS, Cereal Crops Res Unit, Madison, WI 53706 USA.	cynthia.henson@usda.ars.gov			USDA-ARS; University of Wisconsin-Madison	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); University of Wisconsin-Madison	This study was supported by USDA-ARS and the University of Wisconsin-Madison. The fund agency provided general oversight and review but had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKAWA T, 1983, ARCH BIOCHEM BIOPHYS, V224, P169, DOI 10.1016/0003-9861(83)90201-1; ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; Briggs DE, 2009, J I BREWING, V115, P41, DOI 10.1002/j.2050-0416.2009.tb00343.x; Brouwer DJ, 2000, CROP SCI, V40, P1387, DOI 10.2135/cropsci2000.4051387x; Brouwer DJ, 1998, CROP SCI, V38, P1704, DOI 10.2135/cropsci1998.0011183X003800060047x; CAI Q, 1994, THEOR APPL GENET, V89, P606, DOI 10.1007/BF00222455; CATTIVELLI L, 1990, PLANT PHYSIOL, V93, P1504, DOI 10.1104/pp.93.4.1504; CHU TM, 1978, PHYSIOL PLANTARUM, V43, P254, DOI 10.1111/j.1399-3054.1978.tb02573.x; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; Dauwe R, 2012, NEW PHYTOL, V194, P192, DOI 10.1111/j.1469-8137.2011.04027.x; Davey MP, 2009, METABOLOMICS, V5, P138, DOI 10.1007/s11306-008-0127-1; DRAPER SR, 1972, PHYTOCHEMISTRY, V11, P639, DOI 10.1016/0031-9422(72)80025-6; DUKE SH, 1978, PLANT PHYSIOL, V62, P642, DOI 10.1104/pp.62.4.642; DUKE SH, 1981, CROP SCI, V21, P489, DOI 10.2135/cropsci1981.0011183X002100040003x; DUKE SH, 1983, PLANT PHYSIOL, V72, P919, DOI 10.1104/pp.72.4.919; DUKE SH, 1986, PHYSIOL PLANTARUM, V68, P625, DOI 10.1111/j.1399-3054.1986.tb03407.x; DUKE SH, 1981, PLANT PHYSIOL, V67, P449, DOI 10.1104/pp.67.3.449; Fowler DB, 2004, ANN BOT-LONDON, V94, P717, DOI 10.1093/aob/mch196; Francia E, 2004, THEOR APPL GENET, V108, P670, DOI 10.1007/s00122-003-1468-9; Galili G, 2001, CURR OPIN PLANT BIOL, V4, P261, DOI 10.1016/S1369-5266(00)00170-9; GALSTON AW, 1978, PLANT SCI LETT, V11, P69, DOI 10.1016/0304-4211(78)90054-8; Gaufichon L, 2010, PLANT SCI, V179, P141, DOI 10.1016/j.plantsci.2010.04.010; GOAS G, 1976, CAN J BOT, V54, P1221, DOI 10.1139/b76-132; GUO WW, 1992, PLANT PHYSIOL, V100, P915, DOI 10.1104/pp.100.2.915; GUY CL, 1990, ANNU REV PLANT PHYS, V41, P187, DOI 10.1146/annurev.pp.41.060190.001155; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hannah MA, 2010, PLANT PHYSIOL, V152, P2120, DOI 10.1104/pp.109.147306; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; HAYES PM, 1993, GENOME, V36, P66, DOI 10.1139/g93-009; Herman EM, 2006, J EXP BOT, V57, P3601, DOI 10.1093/jxb/erl111; Hughes MA, 1996, J EXP BOT, V47, P291, DOI 10.1093/jxb/47.3.291; Jannink JL, 2005, CROP SCI, V45, P2383, DOI 10.2135/cropsci2005.0285; KANDPAL RP, 1985, PLANT SCI, V40, P73, DOI 10.1016/0168-9452(85)90044-5; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; Kim JS, 2007, NUCLEIC ACIDS RES, V35, P506, DOI 10.1093/nar/gkl1076; Koag MC, 2003, PLANT PHYSIOL, V131, P309, DOI 10.1104/pp.011171; Kobayashi F, 2005, J EXP BOT, V56, P887, DOI 10.1093/jxb/eri081; Korn M, 2010, MOL PLANT, V3, P224, DOI 10.1093/mp/ssp105; Kovacs Z, 2011, PLANT SCI, V180, P61, DOI 10.1016/j.plantsci.2010.08.010; KUO CG, 1986, J AM SOC HORTIC SCI, V111, P746; Le MQ, 2008, CRYOBIOLOGY, V57, P104, DOI 10.1016/j.cryobiol.2008.06.004; Lejeune-Henaut I, 2008, THEOR APPL GENET, V116, P1105, DOI 10.1007/s00122-008-0739-x; Li CD, 2000, THEOR APPL GENET, V101, P1259, DOI 10.1007/s001220051605; Limin AE, 2002, ANN BOT-LONDON, V89, P579, DOI 10.1093/aob/mcf102; Livingston DP, 2007, CRYOBIOLOGY, V54, P154, DOI 10.1016/j.cryobiol.2006.12.004; Livingston DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053468; Livingston DP, 2005, CROP SCI, V45, P1545, DOI 10.2135/cropsci2004.0579; Livingston DP, 1998, PLANT PHYSIOL, V116, P403, DOI 10.1104/pp.116.1.403; Livingston DP, 1996, CROP SCI, V36, P1568, DOI 10.2135/cropsci1996.0011183X003600060027x; MACHACKOVA I, 1989, PHYSIOL PLANTARUM, V76, P603, DOI 10.1111/j.1399-3054.1989.tb05486.x; Maloney PV, 2011, CROP SCI, V51, P490, DOI 10.2135/cropsci2010.04.0224; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; Mazzucotelli E, 2006, J EXP BOT, V57, P3755, DOI 10.1093/jxb/erl141; MOLLER BL, 1976, PLANT PHYSIOL, V57, P687, DOI 10.1104/pp.57.5.687; Moulin M, 2006, PLANT PHYSIOL BIOCH, V44, P474, DOI 10.1016/j.plaphy.2006.08.005; Muslin EH, 2002, PROTEIN ENG, V15, P29, DOI 10.1093/protein/15.1.29; NAIDU BP, 1991, PHYTOCHEMISTRY, V30, P407, DOI 10.1016/0031-9422(91)83693-F; Ohkama-Ohtsu N, 2008, PLANT PHYSIOL, V148, P1603, DOI 10.1104/pp.108.125716; OLIEN CR, 1981, CRYOBIOLOGY, V18, P404, DOI 10.1016/0011-2240(81)90114-0; OLIEN CR, 1984, CROP SCI, V24, P51, DOI 10.2135/cropsci1984.0011183X002400010012x; PALTA JP, 1993, ADVANCES IN PLANT COLD HARDINESS, P143; PALTA JP, 1980, PHYSIOL PLANTARUM, V50, P169, DOI 10.1111/j.1399-3054.1980.tb04446.x; PALTA JP, 1977, PLANT PHYSIOL, V60, P398, DOI 10.1104/pp.60.3.398; PAN A, 1994, THEOR APPL GENET, V89, P900, DOI 10.1007/BF00224516; PEARCE RS, 1977, PLANTA, V134, P159, DOI 10.1007/BF00384966; Pearce RS, 2004, LIFE IN THE FROZEN STATE, P171, DOI 10.1201/9780203647073.ch5; Peters J., 2000, AOSA CONTR; Reinheimer JL, 2004, THEOR APPL GENET, V109, P1267, DOI 10.1007/s00122-004-1736-3; Roessner U, 2002, PLANT CELL REP, V21, P189, DOI 10.1007/s00299-002-0510-8; RUDOLPH AS, 1986, ARCH BIOCHEM BIOPHYS, V245, P134, DOI 10.1016/0003-9861(86)90197-9; Santos AG, 2006, CROP SCI, V46, P203, DOI 10.2135/cropsci2005.0152; SCHOBERT B, 1978, BIOCHIM BIOPHYS ACTA, V541, P270, DOI 10.1016/0304-4165(78)90400-2; Seki Motoaki, 2002, Funct Integr Genomics, V2, P282, DOI 10.1007/s10142-002-0070-6; Shibata S., 1986, Journal of Japanese Society of Grassland Science, V32, P197; Sinha AK, 2002, PLANT PHYSIOL, V128, P1480, DOI 10.1104/pp.010771; Skinner J, 2006, THEOR APPL GENET, V112, P832, DOI 10.1007/s00122-005-0185-y; Steponkus PL, 1998, P NATL ACAD SCI USA, V95, P14570, DOI 10.1073/pnas.95.24.14570; STEPONKUS PL, 1967, PLANT PHYSIOL, V42, P1423, DOI 10.1104/pp.42.10.1423; SULC RM, 1991, CROP SCI, V31, P1575, DOI 10.2135/cropsci1991.0011183X003100060039x; SULC RM, 1991, CROP SCI, V31, P430, DOI 10.2135/cropsci1991.0011183X003100020041x; Sung DY, 2003, TRENDS PLANT SCI, V8, P179, DOI 10.1016/S1360-1385(03)00047-5; SUZUKI Y, 1989, P JPN ACAD B-PHYS, V65, P146, DOI 10.2183/pjab.65.146; TANINO KK, 1985, CAN J BOT, V63, P432, DOI 10.1139/b85-053; Thomashow M. F., 1990, Advances in Genetics, V28, P99; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Toth B, 2003, THEOR APPL GENET, V107, P509, DOI 10.1007/s00122-003-1275-3; Trunova T., 1965, FIZIOL RAST, V12, P70; Usadel B, 2008, PLANT CELL ENVIRON, V31, P518, DOI 10.1111/j.1365-3040.2007.01763.x; Vagujfalvi A, 2003, MOL GENET GENOMICS, V269, P60, DOI 10.1007/s00438-003-0806-6; VANSWAAIJ AC, 1985, PHYSIOL PLANTARUM, V64, P230, DOI 10.1111/j.1399-3054.1985.tb02341.x; VANWAGENEN BC, 1986, TETRAHEDRON, V42, P1117, DOI 10.1016/S0040-4020(01)87515-3; Vranova V, 2011, PLANT SOIL, V342, P31, DOI 10.1007/s11104-010-0673-y; Weinberg MV, 2005, J BACTERIOL, V187, P336, DOI 10.1128/JB.187.1.336-348.2005; Wooten DR, 2007, CROP SCI, V47, P1832, DOI 10.2135/cropsci2006.12.0768; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010	96	7	7	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93085	10.1371/journal.pone.0093085	http://dx.doi.org/10.1371/journal.pone.0093085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675792	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500071
J	Kasatkar, P; Shetty, S; Ghosh, K				Kasatkar, Priyanka; Shetty, Shrimati; Ghosh, Kanjaksha			Genetic Heterogeneity in a Large Cohort of Indian Type 3 von Willebrand Disease Patients	PLOS ONE			English	Article							VONWILLEBRAND-FACTOR GENE; MOLECULAR CHARACTERIZATION; BLEEDING QUESTIONNAIRE; VWF GENE; PREVALENCE; MUTATIONS; DEFECTS; POPULATION; PSEUDOGENE; GENERATION	Background: Though von Willebrand disease (VWD) is a common coagulation disorder, due to the complexity of the molecular analysis of von Willebrand factor gene (VWF), not many reports are available from this country. Large size of the gene, heterogeneous nature of mutations and presence of a highly homologous pseudogene region are the major impediments in the genetic diagnosis of VWD. The study is aimed at unravelling the molecular pathology in a large series of VWD patients from India using an effective strategy. Method: We evaluated 85 unrelated Indian type 3 VWD families to identify the molecular defects using a combination of techniques i.e. PCR-RFLP, direct DNA sequencing and multiple ligation probe amplification (MLPA). Results: Mutations could be characterized in 77 unrelated index cases (ICs). 59 different mutations i.e. nonsense 20 (33.9%), missense 13 (22%), splice site 4 (6.8%), gene conversions 6 (10.2%), insertions 2 (3.4%), duplication 1 (1.7%), small deletions 10 (17%) and large deletions 3 (5.1%) were identified, of which 34 were novel. Two common mutations i.e. p.R1779* and p.L970del were identified in our population with founder effect. Development of alloantibodies to VWF was seen in two patients, one with nonsense mutation (p.R2434*) and the other had a large deletion spanning exons 16-52. Conclusion: The molecular pathology of a large cohort of Indian VWD patients could be identified using a combination of techniques. A wide heterogeneity was observed in the nature of mutations in Indian VWD patients.	[Kasatkar, Priyanka; Shetty, Shrimati; Ghosh, Kanjaksha] King Edward Mem Hosp, Natl Inst Immunohaematol ICMR, Dept Haemostasis & Thrombosis, Bombay, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH); Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital	Ghosh, K (corresponding author), King Edward Mem Hosp, Natl Inst Immunohaematol ICMR, Dept Haemostasis & Thrombosis, Bombay, Maharashtra, India.	kanjakshaghosh@hotmail.com	Ghosh, Kanjaksha/D-7621-2015	Ghosh, Kanjaksha/0000-0002-0645-6565	Council of Scientific and Industrial Research (CSIR); Lady Tata Junior Research Fellowship	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Lady Tata Junior Research Fellowship	This project is funded by Council of Scientific and Industrial Research (CSIR), and a Lady Tata Junior Research Fellowship was granted to one of the authors (PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2013, THROMB HAEMOSTASIS, V109, P652, DOI 10.1160/TH12-10-0737; Ahmad F, 2013, THROMB HAEMOSTASIS, V109, P39, DOI 10.1160/TH12-07-0475; BAHNAK BR, 1991, BLOOD, V78, P1148, DOI 10.1182/blood.V78.4.1148.bloodjournal7841148; Baronciani L, 2003, BLOOD CELL MOL DIS, V30, P264, DOI 10.1016/S1079-9796(03)00033-0; Baronciani L, 2000, THROMB HAEMOSTASIS, V84, P536; Biss TT, 2010, J THROMB HAEMOST, V8, P950, DOI 10.1111/j.1538-7836.2010.03796.x; Bowman M, 2008, J THROMB HAEMOST, V6, P2062, DOI 10.1111/j.1538-7836.2008.03182.x; Bowman M, 2010, J THROMB HAEMOST, V8, P213, DOI 10.1111/j.1538-7836.2009.03661.x; Casana P, 2000, BRIT J HAEMATOL, V111, P552, DOI 10.1046/j.1365-2141.2000.02410.x; Corrales I, 2012, HAEMATOL-HEMATOL J, V97, P1003, DOI 10.3324/haematol.2011.055285; Corrales I, 2009, THROMB HAEMOSTASIS, V101, P570, DOI 10.1160/TH08-08-0500; Eikenboom JCJ, 1998, THROMB HAEMOSTASIS, V79, P709; Gupta PK, 2008, BLOOD CELL MOL DIS, V41, P219, DOI 10.1016/j.bcmd.2008.03.004; Gupta PK, 2005, BRIT J HAEMATOL, V130, P752, DOI 10.1111/j.1365-2141.2005.05660.x; Kasatkar P, 2013, J THROMB HAEMOST, V11, P1784, DOI 10.1111/jth.12323; Kasatkar P, 2014, ANN HEMATOL, V93, P173, DOI 10.1007/s00277-013-1767-4; Kasatkar P, 2010, CLIN CHIM ACTA, V411, P607, DOI 10.1016/j.cca.2009.12.024; MANCUSO DJ, 1991, BIOCHEMISTRY-US, V30, P253, DOI 10.1021/bi00215a036; Mohl A, 2008, J THROMB HAEMOST, V6, P1729, DOI 10.1111/j.1538-7836.2008.03107.x; PATRACCHINI P, 1989, HUM GENET, V83, P264, DOI 10.1007/BF00285168; RODEGHIERO F, 1987, BLOOD, V69, P454; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; SCHNEPPENHEIM R, 1994, HUM GENET, V94, P640; Shahbazi S, 2009, HAEMOPHILIA, V15, P1058, DOI 10.1111/j.1365-2516.2009.02046.x; Solimando M, 2012, AM J HEMATOL, V87, P870, DOI 10.1002/ajh.23265; Surdhar GK, 2001, BLOOD, V98, P248, DOI 10.1182/blood.V98.1.248; Terraube V, 2010, HAEMOPHILIA, V16, P3, DOI 10.1111/j.1365-2516.2009.02005.x; Trasi S, 2006, ACTA HAEMATOL-BASEL, V115, P64, DOI 10.1159/000089468; Trasi S, 2005, INDIAN J MED RES, V121, P653; WERNER EJ, 1993, J PEDIATR-US, V123, P893, DOI 10.1016/S0022-3476(05)80384-1; Xie F, 2006, BLOOD CELL MOL DIS, V36, P385, DOI 10.1016/j.bcmd.2006.03.003; Yadegari H, 2012, THROMB HAEMOSTASIS, V108, P662, DOI 10.1160/TH12-02-0089; ZHANG ZP, 1992, AM J HUM GENET, V51, P850	33	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92575	10.1371/journal.pone.0092575	http://dx.doi.org/10.1371/journal.pone.0092575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675615	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500026
J	Lin, SC; Liu, WC; Jan, JT; Wu, SC				Lin, Shih-Chang; Liu, Wen-Chun; Jan, Jia-Tsrong; Wu, Suh-Chin			Glycan Masking of Hemagglutinin for Adenovirus Vector and Recombinant Protein Immunizations Elicits Broadly Neutralizing Antibodies against H5N1 Avian Influenza Viruses	PLOS ONE			English	Article							DNA VACCINE; PHASE-III; EPITOPE; MICE; TRANSMISSION; RECOGNITION; INFECTION; DESIGN; ADULTS	The highly pathogenic avian influenza (HPAI) H5N1 virus, a known trigger of diseases in poultry and humans, is perceived as a serious threat to public health. There is a clear need for a broadly protective H5N1 vaccine or vaccines for inducing neutralizing antibodies against multiple clades/subclades. We constructed single, double, and triple mutants of glycan-masked hemagglutiinin (HA) antigens at residues 83, 127 and 138 (i.e., g83, g127, g138, g83+g127, g127+g138, g83+g138 and g83+g127+g138), and then obtained their corresponding HA-expressing adenovirus vectors and recombinant HA proteins using a prime-boost immunization strategy. Our results indicate that the glycan-masked g127+g138 double mutant induced more potent HA-inhibition, virus neutralization antibodies, cross-clade protection against heterologous H5N1 clades, correlated with the enhanced bindings to the receptor binding sites and the highly conserved stem region of HA. The immune refocusing stem-specific antibodies elicited by the glycan-masked H5HA g127+g138 and g83+g127+g138 mutants overlapped with broadly neutralizing epitopes of the CR6261 monoclonal antibody that neutralizes most group 1 subtypes. These findings may provide useful information in the development of a broadly protective H5N1 influenza vaccine.	[Lin, Shih-Chang; Liu, Wen-Chun; Wu, Suh-Chin] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Jan, Jia-Tsrong] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Wu, Suh-Chin] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; National Tsing Hua University	Wu, SC (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan.	scwu@mx.nthu.edu.tw	Wu, Suh-Chin/AAV-6233-2021; LIU, WEN-CHUN/ABC-8722-2020; Liu, Wen-Chun/AAU-3193-2021; LIU, WEN-CHUN/AAD-4430-2020	Liu, Wen-Chun/0000-0003-0344-4371; 	National Science Council [NSC-102-2321-B-007-002, NSC-103-2321-B-007-006]; Veterans General Hospitals University Systems of Taiwan Joint Research Program, Taiwan [VGHUST103-G6-1-2]	National Science Council(Ministry of Science and Technology, Taiwan); Veterans General Hospitals University Systems of Taiwan Joint Research Program, Taiwan	This study was supported by the National Science Council (NSC-102-2321-B-007-002, NSC-103-2321-B-007-006) and the Veterans General Hospitals University Systems of Taiwan Joint Research Program (VGHUST103-G6-1-2), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beran J, 2010, CLIN THER, V32, P2186, DOI 10.1016/S0149-2918(11)00024-5; Bommakanti G, 2012, J VIROL, V86, P13434, DOI 10.1128/JVI.01429-12; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Chen MW, 2008, P NATL ACAD SCI USA, V105, P13538, DOI 10.1073/pnas.0806901105; Chen MW, 2011, P NATL ACAD SCI USA, V108, P3510, DOI 10.1073/pnas.1019744108; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Cox RJ, 2011, VACCINE, V29, P8049, DOI 10.1016/j.vaccine.2011.08.042; Das SR, 2011, P NATL ACAD SCI USA, V108, pE1417, DOI 10.1073/pnas.1108754108; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ducatez MF, 2011, P NATL ACAD SCI USA, V108, P349, DOI 10.1073/pnas.1012457108; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Forrest HL, 2009, VACCINE, V27, P4187, DOI 10.1016/j.vaccine.2009.04.050; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Huang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012279; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Langley JM, 2011, J INFECT DIS, V203, P1729, DOI 10.1093/infdis/jir172; Laursen NS, 2013, ANTIVIR RES, V98, P476, DOI 10.1016/j.antiviral.2013.03.021; Lee PS, 2012, P NATL ACAD SCI USA, V109, P17040, DOI 10.1073/pnas.1212371109; Lin SC, 2013, BIOTECHNOL J, V8, P1315, DOI 10.1002/biot.201300116; Lin SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039075; Lin SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020052; Medina RA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005996; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Rao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002432; Schneemann A, 2012, J VIROL, V86, P11686, DOI 10.1128/JVI.01694-12; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Stansell Elizabeth, 2010, Yale Journal of Biology and Medicine, V83, P201; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tsibane T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003067; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Wang SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028757; Wei C., 2012, SCI TRANSL MED, V15, P147; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; World Health Organization, CUM NUMB CONF HUM CA; Yang PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030252; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350; Zhang Y, 2013, SCIENCE, V340, P1459, DOI 10.1126/science.1229455; Zhou F, 2012, J VIROL, V86, P6970, DOI 10.1128/JVI.06930-11	48	34	34	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92822	10.1371/journal.pone.0092822	http://dx.doi.org/10.1371/journal.pone.0092822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671139	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000082
J	Morosan-Puopolo, G; Balakrishnan-Renuka, A; Yusuf, F; Chen, JC; Dai, FP; Zoidl, G; Ludtke, THW; Kispert, A; Theiss, C; Abdelsabour-Khalaf, M; Brand-Saberi, B				Morosan-Puopolo, Gabriela; Balakrishnan-Renuka, Ajeesh; Yusuf, Faisal; Chen, Jingchen; Dai, Fangping; Zoidl, Georg; Luedtke, Timo H. -W.; Kispert, Andreas; Theiss, Carsten; Abdelsabour-Khalaf, Mohammed; Brand-Saberi, Beate			Wnt11 Is Required for Oriented Migration of Dermogenic Progenitor Cells from the Dorsomedial Lip of the Avian Dermomyotome	PLOS ONE			English	Article							CHICK-EMBRYOS; DIFFERENTIAL REGULATION; MUSCLE PROGENITORS; SOMITIC MESODERM; DORSAL PLUMAGE; SEMITIC ORIGIN; NEURAL CREST; DERMIS; EXPRESSION; GENES	The embryonic origin of the dermis in vertebrates can be traced back to the dermomyotome of the somites, the lateral plate mesoderm and the neural crest. The dermal precursors directly overlying the neural tube display a unique dense arrangement and are the first to induce skin appendage formation in vertebrate embryos. These dermal precursor cells have been shown to derive from the dorsomedial lip of the dermomyotome (DML). Based on its expression pattern in the DML, Wnt11 is a candidate regulator of dorsal dermis formation. Using EGFP-based cell labelling and time-lapse imaging, we show that the Wnt11 expressing DML is the source of the dense dorsal dermis. Loss-of-function studies in chicken embryos show that Wnt11 is indeed essential for the formation of dense dermis competent to support cutaneous appendage formation. Our findings show that dermogenic progenitors cannot leave the DML to form dense dorsal dermis following Wnt11 silencing. No alterations were noticeable in the patterning or in the epithelial state of the dermomyotome including the DML. Furthermore, we show that Wnt11 expression is regulated in a manner similar to the previously described early dermal marker cDermo-1. The analysis of Wnt11 mutant mice exhibits an underdeveloped dorsal dermis and strongly supports our gene silencing data in chicken embryos. We conclude that Wnt11 is required for dense dermis and subsequent cutaneous appendage formation, by influencing the cell fate decision of the cells in the DML.	[Morosan-Puopolo, Gabriela; Balakrishnan-Renuka, Ajeesh; Yusuf, Faisal; Chen, Jingchen; Zoidl, Georg; Theiss, Carsten; Abdelsabour-Khalaf, Mohammed; Brand-Saberi, Beate] Ruhr Univ Bochum, Dept Anat & Mol Embryol, Bochum, Germany; [Morosan-Puopolo, Gabriela; Balakrishnan-Renuka, Ajeesh; Dai, Fangping] Univ Freiburg, Dept Mol Embryol, D-79106 Freiburg, Germany; [Morosan-Puopolo, Gabriela; Balakrishnan-Renuka, Ajeesh; Abdelsabour-Khalaf, Mohammed] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Luedtke, Timo H. -W.; Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany; [Brand-Saberi, Beate] Univ Freiburg, Dept Mol Embryol, Inst Anat & Cell Biol, D-79106 Freiburg, Germany	Ruhr University Bochum; University of Freiburg; University of Freiburg; Hannover Medical School; University of Freiburg	Brand-Saberi, B (corresponding author), Ruhr Univ Bochum, Dept Anat & Mol Embryol, Univ Str 150, Bochum, Germany.	beate.brand-saberi@rub.de	Brand-Saberi, Beate/GVT-9451-2022; Abdelsabour-Khalaf, Mohammed/AAG-2804-2021	Abdelsabour-Khalaf, Mohammed/0000-0002-9551-0075	EU's Sixth Framework Program [511978]; DFG [GRK 1104]	EU's Sixth Framework Program(European Commission); DFG(German Research Foundation (DFG))	The project was supported by an EU's Sixth Framework Program grant to Prof. Dr. B. Brand-Saberi (MYORES, 511978) and by the DFG (GRK 1104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Anakwe K, 2003, DEVELOPMENT, V130, P3503, DOI 10.1242/dev.00538; AOYAMA H, 1988, DEVELOPMENT, V104, P15; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Beer HD, 1997, ONCOGENE, V15, P2211, DOI 10.1038/sj.onc.1201383; Ben-Yair R, 2005, DEVELOPMENT, V132, P689, DOI 10.1242/dev.01617; Ben-Yair R, 2003, DEVELOPMENT, V130, P4325, DOI 10.1242/dev.00667; BOBER E, 1994, DEVELOPMENT, V120, P603; Burgess R, 1996, NATURE, V384, P570, DOI 10.1038/384570a0; BURGESS R, 1995, DEV BIOL, V168, P296, DOI 10.1006/dbio.1995.1081; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; CHRISTIANSEN JH, 1995, MECH DEVELOP, V51, P341, DOI 10.1016/0925-4773(95)00383-5; COULY G, 1988, DEVELOPMENT, V103, P101; Dai FP, 2005, DEV BIOL, V285, P80, DOI 10.1016/j.ydbio.2005.06.005; del Barrio MG, 2002, DEVELOPMENT, V129, P1583; Delfini MC, 2009, DEV BIOL, V333, P229, DOI 10.1016/j.ydbio.2009.05.544; Dhouailly D, 2004, INT J DEV BIOL, V48, P85, DOI 10.1387/ijdb.15272373; Garriock RJ, 2007, DEV BIOL, V304, P127, DOI 10.1016/j.ydbio.2006.12.020; Geetha-Loganathan P, 2006, DEVELOPMENT, V133, P2897, DOI 10.1242/dev.02464; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Gros J, 2009, NATURE, V457, P589, DOI 10.1038/nature07564; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hornik C, 2005, DEV BIOL, V277, P42, DOI 10.1016/j.ydbio.2004.08.050; Houzelstein D, 2000, DEVELOPMENT, V127, P2155; Huang RJ, 2000, ANAT EMBRYOL, V202, P369, DOI 10.1007/s004290000130; Huang RJ, 2000, ANAT EMBRYOL, V202, P195, DOI 10.1007/s004290000110; Huang RJ, 2000, DEVELOPMENT, V127, P3789; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; LOGAN C, 1992, DEV GENET, V13, P345, DOI 10.1002/dvg.1020130505; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Marcelle C, 1997, DEVELOPMENT, V124, P3955; Masyuk M, 2013, DEV DYN IN PRESS; MAUGER A, 1972, J EMBRYOL EXP MORPH, V28, P313; MAUGER A, 1972, J EMBRYOL EXP MORPH, V28, P343; Michon F, 2008, DEVELOPMENT, V135, P2797, DOI 10.1242/dev.018341; Michon F, 2007, DEV DYNAM, V236, P755, DOI 10.1002/dvdy.21080; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Olivera-Martinez I, 2000, DEVELOPMENT, V127, P4611; Olivera-Martinez I, 2004, INT J DEV BIOL, V48, P107, DOI 10.1387/ijdb.15272376; Olivera-Martinez I, 2004, INT J DEV BIOL, V48, P93, DOI 10.1387/ijdb.15272374; Olivera-Martinez I, 2002, DEVELOPMENT, V129, P4763; Olivera-Martinez I, 2001, MECH DEVELOP, V100, P233, DOI 10.1016/S0925-4773(00)00540-2; Ordahl CP, 2001, DEVELOPMENT, V128, P1731; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pu Q, 2012, J ANAT, V221, P115, DOI 10.1111/j.1469-7580.2012.01518.x; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Scaal M, 2004, DEV DYNAM, V229, P643, DOI 10.1002/dvdy.10433; Scaal M, 2002, MECH DEVELOP, V110, P51, DOI 10.1016/S0925-4773(01)00552-4; Scaal M, 2001, ANAT EMBRYOL, V203, P1, DOI 10.1007/PL00008244; Sefton M, 1998, DEVELOPMENT, V125, P3111; Shi JL, 2011, DEVELOPMENT, V138, P3135, DOI 10.1242/dev.064394; Sosic D, 2003, CELL CYCLE, V2, P76, DOI 10.4161/cc.2.2.338; Tada M, 2000, DEVELOPMENT, V127, P2227; TANDA N, 1995, BIOCHEM BIOPH RES CO, V211, P123, DOI 10.1006/bbrc.1995.1786; TREMBLAY P, 1994, PHARMACOL THERAPEUT, V61, P205, DOI 10.1016/0163-7258(94)90063-9; Venters SJ, 2002, DEVELOPMENT, V129, P3873; Wilson-Rawls J, 1999, DEVELOPMENT, V126, P5217; Wilting J, 2000, DEV DYNAM, V217, P271, DOI 10.1002/(SICI)1097-0177(200003)217:3<271::AID-DVDY5>3.3.CO;2-U	64	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92679	10.1371/journal.pone.0092679	http://dx.doi.org/10.1371/journal.pone.0092679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671096	gold, Green Submitted, Green Published			2022-12-25	WOS:000333677000063
J	Postma, DBW; den Otter, AR; Zaal, FTJM				Postma, Dees B. W.; den Otter, A. Rob; Zaal, Frank T. J. M.			Keeping Your Eyes Continuously on the Ball While Running for Catchable and Uncatchable Fly Balls	PLOS ONE			English	Article							ACCELERATION CANCELLATION THEORY; UNIFIED FIELDER THEORY; VIRTUAL-REALITY; INFORMATION; BASEBALL; RUN; TRAJECTORIES; INTERCEPTION; MOVEMENTS; STRATEGY	When faced with a fly ball approaching along the sagittal plane, fielders need information for the control of their running to the interception location. This information could be available in the initial part of the ball trajectory, such that the interception location can be predicted from its initial conditions. Alternatively, such predictive information is not available, and running to the interception location involves continuous visual guidance. The latter type of control would predict that fielders keep looking at the approaching ball for most of its flight, whereas the former type of control would fit with looking at the ball during the early part of the ball's flight; keeping the eyes on the ball during the remainder of its trajectory would not be necessary when the interception location can be inferred from the first part of the ball trajectory. The present contribution studied visual tracking of approaching fly balls. Participants were equipped with a mobile eye tracker. They were confronted with tennis balls approaching from about 20 m, and projected in such a way that some balls were catchable and others were not. In all situations, participants almost exclusively tracked the ball with their gaze until just before the catch or until they indicated that a ball was uncatchable. This continuous tracking of the ball, even when running close to their maximum speeds, suggests that participants employed continuous visual control rather than running to an interception location known from looking at the early part of the ball flight.	[Postma, Dees B. W.; den Otter, A. Rob; Zaal, Frank T. J. M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Sect F, Groningen, Netherlands	University of Groningen	Zaal, FTJM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Sect F, Groningen, Netherlands.	f.t.j.m.zaal@umcg.nl	Zaal, Frank TJM/A-5578-2008	Zaal, Frank TJM/0000-0003-2697-3612; Postma, Dees/0000-0002-1108-7549				Adair RK., 2002, PHYS BASEBALL, V3rd; Arzamarski R, 2007, EXP BRAIN RES, V177, P312, DOI 10.1007/s00221-006-0671-8; Bastin J, 2006, HUM MOVEMENT SCI, V25, P718, DOI 10.1016/j.humov.2006.04.001; Bongers RM, 2008, J EXP PSYCHOL HUMAN, V34, P1515, DOI 10.1037/a0011974; Bootsma RJ, 2009, PERCEPTION, V38, P851; Bootsma RJ, 1997, J EXP PSYCHOL HUMAN, V23, P1282; Bosco G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049381; BRANCAZIO PJ, 1985, AM J PHYS, V53, P849, DOI 10.1119/1.14350; Brouwer AM, 2006, VISION RES, V46, P382, DOI 10.1016/j.visres.2005.09.002; Bruce V., 2003, VISUAL PERCEPTION PH, V4th; CHAPMAN S, 1968, AM J PHYS, V36, P868, DOI 10.1119/1.1974297; CHODOSH LA, 1995, SCIENCE, V268, P1682, DOI 10.1126/science.7792585; Coren S., 2004, SENSATION PERCEPTION, DOI [10.1002/0471264385.wei0105, DOI 10.1002/0471264385.WEI0105]; Fajen BR, 2009, INT J SPORT PSYCHOL, V40, P79; Fink PW, 2009, J VISION, V9, DOI 10.1167/9.13.14; Ledouit S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080827; MCBEATH MK, 1995, SCIENCE, V268, P569, DOI 10.1126/science.7725104; McLeod P, 2006, J EXP PSYCHOL HUMAN, V32, P139, DOI 10.1037/0096-1523.32.1.139; McLeod P, 1996, J EXP PSYCHOL HUMAN, V22, P531; McLeod P, 2003, NATURE, V426, P244, DOI 10.1038/426244a; McLeod P, 2002, J EXP PSYCHOL HUMAN, V28, P1499, DOI 10.1037//0096-1523.28.6.1499; McLeod P, 2001, J EXP PSYCHOL HUMAN, V27, P1347, DOI 10.1037/0096-1523.27.6.1347; McLeod P, 2008, VISION RES, V48, P1479, DOI 10.1016/j.visres.2008.03.016; Michaels Claire F., 1992, Ecological Psychology, V4, P199, DOI 10.1207/s15326969eco0404_1; Montagne G, 1999, EXP BRAIN RES, V129, P87, DOI 10.1007/s002210050939; Oudejans RRD, 1999, J EXP PSYCHOL HUMAN, V25, P531, DOI 10.1037/0096-1523.25.2.531; SAXBERG BVH, 1987, BIOL CYBERN, V56, P177, DOI 10.1007/BF00317992; Shaffer DM, 2008, PERCEPT PSYCHOPHYS, V70, P145, DOI 10.3758/PP.70.1.145; Shaffer DM, 2003, J EXP PSYCHOL HUMAN, V29, P1244, DOI 10.1037/0096-1523.29.6.1244; Shaffer DM, 2002, J EXP PSYCHOL HUMAN, V28, P335, DOI 10.1037//0096-1523.28.2.335; Sugar TG, 2006, PSYCHON B REV, V13, P908, DOI 10.3758/BF03194018; Todd J T, 1981, J Exp Psychol Hum Percept Perform, V7, P975; Zaal FTJM, 2012, ATTEN PERCEPT PSYCHO, V74, P1488, DOI 10.3758/s13414-012-0328-6; Zaal FTJM, 2003, J EXP PSYCHOL HUMAN, V29, P537, DOI 10.1037/0096-1523.29.3.537	34	10	10	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92392	10.1371/journal.pone.0092392	http://dx.doi.org/10.1371/journal.pone.0092392			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24670972	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000043
J	Radford, IJ; Dickman, CR; Start, AN; Palmer, C; Carnes, K; Everitt, C; Fairman, R; Graham, G; Partridge, T; Thomson, A				Radford, Ian J.; Dickman, Christopher R.; Start, Antony N.; Palmer, Carol; Carnes, Karin; Everitt, Corrin; Fairman, Richard; Graham, Gordon; Partridge, Thalie; Thomson, Allan			Mammals of Australia's Tropical Savannas: A Conceptual Model of Assemblage Structure and Regulatory Factors in the Kimberley Region	PLOS ONE			English	Article							KAKADU-NATIONAL-PARK; PSEUDANTECHINUS-MACDONNELLENSIS MARSUPIALIA; DASYURUS-HALLUCATUS MARSUPIALIA; NORTHERN AUSTRALIA; WESTERN-AUSTRALIA; TRANSITION MODELS; ARID AUSTRALIA; MITCHELL PLATEAU; BIODIVERSITY CONSERVATION; POPULATION-DYNAMICS	We construct a state-and-transition model for mammals in tropical savannas in northern Australia to synthesize ecological knowledge and understand mammalian declines. We aimed to validate the existence of alternative mammal assemblage states similar to those in arid Australian grasslands, and to speculate on transition triggers. Based on the arid grassland model, we hypothesized that assemblages are partitioned across rainfall gradients and between substrates. We also predicted that assemblages typical of arid regions in boom periods would be prevalent in savannas with higher and more regular rainfall. Data from eight mammal surveys from the Kimberley region, Western Australia (1994 to 2011) were collated. Survey sites were partitioned across rainfall zones and habitats. Data allowed us to identify three assemblage states: State 0:- low numbers of mammals, State II:- dominated by omnivorous rodents and State III:- dominated by rodents and larger marsupials. Unlike arid grasslands, assemblage dominance by insectivorous dasyurids (State I) did not occur in savannas. Mammal assemblages were partitioned across rainfall zones and between substrates as predicted, but-unlike arid regions-were not related strongly to yearly rainfall. Mammal assemblage composition showed high regional stability, probably related to high annual rainfall and predictable wet season resource pulses. As a consequence, we speculate that perpetually booming assemblages in savannas allow top-down control of the ecosystem, with suppression of introduced cats by the dingo, the region's top predator. Under conditions of low or erratic productivity, imposed increasingly by intense fire regimes and introduced herbivore grazing, dingoes may not limit impacts of cats on native mammals. These interacting factors may explain contemporary declines of savanna mammals as well as historical declines in arid Australia. The cat-ecosystem productivity hypothesis raised here differs from the already-articulated cat-habitat structure hypothesis for mammal declines, and we suggest approaches for explicit testing of transition triggers for competing hypotheses.	[Radford, Ian J.; Carnes, Karin; Everitt, Corrin; Fairman, Richard; Thomson, Allan] Dept Pk & Wildlife, Div Sci & Conservat, Kununurra, WA, Australia; [Dickman, Christopher R.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Start, Antony N.] Dept Pk & Wildlife, Div Sci & Conservat, Woodvale, WA, Australia; [Palmer, Carol] Northern Terr Govt, Dept Land Resource Management, Palmerston, NT, Australia; [Graham, Gordon] Conservat Commiss Western Australia, Crawley, WA, Australia; [Partridge, Thalie] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	University of Sydney; Northern Territory Government; Macquarie University	Radford, IJ (corresponding author), Dept Pk & Wildlife, Div Sci & Conservat, Kununurra, WA, Australia.	ian.radford@dpaw.wa.gov.au	Dickman, Christopher/Q-4662-2019	Dickman, Christopher/0000-0002-1067-3730	Department of Parks and Wildlife, Western Australia; Department of Environment and Conservation; Department of Conservation and Land Management	Department of Parks and Wildlife, Western Australia; Department of Environment and Conservation; Department of Conservation and Land Management	Funding for research and component surveys was provided by the Department of Parks and Wildlife, Western Australia, and its predecessors (the Department of Environment and Conservation and the Department of Conservation and Land Management). Department of Parks and Wildlife staff designed the studies and collected data. Analyses undertaken and the decision to prepare and publish this manuscript was made by Departmental staff in conjunction with the University of Sydney.	Abbott I, 2002, WILDLIFE RES, V29, P51, DOI 10.1071/WR01011; Andersen AN, 2005, AUSTRAL ECOL, V30, P155, DOI 10.1111/j.1442-9993.2005.01441.x; Ash A. J., 1982, Proceedings of the Australian Society of Animal Production, V14, P377; Ash A. J., 1997, Rangeland Journal, V19, P123, DOI 10.1071/RJ9970123; Bagchi S, 2012, ECOL APPL, V22, P400, DOI 10.1890/11-0704.1; BEGG RJ, 1981, AUST WILDLIFE RES, V8, P515; Beringer J, 2007, GLOBAL CHANGE BIOL, V13, P990, DOI 10.1111/j.1365-2486.2007.01334.x; Bestelmeyer BT, 2011, J APPL ECOL, V48, P746, DOI 10.1111/j.1365-2664.2011.01982.x; Bestelmeyer BT, 2006, J ARID ENVIRON, V65, P296, DOI 10.1016/j.jaridenv.2005.06.028; BRADLEY AJ, 1987, AUST WILDLIFE RES, V14, P397; Braithwaite R. W., 1993, Australian Mammalogy, V16, P93; BRAITHWAITE RW, 1994, WILDLIFE RES, V21, P203, DOI 10.1071/WR9940203; Braithwaite RW, 1996, WILDLIFE RES, V23, P1, DOI 10.1071/WR9960001; Briske DD, 2008, RANGELAND ECOL MANAG, V61, P359, DOI 10.2111/07-051.1; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Burbidge AA, 2002, J BIOGEOGR, V29, P465, DOI 10.1046/j.1365-2699.2002.00699.x; COOK GD, 1994, AUST J ECOL, V19, P359, DOI 10.1111/j.1442-9993.1994.tb00501.x; Corbett LK, 2003, ECOL STU AN, V169, P126; Czembor CA, 2009, FOREST ECOL MANAG, V259, P165, DOI 10.1016/j.foreco.2009.10.002; Dickman CR, 2010, J MAMMAL, V91, P798, DOI 10.1644/09-MAMM-S-205.1; Dickman CR, 1999, WILDLIFE RES, V26, P389, DOI 10.1071/WR97057; Dickman CR, 2001, WILDLIFE RES, V28, P493, DOI 10.1071/WR00023; Dostine PL, 2001, WILDLIFE RES, V28, P445, DOI 10.1071/WR00049; Forbis TA, 2006, ENVIRON MANAGE, V38, P62, DOI 10.1007/s00267-005-0089-2; Franklin DC, 2005, WILDLIFE RES, V32, P399, DOI 10.1071/WR05052; Fuhlendorf SD, 2004, J APPL ECOL, V41, P604, DOI 10.1111/j.0021-8901.2004.00937.x; Gasaway WC, 1992, ECOL MONOGR, V120, P3; Gibson LA, 2012, RECORDS W AUSTR MU S, V81, P15; Gilfillan SL, 2001, WILDLIFE RES, V28, P469, DOI 10.1071/WR99062; Gilfillan SL, 2001, WILDLIFE RES, V28, P481, DOI 10.1071/WR99063; Hobbs R.J., 2009, NEW MODELS ECOSYSTEM; Hopcraft JGC, 2010, TRENDS ECOL EVOL, V25, P119, DOI 10.1016/j.tree.2009.08.001; JOHNSON C, 2006, AUSTR MAMMAL EXTINCT; KEMPER CM, 1987, J ZOOL, V212, P533, DOI 10.1111/j.1469-7998.1987.tb02923.x; Kennedy M, 2012, AUSTRAL ECOL, V37, P134, DOI 10.1111/j.1442-9993.2011.02256.x; Laundre JW, 2010, CANADIAN J ECOLOGY, V79, P1401; Legge S, 2008, WILDLIFE RES, V35, P33, DOI 10.1071/WR07016; Legge S, 2011, AUSTRAL ECOL, V36, P791, DOI 10.1111/j.1442-9993.2010.02218.x; Letnic M, 2004, J ARID ENVIRON, V59, P85, DOI 10.1016/j.jaridenv.2004.01.014; Letnic M, 2010, BIOL REV, V85, P501, DOI 10.1111/j.1469-185X.2009.00113.x; Letnic M, 2006, BIODIVERS CONSERV, V15, P3847, DOI 10.1007/s10531-005-0601-2; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; Letnic M, 2011, J MAMMAL, V92, P1210, DOI 10.1644/10-MAMM-S-229.1; Litzow MA, 2007, ECOL LETT, V10, P1124, DOI 10.1111/j.1461-0248.2007.01111.x; Madsen T, 1999, ECOLOGY, V80, P989, DOI 10.1890/0012-9658(1999)080[0989:LHCONS]2.0.CO;2; McKenzie NL, 2007, J BIOGEOGR, V34, P597, DOI 10.1111/j.1365-2699.2006.01639.x; MCKENZIE NL, 1981, J BIOGEOGR, V8, P263, DOI 10.2307/2844762; Moran MD, 2002, OIKOS, V98, P116, DOI 10.1034/j.1600-0706.2002.980112.x; Morton S.R., 1985, Australian Mammalogy, V8, P159; NEWSOME AE, 1989, OECOLOGIA, V78, P458, DOI 10.1007/BF00378734; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Ostfeld RS, 2007, PULSED RESOURCES COM, P30; P Grime J., 2012, EVOLUTIONARY STRATEG, DOI [DOI 10.1002/9781118223246, 10.1002/9781118223246]; Palmer C, 2004, BIODIVERS CONSERV; Pardon LG, 2003, J ANIM ECOL, V72, P106, DOI 10.1046/j.1365-2656.2003.00686.x; Partridge TB, 2010, THESIS MACQUARIE U; Price O, 2005, WILDLIFE RES, V32, P435, DOI 10.1071/WR04033; Radford IJ, 2012, AUSTRAL ECOL, V37, P926, DOI 10.1111/j.1442-9993.2011.02352.x; Radford IJ, 2012, AUSTRAL ECOL, V37, P733, DOI 10.1111/j.1442-9993.2012.02413.x; Radford Ian J., 2010, Conservation Science Western Australia, V7, P469; Richards AE, 2012, AUSTRAL ECOL, V37, P712, DOI 10.1111/j.1442-9993.2012.02395.x; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; Rumpff L, 2011, BIOL CONSERV, V144, P1224, DOI 10.1016/j.biocon.2010.10.026; Russell-Smith J, 2003, INT J WILDLAND FIRE, V12, P283, DOI 10.1071/WF03015; Russell-Smith J, 2003, ECOL MONOGR, V73, P349, DOI 10.1890/01-4021; Scheffer M, 2008, ECOSYSTEMS, V11, P226, DOI 10.1007/s10021-007-9118-8; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; SCHMITT LH, 1989, J ZOOL, V217, P539, DOI 10.1111/j.1469-7998.1989.tb02510.x; Scott K, 2012, AUSTRAL ECOL, V37, P693, DOI 10.1111/j.1442-9993.2012.02379.x; Standish RJ., 2009, NEW MODELS ECOSYSTEM; Start AN, 2012, AUST MAMMAL, V34, P36, DOI 10.1071/AM10026; Start A. N., 2007, AUST MAMMAL, V29, P1, DOI [10.1071/AM07001, DOI 10.1071/AM07001]; Suding KN, 2009, TRENDS ECOL EVOL, V24, P271, DOI 10.1016/j.tree.2008.11.012; Sutherland EF, 1999, WILDLIFE RES, V26, P405, DOI 10.1071/WR97045; Thackway R., 1995, INTERIM BIOREGIONALI; Tyler I., 2011, GEOLOGY LANDFORMS KI; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; van Nes EH, 2005, ECOLOGY, V86, P1797, DOI 10.1890/04-0550; Walker M, 2001, OIKOS, V93, P177, DOI 10.1034/j.1600-0706.2001.930201.x; Wang YW, 2012, WILDLIFE RES, V39, P611, DOI 10.1071/WR11210; WESTOBY M, 1989, J RANGE MANAGE, V42, P266, DOI 10.2307/3899492; White T. C. R., 1993, INADEQUATE ENV NITRO; Williams RJ, 2003, INT J WILDLAND FIRE, V12, P391, DOI 10.1071/WF03025; Williams RJ, 1999, AUST J ECOL, V24, P50, DOI 10.1046/j.1442-9993.1999.00946.x; Woinarski JCZ, 2011, WILDLIFE RES, V38, P307, DOI 10.1071/WR10184; Woinarski JCZ, 2010, WILDLIFE RES, V37, P116, DOI 10.1071/WR09125; WOINARSKI JCZ, 1992, WILDLIFE RES, V19, P233, DOI 10.1071/WR9920233; Woinarski JCZ, 2004, AUSTRAL ECOL, V29, P156, DOI 10.1111/j.1442-9993.2004.01333.x; Woinarski JCZ, 2001, AUSTRAL ECOL, V26, P360, DOI 10.1046/j.1442-9993.2001.01121.x; Woinarski JCZ, 1992, RES B, V6; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x; Wolff JO, 1997, J ANIM ECOL, V66, P1, DOI 10.2307/5959; Zweig CL, 2009, ECOLOGY, V90, P1900, DOI 10.1890/08-1392.1	95	32	33	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92341	10.1371/journal.pone.0092341	http://dx.doi.org/10.1371/journal.pone.0092341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670997	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677000041
J	Wildeman, C; Emanuel, N				Wildeman, Christopher; Emanuel, Natalia			Cumulative Risks of Foster Care Placement by Age 18 for US Children, 2000-2011	PLOS ONE			English	Article							HEALTH-STATUS; PROTECTION	Foster care placement is among the most tragic events a child can experience because it more often than not implies that a child has experienced or is at very high risk of experiencing abuse or neglect serious enough to warrant state intervention. Yet it is unclear how many children will experience foster care placement at some point between birth and age 18. Using synthetic cohort life tables and data from the Adoption and Foster Care Analysis and Reporting System (AFCARS), we estimated how many U. S. children were placed in foster care between birth and age 18, finding support for three conclusions. First, up to 5.91% of all U. S. children were ever placed in foster care between their birth and age 18. Second, Native American (up to 15.44%) and Black (up to 11.53%) children were at far higher risk of placement. Foster care is thus quite common in the U. S., especially for historically disadvantaged racial/ethnic groups. Third, differences in foster care placement were minimal between the sexes, indicating that the high risks of foster care placement are shared almost equally by boys and girls.	[Wildeman, Christopher] Yale Univ, Dept Sociol, New Haven, CT 06520 USA; [Emanuel, Natalia] Yale Univ, Dept Econ, New Haven, CT 06520 USA	Yale University; Yale University	Wildeman, C (corresponding author), Yale Univ, Dept Sociol, New Haven, CT 06520 USA.	christopher.wildeman@yale.edu			Children's Bureau; Administration on Children, Youth and Families; Administration for Children and Families; United States Department of Health and Human Services	Children's Bureau; Administration on Children, Youth and Families; Administration for Children and Families(United States Department of Health & Human Services); United States Department of Health and Human Services	Funding for the project was provided by the Children's Bureau, Administration on Children, Youth and Families, Administration for Children and Families, United States Department of Health and Human Services. All analyses and interpretations presented here are solely those of the authors, and the collector of the data, the funder, the Archive, Cornell University and their agents or employees bear no responsibility for the analyses or interpretations presented here. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, AD FOST CAR AN REP S; [Anonymous], 2008, AD FOST CAR AN REP S; [Anonymous], 1926, REP PUBLIC HLTH MED; [Anonymous], 2007, AD FOST CAR AN REP S; [Anonymous], 2009, AD FOST CAR AN REP S; [Anonymous], 2006, AD FOST CAR AN REP S; CHERNOFF R, 1994, PEDIATRICS, V93, P594; Clausen J.M., 1998, J CHILD FAM STUD, V7, P283, DOI [DOI 10.1023/A:1022989411119, 10.1023/A:1022989411119]; Doyle JJ, 2008, J POLIT ECON, V116, P746, DOI 10.1086/590216; Doyle JJ, 2007, AM ECON REV, V97, P1583, DOI 10.1257/aer.97.5.1583; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; HALFON N, 1995, ARCH PEDIAT ADOL MED, V149, P386, DOI 10.1001/archpedi.1995.02170160040006; Harman JS, 2000, ARCH PEDIAT ADOL MED, V154, P1114, DOI 10.1001/archpedi.154.11.1114; Jee S, 2010, CHILD YOUTH SERV REV, V32, P685, DOI 10.1016/j.childyouth.2010.01.004; Magruder J, 2008, CHILD WELFARE, V87, P169; National Data Archive on Child Abuse and Neglect, 2002, AD FOST CAR AN REP S; National Data Archive on Child Abuse and Neglect, 2004, AD FOST CAR AN REP S; National Data Archive on Child Abuse and Neglect, 2003, AD FOST CAR AN REP S; National Data Archive on Child Abuse and Neglect, 2005, AD FOST CAR AN REP S; National Data Archive on Child Abuse and Neglect, 2012, AD FOST CAR AN REP S; National Data Archive on Child Abuse and Neglect, 2011, AD FOST CAR AN REP S; PAN-AFRICAN PARLIAMENT, 2012, 21 ORDINARY SESSION; Preston S., 2000, DEMOGRAPHY MEASURING; Putnam-Hornstein E, 2011, CHILD MALTREATMENT, V16, P163, DOI 10.1177/1077559511411179; StataCorp, 2019, STATA STAT SOFTWARE; U.S. Department of Health and Human Services Administration for Children and Families Administration on Children Youth and Families Children's Bureau, 2012, FED REP SYST AD FOST; U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for Health Statistics CDC WONDER Online Database, 2011, BRIDG RAC POP EST 19	27	100	100	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92785	10.1371/journal.pone.0092785	http://dx.doi.org/10.1371/journal.pone.0092785			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24671254	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677000074
J	Wu, HY; Yang, J; Su, EM; Li, L; Zhao, CQ; Yang, X; Gao, ZW; Pan, MY; Sun, PY; Sun, W; Jiang, YY; Su, X				Wu, Haiya; Yang, Jun; Su, Emily M.; Li, Ling; Zhao, Caiqi; Yang, Xi; Gao, Zhaowei; Pan, Mengyao; Sun, Peiyu; Sun, Wei; Jiang, Yiyi; Su, Xiao			Lipoxin A4 and Platelet Activating Factor Are Involved in E. coli or LPS-Induced Lung Inflammation in CFTR-Deficient Mice	PLOS ONE			English	Article							CYSTIC-FIBROSIS; FACTOR PAF; ACETYLHYDROLASE; NEUTROPHILS; INHIBITION; INJURY; RECRUITMENT; PNEUMONIA; SEPSIS; SHOCK	CFTR (cystic fibrosis transmembrane conductance regulator) is expressed by both neutrophils and platelets. Lack of functional CFTR could lead to severe lung infection and inflammation. Here, we found that mutation of CFTR (F508del) or inhibition of CFTR in mice led to more severe thrombocytopenia, alveolar neutrocytosis and bacteriosis, and lower lipoxin A4/MIP-2 (macrophage inhibitory protein-2) or lipoxin A4/neutrophil ratios in the BAL (bronchoalveolar lavage) during acute E. coli pneumonia. In vitro, inhibition of CFTR promotes MIP-2 production in LPS-stimulated neutrophils; however, lipoxin A4 could dose-dependently suppress this effect. In LPS-induced acute lung inflammation, blockade of PSGL-1 (P-selectin glycoprotein ligand-1) or P-selectin, antagonism of PAF by WEB2086, or correction of mutated CFTR trafficking by KM11060 could significantly increase plasma lipoxin A4 levels in F508del relevant to wildtype mice. Concurrently, F508del mice had higher plasma platelet activating factor (PAF) levels and PAF-AH activity compared to wildtype under LPS challenge. Inhibiting hydrolysis of PAF by a specific PAF-AH (PAF-acetylhydrolase) inhibitor, MAFP, could worsen LPS-induced lung inflammation in F508del mice compared to vehicle treated F508del group. Particularly, depletion of platelets in F508del mice could significantly decrease plasma lipoxin A4 and PAF-AH activity and deteriorate LPS-induced lung inflammation compared to control F508del mice. Taken together, lipoxin A4 and PAF are involved in E. coli or LPS-induced lung inflammation in CFTR-deficient mice, suggesting that lipoxin A4 and PAF might be therapeutic targets for ameliorating CFTR-deficiency deteriorated lung inflammation.	[Wu, Haiya; Li, Ling; Zhao, Caiqi; Yang, Xi; Gao, Zhaowei; Pan, Mengyao; Sun, Peiyu; Sun, Wei; Jiang, Yiyi; Su, Xiao] Chinese Acad Sci, Inst Pasteur Shanghai, Unit Resp Infect & Immun, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Yang, Jun] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Su, Emily M.; Su, Xiao] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); University of California System; University of California Davis; University of California System; University of California San Francisco	Su, X (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Unit Resp Infect & Immun, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.	xsu@ips.ac.cn	Yang, Jun/B-2262-2010; Su, Xiao/CAG-9884-2022	Yang, Jun/0000-0001-8126-1728; Su, Xiao/0000-0002-8692-8365	Parker B. Francis Award; One Hundred Person Project of the Chinese Academy of Sciences [Y316P21209]; Knowledge Innovation Program of the Chinese Academy of Sciences [Y114P11209]; National Natural Science Foundation of China [81270139, 81300058]; Key Project of Science and Technology of Shanghai [12JC1408900]; Elizabeth Nash Memorial fellowship from the Cystic Fibrosis Research Inc; American Asthma Association [09-0269]	Parker B. Francis Award; One Hundred Person Project of the Chinese Academy of Sciences; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology of Shanghai; Elizabeth Nash Memorial fellowship from the Cystic Fibrosis Research Inc; American Asthma Association	Parker B. Francis Award (X. S.); One Hundred Person Project of the Chinese Academy of Sciences (Grant No. Y316P21209, X. S.); The Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. Y114P11209, X. S.); The National Natural Science Foundation of China (Grant No. 81270139, X. S.; 81300058, H.Y.W.); The Key Project of Science and Technology of Shanghai (Grant No. 12JC1408900, X. S.). J. Yang was supported by the Elizabeth Nash Memorial fellowship from the Cystic Fibrosis Research Inc and the American Asthma Association (#09-0269). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEIJER L, 1987, BRIT J PHARMACOL, V92, P803, DOI 10.1111/j.1476-5381.1987.tb11384.x; Ciabattoni G, 2000, AM J RESP CRIT CARE, V162, P1195, DOI 10.1164/ajrccm.162.4.9911071; Dalli J, 2010, AM J PATHOL, V177, P176, DOI 10.2353/ajpath.2010.091149; Dhooghe B, 2013, CLIN BIOCH; Jehle R, 2001, BBA-MOL CELL BIOL L, V1532, P60, DOI 10.1016/S1388-1981(01)00112-3; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; Kell PJ, 2003, J PHARMACOL EXP THER, V307, P1163, DOI 10.1124/jpet.103.055392; Lam FW, 2011, AM J PHYSIOL-HEART C, V300, pH468, DOI 10.1152/ajpheart.00491.2010; Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432; MAKRISTATHIS A, 1993, INFECT IMMUN, V61, P1996, DOI 10.1128/IAI.61.5.1996-2002.1993; Matthay MA, 2007, NAT MED, V13, P780, DOI 10.1038/nm0707-780; Matute-Bello G, 2001, AM J RESP CRIT CARE, V163, P234, DOI 10.1164/ajrccm.163.1.9909034; Mitsios JV, 2006, ARTERIOSCL THROM VAS, V26, P1907, DOI 10.1161/01.ATV.0000228821.79588.ef; O'Sullivan BP, 2005, BLOOD, V105, P4635, DOI 10.1182/blood-2004-06-2098; Owen JS, 2005, J LIPID RES, V46, P373, DOI 10.1194/jlr.D400029-JLR200; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; RABINOVICI R, 1991, CIRC RES, V69, P12, DOI 10.1161/01.RES.69.1.12; Schwarz KB, 2003, J PEDIATR GASTR NUTR, V37, P187, DOI 10.1097/00005176-200308000-00019; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; SERHAN CN, 1990, J CLIN INVEST, V85, P772, DOI 10.1172/JCI114503; Su X, 2004, EXP LUNG RES, V30, P479, DOI 10.1080/01902140490476382; Su X, 2012, AM J RESP CRIT CARE, V186, P472, DOI 10.1164/rccm.201207-1235ED; Su X, 2011, INFLAMM RES, V60, P619, DOI 10.1007/s00011-011-0313-x; Su X, 2010, J IMMUNOL, V184, P401, DOI 10.4049/jimmunol.0901808; Su X, 2009, ANAT REC, V292, P580, DOI 10.1002/ar.20846; Yang JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009190; Zhao CQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082683; Zhou Y, 2013, J INNATE IMMUN, V5, P219, DOI 10.1159/000346568; Zimmerman GA, 2002, CRIT CARE MED, V30, pS294, DOI 10.1097/00003246-200205001-00020	30	11	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93003	10.1371/journal.pone.0093003	http://dx.doi.org/10.1371/journal.pone.0093003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671173	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677000098
J	Amato, SM; Brynildsen, MP				Amato, Stephanie M.; Brynildsen, Mark P.			Nutrient Transitions Are a Source of Persisters in Escherichia coli Biofilms	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA BIOFILMS; GENE-EXPRESSION; RIBOSOMAL-RNA; BACTERIAL PERSISTENCE; MULTIPLE ANTIBIOTICS; MULTIDRUG TOLERANCE; STRINGENT CONTROL; GROWTH; PPGPP; CELLS	Chronic and recurrent infections have been attributed to persisters in biofilms, and despite this importance, the mechanisms of persister formation in biofilms remain unclear. The plethora of biofilm characteristics that could give rise to persisters, including slower growth, quorum signaling, oxidative stress, and nutrient heterogeneity, have complicated efforts to delineate formation pathways that generate persisters during biofilm development. Here we sought to specifically determine whether nutrient transitions, which are a common metabolic stress encountered within surface-attached communities, stimulate persister formation in biofilms and if so, to then identify the pathway. To accomplish this, we established an experimental methodology where nutrient availability to biofilm cells could be controlled exogenously, and then used that method to discover that diauxic carbon source transitions stimulated persister formation in Escherichia coli biofilms. Previously, we found that carbon source transitions stimulate persister formation in planktonic E. coli cultures, through a pathway that involved ppGpp and nucleoid-associated proteins, and therefore, tested the functionality of that pathway in biofilms. Biofilm persister formation was also found to be dependent on ppGpp and nucleoid-associated proteins, but the importance of specific proteins and enzymes between biofilm and planktonic lifestyles was significantly different. Data presented here support the increasingly appreciated role of ppGpp as a central mediator of bacterial persistence and demonstrate that nutrient transitions can be a source of persisters in biofilms.	[Amato, Stephanie M.; Brynildsen, Mark P.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA	Princeton University	Brynildsen, MP (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.	mbrynild@princeton.edu			National Science Foundation; Department of the Army [W81XWH-12-2-0138]; Princeton University; National Science Foundation Division of Materials Research through the Princeton University MRSEC [NSF-DMR 0819860]	National Science Foundation(National Science Foundation (NSF)); Department of the Army; Princeton University(Princeton University); National Science Foundation Division of Materials Research through the Princeton University MRSEC	This work was supported by the National Science Foundation (SMA, Graduate Research Fellowship), the Department of the Army (W81XWH-12-2-0138), and with start-up funds from Princeton University. This research was supported by the National Science Foundation Division of Materials Research through the Princeton University MRSEC (NSF-DMR 0819860). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison KR, 2011, CURR OPIN MICROBIOL, V14, P593, DOI 10.1016/j.mib.2011.09.002; Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Amato SM, 2013, MOL CELL, V50, P475, DOI 10.1016/j.molcel.2013.04.002; AN G, 1979, J BACTERIOL, V137, P1100, DOI 10.1128/JB.137.3.1100-1110.1979; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; BACHI B, 1975, BIOCHEM J, V150, P123; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; BARACCHINI E, 1988, J BIOL CHEM, V263, P2597; Bernier SP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003144; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; BUJARD H, 1987, METHOD ENZYMOL, V155, P416; Claret L, 1996, J MOL BIOL, V263, P126, DOI 10.1006/jmbi.1996.0564; CLARK B, 1976, J GEN MICROBIOL, V95, P191, DOI 10.1099/00221287-95-2-191; Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; Dame RT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002123; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; DORMAN CJ, 1991, INFECT IMMUN, V59, P745, DOI 10.1128/IAI.59.3.745-749.1991; DORMAN CJ, 1988, J BACTERIOL, V170, P2816, DOI 10.1128/jb.170.6.2816-2826.1988; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Fasani RA, 2013, P NATL ACAD SCI USA, V110, pE2528, DOI 10.1073/pnas.1301023110; Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0; Ferullo DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000300; Ferullo DJ, 2008, PLOS GENET, P1; Harrison JJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-53; Harrison JJ, 2009, ANTIMICROB AGENTS CH, V53, P2253, DOI 10.1128/AAC.00043-09; Kang SH, 2003, J BIOL CHEM, V278, P48779, DOI 10.1074/jbc.M308843200; Kint CI, 2012, TRENDS MICROBIOL, V20, P577, DOI 10.1016/j.tim.2012.08.009; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kolmsee T, 2011, MICROBIOL-SGM, V157, P2871, DOI 10.1099/mic.0.052357-0; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Lee H, 2001, MOL GEN GENET, V264, P931, DOI 10.1007/PL00008701; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Li YF, 2007, ANTIMICROB AGENTS CH, V51, P2092, DOI 10.1128/AAC.00052-07; Ma C, 2010, FEMS MICROBIOL LETT, V303, P33, DOI 10.1111/j.1574-6968.2009.01857.x; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8; Moker N, 2010, J BACTERIOL, V192, P1946, DOI 10.1128/JB.01231-09; Monod J., 1942, ACTUALITES SCI IND; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Narang A, 2007, J THEOR BIOL, V244, P326, DOI 10.1016/j.jtbi.2006.08.007; NINNEMANN O, 1992, EMBO J, V11, P1075, DOI 10.1002/j.1460-2075.1992.tb05146.x; Orman MA, 2013, ANTIMICROB AGENTS CH, V57, P4398, DOI 10.1128/AAC.00372-13; Orman MA, 2013, ANTIMICROB AGENTS CH, V57, P3230, DOI 10.1128/AAC.00243-13; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Potrykus K, 2011, ENVIRON MICROBIOL, V13, P563, DOI 10.1111/j.1462-2920.2010.02357.x; PRUSS BM, 1994, J BACTERIOL, V176, P2143; ROSEMAN S, 1990, J BIOL CHEM, V265, P2993; RYALS J, 1982, J BACTERIOL, V151, P1261, DOI 10.1128/JB.151.3.1261-1268.1982; SAIER MH, 1996, ESCHERICHIA COLI SAL; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; Traxler MF, 2006, P NATL ACAD SCI USA, V103, P2374, DOI 10.1073/pnas.0510995103; Vega NM, 2012, NAT CHEM BIOL, V8, P431, DOI [10.1038/NCHEMBIO.915, 10.1038/nchembio.915]; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Wexselblatt E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002925; Williamson KS, 2012, J BACTERIOL, V194, P2062, DOI 10.1128/JB.00022-12; Wu Y, 2012, ANTIMICROB AGENTS CH; XIAO H, 1991, J BIOL CHEM, V266, P5980; Zuroff TR, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-185	65	74	75	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93110	10.1371/journal.pone.0093110	http://dx.doi.org/10.1371/journal.pone.0093110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667358	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600142
J	Emukule, GO; McMorrow, M; Ulloa, C; Khagayi, S; Njuguna, HN; Burton, D; Montgomery, JM; Muthoka, P; Katz, MA; Breiman, RF; Mott, JA				Emukule, Gideon O.; McMorrow, Meredith; Ulloa, Chulie; Khagayi, Sammy; Njuguna, Henry N.; Burton, Deron; Montgomery, Joel M.; Muthoka, Philip; Katz, Mark A.; Breiman, Robert F.; Mott, Joshua A.			Predicting Mortality among Hospitalized Children with Respiratory Illness in Western Kenya, 2009-2012	PLOS ONE			English	Article							INFECTIONS; BURDEN; MANAGEMENT; PNEUMONIA; MALARIA	Background: Pediatric respiratory disease is a major cause of morbidity and mortality in the developing world. We evaluated a modified respiratory index of severity in children (mRISC) scoring system as a standard tool to identify children at greater risk of death from respiratory illness in Kenya. Materials and Methods: We analyzed data from children,5 years old who were hospitalized with respiratory illness at Siaya District Hospital from 2009-2012. We used a multivariable logistic regression model to identify patient characteristics predictive for in-hospital mortality. Model discrimination was evaluated using the concordance statistic. Using bootstrap samples, we re-estimated the coefficients and the optimism of the model. The mRISC score for each child was developed by adding up the points assigned to each factor associated with mortality based on the coefficients in the multivariable model. Results: We analyzed data from 3,581 children hospitalized with respiratory illness; including 218 (6%) who died. Low weight-for-age [adjusted odds ratio (aOR) = 2.1; 95% CI 1.3-3.2], very low weight-for-age (aOR = 3.8; 95% CI 2.7-5.4), caretaker-reported history of unconsciousness (aOR = 2.3; 95% CI 1.6-3.4), inability to drink or breastfeed (aOR = 1.8; 95% CI 1.2-2.8), chest wall in-drawing (aOR = 2.2; 95% CI 1.5-3.1), and being not fully conscious on physical exam (aOR = 8.0; 95% CI 5.1-12.6) were independently associated with mortality. The positive predictive value for mortality increased with increasing mRISC scores. Conclusions: A modified RISC scoring system based on a set of easily measurable clinical features at admission was able to identify children at greater risk of death from respiratory illness in Kenya.	[Emukule, Gideon O.; Khagayi, Sammy; Njuguna, Henry N.; Burton, Deron; Montgomery, Joel M.; Mott, Joshua A.] Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent Kenya, KEMRI, CDC, Nairobi, Kenya; [Emukule, Gideon O.; Khagayi, Sammy; Njuguna, Henry N.; Burton, Deron; Montgomery, Joel M.; Mott, Joshua A.] Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent Kenya, KEMRI, CDC, Kisumu, Kenya; [McMorrow, Meredith] US Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Ulloa, Chulie] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Muthoka, Philip] Minist Publ Hlth & Sanitat, Div Dis Surveillance & Response, Nairobi, Kenya; [Katz, Mark A.] Ctr Dis Control & Prevent, Port Au Prince, Haiti; [Breiman, Robert F.] Emory Univ, Atlanta, GA 30322 USA	Kenya Medical Research Institute; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Stanford University; Emory University	Emukule, GO (corresponding author), Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent Kenya, KEMRI, CDC, Nairobi, Kenya.	GEmukule@ke.cdc.gov	McMorrow, Meredith/M-1274-2019	McMorrow, Meredith/0000-0001-6363-4033	Core Funding of the Global Disease Detection Division of CDC	Core Funding of the Global Disease Detection Division of CDC	The funding for this project is from Core Funding of the Global Disease Detection Division of CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, CASE STUDY INTEGRATE; Barat L, 1999, AM J TROP MED HYG, V60, P1024, DOI 10.4269/ajtmh.1999.60.1024; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Dalal W, 2012, J ACQUIR IMMUNE DEFI; Feikin DR, 2012, B WORLD HEALTH ORGAN, V90, P256, DOI 10.2471/BLT.11.094326; Graham SM, 2001, INT J TUBERC LUNG D, V5, P12; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Harrell Jr FE, 1996, MULTIVARIABLE PROGNO; Hazir T, 2008, LANCET, V371, P49, DOI 10.1016/S0140-6736(08)60071-9; Jeena P, 2005, INT J TUBERC LUNG D, V9, P708; Kahama-Maro J, 2011, LOW QUALITY ROUTINE; Laxminarayan R., 2006, ACUTE RESP INFECT CH; Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350; Mullei K, 2008, IMPLEMENTING IMCT KE; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; National AIDS and STI Control Programme (NASCOP), 2009, KEN AIDS IND SURV 20; Odhiambo FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010016; Pattengale N.D., 2009, MANY BOOTSTRAP REPLI; Reed C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027793; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Shah D, 1999, EVALUATION WHO UNICE; Sullivan M., 2004, STAT EVALUATION MED; Thompson MG, 2012, INFLUENZA MALA UNPUB, P2009; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; WHO, 2008, INT MAN CHILDH ILLN; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Wooldridge J.M., 2016, INTRO ECONOMETRICS M; Zar HJ, 2003, PEDIATR PULM, V36, P457, DOI 10.1002/ppul.10345	30	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92968	10.1371/journal.pone.0092968	http://dx.doi.org/10.1371/journal.pone.0092968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667695	gold, Green Published			2022-12-25	WOS:000333675600111
J	Fayzullina, S; Martin, LJ				Fayzullina, Saniya; Martin, Lee J.			Skeletal Muscle DNA Damage Precedes Spinal Motor Neuron DNA Damage in a Mouse Model of Spinal Muscular Atrophy (SMA)	PLOS ONE			English	Article							DISEASE GENE-PRODUCT; CELL-DEATH; NEUROMUSCULAR-JUNCTION; SELECTIVE VULNERABILITY; SATELLITE CELL; PROTEIN; SURVIVAL; COMPLEX; MICE; EXPRESSION	Spinal Muscular Atrophy (SMA) is a hereditary childhood disease that causes paralysis by progressive degeneration of skeletal muscles and spinal motor neurons. SMA is associated with reduced levels of full-length Survival of Motor Neuron (SMN) protein, due to mutations in the Survival of Motor Neuron 1 gene. The mechanisms by which lack of SMN causes SMA pathology are not known, making it very difficult to develop effective therapies. We investigated whether DNA damage is a perinatal pathological event in SMA, and whether DNA damage and cell death first occur in skeletal muscle or spinal cord of SMA mice. We used a mouse model of severe SMA to ascertain the extent of cell death and DNA damage throughout the body of prenatal and newborn mice. SMA mice at birth (postnatal day 0) exhibited internucleosomal fragmentation in genomic DNA from hindlimb skeletal muscle, but not in genomic DNA from spinal cord. SMA mice at postnatal day 5, compared with littermate controls, exhibited increased apoptotic cell death profiles in skeletal muscle, by hematoxylin and eosin, terminal deoxynucleotidyl transferase dUTP nick end labeling, and electron microscopy. SMA mice had no increased cell death, no loss of choline acetyl transferase (ChAT)-positive motor neurons, and no overt pathology in the ventral horn of the spinal cord. At embryonic days 13 and 15.5, SMA mice did not exhibit statistically significant increases in cell death profiles in spinal cord or skeletal muscle. Motor neuron numbers in the ventral horn, as identified by ChAT immunoreactivity, were comparable in SMA mice and control littermates at embryonic day 15.5 and postnatal day 5. These observations demonstrate that in SMA, disease in skeletal muscle emerges before pathology in spinal cord, including loss of motor neurons. Overall, this work identifies DNA damage and cell death in skeletal muscle as therapeutic targets for SMA.	[Fayzullina, Saniya] Johns Hopkins Sch Med, Div Neuropathol, Dept Pathol, Baltimore, MD 21218 USA; Johns Hopkins Sch Med, Pathobiol Grad Program, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Fayzullina, S (corresponding author), Johns Hopkins Sch Med, Div Neuropathol, Dept Pathol, Baltimore, MD 21218 USA.	saniyaf2004@yahoo.com			National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS) [RO1-NS065895]; NIH-NINDS [5-F31-NS076250-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076250, R01NS065895] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS) grant RO1-NS065895 and NIH-NINDS grant 5-F31-NS076250-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AS, 2004, LAB INVEST, V84, P1271, DOI 10.1038/labinvest.3700163; Battle DJ, 2006, COLD SPRING HARB SYM, V71, P313, DOI 10.1101/sqb.2006.71.001; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Borisov AB, 2000, ANAT RECORD, V258, P305; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; BURKE SW, 1986, J PEDIATR ORTHOPED, V6, P34, DOI 10.1097/01241398-198601000-00007; Burlet P, 1998, HUM MOL GENET, V7, P1927, DOI 10.1093/hmg/7.12.1927; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Campbell L, 1997, AM J HUM GENET, V61, P40, DOI 10.1086/513886; Cande C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3; CARLSON BM, 1973, AM J ANAT, V137, P119, DOI 10.1002/aja.1001370202; Cifuentes-Diaz C, 2001, J CELL BIOL, V152, P1107, DOI 10.1083/jcb.152.5.1107; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Dachs E, 2011, J NEUROPATH EXP NEUR, V70, P444, DOI 10.1097/NEN.0b013e31821cbd8b; Dale JM, 2011, ACTA NEUROPATHOL, V122, P331, DOI 10.1007/s00401-011-0848-5; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Didenko V V., 2002, IN SITU DETECTION DN; DUBOWITZ V, 1964, BRAIN, V87, P707, DOI 10.1093/brain/87.4.707; Fan L, 2002, HUM MOL GENET, V11, P1605, DOI 10.1093/hmg/11.14.1605; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; FERRER I, 1994, NEUROSCI LETT, V182, P77, DOI 10.1016/0304-3940(94)90210-0; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Frugier T, 2002, CURR OPIN GENET DEV, V12, P294, DOI 10.1016/S0959-437X(02)00301-5; Frugier T, 2000, HUM MOL GENET, V9, P849, DOI 10.1093/hmg/9.5.849; Garcia-Cabezas MA, 2004, ACTA NEUROPATHOL, V107, P475, DOI 10.1007/s00401-004-0825-3; GARDNERMEDWIN D, 1967, J NEUROL SCI, V5, P121, DOI 10.1016/0022-510X(67)90013-5; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; Giavazzi A, 2006, J NEUROPATH EXP NEUR, V65, P267, DOI 10.1097/01.jnen.0000205144.54457.a3; Gogliotti RG, 2012, J NEUROSCI, V32, P3818, DOI 10.1523/JNEUROSCI.5775-11.2012; Guettier-Sigrist S, 1998, J NEUROSCI RES, V53, P663, DOI 10.1002/(SICI)1097-4547(19980915)53:6<663::AID-JNR4>3.0.CO;2-3; Guettier-Sigrist S, 2002, MUSCLE NERVE, V25, P700, DOI 10.1002/mus.10081; Hayhurst M, 2012, DEV BIOL, V368, P323, DOI 10.1016/j.ydbio.2012.05.037; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; KATZ B, 1961, PHILOS T ROY SOC B, V243, P221, DOI 10.1098/rstb.1961.0001; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kohn KW, 2005, BIOCHEM BIOPH RES CO, V331, P816, DOI 10.1016/j.bbrc.2005.03.186; KUGELBERG E, 1956, ARCH NEURO PSYCHIATR, V75, P500, DOI 10.1001/archneurpsyc.1956.02330230050005; Labat-Moleur F, 1998, J HISTOCHEM CYTOCHEM, V46, P327, DOI 10.1177/002215549804600306; Lee AJH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046353; Lee YI, 2011, DEV BIOL, V356, P432, DOI 10.1016/j.ydbio.2011.05.667; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Ling KKY, 2012, HUM MOL GENET, V21, P185, DOI 10.1093/hmg/ddr453; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lutz CM, 2011, J CLIN INVEST, V121, P3029, DOI 10.1172/JCI57291; MacLeod M J, 1999, Eur J Paediatr Neurol, V3, P65, DOI 10.1016/S1090-3798(99)80015-4; Martinez-Hernandez R, 2009, J NEUROPATH EXP NEUR, V68, P474, DOI 10.1097/NEN.0b013e3181a10ea1; Massenet S, 2002, MOL CELL BIOL, V22, P6533, DOI 10.1128/MCB.22.18.6533-6541.2002; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Meyer K, 2009, HUM MOL GENET, V18, P546, DOI 10.1093/hmg/ddn382; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Mutsaers CA, 2011, HUM MOL GENET, V20, P4334, DOI 10.1093/hmg/ddr360; Nicole S, 2002, MUSCLE NERVE, V26, P4, DOI 10.1002/mus.10110; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Park GH, 2010, J NEUROSCI, V30, P12005, DOI 10.1523/JNEUROSCI.2208-10.2010; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; PERULA EA, 1989, HISTOL HISTOPATHOL, V4, P265; ROBERTS DF, 1970, ARCH DIS CHILD, V45, P33, DOI 10.1136/adc.45.239.33; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Ruggiu M, 2012, MOL CELL BIOL, V32, P126, DOI 10.1128/MCB.06077-11; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Setola V, 2007, P NATL ACAD SCI USA, V104, P1959, DOI 10.1073/pnas.0610660104; Shafey D, 2005, EXP CELL RES, V311, P49, DOI 10.1016/j.yexcr.2005.08.019; Soler-Botija C, 2002, BRAIN, V125, P1624, DOI 10.1093/brain/awf155; Stadelmann C, 2000, CELL TISSUE RES, V301, P19, DOI 10.1007/s004410000203; STUDITSKY AN, 1964, ANN NY ACAD SCI, V120, P789, DOI 10.1111/j.1749-6632.1964.tb34771.x; Takaku M, 2011, BIOCHEMISTRY-US, V50, P6797, DOI 10.1021/bi200828g; Takizawa Y, 2010, NUCLEIC ACIDS RES, V38, P5059, DOI 10.1093/nar/gkq271; THOMAS NH, 1994, NEUROMUSCULAR DISORD, V4, P497, DOI 10.1016/0960-8966(94)90090-6; Velma V, 2010, FEBS LETT, V584, P4735, DOI 10.1016/j.febslet.2010.11.004; Vitte J, 2007, AM J PATHOL, V171, P1269, DOI 10.2353/ajpath.2007.070399; Vitte J, 2009, ADV EXP MED BIOL, V652, P237, DOI 10.1007/978-90-481-2813-6_16; Walker MP, 2008, HUM MOL GENET, V17, P3399, DOI 10.1093/hmg/ddn234; WEBB JN, 1977, J PATHOL, V123, P175, DOI 10.1002/path.1711230307; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	88	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93329	10.1371/journal.pone.0093329	http://dx.doi.org/10.1371/journal.pone.0093329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667816	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600172
J	Zhang, SJ; Wang, YX; Yuan, J; Jin, JY; Wang, YC; Chang, D; Weng, DH; Greiser, A; Ju, SH				Zhang, Shi-Jun; Wang, Yi-Xiang; Yuan, Jing; Jin, Jiyang; Wang, Yuan-Cheng; Chang, Di; Weng, Dehe; Greiser, Andreas; Ju, Shenghong			Time-Efficient Myocardial Contrast Partition Coefficient Measurement from Early Enhancement with Magnetic Resonance Imaging	PLOS ONE			English	Article							EXTRACELLULAR VOLUME FRACTION; INVERSION-RECOVERY MOLLI; COLD PRESSOR TEST; BLOOD-FLOW; GADOPENTETATE DIMEGLUMINE; INTRAINDIVIDUAL ASSESSMENT; GD-DTPA; T1; FIBROSIS; QUANTIFICATION	Objective: Our purpose was to validate an early enhancement time point for accurately measuring the myocardial contrast partition coefficient (lambda) using dynamic-equilibrium magnetic resonance imaging. Materials and Methods: The pre- and post-contrast longitudinal relaxation rates (reciprocal of T1) of the interventricular septum (R1(m)) and blood pool (R1(b)) were obtained from fifteen healthy volunteers and three diabetic patients with hypertension using two optimized T1 mapping sequences (modified Look-Locker inversion recovery) on a 3-Tesla magnetic resonance scanner. Reference lambda values were calculated as the slope of the regression line of R1(m) versus R1(b) at dynamic equilibrium (multi-point regression method). The simplified pre-/post-enhancement two-acquisition method (two-point method) was used to calculate lambda by relating the change in R1(m) and R1(b) using different protocols according to the acquisition stage of the post-enhancement data point. The agreement with the referential method was tested by calculating Pearson's correlation coefficient and the intra-class correlation coefficient. Results: The lambda values measured by the two-point method increased (from 0.479 +/- 0.041 to 0.534 +/- 0.043) over time from 6 to 45 minutes after contrast and exhibited good correlation with the reference at each time point (r >= 0.875, p<0.05). The intra-class correlation coefficient on absolute agreement with the reference lambda was 0.946, 0.929 and 0.922 at the 6th, 7th and 8th minutes and dropped from 0.878 to 0.403 from the 9th minute on. Conclusions: The time-efficient two-point method at 6-8 minutes after the Gd-DTPA bolus injection exhibited good agreement with the multi-point regression method and can be applied for accurate lambda measurement in normal myocardium.	[Zhang, Shi-Jun; Jin, Jiyang; Wang, Yuan-Cheng; Chang, Di; Ju, Shenghong] Southeast Univ, Jiangsu Key Lab Mol & Funct Imaging, Dept Radiol, Zhongda Hosp,Med Sch, Nanjing, Jiangsu, Peoples R China; [Wang, Yi-Xiang; Yuan, Jing] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China; [Weng, Dehe] Siemens Shenzhen Magnet Resonance, Shenzhen, Peoples R China; [Greiser, Andreas] Siemens AG Healthcare Sect, Erlangen, Bayern, Germany	Southeast University - China; Chinese University of Hong Kong; Prince of Wales Hospital; Siemens AG; Siemens AG	Ju, SH (corresponding author), Southeast Univ, Jiangsu Key Lab Mol & Funct Imaging, Dept Radiol, Zhongda Hosp,Med Sch, Nanjing, Jiangsu, Peoples R China.	jsh0836@hotmail.com	Yuan, Jing/E-4236-2013; Wang, Yi Xiang/I-5952-2016	Yuan, Jing/0000-0001-8112-3608; Wang, Yi Xiang/0000-0001-5697-0717	Major State Basic Research Development Program of China (973 Program) [2013CB733802, 2010CB933903]; National Nature Science Foundation of China (NSFC) [81371538, 81071125, 81071124]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by Major State Basic Research Development Program of China (973 Program, No. 2013CB733802, No. 2010CB933903) and National Nature Science Foundation of China (NSFC, No. 81371538, No. 81071125, No. 81071124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arheden H, 1999, RADIOLOGY, V211, P698, DOI 10.1148/radiology.211.3.r99jn41698; Broberg CS, 2010, CIRC-CARDIOVASC IMAG, V3, P727, DOI 10.1161/CIRCIMAGING.108.842096; Chareonthaitawee P, 2001, CARDIOVASC RES, V50, P151, DOI 10.1016/S0008-6363(01)00202-4; CRAWLEY AP, 1988, MAGN RESON MED, V7, P23, DOI 10.1002/mrm.1910070104; DIESBOURG LD, 1992, MAGNET RESON MED, V23, P239, DOI 10.1002/mrm.1910230205; Efseaff M, 2012, J NUCL CARDIOL, V19, P997, DOI 10.1007/s12350-012-9600-3; Fairbairn TA, 2014, RADIOLOGY, V270, P82, DOI 10.1148/radiol.13122345; Flacke SJ, 2001, RADIOLOGY, V218, P703, DOI 10.1148/radiology.218.3.r01fe18703; Flett AS, 2012, EUR HEART J-CARD IMG, V13, P819, DOI 10.1093/ehjci/jes102; Flett AS, 2010, CIRCULATION, V122, P138, DOI 10.1161/CIRCULATIONAHA.109.930636; Jerosch-Herold M, 2008, AM J PHYSIOL-HEART C, V295, pH1234, DOI 10.1152/ajpheart.00429.2008; Katoh C, 2012, J NUCL CARDIOL, V19, P763, DOI 10.1007/s12350-012-9558-1; Kawel N, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-27; Kawel N, 2012, J MAGN RESON IMAGING, V36, P733, DOI 10.1002/jmri.23651; Kawel N, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-26; Kehr E, 2008, INT J CARDIOVAS IMAG, V24, P61, DOI 10.1007/s10554-007-9223-y; Kellman P, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-56; Kellman P, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-63; Lee JHW, 2011, J HYDRO-ENVIRON RES, V5, P143, DOI 10.1016/j.jher.2011.07.001; Messroghli DR, 2007, J MAGN RESON IMAGING, V26, P1081, DOI 10.1002/jmri.21119; Messroghli DR, 2007, MAGN RESON MED, V58, P34, DOI 10.1002/mrm.21272; Messroghli DR, 2006, RADIOLOGY, V238, P1004, DOI 10.1148/radiol.2382041903; Messroghli DR, 2004, MAGN RESON MED, V52, P141, DOI 10.1002/mrm.20110; Miller CA, 2013, CIRC-CARDIOVASC IMAG, V6, P373, DOI 10.1161/CIRCIMAGING.112.000192; Nacif MS, 2012, RADIOLOGY, V264, P876, DOI 10.1148/radiol.12112458; Puntmann VO, 2013, JACC-CARDIOVASC IMAG, V6, P475, DOI 10.1016/j.jcmg.2012.08.019; Roberts C, 2011, MAGN RESON MED, V65, P108, DOI 10.1002/mrm.22593; Schelbert EB, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-16; Schindler TH, 2007, EUR J NUCL MED MOL I, V34, P1178, DOI 10.1007/s00259-007-0378-5; Sparrow Patrick, 2006, AJR Am J Roentgenol, V187, pW630, DOI 10.2214/AJR.05.1264; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Ugander M, 2012, EUR HEART J, V33, P1268, DOI 10.1093/eurheartj/ehr481; White SK, 2013, JACC-CARDIOVASC IMAG, V6, P955, DOI 10.1016/j.jcmg.2013.01.011	33	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93124	10.1371/journal.pone.0093124	http://dx.doi.org/10.1371/journal.pone.0093124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667489	Green Submitted, gold, Green Published			2022-12-25	WOS:000333675600144
J	El-Azzouny, M; Evans, CR; Treutelaar, MK; Kennedy, RT; Burant, CF				El-Azzouny, Mahmoud; Evans, Charles R.; Treutelaar, Mary K.; Kennedy, Robert T.; Burant, Charles F.			Increased Glucose Metabolism and Glycerolipid Formation by Fatty Acids and GPR40 Receptor Signaling Underlies the Fatty Acid Potentiation of Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell; Diabetes; Fatty Acid Metabolism; G Protein-coupled Receptors (GPCR); Glucose Metabolism; Insulin Secretion; Metabolism; Metabolomics; Fatty Acid Potentiation of GSIS; GPR40	PANCREATIC BETA-CELLS; N-ACYL TAURINES; COA ESTERS; PALMITOYLTRANSFERASE-I; ISLETS; STIMULATION; EXOCYTOSIS; MUNC13-1; CHANNELS; HEALTH	Background: Pathways underlying fatty acid potentiation of glucose-stimulated insulin secretion have not been fully elucidated. Results: In INS-1 cells, fatty acids increase de novo production of glycerolipids and simultaneously increase glucose utilization. GPR40 receptor activation increases these activities. Conclusion: Fatty acids enhance the production of multiple signals supporting glucose-stimulated insulin secretion. Significance: The studies clarify the effects of fatty acids and GPR40 activity in cell insulin secretion. Acute fatty acid (FA) exposure potentiates glucose-stimulated insulin secretion in cells through metabolic and receptor-mediated effects. We assessed the effect of fatty acids on the dynamics of the metabolome in INS-1 cells following exposure to [U-C-13]glucose to assess flux through metabolic pathways. Metabolite profiling showed a fatty acid-induced increase in long chain acyl-CoAs that were rapidly esterified with glucose-derived glycerol-3-phosphate to form lysophosphatidic acid, mono- and diacylglycerols, and other glycerolipids, some implicated in augmenting insulin secretion. Glucose utilization and glycolytic flux increased, along with a reduction in the NADH/NAD(+) ratio, presumably by an increase in conversion of dihydroxyacetone phosphate to glycerol-3-phosphate. The fatty acid-induced increase in glycolysis also resulted in increases in tricarboxylic cycle flux and oxygen consumption. Inhibition of fatty acid activation of FFAR1/GPR40 by an antagonist decreased glycerolipid formation, attenuated fatty acid increases in glucose oxidation, and increased mitochondrial FA flux, as evidenced by increased acylcarnitine levels. Conversely, FFAR1/GPR40 activation in the presence of low FA increased flux into glycerolipids and enhanced glucose oxidation. These results suggest that, by remodeling glucose and lipid metabolism, fatty acid significantly increases the formation of both lipid- and TCA cycle-derived intermediates that augment insulin secretion, increasing our understanding of mechanisms underlying cell insulin secretion.	[El-Azzouny, Mahmoud; Evans, Charles R.; Treutelaar, Mary K.; Burant, Charles F.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48105 USA; [El-Azzouny, Mahmoud; Kennedy, Robert T.] Univ Michigan, Dept Chem, Ann Arbor, MI 48105 USA; [Kennedy, Robert T.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Burant, CF (corresponding author), Univ Michigan, Dept Internal Med, 6309 Brehm Tower,1000 Wall St, Ann Arbor, MI 48105 USA.	burantc@umich.edu	Burant, Charles/GPC-5690-2022; Kennedy, Robert/G-9095-2016	Burant, Charles/0000-0001-9189-5003; Kennedy, Robert/0000-0003-2447-7471; Evans, Charles/0000-0001-6698-5330	National Institutes of Health [DK046960, DK079084, K25DK092558]; Michigan Nutrition Obesity Research Center [P30 DK089503]; Michigan Diabetes Research and Training Center [P60 DK20572]; Michigan Regional Comprehensive Metabolomics Resource Core Grant [U24 DK097153]; Robert C. and Veronica Atkins Foundation; A. Alfred Taubman Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, R01DK046960, P60DK020572, R37DK046960, U24DK097153, R01DK079084, K25DK092558, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Nutrition Obesity Research Center; Michigan Diabetes Research and Training Center; Michigan Regional Comprehensive Metabolomics Resource Core Grant; Robert C. and Veronica Atkins Foundation; A. Alfred Taubman Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK046960 (to R. T. K.), DK079084 (to C. F. B. and R. T. K.), and K25DK092558 (to C. R. E.). This work was also supported by Michigan Nutrition Obesity Research Center Grant P30 DK089503, by Michigan Diabetes Research and Training Center Grant P60 DK20572, by Michigan Regional Comprehensive Metabolomics Resource Core Grant U24 DK097153, by the Robert C. and Veronica Atkins Foundation (to C. F. B.), and by the A. Alfred Taubman Institute (to C.F.B).	Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Bender K, 2006, BIOCHEM SOC T, V34, P811, DOI 10.1042/BST0340811; Branstrom R, 2004, DIABETOLOGIA, V47, P277, DOI 10.1007/s00125-003-1299-x; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Burant CF, 2013, DIABETES CARE, V36, pS175, DOI 10.2337/dcS13-2037; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; Deeney JT, 2000, J BIOL CHEM, V275, P9363, DOI 10.1074/jbc.275.13.9363; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Herrero L, 2005, DIABETES, V54, P462, DOI 10.2337/diabetes.54.2.462; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Lorenz MA, 2013, J BIOL CHEM, V288, P10923, DOI 10.1074/jbc.M112.414961; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; Mulder H, 2004, DIABETES, V53, P122, DOI 10.2337/diabetes.53.1.122; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Oprescu AI, 2007, DIABETES, V56, P2927, DOI 10.2337/db07-0075; Parker SM, 2003, METABOLISM, V52, P1367, DOI 10.1016/S0026-0495(03)00279-8; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Prentki M, 2012, MOL CELL ENDOCRINOL, V353, P88, DOI 10.1016/j.mce.2011.11.004; Rimmerman N, 2008, MOL PHARMACOL, V74, P213, DOI 10.1124/mol.108.045997; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Rubi B, 2002, BIOCHEM J, V364, P219, DOI 10.1042/bj3640219; Saghatelian A, 2006, BIOCHEMISTRY-US, V45, P9007, DOI 10.1021/bi0608008; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Sheu L, 2003, J BIOL CHEM, V278, P27556, DOI 10.1074/jbc.M303203200; Tan B, 2010, J LIPID RES, V51, P112, DOI 10.1194/jlr.M900198-JLR200; Tan B, 2009, J CHROMATOGR B, V877, P2890, DOI 10.1016/j.jchromb.2009.01.002; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Tian YR, 2008, AM J PHYSIOL-ENDOC M, V294, pE1178, DOI 10.1152/ajpendo.90237.2008; Waluk DP, 2013, BIOCHEM BIOPH RES CO, V430, P54, DOI 10.1016/j.bbrc.2012.11.026; Yabuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076280	42	45	45	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13575	13588		10.1074/jbc.M113.531970	http://dx.doi.org/10.1074/jbc.M113.531970			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24675078	Green Published, hybrid			2022-12-25	WOS:000335522800052
J	Liu, S; Sheng, L; Miao, HZ; Saunders, TL; MacDougald, OA; Koenig, RJ; Xu, B				Liu, Shannon; Sheng, Liang; Miao, Hongzhi; Saunders, Thomas L.; MacDougald, Ormond A.; Koenig, Ronald J.; Xu, Bin			SRA Gene Knockout Protects against Diet-induced Obesity and Improves Glucose Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Gene Expression; Gene Knockout; Obesity; RNA	RECEPTOR RNA-ACTIVATOR; INSULIN-RESISTANCE; BROWN ADIPOCYTES; ADIPOSE-TISSUE; WHITE FAT; MUSCLE DIFFERENTIATION; SKELETAL-MUSCLE; NONCODING RNA; PPAR-GAMMA; EXPRESSION	Background: The non-coding RNA, steroid receptor RNA activator (SRA), promotes adipocyte differentiation in vitro. Results: SRA gene knock-out protects against obesity and improves glucose tolerance in mice fed a high fat diet. Conclusion: SRA is an important regulator of adiposity in diet-induced obesity. Significance: This is the first report that the Sra1 gene plays an important role in adipose tissue biology in vivo. We have recently shown that the non-coding RNA, steroid receptor RNA activator (SRA), functions as a transcriptional coactivator of PPAR and promotes adipocyte differentiation in vitro. To assess SRA function in vivo, we have generated a whole mouse Sra1 gene knock-out (SRA(-/-)). Here, we show that the Sra1 gene is an important regulator of adipose tissue mass and function. SRA is expressed at a higher level in adipose tissue than other organs in wild type mice. SRA(-/-) mice are resistant to high fat diet-induced obesity, with decreased fat mass and increased lean content. This lean phenotype of SRA(-/-) mice is associated with decreased expression of a subset of adipocyte marker genes and reduced plasma TNF levels. The SRA(-/-) mice are more insulin sensitive, as evidenced by reduced fasting insulin, and lower blood glucoses in response to IP glucose and insulin. In addition, the livers of SRA(-/-) mice have fewer lipid droplets after high fat diet feeding, and the expression of lipogenesis-associated genes is decreased. To our knowledge, these data are the first to indicate a functional role for SRA in adipose tissue biology and glucose homeostasis in vivo.	[Liu, Shannon; MacDougald, Ormond A.; Koenig, Ronald J.; Xu, Bin] Univ Michigan, Med Ctr, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Sheng, Liang; MacDougald, Ormond A.] Univ Michigan, Med Ctr, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Miao, Hongzhi] Univ Michigan, Med Ctr, Dept Pathol, Ann Arbor, MI 48109 USA; [Saunders, Thomas L.] Univ Michigan, Med Ctr, Div Mol Med & Genet, Transgen Anim Model Core, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Koenig, RJ (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA.	rkoenig@umich.edu; bxu@umich.edu		Saunders, Thom/0000-0003-2015-101X	National Institutes of Health [R01DK62876]; Michigan Diabetes Research Center; NIH [P30DK020572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK062876, P30DK089503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Diabetes Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK62876 (to O. A. M.), a Pilot and Feasibility Grant (to B. X.) from the Michigan Diabetes Research Center, and NIH Grant P30DK020572 to the Chemistry Core of the Michigan Diabetes Research Center.	Arner P, 2005, DIABETOLOGIA, V48, P2203, DOI 10.1007/s00125-005-1956-3; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Coste A, 2008, P NATL ACAD SCI USA, V105, P17187, DOI 10.1073/pnas.0808207105; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Du BW, 2013, J BIOL CHEM, V288, P3036, DOI 10.1074/jbc.M112.440370; Emberley E, 2003, BIOCHEM BIOPH RES CO, V301, P509, DOI 10.1016/S0006-291X(02)03070-X; Even PC, 2012, AM J PHYSIOL-REG I, V303, pR459, DOI 10.1152/ajpregu.00137.2012; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Friedrichs F, 2009, GENOME RES, V19, P395, DOI 10.1101/gr.076653.108; Gburcik V, 2012, AM J PHYSIOL-ENDOC M, V303, pE1053, DOI 10.1152/ajpendo.00104.2012; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hube F, 2011, NUCLEIC ACIDS RES, V39, P513, DOI 10.1093/nar/gkq833; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Kawashima H, 2003, BIOCHEM J, V369, P163, DOI 10.1042/BJ20020743; Lanz RB, 2002, P NATL ACAD SCI USA, V99, P16081, DOI 10.1073/pnas.192571399; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Leygue E, 1999, CANCER RES, V59, P4190; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Murphy LC, 2000, CANCER RES, V60, P6266; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang XT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003756; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu B, 2004, J BIOL CHEM, V279, P33051, DOI 10.1074/jbc.M404930200; Xu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014199; Xu B, 2009, MOL CELL BIOL, V29, P1719, DOI 10.1128/MCB.01010-08; Zhao XS, 2004, MOL CELL, V15, P549, DOI 10.1016/j.molcel.2004.06.044	53	87	96	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13000	13009		10.1074/jbc.M114.564658	http://dx.doi.org/10.1074/jbc.M114.564658			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24675075	Green Published, hybrid			2022-12-25	WOS:000335522800005
J	Yoshimoto, Y; Suzuki, Y; Mimura, K; Ando, K; Oike, T; Sato, H; Okonogi, N; Maruyama, T; Izawa, S; Noda, S; Fujii, H; Kono, K; Nakano, T				Yoshimoto, Yuya; Suzuki, Yoshiyuki; Mimura, Kousaku; Ando, Ken; Oike, Takahiro; Sato, Hiro; Okonogi, Noriyuki; Maruyama, Takanori; Izawa, Shinichiro; Noda, Shin-ei; Fujii, Hideki; Kono, Koji; Nakano, Takashi			Radiotherapy-Induced Anti-Tumor Immunity Contributes to the Therapeutic Efficacy of Irradiation and Can Be Augmented by CTLA-4 Blockade in a Mouse Model	PLOS ONE			English	Article							REGULATORY T-CELLS; LOCAL RADIATION; TUMORS; COMBINATION; INHIBITION; EFFECTOR; GITR	Purpose: There is growing evidence that tumor-specific immune responses play an important role in anti-cancer therapy, including radiotherapy. Using mouse tumor models we demonstrate that irradiation-induced anti-tumor immunity is essential for the therapeutic efficacy of irradiation and can be augmented by modulation of cytotoxic T lymphocyte (CTL) activity. Methods and Materials: C57BL/6 mice, syngeneic EL4 lymphoma cells, and Lewis lung carcinoma (LL/C) cells were used. Cells were injected into the right femurs of mice. Ten days after inoculation, tumors were treated with 30 Gy of local X-ray irradiation and their growth was subsequently measured. The effect of irradiation on tumor growth delay (TGD) was defined as the time (in days) for tumors to grow to 500 mm(3) in the treated group minus that of the untreated group. Cytokine production and serum antibodies were measured by ELISA and flow cytometry. Results: In the EL4 tumor model, tumors were locally controlled by X-ray irradiation and re-introduced EL4 cells were completely rejected. Mouse EL4-specific systemic immunity was confirmed by splenocyte cytokine production and detection of tumor-specific IgG1 antibodies. In the LL/C tumor model, X-ray irradiation also significantly delayed tumor growth (TGD: 15.4 days) and prolonged median survival time (MST) to 59 days (versus 28 days in the non-irradiated group). CD8(+) cell depletion using an anti-CD8 antibody significantly decreased the therapeutic efficacy of irradiation (TGD, 8.7 days; MST, 49 days). Next, we examined whether T cell modulation affected the efficacy of radiotherapy. An anti-CTLA-4 antibody significantly increased the anti-tumor activity of radiotherapy (TGD was prolonged from 13.1 to 19.5 days), while anti-FR4 and anti-GITR antibodies did not affect efficacy. Conclusions: Our results indicate that tumor-specific immune responses play an important role in the therapeutic efficacy of irradiation. Immunomodulation, including CTLA-4 blockade, may be a promising treatment in combination with radiotherapy.	[Yoshimoto, Yuya; Suzuki, Yoshiyuki; Ando, Ken; Oike, Takahiro; Sato, Hiro; Okonogi, Noriyuki; Noda, Shin-ei; Nakano, Takashi] Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gunma 371, Japan; [Mimura, Kousaku; Kono, Koji] Natl Univ Singapore, Dept Surg, Singapore 117548, Singapore; [Kono, Koji] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Mimura, Kousaku; Maruyama, Takanori; Izawa, Shinichiro; Fujii, Hideki; Kono, Koji] Univ Yamanashi, Dept Surg 1, Kofu, Yamanashi, Japan	Gunma University; National University of Singapore; National University of Singapore; University of Yamanashi	Suzuki, Y (corresponding author), Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gunma 371, Japan.	syoshi@med.gunma-u.ac.jp	/CAH-2060-2022; Sato, Hiro/GWU-7659-2022	Okonogi, Noriyuki/0000-0002-9486-1922	MEXT KAKENHI; Grants-in-Aid for Scientific Research [24591834] Funding Source: KAKEN	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported by MEXT KAKENHI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of our manuscript.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Demaria S, 2005, CLIN CANCER RES, V11, P728; Demaria S, 2004, INT J RADIAT ONCOL, V58, P862, DOI 10.1016/j.ijrobp.2003.09.012; Dewan MZ, 2009, CLIN CANCER RES, V15, P5379, DOI 10.1158/1078-0432.CCR-09-0265; Grosso Joseph F, 2013, Cancer Immun, V13, P5; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Schaer DA, 2012, CURR OPIN IMMUNOL, V24, P217, DOI 10.1016/j.coi.2011.12.011; Suzuki Y, 2012, CANCER RES, V72, P3967, DOI 10.1158/0008-5472.CAN-12-0851; Takeda K, 2010, J IMMUNOL, V184, P5493, DOI 10.4049/jimmunol.0903033; Takeshima T, 2010, CANCER RES, V70, P2697, DOI 10.1158/0008-5472.CAN-09-2982; Verginis P, 2008, P NATL ACAD SCI USA, V105, P3479, DOI 10.1073/pnas.0800149105; von Boehmer H, 2013, NAT REV DRUG DISCOV, V12, P51, DOI 10.1038/nrd3683; Yamaguchi T, 2007, IMMUNITY, V27, P145, DOI 10.1016/j.immuni.2007.04.017	17	80	87	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e92572	10.1371/journal.pone.0092572	http://dx.doi.org/10.1371/journal.pone.0092572			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686897	Green Published, Green Submitted, gold			2022-12-25	WOS:000340842300002
J	Fang, C; Stiegeler, E; Cook, GM; Mascher, T; Gebhard, S				Fang, Chong; Stiegeler, Emanuel; Cook, Gregory M.; Mascher, Thorsten; Gebhard, Susanne			Bacillus subtilis as a Platform for Molecular Characterisation of Regulatory Mechanisms of Enterococcus faecalis Resistance against Cell Wall Antibiotics	PLOS ONE			English	Article							GLYCOPEPTIDE ANTIBIOTICS; ANTIMICROBIAL PEPTIDES; VANCOMYCIN RESISTANCE; ESCHERICHIA-COLI; ABC TRANSPORTER; STRESS-RESPONSE; IN-VIVO; BACITRACIN; EXPRESSION; SYSTEM	To combat antibiotic resistance of Enterococcus faecalis, a better understanding of the molecular mechanisms, particularly of antibiotic detection, signal transduction and gene regulation is needed. Because molecular studies in this bacterium can be challenging, we aimed at exploiting the genetically highly tractable Gram-positive model organism Bacillus subtilis as a heterologous host. Two fundamentally different regulators of E. faecalis resistance against cell wall antibiotics, the bacitracin sensor BcrR and the vancomycin-sensing two-component system VanSB-VanRB, were produced in B. subtilis and their functions were monitored using target promoters fused to reporter genes (lacZ and luxABCDE). The bacitracin resistance system BcrR-BcrAB of E. faecalis was fully functional in B. subtilis, both regarding regulation of bcrAB expression and resistance mediated by the transporter BcrAB. Removal of intrinsic bacitracin resistance of B. subtilis increased the sensitivity of the system. The lacZ and luxABCDE reporters were found to both offer sensitive detection of promoter induction on solid media, which is useful for screening of large mutant libraries. The VanSB-VanRB system displayed a gradual dose-response behaviour to vancomycin, but only when produced at low levels in the cell. Taken together, our data show that B. subtilis is a well-suited host for the molecular characterization of regulatory systems controlling resistance against cell wall active compounds in E. faecalis. Importantly, B. subtilis facilitates the careful adjustment of expression levels and genetic background required for full functionality of the introduced regulators.	[Fang, Chong; Stiegeler, Emanuel; Mascher, Thorsten; Gebhard, Susanne] Univ Munich, Dept Biol 1, Martinsried, Germany; [Cook, Gregory M.] Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin, New Zealand	University of Munich; University of Otago	Gebhard, S (corresponding author), Univ Munich, Dept Biol 1, Martinsried, Germany.	susanne.gebhard@bio.lmu.de	Mascher, Thorsten/G-2074-2011; Gebhard, Susanne/F-4154-2012; Cook, Gregory/ABF-4208-2020	Gebhard, Susanne/0000-0003-4783-6115; Mascher, Thorsten/0000-0002-6300-5541	Deutsche Forschungsgemeinschaft (DFG) [GE2164/3-1]; Fonds der Chemischen Industrie; DFG [MA2837/1-3]; James Cook Fellowship; Marsden Fund from the Royal Society of New Zealand; China Scholarship Council	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); DFG(German Research Foundation (DFG)); James Cook Fellowship; Marsden Fund from the Royal Society of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); China Scholarship Council(China Scholarship Council)	Work in the laboratory of SG was supported by grants of the Deutsche Forschungsgemeinschaft (DFG; GE2164/3-1) and the Fonds der Chemischen Industrie. TM would like to acknowledge financial support by the DFG (MA2837/1-3). GMC was supported by a James Cook Fellowship and the Marsden Fund from the Royal Society of New Zealand. CF was supported by a PhD scholarship from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Arthur M, 1996, TRENDS MICROBIOL, V4, P401, DOI 10.1016/0966-842X(96)10063-9; Arthur M, 2001, ANTIMICROB AGENTS CH, V45, P375, DOI 10.1128/AAC.45.2.375-381.2001; Baptista M, 1997, MOL MICROBIOL, V25, P93, DOI 10.1046/j.1365-2958.1997.4401812.x; BARNA JCJ, 1984, ANNU REV MICROBIOL, V38, P339, DOI 10.1146/annurev.mi.38.100184.002011; Bevins CL, 1999, GUT, V45, P911, DOI 10.1136/gut.45.6.911; Bisicchia P, 2011, MOL MICROBIOL, V81, P157, DOI 10.1111/j.1365-2958.2011.07684.x; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Clinical and Laboratory Standards Institute, 2006, M2A9 CLSI, P1; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Derre I, 2000, MOL MICROBIOL, V38, P335, DOI 10.1046/j.1365-2958.2000.02124.x; Gauntlett JC, 2008, J BIOL CHEM, V283, P8591, DOI 10.1074/jbc.M709503200; Gebhard S, 2014, ANTIMICROB AGENTS CH, V58, P1425, DOI 10.1128/AAC.02111-13; Gebhard S, 2012, MOL MICROBIOL, V86, P1295, DOI 10.1111/mmi.12078; Gebhard S, 2011, MOL MICROBIOL, V81, P581, DOI 10.1111/j.1365-2958.2011.07747.x; Gebhard S, 2009, MOL MICROBIOL, V73, P482, DOI 10.1111/j.1365-2958.2009.06787.x; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hiron A, 2011, MOL MICROBIOL, V81, P602, DOI 10.1111/j.1365-2958.2011.07735.x; Hong HJ, 2008, ADV EXP MED BIOL, V631, P200; Joseph P, 2004, MICROBIOL-SGM, V150, P2609, DOI 10.1099/mic.0.27155-0; Kallenberg F, 2013, J BACTERIOL, V195, P3287, DOI 10.1128/JB.00419-13; Kingston AW, 2013, MOL MICROBIOL, V90, P502, DOI 10.1111/mmi.12380; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Manson JM, 2004, ANTIMICROB AGENTS CH, V48, P3743, DOI 10.1128/AAC.48.10.3743-3748.2004; Mascher T, 2003, MOL MICROBIOL, V50, P1591, DOI 10.1046/j.1365-2958.2003.03786.x; Matos R, 2009, INT J ANTIMICROB AG, V34, P142, DOI 10.1016/j.ijantimicag.2009.02.008; Ohki R, 2003, MOL MICROBIOL, V49, P1135, DOI 10.1046/j.1365-2958.2003.03653.x; Pietiainen M, 2005, MICROBIOL-SGM, V151, P1577, DOI 10.1099/mic.0.27761-0; Radeck J, 2013, J BIOL ENG IN PRESS; Rietkotter E, 2008, MOL MICROBIOL, V68, P768, DOI 10.1111/j.1365-2958.2008.06194.x; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Schmalisch M, 2010, J BACTERIOL, V192, P5402, DOI 10.1128/JB.00534-10; Silva JC, 1998, P NATL ACAD SCI USA, V95, P11951, DOI 10.1073/pnas.95.20.11951; Staron A, 2011, ANTIMICROB AGENTS CH, V55, P515, DOI 10.1128/AAC.00352-10; STORM DR, 1973, J BIOL CHEM, V248, P3940; Stulke J, 1997, MOL MICROBIOL, V25, P65, DOI 10.1046/j.1365-2958.1997.4351797.x; Ulijasz AT, 1996, J BACTERIOL, V178, P6305, DOI 10.1128/jb.178.21.6305-6309.1996; Wecke T, 2011, J ANTIMICROB CHEMOTH, V66, P2689, DOI 10.1093/jac/dkr373	40	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93169	10.1371/journal.pone.0093169	http://dx.doi.org/10.1371/journal.pone.0093169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676422	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500085
J	Fischer, NO; Weilhammer, DR; Dunkle, A; Thomas, C; Hwang, M; Corzett, M; Lychak, C; Mayer, W; Urbin, S; Collette, N; Chang, JC; Loots, GG; Rasley, A; Blanchette, CD				Fischer, Nicholas O.; Weilhammer, Dina R.; Dunkle, Alexis; Thomas, Cynthia; Hwang, Mona; Corzett, Michele; Lychak, Cheri; Mayer, Wasima; Urbin, Salustra; Collette, Nicole; Chang, Jiun Chiun; Loots, Gabriela G.; Rasley, Amy; Blanchette, Craig D.			Evaluation of Nanolipoprotein Particles (NLPs) as an In Vivo Delivery Platform	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEINS; GOLD NANOPARTICLES; DRUG-DELIVERY; FUNCTIONALIZED NANOPARTICLES; CHOLESTEROL EFFLUX; MEMBRANE-PROTEINS; TARGETED DELIVERY; AMPHOTERICIN-B; TOXICITY; APOLIPOPROTEIN	Nanoparticles hold great promise for the delivery of therapeutics, yet limitations remain with regards to the use of these nanosystems for efficient long-lasting targeted delivery of therapeutics, including imparting functionality to the platform, in vivo stability, drug entrapment efficiency and toxicity. To begin to address these limitations, we evaluated the functionality, stability, cytotoxicity, toxicity, immunogenicity and in vivo biodistribution of nanolipoprotein particles (NLPs), which are mimetics of naturally occurring high-density lipoproteins (HDLs). We found that a wide range of molecules could be reliably conjugated to the NLP, including proteins, single-stranded DNA, and small molecules. The NLP was also found to be relatively stable in complex biological fluids and displayed no cytotoxicity in vitro at doses as high as 320 mu g/ml. In addition, we observed that in vivo administration of the NLP daily for 14 consecutive days did not induce significant weight loss or result in lesions on excised organs. Furthermore, the NLPs did not display overt immunogenicity with respect to antibody generation. Finally, the biodistribution of the NLP in vivo was found to be highly dependent on the route of administration, where intranasal administration resulted in prolonged retention in the lung tissue. Although only a select number of NLP compositions were evaluated, the findings of this study suggest that the NLP platform holds promise for use as both a targeted and non-targeted in vivo delivery vehicle for a range of therapeutics.	[Fischer, Nicholas O.; Weilhammer, Dina R.; Dunkle, Alexis; Thomas, Cynthia; Hwang, Mona; Corzett, Michele; Lychak, Cheri; Mayer, Wasima; Urbin, Salustra; Collette, Nicole; Loots, Gabriela G.; Rasley, Amy; Blanchette, Craig D.] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94550 USA; [Chang, Jiun Chiun; Loots, Gabriela G.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Merced	Rasley, A (corresponding author), Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94550 USA.	rasley2@llnl.gov; blanchette2@llnl.gov	Loots, Gabriela G/AGA-4868-2022; Fischer, Nicholas/AAE-2409-2019	Loots, Gabriela G/0000-0001-9546-5561; Fischer, Nicholas/0000-0001-7575-4390; Weilhammer, Dina/0000-0002-7618-4702; Rasley, Amy/0000-0002-4767-6628; Collette, Nicole/0000-0002-9068-8712	LLNL LDRD [09-LW-077, 11-LW-015, 11-ERD-016]	LLNL LDRD	LLNL LDRD 09-LW-077; LLNL LDRD 11-LW-015; LLNL LDRD 11-ERD-016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann L, 2008, ORG LETT, V10, P3081, DOI 10.1021/ol801078r; Azarmi S, 2008, ADV DRUG DELIVER REV, V60, P863, DOI 10.1016/j.addr.2007.11.006; Baylon JL, 2013, J AM CHEM SOC, V135, P8542, DOI 10.1021/ja4003525; Bhatt RL, 2003, J MED CHEM, V46, P190, DOI 10.1021/jm020022r; Bhattacharya P, 2010, J VIROL, V84, P361, DOI 10.1128/JVI.01355-09; Blanchette CD, 2008, J LIPID RES, V49, P1420, DOI 10.1194/jlr.M700586-JLR200; Blanchette CD, 2010, BIOCONJUGATE CHEM, V21, P1321, DOI 10.1021/bc100129s; Blanchette CD, 2009, BBA-BIOMEMBRANES, V1788, P724, DOI 10.1016/j.bbamem.2008.11.019; Cappuccio JA, 2008, MOL CELL PROTEOMICS, V7, P2246, DOI 10.1074/mcp.M800191-MCP200; Cappuccio Jenny A., 2009, V498, P273, DOI 10.1007/978-1-59745-196-3_18; CHAPMAN MJ, 1980, J LIPID RES, V21, P789; Chen HT, 2004, J AM CHEM SOC, V126, P10044, DOI 10.1021/ja048548j; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Chromy BA, 2007, J AM CHEM SOC, V129, P14348, DOI 10.1021/ja074753y; Corbierre MK, 2004, LANGMUIR, V20, P2867, DOI 10.1021/la0355702; Courrier HM, 2002, CRIT REV THER DRUG, V19, P425, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i45.40; Cuenca AG, 2006, CANCER-AM CANCER SOC, V107, P459, DOI 10.1002/cncr.22035; Ding Y, 2012, BIOMATERIALS, V33, P8893, DOI 10.1016/j.biomaterials.2012.08.057; Fischer NO, 2013, J AM CHEM SOC, V135, P2044, DOI 10.1021/ja3063293; Fischer NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011643; Fischer NO, 2010, BIOCONJUGATE CHEM, V21, P1018, DOI 10.1021/bc100083d; Fischer NO, 2009, BIOCONJUGATE CHEM, V20, P460, DOI 10.1021/bc8003155; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; Frias JC, 2006, NANO LETT, V6, P2220, DOI 10.1021/nl061498r; Gaidukov Leonid, 2009, BMC Clin Pharmacol, V9, P18, DOI 10.1186/1472-6904-9-18; Gao TJ, 2011, PROTEIN SCI, V20, P437, DOI 10.1002/pro.577; Goodman CM, 2004, BIOCONJUGATE CHEM, V15, P897, DOI 10.1021/bc049951i; GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245; Hoang A, 2012, EUR HEART J, V33, P657, DOI 10.1093/eurheartj/ehr103; Irngartinger M, 2004, EUR J PHARM BIOPHARM, V58, P7, DOI 10.1016/j.ejpb.2004.03.016; Jia H, 2009, NANOMEDICINE-UK, V4, P951, DOI [10.2217/nnm.09.81, 10.2217/NNM.09.81]; Justesen BH, 2013, ANAL CHEM, V85, P3497, DOI 10.1021/ac4000915; Karver MR, 2012, ANGEW CHEM INT EDIT, V51, P920, DOI 10.1002/anie.201104389; Kim TY, 2004, CLIN CANCER RES, V10, P3708, DOI 10.1158/1078-0432.CCR-03-0655; Lattuada M, 2007, LANGMUIR, V23, P2158, DOI 10.1021/la062092x; Lynch I, 2007, ADV COLLOID INTERFAC, V134-35, P167, DOI 10.1016/j.cis.2007.04.021; Ma CIJ, 2012, BIOCHEM CELL BIOL, V90, P636, DOI [10.1139/O2012-015, 10.1139/o2012-015]; Malik N, 1999, ANTI-CANCER DRUG, V10, P767, DOI 10.1097/00001813-199909000-00010; Manchester M, 2006, ADV DRUG DELIVER REV, V58, P1505, DOI 10.1016/j.addr.2006.09.014; Mareeva T, 2010, J IMMUNOL METHODS, V353, P78, DOI 10.1016/j.jim.2009.11.010; Markman M, 2006, EXPERT OPIN PHARMACO, V7, P1469, DOI 10.1517/14656566.7.11.1469; Miyazaki M, 2013, BBA-BIOMEMBRANES, V1828, P1340, DOI 10.1016/j.bbamem.2013.01.012; Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u; NESTLER JE, 1985, ENDOCRINOLOGY, V117, P502, DOI 10.1210/endo-117-2-502; Nguyen CA, 2003, INT J PHARMACEUT, V254, P69, DOI 10.1016/S0378-5173(02)00685-3; NIVEN RW, 1995, CRIT REV THER DRUG, V12, P151, DOI 10.1615/CritRevTherDrugCarrierSyst.v12.i2-3.20; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; Rensen PCN, 2001, ADV DRUG DELIVER REV, V47, P251, DOI 10.1016/S0169-409X(01)00109-0; Rollett A, 2012, INT J PHARMACEUT, V427, P460, DOI 10.1016/j.ijpharm.2012.02.028; RUBIN EM, 1991, P NATL ACAD SCI USA, V88, P434, DOI 10.1073/pnas.88.2.434; Salvati A, 2013, NAT NANOTECHNOL, V8, P137, DOI [10.1038/nnano.2012.237, 10.1038/NNANO.2012.237]; Simon M, 2012, BIOCONJUGATE CHEM, V23, P279, DOI 10.1021/bc200591x; Toledo JD, 2012, J CELL BIOCHEM, V113, P1208, DOI 10.1002/jcb.23453; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Tufteland M, 2008, J PHARM SCI-US, V97, P4425, DOI 10.1002/jps.21325; Wadsater M, 2012, J BIOL CHEM, V287, P34596, DOI 10.1074/jbc.M112.400085; Weilhammer DR, 2013, BIOMATERIALS, V34, P10305, DOI 10.1016/j.biomaterials.2013.09.038; Wu W, 2005, ANGEW CHEM INT EDIT, V44, P6358, DOI 10.1002/anie.200501613; Yuan Y, 2013, J DRUG TARGET, V21, P367, DOI 10.3109/1061186X.2012.757769; Zhang P, 2012, J AM CHEM SOC; Ziv O, 2008, J BIOMED MATER RES A, V85A, P1011, DOI 10.1002/jbm.a.31518	61	39	43	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93342	10.1371/journal.pone.0093342	http://dx.doi.org/10.1371/journal.pone.0093342			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675794	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677500110
J	Huang, FF; Ben Aissa, M; Magron, A; Huard, CC; Godin, C; Levesque, G; Carreau, M				Huang, FengFei; Ben Aissa, Manel; Magron, Audrey; Huard, Caroline C.; Godin, Chantal; Levesque, Georges; Carreau, Madeleine			The Fanconi Anemia Group C Protein Interacts with Uncoordinated 5A and Delays Apoptosis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HEMATOPOIETIC-CELLS; GENE-PRODUCT; EXPRESSION; RECEPTORS; SUPPRESS; CYTOPLASM; RESPONSES; NETRIN-1; PATHWAY	The Fanconi anemia group C protein (FANCC) is one of the several proteins that comprise the Fanconi anemia (FA) network involved in genomic surveillance. FANCC is mainly cytoplasmic and has many functions, including apoptosis suppression through caspase-mediated proteolytic processing. Here, we examined the role of FANCC proteolytic fragments by identifying their binding partners. We performed a yeast two-hybrid screen with caspase-mediated FANCC cleavage products and identified the dependence receptor uncoordinated-5A (UNC5A) protein. Here, we show that FANCC physically interacts with UNC5A, a pro-apoptotic dependence receptor. FANCC interaction occurs through the UNC5A intracellular domain, specifically via its death domain. FANCC modulates cell sensitivity to UNC5A-mediated apoptosis; we observed reduced UNC5A-mediated apoptosis in the presence of FANCC and increased apoptosis in FANCC-depleted cells. Our results show that FANCC interferes with UNC5A's functions in apoptosis and suggest that FANCC may participate in developmental processes through association with the dependence receptor UNC5A.	[Huang, FengFei; Ben Aissa, Manel; Magron, Audrey; Huard, Caroline C.; Carreau, Madeleine] Univ Quebec, Ctr Hosp, Dept Pediat, Quebec City, PQ, Canada; [Godin, Chantal; Levesque, Georges] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada	Laval University; University of Quebec; Laval University	Carreau, M (corresponding author), Univ Quebec, Ctr Hosp, Dept Pediat, Quebec City, PQ, Canada.	madeleine.carreau@crchul.ulaval.ca		Huard, Caroline/0000-0001-9646-0500; Carreau, Madeleine/0000-0002-0582-6114	Canadian Institutes of Health Research (CIHR); Canadian Blood Services; Fanconi Anemia Research Fund Inc.; Fanconi Canada (the Canadian Fanconi Anemia Research Fund/La Fondation Canadienne de Recherche de l'Anemie de Fanconi); FRSQ; Foundation of Stars; CIHR; Fanconi Canada (the Canadian Fanconi Anemia Research Fund)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Blood Services; Fanconi Anemia Research Fund Inc.; Fanconi Canada (the Canadian Fanconi Anemia Research Fund/La Fondation Canadienne de Recherche de l'Anemie de Fanconi); FRSQ(Fonds de la Recherche en Sante du Quebec); Foundation of Stars; CIHR(Canadian Institutes of Health Research (CIHR)); Fanconi Canada (the Canadian Fanconi Anemia Research Fund)	This work was supported in part by grants to MC and GL from the Canadian Institutes of Health Research (CIHR) in partnership with the Canadian Blood Services, the Fanconi Anemia Research Fund Inc., Fanconi Canada (the Canadian Fanconi Anemia Research Fund/La Fondation Canadienne de Recherche de l'Anemie de Fanconi), and FRSQ Senior Investigator Awards (GL and MC). Additional support was provided by training award from the "Foundation of Stars" (FFH, AM and CH) and CIHR in partnership with Fanconi Canada (the Canadian Fanconi Anemia Research Fund, to CH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Issa R, 1999, BLOOD, V94, P818, DOI 10.1182/blood.V94.2.818.414k33_818_824; Arakawa H, 2004, NAT REV CANCER, V4, P978, DOI 10.1038/nrc1504; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Brodeur I, 2004, J BIOL CHEM, V279, P4713, DOI 10.1074/jbc.M301291200; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; Cumming RC, 2001, NAT MED, V7, P814, DOI 10.1038/89937; Cumming RC, 1996, BLOOD, V88, P4558, DOI 10.1182/blood.V88.12.4558.bloodjournal88124558; Dokal I, 2008, BLOOD REV, V22, P141, DOI 10.1016/j.blre.2007.11.003; Engelkamp D, 2002, MECH DEVELOP, V118, P191, DOI 10.1016/S0925-4773(02)00248-4; Gordon SM, 2003, BLOOD, V102, P136, DOI 10.1182/blood-2002-11-3517; Guenebeaud C, 2010, MOL CELL, V40, P863, DOI 10.1016/j.molcel.2010.11.021; Haneline LS, 1998, BLOOD, V91, P4092; Hoatlin ME, 1998, BLOOD, V91, P1418, DOI 10.1182/blood.V91.4.1418; Huard CC, 2013, BLOOD, V121, P1729, DOI 10.1182/blood-2012-02-408997; Kaddar T, 2012, ANEMIA, V2012, DOI 10.1155/2012/425814; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; Koh PS, 1999, EXP HEMATOL, V27, P1, DOI 10.1016/S0301-472X(98)00064-2; Krasnoshtein F, 1996, HUM MOL GENET, V5, P85, DOI 10.1093/hmg/5.1.85; Kruyt FAE, 1996, BLOOD, V87, P938, DOI 10.1182/blood.V87.3.938.bloodjournal873938; Leveille F, 2006, DNA REPAIR AMST; Llambi F, 2005, EMBO J, V24, P1192, DOI 10.1038/sj.emboj.7600584; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Marathi UK, 1996, BLOOD, V88, P2298, DOI 10.1182/blood.V88.6.2298.bloodjournal8862298; Mehlen P, 2011, NAT REV CANCER, V11, P188, DOI 10.1038/nrc3005; Miyamoto Y, 2010, INT J ONCOL, V36, P1253, DOI 10.3892/ijo_00000609; Mukhopadhyay SS, 2006, J CELL BIOL, V175, P225, DOI 10.1083/jcb.200607061; Otsuki T, 1999, J CELL PHYSIOL, V179, P79, DOI 10.1002/(SICI)1097-4652(199904)179:1<79::AID-JCP10>3.0.CO;2-O; Porter AG, 2004, BIOESSAYS, V26, P656, DOI 10.1002/bies.20037; Rathbun RK, 1997, BLOOD, V90, P974, DOI 10.1182/blood.V90.3.974.974_974_985; Rosenberg PS, 2003, BLOOD, V101, P822, DOI 10.1182/blood-2002-05-1498; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; Tremblay CS, 2008, BLOOD, V112, P2062, DOI 10.1182/blood-2008-04-152710; Wang JX, 1998, CANCER RES, V58, P3538; WEVRICK R, 1993, HUM MOL GENET, V2, P655, DOI 10.1093/hmg/2.6.655; Williams ME, 2003, J BIOL CHEM, V278, P17483, DOI 10.1074/jbc.M300415200; YOUSSOUFIAN H, 1994, P NATL ACAD SCI USA, V91, P7975, DOI 10.1073/pnas.91.17.7975	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92811	10.1371/journal.pone.0092811	http://dx.doi.org/10.1371/journal.pone.0092811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676280	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500042
J	Ling, GY; Gao, JX; Zhang, SM; Xie, ZP; Wei, L; Yu, HN; Wang, YP				Ling, Guiying; Gao, Jiuxiang; Zhang, Shumin; Xie, Zeping; Wei, Lin; Yu, Haining; Wang, Yipeng			Cathelicidins from the Bullfrog Rana catesbeiana Provides Novel Template for Peptide Antibiotic Design	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; ANTIMICROBIAL PEPTIDES; FUNCTIONAL-CHARACTERIZATION; GENE CLONING; IDENTIFICATION; LL-37; EXPRESSION; FAMILY; CATHS	Cathelicidins, a class of gene-encoded effector molecules of vertebrate innate immunity, provide a first line of defense against microbial invasions. Although cathelicidins from mammals, birds, reptiles and fishes have been extensively studied, little is known about cathelicidins from amphibians. Here we report the identification and characterization of two cathelicidins (cathelicidin-RC1 and cathelicidin-RC2) from the bullfrog Rana catesbeiana. The cDNA sequences (677 and 700 bp, respectively) encoding the two peptides were successfully cloned from the constructed lung cDNA library of R. catesbeiana. And the deduced mature peptides are composed of 28 and 33 residues, respectively. Structural analysis indicated that cathelicidin-RC1 mainly assumes an amphipathic alpha-helical conformation, while cathelicidin-RC2 could not form stable amphipathic structure. Antimicrobial and bacterial killing kinetic analysis indicated that the synthetic cathelicidin-RC1 possesses potent, broad-spectrum and rapid antimicrobial potency, while cathelicidin-RC2 exhibited very weak antimicrobial activity. Besides, the antimicrobial activity of cathelicidin-RC1 is salt-independent and highly stable. Scanning electron microscopy (SEM) analysis indicated that cathelicidin-RC1 kills microorganisms through the disruption of microbial membrane. Moreover, cathelicidin-RC1 exhibited low cytotoxic activity against mammalian normal or tumor cell lines, and low hemolytic activity against human erythrocytes. The potent, broad-spectrum and rapid antimicrobial activity combined with the salt-independence, high stability, low cytotoxic and hemolytic activities make cathelicidin-RC1 an ideal template for the development of novel peptide antibiotics.	[Wei, Lin; Wang, Yipeng] Soochow Univ, Coll Pharmaceut Sci, Suzhou, Jiangsu, Peoples R China; [Gao, Jiuxiang; Yu, Haining] Dalian Univ Technol, Dept Biosci & Biotechnol, Dalian, Peoples R China; [Zhang, Shumin; Xie, Zeping] Binzhou Med Univ, Pharmaceut Coll, Yantai, Shandong, Peoples R China; [Ling, Guiying] Guizhou Normal Univ, Dept Biol, Guiyang, Guizhou, Peoples R China	Soochow University - China; Dalian University of Technology; Binzhou Medical University; Guizhou Normal University	Yu, HN (corresponding author), Dalian Univ Technol, Dept Biosci & Biotechnol, Dalian, Peoples R China.	yuhaining@dlut.edu.cn; wyp010@163.com	Wang, Yipeng/AAA-1499-2020; Wei, Lin/AAE-3043-2022	Wang, Yipeng/0000-0003-1385-4470; Wei, Lin/0000-0003-3359-2471	Chinese National Natural Science Foundation [41206153, 41076098]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Growth Project for Liaoning Distinguished Young Scientists of Colleges and Universities [LJQ2013010]; Dalian Distinguished Young Scientists Funding [2013J21DW013]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Growth Project for Liaoning Distinguished Young Scientists of Colleges and Universities; Dalian Distinguished Young Scientists Funding	This work was supported by the grants from Chinese National Natural Science Foundation (41206153, 41076098), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, Growth Project for Liaoning Distinguished Young Scientists of Colleges and Universities (LJQ2013010) and Dalian Distinguished Young Scientists Funding (2013J21DW013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Boman HG, 1998, SCAND J IMMUNOL, V48, P15; Chang CI, 2005, INFECT IMMUN, V73, P5053, DOI 10.1128/IAI.73.8.5053-5064.2005; Feng FF, 2011, FEBS J, V278, P1573, DOI 10.1111/j.1742-4658.2011.08080.x; Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.3.CO;2-0; GENNARO R, 1989, INFECT IMMUN, V57, P3142, DOI 10.1128/IAI.57.10.3142-3146.1989; Giles FJ, 2003, LEUKEMIA LYMPHOMA, V44, P1165, DOI 10.1080/1042819031000079159; Goitsuka R, 2007, P NATL ACAD SCI USA, V104, P15063, DOI 10.1073/pnas.0707037104; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hao X, 2012, AMINO ACIDS, V43, P677, DOI 10.1007/s00726-011-1116-7; He WY, 2012, BIOCHIMIE, V94, P649, DOI 10.1016/j.biochi.2011.09.017; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Isaacson Richard E, 2003, Curr Opin Investig Drugs, V4, P999; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Lehrer RI, 2002, CURR OPIN HEMATOL, V9, P18, DOI 10.1097/00062752-200201000-00004; Li Z, 2013, FISH SHELLFISH IMMUN, V34, P1, DOI 10.1016/j.fsi.2012.07.004; Lu ZK, 2010, BIOCHIMIE, V92, P475, DOI 10.1016/j.biochi.2010.01.025; Lu ZK, 2010, FEBS J, V277, P2329, DOI 10.1111/j.1742-4658.2010.07648.x; Maier VH, 2008, MOL IMMUNOL, V45, P3723, DOI 10.1016/j.molimm.2008.06.002; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Radek K, 2007, SEMIN IMMUNOPATHOL, V29, P27, DOI 10.1007/s00281-007-0064-5; Sang Y, 2007, DEV COMP IMMUNOL, V31, P1278, DOI 10.1016/j.dci.2007.03.007; Schlusselhuber M, 2012, ANTIMICROB AGENTS CH, V56, P1749, DOI 10.1128/AAC.05797-11; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Steinstraesser L, 2011, IMMUNOBIOLOGY, V216, P322, DOI 10.1016/j.imbio.2010.07.003; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Wang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022120; Wang YP, 2011, DEV COMP IMMUNOL, V35, P314, DOI 10.1016/j.dci.2010.10.004; Wang YP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003217; Wei L, 2013, J MED CHEM, V56, P3546, DOI 10.1021/jm4004158; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yu HN, 2013, FEBS J, V280, P6022, DOI 10.1111/febs.12521; Zaiou M, 2002, J MOL MED, V80, P549, DOI 10.1007/s00109-002-0350-6; Zanetti M, 2000, ADV EXP MED BIOL, V479, P203; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao H, 2008, PEPTIDES, V29, P1685, DOI 10.1016/j.peptides.2008.06.008	40	31	35	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93216	10.1371/journal.pone.0093216	http://dx.doi.org/10.1371/journal.pone.0093216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675879	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500093
J	Ohkubo, N; Matsubara, E; Yamanouchi, J; Akazawa, R; Aoto, M; Suzuki, Y; Sakai, I; Abe, T; Kiyonari, H; Matsuda, S; Yasukawa, M; Mitsuda, N				Ohkubo, Nobutaka; Matsubara, Etsuko; Yamanouchi, Jun; Akazawa, Rie; Aoto, Mamoru; Suzuki, Yoji; Sakai, Ikuya; Abe, Takaya; Kiyonari, Hiroshi; Matsuda, Seiji; Yasukawa, Masaki; Mitsuda, Noriaki			Abnormal Behaviors and Developmental Disorder of Hippocampus in Zinc Finger Protein 521 (ZFP521) Mutant Mice	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; B-CELL FACTOR-1; PREPULSE INHIBITION; MOUSE MODEL; STEM-CELL; NEURAL DIFFERENTIATION; STARTLE REFLEX; BONE-FORMATION; RETT-SYNDROME; ADULT	Zinc finger protein 521 (ZFP521) regulates a number of cellular processes in a wide range of tissues, such as osteoblast formation and adipose commitment and differentiation. In the field of neurobiology, it is reported to be an essential factor for transition of epiblast stem cells into neural progenitors in vitro. However, the role of ZFP521 in the brain in vivo still remains elusive. To elucidate the role of ZFP521 in the mouse brain, we generated mice lacking exon 4 of the ZFP521 gene. The birth ratio of our ZFP521(Delta/Delta) mice was consistent with Mendel's laws. Although ZFP521(Delta/Delta) pups had no apparent defect in the body and were indistinguishable from ZFP521(+/+) and ZFP521(+/Delta) littermates at the time of birth, ZFP521(Delta/Delta) mice displayed significant weight reduction as they grew, and most of them died before 10 weeks of age. They displayed abnormal behavior, such as hyper-locomotion, lower anxiety and impaired learning, which correspond to the symptoms of schizophrenia. The border of the granular cell layer of the dentate gyrus in the hippocampus of the mice was indistinct and granular neurons were reduced in number. Furthermore, Sox1-positive neural progenitor cells in the dentate gyrus and cerebellum were significantly reduced in number. Taken together, these findings indicate that ZFP521 directly or indirectly affects the formation of the neuronal cell layers of the dentate gyrus in the hippocampus, and thus ZFP521(Delta/Delta) mice displayed schizophrenia-relevant symptoms. ZFP521(Delta/Delta) mice may be a useful research tool as an animal model of schizophrenia.	[Ohkubo, Nobutaka; Akazawa, Rie; Aoto, Mamoru; Suzuki, Yoji; Mitsuda, Noriaki] Ehime Univ, Dept Circulatory Physiol, Toon, Ehime, Japan; [Matsubara, Etsuko; Yamanouchi, Jun; Yasukawa, Masaki] Ehime Univ, Grad Sch Med, Dept Hematol Clin Immunol & Infect Dis, Toon, Ehime, Japan; [Matsuda, Seiji] Ehime Univ, Grad Sch Med, Dept Anat & Embryol, Toon, Ehime, Japan; [Sakai, Ikuya] Matsuyama Univ, Coll Pharmaceut Sci, Sch Clin Pharm, Dept Pathophysiol, Matsuyama, Ehime, Japan; [Abe, Takaya; Kiyonari, Hiroshi] RIKEN, Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo, Japan	Ehime University; Ehime University; Ehime University; RIKEN	Ohkubo, N (corresponding author), Ehime Univ, Dept Circulatory Physiol, Toon, Ehime, Japan.	nobu@m.ehime-u.ac.jp	Kiyonari, Hiroshi/N-7936-2015		KAKENHI grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan [KAKENHI:25870486]; Grants-in-Aid for Scientific Research [24390245] Funding Source: KAKEN	KAKENHI grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (Grants-in-Aid for Scientific Research) grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI:25870486) and Grant-in-Aid for Research Promotion, Ehime University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKSHI VP, 1994, J PHARMACOL EXP THER, V271, P787; Balu DT, 2009, NEUROSCI BIOBEHAV R, V33, P232, DOI 10.1016/j.neubiorev.2008.08.007; BARBU V, 1989, NUCLEIC ACIDS RES, V17, P7115, DOI 10.1093/nar/17.17.7115; Bond HM, 2008, INT J BIOCHEM CELL B, V40, P848, DOI 10.1016/j.biocel.2007.04.006; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; Brandon NJ, 2009, J NEUROSCI, V29, P12768, DOI 10.1523/JNEUROSCI.3355-09.2009; Castellanos FX, 1996, BIOL PSYCHIAT, V39, P33, DOI 10.1016/0006-3223(95)00101-8; Correa D, 2010, DEV CELL, V19, P533, DOI 10.1016/j.devcel.2010.09.008; Gainetdinov RR, 2001, P NATL ACAD SCI USA, V98, P11047, DOI 10.1073/pnas.191353298; Gong R, 2011, SCIENCE, V333, P1642, DOI 10.1126/science.1207675; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Han R, 2012, NEUROSCI LETT, V515, P147, DOI 10.1016/j.neulet.2012.03.032; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Hesse E, 2010, J CELL BIOL, V191, P1271, DOI 10.1083/jcb.201009107; Hesse E, 2010, ANN NY ACAD SCI, V1192, P32, DOI 10.1111/j.1749-6632.2009.05347.x; Jeon B, 2012, NEUROSCIENCE, V224, P191, DOI 10.1016/j.neuroscience.2012.08.035; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Koike H, 2009, BEHAV BRAIN RES, V202, P114, DOI 10.1016/j.bbr.2009.03.028; Kuroda K, 2011, HUM MOL GENET, V20, P4666, DOI 10.1093/hmg/ddr400; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Lobo MK, 2008, J NEUROSCI RES, V86, P2134, DOI 10.1002/jnr.21666; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Matsubara E, 2009, J BIOL CHEM, V284, P3480, DOI 10.1074/jbc.M805874200; Matsuoka Y, 2005, P NATL ACAD SCI USA, V102, P16066, DOI 10.1073/pnas.0504908102; Mega T, 2011, CELL CYCLE, V10, P2129, DOI 10.4161/cc.10.13.16045; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Ohkubo N, 2002, FASEB J, V16, P295, DOI 10.1096/fj.02-0434fje; Ohkubo N, 2007, J NEUROCHEM, V103, P820, DOI 10.1111/j.1471-4159.2007.04804.x; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Pfeiffer V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058259; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Rolland B, 2012, SCHIZOPHR RES TREAT, V2012, DOI 10.1155/2012/839853; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Seriwatanachai D, 2011, FASEB J, V25, P3057, DOI 10.1096/fj.11-183277; Shen SB, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt61; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Takahashi K, 2007, BIOL PSYCHIAT, V62, P148, DOI 10.1016/j.biopsych.2006.06.035; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tomita K, 2011, HUM MOL GENET, V20, P2834, DOI 10.1093/hmg/ddr194; Varty GB, 1995, PSYCHOPHARMACOLOGY, V122, P15, DOI 10.1007/BF02246437; Wang R, 2011, BRAIN RES, V1372, P127, DOI 10.1016/j.brainres.2010.11.059; Warming S, 2003, BLOOD, V101, P1934, DOI 10.1182/blood-2002-08-2652; Wu M, 2009, BONE, V44, P528, DOI 10.1016/j.bone.2008.11.011; Wu WL, 2010, GENES BRAIN BEHAV, V9, P603, DOI 10.1111/j.1601-183X.2010.00591.x; Yamashita M, 2013, PSYCHOPHARMACOLOGY, V227, P741, DOI 10.1007/s00213-013-3009-9	50	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92848	10.1371/journal.pone.0092848	http://dx.doi.org/10.1371/journal.pone.0092848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676388	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677500045
J	Evans, CC; LePard, KJ; Kwak, JW; Stancukas, MC; Laskowski, S; Dougherty, J; Moulton, L; Glawe, A; Wang, YW; Leone, V; Antonopoulos, DA; Smith, D; Chang, EB; Ciancio, MJ				Evans, Christian C.; LePard, Kathy J.; Kwak, Jeff W.; Stancukas, Mary C.; Laskowski, Samantha; Dougherty, Joseph; Moulton, Laura; Glawe, Adam; Wang, Yunwei; Leone, Vanessa; Antonopoulos, Dionysios A.; Smith, Dan; Chang, Eugene B.; Ciancio, Mae J.			Exercise Prevents Weight Gain and Alters the Gut Microbiota in a Mouse Model of High Fat Diet-Induced Obesity	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; PHYSICAL-EXERCISE; LACTOBACILLUS; INFLAMMATION; PREVALENCE; INDUCTION; COMMUNITY; CHILDREN; PROTECTS	Background: Diet-induced obesity (DIO) is a significant health concern which has been linked to structural and functional changes in the gut microbiota. Exercise (Ex) is effective in preventing obesity, but whether Ex alters the gut microbiota during development with high fat (HF) feeding is unknown. Objective: Determine the effects of voluntary Ex on the gastrointestinal microbiota in LF-fed mice and in HF-DIO. Methods: Male C57BL/6 littermates (5 weeks) were distributed equally into 4 groups: low fat (LF) sedentary (Sed) LF/Sed, LF/Ex, HF/Sed and HF/Ex. Mice were individually housed and LF/Ex and HF/Ex cages were equipped with a wheel and odometer to record Ex. Fecal samples were collected at baseline, 6 weeks and 12 weeks and used for bacterial DNA isolation. DNA was subjected both to quantitative PCR using primers specific to the 16S rRNA encoding genes for Bacteroidetes and Firmicutes and to sequencing for lower taxonomic identification using the Illumina MiSeq platform. Data were analyzed using a one or two-way ANOVA or Pearson correlation. Results:HF diet resulted in significantly greater body weight and adiposity as well as decreased glucose tolerance that were prevented by voluntary Ex (p<0.05). Visualization of Unifrac distance data with principal coordinates analysis indicated clustering by both diet and Ex at week 12. Sequencing demonstrated Ex-induced changes in the percentage of major bacterial phyla at 12 weeks. A correlation between total Ex distance and the Delta Ct Bacteroidetes: Delta Ct Firmicutes ratio from qPCR demonstrated a significant inverse correlation (r(2) = 0.35, p = 0.043). Conclusion: Ex induces a unique shift in the gut microbiota that is different from dietary effects. Microbiota changes may play a role in Ex prevention of HF-DIO.	[Evans, Christian C.] Midwestern Univ, Coll Hlth Sci, Dept Phys Therapy, Downers Grove, IL 60515 USA; [LePard, Kathy J.] Midwestern Univ, Coll Osteopath Med, Dept Physiol, Downers Grove, IL 60515 USA; [Kwak, Jeff W.; Stancukas, Mary C.; Dougherty, Joseph; Moulton, Laura; Glawe, Adam; Ciancio, Mae J.] Midwestern Univ, Coll Hlth Sci, Dept Biomed Sci, Downers Grove, IL 60515 USA; [Laskowski, Samantha] Midwestern Univ, Coll Osteopath Med, Downers Grove, IL 60515 USA; [Dougherty, Joseph] Midwestern Univ, Coll Dent Med, Dept Dent Med, Downers Grove, IL 60515 USA; [Wang, Yunwei; Leone, Vanessa; Chang, Eugene B.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Antonopoulos, Dionysios A.; Smith, Dan] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA	Midwestern University; Midwestern University - College of Health Sciences - Illinois; Midwestern University; Midwestern University - Chicago College of Osteopathic Medicine; Midwestern University; Midwestern University - College of Health Sciences - Illinois; Midwestern University; Midwestern University - Chicago College of Osteopathic Medicine; Midwestern University; Midwestern University - College of Dental Medicine - Illinois; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Evans, CC (corresponding author), Midwestern Univ, Coll Hlth Sci, Dept Phys Therapy, Downers Grove, IL 60515 USA.	cevans@midwestern.edu	Antonopoulos, Dionysios/ABE-6212-2020	Antonopoulos, Dionysios/0000-0002-2238-5031; Kwak, Jeff/0000-0003-1481-3654	Midwestern University (MJC), Midwestern University College of Health Sciences Research Facilitation grants; Kenneth A. Suarez Summer Research Fellowship; National Institutes of Health (NIH) of the Digestive Disease Research Core Center, University of Chicago [P30 DK 42086]; NIH [DK097268]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK047722, R01DK097268, R01DK047722, P30DK042086] Funding Source: NIH RePORTER	Midwestern University (MJC), Midwestern University College of Health Sciences Research Facilitation grants; Kenneth A. Suarez Summer Research Fellowship; National Institutes of Health (NIH) of the Digestive Disease Research Core Center, University of Chicago; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was through: Midwestern University (MJC), Midwestern University College of Health Sciences Research Facilitation grants (CCE and MJC), a Kenneth A. Suarez Summer Research Fellowship (SL), National Institutes of Health (NIH) grant P30 DK 42086 to the Host-Microbe Core of the Digestive Disease Research Core Center, University of Chicago and NIH grant DK097268 (EBC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2010, BENEF MICROBES, V1, P189, DOI 10.3920/BM2009.0036; Angelakis E, 2012, FUTURE MICROBIOL, V7, P91, DOI [10.2217/FMB.11.142, 10.2217/fmb.11.142]; Angelakis E, 2012, MICROB PATHOGENESIS, V52, P61, DOI 10.1016/j.micpath.2011.10.004; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Atalay M, 2004, J APPL PHYSIOL, V97, P605, DOI 10.1152/japplphysiol.01183.2003; Aube AC, 2006, GUT, V55, P630, DOI 10.1136/gut.2005.067595; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Bernardeau M, 2002, INT J FOOD MICROBIOL, V77, P19, DOI 10.1016/S0168-1605(02)00059-4; Bervoets L, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-10; Bradley RL, 2008, AM J PHYSIOL-ENDOC M, V295, pE586, DOI 10.1152/ajpendo.00309.2007; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2013, BRIEF FUNCT GENOMICS, V12, P381, DOI 10.1093/bfgp/elt014; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Choi JJ, 2013, ENVIRON HEALTH PERSP, V121, P725, DOI 10.1289/ehp.1306534; Colditz GA, 1997, CANCER CAUSE CONTROL, V8, P649, DOI 10.1023/A:1018458700185; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; DAPOIGNY M, 1991, AM J PHYSIOL, V260, pG646, DOI 10.1152/ajpgi.1991.260.4.G646; de Oliveira EP, 2009, CURR OPIN CLIN NUTR, V12, P533, DOI 10.1097/MCO.0b013e32832e6776; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Eeg-Olofsson K, 2009, DIABETOLOGIA, V52, P65, DOI 10.1007/s00125-008-1190-x; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83; Geurts L, 2014, BENEF MICROBES, V5, P3, DOI 10.3920/BM2012.0065; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Haange SB, 2012, J PROTEOME RES, V11, P5406, DOI 10.1021/pr3006364; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Huang EY, 2013, JPEN-PARENTER ENTER, V37, P746, DOI 10.1177/0148607113486931; Huang P, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-59; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Konhilas JP, 2005, AM J PHYSIOL-HEART C, V289, pH455, DOI 10.1152/ajpheart.00085.2005; KONTUREK SJ, 1973, J APPL PHYSIOL, V34, P324, DOI 10.1152/jappl.1973.34.3.324; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Malago JJ, 2002, CELL STRESS CHAPERON, V7, P191, DOI 10.1379/1466-1268(2002)007<0191:THSRAC>2.0.CO;2; Martins C, 2007, J ENDOCRINOL, V193, P251, DOI 10.1677/JOE-06-0030; Matsumoto M, 2008, BIOSCI BIOTECH BIOCH, V72, P572, DOI 10.1271/bbb.70474; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; MILLER MS, 1981, J PHARMACOL METHOD, V6, P211, DOI 10.1016/0160-5402(81)90110-8; Million M, 2012, MICROB PATHOGENESIS, V53, P100, DOI 10.1016/j.micpath.2012.05.007; Mujico JR, 2013, BRIT J NUTR, V110, P711, DOI 10.1017/S0007114512005612; Musch MW, 1996, AM J PHYSIOL-CELL PH, V270, pC429, DOI 10.1152/ajpcell.1996.270.2.C429; Musch MW, 1999, GASTROENTEROLOGY, V117, P115, DOI 10.1016/S0016-5085(99)70557-3; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Naito E, 2011, J APPL MICROBIOL, V110, P650, DOI 10.1111/j.1365-2672.2010.04922.x; Nathan C, 2008, MOL MED, V14, P485, DOI 10.2119/2008-00038.Nathan; Noble EG, 2006, ACTA PHYSIOL, V187, P495, DOI 10.1111/j.1748-1716.2006.01591.x; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Oliveira AG, 2011, DIABETES, V60, P784, DOI 10.2337/db09-1907; Pedersen BK, 2004, P NUTR SOC, V63, P263, DOI 10.1079/PNS2004338; Peters HPF, 2001, GUT, V48, P435, DOI 10.1136/gut.48.3.435; Petersen AMW, 2006, J PHYSIOL PHARMACOL, V57, P43; Rao SSC, 1999, AM J PHYSIOL-GASTR L, V276, pG1221, DOI 10.1152/ajpgi.1999.276.5.G1221; Rastmanesh R, 2011, CHEM-BIOL INTERACT, V189, P1, DOI 10.1016/j.cbi.2010.10.002; Simoes CD, 2013, J NUTR, V143, P417, DOI 10.3945/jn.112.166322; Tehrani AB, 2012, NEUROGASTROENT MOTIL, V24, P305, DOI 10.1111/j.1365-2982.2012.01895.x; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Wright JD, 2007, J AM DIET ASSOC, V107, P822, DOI 10.1016/j.jada.2007.02.017	70	360	386	12	172	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92193	10.1371/journal.pone.0092193	http://dx.doi.org/10.1371/journal.pone.0092193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670791	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677000035
J	Kaur, S; Momi, N; Chakraborty, S; Wagner, DG; Horn, AJ; Lele, SM; Theodorescu, D; Batra, SK				Kaur, Sukhwinder; Momi, Navneet; Chakraborty, Subhankar; Wagner, David G.; Horn, Adam J.; Lele, Subodh M.; Theodorescu, Dan; Batra, Surinder K.			Altered Expression of Transmembrane Mucins, MUC1 and MUC4, in Bladder Cancer: Pathological Implications in Diagnosis	PLOS ONE			English	Article							MAMMARY-GLAND; CARCINOMA; SURVIVAL; OVEREXPRESSION; GROWTH	Purpose: Radical changes in both expression and glycosylation pattern of transmembrane mucins have been observed in various malignancies. We and others have shown that MUC1 and MUC4, two transmembrane mucins, play a sentinel role in cell signaling events that drive several epithelial malignancies. In the present study, we investigated the expression profile of MUC1 and MUC4 in the non-neoplastic bladder urothelium, in various malignant neoplasms of bladder and in bladder carcinoma cell lines. Material and Methods: Immunohistochemistry was performed on tissue sections from the urinary bladder biopsies, resection samples and tissue microarrays (TMAs) with monoclonal antibodies specific for MUC1 and MUC4. We also investigated their expression in bladder carcinoma cell lines by RT-PCR and immunoblotting. Results: MUC1 is expressed on the apical surface or in umbrella cells of the normal non-neoplastic bladder urothelium. Strong expression of MUC1 was also observed in urothelial carcinoma (UC). MUC1 staining increased from normal urothelium (n = 27, 0.35 +/- 0.12) to urothelial carcinoma (UC, n = 323, H-score, 2.4 +/- 0.22, p <= 0.0001). In contrast to MUC1, MUC4 was expressed in all the layers of non-neoplastic bladder urothelium (n = 14, 2.5 +/- 0.28), both in the cell membrane and cytoplasm. In comparison to non-neoplastic urothelium, the loss of MUC4 expression was observed during urothelial carcinoma (n = 211, 0.56 +/- 0.06). However, re-expression of MUC4 was observed in a subset of metastatic cases of urothelial carcinoma (mean H-score 0.734 +/- 0.9). Conclusion: The expression of MUC1 is increased while that of MUC4 decreased in UC compared to the normal nonneoplastic urothelium. Expression of both MUC1 and MUC4, however, are significantly higher in urothelial carcinoma metastatic cases compared to localized UC. These results suggest differential expression of MUC1 and MUC4 during development and progression of bladder carcinoma.	[Kaur, Sukhwinder; Momi, Navneet; Chakraborty, Subhankar; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Wagner, David G.; Horn, Adam J.; Lele, Subodh M.; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Batra, Surinder K.] Univ Nebraska Med Ctr, Buffett Canc Ctr, Eppley Canc Inst, Omaha, NE USA; [Theodorescu, Dan] Univ Colorado, Ctr Comprehens Canc, Aurora, CO USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Lele, SM (corresponding author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.	slele@unmc.edu; sbatra@unmc.edu			National Institutes of Health [RO1 CA 138791, U54 CA163120, UO1 CA111294, P50 CA127297]; NATIONAL CANCER INSTITUTE [P50CA127297, R01CA138791, U54CA163120, U01CA111294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the grants from the National Institutes of Health (RO1 CA 138791, U54 CA163120, UO1 CA111294, and P50 CA127297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Elazeez TA, 2011, UROL ANNALS, V3, P8, DOI 10.4103/0974-7796.75857; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Chaturvedi P, 2007, MOL CANCER RES, V5, P309, DOI 10.1158/1541-7786.MCR-06-0353; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hauber Hans-Peter, 2006, Can Respir J, V13, P327; Inata J, 2007, INT J CANCER, V120, P2643, DOI 10.1002/ijc.22613; Jacobs BL, 2010, CA-CANCER J CLIN, V60, P244, DOI 10.3322/caac.20077; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kaur S, 2013, CLIN CANC RES; Kawano T, 2008, INT J ONCOL, V33, P153; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Lotan Y, 2005, J CLIN ONCOL, V23, P6533, DOI 10.1200/JCO.2005.05.516; McDermott KM, 2001, INT J CANCER, V94, P783, DOI 10.1002/ijc.1554; Moniaux N, 2004, J HISTOCHEM CYTOCHEM, V52, P253, DOI 10.1177/002215540405200213; Nassar H, 2004, MODERN PATHOL, V17, P1045, DOI 10.1038/modpathol.3800166; Park Hee-Ug, 2003, Pancreas, V26, pe48, DOI 10.1097/00006676-200304000-00022; Patriarca C, 2009, INT J SURG PATHOL, V17, P99, DOI 10.1177/1066896908326918; Patton S, 1995, BBA-REV BIOMEMBRANES, V1241, P407, DOI 10.1016/0304-4157(95)00014-3; Rachagani S, 2009, BIOFACTORS, V35, P509, DOI 10.1002/biof.64; Schroeder JA, 2004, ONCOGENE, V23, P5739, DOI 10.1038/sj.onc.1207713; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simms MS, 1999, BJU INT, V84, P350; Singh AP, 2007, CANCER RES, V67, P433, DOI 10.1158/0008-5472.CAN-06-3114; Singh AP, 2006, PROSTATE, V66, P421, DOI 10.1002/pros.20372; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Xiang Song-tao, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P1114	26	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92742	10.1371/journal.pone.0092742	http://dx.doi.org/10.1371/journal.pone.0092742			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671186	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000070
J	Main, AR; Headley, JV; Peru, KM; Michel, NL; Cessna, AJ; Morrissey, CA				Main, Anson R.; Headley, John V.; Peru, Kerry M.; Michel, Nicole L.; Cessna, Allan J.; Morrissey, Christy A.			Widespread Use and Frequent Detection of Neonicotinoid Insecticides in Wetlands of Canada's Prairie Pothole Region	PLOS ONE			English	Article							CLIMATE-CHANGE; PESTICIDES; EXPOSURE; RECOVERY	Neonicotinoids currently dominate the insecticide market as seed treatments on Canada's major Prairie crops (e. g., canola). The potential impact to ecologically significant wetlands in this dominantly agro-environment has largely been overlooked while the distribution of use, incidence and level of contamination remains unreported. We modelled the spatial distribution of neonicotinoid use across the three Prairie Provinces in combination with temporal assessments of water and sediment concentrations in wetlands to measure four active ingredients (clothianidin, thiamethoxam, imidacloprid and acetamiprid). From 2009 to 2012, neonicotinoid use was increasing; by 2012, applications covered an estimated similar to 11 million hectares (44% of Prairie cropland) with >216,000 kg of active ingredients. Thiamethoxam, followed by clothianidin, were the dominant seed treatments by mass and area. Areas of high neonicotinoid use were identified as high density canola or soybean production. Water sampled four times from 136 wetlands (spring, summer, fall 2012 and spring 2013) across four rural municipalities in Saskatchewan similarly revealed clothianidin and thiamethoxam in the majority of samples. In spring 2012 prior to seeding, 36% of wetlands contained at least one neonicotinoid. Detections increased to 62% in summer 2012, declined to 16% in fall, and increased to 91% the following spring 2013 after ice-off. Peak concentrations were recorded during summer 2012 for both thiamethoxam (range: <LOQ - 1490 ng/L, canola) and clothianidin (range: <LOQ - 3110 ng/L, canola). Sediment samples collected during the same period rarely (6%) contained neonicotinoid concentrations (which did not exceed 20 ng/L). Wetlands situated in barley, canola and oat fields consistently contained higher mean concentrations of neonicotinoids than in grasslands, but no individual crop singularly influenced overall detections or concentrations. Distribution maps indicate neonicotinoid use is increasing and becoming more widespread with concerns for environmental loading, while frequently detected neonicotinoid concentrations in Prairie wetlands suggest high persistence and transport into wetlands.	[Main, Anson R.; Michel, Nicole L.; Morrissey, Christy A.] Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK, Canada; [Headley, John V.; Peru, Kerry M.] Environm Canada, Water Sci & Technol Directorate, Aquat Contaminants Res Div, Saskatoon, SK, Canada; [Cessna, Allan J.] Agr & Agri Food Canada, Sci & Technol Branch, Saskatoon, SK, Canada; [Morrissey, Christy A.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; Environment & Climate Change Canada; Agriculture & Agri Food Canada; University of Saskatchewan	Morrissey, CA (corresponding author), Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK, Canada.	christy.morrissey@usask.ca	Soares, Amadeu/A-8304-2008; Main, Anson/AAP-5899-2020; Serrano, Jose/A-2854-2009	Soares, Amadeu/0000-0003-0879-9470; Serrano, Jose/0000-0002-1565-5216; Morrissey, Christy/0000-0001-8128-4209	Natural Science and Engineering Research Council (NSERC); Environment Canada; University of Saskatchewan's College of Graduate Studies; School of Environment and Sustainability	Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada(CGIAR); University of Saskatchewan's College of Graduate Studies; School of Environment and Sustainability	This study was funded by the Natural Science and Engineering Research Council (NSERC) (http://www.nserc-crsng.gc.ca/index_eng.asp), Environment Canada (http://www.ec.gc.ca/?lang=En) and graduate scholarships from the University of Saskatchewan's College of Graduate Studies (http://www.usask.ca/cgsr/) and the School of Environment and Sustainability (www.usask.ca/sens). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Alexander AC, 2007, ENVIRON TOXICOL CHEM, V26, P1726, DOI 10.1897/07-015R.1; American Bird Conservancy, 2013, IMP NAT MOST WID US; Anderson TA, 2013, CHEMOSPHERE, V92, P84, DOI 10.1016/j.chemosphere.2013.02.054; [Anonymous], ENCY BIODIVERSITY; [Anonymous], [No title captured]; Bartzen BA, 2010, ECOL APPL, V20, P525, DOI 10.1890/08-1650.1; Beketov MA, 2008, SCI TOTAL ENVIRON, V405, P96, DOI 10.1016/j.scitotenv.2008.07.001; Beketov MA, 2008, ENVIRON TOXICOL CHEM, V27, P461, DOI 10.1897/07-322R.1; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Canada Council of Ministers of the Environment,, 2007, CAN ENV QUAL GUID 19; Conly FM, 2001, ENVIRON MONIT ASSESS, V67, P195, DOI 10.1023/A:1006486607040; Donald DB, 2005, ENVIRON TOXICOL CHEM, V24, P2, DOI 10.1897/03-668.1; Donald DB, 1999, SCI TOTAL ENVIRON, V231, P173, DOI 10.1016/S0048-9697(99)00091-1; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Erwin KL, 2009, WETL ECOL MANAG, V17, P71, DOI 10.1007/s11273-008-9119-1; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Gotelli NJ, 2013, ECOSIMR 1 00; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Liess M, 1999, WATER RES, V33, P239, DOI 10.1016/S0043-1354(98)00174-2; Meehan TD, 2011, P NATL ACAD SCI USA, V108, P11500, DOI 10.1073/pnas.1100751108; Pestana JLT, 2009, ENVIRON POLLUT, V157, P2328, DOI 10.1016/j.envpol.2009.03.027; Phillips PJ, 2004, PEST MANAG SCI, V60, P531, DOI 10.1002/ps.879; Rosario-Martinez H., 2013, PHIA POSTHOC INTERAC; SANCHEZBAYO F, 2013, INSECTICIDES DEV SAF, DOI DOI 10.5772/52831; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Stoughton SJ, 2008, ARCH ENVIRON CON TOX, V54, P662, DOI 10.1007/s00244-007-9073-6; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; van der Kamp G, 2009, HYDROGEOL J, V17, P203, DOI 10.1007/s10040-008-0367-1; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Xie W, 2011, J CHROMATOGR A, V1218, P4426, DOI 10.1016/j.chroma.2011.05.026; Xing ZS, 2013, ARCH ENVIRON CON TOX, V64, P208, DOI 10.1007/s00244-012-9833-9; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	45	210	217	5	176	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92821	10.1371/journal.pone.0092821	http://dx.doi.org/10.1371/journal.pone.0092821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671127	gold, Green Submitted, Green Published			2022-12-25	WOS:000333677000081
J	Vandenabeele, SP; Grundy, E; Friswell, MI; Grogan, A; Votier, SC; Wilson, RP				Vandenabeele, Sylvie P.; Grundy, Edward; Friswell, Michael I.; Grogan, Adam; Votier, Stephen C.; Wilson, Rory P.			Excess Baggage for Birds: Inappropriate Placement of Tags on Gannets Changes Flight Patterns	PLOS ONE			English	Article							INTRA-SPECIFIC COMPETITION; FORAGING TRIP DURATION; RADIO TRANSMITTERS; RECORDING DEVICES; FEEDING LOCATIONS; PELAGIC SEABIRD; ADELIE PENGUINS; MORUS-BASSANUS; GPS TRACKING; NORTH-SEA	Devices attached to flying birds can hugely enhance our understanding of their behavioural ecology for periods when they cannot be observed directly. For this, scientists routinely attach units to either birds' backs or their tails. However, inappropriate payload distribution is critical in aircraft and, since birds and planes are subject to the same laws of physics during flight, we considered aircraft aerodynamic constraints to explain flight patterns displayed by northern gannets Sula bassana equipped with (small ca. 14 g) tail- and back-mounted accelerometers and (larger ca. 30 g) tail-mounted GPS units. Tail-mounted GPS-fitted birds showed significantly higher cumulative numbers of flap-glide cycles and a higher pitch angle of the tail than accelerometer-equipped birds, indicating problems with balancing inappropriately placed weights with knock-on consequences relating to energy expenditure. These problems can be addressed by carefully choosing where to place tags on birds according to the mass of the tags and the lifestyle of the subject species.	[Vandenabeele, Sylvie P.; Grundy, Edward; Wilson, Rory P.] Swansea Univ, Biosci Dept, Coll Sci, Swansea, W Glam, Wales; [Friswell, Michael I.] Swansea Univ, Coll Engn, Swansea, W Glam, Wales; [Grogan, Adam] RSPCA Wildlife Dept, Southwater, W Sussex, England; [Votier, Stephen C.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	Swansea University; Swansea University; University of Exeter	Vandenabeele, SP (corresponding author), Swansea Univ, Biosci Dept, Coll Sci, Singleton Pk, Swansea, W Glam, Wales.	vanden.sylvie@gmail.com	Votier, Stephen C/G-2348-2014; Friswell, Michael I/B-5581-2009	Votier, Stephen C/0000-0002-0976-0167; Friswell, Michael I/0000-0003-4677-7395; Vandenabeele, Sylvie/0000-0003-2963-3410	California Department of Fish and Game's Oil Spill Response Trust Fund (through the Oiled Wildlife Care Network at the Wildlife Health Center, School of Veterinary Medicine, University of California, Davis); Royal Society for Prevention of Cruelty to Animals (RSPCA, Wilberforce Way, Southwater, Horsham, West Sussex, United Kingdom)	California Department of Fish and Game's Oil Spill Response Trust Fund (through the Oiled Wildlife Care Network at the Wildlife Health Center, School of Veterinary Medicine, University of California, Davis); Royal Society for Prevention of Cruelty to Animals (RSPCA, Wilberforce Way, Southwater, Horsham, West Sussex, United Kingdom)	This study would have not been carried out without the financial support from the California Department of Fish and Game's Oil Spill Response Trust Fund (through the Oiled Wildlife Care Network at the Wildlife Health Center, School of Veterinary Medicine, University of California, Davis) and the Royal Society for Prevention of Cruelty to Animals (RSPCA, Wilberforce Way, Southwater, Horsham, West Sussex, RH13 9RS, United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2009, NEW ZEAL J ZOOL, V36, P355, DOI 10.1080/03014220909510160; Anderka F.W., 1992, P135; Anderson JD., 2005, ENERGY, V20, P6; Ballard G, 2001, CONDOR, V103, P481, DOI 10.1650/0010-5422(2001)103[0481:EOIAAO]2.0.CO;2; BANNASCH R, 1994, J EXP BIOL, V194, P83; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; Bowlin MS, 2010, METHODS ECOL EVOL, V1, P398, DOI 10.1111/j.2041-210X.2010.00043.x; Croll DA, 1996, J FIELD ORNITHOL, V67, P1; del Hoyo J, 2013, HDB BIRDS WORLD; Federal Aviation Administration US Department of Transportation, 2007, AIRCR WEIGHT BAL HDB; Garthe S, 2007, MAR BIOL, V151, P687, DOI 10.1007/s00227-006-0523-x; GESSAMAN JA, 1988, CONDOR, V90, P662, DOI 10.2307/1368356; Grecian WJ, 2012, BIOL CONSERV, V156, P43, DOI 10.1016/j.biocon.2011.12.010; Green JA, 2009, J EXP BIOL, V212, P471, DOI 10.1242/jeb.026377; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Hamer KC, 2007, MAR ECOL PROG SER, V338, P295, DOI 10.3354/meps338295; Hamer KC, 2009, J ANIM ECOL, V78, P880, DOI 10.1111/j.1365-2656.2009.01549.x; Hamer KC, 2000, MAR ECOL PROG SER, V200, P257, DOI 10.3354/meps200257; Healy Marg, 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P179; Kenward RE., 2000, MANUAL WILDLIFE RADI; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; MILLER GD, 1993, BIOL CONSERV, V63, P223, DOI 10.1016/0006-3207(93)90716-E; MONTEVECCHI WA, 1984, COMP BIOCHEM PHYS A, V78, P15, DOI 10.1016/0300-9629(84)90084-7; Navarro J, 2008, J EXP MAR BIOL ECOL, V358, P14, DOI 10.1016/j.jembe.2008.01.005; NELSON J.B., 1978, SULIDAE GANNETS BOOB; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Powell LA, 1998, J FIELD ORNITHOL, V69, P306; Raymer, 2012, AIAA ED SERIES; Ropert-Coudert Y, 2004, IBIS, V146, P281, DOI 10.1111/j.1474-919x.2003.00250.x; Shepard E., 2008, ENDANGERED SPECIES R, V10; Shepard ELC, 2009, AQUAT BIOL, V4, P235, DOI 10.3354/ab00104; Stauss C, 2012, MAR ECOL PROG SER, V457, P151, DOI 10.3354/meps09734; Stevens B.L., 2015, AIRCRAFT CONTROL SIM; Taylor GK, 2002, J THEOR BIOL, V214, P351, DOI 10.1006/jtbi.2001.2470; Taylor SS, 2001, J AVIAN BIOL, V32, P369, DOI 10.1111/j.0908-8857.2001.320413.x; Vandenabeele SP, 2012, P 11 INT EFF OIL WIL; Vandenabeele SP, 2013, FRONT ECOL ENVIRON, V11, P10, DOI 10.1890/13.WB.002; Vandenabeele SP, 2012, MAR BIOL, V159, P1, DOI 10.1007/s00227-011-1784-6; Votier SC, 2011, MAR BIOL, V158, P355, DOI 10.1007/s00227-010-1563-9; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; WANLESS S, 1989, COLON WATERBIRD, V12, P158, DOI 10.2307/1521336; Watanabe S, 2005, APPL ANIM BEHAV SCI, V94, P117, DOI 10.1016/j.applanim.2005.01.010; WATANUKI Y, 1992, POLAR BIOL, V12, P539; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; WILSON RP, 1989, WILDLIFE SOC B, V17, P77; Wilson RP, 1997, WILDLIFE SOC B, V25, P101	48	47	50	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92657	10.1371/journal.pone.0092657	http://dx.doi.org/10.1371/journal.pone.0092657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671007	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677000061
J	Barbosa, ERM; Tomlinson, KW; Carvalheiro, LG; Kirkman, K; de Bie, S; Prins, HHT; van Langevelde, F				Barbosa, Eduardo R. M.; Tomlinson, Kyle W.; Carvalheiro, Luisa G.; Kirkman, Kevin; de Bie, Steven; Prins, Herbert H. T.; van Langevelde, Frank			Short-Term Effect of Nutrient Availability and Rainfall Distribution on Biomass Production and Leaf Nutrient Content of Savanna Tree Species	PLOS ONE			English	Article							SEMIARID SAVANNAS; MINERAL-NUTRITION; NITROGEN; FIRE; PHOSPHORUS; RESPONSES; SEEDLINGS; DYNAMICS; GROWTH; CARBON	Changes in land use may lead to increased soil nutrient levels in many ecosystems (e. g. due to intensification of agricultural fertilizer use). Plant species differ widely in their response to differences in soil nutrients, and for savannas it is uncertain how this nutrient enrichment will affect plant community dynamics. We set up a large controlled short-term experiment in a semi-arid savanna to test how water supply (even water supply vs. natural rainfall) and nutrient availability (no fertilisation vs. fertilisation) affects seedlings' above-ground biomass production and leaf-nutrient concentrations (N, P and K) of broad-leafed and fine-leafed tree species. Contrary to expectations, neither changes in water supply nor changes in soil nutrient level affected biomass production of the studied species. By contrast, leaf-nutrient concentration did change significantly. Under regular water supply, soil nutrient addition increased the leaf phosphorus concentration of both fine-leafed and broad-leafed species. However, under uneven water supply, leaf nitrogen and phosphorus concentration declined with soil nutrient supply, this effect being more accentuated in broad-leafed species. Leaf potassium concentration of broad-leafed species was lower when growing under constant water supply, especially when no NPK fertilizer was applied. We found that changes in environmental factors can affect leaf quality, indicating a potential interactive effect between land-use changes and environmental changes on savanna vegetation: under more uneven rainfall patterns within the growing season, leaf quality of tree seedlings for a number of species can change as a response to changes in nutrient levels, even if overall plant biomass does not change. Such changes might affect herbivore pressure on trees and thus savanna plant community dynamics. Although longer term experiments would be essential to test such potential effects of eutrophication via changes in leaf nutrient concentration, our findings provide important insights that can help guide management plans that aim to preserve savanna biodiversity.	[Barbosa, Eduardo R. M.; Tomlinson, Kyle W.; de Bie, Steven; Prins, Herbert H. T.; van Langevelde, Frank] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Barbosa, Eduardo R. M.] Univ Brasilia, Inst Ciencias Biol, Dept Bot, Lab Termobiol, Brasilia, DF, Brazil; [Tomlinson, Kyle W.] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Community Ecol & Conservat Grp, Beijing 100864, Yunnan, Peoples R China; [Carvalheiro, Luisa G.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Carvalheiro, Luisa G.] Nat Biodivers Ctr, Leiden, Netherlands; [Kirkman, Kevin; Prins, Herbert H. T.] Univ KwaZulu Natal, Sch Life Sci, Scottsville, South Africa	Wageningen University & Research; Universidade de Brasilia; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; University of Leeds; Naturalis Biodiversity Center; University of Kwazulu Natal	Barbosa, ERM (corresponding author), Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands.	eduardormbarbosa@gmail.com	Carvalheiro, Luisa/D-9414-2012; Barbosa, Eduardo R M/D-3082-2014; Kirkman, Kevin/GNM-5334-2022; Kirkman, Kevin P/F-4160-2010	Carvalheiro, Luisa/0000-0001-7655-979X; Kirkman, Kevin/0000-0001-9580-5191; Kirkman, Kevin P/0000-0001-9580-5191; Moribe Barbosa, Eduardo Rogerio/0000-0001-9464-2247; Van Langevelde, Frank/0000-0001-8870-0797; Prins, Herbert/0000-0003-1131-5107	Shell Research Foundation	Shell Research Foundation	Funding and research assistance for this project were provided by Shell Research Foundation (http://www.shellfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2004, AMBIO, V33, P530, DOI 10.1639/0044-7447(2004)033[0530:SFRTEN]2.0.CO;2; Ahrestani FS, 2011, BASIC APPL ECOL, V12, P634, DOI 10.1016/j.baae.2011.08.008; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P2898, DOI 10.1111/j.1365-2486.2008.01716.x; Barbosa ERM, 2014, OECOLOGIA, V174, P1345, DOI 10.1007/s00442-013-2853-y; Bohrer G, 2001, J VEG SCI, V12, P279, DOI 10.2307/3236612; CHAPIN FS, 1983, ECOLOGY, V64, P376, DOI 10.2307/1937083; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; CHAPIN FS, 1986, AM NAT, V127, P48, DOI 10.1086/284466; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; CHAPIN FS, 1993, AM NAT, V142, pS78, DOI 10.1086/285524; Cheng LL, 2000, J EXP BOT, V51, P1687, DOI 10.1093/jexbot/51.351.1687; Christensen N.L., 1981, FOREST SUCCESSION CO, P230, DOI DOI 10.1007/978-1-4612-5950-3; DUTOIT JT, 1990, ECOLOGY, V71, P149; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Fornara DA, 2008, ECOSCIENCE, V15, P129, DOI 10.2980/1195-6860(2008)15[129:ROWSET]2.0.CO;2; Garg BK, 2004, J PLANT NUTR SOIL SC, V167, P503, DOI 10.1002/jpln.200320368; GOWER ST, 1992, ECOL MONOGR, V62, P43, DOI 10.2307/2937170; Grime J. P., 1979, Plant strategies and vegetation processes.; Higgins SI, 2000, J ECOL, V88, P213, DOI 10.1046/j.1365-2745.2000.00435.x; Hu YC, 2005, J PLANT NUTR SOIL SC, V168, P541, DOI 10.1002/jpln.200420516; Johnston P, 2013, AFRICAN AGR CLIMATE; Kambatuku JR, 2013, ECOHYDROLOGY, V6, P464, DOI 10.1002/eco.1273; Kambatuku JR, 2011, J VEG SCI, V22, P225, DOI 10.1111/j.1654-1103.2010.01239.x; Kgope B. S., 2004, South African Journal of Botany, V70, P760, DOI 10.1016/S0254-6299(15)30177-0; Kitajima K., 2000, Seeds: the ecology of regeneration in plant communities, P331, DOI 10.1079/9780851994321.0331; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Kraaij T, 2006, PLANT ECOL, V186, P235, DOI 10.1007/s11258-006-9125-4; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3; Lehmann CER, 2009, NEW PHYTOL, V181, P508, DOI 10.1111/j.1469-8137.2009.02734.x; Marschner H., 1995, MINERAL NUTR HIGHER, Vsecond, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Miyazaki K, 2012, ATMOS CHEM PHYS, V12, P2263, DOI 10.5194/acp-12-2263-2012; Mucina L., 2006, VEGETATION S AFRICA; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; NOVOZAMSKY I, 1983, COMMUN SOIL SCI PLAN, V14, P239, DOI 10.1080/00103628309367359; Olff H, 2002, NATURE, V415, P901, DOI 10.1038/415901a; Paquin R, 2000, TREE PHYSIOL, V20, P229; Parks SE, 2000, PLANT SOIL, V227, P59, DOI 10.1023/A:1026563926187; Pessarakli M., 2005, HDB PHOTOSYNTHESIS; Polis GA, 1999, OIKOS, V86, P3, DOI 10.2307/3546565; PORTIS AR, 1992, ANNU REV PLANT PHYS, V43, P415, DOI 10.1146/annurev.pp.43.060192.002215; PREGITZER KS, 1990, TREE PHYSIOL, V7, P79, DOI 10.1093/treephys/7.1-2-3-4.79; Prins Herbert H. T., 2008, V23, P129; Prior SA, 1997, TREE PHYSIOL, V17, P397; Rittenhouse LR, 1987, INTEGRATED PEST MANA, P25; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; Sankaran M, 2008, GLOBAL ECOL BIOGEOGR, V17, P236, DOI 10.1111/j.1466-8238.2007.00360.x; Scholes R. J., 1997, P258; Scholes R.J., 1993, AFRICAN SAVANNA SYNT; Scholes RJ, 2003, KRUGER EXPERIENCE EC, P131; Shane MW, 2004, PLANT PHYSIOL, V135, P549, DOI 10.1104/pp.103.035659; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tefera S, 2011, AFR J AGR RES, V6, P2494; TILMAN D, 1986, ECOLOGY, V67, P555, DOI 10.2307/1938598; TILMAN GD, 1984, ECOLOGY, V65, P1445, DOI 10.2307/1939125; Tomlinson KW, 2013, J ECOL, V101, P430, DOI 10.1111/1365-2745.12056; Treydte AC, 2007, PERSPECT PLANT ECOL, V8, P197, DOI 10.1016/j.ppees.2007.03.001; van der Waal C, 2011, OECOLOGIA, V165, P1095, DOI 10.1007/s00442-010-1899-3; van der Waal C, 2009, J ECOL, V97, P430, DOI 10.1111/j.1365-2745.2009.01498.x; van Langevelde F, 2003, ECOLOGY, V84, P337, DOI 10.1890/0012-9658(2003)084[0337:EOFAHO]2.0.CO;2; Van Langevelde F, 2011, ECOSYST FUNCT SAVANN, P257; Venter F.J., 2003, KRUGER EXPERIENCE EC, P83, DOI DOI 10.2989/10220110409485835; Ward D., 2005, African Journal of Range & Forage Science, V22, P101, DOI 10.2989/10220110509485867; Ward D, 2009, BIO HABIT, P1; Ward D, 2011, PLANT ECOL, V212, P245, DOI 10.1007/s11258-010-9818-6; Wiegand K, 2006, PERSPECT PLANT ECOL, V7, P229, DOI 10.1016/j.ppees.2005.10.001; Wijesinghe DK, 2005, J ECOL, V93, P99, DOI 10.1111/j.0022-0477.2004.00934.x; Xu LK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002281; Zuur Alain F., 2009, P1	69	20	22	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92619	10.1371/journal.pone.0092619	http://dx.doi.org/10.1371/journal.pone.0092619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667837	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600055
J	Liu, CH; Xin, N; Zhai, Y; Jiang, LM; Zhai, JM; Zhang, QQ; Qi, J				Liu, Conghui; Xin, Nian; Zhai, Yi; Jiang, Liming; Zhai, Jieming; Zhang, Quanqi; Qi, Jie			Reference Gene Selection for Quantitative Real-Time RT-PCR Normalization in the Half-Smooth Tongue Sole (Cynoglossus semilaevis) at Different Developmental Stages, in Various Tissue Types and on Exposure to Chemicals	PLOS ONE			English	Article							POTENTIAL REFERENCE GENES; EXPRESSION PROFILES; JAPANESE FLOUNDER; KUPFFERS VESICLE; VALIDATION; FISH; SOFTWARE; FEMALE; ASSAYS; L.	Quantitative real time RT-PCR has been described as the most sensitive method for the detection of low abundance mRNA. To date, no reference genes have been screened in the half-smooth tongue sole (Cynoglossus semilaevis). The aim of this study was to select the most stable genes for quantitative real-time RT-PCR. Eight housekeeping genes (18S, TUBA, B2M, ACTB, EF1A, GAPDH, RPL17 and UBCE) were tested at different developmental stages, in different tissues, and following exposure to the drug SB-431542. Using geNorm, BestKeeper and NormFinder software, GAPDH/B2M, GAPDH/18S and UBCE/GAPDH were identified as the most suitable genes from samples taken of different developmental stages while 18S/RPL17 were consistently ranked as the best reference genes for different tissue types. Furthermore, TUBA/B2M, TUBA/UBCE and B2M/TUBA were found to be the most suitable genes in samples treated with the drug, SB-431542 by geNorm, BestKeeper and NormFinder respectively. Across both different developmental stages and tissue types, the combination of 18S and GAPDH was the most stable reference gene analyzed by Ref-Finder. To test and verify the screened reference genes, the expression profiles of LEFTY-normalized to the combination of GAPDH/18S and ACTB were presented. These results will be useful for future gene-expression studies in the half-smooth tongue sole.	[Liu, Conghui; Xin, Nian; Zhai, Yi; Jiang, Liming; Zhang, Quanqi; Qi, Jie] Ocean Univ China, Key Lab Marine Genet & Breeding, Qingdao, Shandong, Peoples R China; [Zhai, Jieming] Laizhou Mingbo Aquat CO Ltd, Laizhou, Shandong, Peoples R China	Ocean University of China	Qi, J (corresponding author), Ocean Univ China, Key Lab Marine Genet & Breeding, Qingdao, Shandong, Peoples R China.	qijie@ouc.edu.cn	Liu, Conghui/AAA-7192-2021	liu, cong hui/0000-0002-8374-2047	National Science Foundation of China [31072204]; National High Technology Research and Development Program of China [2012AA10A401]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This study was financially supported by grants from the National Science Foundation of China (No. 31072204) and the National High Technology Research and Development Program of China (No. 2012AA10A401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamar E, 2010, DEV DYNAM, V239, P2980, DOI 10.1002/dvdy.22431; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aroua S, 2007, GEN COMP ENDOCR, V153, P333, DOI 10.1016/j.ygcen.2007.02.027; Aursnes Ingrid A., 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-104; Bower NI, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-80; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Chechi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032265; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Concha ML, 2000, NEURON, V28, P399, DOI 10.1016/S0896-6273(00)00120-3; Crisafi F, 2011, RES MICROBIOL, V162, P223, DOI 10.1016/j.resmic.2010.11.004; Evrard E, 2010, BIOMARKERS, V15, P111, DOI 10.3109/13547500903315598; Fernandes JMO, 2008, COMP BIOCHEM PHYS B, V150, P23, DOI 10.1016/j.cbpb.2008.01.003; Francescatto L, 2010, DEVELOPMENT, V137, P2753, DOI 10.1242/dev.049627; Hashimoto H, 2002, MECH DEVELOP, V111, P17, DOI 10.1016/S0925-4773(01)00596-2; Hashimoto H, 2007, ZOOL SCI, V24, P137, DOI 10.2108/zsj.24.137; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ingerslev HC, 2006, MOL IMMUNOL, V43, P1194, DOI 10.1016/j.molimm.2005.07.009; Ji XS, 2011, MAR GENOM, V4, P9, DOI 10.1016/j.margen.2010.11.002; Jorgensen SM, 2006, MAR BIOTECHNOL, V8, P398, DOI 10.1007/s10126-005-5164-4; Kortner TM, 2011, AQUACULTURE, V318, P355, DOI 10.1016/j.aquaculture.2011.05.038; Lin XY, 2009, DEVELOPMENT, V136, P207, DOI 10.1242/dev.029561; Lland H, 2006, MYELOID LEUKENMIA ME; Ma Q, 2012, GENE, V511, P341, DOI 10.1016/j.gene.2012.09.082; Ma Q, 2011, COMP BIOCHEM PHYS B, V160, P208, DOI 10.1016/j.cbpb.2011.08.008; Mazmanian G, 2010, GENESIS, V48, P20, DOI 10.1002/dvg.20578; MINAMI T, 1982, B JPN SOC SCI FISH, V48, P1581; Nagae Masaki, 2007, Environmental Sciences, V14, P255; Okada N, 2001, CELL TISSUE RES, V304, P59, DOI 10.1007/s004410100353; Olsvik Pal A, 2008, BMC Res Notes, V1, P47, DOI 10.1186/1756-0500-1-47; Olsvik Pal A, 2007, BMC Physiol, V7, P12, DOI 10.1186/1472-6793-7-12; Overgard AC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-36; Pena Andrea A, 2010, BMC Res Notes, V3, P101, DOI 10.1186/1756-0500-3-101; Schneider I, 2010, DEV BIOL, V348, P22, DOI 10.1016/j.ydbio.2010.08.040; Small BC, 2008, COMP BIOCHEM PHYS B, V151, P296, DOI 10.1016/j.cbpb.2008.07.010; Suzuki T, 2000, APPL OPTICS, V39, P2646, DOI 10.1364/AO.39.002646; Suzuki T, 2009, DEV GROWTH DIFFER, V51, P797, DOI 10.1111/j.1440-169X.2009.01139.x; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wei D, 2011, FISH SHELLFISH IMMUN, V30, P720, DOI 10.1016/j.fsi.2010.12.028; Wloga D, 2009, DEV CELL, V16, P867, DOI 10.1016/j.devcel.2009.04.008; Xiao XQ, 2011, FISH SHELLFISH IMMUN, V30, P1072, DOI 10.1016/j.fsi.2011.02.008; Ye X, 2010, BIOTECHNOL LETT, V32, P1031, DOI 10.1007/s10529-010-0258-0; Zheng WJ, 2011, FISH SHELLFISH IMMUN, V30, P638, DOI 10.1016/j.fsi.2010.12.014; Zhong QW, 2008, MAR BIOTECHNOL, V10, P310, DOI 10.1007/s10126-007-9064-7; Zhou Rui-Xue, 2010, Zoological Research, V31, P141, DOI 10.3724/SP.J.1141.2010.02141; Zhou WB, 2010, AM J PHYSIOL-RENAL, V299, pF55, DOI 10.1152/ajprenal.00043.2010	48	31	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e91715	10.1371/journal.pone.0091715	http://dx.doi.org/10.1371/journal.pone.0091715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667563	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600012
J	Lu, YF; Liu, J; Wu, KC; Qu, Q; Fan, F; Klaassen, CD				Lu, Yuan-Fu; Liu, Jie; Wu, Kai Connie; Qu, Qiang; Fan, Fang; Klaassen, Curtis D.			Overexpression of Nrf2 Protects against Microcystin-Induced Hepatotoxicity in Mice	PLOS ONE			English	Article							LIVER-INJURY; BALB/C MICE; LR; GLUTATHIONE; APOPTOSIS; TOXICITY; PATHWAY	Oxidative stress and glutathione (GSH) depletion are implicated in mycocystin hepatotoxicity. To investigate the role of nuclear factor erythroid 2-related factor 2 (Nrf2) in microcystin-induced liver injury, Nrf2-null, wild-type, and Keap1-hepatocyte knockout (Keap1-HKO) mice were treated with microcystin (50 mu g/kg, i.p.). Blood and liver samples were collected 8 h thereafter. Microcystin increased serum alanine aminotransferase and aspartate aminotransferase activities, and caused extensive inflammation and necrosis in Nrf2-null and wild-type mice, but not in Keap1-HKO mice. Oxidative stress and inflammation are implicated in microcystin-induced hepatotoxicity, as evidenced by increased lipid peroxidation and increased expression of pro-inflammatory genes, such as neutrophil-specific chemokines mKC and MIP-2, and pro-inflammatory cytokines IL-1 beta and IL-6. The increased expression of these pro-inflammatory genes was attenuated in Keap1-HKO mice. Nrf2 and Nqo1 mRNA and protein were higher in Keap1-HKO mice at constitutive levels and after microcystin. To further investigate the mechanism of the protection, hepatic GSH and the mRNA of GSH-related enzymes were determined. Microcystin markedly depleted liver GSH by 60-70% in Nrf2 and WT mice but only 35% in Keap1-HKO mice. The mRNAs of GSH conjugation and peroxide reduction enzymes, such as Gst alpha 1, Gst alpha 4, Gst mu, and Gpx2 were higher in livers of Keap1-HKO mice, together with higher expression of the rate-limiting enzyme for GSH synthesis (Gclc). Organic anion transport polypeptides were increased by microcystin with the most increase in Keap1-HKO mice. In conclusion, this study demonstrates that higher basal levels of Nrf2 and GSH-related genes in Keap1-HKO mice prevented microcystin-induced oxidative stress and liver injury.	[Lu, Yuan-Fu; Liu, Jie; Wu, Kai Connie; Qu, Qiang; Fan, Fang; Klaassen, Curtis D.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Lu, Yuan-Fu; Liu, Jie] Zunyi Med Coll, Minist Educ, Key Lab Basic Pharmacol, Zunyi, Peoples R China	University of Kansas; University of Kansas Medical Center; Zunyi Medical University	Klaassen, CD (corresponding author), Univ Kansas, Med Ctr, Kansas City, KS 66103 USA.	curtisklaassenphd@gmail.com	fan, fang/GQY-9173-2022; Fan, Fang/GRO-2696-2022		National Institutes of Health (NIH) [DK-081461, ES-019487]; Chinese National Science Foundation [81160415]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019487] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health (NIH) grants DK-081461 and ES-019487, as well as by a Chinese National Science Foundation Grant 81160415. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff K, 2001, VET HUM TOXICOL, V43, P294; Buratti FM, 2011, CHEM RES TOXICOL, V24, P926, DOI 10.1021/tx2000976; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Fischer A, 2010, TOXICOL APPL PHARM, V245, P9, DOI 10.1016/j.taap.2010.02.006; Gan NQ, 2010, CHEM RES TOXICOL, V23, P1477, DOI 10.1021/tx1001628; Gan NQ, 2010, TOXICOL APPL PHARM, V247, P129, DOI 10.1016/j.taap.2010.06.005; Gehringer MM, 2004, INT J BIOCHEM CELL B, V36, P931, DOI 10.1016/j.biocel.2003.10.012; Jayaraj R, 2006, TOXICOLOGY, V220, P136, DOI 10.1016/j.tox.2005.12.007; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Klaassen CD, 2010, TOXICOL APPL PHARM, V244, P57, DOI 10.1016/j.taap.2010.01.013; Komatsu M, 2007, TOXICOL SCI, V97, P407, DOI 10.1093/toxsci/kfm054; KONDO F, 1992, CHEM RES TOXICOL, V5, P591, DOI 10.1021/tx00029a002; Konrad FM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/740987; Lacour Sandrine, 2005, Cancer Biomarkers, V1, P29; Liu J, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/305861; Lu H, 2008, TOXICOL SCI, V103, P35, DOI 10.1093/toxsci/kfn038; Okada K, 2009, BIOCHEM BIOPH RES CO, V389, P431, DOI 10.1016/j.bbrc.2009.08.156; Oudra B, 2009, ENVIRON MONIT ASSESS, V149, P437, DOI 10.1007/s10661-008-0220-y; Sass G, 2012, Z GASTROENTEROL, V50, P34, DOI 10.1055/s-0031-1282046; Sun XY, 2011, TOXICOL APPL PHARM, V255, P9, DOI 10.1016/j.taap.2011.05.011; Svircev Z, 2010, J ENVIRON SCI HEAL C, V28, P39, DOI 10.1080/10590500903585382; Vareli K, 2013, MAR DRUGS, V11, P2751, DOI 10.3390/md11082751; Weng D, 2007, TOXICOLOGY, V232, P15, DOI 10.1016/j.tox.2006.12.010; Wu KC, 2012, TOXICOL APPL PHARM, V263, P14, DOI 10.1016/j.taap.2012.05.017; Wu KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039006; Wu KC, 2011, TOXICOL SCI, V123, P590, DOI 10.1093/toxsci/kfr183	26	20	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93013	10.1371/journal.pone.0093013	http://dx.doi.org/10.1371/journal.pone.0093013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667526	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600126
J	Sato, A; Nakashima, H; Nakashima, M; Ikarashi, M; Nishiyama, K; Kinoshita, M; Seki, S				Sato, Atsushi; Nakashima, Hiroyuki; Nakashima, Masahiro; Ikarashi, Masami; Nishiyama, Kiyoshi; Kinoshita, Manabu; Seki, Shuhji			Involvement of the TNF and FasL Produced by CD11b Kupffer Cells/Macrophages in CCl4-Induced Acute Hepatic Injury	PLOS ONE			English	Article							ENCAPSULATED DICHLOROMETHYLENE DIPHOSPHONATE; PHAGOCYTIC B-CELLS; AG+ T-CELLS; MOUSE-LIVER; CARBON-TETRACHLORIDE; ALPHA-GALACTOSYLCERAMIDE; INNATE IMMUNITY; IN-VITRO; MICE; MACROPHAGE	We previously reported that F4/80(+) Kupffer cells are subclassified into CD68(+) Kupffer cells with phagocytic and ROS producing capacity, and CD11b(+) Kupffer cells with cytokine-producing capacity. Carbon tetrachloride (CCl4)-induced hepatic injury is a well-known chemical-induced hepatocyte injury. In the present study, we investigated the immunological role of Kupffer cells/macrophages in CCl4-induced hepatitis in mice. The immunohistochemical analysis of the liver and the flow cytometry of the liver mononuclear cells showed that clodronate liposome (c-lipo) treatment greatly decreased the spindle-shaped F4/80(+) or CD68(+) cells, while the oval-shaped F4/80(+) CD11b(+) cells increased. Notably, severe hepatic injury induced by CCl4 was further aggravated by c-lipo-pretreatment. The population of CD11b(+) Kupffer cells/macrophages dramatically increased 24 hour (h) after CCl4 administration, especially in c-lipo-pretreated mice. The CD11b(+) Kupffer cells expressed intracellular TNF and surface Fas-ligand (FasL). Furthermore, anti-TNF Ab pretreatment (which decreased the FasL expression of CD11b(+) Kupffer cells), anti-FasL Ab pretreatment or gld/gld mice attenuated the liver injury induced by CCl4. CD1d-/- mouse and cell depletion experiments showed that NKT cells and NK cells were not involved in the hepatic injury. The adoptive transfer and cytotoxic assay against primary cultured hepatocytes confirmed the role of CD11b(+) Kupffer cells in CCl4-induced hepatitis. Interestingly, the serum MCP-1 level rapidly increased and peaked at six h after c-lipo pretreatment, suggesting that the MCP-1 produced by c-lipo-phagocytized CD68(+) Kupffer cells may recruit CD11b(+) macrophages from the periphery and bone marrow. The CD11b(+) Kupffer cells producing TNF and FasL thus play a pivotal role in CCl4-induced acute hepatic injury.	[Sato, Atsushi; Nakashima, Hiroyuki; Nakashima, Masahiro; Ikarashi, Masami; Kinoshita, Manabu; Seki, Shuhji] Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama 359, Japan; [Nishiyama, Kiyoshi] Natl Def Med Coll, Dept Surg 1, Tokorozawa, Saitama 359, Japan	National Defense Medical College - Japan; National Defense Medical College - Japan	Nakashima, H (corresponding author), Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama 359, Japan.	hiro1618@ndmc.ac.jp			National Defense Medical College; JSPS KAKENHI [25460508]; Takeda Science Foundation	National Defense Medical College; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by a grant from the National Defense Medical College to S. Seki, JSPS KAKENHI Grant Number 25460508, and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; BRATTIN W J, 1985, Journal of Free Radicals in Biology and Medicine, V1, P27, DOI 10.1016/0748-5514(85)90026-1; Cancro MP, 2012, J LEUKOCYTE BIOL, V91, P519, DOI 10.1189/jlb.1111540; CLAWSON GA, 1989, PATHOL IMMUNOPATH R, V8, P104, DOI 10.1159/000157141; Dambach DM, 2002, HEPATOLOGY, V35, P1093, DOI 10.1053/jhep.2002.33162; GALLIGANI L, 1979, TOXICOL APPL PHARM, V48, P131, DOI 10.1016/S0041-008X(79)80015-0; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Ikarashi M, 2013, J LEUKOCYTE BIOL, V94, P1325, DOI 10.1189/jlb.0313144; Inui T, 2005, J HEPATOL, V43, P670, DOI 10.1016/j.jhep.2005.02.027; Inui T, 2002, J IMMUNOL, V169, P6127, DOI 10.4049/jimmunol.169.11.6127; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kawabata T, 2008, HEPATOLOGY, V48, P1586, DOI 10.1002/hep.22489; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Liu C, LAB INVEST, V90, P1805; Liu ZX, 2004, GASTROENTEROLOGY, V127, P1760, DOI 10.1053/j.gastro.2004.08.053; Louis H, 1998, HEPATOLOGY, V28, P1607, DOI 10.1002/hep.510280621; Matsumoto A, 2006, J HEPATOL, V45, P290, DOI 10.1016/j.jhep.2006.02.012; Naito M, 1996, J LEUKOCYTE BIOL, V60, P337, DOI 10.1002/jlb.60.3.337; Nakagawa R, 2001, J IMMUNOL, V166, P6578, DOI 10.4049/jimmunol.166.11.6578; Nakashima H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049339; Nakashima H, 2008, HEPATOLOGY, V48, P1979, DOI 10.1002/hep.22561; Nakashima M, 2012, J LEUKOCYTE BIOL, V91, P537, DOI 10.1189/jlb.0411214; RABINOWITZ SS, 1991, J EXP MED, V174, P827, DOI 10.1084/jem.174.4.827; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; RECKNAGEL RO, 1989, PHARMACOL THERAPEUT, V43, P139, DOI 10.1016/0163-7258(89)90050-8; SANCHEZMADRID F, 1983, J EXP MED, V158, P586, DOI 10.1084/jem.158.2.586; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Seki S., 2012, IMMUNOGASTROENTEROLO, V1, P76; Seki S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/868345; Shono S, 2011, SHOCK, V36, P484, DOI 10.1097/SHK.0b013e31822dc6e4; SMITH MJ, 1987, J CELL SCI, V87, P113; TAMAYO RP, 1983, HEPATOLOGY, V3, P112; UNAKAR NJ, 1966, ARCH PATHOL, V82, P170; VANROOIJEN N, 1990, CELL TISSUE RES, V260, P215, DOI 10.1007/BF00318625; Yamamoto T, 1996, AM J PATHOL, V149, P1271; Yang YP, 2003, J HEPATOL, V39, P200, DOI 10.1016/S0168-8278(03)00229-0	37	58	60	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92515	10.1371/journal.pone.0092515	http://dx.doi.org/10.1371/journal.pone.0092515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667392	Green Submitted, gold, Green Published			2022-12-25	WOS:000333675600045
J	Zhang, HJ; Ding, WX; He, XH; Yu, HY; Fan, JL; Liu, DY				Zhang, Huanjun; Ding, Weixin; He, Xinhua; Yu, Hongyan; Fan, Jianling; Liu, Deyan			Influence of 20-Year Organic and Inorganic Fertilization on Organic Carbon Accumulation and Microbial Community Structure of Aggregates in an Intensively Cultivated Sandy Loam Soil	PLOS ONE			English	Article							PARTICLE-SIZE FRACTIONS; LONG-TERM APPLICATION; FATTY-ACIDS; NO-TILLAGE; MATTER; BIOMASS; MANURE; BACTERIAL; FOREST; SEQUESTRATION	To evaluate the long-term effect of compost (CM) and inorganic fertilizer (NPK) application on microbial community structure and organic carbon (OC) accumulation at aggregate scale, soils from plots amended with CM, NPK and no fertilizer (control) for 20 years (1989-2009) were collected. Soil was separated into large macroaggregate (>2,000 mu m), small macroaggregate (250-2,000 mu m), microaggregate (53-250 mu m), silt (2-53 mu m) and clay fraction (<2 mu m) by wet-sieving, and their OC concentration and phospholipid fatty acids (PLFA) were measured. The 20-year application of compost significantly (P<0.05) increased OC by 123-134% and accelerated the formation of macroaggregates, but decreased soil oxygen diffusion coefficient. NPK mainly increased OC in macroaggregates and displayed weaker influence on aggregation. Bacteria distributed in all aggregates, while fungi and actinobacteria were mainly in macroaggregates and microaggregates. The ratio of monounsaturated to branched (M/B) PLFAs, as an indicator for the ratio of aerobic to anaerobic microorganisms, increased inversely with aggregate size. Both NPK and especially CM significantly (P<0.05) decreased M/B ratios in all aggregates except the silt fraction compared with the control. The increased organic C in aggregates significantly (P<0.05) negatively correlated with M/B ratios under CM and NPK. Our study suggested that more efficient OC accumulations in aggregates under CM-treated than under NPK-treated soil was not only due to a more effective decrease of actinobacteria, but also a decrease of monounsaturated PLFAs and an increase of branched PLFAs. Aggregations under CM appear to alter micro-habitats to those more suitable for anaerobes, which in turn boosts OC accumulation.	[Zhang, Huanjun; Ding, Weixin; Yu, Hongyan; Fan, Jianling; Liu, Deyan] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [He, Xinhua] Forests NSW, NSW Dept Primary Ind, West Pennant Hills, NSW, Australia; [He, Xinhua] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia	Chinese Academy of Sciences; Institute of Soil Science, CAS; NSW Department of Primary Industries; University of Western Australia	Ding, WX (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	wxding@issas.ac.cn	Fan, Jianling/AAQ-2614-2021; Ding, WeiXin/L-8657-2013; Deyan, Liu/AAZ-2671-2020; Yu, Houyong/R-1592-2016; He, Xinhua/B-8047-2015	Fan, Jianling/0000-0003-3048-2621; Yu, Houyong/0000-0002-6543-5924; He, Xinhua/0000-0002-5570-3454	National Basic Research Program of China [2011CB100503]; Chinese Academy of Sciences [KSCX2-EW-N-08]; National Science Foundation of China [41171190]	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2011CB100503), the Chinese Academy of Sciences (KSCX2-EW-N-08), and National Science Foundation of China (41171190). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagoz Z, 2009, SOIL TILL RES, V103, P419, DOI 10.1016/j.still.2008.12.006; Anders MM, 2010, SOIL SCI SOC AM J, V74, P1339, DOI 10.2136/sssaj2009.0280; Aoyama M, 1999, CAN J SOIL SCI, V79, P295, DOI 10.4141/S98-049; Bach EM, 2010, SOIL BIOL BIOCHEM, V42, P2182, DOI 10.1016/j.soilbio.2010.08.014; BEGUIN P, 1994, FEMS MICROBIOL REV, V13, P25, DOI 10.1016/0168-6445(94)90099-X; Bhattacharyya R, 2010, NUTR CYCL AGROECOSYS, V86, P1, DOI 10.1007/s10705-009-9270-y; Billings SA, 2008, GLOBAL CHANGE BIOL, V14, P1025, DOI 10.1111/j.1365-2486.2008.01562.x; Blagodatsky S, 2012, SOIL BIOL BIOCHEM, V47, P78, DOI 10.1016/j.soilbio.2011.12.015; Bohme L, 2005, AGR ECOSYST ENVIRON, V109, P141, DOI 10.1016/j.agee.2005.01.017; Bossio DA, 2006, SOIL BIOL BIOCHEM, V38, P1223, DOI 10.1016/j.soilbio.2005.09.027; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Bossuyt H, 2002, SOIL SCI SOC AM J, V66, P1965, DOI 10.2136/sssaj2002.1965; Brant JB, 2006, SOIL BIOL BIOCHEM, V38, P2219, DOI 10.1016/j.soilbio.2006.01.022; Carter M. R., 1993, SOIL SAMPLING METHOD, P190; Chenu C, 2001, BIOL FERT SOILS, V34, P349, DOI 10.1007/s003740100419; Davis GB, 1998, IAHS-AISH P, P300; Ding HB, 2005, MAR CHEM, V93, P1, DOI 10.1016/j.marchem.2004.04.004; Ding WX, 2007, SOIL BIOL BIOCHEM, V39, P669, DOI 10.1016/j.soilbio.2006.09.024; Dungait JAJ, 2012, GLOBAL CHANGE BIOL, V18, P1781, DOI 10.1111/j.1365-2486.2012.02665.x; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Feng XJ, 2009, SOIL BIOL BIOCHEM, V41, P804, DOI 10.1016/j.soilbio.2009.01.020; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Hassink J, 1997, PLANT SOIL, V191, P77, DOI 10.1023/A:1004213929699; Helgason BL, 2010, APPL SOIL ECOL, V46, P390, DOI 10.1016/j.apsoil.2010.10.002; Jastrow JD, 1998, SOIL BIOL BIOCHEM, V30, P905, DOI 10.1016/S0038-0717(97)00207-1; Jiang X, 2011, APPL SOIL ECOL, V48, P168, DOI 10.1016/j.apsoil.2011.03.009; John B., 2003, THESIS GEORG AUGUST; Jurgens K, 1999, APPL ENVIRON MICROB, V65, P1241; Kandeler E, 2000, BIOL FERT SOILS, V32, P390, DOI 10.1007/s003740000268; KILLHAM K, 1993, SOIL BIOL BIOCHEM, V25, P57, DOI 10.1016/0038-0717(93)90241-3; Kindler R, 2009, ORG GEOCHEM, V40, P29, DOI 10.1016/j.orggeochem.2008.09.005; Kolbl A, 2004, J PLANT NUTR SOIL SC, V167, P45, DOI 10.1002/jpln.200321185; Kong AYY, 2005, SOIL SCI SOC AM J, V69, P1078, DOI 10.2136/sssaj2004.0215; Kutilek M., 1994, SOIL HYDROLOGY; Ladd JN, 1996, SOIL BIOL BIOCHEM, V28, P893, DOI 10.1016/0038-0717(96)00069-7; Manna MC, 2006, SOIL SCI SOC AM J, V70, P121, DOI 10.2136/sssaj2005.0180; Mikha MM, 2004, SOIL SCI SOC AM J, V68, P809, DOI 10.2136/sssaj2004.0809; Olsson PA, 1999, FEMS MICROBIOL ECOL, V29, P303, DOI 10.1111/j.1574-6941.1999.tb00621.x; Petersen SO, 1997, GEODERMA, V78, P181, DOI 10.1016/S0016-7061(97)00032-3; Ponder F, 2002, APPL SOIL ECOL, V19, P173, DOI 10.1016/S0929-1393(01)00182-2; RAJENDRAN N, 1992, APPL ENVIRON MICROB, V58, P562, DOI 10.1128/AEM.58.2.562-571.1992; Rappoldt C, 1999, GEODERMA, V88, P329, DOI 10.1016/S0016-7061(98)00112-8; Ruamps LS, 2011, SOIL BIOL BIOCHEM, V43, P280, DOI 10.1016/j.soilbio.2010.10.010; Said-Pullicino D, 2007, CHEMOSPHERE, V66, P2166, DOI 10.1016/j.chemosphere.2006.09.010; Sarkar S, 2003, J AGR SCI-CAMBRIDGE, V140, P419, DOI 10.1017/S0021859603003186; Sessitsch A, 2001, APPL ENVIRON MICROB, V67, P4215, DOI 10.1128/AEM.67.9.4215-4224.2001; Simpson AJ, 2007, ENVIRON SCI TECHNOL, V41, P876, DOI 10.1021/es061576c; SINGH S, 1995, SOIL BIOL BIOCHEM, V27, P1027, DOI 10.1016/0038-0717(95)00014-6; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Six J, 2000, SOIL SCI SOC AM J, V64, P681, DOI 10.2136/sssaj2000.642681x; Soil Survey Staff, 2010, KEYS SOIL TAX, P106; Spring S, 2000, FEMS MICROBIOL REV, V24, P573, DOI 10.1016/S0168-6445(00)00046-2; Strong DT, 2004, EUR J SOIL SCI, V55, P739, DOI 10.1111/j.1365-2389.2004.00639.x; Su YZ, 2006, NUTR CYCL AGROECOSYS, V75, P285, DOI 10.1007/s10705-006-9034-x; Sundh I, 1997, APPL ENVIRON MICROB, V63, P1476, DOI 10.1128/AEM.63.4.1476-1482.1997; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Verchot LV, 2011, GEODERMA, V161, P182, DOI 10.1016/j.geoderma.2010.12.017; Wixon DL, 2013, SOIL BIOL BIOCHEM, V57, P769, DOI 10.1016/j.soilbio.2012.08.016; Wright AL, 2004, SOIL SCI SOC AM J, V68, P507, DOI 10.2136/sssaj2004.0507; Yu HY, 2012, SOIL TILL RES, V124, P170, DOI 10.1016/j.still.2012.06.011; Yu HY, 2012, BIOL FERT SOILS, V48, P325, DOI 10.1007/s00374-011-0629-2; Zhuang J, 2008, SOIL SCI SOC AM J, V72, P212, DOI 10.2136/sssaj2007.0001S6; Zibilske LM, 2007, SOIL SCI SOC AM J, V71, P133, DOI 10.2136/sssaj2006.0167	63	64	73	7	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92733	10.1371/journal.pone.0092733	http://dx.doi.org/10.1371/journal.pone.0092733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667543	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600068
J	Tonkin, ML; Beck, JR; Bradley, PJ; Boulanger, MJ				Tonkin, Michelle L.; Beck, Josh R.; Bradley, Peter J.; Boulanger, Martin J.			The Inner Membrane Complex Sub-compartment Proteins Critical for Replication of the Apicomplexan Parasite Toxoplasma gondii Adopt a Pleckstrin Homology Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Division; Parasite; Protein-Protein Interactions; Structural Biology; X-ray Crystallography; Apicomplexa; Inner Membrane Complex; Pleckstrin Homology Fold; Toxoplasma gondii; Endodyogeny	STRUCTURAL BASIS; DOMAINS; IDENTIFICATION; LOCALIZATION; SARCOCYSTIS; GLIDEOSOME; COMPONENT; ALIGNMENT; ACCURACY; SEQUENCE	Background: Inner membrane complex sub-compartment Proteins (ISPs) are critical for proper cell division of apicomplexan parasites, but the mechanism is unknown. Results: ISPs adopt a pleckstrin homology (PH)-fold yet do not retain phospholipid-binding activity. Conclusion: ISPs appear to repurpose the phospholipid-binding site to recruit protein partners. Significance: First structural characterization of an ISP from any organism. Toxoplasma gondii, an apicomplexan parasite prevalent in developed nations, infects up to one-third of the human population. The success of this parasite depends on several unique structures including an inner membrane complex (IMC) that lines the interior of the plasma membrane and contains proteins important for gliding motility and replication. Of these proteins, the IMC sub-compartment proteins (ISPs) have recently been shown to play a role in asexual T. gondii daughter cell formation, yet the mechanism is unknown. Complicating mechanistic characterization of the ISPs is a lack of sequence identity with proteins of known structure or function. In support of elucidating the function of ISPs, we first determined the crystal structures of representative members TgISP1 and TgISP3 to a resolution of 2.10 and 2.32 , respectively. Structural analysis revealed that both ISPs adopt a pleckstrin homology fold often associated with phospholipid binding or protein-protein interactions. Substitution of basic for hydrophobic residues in the region that overlays with phospholipid binding in related pleckstrin homology domains, however, suggests that ISPs do not retain phospholipid binding activity. Consistent with this observation, biochemical assays revealed no phospholipid binding activity. Interestingly, mapping of conserved surface residues combined with crystal packing analysis indicates that TgISPs have functionally repurposed the phospholipid-binding site likely to coordinate protein partners. Recruitment of larger protein complexes may also be aided through avidity-enhanced interactions resulting from multimerization of the ISPs. Overall, we propose a model where TgISPs recruit protein partners to the IMC to ensure correct progression of daughter cell formation.	[Tonkin, Michelle L.; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Beck, Josh R.; Bradley, Peter J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of Victoria; University of California System; University of California Los Angeles	Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	mboulang@uvic.ca			Canadian Institutes for Health Research [MOP82915]; National Institutes of Health Microbial Pathogenesis [T32 AI07323, RO1 AI064616]; Natural Sciences and Engineering Research Council of Canada Alexander Graham Bell Canada Graduate Scholarship [CGSD3]; Ventura Neale Trust Endowed PEO Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064616, T32AI007323] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health Microbial Pathogenesis; Natural Sciences and Engineering Research Council of Canada Alexander Graham Bell Canada Graduate Scholarship; Ventura Neale Trust Endowed PEO Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Canadian Institutes for Health Research Grant MOP82915 (to M. J. B.), a National Institutes of Health Microbial Pathogenesis Training Grant T32 AI07323 (to J. R. B.), and Grant RO1 AI064616 (to P. J. B.).; Supported by a Natural Sciences and Engineering Research Council of Canada Alexander Graham Bell Canada Graduate Scholarship (CGSD3) and a Ventura Neale Trust Endowed PEO Scholar Award.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Chaudhary K, 2005, J BIOL CHEM, V280, P22053, DOI 10.1074/jbc.M503178200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; de Miguel N, 2008, BIOL CELL, V100, P479, DOI 10.1042/BC20080004; DHAESE J, 1977, INT J PARASITOL, V7, P505, DOI 10.1016/0020-7519(77)90014-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Fung CN, 2012, MOL BIOCHEM PARASIT, V184, P99, DOI 10.1016/j.molbiopara.2012.05.002; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Morrissette NS, 1997, J CELL SCI, V110, P35; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PORCHET E, 1977, Z PARASITENKD, V54, P101, DOI 10.1007/BF00380795; Poulin B, 2013, BIOL OPEN, V2, P1160, DOI 10.1242/bio.20136163; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; Rayavara K, 2009, MOL BIOCHEM PARASIT, V167, P135, DOI 10.1016/j.molbiopara.2009.05.006; Scheffzek K, 2012, FEBS LETT, V586, P2662, DOI 10.1016/j.febslet.2012.06.006; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Striepen B, 2007, PLOS PATHOG, V3, P691, DOI 10.1371/journal.ppat.0030078; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tonkin ML, 2012, ACTA CRYSTALLOGR F, V68, P832, DOI 10.1107/S174430911202297X; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu Q, 2010, J MOL BIOL, V396, P31, DOI 10.1016/j.jmb.2009.11.006; Yao LB, 1999, J BIOL CHEM, V274, P19752, DOI 10.1074/jbc.274.28.19752; Zhou MM, 1996, NAT STRUCT BIOL, V3, P388, DOI 10.1038/nsb0496-388	50	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13962	13973		10.1074/jbc.M114.548891	http://dx.doi.org/10.1074/jbc.M114.548891			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24675080	hybrid, Green Published			2022-12-25	WOS:000335984600027
J	Chen, RJ; Chang, CY; Chang, LW; Siao, SH; Ho, YS; Wu, CH; Foo, NP; Lin, PP; Wang, YJ				Chen, Rong-Jane; Chang, Chu-Yung; Chang, Louis W.; Siao, Shih-He; Ho, Yuan-Soon; Wu, Chih-Hsiung; Foo, Ning-Ping; Lin, Pinpin; Wang, Ying-Jan			The Regulation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-Induced Lung Tumor Promotion by Estradiol in Female A/J Mice	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; NF-KAPPA-B; ESTROGEN-RECEPTOR; CANCER; BETA; EXPRESSION; CELLS; WOMEN; EPIDEMIOLOGY; EXPOSURE	Epidemiological studies indicate that women are at a higher risk developing lung cancer than men are. It is suggested that estrogen is one of the most important factors in lung cancer development in females. Additionally, cigarette smoke, and environmental pollutants, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), may play salient roles in female lung carcinogenesis. However, the mechanisms responsible for the interaction of these factors in the promotion of lung cancer are still poorly understood. The present study was designed to explore two ideas: first, the synergistic lung tumorigenic effects of 4-(methylnitrosamino)-1-(3-pyridyl)-butanol (NNK) combined with TCDD, 17 beta-estradiol (E2) or both through a long-term treatment experiment, and second, to identify early changes in the inflammatory and signaling pathways through short-term treatment experiments. The results indicate that A/J mice given E2 had strong effects in potentiating NNK-induced activation of MAPK signaling, NF kappa B, and COX-2 expression. In the long-term exposure model, E2 had a strong tumor promoting effect, whereas TCDD antagonized this effect in A/J mice. We conclude that treatment with NNK combined with either E2 or TCDD induces lung carcinogenesis and the promotion effects could be correlated with lung inflammation. E2 was shown to potentiate NNK-induced inflammation, cell proliferation, thereby leading to lung tumorigenesis.	[Chen, Rong-Jane; Chang, Chu-Yung; Siao, Shih-He; Foo, Ning-Ping; Wang, Ying-Jan] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Chen, Rong-Jane] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Ho, Yuan-Soon] Taipei Med Univ, Sch Med Technol & Biotechnol, Taipei, Taiwan; [Wu, Chih-Hsiung] Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Sch Med, Taipei, Taiwan; [Ho, Yuan-Soon; Wu, Chih-Hsiung] Taipei Med Univ, Ctr Excellence Canc Res, Taipei, Taiwan; [Foo, Ning-Ping] Chi Mei Med Ctr, Dept Emergency Med, Tainan, Taiwan; [Foo, Ning-Ping] China Med Univ, Tainan Municipal An Nan Hosp, Dept Emergency Med, Tainan, Taiwan; [Lin, Pinpin] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan Town, Taiwan	National Cheng Kung University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Chi Mei Hospital; China Medical University Taiwan; National Health Research Institutes - Taiwan	Lin, PP (corresponding author), Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan Town, Taiwan.	pplin@nhri.org.tw; yjwang@mail.ncku.edu.tw	Lin, Pinpin/B-2668-2010; Lin, PinPin/A-2006-2019	Lin, Pinpin/0000-0001-5459-907X; Lin, PinPin/0000-0001-5459-907X	National Science Council (NSC) [102-2314-B-006-034]; Taipei Medical University, Center of Excellence for Cancer Research (TMU-CECR) [DOH101-TD-C-111-008]; Division of Environmental Health and Occupation Medicine (DEHOM), National Health Research Institutes (NHRI), Taiwan [EO-097-PP-03]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Taipei Medical University, Center of Excellence for Cancer Research (TMU-CECR); Division of Environmental Health and Occupation Medicine (DEHOM), National Health Research Institutes (NHRI), Taiwan	The study by the National Science Council (NSC 102-2314-B-006-034), Taipei Medical University, Center of Excellence for Cancer Research (TMU-CECR, DOH101-TD-C-111-008), and (EO-097-PP-03) from the Division of Environmental Health and Occupation Medicine (DEHOM), National Health Research Institutes (NHRI), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2011, RESPIRATION, V81, P265, DOI 10.1159/000324601; Al-Wadei HAN, 2010, LUNG CANCER, V69, P33, DOI 10.1016/j.lungcan.2009.09.011; Anumanthan G, 2005, BRIT J CANCER, V93, P1157, DOI 10.1038/sj.bjc.6602831; Babbar N, 2006, CANCER RES, V66, P11125, DOI 10.1158/0008-5472.CAN-06-3174; Barta P, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-4; Belani CP, 2007, LUNG CANCER, V55, P15, DOI 10.1016/j.lungcan.2006.09.008; Belcher SM, 2012, ENDOCRINOLOGY, V153, P712, DOI 10.1210/en.2011-1772; Biselli PJC, 2011, BRAZ J MED BIOL RES, V44, P460, DOI 10.1590/S0100-879X2011007500040; Chang LW, 2007, CARCINOGENESIS, V28, P1606, DOI 10.1093/carcin/bgm013; Chen RJ, 2011, J ONCOL, V2011, DOI 10.1155/2011/654931; Chen ZL, 2011, CANCER LETT, V308, P14, DOI 10.1016/j.canlet.2011.04.007; Egleston BL, 2009, SEMIN ONCOL, V36, P506, DOI 10.1053/j.seminoncol.2009.09.003; Fu JB, 2005, CHEST, V127, P768, DOI 10.1378/chest.127.3.768; Fucic A, 2010, TOXICOL PATHOL, V38, P849, DOI 10.1177/0192623310378136; Gordon T, 2009, CANCER LETT, V275, P213, DOI 10.1016/j.canlet.2008.10.012; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hammoud Z, 2008, ENDOCR-RELAT CANCER, V15, P475, DOI 10.1677/ERC-08-0002; IgnarTrowbridge DM, 1996, ENDOCRINOLOGY, V137, P1735, DOI 10.1210/en.137.5.1735; Kalkhoven E, 1996, J BIOL CHEM, V271, P6217, DOI 10.1074/jbc.271.11.6217; Karabela SP, 2011, NEOPLASIA, V13, P1143, DOI 10.1593/neo.111224; Kitajima M, 2004, REPROD TOXICOL, V18, P793, DOI 10.1016/j.reprotox.2004.04.012; Klass BR, 2009, POSTGRAD MED J, V85, P9, DOI 10.1136/pgmj.2008.069831; Kohle C, 2002, ARCH BIOCHEM BIOPHYS, V402, P172, DOI 10.1016/S0003-9861(02)00076-0; Liu C, 2011, CANCER PREV RES, V4, P1255, DOI 10.1158/1940-6207.CAPR-10-0384; Majidi M, 2007, CANCER RES, V67, P6863, DOI 10.1158/0008-5472.CAN-07-0483; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; Mountzios G, 2008, CLIN CANCER RES, V14, P4096, DOI 10.1158/1078-0432.CCR-07-4150; MOUSTAKAS A, 1993, J BIOL CHEM, V268, P22215; Niikawa H, 2008, CLIN CANCER RES, V14, P4417, DOI 10.1158/1078-0432.CCR-07-1950; Palvimo JJ, 1996, J BIOL CHEM, V271, P24151, DOI 10.1074/jbc.271.39.24151; Peng J, 2013, CARCINOGENESIS; Seymour Brian W P, 2002, Dev Immunol, V9, P47, DOI 10.1080/1044667021000003989; Siegfried JM, 2009, SEMIN ONCOL, V36, P524, DOI 10.1053/j.seminoncol.2009.10.004; Stabile LP, 2002, CANCER RES, V62, P2141; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Takemoto K, 2004, ARCH TOXICOL, V78, P309, DOI 10.1007/s00204-004-0550-7; Tan AR, 2009, BREAST CANCER RES TR, V115, P453, DOI 10.1007/s10549-008-0184-1; Tang HX, 2013, INT J CANCER, V133, P2473, DOI 10.1002/ijc.28262; Thomas L, 2005, CHEST, V128, P370, DOI 10.1378/chest.128.1.370; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; Wang WL, 1998, ARCH BIOCHEM BIOPHYS, V356, P239, DOI 10.1006/abbi.1998.0782; Wang YJ, 2011, J HAZARD MATER, V186, P869, DOI 10.1016/j.jhazmat.2010.11.082; Wolff H, 1998, CANCER RES, V58, P4997; Zang EA, 1996, JNCI-J NATL CANCER I, V88, P183, DOI 10.1093/jnci/88.3-4.183	45	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93152	10.1371/journal.pone.0093152	http://dx.doi.org/10.1371/journal.pone.0093152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682076	Green Published, gold, Green Submitted			2022-12-25	WOS:000333678100027
J	Song, Y; Demmer, DL; Pinniger, GJ; Lavin, T; MacMillan, MV; Pillow, JJ; Bakker, AJ				Song, Yong; Demmer, Denise L.; Pinniger, Gavin J.; Lavin, Tina; MacMillan, Mia V.; Pillow, Jane J.; Bakker, Anthony J.			Effect of Maternal Steroid on Developing Diaphragm Integrity	PLOS ONE			English	Article							RAT DIAPHRAGM; SKELETAL-MUSCLE; CONTRACTILE PROPERTIES; MECHANISMS; FETAL; STIMULATION; CAPACITY; PRETERM	Antenatal steroids reduce the severity of initial respiratory distress of premature newborn babies but may have an adverse impact on other body organs. The study aimed to examine the effect of maternal steroids on postnatal respiratory muscle function during development and elucidate the mechanisms underlying the potential myopathy in newborn rats. Pregnant rats were treated with intramuscular injections of 0.5 mg/kg betamethasone 7 d and 3 d before birth. Newborn diaphragms were dissected for assessment of contractile function at 2 d, 7 d or 21 d postnatal age (PNA), compared with age-matched controls. The expression of myosin heavy chain (MHC) isoforms and atrophy-related genes and activity of intracellular molecular signalling were measured using quantitative PCR and/or Western blot. With advancing PNA, neonatal MHC gene expression decreased progressively while MHC IIb and IIx isoforms increased. Protein metabolic signalling showed high baseline activity at 2 d PNA, and significantly declined at 7 d and 21 d. Antenatal administration of betamethasone significantly decreased diaphragm force production, fatigue resistance, total fast fibre content and anabolic signalling activity (Akt and 4E-BP1) in 21 d diaphragm. These responses were not observed in 2 d or 7 d postnatal diaphragm. Results demonstrate that maternal betamethasone treatment causes postnatal diaphragmatic dysfunction at 21 d PNA, which is attributed to MHC II protein loss and impairment of the anabolic signalling pathway. Developmental modifications in MHC fibre composition and protein signalling account for the age-specific diaphragm dysfunction.	[Song, Yong; Demmer, Denise L.; Pinniger, Gavin J.; Lavin, Tina; MacMillan, Mia V.; Pillow, Jane J.; Bakker, Anthony J.] Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia; [Song, Yong; Lavin, Tina; Pillow, Jane J.] Univ Western Australia, Ctr Neonatal Res & Educ, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Pillow, Jane J.] King Edward Mem Hosp, Women & Newborns Hlth Serv, Perth, WA, Australia; [Pillow, Jane J.] Princess Margaret Hosp, Perth, WA, Australia	University of Western Australia; University of Western Australia; King Edward Memorial Hospital	Bakker, AJ (corresponding author), Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia.	tony.bakker@uwa.edu.au	Pinniger, Gavin/F-1421-2013; Song, Yong/C-2407-2013; Pillow, Jane/A-3335-2009	Pinniger, Gavin/0000-0002-4400-0817; Pillow, Jane/0000-0002-6500-0138; Song, Yong/0000-0002-8178-5641; Demmer, Denise/0000-0003-0751-7304	University of Western Australia Research Development Award; Women and Infants Research Foundation; National Health and Medical Research Foundation [APP1010665]	University of Western Australia Research Development Award; Women and Infants Research Foundation; National Health and Medical Research Foundation	This study was supported by the University of Western Australia Research Development Award (YS), Women and Infants Research Foundation (TL) and National Health and Medical Research Foundation APP1010665 (JJP, GJP, AJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davis TA, 2001, AM J PHYSIOL-ENDOC M, V280, pE770, DOI 10.1152/ajpendo.2001.280.5.E770; Davis TA, 2009, CURR OPIN CLIN NUTR, V12, P78, DOI 10.1097/MCO.0b013e32831cef9f; Dehoux MJM, 2003, FEBS LETT, V544, P214, DOI 10.1016/S0014-5793(03)00505-2; Dekhuijzen PNR, 1996, AM J RESP CRIT CARE, V153, P769, DOI 10.1164/ajrccm.153.2.8564131; Dimitriou G, 2003, PEDIATR PULM, V35, P17, DOI 10.1002/ppul.10209; Dureuil B, 1998, REPROD NUTR DEV, V38, P175, DOI 10.1051/rnd:19980204; Eason JM, 2000, PHYS THER, V80, P160, DOI 10.1093/ptj/80.2.160; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Geiger PC, 2006, J APPL PHYSIOL, V101, P1546, DOI 10.1152/japplphysiol.00221.2006; Geiger PC, 2000, J APPL PHYSIOL, V89, P695, DOI 10.1152/jappl.2000.89.2.695; Geiger PC, 2001, J APPL PHYSIOL, V90, P380, DOI 10.1152/jappl.2001.90.1.380; Gokulakrishnan G, 2012, AM J PHYSIOL-REG I, V302, pR1143, DOI 10.1152/ajpregu.00466.2011; HEINER L, 1980, ACTA PHYSIOL HUNG, V55, P51; KEENS TG, 1978, J APPL PHYSIOL, V44, P909, DOI 10.1152/jappl.1978.44.6.909; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Kowalski KE, 2013, EXP NEUROL, V247, P689, DOI 10.1016/j.expneurol.2013.03.006; LASZEWSKI B, 1985, AM J PHYSIOL, V248, pE363, DOI 10.1152/ajpendo.1985.248.3.E363; Lavin T, 2013, PEDIATR PULM, V48, P640, DOI 10.1002/ppul.22762; MOORE BJ, 1989, J APPL PHYSIOL, V67, P2420, DOI 10.1152/jappl.1989.67.6.2420; Nava S, 1996, AM J RESP CRIT CARE, V153, P1888, DOI 10.1164/ajrccm.153.6.8665051; Niedzwiecka A, 2002, BIOCHEMISTRY-US, V41, P12140, DOI 10.1021/bi0258142; Orellana RA, 2012, AM J PHYSIOL-REG I, V302, pR682, DOI 10.1152/ajpregu.00259.2011; PETER JB, 1970, BIOCHEM PHARMACOL, V19, P1627, DOI 10.1016/0006-2952(70)90151-6; POLLA B, 1994, ACTA PHYSIOL SCAND, V151, P353, DOI 10.1111/j.1748-1716.1994.tb09754.x; Racz GZ, 2003, AM J RESP CRIT CARE, V168, P297, DOI 10.1164/rccm.200206-541OC; Sassoon CSH, 2008, MUSCLE NERVE, V38, P1161, DOI 10.1002/mus.21048; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Shanely RA, 2003, CHEST, V123, P195, DOI 10.1378/chest.123.1.195; SHOJI S, 1976, EXP NEUROL, V51, P304, DOI 10.1016/0014-4886(76)90255-7; SMITH D, 1988, AM J PHYSIOL, V254, pC661, DOI 10.1152/ajpcell.1988.254.5.C661; Song Y, 2013, AM J RESP CELL MOL, V49, P866, DOI 10.1165/rcmb.2013-0107OC; Song Y, 2013, EXP BIOL MED, V238, P913, DOI 10.1177/1535370213494562; Song Y, 2012, ANAT REC, V295, P864, DOI 10.1002/ar.22436; TRANG TTH, 1992, AM REV RESPIR DIS, V146, P26, DOI 10.1164/ajrccm/146.1.26; VanBalkom RHH, 1997, J APPL PHYSIOL, V83, P1062, DOI 10.1152/jappl.1997.83.4.1062; Watchko JF, 1998, COMP BIOCHEM PHYS B, V119, P459, DOI 10.1016/S0305-0491(98)00006-6	36	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93224	10.1371/journal.pone.0093224	http://dx.doi.org/10.1371/journal.pone.0093224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681552	gold, Green Published, Green Submitted			2022-12-25	WOS:000333678100033
J	Bonfiglio, L; Piarulli, A; Olcese, U; Andre, P; Arrighi, P; Frisoli, A; Rossi, B; Bergamasco, M; Carboncini, MC				Bonfiglio, Luca; Piarulli, Andrea; Olcese, Umberto; Andre, Paolo; Arrighi, Pieranna; Frisoli, Antonio; Rossi, Bruno; Bergamasco, Massimo; Carboncini, Maria Chiara			Spectral Parameters Modulation and Source Localization of Blink-Related Alpha and Low-Beta Oscillations Differentiate Minimally Conscious State from Vegetative State/Unresponsive Wakefulness Syndrome	PLOS ONE			English	Article							DEFAULT MODE NETWORK; ELECTROMAGNETIC TOMOGRAPHY; BRAIN ACTIVITY; RESTING-STATE; DIFFERENT REFERENCES; OBJECT RECOGNITION; DELTA OSCILLATIONS; EEG; CONNECTIVITY; MEMORY	Recently, the cortical source of blink-related delta oscillations (delta BROs) in resting healthy subjects has been localized in the posterior cingulate cortex/precuneus (PCC/PCu), one of the main core-hubs of the default-mode network. This has been interpreted as the electrophysiological signature of the automatic monitoring of the surrounding environment while subjects are immersed in self-reflecting mental activities. Although delta BROs were directly correlated to the degree of consciousness impairment in patients with disorders of consciousness, they failed to differentiate vegetative state/unresponsive wakefulness syndrome (VS/UWS) from minimally conscious state (MCS). In the present study, we have extended the analysis of BROs to frequency bands other than delta in the attempt to find a biological marker that could support the differential diagnosis between VS/UWS and MCS. Four patients with VS/UWS, 5 patients with MCS, and 12 healthy matched controls (CTRL) underwent standard 19-channels EEG recordings during resting conditions. Three-second-lasting EEG epochs centred on each blink instance were submitted to time-frequency analyses in order to extract the normalized Blink-Related Synchronization/Desynchronization (nBRS/BRD) of three bands of interest (low-alpha, high-alpha and low-beta) in the time-window of 50-550 ms after the blink-peak and to estimate the corresponding cortical sources of electrical activity. VS/UWS nBRS/BRD levels of all three bands were lower than those related to both CTRL and MCS, thus enabling the differential diagnosis between MCS and VS/UWS. Furthermore, MCS showed an intermediate signal intensity on PCC/PCu between CTRL and VS/UWS and a higher signal intensity on the left temporo-parieto-occipital junction and inferior occipito-temporal regions when compared to VS/UWS. This peculiar pattern of activation leads us to hypothesize that resting MCS patients have a bottom-up driven activation of the task positive network and thus are tendentially prone to respond to environmental stimuli, even though in an almost unintentional way.	[Bonfiglio, Luca; Arrighi, Pieranna; Rossi, Bruno; Carboncini, Maria Chiara] Univ Pisa, Sch Phys Med & Rehabil, Dept Translat Res New Technol Med & Surg, Pisa, Italy; [Piarulli, Andrea; Frisoli, Antonio; Bergamasco, Massimo] Scuola Super Sant Anna, PERCRO Lab, TeCIP Inst, Pisa, Italy; [Olcese, Umberto] Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy; [Andre, Paolo] Univ Siena, Dept Med & Surg Sci & Neurosci, I-53100 Siena, Italy	University of Pisa; Scuola Superiore Sant'Anna; Istituto Italiano di Tecnologia - IIT; University of Siena	Bonfiglio, L (corresponding author), Univ Pisa, Sch Phys Med & Rehabil, Dept Translat Res New Technol Med & Surg, Pisa, Italy.	bubobis@gmail.com	; Carboncini, Maria Chiara/I-9445-2018	ROSSI, BRUNO/0000-0003-1914-8593; Carboncini, Maria Chiara/0000-0002-3345-1524; Olcese, Umberto/0000-0001-6968-2503; BERGAMASCO, Massimo/0000-0002-7418-2332; Bonfiglio, Luca/0000-0001-5097-1014; piarulli, andrea/0000-0003-4516-2671	Scuola Superiore Sant'Anna	Scuola Superiore Sant'Anna	This study has been partially supported by a scholarship from Scuola Superiore Sant'Anna (AP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anticevic A, 2010, NEUROIMAGE, V49, P2638, DOI 10.1016/j.neuroimage.2009.11.008; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bardin JC, 2012, ARCH NEUROL-CHICAGO, V69, P176, DOI 10.1001/archneurol.2011.892; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Basar E, 2006, PROG BRAIN RES, V159, P43, DOI 10.1016/S0079-6123(06)59004-1; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Boly M, 2011, CURR OPIN NEUROL, V24, P394, DOI 10.1097/WCO.0b013e328347da94; Bonfiglio L, 2013, HUM BRAIN MAPP, V34, P2178, DOI 10.1002/hbm.22056; Bonfiglio L, 2011, INT J PSYCHOPHYSIOL, V80, P44, DOI 10.1016/j.ijpsycho.2011.01.002; Bonfiglio L, 2009, NEUROSCI LETT, V449, P57, DOI 10.1016/j.neulet.2008.10.039; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Bruno MA, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-35; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Burianova H, 2010, NEUROIMAGE, V49, P865, DOI 10.1016/j.neuroimage.2009.08.066; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cincotti F, 2004, METHOD INFORM MED, V43, P114; Clemens B, 2010, CLIN NEUROPHYSIOL, V121, P848, DOI 10.1016/j.clinph.2010.01.020; Collette F, 2001, MEMORY, V9, P249, DOI 10.1080/09658210143000056; Crick F., 1990, Seminars in the Neurosciences, V2, P263; Crone JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026373; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Damasio AR, 1999, FEELING WHAT APPENS; DiQuattro NE, 2011, J NEUROSCI, V31, P18026, DOI 10.1523/JNEUROSCI.4040-11.2011; Dobson A. J., 2010, INTRO GEN LINEAR MOD, V2nd; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gerlach C, 2002, NEUROPSYCHOLOGIA, V40, P1254, DOI 10.1016/S0028-3932(01)00222-6; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gosseries O, 2011, FUNCT NEUROL, V26, P25; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hagan C., 1979, REHABILITATION HEAD; Hayes SM, 2007, HIPPOCAMPUS, V17, P873, DOI 10.1002/hipo.20319; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Huberle E, 2012, BRAIN STRUCT FUNCT, V217, P735, DOI 10.1007/s00429-011-0369-y; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Kassuba T, 2011, NEUROIMAGE, V56, P1566, DOI 10.1016/j.neuroimage.2011.02.032; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P369, DOI 10.1016/j.clinph.2005.08.033; Kochan NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023960; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 2006, J CLIN INVEST, V116, P1823, DOI 10.1172/JCI29172; Liljestrom M, 2008, NEUROIMAGE, V41, P1132, DOI 10.1016/j.neuroimage.2008.03.016; Makeig S, 1996, ADV NEUR IN, V8, P145; Manly BFJ, 1997, RANDOMIZATION BOOTST; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mayberg HS, 1997, NEUROREPORT, V8, P1057, DOI 10.1097/00001756-199703030-00048; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Moore CJ, 1999, NEUROIMAGE, V10, P181, DOI 10.1006/nimg.1999.0450; Nakamura K, 2005, NEUROIMAGE, V28, P521, DOI 10.1016/j.neuroimage.2004.11.055; Nakano T, 2013, P NATL ACAD SCI USA, V110, P702, DOI 10.1073/pnas.1214804110; Noirhomme Q, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00160; Nunez PL, 1999, CLIN NEUROPHYSIOL, V110, P469, DOI 10.1016/S1388-2457(98)00043-1; Olbrich S, 2009, NEUROIMAGE, V45, P319, DOI 10.1016/j.neuroimage.2008.11.014; Ovadia-Caro S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037238; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Park H, 2012, BRAIN RES, V1471, P81, DOI 10.1016/j.brainres.2012.07.012; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; PERRIN F, 1987, IEEE T BIO-MED ENG, V34, P283, DOI 10.1109/TBME.1987.326089; Phillips JS, 2009, NEUROIMAGE, V46, P1209, DOI 10.1016/j.neuroimage.2009.02.044; Picard N, 2003, CEREB CORTEX, V13, P977, DOI 10.1093/cercor/13.9.977; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Roberts DJ, 2013, CEREB CORTEX, V23, P2568, DOI 10.1093/cercor/bhs224; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Sabes PN, 2011, PROG BRAIN RES, V191, P195, DOI 10.1016/B978-0-444-53752-2.00004-7; Schendan HE, 2009, NEUROIMAGE, V44, P1423, DOI 10.1016/j.neuroimage.2008.09.061; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Silva S, 2010, NEUROLOGY, V74, P313, DOI 10.1212/WNL.0b013e3181cbcd96; Smallwood J, 2012, BRAIN RES, V1428, P60, DOI 10.1016/j.brainres.2011.03.072; Sommer WH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003167; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Steinvorth S, 2006, NEUROIMAGE, V30, P285, DOI 10.1016/j.neuroimage.2005.09.025; Talairach J., 1988, COPLANAR STEREOTAXIC, V147; Thibaut A, 2012, J REHABIL MED, V44, P487, DOI 10.2340/16501977-0940; Thut G, 2005, CEREB CORTEX, V15, P628, DOI 10.1093/cercor/bhh164; TOWLE VL, 1993, ELECTROEN CLIN NEURO, V86, P1, DOI 10.1016/0013-4694(93)90061-Y; Uecker A, 1997, LEARN MEMORY, V4, P337, DOI 10.1101/lm.4.4.337; Valdes-Hernandez PA, 2009, J NEUROSCI METH, V185, P125, DOI 10.1016/j.jneumeth.2009.09.005; van Leeuwen C, 2011, HUMANA MENTE, P35; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Ward AM, 2014, HUM BRAIN MAPP, V35, P1061, DOI 10.1002/hbm.22234; Weisberg S., 2005, WILEY SERIES PROBABI, V528; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wierenga CE, 2009, J INT NEUROPSYCH SOC, V15, P169, DOI 10.1017/S1355617709090468; Wu DY, 2011, CLIN NEUROPHYSIOL, V122, P490, DOI 10.1016/j.clinph.2010.05.036; Yao DZ, 2007, COMPUT BIOL MED, V37, P1529, DOI 10.1016/j.compbiomed.2007.02.002; Yao DZ, 2005, PHYSIOL MEAS, V26, P173, DOI 10.1088/0967-3334/26/3/003	95	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93252	10.1371/journal.pone.0093252	http://dx.doi.org/10.1371/journal.pone.0093252			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676098	Green Published, gold			2022-12-25	WOS:000333677500098
J	Dong, XF; Li, R; Xiu, P; Dong, XS; Xu, ZZ; Zhai, B; Liu, F; Jiang, HC; Sun, XY; Li, J; Qiao, HQ				Dong, Xiaofeng; Li, Rui; Xiu, Peng; Dong, Xuesong; Xu, Zongzhen; Zhai, Bo; Liu, Feng; Jiang, Hongchi; Sun, Xueying; Li, Jie; Qiao, Haiquan			Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2-Dependent and -Independent Pathways	PLOS ONE			English	Article							E-CADHERIN; GROWTH-FACTOR; CELL-PROLIFERATION; DOWN-REGULATION; AUTOPHAGY; CYCLOOXYGENASE-2; INVASION; EXPRESSION; APOPTOSIS; MIGRATION	Background: Cyclooxygenase (COX)-2 is overexpressed in many types of cancers including hepatocellular carcinoma (HCC). Meloxicam, a selective COX-2 inhibitor, has shown potential therapeutic effects against HCC, but the mechanisms accounting for its anti-cancer activities remain unclear. Methods and Findings: Meloxicam inhibited the ability of human HCC cells expressing higher levels of COX-2 to migrate, invade, adhere and form colonies through upregulating the expression of E-cadherin and downregulating the expression of matrix metalloproteinase (MMP) -2. Meloxicam induced cell apoptosis by upregulating pro-apoptotic proteins including Bax and Fas-L, and downregulating anti-apoptotic proteins including survivin and myeloid cell leukemia-1 (Mcl-1), through inhibiting phosphorylation of AKT. Addition of prostaglandin E2 (PGE2), the major product of COX-2, could abrogate the effects of meloxicam on the expression of survivin and myeloid cell leukemia-1 (Mcl-1), but not Bax and Fas-L, indicating that meloxicam induces cell apoptosis via both COX-2-dependent and -independent pathways. Meloxicam also induced cell autophagy by upregulating Beclin 1 and light chain 3-II. Specific inhibition of autophagy by 3-methyladenine and chloroquine had little effect on cell apoptosis but could enhance the pro-apoptotic effects of meloxicam by further upregulating the expression of Bax. Conclusions: Meloxicam executes its antitumor effects by targeting the COX-2/MMP-2/E-cadherin, AKT, apoptotic and autophagic pathways in COX-2-dependent and -independent pathways, and inhibition of cell autophagy could help to overcome the resistance to meloxicam-induced apoptosis in HCC.	[Dong, Xiaofeng; Xiu, Peng; Xu, Zongzhen; Liu, Feng; Li, Jie] Shandong Univ, Qianfoshan Hosp, Dept Gen Surg, Jinan 250100, Peoples R China; [Li, Rui] Liaocheng Peoples Hosp, Dept Gen Surg, Liaocheng, Peoples R China; [Dong, Xuesong; Zhai, Bo; Jiang, Hongchi; Sun, Xueying; Qiao, Haiquan] Harbin Med Univ, Affiliated Hosp 1, Hepatosplen Surg Ctr, Dept Gen Surg, Harbin, Peoples R China; [Sun, Xueying] Univ Auckland, Fac Med & Hlth Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Harbin Medical University; University of Auckland	Li, J (corresponding author), Shandong Univ, Qianfoshan Hosp, Dept Gen Surg, Jinan 250100, Peoples R China.	lijie0503@126.com; qiaohaiquan@hotmail.com	Jiang, HongChi/M-5031-2018	Jiang, HongChi/0000-0001-8215-8984; Sun, Xueying/0000-0002-8065-8747; Li, Jie/0000-0002-2540-7494	National Natural Scientific Foundation of China [30972890, 81172331]; Shandong Provincial Science and Technology Development Planning, China [2010GSF10230]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Science and Technology Development Planning, China	This research was supported from the National Natural Scientific Foundation of China (http://www.nsfc.gov.cn) (30972890 and 81172331), and Shandong Provincial Science and Technology Development Planning, China (www.sdstc.gov.cn) (2010GSF10230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali-Fehmi R, 2005, AM J OBSTET GYNECOL, V192, P819, DOI 10.1016/j.ajog.2004.10.587; Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Banu SK, 2008, ENDOCRINOLOGY, V149, P1180, DOI 10.1210/en.2007-1168; Brouxhon SM, 2014, ONCOGENE, V33, P225, DOI 10.1038/onc.2012.563; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; David Rachel, 2012, Nat Rev Mol Cell Biol, V13, P136, DOI 10.1038/nrm3287; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dohadwala M, 2006, CANCER RES, V66, P5338, DOI 10.1158/0008-5472.CAN-05-3635; Grabowska MM, 2012, FRONT BIOSCI-LANDMRK, V17, P1948, DOI 10.2741/4031; He CJ, 2012, CANCER SCI, V103, P528, DOI 10.1111/j.1349-7006.2011.02177.x; Huang SB, 2010, AUTOPHAGY, V6, P256, DOI 10.4161/auto.6.2.11124; Jang TJ, 2010, VIRCHOWS ARCH, V457, P319, DOI 10.1007/s00428-010-0943-3; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang X, 2009, CANCER SCI, V100, P2226, DOI 10.1111/j.1349-7006.2009.01306.x; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kern MA, 2004, CARCINOGENESIS, V25, P1193, DOI 10.1093/carcin/bgh110; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kwon SH, 2012, CLIN MOL HEPATOL, V18, P287, DOI 10.3350/cmh.2012.18.3.287; Larkins TL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-181; Lau MT, 2011, ONCOGENE, V30, P2753, DOI 10.1038/onc.2011.6; Lau MT, 2012, CANCER LETT, V326, P191, DOI 10.1016/j.canlet.2012.08.016; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li J, 2006, J GASTROEN HEPATOL, V21, P1814, DOI 10.1111/j.1440-1746.2006.04366.x; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Ma LX, 2012, INVEST NEW DRUG, V30, P508, DOI 10.1007/s10637-010-9578-0; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Margineanu Eliana, 2008, Rev Med Chir Soc Med Nat Iasi, V112, P432; Mima K, 2013, ONCOL LETT, V5, P149, DOI 10.3892/ol.2012.954; Naruse T, 2006, CARCINOGENESIS, V27, P584, DOI 10.1093/carcin/bgi240; Rizzo MT, 2011, CLIN CHIM ACTA, V412, P671, DOI 10.1016/j.cca.2010.12.026; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; Su MF, 2013, J ONCOL, V2013, DOI 10.1155/2013/102735; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vo BT, 2013, ENDOCRINOLOGY, V154, P1768, DOI 10.1210/en.2012-2074; Wang DZ, 2005, GASTROENTEROLOGY, V128, P1445, DOI 10.1053/j.gastro.2004.09.080; Wang JZ, 2011, J HEPATOL, V55, P359, DOI 10.1016/j.jhep.2010.10.043; Wei Z, 2013, CELL SIGNAL, V25, P931, DOI 10.1016/j.cellsig.2013.01.011; Xiu P, 2013, CANCER SCI, V104, P375, DOI 10.1111/cas.12088; Zhang CH, 2012, J SURG RES, V174, P120, DOI 10.1016/j.jss.2010.10.030; Zhou LD, 2010, MED ONCOL, V27, P255, DOI 10.1007/s12032-009-9201-4; Zhou L, 2013, DIGEST DIS SCI, V58, P1016, DOI 10.1007/s10620-012-2434-7	44	34	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92864	10.1371/journal.pone.0092864	http://dx.doi.org/10.1371/journal.pone.0092864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675684	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677500047
J	Justa, S; Zhou, XQ; Sarkar, S				Justa, Shivali; Zhou, Xiaoqun; Sarkar, Sujata			Endogenous IL-22 Plays a Dual Role in Arthritis: Regulation of Established Arthritis via IFN-gamma Responses	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; INTERFERON-GAMMA; RHEUMATOID-ARTHRITIS; INTERLEUKIN 22; TH17 CELLS; T-CELLS; B-CELLS; AIRWAY INFLAMMATION; PROTECTIVE ROLE; DEFICIENT MICE	Objective: IL-22 is elevated in patients with inflammatory arthritis and correlates with disease activity. IL-22 deficient mice have reduced incidence of arthritis. Recombinant IL-22 restrains progression of arthritis via increase in IL-10 responses when administered prior to onset of arthritis. These findings imply a possible dual role of IL-22 in inflammatory arthritis depending on the phase of arthritis. Experiments outlined here were designed to elucidate the contribution of endogenous IL-22 before and after the onset of arthritis. Methods: Collagen induced arthritis (CIA) was induced in DBA1 or IFN-gamma deficient mice following immunization with collagen and complete Freund's adjuvant. Anti-IL-22 antibody or isotype control were administered prior to or after onset of arthritis and disease progression assessed by clinical scoring and histopathology. IL-22, IL-17 and IFN-gamma responses were measured by ELISA and flowcytometry. Anti-collagen antibody responses were analyzed by ELISA. Expression of IL-22R1 in CD4+ cells was elucidated by flowcytometry and real time PCR. Results: Collagen specific IL-22 responses were expanded during arthritis and IL-22 producing cells were discrete from IL-17 or IFN-gamma producing cells. Neutralization of IL-22 after onset of arthritis resulted in significant increase in Th1 responses and significantly reduced severity of arthritis. CD4+ cells from arthritic mice showed increased surface expression of IL-22R1. In vitro, CD4+ T cells cultured with antigen presenting cells in the presence or absence of IL-22 suppressed or induced IFN-gamma, respectively. The protective effect of anti-IL-22 was reversed in IFN-gamma deficient mice. Moreover, administration of anti-IL-22 prior to onset of arthritis augmented arthritis severity. Conclusion: We show for the first time that IL-22 plays a dual role: protective prior to the onset of arthritis and pathogenic after onset of arthritis. The pathogenic effect of IL-22 is dependent on suppression of IFN-gamma responses. IL-17 responses remained unchanged with the administration of anti-IL22 antibody. IL-22R1 is upregulated on CD4+ T cells during arthritis and regulates IFN-gamma in T cells.	[Sarkar, Sujata] Univ Arizona, Dept Med, Rheumatol Sect, Tucson, AZ 85721 USA; Univ Arizona, Arizona Arthrit Ctr, Tucson, AZ USA	University of Arizona; University of Arizona	Sarkar, S (corresponding author), Univ Arizona, Dept Med, Rheumatol Sect, Tucson, AZ 85721 USA.	ssarkar@email.arizona.edu		Justa, Shivali/0000-0002-1166-844X	National Institutes of Health [AR054323]; Arthritis National Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR054323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis National Research Foundation(National Research Foundation of Korea); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health AR054323 (http://www.nih.gov/), Arthritis National Research Foundation (http://www.curearthritis.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bard JD, 2008, LEUKEMIA, V22, P1595, DOI 10.1038/leu.2008.129; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Chang H, 2006, J IMMUNOL, V177, P3635, DOI 10.4049/jimmunol.177.6.3635; Chu CQ, 2007, ARTHRITIS RHEUM, V56, P1145, DOI 10.1002/art.22453; Chu CQ, 2003, ANN RHEUM DIS, V62, P983, DOI 10.1136/ard.62.10.983; da Rocha LF, 2012, J RHEUMATOL, V39, P1320, DOI 10.3899/jrheum.111027; Geboes L, 2009, ARTHRITIS RHEUM-US, V60, P390, DOI 10.1002/art.24220; Gelebart P, 2011, TRANSL ONCOL, V4, P9, DOI 10.1593/tlo.10172; Guedez YB, 2001, ARTHRITIS RHEUM, V44, P2413, DOI 10.1002/1529-0131(200110)44:10<2413::AID-ART406>3.0.CO;2-E; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Irmler I, 2007, Z RHEUMATOL, V66, P17; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Ke Y, 2011, J IMMUNOL, V187, P2130, DOI 10.4049/jimmunol.1100482; Kelchtermans H, 2007, J LEUKOCYTE BIOL, V81, P1044, DOI 10.1189/jlb.0806486; Kim KW, 2012, ARTHRITIS RHEUM-US, V64, P1015, DOI 10.1002/art.33446; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Lecart S, 2002, INT IMMUNOL, V14, P1351, DOI 10.1093/intimm/dxf096; Leipe J, 2011, ANN RHEUM DIS, V70, P1453, DOI 10.1136/ard.2011.152074; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; ManourySchwartz B, 1997, J IMMUNOL, V158, P5501; Marijnissen RJ, 2011, ARTHRITIS RHEUM-US, V63, P2939, DOI 10.1002/art.30469; Mitra A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3781; Nakagome K, 2011, J IMMUNOL, V187, P5077, DOI 10.4049/jimmunol.1001560; Nakahama T, 2011, P NATL ACAD SCI USA, V108, P14222, DOI 10.1073/pnas.1111786108; NAKAJIMA H, 1990, CLIN EXP IMMUNOL, V81, P441; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Oral HB, 2006, EUR J IMMUNOL, V36, P380, DOI 10.1002/eji.200425523; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Sarkar S, 2013, ARTHRITIS RHEUM-US, V65, P960, DOI 10.1002/art.37849; Sarkar S, 2010, RHEUM DIS CLIN N AM, V36, P345, DOI 10.1016/j.rdc.2010.02.006; Sarkar S, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2838; Savan R, 2011, BLOOD, V117, P575, DOI 10.1182/blood-2010-05-285908; Schurgers E, 2011, J INTERF CYTOK RES, V31, P917, DOI 10.1089/jir.2011.0056; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SNAPPER CM, 1988, J IMMUNOL, V140, P2121; Snapper CM, 1996, INT IMMUNOL, V8, P877, DOI 10.1093/intimm/8.6.877; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JCI33194, 10.1172/JC133194]; Sugita S, 2013, J IMMUNOL, V190, P5799, DOI 10.4049/jimmunol.1202677; van Hamburg JP, 2013, ANN RHEUM DIS; Vermeire K, 1997, J IMMUNOL, V158, P5507; Williams AS, 2007, ARTHRITIS RHEUM-US, V56, P2244, DOI 10.1002/art.22732; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2005, GENES IMMUN, V6, P8, DOI 10.1038/sj.gene.6364144; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031000, 10.1371/journal.pone.0037865]; Zhang L, 2011, J CLIN IMMUNOL, V31, P606, DOI 10.1007/s10875-011-9540-8; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	53	39	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93279	10.1371/journal.pone.0093279	http://dx.doi.org/10.1371/journal.pone.0093279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676270	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677500101
J	Liu, S; An, J; Lin, JH; Liu, YL; Bao, LD; Zhang, W; Zhao, JJ				Liu, Shuang; An, Jie; Lin, Jianhong; Liu, Yanli; Bao, Lidao; Zhang, Wen; Zhao, Jian-Jun			Single Nucleotide Polymorphisms of MicroRNA Processing Machinery Genes and Outcome of Hepatocellular Carcinoma	PLOS ONE			English	Article							NUCLEAR EXPORT; CANCER; EPIDEMIOLOGY; PRECURSORS; CHINA; RISK	MicroRNA (miRNA)-related single nucleotide polymorphisms (miR-SNPs) can affect cancer development, treatment efficacy and patients prognosis. We examined 6 miR-SNPs in miRNA processing machinery genes including exportin 5 (XPO5) (rs11077), Ran-GTPase (RAN) (rs14035), Dicer (rs3742330), Trinucleotide Repeat Containing 6B (TNRC6B) (rs9623117), GEMIN3 (rs197412), GEMIN4 (rs2740348) in 108 surgically resected HCC patients and evaluated the impact of these miR-SNPs on HCC outcome. Among the 6 SNPs, only the A/A genotype of rs11077 located in XPO5 3'UTR was identified to associated independently with worse survival in HCC patients by multivariate analysis with relative risk, 0.395; 95% CI, 0.167-0.933; p = 0.034. This is the first study reporting that polymorphisms related to miRSNPs have prognostic value in hepatocellular carcinoma and identify the A/A genotype of rs11077 SNP site located in XPO5 3'UTR can help to predict worse prognosis in patients.	[Liu, Shuang; An, Jie; Liu, Yanli; Zhang, Wen] Bethune Int Peace Hosp, Dept Pathol, Shijiazhuang, Peoples R China; [Lin, Jianhong; Bao, Lidao; Zhao, Jian-Jun] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Liu, S (corresponding author), Bethune Int Peace Hosp, Dept Pathol, Shijiazhuang, Peoples R China.	Liu_Shuang11@hotmail.com; Jianjun_zhao@dfci.harvard.edu			Bethune International Peace Hospital (BIPH) research grant; SPORE career development award from Dana-Farber Cancer Institute (DFCI); Multiple Myeloma Research Foundation (MMRF) award	Bethune International Peace Hospital (BIPH) research grant; SPORE career development award from Dana-Farber Cancer Institute (DFCI); Multiple Myeloma Research Foundation (MMRF) award	SL is supported by Bethune International Peace Hospital (BIPH) research grant. JL is supported by SPORE career development award from Dana-Farber Cancer Institute (DFCI). JJZ is supported by Multiple Myeloma Research Foundation (MMRF) award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boni V, 2011, PHARMACOGENOMICS J, V11, P429, DOI 10.1038/tpj.2010.58; Caldwell S, 2009, J GASTROENTEROL, V44, P96, DOI 10.1007/s00535-008-2258-6; Campayo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022509; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; de Larrea CF, 2012, CLIN CANCER RES, V18, P3697, DOI 10.1158/1078-0432.CCR-12-0191; Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300; Guo ZJ, 2012, INT J CANCER, V131, P1318, DOI 10.1002/ijc.27352; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lu L, 2008, ANN NY ACAD SCI, V1141, P304, DOI 10.1196/annals.1441.025; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maki A, 2007, ANN SURG ONCOL, V14, P1182, DOI 10.1245/s10434-006-9049-1; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Minagawa M, 2003, ANN SURG, V238, P703, DOI 10.1097/01.sla.0000094549.11754.e6; OKADA S, 1994, GASTROENTEROLOGY, V106, P1618, DOI 10.1016/0016-5085(94)90419-7; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Wang CJ, 2011, BIOCHEM BIOPH RES CO, V406, P493, DOI 10.1016/j.bbrc.2011.02.088; Yao GB, 2000, J MED VIROL, V61, P392, DOI 10.1002/1096-9071(200007)61:3&lt;392::AID-JMV19&gt;3.0.CO;2-V; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	23	35	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92791	10.1371/journal.pone.0092791	http://dx.doi.org/10.1371/journal.pone.0092791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676133	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500039
J	Luo, JY; Hu, YC; Kong, WJ; Yang, MH				Luo, Jiaoyang; Hu, Yichen; Kong, Weijun; Yang, Meihua			Evaluation and Structure-Activity Relationship Analysis of a New Series of Arylnaphthalene lignans as Potential Anti-Tumor Agents	PLOS ONE			English	Article							JUSTICIA-PROCUMBENS; TOPOISOMERASE-II; 6'-HYDROXY JUSTICIDIN; ANTIVIRAL ACTIVITY; CANCER; APOPTOSIS; GL331; MITOCHONDRIA; GLYCOSIDES; DIPHYLLIN	Arylnaphthalene lignan lactones have attracted considerable interest because of their anti-tumor and anti-hyperlipidimic activities. However, to our knowledge, few studies have explored the effects of these compounds on human leukemia cell lines. In this study, five arylnaphthalene lignans including 6'-hydroxy justicidin A (HJA), 6'-hydroxy justicidin B (HJB), justicidin B (JB), chinensinaphthol methyl ether (CME) and Taiwanin E methyl ether (TEME) were isolated from Justicia procumbens and their effects on the proliferation and apoptosis of the human leukemia K562 cell line were investigated then used to assess structure-activity relationships. To achieve these aims, cytotoxicity was assayed using the MTT assay, while intracellular SOD activity was detected using the SOD Activity Assay kit. Apoptosis was measured by both the using a cycle TEST PLUS DNA reagent kit as well as the FITC Annexin V apoptosis detection kit in combination with flow cytometry. Activation of caspase-mediated apoptosis was evaluated using a FITC active Caspase-3 apoptosis kit and flow cytometry. The results indicated that HJB, HJA and JB significantly inhibited the growth of K562 cells by decreasing both proliferation and SOD activity and inducing apoptosis. The sequence of anti-proliferative activity induced by the five tested arylnaphthalenes by decreasing strength was HJB > HJA > JB > CME > TEME > HJB, HJA and JB also decreased SOD activity and induced apoptosis in a dose-dependent manner. Activation of caspase-3 further indicated that HJB, HJA and JB induced caspase-dependent intrinsic and/or extrinsic apoptosis pathways. Together, these assays suggest that arylnaphthalene lignans derived from Justicia procumbens induce apoptosis to varying degrees, through a caspase-dependent pathway in human leukemia K562 cells. Furthermore, analysis of structure-activity relationships suggest that hydroxyl substitution at C-1 and C-6' significantly increased the antiproliferative activity of arylnaphthalene lignans while a methoxyl at C-1 significantly decreased the effect.	[Yang, Meihua] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, MH (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	yangmeihua15@hotmail.com			Beijing Natural Science Foundation of China [7112092]; Program for PUMC Innovative Foundation; Specialized Research Fund for the Doctoral Program of Higher Education [20111106110034]	Beijing Natural Science Foundation of China(Beijing Natural Science Foundation); Program for PUMC Innovative Foundation; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work received financial support from the Beijing Natural Science Foundation of China (7112092), the Program for PUMC Innovative Foundation and Specialized Research Fund for the Doctoral Program of Higher Education (20111106110034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MAGN RESON CHEM, V44, P727; Asano J, 1996, PHYTOCHEMISTRY, V42, P713, DOI 10.1016/0031-9422(96)00024-6; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Barret JM, 2002, ANTICANCER RES, V22, P187; Bechtel W, 2009, ANTICANCER RES, V29, P4559; BRINGMANN G, 1990, ANGEW CHEM INT EDIT, V29, P977, DOI 10.1002/anie.199009771; Charlton JL, 1998, J NAT PROD, V61, P1447, DOI 10.1021/np980136z; Chen CC, 1996, J NAT PROD, V59, P1149, DOI 10.1021/np960443+; Daley L, 1997, TETRAHEDRON LETT, V38, P2673, DOI 10.1016/S0040-4039(97)00450-4; Daley L, 1998, J MED CHEM, V41, P4475, DOI 10.1021/jm9800752; Day SH, 2002, J NAT PROD, V65, P379, DOI 10.1021/np0101651; Deng J.Y., 2009, CHINESE PHARMACOL B, V25, P190; DIGIORGIO C, 2005, PLANTA MED, V71, P366; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Elfahmi, 2006, J NAT PROD, V69, P55, DOI 10.1021/np050288b; FUKAMIYA N, 1986, J NAT PROD, V49, P348, DOI 10.1021/np50044a030; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He XL, 2012, J ETHNOPHARMACOL, V144, P284, DOI 10.1016/j.jep.2012.09.010; Huang TS, 1999, PHARMACEUT RES, V16, P997, DOI 10.1023/A:1018971313256; Huang TS, 2000, APOPTOSIS, V5, P79, DOI 10.1023/A:1009693811093; Ionkova I, 2013, PHARMACOGN MAG, V9, P39, DOI 10.4103/0973-1296.108138; Jiang H, 2007, EUR J PHARMACOL, V559, P98, DOI 10.1016/j.ejphar.2006.12.017; KIMURA M, 1985, PLANTA MED, V51, P291, DOI 10.1055/s-2007-969493; Lee CC, 2001, PHARMACEUT RES, V18, P846, DOI 10.1023/A:1011048831698; Lin SK, 2001, MOL PHARMACOL, V60, P768; Luo ZL, 2013, J SEP SCI, V36, P699, DOI 10.1002/jssc.201200851; MCGAHON A, 1994, BLOOD, V83, P1179, DOI 10.1182/blood.V83.5.1179.bloodjournal8351179; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Potokar M, 2003, FEBS LETT, V544, P153, DOI 10.1016/S0014-5793(03)00494-0; Qiu F, 2012, J PHARMACEUT BIOMED, V70, P539, DOI 10.1016/j.jpba.2012.05.002; Ramesh C, 2003, CHEM PHARM BULL, V51, P1299, DOI 10.1248/cpb.51.1299; Rassmann I, 1999, INVEST NEW DRUG, V16, P319, DOI 10.1023/A:1006293830585; Roth W, 2002, NAT MED, V8, P216, DOI 10.1038/nm0302-216; Su CL, 2006, FEBS LETT, V580, P3185, DOI 10.1016/j.febslet.2006.04.085; Susplugas S, 2005, J NAT PROD, V68, P734, DOI 10.1021/np050028u; Utsugi T, 1996, CANCER RES, V56, P2809; VanVliet DS, 1999, TETRAHEDRON LETT, V40, P2259, DOI 10.1016/S0040-4039(99)00220-8; WANG JZ, 1993, ANTI-CANCER DRUG DES, V8, P193; Wu SJ, 2006, CHEM PHARM BULL, V54, P1223, DOI 10.1248/cpb.54.1223; Yang MH, 2006, MAGN RESON CHEM, V44, P727, DOI 10.1002/mrc.1830; Yang MH, 2006, J PHARMACEUT BIOMED, V41, P662, DOI 10.1016/j.jpba.2005.12.014; Zhang P., 2009, CHINESE PHARMACOL B, V25, P173; Zhang Peng, 2010, Zhongguo Yaolixue Yu Dulixue Zazhi, V24, P207, DOI 10.3867/j.issn.1000-3002.2010.03.009; Zhou SJ, 2012, J CHROMATOGR B, V903, P75, DOI 10.1016/j.jchromb.2012.06.045	46	19	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93516	10.1371/journal.pone.0093516	http://dx.doi.org/10.1371/journal.pone.0093516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675875	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500133
J	Reverchon, M; Rame, C; Cognie, J; Briant, E; Elis, S; Guillaume, D; Dupont, J				Reverchon, Maxime; Rame, Christelle; Cognie, Juliette; Briant, Eric; Elis, Sebastien; Guillaume, Daniel; Dupont, Joelle			Resistin in Dairy Cows: Plasma Concentrations during Early Lactation, Expression and Potential Role in Adipose Tissue	PLOS ONE			English	Article							REGULATE LIPID-METABOLISM; GROWTH-HORMONE RECEPTOR; NEGATIVE-ENERGY BALANCE; HUMAN GRANULOSA-CELLS; GENE-EXPRESSION; MESSENGER-RNA; BOVINE HEPATOCYTES; TRANSITION PERIOD; SIGNALING PATHWAY; INSULIN	Resistin is an adipokine that has been implicated in energy metabolism regulation in rodents but has been little studied in dairy cows. We determined plasma resistin concentrations in early lactation in dairy cows and investigated the levels of resistin mRNA and protein in adipose tissue and the phosphorylation of several components of insulin signaling pathways one week post partum (1 WPP) and at five months of gestation (5 MG). We detected resistin in mature bovine adipocytes and investigated the effect of recombinant bovine resistin on lipolysis in bovine adipose tissue explants. ELISA showed that plasma resistin concentration was low before calving, subsequently increasing and reaching a peak at 1 WPP, decreasing steadily thereafter to reach pre-calving levels at 6 WPP. Plasma resistin concentration was significantly positively correlated with plasma non esterified fatty acid (NEFA) levels and negatively with milk yield, dry matter intake and energy balance between WPP1 to WPP22. We showed, by quantitative RT-PCR and western blotting, that resistin mRNA and protein levels in adipose tissue were higher at WPP1 than at 5 MG. The level of phosphorylation of several early and downstream insulin signaling components (IR beta, IRS-1, IRS-2, Akt, MAPK ERK1/2, P70S6K and S6) in adipose tissue was also lower at 1 WPP than at 5 MG. Finally, we showed that recombinant bovine resistin increased the release of glycerol and mRNA levels for ATGL (adipose triglyceride lipase) and HSL (hormone-sensitive lipase) in adipose tissue explants. Overall, resistin levels were high in the plasma and adipose tissue and were positively correlated with NEFA levels after calving. Resistin is expressed in bovine mature adipocytes and promotes lipid mobilization in adipose explants in vitro.	[Reverchon, Maxime; Rame, Christelle; Cognie, Juliette; Briant, Eric; Elis, Sebastien; Guillaume, Daniel; Dupont, Joelle] INRA, Physiol Reprod & Comportements, UMR 7247, F-37380 Nouzilly, France; [Reverchon, Maxime; Rame, Christelle; Cognie, Juliette; Briant, Eric; Elis, Sebastien; Guillaume, Daniel; Dupont, Joelle] CNRS, Physiol Reprod & Comportements, UMR6175, Nouzilly, France; [Reverchon, Maxime; Rame, Christelle; Cognie, Juliette; Briant, Eric; Elis, Sebastien; Guillaume, Daniel; Dupont, Joelle] Univ Tours, Tours, France; [Reverchon, Maxime; Rame, Christelle; Cognie, Juliette; Briant, Eric; Elis, Sebastien; Guillaume, Daniel; Dupont, Joelle] Inst Francais Cheval, Nouzilly, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Universite de Tours	Dupont, J (corresponding author), INRA, Physiol Reprod & Comportements, UMR 7247, F-37380 Nouzilly, France.	jdupont@tours.fr	Elis, Sebastien/K-6158-2019	Juliette, Cognie/0000-0003-0908-9833; reverchon, maxime/0000-0001-8329-7708	Institut National de la Recherche Agronomique; Region Centre "Adipofertikines proposal''	Institut National de la Recherche Agronomique; Region Centre "Adipofertikines proposal''(Region Centre-Val de Loire)	This work was financially supported by Institut National de la Recherche Agronomique and partly by Region Centre "Adipofertikines proposal''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes KM, 2009, CURR PROTEIN PEPT SC, V10, P96, DOI 10.2174/138920309787315239; Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; Bauman DE, 2000, GROWTH REPROD, V2000, P331; Bell AW, 1997, J MAMMARY GLAND BIOL, V2, P265, DOI 10.1023/A:1026336505343; BELL AW, 1995, J ANIM SCI, V73, P2804, DOI 10.2527/1995.7392804x; Benomar Y, 2013, DIABETES, V62, P102, DOI 10.2337/db12-0237; Block SS, 2001, J ENDOCRINOL, V171, P339, DOI 10.1677/joe.0.1710339; BLUM JW, 1973, J DAIRY SCI, V56, P459, DOI 10.3168/jds.S0022-0302(73)85200-2; Bossaert P, 2008, J DAIRY SCI, V91, P3363, DOI 10.3168/jds.2008-0994; Butler ST, 2003, J ENDOCRINOL, V176, P205, DOI 10.1677/joe.0.1760205; Chen H, 2013, J STEROID BIOCHEM, V138, P445, DOI 10.1016/j.jsbmb.2013.08.013; Coyral-Castel S, 2013, ANIMAL, V7, P610, DOI 10.1017/S1751731112002133; Coyral-Castel S, 2010, DOMEST ANIM ENDOCRIN, V38, P272, DOI 10.1016/j.domaniend.2009.12.002; Delhanty PJD, 2002, ENDOCRINOLOGY, V143, P2445, DOI 10.1210/en.143.6.2445; Derosa G, 2013, INFLAMMATION, V36, P914, DOI 10.1007/s10753-013-9620-4; Dupont J, 2000, J BIOL CHEM, V275, P35893, DOI 10.1074/jbc.M006741200; Dupont J, 2003, RECENT PROG HORM RES, V58, P325, DOI 10.1210/rp.58.1.325; Dupont J, 2001, HORM RES, V55, P22, DOI 10.1159/000063469; Etherton TD, 1998, PHYSIOL REV, V78, P745, DOI 10.1152/physrev.1998.78.3.745; Giesy SL, 2012, ENDOCRINOLOGY, V153, P5834, DOI 10.1210/en.2012-1765; Ingvartsen KL, 2001, DOMEST ANIM ENDOCRIN, V21, P215, DOI 10.1016/S0739-7240(02)00119-4; Jarrige R., 1989, RUMINANT NUTR RECOMM; Kaser S, 2003, BIOCHEM BIOPH RES CO, V309, P286, DOI 10.1016/j.bbrc.2003.07.003; Koltes DA, 2012, DOMEST ANIM ENDOCRIN, V43, P307, DOI 10.1016/j.domaniend.2012.05.004; Koltes DA, 2011, J DAIRY SCI, V94, P1839, DOI 10.3168/jds.2010-3769; Komatsu T, 2003, J ENDOCRINOL, V178, pR1, DOI 10.1677/joe.0.178R001; Lemor A, 2009, DOMEST ANIM ENDOCRIN, V37, P37, DOI 10.1016/j.domaniend.2009.01.004; Li XW, 2013, CELL BIOCHEM BIOPHYS, V67, P1157, DOI 10.1007/s12013-013-9629-1; Lim CT, 2010, J MOL ENDOCRINOL, V44, P87, DOI 10.1677/JME-09-0063; Locher LF, 2012, J DAIRY SCI, V95, P2497, DOI 10.3168/jds.2011-4830; Maillard V, 2011, REPRODUCTION, V141, P467, DOI 10.1530/REP-10-0419; MCNAMARA JP, 1986, J DAIRY SCI, V69, P3042, DOI 10.3168/jds.S0022-0302(86)80767-6; MCNAMARA JP, 1991, J DAIRY SCI, V74, P706, DOI 10.3168/jds.S0022-0302(91)78217-9; Mielenz M, 2013, J DAIRY SCI, V96, P278, DOI 10.3168/jds.2012-5816; Mostowik M, 2013, CARDIOVASC DRUG THER, V27, P289, DOI 10.1007/s10557-013-6457-x; Mukesh M, 2010, DOMEST ANIM ENDOCRIN, V38, P168, DOI 10.1016/j.domaniend.2009.10.001; Nozue H, 2007, METABOLISM, V56, P1514, DOI 10.1016/j.metabol.2007.06.018; Ohtani Y, 2012, ANIM SCI J, V83, P788, DOI 10.1111/j.1740-0929.2012.01029.x; Opsomer G, 1999, ANIM REPROD SCI, V56, P211, DOI 10.1016/S0378-4320(99)00048-2; Ort T, 2005, ENDOCRINOLOGY, V146, P2200, DOI 10.1210/en.2004-1421; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Radcliff RP, 2003, J DAIRY SCI, V86, P3920, DOI 10.3168/jds.S0022-0302(03)74000-4; Reverchon M, 2013, FERTIL STERIL, V100, P247, DOI 10.1016/j.fertnstert.2013.03.008; Reverchon M, 2012, HUM REPROD, V27, P1790, DOI 10.1093/humrep/des089; Rhoads RP, 2004, J NUTR, V134, P1020, DOI 10.1093/jn/134.5.1020; Sadri H, 2010, J ANIM PHYSIOL AN N, V94, pe194, DOI 10.1111/j.1439-0396.2010.01005.x; Sanchez-Solana B, 2012, MOL ENDOCRINOL, V26, P110, DOI 10.1210/me.2011-1027; Saremi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086211; SAS INSTITUTE INC, 2009, SAS STAT 9 2 US GUID; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Singh SP, 2014, J DAIRY SCI IN PRESS; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sumner JM, 2007, J DAIRY SCI, V90, P5237, DOI 10.3168/jds.2007-0307; Takahashi H, 2013, J DERMATOL, V40, P475, DOI 10.1111/1346-8138.12122; VAZQUEZANON M, 1994, J DAIRY SCI, V77, P1521, DOI 10.3168/jds.S0022-0302(94)77092-2; Wathes DC, 2013, REPROD FERT DEVELOP, V25, P48, DOI 10.1071/RD12272	57	32	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93198	10.1371/journal.pone.0093198	http://dx.doi.org/10.1371/journal.pone.0093198			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675707	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677500087
J	Yasuda, M; Tanaka, Y; Ryu, M; Tsuda, S; Nakazawa, T				Yasuda, Masayuki; Tanaka, Yuji; Ryu, Morin; Tsuda, Satoru; Nakazawa, Toru			RNA Sequence Reveals Mouse Retinal Transcriptome Changes Early after Axonal Injury	PLOS ONE			English	Article							GANGLION-CELL DEATH; OPEN-ANGLE GLAUCOMA; UNFOLDED PROTEIN RESPONSE; NORMAL-TENSION GLAUCOMA; OPTIC-NERVE CRUSH; GENE-EXPRESSION; OXIDATIVE STRESS; KAINIC ACID; RAT RETINA; INDUCED NEUROTOXICITY	Glaucoma is an ocular disease characterized by progressive retinal ganglion cell (RGC) death caused by axonal injury. However, the underlying mechanisms involved in RGC death remain unclear. In this study, we investigated changes in the transcriptome profile following axonal injury in mice (C57BL/6) with RNA sequencing (RNA-seq) technology. The experiment group underwent an optic nerve crush (ONC) procedure to induce axonal injury in the right eye, and the control group underwent a sham procedure. Two days later, we extracted the retinas and performed RNA-seq and a pathway analysis. We identified 177 differentially expressed genes with RNA-seq, notably the endoplasmic reticulum (ER) stress-related genes Atf3, Atf4, Atf5, Chac1, Chop, Egr1 and Trb3, which were significantly upregulated. The pathway analysis revealed that ATF4 was the most significant upstream regulator. The antioxidative response-related genes Hmox1 and Srxn1, as well as the immune response-related genes C1qa, C1qb and C1qc, were also significantly upregulated. To our knowledge, this is the first reported RNA-seq investigation of the retinal transcriptome and molecular pathways in the early stages after axonal injury. Our results indicated that ER stress plays a key role under these conditions. Furthermore, the antioxidative defense and immune responses occurred concurrently in the early stages after axonal injury. We believe that our study will lead to a better understanding of and insight into the molecular mechanisms underlying RGC death after axonal injury.	[Yasuda, Masayuki; Tanaka, Yuji; Ryu, Morin; Tsuda, Satoru; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan	Tohoku University	Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan.	ntoru@oph.med.tohoku.ac.jp			Ministry of Education, Science and Technology of Japan [24659756, 40625513]; JST Center for Revitalization Promotion; Great East Japan Earthquake Reconstruction Support project of the RIKEN Omics Science Center; RIKEN Genome Analysis Service (GeNAS); Illumina Co.; CLC Bio Co.	Ministry of Education, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST Center for Revitalization Promotion; Great East Japan Earthquake Reconstruction Support project of the RIKEN Omics Science Center; RIKEN Genome Analysis Service (GeNAS); Illumina Co.; CLC Bio Co.	This study was supported in part by Grants-in-Aid from the Ministry of Education, Science and Technology of Japan (24659756 for T.N. and 40625513 for Y.T.) (http://www.mext.go.jp/english/). This study was also supported by JST Center for Revitalization Promotion (http://www.jst.go.jp/fukkou/), All Japan Coffee Association (http://coffee.ajca.or.jp/news/othernews/h26josei), Senju Pharmaceutical Co., Ltd. (http://www.senju.co.jp/) and NIDEK Co., Ltd. (http://www.nidek.co.jp/index-j.html). This study was also supported by the Great East Japan Earthquake Reconstruction Support project of the RIKEN Omics Science Center, the RIKEN Genome Analysis Service (GeNAS), Illumina Co. and CLC Bio Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLCUTT D, 1984, DEV BRAIN RES, V16, P231, DOI 10.1016/0165-3806(84)90028-2; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Calkins DJ, 2012, PROG RETIN EYE RES, V31, P702, DOI 10.1016/j.preteyeres.2012.07.001; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Chiba N, 2011, CLIN OPHTHALMOL, V5, P1549, DOI 10.2147/OPTH.S22097; Chidlow G, 2005, MOL VIS, V11, P387; Crehan H, 2012, IMMUNOBIOLOGY, V217, P244, DOI 10.1016/j.imbio.2011.07.017; Dabney A., QVALUE Q VALUE ESTIM; De Moraes CGV, 2011, ARCH OPHTHALMOL-CHIC, V129, P562, DOI 10.1001/archophthalmol.2011.72; EHRLICH D, 1987, BRAIN RES, V415, P342, DOI 10.1016/0006-8993(87)90217-4; Fernandes KA, 2013, EXP EYE RES, V112, P106, DOI 10.1016/j.exer.2013.04.021; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Folkersen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007677; Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892; Greenwald JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034804; Gusberti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078457; Harada C, 2010, CELL DEATH DIFFER, V17, P1751, DOI 10.1038/cdd.2010.62; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Himori N, 2013, J NEUROCHEM; Hollands H, 2013, JAMA-J AM MED ASSOC, V309, P2035, DOI 10.1001/jama.2013.5099; Honjo M, 2000, INVEST OPHTH VIS SCI, V41, P552; Hu Y, 2012, NEURON, V73, P445, DOI 10.1016/j.neuron.2011.11.026; Huang TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028768; Kamei S, 2005, INVEST OPHTH VIS SCI, V46, P4288, DOI 10.1167/iovs.03-1407; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim C, 2006, MOL VIS, V12, P1640; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kitaoka Y, 2006, INVEST OPHTH VIS SCI, V47, P1448, DOI 10.1167/iovs.05-0299; Kumar A, 2012, EMBO REP, V13, P1095, DOI 10.1038/embor.2012.156; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lam TT, 1999, INVEST OPHTH VIS SCI, V40, P2391; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Levkovitch-Verbin H, 2000, INVEST OPHTH VIS SCI, V41, P4169; Li Y, 1999, INVEST OPHTH VIS SCI, V40, P1004; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Liu Y, 2012, FREE RADICAL BIO MED, V52, P909, DOI 10.1016/j.freeradbiomed.2011.12.013; Logue SE, 2013, APOPTOSIS, V18, P537, DOI 10.1007/s10495-013-0818-6; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nakazawa T, 2008, J NEUROSCI RES, V86, P136, DOI 10.1002/jnr.21472; Nakazawa T, 2007, J NEUROCHEM, V100, P1018, DOI 10.1111/j.1471-4159.2006.04274.x; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Prat-Vidal C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054785; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Rowley JW, 2013, BLOOD, V121, P5255, DOI 10.1182/blood-2013-03-487991; Ryu M, 2012, J NEUROSCI RES, V90, P802, DOI 10.1002/jnr.22800; Saili KS, 2013, REPROD TOXICOL, V38, P89, DOI 10.1016/j.reprotox.2013.03.009; Seki T, 2006, ANN NY ACAD SCI, V1070, P531, DOI 10.1196/annals.1317.074; Shanab AY, 2012, NEUROBIOL DIS, V48, P556, DOI 10.1016/j.nbd.2012.07.025; SILIPRANDI R, 1992, VISUAL NEUROSCI, V8, P567, DOI 10.1017/S0952523800005666; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tanaka H, 2004, NEUROSCIENCE, V127, P155, DOI 10.1016/j.neuroscience.2004.05.010; Team RC, 2013, R LANGUAGE ENV STAT; Templeton JP, 2013, INVEST OPHTH VIS SCI, V54, P2599, DOI 10.1167/iovs.12-11175; Tong M, 2012, CANCER RES, V72, P6024, DOI 10.1158/0008-5472.CAN-12-1269; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Warnes GR, 2013, GPLOTS VARIOUS R PRO; Watkins TA, 2013, P NATL ACAD SCI USA, V110, P4039, DOI 10.1073/pnas.1211074110; Weinreb RN, 2004, AM J OPHTHALMOL, V138, P458, DOI 10.1016/j.ajo.2004.04.054; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	78	57	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93258	10.1371/journal.pone.0093258	http://dx.doi.org/10.1371/journal.pone.0093258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676137	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500099
J	Chen, D; Bao, L; Lu, SQ; Xu, F				Chen, Du; Bao, Long; Lu, Shi-qi; Xu, Feng			Serum Albumin and Prealbumin Predict the Poor Outcome of Traumatic Brain Injury	PLOS ONE			English	Article							GLYCEMIC CONTROL; HYPERGLYCEMIA; RESUSCITATION; PROGNOSIS; CHILDREN	Background: Serum albumin and prealbumin are both negative acute-phase reactants, and usually at low levels in stress. We aim to determine their predictive values for poor outcome of traumatic brain injury (TBI). Methods: A total of 326 patients of TBI were enrolled and followed-up by telephone 6 months after discharge. They were divided into a favorable group (GOS: 3 to 5) and an unfavorable group (GOS: 1 to 2). Serum albumin and prealbumin were measured from vein blood within 24 h after admission. Results: Ninety one (27.9%) patients were with poor outcome (GOS: 1 to 2). The unfavorable group had lower albumin and prealbumin (P, 0.001). Albumin and prealbumin were both positively correlated with GCS (r = 0.489, P < 0.001; r = 0.222, P < 0.001, respectively) and GOS (r = 0.518, P < 0.001; r = 0.314, P < 0.001, respectively). After adjustment for confounding factors, the odds ratios of albumin and prealbumin were 0.866, 95% CI: 0.829 to 0.904 and 0.990, 95% CI: 0.985 to 0.995, respectively. In subgroup of GCS <= 8 (n = 101), the crude and adjusted odds ratios of serum albumin were both statistically significant (P = 0.027, P = 0.033, respectively), while prealbumin were not (P = 0.553, P = 0.576, respectively). The AUC of albumin for predicting poor outcome was 0.762, 95% CI: 0.712 to 0.807, which was significantly higher than that of prealbumin (0.664, 95% CI: 0.610 to 0.715). In analyses of all patients and subgroup of GCS <= 8, the AUCs of serum albumin were both significantly higher than those of prealbumin (P = 0.001, P = 0.045, respectively). Conclusions: Both serum albumin and prealbumin could predict the poor outcome of TBI, but the former is much better, especially, in patients with severe TBI.	[Chen, Du; Bao, Long; Lu, Shi-qi; Xu, Feng] Soochow Univ, Affiliated Hosp 1, Dept Emergency Med, Suzhou, Peoples R China	Soochow University - China	Xu, F (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Emergency Med, Suzhou, Peoples R China.	sdfyycd@foxmail.com	Chen, Du/AAM-8789-2021	Chen, Du/0000-0001-6990-3310				Belayev L, 1999, J NEUROTRAUM, V16, P445, DOI 10.1089/neu.1999.16.445; Bernard F, 2008, J TRAUMA, V64, P872, DOI 10.1097/TA.0b013e31803428cc; Cabassi A, 2013, INT J CARDIOL; Collins N, 2001, Adv Skin Wound Care, V14, P235, DOI 10.1097/00129334-200109000-00009; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gao C, 2011, CLIN EXP MED, V11, P49, DOI 10.1007/s10238-010-0103-8; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kawai H, 2012, WORLD J SURG, V36, P2853, DOI 10.1007/s00268-012-1766-y; Kramer AH, 2012, CRIT CARE, V16, DOI 10.1186/cc11812; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Matsushima K, 2012, J CRIT CARE, V27, P125, DOI 10.1016/j.jcrc.2011.08.012; Melo JRT, 2010, ACTA NEUROCHIR, V152, P1559, DOI 10.1007/s00701-010-0680-z; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nelson DW, 2012, J NEUROTRAUM, V29, P2613, DOI 10.1089/neu.2012.2468; ROCCA B, 1987, Annales Francaises d'Anesthesie et de Reanimation, V6, P476, DOI 10.1016/S0750-7658(87)80091-6; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rossi JL, 2011, J NEUROSCI RES, V89, P852, DOI 10.1002/jnr.22600; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Saadat SMS, 2012, CHILD NERV SYST, V28, P1773, DOI 10.1007/s00381-012-1753-5; Sharma Deepak, 2012, Anesthesiol Clin, V30, P333, DOI 10.1016/j.anclin.2012.04.003; Shutter L, 2012, CRIT CARE MED, V40, P1995, DOI 10.1097/CCM.0b013e3182514c15; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Wahlstrom MR, 2009, ACTA ANAESTH SCAND, V53, P18, DOI 10.1111/j.1399-6576.2008.01798.x; Yang Tian-jun, 2013, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V25, P301, DOI 10.3760/cma.j.issn.2095-4352.2013.05.016; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767	28	28	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93167	10.1371/journal.pone.0093167	http://dx.doi.org/10.1371/journal.pone.0093167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671050	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677000123
J	Gates, MC; Woolhouse, MEJ				Gates, M. Carolyn; Woolhouse, Mark E. J.			Suboptimal Herd Performance Amplifies the Spread of Infectious Disease in the Cattle Industry	PLOS ONE			English	Article							VIRAL DIARRHEA VIRUS; LEVEL RISK-FACTORS; DAIRY HERDS; REPRODUCTIVE-PERFORMANCE; BOVINE TUBERCULOSIS; CALVING INTERVAL; REPLACEMENT POLICIES; LIVESTOCK MOVEMENTS; BREEDING OBJECTIVES; NETWORK ANALYSIS	Farms that purchase replacement breeding cattle are at increased risk of introducing many economically important diseases. The objectives of this analysis were to determine whether the total number of replacement breeding cattle purchased by individual farms could be reduced by improving herd performance and to quantify the effects of such reductions on the industry-level transmission dynamics of infectious cattle diseases. Detailed information on the performance and contact patterns of British cattle herds was extracted from the national cattle movement database as a case example. Approximately 69% of beef herds and 59% of dairy herds with an average of at least 20 recorded calvings per year purchased at least one replacement breeding animal. Results from zero-inflated negative binomial regression models revealed that herds with high average ages at first calving, prolonged calving intervals, abnormally high or low culling rates, and high calf mortality rates were generally more likely to be open herds and to purchase greater numbers of replacement breeding cattle. If all herds achieved the same level of performance as the top 20% of herds, the total number of replacement beef and dairy cattle purchased could be reduced by an estimated 34% and 51%, respectively. Although these purchases accounted for only 13% of between-herd contacts in the industry trade network, they were found to have a disproportionately strong influence on disease transmission dynamics. These findings suggest that targeting extension services at herds with suboptimal performance may be an effective strategy for controlling endemic cattle diseases while simultaneously improving industry productivity.	[Gates, M. Carolyn; Woolhouse, Mark E. J.] Univ Edinburgh, Ctr Immun Infect & Evolut, Sch Biol Sci, Epidemiol Grp,Ashworth Labs, Edinburgh, Midlothian, Scotland	University of Edinburgh	Gates, MC (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Sch Biol Sci, Epidemiol Grp,Ashworth Labs, Edinburgh, Midlothian, Scotland.	CarolynGatesVMD@gmail.com		Woolhouse, Mark/0000-0003-3765-8167; Gates, M Carolyn/0000-0002-7790-1945	Scottish Government; Principal's Career Development Scholarship; Scottish Overseas Research Student Award Scheme through the University of Edinburgh	Scottish Government; Principal's Career Development Scholarship; Scottish Overseas Research Student Award Scheme through the University of Edinburgh	This work was undertaken through the Centre of Expertise on Animal Disease Outbreaks (EPIC) supported by the Scottish Government and has made use of the resources provided by the Edinburgh Compute and Data Facility (ECDF). MCG was supported by the Principal's Career Development Scholarship and Scottish Overseas Research Student Award Scheme through the University of Edinburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadland D, 2004, J ECON DYN CONTROL, V28, P1977, DOI 10.1016/j.jedc.2003.08.003; Abernethy DA, 2013, VET REC, V172, DOI 10.1136/vr.100969; Alvarez LG, 2011, EPIDEMIOL INFECT, V139, P1863, DOI 10.1017/S0950268811000070; Amer PR, 2001, LIVEST PROD SCI, V67, P223, DOI 10.1016/S0301-6226(00)00201-3; [Anonymous], 2010, R LANG ENV STAT COMP; Arbel R, 2001, J DAIRY SCI, V84, P600, DOI 10.3168/jds.S0022-0302(01)74513-4; Aznar MN, 2011, PREV VET MED, V98, P119, DOI 10.1016/j.prevetmed.2010.11.004; Baptista Filipa Matos, 2007, Vet Ital, V43, P611; Bascom SS, 1998, J DAIRY SCI, V81, P2299, DOI 10.3168/jds.S0022-0302(98)75810-2; Berry DP, 2009, LIVEST SCI, V123, P44, DOI 10.1016/j.livsci.2008.10.005; Bigras-Poulin M, 2006, PREV VET MED, V76, P11, DOI 10.1016/j.prevetmed.2006.04.004; Borman JM, 2004, AUST J EXP AGR, V44, P507, DOI 10.1071/EA02217; BOURDON RM, 1983, J ANIM SCI, V57, P1412, DOI 10.2527/jas1983.5761412x; Brickell JS, 2009, ANIMAL, V3, P1175, DOI 10.1017/S175173110900456X; BRITT JH, 1985, J DAIRY SCI, V68, P1585, DOI 10.3168/jds.S0022-0302(85)80997-8; Brooks-Pollock E, 2009, PREV VET MED, V92, P360, DOI 10.1016/j.prevetmed.2009.08.022; Carslake D, 2011, PHILOS T R SOC B, V366, P1975, DOI 10.1098/rstb.2010.0396; Dal Zotto R, 2009, J ANIM SCI, V87, P3053, DOI 10.2527/jas.2008-1620; Department for Environment Food and Rural Affairs, 2010, BOV SPONG ENC CHRON; Ersboll A., 2003, ACTA VET SCAND, V44, P49, DOI [10.1186/1751-0147-44-S1-P49, DOI 10.1186/1751-0147-44-S1-P49]; Ettema JF, 2004, J DAIRY SCI, V87, P2730, DOI 10.3168/jds.S0022-0302(04)73400-1; Ezanno P, 2006, ANIM RES, V55, P189, DOI 10.1051/animres:2006013; Ezanno P, 2008, VET RES, V39, DOI 10.1051/vetres:2008016; Funston RN, 2004, J ANIM SCI, V82, P3094; GARTNER JA, 1981, AGR SYST, V7, P289, DOI 10.1016/0308-521X(81)90040-8; Gates MC, 2013, VET J, V198, P631, DOI 10.1016/j.tvjl.2013.09.017; Gates MC, 2013, VET REC, V173, P499, DOI 10.1136/vr.101488; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Green DM, 2007, VET REC, V161, P439, DOI 10.1136/vr.161.13.439; Groenendaal H, 2004, J DAIRY SCI, V87, P2146, DOI 10.3168/jds.S0022-0302(04)70034-X; Grohn YT, 2000, ANIM REPROD SCI, V60, P605, DOI 10.1016/S0378-4320(00)00085-3; Hadley GL, 2006, J DAIRY SCI, V89, P2286, DOI 10.3168/jds.S0022-0302(06)72300-1; Haworth GM, 2008, VET REC, V162, P643, DOI 10.1136/vr.162.20.643; Heikkila AM, 2008, J DAIRY SCI, V91, P2342, DOI 10.3168/jds.2007-0736; Hickson RE, 2010, ANIM PROD SCI, V50, P354, DOI 10.1071/AN09180; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; KORVER S, 1979, LIVEST PROD SCI, V6, P29, DOI 10.1016/0301-6226(79)90029-0; Le Cozler Y, 2008, ANIMAL, V2, P1393, DOI 10.1017/S1751731108002498; Lombard JE, 2007, J DAIRY SCI, V90, P1751, DOI 10.3168/jds.2006-295; MacGregor RG, 1999, LIVEST PROD SCI, V57, P181, DOI 10.1016/S0301-6226(98)00158-4; Madders B, 2006, REV LIVESTOCK MOVEME, P36; Mitchell A, 2005, ANIM SCI, V80, P265, DOI 10.1079/ASC50020265; Natale F, 2011, PREV VET MED, V98, P111, DOI 10.1016/j.prevetmed.2010.11.013; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Ortiz-Pelaez A, 2008, VET J, V176, P177, DOI 10.1016/j.tvjl.2007.02.006; Raboisson D, 2013, J DAIRY SCI, V96, P2913, DOI 10.3168/jds.2012-6010; Rautureau S, 2012, ANIMAL, V6, P1152, DOI 10.1017/S1751731111002631; Rautureau S, 2011, TRANSBOUND EMERG DIS, V58, P110, DOI 10.1111/j.1865-1682.2010.01187.x; Robinson SE, 2007, PREV VET MED, V81, P21, DOI 10.1016/j.prevetmed.2007.04.011; Robinson SE, 2007, J R SOC INTERFACE, V4, P669, DOI 10.1098/rsif.2007.0214; Robinson Susan E, 2006, BMC Vet Res, V2, P11, DOI 10.1186/1746-6148-2-11; Roughsedge T, 2003, ANIM SCI, V77, P403, DOI 10.1017/S1357729800054357; Rufenacht J, 2001, THERIOGENOLOGY, V56, P199, DOI 10.1016/S0093-691X(01)00556-8; Stahl K, 2008, PREV VET MED, V83, P285, DOI 10.1016/j.prevetmed.2007.08.005; Svensson C, 2003, PREV VET MED, V58, P179, DOI 10.1016/S0167-5877(03)00046-1; Thomsen PT, 2006, VET REC, V158, P622, DOI 10.1136/vr.158.18.622; Tinsley M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-11; Tiwari A, 2005, VET MICROBIOL, V109, P147, DOI 10.1016/j.vetmic.2005.05.011; Valle PS, 2001, PREV VET MED, V51, P17, DOI 10.1016/S0167-5877(01)00204-5; van Schaik G, 1998, PREV VET MED, V34, P125, DOI 10.1016/S0167-5877(97)00085-8; VANARENDONK JAM, 1985, LIVEST PROD SCI, V13, P101, DOI 10.1016/0301-6226(85)90014-4; Vargas B, 2001, LIVEST PROD SCI, V69, P17, DOI 10.1016/S0301-6226(00)00250-5; Veerkamp RF, 2002, LIVEST PROD SCI, V76, P137, DOI 10.1016/S0301-6226(02)00006-4; Vernon MC, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-31; Vernon MC, 2009, P ROY SOC B-BIOL SCI, V276, P469, DOI 10.1098/rspb.2008.1009; Volkova VV, 2010, EPIDEMICS-NETH, V2, P116, DOI 10.1016/j.epidem.2010.05.004; Wathes DC, 2008, ANIMAL, V2, P1135, DOI 10.1017/S1751731108002322; Woodbine KA, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-5; Woodbine KA, 2009, PREV VET MED, V89, P102, DOI 10.1016/j.prevetmed.2009.02.005; Youngquist R S., 1997, CURRENT THERAPY LARG, V2nd	71	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93410	10.1371/journal.pone.0093410	http://dx.doi.org/10.1371/journal.pone.0093410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671129	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000141
J	Hiraki, LT; Joshi, AD; Ng, K; Fuchs, CS; Ma, J; Hazra, A; Peters, U; Karlson, EW; Giovannucci, E; Kraft, P; Chan, AT				Hiraki, Linda T.; Joshi, Amit D.; Ng, Kimmie; Fuchs, Charles S.; Ma, Jing; Hazra, Aditi; Peters, Ulrike; Karlson, Elizabeth W.; Giovannucci, Edward; Kraft, Peter; Chan, Andrew T.			Joint Effects of Colorectal Cancer Susceptibility Loci, Circulating 25-Hydroxyvitamin D Risk of Colorectal Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VITAMIN-D; COLON-CANCER; DISEASE; METAANALYSIS; CALCIUM; SCAN; LOCATIONS; 8Q24	Background: Genome wide association studies (GWAS) have identified several SNPs associated with colorectal cancer (CRC) susceptibility. Vitamin D is also inversely associated with CRC risk. Methods: We examined main and joint effects of previously GWAS identified genetic markers of CRC and plasma 25-hydroxyvitamin D (25(OH)D) on CRC risk in three prospective cohorts: the Nurses' Health Study (NHS), the Health Professionals Follow-up Study (HPFS), and the Physicians' Health Study (PHS). We included 1895 CRC cases and 2806 controls with genomic DNA. We calculated odds ratios and 95% confidence intervals for CRC associated with additive genetic risk scores (GRSs) comprised of all CRC SNPs and subsets of these SNPs based on proximity to regions of increased vitamin D receptor binding to vitamin D response elements (VDREs), based on published ChiP-seq data. Among a subset of subjects with additional prediagnostic 25(OH)D we tested multiplicative interactions between plasma 25(OH)D and GRS's. We used fixed effects models to meta-analyze the three cohorts. Results: The per allele multivariate OR was 1.12 (95% CI, 1.06-1.19) for GRS-proximalVDRE; and 1.10 (95% Cl, 1.06-1.14) for GRS-nonproxVDRE. The lowest quartile of plasma 25(OH)D compared with the highest, had a multivariate OR of 0.63 (95% Cl, 0.48-0.82) for CRC. We did not observe any significant interactions between any GRSs and plasma 25(OH)D. Conclusions: We did not observe evidence for the modification of genetic susceptibility for CRC according to vitamin D status, or evidence that the effect of common CRC risk alleles differed according to their proximity to putative VDR binding sites.	[Hiraki, Linda T.; Joshi, Amit D.; Hazra, Aditi; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Ng, Kimmie; Fuchs, Charles S.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Fuchs, Charles S.; Ma, Jing; Hazra, Aditi; Giovannucci, Edward; Chan, Andrew T.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Fuchs, Charles S.; Ma, Jing; Hazra, Aditi; Karlson, Elizabeth W.; Giovannucci, Edward; Chan, Andrew T.] Harvard Univ, Sch Med, Boston, MA USA; [Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Karlson, Elizabeth W.] Brigham & Womens Hosp, Dept Med, Div Rheumatol, Boston, MA 02115 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Dept Med, Div Gastroenterol, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Fred Hutchinson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Chan, AT (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	ACHAN@partners.org	Chan, Andrew T/P-8293-2014; Hiraki, Linda/AAN-6411-2021	Chan, Andrew T/0000-0001-7284-6767; 	National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services [U01 CA137088, R01 CA059045, RO1 CA137178, K24 DK098311]; Canadian Institute of Health Research (CIHR) Fellowship Award; NIH [5K07CA148894]; NATIONAL CANCER INSTITUTE [R01CA059045, R01CA137178, U01CA137088, K07CA148894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR052403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK098311] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institute of Health Research (CIHR) Fellowship Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support was provided by National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (U01 CA137088; R01 CA059045; RO1 CA137178; K24 DK098311). Dr. Hiraki was supported by a Canadian Institute of Health Research (CIHR) Fellowship Award, Dr. Ng was supported by an NIH 5K07CA148894 award. Dr. Chan is a Damon Runyon Clinical Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, NEW ENGL J MED, V321, P129, DOI DOI 10.1056/NEJM198907203210301; BELANGER CF, 1978, AM J NURS, V78, P1039, DOI 10.2307/3462013; BOSTICK RM, 1993, AM J EPIDEMIOL, V137, P1302, DOI 10.1093/oxfordjournals.aje.a116640; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Carlberg C, 2012, ANTICANCER RES, V32, P271; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Feskanich D, 2004, CANCER EPIDEM BIOMAR, V13, P1502; GARLAND C, 1985, LANCET, V1, P307, DOI 10.1016/S0140-6736(85)91082-7; Gorham ED, 2007, AM J PREV MED, V32, P210, DOI 10.1016/j.amepre.2006.11.004; Haiman CA, 2007, CANCER RES, V67, P1893, DOI 10.1158/0008-5472.CAN-06-4123; Heikkinen S, 2011, NUCLEIC ACIDS RES, V39, P9181, DOI 10.1093/nar/gkr654; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Hutter CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-670; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Kearney J, 1996, AM J EPIDEMIOL, V143, P907, DOI 10.1093/oxfordjournals.aje.a008834; Kocarnik JD, 2010, CANC EPIDEMIOL BIOMA; Lee JE, 2011, CANCER PREV RES, V4, P735, DOI 10.1158/1940-6207.CAPR-10-0289; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; Martinez ME, 1996, JNCI-J NATL CANCER I, V88, P1375, DOI 10.1093/jnci/88.19.1375; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Peters U, 2012, GASTROENTEROLOGY; Peters U, 2011, HUM GENET; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Woolcott CG, 2010, CANCER EPIDEM BIOMAR, V19, P130, DOI 10.1158/1055-9965.EPI-09-0475; Wu K, 2007, J NATL CANCER I, V99, P1120, DOI 10.1093/jnci/djm038; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	38	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92212	10.1371/journal.pone.0092212	http://dx.doi.org/10.1371/journal.pone.0092212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670869	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000036
J	Varma, S; Pommier, Y; Sunshine, M; Weinstein, JN; Reinhold, WC				Varma, Sudhir; Pommier, Yves; Sunshine, Margot; Weinstein, John N.; Reinhold, William C.			High Resolution Copy Number Variation Data in the NCI-60 Cancer Cell Lines from Whole Genome Microarrays Accessible through CellMiner	PLOS ONE			English	Article							HUMAN BREAST-TUMORS; DRUG-SENSITIVITY; MULTIDRUG-RESISTANCE; EXPRESSION PROFILES; GENE-EXPRESSION; MESSENGER-RNA; ARRAY-CGH; PANEL; MALIGNANCIES; PHARMACOLOGY	Array-based comparative genomic hybridization (aCGH) is a powerful technique for detecting gene copy number variation. It is generally considered to be robust and convenient since it measures DNA rather than RNA. In the current study, we combine copy number estimates from four different platforms Agilent 44 K, NimbleGen 385 K, Affymetrix 500 K and Illumina Human1Mv1_C) to compute a reliable, high-resolution, easy to understand output for the measure of copy number changes in the 60 cancer cells of the NCI-DTP (the NCI-60). We then relate the results to gene expression. We explain how to access that database using our CellMiner web-tool and provide an example of the ease of comparison with transcript expression, whole exome sequencing, rnicroRNA expression and response to 20,000 drugs and other chemical compounds. We then demonstrate how the data can be analyzed integratively with transcript expression data for the whole genome (26,065 genes). Comparison of copy number and expression levels shows an overall medium high correlation (median r=0.247), with significantly higher correlations (median r=0.408) for the known tumor suppressor genes. That observation is consistent with the hypothesis that gene loss IS an important mechanism for tumor suppressor inactivation. An integrated analysis of concurrent DNA copy number and gene expression change is presented. Limiting attention to focal DNA gains or losses we identify and reveal novel candidate tumor suppressors With matching alterations in transcript level.	[Varma, Sudhir; Pommier, Yves; Sunshine, Margot; Reinhold, William C.] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Varma, Sudhir] HiThru Analyt Inc, Laurel, MD USA; [Sunshine, Margot] Syst Res & Applicat Corp, Fairfax, VA USA; [Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat, Houston, TX 77030 USA; [Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Computat Biol, Houston, TX 77030 USA; [Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Pommier, Y (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	pommier@nih.gov; wcr@mail.nih.gov	Varma, Sudhir/N-8763-2014; Reinhold, William/J-6704-2017	Varma, Sudhir/0000-0002-4096-4782; Reinhold, William/0000-0001-5513-9323; Weinstein, John/0000-0001-9401-6908	Center for Cancer Research, Intramural Program of the National Cancer Institute; NATIONAL CANCER INSTITUTE [P50CA100632, P30CA016672, ZICBC011475] Funding Source: NIH RePORTER	Center for Cancer Research, Intramural Program of the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Center for Cancer Research, Intramural Program of the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Baumbusch LO, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-379; Bussey KJ, 2006, MOL CANCER THER, V5, P853, DOI 10.1158/1535-7163.MCT-05-0155; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chang SS, 2010, ORL-J OTO-RHIN-LARYN, V72, P337, DOI 10.1159/000320597; Costa JL, 2008, SEMIN RADIAT ONCOL, V18, P98, DOI 10.1016/j.semradonc.2007.10.005; Davies JJ, 2005, CHROMOSOME RES, V13, P237, DOI 10.1007/s10577-005-2168-x; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gmeiner WH, 2010, MOL CANCER THER, V9, P3105, DOI 10.1158/1535-7163.MCT-10-0674; Goh XY, 2011, GUT; Gu W, 2008, CANC INFORM, V2008; Holbeck SL, 2010, MOL CANCER THER, V9, P1451, DOI 10.1158/1535-7163.MCT-10-0106; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; JEN J, 1994, CANCER RES, V54, P6353; Kuwano M, 2003, CANCER SCI, V94, P9, DOI 10.1111/j.1349-7006.2003.tb01344.x; Lai LA, 2007, GENE CHROMOSOME CANC, V46, P532, DOI 10.1002/gcc.20435; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; OGAWA S, 1994, BLOOD, V84, P2431, DOI 10.1182/blood.V84.8.2431.bloodjournal8482431; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Platzer P, 2002, CANCER RES, V62, P1134; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Reiman A, 2012, ANTICANCER RES, V32, P4663; Reinhold WC, 2007, MOL CANCER THER, V6, P391, DOI 10.1158/1535-7163.MCT-06-0609; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Reinhold WC, 2010, CANCER RES, V70, P2191, DOI 10.1158/0008-5472.CAN-09-3528; Roschke AV, 2003, CANCER RES, V63, P8634; Ruan XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031628; Schwab M, 1998, BIOESSAYS, V20, P473, DOI 10.1002/(SICI)1521-1878(199806)20:6<473::AID-BIES5>3.3.CO;2-N; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Vincent LM, 2010, MOL GENET METAB, V101, P62, DOI 10.1016/j.ymgme.2010.05.015; Weaver BAA, 2007, CANCER RES, V67, P10103, DOI 10.1158/0008-5472.CAN-07-2266; Weinstein JN, 2003, CR BIOL, V326, P909, DOI 10.1016/j.crvi.2003.08.005; Weinstein JN, 2002, CURR OPIN PHARMACOL, V2, P361, DOI 10.1016/S1471-4892(02)00185-6; Weinstein JN, 2006, MOL CANCER THER, V5, P2601, DOI 10.1158/1535-7163.MCT-06-0640; Weinstein JN, 2012, NATURE, V483, P544, DOI 10.1038/483544a; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2; Zeeberg BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040062	42	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92047	10.1371/journal.pone.0092047	http://dx.doi.org/10.1371/journal.pone.0092047			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670534	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677000031
J	Klein, C; Hain, EG; Braun, J; Riek, K; Mueller, S; Steiner, B; Sack, I				Klein, Charlotte; Hain, Elisabeth G.; Braun, Juergen; Riek, Kerstin; Mueller, Susanne; Steiner, Barbara; Sack, Ingolf			Enhanced Adult Neurogenesis Increases Brain Stiffness: In Vivo Magnetic Resonance Elastography in a Mouse Model of Dopamine Depletion	PLOS ONE			English	Article							PRECURSOR CELL-PROLIFERATION; HIPPOCAMPAL NEUROGENESIS; VISCOELASTIC PROPERTIES; NEURONS; PROJECTIONS; BEHAVIOR; MPTP; RAT	The mechanical network of the brain is a major contributor to neural health and has been recognized by in vivo magnetic resonance elastography (MRE) to be highly responsive to diseases. However, until now only brain softening was observed and no mechanism was known that reverses the common decrement of neural elasticity during aging or disease. We used MRE in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP) mouse model for dopaminergic neurodegeneration as observed in Parkinson's disease (PD) to study the mechanical response of the brain on adult hippocampal neurogenesis as a robust correlate of neuronal plasticity in healthy and injured brain. We observed a steep transient rise in elasticity within the hippocampal region of up to over 50% six days after MPTP treatment correlating with increased neuronal density in the dentate gyrus, which could not be detected in healthy controls. Our results provide the first indication that new neurons reactively generated following neurodegeneration substantially contribute to the mechanical scaffold of the brain. Diagnostic neuroimaging may thus target on regions of the brain displaying symptomatically elevated elasticity values for the detection of neuronal plasticity following neurodegeneration.	[Klein, Charlotte; Hain, Elisabeth G.; Steiner, Barbara] Charite, Dept Neurol, D-13353 Berlin, Germany; [Braun, Juergen] Charite, Inst Med Informat, D-13353 Berlin, Germany; [Riek, Kerstin; Sack, Ingolf] Charite, Dept Radiol, D-13353 Berlin, Germany; [Mueller, Susanne] Ctr Stroke Res Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Steiner, B (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	barbara.steiner@charite.de		Braun, Jurgen/0000-0001-5183-7546; Hain, Elisabeth G./0000-0001-5755-5339; Steiner, Barbara/0000-0003-2106-4532; Mueller, Susanne/0000-0002-5053-2211	German Research Foundation [Sa 901/4]; Else Kroener Fresenius Foundation [P21/10//A141/09]	German Research Foundation(German Research Foundation (DFG)); Else Kroener Fresenius Foundation	The work was supported by the German Research Foundation (Sa 901/4 to IS) and by the Else Kroener Fresenius Foundation (P21/10//A141/09 to BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2005, J NEUROSCI, V25, P8217, DOI 10.1523/JNEUROSCI.1859-05.2005; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Baker SA, 2004, EUR J NEUROSCI, V20, P575, DOI 10.1111/j.1460-9568.2004.03486.x; Barnhill E, 2013, PHYSIOL MEAS, V34, P1675, DOI 10.1088/0967-3334/34/12/1675; Borta A, 2007, J NEUROCHEM, V100, P587, DOI 10.1111/j.1471-4159.2006.04241.x; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Clayton EH, 2012, J R SOC INTERFACE, V9, P2899, DOI 10.1098/rsif.2012.0325; Freimann FB, 2013, NMR BIOMED, V26, P1534, DOI 10.1002/nbm.2987; Freundlieb N, 2006, J NEUROSCI, V26, P2321, DOI 10.1523/JNEUROSCI.4859-05.2006; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gasbarri A, 1997, PROG NEURO-PSYCHOPH, V21, P1, DOI 10.1016/S0278-5846(96)00157-1; GASBARRI A, 1994, BRAIN RES, V668, P71, DOI 10.1016/0006-8993(94)90512-6; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Guo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071807; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Huehnchen P, 2011, GLIA, V59, P132, DOI 10.1002/glia.21082; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Johnson CL, 2013, NEUROIMAGE, V79, P145, DOI 10.1016/j.neuroimage.2013.04.089; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kippin TE, 2005, J NEUROSCI, V25, P5815, DOI 10.1523/JNEUROSCI.1120-05.2005; Klaissle P, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-132; KOPIN IJ, 1987, ENVIRON HEALTH PERSP, V75, P45, DOI 10.2307/3430575; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Kurkowska-Jastrzebska I, 1999, EXP NEUROL, V156, P50, DOI 10.1006/exnr.1998.6993; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lesemann A, 2012, BRAIN RES, V1457, P51, DOI 10.1016/j.brainres.2012.03.046; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; Muthupillai R, 1996, NAT MED, V2, P601, DOI 10.1038/nm0596-601; Papazoglou S, 2008, PHYS MED BIOL, V53, P3147, DOI 10.1088/0031-9155/53/12/005; Park JH, 2010, EXP NEUROL, V222, P267, DOI 10.1016/j.expneurol.2010.01.004; Peng J, 2008, NEUROSCIENCE, V153, P664, DOI 10.1016/j.neuroscience.2008.02.063; Posnansky O, 2012, PHYS MED BIOL, V57, P4023, DOI 10.1088/0031-9155/57/12/4023; Riek K, 2012, NEUROIMAGE-CLIN, V1, P81, DOI 10.1016/j.nicl.2012.09.003; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Sack I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023451; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; SCATTON B, 1980, NEUROSCI LETT, V18, P125, DOI 10.1016/0304-3940(80)90314-6; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; Steiner B, 2008, NEUROSCIENCE, V154, P521, DOI 10.1016/j.neuroscience.2008.04.023; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Streitberger KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029888; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tully B, 2011, J FLUID MECH, V667, P188, DOI 10.1017/S0022112010004428; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Weaver JB, 2012, PHYS MED BIOL, V57, P7275, DOI 10.1088/0031-9155/57/22/7275; Wuerfel J, 2010, NEUROIMAGE, V49, P2520, DOI 10.1016/j.neuroimage.2009.06.018; Yang P, 2008, J NEUROSCI, V28, P2231, DOI 10.1523/JNEUROSCI.3574-07.2008	52	45	45	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92582	10.1371/journal.pone.0092582	http://dx.doi.org/10.1371/journal.pone.0092582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667730	Green Published, gold			2022-12-25	WOS:000333675600051
J	Liu, SH; Li, YJ; Wu, HH; Lee, CC; Lin, CY; Weng, CH; Chen, YC; Chang, MY; Hsu, HH; Fang, JT; Hung, CC; Yang, CW; Tian, YC				Liu, Shou-Hsuan; Li, Yi-Jung; Wu, Hsin-Hsu; Lee, Cheng-Chia; Lin, Chan-Yu; Weng, Cheng-Hao; Chen, Yung-Chang; Chang, Ming-Yang; Hsu, Hsiang-Hao; Fang, Ji-Tseng; Hung, Cheng-Chieh; Yang, Chih-Wei; Tian, Ya-Chung			High-Sensitivity C-Reactive Protein Predicts Mortality and Technique Failure in Peritoneal Dialysis Patients	PLOS ONE			English	Article							RESIDUAL RENAL-FUNCTION; SOLUTE TRANSPORT RATE; SERUM-ALBUMIN; HEMODIALYSIS-PATIENTS; CARDIOVASCULAR-DISEASE; CHRONIC INFLAMMATION; ALL-CAUSE; MEMBRANE-TRANSPORT; SURVIVAL; OUTCOMES	Introduction: An elevated level of serum C-reactive protein (CRP) is widely considered an indicator of an underlying inflammatory disease and a long-term prognostic predictor for dialysis patients. This cross-sectional cohort study was designed to assess the correlation between the level of high-sensitivity CRP (HS-CRP) and the outcome of peritoneal dialysis (PD) patients. Methods: A total of 402 patients were stratified into 3 tertiles (lower, middle, upper) according to serum HS-CRP level and and followed up from October 2009 to September 2011. During follow-up, cardiovascular events, infection episodes, technique failure, and mortality rate were recorded. Results: During the 24-month follow-up, 119 of 402 patients (29.6%) dropped out from PD, including 28 patients (7.0%) who died, 81 patients (20.1%) who switched to hemodialysis, and 10 patients (2.5%) who underwent kidney transplantation. The results of Kaplan-Meier analysis and log-rank test demonstrated a significant difference in the cumulative patient survival rate across the 3 tertiles (the lowest rate in upper tertile). On multivariate Cox regression analysis, only higher HS-CRP level, older age, the presence of diabetes mellitus (DM), lower serum albumin level, and the occurrence of cardiovascular events during follow-up were identified as independent predictors of mortality. Every 1 mg/L increase in HS-CRP level was independently predictive of a 1.4% increase in mortality. Multivariate Cox regression analysis also showed that higher HS-CRP level, the presence of DM, lower hemoglobin level, lower serum albumin level, higher dialysate/plasma creatinine ratio, and the occurrence of infective episodes and cardiovascular events during follow-up were independent predictors of technique failure. Conclusions: The present study shows the importance of HS-CRP in the prediction of 2-year mortality and technique survival in PD patients independent of age, diabetes, hypoalbuminemia, and the occurrence of cardiovascular events.	[Liu, Shou-Hsuan; Li, Yi-Jung; Wu, Hsin-Hsu; Lee, Cheng-Chia; Lin, Chan-Yu; Weng, Cheng-Hao; Chen, Yung-Chang; Chang, Ming-Yang; Hsu, Hsiang-Hao; Fang, Ji-Tseng; Hung, Cheng-Chieh; Yang, Chih-Wei; Tian, Ya-Chung] Chang Gung Univ, Kidney Res Ctr, Dept Nephrol, Lin Kou Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Liu, Shou-Hsuan; Li, Yi-Jung; Wu, Hsin-Hsu; Lee, Cheng-Chia; Lin, Chan-Yu; Weng, Cheng-Hao; Chen, Yung-Chang; Chang, Ming-Yang; Hsu, Hsiang-Hao; Fang, Ji-Tseng; Hung, Cheng-Chieh; Yang, Chih-Wei; Tian, Ya-Chung] Chang Gung Univ, Dept Med, Tao Yuan, Taiwan; [Li, Yi-Jung; Wu, Hsin-Hsu; Weng, Cheng-Hao] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University	Tian, YC (corresponding author), Chang Gung Univ, Kidney Res Ctr, Dept Nephrol, Lin Kou Chang Gung Mem Hosp, Tao Yuan, Taiwan.	dryctian@adm.cgmh.org.tw	Chang, Ming-Yang/AGH-5397-2022	Chang, Ming-Yang/0000-0001-8899-0376; Lee, Cheng-Chia/0000-0002-6973-5908; Wu, Hsin Hsu/0000-0002-0028-7836				Ates K, 2005, PERITON DIALYSIS INT, V25, P256; Avram Morrell M, 2005, Adv Perit Dial, V21, P154; Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158; Brimble KS, 2006, J AM SOC NEPHROL, V17, P2591, DOI 10.1681/ASN.2006030194; Calle MC, 2012, DIABETES METAB; Chen HY, 2010, QJM-INT J MED, V103, P837, DOI 10.1093/qjmed/hcq036; Cho JH, 2010, NEPHROL DIAL TRANSPL, V25, P1964, DOI 10.1093/ndt/gfp767; Choi HY, 2010, NEPHROL DIAL TRANSPL, V25, P1266, DOI 10.1093/ndt/gfp598; Chung SH, 2003, NEPHROL DIAL TRANSPL, V18, P590, DOI 10.1093/ndt/18.3.590; Chung SH, 2001, NEPHROL DIAL TRANSPL, V16, P2240, DOI 10.1093/ndt/16.11.2240; Churchill DN, 1998, J AM SOC NEPHROL, V9, P1285; Corrado E, 2007, G ITAL CARDIOL, V8, P327, DOI 10.1714/681.7922; Don BR, 2000, J NEPHROL, V13, P249; Ducloux D, 2002, KIDNEY INT, V62, P1417, DOI 10.1111/j.1523-1755.2002.kid562.x; Filiopoulos Vasilis, 2009, Inflammation & Allergy Drug Targets, V8, P369; Filiopoulos V, 2009, INT J ARTIF ORGANS, V32, P872, DOI 10.1177/039139880903201206; Fine A, 2002, KIDNEY INT, V61, P615, DOI 10.1046/j.1523-1755.2002.00145.x; Herzig KA, 2001, J AM SOC NEPHROL, V12, P814, DOI 10.1681/ASN.V124814; Honda H, 2006, AM J KIDNEY DIS, V47, P139, DOI 10.1053/j.ajkd.2005.09.014; Johnson David W, 2007, Hemodial Int, V11, P1, DOI 10.1111/j.1542-4758.2007.00146.x; Jones CH, 1997, NEPHROL DIAL TRANSPL, V12, P554, DOI 10.1093/ndt/12.3.554; Kang SH, 2012, RENAL FAILURE, V34, P149, DOI 10.3109/0886022X.2011.646808; Kaul K, 2010, CURR DIABETES REV, V6, P294, DOI 10.2174/157339910793360851; Kavanagh D, 2004, NEPHROL DIAL TRANSPL, V19, P2584, DOI 10.1093/ndt/gfh386; Kaysen GA, 2000, KIDNEY INT, V58, P346, DOI 10.1046/j.1523-1755.2000.00172.x; Kaysen GA, 2009, CLIN J AM SOC NEPHRO, V4, pS56, DOI 10.2215/CJN.03090509; Krediet RT, 2010, NAT REV NEPHROL, V6, P451, DOI 10.1038/nrneph.2010.68; Lacson E, 2004, SEMIN DIALYSIS, V17, P438, DOI 10.1111/j.0894-0959.2004.17604.x; Li PKT, 2005, PERITON DIALYSIS INT, V25, pS80; Liao CT, 2009, NEPHROL DIAL TRANSPL, V24, P2909, DOI 10.1093/ndt/gfp056; Meuwese CL, 2011, NAT REV NEPHROL, V7, P166, DOI 10.1038/nrneph.2011.2; Mujais S, 2006, KIDNEY INT, V70, pS21, DOI 10.1038/sj.ki.5001912; Noh H, 1998, PERITON DIALYSIS INT, V18, P387; Nolan CR, 2005, J AM SOC NEPHROL, V16, pS120, DOI 10.1681/ASN.2005060662; Oh KH, 2008, NEPHROL DIAL TRANSPL, V23, P2356, DOI 10.1093/ndt/gfm921; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; Panichi V, 2000, BLOOD PURIFICAT, V18, P183, DOI 10.1159/000014417; Pecoits-Filho R, 2004, PERITON DIALYSIS INT, V24, P327; Perez-Flores Isabel, 2007, Adv Perit Dial, V23, P140; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Rumpsfeld M, 2006, J AM SOC NEPHROL, V17, P271, DOI 10.1681/ASN.2005050566; Stenvinkel P, 2005, BLOOD PURIFICAT, V23, P72, DOI 10.1159/000082014; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Torzewski J, 1998, ARTERIOSCL THROM VAS, V18, P1386, DOI 10.1161/01.ATV.18.9.1386; VOLANAKIS JE, 1981, J IMMUNOL, V126, P1820; Wang AYM, 2009, NEPHROL DIAL TRANSPL, V24, P3826, DOI 10.1093/ndt/gfp325; Wang AYM, 2003, J AM SOC NEPHROL, V14, P1871, DOI 10.1097/01.ASN.0000070071.57901.B3; Wang T, 1999, PERITON DIALYSIS INT, V19, P17; Wanner C, 2002, NEPHROL DIAL TRANSPL, V17, P29, DOI 10.1093/ndt/17.suppl_8.29; Wanner C, 2009, SEMIN DIALYSIS, V22, P438, DOI 10.1111/j.1525-139X.2009.00596.x; Westhuyzen J, 2005, ANN CLIN LAB SCI, V35, P46; Windgassen EB, 2011, POSTGRAD MED, V123, P114, DOI 10.3810/pgm.2011.01.2252; Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9; Yeun JY, 1997, AM J KIDNEY DIS, V30, P923, DOI 10.1016/S0272-6386(97)90105-0; Zalunardo NY, 2007, KIDNEY INT, V71, P687, DOI 10.1038/sj.ki.5002127	55	24	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93063	10.1371/journal.pone.0093063	http://dx.doi.org/10.1371/journal.pone.0093063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667814	gold, Green Published, Green Submitted			2022-12-25	WOS:000333675600134
J	Wadhawan, M; Singh, N; Rathaur, S				Wadhawan, Mohit; Singh, Neetu; Rathaur, Sushma			Inhibition of Cathepsin B by E-64 Induces Oxidative Stress and Apoptosis in Filarial Parasite	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; SETARIA-CERVI; CELL-DEATH; CYSTEINE PROTEASES; STRUCTURAL BASIS; ACID; IDENTIFICATION; PURIFICATION; PHOSPHATASES; OXIDASE	Background: Current available antifilarial drug strategies only eliminate the larval stages of filarial parasites. Therefore, there is an urgent need of drugs which are macrofilaricidals. Identification of molecular targets crucial for survival of parasite is a prerequisite for drug designing. Cathepsin B, a cysteine protease family member is known to play crucial role in the normal growth, digestion of nutrients, exsheathment of the helminth parasites. Therefore, we targeted this enzyme in the filarial parasite using its specific inhibitor, E-64. Methods and Findings: We have exposed the parasites to E-64 and observed their motility and viability at various time intervals. It caused marked decrease in the motility and viability of the parasites ultimately leading to their death after 8 hours. It is well known that E-64 protects the cell from apoptosis, however, it causes apoptotic effect in carcinoma cell lines. To understand the mechanism of action of E-64 on parasite survival, we have measured levels of different apoptotic markers in the treated parasites. E-64 significantly reduced the level of ced-9 and activity of tyrosine phosphatases, cytochrome c oxidase. It also activated ced-3, homolog of mammalian caspase 3 suggesting initiation of an apoptotic like event in the filarial parasites. Different antioxidant enzymes were also evaluated to further explore the mechanism behind the death of the parasites. There was marked decrease in the level of GSH and activity of Glutathione reductase and glutathione-s-transferase leading to increased generation of reactive oxygen species. This led to the induced oxidation of fatty acids and protein which might alter the mitochondrial membrane permeability. Conclusion: This study suggests that inhibition of cathepsin B by E-64 generates oxidative stress followed by mitochondrial mediated apoptotic like event in filarial parasites leading to their death. Hence, suggesting filarial cathepsin B as a potential chemotherapeutic target for lymphatic filariasis.	[Wadhawan, Mohit; Singh, Neetu; Rathaur, Sushma] Banaras Hindu Univ, Fac Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Rathaur, S (corresponding author), Banaras Hindu Univ, Fac Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India.	surathaur@rediffmail.com	Wadhawan, Mohit/GYJ-2459-2022		Alexander von Humboldt, Germany; Council of Scientific and Industrial research, India	Alexander von Humboldt, Germany; Council of Scientific and Industrial research, India(Council of Scientific & Industrial Research (CSIR) - India)	Authors gratefully acknowledge Alexander von Humboldt, Germany and Council of Scientific and Industrial research, India for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi SK, 2009, AM J TROP MED HYG, V80, P764, DOI 10.4269/ajtmh.2009.80.764; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Barrett A.J., 1997, PROTEINASES MAMMALIA, P240; Behm CA, 2005, TRENDS PARASITOL, V21, P97, DOI 10.1016/j.pt.2004.12.003; Behm CA, 2000, PARASITOL TODAY, V16, P202, DOI 10.1016/S0169-4758(99)01620-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley PJ, 1997, MOL BIOCHEM PARASIT, V89, P1, DOI 10.1016/S0166-6851(97)00098-4; Caffrey CR, 1997, PARASITOL RES, V83, P632, DOI 10.1007/s004360050310; CARLBERG I, 1981, ANAL BIOCHEM, V116, P531, DOI 10.1016/0003-2697(81)90398-5; Castino R, 2002, INT J CANCER, V97, P775, DOI 10.1002/ijc.10139; Chantree P, 2013, EXP PARASITOL, V135, P102, DOI 10.1016/j.exppara.2013.06.010; Choi HS, 2006, J IMMUNOASS IMMUNOCH, V27, P31, DOI 10.1080/15321810500403722; Correnti JA, 2005, MOL BIOCHEM PARASIT, V143, P209, DOI 10.1016/j.molbiopara.2005.06.007; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Ericson NG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002689; Ginger C.D., 1983, WHOOCPOCT831; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hemachand T, 2002, J CELL SCI, V115, P2053; HEYNEMAN RA, 1984, J LEUKOCYTE BIOL, V36, P751, DOI 10.1002/jlb.36.6.751; Horvitz HR, 1999, CANCER RES, V59, p1701S; KATUNUMA N, 1995, METHOD ENZYMOL, V251, P382, DOI 10.1016/0076-6879(95)51142-3; KAUSHAL NA, 1987, IMMUNOL INVEST, V16, P139, DOI 10.3109/08820138709030571; Kim R, 2005, CANCER-AM CANCER SOC, V103, P1551, DOI 10.1002/cncr.20947; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Levinthal DJ, 2005, J BIOL CHEM, V280, P5875, DOI 10.1074/jbc.M410771200; Liu LX, 1996, NEW ENGL J MED, V334, P1178, DOI 10.1056/NEJM199605023341808; Lopez CJ, 2005, NEUROSCI LETT, V386, P78, DOI 10.1016/j.neulet.2005.04.089; Malla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013731; Matsumoto K, 1999, BIOPOLYMERS, V51, P99, DOI 10.1002/(SICI)1097-0282(1999)51:1<99::AID-BIP11>3.0.CO;2-R; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Paradies G, 1998, FEBS LETT, V424, P155, DOI 10.1016/S0014-5793(98)00161-6; Pokharel DR, 2009, PARASITOL RES, V104, P1399, DOI 10.1007/s00436-009-1336-x; Rozman-Pungercar J, 2003, CELL DEATH DIFFER, V10, P881, DOI 10.1038/sj.cdd.4401247; Saini P, 2012, PARASITOL INT, V61, P520, DOI 10.1016/j.parint.2012.04.002; Schroeter H, 2001, BIOCHEM J, V358, P547, DOI 10.1042/0264-6021:3580547; Sener G, 2005, FUND CLIN PHARMACOL, V19, P155, DOI 10.1111/j.1472-8206.2005.00322.x; Singh A, 2005, BIOCHEM BIOPH RES CO, V331, P1069, DOI 10.1016/j.bbrc.2005.03.235; Singh A, 2010, BIOCHIMIE, V92, P894, DOI 10.1016/j.biochi.2010.03.018; TAGA EM, 1982, ARCH BIOCHEM BIOPHYS, V214, P505, DOI 10.1016/0003-9861(82)90054-6; Tort J, 1999, ADV PARASIT, V43, P161, DOI 10.1016/S0065-308X(08)60243-2; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Tsou PS, 2012, ARTHRITIS RHEUM-US, V64, P1978, DOI 10.1002/art.34336; von Haefen C, 2003, ONCOGENE, V22, P2236, DOI 10.1038/sj.onc.1206280; World Health Organization, 2010, WHO GLOB PROGR EL LY; Yadav SS, 2013, PARASITOL INT, V62, P193, DOI 10.1016/j.parint.2012.12.008; Yamamoto A, 2002, BBA-PROTEIN STRUCT M, V1597, P244, DOI 10.1016/S0167-4838(02)00284-4	50	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93161	10.1371/journal.pone.0093161	http://dx.doi.org/10.1371/journal.pone.0093161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667798	Green Submitted, gold, Green Published			2022-12-25	WOS:000333675600151
J	Hashimoto, Y; Shirane, M; Matsuzaki, F; Saita, S; Ohnishi, T; Nakayama, KI				Hashimoto, Yutaka; Shirane, Michiko; Matsuzaki, Fumiko; Saita, Shotaro; Ohnishi, Takafumi; Nakayama, Keiichi I.			Protrudin Regulates Endoplasmic Reticulum Morphology and Function Associated with the Pathogenesis of Hereditary Spastic Paraplegia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum Stress; Endoplasmic Reticulum (ER); Membrane Structure; Neurodegenerative Diseases; Proteomics	HOMOTYPIC FUSION; ER; PROTEINS; NETWORK; MEMBRANES; MUTATION; ORGANIZATION; TRAFFICKING; INHERITANCE; PATHWAYS	Background: Certain hereditary spastic paraplegia (HSP)-related proteins possess hairpin domains and regulate the morphology of the endoplasmic reticulum (ER) network. Results: Protrudin possesses a hairpin domain and interacts with HSP-related proteins. Conclusion: Protrudin regulates ER morphology and function. Significance: Mutant protrudin produced in certain individuals with HSP is prone to form microaggregates that induce ER stress. Protrudin is a membrane protein that regulates polarized vesicular trafficking in neurons. The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia (SPG) 33. We have now generated mice that express a transgene for dual epitope-tagged protrudin under control of a neuron-specific promoter, and we have subjected highly purified protrudin-containing complexes isolated from the brain of these mice to proteomics analysis to identify proteins that associate with protrudin. Protrudin was found to interact with other HSP-related proteins including myelin proteolipid protein 1 (SPG2), atlastin-1 (SPG3A), REEP1 (SPG31), REEP5 (similar to REEP1), Kif5A (SPG10), Kif5B, Kif5C, and reticulon 1, 3, and 4 (similar to reticulon 2, SPG12). Membrane topology analysis indicated that one of three hydrophobic segments of protrudin forms a hydrophobic hairpin domain similar to those of other SPG proteins. Protrudin was found to localize predominantly to the tubular endoplasmic reticulum (ER), and forced expression of protrudin promoted the formation and stabilization of the tubular ER network. The protrudin(G191V) mutant, which has been identified in a subset of HSP patients, manifested an increased intracellular stability, and cells expressing this mutant showed an increased susceptibility to ER stress. Our results thus suggest that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP.	[Hashimoto, Yutaka; Shirane, Michiko; Matsuzaki, Fumiko; Saita, Shotaro; Ohnishi, Takafumi; Nakayama, Keiichi I.] Kyushu Univ, Dept Mol & Cellular Biol, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Shirane, M (corresponding author), Kyushu Univ, Dept Mol & Cellular Biol, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	smichi@bioreg.kyushu-u.ac.jp		Shirane, Michiko/0000-0002-8297-9245; Matsuzaki, Fumiko/0000-0001-9370-6456; Saita, Shotaro/0000-0002-7406-8361	Japan Society for the Promotion of Science KAKENHI	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Japan Society for the Promotion of Science KAKENHI Grant-in-Aid for Young Scientists (S) (to M.S.).	Alazami AM, 2011, NEUROGENETICS, V12, P333, DOI 10.1007/s10048-011-0291-8; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Anwar K, 2012, J CELL BIOL, V197, P209, DOI 10.1083/jcb.201111115; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Chang J, 2013, P NATL ACAD SCI USA, V110, P14954, DOI 10.1073/pnas.1307391110; Finsterer J, 2012, J NEUROL SCI, V318, P1, DOI 10.1016/j.jns.2012.03.025; HARDING AE, 1983, LANCET, V1, P1151; Hu JJ, 2011, CELL, V147, P1226, DOI 10.1016/j.cell.2011.11.022; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Levine T, 2005, CURR OPIN CELL BIOL, V17, P362, DOI 10.1016/j.ceb.2005.06.005; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Mannan AU, 2006, AM J HUM GENET, V79, P351, DOI 10.1086/504927; Marques VD, 2006, MUSCLE NERVE, V34, P731, DOI 10.1002/mus.20657; Martignoni M, 2008, AM J HUM GENET, V83, P127, DOI 10.1016/j.ajhg.2008.05.014; Matsumoto M, 2009, PROTEOMICS, V9, P3549, DOI 10.1002/pmic.200900011; Matsuzaki F, 2011, MOL BIOL CELL, V22, P4602, DOI 10.1091/mbc.E11-01-0068; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Saita S, 2009, J BIOL CHEM, V284, P13766, DOI 10.1074/jbc.M807938200; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Yagi T, 2011, HUM MOL GENET, V20, P3831, DOI 10.1093/hmg/ddr304; Zhang CL, 2012, J CELL BIOCHEM, V113, P2296, DOI 10.1002/jcb.24100; Zhu PP, 2006, HUM MOL GENET, V15, P1343, DOI 10.1093/hmg/ddl054	36	43	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					12946	12961		10.1074/jbc.M113.528687	http://dx.doi.org/10.1074/jbc.M113.528687			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24668814	Green Published, hybrid			2022-12-25	WOS:000335522800001
J	Michel, M; Wilhelmi, I; Schultz, AS; Preussner, M; Heyd, F				Michel, Monika; Wilhelmi, Ilka; Schultz, Astrid-Solveig; Preussner, Marco; Heyd, Florian			Activation-induced Tumor Necrosis Factor Receptorassociated Factor 3 ( Traf3) Alternative Splicing Controls the Noncanonical Nuclear Factor kappa B Pathway and Chemokine Expression in Human T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Nuclear Factor B (NFB); RNA Splicing; T Cell; TRAF	PROTEIN-INTERACTION NETWORKS; PRE-MESSENGER-RNA; MESENCHYMAL TRANSITION; HELPER-CELLS; KINASE; REGULATORS; RECEPTOR; VARIANTS; DYNAMICS; PROGRAM	Background: Many pre-mRNAs are alternatively spliced upon T cell activation, but functional implications remain largely unexplored. Results: Alternative splicing of the signaling adaptor Traf3 controls expression of effector proteins in activated T cells. Conclusion: Cell type-specific and activation-dependent alternative splicing regulates signaling and gene expression in T cells. Significance: Alternative splicing plays a fundamental role in regulating functionality upon T cell activation. The noncanonical nuclear factor B (ncNFB) pathway regulates the expression of chemokines required for secondary lymphoid organ formation and thus plays a pivotal role in adaptive immunity. Whereas ncNFB signaling has been well described in stromal cells and B cells, its role and regulation in T cells remain largely unexplored. ncNFB activity critically depends on the upstream NFB-inducing kinase (NIK). NIK expression is negatively regulated by the full-length isoform of TNF receptor-associated factor 3 (Traf3) as formation of a NIK-Traf3-Traf2 complex targets NIK for degradation. Here we show that T cell-specific and activation-dependent alternative splicing generates a Traf3 isoform lacking exon 8 (Traf3DE8) that, in contrast to the full-length protein, activates ncNFB signaling. Traf3DE8 disrupts the NIK-Traf3-Traf2 complex and allows accumulation of NIK to initiate ncNFB signaling in activated T cells. ncNFB activity results in expression of several chemokines, among them B cell chemoattractant (CxCL13), both in a model T cell line and in primary human CD4(+) T cells. Because CxCL13 plays an important role in B cell migration and activation, our data suggest an involvement and provide a mechanistic basis for Traf3 alternative splicing and ncNFB activation in contributing to T cell-dependent adaptive immunity.	[Michel, Monika; Wilhelmi, Ilka; Schultz, Astrid-Solveig; Preussner, Marco; Heyd, Florian] Univ Marburg, Inst Mol Biol & Tumor Res IMT, D-35032 Marburg, Germany	Philipps University Marburg	Heyd, F (corresponding author), Free Univ Berlin, Inst Chem & Biochem, Takustr 6, D-14195 Berlin, Germany.	florian.heyd@fu-berlin.de			Emmy-Noether Fellowship from the Deutsche Forschungsgemeinschaft [HE 5398/3-1]; Fritz Thyssen Foundation [Az. 10.12.1.158]	Emmy-Noether Fellowship from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fritz Thyssen Foundation	This work was supported by Emmy-Noether Fellowship HE 5398/3-1 from the Deutsche Forschungsgemeinschaft. This work was also supported by Fritz Thyssen Foundation Grant Az. 10.12.1.158.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; He JQ, 2007, J BIOL CHEM, V282, P3688, DOI 10.1074/jbc.M610271200; He LS, 2004, J BIOL CHEM, V279, P55855, DOI 10.1074/jbc.M407284200; Heyd F, 2011, BIOCHEM BIOPH RES CO, V414, P743, DOI 10.1016/j.bbrc.2011.09.149; Heyd F, 2010, MOL CELL, V40, P126, DOI 10.1016/j.molcel.2010.09.013; Heyd F, 2009, MOL CELL, V33, P674, DOI 10.1016/j.molcel.2009.03.001; Hu HB, 2013, NATURE, V494, P371, DOI 10.1038/nature11831; Hu HB, 2011, P NATL ACAD SCI USA, V108, P12827, DOI 10.1073/pnas.1105774108; Ishimaru N, 2006, NAT IMMUNOL, V7, P763, DOI 10.1038/ni1351; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lynch KW, 2000, MOL CELL BIOL, V20, P70, DOI 10.1128/MCB.20.1.70-80.2000; Manzo A, 2008, ARTHRITIS RHEUM, V58, P3377, DOI 10.1002/art.23966; Martinez NM, 2013, IMMUNOL REV, V253, P216, DOI 10.1111/imr.12047; Martinez NM, 2012, RNA, V18, P1029, DOI 10.1261/rna.032243.112; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; McPherson AJ, 2012, J BIOL CHEM, V287, P23010, DOI 10.1074/jbc.M112.350538; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Razani B, 2011, IMMUNOL REV, V244, P44, DOI 10.1111/j.1600-065X.2011.01059.x; de Guinoa JS, 2011, BLOOD, V118, P1560, DOI 10.1182/blood-2011-01-332106; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; van Eyndhoven WG, 1999, MOL IMMUNOL, V36, P647, DOI 10.1016/S0161-5890(99)00079-6; Warzecha CC, 2012, SEMIN CANCER BIOL, V22, P417, DOI 10.1016/j.semcancer.2012.04.003; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Xie P, 2011, J IMMUNOL, V186, P143, DOI 10.4049/jimmunol.1000290; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	40	19	19	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13651	13660		10.1074/jbc.M113.526269	http://dx.doi.org/10.1074/jbc.M113.526269			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24671418	Green Published, hybrid			2022-12-25	WOS:000335522800058
J	Uechi, H; Hamazaki, J; Murata, S				Uechi, Hiroyuki; Hamazaki, Jun; Murata, Shigeo			Characterization of the Testis-specific Proteasome Subunit alpha 4s in Mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Proteasome; Sperm; Spermatogenesis; Testis; Ubiquitin	INTERFERON-GAMMA; 26S PROTEASOMES; 20S PROTEASOMES; DNA-REPAIR; DEGRADATION; COMPLEX; SYSTEM; CELLS; DESTRUCTION; CHAPERONES	Background: Two subtypes of proteasome core particles (CPs) with tissue-specific subunits have been identified in mammals. Results: Mammals have an additional proteasome subunit, 4s, which forms the male germ-specific CP. Conclusion: The 4s-containing CP is a new subtype of CP with unique properties distinct from the constitutive CP. Significance: Our results provide a clue for understanding the role of the proteasome in mammalian testes. The 26 S proteasome is responsible for regulated proteolysis in eukaryotic cells. It is composed of one 20 S core particle (CP) flanked by one or two 19 S regulatory particles. The CP is composed of seven different -type subunits (1-7) and seven different -type subunits, three of which are catalytic. Vertebrates encode four additional catalytic subunits that are expressed predominantly in immune tissues and produce distinct subtypes of CPs particularly well suited for the acquired immune system. In contrast, the diversity of subunits remains poorly understood. Recently, another subunit, referred to as 4s, was reported. However, little is known about 4s. Here we provide a detailed characterization of 4s and the 4s-containing CP. 4s is exclusively expressed in germ cells that enter the meiotic prophase and is incorporated into the CP in place of 4. A comparison of structural models revealed that the differences in the primary sequences between 4 and 4s are located on the outer surface of the CP, suggesting that 4s interacts with specific molecules via these unique regions. 4s-containing CPs account for the majority of the CPs in mouse sperm. The catalytic subunits in the 4s-containing CP are 1, 2, and 5, and immunosubunits are not included in the 4s-containing CP. 4s-containing CPs have a set of peptidase activities almost identical to those of 4-containing CPs. Our results provide a basis for understanding the role of 4s and male germ cell-specific proteasomes in mammals.	[Uechi, Hiroyuki; Hamazaki, Jun; Murata, Shigeo] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Murata, S (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	smurata@mol.f.u-tokyo.ac.jp	hamazaki, jun/AAG-4823-2019; Murata, Shigeo/A-1426-2010	hamazaki, jun/0000-0002-7145-3424; Murata, Shigeo/0000-0002-3177-3503	Grants-in-Aid for Scientific Research [26000014] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Alsheimer M, 2010, CYTOGENET GENOME RES, V128, P162, DOI 10.1159/000303341; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Blanco-Rodriguez J, 1999, BIOL REPROD, V61, P1541, DOI 10.1095/biolreprod61.6.1541; BREUCKER H, 1985, CELL TISSUE RES, V240, P303; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dong JB, 2004, J BIOL CHEM, V279, P21334, DOI 10.1074/jbc.M401022200; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Jia YX, 2009, J IMMUNOL, V183, P4241, DOI 10.4049/jimmunol.0901646; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kent J, 1996, DEVELOPMENT, V122, P2813; Liu X, 2006, MOL CELL, V22, P317, DOI 10.1016/j.molcel.2006.04.007; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Russell L. D., 1990, HISTOLOGICAL HISTOPA, P41; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; TAJIMA Y, 1991, DEVELOPMENT, V113, P1031; Takahama Y, 2012, CURR OPIN IMMUNOL, V24, P92, DOI 10.1016/j.coi.2012.01.006; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Tanaka K, 1998, IMMUNOL REV, V163, P161; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	31	35	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12365	12374		10.1074/jbc.M114.558866	http://dx.doi.org/10.1074/jbc.M114.558866			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24668818	Green Published, hybrid			2022-12-25	WOS:000335581400015
J	Shi, Y; Xu, XT; Tan, Y; Mao, S; Fang, SR; Gu, W				Shi, Ying; Xu, Xiantao; Tan, Yan; Mao, Shan; Fang, Surong; Gu, Wei			A Liver-X-Receptor Ligand, T0901317, Attenuates IgE Production and Airway Remodeling in Chronic Asthma Model of Mice	PLOS ONE			English	Article							CHOLESTEROL EFFLUX; MURINE MODEL; LXR-ALPHA; INFLAMMATION; EXPRESSION; AGONIST; GROWTH; CELLS; BETA	The liver-X-receptors have shown anti-inflammatory ability in several animal models of respiratory disease. Our purpose is to investigate the effect of LXR ligand in allergen-induced airway remodeling in mice. Ovalbumin-sensitized mice were chronically challenged with aerosolized ovalbumin for 8 weeks. Some mice were administered a LXR agonist, T0901317 (12.5, 25, 50 mg/kg bodyweight) before challenge. Then mice were evaluated for airway inflammation, airway hyperresponsiveness and airway remodeling. T0901317 failed to attenuate the inflammatory cells and Th2 cytokines in bronchoalveolar lavage fluid. But the application of T0901317 reduced the thickness of airway smooth muscle and the collagen deposition. Meanwhile, T0901317 treatment evidently abolished the high level of OVA-specific IgE, TGF-beta 1 and MMP-9 in lung. So LXRs may attenuate the progressing of airway remodeling, providing a potential treatment of asthma.	[Shi, Ying; Xu, Xiantao; Tan, Yan; Mao, Shan; Fang, Surong; Gu, Wei] Nanjing Med Univ, Dept Resp Med, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Gu, W (corresponding author), Nanjing Med Univ, Dept Resp Med, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China.	sykxss@163.com			National Natural Science Foundation of China [81100010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by the National Natural Science Foundation of China grant 81100010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benayoun L, 2003, M S-MED SCI, V19, P319, DOI 10.1051/medsci/2003193319; Birrell MA, 2008, J IMMUNOL, V181, P4265, DOI 10.4049/jimmunol.181.6.4265; Blaschke F, 2004, CIRC RES, V95, pE110, DOI 10.1161/01.RES.0000150368.56660.4f; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Brown SD, 2012, J ALLERGY CLIN IMMUN, V129, P388, DOI 10.1016/j.jaci.2011.11.037; BRUSSELLE GG, 1994, CLIN EXP ALLERGY, V24, P73, DOI 10.1111/j.1365-2222.1994.tb00920.x; Castrillo A, 2003, J BIOL CHEM, V278, P10443, DOI 10.1074/jbc.M213071200; Costet P, 2000, J BIOL CHEM, V275, P28240; Crisafulli C, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-19; Delvecchio CJ, 2007, MOL ENDOCRINOL, V21, P1324, DOI 10.1210/me.2007-0017; Fowler AJ, 2003, J INVEST DERMATOL, V120, P246, DOI 10.1046/j.1523-1747.2003.12033.x; Hamelmann E, 1999, ALLERGY, V54, P297, DOI 10.1034/j.1398-9995.1999.00085.x; Heine G, 2009, J IMMUNOL, V182, P5276, DOI 10.4049/jimmunol.0801804; Houck KA, 2004, MOL GENET METAB, V83, P184, DOI 10.1016/j.ymgme.2004.07.007; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Lee YC, 2001, J ALLERGY CLIN IMMUN, V108, P1021, DOI 10.1067/mai.2001.120132; Li YTY, 2007, ARTERIOSCL THROM VAS, V27, P2606, DOI 10.1161/ATVBAHA.107.152694; Louis R, 2012, CLIN CHEST MED, V33, P531, DOI 10.1016/j.ccm.2012.05.004; Makinde T, 2007, IMMUNOL CELL BIOL, V85, P348, DOI 10.1038/sj.icb.7100044; Nunomura S, 2010, FEBS LETT, V584, P1143, DOI 10.1016/j.febslet.2010.02.006; Park MC, 2010, RHEUMATOLOGY, V49, P882, DOI 10.1093/rheumatology/keq007; Smoak K, 2008, J IMMUNOL, V180, P3305, DOI 10.4049/jimmunol.180.5.3305; Solan PD, 2011, SHOCK, V35, P367, DOI 10.1097/SHK.0b013e3181f7d742; Tagaya Etsuko, 2007, Allergol Int, V56, P331; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; Walter DM, 2001, J IMMUNOL, V167, P4668, DOI 10.4049/jimmunol.167.8.4668; Wang DM, 2011, INT IMMUNOPHARMACOL, V11, P2098, DOI 10.1016/j.intimp.2011.09.002; Warner SM, 2008, CURR OPIN ALLERGY CL, V8, P44, DOI 10.1097/ACI.0b013e3282f3b5cb	30	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92668	10.1371/journal.pone.0092668	http://dx.doi.org/10.1371/journal.pone.0092668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681543	gold, Green Published, Green Submitted			2022-12-25	WOS:000333678100013
J	Basner, M; Dinges, DF; Mollicone, DJ; Savelev, I; Ecker, AJ; Di Antonio, A; Jones, CW; Hyder, EC; Kan, K; Morukov, BV; Sutton, JP				Basner, Mathias; Dinges, David F.; Mollicone, Daniel J.; Savelev, Igor; Ecker, Adrian J.; Di Antonio, Adrian; Jones, Christopher W.; Hyder, Eric C.; Kan, Kevin; Morukov, Boris V.; Sutton, Jeffrey P.			Psychological and Behavioral Changes during Confinement in a 520-Day Simulated Interplanetary Mission to Mars	PLOS ONE			English	Article							INTERNATIONAL-SPACE-STATION; VIGILANCE TEST PVT; SLEEP-DEPRIVATION; MOOD STATES; SOCIAL DESIRABILITY; POLAR EXPEDITIONS; DOSE-RESPONSE; PERFORMANCE; DURATION; VALIDITY	Behavioral health risks are among the most serious and difficult to mitigate risks of confinement in space craft during long-duration space exploration missions. We report on behavioral and psychological reactions of a multinational crew of 6 healthy males confined in a 550 m(3) chamber for 520 days during the first Earth-based, high-fidelity simulated mission to Mars. Rest-activity of crewmembers was objectively measured throughout the mission with wrist-worn actigraphs. Once weekly throughout the mission crewmembers completed the Beck Depression Inventory-II (BDI-II), Profile of Moods State short form (POMS), conflict questionnaire, the Psychomotor Vigilance Test (PVT-B), and series of visual analogue scales on stress and fatigue. We observed substantial inter-individual differences in the behavioral responses of crewmembers to the prolonged mission confinement and isolation. The crewmember with the highest average POMS total mood disturbance score throughout the mission also reported symptoms of depression in 93% of mission weeks, which reached mild-to-moderate levels in >10% of mission weeks. Conflicts with mission control were reported five times more often than conflicts among crewmembers. Two crewmembers who had the highest ratings of stress and physical exhaustion accounted for 85% of the perceived conflicts. One of them developed a persistent sleep onset insomnia with ratings of poor sleep quality, which resulted in chronic partial sleep deprivation, elevated ratings of daytime tiredness, and frequent deficits in behavioral alertness. Sleep-wake timing was altered in two other crewmembers, beginning in the first few months of the mission and persisting throughout. Two crewmembers showed neither behavioral disturbances nor reports of psychological distress during the 17-month period of mission confinement. These results highlight the importance of identifying behavioral, psychological, and biological markers of characteristics that predispose prospective crewmembers to both effective and ineffective behavioral reactions during the confinement of prolonged spaceflight, to inform crew selection, training, and individualized countermeasures.	[Basner, Mathias; Dinges, David F.; Ecker, Adrian J.; Di Antonio, Adrian; Jones, Christopher W.; Hyder, Eric C.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mollicone, Daniel J.; Kan, Kevin] Pulsar Informat, Philadelphia, PA USA; [Savelev, Igor] Wyle, Houston, TX USA; [Savelev, Igor; Sutton, Jeffrey P.] Natl Space Biomed Res Inst, Houston, TX USA; [Morukov, Boris V.] Minist Publ Hlth Russia, Inst Biomed Problems, Moscow, Russia; [Sutton, Jeffrey P.] Baylor Coll Med, Ctr Space Med, Houston, TX 77030 USA; [Sutton, Jeffrey P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University of Pennsylvania; Pennsylvania Medicine; Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; Baylor College of Medicine; Baylor College of Medicine	Basner, M (corresponding author), Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA.	basner@upenn.edu	Jones, Christopher W./AAA-2754-2020; Dinges, David/P-7183-2019	Jones, Christopher W./0000-0002-8173-721X; 	National Space Biomedical Research Institute (NSBRI) [NASA NCC 9-58]; Institute for Experimental Psychiatry Research Foundation	National Space Biomedical Research Institute (NSBRI); Institute for Experimental Psychiatry Research Foundation	The research was supported by the National Space Biomedical Research Institute (NSBRI) through NASA NCC 9-58, and by the Institute for Experimental Psychiatry Research Foundation. The funders had no role in study design, data collection and analysis, and decision to publish. Jeffrey Sutton is President, CEO and Institute Director of NSBRI. He helped in the preparation of the manuscript. The Friedkin Chair for Research in Sensory System Integration and Space Medicine to Jeffrey Sutton is also acknowledged.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Antonovsky A., 1987, UNRAVELING MYSTERY H; Baisden DL, 2008, AVIAT SPACE ENVIR MD, V79, P629, DOI 10.3357/ASEM.2314.2008; Ball H., 2001, SAFE PASSAGE ASTRONA; Basner M, 2013, P NATL ACAD SCI USA, V110, P2635, DOI 10.1073/pnas.1212646110; Basner M, 2011, ACTA ASTRONAUT, V69, P949, DOI 10.1016/j.actaastro.2011.07.015; Basner M, 2011, J OCCUP ENVIRON MED, V53, P1146, DOI 10.1097/JOM.0b013e31822b8356; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Blake BF, 2006, PERS INDIV DIFFER, V40, P1625, DOI 10.1016/j.paid.2005.12.007; Boyd JE, 2007, ACTA ASTRONAUT, V61, P668, DOI 10.1016/j.actaastro.2006.12.002; CURRAN SL, 1995, PSYCHOL ASSESSMENT, V7, P80, DOI 10.1037/1040-3590.7.1.80; Feichtinger E, 2012, AER C; Griofa MO, 2011, AVIAT SPACE ENVIR MD, V82, P434, DOI 10.3357/ASEM.2570.2011; Inoue N, 2004, AVIAT SPACE ENVIR MD, V75, pC28; Kanas N, 2009, ACTA ASTRONAUT, V64, P659, DOI 10.1016/j.actaastro.2008.12.005; KELLY AD, 1993, AVIAT SPACE ENVIR MD, V64, P795; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lapierrea J, 2009, ACTA ASTRONAUT, V64, P1304, DOI 10.1016/j.actaastro.2009.01.002; Leon GR, 2011, J ENVIRON PSYCHOL, V31, P353, DOI 10.1016/j.jenvp.2011.08.001; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Mollicone DJ, 2008, ACTA ASTRONAUT, V63, P833, DOI 10.1016/j.actaastro.2007.12.005; Palinkas LA, 2008, LANCET, V371, P153, DOI 10.1016/S0140-6736(07)61056-3; Rosnet E, 1998, ACTA ASTRONAUT, V42, P265; Sandal GM, 2004, AVIAT SPACE ENVIR MD, V75, pC44; Sandal GM, 1996, AVIAT SPACE ENVIR MD, V67, P227; SHACHAM S, 1983, J PERS ASSESS, V47, P305, DOI 10.1207/s15327752jpa4703_14; Shved D M, 2013, Aviakosm Ekolog Med, V47, P19; Slack KJ, 2009, RISK BEHAV PSYCHIAT; Stober J, 2001, EUR J PSYCHOL ASSESS, V17, P222, DOI 10.1027//1015-5759.17.3.222; Stuster J, 2005, AVIAT SPACE ENVIR MD, V76, pB78; Stuster J, 2000, AVIAT SPACE ENVIR MD, V71, pA17; Suedfeld P, 1998, J ENVIRON PSYCHOL, V18, P95, DOI 10.1006/jevp.1998.0090; SUEDFELD P, 1991, ENVIRON BEHAV, V23, P653, DOI 10.1177/0013916591236001; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117	37	94	98	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93298	10.1371/journal.pone.0093298	http://dx.doi.org/10.1371/journal.pone.0093298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SW	24675720	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677500107
J	Coverdale, TC; Brisson, CP; Young, EW; Yin, SF; Donnelly, JP; Bertness, MD				Coverdale, Tyler C.; Brisson, Caitlin P.; Young, Eric W.; Yin, Stephanie F.; Donnelly, Jeffrey P.; Bertness, Mark D.			Indirect Human Impacts Reverse Centuries of Carbon Sequestration and Salt Marsh Accretion	PLOS ONE			English	Article							GLOBAL CLIMATE-CHANGE; SEA-LEVEL RISE; DIE-OFF; CORAL-REEF; TROPHIC CASCADES; ECOSYSTEMS; DEGRADATION; DISTURBANCE; RESILIENCE; FLUX	Direct and indirect human impacts on coastal ecosystems have increased over the last several centuries, leading to unprecedented degradation of coastal habitats and loss of ecological services. Here we document a two-century temporal disparity between salt marsh accretion and subsequent loss to indirect human impacts. Field surveys, manipulative experiments and GIS analyses reveal that crab burrowing weakens the marsh peat base and facilitates further burrowing, leading to bank calving, disruption of marsh accretion, and a loss of over two centuries of sequestered carbon from the marsh edge in only three decades. Analogous temporal disparities exist in other systems and are a largely unrecognized obstacle in attaining sustainable ecosystem services in an increasingly human impacted world. In light of the growing threat of indirect impacts worldwide and despite uncertainties in the fate of lost carbon, we suggest that estimates of carbon emissions based only on direct human impacts may significantly underestimate total anthropogenic carbon emissions.	[Coverdale, Tyler C.; Brisson, Caitlin P.; Young, Eric W.; Yin, Stephanie F.; Bertness, Mark D.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Donnelly, Jeffrey P.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Brown University; Woods Hole Oceanographic Institution	Coverdale, TC (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	Tyler_Coverdale@Brown.edu		Brisson, Caitlin/0000-0001-8567-1863; Coverdale, Tyler/0000-0003-0910-9187	National Science Foundation Biological Oceanography Program; Brown University Undergraduate Teaching and Research Award Program	National Science Foundation Biological Oceanography Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Brown University Undergraduate Teaching and Research Award Program	This research was made possible by a grant from the National Science Foundation Biological Oceanography Program and the Brown University Undergraduate Teaching and Research Award Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardy T., 2005, ECOSYSTEM HUMAN WELL; Alongi DM, 2008, ESTUAR COAST SHELF S, V76, P1, DOI 10.1016/j.ecss.2007.08.024; Altieri AH, 2013, ECOLOGY, V94, P1647, DOI 10.1890/12-1781.1; Altieri AH, 2012, ECOLOGY, V93, P1402, DOI 10.1890/11-1314.1; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bell SS, 2002, ECOL APPL, V12, P206, DOI 10.1890/1051-0761(2002)012[0206:ATIOBP]2.0.CO;2; Bertness MD, 2008, CONSERV BIOL, V22, P618, DOI 10.1111/j.1523-1739.2008.00962.x; Chmura GL, 2013, OCEAN COAST MANAGE, V83, P25, DOI 10.1016/j.ocecoaman.2011.09.006; Coverdale TC, 2013, CONSERV BIOL, V27, P1041, DOI 10.1111/cobi.12052; Coverdale TC, 2013, FRONT ECOL ENVIRON, V11, P69, DOI 10.1890/120130; Coverdale TC, 2012, ECOLOGY, V93, P2085, DOI 10.1890/12-0010.1; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; Dean WE, 1998, GEOLOGY, V26, P535, DOI 10.1130/0091-7613(1998)026<0535:MASOCB>2.3.CO;2; Deegan LA, 2012, NATURE, V490, P388, DOI 10.1038/nature11533; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Ellison AM, 1996, BIOTROPICA, V28, P549, DOI 10.2307/2389096; Erftemeijer PLA, 2006, MAR POLLUT BULL, V52, P1553, DOI 10.1016/j.marpolbul.2006.09.006; Escapa M, 2007, LIMNOL OCEANOGR, V52, P2340, DOI 10.4319/lo.2007.52.6.2340; GEDAN KB, 2009, HUMAN IMPACTS SALT M, P253; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jefferies RL, 2006, J ECOL, V94, P234, DOI 10.1111/j.1365-2745.2005.01086.x; Korner C, 2003, SCIENCE, V300, P1242, DOI 10.1126/science.1084460; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; LORD CJ, 1983, GEOCHIM COSMOCHIM AC, V47, P1381, DOI 10.1016/0016-7037(83)90296-X; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2004, ECOL APPL, V14, P1428, DOI 10.1890/03-5027; Macreadie PI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069244; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Metz ORDB, 2007, CLIMATE CHANGE 2007; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; ODUM E. P., 1959, PROC NATL ACAD SCI, V45, P617, DOI 10.1073/pnas.45.4.617; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; OSGOOD DT, 1993, ESTUARIES, V16, P815, DOI 10.2307/1352440; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Ranasinghe R, 2013, NAT CLIM CHANGE, V3, P83, DOI [10.1038/NCLIMATE1664, 10.1038/nclimate1664]; SEILER W, 1980, CLIMATIC CHANGE, V2, P207, DOI 10.1007/BF00137988; Siikamaki J, 2012, P NATL ACAD SCI USA, V109, P14369, DOI 10.1073/pnas.1200519109; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; Stuiver M, 1998, RADIOCARBON, V40, P1127, DOI 10.1017/S0033822200019172; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; Wilmers CC, 2012, FRONT ECOL ENVIRON, V10, P409, DOI 10.1890/110176	51	60	60	4	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93296	10.1371/journal.pone.0093296	http://dx.doi.org/10.1371/journal.pone.0093296			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675669	gold, Green Published			2022-12-25	WOS:000333677500106
J	Macabelli, CH; Ferreira, RM; Gimenes, LU; de Carvalho, NAT; Soares, JG; Ayres, H; Ferraz, ML; Watanabe, YF; Watanabe, OY; Sangalli, JR; Smith, LC; Baruselli, PS; Meirelles, FV; Chiaratti, MR				Macabelli, Carolina Habermann; Ferreira, Roberta Machado; Gimenes, Lindsay Unno; Tonizza de Carvalho, Nelcio Antonio; Soares, Julia Gleyci; Ayres, Henderson; Ferraz, Marcio Leao; Watanabe, Yeda Fumie; Watanabe, Osnir Yoshime; Sangalli, Juliano Rodrigues; Smith, Lawrence Charles; Baruselli, Pietro Sampaio; Meirelles, Flavio Vieira; Chiaratti, Marcos Roberto			Reference Gene Selection for Gene Expression Analysis of Oocytes Collected from Dairy Cattle and Buffaloes during Winter and Summer	PLOS ONE			English	Article							REAL-TIME PCR; HEAT-STRESS; IN-VITRO; MESSENGER-RNA; DEVELOPMENTAL COMPETENCE; EMBRYO PRODUCTION; ENVIRONMENTAL-TEMPERATURE; PREIMPLANTATION EMBRYOS; BOVINE OOCYTES; MOUSE OOCYTES	Oocytes from dairy cattle and buffaloes have severely compromised developmental competence during summer. While analysis of gene expression is a powerful technique for understanding the factors affecting developmental hindrance in oocytes, analysis by real-time reverse transcription PCR (RT-PCR) relies on the correct normalization by reference genes showing stable expression. Furthermore, several studies have found that genes commonly used as reference standards do not behave as expected depending on cell type and experimental design. Hence, it is recommended to evaluate expression stability of candidate reference genes for a specific experimental condition before employing them as internal controls. In acknowledgment of the importance of seasonal effects on oocyte gene expression, the aim of this study was to evaluate the stability of expression levels of ten well-known reference genes (ACTB, GAPDH, GUSB, HIST1H2AG, HPRT1, PPIA, RPL15, SDHA, TBP and YWHAZ) using oocytes collected from different categories of dairy cattle and buffaloes during winter and summer. A normalization factor was provided for cattle (RPL15, PPIA and GUSB) and buffaloes (YWHAZ, GUSB and GAPDH) based on the expression of the three most stable reference genes in each species. Normalization of non-reference target genes by these reference genes was shown to be considerably different from normalization by less stable reference genes, further highlighting the need for careful selection of internal controls. Therefore, due to the high variability of reference genes among experimental groups, we conclude that data normalized by internal controls can be misleading and should be compared to not normalized data or to data normalized by an external control in order to better interpret the biological relevance of gene expression analysis.	[Macabelli, Carolina Habermann; Chiaratti, Marcos Roberto] Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, BR-13560 Sao Carlos, SP, Brazil; [Macabelli, Carolina Habermann; Ferreira, Roberta Machado; Sangalli, Juliano Rodrigues; Meirelles, Flavio Vieira; Chiaratti, Marcos Roberto] Univ Sao Paulo, Fac Zootecnia & Engn Alimentos, Dept Med Vet, Pirassununga, SP, Brazil; [Ferreira, Roberta Machado; Soares, Julia Gleyci; Ayres, Henderson; Baruselli, Pietro Sampaio] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Reprod Anim, Sao Paulo, Brazil; [Gimenes, Lindsay Unno] Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Reprod Anim, Jaboticabal, SP, Brazil; [Tonizza de Carvalho, Nelcio Antonio] APTA, Unidade Pesquisa Desenvolvimento Registro, Registro, SP, Brazil; [Ayres, Henderson] Vida Reprod Consultoria, Cravinhos, SP, Brazil; [Ferraz, Marcio Leao] MSD Saude Anim, Sao Paulo, Brazil; [Watanabe, Yeda Fumie; Watanabe, Osnir Yoshime] LTDA, WTA Tecnol Aplicada, Cravinhos, SP, Brazil; [Sangalli, Juliano Rodrigues; Meirelles, Flavio Vieira; Chiaratti, Marcos Roberto] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Cirurgia, Sao Paulo, Brazil; [Smith, Lawrence Charles] Univ Montreal, Fac Med Vet, Ctr Rech Reprod Anim, St Hyacinthe, PQ J2S 7C6, Canada	Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universite de Montreal	Chiaratti, MR (corresponding author), Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, BR-13560 Sao Carlos, SP, Brazil.	chiarattimr@gmail.com	Chiaratti, Marcos R/C-2727-2012; Smith, Lawrence C/K-4658-2012; Gimenes, Lindsay U./B-6510-2013; Meirelles, Flavio V/B-5048-2010; Sangalli, Juliano Rodrigues/C-1834-2013; Baruselli, Pietro Sampaio/C-7600-2012; Macabelli, Carolina/G-5355-2016; Smith, Lawrence/AAP-4321-2021; CTC USP, CEPID 13 18/J-8951-2014	Chiaratti, Marcos R/0000-0001-8805-9469; Gimenes, Lindsay U./0000-0002-7644-675X; Meirelles, Flavio V/0000-0003-0372-4920; Baruselli, Pietro Sampaio/0000-0002-6773-4450; Smith, Lawrence/0000-0001-8766-0148; CTC USP, CEPID 13 18/0000-0002-7123-9524	Sao Paulo Research Foundation (FAPESP) [2009/00938-3, 2010/13384-3, 2010/09561-7, 2011/14207-0, 2012/07510-1]; National Counsel of Technological and Scientific Development (CNPq) [476229/2011-1]; Coordination for the Improvement of Higher Level Personnel (CAPES)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The research was granted by Sao Paulo Research Foundation (FAPESP; grant numbers 2009/00938-3, 2010/13384-3, 2010/09561-7, 2011/14207-0 and 2012/07510-1), National Counsel of Technological and Scientific Development (CNPq; grant number 476229/2011-1) and Coordination for the Improvement of Higher Level Personnel (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Katanani YM, 2002, J DAIRY SCI, V85, P390, DOI 10.3168/jds.S0022-0302(02)74086-1; Andre G, 2011, J DAIRY SCI, V94, P4502, DOI 10.3168/jds.2010-4139; Bettegowda A, 2006, MOL REPROD DEV, V73, P267, DOI 10.1002/mrd.20333; Biase F. H., 2012, ZYGOTE, V10, P1; Bower NI, 2007, BIOTECHNIQUES, V42, P197, DOI 10.2144/000112314; Camargo LSA, 2007, THERIOGENOLOGY, V68, P626, DOI 10.1016/j.theriogenology.2007.03.029; CAVESTANY D, 1985, J DAIRY SCI, V68, P1471, DOI 10.3168/jds.S0022-0302(85)80985-1; Chiaratti MR, 2010, BIOL REPROD, V82, P76, DOI 10.1095/biolreprod.109.077776; Das GK, 2010, REPROD DOMEST ANIM, V45, pe483, DOI 10.1111/j.1439-0531.2010.01598.x; De Bem THC, 2011, CELL REPROGRAM, V13, P419, DOI 10.1089/cell.2011.0010; Desitter I, 2011, ANTICANCER RES, V31, P427; Di Francesco S, 2012, THERIOGENOLOGY, V78, P1839, DOI 10.1016/j.theriogenology.2012.07.022; Di Francesco S, 2012, THERIOGENOLOGY, V77, P148, DOI 10.1016/j.theriogenology.2011.07.028; Di Francesco S, 2011, ANIM REPROD SCI, V123, P48, DOI 10.1016/j.anireprosci.2010.11.009; Donnison M, 2004, BIOL REPROD, V71, P1813, DOI 10.1095/biolreprod.104.032367; Duncan FE, 2010, METHOD ENZYMOL, V477, P457, DOI 10.1016/S0076-6879(10)77023-3; EALY AD, 1993, J DAIRY SCI, V76, P2899, DOI 10.3168/jds.S0022-0302(93)77629-8; Ferreira RM, 2011, J DAIRY SCI, V94, P2383, DOI 10.3168/jds.2010-3904; Gendelman M, 2012, ANIM REPROD SCI, V134, P125, DOI 10.1016/j.anireprosci.2012.07.009; Gendelman M, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092882; Gimenes LU, 2011, ANIM REPROD SCI, V123, P175, DOI 10.1016/j.anireprosci.2010.12.004; Gimenes LU, 2010, REPROD FERT DEVELOP, V22, P293, DOI 10.1071/RDv22n1Ab273; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Hansen PJ, 2009, PHILOS T R SOC B, V364, P3341, DOI 10.1098/rstb.2009.0131; Hansen PJ, 2001, THERIOGENOLOGY, V55, P91, DOI 10.1016/S0093-691X(00)00448-9; Hansen PJ, 1999, J ANIM SCI, V77, P36; Haque N, 2012, J ANIM PHYSIOL AN N, V96, P920, DOI 10.1111/j.1439-0396.2011.01208.x; Hayashi S, 2003, BIOL REPROD, V69, P1170, DOI 10.1095/biolreprod.103.016832; Kadokawa H, 2012, ANIM SCI J, V83, P439, DOI 10.1111/j.1740-0929.2012.01011.x; Klatsky PC, 2010, MOL HUM REPROD, V16, P938, DOI 10.1093/molehr/gaq077; Kumar P, 2012, REPROD DOMEST ANIM, V47, pe88, DOI 10.1111/j.1439-0531.2012.01998.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Mamo S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-151; Manjunatha BM, 2009, ANIM REPROD SCI, V111, P376, DOI 10.1016/j.anireprosci.2008.03.003; Megahed GA, 2008, REPROD DOMEST ANIM, V43, P672, DOI 10.1111/j.1439-0531.2007.00968.x; Nandi S, 2001, VET REC, V148, P278, DOI 10.1136/vr.148.9.278; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Robert C, 2002, BIOL REPROD, V67, P1465, DOI 10.1095/biolreprod.102.006320; Roth Z, 2008, REPROD DOMEST ANIM, V43, P238, DOI 10.1111/j.1439-0531.2008.01168.x; Sakatani M, 2012, J DAIRY SCI, V95, P3080, DOI 10.3168/jds.2011-4986; Sakatani M, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-3; Schmitz KJ, 2011, J CLIN PATHOL, V64, P529, DOI 10.1136/jcp.2010.085621; Sharma GT, 2012, REPROD DOMEST ANIM, V47, P975, DOI 10.1111/j.1439-0531.2012.02002.x; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Thelie A, 2009, MOL REPROD DEV, V76, P773, DOI 10.1002/mrd.21031; Thundathil J, 2005, MOL REPROD DEV, V71, P405, DOI 10.1002/mrd.20260; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vigneault C, 2007, MOL REPROD DEV, V74, P703, DOI 10.1002/mrd.20665; Wolfenson D, 2000, ANIM REPROD SCI, V60, P535, DOI 10.1016/S0378-4320(00)00102-0; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yadav A, 2013, REPROD DOMEST ANIM; Zicarelli L, 2010, SOC REPROD FERTIL, V67, P443	55	37	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93287	10.1371/journal.pone.0093287	http://dx.doi.org/10.1371/journal.pone.0093287			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676354	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500103
J	Patrick, SK; Musselman, KE; Tajino, J; Ou, HC; Bastian, AJ; Yang, JF				Patrick, Susan K.; Musselman, Kristin E.; Tajino, Junichi; Ou, Hsiu-Chung; Bastian, Amy J.; Yang, Jaynie F.			Prior Experience but Not Size of Error Improves Motor Learning on the Split-Belt Treadmill in Young Children	PLOS ONE			English	Article							LOCOMOTOR ADAPTATION; CEREBELLAR CONTRIBUTIONS; VISUOMOTOR ADAPTATION; KINEMATIC COORDINATION; INTERNAL-MODEL; WALKING; PROPRIOCEPTION; PROGRESSION; GENERATION; PATTERNS	Children can modify learned motor skills, such as walking, to adapt to new environments. Movement errors in these new situations drive the learning. We used split-belt walking to determine whether size of the error affects the degree of learning. Twenty-two children (aged 2-5 y) walked on the split-belt treadmill on two separate days spaced 1 week apart. Twenty-eight adults served as controls. On Day 1, children experienced an abrupt change in belt speeds (from 1: 1 to 2: 1 differential) resulting in large errors, or a gradual change (same change in speed over 12-15 min), resulting in small errors. Learning was measured by the size of the aftereffect upon return to a 1: 1 differential. On Day 2 (1 week later), the leg on the fast belt was reversed, as was the method of introducing the speed differential. We found that the error size did not affect learning. Unexpectedly, learning was greater on Day 2 compared to Day 1, especially for children under 4 y of age, despite the fact that the task was opposite to that of Day 1, and did not influence learning in adults. Hence, 11 additional children under 4 y of age were tested with belts running at the same speed on Day 1, and with a 2: 1 speed differential (abrupt introduction) on Day 2. Surprisingly, learning was again greater on Day 2. We conclude that size of error during split-belt walking does not affect learning, but experience on a treadmill does, especially for younger children.	[Patrick, Susan K.; Tajino, Junichi; Ou, Hsiu-Chung; Yang, Jaynie F.] Univ Alberta, Dept Phys Therapy, Edmonton, AB, Canada; [Patrick, Susan K.; Tajino, Junichi; Ou, Hsiu-Chung; Yang, Jaynie F.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Musselman, Kristin E.; Bastian, Amy J.] Kennedy Krieger Inst, Baltimore, MD USA; [Musselman, Kristin E.; Bastian, Amy J.] Johns Hopkins Sch Med, Baltimore, MD USA	University of Alberta; University of Alberta; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins Medicine	Yang, JF (corresponding author), Univ Alberta, Dept Phys Therapy, Edmonton, AB, Canada.	jaynie.yang@ualberta.ca	Ou, Hsiu-Chung/AAQ-2489-2020	Ou, Hsiu-Chung/0000-0001-6794-3431; Musselman, Kristin/0000-0001-8336-8211; Yang, Jaynie/0000-0002-7507-8924	Natural Sciences and Engineering Research Council of Canada [13818-2011]; National Institutes of Health USA [HD048741]; Canadian Institutes of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD048741] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Natural Sciences and Engineering Research Council of Canada 13818-2011 to JFY, National Institutes of Health USA HD048741 to AJB, Canadian Institutes of Health Research Fellowship to KEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPS R, 1989, NEUROSCI LETT, V102, P205, DOI 10.1016/0304-3940(89)90079-7; Barthelemy D, 2011, PROG BRAIN RES, V192, P181, DOI 10.1016/B978-0-444-53355-5.00012-9; Bastian AJ, 2008, CURR OPIN NEUROL, V21, P628, DOI 10.1097/WCO.0b013e328315a293; Bosco G, 2001, PHYSIOL REV, V81, P539, DOI 10.1152/physrev.2001.81.2.539; Braun DA, 2010, BEHAV BRAIN RES, V206, P157, DOI 10.1016/j.bbr.2009.08.031; Brown TG, 1914, J PHYSIOL-LONDON, V48, P18; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; Capio CM, 2013, J INTELL DISABIL RES, V57, P295, DOI 10.1111/j.1365-2788.2012.01535.x; Capio CM, 2012, BMC SPORTS SCI MED R, V4, DOI 10.1186/1758-2555-4-1; Caviness VS, 1996, CEREB CORTEX, V6, P726, DOI 10.1093/cercor/6.5.726; Cheron G, 2001, EXP BRAIN RES, V137, P455, DOI 10.1007/s002210000663; Choi JT, 2009, BRAIN, V132, P722, DOI 10.1093/brain/awn333; Criscimagna-Hemminger SE, 2010, J NEUROPHYSIOL, V103, P2275, DOI 10.1152/jn.00822.2009; Gibo TL, 2013, J NEUROPHYSIOL, V110, P322, DOI 10.1152/jn.00745.2012; Haslam C, 2012, NEUROPSYCHOL REHABIL, V22, P697, DOI 10.1080/09602011.2012.686820; Huang VS, 2009, J NEUROPHYSIOL, V102, P931, DOI 10.1152/jn.00237.2009; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Ingram HA, 2000, EXP BRAIN RES, V132, P114, DOI 10.1007/s002219900322; Ivanenko YP, 2004, J EXP BIOL, V207, P3797, DOI 10.1242/jeb.01214; Jayaram G, 2012, J NEUROPHYSIOL, V107, P2950, DOI 10.1152/jn.00645.2011; Jayaram G, 2011, CEREB CORTEX, V21, P1901, DOI 10.1093/cercor/bhq263; Kagerer FA, 2006, HUM MOVEMENT SCI, V25, P622, DOI 10.1016/j.humov.2006.06.003; Kagerer FA, 1997, EXP BRAIN RES, V115, P557, DOI 10.1007/PL00005727; Klassen J, 2005, EXP BRAIN RES, V164, P250, DOI 10.1007/s00221-005-2247-4; Kluzik J, 2008, J NEUROPHYSIOL, V100, P1455, DOI 10.1152/jn.90334.2008; Krakauer JW, 2011, CURR OPIN NEUROBIOL, V21, P636, DOI 10.1016/j.conb.2011.06.012; Le Ray D, 2011, PROG BRAIN RES, V188, P51, DOI 10.1016/B978-0-444-53825-3.00009-7; Malone LA, 2013, NEUROREHABIL NEURAL; Malone LA, 2012, J NEUROPHYSIOL, V108, P672, DOI 10.1152/jn.00391.2011; Malone LA, 2011, J NEUROSCI, V31, P15136, DOI 10.1523/JNEUROSCI.1367-11.2011; Malone LA, 2010, J NEUROPHYSIOL, V103, P1954, DOI 10.1152/jn.00832.2009; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Michel C, 2007, J COGNITIVE NEUROSCI, V19, P341, DOI 10.1162/jocn.2007.19.2.341; MOORE R, 1964, J EXP ANAL BEHAV, V7, P269, DOI 10.1901/jeab.1964.7-269; Morton SM, 2004, J NEUROPHYSIOL, V92, P2497, DOI 10.1152/jn.00129.2004; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; Musselman KE, 2011, J NEUROPHYSIOL, V105, P2195, DOI 10.1152/jn.01002.2010; Reisman DS, 2013, NEUROREHAB NEURAL RE, V27, P460, DOI 10.1177/1545968312474118; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; Robertson EM, 1999, NEUROREPORT, V10, P1029, DOI 10.1097/00001756-199904060-00025; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Saksena S, 2008, CEREBELLUM, V7, P392, DOI 10.1007/s12311-008-0041-0; Savin DN, 2013, NEUROREHAB NEURAL RE, V27, P24, DOI 10.1177/1545968311434552; Schlerf JE, 2013, J NEUROPHYSIOL, V109, P1164, DOI 10.1152/jn.00654.2011; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Tiemeier H, 2010, NEUROIMAGE, V49, P63, DOI 10.1016/j.neuroimage.2009.08.016; Torres-Oviedo G, 2012, J NEUROPHYSIOL, V107, P346, DOI 10.1152/jn.00570.2011; Vasudevan EVL, 2011, J NEUROSCI, V31, P3055, DOI 10.1523/JNEUROSCI.5781-10.2011; Vasudevan EVL, 2010, J NEUROPHYSIOL, V103, P183, DOI 10.1152/jn.00501.2009; Xu-Wilson M, 2009, J NEUROSCI, V29, P12930, DOI 10.1523/JNEUROSCI.3115-09.2009	53	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93349	10.1371/journal.pone.0093349	http://dx.doi.org/10.1371/journal.pone.0093349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SW	24675816	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500111
J	Yoshimura, H; Takumi, Y; Nishio, S; Suzuki, N; Iwasa, Y; Usami, S				Yoshimura, Hidekane; Takumi, Yutaka; Nishio, Shin-ya; Suzuki, Nobuyoshi; Iwasa, Yoh-ichiro; Usami, Shin-ichi			Deafness Gene Expression Patterns in the Mouse Cochlea Found by Microarray Analysis	PLOS ONE			English	Article							NONSYNDROMIC DEAFNESS; WFS1 GENE; MUTATIONS; DOMINANT; IMPAIRMENT; FAMILY; TMC1	Background: Tonotopy is one of the most fundamental principles of auditory function. While gradients in various morphological and physiological characteristics of the cochlea have been reported, little information is available on gradient patterns of gene expression. In addition, the audiograms in autosomal dominant non syndromic hearing loss can be distinctive, however, the mechanism that accounts for that has not been clarified. We thought that it is possible that tonotopic gradients of gene expression within the cochlea account for the distinct audiograms. Methodology/Principal Findings: We compared expression profiles of genes in the cochlea between the apical, middle, and basal turns of the mouse cochlea by microarray technology and quantitative RT-PCR. Of 24,547 genes, 783 annotated genes expressed more than 2-fold. The most remarkable finding was a gradient of gene expression changes in four genes (Pou4f3, Slc17a8, Tmc1, and Crym) whose mutations cause autosomal dominant deafness. Expression of these genes was greater in the apex than in the base. Interestingly, expression of the Emilin-2 and Tectb genes, which may have crucial roles in the cochlea, was also greater in the apex than in the base. Conclusions/Significance: This study provides baseline data of gradient gene expression in the cochlea. Especially for genes whose mutations cause autosomal dominant non syndromic hearing loss (Pou4f3, Slc17a8, Tmc1, and Crym) as well as genes important for cochlear function (Emilin-2 and Tectb), gradual expression changes may help to explain the various pathological conditions.	[Yoshimura, Hidekane; Takumi, Yutaka; Nishio, Shin-ya; Suzuki, Nobuyoshi; Iwasa, Yoh-ichiro; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan	Shinshu University	Takumi, Y (corresponding author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan.	takumi@shinshu-u.ac.jp		Nishio, Shin-ya/0000-0001-6640-2297	Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Science and Culture of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan (S.U.), and by a Grant-in-Aid for Scientific Research from the (then) Ministry of Education, Science and Culture of Japan (http://www.mext.go.jp/english/) (S.U., Y.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2003, AM J HUM GENET, V72, P73, DOI 10.1086/345398; Amma LL, 2003, MOL CELL NEUROSCI, V23, P460, DOI 10.1016/S1044-7431(03)00075-7; Bosl WJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-93; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; Cryns K, 2003, HUM MUTAT, V22, P275, DOI 10.1002/humu.10258; de Heer AMR, 2009, ANN OTO RHINOL LARYN, V118, P313, DOI 10.1177/000348940911800413; Frucht CS, 2011, JARO-J ASSOC RES OTO, V412, P23; Fukuoka H, 2007, J HUM GENET, V52, P510, DOI 10.1007/s10038-007-0144-3; Ghaffari R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1094; Hildebrand MS, 2008, GENET MED, V10, P297, DOI 10.1097/GIM.0b013e318187e106; Hilgert N, 2008, CLIN GENET, V74, P223, DOI 10.1111/j.1399-0004.2008.01053.x; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Lee HK, 2010, BIOCHEM BIOPH RES CO, V396, P626, DOI 10.1016/j.bbrc.2010.04.132; Mann ZF, 2011, HEARING RES, V276, P2, DOI 10.1016/j.heares.2011.01.011; Morris KA, 2005, JARO-J ASSOC RES OTO, V6, P75, DOI 10.1007/s10162-004-5046-x; Ruel J, 2008, AM J HUM GENET, V83, P278, DOI 10.1016/j.ajhg.2008.07.008; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; Sato T, 2009, ACTA OTO-LARYNGOL, V129, P12, DOI 10.1080/00016480902926464; Smith R.J.H., 1993, GENEREVIEWS	19	25	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92547	10.1371/journal.pone.0092547	http://dx.doi.org/10.1371/journal.pone.0092547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676347	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500024
J	Zhang, L; Ma, LY; Wang, Z; Wang, Y; Zhang, J; Wang, HN; Shao, YM				Zhang, Lei; Ma, Liying; Wang, Zheng; Wang, Yan; Zhang, Jing; Wang, Haining; Shao, Yiming			Alterations in HIV-1 gp120 V3 Region Are Necessary but Not Sufficient for Coreceptor Switching in CRF07_BC in China	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SYNCYTIUM-INDUCING PHENOTYPE; AMINO-ACID SUBSTITUTIONS; BIOLOGICAL PHENOTYPE; DISEASE PROGRESSION; SEQUENCE VARIATION; USAGE PREDICTION; CXCR4 TROPISM; TYPE-1 CLONES; CELL TROPISM	The most predominant HIV-1 strains in China's current epidemic is the Circulating Recombinant Form 07_BC (CRF07_BC). CRF07_BC is mainly considered as a CCR5-tropic (R5) virus, since CXCR4-tropic (X4) viruses have thus far not been found in this subtype, and the molecular determinants of coreceptor switching remain unknown. To investigate the mechanisms underlying coreceptor requirement in CRF07_BC viruses, we characterized a panel of pNL4-3-based chimeric viruses with mutated V3 loop regions derived from an HIV-1 CRF07_BC infectious clone pXJDC13. Among 17 chimeric viruses, seven were dual-tropic and induced syncytium formation in MT-2 cells. Two amino acid insertions between positions 13 and 14, as well as arginine substitution at position 11 or 16 (IG insertion and P16R mutation or MG insertion and S11R mutation), conferred the chimeric viruses CXCR4-tropic features, which were same as subtype C X4 viruses. Next, to construct CRF07_BC X4 variants, mutated V3 loops were cloned into the CRF07_BC infectious clone pXJDC13. These V3 loops, which in the pNL4-3 backbone conferred chimeric viruses with CXCR4-using ability, abrogated infectivity completely in the CRF07_BC pXJDC13 genetic background. Similarly, IG insertion or MG insertion and S11R mutation dramatically diminished or completely abolished viral infectivity in other envelopes of subtype C or CRF07_BC. These results suggest that the effects of IG insertion and P16R mutation or MG insertion and S11R mutation on CXCR4 usage are context dependent, and additional mutations elsewhere in the envelope are needed to compensate for these fitness-reducing alterations.	[Zhang, Lei; Ma, Liying; Wang, Zheng; Wang, Yan; Zhang, Jing; Wang, Haining; Shao, Yiming] China CDC, Natl Ctr AIDS STD Control & Prevent NCAIDS, State Key Lab Infect Dis Prevent & Control, Div Res Virol & Immunol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Shao, YM (corresponding author), China CDC, Natl Ctr AIDS STD Control & Prevent NCAIDS, State Key Lab Infect Dis Prevent & Control, Div Res Virol & Immunol, Beijing, Peoples R China.	yshao08@gmail.com		Wang, Yan/0000-0002-8031-0716	National Science and Technology Major Project [2012ZX10001008]; National Natural Science Foundation of China [81020108030, 81261120384, 81172733, 81101281]; State Key Laboratory for Infectious Diseases Prevention and Control [2011SKLID102]	National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory for Infectious Diseases Prevention and Control	This work was supported by National Science and Technology Major Project (grant 2012ZX10001008), the National Natural Science Foundation of China (grants 81020108030, 81261120384, 81172733 and 81101281), and the Key Project of the State Key Laboratory for Infectious Diseases Prevention and Control (No. 2011SKLID102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorndal A, 1997, J VIROL, V71, P7478; Brumme ZL, 2004, AIDS, V18, pF1, DOI 10.1097/00002030-200403050-00001; Cashin K, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-24; Cilliers T, 2003, J VIROL, V77, P4449, DOI 10.1128/JVI.77.7.4449-4456.2003; Coetzer M, 2006, VIROLOGY, V356, P95, DOI 10.1016/j.virol.2006.07.030; Coetzer M, 2011, JAIDS-J ACQ IMM DEF, V56, P9, DOI 10.1097/QAI.0b013e3181f63906; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Dash PK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-25; DEJONG JJ, 1992, J VIROL, V66, P757, DOI 10.1128/JVI.66.2.757-765.1992; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Doms RW, 1997, VIROLOGY, V235, P179, DOI 10.1006/viro.1997.8703; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; He X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047289; Hoffman NG, 2002, J VIROL, V76, P3852, DOI 10.1128/JVI.76.8.3852-3864.2002; Huang W, 2008, J VIROL, V82, P5584, DOI 10.1128/JVI.02676-07; Huang W, 2007, J VIROL, V81, P7885, DOI 10.1128/JVI.00218-07; Huang W, 2011, VIROLOGY, V409, P308, DOI 10.1016/j.virol.2010.09.026; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Jakobsen MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065950; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; KARLSSON A, 1994, J CLIN MICROBIOL, V32, P364, DOI 10.1128/JCM.32.2.364-370.1994; Kato K, 1999, J VIROL, V73, P5520, DOI 10.1128/JVI.73.7.5520-5526.1999; KOOT M, 1992, AIDS, V6, P49, DOI 10.1097/00002030-199201000-00006; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Lin NH, 2012, VIROLOGY, V433, P296, DOI 10.1016/j.virol.2012.08.013; Ma LY, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-45; Pastore C, 2004, J VIROL, V78, P7565, DOI 10.1128/JVI.78.14.7565-7574.2004; Pastore C, 2007, J VIROL, V81, P8165, DOI 10.1128/JVI.02792-06; Rana S, 1997, J VIROL, V71, P3219, DOI 10.1128/JVI.71.4.3219-3227.1997; RICHMAN DD, 1994, J INFECT DIS, V169, P968, DOI 10.1093/infdis/169.5.968; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Sing T, 2007, ANTIVIR THER, V12, P1097; Singh A, 2009, TEXTS COMPUT SCI, P1; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Taylor BM, 2008, J VIROL, V82, P5460, DOI 10.1128/JVI.01049-07; TERSMETTE M, 1989, J VIROL, V63, P2118, DOI 10.1128/JVI.63.5.2118-2125.1989; United States Food and Drug Administration, 2014, ANT DRUGS US TREATM; van Rij RP, 2002, J VIROL, V76, P3054, DOI 10.1128/JVI.76.6.3054-3058.2002; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079177; Yu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017605; Zhang CY, 2009, INT J INFECT DIS, V13, pE212, DOI 10.1016/j.ijid.2008.12.010; Zhang H, 2010, VIROLOGY, V407, P68, DOI 10.1016/j.virol.2010.07.047	46	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93426	10.1371/journal.pone.0093426	http://dx.doi.org/10.1371/journal.pone.0093426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676404	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500123
J	Zhao, GY; Liu, CF; Kou, ZH; Gao, TT; Pan, T; Wu, XH; Yu, H; Guo, Y; Zeng, Y; Du, LY; Jiang, SB; Sun, SH; Zhou, YS				Zhao, Guangyu; Liu, Chenfeng; Kou, Zhihua; Gao, Tongtong; Pan, Ting; Wu, Xiaohong; Yu, Hong; Guo, Yan; Zeng, Yang; Du, Lanying; Jiang, Shibo; Sun, Shihui; Zhou, Yusen			Differences in the Pathogenicity and Inflammatory Responses Induced by Avian Influenza A/H7N9 Virus Infection in BALB/c and C57BL/6 Mouse Models	PLOS ONE			English	Article							A H7N9 VIRUS; NECROSIS-FACTOR RECEPTORS; T-CELL RESPONSES; TNF-ALPHA; LUNG INJURY; NEUTROPHILS; MICE; IMMUNOPATHOLOGY; INTERLEUKIN-1; PATHOGENESIS	Avian influenza A/H7N9 virus infection causes pneumonia in humans with a high case fatality rate. However, virus-induced modulation of immune responses is being recognized increasingly as a factor in the pathogenesis of this disease. In this study, we compared the pathogenicity of A/H7N9 infection in BALB/c and C57BL/6 mouse models, and investigated the putative involvement of proinflammatory cytokines in lung injury and viral clearance. In both mouse strains, A/Anhui/1/2013(H7N9) infection with 10(6) TCID50 resulted in viral replication in lung, severe body weight loss and acute lung injury. During the early infection stage, infected C57BL/6 mice exhibited more severe lung injury, slower recovery from lung damage, less effective viral clearance, higher levels of interlukine (IL)-6, monocyte chemotactic protein (MCP)-1, and IL-1 beta, and lower levels of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma than infected BALB/c mice. These results suggest that TNF-alpha and IFN-gamma may help suppress viral gene expression and increase viral clearance, and that IL-6 and MCP-1 may contribute to lung injury in A/H7N9-infected individuals. In addition, lung damage and the distribution of virus antigen in tissues were similar in young and middle-aged mice. These results suggest that the more serious lung injury in middle-aged or older H7N9 cases is not mainly caused by differences in viral replication in the lung but probably by a dysregulated immune response induced by underlying comorbidities. These results indicate that the extent of dysregulation of the host immune response after H7N9 virus infection most probably determines the outcome of H7N9 virus infection.	[Zhao, Guangyu; Liu, Chenfeng; Kou, Zhihua; Gao, Tongtong; Pan, Ting; Wu, Xiaohong; Yu, Hong; Guo, Yan; Zeng, Yang; Sun, Shihui; Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Du, Lanying; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Educ & Hlth, Shanghai, Peoples R China; [Jiang, Shibo] Fudan Univ, Inst Med Microbiol, Shanghai, Peoples R China	Beijing Institute of Microbiology & Epidemiology; New York Blood Center; Fudan University; Fudan University	Sun, SH (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	sunsh01@163.com; yszhou@bmi.ac.cn	Yu, Hongwei/L-3754-2017; Jiang, Shibo/L-4500-2014	Yu, Hongwei/0000-0002-5607-0628; Jiang, Shibo/0000-0001-8283-7135	Project on Human H7N9 from the Ministry of Science and Technology of China [KJYJ-2013-01-04]; National Projects of Infectious Disease [2012ZX10004502]; NSFC of China [81371805]; Shanghai Joint Research Projects on the Prevention and Control of Avian Influenza H7N9 Virus [2013QLG010]	Project on Human H7N9 from the Ministry of Science and Technology of China; National Projects of Infectious Disease; NSFC of China(National Natural Science Foundation of China (NSFC)); Shanghai Joint Research Projects on the Prevention and Control of Avian Influenza H7N9 Virus	This work was supported by grants from the Project on Human H7N9 from the Ministry of Science and Technology of China (KJYJ-2013-01-04), the National Projects of Infectious Disease (2012ZX10004502), the NSFC of China (81371805), and Shanghai Joint Research Projects on the Prevention and Control of Avian Influenza H7N9 Virus (2013QLG010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANKS WA, 1994, NEUROSCI LETT, V179, P53, DOI 10.1016/0304-3940(94)90933-4; Belisle SE, 2010, J VIROL, V84, P12576, DOI 10.1128/JVI.01310-10; Buczynski BW, 2013, AM J PHYSIOL-LUNG C, V305, pL282, DOI 10.1152/ajplung.00112.2013; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Chi Y, 2013, J INFECT DIS, V208, P1962, DOI 10.1093/infdis/jit440; Chiaretti A, 2013, INT J INFECT DIS, V17, pE1186, DOI 10.1016/j.ijid.2013.07.006; Damjanovic D, 2011, AM J PATHOL, V179, P2963, DOI 10.1016/j.ajpath.2011.09.003; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; Fujisawa H, 2008, J VIROL, V82, P2772, DOI 10.1128/JVI.01210-07; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liang S, 2009, MECH AGEING DEV, V130, P538, DOI 10.1016/j.mad.2009.06.006; Maue AC, 2009, TRENDS IMMUNOL, V30, P301, DOI 10.1016/j.it.2009.04.007; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; Mok CKP, 2013, MBIO, V4, DOI 10.1128/mBio.00362-13; Otte A, 2011, AM J PATHOL, V179, P230, DOI 10.1016/j.ajpath.2011.03.041; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Singh A, 2007, J VIROL, V81, P6502, DOI 10.1128/JVI.00163-07; Smallman-Raynor M, 2007, EMERG INFECT DIS, V13, P510, DOI 10.3201/eid1303.060849; Sun SH, 2013, AM J RESP CELL MOL, V49, P221, DOI 10.1165/rcmb.2012-0428OC; Suresh M, 2005, J VIROL, V79, P202, DOI 10.1128/JVI.79.1.202-213.2005; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; van Helden MJG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052027; Weber O, 2003, J GEN VIROL, V84, P1843, DOI 10.1099/vir.0.19138-0; WHO, 2013, HUM INF AV INFL A H7; Wortzman ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068911; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002; Zganiacz A, 2004, J CLIN INVEST, V113, P401, DOI 10.1172/JCI200418991; Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-9; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379	37	15	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92987	10.1371/journal.pone.0092987	http://dx.doi.org/10.1371/journal.pone.0092987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676272	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677500062
J	Li, ZJ; Xiang, Y; Xiang, LX; Xiao, YN; Li, FJ; Hao, P				Li, Zhongjun; Xiang, Yang; Xiang, Lixin; Xiao, Yanni; Li, Fengjie; Hao, Ping			ALDH Maintains the Stemness of Lung Adenoma Stem Cells by Suppressing the Notch/CDK2/CCNE Pathway	PLOS ONE			English	Article							CANCER-CELLS; CYCLE ARREST; EXPRESSION; CARCINOMA; PROGRESSION; PHENOTYPES; INDUCTION; LEUKEMIA; MARKERS; HEAD	Objective: To evaluate the expression of ALDH1A1 in lung adenoma stem cells (LASCs) and maintenance of their stemness through the Notch pathway. Methods: LASCs (A549s) were isolated from lung adenoma cells (A549) and identified by their coexpression of CD133 and CD326 and their capacity formulti-directional differentiation. Expression of ALDH1A1 in A549 and A549s cells were evaluated by Real-time PCR. Effects of ALDH1A1 upregulation in A549 cells and its downregulation in A549s cells on the clonogenicity and cell cycle were assessed by colony-forming unit assay. Moreover, the effects of ALDH1A1 on the Notch pathway, and thus on the cell cycle, were studied. Results: A549s cells were successfully isolated and identified. ALDH1A1expression was significantly higher in A549s than in A549 cells. Clonogenicity was significantly decreased in A549s cells treated with ALDH1A1 siRNA. Duration of the G1 stage of the cell cycle increased after ALDH1A1 was overexpressed, or decreased with ALDH1A1 siRNA. ALDH1A1, Notch1, -2, and -3, CDK2, and CCNE1 expression levels were higher in A549s cells than in A549 cells. Expression of Notch1, -2, and -3, CDK2, and CCNE1 was significantly decreased by upregulation of ALDH1A1 in A549 cells, but increased by its interruption in A549s cells. When Notch3 or CDK2 expression was downregulated, the expression levels of ALDH1A1, Notch1, -2, and -3, CDK2, and CCNE1 were reduced in all cell types. Conclusion: ALDH1A1 expression improved clonogenicity and inhibited the cell cycle, maintaining the stemness of the A549s cells; this may involve suppression of the Notch/CDK2/Cyclin pathway.	[Hao, Ping] Third Mil Med Univ, Affiliated Hosp 2, Dept Oncol, Chongqing, Peoples R China; [Li, Zhongjun; Xiang, Yang; Xiang, Lixin; Xiao, Yanni; Li, Fengjie] Third Mil Med Univ, Affiliated Hosp 2, Dept Blood Transfus, Chongqing, Peoples R China	Army Medical University; Army Medical University	Hao, P (corresponding author), Third Mil Med Univ, Affiliated Hosp 2, Dept Oncol, Chongqing, Peoples R China.	haoping833@hotmail.com			National Natural Science Foundation of China [81071911]; Natural Science Foundation Project of Chongqing [CSTC2009BB5148]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing(Natural Science Foundation of Chongqing)	This study was supported by the National Natural Science Foundation of China (Grant no. 81071911) and the Natural Science Foundation Project of Chongqing (CSTC2009BB5148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgeer M, 2013, THORAX, V68, P1095, DOI 10.1136/thoraxjnl-2012-203021; Alamgeer M, 2013, RESPIROLOGY, V18, P757, DOI 10.1111/resp.12094; Alison MR, 2012, CANCER TREAT REV, V38, P589, DOI 10.1016/j.ctrv.2012.03.003; Arafat K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066931; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chen Y, 2011, BIOCHEM BIOPH RES CO, V405, P173, DOI 10.1016/j.bbrc.2011.01.002; Debeb BG, 2012, BREAST CANCER RES TR, V134, P495, DOI 10.1007/s10549-012-2075-8; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Furuichi Y, 2007, CANCER RES, V67, P9852, DOI 10.1158/0008-5472.CAN-07-0105; Geissler C, 2012, IN VIVO, V26, P593; Gomez-Casal R, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-94; Guo DM, 2009, LEUKEMIA RES, V33, P678, DOI 10.1016/j.leukres.2008.10.026; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kuang BH, 2013, BRIT J CANCER, V109, P1252, DOI 10.1038/bjc.2013.439; Li H, 2013, ONCOGENE; Luo YC, 2012, STEM CELLS, V30, P2100, DOI 10.1002/stem.1193; Marei HES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033542; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Park SH, 2012, EXP EYE RES, V101, P16, DOI 10.1016/j.exer.2012.05.009; Qi RZ, 2003, CANCER RES, V63, P8323; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Steg AD, 2012, CLIN CANCER RES, V18, P869, DOI 10.1158/1078-0432.CCR-11-2188; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Wang KF, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0574-z; Xia Hui, 2013, Zhongguo Fei Ai Za Zhi, V16, P400, DOI 10.3779/j.issn.1009-3419.2013.08.02; Yatabe Y, 2011, LUNG CANCER, V74, P7, DOI 10.1016/j.lungcan.2011.05.021; Zhang X, 2011, TRANSPL P, V43, P2770, DOI 10.1016/j.transproceed.2011.05.048; Zhang ZC, 2012, ORAL ONCOL, V48, P1, DOI 10.1016/j.oraloncology.2011.10.004	30	20	20	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92669	10.1371/journal.pone.0092669	http://dx.doi.org/10.1371/journal.pone.0092669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671051	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677000062
J	Liu, F; Qimuge; Hao, JF; Yan, HJ; Bach, T; Fan, LF; Morigen				Liu, Feng; Qimuge; Hao, Jianfeng; Yan, Huijuan; Bach, Trond; Fan, Lifei; Morigen			AspC-Mediated Aspartate Metabolism Coordinates the Escherichia coli Cell Cycle	PLOS ONE			English	Article							DNA-REPLICATION; GROWTH-RATE; SALMONELLA-TYPHIMURIUM; FLOW-CYTOMETRY; CHROMOSOME-REPLICATION; CARBON METABOLISM; ACID BIOSYNTHESIS; MOLECULAR-CLONING; INITIATION MASS; SIZE CONTROL	Background: The fast-growing bacterial cell cycle consists of at least two independent cycles of chromosome replication and cell division. To ensure proper cell cycles and viability, chromosome replication and cell division must be coordinated. It has been suggested that metabolism could affect the Escherichia coli cell cycle, but the idea is still lacking solid evidences. Methodology/Principle Findings: We found that absence of AspC, an aminotransferase that catalyzes synthesis of aspartate, led to generation of small cells with less origins and slow growth. In contrast, excess AspC was found to exert the opposite effect. Further analysis showed that AspC-mediated aspartate metabolism had a specific effect in the cell cycle, as only extra aspartate of the 20 amino acids triggered production of bigger cells with more origins per cell and faster growth. The amount of DnaA protein per cell was found to be changed in response to the availability of AspC. Depletion of (p)ppGpp by Delta re/A Delta spoT led to a slight delay in initiation of replication, but did not change the replication pattern found in the Delta aspC mutant. Conclusion/Significances:The results suggest that AspC-mediated metabolism of aspartate coordinates the E. coli cell cycle through altering the amount of the initiator protein DnaA per cell and the division signal UDP-glucose. Furthermore, AspC sequence conservation suggests similar functions in other organisms.	[Liu, Feng; Qimuge; Hao, Jianfeng; Yan, Huijuan; Fan, Lifei; Morigen] Inner Mongolia Univ, Sch Life Sci, Hohhot, Peoples R China; [Bach, Trond] Univ Oslo, Fac Med, Dept Pharmacol, Oslo, Norway; [Bach, Trond] Oslo Univ Hosp, Oslo, Norway	Inner Mongolia University; University of Oslo; University of Oslo	Fan, LF (corresponding author), Inner Mongolia Univ, Sch Life Sci, Hohhot, Peoples R China.	fanlifei95@gmail.com; morigenm@hotmail.com			National Natural Science Foundation of China "NSFC" [31060015]; Natural Science Foundation of Inner Mongolia [2010Zd14, 20102009]; Program of Higher-level Talents of Inner Mongolia University "SPH-IMU" [Z20090107]	National Natural Science Foundation of China "NSFC"(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Inner Mongolia; Program of Higher-level Talents of Inner Mongolia University "SPH-IMU"	The work was supported by grants from the National Natural Science Foundation of China "NSFC"(Grant no. 31060015 to Morigen), the Natural Science Foundation of Inner Mongolia (Grant no. 2010Zd14 and 20102009 to Morigen), and the Program of Higher-level Talents of Inner Mongolia University "SPH-IMU" (Grant no. Z20090107 to Morigcn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER TA, 1987, J BIOL CHEM, V262, P6877; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BOYE E, 1991, RES MICROBIOL, V142, P131, DOI 10.1016/0923-2508(91)90020-B; Boye E, 2003, EMBO REP, V4, P757, DOI 10.1038/sj.embor.embor895; BRAMHILL D, 1988, CELL, V54, P915, DOI 10.1016/0092-8674(88)90102-X; BRAUN RE, 1985, CELL, V40, P159, DOI 10.1016/0092-8674(85)90319-8; CHIARAMELLO AE, 1989, J BACTERIOL, V171, P4272, DOI 10.1128/JB.171.8.4272-4280.1989; Chien AC, 2012, CURR BIOL, V22, pR340, DOI 10.1016/j.cub.2012.02.032; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; CRONAN JE, 1982, J BACTERIOL, V149, P916, DOI 10.1128/JB.149.3.916-922.1982; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DONACHIE WD, 1968, NATURE, V219, P1077, DOI 10.1038/2191077a0; FANTES P, 1977, EXP CELL RES, V107, P377, DOI 10.1016/0014-4827(77)90359-7; GLANSDORFF N, 1965, GENETICS, V51, P167; Goh EB, 2005, J BACTERIOL, V187, P4890, DOI 10.1128/JB.187.14.4890-4899.2005; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; HANAWALT PC, 1961, J MOL BIOL, V3, P156, DOI 10.1016/S0022-2836(61)80042-9; HAYASHI H, 1993, BIOCHEMISTRY-US, V32, P12229, DOI 10.1021/bi00096a036; Hill NS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003663; Hill NS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002549; HIRAGA S, 1975, MOL GEN GENET, V137, P239, DOI 10.1007/BF00333019; Janniere L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000447; Jin DJ, 2012, FEMS MICROBIOL REV, V36, P269, DOI 10.1111/j.1574-6976.2011.00279.x; Jin L, 1999, PROTEINS, V37, P729, DOI 10.1002/(SICI)1097-0134(19991201)37:4<729::AID-PROT21>3.0.CO;2-F; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; LOBNEROLESEN A, 1989, CELL, V57, P881, DOI 10.1016/0092-8674(89)90802-7; LU M, 1994, J BACTERIOL, V176, P5847, DOI 10.1128/JB.176.18.5847-5851.1994; Maciag M, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-19; Maciag-Dorszynska M, 2013, FEBS OPEN BIO, V3, P161, DOI 10.1016/j.fob.2013.03.001; Miller RV., 1992, VIRUS MEDIATED GENE, P51; Morigen, 2003, MOL MICROBIOL, V50, P349, DOI 10.1046/j.1365-2958.2003.03695.x; Morigen, 2005, J BACTERIOL, V187, P3913, DOI 10.1128/JB.187.12.3913-3920.2005; Morigen, 2001, BBA-GENE STRUCT EXPR, V1521, P73; Ote T, 2006, MOL MICROBIOL, V59, P265, DOI 10.1111/j.1365-2958.2005.04932.x; PLAMANN MD, 1983, NUCLEIC ACIDS RES, V11, P2065, DOI 10.1093/nar/11.7.2065; Potrykus K, 2011, ENVIRON MICROBIOL, V13, P563, DOI 10.1111/j.1462-2920.2010.02357.x; RICHAUD C, 1987, J BACTERIOL, V169, P1454, DOI 10.1128/jb.169.4.1454-1459.1987; Ryan VT, 2002, MOL MICROBIOL, V46, P113, DOI 10.1046/j.1365-2958.2002.03129.x; SARGENT MG, 1975, J BACTERIOL, V123, P7, DOI 10.1128/JB.123.1.7-19.1975; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; SKARSTAD K, 1983, J BACTERIOL, V154, P656, DOI 10.1128/JB.154.2.656-662.1983; SKARSTAD K, 1985, J BACTERIOL, V163, P661, DOI 10.1128/JB.163.2.661-668.1985; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; Tedeschi G, 2010, BIOCHIMIE, V92, P1335, DOI 10.1016/j.biochi.2010.06.015; Teplyakov A, 2004, J BACTERIOL, V186, P7134, DOI 10.1128/JB.186.21.7134-7140.2004; Viola RE, 2001, ACCOUNTS CHEM RES, V34, P339, DOI 10.1021/ar000057q; Wang JD, 2009, NAT REV MICROBIOL, V7, P822, DOI 10.1038/nrmicro2202; WASSERMAN SA, 1983, J BACTERIOL, V153, P1439, DOI 10.1128/JB.153.3.1439-1450.1983; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; WECHSLER JA, 1971, MOL GEN GENET, V113, P273, DOI 10.1007/BF00339547; WHALEN WA, 1982, J BACTERIOL, V150, P739, DOI 10.1128/JB.150.2.739-746.1982; White D., 2007, PHYSL BIOCH PROKARYO; WOLD S, 1994, EMBO J, V13, P2097, DOI 10.1002/j.1460-2075.1994.tb06485.x; XIAO H, 1991, J BIOL CHEM, V266, P5980; Yao ZZ, 2012, P NATL ACAD SCI USA, V109, pE2561, DOI 10.1073/pnas.1209742109; Zhang Y, 2008, CELL MOL LIFE SCI, V65, P3699, DOI 10.1007/s00018-008-8295-8; ZYSKIND JW, 1992, CELL, V69, P5, DOI 10.1016/0092-8674(92)90112-P; ZYSKIND JW, 1977, J BACTERIOL, V129, P1476, DOI 10.1128/JB.129.3.1476-1486.1977	58	20	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92229	10.1371/journal.pone.0092229	http://dx.doi.org/10.1371/journal.pone.0092229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670900	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000037
J	Noisette, F; Comtet, T; Legrand, E; Bordeyne, F; Davoult, D; Martin, S				Noisette, Fanny; Comtet, Thierry; Legrand, Erwann; Bordeyne, Francois; Davoult, Dominique; Martin, Sophie			Does Encapsulation Protect Embryos from the Effects of Ocean Acidification? The Example of Crepidula fornicata	PLOS ONE			English	Article							CARBON-DIOXIDE CONCENTRATIONS; OYSTER SACCOSTREA-GLOMERATA; LIFE-HISTORY STAGES; LARVAL DEVELOPMENT; ELEVATED PCO(2); EGG CAPSULES; REDUCED PH; SEA-WATER; FUTURE; GASTROPOD	Early life history stages of marine organisms are generally thought to be more sensitive to environmental stress than adults. Although most marine invertebrates are broadcast spawners, some species are brooders and/or protect their embryos in egg or capsules. Brooding and encapsulation strategies are typically assumed to confer greater safety and protection to embryos, although little is known about the physico-chemical conditions within egg capsules. In the context of ocean acidification, the protective role of encapsulation remains to be investigated. To address this issue, we conducted experiments on the gastropod Crepidula fornicata. This species broods its embryos within capsules located under the female and veliger larvae are released directly into the water column. C. fornicata adults were reared at the current level of CO2 partial pressure (pCO(2)) (390 mu atm) and at elevated levels (750 and 1400 mu atm) before and after fertilization and until larval release, such that larval development occurred entirely at a given pCO(2). The pCO(2) effects on shell morphology, the frequency of abnormalities and mineralization level were investigated on released larvae. Shell length decreased by 6% and shell surface area by 11% at elevated pCO(2) (1400 matm). The percentage of abnormalities was 1.5-to 4-fold higher at 750 matm and 1400 matm pCO(2), respectively, than at 390 mu atm. The intensity of birefringence, used as a proxy for the mineralization level of the larval shell, also decreased with increasing pCO(2). These negative results are likely explained by increased intracapsular acidosis due to elevated pCO(2) in extracapsular seawater. The encapsulation of C. fornicata embryos did not protect them against the deleterious effects of a predicted pCO(2) increase. Nevertheless, C. fornicata larvae seemed less affected than other mollusk species. Further studies are needed to identify the critical points of the life cycle in this species in light of future ocean acidification.	[Noisette, Fanny; Comtet, Thierry; Legrand, Erwann; Bordeyne, Francois; Davoult, Dominique; Martin, Sophie] Univ Paris 06, Sorbonne Univ, Stn Biol Roscoff, UMR 7144, Roscoff, France; [Noisette, Fanny; Comtet, Thierry; Legrand, Erwann; Bordeyne, Francois; Davoult, Dominique; Martin, Sophie] CNRS, Stn Biol Roscoff, UMR 7144, Roscoff, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Noisette, F (corresponding author), Univ Paris 06, Sorbonne Univ, Stn Biol Roscoff, UMR 7144, Roscoff, France.	fanny.noisette@sb-roscoff.fr	Davoult, dominique/D-5932-2012; Comtet, Thierry/ABE-3212-2021	Davoult, dominique/0000-0001-8678-3998; MARTIN, Sophie/0000-0002-1256-3674; Legrand, Erwann/0000-0001-5224-5227	CALCAO project; Region Bretagne; European Community [211384]; Interreg IV a France (Channel) - England Marinexus project [4073]; FEDER programme	CALCAO project; Region Bretagne(Region Bretagne); European Community(European Commission); Interreg IV a France (Channel) - England Marinexus project; FEDER programme(European Commission)	This work was supported by the CALCAO project, which received funding from the Region Bretagne, and contributed to the "European Project on Ocean Acidification" (EPOCA) funded by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 211384. It was also supported by the Interreg IV a France (Channel) - England Marinexus project no4073 funded by the FEDER programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TR, 2012, STUDENT RES PAPERS; Andersen S, 2013, BIOGEOSCIENCES, V10, P6161, DOI 10.5194/bg-10-6161-2013; Anil AC, 2001, J EXP MAR BIOL ECOL, V263, P125, DOI 10.1016/S0022-0981(01)00280-5; [Anonymous], 2009, BIOGEOSCI DISCUSS, DOI DOI 10.5194/BGD-6-3109-2009; Auzoux-Bordenave S, 2010, J STRUCT BIOL, V171, P277, DOI 10.1016/j.jsb.2010.05.012; Barros P, 2013, J EXP MAR BIOL ECOL, V440, P200, DOI 10.1016/j.jembe.2012.12.014; Barry J. P., 2010, GUIDE BEST PRACTICES, P260; Bechmann RK, 2011, J TOXICOL ENV HEAL A, V74, P424, DOI 10.1080/15287394.2011.550460; Blanchard M, 1995, HALIOTIS, V24, P75; Blanchard Michel, 1997, Scientia Marina, V61, P109; Brante A, 2008, MAR ECOL PROG SER, V368, P197, DOI 10.3354/meps07605; Brante A, 2009, J EXP BIOL, V212, P2287, DOI 10.1242/jeb.016329; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Byrne M, 2011, P ROY SOC B-BIOL SCI, V278, P2376, DOI 10.1098/rspb.2010.2404; Chan KYK, 2011, J EXP BIOL, V214, P3857, DOI 10.1242/jeb.054809; Chaparro OR, 2009, J EXP MAR BIOL ECOL, V377, P107, DOI 10.1016/j.jembe.2009.07.001; Chaparro OR, 2009, MAR ECOL PROG SER, V374, P145, DOI 10.3354/meps07777; Chua CM, 2013, MAR ECOL PROG SER, V475, P85, DOI 10.3354/meps10077; Crim RN, 2011, J EXP MAR BIOL ECOL, V400, P272, DOI 10.1016/j.jembe.2011.02.002; Davis AR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064808, 10.1371/journal.pone.0055939]; de Mahieu G.C., 1974, Cahiers Biol Mar, V15, P215; Dickson A. G., 2007, PICES SPECIAL PUBLIC, DOI DOI 10.1159/000331784; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dorey N, 2013, MAR BIOL, V160, P2007, DOI 10.1007/s00227-012-2059-6; Dupont S, 2013, MAR BIOL, V160, P1835, DOI 10.1007/s00227-012-1921-x; Dupont S, 2010, ESTUAR COAST SHELF S, V89, P182, DOI 10.1016/j.ecss.2010.06.013; Dupont S, 2008, MAR ECOL PROG SER, V373, P285, DOI 10.3354/meps07800; Egilsdottir H, 2009, MAR POLLUT BULL, V58, P1187, DOI 10.1016/j.marpolbul.2009.03.017; Ellis RP, 2009, AQUAT BIOL, V5, P41, DOI 10.3354/ab00118; EYSTER LS, 1986, BIOL BULL-US, V170, P211, DOI 10.2307/1541804; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Fernandes DAO, 2012, INTEGR COMP BIOL, V52, pE244; Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939; Gazeau F, 2010, BIOGEOSCIENCES, V7, P2051, DOI 10.5194/bg-7-2051-2010; Gazeau F, 2013, MAR BIOL, V160, P2207, DOI 10.1007/s00227-013-2219-3; Gazeau F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023010; Ginger KWK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064147; Gutowska MA, 2009, MAR BIOL, V156, P515, DOI 10.1007/s00227-008-1096-7; Hettinger A, 2013, BIOGEOSCIENCES, V10, P6629, DOI 10.5194/bg-10-6629-2013; Hickman CS, 1999, INVERTEBR BIOL, V118, P346, DOI 10.2307/3227006; Hickman CS, 2001, EVOL DEV, V3, P18, DOI 10.1046/j.1525-142x.2001.01003.x; Hoegh-Guldberg O, 2009, CORAL REEFS, V28, P569, DOI 10.1007/s00338-009-0508-6; IPCC, 2013, CLIM CAHGN 2013 PHYS; Jansson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068198; Kim K-S, 2013, BIOGEOSCI DISCUSS, V10, P7413, DOI DOI 10.5194/BGD-10-7413-; Kimura R, 2011, FISH OCEANOGR, V20, P357, DOI 10.1111/j.1365-2419.2011.00589.x; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Kurihara H, 2007, AQUAT BIOL, V1, P91, DOI 10.3354/ab00009; Kurihara H, 2009, AQUAT BIOL, V4, P225, DOI 10.3354/ab00109; Lenz M, 2011, ENVIRON RES, V111, P943, DOI 10.1016/j.envres.2011.05.001; Lewis E., 1998, PROGRAM DEV CO2 SYST; Li JQ, 2013, MAR POLLUT BULL, V74, P320, DOI 10.1016/j.marpolbul.2013.06.035; Maeda-Martinez AN, 2008, MAR BIOL, V154, P643, DOI 10.1007/s00227-008-0957-4; MAEDAMARTINEZ AN, 1987, COMP BIOCHEM PHYS A, V86, P21, DOI 10.1016/0300-9629(87)90270-2; Martin S, 2011, J EXP BIOL, V214, P1357, DOI 10.1242/jeb.051169; Marxen JC, 2003, J MOLLUS STUD, V69, P113, DOI 10.1093/mollus/69.2.113; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; Montory JA, 2009, MAR ECOL PROG SER, V374, P157, DOI 10.3354/meps07780; Moran D, 2011, AQUAT TOXICOL, V102, P24, DOI 10.1016/j.aquatox.2010.12.014; Munday PL, 2011, MAR ECOL PROG SER, V423, P211, DOI 10.3354/meps08990; Nguyen HD, 2012, GLOBAL CHANGE BIOL, V18, P2466, DOI 10.1111/j.1365-2486.2012.02714.x; Noisette F, 2013, J PHYCOL, V49, P746, DOI 10.1111/jpy.12085; Occhipinti-Ambrogi A, 2007, MAR POLLUT BULL, V55, P342, DOI 10.1016/j.marpolbul.2006.11.014; ORTON J.H., 1912, J MAR BIOL ASSOC UK, V9, P437, DOI DOI 10.1017/S0025315400048372; Padilla-Gamino JL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0155; Pansch C, 2013, ICES J MAR SCI, V70, P805, DOI 10.1093/icesjms/fst092; Parker Laura M., 2013, Biology - Basel, V2, P651, DOI 10.3390/biology2020651; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; PECHENIK JA, 1983, J EXP MAR BIOL ECOL, V71, P165, DOI 10.1016/0022-0981(93)90071-U; PECHENIK JA, 1982, J EXP MAR BIOL ECOL, V63, P195, DOI 10.1016/0022-0981(82)90178-2; PECHENIK JA, 1984, J EXP MAR BIOL ECOL, V74, P241, DOI 10.1016/0022-0981(84)90128-X; Peck LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066033; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Przeslawski Rachel, 2004, Molluscan Research, V24, P43, DOI 10.1071/MR04001; Putnam HM, 2013, MAR BIOL, V160, P2157, DOI 10.1007/s00227-012-2129-9; R Core Team, 2021, R LANG ENV STAT COMP; Range P, 2012, J EXP MAR BIOL ECOL, V424, P89, DOI 10.1016/j.jembe.2012.05.010; Rasband WS, 2012, HEALTH USNIO; Richard J, 2006, MAR BIOL, V149, P789, DOI 10.1007/s00227-005-0157-4; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rigal F, 2009, THESIS U PM CURIE; Ross PM, 2011, WATER-SUI, V3, P1005, DOI 10.3390/w3041005; Scherrer B., 1984, BIOSTATISTIQUES; Schonitzer V, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-71; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; Thiyagarajan V, 2012, AQUACULTURE, V370, P90, DOI 10.1016/j.aquaculture.2012.09.025; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Van Colen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044655; Vehmaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048538; Watson SA, 2009, J SHELLFISH RES, V28, P431, DOI 10.2983/035.028.0302; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; White MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061065; Widdicombe S, 2008, J EXP MAR BIOL ECOL, V366, P187, DOI 10.1016/j.jembe.2008.07.024; Zar JH, 1974, BIOSTATISTICAL ANAL	104	28	28	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93021	10.1371/journal.pone.0093021	http://dx.doi.org/10.1371/journal.pone.0093021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671195	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000102
J	Dan, ZW; Liu, P; Huang, WC; Zhou, W; Yao, GX; Hu, J; Zhu, RS; Lu, BR; Zhu, YG				Dan, Zhiwu; Liu, Ping; Huang, Wenchao; Zhou, Wei; Yao, Guoxin; Hu, Jun; Zhu, Renshan; Lu, Baorong; Zhu, Yingguo			Balance between a Higher Degree of Heterosis and Increased Reproductive Isolation: A Strategic Design for Breeding Inter-Subspecific Hybrid Rice	PLOS ONE			English	Article							ORYZA-SATIVA L; MICROSATELLITE MARKERS; SPIKELET FERTILITY; GENETIC DIVERSITY; POLLEN STERILITY; JAPONICA; INDICA; DIFFERENTIATION; L.; IDENTIFICATION	The application of heterosis (hybrid vigor) has brought great success to plant breeding, particularly of hybrid rice, achieving significant yield increases. Attempts to explore the heterosis of inter-subspecific hybrids between indica and japonica rice, which result in even greater yield increases, have greatly increased in the past decades. However, because of the reduced seed setting rate in F-1 hybrids as a result of increased reproductive isolation, the application of inter-subspecific hybrids in rice has slowed. Understanding the balance between heterosis and the reproductive isolation of inter-subspecific hybrids will facilitate the strategic design of inter-subspecific hybrid breeding. In this study, five indica and seven japonica rice varieties were chosen as the parental lines of a complete diallel mating design. Data from six group traits from all of the hybrids and inbred lines were collected. We found that the grain weight per plant, grain number per panicle, tiller per plant, thousand grain weight and plant height, which reflected increased heterosis, were associated with the genetic divergence index (GDI) of the parents. Meanwhile, owing to the reduced seed setting rate, which was also associated with the parents' GDI, the grain production of the hybrids was negatively affected. After analyzing the relationships between the GDI of indica-japonica parents and the grain weight per plant of the F-1 hybrids, an ideal GDI value (0.37) for the two indica-japonica parents that could provide an optimal balance between the inter-subspecific heterosis and reproductive isolation was proposed. Our findings will help in the strategic design of an inter-subspecific hybrid rice breeding program by identifying the ideal indica and japonica parents for a hybrid combination to achieve hybrid rice with an optimal yield. This strategic design of an inter-subspecific hybrid rice breeding program will be time saving and cost effective.	[Dan, Zhiwu; Huang, Wenchao; Zhou, Wei; Yao, Guoxin; Hu, Jun; Zhu, Renshan; Zhu, Yingguo] Wuhan Univ, State Key Lab Hybrid Rice, Coll Life Sci, Wuhan 430072, Peoples R China; [Dan, Zhiwu; Huang, Wenchao; Zhou, Wei; Yao, Guoxin; Hu, Jun; Zhu, Renshan; Zhu, Yingguo] Wuhan Univ, Minist Educ, Engn Res Ctr Plant Biotechnol & Germplasm Utiliza, Wuhan 430072, Peoples R China; [Liu, Ping; Lu, Baorong] Fudan Univ, Inst Biodivers Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China	Wuhan University; Wuhan University; Fudan University	Zhu, YG (corresponding author), Wuhan Univ, State Key Lab Hybrid Rice, Coll Life Sci, Wuhan 430072, Peoples R China.	zhuyg@public.wh.hb.cn	huang, wen/GXW-0661-2022; Lu, Bao-Rong/C-3130-2009; Dan, Zhiwu/AAM-5103-2021; Dan, Zhiwu/AAC-7071-2022	Lu, Bao-Rong/0000-0002-0214-2390; Dan, Zhiwu/0000-0002-3930-9158	National Natural Science Foundation of China [C130401]; National High-Tech Research and Development Project [2011AA10A101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Project(National High Technology Research and Development Program of China)	This work is supported by funds from the National Natural Science Foundation of China (C130401) and the National High-Tech Research and Development Project (2011AA10A101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng SH, 2007, ANN BOT-LONDON, V100, P959, DOI 10.1093/aob/mcm121; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; He JH, 2011, J EXP BOT, V62, P4433, DOI 10.1093/jxb/err098; Ji Q, 2010, J GENET GENOMICS, V37, P57, DOI 10.1016/S1673-8527(09)60025-4; [姜健 Jiang Jian], 2002, 吉林农业科学, V27, P3; Jiang T, 1999, J AGR BIOTECHNOLOGY, V7, P295; Jiang T, 1999, SCI AGR SINICA, V32, P1; Johns MA, 2007, FUNCT INTEGR GENOMIC, V7, P135, DOI 10.1007/s10142-006-0036-1; Khush G. S., 1995, Geojournal, V35, P329, DOI 10.1007/BF00989140; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Khush GS, 1996, 1996 INCREASING YIEL, P36; Li H, 2012, GUANGDONG AGR SCI, V21; Li RH, 1998, MOL BREEDING, V4, P205, DOI 10.1023/A:1009658310154; Li WT, 2008, THEOR APPL GENET, V116, P915, DOI 10.1007/s00122-008-0723-5; Li YaLi, 2012, Southwest China Journal of Agricultural Sciences, V25, P347; Li ZK, 1997, GENETICS, V145, P1139; Lin S, 1980, HYBRID RICE BREEDING, P35; Long H, 2003, SCI AGR SINICA, V36, P1; Lu BR, 2009, PROG NAT SCI-MATER, V19, P1241, DOI 10.1016/j.pnsc.2009.01.011; Mizuta Y, 2010, P NATL ACAD SCI USA, V107, P20417, DOI 10.1073/pnas.1003124107; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nakamura Y, 2002, STARCH-STARKE, V54, P117, DOI [10.1002/1521-379X(200204)54:3/4<117::AID-STAR117>3.0.CO;2-2, 10.1002/1521-379X(200204)54:3/4&lt;117::AID-STAR117&gt;3.0.CO;2-2]; Ouyang YD, 2010, CURR OPIN PLANT BIOL, V13, P186, DOI 10.1016/j.pbi.2010.01.002; Qi YW, 2009, J GENET GENOMICS, V36, P305, DOI 10.1016/S1673-8527(08)60119-8; Singh SP, 2006, THEOR APPL GENET, V113, P509, DOI 10.1007/s00122-006-0316-0; Song X, 2005, THEOR APPL GENET, V110, P205, DOI 10.1007/s00122-004-1798-2; Sun C, 2000, ACTA AGRON SIN, V26, P641; Sun J, 1999, J TIANJIN AGR COLL, V6, P1; Vanniarajan C, 2012, J GENET, V91, P9, DOI 10.1007/s12041-012-0146-6; Wang MM, 2013, BREEDING SCI, V63, P227, DOI 10.1270/jsbbs.63.227; Xu Hai, 2012, Journal of Shenyang Agricultural University, V43, P704; YANG GP, 1994, MOL GEN GENET, V245, P187, DOI 10.1007/BF00283266; Yang S, 1962, ZUOWUXUEBAO, V1, P97; Yuan L, 1998, CHINA IRRI IMPROVING, P10; Zeng SX, 1980, ACTA AGRON SIN, V6, P193; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; ZHANG QF, 1992, THEOR APPL GENET, V83, P495, DOI 10.1007/BF00226539	38	20	20	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93122	10.1371/journal.pone.0093122	http://dx.doi.org/10.1371/journal.pone.0093122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667442	gold, Green Submitted, Green Published			2022-12-25	WOS:000333675600143
J	Darkoh, C; Comer, L; Zewdie, G; Harold, S; Snyder, N; DuPont, HL				Darkoh, Charles; Comer, Latoya; Zewdie, Getie; Harold, Stephen; Snyder, Ned; DuPont, Herbert L.			Chemotactic Chemokines Are Important in the Pathogenesis of Irritable Bowel Syndrome	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; RHEUMATOID-ARTHRITIS; EXPRESSION; DISEASE; MCP-1; PREVALENCE; CLONING; IBS; EPIDEMIOLOGY; INFLAMMATION	Irritable bowel syndrome (IBS) is one of the most frequently diagnosed disorders, affecting about 20% of the general population in Western countries. This syndrome poses an enormous socio-economic burden, impairs the quality of life substantially, and increases healthcare costs. IBS can be classified as either idiopathic (ID-IBS) with unknown etiology or post-infectious (PI-IBS), which develops after a bout of acute diarrhea or gastroenteritis. Little is known about the immunopathogenesis of these two forms of IBS. We evaluated various biomarkers in clinical samples of ID-IBS and PI-IBS patients with the goal to test the hypothesis that the immunologic presentations of these forms of IBS are similar, despite their apparent different etiologic origins. Sera and stool samples from PI-IBS, ID-IBS, and healthy volunteers were analyzed for relative amounts of 36 different biomarkers using the Proteome Profiler Human Cytokine Array Panel A Kit and quantitative ELISA. Our results demonstrated significantly high levels of chemotactic chemokines monocytes chemotactic protein-1 (CCL2) [p-value = 0.003], macrophage inflammatory protein-1 beta (CCL4) [p-value = 0.010], and CXCL16 (p-value 0.001) in the sera and stools of both ID-IBS and PI-IBS patients. Furthermore, pro-inflammatory cytokines (IFN-gamma, IL-1 beta, and TNF-alpha) were significantly higher in IBS patients. Anti-inflammatory cytokines (IL-10, IL-4, and IL-13) were variable except IL-10, which was significantly higher in the healthy volunteers than the IBS patients. Remarkably, the amounts and expression pattern of these biomarkers were not significantly different between ID-IBS and PI-IBS. Thus, ID-IBS and PI-IBS present similar immunologic and clinical phenotypes, in spite of their different etiologic origins.	[Darkoh, Charles; Zewdie, Getie; DuPont, Herbert L.] Univ Texas Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Ctr Infect Dis, Houston, TX 77030 USA; [Comer, Latoya; DuPont, Herbert L.] Univ Texas Houston, Sch Med, Houston, TX USA; [Harold, Stephen; Snyder, Ned; DuPont, Herbert L.] Kelsey Res Fdn, Houston, TX USA; [Snyder, Ned; DuPont, Herbert L.] Kelsey Seybold Clin, Houston, TX USA; [DuPont, Herbert L.] St Lukes Med Ctr, Houston, TX USA; [DuPont, Herbert L.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Darkoh, C (corresponding author), Univ Texas Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Ctr Infect Dis, Houston, TX 77030 USA.	Charles.darkoh@uth.tmc.edu	DuPont, Herbert/AAH-6776-2021	Darkoh, Charles/0000-0003-0063-7856	University of Texas School of Public Health; Public Health Service Grant [DK56338]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	University of Texas School of Public Health; Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part, by discretionary funds from The University of Texas School of Public Health and Public Health Service Grant DK56338, which funds the Texas Medical Center Digestive Disease Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara G, 2004, ALIMENT PHARM THER, V20, P1, DOI 10.1111/j.1365-2036.2004.02036.x; BRIELAND JK, 1992, AM J RESP CELL MOL, V7, P134, DOI 10.1165/ajrcmb/7.2.134; Chang L, 2012, AM J GASTROENTEROL, V107, P262, DOI 10.1038/ajg.2011.423; Chen JL, 2012, BMC GASTROENTEROL, V2012, P1, DOI DOI 10.1186/1471-230X-12-91; Day C, 2009, EXP LUNG RES, V35, P272, DOI 10.1080/01902140802635517; Diegelmann J, 2010, INFLAMM BOWEL DIS, V16, P1871, DOI 10.1002/ibd.21306; Dorn SD, 2009, J CLIN GASTROENTEROL, V43, P214, DOI 10.1097/MCG.0b013e31815bd749; Dunlop SP, 2003, AM J GASTROENTEROL, V98, P1578, DOI 10.1016/S0002-9270(03)000375-7; DuPont HL, 2011, CURR OPIN INFECT DIS, V24, P503, DOI 10.1097/QCO.0b013e32834a962d; DuPont HL, 2010, AM J TROP MED HYG, V82, P301, DOI 10.4269/ajtmh.2010.09-0538; Engel MA, 2010, J GASTROENTEROL, V45, P571, DOI 10.1007/s00535-010-0219-3; FAHEY TJ, 1992, J IMMUNOL, V148, P2764; Faresjo A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-832; Gao JG, 2013, EXP THER MED, V6, P93, DOI 10.3892/etm.2013.1101; Gunn MD, 1997, J IMMUNOL, V158, P376; Haagsma JA, 2010, EPIDEMIOL INFECT, V138, P1650, DOI 10.1017/S0950268810000531; Hasegawa M, 1999, CLIN EXP IMMUNOL, V117, P159; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Ji S, 2005, J GASTROEN HEPATOL, V20, P381, DOI 10.1111/j.1440-1746.2005.03574.x; JIANG YL, 1992, J IMMUNOL, V148, P2423; JONES ML, 1992, J IMMUNOL, V149, P2147; LEONARD EJ, 1990, IMMUNOL TODAY, V11, P97, DOI 10.1016/0167-5699(90)90035-8; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Marshall JK, 2006, GASTROENTEROLOGY, V131, P445, DOI 10.1053/j.gastro.2006.05.053; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; McKernan DP, 2011, ALIMENT PHARM THER, V33, P1045, DOI 10.1111/j.1365-2036.2011.04624.x; MORITA N, 1995, J GASTROENTEROL, V30, P1; Nanki T, 2005, ARTHRITIS RHEUM, V52, P3004, DOI 10.1002/art.21301; Okhuysen PC, 2004, AM J GASTROENTEROL, V99, P1774, DOI 10.1111/j.1572-0241.2004.30435.x; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Rana S V, 2012, Trop Gastroenterol, V33, P251; Romero-Valdovinos M, 2012, MOL BIOL REP, V39, P8837, DOI 10.1007/s11033-012-1745-2; Ruth JH, 2006, ARTHRITIS RHEUM-US, V54, P765, DOI 10.1002/art.21662; Schmulson M, 2012, AM J GASTROENTEROL, V107, P747, DOI 10.1038/ajg.2011.484; Shimaoka T, 2000, J BIOL CHEM, V275, P40663, DOI 10.1074/jbc.C000761200; STAHL RAK, 1993, KIDNEY INT, V44, P1036, DOI 10.1038/ki.1993.346; Swan C, 2013, GUT, V62, P985, DOI 10.1136/gutjnl-2011-301213; Thabane M, 2009, AM J GASTROENTEROL, V104, P2267, DOI 10.1038/ajg.2009.302; Thompson WG, 2000, ROME 2 FUNCTIONAL GA, V2nd, P351; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Wilbanks A, 2001, J IMMUNOL, V166, P5145, DOI 10.4049/jimmunol.166.8.5145; YOSHIMURA T, 1989, FEBS LETT, V244, P487, DOI 10.1016/0014-5793(89)80590-3	44	40	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93144	10.1371/journal.pone.0093144	http://dx.doi.org/10.1371/journal.pone.0093144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667736	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600149
J	de Oliveira, JMPF; Costa, M; Pedrosa, T; Pinto, P; Remedios, C; Oliveira, H; Pimentel, F; Almeida, L; Santos, C				Ferreira de Oliveira, Jose Miguel P.; Costa, Maria; Pedrosa, Tiago; Pinto, Pedro; Remedios, Catarina; Oliveira, Helena; Pimentel, Francisco; Almeida, Luis; Santos, Conceicao			Sulforaphane Induces Oxidative Stress and Death by p53-Independent Mechanism: Implication of Impaired Glutathione Recycling	PLOS ONE			English	Article							NF-KAPPA-B; CELL-CYCLE ARREST; TRAIL-INDUCED APOPTOSIS; INHIBITS TUMOR-GROWTH; CANCER-CELLS; CHEMOPREVENTIVE AGENTS; ISOTHIOCYANATE SULFORAPHANE; 2-OXOHEXYL ISOTHIOCYANATE; HISTONE DEACETYLASE; OSTEOSARCOMA CELLS	Sulforaphane (SFN) is a naturally-occurring isothiocyanate best known for its role as an indirect antioxidant. Notwithstanding, in different cancer cell lines, SFN may promote the accumulation of reactive oxygen species (ROS) and cause cell death e.g. by apoptosis. Osteosarcoma often becomes chemoresistant, and new molecular targets to prevent drug resistance are needed. Here, we aimed to determine the effect of SFN on ROS levels and to identify key biomarkers leading to ROS unbalance and apoptosis in the p53-null MG-63 osteosarcoma cell line. MG-63 cells were exposed to SFN for up to 48 h. At 10 mu M concentration or higher, SFN decreased cell viability, increased the% early apoptotic cells and increased caspase 3 activity. At these higher doses, SFN increased ROS levels, which correlated with apoptotic endpoints and cell viability decline. In exposed cells, gene expression analysis revealed only partial induction of phase-2 detoxification genes. More importantly, SFN inhibited ROS-scavenging enzymes and impaired glutathione recycling, as evidenced by inhibition of glutathione reductase (GR) activity and combined inhibition of glutathione peroxidase (GPx) gene expression and enzyme activity. In conclusion, SFN induced oxidative stress and apoptosis via a p53-independent mechanism. GPx expression and activity were found associated with ROS accumulation in MG-63 cells and are potential biomarkers for the efficacy of ROS-inducing agents e. g. as co-adjuvant drugs in osteosarcoma.	[Ferreira de Oliveira, Jose Miguel P.; Costa, Maria; Pedrosa, Tiago; Pinto, Pedro; Remedios, Catarina; Oliveira, Helena; Santos, Conceicao] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Ferreira de Oliveira, Jose Miguel P.; Costa, Maria; Pedrosa, Tiago; Pinto, Pedro; Remedios, Catarina; Oliveira, Helena; Santos, Conceicao] Univ Aveiro, Dept Biol, Lab Biotechnol & Cyt, P-3800 Aveiro, Portugal; [Pimentel, Francisco] Lenitudes, Lisbon, Portugal; [Pimentel, Francisco] Univ Fernando Pessoa, Fac Hlth Sci, Oporto, Portugal; [Pimentel, Francisco] Univ Coimbra, Ctr Hlth Studies & Res, Coimbra, Portugal; [Pimentel, Francisco] Univ Beira Interior, Fac Ciencias Saude, Covilha, Portugal; [Almeida, Luis] Luzitin SA, Coimbra, Portugal; [Almeida, Luis] Blueclin Phase I, Oporto, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade Fernando Pessoa; Universidade de Coimbra; Universidade da Beira Interior	de Oliveira, JMPF (corresponding author), Univ Aveiro, CESAM, Campus Univ Santiago, P-3800 Aveiro, Portugal.	oliveira.miguel@ua.pt	Santos, Conceição/ABE-6172-2020; Pimentel, Francisco/M-3619-2013; Ferreira de Oliveira, Jose Miguel P/F-6250-2011; Remédios, Catarina/G-6836-2011; Almeida, Luis/E-3870-2010; Ferreira de Oliveira, José Miguel P./AFM-8368-2022; Santos, Conceição LV/A-8651-2008; de Oliveira, Jose Miguel Ferreira/AAU-8778-2020; santos, conceição/GQQ-7378-2022; Oliveira, Helena/M-5068-2013	Santos, Conceição/0000-0003-4129-6381; Pimentel, Francisco/0000-0001-5993-5132; Ferreira de Oliveira, Jose Miguel P/0000-0002-3883-0806; Remédios, Catarina/0000-0001-9567-2130; Almeida, Luis/0000-0002-4861-8649; Ferreira de Oliveira, José Miguel P./0000-0002-3883-0806; Santos, Conceição LV/0000-0003-4129-6381; de Oliveira, Jose Miguel Ferreira/0000-0002-3883-0806; Oliveira, Helena/0000-0002-4673-0696; Pinto, Pedro/0000-0002-3794-3833; Marques da Costa, Maria Eugenia/0000-0002-1498-603X	Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/48853/2008, SFRH/BPD/74868/2010]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This study was supported by the Portuguese Foundation for Science and Technology (FCT, http://www.fct.pt/) through the post-doctoral fellowships of HO (SFRH/BPD/48853/2008) and JMPFO (SFRH/BPD/74868/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljubran AH, 2009, ANN ONCOL, V20, P1136, DOI 10.1093/annonc/mdn731; Barcelo S, 1996, CARCINOGENESIS, V17, P277, DOI 10.1093/carcin/17.2.277; Bielack SS, 2009, J CLIN ONCOL, V27, P557, DOI 10.1200/JCO.2008.16.2305; Dringen R, 2002, METHOD ENZYMOL, V348, P281, DOI 10.1016/S0076-6879(02)48646-6; ervinka M, 2009, FOOD CHEM TOXICOL, V47, P2366; Feridooni T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022801; Ferreira de Oliveira JMP, 2014, SULFORAPHANE INDUCES; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Gao XQ, 2001, P NATL ACAD SCI USA, V98, P15221, DOI 10.1073/pnas.261572998; Gorlick R, 2010, J BONE MINER RES, V25, P683, DOI 10.1002/jbmr.77; Hayes JD, 2008, EUR J NUTR, V47, P73, DOI 10.1007/s00394-008-2009-8; Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009; Hu R, 2006, CANCER LETT, V243, P170, DOI 10.1016/j.canlet.2005.11.050; Hu Y, 2007, BIOL CHEM, V388, P1069, DOI 10.1515/BC.2007.135; Jakubikova J, 2011, HAEMATOL-HEMATOL J, V96, P1170, DOI 10.3324/haematol.2010.029363; Jeong WS, 2004, PHARM RES-DORDR, V21, P661, DOI 10.1023/B:PHAM.0000022413.43212.cf; Kim H, 2006, CANCER RES, V66, P1740, DOI 10.1158/0008-5472.CAN-05-1568; Kim MR, 2011, MOL MED REP, V4, P929, DOI 10.3892/mmr.2011.520; Kwak MK, 2007, FREE RADICAL BIO MED, V43, P809, DOI 10.1016/j.freeradbiomed.2007.05.029; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Matsui TA, 2007, ONCOL REP, V18, P1263; Matsui T, 2006, CARCINOGENESIS, V27, P1768, DOI 10.1093/carcin/bgl015; Misiewicz I, 2003, ONCOL REP, V10, P2045; Misiewicz I, 2007, PHARMACOL REP, V59, P80; Moon DO, 2009, CANCER LETT, V274, P132, DOI 10.1016/j.canlet.2008.09.013; Mukherjee S, 2010, BRIT J NUTR, V103, P815, DOI 10.1017/S0007114509992492; Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pham NA, 2004, MOL CANCER THER, V3, P1239; Picci P, 2010, ANN ONCOL, V21, P1366, DOI 10.1093/annonc/mdp502; Quick KL, 2000, J NEUROSCI METH, V97, P139, DOI 10.1016/S0165-0270(00)00179-5; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Ritter J, 2010, ANN ONCOL, V21, P320, DOI 10.1093/annonc/mdq276; Rozen S, 2000, Methods Mol Biol, V132, P365; Sestili P, 2010, MUTAT RES-FUND MOL M, V689, P65, DOI 10.1016/j.mrfmmm.2010.05.003; Shankar S, 2008, CLIN CANCER RES, V14, P6855, DOI 10.1158/1078-0432.CCR-08-0903; Shen GX, 2005, ANTIOXID REDOX SIGN, V7, P1648, DOI 10.1089/ars.2005.7.1648; Singh SV, 2005, J BIOL CHEM, V280, P19911, DOI 10.1074/jbc.M412443200; Smith AD, 2002, METHOD ENZYMOL, V347, P113; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tarozzi A, 2009, J NEUROCHEM, V111, P1161, DOI 10.1111/j.1471-4159.2009.06394.x; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Tsang WP, 2003, LIFE SCI, V73, P2047, DOI 10.1016/S0024-3205(03)00566-6; Wachtel M, 2010, CANCER TREAT REV, V36, P318, DOI 10.1016/j.ctrv.2010.02.007; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Xiao D, 2009, PHARM RES-DORDR, V26, P1729, DOI 10.1007/s11095-009-9883-5; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; Zanichelli F, 2012, APOPTOSIS, V17, P964, DOI 10.1007/s10495-012-0740-3; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhu H, 2008, CARDIOVASC TOXICOL, V8, P115, DOI 10.1007/s12012-008-9020-4; Zhu M, 2004, MOL CARCINOGEN, V41, P179, DOI 10.1002/mc.20052	53	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92980	10.1371/journal.pone.0092980	http://dx.doi.org/10.1371/journal.pone.0092980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667842	gold, Green Published, Green Submitted			2022-12-25	WOS:000333675600117
J	Patel, RB; Mathur, MB; Gould, M; Uyeki, TM; Bhattacharya, J; Xiao, Y; Khazeni, N				Patel, Rita B.; Mathur, Maya B.; Gould, Michael; Uyeki, Timothy M.; Bhattacharya, Jay; Xiao, Yang; Khazeni, Nayer			Demographic and Clinical Predictors of Mortality from Highly Pathogenic Avian Influenza A (H5N1) Virus Infection: CART Analysis of International Cases	PLOS ONE			English	Article							PUBLIC-HEALTH; UNITED-STATES; HOST GENETICS; SUSCEPTIBILITY; SEROEVIDENCE; MORBIDITY; INDONESIA; CHILDREN; DEATHS; ASIA	Background: Human infections with highly pathogenic avian influenza (HPAI) A (H5N1) viruses have occurred in 15 countries, with high mortality to date. Determining risk factors for morbidity and mortality from HPAI H5N1 can inform preventive and therapeutic interventions. Methods: We included all cases of human HPAI H5N1 reported in World Health Organization Global Alert and Response updates and those identified through a systematic search of multiple databases (PubMed, Scopus, and Google Scholar), including articles in all languages. We abstracted predefined clinical and demographic predictors and mortality and used bivariate logistic regression analyses to examine the relationship of each candidate predictor with mortality. We developed and pruned a decision tree using nonparametric Classification and Regression Tree methods to create risk strata for mortality. Findings: We identified 617 human cases of HPAI H5N1 occurring between December 1997 and April 2013. The median age of subjects was 18 years (interquartile range 6-29 years) and 54% were female. HPAI H5N1 case-fatality proportion was 59%. The final decision tree for mortality included age, country, per capita government health expenditure, and delay from symptom onset to hospitalization, with an area under the receiver operator characteristic (ROC) curve of 0.81 (95% CI: 0.76-0.86). Interpretation: A model defined by four clinical and demographic predictors successfully estimated the probability of mortality from HPAI H5N1 illness. These parameters highlight the importance of early diagnosis and treatment and may enable early, targeted pharmaceutical therapy and supportive care for symptomatic patients with HPAI H5N1 virus infection.	[Patel, Rita B.; Mathur, Maya B.; Khazeni, Nayer] Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [Gould, Michael] Kaiser Permanente So Calif, Pasadena, CA 91101 USA; [Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Bhattacharya, Jay; Khazeni, Nayer] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Bhattacharya, Jay; Khazeni, Nayer] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Xiao, Yang] Univ S Carolina, Dept Languages Literatures & Cultures, Columbia, SC 29208 USA	Stanford University; Kaiser Permanente; Centers for Disease Control & Prevention - USA; Stanford University; Stanford University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Mathur, MB (corresponding author), Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, Stanford, CA 94305 USA.	mmathur@stanford.edu		Xiao-Desai, Yang/0000-0002-3609-2758	Agency for Healthcare Research and Quality [1 K08 HS019816]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS019816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG017253] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Agency for Healthcare Research and Quality (1 K08 HS019816, Dr. Khazeni). See http://www.ahrq.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Adisasmito W, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-571; Adisasmito W, 2010, J INFECT DIS, V202, P1154, DOI 10.1086/656316; [Anonymous], 2013, WHO GLOBAL HLTH OBSE; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Bird SM, 2008, LANCET, V372, P696, DOI 10.1016/S0140-6736(08)61126-5; Boltz DA, 2008, J INFECT DIS, V197, P1315, DOI 10.1086/586711; BREIMAN L., 1984, CRC PRESS; Cavailler P, 2010, J CLIN VIROL, V48, P123, DOI 10.1016/j.jcv.2010.02.021; Chan PKS, 2012, J INFECT DIS, V206, P1359, DOI 10.1093/infdis/jis509; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; Chmielewski R, 2011, ANNU REV FOOD SCI T, V2, P37, DOI 10.1146/annurev-food-022510-133710; Coker R, 2006, LANCET, V368, P886, DOI 10.1016/S0140-6736(06)69209-X; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; Cox CM, 2011, CLIN INFECT DIS, V52, pS69, DOI 10.1093/cid/ciq011; Cunha BA, 2004, INFECT DIS CLIN N AM, V18, P141, DOI 10.1016/S0891-5520(03)00095-3; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Harrell FE, 2001, REGRESSION MODELING; Hastie TJ, 2011, ELEMENTS STAT LEARNI; Horby P, 2010, EPIDEMIOL INFECT, V138, P1550, DOI 10.1017/S0950268810000518; Horby P, 2013, INFLUENZA OTHER RESP, V7, P37, DOI 10.1111/irv.12079; Horby P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033180; Kandeel A, 2010, EMERG INFECT DIS, V16, P1101, DOI 10.3201/eid1607.091695; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Kayali G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017730; Liao QH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071765; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Muller R, 2008, CLIN CHIM ACTA, V394, P1, DOI 10.1016/j.cca.2008.04.007; Murakami DR, 2008, 13 INT C INF DIS; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Pongcharoensuk P, 2012, HEALTH POLICY PLANN, V27, P374, DOI 10.1093/heapol/czr056; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Toner ES, 2013, CLIN INFECT DIS, V56, P1206, DOI 10.1093/cid/cit047; Uyeki TM, 2009, CLIN INFECT DIS, V49, P279, DOI 10.1086/600035; Van Kerkhove MD, 2012, SCIENCE, V336, DOI 10.1126/science.1221434; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; Wang TT, 2012, SCIENCE, V335, P1463, DOI 10.1126/science.1218888; Western Pacific Regional Office of the World Health Organization, 2013, 22 NEW HUM CAS AV IN; Western Pacific Regional Office of the World Health Organization, 2013, AV INFL H5N1 WEEKL U; WHO/GIP, 2003, CUM NUMB CONF HUM CA; World Health Organization, 2013, WHO H5N1 CLIN CAS SU; World Health Organization, 2013, WHO CAS DEF HUM INF; Yalcin C, 2010, AVIAN DIS, V54, P390, DOI 10.1637/8710-031809-Reg.1; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	47	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e91630	10.1371/journal.pone.0091630	http://dx.doi.org/10.1371/journal.pone.0091630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667532	Green Submitted, Green Published, gold			2022-12-25	WOS:000333675600011
J	Steenbergh, AK; Bodelier, PLE; Slomp, CP; Laanbroek, HJ				Steenbergh, Anne K.; Bodelier, Paul L. E.; Slomp, Caroline P.; Laanbroek, Hendrikus J.			Effect of Redox Conditions on Bacterial Community Structure in Baltic Sea Sediments with Contrasting Phosphorus Fluxes	PLOS ONE			English	Article							BIOGEOCHEMICAL PROCESSES; FRESH-WATER; MARINE; REGENERATION; POPULATIONS; DIVERSITY	Phosphorus release from sediments can exacerbate the effect of eutrophication in coastal marine ecosystems. The flux of phosphorus from marine sediments to the overlying water is highly dependent on the redox conditions at the sediment-water interface. Bacteria are key players in the biological processes that release or retain phosphorus in marine sediments. To gain more insight in the role of bacteria in phosphorus release from sediments, we assessed the effect of redox conditions on the structure of bacterial communities. To do so, we incubated surface sediments from four sampling sites in the Baltic Sea under oxic and anoxic conditions and analyzed the fingerprints of the bacterial community structures in these incubations and the original sediments. This paper describes the effects of redox conditions, sampling station, and sample type (DNA, RNA, or whole-cell sample) on bacterial community structure in sediments. Redox conditions explained only 5% of the variance in community structure, and bacterial communities from contrasting redox conditions showed considerable overlap. We conclude that benthic bacterial communities cannot be classified as being typical for oxic or anoxic conditions based on community structure fingerprints. Our results suggest that the overall structure of the benthic bacterial community has only a limited impact on benthic phosphate fluxes in the Baltic Sea.	[Steenbergh, Anne K.; Bodelier, Paul L. E.; Laanbroek, Hendrikus J.] Netherlands Inst Ecol NIOO KNAW, Wageningen, Netherlands; [Slomp, Caroline P.] Univ Utrecht, Fac Geosci, Dept Earth Sci Geochem, Utrecht, Netherlands; [Laanbroek, Hendrikus J.] Univ Utrecht, Fac Sci, Inst Environm Biol, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Utrecht University; Utrecht University	Steenbergh, AK (corresponding author), Netherlands Inst Ecol NIOO KNAW, Wageningen, Netherlands.	a.steenbergh@nioo.knaw.nl	Laanbroek, Hendrikus/AAV-9215-2020; Slomp, Caroline P/A-9406-2012; Bodelier, Paul/AAF-8353-2020; Bodelier, Paul L/A-9591-2011; Haygarth, Philip Matthew/F-6790-2014; Laanbroek, Hendrikus J./C-3830-2008; KNAW, NIOO-KNAW/A-4320-2012	Laanbroek, Hendrikus/0000-0003-2400-3399; Slomp, Caroline P/0000-0002-7272-0109; Bodelier, Paul/0000-0002-5757-5572; Bodelier, Paul L/0000-0002-5757-5572; Laanbroek, Hendrikus J./0000-0003-2400-3399; Steenbergh, Anne/0000-0002-0360-5078; KNAW, NIOO-KNAW/0000-0002-3835-159X	Darwin Center for Biogeosciences [142.16.1101]; Baltic Sea foundation; Netherlands Organisation for Scientific Research (Vidi NWO); EU-BONUS project HYPER; European Research Council under the European Community [278364]	Darwin Center for Biogeosciences; Baltic Sea foundation; Netherlands Organisation for Scientific Research (Vidi NWO)(Netherlands Organization for Scientific Research (NWO)); EU-BONUS project HYPER; European Research Council under the European Community(European Research Council (ERC))	This work was funded by grants from the Darwin Center for Biogeosciences (http://www.darwincenter.nl/; grant number 142.16.1101), the Baltic Sea 2020 foundation (http://www.balticsea2020.org/), the Netherlands Organisation for Scientific Research (Vidi NWO to C.P. Slomp; http://www.nwo.nl/), the EU-BONUS project HYPER (http://www.bonusportal.org/) and the European Research Council (http://erc.europa.eu/) under the European Community's Seventh Framework Programme for ERC Starting Grant 278364. This is publication number XXX of the Netherlands Institute of Ecology (NIOO-KNAW), and publication number XXX of the Darwin Center for Biogeosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algeo TJ, 2007, PALAEOGEOGR PALAEOCL, V256, P130, DOI 10.1016/j.palaeo.2007.02.029; Bodrossy L, 2006, APPL ENVIRON MICROB, V72, P1672, DOI 10.1128/AEM.72.2.1672-1676.2006; Brock J, 2011, ISME J, V5, P497, DOI 10.1038/ismej.2010.135; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Edlund A, 2006, ENVIRON MICROBIOL, V8, P223, DOI 10.1111/j.1462-2920.2005.00887.x; Edlund A, 2008, ENVIRON MICROBIOL, V10, P2051, DOI 10.1111/j.1462-2920.2008.01624.x; Emeis K, 2002, J MARINE SYST, V35, P151, DOI 10.1016/S0924-7963(02)00127-6; Emeis KC, 2000, MAR GEOL, V167, P43, DOI 10.1016/S0025-3227(00)00015-3; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Frossard A, 2012, ISME J, V6, P680, DOI 10.1038/ismej.2011.134; GACHTER R, 1993, HYDROBIOLOGIA, V253, P103, DOI 10.1007/BF00050731; Grote J, 2008, APPL ENVIRON MICROB, V74, P7546, DOI 10.1128/AEM.01186-08; Illian JB, 2009, J MICROBIOL METH, V79, P89, DOI 10.1016/j.mimet.2009.08.010; INGALL E, 1994, GEOCHIM COSMOCHIM AC, V58, P2571, DOI 10.1016/0016-7037(94)90033-7; Jilbert T, 2011, BIOGEOSCIENCES, V8, P1699, DOI 10.5194/bg-8-1699-2011; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lindahl V, 1996, J MICROBIOL METH, V25, P279, DOI 10.1016/0167-7012(95)00102-6; Llobet-Brossa E, 1998, APPL ENVIRON MICROB, V64, P2691; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Luo HW, 2009, P NATL ACAD SCI USA, V106, P21219, DOI 10.1073/pnas.0907586106; Mermillod-Blondin F, 2011, J N AM BENTHOL SOC, V30, P770, DOI 10.1899/10-121.1; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Oksanen J., 2016, R PACKAG; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Pett-Ridge J, 2005, APPL ENVIRON MICROB, V71, P6998, DOI 10.1128/AEM.71.11.6998-7007.2005; Ramsay J. O., 2011, FDA FUNCTIONAL DATA; REDFIELD AC, 1958, AM SCI, V46, P205; SANDER BC, 1993, MICROB ECOL, V26, P79, DOI 10.1007/BF00177045; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sinkko H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021555; Soetaert K, 2007, MAR CHEM, V105, P30, DOI 10.1016/j.marchem.2006.12.012; Steenbergh AK, 2013, ENVIRON MICROBIOL, V15, P1572, DOI 10.1111/1462-2920.12042; Steenbergh AK, 2011, LIMNOL OCEANOGR, V56, P2018, DOI 10.4319/lo.2011.56.6.2018; Steenbergh AK, 2010, FEMS MICROBIOL ECOL, V71, P12, DOI 10.1111/j.1574-6941.2009.00782.x; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sukenik A, 2012, ISME J, V6, P670, DOI 10.1038/ismej.2011.128; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zinger L, 2011, PLOS ONE, V6	40	9	9	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92401	10.1371/journal.pone.0092401	http://dx.doi.org/10.1371/journal.pone.0092401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667801	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600037
J	Abad, E; Rommel, JB; Kastner, J				Abad, Enrique; Rommel, Judith B.; Kaestner, Johannes			Reaction Mechanism of the Bicopper Enzyme Peptidylglycine alpha-Hydroxylating Monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computer Modeling; Copper; Enzyme Catalysis; Metalloproteins; Post-translational Modification; Kinetic Isotope Effects; PHM; QM; MM Simulation; Quantum Tunneling; Reaction Mechanism	DOPAMINE BETA-MONOOXYGENASE; AMIDATING ENZYME; MOLECULAR-DYNAMICS; MONONUCLEAR COPPER; ELECTRON-TRANSFER; ACTIVE-SITE; BASIS-SETS; CATALYTIC MECHANISM; POTENTIAL SURFACES; QM/MM SIMULATIONS	Background: Peptidylglycine -hydroxylating monooxygenase catalyzes the generation of C-terminal carboxamides of peptide hormones, neurotransmitters, and growth factors for biological activation. Results: We compare several possible reaction mechanisms by means of quantum mechanics/molecular mechanics calculations. Conclusion: Our results suggest that the most likely abstracting species is [CuOOH](2+). Significance: Our computational study proposes a new mechanism, which explains the experimental observations. Peptidylglycine -hydroxylating monooxygenase is a noninteracting bicopper enzyme that stereospecifically hydroxylates the terminal glycine of small peptides for its later amidation. Neuroendocrine messengers, such as oxytocin, rely on the biological activity of this enzyme. Each catalytic turnover requires one oxygen molecule, two protons from the solvent, and two electrons. Despite this enzyme having been widely studied, a consensus on the reaction mechanism has not yet been found. Experiments and theoretical studies favor a pro-S abstraction of a hydrogen atom followed by the rebinding of an OH group. However, several hydrogen-abstracting species have been postulated; because two protons are consumed during the reaction, several protonation states are available. An electron transfer between the copper atoms could play a crucial role for the catalysis as well. This leads to six possible abstracting species. In this study, we compare them on equal footing. We perform quantum mechanics/molecular mechanics calculations, considering the glycine hydrogen abstraction. Our results suggest that the most likely mechanism is a protonation of the abstracting species before the hydrogen abstraction and another protonation as well as a reduction before OH rebinding.	[Abad, Enrique; Rommel, Judith B.; Kaestner, Johannes] Univ Stuttgart, Inst Theoret Chem, Computat Biochem Grp, D-70569 Stuttgart, Germany	University of Stuttgart	Kastner, J (corresponding author), Univ Stuttgart, Inst Theoret Chem, Computat Biochem Grp, Pfaffenwaldring 55, D-70569 Stuttgart, Germany.	kaestner@theochem.uni-stuttgart.de	Kästner, Johannes/E-3460-2010; Abad, Enrique/A-1201-2012	Kästner, Johannes/0000-0001-6178-7669; Abad, Enrique/0000-0002-4214-7874; Rommel, Judith B./0000-0001-9082-0798	Alexander von Humboldt Foundation; Landesstiftung Baden-Wurttemberg; Cluster of Excellence in Simulation Technology [EXC 310/1]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Landesstiftung Baden-Wurttemberg; Cluster of Excellence in Simulation Technology	This work was supported by the Alexander von Humboldt Foundation, Landesstiftung Baden-Wurttemberg, and Cluster of Excellence in Simulation Technology Grant EXC 310/1 (University of Stuttgart).	Bauman AT, 2006, J BIOL CHEM, V281, P4190, DOI 10.1074/jbc.M511199200; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bell J, 1997, BIOCHEMISTRY-US, V36, P16239, DOI 10.1021/bi970903d; Billeter SR, 2000, PHYS CHEM CHEM PHYS, V2, P2177, DOI 10.1039/a909486e; BRADBURY AF, 1990, EUR J BIOCHEM, V189, P363, DOI 10.1111/j.1432-1033.1990.tb15497.x; Chen P, 2004, P NATL ACAD SCI USA, V101, P13105, DOI 10.1073/pnas.0402114101; Chen P, 2004, J AM CHEM SOC, V126, P4991, DOI 10.1021/ja031564g; Crespo A, 2006, J AM CHEM SOC, V128, P12817, DOI 10.1021/ja062876x; de la Lande A, 2008, CHEM-EUR J, V14, P6465, DOI 10.1002/chem.200701595; de la Lande A, 2007, J AM CHEM SOC, V129, P11700, DOI 10.1021/ja070329l; Eckart C, 1930, PHYS REV, V35, P1303, DOI 10.1103/PhysRev.35.1303; EIPPER BA, 1983, P NATL ACAD SCI-BIOL, V80, P5144, DOI 10.1073/pnas.80.16.5144; Evans JP, 2003, J BIOL CHEM, V278, P49691, DOI 10.1074/jbc.M300797200; FARRINGTON GK, 1990, J BIOL CHEM, V265, P1036; Francisco WA, 2002, J AM CHEM SOC, V124, P8194, DOI 10.1021/ja025758s; Francisco WA, 1998, BIOCHEMISTRY-US, V37, P8244, DOI 10.1021/bi973004y; Francisco WA, 2003, BIOCHEMISTRY-US, V42, P1813, DOI 10.1021/bi020592t; FREEMAN JC, 1993, J AM CHEM SOC, V115, P4923, DOI 10.1021/ja00064a077; GILLAN MJ, 1987, J PHYS C SOLID STATE, V20, P3621, DOI 10.1088/0022-3719/20/24/005; Goumans TPM, 2009, PHYS CHEM CHEM PHYS, V11, P5431, DOI 10.1039/b816905e; Henkelman G, 1999, J CHEM PHYS, V111, P7010, DOI 10.1063/1.480097; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iwai N., 1993, Proceedings of the American Association for Cancer Research Annual Meeting, V34, P266; Jonsson H., 1998, CLASSICAL QUANTUM DY; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kastner J, 2010, MOL PHYS, V108, P293, DOI 10.1080/00268970903446764; Kaestner J, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2815812; Kastner J, 2009, J PHYS CHEM A, V113, P11856, DOI 10.1021/jp9028968; Kamachi T, 2005, INORG CHEM, V44, P4226, DOI 10.1021/ic048477p; KATOPODIS AG, 1990, BIOCHEMISTRY-US, V29, P4541, DOI 10.1021/bi00471a006; Klinman JP, 2006, J BIOL CHEM, V281, P3013, DOI 10.1074/jbc.R500011200; Klinman JP, 1996, CHEM REV, V96, P2541, DOI 10.1021/cr950047g; KULATHILA R, 1994, ARCH BIOCHEM BIOPHYS, V311, P191, DOI 10.1006/abbi.1994.1225; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; Lonsdale R, 2010, J PHYS CHEM B, V114, P1156, DOI 10.1021/jp910127j; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martinez A, 1996, MOL CELL ENDOCRINOL, V123, P113, DOI 10.1016/S0303-7207(96)03903-2; Mclntyre NR, 2009, J AM CHEM SOC, V131, P10308, DOI 10.1021/ja902716d; Melia C, 2013, CHEM-EUR J, V19, P17328, DOI 10.1002/chem.201301000; Metz S, 2014, WIRES COMPUT MOL SCI, V4, P101, DOI 10.1002/wcms.1163; NOCEDAL J, 1980, MATH COMPUT, V35, P773, DOI 10.1090/S0025-5718-1980-0572855-7; NOGUCHI M, 1992, BIOCHEM J, V283, P883, DOI 10.1042/bj2830883; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Peterson RL, 2013, J AM CHEM SOC, V135, P16454, DOI 10.1021/ja4065377; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prigge ST, 2004, SCIENCE, V304, P864, DOI 10.1126/science.1094583; Prigge ST, 1999, NAT STRUCT BIOL, V6, P976; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; RAMER SE, 1988, J AM CHEM SOC, V110, P8526, DOI 10.1021/ja00233a032; Rommel JB, 2011, J AM CHEM SOC, V133, P10195, DOI 10.1021/ja202312d; Rudzka K, 2013, J BIOL INORG CHEM, V18, P223, DOI 10.1007/s00775-012-0967-z; Saldise L, 1996, J HISTOCHEM CYTOCHEM, V44, P3, DOI 10.1177/44.1.8543779; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Sherwood P, 2003, J MOL STRUC-THEOCHEM, V632, P1, DOI 10.1016/S0166-1280(03)00285-9; Smith W, 2002, MOL SIMULAT, V28, P385, DOI 10.1080/08927020290018769; TIAN GC, 1994, BIOCHEMISTRY-US, V33, P226, DOI 10.1021/bi00167a030; University of Karlsruhe and Forschungszentrum Karlsruhe GmbH, 2009, TURBOMOLE VERS 6 0 2; Von Arnim M, 1998, J COMPUT CHEM, V19, P1746, DOI 10.1002/(SICI)1096-987X(19981130)19:15<1746::AID-JCC7>3.0.CO;2-N; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; WARSHEL A, 1972, J AM CHEM SOC, V94, P5612, DOI 10.1021/ja00771a014; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Weigend F, 1998, CHEM PHYS LETT, V294, P143, DOI 10.1016/S0009-2614(98)00862-8; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401	63	24	25	1	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13726	13738		10.1074/jbc.M114.558494	http://dx.doi.org/10.1074/jbc.M114.558494			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24668808	Green Published, hybrid			2022-12-25	WOS:000335984600007
J	Avila, CL; Torres-Bugeau, CM; Barbosa, LRS; Sales, EM; Ouidja, MO; Socias, SB; Celej, MS; Raisman-Vozari, R; Papy-Garcia, D; Itri, R; Chehin, RN				Avila, Cesar L.; Torres-Bugeau, Clarisa M.; Barbosa, Leandro R. S.; Sales, Elisa Morande; Ouidja, Mohand O.; Socias, Sergio B.; Soledad Celej, M.; Raisman-Vozari, Rita; Papy-Garcia, Dulce; Itri, Rosangela; Chehin, Rosana N.			Structural Characterization of Heparin-induced Glyceraldehyde-3-phosphate Dehydrogenase Protofibrils Preventing alpha- Synuclein Oligomeric Species Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-Synuclein; Cell Permeabilization; Molecular Modeling; Parkinson Disease; X-ray Scattering; GAPDH; Protofibril Structure	PROTEIN-PROTEIN INTERACTIONS; PARKINSONS-DISEASE; CROSS-LINKING; GROWTH-FACTOR; FORCE-FIELD; FORMS; FIBRILS; GAPDH; GLYCOSAMINOGLYCANS; PERMEABILIZATION	Background: Although glycosaminoglycan-induced GAPDH prefibrillar species accelerates -synuclein aggregation, its role in toxicity remains unclear. Results: The toxic effect exerted by -synuclein oligomers on cell culture was abolished by GAPDH protofibril, which was identified and structurally characterized. Conclusion: GAPDH protofibrils can efficiently sequester -synuclein toxic oligomers. Significance: GAPDH protofibrils may play an important role in neuronal proteostasis and could open a novel therapeutic strategy for synucleinopathies. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a multifunctional enzyme that has been associated with neurodegenerative diseases. GAPDH colocalizes with -synuclein in amyloid aggregates in post-mortem tissue of patients with sporadic Parkinson disease and promotes the formation of Lewy body-like inclusions in cell culture. In a previous work, we showed that glycosaminoglycan-induced GAPDH prefibrillar species accelerate the conversion of -synuclein to fibrils. However, it remains to be determined whether the interplay among glycosaminoglycans, GAPDH, and -synuclein has a role in pathological states. Here, we demonstrate that the toxic effect exerted by -synuclein oligomers in dopaminergic cell culture is abolished in the presence of GAPDH prefibrillar species. Structural analysis of prefibrillar GAPDH performed by small angle x-ray scattering showed a particle compatible with a protofibril. This protofibril is shaped as a cylinder 22 nm long and a cross-section diameter of 12 nm. Using biocomputational techniques, we obtained the first all-atom model of the GAPDH protofibril, which was validated by cross-linking coupled to mass spectrometry experiments. Because GAPDH can be secreted outside the cell where glycosaminoglycans are present, it seems plausible that GAPDH protofibrils could be assembled in the extracellular space kidnapping -synuclein toxic oligomers. Thus, the role of GAPDH protofibrils in neuronal proteostasis must be considered. The data reported here could open alternative ways in the development of therapeutic strategies against synucleinopathies like Parkinson disease.	[Avila, Cesar L.; Torres-Bugeau, Clarisa M.; Chehin, Rosana N.] CONICET UNT, Inst Super Invest Biol INSIBIO, San Miguel De Tucuman, Argentina; [Avila, Cesar L.; Torres-Bugeau, Clarisa M.; Chehin, Rosana N.] CONICET UNT, Inst Quim Biol Dr Bernabe Bloj, FBQF UNT, San Miguel De Tucuman, Argentina; [Barbosa, Leandro R. S.; Sales, Elisa Morande; Itri, Rosangela] Univ Sao Paulo, Inst Fis, BR-01498 Sao Paulo, Brazil; [Ouidja, Mohand O.; Socias, Sergio B.; Raisman-Vozari, Rita] CNRS, INSERM U1127, UMR 7225, Inst Cerveau & Moelle Epiniere, Paris, France; [Ouidja, Mohand O.; Papy-Garcia, Dulce] Univ Paris Est Creteil, CNRS EAC 7149, Lab Croissance Reparat & Regenerat Tissulaires, F-94000 Creteil, France; [Soledad Celej, M.] Univ Nacl Cordoba, Dept Quim, Ctr Invest Quim Biol Cordoba, CONICET,Fac Ciencias Quim, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade de Sao Paulo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Chehin, RN (corresponding author), CONICET UNT, Inst Super Invest Biol INSIBIO, Chacabuco 461,T4000ILI, San Miguel De Tucuman, Argentina.	rosana@fbqf.unt.edu.ar	Barbosa, L. R. S./AAN-7787-2020; Itri, Rosangela/B-4312-2014; Celej, Maria Soledad/N-5709-2019; Barbosa, Leandro Ramos Souza/GRJ-9680-2022; Barbosa, Leandro Ramos Souza/E-6577-2012	Celej, Maria Soledad/0000-0002-7831-9244; Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Itri, Rosangela/0000-0001-9311-0804; Morande Sales, Elisa/0000-0001-8311-8562; Chehin, Rosana/0000-0003-3504-7952; Avila, Cesar Luis/0000-0003-0187-7915	Florencio Fiorini Foundation [A12S02]; CIUNT [D439-1]; ANPCyT [PICT-2011-0761]; Conselho Nacional de Pesquisa e Desenvolvimento	Florencio Fiorini Foundation; CIUNT; ANPCyT(ANPCyT); Conselho Nacional de Pesquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported in part by grants from Florencio Fiorini Foundation; Ecos-Sud Grant A12S02, and CIUNT Grant D439-1.; Supported by ANPCyT Grant PICT-2011-0761.; Supported by research fellowships from Conselho Nacional de Pesquisa e Desenvolvimento.	Allen M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.08.002; ARRONDO JLR, 1994, BIOCHEMISTRY-US, V33, P11650, DOI 10.1021/bi00204a029; Barbosa LRS, 2010, BIOPHYS J, V98, P147, DOI 10.1016/j.bpj.2009.09.056; BARBOSA LRS, 2013, PROTEINS SOLUTION IN, P49; BLACK SD, 1991, ANAL BIOCHEM, V193, P72, DOI 10.1016/0003-2697(91)90045-U; Butterfield DA, 2010, J ALZHEIMERS DIS, V20, P369, DOI 10.3233/JAD-2010-1375; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Carlile GW, 2000, MOL PHARMACOL, V57, P2; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chai YJ, 2013, FEBS LETT, V587, P452, DOI 10.1016/j.febslet.2013.01.008; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Cowan-Jacob SW, 2003, ACTA CRYSTALLOGR D, V59, P2218, DOI 10.1107/S0907444903020493; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Diaz-Nido J, 2002, PEPTIDES, V23, P1323, DOI 10.1016/S0196-9781(02)00068-2; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Engel M, 1998, J BIOL CHEM, V273, P20058, DOI 10.1074/jbc.273.32.20058; Fancy DA, 2000, CHEM BIOL, V7, P697, DOI 10.1016/S1074-5521(00)00020-X; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; FINER EG, 1972, BIOCHIM BIOPHYS ACTA, V260, P49, DOI 10.1016/0005-2760(72)90073-2; FOLCH J, 1957, J BIOL CHEM, V226, P497; Giehm L, 2011, P NATL ACAD SCI USA, V108, P3246, DOI 10.1073/pnas.1013225108; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kaylor J, 2005, J MOL BIOL, V353, P357, DOI 10.1016/j.jmb.2005.08.046; KENDALL DA, 1982, J BIOL CHEM, V257, P3892; Kim HY, 2009, J AM CHEM SOC, V131, P17482, DOI 10.1021/ja9077599; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; KUMAGAI H, 1983, J BIOCHEM-TOKYO, V93, P1259, DOI 10.1093/oxfordjournals.jbchem.a134260; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee SJ, 2008, J MOL NEUROSCI, V34, P17, DOI 10.1007/s12031-007-0012-9; Leverenz JB, 2007, BRAIN PATHOL, V17, P139, DOI 10.1111/j.1750-3639.2007.00048.x; Lin H, 1999, BIOCHEMISTRY-US, V38, P11189, DOI 10.1021/bi982997c; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Huynh MB, 2012, J BIOL CHEM, V287, P11363, DOI 10.1074/jbc.M111.335901; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; MORERO RD, 1985, BIOCHEMISTRY-US, V24, P1904, DOI 10.1021/bi00329a015; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; Oliveira CLP, 2009, J MOL BIOL, V387, P147, DOI 10.1016/j.jmb.2009.01.020; Ortore MG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061904; Ortore MG, 2009, J R SOC INTERFACE, V6, pS619, DOI 10.1098/rsif.2009.0163.focus; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Rzepiela AJ, 2010, J COMPUT CHEM, V31, P1333, DOI 10.1002/jcc.21415; Sacino AN, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt151; Schneidman-Duhovny D, 2005, PROTEINS, V60, P224, DOI 10.1002/prot.20562; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spinozzi F, 2007, J PHYS CHEM B, V111, P3822, DOI 10.1021/jp063427m; Steiner JA, 2011, CELL DEATH DIFFER, V18, P1425, DOI 10.1038/cdd.2011.53; Torres-Bugeau CM, 2012, J BIOL CHEM, V287, P2398, DOI 10.1074/jbc.M111.303503; Tsuchiya K, 2005, EUR J NEUROSCI, V21, P317, DOI 10.1111/j.1460-9568.2005.03870.x; van Rooijen BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014292; Vendruscolo M, 1999, PHYS REV LETT, V82, P656, DOI 10.1103/PhysRevLett.82.656; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Walker, 1955, SMALL ANGLE SCATTERI, P7; WEBER K, 1969, J BIOL CHEM, V244, P4406; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Xu KY, 1998, J HISTOCHEM CYTOCHEM, V46, P419, DOI 10.1177/002215549804600401; Yang WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064389; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	70	26	26	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13838	13850		10.1074/jbc.M113.544288	http://dx.doi.org/10.1074/jbc.M113.544288			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24671416	Green Published, hybrid			2022-12-25	WOS:000335984600017
J	Han, HJ; Kursula, P				Han, Huijong; Kursula, Petri			Periaxin and AHNAK Nucleoprotein 2 Form Intertwined Homodimers through Domain Swapping	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Myelin; Protein Domains; Protein Structure; Protein-Protein Interactions; X-ray Scattering; PDZ Domain; Dimerization; Domain Swapping	MYELINATING SCHWANN-CELLS; PDZ DOMAIN; BIOLOGICAL MACROMOLECULES; RESOLUTION STRUCTURE; SOLUTION SCATTERING; CRYSTAL-STRUCTURE; COMPLEX REVEALS; PROTEIN COMPLEX; BINDING; RECOGNITION	Background: Periaxin and AHNAK nucleoprotein 2 contain a poorly conserved PDZ domain. Results: The crystal structures for the PDZ domains were determined. Conclusion: Both PDZ domains form intertwined domain-swapped homodimers. Significance: The structures have implications for the organization of complexes involving the periaxin/AHNAK family. Periaxin (PRX) is an abundant protein in the peripheral nervous system, with an important role in myelination. PRX participates in large molecular complexes, most likely through the interactions of its N-terminal PSD-95/Discs-large/ZO-1 (PDZ)-like domain. We present the crystal structures of the PDZ-like domains from PRX and its homologue AHNAK nucleoprotein 2 (AHNAK2). The unique intertwined, domain-swapped dimers provide a structural basis for the homodimerization of both proteins. The core of the homodimer is formed by a 6-stranded antiparallel sheet, with every other strand from a different chain. The AHNAK2 PDZ domain structure contains a bound class III ligand peptide. The binding pocket is preformed, and the peptide-PDZ interactions have unique aspects, including two salt bridges and weak recognition of the peptide C terminus. Tight homodimerization may be central to the scaffolding functions of PRX and AHNAK2 in molecular complexes linking the extracellular matrix to the cytoskeletal network.	[Han, Huijong; Kursula, Petri] Univ Oulu, Fac Biochem & Mol Med, Oulu 90014, Finland; [Han, Huijong; Kursula, Petri] Univ Oulu, Bioctr Oulu, Oulu 90014, Finland; [Han, Huijong; Kursula, Petri] German Elect Synchrotron DESY, D-22607 Hamburg, Germany; [Kursula, Petri] Univ Hamburg, Dept Chem, D-22607 Hamburg, Germany	University of Oulu; University of Oulu; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg	Kursula, P (corresponding author), Univ Oulu, Fac Biochem & Mol Med, POB 3000, Oulu 90014, Finland.	petri.kursula@oulu.fi	Kursula, Petri/AAF-4563-2020	Kursula, Petri/0000-0001-8529-3751; Han, Huijong/0000-0002-1197-3014	Hamburg Research and Science Foundation (Germany); Academy of Finland; Sigrid Juselius Foundation (Finland)	Hamburg Research and Science Foundation (Germany); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation (Finland)(Sigrid Juselius Foundation)	This work was supported by grants from the Hamburg Research and Science Foundation (Germany), the Academy of Finland, and the Sigrid Juselius Foundation (Finland) (to P. K.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Albright RA, 1996, BIOCHEMISTRY-US, V35, P735, DOI 10.1021/bi951958n; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; de Morree A, 2012, FASEB J, V26, P93, DOI 10.1096/fj.11-187971; De Seranno S, 2006, J BIOL CHEM, V281, P35030, DOI 10.1074/jbc.M606545200; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; Dytrych L, 1998, J BIOL CHEM, V273, P5794, DOI 10.1074/jbc.273.10.5794; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fanning AS, 2007, J BIOL CHEM, V282, P37710, DOI 10.1074/jbc.M707255200; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gentil BJ, 2001, J BIOL CHEM, V276, P23253, DOI 10.1074/jbc.M010655200; Gianni S, 2007, P NATL ACAD SCI USA, V104, P128, DOI 10.1073/pnas.0602770104; Gillespie CS, 2000, NEURON, V26, P523, DOI 10.1016/S0896-6273(00)81184-8; GILLESPIE CS, 1994, NEURON, V12, P497, DOI 10.1016/0896-6273(94)90208-9; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GREEN SM, 1995, NAT STRUCT BIOL, V2, P746, DOI 10.1038/nsb0995-746; Guilbot A, 2001, HUM MOL GENET, V10, P415, DOI 10.1093/hmg/10.4.415; Han HJ, 2013, ACTA CRYSTALLOGR F, V69, P804, DOI 10.1107/S1744309113016266; Han HJ, 2013, BIOFACTORS, V39, P233, DOI 10.1002/biof.1076; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Huang DB, 2005, STRUCTURE, V13, P1365, DOI 10.1016/j.str.2005.06.018; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Im YJ, 2003, J BIOL CHEM, V278, P48099, DOI 10.1074/jbc.M306919200; Im YJ, 2003, J BIOL CHEM, V278, P8501, DOI 10.1074/jbc.M212263200; Ivarsson Y, 2012, FEBS LETT, V586, P2638, DOI 10.1016/j.febslet.2012.04.015; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalyoncu S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-357; Komuro A, 2004, P NATL ACAD SCI USA, V101, P4053, DOI 10.1073/pnas.0308619101; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kursula P, 2008, AMINO ACIDS, V34, P175, DOI 10.1007/s00726-006-0479-7; Kursula P, 2001, INT J MOL MED, V8, P475; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Maddala R, 2011, DEV BIOL, V357, P179, DOI 10.1016/j.ydbio.2011.06.036; Marg A, 2010, BIOCHEM BIOPH RES CO, V401, P143, DOI 10.1016/j.bbrc.2010.09.030; Marsh JA, 2013, CELL, V153, P461, DOI 10.1016/j.cell.2013.02.044; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nomme J, 2011, J BIOL CHEM, V286, P43352, DOI 10.1074/jbc.M111.304089; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Patzig J, 2011, J NEUROSCI, V31, P16369, DOI 10.1523/JNEUROSCI.4016-11.2011; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Scherer SS, 1995, DEVELOPMENT, V121, P4265; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sherman DL, 2001, NEURON, V30, P677, DOI 10.1016/S0896-6273(01)00327-0; SHTIVELMAN E, 1992, P NATL ACAD SCI USA, V89, P5472, DOI 10.1073/pnas.89.12.5472; Straub BK, 2003, J CELL SCI, V116, P4985, DOI 10.1242/jcs.00815; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takashima H, 2002, ANN NEUROL, V51, P709, DOI 10.1002/ana.10213; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Zacharias U, 2011, J MUSCLE RES CELL M, V32, P271, DOI 10.1007/s10974-011-9271-8; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	61	23	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14121	14131		10.1074/jbc.M114.554816	http://dx.doi.org/10.1074/jbc.M114.554816			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24675079	Green Published, hybrid			2022-12-25	WOS:000335984600040
J	Vande Voorde, J; Sabuncuoglu, S; Noppen, S; Hofer, A; Ranjbarian, F; Fieuws, S; Balzarini, J; Liekens, S				Vande Voorde, Johan; Sabuncuoglu, Suna; Noppen, Sam; Hofer, Anders; Ranjbarian, Farahnaz; Fieuws, Steffen; Balzarini, Jan; Liekens, Sandra			Nucleoside-catabolizing Enzymes in Mycoplasma-infected Tumor Cell Cultures Compromise the Cytostatic Activity of the Anticancer Drug Gemcitabine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Cancer Therapy; Nucleoside Nucleotide Analogs; Nucleoside Nucleotide Metabolism; Phosphorylase; Mycoplasma hyorhinis; Cytidine Deaminase; Gemcitabine; Mycoplasma; Pyrimidine Nucleoside Phosphorylase	SENSITIVE PCR-ELISA; CYTIDINE DEAMINASE; PROSTATE-CANCER; IN-VITRO; THYMIDINE PHOSPHORYLASE; CYTOSINE-ARABINOSIDE; HYORHINIS INFECTION; CONSERVED DNA; LUNG-CANCER; INHIBITION	Background: Gemcitabine is used to treat solid tumors. Some mycoplasmas preferentially colonize tumors in patients. Results: Mycoplasma-encoded cytidine deaminase and pyrimidine nucleoside phosphorylase compromise the cytostatic/antitumor activity of gemcitabine in mycoplasma-infected tumor cell cultures and xenografts in mice. Conclusion: Tumor-associated mycoplasmas may decrease the therapeutic efficiency of gemcitabine. Significance: Current treatment of mycoplasma-infected tumors with gemcitabine may be suboptimal. The intracellular metabolism and cytostatic activity of the anticancer drug gemcitabine (2,2-difluoro-2-deoxycytidine; dFdC) was severely compromised in Mycoplasma hyorhinis-infected tumor cell cultures. Pronounced deamination of dFdC to its less cytostatic metabolite 2,2-difluoro-2-deoxyuridine was observed, both in cell extracts and spent culture medium (i.e. tumor cell-free but mycoplasma-containing) of mycoplasma-infected tumor cells. This indicates that the decreased antiproliferative activity of dFdC in such cells is attributed to a mycoplasma cytidine deaminase causing rapid drug catabolism. Indeed, the cytostatic activity of gemcitabine could be restored by the co-administration of tetrahydrouridine (a potent cytidine deaminase inhibitor). Additionally, mycoplasma-derived pyrimidine nucleoside phosphorylase (PyNP) activity indirectly potentiated deamination of dFdC: the natural pyrimidine nucleosides uridine, 2-deoxyuridine and thymidine inhibited mycoplasma-associated dFdC deamination but were efficiently catabolized (removed) by mycoplasma PyNP. The markedly lower anabolism and related cytostatic activity of dFdC in mycoplasma-infected tumor cells was therefore also (partially) restored by a specific TP/PyNP inhibitor (TPI), or by exogenous thymidine. Consequently, no effect on the cytostatic activity of dFdC was observed in tumor cell cultures infected with a PyNP-deficient Mycoplasma pneumoniae strain. Because it has been reported that some commensal mycoplasma species (including M. hyorhinis) preferentially colonize tumor tissue in cancer patients, our findings suggest that the presence of mycoplasmas in the tumor microenvironment could be a limiting factor for the anticancer efficiency of dFdC-based chemotherapy. Accordingly, a significantly decreased antitumor effect of dFdC was observed in mice bearing M. hyorhinis-infected murine mammary FM3A tumors compared with uninfected tumors.	[Vande Voorde, Johan; Sabuncuoglu, Suna; Noppen, Sam; Balzarini, Jan; Liekens, Sandra] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; [Hofer, Anders; Ranjbarian, Farahnaz] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Fieuws, Steffen] KU Leuven Univ Leuven, B-3000 Louvain, Belgium; [Fieuws, Steffen] Univ Hasselt, B-3000 Louvain, Belgium	KU Leuven; Umea University; KU Leuven; Hasselt University	Balzarini, J (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Minderbroedersstr 10,Blok X Bus 1030, B-3000 Louvain, Belgium.	jan.balzarini@rega.kuleuven.be	Noppen, Sam/F-8681-2018	Noppen, Sam/0000-0002-2831-5042; Vande Voorde, Johan/0000-0002-7686-0926; Hofer, Anders/0000-0003-2890-2957	Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen [G.0486.08]; KU Leuven [GOA 10/014]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); KU Leuven (BOF-F)	Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen(FWO); KU Leuven(KU Leuven); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KU Leuven (BOF-F)(KU Leuven)	This work was supported in part by "Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen" Krediet number G.0486.08 and KU Leuven Grant GOA 10/014.; Supported by a Ph.D. grant from the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen).; Supported by a postdoctoral grant of the KU Leuven (BOF-F).	Amit M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.27231; Apostolou P, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-137; AYUSAWA D, 1980, SOMAT CELL GENET, V6, P261, DOI 10.1007/BF01538800; BALZARINI J, 1984, BIOCHIM BIOPHYS ACTA, V785, P36, DOI 10.1016/0167-4838(84)90231-0; Bardenheuer W, 2005, LEUKEMIA, V19, P2281, DOI 10.1038/sj.leu.2403977; Barykova YA, 2011, ONCOTARGET, V2, P289; Bergman A. M., 2006, DEOXYNUCLEOSIDE ANAL, P225; Bronckaers A, 2008, BIOCHEM PHARMACOL, V76, P188, DOI 10.1016/j.bcp.2008.04.019; Chan PJ, 1996, GYNECOL ONCOL, V63, P258, DOI 10.1006/gyno.1996.0316; Cummins J, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-11; Erturhan SM, 2013, INT UROL NEPHROL, V45, P33, DOI 10.1007/s11255-012-0299-5; Essig A, 2000, INT J MED MICROBIOL, V290, P289; Finch Lloyd R., 1992, P211; Fukushima M, 2000, BIOCHEM PHARMACOL, V59, P1227, DOI 10.1016/S0006-2952(00)00253-7; Galmarini CM, 2002, LANCET ONCOL, V3, P415, DOI 10.1016/S1470-2045(02)00788-X; Goodison S., 2013, GENOME ANNOUNC, V1, P1; HEINEMANN V, 1990, MOL PHARMACOL, V38, P567; HEINEMANN V, 1988, CANCER RES, V48, P4024; HEINEMANN V, 1995, SEMIN ONCOL, V22, P11; HIRSCHBERG L, 1989, HYBRIDOMA, V8, P249, DOI 10.1089/hyb.1989.8.249; Huang GC, 2012, J BIOL CHEM, V287, P23196, DOI 10.1074/jbc.M112.351940; HUANG P, 1991, CANCER RES, V51, P6110; Huang S, 2001, WORLD J GASTROENTERO, V7, P266; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; JAKWAY JP, 1984, J IMMUNOL METHODS, V67, P337, DOI 10.1016/0022-1759(84)90473-3; Kidder M, 1998, GYNECOL ONCOL, V71, P254, DOI 10.1006/gyno.1998.5177; Krause Duncan C., 1992, P417; KREIS W, 1991, LEUKEMIA, V5, P991; Liekens S, 2009, LANCET ONCOL, V10, P628, DOI 10.1016/S1470-2045(09)70037-3; Mager DL, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-14; MCELWAIN MC, 1988, INT J SYST BACTERIOL, V38, P417, DOI 10.1099/00207713-38-4-417; MERKENSCHLAGER M, 1988, IMMUNOLOGY, V63, P125; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; NAKANO N, 1966, TOHOKU J EXP MED, V88, P69, DOI 10.1620/tjem.88.69; NEALE GAM, 1984, J BACTERIOL, V158, P943, DOI 10.1128/JB.158.3.943-947.1984; Neff T, 1996, EXP HEMATOL, V24, P1340; Parker WB, 2009, CHEM REV, V109, P2880, DOI 10.1021/cr900028p; PATTERSON AV, 1995, BRIT J CANCER, V72, P669, DOI 10.1038/bjc.1995.392; Pehlivan M, 2005, UROLOGY, V65, P411, DOI 10.1016/j.urology.2004.10.015; Pehlivan M, 2004, LUNG CANCER, V45, P129, DOI 10.1016/j.lungcan.2004.01.007; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; ROSS DD, 1994, BIOCHEM PHARMACOL, V48, P1619, DOI 10.1016/0006-2952(94)90207-0; SINIGAGLIA F, 1985, EUR J IMMUNOL, V15, P692, DOI 10.1002/eji.1830150710; THAM TN, 1993, J BACTERIOL, V175, P5281, DOI 10.1128/JB.175.16.5281-5285.1993; Urbanek C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-233; Vande Voorde J, 2012, BIOCHEM J, V445, P113; Vande Voorde J, 2013, MOL PHARMACOL, V84, P865, DOI 10.1124/mol.113.088625; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Wang L, 2014, NUCLEOSIDES IN PRESS; Weizman N, 2014, ONCOGENE, V33, P3812, DOI 10.1038/onc.2013.357; XU YZ, 1992, BIOCHEM PHARMACOL, V44, P1819; Yang H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-132; Yoshida T, 2010, DRUG METAB DISPOS, V38, P1814, DOI 10.1124/dmd.110.034397; Yoshino T, 2012, LANCET ONCOL, V13, P993, DOI 10.1016/S1470-2045(12)70345-5	56	74	75	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13054	13065		10.1074/jbc.M114.558924	http://dx.doi.org/10.1074/jbc.M114.558924			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24668817	Green Published, hybrid			2022-12-25	WOS:000335522800009
J	Shimizu, F; Tasaki, A; Sano, Y; Ju, MH; Nishihara, H; Oishi, M; Koga, M; Kawai, M; Kanda, T				Shimizu, Fumitaka; Tasaki, Ayako; Sano, Yasuteru; Ju, Mihua; Nishihara, Hideaki; Oishi, Mariko; Koga, Michiaki; Kawai, Motoharu; Kanda, Takashi			Sera from Remitting and Secondary Progressive Multiple Sclerosis Patients Disrupt the Blood-Brain Barrier	PLOS ONE			English	Article							CLINICAL-COURSE; WHITE-MATTER; LESIONS; MATRIX-METALLOPROTEINASE-9; NATALIZUMAB; EXPRESSION; PHASES; IMMUNE	Background: Pathological destruction of blood-brain barrier (BBB) has been thought to be the initial key event in the process of developing multiple sclerosis (MS). The purpose of the present study was to clarify the possible molecular mechanisms responsible for the malfunction of BBB by sera from relapse-remitting MS (RRMS) and secondary progressive MS (SPMS) patients. Methods: We evaluated the effects of sera from the patients in the relapse phase of RRMS (RRMS-R), stable phase of RRMS (RRMS-S) and SPMS on the expression of tight junction proteins and vascular cell adhesion protein-1 (VCAM-1), and on the transendothelial electrical resistance (TEER) in human brain microvascular endothelial cells (BMECs). Results: Sera from the RRMS-R or SPMS patients decreased the claudin-5 protein expression and the TEER in BMECs. In RRMS-R, this effect was restored after adding an MMP inhibitor, and the MMP-2/9 secretion by BMECs was significantly increased after the application of patients' sera. In SPMS, the immunoglobulin G (IgG) purified from patients' sera also decreased the claudin-5 protein expression and the TEER in BMECs. The sera and purified IgG from all MS patients increased the VCAM-1 protein expression in BMECs. Conclusions: The up-regulation of autocrine MMP-2/9 by BMECs after exposure to sera from RRMS-R patients or the autoantibodies against BMECs from SPMS patients can compromise the BBB. Both RRMS-S and SPMS sera increased the VCAM-1 expression in the BBB, thus indicating that targeting the VCAM-1 in the BBB could represent a possible therapeutic strategy for even the stable phase of MS and SPMS.	[Shimizu, Fumitaka; Tasaki, Ayako; Sano, Yasuteru; Ju, Mihua; Nishihara, Hideaki; Oishi, Mariko; Koga, Michiaki; Kawai, Motoharu; Kanda, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi 755, Japan	Yamaguchi University	Kanda, T (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi 755, Japan.	tkanda@yamaguchi-u.ac.jp	Koga, Michiaki/L-4825-2019; Nishihara, Hideaki/AAJ-7563-2021	Koga, Michiaki/0000-0002-1356-955X; Nishihara, Hideaki/0000-0002-2990-835X	Japan Society for the Promotion of Science, Tokyo, Japan [24790886, 22790821, 23659457]; Ministry of Health, Labor and Welfare of Japan [K2002528]; Yamaguchi University Hospital	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Yamaguchi University Hospital	This work was supported in part by research grants (Nos. 24790886, Nos. 22790821, and Nos. 23659457) from the Japan Society for the Promotion of Science, Tokyo, Japan, by a Health and Labor Sciences Research Grant for research on intractable diseases (Neuroimmunological Disease Research Committee) from the Ministry of Health, Labor and Welfare of Japan (K2002528) and also by a Translational Research Promotion Grant from Yamaguchi University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Anderson VM, 2006, J MAGN RESON IMAGING, V23, P605, DOI 10.1002/jmri.20550; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Benesova Y, 2009, MULT SCLER J, V15, P316, DOI 10.1177/1352458508099482; Bradl M, 2009, SEMIN IMMUNOPATHOL, V31, P455, DOI 10.1007/s00281-009-0182-3; BROSNAN CF, 1995, NEUROLOGY, V45, pS16, DOI 10.1212/WNL.45.6_Suppl_6.S16; Cadavid D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053297; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Cotton F, 2003, NEUROLOGY, V60, P640, DOI 10.1212/01.WNL.0000046587.83503.1E; Engelhardt B, 2010, CLIN EXP NEUROIMMUNO, V1, P79, DOI DOI 10.1111/J.1759-1961.2010.009.X; Engelhardt B, 2008, NEURODEGENER DIS, V5, P16, DOI 10.1159/000109933; GIJBELS K, 1994, J CLIN INVEST, V94, P2177, DOI 10.1172/JCI117578; Hochmeister S, 2006, J NEUROPATH EXP NEUR, V65, P855, DOI 10.1097/01.jnen.0000235119.52311.16; Kirk J, 2003, J PATHOL, V201, P319, DOI 10.1002/path.1434; Larochelle C, 2011, FEBS LETT, V585, P3770, DOI 10.1016/j.febslet.2011.04.066; Lassmann H, 2007, CURR NEUROL NEUROSCI, V7, P239, DOI 10.1007/s11910-007-0036-0; Leech S, 2007, NEUROPATH APPL NEURO, V33, P86, DOI 10.1111/j.1365-2990.2006.00781.x; Leppert D, 1998, BRAIN, V121, P2327, DOI 10.1093/brain/121.12.2327; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Miller DH, 2007, NEUROLOGY, V68, P1390, DOI 10.1212/01.wnl.0000260064.77700.fd; Minagar A, 2003, MULT SCLER, V9, P235, DOI 10.1191/1352458503ms916oa; Murphy G, 1997, MATRIX BIOL, V15, P511, DOI 10.1016/S0945-053X(97)90025-1; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Plumb J, 2002, BRAIN PATHOL, V12, P154; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Sano Y, 2010, J CELL PHYSIOL, V225, P519, DOI 10.1002/jcp.22232; Shimizu F, 2013, ADV NEUROBIOL, V7, P157, DOI 10.1007/978-1-4614-8313-7_10; Shimizu F, 2012, J NEUROL NEUROSUR PS, V83, P288, DOI 10.1136/jnnp-2011-300434; Su JJ, 2006, J NEUROL SCI, V243, P21, DOI 10.1016/j.jns.2005.11.006; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Zamvil SS, 2003, NEURON, V38, P685, DOI 10.1016/S0896-6273(03)00326-X; Zivadinov R, 2007, INT REV NEUROBIOL, V79, P449, DOI 10.1016/S0074-7742(07)79020-7; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	37	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e92872	10.1371/journal.pone.0092872	http://dx.doi.org/10.1371/journal.pone.0092872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686948	Green Submitted, Green Published, gold			2022-12-25	WOS:000340842300003
J	Kiuru, A; Kamarainen, M; Heinavaara, S; Pylkas, K; Chapman, K; Koivistoinen, A; Parviainen, T; Winqvist, R; Kadhim, M; Launonen, V; Lindholm, C				Kiuru, Anne; Kamarainen, Meerit; Heinavaara, Sirpa; Pylkas, Katri; Chapman, Kim; Koivistoinen, Armi; Parviainen, Teuvo; Winqvist, Robert; Kadhim, Munira; Launonen, Virpi; Lindholm, Carita			Assessment of Targeted and Non-Targeted Responses in Cells Deficient in ATM Function following Exposure to Low and High Dose X-Rays	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA HETEROZYGOTES; NIJMEGEN BREAKAGE SYNDROME; NORMAL HUMAN FIBROBLASTS; IONIZING-RADIATION; BREAST-CANCER; SENSITIVE INDIVIDUALS; LET RADIATION; IN-VITRO; RADIOSENSITIVITY; DAMAGE	Radiation sensitivity at low and high dose exposure to X-rays was investigated by means of chromosomal aberration (CA) analysis in heterozygous ATM mutation carrier and A-T patient (biallelic ATM mutation) lymphoblastoid cell lines (LCLs). Targeted and non-targeted responses to acutely delivered irradiation were examined by applying a co-culture system that enables study of both directly irradiated cells and medium-mediated bystander effects in the same experimental setting. No indication of radiation hypersensitivity was observed at doses of 0.01 Gy or 0.1 Gy for the ATM mutation carrier LCL. The A-T patient cells also did not show low-dose response. There was significant increase in unstable CA yields for both ATM mutation carrier and A-T LCLs at 1 and 2 Gy, the A-T cells displaying more distinct dose dependency. Both chromosome and chromatid type aberrations were induced at an increased rate in the irradiated A-T cells, whereas for ATM carrier cells, only unstable chromosomal aberrations were increased above the level observed in the wild type cell line. No bystander effect could be demonstrated in any of the cell lines or doses applied. Characteristics typical for the A-T cell line were detected, i.e., high baseline frequency of CA that increased with dose. In addition, dose-dependent loss of cell viability was observed. In conclusion, CA analysis did not demonstrate low-dose (<= 100 mGy) radiosensitivity in ATM mutation carrier cells or A-T patient cells. However, both cell lines showed increased radiosensitivity at high dose exposure.	[Kiuru, Anne; Kamarainen, Meerit; Heinavaara, Sirpa; Koivistoinen, Armi; Parviainen, Teuvo; Launonen, Virpi; Lindholm, Carita] STUK Radiat & Nucl Safety Author, Helsinki, Finland; [Pylkas, Katri; Winqvist, Robert] Univ Oulu, Dept Clin Chem, Lab Canc Genet & Tumor Biol, Oulu Univ Hosp, Oulu, Finland; [Pylkas, Katri; Winqvist, Robert] Univ Oulu, Bioctr Oulu, Oulu Univ Hosp, Oulu, Finland; [Chapman, Kim; Kadhim, Munira] Oxford Brookes Univ, Oxford OX3 0BP, England	Radiation & Nuclear Safety Authority (STUK); University of Oulu; University of Oulu; Oxford Brookes University	Lindholm, C (corresponding author), STUK Radiat & Nucl Safety Author, Helsinki, Finland.	carita.lindholm@stuk.fi		Heinavaara, Sirpa/0000-0002-8308-9922; Pylkas, Katri/0000-0002-2449-0521; Winqvist, Robert/0000-0003-0932-9104	EU FP6 [NOTE IP 036465 (FI6R)]; Cancer Foundation Finland sr [130168] Funding Source: researchfish	EU FP6(European Commission); Cancer Foundation Finland sr	This work was financially supported by the EU FP6 (NOTE IP 036465 (FI6R), and the institutes where the work has been performed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Baskar R, 2007, INT J RADIAT BIOL, V83, P551, DOI 10.1080/09553000701384499; Burdak-Rothkamm S, 2008, CANCER RES, V68, P7059, DOI 10.1158/0008-5472.CAN-08-0545; Dauer LT, 2010, RADIAT PROT DOSIM, V140, P103, DOI 10.1093/rpd/ncq141; George KA, 2009, RADIAT RES, V171, P752, DOI 10.1667/RR1680.1; Groesser T, 2008, RADIAT RES, V170, P794, DOI 10.1667/RR1458.1; Guertler A, 2011, RADIAT PROT DOSIM, V143, P487, DOI 10.1093/rpd/ncq515; Hada M, 2011, MUTAT RES-FUND MOL M, V716, P76, DOI 10.1016/j.mrfmmm.2011.08.006; HIGURASHI M, 1973, CANCER-AM CANCER SOC, V32, P380, DOI 10.1002/1097-0142(197308)32:2<380::AID-CNCR2820320214>3.0.CO;2-2; Jeggo P, 2010, RADIAT RES, V174, P825, DOI 10.1667/RR1844.1; Kadhim M, 2013, MUTAT RES-REV MUTAT, V752, P84, DOI 10.1016/j.mrrev.2012.12.001; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Morgan WF, 2012, RADIAT RES, V178, pAV223, DOI 10.1667/RRAV19.1; Neubauer S, 2002, RADIAT RES, V157, P312, DOI 10.1667/0033-7587(2002)157[0312:ROATAN]2.0.CO;2; PANDITA TK, 1992, RADIAT RES, V131, P214, DOI 10.2307/3578443; Pincheira J, 2001, MUTAGENESIS, V16, P419, DOI 10.1093/mutage/16.5.419; Prasad KN, 2004, EXP BIOL MED, V229, P378, DOI 10.1177/153537020422900505; Pylkas K, 2007, CARCINOGENESIS, V28, P1040, DOI 10.1093/carcin/bgl237; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Scientific Committee on the Effects of Atomic Radiation UNSCEAR, 2006, EFF ION RAD, V1; Sowa MB, 2011, RADIAT PROT DOSIM, V143, P311, DOI 10.1093/rpd/ncq487; Sowa MB, 2010, INT J RADIAT BIOL, V86, P102, DOI 10.3109/09553000903419957; Stumm M, 2001, CYTOGENET CELL GENET, V92, P186, DOI 10.1159/000056900; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; Taylor AMR, 2005, J CLIN PATHOL, V58, P1009, DOI 10.1136/jcp.2005.026062; WAGHRAY M, 1990, HUM GENET, V84, P532; WEEKS DE, 1991, RADIAT RES, V128, P90, DOI 10.2307/3578071; WIENCKE JK, 1992, CANCER CAUSE CONTROL, V3, P237, DOI 10.1007/BF00124257; Wright EG, 2010, MUTAT RES-FUND MOL M, V687, P28, DOI 10.1016/j.mrfmmm.2010.01.014; Yang H, 2007, Radiats Biol Radioecol, V47, P302; Yang HY, 2005, ONCOGENE, V24, P2096, DOI 10.1038/sj.onc.1208439	31	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93211	10.1371/journal.pone.0093211	http://dx.doi.org/10.1371/journal.pone.0093211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681528	Green Published, Green Submitted, gold			2022-12-25	WOS:000333678100032
J	Kuo, YH; Lu, SN; Chen, CH; Chang, KC; Hung, CH; Tai, WC; Tsai, MC; Tseng, PL; Hu, TH; Wang, JH				Kuo, Yuan-Hung; Lu, Sheng-Nan; Chen, Chien-Hung; Chang, Kuo-Chin; Hung, Chao-Hung; Tai, Wei-Chen; Tsai, Ming-Chao; Tseng, Po-Lin; Hu, Tsung-Hui; Wang, Jing-Houng			The Changes of Liver Stiffness and Its Associated Factors for Chronic Hepatitis B Patients with Entecavir Therapy	PLOS ONE			English	Article							TRANSIENT ELASTOGRAPHY; HEPATOCELLULAR-CARCINOMA; ANTIVIRAL THERAPY; DIABETES-MELLITUS; NATURAL-HISTORY; VIRUS INFECTION; FIBROSIS; BIOPSY; MECHANISMS; LAMIVUDINE	Liver stiffness measurement (LSM) using transient elastography has been proposed to assess liver fibrosis well in various liver diseases. This study was to determine the changes of LSM and its associated factors for chronic hepatitis B (CHB) patients undergoing Entecavir therapy. Consecutive CHB patients underwent Entecavir therapy with two LSMs were enrolled. Patients with aspartate transaminase (AST) and/or alanine transaminase >= 200 IU/L were excluded. The retrospective study enrolled 233 patients including 132 without cirrhosis (group 1) and 101 with cirrhosis (group 2). The mean values of initial liver stiffness were 7.9 and 16.6 kPa for patients in group 1 and group 2, respectively (p<0.001). In addition to the decline of transaminase levels, there was significant reduction of liver stiffness value in a mean interval of 52.8 and 61.9 weeks between the two LSMs for patients in group 1 and 2, respectively (p<0.001). Multivariate analysis showed that higher initial LSM value and presence of hepatitis B e-antigen were associated with a greater decline of LSM value, whereas follow-up AST >= 40 IU/L with increased LSM value for group 1 patients. For group 2 patients, longer interval between the two LSMs, higher initial LSM value and AST >= 40 IU/L were associated with a greater decline of LSM value, whereas presence of diabetes mellitus (DM) contributed to increased LSM value. In conclusion, CHB patients improved their LSM values after Entecavir therapy. Higher initial LSM value contributed to greater LSM reduction. However, in cirrhotic patients, DM was associated with an increased LSM value after therapy.	[Wang, Jing-Houng] Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Wang, JH (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.	wajing@cgmh.org.tw	Tsai, Ming Chao/ABA-9806-2020	, Ming-Chao/0000-0002-3613-2051	Chang Gung Memorial Hospital; National Council of Science, Taiwan	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Council of Science, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by research grants from Chang Gung Memorial Hospital and the National Council of Science, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arase Y, 2013, HEPATOLOGY, V57, P964, DOI 10.1002/hep.26087; Benvegnu L, 2004, GUT, V53, P744, DOI 10.1136/gut.2003.020263; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Hung CH, 2011, EXPERT REV ANTI-INFE, V9, P525, DOI [10.1586/eri.11.33, 10.1586/ERI.11.33]; Corpechot C, 2006, HEPATOLOGY, V43, P1118, DOI 10.1002/hep.21151; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Fung J, 2010, HEPATOL INT, V4, P716, DOI 10.1007/s12072-010-9189-z; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gao C, 2010, WORLD J GASTROENTERO, V16, P4467, DOI 10.3748/wjg.v16.i35.4467; Hung CH, 2003, J GASTROENTEROL, V38, P153, DOI 10.1007/s005350300025; Hung CH, 2011, INT J CANCER, V128, P2344, DOI 10.1002/ijc.25585; Ko WH, 2012, HEPATOL RES, V42, P774, DOI 10.1111/j.1872-034X.2012.00979.x; Lam Yuk-Fai, 2011, Curr Hepat Rep, V10, P235, DOI 10.1007/s11901-011-0109-z; Lampertico P, 2012, GUT, V61, P18, DOI 10.1136/gutjnl-2012-302085; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; MAHARAJ B, 1986, LANCET, V1, P523; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Masuzaki R, 2009, HEPATOLOGY, V49, P1954, DOI 10.1002/hep.22870; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Ogawa E, 2009, ANTIVIR RES, V83, P127, DOI 10.1016/j.antiviral.2009.04.002; Osakabe K, 2011, J GASTROENTEROL, V46, P1324, DOI 10.1007/s00535-011-0444-4; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Wang JH, 2010, J GASTROEN HEPATOL, V25, P964, DOI 10.1111/j.1440-1746.2009.06194.x; Wang JH, 2009, J GASTROENTEROL, V44, P439, DOI 10.1007/s00535-009-0017-y; Wong GLH, 2011, ANTIVIR THER, V16, P165, DOI 10.3851/IMP1726; Yuen MF, 2005, ALIMENT PHARM THERAP, V21, P841, DOI 10.1111/j.1365-2036.2005.02410.x	30	21	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93160	10.1371/journal.pone.0093160	http://dx.doi.org/10.1371/journal.pone.0093160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682088	Green Published, gold, Green Submitted			2022-12-25	WOS:000333678100028
J	Flis, S; Gnyszka, A; Flis, K				Flis, Sylwia; Gnyszka, Agnieszka; Flis, Krzysztof			DNA Methyltransferase Inhibitors Improve the Effect of Chemotherapeutic Agents in SW48 and HT-29 Colorectal Cancer Cells	PLOS ONE			English	Article							EPIGENETIC THERAPY; METHYLATION INHIBITOR; COLON-CANCER; ZEBULARINE; DECITABINE; DAMAGE; DRUG; 5-AZA-2'-DEOXYCYTIDINE; DEMETHYLATION; AZACITIDINE	DNA methylation is an epigenetic phenomenon known to play an important role in the development and progression of human cancer. Enzyme responsible for this process is DNA methyltransferase 1 (DNMT1) that maintains an altered methylation pattern by copying it from parent to daughter DNA strands after replication. Aberrant methylation of the promoter regions of genes critical for normal cellular functions is potentially reversible. Therefore, inactivation of DNMT1 seems to be a valuable target for the development of cancer therapies. Currently, the most popular DNMT inhibitors (DNMTi) are cytidine analogues like 5-azacytidine, 5-aza-2'-deoxycytidine (decitabine) and pyrimidin-2-one ribonucleoside (zebularine). In colorectal cancer, epigenetic modifications play an essential role at each step of carcinogenesis. Therefore, we have addressed the hypothesis that DNA methyltransferase inhibitors may potentiate inhibitory effects of classical chemotherapeutic agents, such as oxaliplatin and 5-fluorouracil (5-FU), commonly used in colorectal cancer therapy. Here, our report shows that DNMTi can have positive interactions with standard chemotherapeutics in colorectal cancer treatment. Using pharmacological models for the drug-drug interaction analysis, we have revealed that the combination of decitabine with 5-FU or oxaliplatin shows the most attractive interaction (synergism), whereas the effect of zebularine in combinations with chemotherapeutics is moderate and may be depended on genetic/epigenetic background of a cell line or secondary drug used in combination. Our results suggest that DNMTi administered in combination with standard chemotherapeutics might improve the treatment of patients with colorectal cancers.	[Flis, Sylwia; Gnyszka, Agnieszka] Natl Med Inst, Dept Pharmacol, Warsaw, Poland; [Flis, Krzysztof] Polish Acad Sci, Inst Biochem & Biophys, Dept Genet, Warsaw, Poland	National Medicines Institute Lekow (NIL); Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Flis, S (corresponding author), Natl Med Inst, Dept Pharmacol, Warsaw, Poland.	sylwia.flis@yahoo.pl	Flis, Sylwia/N-6795-2013; FLIS, Krzysztof/K-6559-2012	Flis, Sylwia/0000-0002-6071-9952	National Science Center of Poland [N405 139139]	National Science Center of Poland(National Science Centre, Poland)	This study was supported by grant no. N405 139139 from the National Science Center of Poland (http://www.ncn.gov.pl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton K, 2007, J CLIN ONCOL, V25, P4603, DOI 10.1200/JCO.2007.10.8688; Bardhan Kankana, 2013, Cancers (Basel), V5, P676, DOI 10.3390/cancers5020676; Ben-Kasus T, 2005, BIOCHEM PHARMACOL, V70, P121, DOI 10.1016/j.bcp.2005.04.010; Blinman P, 2010, EUR J CANCER, V46, P1800, DOI 10.1016/j.ejca.2009.12.032; Chau I, 2006, ANN ONCOL, V17, P1347, DOI 10.1093/annonc/mdl029; Cheng JC, 2004, MOL CELL BIOL, V24, P1270, DOI 10.1128/MCB.24.3.1270-1278.2004; Cheng JC, 2004, CANCER CELL, V6, P151, DOI 10.1016/j.ccr.2004.06.023; CHOU TC, 1983, TRENDS PHARMACOL SCI, V4, P450, DOI 10.1016/0165-6147(83)90490-X; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cowan LA, 2010, EPIGENOMICS-UK, V2, P71, DOI 10.2217/EPI.09.44; Crea F, 2009, MOL CANCER THER, V8, P1964, DOI 10.1158/1535-7163.MCT-09-0027; Deng G, 2002, BRIT J CANCER, V86, P574, DOI 10.1038/sj.bjc.6600148; Esteller M, 2001, CANCER RES, V61, P2816; Flis S, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-10; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Gessner PK, 1995, TOXICOLOGY, V105, P161, DOI 10.1016/0300-483X(95)03210-7; Gnyszka A, 2013, ANTICANCER RES, V33, P2989; Goffin J, 2002, ANN ONCOL, V13, P1699, DOI 10.1093/annonc/mdf314; Hellebrekers DMEI, 2007, BBA-REV CANCER, V1775, P76, DOI 10.1016/j.bbcan.2006.07.003; Holleran JL, 2005, CLIN CANCER RES, V11, P3862, DOI 10.1158/1078-0432.CCR-04-2406; Issa JP, 2000, ANN NY ACAD SCI, V910, P140; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; LEE T, 1974, CANCER RES, V34, P2482; Lemaire M, 2005, ANTI-CANCER DRUG, V16, P301, DOI 10.1097/00001813-200503000-00009; Lind GE, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-28; Mahyar-Roemer M, 2001, INT J CANCER, V94, P615, DOI 10.1002/ijc.1516; Marquez VE, 2005, ANN NY ACAD SCI, V1058, P246, DOI 10.1196/annals.1359.037; Mossman D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-366; National Cancer Institute website, CANC DRUG INF FDA AP; Nowsheen S., 2012, Experimental Oncology, V34, P243; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Pogribny IP, 2013, CANCER LETT, V334, P39, DOI 10.1016/j.canlet.2012.09.010; Riches LC, 2008, MUTAGENESIS, V23, P331, DOI 10.1093/mutage/gen039; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Skladanowski A, 2009, CHEM REV, V109, P2951, DOI 10.1021/cr900026u; Toledo LI, 2011, MOL ONCOL, V5, P368, DOI 10.1016/j.molonc.2011.07.002; Yoo CB, 2004, BIOCHEM SOC T, V32, P910, DOI 10.1042/BST0320910; Yoo CB, 2008, CANCER PREV RES, V1, P233, DOI 10.1158/1940-6207.CAPR-07-0008	39	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92305	10.1371/journal.pone.0092305	http://dx.doi.org/10.1371/journal.pone.0092305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676085	gold, Green Submitted, Green Published			2022-12-25	WOS:000333677500019
J	Meric, G; Yahara, K; Mageiros, L; Pascoe, B; Maiden, MCJ; Jolley, KA; Sheppard, SK				Meric, Guillaume; Yahara, Koji; Mageiros, Leonardos; Pascoe, Ben; Maiden, Martin C. J.; Jolley, Keith A.; Sheppard, Samuel K.			A Reference Pan-Genome Approach to Comparative Bacterial Genomics: Identification of Novel Epidemiological Markers in Pathogenic Campylobacter	PLOS ONE			English	Article							BY-GENE APPROACH; METHYLCITRATE CYCLE; ESCHERICHIA-COLI; HOST-SPECIFICITY; JEJUNI; SEQUENCE; ASSOCIATION; METABOLISM; EVOLUTION; GENOTYPES	The increasing availability of hundreds of whole bacterial genomes provides opportunities for enhanced understanding of the genes and alleles responsible for clinically important phenotypes and how they evolved. However, it is a significant challenge to develop easy-to-use and scalable methods for characterizing these large and complex data and relating it to disease epidemiology. Existing approaches typically focus on either homologous sequence variation in genes that are shared by all isolates, or non-homologous sequence variation - focusing on genes that are differentially present in the population. Here we present a comparative genomics approach that simultaneously approximates core and accessory genome variation in pathogen populations and apply it to pathogenic species in the genus Campylobacter. A total of 7 published Campylobacter jejuni and Campylobacter coli genomes were selected to represent diversity across these species, and a list of all loci that were present at least once was compiled. After filtering duplicates a 7-isolate reference pan-genome, of 3,933 loci, was defined. A core genome of 1,035 genes was ubiquitous in the sample accounting for 59% of the genes in each isolate (average genome size of 1.68 Mb). The accessory genome contained 2,792 genes. A Campylobacter population sample of 192 genomes was screened for the presence of reference pan-genome loci with gene presence defined as a BLAST match of >= 70% identity over >= 50% of the locus length - aligned using MUSCLE on a gene-by-gene basis. A total of 21 genes were present only in C. coli and 27 only in C. jejuni, providing information about functional differences associated with species and novel epidemiological markers for population genomic analyses. Homologs of these genes were found in several of the genomes used to define the pan-genome and, therefore, would not have been identified using a single reference strain approach.	[Meric, Guillaume; Yahara, Koji; Mageiros, Leonardos; Pascoe, Ben; Sheppard, Samuel K.] Swansea Univ, Inst Life Sci, Coll Med, Swansea, W Glam, Wales; [Yahara, Koji] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan; [Maiden, Martin C. J.; Jolley, Keith A.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Swansea University; University of Tokyo; University of Oxford	Sheppard, SK (corresponding author), Swansea Univ, Inst Life Sci, Coll Med, Swansea, W Glam, Wales.	s.k.sheppard@swansea.ac.uk	Maiden, Martin/N-6805-2019; Méric, Guillaume/AAD-2364-2019; Pascoe, Ben/C-2253-2009; Jolley, Keith/ABE-8587-2020; Pascoe, Ben/AAD-2728-2019; Maiden, Martin C J/C-5055-2014; Méric, Guillaume/R-3947-2017	Maiden, Martin/0000-0001-6321-5138; Méric, Guillaume/0000-0001-6288-9958; Pascoe, Ben/0000-0001-6376-5121; Jolley, Keith/0000-0002-0751-0287; Maiden, Martin C J/0000-0001-6321-5138; Méric, Guillaume/0000-0001-6288-9958; Sheppard, Samuel/0000-0001-6901-3203	Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust; BBSRC [BB/I02464X/1] Funding Source: UKRI; MRC [G0801929] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I02464X/1] Funding Source: researchfish; Medical Research Council [G0801929] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by various funding sources from the Biotechnology and Biological Sciences Research Council (BBSRC), and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Biggs PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027121; Chen YS, 2013, ANTIMICROB AGENTS CH, V57, P5398, DOI 10.1128/AAC.00669-13; de Haan CPA, 2012, APPL ENVIRON MICROB, V78, P5550, DOI 10.1128/AEM.01023-12; Duncan SH, 2004, BRIT J NUTR, V91, P915, DOI 10.1079/BJN20041150; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Friis C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012253; Griekspoor P, 2013, MOL ECOL, V22, P1463, DOI 10.1111/mec.12144; Gripp E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-584; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Katz LS, 2013, MBIO, V4, DOI 10.1128/mBio.00398-13; Kessel A S, 2001, Commun Dis Public Health, V4, P171; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; OLSVIK O, 1993, J CLIN MICROBIOL, V31, P22, DOI 10.1128/JCM.31.1.22-25.1993; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; Sheppard SK, 2013, P NATL ACAD SCI USA, V110, P11923, DOI 10.1073/pnas.1305559110; Sheppard SK, 2013, MOL ECOL, V22, P1051, DOI 10.1111/mec.12162; Sheppard SK, 2012, GENES-BASEL, V3, P261, DOI 10.3390/genes3020261; Sheppard SK, 2011, MOL ECOL, V20, P3484, DOI 10.1111/j.1365-294X.2011.05179.x; Sheppard SK, 2011, MICROBIOL-SGM, V157, P1066, DOI 10.1099/mic.0.045153-0; Sheppard SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015708; Sheppard SK, 2010, APPL ENVIRON MICROB, V76, P5269, DOI 10.1128/AEM.00124-10; Sheppard SK, 2009, INT J FOOD MICROBIOL, V134, P96, DOI 10.1016/j.ijfoodmicro.2009.02.010; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; Snipen L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-385; Stahl M, 2011, P NATL ACAD SCI USA, V108, P7194, DOI 10.1073/pnas.1014125108; Upton AM, 2007, MICROBIOL-SGM, V153, P3973, DOI 10.1099/mic.0.2007/011726-0; Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109; Zhang W, 2006, GENOME RES, V16, P757, DOI 10.1101/gr.4759706	43	87	87	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92798	10.1371/journal.pone.0092798	http://dx.doi.org/10.1371/journal.pone.0092798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676150	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500040
J	Riedel, C; von Kries, R; Buyken, AE; Diethelm, K; Keil, T; Grabenhenrich, L; Muller, MJ; Plachta-Danielzik, S				Riedel, Christina; von Kries, Ruediger; Buyken, Anette E.; Diethelm, Katharina; Keil, Thomas; Grabenhenrich, Linus; Mueller, Manfred J.; Plachta-Danielzik, Sandra			Overweight in Adolescence Can Be Predicted at Age 6 Years: A CART Analysis in German Cohorts	PLOS ONE			English	Article							BODY-MASS INDEX; SCHOOL-BASED INTERVENTIONS; KIEL OBESITY PREVENTION; PHYSICAL-ACTIVITY; RISK-FACTORS; CHILDHOOD OVERWEIGHT; PARENTAL OBESITY; YOUNG ADULTHOOD; BIRTH COHORT; CHILDREN	Objective: To examine, whether overweight in adolescents can be predicted from the body mass index (BMI) category, at the age of 6, the mother's education level and mother's obesity and to quantify the proportion of overweight at the age of 14 that can be explained by these predictors. Method: Pooled data from three German cohorts providing anthropometric and other relevant data to a total of 1 287 children. We used a classification and regression tree (CART) approach to identify the contribution of BMI category at the age of 6 (obese: BMI>97th percentile (P97); overweight: P90<BMI <= P97; high normal weight: P75<BMI <= P90; third quartile: P50<BMI <= P75; below the median: <= P50), maternal education level and maternal obesity for prediction of overweight/obesity (BMI>P90) at the age of 14. Results: While 4.8% [95% CI: 3.2; 7.0] of 651 boys and 4.1% [95% CI: 2.6; 6.2] of 636 girls with a BMI<P75 at age 6 were overweight/obese in adolescence, prevalence increased to 41.3% [95% CI: 31.9; 51.1] and 42.5% [95% CI: 33.8; 51.6], respectively, in those with BMI >= P75. The lowest prevalence was 1.9% [95% CI: 0.8; 3.8] in boys with a BMI <= P50 and the highest prevalence 91.7% [95% CI: 61.5; 99.8] with a BMI>P97 (similar results for girls). BMI >= P75 at the age of 6 explained 63.5% [95% CI: 51.1; 74.5]) and 72.0% [95% CI: 60.4; 81.8] of overweight/obesity at the age of 14 in boys and girls, respectively. Conclusions: Overweight/obesity in adolescence can be predicted by BMI category at the age of 6 allowing for parent counselling or risk guided interventions in children with BMI >= P75, who accounted for >2/3 of overweight/obesity in adolescents.	[Riedel, Christina; von Kries, Ruediger] Univ Munich, Inst Social Paediat & Adolescent Med, Munich, Germany; [Buyken, Anette E.; Diethelm, Katharina] Univ Bonn, IEL Nutr Epidemiol, DONALD Study, Res Inst Child Nutr, Dortmund, Germany; [Keil, Thomas; Grabenhenrich, Linus] Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany; [Mueller, Manfred J.; Plachta-Danielzik, Sandra] Univ Kiel, Inst Human Nutr & Food Sci, Kiel, Germany	University of Munich; University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel	Riedel, C (corresponding author), Univ Munich, Inst Social Paediat & Adolescent Med, Munich, Germany.	christina.riedel@med.uni-muenchen.de		Sobotzki, Christina/0000-0002-0956-0050; Grabenhenrich, Linus/0000-0002-9300-6625	Ministry of Science and Research of North Rhine Westphalia, Germany; Deutsche Forschungsgemeinschaft [DFG Mu 5.1, 5.2, 5.3, 5.5]; German Federal Ministry of Education and Research (Competence Network Obesity) [FKZ: 01GI1121A]	Ministry of Science and Research of North Rhine Westphalia, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (Competence Network Obesity)	The DONALD Study is funded by the Ministry of Science and Research of North Rhine Westphalia, Germany. KOPS was funded by Deutsche Forschungsgemeinschaft (DFG Mu 5.1, 5.2, 5.3 and 5.5). This analysis was supported by the German Federal Ministry of Education and Research (Competence Network Obesity; project: "Life Course Approach To Obesity Research: From Epidemiology to Future Strategies of Prevention - EPI Germany" [FKZ: 01GI1121A]). Neither of the funding agencies had any influence on the study conduct and report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer O, 2011, OBESITY, V19, P1069, DOI 10.1038/oby.2010.250; Bergmann R L, 1994, Pediatr Allergy Immunol, V5, P19, DOI 10.1111/j.1399-3038.1994.tb00343.x; BREIMAN L., 1984, CRC PRESS; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; Buyken AE, 2012, BUNDESGESUNDHEITSBLA, V55, P875, DOI 10.1007/s00103-012-1503-6; Clark L A., 1992, TREE BASED MODELS ST, P377; Clopper C, 1934, BIOMETRIKA, V26; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Fallon B, 2013, CHILD ADOL PSYCH MEN, V7, DOI 10.1186/1753-2000-7-4; Field AE, 2005, OBES RES, V13, P163, DOI 10.1038/oby.2005.21; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; Fryar C.D., 2012, PREVALENCE OBESITY C, V1960; Guo SS, 2002, AM J CLIN NUTR, V76, P653, DOI 10.1093/ajcn/76.3.653; GUO SS, 1994, AM J CLIN NUTR, V59, P810, DOI 10.1093/ajcn/59.4.810; Haines J, 2013, JAMA PEDIAT; Harris KC, 2009, CAN MED ASSOC J, V180, P719, DOI 10.1503/cmaj.080966; Hector D., 2012, EVIDENCE UPDATE OBES; Herman KM, 2009, INT J PEDIATR OBES, V4, P281, DOI 10.3109/17477160802596171; Hoffmann S, 2012, OBESITY; Hughes AR, 2011, PREV MED, V52, P300, DOI 10.1016/j.ypmed.2011.02.014; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Jackson-Leach R, 2006, INT J PEDIATR OBES, V1, P26, DOI 10.1080/17477160600586614; Karaolis-Danckert N, 2008, AM J CLIN NUTR, V87, P1356, DOI 10.1093/ajcn/87.5.1356; Katz DL, 2008, INT J OBESITY, V32, P1780, DOI 10.1038/ijo.2008.158; Kroke A, 2004, EUR J NUTR, V43, P45, DOI 10.1007/s00394-004-0445-7; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Lavelle HV, 2012, J PUBLIC HEALTH-UK, V34, P360, DOI 10.1093/pubmed/fdr116; Lazaar N, 2007, ACTA PAEDIATR, V96, P1321, DOI 10.1111/j.1651-2227.2007.00426.x; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Li CY, 2007, OBESITY, V15, P760, DOI 10.1038/oby.2007.585; Linabery AM, 2013, PEDIATR OBES, V8, P159, DOI 10.1111/j.2047-6310.2012.00100.x; Magarey AM, 2003, INT J OBESITY, V27, P505, DOI 10.1038/sj.ijo.0802251; Must A, 1996, AM J CLIN NUTR, V63, P445, DOI 10.1093/ajcn/63.3.445; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ogden CL, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.4.e1; Padez C, 2005, ACTA PAEDIATR, V94, P1550, DOI 10.1080/08035250510042924; Pei Z, 2013, EUR J CLIN NUTR, V67, P855, DOI 10.1038/ejcn.2013.80; PISUNYER FX, 1991, AM J CLIN NUTR, V53, pS1595; Plachta-Danielzik S, 2012, BUNDESGESUNDHEITSBLA, V55, P885, DOI 10.1007/s00103-012-1494-3; Plachta-Danielzik S, 2007, OBESITY, V15, P3159, DOI 10.1038/oby.2007.376; Plachta-Danielzik S, 2012, PEDIATRICS, V130, pE865, DOI 10.1542/peds.2011-3296; Plachta-Danielzik S, 2008, OBESITY FACTS, V1, P325, DOI 10.1159/000176609; Power C, 1997, AM J CLIN NUTR, V66, P1094, DOI 10.1093/ajcn/66.5.1094; Rochat MK, 2010, J ALLERGY CLIN IMMUN, V126, P1170, DOI 10.1016/j.jaci.2010.09.008; Rokach L, 2007, DATA MINING DECISION; Shih YS, 2001, STAT PROBABIL LETT, V54, P341, DOI 10.1016/S0167-7152(00)00188-7; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Starc G, 2011, PUBLIC HEALTH NUTR, V14, P49, DOI 10.1017/S1368980010000741; Sung YW, 2012, OBES REV; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; von Kries R, 2012, INT J OBESITY, V36, P505, DOI 10.1038/ijo.2011.251; von Kries R, 2012, PEDIAT OBES IN PRESS; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Williams S, 2001, INT J OBESITY, V25, P158, DOI 10.1038/sj.ijo.0801512; Yohannes Y, 1999, CLASSIFICAITON REGRE	56	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93581	10.1371/journal.pone.0093581	http://dx.doi.org/10.1371/journal.pone.0093581			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676281	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500141
J	Tevy, MF; Seyres, D; Traina, C; Perrin, L; Capovilla, M				Tevy, Maria Florencia; Seyres, Denis; Traina, Concetta; Perrin, Laurent; Capovilla, Maria			Ndae1 Expression and Regulation in Drosophila Embryos	PLOS ONE			English	Article							DORSAL-VENTRAL PATTERN; SIGNALING PATHWAY; SLC4 FAMILY; PROTEIN; GRADIENT; AMNIOSEROSA; MORPHOGEN; CLOSURE; TOLL; LOCALIZATION	The construction and prediction of cell fate maps at the whole embryo level require the establishment of an accurate atlas of gene expression patterns throughout development and the identification of the corresponding cis-regulatory sequences. However, while the expression and regulation of genes encoding upstream developmental regulators such as transcription factors or signaling pathway components have been analyzed in detail, up to date the number of cis-regulatory sequences identified for downstream effector genes, like ion channels, pumps and exchangers, is very low. The control and regulation of ion homeostasis in each cell, including at blastoderm stages, are essential for normal embryonic development. In this study, we analyzed in detail the embryonic expression pattern and cis-regulatory modules of the Drosophila Na+-driven anion exchanger 1 (Ndae1) gene, involved in the regulation of pH homeostasis. We show that Ndae1 is expressed in a tight and complex spatial-temporal pattern. In particular, we report that this downstream effector gene is under the control of the canonical dorsal-ventral patterning cascade through dorsal, Toll, twist and snail at early embryogenesis. Moreover, we identify several cis-regulatory modules, some of which control discrete and non-overlapping aspects of endogenous gene expression throughout development.	[Tevy, Maria Florencia; Traina, Concetta] Univ Ferrara, Dulbecco Telethon Inst, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Seyres, Denis; Perrin, Laurent] INSERM, UMR 1090, TAGC, F-13258 Marseille, France; [Seyres, Denis; Perrin, Laurent] Aix Marseille Univ, UMR 1090, TAGC, Marseille, France; [Perrin, Laurent] CNRS, Marseille, France; [Capovilla, Maria] INRA CNRS UNS, UMR 7254, Inst Sophia Agrobiotech, Sophia Antipolis, France	Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Ferrara; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Capovilla, M (corresponding author), INRA CNRS UNS, UMR 7254, Inst Sophia Agrobiotech, Sophia Antipolis, France.	Maria.Capovilla@sophia.inra.fr	Seyres, Denis/ABE-3666-2021; Perrin, Laurent/L-8301-2016; Tevy, Florencia/AAF-6583-2019; Capovilla, Maria/O-8483-2016	Perrin, Laurent/0000-0002-4139-8743; Tevy, Florencia/0000-0002-8915-1328; Capovilla, Maria/0000-0002-1308-7964; Seyres, Denis/0000-0002-2066-6980	Dulbecco Telethon Institute [3021]	Dulbecco Telethon Institute(Fondazione Telethon)	Funding provided by Dulbecco Telethon Institute grant n. 3021 (http://dti.telethon.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio V, 2012, DEV DYNAM, V241, P190, DOI 10.1002/dvdy.22763; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Bernardoni R, 1999, DEV BIOL, V216, P265, DOI 10.1006/dbio.1999.9511; Buecker C, 2012, TRENDS GENET, V28, P276, DOI 10.1016/j.tig.2012.02.008; Cerrone M, 2012, CURR OPIN CARDIOL, V27, P242, DOI 10.1097/HCO.0b013e328352429d; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Cordat E, 2009, BIOCHEM J, V417, P423, DOI 10.1042/BJ20081634; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Fernandez BG, 2007, MECH DEVELOP, V124, P884, DOI 10.1016/j.mod.2007.09.002; FitzHarris G, 2009, REPRODUCTION, V138, P619, DOI 10.1530/REP-09-0112; Fontenele M, 2009, MECH DEVELOP, V126, P737, DOI 10.1016/j.mod.2009.04.005; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Frise E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.102; Ganetzky B, 2000, KIDNEY INT, V57, P766, DOI 10.1046/j.1523-1755.2000.00913.x; Gurnett CA, 2008, ARCH NEUROL-CHICAGO, V65, P550, DOI 10.1001/archneur.65.4.550; Herrmann C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks543; Hong JW, 2008, P NATL ACAD SCI USA, V105, P20072, DOI 10.1073/pnas.0806476105; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Ip YT, 2002, CURR OPIN GENET DEV, V12, P423, DOI 10.1016/S0959-437X(02)00320-9; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; Jacobs S, 2008, P NATL ACAD SCI USA, V105, P311, DOI 10.1073/pnas.0705487105; JARIAL MS, 1987, TISSUE CELL, V19, P559, DOI 10.1016/0040-8166(87)90048-6; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Kazemian M, 2010, PLOS BIOL, DOI [10.1371/journal.-pbio.1000456, DOI 10.1371/J0URNAL.-PBI0.1000456]; Keyser P, 2007, INSECT BIOCHEM MOLEC, V37, P356, DOI 10.1016/j.ibmb.2006.12.009; Lamka ML, 1999, DEV BIOL, V214, P102, DOI 10.1006/dbio.1999.9409; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; Mehta A, 2008, BIOCHEM SOC T, V36, P1313, DOI 10.1042/BST0361313; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Narasimha M, 2004, CURR BIOL, V14, P381, DOI 10.1016/j.cub.2004.02.033; Naval-Sanchez M, 2013, GENOME RES, V23, P74, DOI 10.1101/gr.140426.112; Parker MD, 2012, J PHYSIOL-LONDON, V590, P2009, DOI 10.1113/jphysiol.2011.224733; Perrin L, 2004, DEV BIOL, V272, P419, DOI 10.1016/j.ydbio.2004.04.036; Pym ECG, 2006, NEURAL DEV, V1, DOI 10.1186/1749-8104-1-3; Reeves GT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000836; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; Romero MF, 2000, J BIOL CHEM, V275, P24552, DOI 10.1074/jbc.M003476200; Romero MF, 2013, MOL ASPECTS MED, V34, P159, DOI 10.1016/j.mam.2012.10.008; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Sciortino CM, 2001, AM J PHYSIOL-CELL PH, V281, pC449, DOI 10.1152/ajpcell.2001.281.2.C449; Scuderi A, 2005, DEV DYNAM, V232, P791, DOI 10.1002/dvdy.20306; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Sinning A, 2011, J NEUROSCI, V31, P7300, DOI 10.1523/JNEUROSCI.0269-11.2011; Soleimani M, 2000, KIDNEY INT, V57, P371, DOI 10.1046/j.1523-1755.2000.00857.x; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; STEWARD R, 1989, CELL, V59, P1179, DOI 10.1016/0092-8674(89)90773-3; Krepischi AC, 2010, EPILEPSIA, V51, P2457, DOI 10.1111/j.1528-1167.2010.02742.x; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; Wada A, 2007, DEV BIOL, V301, P340, DOI 10.1016/j.ydbio.2006.09.020; WINANS KA, 1995, MOL BIOL CELL, V6, P587, DOI 10.1091/mbc.6.5.587; Winkelmann A, 2014, J CLIN INVEST, V124, P696, DOI 10.1172/JCI71472; Wolfram V, 2012, NEURON, V75, P663, DOI 10.1016/j.neuron.2012.06.015	60	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92956	10.1371/journal.pone.0092956	http://dx.doi.org/10.1371/journal.pone.0092956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676142	Green Published, gold			2022-12-25	WOS:000333677500060
J	Zheng, LB; Sun, XY; Zhu, X; Lv, FX; Zhong, ZY; Zhang, F; Guo, WH; Cao, WW; Yang, LM; Tian, Y				Zheng, Longbin; Sun, Xinyong; Zhu, Xing; Lv, Fengxiang; Zhong, Zhaoyu; Zhang, Feng; Guo, Wenhui; Cao, Wenwu; Yang, Liming; Tian, Ye			Apoptosis of THP-1 Derived Macrophages Induced by Sonodynamic Therapy Using a New Sonosensitizer Hydroxyl Acetylated Curcumin	PLOS ONE			English	Article							HEMATOPORPHYRIN MONOMETHYL ETHER; REGULATORY ELEMENT PATHWAY; LDL RECEPTOR EXPRESSION; CELLS IN-VITRO; PROTOPORPHYRIN IX; ATHEROSCLEROTIC PLAQUES; 5-AMINOLEVULINIC ACID; PHOTODYNAMIC THERAPY; SARCOMA-180 CELLS; MDA-MB-231 CELLS	Curcumin is extracted from the rhizomes of the traditional Chinese herb Curcuma longa. Our previous study indicated curcumin was able to function as a sonosensitizer. Hydroxyl acylated curcumin was synthesized from curcumin to eliminate the unstable hydroxy perssad in our group. The potential use of Hydroxyl acylated curcumin as a sonosensitizer for sonodynamic therapy (SDT) requires further exploration. This study investigated the sonodynamic effect of Hydroxyl acylated curcumin on THP-1 macrophage. THP-1 macrophages were cultured with Hydroxyl acylated curcumin at a concentration of 5.0 mu g/mL for 4 hours and then exposed to pulse ultrasound irradiation (0.5 W/cm(2) with 1.0 MHz) for 5 min, 10 min and 15 min. Six hours later, cell viability decreased significantly by CCK-8 assay. After ultrasound irradiation, the ratio of apoptosis and necrosis in SDT group was higher than that in control, Hydroxyl acylated curcumin alone and ultrasound alone. Moreover, the apoptotic rate was higher than necrotic rate with the flow cytometry analysis. Furthermore, Hydroxyl acylated curcumin-SDT induced reactive oxygen species (ROS) generation in THP-1 macrophages immediately after the ultrasound treatment while ROS generation was reduced significantly with the scavenger of singlet oxygen Sodium azide (NaN3). Hydroxyl acylated curcumin-SDT led to a conspicuous loss of mitochondrial membrane potential (MMP) compared with other groups, while MMP was increased significantly with the scavenger of singlet oxygen Sodium azide (NaN3), ROS inhibitor N-acetyl cysteine (NAC) and Mitochondrial Permeability Transition Pore (MPTP) inhibitor Cyclosporin A (CsA). The cytochrome C, cleaved-Caspase-9, cleaved-Caspase-3 and cleaved-PARP upregulated after SDT through Western blotting. These findings suggested that Hydroxyl acylated curcumin under low-intensity ultrasound had sonodynamic effect on THP-1 macrophages via generation of intracellular singlet oxygen and mitochondria-caspase signaling pathway, indicating that Hydroxyl acylated curcumin could be used as a novel sonosensitizer in SDT for atherosclerosis.	[Zheng, Longbin; Zhu, Xing; Zhong, Zhaoyu; Zhang, Feng; Guo, Wenhui; Yang, Liming; Tian, Ye] Harbin Med Univ, Dept Pathophysiol, Key Lab Myocardial Ischemia, Minist Educ, Harbin, Heilongjiang, Peoples R China; [Sun, Xinyong; Tian, Ye] Harbin Med Univ, Affiliated Hosp 1, Div Cardiol, Harbin, Heilongjiang, Peoples R China; [Lv, Fengxiang] Peking Univ, Inst Mol Med, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Cao, Wenwu] Harbin Inst Technol, Lab Sono & Photo Theranost Technol, Harbin 150006, Heilongjiang, Peoples R China; [Cao, Wenwu] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA	Harbin Medical University; Harbin Medical University; Peking University; Harbin Institute of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Yang, LM (corresponding author), Harbin Med Univ, Dept Pathophysiol, Key Lab Myocardial Ischemia, Minist Educ, Harbin, Heilongjiang, Peoples R China.	limingyang@ems.hrbmu.edu.cn; yetian@ems.hrbmu.edu.cn	Cao, Wenwu/F-6091-2012	Cao, Wenwu/0000-0002-2447-1486	National Natural Science Foundation of China [81000688, 81271734]; Heilongjiang Provincial Youth Science Foundation [QC2011C002]; Foundation of Science and Technology Innovation Talent of Harbin Science and Technology Bureau [2011RFQXS072]; Wu Liande Youth Science Foundation of Harbin Medical University [WLD-QN1104]; Postdoctoral Science-research Developmental Foundation of Heilongjiang Province [LBH-Q12049]; Key Laboratory of Myocardial Ischemia, Harbin Medical University, Chinese Ministry of Education [KF201212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Provincial Youth Science Foundation; Foundation of Science and Technology Innovation Talent of Harbin Science and Technology Bureau; Wu Liande Youth Science Foundation of Harbin Medical University; Postdoctoral Science-research Developmental Foundation of Heilongjiang Province; Key Laboratory of Myocardial Ischemia, Harbin Medical University, Chinese Ministry of Education	This study was supported by the National Natural Science Foundation of China (81000688, 81271734), Heilongjiang Provincial Youth Science Foundation (QC2011C002), Foundation of Science and Technology Innovation Talent of Harbin Science and Technology Bureau (2011RFQXS072), Wu Liande Youth Science Foundation of Harbin Medical University (WLD-QN1104), Postdoctoral Science-research Developmental Foundation of Heilongjiang Province (LBH-Q12049), and Key Laboratory of Myocardial Ischemia, Harbin Medical University, Chinese Ministry of Education (KF201212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JC, 2012, INT J ONCOL, V41, P2184, DOI 10.3892/ijo.2012.1661; Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; [许川山 Xu Chuanshan], 2005, [激光杂志, Laser Journal], V26, P86; Cheng JL, 2013, INT J NANOMED, V8, P669, DOI 10.2147/IJN.S39844; Cheng JL, 2010, J PHOTOCH PHOTOBIO B, V101, P9, DOI 10.1016/j.jphotobiol.2010.06.005; Croons V, 2010, CURR VASC PHARMACOL, V8, P495, DOI 10.2174/157016110791330816; Dai SC, 2009, ACTA NEUROCHIR, V151, P1655, DOI 10.1007/s00701-009-0456-5; De Meyer I, 2012, BRIT J CLIN PHARMACO, V74, P246, DOI 10.1111/j.1365-2125.2012.04211.x; Dou XB, 2008, PLANTA MED, V74, P1374, DOI 10.1055/s-2008-1081316; [窦晓兵 Dou Xiaobing], 2005, [中国药学杂志, Chinese Pharmaceutical Journal], V40, P980; Estronca LMBB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034822; Fan CL, 2006, PHARMACOL REP, V58, P577; [范春雷 Fan Chunlei], 2006, [中国药学杂志, Chinese Pharmaceutical Journal], V41, P664; Fan CL, 2006, J ETHNOPHARMACOL, V105, P251, DOI 10.1016/j.jep.2005.11.009; Feril LB, 2005, CANCER LETT, V221, P145, DOI 10.1016/j.canlet.2004.08.034; Gao QP, 2011, ULTRASOUND MED BIOL, V37, P1478, DOI 10.1016/j.ultrasmedbio.2011.05.846; Guo SY, 2013, INT J NANOMED, V8, P2239, DOI 10.2147/IJN.S43717; Honda H, 2004, ULTRASOUND MED BIOL, V30, P683, DOI 10.1016/j.ultrasmedbio.2004.02.008; Jin H, 2011, J CELL BIOCHEM, V112, P169, DOI 10.1002/jcb.22912; Kzhyshkowska J, 2012, IMMUNOBIOLOGY, V217, P492, DOI 10.1016/j.imbio.2012.02.015; Li HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059473; Li JH, 2011, INT J RADIAT BIOL, V87, P1061, DOI 10.3109/09553002.2011.584938; Li YX, 2012, ULTRASONICS, V52, P490, DOI 10.1016/j.ultras.2011.10.013; Lotta LA, 2010, EUR J INTERN MED, V21, P74, DOI 10.1016/j.ejim.2009.11.003; Martinet W, 2007, TRENDS CARDIOVAS MED, V17, P69, DOI 10.1016/j.tcm.2006.12.004; Mi N, 2009, ULTRASOUND MED BIOL, V35, P680, DOI 10.1016/j.ultrasmedbio.2008.07.002; Newman CMH, 2007, GENE THER, V14, P465, DOI 10.1038/sj.gt.3302925; Ohmura T, 2011, ANTICANCER RES, V31, P2527; Peng CH, 2011, J PHOTOCH PHOTOBIO B, V102, P26, DOI 10.1016/j.jphotobiol.2010.09.001; Perdiguero EG, 2013, COLD SH Q B, V78, P91, DOI 10.1101/sqb.2013.78.020032; Qian Ying, 2006, Zhongguo Yaolixue Tongbao, V22, P828; Rossi A, 2006, INT J CARDIOL, V111, P263, DOI 10.1016/j.ijcard.2005.08.030; Sharma RA, 2007, ADV EXP MED BIOL, V595, P453; Sheridan C, 2010, MITOCHONDRION, V10, P640, DOI 10.1016/j.mito.2010.08.005; Shibaguchi H, 2011, ANTICANCER RES, V31, P2425; Shohet RV, 2000, CIRCULATION, V101, P2554, DOI 10.1161/01.CIR.101.22.2554; Song W, 2011, ANTICANCER RES, V31, P39; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tachibana K, 2008, ULTRASONICS, V48, P253, DOI 10.1016/j.ultras.2008.02.003; Tang W, 2008, J ULTRAS MED, V27, P645, DOI 10.7863/jum.2008.27.4.645; Tang W, 2010, ULTRASONICS, V50, P567, DOI 10.1016/j.ultras.2009.12.001; Tang W, 2009, ULTRASONICS, V49, P786, DOI 10.1016/j.ultras.2009.06.002; Wang FP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/737264; Wang HP, 2013, ULTRASOUND MED BIOL, V39, P1713, DOI 10.1016/j.ultrasmedbio.2013.03.017; Wang XB, 2010, ULTRASOUND MED BIOL, V36, P667, DOI 10.1016/j.ultrasmedbio.2009.09.006; Wang XB, 2011, ULTRASONICS, V51, P539, DOI 10.1016/j.ultras.2010.12.001; Wang XB, 2010, ULTRASONICS, V50, P803, DOI 10.1016/j.ultras.2010.04.004; Xiang JY, 2011, ULTRASONICS, V51, P390, DOI 10.1016/j.ultras.2010.11.005; Xu ZY, 2013, ULTRASONICS, V53, P232, DOI 10.1016/j.ultras.2012.06.005; Yumita N, 2010, CANCER CHEMOTH PHARM, V66, P1071, DOI 10.1007/s00280-010-1264-6; Zolochevska O, 2011, HUM GENE THER, V22, P1537, DOI 10.1089/hum.2011.076	51	48	54	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93133	10.1371/journal.pone.0093133	http://dx.doi.org/10.1371/journal.pone.0093133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676101	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677500079
J	Cortelazzo, A; De Felice, C; Pecorelli, A; Belmonte, G; Signorini, C; Leoncini, S; Zollo, G; Capone, A; Della Giovampaola, C; Sticozzi, C; Valacchi, G; Ciccoli, L; Guerranti, R; Hayek, J				Cortelazzo, Alessio; De Felice, Claudio; Pecorelli, Alessandra; Belmonte, Giuseppe; Signorini, Cinzia; Leoncini, Silvia; Zollo, Gloria; Capone, Antonietta; Della Giovampaola, Cinzia; Sticozzi, Claudia; Valacchi, Giuseppe; Ciccoli, Lucia; Guerranti, Roberto; Hayek, Joussef			Beta-Actin Deficiency with Oxidative Posttranslational Modifications in Rett Syndrome Erythrocytes: Insights into an Altered Cytoskeletal Organization	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; MECP2 DEFICIENCY; DELAYED MATURATION; MENTAL-RETARDATION; CEREBRAL-CORTEX; STRESS; REVERSIBILITY; EXPRESSION; MODELS; MICE	Beta-actin, a critical player in cellular functions ranging from cell motility and the maintenance of cell shape to transcription regulation, was evaluated in the erythrocyte membranes from patients with typical Rett syndrome (RTT) and methyl CpG binding protein 2 (MECP2) gene mutations. RTT, affecting almost exclusively females with an average frequency of 1:10,000 female live births, is considered the second commonest cause of severe cognitive impairment in the female gender. Evaluation of beta-actin was carried out in a comparative cohort study on red blood cells (RBCs), drawn from healthy control subjects and RTT patients using mass spectrometry-based quantitative analysis. We observed a decreased expression of the beta-actin isoforms (relative fold changes for spots 1, 2 and 3:-1.82 +/- 0.15, -2.15 +/- 0.06, and -2.59 +/- 0.48, respectively) in pathological RBCs. The results were validated by western blotting and immunofluorescence microscopy. In addition, betaactin from RTT patients also showed a dramatic increase in oxidative posttranslational modifications (PTMs) as the result of its binding with the lipid peroxidation product 4-hydroxy-2-nonenal (4-HNE). Our findings demonstrate, for the first time, a beta-actin down-regulation and oxidative PTMs for RBCs of RTT patients, thus indicating an altered cytoskeletal organization.	[Cortelazzo, Alessio; Guerranti, Roberto] Univ Siena, Dept Med Biotechnol, I-53100 Siena, Italy; [Cortelazzo, Alessio; Pecorelli, Alessandra; Leoncini, Silvia; Zollo, Gloria; Hayek, Joussef] AOUS, Univ Hosp, Child Neuropsychiat Unit, Siena, Italy; [De Felice, Claudio] AOUS, Univ Hosp, Neonatal Intens Care Unit, Siena, Italy; [Pecorelli, Alessandra; Signorini, Cinzia; Leoncini, Silvia; Zollo, Gloria; Ciccoli, Lucia] Univ Siena, Dept Mol & Dev Med, I-53100 Siena, Italy; [Belmonte, Giuseppe] AOUS, Univ Hosp, Dept Med Sci Surg & Neurosci, Siena, Italy; [Capone, Antonietta; Della Giovampaola, Cinzia] Univ Siena, Dept Life Sci, I-53100 Siena, Italy; [Sticozzi, Claudia; Valacchi, Giuseppe] Univ Ferrara, Dept Sci Life & Biotechnol, I-44100 Ferrara, Italy; [Valacchi, Giuseppe] Kyung Hee Univ, Dept Food & Nutr, Seoul, South Korea	University of Siena; University of Siena; University Hospital of Siena; University of Siena; University Hospital of Siena; University of Siena; University of Siena; University Hospital of Siena; University of Siena; University of Ferrara; Kyung Hee University	Cortelazzo, A (corresponding author), Univ Siena, Dept Med Biotechnol, Via Laterina 8, I-53100 Siena, Italy.	alessio.cortelazzo@ao-siena.toscana.it	De Felice, Claudio/AAB-6859-2022; Leoncini, Silvia/ABG-5652-2020; Cortelazzo, Alessio/Q-4005-2016	De Felice, Claudio/0000-0002-9881-3119; Leoncini, Silvia/0000-0002-7027-1207; Cortelazzo, Alessio/0000-0003-1010-5255; Ciccoli, Lucia/0000-0002-0120-3980; hayek, joussef/0000-0002-0440-2491	Tuscany Region [Bando Salute], Italy	Tuscany Region [Bando Salute], Italy	The work was supported by Tuscany Region [Bando Salute 2009, "Antioxidants (omega-3 Polyunsaturated Fatty Acids, lipoic acid) supplementation in Rett syndrome: A novel approach to therapy"], Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuhatzira L, 2009, HUM MOL GENET, V18, P1415, DOI 10.1093/hmg/ddp048; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Belichenko NP, 2009, NEUROBIOL DIS, V34, P71, DOI 10.1016/j.nbd.2008.12.016; Belichenko PV, 2009, J COMP NEUROL, V514, P240, DOI 10.1002/cne.22009; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; Ciccoli L, 2012, BBA-GEN SUBJECTS, V1820, P511, DOI 10.1016/j.bbagen.2011.12.002; Cobb S, 2010, BIOCHEM SOC T, V38, P498, DOI 10.1042/BST0380498; De Felice C, 2012, ANN NY ACAD SCI, V1259, P121, DOI 10.1111/j.1749-6632.2012.06611.x; De Felice C, 2009, FREE RADICAL BIO MED, V47, P440, DOI 10.1016/j.freeradbiomed.2009.05.016; Delepine C, 2013, FEBS LETT, V587, P245, DOI 10.1016/j.febslet.2012.11.033; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Farah ME, 2011, CYTOSKELETON, V68, P340, DOI 10.1002/cm.20516; Francke U, 2006, NAT CLIN PRACT NEURO, V2, P212, DOI 10.1038/ncpneuro0148; Fukuda T, 2005, J NEUROPATH EXP NEUR, V64, P537, DOI 10.1093/jnen/64.6.537; Gadalla KKE, 2011, BIOCHEM J, V439, P1, DOI 10.1042/BJ20110648; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Herman IM, 1993, CURR OPIN CELL BIOL, V5, P48, DOI 10.1016/S0955-0674(05)80007-9; Kaufmann WE, 2000, CEREB CORTEX, V10, P992, DOI 10.1093/cercor/10.10.992; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kishi N, 2010, EXP NEUROL, V222, P51, DOI 10.1016/j.expneurol.2009.12.007; KUNZE D, 1993, EUR J CLIN CHEM CLIN, V31, P477; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leoncini S, 2011, REDOX REP, V16, P145, DOI 10.1179/1351000211Y.0000000004; Nans A, 2011, BIOPHYS J, V101, P2341, DOI 10.1016/j.bpj.2011.09.050; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Pecorelli A, 2011, CLIN BIOCHEM, V44, P368, DOI 10.1016/j.clinbiochem.2011.01.007; Signorini C, 2011, CLIN CHIM ACTA, V412, P1399, DOI 10.1016/j.cca.2011.04.016; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Sticozzi C, 2013, EUR J PHARM SCI, V49, P133, DOI 10.1016/j.ejps.2013.02.009; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6	36	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93181	10.1371/journal.pone.0093181	http://dx.doi.org/10.1371/journal.pone.0093181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671107	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000125
J	Kapoor, A; Forman, M; Arav-Boger, R				Kapoor, Arun; Forman, Michael; Arav-Boger, Ravit			Activation of Nucleotide Oligomerization Domain 2 (NOD2) by Human Cytomegalovirus Initiates Innate Immune Responses and Restricts Virus Replication	PLOS ONE			English	Article							HUMAN INFECTIOUS-DISEASE; CROHNS-DISEASE; CYTOKINE RESPONSES; HOST-DEFENSE; SUSCEPTIBILITY; RECEPTORS; GENETICS; RNA; TRANSPLANTATION; PEPTIDOGLYCAN	Nucleotide-binding oligomerization domain 2 (NOD2) is an important innate immune sensor of bacterial pathogens. Its induction results in activation of the classic NF-kappa B pathway and alternative pathways including type I IFN and autophagy. Although the importance of NOD2 in recognizing RNA viruses has recently been identified, its role in sensing DNA viruses has not been studied. We report that infection with human cytomegalovirus (HCMV) results in significant induction of NOD2 expression, beginning as early as 2 hours post infection and increasing steadily 24 hours post infection and afterwards. Infection with human herpesvirus 1 and 2 does not induce NOD2 expression. While the HCMV-encoded glycoprotein B is not required for NOD2 induction, a replication competent virion is necessary. Lentivirus-based NOD2 knockdown in human foreskin fibroblasts (HFFs) and U373 glioma cells leads to enhanced HCMV replication along with decreased levels of interferon beta (IFN-beta) and the pro-inflammatory cytokine, IL8. NOD2 induction in HCMV-infected cells activates downstream NF-kappa B and interferon pathways supported by reduced nuclear localization of NF-kappa B and pIRF3 in NOD2 knockdown HFFs. Stable overexpression of NOD2 in HFFs restricts HCMV replication in association with increased levels of IFN-b and IL8. Similarly, transient overexpression of NOD2 in U373 cells or its downstream kinase, RIPK2, results in decreased HCMV replication and enhanced cytokine responses. However, overexpression of a mutant NOD2, 3020insC, associated with severe Crohn's disease, results in enhanced HCMV replication and decreased levels of IFN-b in U373 cells. These results show for the first time that NOD2 plays a significant role in HCMV replication and may provide a model for studies of HCMV recognition by the host cell and HCMV colitis in Crohn's disease.	[Kapoor, Arun; Arav-Boger, Ravit] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Forman, Michael] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Arav-Boger, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	boger@jhmi.edu	Kapoor, Arun/E-8333-2016; Kapoor, Arun/AGR-6910-2022; Kapoor, Arun/AAE-8373-2020	Kapoor, Arun/0000-0002-5811-9093; Kapoor, Arun/0000-0002-5811-9093; Kapoor, Arun/0000-0002-5811-9093	Open Access Promotion Fund of the Johns Hopkins University Libraries	Open Access Promotion Fund of the Johns Hopkins University Libraries	Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Borm MEA, 2008, GENES IMMUN, V9, P274, DOI 10.1038/gene.2008.9; Browne EP, 2001, J VIROL, V75, P12319, DOI 10.1128/JVI.75.24.12319-12330.2001; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Child SJ, 2002, J VIROL, V76, P4912, DOI 10.1128/JVI.76.10.4912-4918.2002; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; DeFilippis VR, 2010, J VIROL, V84, P585, DOI 10.1128/JVI.01748-09; Deshmukh HS, 2009, INFECT IMMUN, V77, P1376, DOI 10.1128/IAI.00940-08; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Griffiths PD, 2000, J ANTIMICROB CHEMOTH, V45, P29, DOI 10.1093/jac/45.suppl_4.29; He R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-40; Hill AVS, 2001, ANNU REV GENOM HUM G, V2, P373, DOI 10.1146/annurev.genom.2.1.373; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kapoor A, 2013, ANTIMICROB AGENTS CH, V57, P2761, DOI 10.1128/AAC.00029-13; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Kijpittayarit S, 2007, CLIN INFECT DIS, V44, P1315, DOI 10.1086/514339; Kim JJ, 2010, DIGEST DIS SCI, V55, P1059, DOI 10.1007/s10620-010-1126-4; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Matsuoka K, 2007, AM J GASTROENTEROL, V102, P331, DOI 10.1111/j.1572-0241.2006.00989.x; MOLVIG J, 1988, SCAND J IMMUNOL, V27, P705, DOI 10.1111/j.1365-3083.1988.tb02404.x; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937; Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500; Rahbar A, 2003, INFLAMM BOWEL DIS, V9, P154, DOI 10.1097/00054725-200305000-00002; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Shaw MH, 2011, TRENDS IMMUNOL, V32, P73, DOI 10.1016/j.it.2010.12.007; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Tanaka Y, 2002, BONE MARROW TRANSPL, V30, P315, DOI 10.1038/sj.bmt.1703661; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Travassos LH, 2010, AUTOPHAGY, V6, P409, DOI 10.4161/auto.6.3.11305; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Watanabe T, 2011, GUT MICROBES, V2, P61, DOI 10.4161/gmic.2.1.15162; Watanabe T, 2010, J CLIN INVEST, V120, P1645, DOI 10.1172/JCI39481; Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6; Xu YX, 2001, J VIROL, V75, P10683, DOI 10.1128/JVI.75.22.10683-10695.2001; YOW MD, 1992, NEW ENGL J MED, V326, P702, DOI 10.1056/NEJM199203053261010	49	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92704	10.1371/journal.pone.0092704	http://dx.doi.org/10.1371/journal.pone.0092704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671169	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000067
J	Nettiksimmons, J; Simonsick, EM; Harris, T; Satterfield, S; Rosano, C; Yaffe, K				Nettiksimmons, Jasmine; Simonsick, Eleanor M.; Harris, Tamara; Satterfield, Suzanne; Rosano, Caterina; Yaffe, Kristine		Hlth ABC Study	The Associations between Serum Brain-Derived Neurotrophic Factor, Potential Confounders, and Cognitive Decline: A Longitudinal Study	PLOS ONE			English	Article							BDNF MESSENGER-RNA; ALZHEIMERS-DISEASE; CARDIORESPIRATORY FITNESS; DECREASED-LEVELS; BLOOD-BRAIN; IMPAIRMENT; DEPRESSION; SURVIVAL; NEURONS; MEN	Brain-derived neurotrophic factor (BDNF) plays a role in the maintenance and function of neurons. Although persons with Alzheimer's disease have lower cortical levels of BDNF, evidence regarding the association between circulating BDNF and cognitive function is conflicting. We sought to determine the correlates of BDNF level and whether BDNF level was prospectively associated with cognitive decline in healthy older adults. We measured serum BDNF near baseline in 912 individuals. Cognitive status was assessed repeatedly with the modified Mini-Mental Status Examination and the Digit Symbol Substitution test over the next 10 years. We evaluated the association between BDNF and cognitive decline with longitudinal models. We also assessed the association between BDNF level and demographics, comorbidities and health behaviors. We found an association between serum BDNF and several characteristics that are also associated with dementia (race and depression), suggesting that future studies should control for these potential confounders. We did not find evidence of a longitudinal association between serum BDNF and subsequent cognitive test trajectories in older adults, although we did identify a potential trend toward a cross-sectional association. Our results suggest that serum BDNF may have limited utility as a biomarker of prospective cognitive decline.	[Nettiksimmons, Jasmine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Simonsick, Eleanor M.] NIA, Clin Res Branch, Baltimore, MD 21224 USA; [Harris, Tamara] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, Bethesda, MD 20892 USA; [Satterfield, Suzanne] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA; [Rosano, Caterina] Univ Pittsburgh, Dept Epidemiol, Ctr Aging & Populat Hlth, Pittsburgh, PA 15261 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco Vet Affairs Med Ctr, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco Vet Affairs Med Ctr, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco Vet Affairs Med Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Tennessee System; University of Tennessee Health Science Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Nettiksimmons, J (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	Jasmine.nettiksimmons@ucsf.edu	Simonsick, Eleanor/W-6864-2019	Rosano, Caterina/0000-0002-4271-6010; Rosano, Caterina/0000-0002-0909-1506	NIA [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106, R01-AG028050]; NINR [R01-NR012459]; Intramural Research Program of the NIH, National Institute of Aging; American Health Assistance Foundation [A201-0029]; National Institute of Aging [K24AG031155]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG007390, N01AG062106, N01AG062103, N01AG062101, P30AG024827, K24AG031155, R01AG028050] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Intramural Research Program of the NIH, National Institute of Aging; American Health Assistance Foundation(BrightFocus Foundation); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the following: NIA contract numbers: N01-AG-6-2101; N01-AG-6-2103; N01-AG-6-2106; NIA grant numbers: R01-AG028050, NINR grant R01-NR012459. This research was supported in part by the Intramural Research Program of the NIH, National Institute of Aging and by a grant from the American Health Assistance Foundation, grant number A201-0029. Dr. Yaffe is supported in part by a National Institute of Aging Grant (K24AG031155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; Angelucci F, 2010, CURR ALZHEIMER RES, V7, P15, DOI 10.2174/156720510790274473; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Bus BAA, 2011, PSYCHONEUROENDOCRINO, V36, P228, DOI 10.1016/j.psyneuen.2010.07.013; Currie J, 2009, NEUROSCI LETT, V451, P152, DOI 10.1016/j.neulet.2008.12.043; Driscoll I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035217; Fahnestock M, 2011, FUTUR NEUROL, V6, P627, DOI 10.2217/FNL.11.44; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gunstad J, 2008, J GERIATR PSYCH NEUR, V21, P166, DOI 10.1177/0891988708316860; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Holsinger RMD, 2000, MOL BRAIN RES, V76, P347, DOI 10.1016/S0169-328X(00)00023-1; Jung SH, 2011, EUR J APPL PHYSIOL, V111, P303, DOI 10.1007/s00421-010-1658-5; Klein AB, 2011, INT J NEUROPSYCHOPH, V14, P347, DOI 10.1017/S1461145710000738; Lang UE, 2004, NEUROPSYCHOPHARMACOL, V29, P795, DOI 10.1038/sj.npp.1300382; Laske C, 2006, J NEURAL TRANSM, V113, P1217, DOI 10.1007/s00702-005-0397-y; Laske C, 2007, J PSYCHIATR RES, V41, P387, DOI 10.1016/j.jpsychires.2006.01.014; Laske C, 2011, INT J NEUROPSYCHOPH, V14, P399, DOI 10.1017/S1461145710001008; Leyhe T, 2008, EUR ARCH PSY CLIN N, V258, P124, DOI 10.1007/s00406-007-0764-9; Li G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005424; Minelli A, 2011, EUR ARCH PSY CLIN N, V261, P323, DOI 10.1007/s00406-011-0189-3; Molendijk ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048046; MURPHY PW, 1993, J READING, V37, P124; O'Bryant SE, 2011, DEMENT GERIATR COGN, V31, P31, DOI 10.1159/000321980; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Wechsler D., 1997, WECHSLER ADULT INTEL; Yasutake C, 2006, EUR ARCH PSY CLIN N, V256, P402, DOI [10.1007/s00406-006-0652-8, 10.1007/s00406-006-0702-2]; Yu H, 2008, J CLIN PSYCHIAT, V69, P1104, DOI 10.4088/JCP.v69n0710; Ziegenhorn AA, 2007, NEUROBIOL AGING, V28, P1436, DOI 10.1016/j.neurobiolaging.2006.06.011	35	48	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91339	10.1371/journal.pone.0091339	http://dx.doi.org/10.1371/journal.pone.0091339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670553	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000333677000018
J	Zueva, KJ; Lumme, J; Veselov, AE; Kent, MP; Lien, S; Primmer, CR				Zueva, Ksenia J.; Lumme, Jaakko; Veselov, Alexey E.; Kent, Matthew P.; Lien, Sigbjorn; Primmer, Craig R.			Footprints of Directional Selection in Wild Atlantic Salmon Populations: Evidence for Parasite-Driven Evolution?	PLOS ONE			English	Article							INFECTIOUS PANCREATIC NECROSIS; GYRODACTYLUS-SALARIS MALMBERG; HISTOCOMPATIBILITY CLASS-I; GENE ONTOLOGY CATEGORIES; IMMUNE-RELEVANT GENES; FATTY-ACIDS; SALINITY TOLERANCE; NATURAL-SELECTION; PROTEIN-KINASE; LOCAL ADAPTATION	Mechanisms of host-parasite co-adaptation have long been of interest in evolutionary biology; however, determining the genetic basis of parasite resistance has been challenging. Current advances in genome technologies provide new opportunities for obtaining a genome-scale view of the action of parasite-driven natural selection in wild populations and thus facilitate the search for specific genomic regions underlying inter-population differences in pathogen response. European populations of Atlantic salmon (Salmo salar L.) exhibit natural variance in susceptibility levels to the ectoparasite Gyrodactylus salaris Malmberg 1957, ranging from resistance to extreme susceptibility, and are therefore a good model for studying the evolution of virulence and resistance. However, distinguishing the molecular signatures of genetic drift and environment-associated selection in small populations such as land-locked Atlantic salmon populations presents a challenge, specifically in the search for pathogen-driven selection. We used a novel genome-scan analysis approach that enabled us to i) identify signals of selection in salmon populations affected by varying levels of genetic drift and ii) separate potentially selected loci into the categories of pathogen (G. salaris)-driven selection and selection acting upon other environmental characteristics. A total of 4631 single nucleotide polymorphisms (SNPs) were screened in Atlantic salmon from 12 different northern European populations. We identified three genomic regions potentially affected by parasite-driven selection, as well as three regions presumably affected by salinity-driven directional selection. Functional annotation of candidate SNPs is consistent with the role of the detected genomic regions in immune defence and, implicitly, in osmoregulation. These results provide new insights into the genetic basis of pathogen susceptibility in Atlantic salmon and will enable future searches for the specific genes involved.	[Zueva, Ksenia J.; Primmer, Craig R.] Univ Turku, Dept Biol, SF-20500 Turku, Finland; [Lumme, Jaakko] Univ Oulu, Dept Biol, Oulu, Finland; [Veselov, Alexey E.] RAS, Inst Biol, Karelian Res Ctr, Petrozavodsk, Russia; [Kent, Matthew P.; Lien, Sigbjorn] Norwegian Univ Life Sci, Ctr Integrat Genet CIGENE, As, Norway; [Kent, Matthew P.; Lien, Sigbjorn] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway	University of Turku; University of Oulu; Russian Academy of Sciences; Karelian Research Centre of the Russian Academy of Sciences; Institute of Biology of Karelian Research Centre RAS; Norwegian University of Life Sciences; Norwegian University of Life Sciences	Zueva, KJ (corresponding author), Univ Turku, Dept Biol, SF-20500 Turku, Finland.	ksezue@utu.fi	Primmer, Craig R/B-8179-2008	Primmer, Craig R/0000-0002-3687-8435; Zueva, Ksenia/0000-0002-9812-214X	Finnish Academy; NordForsk; Finnish Population Genetics Graduate School	Finnish Academy(Academy of Finland); NordForsk; Finnish Population Genetics Graduate School	This study was supported by grants from the Finnish Academy and NordForsk (to CRP), and by Finnish Population Genetics Graduate School (to KJZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2006, TRENDS ECOL EVOL, V21, P433, DOI 10.1016/j.tree.2006.05.010; Adelman JS, 2013, AM NAT, V181, P674, DOI 10.1086/670024; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Anderson M, 2002, J NUTR, V132, P3566, DOI 10.1093/jn/132.12.3566; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Armstrong JD, 2003, FISH RES, V62, P143, DOI 10.1016/S0165-7836(02)00160-1; Asp E, 2008, EUKARYOT CELL, V7, P328, DOI 10.1128/EC.00358-07; BAKKE TA, 1990, J FISH BIOL, V37, P577, DOI 10.1111/j.1095-8649.1990.tb05890.x; Bandyopadhyay A, 2002, J BIOL CHEM, V277, P2360, DOI 10.1074/jbc.M107790200; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; BJORCK S, 1995, QUATERN INT, V27, P19, DOI 10.1016/1040-6182(94)00057-C; Bourret V, 2013, MOL ECOL, V22, P532, DOI 10.1111/mec.12003; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Brenna-Hansen S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-432; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; Calder PC, 2001, LIPIDS, V36, P1007, DOI 10.1007/s11745-001-0812-7; Calder PC, 1998, BRAZ J MED BIOL RES, V31, P467, DOI 10.1590/S0100-879X1998000400002; Carballeira NM, 2008, PROG LIPID RES, V47, P50, DOI 10.1016/j.plipres.2007.10.002; Carval D, 2010, EVOLUTION, V64, P2988, DOI 10.1111/j.1558-5646.2010.01035.x; Chang WH, 2004, CELL CALCIUM, V35, P183, DOI 10.1016/j.ceca.2003.10.012; Cunningham R, 2007, J AM SOC NEPHROL, V18, P1419, DOI 10.1681/ASN.2006090980; Cutter AD, 2013, NAT REV GENET, V14, P262, DOI 10.1038/nrg3425; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; Dionne M, 2007, EVOLUTION, V61, P2154, DOI 10.1111/j.1558-5646.2007.00178.x; Dionne M, 2009, PHILOS T R SOC B, V364, P1555, DOI 10.1098/rstb.2009.0011; Duffy MA, 2009, J ANIM ECOL, V78, P1106, DOI 10.1111/j.1365-2656.2009.01568.x; Eizaguirre C, 2010, J FISH BIOL, V77, P2023, DOI 10.1111/j.1095-8649.2010.02819.x; ELLIOTT JM, 1991, FRESHWATER BIOL, V25, P61, DOI 10.1111/j.1365-2427.1991.tb00473.x; Elphinstone MS, 2003, MOL ECOL NOTES, V3, P317, DOI 10.1046/j.1471-8286.2003.00397.x; Ewart KV, 2005, DEV COMP IMMUNOL, V29, P333, DOI [10.1016/j.dci.2004.08.084, 10.1016/j.dci.2004.08.004]; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frichot E, 2013, MOL BIOL EVOL, V30, P1687, DOI 10.1093/molbev/mst063; Gilbey J, 2004, ANIM GENET, V35, P98, DOI 10.1111/j.1365-2052.2004.01091.x; Gilbey J, 2006, DIS AQUAT ORGAN, V71, P119, DOI 10.3354/dao071119; GONZALEZCABRERA PJ, 1995, J EXP BIOL, V198, P2279; Grimholt U, 2003, IMMUNOGENETICS, V55, P210, DOI 10.1007/s00251-003-0567-8; Harbige LS, 2003, LIPIDS, V38, P323, DOI 10.1007/s11745-003-1067-z; Harris PD, 2011, PARASITES PATHOGENS; HARTLEY SE, 1984, CHROMOSOMA, V89, P377, DOI 10.1007/BF00331255; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Homer CR, 2012, J BIOL CHEM, V287, P25565, DOI 10.1074/jbc.M111.326835; Houston RD, 2010, HEREDITY, V105, P318, DOI 10.1038/hdy.2009.171; Houston RD, 2008, GENETICS, V178, P1109, DOI 10.1534/genetics.107.082974; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Imen R, 2013, MAR FRESHW BEHAV PHY, V46, P59, DOI 10.1080/10236244.2013.793470; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; JOHNSEN BO, 1991, AQUACULTURE, V98, P289, DOI 10.1016/0044-8486(91)90393-L; Jolley KA, 2005, MOL BIOL EVOL, V22, P562, DOI 10.1093/molbev/msi041; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Kania PW, 2010, J HELMINTHOL, V84, P166, DOI 10.1017/S0022149X09990460; KAZAKOV RV, 1991, J FISH BIOL, V39, P1, DOI 10.1111/j.1095-8649.1991.tb04335.x; Kheriji S, 2003, AQUACULT INT, V11, P571, DOI 10.1023/B:AQUI.0000013321.93743.6d; Kiiskinen P, 2003, ANN ZOOL FENN, V40, P441; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kjoglum S, 2006, FISH SHELLFISH IMMUN, V21, P431, DOI 10.1016/j.fsi.2006.02.001; Konishi H, 1996, P NATL ACAD SCI USA, V93, P7639, DOI 10.1073/pnas.93.15.7639; Kuusela J, 2009, ANN ZOOL FENN, V46, P21, DOI 10.5735/086.046.0103; Langefors A, 2001, P ROY SOC B-BIOL SCI, V268, P479, DOI 10.1098/rspb.2000.1378; Larsen PF, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-12; Le Bras Y, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-46; Lien S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-615; Lindenstrom T, 2006, J FISH DIS, V29, P123, DOI 10.1111/j.1365-2761.2006.00696.x; Liska AJ, 2004, PLANT PHYSIOL, V136, P2806, DOI 10.1104/pp.104.039438; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054451; Lohm J, 2002, P ROY SOC B-BIOL SCI, V269, P2029, DOI 10.1098/rspb.2002.2114; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Makinen HS, 2008, MOL ECOL, V17, P3565, DOI 10.1111/j.1365-294X.2008.03714.x; Matejusova I, 2006, INT J PARASITOL, V36, P1175, DOI 10.1016/j.ijpara.2006.04.009; Matsumoto M, 2009, PROTEOMICS, V9, P3549, DOI 10.1002/pmic.200900011; Miyamoto S, 2005, J BIOL CHEM, V280, P28251, DOI 10.1074/jbc.M414129200; Moen T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-368; Nakanishi T, 2002, DEV COMP IMMUNOL, V26, P131, DOI 10.1016/S0145-305X(01)00055-6; Nearing J, 2002, P NATL ACAD SCI USA, V99, P9231, DOI 10.1073/pnas.152294399; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nilsson J, 2001, MOL ECOL, V10, P89, DOI 10.1046/j.1365-294X.2001.01168.x; Norman JD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-420; Norman JD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-81; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; Oleksyk TK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001712; Olsen JB, 2011, CONSERV GENET, V12, P223, DOI 10.1007/s10592-010-0135-3; Ozerov MY, 2010, CONSERV GENET, V11, P1711, DOI 10.1007/s10592-010-0064-1; Papakostas S, 2012, MOL ECOL, V21, P3516, DOI 10.1111/j.1365-294X.2012.05553.x; Papakostas S, 2010, J PROTEOME RES, V9, P4790, DOI 10.1021/pr100507s; Pavlidis P, 2012, MOL BIOL EVOL, V29, P3237, DOI 10.1093/molbev/mss136; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Piertney SB, 2010, GENETICA, V138, P419, DOI 10.1007/s10709-008-9322-2; Pompeia C, 2000, BRAZ J MED BIOL RES, V33, P1255, DOI 10.1590/S0100-879X2000001100001; Primmer CR, 2013, MOL ECOL, V22, P3216, DOI 10.1111/mec.12309; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Rise ML, 2004, PHYSIOL GENOMICS, V20, P21, DOI 10.1152/physiolgenomics.00036.2004; Roberge C, 2007, MOL IMMUNOL, V44, P1374, DOI 10.1016/j.molimm.2006.05.005; Rokas A, 2009, TRENDS ECOL EVOL, V24, P192, DOI 10.1016/j.tree.2008.11.004; Saarnisto M, 2001, GLOBAL PLANET CHANGE, V31, P387, DOI 10.1016/S0921-8181(01)00131-X; Schlenke TA, 2003, GENETICS, V164, P1471; Schlotterer C, 2003, TRENDS GENET, V19, P32, DOI 10.1016/S0168-9525(02)00012-4; Schmid-Hempel P, 2001, NATURWISSENSCHAFTEN, V88, P147, DOI 10.1007/s001140100222; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; STAURNES M, 1994, COMP BIOCHEM PHYS A, V109, P413, DOI 10.1016/0300-9629(94)90145-7; Sun CM, 2013, NUCLEIC ACIDS RES, V41, P7512, DOI 10.1093/nar/gkt510; Sutton JT, 2011, MOL ECOL, V20, P4408, DOI 10.1111/j.1365-294X.2011.05292.x; Teacher AGF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004616; Tielens AG, 2006, 20 UNUSIAL ASPECTS M; Tonteri A, 2005, ANN ZOOL FENN, V42, P1; Tonteri A, 2010, MOL ECOL, V19, P1273, DOI 10.1111/j.1365-294X.2010.04573.x; Tonteri A, 2009, CAN J FISH AQUAT SCI, V66, P717, DOI 10.1139/F09-010; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; Tsoi SCM, 2004, MAR BIOTECHNOL, V6, P199, DOI 10.1007/s10126-002-0101-2; Van Anholt RD, 2012, FISH PHYSIOL BIOCHEM, V38, P703, DOI 10.1007/s10695-011-9552-6; Vasemagi A, 2005, MOL BIOL EVOL, V22, P1067, DOI 10.1093/molbev/msi093; Vasemagi A, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/628204; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Wand M.P., 1995, MONOGRAPHS STAT APPL; Weinman EJ, 2006, LONGITUDINAL STUDY U, V21202, P838; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whitehead A, 2012, J EXP BIOL, V215, P1293, DOI 10.1242/jeb.062075; Whiteley AR, 2011, MOL ECOL, V20, P4259, DOI 10.1111/j.1365-294X.2011.05272.x; Wikelski M, 2004, ECOL SOC, V9; Wysocki M, 2012, ANIM GENET, V43, P328, DOI 10.1111/j.1365-2052.2011.02251.x; Zhao HX, 2012, BIOL PLANTARUM, V56, P64, DOI 10.1007/s10535-012-0017-2; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	133	28	29	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91672	10.1371/journal.pone.0091672	http://dx.doi.org/10.1371/journal.pone.0091672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670947	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000024
J	Chou, PS; Chang, WC; Chou, WP; Liu, ME; Lai, CL; Liu, CK; Ku, YC; Tsai, SJ; Chou, YH; Chang, WP				Chou, Ping-Song; Chang, Wei-Chiao; Chou, Wei-Po; Liu, Mu-En; Lai, Chiou-Lian; Liu, Ching-Kuan; Ku, Yan-Chiou; Tsai, Shih-Jen; Chou, Yii-Her; Chang, Wei-Pin			Increased Risk of Benign Prostate Hyperplasia in Sleep Apnea Patients: A Nationwide Population-Based Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; INTERMITTENT HYPOXIA; GLUCOSE-INTOLERANCE; PATHOGENESIS; ASSOCIATION; ATHEROSCLEROSIS; METAANALYSIS; HIF-1-ALPHA	Background: Sleep apnea (SA) is a common sleep disorder characterized by chronic intermittent hypoxia (IH). Chronic IH induces systemic inflammatory processes, which can cause tissue damage and contribute to prostatic enlargement. The purpose of this study was to evaluate the association between benign prostate hyperplasia (BPH) and SA in a Taiwanese population. Methods: The study population was identified from Taiwan's National Health Insurance Research Database (NHIRD) and contained 202 SA patients and 1010 control patients. The study cohort consisted of men aged >= 30 years who were newly diagnosed with SA between January 1997 and December 2005. Each patient was monitored for 5 years from the index date for the development of BPH. A Cox regression analysis was used to calculate the hazard ratios (HRs) for BPH in the SA and control patients. Results: During the 5-year follow-up, 18 SA patients (8.9%) and 32 non-SA control patients (3.2%) developed BPH. The adjusted HR for BPH was 2.35-fold higher in the patients with SA than in the control patients (95% confidence interval (CI) 1.28-4.29, P<.01). We further divided the SA patients into 4 age groups. After adjusting for potential confounding factors, the highest adjusted HR for BPH in the SA patients compared with the control patients was 5.59 (95% CI = 2.19-14.31, P<.001) in the patients aged between 51 and 65 years. Conclusion: Our study results indicate that patients with SA are associated with increased longitudinal risk of BPH development, and that the effects of SA on BPH development are age-dependent.	[Chou, Ping-Song; Lai, Chiou-Lian; Liu, Ching-Kuan] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Chou, Wei-Po] Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Liu, Mu-En] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Lai, Chiou-Lian; Liu, Ching-Kuan] Kaohsiung Med Univ, Coll Med, Fac Med, Dept & Masters Program Neurol, Kaohsiung, Taiwan; [Ku, Yan-Chiou] Kaohsiung Vet Gen Hosp, Dept Nursing, Kaohsiung, Taiwan; [Tsai, Shih-Jen] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Chou, Yii-Her] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Urol, Kaohsiung, Taiwan; [Chou, Yii-Her] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Chang, Wei-Pin] Yuanpei Univ, Dept Healthcare Management, Hsinchu, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Taipei Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chou, YH (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Med, Dept Urol, Kaohsiung, Taiwan.	yihech@gap.kmu.edu.tw; wpchang@mail.ypu.edu.tw	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X; Chang, Wei-Chiao/0000-0002-8573-5924; Chou, Ping-Song/0000-0003-3693-3323; Chou, Wei-Po/0000-0001-8525-6010				Arnardottir ES, 2009, SLEEP, V32, P447, DOI 10.1093/sleep/32.4.447; Berger AP, 2006, BJU INT, V98, P1038, DOI 10.1111/j.1464-410X.2006.06400.x; Berger AP, 2005, BJU INT, V96, P1073, DOI 10.1111/j.1464-410X.2005.05777.x; Bostanci Y, 2013, CURR OPIN UROL, V23, P5, DOI 10.1097/MOU.0b013e32835abd4a; Chang WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078655; Devulapally K, 2009, HEART FAIL REV, V14, P155, DOI 10.1007/s10741-008-9101-2; Drager LF, 2011, CHEST, V140, P534, DOI 10.1378/chest.10-2223; Fibbi B, 2010, INT J ANDROL, V33, P475, DOI 10.1111/j.1365-2605.2009.00972.x; Gandaglia G, 2013, BJU INT, V112, P432, DOI 10.1111/bju.12118; Garvey JF, 2009, EUR RESPIR J, V33, P1195, DOI 10.1183/09031936.00111208; Haffner SM, 2000, INT J OBESITY, V24, pS56, DOI 10.1038/sj.ijo.0801279; Hatipoglu U, 2003, RESPIRATION, V70, P665, DOI 10.1159/000075218; Kang SH, 2012, BJU INT, V110, pE851, DOI 10.1111/j.1464-410X.2012.11342.x; Kesarwani P, 2010, INDIAN J CLIN BIOCHE, V25, P342, DOI 10.1007/s12291-010-0072-4; Kim HJ, 2013, BBA-MOL BASIS DIS, V1832, P183, DOI 10.1016/j.bbadis.2012.09.002; Kullisaar T, 2012, PROSTATE, V72, P977, DOI 10.1002/pros.21502; Lee Won, 2008, Expert Rev Respir Med, V2, P349, DOI 10.1586/17476348.2.3.349; Liu ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061771; Loke YK, 2012, CIRC-CARDIOVASC QUAL, V5, P720, DOI 10.1161/CIRCOUTCOMES.111.964783; Macoska JA, 2011, DIFFERENTIATION, V82, P253, DOI 10.1016/j.diff.2011.04.003; Mannarino MR, 2012, EUR J INTERN MED, V23, P586, DOI 10.1016/j.ejim.2012.05.013; McNicholas WT, 2009, PROG CARDIOVASC DIS, V51, P392, DOI 10.1016/j.pcad.2008.10.005; McVary KT, 2006, AM J MANAG CARE, V12, pS122; Pamidi S, 2010, BEST PRACT RES CL EN, V24, P703, DOI 10.1016/j.beem.2010.08.009; Punjabi NM, 2004, AM J EPIDEMIOL, V160, P521, DOI 10.1093/aje/kwh261; Punjabi NM, 2003, RESP PHYSIOL NEUROBI, V136, P167, DOI 10.1016/S1569-9048(03)00079-X; Robert G, 2009, PROSTATE, V69, P1774, DOI 10.1002/pros.21027; Ryan S, 2009, THORAX, V64, P631, DOI 10.1136/thx.2008.105577; Schenk JM, 2010, AM J EPIDEMIOL, V171, P571, DOI 10.1093/aje/kwp406; St Sauver Jennifer L, 2008, Curr Prostate Rep, V6, P67, DOI 10.1007/s11918-008-0011-5; Varvarigou V, 2011, SLEEP, V34, P1461, DOI 10.5665/sleep.1376; Vikram A, 2010, EUR J PHARMACOL, V641, P75, DOI 10.1016/j.ejphar.2010.05.042; Wang ZW, 2011, DIFFERENTIATION, V82, P261, DOI 10.1016/j.diff.2011.04.004; Williams AM, 1999, J ANDROL, V20, P474; Yamamoto H, 2007, HYPERTENS RES, V30, P1065, DOI 10.1291/hypres.30.1065; Yuan G, 2008, J CELL PHYSIOL, V217, P674, DOI 10.1002/jcp.21537	36	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93081	10.1371/journal.pone.0093081	http://dx.doi.org/10.1371/journal.pone.0093081			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667846	Green Submitted, Green Published, gold			2022-12-25	WOS:000333675600136
J	Courtot, M; Brinkman, RR; Ruttenberg, A				Courtot, Melanie; Brinkman, Ryan R.; Ruttenberg, Alan			The Logic of Surveillance Guidelines: An Analysis of Vaccine Adverse Event Reports from an Ontological Perspective	PLOS ONE			English	Article							CLASSIFICATION; ANAPHYLAXIS; RISK	Background: When increased rates of adverse events following immunization are detected, regulatory action can be taken by public health agencies. However to be interpreted reports of adverse events must be encoded in a consistent way. Regulatory agencies rely on guidelines to help determine the diagnosis of the adverse events. Manual application of these guidelines is expensive, time consuming, and open to logical errors. Representing these guidelines in a format amenable to automated processing can make this process more efficient. Methods and Findings: Using the Brighton anaphylaxis case definition, we show that existing clinical guidelines used as standards in pharmacovigilance can be logically encoded using a formal representation such as the Adverse Event Reporting Ontology we developed. We validated the classification of vaccine adverse event reports using the ontology against existing rule-based systems and a manually curated subset of the Vaccine Adverse Event Reporting System. However, we encountered a number of critical issues in the formulation and application of the clinical guidelines. We report these issues and the steps being taken to address them in current surveillance systems, and in the terminological standards in use. Conclusions: By standardizing and improving the reporting process, we were able to automate diagnosis confirmation. By allowing medical experts to prioritize reports such a system can accelerate the identification of adverse reactions to vaccines and the response of regulatory agencies. This approach of combining ontology and semantic technologies can be used to improve other areas of vaccine adverse event reports analysis and should inform both the design of clinical guidelines and how they are used in the future.	[Courtot, Melanie; Brinkman, Ryan R.] BC Canc Agcy, Vancouver, BC, Canada; [Brinkman, Ryan R.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Ruttenberg, Alan] SUNY Buffalo, Sch Dent Med, Buffalo, NY 14260 USA	British Columbia Cancer Agency; University of British Columbia; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Courtot, M (corresponding author), BC Canc Agcy, Vancouver, BC, Canada.	mcourtot@gmail.com	Brinkman, Ryan/B-1108-2008	Brinkman, Ryan/0000-0002-9765-2990; Ruttenberg, Alan/0000-0002-1604-3078; Courtot, Melanie/0000-0002-9551-6370	PHAC/CIHR Influenza Research Network (PCIRN); Michael Smith Foundation for Health Research (MSFHR)	PHAC/CIHR Influenza Research Network (PCIRN); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	MC's work was partially funded by the PHAC/CIHR Influenza Research Network (PCIRN, http://pcirn.ca) and the Michael Smith Foundation for Health Research (MSFHR, http://www.msfhr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aduna, SES TRIP; Amit S., 2001, IEEE DATA ENG B, V24, P35; [Anonymous], 2013, CNN; Avorn J, 2000, ANN INTERN MED, V133, P128, DOI 10.7326/0003-4819-133-2-200007180-00012; Ball LK, 1998, PEDIATRICS, V101, P453, DOI 10.1542/peds.101.3.453; Banerji A, 2013, DIR DEV, P1; Bonhoeffer J, 2002, VACCINE, V21, P298, DOI 10.1016/S0264-410X(02)00449-8; Botsis T, 2013, DRUG SAFETY, V36, P573, DOI 10.1007/s40264-013-0064-4; Botsis T, 2011, J AM MED INFORM ASSN, V18, P631, DOI 10.1136/amiajnl-2010-000022; Brighton Collaboration, ABC TOOL; CHEN RT, 1994, VACCINE, V12, P542, DOI 10.1016/0264-410X(94)90315-8; Courtot M, 2011, P INT C BIOM ONT ICB; DiMiceli L, 2006, VACCINE, V24, P703, DOI 10.1016/j.vaccine.2005.07.069; Gagnier JJ, 2013, J CLIN EPIDEMIOLOGY; Gatto M, 2013, CLIN RHEUMATOL, P1; Glanz JM, 2009, PEDIATRICS, V123, P1446, DOI 10.1542/peds.2008-2150; Gold MS, 2010, VACCINE, V28, P4487, DOI 10.1016/j.vaccine.2010.04.041; Horridge M., 2006, OWLED, V216; Horridge M, SEMANTIC WEB, V2, P11; Iskander JK, 2004, PEDIATR ANN, V33, P599, DOI 10.3928/0090-4481-20040901-11; Kelso JM, 1999, J ALLERGY CLIN IMMUN, V103, P698, DOI 10.1016/S0091-6749(99)70245-9; Kohl K S, 2005, ADV PATIENT SAFETY R, V2, P87; Lindsey NP, 2008, VACCINE, V26, P6077, DOI 10.1016/j.vaccine.2008.09.009; Minard J, 2013, J ASTHMA, P1; Moro PL, 2013, VACCINE, P2011; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Scheifele David W, 2003, Semin Pediatr Infect Dis, V14, P213, DOI 10.1016/S1045-1870(03)00036-0; Shearer Rob, 2008, OWLED, V432; Sirin E, 2007, J WEB SEMANT, V5, P51, DOI 10.1016/j.websem.2007.03.004; Slade BA, 2009, JAMA-J AM MED ASSOC, V302, P750, DOI 10.1001/jama.2009.1201; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Smith B, 2008, FRONT ARTIF INTEL AP, V183, P21, DOI 10.3233/978-1-58603-923-3-21; WHO Global Advisory Committee on Vaccine Safety, 2013, M HELD 12 13 JUN; Zafrir Y, 2012, LUPUS, V21, P146, DOI 10.1177/0961203311429318	34	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92632	10.1371/journal.pone.0092632	http://dx.doi.org/10.1371/journal.pone.0092632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667848	gold, Green Published			2022-12-25	WOS:000333675600056
J	Graumann, K				Graumann, Katja			Evidence for LINC1-SUN Associations at the Plant Nuclear Periphery	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; LINC COMPLEXES; SUN PROTEINS; ENVELOPE; CYTOSKELETON; MORPHOLOGY; BRIDGES; DOMAIN; RANGAP; SHAPE	Sad1/UNC84 (SUN) domain proteins are a highly conserved family of inner nuclear membrane localised proteins in eukaryotes. One of their main functions is as key components of nucleo-cytoskeletal bridging complexes, in which SUN proteins associate with nucleoskeletal elements. In metazoans these are the lamins, which form a supportive structural network termed the lamina. Plants lack sequence homologs of lamins but have a similar nucleoplasmic structural network to support the plant NE. Putative components of this plant lamina-like structure are Little Nuclei (LINC) proteins, which bear structural resemblance to lamins and fulfil similar functions. This work explores the associations between AtLINC1, AtSUN1 and AtSUN2. AtLINC1 is recruited to the NE by SUN proteins and is immobilised therein. This recruitment and the immobile properties are likely due to AtSUN1/2-AtLINC1 protein interactions occurring in planta. In addition, the SUN N-terminus appears to play an important role in mediating these interactions. The associations between AtLINC1 and plant SUN proteins are a first indicator of how the nucleoskeleton may be anchored to the nuclear membrane in plants. Building on the previous characterisation of Klarsicht/Anc1/Syne1 homology (KASH) like proteins in plants, this study advances the identification and characterisation of nucleo-cytoskeletal bridging complexes in plants.	Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England	Oxford Brookes University	Graumann, K (corresponding author), Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England.	kgraumann@brookes.ac.uk	Graumann, Katja/AAS-9247-2020; Graumann, Katja/N-8838-2016	Graumann, Katja/0000-0002-1529-8255; Graumann, Katja/0000-0002-1529-8255	Leverhulme Trust [F00382/H, ECF-2012-006]	Leverhulme Trust(Leverhulme Trust)	This research was funded by a Leverhulme Trust research grant (F00382/H) and a Leverhulme Trust Early Career Fellowhip (ECF-2012-006), http://www.leverhulme.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ciska M, 2013, J EXP BOT, V64, P1553, DOI 10.1093/jxb/ert020; Dittmer TA, 2007, PLANT CELL, V19, P2793, DOI 10.1105/tpc.107.053231; Fiserova J, 2009, PLANT J, V59, P243, DOI 10.1111/j.1365-313X.2009.03865.x; Graumann K, 2011, BIOCHEM J, V435, P661, DOI 10.1042/BJ20101769; Graumann K, 2013, NUCLEUS-AUSTIN, V4, P3, DOI 10.4161/nucl.23385; Graumann K, 2010, BIOCHEM SOC T, V38, P741, DOI 10.1042/BST0380741; Graumann K, 2010, PLANT J, V61, P134, DOI 10.1111/j.1365-313X.2009.04038.x; Graunnann K, 2007, BIOL CELL, V99, P553, DOI [10.1042/BC20070013, 10.1042/BC20070033]; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Kimura Y, 2010, CHROMOSOMA, V119, P195, DOI 10.1007/s00412-009-0248-y; Masuda K, 1997, EXP CELL RES, V232, P173, DOI 10.1006/excr.1997.3531; Meier I, 2007, J EXP BOT, V58, P27, DOI 10.1093/jxb/erl009; Mejat A, 2010, NUCLEUS-PHILA, V1, P40, DOI 10.4161/nucl.1.1.10530; Murphy SP, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-269; Oda Y, 2011, PLANT J, V66, P629, DOI 10.1111/j.1365-313X.2011.04523.x; Sakamoto Y, 2013, PLANT CELL PHYSIOL, V54, P622, DOI 10.1093/pcp/pct031; Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Tamura K, 2013, CURR BIOL, V23, P1776, DOI 10.1016/j.cub.2013.07.035; van Damme D, 2004, PLANT J, V40, P386, DOI 10.1111/j.1365-313X.2004.02222.x; Xu XM, 2007, CURR BIOL, V17, P1157, DOI 10.1016/j.cub.2007.05.076; Zhou X, 2012, J CELL BIOL, V196, P203, DOI 10.1083/jcb.201108098	23	49	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93406	10.1371/journal.pone.0093406	http://dx.doi.org/10.1371/journal.pone.0093406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667841	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600174
J	Quan, QM; Chen, LL; Wang, X; Li, S; Yang, XL; Zhu, YG; Wang, M; Cheng, Z				Quan, Qing-Mei; Chen, Ling-Ling; Wang, Xi; Li, Shan; Yang, Xiao-Ling; Zhu, Yun-Guo; Wang, Mu; Cheng, Zhou			Genetic Diversity and Distribution Patterns of Host Insects of Caterpillar Fungus Ophiocordyceps sinensis in the Qinghai-Tibet Plateau	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; CORDYCEPS-SINENSIS; CHLOROPLAST PHYLOGEOGRAPHY; MOLECULAR PHYLOGEOGRAPHY; QUATERNARY CLIMATE; STATISTICAL TESTS; POPULATION-GROWTH; UPLIFT; CONSEQUENCES; MAXIMUM	The caterpillar fungus Ophiocordyceps sinensis is one of the most valuable medicinal fungi in the world, and it requires host insects in family Hepialidae (Lepidoptera) to complete its life cycle. However, the genetic diversity and phylogeographic structures of the host insects remain to be explored. We analyzed the genetic diversity and temporal and spatial distribution patterns of genetic variation of the host insects throughout the O. sinensis distribution. Abundant haplotype and nucleotide diversity mainly existed in the areas of Nyingchi, ShangriLa, and around the edge of the Qinghai-Tibet Plateau, where are considered as the diversity center or micro-refuges of the host insects of O. sinensis. However, there was little genetic variation among host insects from 72.1% of all populations, indicating that the host species composition might be relatively simple in large-scale O. sinensis populations. All host insects are monophyletic except for those from four O. sinensis populations around Qinghai Lake. Significant phylogeographic structure (N-ST > G(ST), P < 0.05) was revealed for the monophyletic host insects, and the three major phylogenetic groups corresponded with specific geographical areas. The divergence of most host insects was estimated to have occurred at ca. 3.7 Ma, shortly before the rapid uplift of the QTP. The geographical distribution and star-like network of the haplotypes implied that most host insects were derived from the relicts of a once-widespread host that subsequently became fragmented. Neutrality tests, mismatch distribution analysis, and expansion time estimation confirmed that most host insects presented recent demographic expansions that began ca. 0.118 Ma in the late Pleistocene. Therefore, the genetic diversity and distribution of the present-day insects should be attributed to effects of the Qinghai-Tibet Plateau uplift and glacial advance/retreat cycles during the Quaternary ice age. These results provide valuable information to guide the protection and sustainable use of these host insects as well as O. sinensis.	[Quan, Qing-Mei; Chen, Ling-Ling; Wang, Xi; Li, Shan; Yang, Xiao-Ling; Zhu, Yun-Guo; Cheng, Zhou] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Wang, Mu] Agr & Anim Husb Coll Tibet, Sch Plant Sci & Technol, Nyingchi, Tibet, Peoples R China	Tongji University; Tibet Agriculture & Animal Husbandry University	Cheng, Z (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	chengzhou@tongji.edu.cn	Chen, Ling-Ling/AAY-3547-2021	CHENG, Zhou/0000-0001-5866-748X	National Natural Science Foundation of China [31270068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (31270068) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Avise John C., 2004, P1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Buenz EJ, 2005, J ETHNOPHARMACOL, V96, P19, DOI 10.1016/j.jep.2004.09.029; Chen ST, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-58; Chen SY, 2008, BOT J LINN SOC, V157, P125, DOI 10.1111/j.1095-8339.2008.00785.x; Chen WY, 1980, VERTEBRAT PALASIATIC, V1, P52; Chu HF, 2004, FAUNA SINICA, V38, P291; Drummond A. J., 2010, GENEIOUS VERSION 4 8; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Falk DA, 1991, GENETICS CONSERVATIO; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Ge XJ, 2002, CONSERV GENET, V3, P351, DOI 10.1023/A:1020579617678; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huenneke LF, 1991, ECOLOGICAL IMPLICATI, P31; KUTZBACH JE, 1989, J GEOPHYS RES-ATMOS, V94, P18393, DOI 10.1029/JD094iD15p18393; Li J.J., 1998, CHINESE SCI BULL, V43, P1569, DOI DOI 10.1360/CSB1998-43-15-1569; LI SP, 2004, OXIDAT STRESS DIS, P657; Li Yu-Ling, 2007, Chinese Bulletin of Entomology, V44, P285; Liang HH, 2008, J MICROBIOL, V46, P549, DOI 10.1007/s12275-008-0107-1; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu F., 2005, CHONGQING J RES CHIN, V51, P45; Madsen DB, 2008, QUATERNARY RES, V69, P316, DOI 10.1016/j.yqres.2007.10.013; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; Newton AC, 1999, TRENDS ECOL EVOL, V14, P140, DOI 10.1016/S0169-5347(98)01555-9; Nylander J, 2008, MRMODELTEST2 V 2 3 P; PONS O, 1995, THEOR APPL GENET, V90, P462, DOI 10.1007/BF00221991; Pons O, 1996, GENETICS, V144, P1237; Qi W.L., 2007, PRATACULTURE ANIMAL, V7, P33; Qiang XK, 2001, EARTH PLANET SC LETT, V187, P83, DOI 10.1016/S0012-821X(01)00281-3; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Quan QM, 2014, J MICROBIOL, V52, P99, DOI 10.1007/s12275-014-3391-y; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Shi Y, 2002, QUATERN INT, V97-8, P79, DOI 10.1016/S1040-6182(02)00053-8; Shi Y.F., 1999, ACTA GEOGRAPH SIN, V54, P10, DOI DOI 10.1007/S11295-016-0968-0; Shi YF, 1998, UPLIFT ENV CHANGES Q; Shimitsu D, 1978, GREEN; SLATKIN M, 1991, GENETICS, V129, P555; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Suzuki H, 2003, BIOL J LINN SOC, V80, P469, DOI 10.1046/j.1095-8312.2003.00253.x; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEMPLETON AR, 1990, ANN MO BOT GARD, V77, P13, DOI 10.2307/2399621; The State Pharmacopoeia Commission of PR China, 2010, PHARM PEOPL REP CHIN, V1, P224; Thomas JA, 2005, PHILOS T R SOC B, V360, P339, DOI 10.1098/rstb.2004.1585; Wang BS, 2011, MOL ECOL, V20, P3796, DOI 10.1111/j.1365-294X.2011.05157.x; Wang CS, 2008, P NATL ACAD SCI USA, V105, P4987, DOI 10.1073/pnas.0703595105; Wang GD, 1995, CORDYCEPS SPECIES EC, P307; Wang XL, 2011, ZOOKEYS, P43, DOI 10.3897/zookeys.127.802; Yang Darong, 1996, Acta Entomologica Sinica, V39, P413; Yang FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037196; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yang P, 2005, QINGHAI ENV, V3, P93; Yang SJ, 2009, PROG NAT SCI-MATER, V19, P789, DOI 10.1016/j.pnsc.2008.10.006; Yao YJ, 2004, SCI NEWS, V15, P28; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Yuan B.Y., 1990, QUATERNARY SCI, V3, P233; Yuan Y, 2012, J ANHUI AGR SCI, V40, P9815; Zakharov EV, 2004, SYST BIOL, V53, P193, DOI 10.1080/10635150490423403; Zeng LY, 2010, J SYST EVOL, V48, P257, DOI 10.1111/j.1759-6831.2010.00084.x; Zhan XJ, 2011, MOL ECOL, V20, P3014, DOI 10.1111/j.1365-294X.2011.05144.x; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x; Zhang TC, 2011, MOL PHYLOGENET EVOL, V60, P1, DOI 10.1016/j.ympev.2011.04.009; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X; Zhou C, 2007, PROG NAT SCI-MATER, V17, P789, DOI 10.1080/10002007088537474; Zhu HY, 2006, CRISIS BREAKTHROUGH, P291; Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P289, DOI 10.1089/acm.1998.4.3-289; Zhuo Z, 1998, EPISODES, V21, P152; Zou ZW, 2010, J HUNAN U SCI TECHNO, V25, P114, DOI DOI 10.3969/J.ISSN.1672-9102.2010.01.025	80	31	31	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92293	10.1371/journal.pone.0092293	http://dx.doi.org/10.1371/journal.pone.0092293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667533	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600030
J	Sakka, L; Deletage, N; Lalloue, F; Duval, A; Chazal, J; Lemaire, JJ; Meiniel, A; Monnerie, H; Gobron, S				Sakka, Laurent; Deletage, Nathalie; Lalloue, Fabrice; Duval, Amelie; Chazal, Jean; Lemaire, Jean-Jacques; Meiniel, Annie; Monnerie, Hubert; Gobron, Stephane			SCO-Spondin Derived Peptide NX210 Induces Neuroprotection In Vitro and Promotes Fiber Regrowth and Functional Recovery after Spinal Cord Injury	PLOS ONE			English	Article							TYPE-1 REPEAT TSR; SUBCOMMISSURAL ORGAN; NEURITE OUTGROWTH; REISSNERS FIBER; TIRILAZAD MESYLATE; PLACING REACTIONS; CONTUSION MODEL; POTENT ACTIVITY; REGENERATION; COMPLEX	In mammals, the limited regenerating potential of the central nervous system (CNS) in adults contrasts with the plasticity of the embryonic and perinatal periods. SCO (subcommissural organ)-spondin is a protein secreted early by the developing central nervous system, potentially involved in the development of commissural fibers. SCO-spondin stimulates neuronal differentiation and neurite growth in vitro. NX210 oligopeptide was designed from SCO-spondin's specific thrombospondin type 1 repeat (TSR) sequences that support the main neurogenic properties of the molecule. The objective of this work was to assess the neuroprotective and neuroregenerative properties of NX210 in vitro and in vivo for the treatment of spinal cord injury (SCI). In vitro studies were carried out on the B104 neuroblastoma cell line demonstrating neuroprotection by the resistance to oxidative damage using hydrogen peroxide and the measure of cell viability by metabolic activity. In vivo studies were performed in two rat models of SCI: (1) a model of aspiration of dorsal funiculi followed by the insertion of a collagen tube in situ to limit collateral sprouting; white matter regeneration was assessed using neurofilament immunostaining; (2) a rat spinal cord contusion model to assess functional recovery using BBB scale and reflex testing. We demonstrate for the first time that NX210 (a) provides neuroprotection to oxidative stress in the B104 neuroblastoma cells, (b) stimulates axonal regrowth in longitudinally oriented neofibers in the aspiration model of SCI and (c) significantly improves functional recovery in the contusive model of SCI.	[Sakka, Laurent; Chazal, Jean; Lemaire, Jean-Jacques] Univ Auvergne, EA7282, Fac Med, Clermont Ferrand, France; [Deletage, Nathalie; Duval, Amelie; Gobron, Stephane] Neuronax, Biopole Clermont Limagne, St Beauzire, France; [Sakka, Laurent; Chazal, Jean; Lemaire, Jean-Jacques] Ctr Hosp & Univ Clermont Ferrand, Serv Neurochirurg, Clermont Ferrand, France; [Lalloue, Fabrice] Fac Med Limoges, EA3842, F-87025 Limoges, France; [Meiniel, Annie] Univ Auvergne, Lab GReD Inserm CNRS U110, UMR 629, Fac Med, Clermont Ferrand, France; [Monnerie, Hubert] Childrens Hosp Philadelphia, Dept Neurol, Philadelphia, PA 19104 USA	Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Sakka, L (corresponding author), Univ Auvergne, EA7282, Fac Med, Clermont Ferrand, France.	laurent.sakka@udamail.fr	Gobron, Stephane/AAJ-5390-2021	Lalloue, Fabrice/0000-0003-0382-4948; Lemaire, Jean-Jacques/0000-0003-4395-5328; Gobron, Stephane/0000-0002-2318-352X	European Regional Development Fund; Regional Council of Auvergne	European Regional Development Fund(European Commission); Regional Council of Auvergne(Region Auvergne-Rhone-Alpes)	This work was supported by the European Regional Development Fund (http://ec.europa.eu/regional_policy/thefunds/regional/index_fr.cfm) and the Regional Council of Auvergne (http://www.auvergne.fr). The funders (European Regional Development Fund and the Regional Council of Auvergne) had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams JC, 2000, DEV DYNAM, V218, P280; AMASSIAN VE, 1973, J PHYSIOL-LONDON, V230, pP55; Bamdad M, 2004, CELL TISSUE RES, V315, P15, DOI 10.1007/s00441-003-0793-2; Bao F, 2008, EXP NEUROL, V214, P160, DOI 10.1016/j.expneurol.2008.09.006; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Barreiro-Iglesias A, 2009, NEUROSCI LETT, V464, P34, DOI 10.1016/j.neulet.2009.08.019; Barros CS, 2009, DEVELOPMENT, V136, P2717, DOI 10.1242/dev.038679; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bignami G, 1996, ENVIRON HEALTH PERSP, V104, P285, DOI 10.2307/3432648; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; BRADLEY NS, 1983, EXP NEUROL, V82, P73, DOI 10.1016/0014-4886(83)90244-3; Buss A, 2007, BRAIN, V130, P940, DOI 10.1093/brain/awl374; Cao QL, 2005, EXP NEUROL, V191, pS3, DOI 10.1016/j.expneurol.2004.08.026; Chen ZL, 2009, DEV BIOL, V327, P158, DOI 10.1016/j.ydbio.2008.12.006; Chernoff EAG, 1996, INT J DEV BIOL, V40, P823; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; DIDIER R, 1992, DEV NEUROSCI-BASEL, V14, P44, DOI 10.1159/000111646; Dietz V, 2006, LANCET NEUROL, V5, P688, DOI 10.1016/S1474-4422(06)70522-1; DONATELLE JM, 1977, J COMP NEUROL, V175, P207, DOI 10.1002/cne.901750205; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Duchossoy Y, 2001, EXP NEUROL, V167, P329, DOI 10.1006/exnr.2000.7556; Estivill-Torrus G, 2001, MECH DEVELOP, V109, P215, DOI 10.1016/S0925-4773(01)00527-5; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Fehlings MG, 2010, SPINE, V35, pS166, DOI 10.1097/BRS.0b013e3181f386f6; Ferretti P, 2003, DEV DYNAM, V226, P245, DOI 10.1002/dvdy.10226; FORSSBERG H, 1974, ACTA PHYSIOL SCAND, V92, P114, DOI 10.1111/j.1748-1716.1974.tb05727.x; Fouad K, 2000, BEHAV BRAIN RES, V115, P107, DOI 10.1016/S0166-4328(00)00244-8; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; Gerlai R, 1999, TRENDS NEUROSCI, V22, P47, DOI 10.1016/S0166-2236(98)01346-0; Gobron S, 2000, GLIA, V32, P177, DOI 10.1002/1098-1136(200011)32:2<177::AID-GLIA70>3.0.CO;2-V; Gu XQ, 1996, BRAIN RES, V735, P50; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Hawthorne AL, 2011, J NEUROSCI, V31, P5605, DOI 10.1523/JNEUROSCI.6663-10.2011; Hilario JD, 2009, DEV BIOL, V326, P190, DOI 10.1016/j.ydbio.2008.11.007; Hill CE, 2001, EXP NEUROL, V171, P153, DOI 10.1006/exnr.2001.7734; HUBER G, 1985, J CELL BIOL, V100, P496, DOI 10.1083/jcb.100.2.496; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Lehmann C, 2005, DEV BRAIN RES, V154, P1, DOI 10.1016/j.devbrainres.2004.09.009; Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Meiniel A, 2003, INT REV CYTOL, V230, P1, DOI 10.1016/S0074-7696(03)30001-4; Meiniel A, 1996, PROG HISTOCHEM CYTOC, V30, P1; Meiniel A, 2001, MICROSC RES TECHNIQ, V52, P484, DOI 10.1002/1097-0029(20010301)52:5<484::AID-JEMT1034>3.0.CO;2-0; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Monnerie H, 1997, CELL TISSUE RES, V287, P285, DOI 10.1007/s004410050753; Monnerie H, 1998, CELL TISSUE RES, V293, P407, DOI 10.1007/s004410051132; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Roof RL, 2001, STROKE, V32, P2648, DOI 10.1161/hs1101.097397; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Saunders NR, 1998, J NEUROSCI, V18, P339; Sedy J, 2008, NEUROSCI BIOBEHAV R, V32, P550, DOI 10.1016/j.neubiorev.2007.10.001; Seki T, 2002, NEUROSURGERY, V50, P1075, DOI 10.1097/00006123-200205000-00024; Snow DM, 2003, EXP NEUROL, V182, P310, DOI 10.1016/S0014-4886(03)00034-7; Stanic K, 2010, DEV DYNAM, V239, P2584, DOI 10.1002/dvdy.22387; Toda M, 1999, DEV BRAIN RES, V114, P193, DOI 10.1016/S0165-3806(99)00030-9; TYNDALE RF, 1994, J NEUROSCI, V14, P5417; vonEuler M, 1997, EXP NEUROL, V145, P502, DOI 10.1006/exnr.1997.6481; Yoo S, 2003, J NEUROSCI RES, V74, P541, DOI 10.1002/jnr.10771; Zisman S, 2007, J CELL BIOL, V178, P1237, DOI 10.1083/jcb.200702184	64	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93179	10.1371/journal.pone.0093179	http://dx.doi.org/10.1371/journal.pone.0093179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667843	Green Submitted, Green Published, gold			2022-12-25	WOS:000333675600154
J	Terao, M; Tani, M; Itoi, S; Yoshimura, T; Hamasaki, T; Murota, H; Katayama, I				Terao, Mika; Tani, Mamori; Itoi, Saori; Yoshimura, Takuji; Hamasaki, Toshimitsu; Murota, Hiroyuki; Katayama, Ichiro			11 beta-Hydroxysteroid Dehydrogenase 1 Specific Inhibitor Increased Dermal Collagen Content and Promotes Fibroblast Proliferation	PLOS ONE			English	Article							GLUCOCORTICOID SYNTHESIS; CARDIAC STEROIDOGENESIS; SKIN COLLAGEN; EXPRESSION; TYPE-1; RECEPTOR; 11-BETA-HSD1; PROGRESSION; METABOLISM; RESPONSES	Glucocorticoids (GCs) are one of the most effective anti-inflammatory drugs for treating acute and chronic inflammatory diseases. However, several studies have shown that GCs alter collagen metabolism in the skin and induce skin atrophy. Cortisol is the endogenous GC that is released in response to various stressors. Over the last decade, extraadrenal cortisol production in various tissues has been reported. Skin also synthesizes cortisol through a de novo pathway and through an activating enzyme. 11 beta-hydroxysteroid dehydrogenase 1 (11 beta-HSD1) is the enzyme that catalyzes the conversion of hormonally inactive cortisone to active cortisol in cells. We previously found that 11 beta-HSD1 negatively regulates proliferation of keratinocytes. To determine the function of 11 beta-HSD1 in dermal fibroblasts and collagen metabolism, the effect of a selective 11 beta-HSD1 inhibitor was studied in mouse tissues and dermal fibroblasts. The expression of 11 beta-HSD1 increased with age in mouse skin. Subcutaneous injection of a selective 11 beta-HSD1 inhibitor increased dermal thickness and collagen content in the mouse skin. In vitro, proliferation of dermal fibroblasts derived from 11 beta-HSD1 null mice (Hsd11b1(-/-) mice) was significantly increased compared with fibroblasts from wild-type mice. However, in vivo, dermal thickness of Hsd11b1(-/-) mice was not altered in 3-month-old and 1-year-old mouse skin compared with wild-type mouse skin. These in vivo findings suggest the presence of compensatory mechanisms in Hsd11b1(-/-) mice. Our findings suggest that 11 beta-HSD1 inhibition may reverse the decreased collagen content observed in intrinsically and extrinsically aged skin and in skin atrophy that is induced by GC treatment.	[Terao, Mika; Tani, Mamori; Itoi, Saori; Murota, Hiroyuki; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka, Japan; [Yoshimura, Takuji] Osaka Univ, Sch Med, Inst Expt Anim Sci, Lab Reprod Engn, Suita, Osaka 565, Japan; [Hamasaki, Toshimitsu] Osaka Univ, Grad Sch Med, Dept Biomed Stat, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Terao, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka, Japan.	mterao@derma.med.osaka-u.ac.jp	Hamasaki, Toshimitsu/N-3851-2015	Hamasaki, Toshimitsu/0000-0002-4928-1160; Yoshimura, Takuji/0000-0002-7856-0679	Japan Society for the Promotion of Science [24659529, 24689045]; Cosmetology Research Foundation; Grants-in-Aid for Scientific Research [24659529] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cosmetology Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Exploratory Research (No. 24659529) and Grant-in-Aid for Young Scientists (A) (No. 24689045) and from the Japan Society for the Promotion of Science and The Cosmetology Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbeck M, 2010, EXP DERMATOL, V19, P757, DOI 10.1111/j.1600-0625.2010.01099.x; Baumann L, 2007, J PATHOL, V211, P241, DOI 10.1002/path.2098; Chebotaev D, 2007, MOL CARCINOGEN, V46, P732, DOI 10.1002/mc.20349; Chebotaev DV, 2007, J INVEST DERMATOL, V127, P2749, DOI 10.1038/sj.jid.5700992; Chung JH, 2000, J INVEST DERMATOL, V115, P177, DOI 10.1046/j.1523-1747.2000.00009.x; Cirillo N, 2011, J CELL BIOCH; Coste A, 2007, P NATL ACAD SCI USA, V104, P13098, DOI 10.1073/pnas.0702440104; Davies E, 2003, CLIN EXP PHARMACOL P, V30, P437, DOI 10.1046/j.1440-1681.2003.03867.x; Ezure T, 2010, EXP DERMATOL, V19, P878, DOI 10.1111/j.1600-0625.2009.00970.x; FENSKE NA, 1986, J AM ACAD DERMATOL, V15, P571, DOI 10.1016/S0190-9622(86)70208-9; Hannen RF, 2011, BIOCHEM BIOPH RES CO, V404, P62, DOI 10.1016/j.bbrc.2010.11.059; Hardy R, 2008, ANN RHEUM DIS, V67, P1204, DOI 10.1136/ard.2008.090662; Hermanowski-Vosatka A, 2005, J EXP MED, V202, P517, DOI 10.1084/jem.20050119; Hostettler N, 2012, ALLERGY, V67, P227, DOI 10.1111/j.1398-9995.2011.02749.x; Ishii T, 2007, FEBS LETT, V581, P349, DOI 10.1016/j.febslet.2006.11.032; Kayes-Wandover KM, 2000, J CLIN ENDOCR METAB, V85, P2519, DOI 10.1210/jc.85.7.2519; Kohl E, 2011, J EUR ACAD DERMATOL, V25, P873, DOI 10.1111/j.1468-3083.2010.03963.x; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; LEHMANN P, 1983, J INVEST DERMATOL, V81, P169, DOI 10.1111/1523-1747.ep12543603; Mueller M, 2006, J EXP MED, V203, P2057, DOI 10.1084/jem.20060357; Noti M, 2010, J EXP MED, V207, P1057, DOI 10.1084/jem.20090849; Nuutinen P, 2001, J EUR ACAD DERMATOL, V15, P361, DOI 10.1046/j.1468-3083.2001.00272-4.x; Odermatt A, 2006, MOL CELL ENDOCRINOL, V248, P15, DOI 10.1016/j.mce.2005.11.040; Ohtani T, 2009, J HYPERTENS, V27, P1074, DOI 10.1097/HJH.0b013e328326cb04; Oishi Y, 2002, BRIT J DERMATOL, V147, P859, DOI 10.1046/j.1365-2133.2002.04949.x; Quan TH, 2010, J INVEST DERMATOL, V130, P415, DOI 10.1038/jid.2009.224; SALDANHA C, 1986, CLIN EXP RHEUMATOL, V4, P365; Sandeep TC, 2001, TRENDS ENDOCRIN MET, V12, P446, DOI 10.1016/S1043-2760(01)00499-4; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Seckl JR, 2001, ENDOCRINOLOGY, V142, P1371, DOI 10.1210/en.142.4.1371; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2004, EUR J BIOCHEM, V271, P4178, DOI 10.1111/j.1432-1033.2004.04356.x; Slominski A, 2006, J INVEST DERMATOL, V126, P1177, DOI 10.1038/sj.jid.5700204; Slominski Andrzej, 2008, Drug Discov Today Dis Mech, V5, P137; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Terao M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025039; Terao M, 2010, EXP DERMATOL, V19, P38, DOI 10.1111/j.1600-0625.2009.00973.x; Tiganescu A, 2013, J CLIN INVEST, V123, P3051, DOI 10.1172/JCI64162; Tiganescu A, 2011, J INVEST DERMATOL, V131, P30, DOI 10.1038/jid.2010.257; Vukelic S, 2011, J BIOL CHEM, V286, P10265, DOI 10.1074/jbc.M110.188268; Young MJ, 2001, J CLIN ENDOCR METAB, V86, P5121, DOI 10.1210/jc.86.11.5121; Zhou JG, 2005, STEROIDS, V70, P407, DOI 10.1016/j.steroids.2005.02.006	42	18	19	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93051	10.1371/journal.pone.0093051	http://dx.doi.org/10.1371/journal.pone.0093051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667799	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600133
J	Xiong, HY; Li, JJ; Liu, PL; Duan, JZ; Zhao, Y; Guo, X; Li, Y; Zhang, HL; Ali, J; Li, ZC				Xiong, Haiyan; Li, Jinjie; Liu, Pengli; Duan, Junzhi; Zhao, Yan; Guo, Xiao; Li, Yang; Zhang, Hongliang; Ali, Jauhar; Li, Zichao			Overexpression of OsMYB48-1, a Novel MYB-Related Transcription Factor, Enhances Drought and Salinity Tolerance in Rice	PLOS ONE			English	Article							RESPONSIVE GENE-EXPRESSION; ABSCISIC-ACID BIOSYNTHESIS; OSMOTIC-STRESS TOLERANCE; FUNCTIONAL-ANALYSIS; WATER-STRESS; GRAIN-YIELD; LEA GENE; COLD; SALT; DEHYDRATION	MYB-type transcription factors (TFs) play essential roles in plant growth, development and respond to environmental stresses. Role of MYB-related TFs of rice in drought stress tolerance is not well documented. Here, we report the isolation and characterization of a novel MYB-related TF, OsMYB48-1, of rice. Expression of OsMYB48-1 was strongly induced by polyethylene glycol (PEG), abscisic acid (ABA), H2O2, and dehydration, while being slightly induced by high salinity and cold treatment. The OsMYB48-1 protein was localized in the nucleus with transactivation activity at the C terminus. Overexpression of OsMYB48-1 in rice significantly improved tolerance to simulated drought and salinity stresses caused by mannitol, PEG, and NaCl, respectively, and drought stress was caused by drying the soil. In contrast to wild type plants, the overexpression lines exhibited reduced rate of water loss, lower malondialdehyde (MDA) content and higher proline content under stress conditions. Moreover, overexpression plants were hypersensitive to ABA at both germination and post-germination stages and accumulated more endogenous ABA under drought stress conditions. Further studies demonstrated that overexpression of OsMYB48-1 could regulate the expression of some ABA biosynthesis genes (OsNCED4, OsNCED5), early signaling genes (OsPP2C68, OSRK1) and late responsive genes (RAB21, OsLEA3, RAB16C and RAB16D) under drought stress conditions. Collectively, these results suggested that OsMYB48-1 functions as a novel MYB-related TF which plays a positive role in drought and salinity tolerance by regulating stress-induced ABA synthesis.	[Xiong, Haiyan; Li, Jinjie; Liu, Pengli; Duan, Junzhi; Zhao, Yan; Guo, Xiao; Li, Yang; Zhang, Hongliang; Li, Zichao] China Agr Univ, Minist Educ, Key Lab Crop Heterosis & Utilizat, Beijing 100094, Peoples R China; [Xiong, Haiyan; Li, Jinjie; Liu, Pengli; Duan, Junzhi; Zhao, Yan; Guo, Xiao; Li, Yang; Zhang, Hongliang; Li, Zichao] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Beijing 100094, Peoples R China; [Ali, Jauhar] Int Rice Res Inst, Manila, Philippines	China Agricultural University; China Agricultural University; CGIAR; International Rice Research Institute (IRRI)	Li, ZC (corresponding author), China Agr Univ, Minist Educ, Key Lab Crop Heterosis & Utilizat, Beijing 100094, Peoples R China.	lizichao@cau.edu.cn	Xiong, Haiyan/AAL-9383-2021; Ali, Jauhar Ali or A. Jauhar/E-4432-2012; Li, Zichao/AAS-8954-2021	Xiong, Haiyan/0000-0003-4145-2719; Ali, Jauhar Ali or A. Jauhar/0000-0002-3177-2607; Li, Zichao/0000-0002-3186-1132	National Natural Science Foundation of China [31061140458]; Ministry of Agriculture of the People's Republic of China [2011ZX08009-003-002]; National Basic Research Program of China [2010CB125904]; Program of the Co-Construction with Beijing Municipal Commission of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs); National Basic Research Program of China(National Basic Research Program of China); Program of the Co-Construction with Beijing Municipal Commission of Education of China	This work was supported by grants from National Natural Science Foundation of China (Grant No. 31061140458. http://www.nsfc.gov.cn/Portal0/default166.htm); Ministry of Agriculture of the People's Republic of China (Grant No. 2011ZX08009-003-002. http://english.agri.gov.cn/np/); National Basic Research Program of China (Grant No. 2010CB125904. http://www.973.gov.cn/English/Index.aspx); the Program of the Co-Construction with Beijing Municipal Commission of Education of China (http://english.bjedu.gov.cn/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Chae MJ, 2007, PLANT MOL BIOL, V63, P151, DOI 10.1007/s11103-006-9079-x; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chen ZZ, 2005, PLANT J, V43, P273, DOI 10.1111/j.1365-313X.2005.02452.x; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Denekamp M, 2003, PLANT PHYSIOL, V132, P1415, DOI 10.1104/pp.102.019273; Du H, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1, DOI 10.1134/S0006297909010015; Duan JZ, 2012, PLANT SCI, V196, P143, DOI 10.1016/j.plantsci.2012.08.003; El-kereamy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052030; Finkelstein Ruth R., 2002, Plant Cell, V14, pS15; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Ganesan G, 2012, J EXP BOT, V63, P4549, DOI 10.1093/jxb/ers135; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hou X, 2009, P NATL ACAD SCI USA, V106, P6410, DOI 10.1073/pnas.0901940106; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Hwang SG, 2010, PLANT SCI, V178, P12, DOI 10.1016/j.plantsci.2009.09.014; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Lu CA, 2002, PLANT CELL, V14, P1963, DOI 10.1105/tpc.001735; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Oh SJ, 2009, PLANT PHYSIOL, V150, P1368, DOI 10.1104/pp.109.137554; Pasquali G, 2008, PLANT CELL REP, V27, P1677, DOI 10.1007/s00299-008-0587-9; RoyChoudhury A, 2007, PLANT CELL REP, V26, P1839, DOI 10.1007/s00299-007-0371-2; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Shin D, 2011, PLANT PHYSIOL, V155, P421, DOI 10.1104/pp.110.163634; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Song SY, 2011, PLANTA, V234, P331, DOI 10.1007/s00425-011-1403-2; Su CF, 2010, PLANT PHYSIOL, V153, P145, DOI 10.1104/pp.110.153015; Tang N, 2012, PLANT PHYSIOL, V158, P1755, DOI 10.1104/pp.111.190389; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Vannini C, 2007, PLANT SCI, V173, P231, DOI 10.1016/j.plantsci.2007.05.007; Wang HG, 2007, THEOR APPL GENET, V115, P1109, DOI 10.1007/s00122-007-0637-7; Wang HH, 2007, PLANT MOL BIOL, V65, P799, DOI 10.1007/s11103-007-9244-x; Wang M, 2004, PLANT MOL BIOL REP, V22, P409, DOI 10.1007/BF02772683; Wang ZY, 2011, PLANT CELL, V23, P1971, DOI 10.1105/tpc.110.081943; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Xiao BZ, 2007, THEOR APPL GENET, V115, P35, DOI 10.1007/s00122-007-0538-9; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Yue YS, 2012, J EXP BOT, V63, P3741, DOI 10.1093/jxb/ers069; Zhang LC, 2012, J EXP BOT, V63, P5873, DOI 10.1093/jxb/ers237; Zhu QH, 2004, PLANT PHYSIOL, V135, P1514, DOI 10.1104/pp.104.041459	50	212	236	18	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92913	10.1371/journal.pone.0092913	http://dx.doi.org/10.1371/journal.pone.0092913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667379	gold, Green Submitted, Green Published			2022-12-25	WOS:000333675600104
J	Ojo, KK; Reid, MC; Siddaramaiah, LK; Muller, J; Winzer, P; Zhang, ZS; Keyloun, KR; Vidadala, RSR; Merritt, EA; Hol, WGJ; Maly, DJ; Fan, EK; Van Voorhis, WC; Hemphill, A				Ojo, Kayode K.; Reid, Molly C.; Siddaramaiah, Latha Kallur; Mueller, Joachim; Winzer, Pablo; Zhang, Zhongsheng; Keyloun, Katelyn R.; Vidadala, Rama Subba Rao; Merritt, Ethan A.; Hol, Wim G. J.; Maly, Dustin J.; Fan, Erkang; Van Voorhis, Wesley C.; Hemphill, Andrew			Neospora caninum Calcium-Dependent Protein Kinase 1 Is an Effective Drug Target for Neosporosis Therapy	PLOS ONE			English	Article							TOXOPLASMA-GONDII TACHYZOITES; HOST-CELLS; INHIBITORS; INVASION; MICE; CDPK1; TRANSMISSION; CHALLENGE; SECRETION; INFECTION	Despite the enormous economic importance of Neospora caninum related veterinary diseases, the number of effective therapeutic agents is relatively small. Development of new therapeutic strategies to combat the economic impact of neosporosis remains an important scientific endeavor. This study demonstrates molecular, structural and phenotypic evidence that N. caninum calcium-dependent protein kinase 1 (NcCDPK1) is a promising molecular target for neosporosis drug development. Recombinant NcCDPK1 was expressed, purified and screened against a select group of bumped kinase inhibitors (BKIs) previously shown to have low IC(50)s against Toxoplasma gondii CDPK1 and T. gondii tachyzoites. NcCDPK1 was inhibited by low concentrations of BKIs. The three-dimensional structure of NcCDPK1 in complex with BKIs was studied crystallographically. The BKI-NcCDPK1 structures demonstrated the structural basis for potency and selectivity. Calcium-dependent conformational changes in solution as characterized by small-angle X-ray scattering are consistent with previous structures in low Calcium-state but different in the Calcium-bound active state than predicted by X-ray crystallography. BKIs effectively inhibited N. caninum tachyzoite proliferation in vitro. Electron microscopic analysis of N. caninum cells revealed ultra-structural changes in the presence of BKI compound 1294. BKI compound 1294 interfered with an early step in Neospora tachyzoite host cell invasion and egress. Prolonged incubation in the presence of 1294 interfered produced observable interference with viability and replication. Oral dosing of BKI compound 1294 at 50 mg/kg for 5 days in established murine neosporosis resulted in a 10-fold reduced cerebral parasite burden compared to untreated control. Further experiments are needed to determine the PK, optimal dosage, and duration for effective treatment in cattle and dogs, but these data demonstrate proof-of-concept for BKIs, and 1294 specifically, for therapy of bovine and canine neosporosis.	[Ojo, Kayode K.; Reid, Molly C.; Keyloun, Katelyn R.; Van Voorhis, Wesley C.] Univ Washington, Dept Med, Div Allergy & Infect Dis, CERID, Seattle, WA 98195 USA; [Siddaramaiah, Latha Kallur; Zhang, Zhongsheng; Merritt, Ethan A.; Hol, Wim G. J.; Fan, Erkang] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Mueller, Joachim; Winzer, Pablo; Hemphill, Andrew] Univ Bern, Vetsuisse Fac, Inst Parasitol, Bern, Switzerland; [Vidadala, Rama Subba Rao; Maly, Dustin J.] Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Bern; University of Washington; University of Washington Seattle	Ojo, KK (corresponding author), Univ Washington, Dept Med, Div Allergy & Infect Dis, CERID, Seattle, WA 98195 USA.	ojo67kk@u.washington.edu; wesley@uw.edu; andrew.hemphill@vetsuisse.unibe.ch	Ojo, Kayode/AAB-2490-2019; Ojo, Kayode K/X-9307-2019; Zhang, zs/GXN-3521-2022	Ojo, Kayode K/0000-0002-2007-2170; Muller, Joachim/0000-0001-8189-9270; Maly, Dustin/0000-0003-0094-0177; Hemphill, Andrew/0000-0002-0622-2128	National Institutes of Health [1 R01 AI089441, 5 R01 AI080625, R01GM086858]; University of Washington Plein Endowment for Geriatric Pharmacy Research; Swiss National Science Foundation [310030 146162]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089441, R01AI080625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Plein Endowment for Geriatric Pharmacy Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants (1 R01 AI089441 and 5 R01 AI080625 to WCVV) and (R01GM086858 to DJM). KRK was supported by a training scholarship from the University of Washington Plein Endowment for Geriatric Pharmacy Research. The Hemphill lab was supported by the Swiss National Science Foundation grant 310030 146162. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber JS, 1996, VET REC, V139, P439, DOI 10.1136/vr.139.18.439; Barna F, 2013, ANTIMICROB AGENTS CH, V57, P5747, DOI 10.1128/AAC.02446-12; Brumlik MJ, 2004, INT J PARASITOL, V34, P1245, DOI 10.1016/j.ijpara.2004.07.007; Castellanos-Gonzalez A, 2013, J INFECT DIS, V208, P1342, DOI 10.1093/infdis/jit327; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; Darius AK, 2004, PARASITOL RES, V92, P520, DOI 10.1007/s00436-003-1062-8; Debache K, 2010, PARASITOLOGY, V137, P229, DOI 10.1017/S0031182009991259; Dubey JP, 2007, CLIN MICROBIOL REV, V20, P323, DOI 10.1128/CMR.00031-06; Dubey JP, 1996, VET PARASITOL, V67, P1, DOI 10.1016/S0304-4017(96)01035-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esposito M, 2007, INT J PARASITOL, V37, P183, DOI 10.1016/j.ijpara.2006.10.009; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Hemphill A, 2006, PARASITOLOGY, V133, P261, DOI 10.1017/S0031182006000485; Hemphill A, 2004, MICROSC MICROANAL, V10, P602, DOI 10.1017/S1431927604040930; Hemphill A, 1996, PARASITOLOGY, V112, P183, DOI 10.1017/S0031182000084754; Johnson SM, 2012, J MED CHEM, V55, P2416, DOI 10.1021/jm201713h; Kayode KO, 2011, MOL BIOCHEM PARASIT, V176, P98, DOI 10.1016/j.molbiopara.2010.12.009; Kieschnick H, 2001, J BIOL CHEM, V276, P12369, DOI 10.1074/jbc.M011045200; Kim JT, 2002, VET PARASITOL, V103, P53, DOI 10.1016/S0304-4017(01)00580-5; Kritzner Sandra, 2002, Ann Clin Microbiol Antimicrob, V1, P4, DOI 10.1186/1476-0711-1-4; Kropf C, 2012, PARASITOLOGY, V139, P208, DOI 10.1017/S0031182011001776; Kuster T, 2012, J AM ASSOC LAB ANIM, V51, P219; Kwon HJ, 2003, VET PARASITOL, V112, P269, DOI 10.1016/S0304-4017(03)00035-9; Larson ET, 2012, J MED CHEM, V55, P2803, DOI 10.1021/jm201725v; Leepin A, 2008, ANTIMICROB AGENTS CH, V52, P1999, DOI 10.1128/AAC.01236-07; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LINDSAY DS, 1994, AM J VET RES, V55, P976; Lindsay DS, 1999, VET PARASITOL, V82, P327, DOI 10.1016/S0304-4017(99)00054-0; Liu HG, 2012, ACTA CRYSTALLOGR A, V68, P278, DOI 10.1107/S010876731104788X; Lourido S, 2013, ACS CHEM BIOL; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Mazuz ML, 2012, VET PARASITOL, V187, P99, DOI 10.1016/j.vetpar.2011.12.020; McAllister MM, 1998, INT J PARASITOL, V28, P1473, DOI 10.1016/S0020-7519(98)00138-6; Mccoy JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003066; Murphy RC, 2010, ACS MED CHEM LETT, V1, P331, DOI 10.1021/ml100096t; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ojo KK, 2014, J INFECT DIS, V209, P275, DOI 10.1093/infdis/jit522; Ojo KK, 2012, J CLIN INVEST, V122, P2301, DOI 10.1172/JCI61822; Ojo KK, 2010, NAT STRUCT MOL BIOL, V17, P602, DOI 10.1038/nsmb.1818; Reichel MP, 2013, INT J PARASITOL, V43, P133, DOI 10.1016/j.ijpara.2012.10.022; Romero JJ, 2004, VET PARASITOL, V123, P149, DOI 10.1016/j.vetpar.2004.06.016; Schorer M, 2012, INT J PARASITOL-DRUG, V2, P109, DOI 10.1016/j.ijpddr.2012.03.001; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sugi T, 2010, EUKARYOT CELL, V9, P667, DOI 10.1128/EC.00351-09; Wernimont AK, 2010, NAT STRUCT MOL BIOL, V17, P596, DOI 10.1038/nsmb.1795; Weston JF, 2012, PREV VET MED, V103, P136, DOI 10.1016/j.prevetmed.2011.08.010; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495	50	49	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92929	10.1371/journal.pone.0092929	http://dx.doi.org/10.1371/journal.pone.0092929			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681759	Green Submitted, Green Published, gold			2022-12-25	WOS:000333678100019
J	Chen, J; Xu, X; Wu, J; Ling, Q; Wang, K; Wang, WL; Zhang, M; Shen, Y; Zhou, L; Xie, HY; Zheng, SS				Chen, Jun; Xu, Xiao; Wu, Jian; Ling, Qi; Wang, Kai; Wang, Weilin; Zhang, Min; Shen, Yan; Zhou, Lin; Xie, Haiyang; Zheng, Shusen			The Stratifying Value of Hangzhou Criteria in Liver Transplantation for Hepatocellular Carcinoma	PLOS ONE			English	Article							LIVING DONOR; MILAN CRITERIA; ADULT PATIENTS; RECURRENCE; EXPERIENCE; SURVIVAL; KOREA	Background/Aims: The selection criteria for patients with hepatocellular carcinoma (HCC) as candidates for deceased donor liver transplantation (DDLT) are well studied. In this era of limited deceased donor organs, the value of living donor liver transplantation (LDLT) for HCC remains controversial. The aim of the present study was to verify the stratification value of the Hangzhou criteria for LDLT. Methods: The data of 47 LDLT recipients and 94 matched DDLT recipients at our center were evaluated. Overall survival and tumor-free survival were calculated. Prognostic factors influencing post-liver transplantation (LT) survival were identified. The stratification values of the Hangzhou criteria and Milan criteria were compared. Results: LDLT recipients spent much less time on the waiting list. The post-LT survival of recipients fulfilling the Milan criteria and recipients fulfilling the Hangzhou criteria were comparable (P>0.05). The overall and tumor-free survival did not differ statistically between the two groups. In both groups, more recipients not meeting the Milan criteria but with a satisfactory outcome were identified by the Hangzhou criteria. Among recipients who did not meet the Hangzhou criteria, tumor-free survival was better for the LDLT recipients than the DDLT recipients (P = 0.024). Conclusions: The Hangzhou criteria are reliable for stratifying HCC patients in terms of prognosis. HCC patients fulfilling the Hangzhou criteria gain satisfactory survival from LT. Outcomes after LDLT are better than those after DDLT for HCC patients who do not meet the Hangzhou criteria.	[Chen, Jun; Xu, Xiao; Wu, Jian; Ling, Qi; Wang, Kai; Wang, Weilin; Zhang, Min; Shen, Yan; Zhou, Lin; Xie, Haiyang; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Surg,Div Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Xiao; Zheng, Shusen] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Surg,Div Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China.	zyzss@zju.edu.cn			Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81121002]; National ST Major Project [2012ZX10002017]; Zhejiang Provincial Medical Foundation for Young Excellent Scholars [2008QN012]; National High-tech R&D Program of China (863 Program) [2012AA020204]; Medical science and technology plan of Zhejiang province [2011ZDA007]	Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National ST Major Project; Zhejiang Provincial Medical Foundation for Young Excellent Scholars; National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); Medical science and technology plan of Zhejiang province	This study is supported by the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (Grant No. 81121002); the National S&T Major Project (No. 2012ZX10002017); the Grant from Zhejiang Provincial Medical Foundation for Young Excellent Scholars (NO. 2008QN012); the National High-tech R&D Program of China (863 Program) (No. 2012AA020204); the Medical science and technology plan of Zhejiang province (No. 2011ZDA007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audet M, 2009, LIVER TRANSPLANT, V15, P822, DOI 10.1002/lt.21765; Bhangui P, 2011, HEPATOLOGY, V53, P1570, DOI 10.1002/hep.24231; Busuttil RW, 2008, HEPATOB PANCREAT DIS, V7, P235; Di Sandro S, 2009, TRANSPL P, V41, P1283, DOI 10.1016/j.transproceed.2009.03.022; Fan ST, 2008, HEPATOB PANCREAT DIS, V7, P233; Fisher RA, 2007, AM J TRANSPLANT, V7, P1601, DOI 10.1111/j.1600-6143.2007.01802.x; Hsu HT, 2006, TRANSPLANT P, V38, P2102, DOI 10.1016/j.transproceed.2006.07.021; Hwang S, 2007, TRANSPL P, V39, P1526, DOI 10.1016/j.transproceed.2007.03.066; Hwang S, 2005, LIVER TRANSPLANT, V11, P1265, DOI 10.1002/lt.20549; Kulik L, 2004, GASTROENTEROLOGY, V127, pS277, DOI 10.1053/j.gastro.2004.09.042; Lee KK, 2010, J SURG ONCOL, V101, P47, DOI 10.1002/jso.21415; Lee SG, 2012, TRANSPL P, V44, P520, DOI 10.1016/j.transproceed.2012.02.003; Lee SG, 2008, LIVER TRANSPLANT, V14, P935, DOI 10.1002/lt.21445; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Lo CM, 2007, BRIT J SURG, V94, P78, DOI 10.1002/bjs.5528; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Todo S, 2004, ANN SURG, V240, P451, DOI 10.1097/01.sla.0000137129.98894.42; Vakili K, 2009, LIVER TRANSPLANT, V15, P1861, DOI 10.1002/lt.21940; Woo HY, 2008, LIVER INT, V28, P1120, DOI 10.1111/j.1478-3231.2008.01785.x; Yao FY, 2002, LIVER TRANSPLANT, V8, P873, DOI 10.1053/jlts.2002.34923; Yao FY, 2002, LIVER TRANSPLANT, V8, P765, DOI 10.1053/jlts.2002.34892; Zheng SS, 2008, TRANSPLANTATION, V85, P1726, DOI 10.1097/TP.0b013e31816b67e4	23	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93128	10.1371/journal.pone.0093128	http://dx.doi.org/10.1371/journal.pone.0093128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676010	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500077
J	Scheinost, D; Shen, XL; Finn, E; Sinha, R; Constable, RT; Papademetris, X				Scheinost, Dustin; Shen, Xilin; Finn, Emily; Sinha, Rajita; Constable, R. Todd; Papademetris, Xenophon			Coupled Intrinsic Connectivity Distribution Analysis: A Method for Exploratory Connectivity Analysis of Paired fMRI Data	PLOS ONE			English	Article							VOXEL-BASED MEASURE; FUNCTIONAL CONNECTIVITY; BRAIN; PARCELLATION	We present a novel voxel-based connectivity approach for paired functional magnetic resonance imaging (fMRI) data collected under two different conditions labeled the Coupled Intrinsic Connectivity Distribution (coupled-ICD). Our proposed method jointly models both conditions to incorporate additional paired information into the connectivity metric. Voxel-based connectivity holds promise as a clinical tool to characterize a wide range of neurological and psychiatric diseases, and monitor their treatment. As such, examining paired connectivity data such as scans acquired pre- and post-intervention is an important application for connectivity methodologically. When presented with data from paired conditions, conventional voxel-based methods analyze each condition separately. However, summarizing each connection separately can misrepresent patterns of changes in connectivity. We show that commonly used methods can underestimate functional changes and subsequently introduce and evaluate our solution to this problem, the coupled-ICD metric, using two studies: 1) healthy controls scanned awake and under anesthesia, and 2) cocaine-dependent subjects and healthy controls scanned while being presented with relaxing or drug-related imagery cues. The coupled-ICD approach detected differences between paired conditions in similar brain regions as the conventional approaches while also revealing additional changes in regions not identified using conventional voxel-based connectivity analyses. Follow-up seed-based analyses on data independent from the voxel-based results also showed connectivity differences between conditions in regions detected by coupled-ICD. This approach of jointly analyzing paired resting-state scans provides a new and important tool with many applications for clinical and basic neuroscience research.	[Scheinost, Dustin; Constable, R. Todd; Papademetris, Xenophon] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Shen, Xilin; Constable, R. Todd; Papademetris, Xenophon] Yale Univ, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Finn, Emily] Yale Univ, Interdept Neurosci Program, New Haven, CT USA; [Sinha, Rajita] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Constable, R. Todd] Yale Univ, Dept Neurosurg, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Scheinost, D (corresponding author), Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.	dustin.scheinost@yale.edu	Finn, Emily S./I-2205-2019; Constable, R. Todd/ABE-8038-2021; Scheinost, Dustin/Q-2857-2018	Finn, Emily S./0000-0001-8591-3068; Constable, R. Todd/0000-0001-5661-9521; Scheinost, Dustin/0000-0002-6301-1167	National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health [R01 EB009666]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009666] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health (R01 EB009666) http://www.nibib.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beu M, 2009, J NEUROSCI METH, V176, P263, DOI 10.1016/j.jneumeth.2008.08.036; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Constable RT, 2013, NEUROIMAGE, V64, P371, DOI 10.1016/j.neuroimage.2012.09.008; Finn ES, 2014, BIOL PSYCHIAT, V76, P397, DOI 10.1016/j.biopsych.2013.08.031; Hampson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044067; Hampson M, 2011, BRAIN CONNECT, V1, P91, DOI 10.1089/brain.2011.0002; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Joshi A, 2011, NEUROINFORMATICS, V9, P69, DOI 10.1007/s12021-010-9092-8; Li CSR, 2008, NEUROSCI BIOBEHAV R, V32, P581, DOI 10.1016/j.neubiorev.2007.10.003; Lui S, 2010, ARCH GEN PSYCHIAT, V67, P783, DOI 10.1001/archgenpsychiatry.2010.84; Martuzzi R, 2011, NEUROIMAGE, V58, P1044, DOI 10.1016/j.neuroimage.2011.06.075; Martuzzi R, 2010, NEUROIMAGE, V49, P823, DOI 10.1016/j.neuroimage.2009.07.028; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Papademetris X, 2004, LECT NOTES COMPUT SC, V3216, P763; Potenza MN, 2012, AM J PSYCHIAT, V169, P406, DOI 10.1176/appi.ajp.2011.11020289; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Scheinost D, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.24; Scheinost D, 2012, NEUROIMAGE, V62, P1510, DOI 10.1016/j.neuroimage.2012.05.073; Seo D, 2011, HUM BRAIN MAPP, V32, P1998, DOI 10.1002/hbm.21165; Shen X, 2013, NEUROIMAGE, V82, P403, DOI 10.1016/j.neuroimage.2013.05.081; Shen X, 2010, NEUROIMAGE, V50, P1027, DOI 10.1016/j.neuroimage.2009.12.119; Simpson SL, 2012, NEUROIMAGE, V60, P1117, DOI 10.1016/j.neuroimage.2012.01.071; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wexler BE, 2001, AM J PSYCHIAT, V158, P86, DOI 10.1176/appi.ajp.158.1.86; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	30	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93544	10.1371/journal.pone.0093544	http://dx.doi.org/10.1371/journal.pone.0093544			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676034	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677500137
J	Chen, C; Bales, P; Greenfield, J; Heselpoth, RD; Nelson, DC; Herzberg, O				Chen, Chen; Bales, Patrick; Greenfield, Julia; Heselpoth, Ryan D.; Nelson, Daniel C.; Herzberg, Osnat			Crystal Structure of ORF210 from E. coli O157:H1 Phage CBA120 (TSP1), a Putative Tailspike Protein	PLOS ONE			English	Article							SUBSTRATE-ASSISTED CATALYSIS; ESCHERICHIA-COLI; BETA-HELICES; TAIL SPIKE; LIPOPOLYSACCHARIDE; CRYSTALLOGRAPHY; DENSITY; SYSTEM; PHENIX	Bacteriophage tailspike proteins act as primary receptors, often possessing endoglycosidase activity toward bacterial lipopolysaccharides or other exopolysaccharides, which enable phage absorption and subsequent DNA injection into the host. Phage CBA120, a contractile long-tailed Viunalikevirus phage infects the virulent Escherichia coli O157:H7. This phage encodes four putative tailspike proteins exhibiting little amino acid sequence identity, whose biological roles and substrate specificities are unknown. Here we focus on the first tailspike, TSP1, encoded by the orf210 gene. We have discovered that TSP1 is resistant to protease degradation, exhibits high thermal stability, but does not cleave the O157 antigen. An immunedot blot has shown that TSP1 binds strongly to non-O157:H7 E. coli cells and more weakly to K. pneumoniae cells, but exhibits little binding to E. coli O157:H7 strains. To facilitate structure-function studies, we have determined the crystal structure of TSP1 to a resolution limit of 1.8 angstrom. Similar to other tailspikes proteins, TSP1 assembles into elongated homotrimers. The receptor binding region of each subunit adopts a right-handed parallel beta helix, reminiscent yet not identical to several known tailspike structures. The structure of the N-terminal domain that binds to the virion particle has not been seen previously. Potential endoglycosidase catalytic sites at the three subunit interfaces contain two adjacent glutamic acids, unlike any catalytic machinery observed in other tailspikes. To identify potential sugar binding sites, the crystal structures of TSP1 in complexes with glucose, alpha-maltose, or alpha-lactose were determined. These structures revealed that each sugar binds in a different location and none of the environments appears consistent with an endoglycosidase catalytic site. Such sites may serve to bind sugar units of a yet to be identified bacterial exopolysaccharide.	[Chen, Chen; Bales, Patrick; Greenfield, Julia; Heselpoth, Ryan D.; Nelson, Daniel C.; Herzberg, Osnat] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA; [Greenfield, Julia; Herzberg, Osnat] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Nelson, Daniel C.] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Herzberg, O (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA.	osnat@umd.edu	Nelson, Daniel C./I-2198-2012	Nelson, Daniel C./0000-0003-3248-4831; Herzberg, Osnat/0000-0003-2823-7627	Department of Defense [DM102823]	Department of Defense(United States Department of Defense)	Support was provided by the Department of Defense, award DM102823 (to DCN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adriaenssens EM, 2012, ARCH VIROL, V157, P2035, DOI 10.1007/s00705-012-1360-5; Andres D, 2012, MOL MICROBIOL, V83, P1244, DOI 10.1111/j.1365-2958.2012.08006.x; Barbirz S, 2008, MOL MICROBIOL, V69, P303, DOI 10.1111/j.1365-2958.2008.06311.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Casjens SR, 2012, ADV EXP MED BIOL, V726, P143, DOI 10.1007/978-1-4614-0980-9_7; Casjens SR, 2011, VIROLOGY, V411, P393, DOI 10.1016/j.virol.2010.12.046; Chao KL, 2007, BIOCHEMISTRY-US, V46, P6911, DOI 10.1021/bi700382g; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039; Ikegami T, 2000, J BIOL CHEM, V275, P13654, DOI 10.1074/jbc.275.18.13654; Iseli B, 1996, FEBS LETT, V382, P186, DOI 10.1016/0014-5793(96)00174-3; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Kryshtafovych A, 2014, PROTEINS, V82, P26, DOI 10.1002/prot.24489; Kutter EM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-430; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leiman PG, 2008, MOL MICROBIOL, V69, P287, DOI 10.1111/j.1365-2958.2008.06241.x; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mitraki A, 2002, J STRUCT BIOL, V137, P236, DOI 10.1006/jsbi.2002.4447; Moult J, 2014, PROTEINS, V82, P1, DOI 10.1002/prot.24452; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; Rezania Simin, 2011, Avicenna Journal of Medical Biotechnology, V3, P3; Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584; STURTEVANT JM, 1989, J BIOL CHEM, V264, P10693; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Walter M, 2008, J VIROL, V82, P2265, DOI 10.1128/JVI.01641-07; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Xiang Y, 2009, MOL CELL, V34, P375, DOI 10.1016/j.molcel.2009.04.009; YODER MD, 1995, FASEB J, V9, P335, DOI 10.1096/fasebj.9.5.7896002	40	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93156	10.1371/journal.pone.0093156	http://dx.doi.org/10.1371/journal.pone.0093156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671238	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677000122
J	Chon, YE; Kim, SU; Park, JY; Kim, DY; Ahn, SH; Han, KH; Chon, CY; Lee, S				Chon, Young Eun; Kim, Seung Up; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon; Lee, Sak			Dynamics of the Liver Stiffness Value Using Transient Elastography during the Perioperative Period in Patients with Valvular Heart Disease	PLOS ONE			English	Article							NATRIURETIC PEPTIDE LEVELS; FAILURE; DIAGNOSIS; CIRRHOSIS; FIBROSIS; ULTRASOUND; SEVERITY; SYMPTOMS; MARKER; IMPACT	Background/Aims: Liver congestion due to heart failure in patients with valvular heart disease (VHD) can result in an overestimate of the liver stiffness (LS) as assessed by transient elastography (TE). This prospective pilot study investigated the dynamics of LS during the perioperative valve operation period. Methods: Thirty-two patients who underwent a valve operation (case) and 12 who underwent a varicose vein operation (control) were prospectively enrolled. LS and cardiologic parameters at three time points [baseline, post-operative day (POD) 7, and POD90] were collected. Results: LS at three time points were consistently higher in the case group than those in the control group, although all participants did not show evidence of underlying chronic liver disease (all P<0.05). In the case group, LS at POD7 increased slightly from the LS at baseline (median 7.9 -> 8.4 kPa, P = 0.816), whereas LS at POD90 decreased significantly from the LS at POD7 (median 8.4 -> 6.0 kPa; P = 0.026). LS was significantly correlated with N-terminal-pro brain natriuretic peptide (NT-proBNP) (rho = 0.412), left ventricular ejection fraction (rho = -0.494), and central venous pressure during the operation (rho = 0.555) at baseline (all P<0.05). LS was significantly correlated with NT-proBNP (rho = 0.526) and right ventricular pressure (rho = 0.572) at POD7, whereas LS was significantly correlated with NT-proBNP (rho = 0.590) at POD90 (all P<0.05). Conclusions: LS can be overestimated in patients with VHD due to hepatic congestion. However, LS can be dynamically reversed during the perioperative period reflecting the restoration of cardiac function after a successful operation.	[Chon, Young Eun; Kim, Seung Up; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Seung Up; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Lee, Sak] Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Chon, Young Eun; Kim, Seung Up; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon] Liver Cirrhosis Clin Res Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, S (corresponding author), Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.	SAK911@yuhs.ac	Park, Jun Yong/H-7127-2019	Lee, Sak/0000-0001-6130-2342; Kim, Seung Up/0000-0002-9658-8050; Han, Kwang-Hyub/0000-0003-3960-6539; Ahn, Sang Hoon/0000-0002-3629-4624; Park, Jun Yong/0000-0001-6324-2224				Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Bettencourt P, 2004, CIRCULATION, V110, P2168, DOI 10.1161/01.CIR.0000144310.04433.BE; Bioulac-Sage P, 2009, J HEPATOL, V50, P423, DOI 10.1016/j.jhep.2008.11.003; Brookes CIO, 1997, J HEART VALVE DIS, V6, P608; Chon YE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044930; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Colli A, 2010, RADIOLOGY, V257, P872, DOI 10.1148/radiol.10100013; Feringa HHH, 2007, INT J CARDIOVAS IMAG, V23, P159, DOI 10.1007/s10554-006-9138-z; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420; Gardner RS, 2003, EUR HEART J, V24, P1735, DOI 10.1016/j.ehj.2003.07.005; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; Hall C, 2004, EUR J HEART FAIL, V6, P257, DOI 10.1016/j.ejheart.2003.12.015; Hopper I, 2012, EUR J HEART FAIL, V14, P621, DOI 10.1093/eurjhf/hfs044; Januzzi JL, 2006, EUR HEART J, V27, P330, DOI 10.1093/eurheartj/ehi631; Kiesewetter CH, 2007, HEART, V93, P579, DOI 10.1136/hrt.2006.094516; Kim SU, 2010, LIVER INT, V30, P268, DOI 10.1111/j.1478-3231.2009.02172.x; Kim SU, 2009, LIVER INT, V29, P810, DOI 10.1111/j.1478-3231.2008.01894.x; Kim SU, 2009, LIVER INT, V29, P760, DOI 10.1111/j.1478-3231.2009.02035.x; Lebray P, 2008, HEPATOLOGY, V48, P2089, DOI 10.1002/hep.22594; Levin ER, 1998, NEW ENGL J MED, V339, P321; Mair J, 2001, CLIN CHEM LAB MED, V39, P571, DOI 10.1515/CCLM.2001.093; Mayer SA, 2004, AM J CARDIOL, V93, P1002, DOI 10.1016/j.amjcard.2004.01.008; Millonig G, 2008, HEPATOLOGY, V48, P1718, DOI 10.1002/hep.22577; Millonig G, 2010, J HEPATOL, V52, P206, DOI 10.1016/j.jhep.2009.11.018; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Sagir A, 2008, HEPATOLOGY, V47, P592, DOI 10.1002/hep.22056; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13; Sharma P, 2012, RADIOLOGY, V263, P893, DOI 10.1148/radiol.12111046; Simonovsky V, 1999, BRIT J RADIOL, V72, P29, DOI 10.1259/bjr.72.853.10341686; Sutton TM, 2003, J AM COLL CARDIOL, V41, P2280, DOI 10.1016/S0735-1097(03)00486-8; Woo JJ, 2008, YONSEI MED J, V49, P625, DOI 10.3349/ymj.2008.49.4.625	34	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92795	10.1371/journal.pone.0092795	http://dx.doi.org/10.1371/journal.pone.0092795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670988	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000076
J	Jelbert, SA; Taylor, AH; Cheke, LG; Clayton, NS; Gray, RD				Jelbert, Sarah A.; Taylor, Alex H.; Cheke, Lucy G.; Clayton, Nicola S.; Gray, Russell D.			Using the Aesop's Fable Paradigm to Investigate Causal Understanding of Water Displacement by New Caledonian Crows	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; ORANGUTANS PONGO-PYGMAEUS; MONKEYS CEBUS-APELLA; CORVUS-MONEDULOIDES; TOOL-USE; FOLK PHYSICS; HOOK-TOOLS; TUBE TASK; SOLVE; COGNITION	Understanding causal regularities in the world is a key feature of human cognition. However, the extent to which non-human animals are capable of causal understanding is not well understood. Here, we used the Aesop's fable paradigm - in which subjects drop stones into water to raise the water level and obtain an out of reach reward - to assess New Caledonian crows' causal understanding of water displacement. We found that crows preferentially dropped stones into a water-filled tube instead of a sand-filled tube; they dropped sinking objects rather than floating objects; solid objects rather than hollow objects, and they dropped objects into a tube with a high water level rather than a low one. However, they failed two more challenging tasks which required them to attend to the width of the tube, and to counter-intuitive causal cues in a U-shaped apparatus. Our results indicate that New Caledonian crows possess a sophisticated, but incomplete, understanding of the causal properties of displacement, rivalling that of 5-7 year old children.	[Jelbert, Sarah A.; Taylor, Alex H.; Gray, Russell D.] Univ Auckland, Dept Psychol, Auckland, New Zealand; [Cheke, Lucy G.; Clayton, Nicola S.] Univ Cambridge, Dept Psychol, Cambridge, England	University of Auckland; University of Cambridge	Jelbert, SA (corresponding author), Univ Auckland, Dept Psychol, Auckland, New Zealand.	s.jelbert@auckland.ac.nz	Taylor, Alex H/D-6428-2012; Gray, Russell/H-2078-2015	Gray, Russell/0000-0002-9858-0191; Taylor, Alex/0000-0003-3492-7667; Clayton, Nicola/0000-0003-1835-423X; Cheke, Lucy/0000-0001-5588-7575; Jelbert, Sarah/0000-0002-7503-0648	New Zealand Marsden Fund; University of Auckland Doctoral Scholarship	New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); University of Auckland Doctoral Scholarship	This work was supported by a grant from the New Zealand Marsden Fund (RDG) and a University of Auckland Doctoral Scholarship (SAJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird CD, 2009, P NATL ACAD SCI USA, V106, P10370, DOI 10.1073/pnas.0901008106; Bird CD, 2009, CURR BIOL, V19, P1410, DOI 10.1016/j.cub.2009.07.033; Call J, 2004, J COMP PSYCHOL, V118, P232, DOI 10.1037/0735-7036.118.2.232; Chappell J, 2002, ANIM COGN, V5, P71, DOI 10.1007/s10071-002-0130-2; Chappell J, 2004, ANIM COGN, V7, P121, DOI 10.1007/s10071-003-0202-y; Cheke LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040574; Cheke LG, 2011, ANIM COGN, V14, P441, DOI 10.1007/s10071-011-0379-4; Hanus D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019555; Heinrich B, 2005, ETHOLOGY, V111, P962, DOI 10.1111/j.1439-0310.2005.01133.x; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Hunt GR, 2002, EMU, V102, P283, DOI 10.1071/MU01037; Hunt GR, 2004, P ROY SOC B-BIOL SCI, V271, pS88, DOI 10.1098/rsbl.2003.0085; Hunt GR, 2004, ANIM COGN, V7, P114, DOI 10.1007/s10071-003-0200-0; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Kenward B, 2004, IBIS, V146, P652, DOI 10.1111/j.1474-919x.2004.00299.x; LIMONGELLI L, 1995, J COMP PSYCHOL, V109, P18, DOI 10.1037/0735-7036.109.1.18; Martin-Ordas G, 2008, ANIM COGN, V11, P423, DOI 10.1007/s10071-007-0132-1; Mendes N, 2007, BIOL LETTERS, V3, P453, DOI 10.1098/rsbl.2007.0198; Mulcahy NJ, 2006, ANIM COGN, V9, P193, DOI 10.1007/s10071-006-0019-6; Mulcahy NJ, 2009, J COMP PSYCHOL, V123, P304, DOI 10.1037/a0016222; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Penn DC, 2007, ANNU REV PSYCHOL, V58, P97, DOI 10.1146/annurev.psych.58.110405.085555; Povinelli D.J., 2000, FOLK PHYS APES CHIMP; Seed AM, 2006, CURR BIOL, V16, P697, DOI 10.1016/j.cub.2006.02.066; Seed A, 2012, PHILOS T R SOC B, V367, P2743, DOI 10.1098/rstb.2012.0222; Seed A, 2010, CURR BIOL, V20, pR1032, DOI 10.1016/j.cub.2010.09.042; Seed AM, 2009, J EXP PSYCHOL ANIM B, V35, P23, DOI 10.1037/a0012925; Silva FJ, 2005, LEARN BEHAV, V33, P47; SMITH C, 1985, COGNITION, V21, P177, DOI 10.1016/0010-0277(85)90025-3; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; SPELKE ES, 1991, J PIAGET SY, P133; Taylor AH, 2009, P R SOC B, V276, P247, DOI 10.1098/rspb.2008.1107; Taylor AH, 2007, CURR BIOL, V17, P1504, DOI 10.1016/j.cub.2007.07.057; Taylor AH, 2012, P ROY SOC B-BIOL SCI, V279, P4977, DOI 10.1098/rspb.2012.1998; Taylor AH, 2012, P NATL ACAD SCI USA, V109, P16389, DOI 10.1073/pnas.1208724109; Taylor AH, 2012, BEHAV BRAIN SCI, V35, P241, DOI 10.1017/S0140525X11001956; Taylor AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026887; Taylor AH, 2010, P ROY SOC B-BIOL SCI, V277, P2637, DOI 10.1098/rspb.2010.0285; Taylor AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009345; Taylor AH, 2009, CURR BIOL, V19, pR731, DOI 10.1016/j.cub.2009.07.055; Tebbich S, 2007, ANIM COGN, V10, P225, DOI 10.1007/s10071-006-0061-4; Tecwyn EC, 2012, ANIM COGN, V15, P121, DOI 10.1007/s10071-011-0438-x; Teschke I, 2011, ANIM COGN, V14, P555, DOI 10.1007/s10071-011-0390-9; Troscianko J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2111; VISALBERGHI E, 1995, J COMP PSYCHOL, V109, P52, DOI 10.1037/0735-7036.109.1.52; Visalberghi E, 1998, BEHAV PROCESS, V42, P189, DOI 10.1016/S0376-6357(97)00076-4; VISALBERGHI E, 1994, J COMP PSYCHOL, V108, P15, DOI 10.1037/0735-7036.108.1.15; von Bayern AMP, 2009, CURR BIOL, V19, P1965, DOI 10.1016/j.cub.2009.10.037; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; Weir AAS, 2006, ANIM COGN, V9, P317, DOI 10.1007/s10071-006-0052-5	50	58	59	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92895	10.1371/journal.pone.0092895	http://dx.doi.org/10.1371/journal.pone.0092895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671252	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677000090
J	Ogino, K; Zhang, R; Takahashi, H; Takemoto, K; Kubo, M; Murakami, I; Wang, DH; Fujikura, Y				Ogino, Keiki; Zhang, Ran; Takahashi, Hidekazu; Takemoto, Kei; Kubo, Masayuki; Murakami, Ikuo; Wang, Da-Hong; Fujikura, Yoshihisa			Allergic Airway Inflammation by Nasal Inoculation of Particulate Matter (PM2.5) in NC/Nga Mice	PLOS ONE			English	Article							ASTHMA-LIKE RESPONSES; CYTOKINE EXPRESSION; NALP3 INFLAMMASOME; PRIMER DATABASE; SKIN-LESIONS; POLLUTION; MORTALITY; HYPERRESPONSIVENESS; ACTIVATION; ARGINASE	To evaluate the effect of airborne particulate matter 2.5 (PM2.5) in winter on airway inflammation, water-soluble supernatant (Sup) and water-insoluble precipitate (Pre) in PM2.5 were inoculated in NC/Nga mice with high sensitivity to mite allergens. Sup with aluminum oxide was injected intraperitoneally for sensitization. Five days later, Sup, Pre or both Sup and Pre were inoculated via the nasal route five times for more sensitization and a challenge inoculation on the 11th day in NC/Nga mice. On the 12th day, mice were examined for airway hyperresponsiveness (AHR), BALF cell count and IL-1 beta concentration, mRNA expression of Th-1 and Th-2 cytokines, chemokines such as eotaxin 1 and eotaxin 2, inflammasomal complex molecules such as IL-1 beta, caspase 1 and the nucleotide-binding domain and leucine-rich repeat protein 3 (NLRP3) in lung tissue as well as histopathology. The synergistic effect of Sup and Pre was observed in terms of increases in AHR, BALF cells, the mRNA expression of IL-13, eotaxin1 and IL-1 beta, and the IL-1 beta concentration in BALF. Intracellular deposits of insoluble particulates were observed in macrophages around inflammatory granulation of the mouse group treated with Sup and Pre. These results suggest that PM2.5 can induce airway hyperresponsiveness in mice with genetically high sensitivity to mite allergens by an inflammasome-associated mechanism and synergistic action of insoluble particulates and soluble components.	[Ogino, Keiki; Zhang, Ran; Takemoto, Kei; Kubo, Masayuki; Wang, Da-Hong] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Publ Hlth, Okayama 7008530, Japan; [Takahashi, Hidekazu] Yamaguchi Univ, Grad Sch Med, Dept Publ Hlth, Ube, Yamaguchi 755, Japan; [Murakami, Ikuo] Otsuka Pharmaceut Co Ltd, Inst New Drug Discovery 3, Tokushima, Japan; [Fujikura, Yoshihisa] Oita Univ, Fac Med, Dept Mol Anat, Yufu, Oita, Japan	Okayama University; Yamaguchi University; Otsuka Pharmaceutical; Oita University	Ogino, K (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Publ Hlth, Okayama 7008530, Japan.	kogino@md.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government [21659156]	Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Science Research No. 21659156 from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 1999, NATURE, V402, pB31, DOI 10.1038/35037026; Bengalli R, 2013, BIOMED RES INT, DOI [10.1155/2013/158093, DOI 10.1155/2013/158093)]; Costa DL, 1997, ENVIRON HEALTH PERSP, V105, P1053, DOI 10.2307/3433509; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Fujimaki H, 1997, TOXICOLOGY, V116, P227, DOI 10.1016/S0300-483X(96)03539-1; Ganz M, 2011, WORLD J GASTROENTERO, V17, P4772, DOI 10.3748/wjg.v17.i43.4772; Gavett SH, 2003, ENVIRON HEALTH PERSP, V111, P1471, DOI 10.1289/ehp.6300; Gavett SH, 1997, ENVIRON RES, V72, P162, DOI 10.1006/enrs.1997.3732; Gonzalez-Benitez JF, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/614345; Hirota JA, 2012, J ALLERGY CLIN IMMUN, V129, P1116, DOI 10.1016/j.jaci.2011.11.033; Inoue K, 2005, ARCH TOXICOL, V79, P595, DOI 10.1007/s00204-005-0668-2; Kubo M, 2005, FREE RADICAL RES, V39, P719, DOI 10.1080/10715760500139260; LE JM, 1986, J IMMUNOL, V136, P4525; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; NAGAI H, 1993, LIFE SCI, V53, pPL243, DOI 10.1016/0024-3205(93)90545-E; Nakae S, 2003, INT IMMUNOL, V15, P483, DOI 10.1093/intimm/dxg054; OBERDORSTER G, 1994, ENVIRON HEALTH PERSP, V102, P173, DOI 10.2307/3432080; Ogino K, 2012, ENVIRON TOXICOL, DOI [10.1002/tox.21791, DOI 10.1002/T0X.21791)]; Ormstad H, 1998, TOXICOLOGY, V129, P227, DOI 10.1016/S0300-483X(98)00079-1; Ormstad H, 2000, TOXICOLOGY, V152, P53, DOI 10.1016/S0300-483X(00)00292-4; PlattsMills TAE, 1997, NEW ENGL J MED, V336, P1382, DOI 10.1056/NEJM199705083361909; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; POPE CA, 1989, AM J PUBLIC HEALTH, V79, P623, DOI 10.2105/AJPH.79.5.623; Rodriguez D, 2003, J IMMUNOL, V171, P1001, DOI 10.4049/jimmunol.171.2.1001; Sasakawa T, 2001, INT ARCH ALLERGY IMM, V126, P239, DOI 10.1159/000049520; Schmitz N, 2003, EUR J IMMUNOL, V33, P991, DOI 10.1002/eji.200323801; SCHWARTZ J, 1994, ENVIRON RES, V64, P36, DOI 10.1006/enrs.1994.1005; Schwarze PE, 2006, HUM EXP TOXICOL, V25, P559, DOI 10.1177/096032706072520; Shibamori M, 2006, LIFE SCI, V78, P987, DOI 10.1016/j.lfs.2005.06.020; Suto H, 1999, INT ARCH ALLERGY IMM, V120, P70, DOI 10.1159/000053599; Takahashi N, 2010, AM J PHYSIOL-LUNG C, V299, pL17, DOI 10.1152/ajplung.00216.2009; Takano H, 1997, AM J RESP CRIT CARE, V156, P36, DOI 10.1164/ajrccm.156.1.9610054; Takemoto K, 2007, AM J PHYSIOL-LUNG C, V293, pL1419, DOI 10.1152/ajplung.00418.2006; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tran HB, 2012, J ALLERGY, DOI [10.1155/2012/819176, DOI 10.1155/2012/819176)]; Utell MJ, 1995, TOXICOL LETT, V82-3, P47, DOI 10.1016/0378-4274(95)03467-6; Walters DM, 2001, AM J RESP CRIT CARE, V164, P1438, DOI 10.1164/ajrccm.164.8.2007121; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Yin Y, 2013, FRONT BIOSCI-LANDMRK, V18, P638, DOI 10.2741/4127	43	75	85	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92710	10.1371/journal.pone.0092710	http://dx.doi.org/10.1371/journal.pone.0092710			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671176	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677000068
J	Spaans, VM; Trietsch, MD; Crobach, S; Stelloo, E; Kremer, D; Osse, EM; ter Haar, NT; van Eijk, R; Muller, S; van Wezel, T; Trimbos, JB; Bosse, T; Smit, VTHBM; Fleuren, GJ				Spaans, Vivian M.; Trietsch, Marjolijn D.; Crobach, Stijn; Stelloo, Ellen; Kremer, Dennis; Osse, Elisabeth M.; ter Haar, Natalja T.; van Eijk, Ronald; Muller, Susanne; van Wezel, Tom; Trimbos, J. Baptist; Bosse, Tjalling; Smit, Vincent T. H. B. M.; Fleuren, Gert Jan			Designing a High-Throughput Somatic Mutation Profiling Panel Specifically for Gynaecological Cancers	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; PRIMARY ENDOMETRIAL; TP53 MUTATIONS; GENE-MUTATIONS; OVARIAN; PTEN; P53; CARCINOMAS; SURVIVAL; RECEPTOR	Somatic mutations play a major role in tumour initiation and progression. The mutation status of a tumour may predict prognosis and guide targeted therapies. The majority of techniques to study oncogenic mutations require high quality and quantity DNA or are analytically challenging. Mass-spectrometry based mutation analysis however is a relatively simple and high-throughput method suitable for formalin-fixed, paraffin-embedded (FFPE) tumour material. Targeted gene panels using this technique have been developed for several types of cancer. These current cancer hotspot panels are not focussed on the genes that are most relevant in gynaecological cancers. In this study, we report the design and validation of a novel, mass-spectrometry based panel specifically for gynaecological malignancies and present the frequencies of detected mutations. Using frequency data from the online Catalogue of Somatic Mutations in Cancer, we selected 171 somatic hotspot mutations in the 13 most important genes for gynaecological cancers, being BRAF, CDKN2A, CTNNB1, FBXW7, FGFR2, FGFR3, FOXL2, HRAS, KRAS, NRAS, PIK3CA, PPP2R1A and PTEN. A total of 546 tumours (205 cervical, 227 endometrial, 89 ovarian, and 25 vulvar carcinomas) were used to test and validate our panel, and to study the prevalence and spectrum of somatic mutations in these types of cancer. The results were validated by testing duplicate samples and by allele-specific qPCR. The panel presented here using mass-spectrometry shows to be reproducible and high-throughput, and is usefull in FFPE material of low quality and quantity. It provides new possibilities for studying large numbers of gynaecological tumour samples in daily practice, and could be useful in guided therapy selection.	[Spaans, Vivian M.; Trietsch, Marjolijn D.; Crobach, Stijn; Stelloo, Ellen; Osse, Elisabeth M.; ter Haar, Natalja T.; van Eijk, Ronald; van Wezel, Tom; Bosse, Tjalling; Smit, Vincent T. H. B. M.; Fleuren, Gert Jan] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Spaans, Vivian M.; Trimbos, J. Baptist] Leiden Univ, Dept Gynaecol, Med Ctr, Leiden, Netherlands; [Kremer, Dennis] Leiden Univ, Dept Mol Epidemiol, Med Ctr, Leiden, Netherlands; [Muller, Susanne] Sequenom GmbH, Hamburg, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Trietsch, MD (corresponding author), Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands.	M.D.Trietsch@lumc.nl	van Wezel, Tom/AAL-5626-2021; van Wezel, Tom/A-9599-2008; van Wezel, Tom/Z-3092-2019; Smit, Vincent/AAD-1811-2022; Bosse, Tjalling/AFX-6970-2022	van Wezel, Tom/0000-0001-5773-7730; van Wezel, Tom/0000-0001-5773-7730; Smit, Vincent/0000-0003-3730-5652; Bosse, Tjalling/0000-0002-6881-8437; van Eijk, Ronald/0000-0001-7955-6295				Bell DA, 2005, MODERN PATHOL, V18, pS19, DOI 10.1038/modpathol.3800306; Berek JS, 2010, GYNECOLOGIC ONCOLOGY; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Choschzick M, 2011, INT J GYNECOL PATHOL, V30, P497, DOI 10.1097/PGP.0b013e3182184c7a; Cote ML, 2012, INT J GYNECOL CANCER, V22, P1367, DOI 10.1097/IGC.0b013e31826b1110; Cottrell CE, 2014, J MOL DIAGN, V16, P89, DOI 10.1016/j.jmoldx.2013.10.002; de Jong AE, 2004, CLIN CANCER RES, V10, P972, DOI 10.1158/1078-0432.CCR-0956-3; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Dutton-Regester K, 2012, MOL CANCER THER, V11, P888, DOI 10.1158/1535-7163.MCT-11-0676; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Garcia-Dios DA, 2013, GYNECOL ONCOL, V128, P327, DOI 10.1016/j.ygyno.2012.11.037; Gemignani ML, 2003, GYNECOL ONCOL, V90, P378, DOI 10.1016/S0090-8258(03)00264-6; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Ho CM, 2009, GYNECOL ONCOL, V112, P307, DOI 10.1016/j.ygyno.2008.09.040; Holway AH, 2000, CLIN CANCER RES, V6, P3228; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kanagal-Shamanna R, 2013, MOD PATHOL, V10; Kinde I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004952; Krakstad C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052795; Lax SF, 2000, CANCER-AM CANCER SOC, V88, P814, DOI 10.1002/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.3.CO;2-L; Liang H, 2012, GENOME RES, V22, P2120, DOI 10.1101/gr.137596.112; Loyo M, 2013, HEAD NECK-J SCI SPEC, V35, P454, DOI 10.1002/hed.23100; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Maeng CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041655; McCluggage WG, 2002, INT J GYNECOL PATHOL, V21, P11, DOI 10.1097/00004347-200201000-00003; McConechy MK, 2011, J PATHOL, V223, P567, DOI 10.1002/path.2848; McIntyre JB, 2013, GYNECOL ONCOL, V128, P409, DOI 10.1016/j.ygyno.2012.12.019; Nagendra DC, 2012, MOL CARCINOGEN, V51, P826, DOI 10.1002/mc.20850; Nout RA, 2012, GYNECOL ONCOL, V126, P466, DOI 10.1016/j.ygyno.2012.05.012; Santarpia L, 2012, BREAST CANCER RES TR, V134, P333, DOI 10.1007/s10549-012-2035-3; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Shih IM, 2011, AM J PATHOL, V178, P1442, DOI 10.1016/j.ajpath.2011.01.009; Soufir N, 2007, BRIT J DERMATOL, V156, P448, DOI 10.1111/j.1365-2133.2006.07604.x; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tornesello ML, 2013, GYNECOL ONCOL, V128, P442, DOI 10.1016/j.ygyno.2012.11.017; Ulahannan D, 2013, BRIT J CANCER, V109, P827, DOI 10.1038/bjc.2013.416; van Eijk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017791; Wegman P, 2011, INT J GYNECOL CANCER, V21, P86, DOI 10.1097/IGC.0b013e3182049924; Wright AA, 2013, CANCER-AM CANCER SOC, V119, P3776, DOI 10.1002/cncr.28288	46	35	36	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93451	10.1371/journal.pone.0093451	http://dx.doi.org/10.1371/journal.pone.0093451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671188	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000146
J	Peeling, P; Sim, M; Badenhorst, CE; Dawson, B; Govus, AD; Abbiss, CR; Swinkels, DW; Trinder, D				Peeling, Peter; Sim, Marc; Badenhorst, Claire E.; Dawson, Brian; Govus, Andrew D.; Abbiss, Chris R.; Swinkels, Dorine W.; Trinder, Debbie			Iron Status and the Acute Post-Exercise Hepcidin Response in Athletes	PLOS ONE			English	Article							SERUM HEPCIDIN; INFLAMMATION; DEFICIENCY; EXERCISE; PARAMETERS; INTENSITY; CYTOKINES; HEMOLYSIS; MEDIATOR	This study explored the relationship between serum ferritin and hepcidin in athletes. Baseline serum ferritin levels of 54 athletes from the control trial of five investigations conducted in our laboratory were considered; athletes were grouped according to values <30 mu g/L (SF<30), 30-50 mu g/L (SF30-50), 50-100 mu g/L (SF50-100), or >100 mu g/L (SF>100). Data pooling resulted in each athlete completing one of five running sessions: (1) 8x3 min at 85% vVO(2peak); (2) 5x4 min at 90% vVO(2peak); (3) 90 min continuous at 75% vVO(2peak); (4) 40 min continuous at 75% vVO(2peak); (5) 40 min continuous at 65% vVO(2peak). Athletes from each running session were represented amongst all four groups; hence, the mean exercise duration and intensity were not different (p>0.05). Venous blood samples were collected pre-, post-and 3 h post-exercise, and were analysed for serum ferritin, iron, interleukin-6 (IL-6) and hepcidin-25. Baseline and post-exercise serum ferritin levels were different between groups (p<0.05). There were no group differences for pre- or post-exercise serum iron or IL-6 (p>0.05). Post-exercise IL-6 was significantly elevated compared to baseline within each group (p<0.05). Pre- and 3 h post-exercise hepcidin-25 was sequentially greater as the groups baseline serum ferritin levels increased (p<0.05). However, post-exercise hepcidin levels were only significantly elevated in three groups (SF30-50, SF50-100, and SF>100; p<0.05). An athlete's iron stores may dictate the baseline hepcidin levels and the magnitude of post-exercise hepcidin response. Low iron stores suppressed post-exercise hepcidin, seemingly overriding any inflammatory-driven increases.	[Peeling, Peter; Sim, Marc; Badenhorst, Claire E.; Dawson, Brian] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Crawley, WA, Australia; [Govus, Andrew D.; Abbiss, Chris R.] Edith Cowan Univ, Sch Exercise & Hlth Sci, Ctr Exercise & Sports Sci Res, Churchlands, WA 6018, Australia; [Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Genet Endocrine & Metab Dis, Nijmegen, Netherlands; [Swinkels, Dorine W.] Hepcidinanal Com, Nijmegen, Netherlands; [Trinder, Debbie] Univ Western Australia, Sch Med & Pharmacol, Fremantle, WA, Australia	University of Western Australia; Edith Cowan University; Radboud University Nijmegen; University of Western Australia	Peeling, P (corresponding author), Univ Western Australia, Sch Sport Sci Exercise & Hlth, Crawley, WA, Australia.	peter.peeling@uwa.edu.au	Swinkels, Dorine W./H-8098-2014; Peeling, Peter/H-5615-2014; Badenhorst, Claire/AAS-7194-2021	Swinkels, Dorine W./0000-0002-1040-9446; Badenhorst, Claire/0000-0002-8434-9730; Govus, Andrew/0000-0001-6224-0454; Abbiss, Chris/0000-0003-3940-5542; Peeling, Peter/0000-0002-3895-0015; Sim, Marc/0000-0001-5166-0605				Auersperger I, 2012, INT J SPORT NUTR EXE, V22, P55, DOI 10.1123/ijsnem.22.1.55; Australasia RCoPo, 2013, IR STUD STAND REP PR; Darshan D, 2010, HAEMATOL-HEMATOL J, V95, P1660, DOI 10.3324/haematol.2010.022426; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Garvican LA, 2014, MED SCI SPORT EXER, V46, P376, DOI 10.1249/MSS.0b013e3182a53594; Jaeggi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057513; Karl JP, 2010, AM J CLIN NUTR, V92, P93, DOI 10.3945/ajcn.2010.29185; Kroot JJC, 2011, CLIN CHEM, V57, P1650, DOI 10.1373/clinchem.2009.140053; Liu QD, 2012, J CLIN INVEST, V122, P4635, DOI 10.1172/JCI63924; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Peeling P, 2008, EUR J APPL PHYSIOL, V103, P381, DOI 10.1007/s00421-008-0726-6; Peeling P, 2010, EUR J APPL PHYSIOL, V110, P877, DOI 10.1007/s00421-010-1594-4; Peeling P, 2009, INT J SPORT NUTR EXE, V19, P583, DOI 10.1123/ijsnem.19.6.583; Peeling P, 2009, MED SCI SPORT EXER, V41, P1138, DOI 10.1249/MSS.0b013e318192ce58; Peeling P, 2009, EUR J APPL PHYSIOL, V106, P51, DOI 10.1007/s00421-009-0988-7; Piperno A, 2011, BLOOD, V117, P2953, DOI 10.1182/blood-2010-08-299859; Robson-Ansley P, 2011, CYTOKINE, V53, P196, DOI 10.1016/j.cyto.2010.10.001; Roecker L, 2005, EUR J APPL PHYSIOL, V95, P569, DOI 10.1007/s00421-005-0055-y; Schaap CCM, 2013, CLIN CHEM, V59, P527, DOI 10.1373/clinchem.2012.194977; Sim M, 2013, INT J SPORT NUTR EXE, V23, P178, DOI 10.1123/ijsnem.23.2.178; Sim M, 2012, EUR J APPL PHYSIOL, V112, P1889, DOI 10.1007/s00421-011-2156-0; Talbot NP, 2012, BLOOD, V119, P857, DOI 10.1182/blood-2011-03-341776; Telford RD, 2003, J APPL PHYSIOL, V94, P38, DOI 10.1152/japplphysiol.00631.2001; van Santen S, 2011, ARTHRITIS RHEUM-US, V63, P3672, DOI 10.1002/art.30623	27	104	107	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93002	10.1371/journal.pone.0093002	http://dx.doi.org/10.1371/journal.pone.0093002			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667393	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600123
J	Prinz, RD; Willis, CM; van Kuppevelt, TH; Kluppel, M				Prinz, Robert D.; Willis, Catherine M.; van Kuppevelt, Toin H.; Klueppel, Michael			Biphasic Role of Chondroitin Sulfate in Cardiac Differentiation of Embryonic Stem Cells through Inhibition of Wnt/beta-Catenin Signaling	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-1; CARDIOMYOCYTE DIFFERENTIATION; BRAIN-DEVELOPMENT; SPINAL-CORD; IN-VITRO; WNT; CANCER; PROTEOGLYCANS; MAINTENANCE; BIGLYCAN	The glycosaminoglycan chondroitin sulfate is a critical component of proteoglycans on the cell surface and in the extracellular matrix. As such, chondroitin sulfate side chains and the sulfation balance of chondroitin play important roles in the control of signaling pathways, and have a functional importance in human disease. In contrast, very little is known about the roles of chondroitin sulfate molecules and sulfation patterns during mammalian development and cell lineage specification. Here, we report a novel biphasic role of chondroitin sulfate in the specification of the cardiac cell lineage during embryonic stem cell differentiation through modulation of Wnt/beta-catenin signaling. Lineage marker analysis demonstrates that enzymatic elimination of endogenous chondroitin sulfates leads to defects specifically in cardiac differentiation. This is accompanied by a reduction in the number of beating cardiac foci. Mechanistically, we show that endogenous chondroitin sulfate controls cardiac differentiation in a temporal biphasic manner through inhibition of the Wnt/beta-catenin pathway, a known regulatory pathway for the cardiac lineage. Treatment with a specific exogenous chondroitin sulfate, CS-E, could mimic these biphasic effects on cardiac differentiation and Wnt/beta-catenin signaling. These results establish chondroitin sulfate and its sulfation balance as important regulators of cardiac cell lineage decisions through control of the Wnt/beta-catenin pathway. Our work suggests that targeting the chondroitin biosynthesis and sulfation machinery is a novel promising avenue in regenerative strategies after heart injury.	[Prinz, Robert D.; Willis, Catherine M.; Klueppel, Michael] Ann & Robert H Lurie Childrens Hosp Chicago Res C, Chicago, IL 60611 USA; [Willis, Catherine M.; Klueppel, Michael] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Klueppel, Michael] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [van Kuppevelt, Toin H.] Radboud Inst Mol Life Sci, Dept Biochem, Nijmegen, Netherlands	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Kluppel, M (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago Res C, Chicago, IL 60611 USA.	m-kluppel@northwestern.edu	van Kuppevelt, A.H.M.S.M./L-4463-2015		Ann and Robert H. Lurie Children's Hospital of Chicago Research Center	Ann and Robert H. Lurie Children's Hospital of Chicago Research Center	The authors wish to acknowledge financial support from the Ann and Robert H. Lurie Children's Hospital of Chicago Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asimakopoulou AP, 2008, IN VIVO, V22, P385; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bartus K, 2012, EXP NEUROL, V235, P5, DOI 10.1016/j.expneurol.2011.08.008; BASHEY RI, 1993, MATRIX, V13, P363, DOI 10.1016/S0934-8832(11)80041-7; Behrens J, 2005, BIOCHEM SOC T, V33, P672, DOI 10.1042/BST0330672; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Chen K, 2008, J CELL BIOCHEM, V104, P119, DOI 10.1002/jcb.21604; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dell'Era P, 2003, CIRC RES, V93, P414, DOI 10.1161/01.RES.0000089460.12061.E1; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Gardner RT, 2013, J NEUROSCI, V33, P7175, DOI 10.1523/JNEUROSCI.5866-12.2013; Gaspar C, 2004, INT J DEV BIOL, V48, P377, DOI 10.1387/ijdb.041807cg; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Heegaard AM, 2007, CIRCULATION, V115, P2731, DOI 10.1161/CIRCULATIONAHA.106.653980; Hermanns P, 2008, AM J HUM GENET, V82, P1368, DOI 10.1016/j.ajhg.2008.05.006; Hinek A, 2005, AM J MED GENET A, V133A, P1, DOI 10.1002/ajmg.a.30495; Hirata A, 2013, DEVELOPMENT, V140, P66, DOI 10.1242/dev.084103; Huelsken J, 2009, EUR J IMMUNOL, V39, P3582, DOI 10.1002/eji.200838982; Hwang JY, 2008, AM J PATHOL, V173, P1919, DOI 10.2353/ajpath.2008.070875; Kluppel M, 2012, EUR J HUM GENET, V20, P870, DOI 10.1038/ejhg.2012.12; Kluppel M, 2011, MOL CELL BIOCHEM, V351, P1, DOI 10.1007/s11010-010-0705-1; Kluppel M, 2010, PROG MOL BIOL TRANSL, V93, P113, DOI 10.1016/S1877-1173(10)93006-8; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kluppel M, 2002, MECH DEVELOP, V118, P77, DOI 10.1016/S0925-4773(02)00198-3; Kuhl SJ, 2013, BBA-GEN SUBJECTS, V1830, P2297, DOI 10.1016/j.bbagen.2012.08.010; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Kwon C, 2008, CELL CYCLE, V7, P3815, DOI 10.4161/cc.7.24.7189; Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014; Lam AP, 2011, CURR OPIN RHEUMATOL, V23, P562, DOI 10.1097/BOR.0b013e32834b3309; Mizumoto S, 2013, GLYCOCONJUGATE J, V30, P619, DOI 10.1007/s10719-012-9463-5; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2005, SCI STKE; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Nagy A, 2006, CSH PROTOCOLS, V2006; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Oerlemans MIFJ, 2010, BASIC RES CARDIOL, V105, P631, DOI 10.1007/s00395-010-0100-9; Peal DS, 2009, DEV DYNAM, V238, P3103, DOI 10.1002/dvdy.22154; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Prinz RD, 2011, GENET MOL RES, V10, P3901, DOI 10.4238/2011.December.8.9; Prosperi JR, 2010, CURR DRUG TARGETS, V11, P1074; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Purushothaman A, 2012, J BIOL CHEM, V287, P2935, DOI 10.1074/jbc.R111.298430; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ronca R, 2009, J CELL MOL MED, V13, P1489, DOI 10.1111/j.1582-4934.2009.00805.x; Sato T, 2011, J BIOL CHEM, V286, P5803, DOI 10.1074/jbc.M110.159244; Smetsers TFCM, 2004, J INVEST DERMATOL, V122, P707, DOI 10.1111/j.0022-202X.2004.22316.x; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; Theocharis AD, 2006, ADV PHARMACOL, V53, P281, DOI 10.1016/S1054-3589(05)53013-8; Theocharis AD, 2000, BBA-MOL BASIS DIS, V1502, P201, DOI 10.1016/S0925-4439(00)00051-X; Theocharis AD, 2002, BIOCHIMIE, V84, P667, DOI 10.1016/S0300-9084(02)01428-1; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Tuysuz B, 2009, CLIN GENET, V75, P375, DOI 10.1111/j.1399-0004.2009.01167.x; Uchimura K, 2002, J BIOL CHEM, V277, P1443, DOI 10.1074/jbc.M104719200; Uebelhart D, 2008, OSTEOARTHR CARTILAGE, V16, pS19, DOI 10.1016/j.joca.2008.06.006; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; van Es JH, 2005, TRENDS MOL MED, V11, P496, DOI 10.1016/j.molmed.2005.09.008; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Westermann D, 2008, CIRCULATION, V117, P1269, DOI 10.1161/CIRCULATIONAHA.107.714147; Willis CM, 2009, GENET MOL RES, V8, P1331, DOI 10.4238/vol8-4gmr673; Willis CM, 2012, J BIOL CHEM, V287, P37042, DOI 10.1074/jbc.M112.391490; Wilson DG, 2012, DEV BIOL, V363, P413, DOI 10.1016/j.ydbio.2012.01.005; Yu PP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059285	67	24	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92381	10.1371/journal.pone.0092381	http://dx.doi.org/10.1371/journal.pone.0092381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667694	gold, Green Published, Green Submitted			2022-12-25	WOS:000333675600034
J	Steiner, T; Francescut, L; Byrne, S; Hughes, T; Jayanthi, A; Guschina, I; Harwood, J; Cianflone, K; Stover, C; Francis, S				Steiner, Tanja; Francescut, Lorenza; Byrne, Simon; Hughes, Timothy; Jayanthi, Archana; Guschina, Irina; Harwood, John; Cianflone, Katherine; Stover, Cordula; Francis, Sheila			Protective Role for Properdin in Progression of Experimental Murine Atherosclerosis	PLOS ONE			English	Article							ACYLATION-STIMULATING PROTEIN; RECEPTOR-DEFICIENT MICE; MACROPHAGE PLASTICITY; ALTERNATIVE PATHWAY; COMPLEMENT; C3; ACTIVATION; DIET; SUSCEPTIBILITY; POLARIZATION	Genetic, dietary and immune factors contribute to the pathogenesis of atherosclerosis in humans and mice. Complement activation is an integral part of the innate immune defence but also shapes cellular responses and influences directly triglyceride synthesis. Deficiency of Factor B of the alternative pathway (AP) of complement is beneficial in LDLR-/- mice fed a high fat diet. The serum glycoprotein properdin is a key positive regulator of the AP but has not been studied in experimental atherosclerosis. Atherosclerosis was assessed after feeding low fat (LFD) or high fat (HFD) Western type diets to newly generated LDLR-/- Properdin(KO) ((LDLR-/-PKO)) and (LDLR-/-PWT) mice. Lipids, lymphocytes and monocytes were similar among genotypes, genders and diets. Complement C3, but not C3a(desarg), levels were enhanced in LDLR-/- P-KO mice regardless of diet type or gender. Non-esterified fatty acids (NEFA) were decreased in male (LDLR-/-PKO) fed a HFD compared with controls. All mice showed significant atherosclerotic burden in aortae and at aortic roots but male LDLR-/- mice fed a LFD were affected to the greatest extent by the absence of properdin. The protective effect of properdin expression was overwhelmed in both genders of LDLR-/- mice when fed a HFD. We conclude that properdin plays an unexpectedly beneficial role in the development and progression of early atherosclerotic lesions.	[Steiner, Tanja; Francis, Sheila] Univ Sheffield, Sch Med, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Francescut, Lorenza; Byrne, Simon; Stover, Cordula] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Hughes, Timothy; Jayanthi, Archana] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Guschina, Irina; Harwood, John] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Cianflone, Katherine] Univ Laval, CRIUCPQ, Quebec City, PQ, Canada	University of Sheffield; University of Leicester; Cardiff University; Cardiff University; Laval University	Francis, S (corresponding author), Univ Sheffield, Sch Med, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England.	s.francis@sheffield.ac.uk	Harwood, John L/A-4308-2010	Harwood, John/0000-0003-2377-2612; Stover, Cordula/0000-0002-0125-4868; Francis, Sheila/0000-0001-6552-0339	British Heart Foundation [PG/09/053/27836]; British Heart Foundation [PG/13/28/29833] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	British Heart Foundation grant PG/09/053/27836 funded this research. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bacci M, 2009, AM J PATHOL, V175, P547, DOI 10.2353/ajpath.2009.081011; Bolego C, 2013, ARTERIOSCL THROM VAS, V33, P1127, DOI 10.1161/ATVBAHA.113.301328; Buono C, 2002, CIRCULATION, V105, P3025, DOI 10.1161/01.CIR.0000019584.04929.83; Camous L, 2011, BLOOD, V117, P1340, DOI 10.1182/blood-2010-05-283564; Cianflone K, 2004, J LIPID RES, V45, P124, DOI 10.1194/jlr.M300214-JLR200; DAVIS AE, 1979, J CLIN INVEST, V64, P721, DOI 10.1172/JCI109515; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856; Fisette A, 2013, IMMUNOBIOLOGY, V218, P127, DOI 10.1016/j.imbio.2012.04.001; Francescut L, 2012, J INNATE IMMUN, V4, P260, DOI 10.1159/000332435; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Glenn S, 2014, MED MICROBI IN PRESS; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Joven J, 2007, ATHEROSCLEROSIS, V195, pE85, DOI 10.1016/j.atherosclerosis.2007.06.012; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Lewis RD, 2011, AM J PATHOL, V179, P1601, DOI 10.1016/j.ajpath.2011.06.015; Lutz HU, 2007, MOL IMMUNOL, V44, P3862, DOI 10.1016/j.molimm.2007.06.146; LYNCH DM, 1993, EUR J IMMUNOGENET, V20, P1, DOI 10.1111/j.1744-313X.1993.tb00090.x; Malik TH, 2010, CIRCULATION, V122, P1948, DOI 10.1161/CIRCULATIONAHA.110.981365; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mogilenko DA, 2012, J BIOL CHEM, V287, P5954, DOI 10.1074/jbc.M111.289322; Paglialunga S, 2008, AM J PHYSIOL-ENDOC M, V294, pE521, DOI 10.1152/ajpendo.00590.2007; Paglialunga Sabina, 2010, BMC Physiology, V10, P4, DOI 10.1186/1472-6793-10-4; Persson L, 2004, ARTERIOSCL THROM VAS, V24, P1062, DOI 10.1161/01.ATV.0000127302.24266.40; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Singh U, 2004, CLIN SCI, V106, P421, DOI 10.1042/CS20030375; Stover CM, 2008, J IMMUNOL, V180, P3313, DOI 10.4049/jimmunol.180.5.3313; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Yasojima K, 2001, ARTERIOSCL THROM VAS, V21, P1214, DOI 10.1161/hq0701.092160; Yun S, 2008, ARTERIOSCL THROM VAS, V28, P1714, DOI 10.1161/ATVBAHA.108.169912	33	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92404	10.1371/journal.pone.0092404	http://dx.doi.org/10.1371/journal.pone.0092404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667818	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600038
J	Wu, M; Du, Y; Liu, YW; He, YQ; Yang, CX; Wang, WJ; Gao, F				Wu, Man; Du, Yan; Liu, Yiwen; He, Yiqing; Yang, Cuixia; Wang, Wenjuan; Gao, Feng			Low Molecular Weight Hyaluronan Induces Lymphangiogenesis through LYVE-1-Mediated Signaling Pathways	PLOS ONE			English	Article							ANGIOGENIC OLIGOSACCHARIDES; TUMOR LYMPHANGIOGENESIS; ENDOTHELIAL-CELLS; CANCER METASTASIS; PROSTATE-CANCER; BREAST-CANCER; TISSUE-INJURY; PROMOTES; GROWTH; RECEPTOR	Hyaluronan (HA), a large nonsulfated glycosaminogycan in the extracellular matrix, whose degraded fragments termed as low molecular weight hyaluronan (LMW-HA), has been reported as an important regulator of angiogenesis. However, little is known about the influence of LMW-HA on lymphangiogenesis. In this study, we try to explore the in vitro effects of LMW-HA on lymphangiogenesis and identify the underlying molecular mechanisms. Our results showed that LMW-HA stimulation significantly increased lymphatic endothelial cells (LECs) proliferation, migration and tube formation. Further experiments demonstrated that LMW-HA altered actin cytoskeleton rearrangement and increased the formation of intense stress fibers, lamellipodia and filopodia. Mechanistically, LMW-HA stimulation resulted in rapid tyrosine phosphorylation of protein kinase C alpha/beta II (PKC alpha/beta II) and extracellular-regulated kinase 1/2 (ERK1/2). Lymphalic vessel endotheilial hyaluronan receptor 1 (LYVE-1), a homologue of CD44, is the main cell surface receptor for HA in LECs. Blocking the binding interaction of LMW-HA with LYVE-1 using neutralizing anti-LYVE-1 antibodies significantly inhibited LECs proliferation, migration, tube formation and signal transduction induced by LMW-HA, suggesting that LMW-HA may play a critical role in the processes required for lymphangiogenesis through interactions with its receptor LYVE-1 and triggering intracellular signal cascades.	[Wu, Man; Du, Yan; Liu, Yiwen; He, Yiqing; Yang, Cuixia; Wang, Wenjuan] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Mol Biol, Shanghai 200030, Peoples R China; [Gao, Feng] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Mol Biol & Clin Lab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, F (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Mol Biol & Clin Lab, Shanghai 200030, Peoples R China.	gao3507@126.com	Wu, Man/AAH-6253-2020; liu, yi/GXE-9662-2022		National Natural Science Foundation of China [81071814, 81172027, 81272479]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors' research was supported by the National Natural Science Foundation of China (No. 81071814, 81172027 and 81272479) http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Chalkiadaki G, 2011, CANCER LETT, V312, P235, DOI 10.1016/j.canlet.2011.08.016; Chang VWH, 2001, GENE, V267, P201, DOI 10.1016/S0378-1119(01)00400-0; Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J; Du Y, 2011, CLIN INVEST MED, V34, pE45; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Gao F, 2006, J BIOMED MATER RES B, V78B, P385, DOI 10.1002/jbm.b.30499; Guo LX, 2005, ACTA BIOCH BIOPH SIN, V37, P601, DOI 10.1111/j.1745-7270.2005.00083.x; Hayen W, 1999, J CELL SCI, V112, P2241; Hou WH, 2012, FEBS LETT, V586, P1480, DOI 10.1016/j.febslet.2012.04.001; Hou WH, 2011, J CELL SCI, V124, P1231, DOI 10.1242/jcs.078154; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Kouvidi K, 2011, J BIOL CHEM, V286, P38509, DOI 10.1074/jbc.M111.275875; KUMAR S, 1989, INT J CANCER, V44, P445, DOI 10.1002/ijc.2910440311; Kuzmenko ES, 2004, INT J BIOCHEM CELL B, V36, P519, DOI 10.1016/j.biocel.2003.09.010; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Liu NF, 2001, CANCER RES, V61, P5207; Lokeshwar VB, 2001, J BIOL CHEM, V276, P11922, DOI 10.1074/jbc.M008432200; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Mattila MMT, 2002, INT J CANCER, V98, P946, DOI 10.1002/ijc.10283; Mumprecht V, 2009, J CELL MOL MED, V13, P1405, DOI 10.1111/j.1582-4934.2009.00834.x; Nightingale TD, 2009, J BIOL CHEM, V284, P3935, DOI 10.1074/jbc.M805105200; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; OCONNELL KA, 1990, J IMMUNOL, V144, P521; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Qian Y, 1998, ONCOGENE, V16, P2185, DOI 10.1038/sj.onc.1201753; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Sathish KG, 2008, THESIS U SO CALIFORN; SHERMAN L, 1994, CURR OPIN CELL BIOL, V6, P726, DOI 10.1016/0955-0674(94)90100-7; Simpson MA, 2002, AM J PATHOL, V161, P849, DOI 10.1016/S0002-9440(10)64245-9; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Slevin M, 2004, INT J CANCER, V109, P793, DOI 10.1002/ijc.20059; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Slevin M, 1998, LAB INVEST, V78, P987; Slomiany MG, 2009, CANCER RES, V69, P4992, DOI 10.1158/0008-5472.CAN-09-0143; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954; Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; TURLEY EA, 1994, GLIA, V12, P68, DOI 10.1002/glia.440120109; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang YY, 2002, CANCER RES, V62, P3962	48	51	53	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92857	10.1371/journal.pone.0092857	http://dx.doi.org/10.1371/journal.pone.0092857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667755	gold, Green Submitted, Green Published			2022-12-25	WOS:000333675600092
J	Chatterjee, M; Seizer, P; Borst, O; Schonberger, T; Mack, A; Geisler, T; Langer, HF; May, AE; Vogel, S; Lang, F; Gawaz, M				Chatterjee, Madhumita; Seizer, Peter; Borst, Oliver; Schoenberger, Tanja; Mack, Andreas; Geisler, Tobias; Langer, Harald F.; May, Andreas E.; Vogel, Sebastian; Lang, Florian; Gawaz, Meinrad			SDF-1 alpha induces differential trafficking of CXCR4-CXCR7 involving cyclophilin A, CXCR7 ubiquitination and promotes platelet survival	FASEB JOURNAL			English	Article						platelets; chemokine; receptor; apoptosis	CELL-SURVIVAL; CHEMOKINE RECEPTOR; PROGENITOR CELLS; ACTIVATION; APOPTOSIS; MIGRATION; ADHESION; CXCL12; INFLAMMATION; RECRUIT	Platelet-derived SDF-1 alpha (CXCL12) mediates inflammatory and regenerative mechanisms. The present study characterizes the effect of SDF-1 alpha ligation in platelets. SDF-1 alpha (0-100 mu M) dose and time dependently caused internalization of its receptor CXCR4 (28.9 +/- 1.6 vs. 16.1 +/- 1.9 in SDF-1 alpha -treated platelets), coupled to the surface externalization of CXCR7 (65.5 +/- 8 vs. 162.8 +/- 27.6 following SDF-1 alpha treatment), both in vitro and in vivo. This was inhibited in the presence of AMD3100 (100 mu M), CXCR4 blocking and vesicular transport inhibitors (brefeldin A, 10 mu M; rapamycin, 100 nM). SDF-1 alpha/CXCR-4-mediated CXCR7 translocation was significantly reduced by inhibitors of ERK1/2-(U0126-10 mu M) and cyclophilinA (CyPA)(NIM811-10 mu M) by 28 and 46%, respectively. Further, SDF-1 alpha-induced downstream phosphorylation of Erk1/2 led to CyPA-dependent ubiquitination of CXCR7, which is essential for its surface translocation. CyPA-PPIase-activity inhibitor NIM-811, Erk1/2, and E1-ligase inhibitor(PYR-41-25 mu M) significantly abolished SDF-1 alpha-driven CXCR7 ubiquitination and subsequent surface translocation. SDF-1 alpha induced CXCR7 ubiquitination, and its surface exposure was observed in wild-type murine platelets, but not in CyPA-deficient platelets. SDF-1 alpha/CXCR4-CyPA-dependent CXCR7 translocation and its subsequent ligation attenuated activation-induced apoptosis both in vitro and when administered in vivo. This antiapoptotic effect of SDF-1 alpha was abrogated by blocking CXCR7, also significantly affected in Cypa(-/-) platelets. Thus, we decipher a novel mechanism, whereby SDF-1 alpha regulates relative receptor availability in circulating platelets and exerts its prosurvival benefits.	[Chatterjee, Madhumita; Seizer, Peter; Borst, Oliver; Schoenberger, Tanja; Geisler, Tobias; Langer, Harald F.; May, Andreas E.; Vogel, Sebastian; Gawaz, Meinrad] Univ Tubingen, Med Klin 3, D-72076 Tubingen, Germany; [Lang, Florian] Univ Tubingen, Inst Physiol, D-72076 Tubingen, Germany; [Mack, Andreas] Univ Tubingen, Inst Anat, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Gawaz, M (corresponding author), Univ Tubingen, Med Klin 3, Otfried Muller Str 10, D-72076 Tubingen, Germany.	meinrad.gawaz@med.uni-tuebingen.de	Geisler, Tobias/AAO-4472-2020	Mack, Andreas/0000-0001-7591-4374; Borst, Oliver/0000-0003-4002-4085; Vogel, Sebastian/0000-0002-3284-0464; Chatterjee, Madhumita/0000-0002-3428-4107	Deutsche Forschungsgemeinschaft (Klinische Forschungsgruppe KFO-274: Platelets-Molecular Mechanisms and Translational Implications); Deutsche Forschungsgemeinschaft (Transregio-SFB: Inflammatory Cardiomyopathy)	Deutsche Forschungsgemeinschaft (Klinische Forschungsgruppe KFO-274: Platelets-Molecular Mechanisms and Translational Implications); Deutsche Forschungsgemeinschaft (Transregio-SFB: Inflammatory Cardiomyopathy)	The authors thank Ms. Christina Flaum for her technical expertise. The study was supported by the Deutsche Forschungsgemeinschaft (Klinische Forschungsgruppe KFO-274: Platelets-Molecular Mechanisms and Translational Implications, and the Transregio-SFB: Inflammatory Cardiomyopathy). The authors declare no conflicts of interest.	Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Borst O, 2012, CIRC RES, V111, P1297, DOI 10.1161/CIRCRESAHA.112.276444; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Canals M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034192; Chatterjee M, 2011, BLOOD, V117, P3907, DOI 10.1182/blood-2010-12-327007; Elvers M, 2012, BLOOD, V120, P1317, DOI 10.1182/blood-2011-12-398438; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gleissner CA, 2008, ARTERIOSCL THROM VAS, V28, P1920, DOI 10.1161/ATVBAHA.108.169417; Guillemot E, 2012, BRIT J CANCER, V107, P1944, DOI 10.1038/bjc.2012.503; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Hattermann K, 2012, ONCOL REP, V27, P1348, DOI 10.3892/or.2012.1674; Kraemer BF, 2010, J MOL MED, V88, P1277, DOI 10.1007/s00109-010-0680-8; Kumar R, 2012, CELL IMMUNOL, V272, P230, DOI 10.1016/j.cellimm.2011.09.015; Langer H, 2006, CIRC RES, V98, pE2, DOI 10.1161/01.RES.0000201285.87524.9e; Lapham CK, 2002, J LEUKOCYTE BIOL, V72, P1206; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Leytin V, 2012, BLOOD REV, V26, P51, DOI 10.1016/j.blre.2011.10.002; Li T, 2011, J PATHOL, V223, P519, DOI 10.1002/path.2829; Liu HQ, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-147; Liu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031063; Mahabaleshwar H, 2008, CELL ADHES MIGR, V2, P69, DOI 10.4161/cam.2.2.6027; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Odemis V, 2012, GLIA, V60, P372, DOI 10.1002/glia.22271; Pan H, 2008, J BIOL CHEM, V283, P623, DOI 10.1074/jbc.M704934200; Rath D, 2014, EUR HEART J, V35, P386, DOI 10.1093/eurheartj/eht448; Seizer P, 2012, J MOL CELL CARDIOL, V53, P6, DOI 10.1016/j.yjmcc.2012.03.004; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Vogler M, 2011, BLOOD, V117, P7145, DOI 10.1182/blood-2011-03-344812; Wang JF, 1998, BLOOD, V92, P756, DOI 10.1182/blood.V92.3.756.415k36_756_764; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Zhu B, 2012, STEM CELLS, V30, P2571, DOI 10.1002/stem.1239	36	43	44	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2864	2878		10.1096/fj.14-249730	http://dx.doi.org/10.1096/fj.14-249730			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24668750				2022-12-25	WOS:000337949400012
J	da Costa, KA; Corbin, KD; Niculescu, MD; Galanko, JA; Zeisel, SH				da Costa, Kerry-Ann; Corbin, Karen D.; Niculescu, Mihai D.; Galanko, Joseph A.; Zeisel, Steven H.			Identification of new genetic polymorphisms that alter the dietary requirement for choline and vary in their distribution across ethnic and racial groups	FASEB JOURNAL			English	Article						SNP; creatine kinase; fatty liver; muscle	PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; HOMOCYSTEINE S-METHYLTRANSFERASE; 1-CARBON METABOLISM; HEPATIC STEATOSIS; BETAINE; NUTRIENT; WOMEN; RISK; METHYLATION; HUMANS	Effect alleles (alleles with a polymorphism that is associated with the effect being measured) in a small number of single-nucleotide polymorphisms (SNPs) are known to influence the dietary requirement for choline. In this study, we examined a much larger number of SNPs (n = 200) in 10 genes related to choline metabolism for associations with development of organ dysfunction (liver or muscle) when 79 humans were fed a low-choline diet. We confirmed that effect alleles in SNPs such as the C allele of PEMT rs12325817 increase the risk of developing organ dysfunction in women when they consume a diet low in choline, and we identified novel effect alleles, such as the C allele of CHKA SNP rs7928739, that alter dietary choline requirements. When fed a low-choline diet, some people presented with muscle damage rather than liver damage; several effect alleles in SLC44A1 (rs7873937, G allele; rs2771040, G; rs6479313, G; rs16924529, A; and rs3199966, C) and one in CHKB (rs1557502, A) were more common in these individuals. This suggests that pathways related to choline metabolism are more important for normal muscle function than previously thought. In European, Mexican, and Asian Americans, and in individuals of African descent, we examined the prevalence of the effect alleles in SNPs that alter choline requirement and found that they are differentially distributed among people of different ethnic and racial backgrounds. Overall, our study has identified novel genetic variants that modulate choline requirements and suggests that the dietary requirement for choline may be different across racial and ethnic groups.	[da Costa, Kerry-Ann; Zeisel, Steven H.] Univ N Carolina, Sch Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA; [da Costa, Kerry-Ann; Zeisel, Steven H.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Galanko, Joseph A.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Corbin, Karen D.; Niculescu, Mihai D.; Zeisel, Steven H.] Univ North Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zeisel, SH (corresponding author), Inst Nutr Res, 500 Laureate Way, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu	Core, Mammalian Genotyping/AFU-1631-2022	Corbin, Karen/0000-0003-2065-0003	U.S. National Institutes of Health [DK55865]; University of North Carolina (UNC) Nutrition and Obesity Research Center [DK56350]; UNC Gastrointestinal Research Center [DK03498]; UNC Clinical and Translational Research Center [M01RR00046, UL1RR025747]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000046, UL1RR025747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055865, P30DK034987, P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina (UNC) Nutrition and Obesity Research Center; UNC Gastrointestinal Research Center; UNC Clinical and Translational Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by grants from the U.S. National Institutes of Health to S.H.Z. (DK55865), the University of North Carolina (UNC) Nutrition and Obesity Research Center (DK56350), the UNC Gastrointestinal Research Center (DK03498) and the UNC Clinical and Translational Research Center (M01RR00046 and UL1RR025747). The clinical study is registered at Clinical-Trials.gov (NCT00065546; http://www.clinicaltrials.gov). The authors thank the Mammalian Genotyping Core at UNC Chapel Hill for their assistance on this project, and especially Amanda Beaty for her patience and generosity. The authors also thank Mihai George Mehedint, Huili Wang, Hye Mee Hwang and Robin Betsch for their technical assistance in this study, and Fred Wright for his statistical advice. Author contributions: K.-A.D. was responsible for sample collection, genotyping, data interpretation and preparation of the manuscript; K. D. C. assisted with the genotyping, SNP analysis, and preparation of the manuscript; M.D.N. was responsible for the design and setup of the PEMT rs12325817 genotyping; J.A.G. assisted with statistical analyses; S.H.Z. was responsible for overall experimental design and data interpretation and assisted with the preparation of the manuscript. The authors declare no conflicts of interest.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BUCHMAN AL, 1995, HEPATOLOGY, V22, P1399, DOI 10.1002/hep.1840220510; Busby MG, 2004, J AM DIET ASSOC, V104, P1836, DOI 10.1016/j.jada.2004.09.027; Chester DN., 2011, DIETARY INTAKES CHOL; Cho E, 2006, AM J CLIN NUTR, V83, P905, DOI 10.1093/ajcn/83.4.905; Cho E, 2007, JNCI-J NATL CANCER I, V99, P1224, DOI 10.1093/jnci/djm082; Collinsova M, 2006, J NUTR, V136, P1493, DOI 10.1093/jn/136.6.1493; Corbin KD, 2013, FASEB J, V27, P1674, DOI 10.1096/fj.12-219097; da Costa KA, 2004, AM J CLIN NUTR, V80, P163; da Costa KA, 2006, FASEB J, V20, P1336, DOI 10.1096/fj.06-5734com; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Dominguez-Salas P, 2013, AM J CLIN NUTR, V97, P1217, DOI 10.3945/ajcn.112.048462; Enaw JOE, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-36; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Fischer LM, 2010, AM J CLIN NUTR, V92, P1113, DOI 10.3945/ajcn.2010.30064; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Hung J, 2008, J AM COLL NUTR, V27, P253, DOI 10.1080/07315724.2008.10719697; Institute of Medicine, 1998, DIET REF INT THIAM R, P390, DOI [DOI 10.17226/6015, 10.17226/6015]; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kimm SYS, 2002, AM J CLIN NUTR, V75, P714, DOI 10.1093/ajcn/75.4.714; Kohlmeier M, 2005, P NATL ACAD SCI USA, V102, P16025, DOI 10.1073/pnas.0504285102; Lee JE, 2010, CANCER EPIDEM BIOMAR, V19, P884, DOI 10.1158/1055-9965.EPI-09-1295; Li ZY, 2005, J BIOL CHEM, V280, P37798, DOI 10.1074/jbc.M508575200; Michel Vera, 2012, Central Nervous System Agents in Medicinal Chemistry, V12, P70; Michel V, 2011, FOOD FUNCT, V2, P53, DOI 10.1039/c0fo00069h; Michel V, 2009, FASEB J, V23, P2749, DOI 10.1096/fj.08-121491; Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010; Resseguie M, 2007, FASEB J, V21, P2622, DOI 10.1096/fj.07-8227com; Resseguie ME, 2011, J BIOL CHEM, V286, P1649, DOI 10.1074/jbc.M110.106922; Sambrook J, 2001, MOL CLONING LAB MANU; Shaw GM, 2006, EPIDEMIOLOGY, V17, P285, DOI 10.1097/01.ede.0000208348.30012.35; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; Shen R, 2005, MUTAT RES-FUND MOL M, V573, P70, DOI 10.1016/j.mrfmmm.2004.07.022; Shin W, 2010, J NUTR, V140, P975, DOI 10.3945/jn.110.121186; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Traiffort E, 2013, MOL ASPECTS MED, V34, P646, DOI 10.1016/j.mam.2012.10.011; Walkey CJ, 1999, BBA-MOL CELL BIOL L, V1436, P405, DOI 10.1016/S0005-2760(98)00147-7; Wu GS, 2010, BIOCHEM CELL BIOL, V88, P559, DOI 10.1139/O09-160; Yan JA, 2011, AM J CLIN NUTR, V93, P348, DOI 10.3945/ajcn.110.005975; Zeisel SH, 2003, J NUTR, V133, P1302; ZEISEL SH, 1995, J NUTR, V125, P3049; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156	44	44	44	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2970	2978		10.1096/fj.14-249557	http://dx.doi.org/10.1096/fj.14-249557			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24671709	Green Published, Green Submitted			2022-12-25	WOS:000337949400020
J	Dubois, V; Laurent, MR; Sinnesael, M; Cielen, N; Helsen, C; Clinckemalie, L; Spans, L; Gayan-Ramirez, G; Deldicque, L; Hespel, P; Carmeliet, G; Vanderschueren, D; Claessens, F				Dubois, Vanessa; Laurent, Michal R.; Sinnesael, Mieke; Cielen, Nele; Helsen, Christine; Clinckemalie, Liesbeth; Spans, Lien; Gayan-Ramirez, Ghislaine; Deldicque, Louise; Hespel, Peter; Carmeliet, Geert; Vanderschueren, Dirk; Claessens, Frank			A satellite cell-specific knockout of the androgen receptor reveals myostatin as a direct androgen target in skeletal muscle	FASEB JOURNAL			English	Article						mouse model; fiber type; microarray; DNA response element; hormone response element	GROWTH-FACTOR; BODY-COMPOSITION; MALE-MICE; MYOGENIC DIFFERENTIATION; SIGNALING PATHWAYS; RAT MODEL; TESTOSTERONE; EXPRESSION; STRENGTH; MASS	Androgens have well-established anabolic actions on skeletal muscle, although the direct effects of the androgen receptor (AR) in muscle remain unclear. We generated satellite cell-specific AR-knockout (satARKO) mice in which the AR is selectively ablated in satellite cells, the muscle precursor cells. Total-limb maximal grip strength is decreased by 7% in satARKO mice, with soleus muscles containing similar to 10% more type I fibers and 10% less type IIa fibers than the corresponding control littermates. The weight of the perineal levator ani muscle is markedly reduced (similar to 52%). Thus, muscle AR is involved in fiber-type distribution and force production of the limb muscles, while it is a major determinant of the perineal muscle mass. Surprisingly, myostatin (Mstn), a strong inhibitor of skeletal muscle growth, is one of the most androgen-responsive genes (6-fold reduction in satARKO) through direct transcription activation by the AR. Consequently, muscle hypertrophy in response to androgens is augmented in Mstn-knockout mice. Our finding that androgens induce Mstn signaling to restrain their own anabolic actions has implications for the treatment of muscle wasting disorders.	[Dubois, Vanessa; Laurent, Michal R.; Helsen, Christine; Clinckemalie, Liesbeth; Spans, Lien; Claessens, Frank] Katholieke Univ Leuven, Mol Endocrinol Lab, B-3000 Leuven, Belgium; [Laurent, Michal R.] Katholieke Univ Leuven, Div Gerontol & Geriatr, B-3000 Leuven, Belgium; [Sinnesael, Mieke; Carmeliet, Geert; Vanderschueren, Dirk] Katholieke Univ Leuven, Div Clin & Expt Endocrinol, B-3000 Leuven, Belgium; [Cielen, Nele; Gayan-Ramirez, Ghislaine] Katholieke Univ Leuven, Div Pneumol, B-3000 Leuven, Belgium; [Deldicque, Louise; Hespel, Peter] Katholieke Univ Leuven, Exercise Physiol Res Grp, B-3000 Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven	Claessens, F (corresponding author), Katholieke Univ Leuven, Campus Gasthuisberg O&N1 POB 901,Herestr 49, B-3000 Leuven, Belgium.	frank.claessens@med.kuleuven.be	Dubois, Vanessa/ABF-9551-2021; Laurent, Michaël R./D-5748-2011; Claessens, Frank/M-8565-2016	Dubois, Vanessa/0000-0001-8894-2980; Laurent, Michaël R./0000-0001-9681-8330; Claessens, Frank/0000-0002-8676-7709; Gayan-Ramirez, Ghislaine/0000-0001-9652-7437; Deldicque, Louise/0000-0003-3393-5278; Hespel, Peter/0000-0003-1283-2229; vanderschueren, dirk/0000-0003-1395-0104; Helsen, Christine/0000-0003-1048-2798	Flemish Fund for Scientific Research (FWO) [G.0858.11N]; KU Leuven [OT/11/081, OT/09/035]; FWO	Flemish Fund for Scientific Research (FWO)(FWO); KU Leuven(KU Leuven); FWO(FWO)	This work was supported by research grants from the Flemish Fund for Scientific Research (FWO; G.0858.11N) and from KU Leuven (OT/11/081, OT/09/035). V. D. and M. R. L. are holders of a doctoral fellowship of the FWO. The authors thank R. Bollen, H. Debruyn, D. Schollaert, E. Van Herck, L. Deboel, R. Van Looveren, K. Moermans, and M. Ramaekers for their excellent technical assistance and their colleagues of the Molecular Endocrinology Laboratory for the helpful discussions. The authors thank Alexandra C. McPherron and Se-Jin Lee (Johns Hopkins University, Baltimore, MD, USA) for the kind gift of the Mstn-KO mice.	Axell AM, 2006, AM J PHYSIOL-ENDOC M, V291, pE506, DOI 10.1152/ajpendo.00058.2006; Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/nejm199607043350101; Bhasin S, 2001, AM J PHYSIOL-ENDOC M, V281, pE1172, DOI 10.1152/ajpendo.2001.281.6.E1172; Bodine SC, 2013, INT J BIOCHEM CELL B, V45, P2200, DOI 10.1016/j.biocel.2013.06.011; Braga M, 2012, MOL CELL ENDOCRINOL, V350, P39, DOI 10.1016/j.mce.2011.11.019; Callewaert F, 2010, J ENDOCRINOL, V207, P127, DOI 10.1677/JOE-10-0209; Callewaert F, 2009, FASEB J, V23, P232, DOI 10.1096/fj.08-113456; Canalis E, 2013, NAT REV ENDOCRINOL, V9, P575, DOI 10.1038/nrendo.2013.154; Chambon C, 2010, P NATL ACAD SCI USA, V107, P14327, DOI 10.1073/pnas.1009536107; Chen Y, 2005, J ENDOCRINOL, V186, P21, DOI 10.1677/joe.1.05976; Claessens Frank, 2008, Nucl Recept Signal, V6, pe008, DOI 10.1621/nrs.06008; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; Denayer S, 2010, MOL ENDOCRINOL, V24, P898, DOI 10.1210/me.2009-0310; Diel P, 2008, J MOL ENDOCRINOL, V40, P231, DOI 10.1677/JME-07-0175; Diel P, 2010, MOL CELL ENDOCRINOL, V330, P1, DOI 10.1016/j.mce.2010.08.015; Dubois V, 2012, CELL MOL LIFE SCI, V69, P1651, DOI 10.1007/s00018-011-0883-3; Ebner N, 2013, MATURITAS, V75, P199, DOI 10.1016/j.maturitas.2013.03.014; Estrada M, 2000, AM J PHYSIOL-ENDOC M, V279, pE132, DOI 10.1152/ajpendo.2000.279.1.E132; Fassbender A, 2012, HUM REPROD, V27, P2020, DOI 10.1093/humrep/des127; Finkelstein JS, 2013, NEW ENGL J MED, V369, P1011, DOI 10.1056/NEJMoa1206168; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; Gaussin V, 2005, CARDIOVASC RES, V68, P347, DOI 10.1016/j.cardiores.2005.09.007; Gentile MA, 2010, J MOL ENDOCRINOL, V44, P55, DOI 10.1677/JME-09-0048; Gielen E, 2012, CALCIFIED TISSUE INT, V91, P161, DOI 10.1007/s00223-012-9622-5; Han HQ, 2013, INT J BIOCHEM CELL B, V45, P2333, DOI 10.1016/j.biocel.2013.05.019; Helsen C, 2012, MOL CELL BIOL, V32, P3033, DOI 10.1128/MCB.00151-12; Ibebunjo C, 2011, AM J PHYSIOL-ENDOC M, V300, pE327, DOI 10.1152/ajpendo.00402.2010; Johansen JA, 2007, J NEUROENDOCRINOL, V19, P823, DOI 10.1111/j.1365-2826.2007.01592.x; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; Kovacheva EL, 2010, ENDOCRINOLOGY, V151, P628, DOI 10.1210/en.2009-1177; Lakshman KM, 2009, MOL CELL ENDOCRINOL, V302, P26, DOI 10.1016/j.mce.2008.12.019; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Li TT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-186; Ma K, 2001, AM J PHYSIOL-ENDOC M, V281, pE1128, DOI 10.1152/ajpendo.2001.281.6.E1128; MacLean HE, 2008, FASEB J, V22, P2676, DOI 10.1096/fj.08-105726; MacLean HE, 2009, ENDOCRINOLOGY, V150, P3437, DOI 10.1210/en.2009-0438; Matsakas A, 2012, EXP PHYSIOL, V97, P125, DOI 10.1113/expphysiol.2011.063008; Matsumoto A, 1996, J NEUROENDOCRINOL, V8, P553, DOI 10.1046/j.1365-2826.1996.04899.x; McFarlane C, 2008, EXP CELL RES, V314, P317, DOI 10.1016/j.yexcr.2007.09.012; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Mendler L, 2007, BIOCHEM BIOPH RES CO, V361, P237, DOI 10.1016/j.bbrc.2007.07.023; Monks DA, 2004, J COMP NEUROL, V473, P59, DOI 10.1002/cne.20088; Mosler S, 2013, INT J SPORTS MED, V34, P567, DOI 10.1055/s-0032-1312585; Mosler S, 2012, ARCH TOXICOL, V86, P109, DOI 10.1007/s00204-011-0740-z; Ophoff J, 2009, ENDOCRINOLOGY, V150, P3558, DOI 10.1210/en.2008-1509; Ophoff J, 2009, BIOCHEM BIOPH RES CO, V378, P139, DOI 10.1016/j.bbrc.2008.11.016; Raskin K, 2009, J NEUROSCI, V29, P4461, DOI 10.1523/JNEUROSCI.0296-09.2009; Rinaldi M, 2012, DIS MODEL MECH, V5, P333, DOI 10.1242/dmm.008508; Rolf C, 1998, BAILLIERE CLIN ENDOC, V12, P521, DOI 10.1016/S0950-351X(98)80305-4; Serra C, 2011, ENDOCRINOLOGY, V152, P193, DOI 10.1210/en.2010-0802; Seuntjens E, 2009, CYTOKINE GROWTH F R, V20, P449, DOI 10.1016/j.cytogfr.2009.10.005; Singh R, 2009, ENDOCRINOLOGY, V150, P1259, DOI 10.1210/en.2008-0858; Sinha-Hikim I, 2004, J CLIN ENDOCR METAB, V89, P5245, DOI 10.1210/jc.2004-0084; Storer TW, 2003, J CLIN ENDOCR METAB, V88, P1478, DOI 10.1210/jc.2002-021231; Szulc P, 2012, J CLIN ENDOCR METAB, V97, P3700, DOI 10.1210/jc.2012-1273; Vandenput L, 2002, J BONE MINER RES, V17, P2080, DOI 10.1359/jbmr.2002.17.11.2080; Vanderschueren D, 2000, ENDOCRINOLOGY, V141, P1642, DOI 10.1210/en.141.5.1642; Verrijdt G, 2002, J BIOL CHEM, V277, P35191, DOI 10.1074/jbc.M205928200; Wyce A, 2010, MOL ENDOCRINOL, V24, P1665, DOI 10.1210/me.2010-0138	61	68	75	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2979	2994		10.1096/fj.14-249748	http://dx.doi.org/10.1096/fj.14-249748			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24671706				2022-12-25	WOS:000337949400021
J	Macneale, KH; Spromberg, JA; Baldwin, DH; Scholz, NL				Macneale, Kate H.; Spromberg, Julann A.; Baldwin, David H.; Scholz, Nathaniel L.			A Modeled Comparison of Direct and Food Web-Mediated Impacts of Common Pesticides on Pacific Salmon	PLOS ONE			English	Article							MACROINVERTEBRATE COMMUNITY RESPONSE; CHINOOK SALMON; BEHAVIORAL IMPAIRMENT; INSECTICIDE; CHLORPYRIFOS; POPULATION; TOXICITY; RIVER; DIAZINON; EXPOSURE	In the western United States, pesticides used in agricultural and urban areas are often detected in streams and rivers that support threatened and endangered Pacific salmon. Although concentrations are rarely high enough to cause direct salmon mortality, they can reach levels sufficient to impair juvenile feeding behavior and limit macroinvertebrate prey abundance. This raises the possibility of direct adverse effects on juvenile salmon health in tandem with indirect effects on salmon growth as a consequence of reduced prey abundance. We modeled the growth of ocean-type Chinook salmon (Oncorhynchus tshawytscha) at the individual and population scales, investigating insecticides that differ in how long they impair salmon feeding behavior and in how toxic they are to salmon compared to macroinvertebrates. The relative importance of these direct vs. indirect effects depends both on how quickly salmon can recover and on the relative toxicity of an insecticide to salmon and their prey. Model simulations indicate that when exposed to a long-acting organophosphate insecticide that is highly toxic to salmon and invertebrates (e. g., chlorpyrifos), the long-lasting effect on salmon feeding behavior drives the reduction in salmon population growth with reductions in prey abundance having little additional impact. When exposed to short-acting carbamate insecticides at concentrations that salmon recover from quickly but are lethal to invertebrates (e. g., carbaryl), the impacts on salmon populations are due primarily to reductions in their prey. For pesticides like carbaryl, prey sensitivity and how quickly the prey community can recover are particularly important in determining the magnitude of impact on their predators. In considering both indirect and direct effects, we develop a better understanding of potential impacts of a chemical stressor on an endangered species and identify data gaps (e.g., prey recovery rates) that contribute uncertainty to these assessments.	[Macneale, Kate H.; Spromberg, Julann A.; Baldwin, David H.; Scholz, Nathaniel L.] NOAA, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Macneale, KH (corresponding author), NOAA, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	Kate.Macneale@gmail.com	Scholz, Nathaniel L/L-1642-2013	Scholz, Nathaniel L/0000-0001-6207-0272	National Oceanic and Atmospheric Administration	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	The National Oceanic and Atmospheric Administration provided funding for the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BS, 2006, ENVIRON TOXICOL CHEM, V25, P1160, DOI 10.1897/05-231R.1; Ashauer R, 2007, ENVIRON SCI TECHNOL, V41, P5535, DOI 10.1021/es070283w; Beauvais SL, 2000, ENVIRON TOXICOL CHEM, V19, P1875, DOI [10.1002/etc.5620190722, 10.1897/1551-5028(2000)019&lt;1875:PMONOD&gt;2.3.CO;2]; BRAZNER JC, 1990, CAN J FISH AQUAT SCI, V47, P1157, DOI 10.1139/f90-135; BRETT JR, 1969, J FISH RES BOARD CAN, V26, P2363, DOI 10.1139/f69-230; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Chambers JE, 2002, HUM ECOL RISK ASSESS, V8, P165, DOI 10.1080/20028091056809; Chen XD, 2010, ECOTOXICOLOGY, V19, P1124, DOI 10.1007/s10646-010-0495-y; Colville A, 2008, ECOTOXICOLOGY, V17, P173, DOI 10.1007/s10646-007-0181-x; CUFFNEY T F, 1984, Freshwater Invertebrate Biology, V3, P153, DOI 10.2307/1467120; DAVIES PE, 1993, AQUAT TOXICOL, V27, P201, DOI 10.1016/0166-445X(93)90055-6; Ferrari A, 2004, ECOTOX ENVIRON SAFE, V57, P420, DOI 10.1016/S0147-6513(02)00069-6; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Gilliom RJ, 2007, ENVIRON SCI TECHNOL, V41, P3407; Greene CM, 2004, CAN J FISH AQUAT SCI, V61, P590, DOI 10.1139/F04-024; Groner ML, 2011, FRESHWATER BIOL, V56, P2391, DOI 10.1111/j.1365-2427.2011.02667.x; HEALEY MC, 1984, CAN J FISH AQUAT SCI, V41, P476, DOI 10.1139/f84-057; Heckmann LH, 2005, ENVIRON TOXICOL CHEM, V24, P582, DOI 10.1897/04-117R.1; Howell P., 1985, STOCK ASSESSMENT COL; Hutchens JJ, 1998, J N AM BENTHOL SOC, V17, P518, DOI 10.2307/1468369; Johnson HM, 2011, J AM WATER RESOUR AS, V47, P265, DOI 10.1111/j.1752-1688.2010.00507.x; Johnson LL, 2007, SCI TOTAL ENVIRON, V374, P342, DOI 10.1016/j.scitotenv.2006.11.051; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Kostow K, 1995, BIENNIAL REPORT STAT; KREUTZWEISER DP, 1990, CAN J FISH AQUAT SCI, V47, P1387, DOI 10.1139/f90-158; KREUTZWEISER DP, 1991, ARCH ENVIRON CON TOX, V20, P330, DOI 10.1007/BF01064398; Labenia JS, 2007, MAR ECOL PROG SER, V329, P1, DOI 10.3354/meps329001; Laetz CA, 2013, ENVIRON SCI TECHNOL, V47, P2925, DOI 10.1021/es305058y; Laetz CA, 2009, ENVIRON HEALTH PERSP, V117, P348, DOI 10.1289/ehp.0800096; Liess M, 1999, ENVIRON TOXICOL CHEM, V18, P1948, DOI [10.1897/1551-5028(1999)018&lt;1948:LICAPR&gt;2.3.CO;2, 10.1002/etc.5620180913]; LUGTHART GJ, 1990, FRESHWATER BIOL, V24, P417, DOI 10.1111/j.1365-2427.1990.tb00721.x; Lydy MJ, 2004, ARCH ENVIRON CON TOX, V48, P49, DOI 10.1007/s00244-004-0056-6; Mohr S, 2012, AQUAT TOXICOL, V110, P25, DOI 10.1016/j.aquatox.2011.11.016; Moore A, 1996, J FISH BIOL, V48, P758, DOI 10.1111/j.1095-8649.1996.tb01470.x; MORGAN MJ, 1990, ENVIRON TOXICOL CHEM, V9, P489, DOI [10.1897/1552-8618(1990)9[489:EOFOTF]2.0.CO;2, 10.1002/etc.5620090412]; Naiman RJ, 2012, P NATL ACAD SCI USA, V109, P21201, DOI 10.1073/pnas.1213408109; Nelson T.S., 2004, JUVENILE CHINOOK MIG; [NRC] National Research Council, 2013, ASS RISKS END THREAT, P142; Power M., 1998, J AQUAT ECOSYST STRE, V6, P253, DOI DOI 10.1023/A:1009991620319; PSCCTC, 2002, PAC SALM COMM JOINT; PUSEY BJ, 1994, ECOTOX ENVIRON SAFE, V27, P221, DOI 10.1006/eesa.1994.1019; Ratner S, 1997, CONSERV BIOL, V11, P879, DOI 10.1046/j.1523-1739.1997.95457.x; RAVEN PJ, 1989, ENVIRON POLLUT, V59, P55, DOI 10.1016/0269-7491(89)90021-3; Relyea RA, 2008, ECOL APPL, V18, P1728, DOI 10.1890/08-0454.1; Rohr JR, 2006, TRENDS ECOL EVOL, V21, P606, DOI 10.1016/j.tree.2006.07.002; Roni Philip, 1995, North American Journal of Fisheries Management, V15, P325, DOI 10.1577/1548-8675(1995)015<0325:GVISAA>2.3.CO;2; Sandahl JF, 2005, ENVIRON TOXICOL CHEM, V24, P136, DOI 10.1897/04-195R.1; Scholz NL, 2000, CAN J FISH AQUAT SCI, V57, P1911, DOI 10.1139/cjfas-57-9-1911; Schulz R, 2004, J ENVIRON QUAL, V33, P419, DOI 10.2134/jeq2004.0419; Schulz R, 2002, ENVIRON TOXICOL CHEM, V21, P2172, DOI [10.1002/etc.5620211021, 10.1897/1551-5028(2002)021&lt;2172:ACMAFA&gt;2.0.CO;2]; den Brink PJ, 2006, HUM ECOL RISK ASSESS, V12, P645, DOI 10.1080/10807030500430559; vandenBrink PJ, 1996, ENVIRON TOXICOL CHEM, V15, P1143, DOI [10.1897/1551-5028(1996)015&lt;1143:EOTIDA&gt;2.3.CO;2, 10.1002/etc.5620150719]; WALLACE JB, 1989, HYDROBIOLOGIA, V179, P135, DOI 10.1007/BF00007601; WARD S, 1995, ECOTOX ENVIRON SAFE, V30, P2, DOI 10.1006/eesa.1995.1002; Weatherley AH, 1995, PHYSL ECOLOGY PACIFI, P103; Werner I, 2000, ENVIRON TOXICOL CHEM, V19, P215, DOI [10.1897/1551-5028(2000)019&lt;0215:ICTTCD&gt;2.3.CO;2, 10.1002/etc.5620190126]; Weston DP, 2012, ENVIRON TOXICOL CHEM, V31, P1579, DOI 10.1002/etc.1847	57	17	17	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e92436	10.1371/journal.pone.0092436	http://dx.doi.org/10.1371/journal.pone.0092436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686837	Green Published, gold, Green Submitted			2022-12-25	WOS:000340842300001
J	Valles, SM; Bell, S; Firth, AE				Valles, Steven M.; Bell, Susanne; Firth, Andrew E.			Solenopsis invicta virus 3: Mapping of Structural Proteins, Ribosomal Frameshifting, and Similarities to Acyrthosiphon pisum virus and Kelp fly virus	PLOS ONE			English	Article							HEMORRHAGIC-DISEASE VIRUS; TRANSLATION TERMINATION-REINITIATION; FELINE CALICIVIRUS; CAPSID PROTEIN; NUCLEOTIDE-SEQUENCE; SOLENOPSIS-INVICTA; MURINE NOROVIRUS; RNA VIRUSES; IN-VITRO; FIRE ANT	Solenopsis invicta virus 3 (SINV-3) is a positive-sense single-stranded RNA virus that infects the red imported fire ant, Solenopsis invicta. We show that the second open reading frame (ORF) of the dicistronic genome is expressed via a frameshifting mechanism and that the sequences encoding the structural proteins map to both ORF2 and the 3' end of ORF1, downstream of the sequence that encodes the RNA-dependent RNA polymerase. The genome organization and structural protein expression strategy resemble those of Acyrthosiphon pisum virus (APV), an aphid virus. The capsid protein that is encoded by the 3' end of ORF1 in SINV-3 and APV is predicted to have a jelly-roll fold similar to the capsid proteins of picornaviruses and caliciviruses. The capsid-extension protein that is produced by frameshifting, includes the jelly-roll fold domain encoded by ORF1 as its N-terminus, while the C-terminus encoded by the 5' half of ORF2 has no clear homology with other viral structural proteins. A third protein, encoded by the 3' half of ORF2, is associated with purified virions at substoichiometric ratios. Although the structural proteins can be translated from the genomic RNA, we show that SINV-3 also produces a subgenomic RNA encoding the structural proteins. Circumstantial evidence suggests that APV may also produce such a subgenomic RNA. Both SINV-3 and APV are unclassified picorna-like viruses distantly related to members of the order Picornavirales and the family Caliciviridae. Within this grouping, features of the genome organization and capsid domain structure of SINV-3 and APV appear more similar to caliciviruses, perhaps suggesting the basis for a "Calicivirales" order.	[Valles, Steven M.] ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL USA; [Bell, Susanne; Firth, Andrew E.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	United States Department of Agriculture (USDA); University of Cambridge	Firth, AE (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	aef24@cam.ac.uk		Firth, Andrew/0000-0002-7986-9520	Wellcome Trust [088789]; U.K. Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J007072/1, BB/J015652/1]; BBSRC [BB/J007072/1, BB/J015652/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J015652/1, BB/J007072/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work in the AEF lab was funded by grants from the Wellcome Trust (www.wellcome.ac.uk) (088789) and the U.K. Biotechnology and Biological Sciences Research Council (BBSRC; www.bbsrc.ac.uk) (BB/J007072/1 and BB/J015652/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abente EJ, 2013, J VIROL, V87, P3003, DOI 10.1128/JVI.02480-12; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], [No title captured]; BRAULT V, 1995, EMBO J, V14, P650, DOI 10.1002/j.1460-2075.1995.tb07043.x; Brown CM, 1996, J VIROL, V70, P5884, DOI 10.1128/JVI.70.9.5884-5892.1996; Chen R, 2006, P NATL ACAD SCI USA, V103, P8048, DOI 10.1073/pnas.0600421103; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Firth AE, 2011, NUCLEIC ACIDS RES, V39, P6679, DOI 10.1093/nar/gkr224; Glass PJ, 2000, J VIROL, V74, P6581, DOI 10.1128/JVI.74.14.6581-6591.2000; Goodfellow I, 2011, CURR OPIN VIROL, V1, P355, DOI 10.1016/j.coviro.2011.09.003; Graff J, 2005, J VIROL, V79, P1017, DOI 10.1128/JVI.79.2.1017-1026.2005; GUILLEY H, 1994, VIROLOGY, V202, P1012, DOI 10.1006/viro.1994.1429; Hartley CJ, 2005, J VIROL, V79, P13385, DOI 10.1128/JVI.79.21.13385-13398.2005; Herbert TP, 1996, J GEN VIROL, V77, P123, DOI 10.1099/0022-1317-77-1-123; Katpally U, 2010, J VIROL, V84, P5836, DOI 10.1128/JVI.00314-10; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koonin EV, 2008, NAT REV MICROBIOL, V6, P925, DOI 10.1038/nrmicro2030; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Gall O, 2008, ARCH VIROL, V153, P715, DOI 10.1007/s00705-008-0041-x; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; LIU BL, 1995, ARCH VIROL, V140, P1345, DOI 10.1007/BF01322662; LOH EY, 1989, SCIENCE, V243, P217, DOI 10.1126/science.2463672; Loughran G, 2011, P NATL ACAD SCI USA, V108, pE1111, DOI 10.1073/pnas.1102932108; Luttermann C, 2007, J BIOL CHEM, V282, P7056, DOI 10.1074/jbc.M608948200; McCormick CJ, 2008, J VIROL, V82, P8917, DOI 10.1128/JVI.02362-07; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; MEYERS G, 1991, VIROLOGY, V184, P677, DOI 10.1016/0042-6822(91)90437-G; Morales M, 2004, J BIOL CHEM, V279, P17013, DOI 10.1074/jbc.M313674200; Napthine S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008390; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; PRASAD BVV, 1994, J VIROL, V68, P5117, DOI 10.1128/JVI.68.8.5117-5125.1994; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ryabov EV, 2009, P NATL ACAD SCI USA, V106, P8465, DOI 10.1073/pnas.0901389106; Sanfacon H, 2009, ARCH VIROL, V154, P899, DOI 10.1007/s00705-009-0367-z; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; SCOTTI PD, 1976, J GEN VIROL, V30, P1, DOI 10.1099/0022-1317-30-1-1; Simmonds P, 2008, NUCLEIC ACIDS RES, V36, P2530, DOI 10.1093/nar/gkn096; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Song YT, 2012, P NATL ACAD SCI USA, V109, P14301, DOI 10.1073/pnas.1211484109; Sosnovtsev SV, 2000, VIROLOGY, V277, P193, DOI 10.1006/viro.2000.0579; Sosnovtsev SV, 2005, J VIROL, V79, P4012, DOI 10.1128/JVI.79.7.4012-4024.2005; Sosnovtsev SV, 1998, J VIROL, V72, P3051, DOI 10.1128/JVI.72.4.3051-3059.1998; Subba-Reddy CV, 2012, J VIROL, V86, P10138, DOI 10.1128/JVI.01208-12; Valles SM, 2013, J INVERTEBR PATHOL, V113, P198, DOI 10.1016/j.jip.2013.04.003; Valles SM, 2009, VIROLOGY, V388, P354, DOI 10.1016/j.virol.2009.03.028; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; vandenHeuvel JFJM, 1997, J INVERTEBR PATHOL, V70, P169, DOI 10.1006/jipa.1997.4691; vanderWilk F, 1997, VIROLOGY, V238, P353, DOI 10.1006/viro.1997.8835; Vongpunsawad S, 2013, J VIROL, V87, P4818, DOI 10.1128/JVI.03508-12	52	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93497	10.1371/journal.pone.0093497	http://dx.doi.org/10.1371/journal.pone.0093497			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686475	gold, Green Published, Green Submitted			2022-12-25	WOS:000340842300015
J	Abate-Daga, D; Speiser, DE; Chinnasamy, N; Zheng, ZL; Xu, H; Feldman, SA; Rosenberg, SA; Morgan, RA				Abate-Daga, Daniel; Speiser, Daniel E.; Chinnasamy, Nachimuthu; Zheng, Zhili; Xu, Hui; Feldman, Steven A.; Rosenberg, Steven A.; Morgan, Richard A.			Development of a T Cell Receptor Targeting an HLA-A*0201 Restricted Epitope from the Cancer-Testis Antigen SSX2 for Adoptive Immunotherapy of Cancer	PLOS ONE			English	Article							MULTIPLE-MYELOMA; CANCER/TESTIS ANTIGENS; HUMAN-LYMPHOCYTES; GENE-THERAPY; TCR; EXPRESSION; REGRESSION; RESPONSES; TOXICITY; IDENTIFICATION	The clinical success of adoptive immunotherapy of cancer relies on the selection of target antigens that are highly expressed in tumor cells but absent in essential normal tissues. A group of genes that encode the cancer/testis or cancer germline antigens have been proposed as ideal targets for immunotherapy due to their high expression in multiple cancer types and their restricted expression in immunoprivileged normal tissues. In the present work we report the isolation and characterization of human T cell receptors (TCRs) with specificity for synovial sarcoma X breakpoint 2 (SSX2), a cancer/testis antigen expressed in melanoma, prostate cancer, lymphoma, multiple myeloma and pancreatic cancer, among other tumors. We isolated seven HLA-A2 restricted T cell receptors from natural T cell clones derived from tumor-infiltrated lymph nodes of two SSX2-seropositive melanoma patients, and selected four TCRs for cloning into retroviral vectors. Peripheral blood lymphocytes (PBL) transduced with three of four SSX2 TCRs showed SSX2(41-49) (KASEKIFYV) peptide specific reactivity, tumor cell recognition and tetramer binding. One of these, TCR-5, exhibited tetramer binding in both CD4 and CD8 cells and was selected for further studies. Antigen-specific and HLA-A*0201-restricted interferon-gamma release, cell lysis and lymphocyte proliferation was observed following culture of TCR engineered human PBL with relevant tumor cell lines. Codon optimization was found to increase TCR-5 expression in transduced T cells, and this construct has been selected for development of clinical grade viral vector producing cells. The tumor-specific pattern of expression of SSX2, along with the potent and selective activity of TCR-5, makes this TCR an attractive candidate for potential TCR gene therapy to treat multiple cancer histologies.	[Abate-Daga, Daniel; Chinnasamy, Nachimuthu; Zheng, Zhili; Xu, Hui; Feldman, Steven A.; Rosenberg, Steven A.; Morgan, Richard A.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA; [Speiser, Daniel E.] Univ Lausanne, Dept Oncol, Ludwig Ctr, Lausanne, Switzerland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Lausanne	Abate-Daga, D (corresponding author), NCI, Surg Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	daniel.abate-daga@nih.gov	Speiser, Daniel E./F-2173-2013	Abate-Daga, Daniel/0000-0002-2571-0215	Milstein Family Foundation; Intramural Research Program of The Center for Cancer Research, National Cancer Institute, Bethesda MD; NATIONAL CANCER INSTITUTE [ZIABC010985] Funding Source: NIH RePORTER	Milstein Family Foundation; Intramural Research Program of The Center for Cancer Research, National Cancer Institute, Bethesda MD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported in part by a contribution from the Milstein Family Foundation and by the Intramural Research Program of The Center for Cancer Research, National Cancer Institute, Bethesda MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanackovic D, 2007, BLOOD, V109, P1103, DOI 10.1182/blood-2006-04-014480; Atanackovic D, 2009, CLIN CANCER RES, V15, P1343, DOI 10.1158/1078-0432.CCR-08-0989; Ayyoub M, 2002, J IMMUNOL, V168, P1717, DOI 10.4049/jimmunol.168.4.1717; Ayyoub M, 2003, CANCER RES, V63, P5601; Bricard G, 2005, J IMMUNOL, V174, P1709, DOI 10.4049/jimmunol.174.3.1709; Chinnasamy N, 2011, J IMMUNOL, V186, P685, DOI 10.4049/jimmunol.1001775; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; CREW AJ, 1995, EMBO J, V14, P2333, DOI 10.1002/j.1460-2075.1995.tb07228.x; Davis JL, 2010, CLIN CANCER RES, V16, P5852, DOI 10.1158/1078-0432.CCR-10-1280; dos Santos NR, 2000, CANCER RES, V60, P1654; Dubovsky JA, 2007, PROSTATE, V67, P1781, DOI 10.1002/pros.20665; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Garcia CB, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-189; Guo ZS, 2006, CANCER RES, V66, P1105, DOI 10.1158/0008-5472.CAN-05-3020; Gure AO, 2002, INT J CANCER, V101, P448, DOI 10.1002/ijc.10634; Hoffman-Censits J, 2013, SEMIN ONCOL, V40, P361, DOI 10.1053/j.seminoncol.2013.04.015; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Hughes MS, 2005, HUM GENE THER, V16, P457, DOI 10.1089/hum.2005.16.457; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kharfan-Dabaja MA, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-2; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Ochi T, 2011, BLOOD, V118, P1495, DOI 10.1182/blood-2011-02-337089; Onodera M, 1997, HUM GENE THER, V8, P1189, DOI 10.1089/hum.1997.8.10-1189; Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272; Parkhurst MR, 2009, CLIN CANCER RES, V15, P169, DOI 10.1158/1078-0432.CCR-08-1638; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Przybyl Joanna, 2012, Sarcoma, V2012, P249219, DOI 10.1155/2012/249219; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003634; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Shiraishi T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-153; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Smith HA, 2011, CANCER RES, V71, P6785, DOI 10.1158/0008-5472.CAN-11-2127; Suri A, 2006, EXPERT OPIN BIOL TH, V6, P379, DOI 10.1517/14712598.6.4.379; Taylor BJ, 2005, J IMMUNOTHER, V28, P564, DOI 10.1097/01.cji.0000175685.36239.e5; Tureci O, 1996, CANCER RES, V56, P4766; Wargo JA, 2009, CANCER IMMUNOL IMMUN, V58, P383, DOI 10.1007/s00262-008-0562-x; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Zhao YB, 2005, J IMMUNOL, V174, P4415, DOI 10.4049/jimmunol.174.7.4415	49	18	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93321	10.1371/journal.pone.0093321	http://dx.doi.org/10.1371/journal.pone.0093321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681846	Green Published, Green Submitted, gold			2022-12-25	WOS:000333678100042
J	Tjokro, NO; Rocco, CJ; Priyadarshini, R; Davey, ME; Goodman, SD				Tjokro, Natalia O.; Rocco, Christopher J.; Priyadarshini, Richa; Davey, Mary E.; Goodman, Steven D.			A Biochemical Analysis of the Interaction of Porphyromonas gingivalis HU PG0121 Protein with DNA	PLOS ONE			English	Article							6 CAPSULAR SEROTYPES; ESCHERICHIA-COLI HU; BINDING PROTEIN; CRUCIFORM DNA; HIGH-AFFINITY; BACILLUS-SUBTILIS; STRANDED-DNA; TRANSCRIPTION; GENE; BACTERIA	K-antigen capsule, a key virulence determinant of the oral pathogen Porphyromonas gingivalis, is synthesized by proteins encoded in a series of genes transcribed as a large polycistronic message. Previously, we identified a 77-base pair inverted repeat region with the potential to form a large stem-loop structure at the 5' end of this locus. PG0121, one of two genes flanking the capsule operon, was found to be co-transcribed with the operon and to share high similarity to the DNA binding protein HU from Escherichia coli. A null mutation in PG0121 results in down-regulation of transcription of the capsule synthesis genes and production of capsule. Furthermore, we have also shown that PG0121 gene can complement multiple deficiencies in a strain of E. coli that is deficient for both the alpha and beta subunits of HU. Here, we examined the biochemical properties of the interaction of PG0121 to DNA with the emphasis on the kinds of nucleic acid architectures that may be encountered at the 77-bp inverted repeat. We have concluded that although some DNA binding characteristics are shared with E. coli HU, HU PG0121 also shows some distinct characteristics that set it apart from other HU-like proteins tested to date. We discuss our results in the context of how PG0121 may affect the regulation of the K-antigen capsule expression.	[Tjokro, Natalia O.] Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA USA; [Priyadarshini, Richa; Davey, Mary E.] Forsyth Inst, Dept Mol Genet, Boston, MA USA; [Rocco, Christopher J.; Goodman, Steven D.] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Res Inst, Columbus, OH USA	University of Southern California; Harvard University; Forsyth Institute; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Davey, ME (corresponding author), Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA.	mdavey@dental.ufl.edu; steven.goodman@nationwidechildrens.org	Davey, Mary Ellen/H-6259-2019; Goodman, Steven/C-5732-2013	Davey, Mary Ellen/0000-0001-8129-0537	National Institutes of Health [5R01DE019117-06]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grant 5R01DE019117-06 (NIH; www.nih.gov) to MED and SDG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti-Segui C, 2010, J BACTERIOL, V192, P6217, DOI 10.1128/JB.00106-10; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Balandina A, 2002, J BIOL CHEM, V277, P27622, DOI 10.1074/jbc.M201978200; Balandina A, 2001, MOL MICROBIOL, V39, P1069, DOI 10.1046/j.1365-2958.2001.02305.x; Bensaid A, 1996, J MOL BIOL, V256, P292, DOI 10.1006/jmbi.1996.0086; BONNEFOY E, 1994, J MOL BIOL, V242, P116, DOI 10.1006/jmbi.1994.1563; BOUBRIK F, 1995, P NATL ACAD SCI USA, V92, P3958, DOI 10.1073/pnas.92.9.3958; Brunner J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-5; CASTAING B, 1995, J BIOL CHEM, V270, P10291, DOI 10.1074/jbc.270.17.10291; Chatzidaki-Livanis M, 2009, J BACTERIOL, V191, P7288, DOI 10.1128/JB.00500-09; Chen C, 2004, BIOCHEM J, V383, P343, DOI 10.1042/BJ20040938; Claret L, 1997, J MOL BIOL, V273, P93, DOI 10.1006/jmbi.1997.1310; Dierickx K, 2003, J PERIODONTOL, V74, P844, DOI 10.1902/jop.2003.74.6.844; DRI AM, 1991, J BACTERIOL, V173, P2852, DOI 10.1128/JB.173.9.2852-2863.1991; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; DURRENBERGER M, 1988, J BACTERIOL, V170, P4757; FILUTOWICZ M, 1983, MOL GEN GENET, V191, P282, DOI 10.1007/BF00334827; GELLERT M, 1983, P NATL ACAD SCI-BIOL, V80, P5545, DOI 10.1073/pnas.80.18.5545; Ghosh S, 2004, J MOL BIOL, V337, P561, DOI 10.1016/j.jmb.2004.02.010; Giangrossi M, 2002, MOL MICROBIOL, V44, P205, DOI 10.1046/j.1365-2958.2002.02868.x; Gonzalez D, 2003, INFECT IMMUN, V71, P2283, DOI 10.1128/IAI.71.4.2283-2287.2003; Grove A, 1996, J MOL BIOL, V260, P196, DOI 10.1006/jmbi.1996.0392; Grove A, 2001, J MOL BIOL, V311, P491, DOI 10.1006/jmbi.2001.4763; Grove A, 2011, CURR ISSUES MOL BIOL, V13, P1; Hashimoto M, 2003, J BIOL CHEM, V278, P28501, DOI 10.1074/jbc.M303970200; HODGESGARCIA Y, 1989, J BIOL CHEM, V264, P14621; HORWITZ MSZ, 1988, SCIENCE, V241, P703, DOI 10.1126/science.2456617; Jia X, 1996, J MOL BIOL, V263, P259, DOI 10.1006/jmbi.1996.0573; Kamashev D, 1999, EMBO J, V18, P5434, DOI 10.1093/emboj/18.19.5434; Kamashev D, 2000, EMBO J, V19, P6527, DOI 10.1093/emboj/19.23.6527; Kamashev D, 2008, NUCLEIC ACIDS RES, V36, P1026, DOI 10.1093/nar/gkm667; KELLENBERGER E, 1992, FEMS MICROBIOL LETT, V100, P361, DOI 10.1016/0378-1097(92)90233-E; KOHNO K, 1990, J MOL BIOL, V213, P27, DOI 10.1016/S0022-2836(05)80119-6; KOHNO K, 1994, J BIOCHEM-TOKYO, V115, P1113, DOI 10.1093/oxfordjournals.jbchem.a124466; Kreth J, 2007, MICROBIOL-SGM, V153, P1799, DOI 10.1099/mic.0.2007/005975-0; Laine ML, 1997, J DENT RES, V76, P1840, DOI 10.1177/00220345970760120601; Laine ML, 1998, ORAL MICROBIOL IMMUN, V13, P322, DOI 10.1111/j.1399-302X.1998.tb00714.x; LAVOIE BD, 1994, J BIOL CHEM, V269, P15571; Lewis DEA, 1999, MOL MICROBIOL, V31, P451, DOI 10.1046/j.1365-2958.1999.01186.x; Li SS, 1998, J BACTERIOL, V180, P3750, DOI 10.1128/JB.180.15.3750-3756.1998; LILLEY DMJ, 1993, ANNU REV BIOPH BIOM, V22, P299, DOI 10.1146/annurev.bb.22.060193.001503; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Miyabe I, 2000, INT J RADIAT BIOL, V76, P43; OGASAWARA N, 1981, MOL GEN GENET, V181, P332, DOI 10.1007/BF00425607; ORR E, 1979, MOL GEN GENET, V177, P103, DOI 10.1007/BF00267259; PANAYOTATOS N, 1987, J BIOL CHEM, V262, P11364; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pinson V, 1999, J MOL BIOL, V287, P485, DOI 10.1006/jmbi.1999.2631; PONTIGGIA A, 1993, MOL MICROBIOL, V7, P343, DOI 10.1111/j.1365-2958.1993.tb01126.x; Priyadarshini R, 2013, MICROBIOL-SGM, V159, P219, DOI 10.1099/mic.0.061002-0; PRUSS GJ, 1989, CELL, V56, P521, DOI 10.1016/0092-8674(89)90574-6; Rouviere-Yaniv J, 1990, AM SOC MICROBIOL; ROUVIEREYANIV J, 1979, FEBS LETT, V106, P297, DOI 10.1016/0014-5793(79)80518-9; ROUVIEREYANIV J, 1979, CELL, V17, P265, DOI 10.1016/0092-8674(79)90152-1; Sharadamma N, 2010, NUCLEIC ACIDS RES, V38, P3555, DOI 10.1093/nar/gkq064; SINDEN RR, 1983, P NATL ACAD SCI-BIOL, V80, P1797, DOI 10.1073/pnas.80.7.1797; SINGLETON CK, 1982, J BIOL CHEM, V257, P6292; TANAKA I, 1984, NATURE, V310, P376, DOI 10.1038/310376a0; VANWINKELHOFF AJ, 1993, ORAL MICROBIOL IMMUN, V8, P259; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0	62	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93266	10.1371/journal.pone.0093266	http://dx.doi.org/10.1371/journal.pone.0093266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681691	gold, Green Published, Green Submitted			2022-12-25	WOS:000333678100037
J	Keck, BP; Marion, ZH; Martin, DJ; Kaufman, JC; Harden, CP; Schwartz, JS; Strange, RJ				Keck, Benjamin P.; Marion, Zachary H.; Martin, Derek J.; Kaufman, Jason C.; Harden, Carol P.; Schwartz, John S.; Strange, Richard J.			Fish Functional Traits Correlated with Environmental Variables in a Temperate Biodiversity Hotspot	PLOS ONE			English	Article							FRESH-WATER FISHES; LIFE-HISTORY TRAITS; STREAM FISH; LAND-USE; TELEOSTEI PERCIDAE; BIOTIC INTEGRITY; SPECIES TRAITS; DIVERSITY; ASSEMBLAGES; DIVERSIFICATION	The global biodiversity crisis has invigorated the search for generalized patterns in most disciplines within the natural sciences. Studies based on organismal functional traits attempt to broaden implications of results by identifying the response of functional traits, instead of taxonomic units, to environmental variables. Determining the functional trait responses enables more direct comparisons with, or predictions for, communities of different taxonomic composition. The North American freshwater fish fauna is both diverse and increasingly imperiled through human mediated disturbances, including climate change. The Tennessee River, USA, contains one of the most diverse assemblages of freshwater fish in North America and has more imperiled species than other rivers, but there has been no trait-based study of community structure in the system. We identified 211 localities in the upper Tennessee River that were sampled by the Tennessee Valley Authority between 2009 and 2011 and compiled fish functional traits for the observed species and environmental variables for each locality. Using fourth corner analysis, we identified significant correlations between many fish functional traits and environmental variables. Functional traits associated with an opportunistic life history strategy were correlated with localities subject to greater land use disturbance and less flow regulation, while functional traits associated with a periodic life history strategy were correlated with localities subject to regular disturbance and regulated flow. These are patterns observed at the continental scale, highlighting the generalizability of trait-based methods. Contrary to studies that found no community structure differences when considering riparian buffer zones, we found that fish functional traits were correlated with different environmental variables between analyses with buffer zones vs. entire catchment area land cover proportions. Using existing databases and fourth corner analysis, our results support the broad application potential for trait-based methods and indicate trait-based methods can detect environmental filtering by riparian zone land cover.	[Keck, Benjamin P.; Strange, Richard J.] Univ Tennessee, Dept Forestry Wildlife & Fisheries, Knoxville, TN 37996 USA; [Marion, Zachary H.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Martin, Derek J.; Kaufman, Jason C.; Harden, Carol P.] Univ Tennessee, Dept Geog, Knoxville, TN 37996 USA; [Schwartz, John S.] Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Keck, BP (corresponding author), Univ Tennessee, Dept Forestry Wildlife & Fisheries, Knoxville, TN 37996 USA.	bkeck@utk.edu	Marion, Zachary/I-9102-2016	Marion, Zachary/0000-0002-7351-1819; Kaufman, Jason/0000-0001-5482-6914	University of Tennessee Institute for a Secure and Sustainable Environment; University of Tennessee AgResearch	University of Tennessee Institute for a Secure and Sustainable Environment; University of Tennessee AgResearch	The University of Tennessee Institute for a Secure and Sustainable Environment (http://isse.utk.edu/) and University of Tennessee AgResearch (http://agresearch.tennessee.edu/) provided funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 1997, FRESHWATER BIOL, V37, P149, DOI 10.1046/j.1365-2427.1997.d01-546.x; Anderson J. M., 1976, GEOLOGICAL SURVEY PR; Angermeier PL, 1999, ECOL APPL, V9, P335, DOI 10.2307/2641189; Aubin I, 2013, BIODIVERS CONSERV, V22, P2957, DOI 10.1007/s10531-013-0565-6; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Berendzen PB, 2008, MOL PHYLOGENET EVOL, V46, P721, DOI 10.1016/j.ympev.2007.07.008; Blanton RE, 2013, MOL PHYLOGENET EVOL, V66, P679, DOI 10.1016/j.ympev.2012.10.022; Blanton RE, 2008, ZOOTAXA, P1; Brind'Amour A, 2011, ECOL APPL, V21, P363, DOI 10.1890/09-2178.1; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Clements MD, 2012, MOL PHYLOGENET EVOL, V63, P159, DOI 10.1016/j.ympev.2012.01.001; Deyton EB, 2009, WATER AIR SOIL POLL, V196, P3, DOI 10.1007/s11270-008-9753-5; Doledec S, 1996, ENVIRON ECOL STAT, V3, P143, DOI 10.1007/BF02427859; Douglas M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0672; Dray S, 2008, ECOLOGY, V89, P3400, DOI 10.1890/08-0349.1; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dudgeon D, 2010, CURR OPIN ENV SUST, V2, P422, DOI 10.1016/j.cosust.2010.09.001; ETNIER D A, 1991, Journal of the Tennessee Academy of Science, V66, P129; Etnier D. A., 1993, FISHES TENNESSEE; Etnier David A., 1997, P87; Fischer JR, 2010, T AM FISH SOC, V139, P185, DOI 10.1577/T09-050.1; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Frimpong EA, 2009, FISHERIES, V34, P487, DOI 10.1577/1548-8446-34.10.487; Frimpong EA, 2010, AM FISH S S, V73, P109; George AL, 2009, FISHERIES, V34, P529, DOI 10.1577/1548-8446-34.11.529; Gillson L, 2013, TRENDS ECOL EVOL, V28, P135, DOI 10.1016/j.tree.2012.10.008; Goldsworthy CA, 2006, AM MIDL NAT, V156, P331, DOI 10.1674/0003-0031(2006)156[331:GBCRAS]2.0.CO;2; Helms BS, 2011, J N AM BENTHOL SOC, V30, P1095, DOI 10.1899/10-093.1; Hocutt C. H., 1986, ZOOGEOGRAPHY N AM FR; Hollingsworth PR, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-272; Hollingsworth PR, 2009, EVOLUTION, V63, P228, DOI 10.1111/j.1558-5646.2008.00531.x; HOLM S, 1979, SCAND J STAT, V6, P65; Institute ESR, 2011, ARCGIS DESKT REL 10; Jaramillo-Villa U, 2010, J FISH BIOL, V76, P2401, DOI 10.1111/j.1095-8649.2010.02629.x; Jelks HL, 2008, FISHERIES, V33, P372, DOI 10.1577/1548-8446-33.8.372; Keck BP, 2013, B PEABODY MUS NAT HI, V54, P3, DOI 10.3374/014.054.0101; Keck BP, 2010, MOL ECOL, V19, P5030, DOI 10.1111/j.1365-294X.2010.04866.x; Krober W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035742; Lamouroux N, 2002, ECOLOGY, V83, P1792, DOI 10.2307/3071765; Larson ER, 2012, GLOBAL ECOL BIOGEOGR, V21, P1114, DOI 10.1111/j.1466-8238.2012.00758.x; Layman Steven R., 2012, Bulletin Alabama Museum of Natural History, V30, P1; Legendre P, 1997, ECOLOGY, V78, P547; Leidy Robert A., 1998, P187; Leveque C, 2008, HYDROBIOLOGIA, V595, P545, DOI 10.1007/s10750-007-9034-0; Logez M, 2013, ECOGRAPHY, V36, P80, DOI 10.1111/j.1600-0587.2012.07447.x; Lujan NK, 2013, J BIOGEOGR, V40, P1715, DOI 10.1111/jbi.12131; Luther ET, 1977, OUR RESTLES EARTH GE; Marzin A, 2013, HYDROBIOLOGIA, V704, P375, DOI 10.1007/s10750-012-1254-2; Matono P, 2013, ENVIRON MANAGE, V52, P1213, DOI 10.1007/s00267-013-0152-3; McDonald RI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050219; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mims MC, 2010, ECOL FRESHW FISH, V19, P390, DOI 10.1111/j.1600-0633.2010.00422.x; Mims MC, 2013, FRESHWATER BIOL, V58, P50, DOI 10.1111/fwb.12037; Moodley D, 2013, PLOS ONE, V8; Naiman RJ, 2011, ECOL RES, V26, P865, DOI 10.1007/s11284-010-0693-3; Near TJ, 2011, SYST BIOL, V60, P565, DOI 10.1093/sysbio/syr052; Olden JD, 2010, DIVERS DISTRIB, V16, P496, DOI 10.1111/j.1472-4642.2010.00655.x; Oliveira JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045787; Pease AA, 2012, FRESHWATER BIOL, V57, P1060, DOI 10.1111/j.1365-2427.2012.02768.x; Piller KR, 2008, MOL PHYLOGENET EVOL, V46, P974, DOI 10.1016/j.ympev.2007.11.023; Poff NL, 2006, J N AM BENTHOL SOC, V25, P730, DOI 10.1899/0887-3593(2006)025[0730:FTNONA]2.0.CO;2; Rakes PL, 1999, ENVIRON BIOL FISH, V55, P31, DOI 10.1023/A:1007531927209; Rashleigh B, 2004, SOUTHEAST NAT, V3, P621, DOI 10.1656/1528-7092(2004)003[0621:FAGITU]2.0.CO;2; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; ROBINS CR, 1961, COPEIA, P305; Roth NE, 1996, LANDSCAPE ECOL, V11, P141, DOI 10.1007/BF02447513; Roy AH, 2007, LANDSCAPE ECOL, V22, P385, DOI 10.1007/s10980-006-9034-x; Schloss CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028788; Schuldt A, 2012, ECOL LETT, V15, P732, DOI 10.1111/j.1461-0248.2012.01792.x; Schwartz JS, 2008, AQUAT CONSERV, V18, P852, DOI 10.1002/aqc.905; Schwartz JS, 2011, ENVIRON MONIT ASSESS, V179, P347, DOI 10.1007/s10661-010-1741-8; Shute JR, 2005, SOUTHEAST NAT, V4, P93, DOI 10.1656/1528-7092(2005)004[0093:ROFIFI]2.0.CO;2; Sternberg D, 2013, FRESHWATER BIOL, V58, P1767, DOI 10.1111/fwb.12166; Team R. D. C., 2008, R LANG ENV STAT COMP; Tedesco PA, 2008, OECOLOGIA, V156, P691, DOI 10.1007/s00442-008-1021-2; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thornbury, 1965, REGIONAL GEOMORPHOLO; Wang LZ, 1997, FISHERIES, V22, P6, DOI 10.1577/1548-8446(1997)022&lt;0006:IOWLUO&gt;2.0.CO;2; Wiescher PT, 2012, OECOLOGIA, V169, P1063, DOI 10.1007/s00442-012-2262-7; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242	81	29	29	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93237	10.1371/journal.pone.0093237	http://dx.doi.org/10.1371/journal.pone.0093237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676053	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500097
J	Lunina, AA; Vereshchaka, AL				Lunina, Anastasia A.; Vereshchaka, Alexandr L.			Distribution of Hydrothermal Alvinocaridid Shrimps: Effect of Geomorphology and Specialization to Extreme Biotopes	PLOS ONE			English	Article							CENTRAL INDIAN RIDGE; CARIDEA ALVINOCARIDIDAE; DECAPOD CRUSTACEANS; VENT SHRIMPS; COLD SEEPS; GENUS; BRESILIIDAE; BIOGEOGRAPHY; FIELD; PACIFIC	The aim of this study is to review of our knowledge about distribution of recently known species of vent shrimps and to analyze factors influencing distribution patterns. Analyses are based upon (1) original material taken during eight cruises in the Atlantic Ocean (a total of 5861 individuals) and (2) available literature data from the Atlantic, Pacific, and Indian Oceans. Vent shrimps have two patterns of the species ranges: local (single vent site) and regional (three - six vent sites). Pacific species ranges are mainly of the local type and the Atlantic species ranges are of the regional type. The regional type of species ranges may be associated with channels providing easy larval dispersal (rift valleys, trenches), while the local type is characteristic for other areas. Specialization of a shrimp genus to extreme vent habitats leads to two effects: (1) an increase in the number of vent fields inhabited by the genus and (2) a decrease of species number within the genus.	[Lunina, Anastasia A.; Vereshchaka, Alexandr L.] Russian Acad Sci, PP Shirshov Inst Oceanol, Lab Struct & Dynam Plankton Communities, Moscow, Russia	Russian Academy of Sciences; Shirshov Institute of Oceanology	Lunina, AA (corresponding author), Russian Acad Sci, PP Shirshov Inst Oceanol, Lab Struct & Dynam Plankton Communities, Moscow, Russia.	yalunina@list.ru	Lunina, Anastasia/L-3699-2014; Vereshchaka, Alexander L/E-6205-2014	Lunina, Anastasia/0000-0002-1105-8027; Vereshchaka, Alexander L/0000-0002-6756-2468	Ministry of Education and Science of the Russian Federation; Russian Foundation for Basic Research; Program for a Basic Research of the Presidium of the Russian Academy of Sciences	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program for a Basic Research of the Presidium of the Russian Academy of Sciences(Russian Academy of Sciences)	The studies were supported by the Ministry of Education and Science of the Russian Federation, by the Russian Foundation for Basic Research, and by the Program for a Basic Research of the Presidium of the Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahyong ST, 2009, CRUSTACEANA, V82, P775, DOI 10.1163/156854009X427333; Bachraty C, 2009, DEEP-SEA RES PT I, V56, P1371, DOI 10.1016/j.dsr.2009.01.009; Beltenev V., 2009, INTERRIDGE NEWS, V18, P13; Bogdanov Y, 2002, GEOLOGICAL DEEP SEA; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; Desbruyeres D, 1982, HDB DEEP SEA HYDROTH, P191; Desbruyeres D, 1986, HDB DEEP SEA HYDROTH, P191; Fabri MC, 2011, J MAR BIOL ASSOC UK, V91, P1, DOI 10.1017/S0025315410000731; Foote M, 2012, BIOL LETTERS, V8, P135, DOI 10.1098/rsbl.2011.0521; Fujikura Katsunori, 1996, JAMSTEC Journal of Deep Sea Research, V12, P133; Fujikura Katsunori, 1995, JAMSTEC Journal of Deep Sea Research, V11, P227; Gebruk A.V., 2006, EKOSISTEMY ATLANTICH, P119; Gebruk A.V, 2002, BIOL HYDROTHERMAL SY, P185; Gebruk AV, 1997, ADV MAR BIOL, V32, P93; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P485, DOI 10.1017/S0025315400002186; Gurvich E, 1998, METALLLIFEROUS SEDIM; Hilario A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016309; KIKUCHI T, 1995, J CRUSTACEAN BIOL, V15, P771, DOI 10.2307/1548826; Kikuchi Tomohiko, 2000, Species Diversity, V5, P135; Komai T, 2006, SCI MAR, V70, P109, DOI 10.3989/scimar.2006.70n1109; Komai T, 2004, J MAR BIOL ASSOC UK, V84, P1179, DOI 10.1017/S0025315404010628h; Komai T, 2006, DENISIA, V18, P410; Komai Tomoyuki, 2007, Species Diversity, V12, P237; Komai T, 2010, ZOOTAXA, P15; Lavin AM, 2003, DEEP-SEA RES PT I, V50, P1099, DOI 10.1016/S0967-0637(03)00095-5; Limen H, 2006, CAH BIOL MAR, V47, P457; Lunina A, 2011, THESIS PP SHIRSHOV I; Lunina A A, 2008, Dokl Biol Sci, V421, P266, DOI 10.1134/S0012496608040133; Lunina AA, 2010, ZOOTAXA, P69; Martin J.W., 2005, CONTRIBUTIONS SCI NA, V145, P445, DOI 10.1111/j.1096-3642.2005.00178.x; Martin JW, 2005, ZOOL J LINN SOC-LOND, V145, P445, DOI 10.1111/j.1096-3642.2005.00178.x; Martin JW, 2005, P BIOL SOC WASH, V118, P183, DOI 10.2988/0006-324X(2005)118[183:ANSOTS]2.0.CO;2; MARTIN JW, 1995, P BIOL SOC WASH, V108, P220; Martin W, 2008, NAT REV MICROBIOL, V6, P805, DOI 10.1038/nrmicro1991; Mironov A.N., 2002, BIOLOGIYA GIDROTERMA, P410; Morozov EG, 2010, ABYSSAL CHANNELS IN THE ATLANTIC OCEAN: WATER STRUCTURE AND FLOWS, P1, DOI 10.1007/978-90-481-9358-5; Nakamura K, 2012, PLOS ONE, V7, P1; NYE V, 2011, J MAR BIOL ASSOC UK, V92, P1; Pedersen RB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1124; Ramirez-Llodra E, 2006, J MAR BIOL ASSOC UK, V86, P1347, DOI 10.1017/S0025315406014378; Ramirez-Llodra E, 2007, OCEANOGRAPHY, V20, P30, DOI 10.5670/oceanog.2007.78; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Roterman CN, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0718; Rouse GW, 2009, MAR BIOL, V156, P395, DOI 10.1007/s00227-008-1091-z; SEGONZAC M, 1993, CAH BIOL MAR, V34, P535; Shank TM, 2003, P BIOL SOC WASH, V116, P158; Shank TM, 1999, MOL PHYLOGENET EVOL, V13, P244, DOI 10.1006/mpev.1999.0642; SHANK TM, 1997, HDB DEEP SEA HYDROTH, P191; SMITH DK, 1993, NATURE, V365, P707, DOI 10.1038/365707a0; Stephens JC, 2000, J PHYS OCEANOGR, V30, P622, DOI 10.1175/1520-0485(2000)030<0622:DPOABW>2.0.CO;2; Tunnicliffe V, 1998, ADV MAR BIOL, V34, P353, DOI 10.1016/S0065-2881(08)60213-8; Tyler PA, 2003, HYDROBIOLOGIA, V503, P9, DOI 10.1023/B:HYDR.0000008492.53394.6b; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; Van Dover CL, 2001, SCIENCE, V294, P818, DOI 10.1126/science.1064574; Vereshchaka AL, 1997, DEEP-SEA RES PT I, V44, P1905, DOI 10.1016/S0967-0637(97)00031-9; Vereshchaka AL, 1998, DOKL AKAD NAUK, V360, P269; Vereshchaka Alexander L., 2000, Galathea Report, V18, P69; Watabe H, 2002, ZOOL SCI, V19, P1167, DOI 10.2108/zsj.19.1167; Watabe Hajime, 2000, JAMSTEC Journal of Deep Sea Research, V17, P29; WEATHERLY GL, 1982, J MAR RES, V40, P985; Webber WR, 2004, ZOOTAXA, P1; Wheeler AJ, 2013, GEOCHEM GEOPHY GEOSY, V14, P4170, DOI 10.1002/ggge.20243; WILLIAMS A B, 1982, Journal of Crustacean Biology, V2, P136, DOI 10.2307/1548118; WILLIAMS AB, 1995, P BIOL SOC WASH, V108, P228; WILLIAMS AB, 1988, FISH B-NOAA, V86, P263; WILLIAMS AB, 1986, J CRUSTACEAN BIOL, V6, P446, DOI 10.2307/1548184; WUNSCH C, 1984, J PHYS OCEANOGR, V14, P1712, DOI 10.1175/1520-0485(1984)014<1712:AEAOCM>2.0.CO;2; Yang JS, 2013, MOL BIOL EVOL, V30, P305, DOI 10.1093/molbev/mss224; Zelnio KA, 2009, P BIOL SOC WASH, V122, P52, DOI 10.2988/07-28.1; Zierenberg RA, 2000, P NATL ACAD SCI USA, V97, P12961, DOI 10.1073/pnas.210395997; Zonnenshine L, 1992, HYDROTHERMAL FORMATI, P12	71	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92802	10.1371/journal.pone.0092802	http://dx.doi.org/10.1371/journal.pone.0092802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676215	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677500041
J	Maciel-de-Freitas, R; Avendanho, FC; Santos, R; Sylvestre, G; Araujo, SC; Lima, JBP; Martins, AJ; Coelho, GE; Valle, D				Maciel-de-Freitas, Rafael; Avendanho, Fernando Campos; Santos, Rosangela; Sylvestre, Gabriel; Araujo, Simone Costa; Pereira Lima, Jose Bento; Martins, Ademir Jesus; Coelho, Giovanini Evelim; Valle, Denise			Undesirable Consequences of Insecticide Resistance following Aedes aegypti Control Activities Due to a Dengue Outbreak	PLOS ONE			English	Article							RIO-DE-JANEIRO; SCALE FIELD TRIAL; CONTAINER PRODUCTIVITY; MANAGEMENT STRATEGIES; CULICIDAE; DIPTERA; SURVEILLANCE; POPULATIONS; MOSQUITOS	Background: During a dengue outbreak with co-circulation of DENV-1 and -2 in the city of Boa Vista, one patient was diagnosed with DENV-4, a serotype supposed absent from Brazil for almost 30 years. The re-emergence of DENV-4 triggered the intensification of mechanical and chemical Aedes aegypti control activities in order to reduce vector density and avoid DENV-4 dissemination throughout the country. Methods/Principal Findings: Vector control activities consisted of (a) source reduction, (b) application of diflubenzuron against larvae and (c) vehicle-mounted space spraying of 2% deltamethrin to eliminate adults. Control activity efficacy was monitored by comparing the infestation levels and the number of eggs collected in ovitraps before and after interventions, performed in 22 Boa Vista districts, covering an area of similar to 80% of the city and encompassing 56,837 dwellings. A total of 94,325 containers were eliminated or treated with diflubenzuron. The most frequently positive containers were small miscellaneous receptacles, which corresponded to 59% of all positive breeding sites. Insecticide resistance to deltamethrin was assessed before, during and after interventions by dose-response bioassays adopting WHO-based protocols. The intense use of the pyrethroid increased fourfold the resistance ratio of the local Ae. aegypti population only six months after the beginning of vector control. Curiously, this trend was also observed in the districts in which no deltamethrin was applied by the public health services. On the other hand, changes in the resistance ratio to the organophosphate temephos seemed less influenced by insecticide in Boa Vista. Conclusions: Despite the intense effort, mosquito infestation levels were only slightly reduced. Besides, the median number of eggs in ovitraps remained unaltered after control activity intensification. The great and rapid increase in pyrethroid resistance levels of natural Ae. aegypti populations is discussed in the context of both public and domestic intensification of chemical control due to a dengue outbreak.	[Maciel-de-Freitas, Rafael; Sylvestre, Gabriel] Fiocruz MS, Inst Oswaldo Cruz, Lab Transmissores Hematozoarios, BR-21045900 Rio De Janeiro, Brazil; [Avendanho, Fernando Campos; Coelho, Giovanini Evelim] Minist Saude, Secretaria Vigilancia Saude, Brasilia, DF, Brazil; [Santos, Rosangela] Secretaria Estadual Saude Roraima, Boa Vista, Brazil; [Araujo, Simone Costa; Pereira Lima, Jose Bento; Martins, Ademir Jesus] Fiocruz MS, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetores, BR-21045900 Rio De Janeiro, Brazil; [Araujo, Simone Costa; Pereira Lima, Jose Bento; Martins, Ademir Jesus] Inst Biol Exercito, Rio De Janeiro, Brazil; [Martins, Ademir Jesus; Valle, Denise] INCT EM, Rio De Janeiro, Brazil; [Valle, Denise] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Maciel-de-Freitas, R (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Transmissores Hematozoarios, BR-21045900 Rio De Janeiro, Brazil.	freitas@ioc.fiocruz.br; dvalle@ioc.fiocruz.br	Martins, Ademir J./B-4117-2009; Maciel-de-Freitas, Rafael/J-1997-2012; Martins, Ademir/W-3251-2019; Valle, Denise/F-5069-2013	Martins, Ademir/0000-0001-5739-1215; Maciel-de-Freitas, Rafael/0000-0002-2198-6492				[Anonymous], 2002, PNCD PROGR NAC CONTR; [Anonymous], 1981, INSTRUCTIONS DETERMI; Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2; Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878; Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004; David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019; de Souza RP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001439; Eisen L, 2009, J MED ENTOMOL, V46, P1245, DOI 10.1603/033.046.0601; Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Hemingway J, 1997, PESTIC SCI, V51, P375, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;375::AID-PS636&gt;3.0.CO;2-K; Kuno G, 2010, J MED ENTOMOL, V47, P957, DOI 10.1603/ME10152; Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5; Linss JGB, 2014, PARASITES V IN PRESS; Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056; Maciel-de-Freitas R, 2011, TROP MED INT HEALTH, V16, P965, DOI 10.1111/j.1365-3156.2011.02797.x; MALLET J, 1989, TRENDS ECOL EVOL, V4, P336, DOI 10.1016/0169-5347(89)90088-8; Marcombe S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001202; Martins AJ, 2009, TROP MED INT HEALTH, V14, P1351, DOI 10.1111/j.1365-3156.2009.02378.x; Ministerio da Saude, 2009, BRAZ GUID PREV CONTR; Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Nathan MB, 2007, RECENT EPIDEMIOLOGIC, P30; Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001; Penilla RP, 1998, MED VET ENTOMOL, V12, P217, DOI 10.1046/j.1365-2915.1998.00123.x; Pilger D, 2011, TROP MED INT HEALTH, V16, P1143, DOI 10.1111/j.1365-3156.2011.02818.x; Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531; RAYMOND M, 1985, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V23, P117; Reiter P., 2001, GUIDELINES ASSESSING; Rozendaal J.A., 1997, VECTOR CONTROL METHO; Saavedra-Rodriguez K, 2012, INSECT MOL BIOL, V21, P61, DOI 10.1111/j.1365-2583.2011.01113.x; SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922; Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681; WHO, 1998, WHOCDSCPCMAL9812; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002	35	87	92	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92424	10.1371/journal.pone.0092424	http://dx.doi.org/10.1371/journal.pone.0092424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676277	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500022
J	Wansleeben, C; Bowie, E; Hotten, DF; Yu, YRA; Hogan, BLM				Wansleeben, Carolien; Bowie, Emily; Hotten, Danielle F.; Yu, Yen-Rei A.; Hogan, Brigid L. M.			Age-Related Changes in the Cellular Composition and Epithelial Organization of the Mouse Trachea	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; LYMPHOID-TISSUE BALT; STEM-CELLS; INNATE IMMUNITY; BASAL-CELLS; LUNG; AIRWAY; MICE; SENESCENCE; HOMEOSTASIS	We report here senescent changes in the structure and organization of the mucociliary pseudostratified epithelium of the mouse trachea and main stem bronchi. We confirm previous reports of the gradual appearance of age-related, gland-like structures (ARGLS) in the submucosa, especially in the intercartilage regions and carina. Immunohistochemistry shows these structures contain ciliated and secretory cells and Krt5+ basal cells, but not the myoepithelial cells or ciliated ducts typical of normal submucosal glands. Data suggest they arise de novo by budding from the surface epithelium rather than by delayed growth of rudimentary or cryptic submucosal glands. In old mice the surface epithelium contains fewer cells per unit length than in young mice and the proportion of Krt5+, p63+ basal cells is reduced in both males and females. However, there appears to be no significant difference in the ability of basal stem cells isolated from individual young and old mice to form clonal tracheospheres in culture or in the ability of the epithelium to repair after damage by inhaled sulfur dioxide. Gene expression analysis by Affymetrix microarray and quantitative PCR, as well as immunohistochemistry and flow sorting studies, are consistent with low-grade chronic inflammation in the tracheas of old versus young mice and an increase in the number of immune cells. The significance of these changes for ARGL formation are not clear since several treatments that induce acute inflammation in young mice did not result in budding of the surface epithelium.	[Wansleeben, Carolien; Bowie, Emily; Hogan, Brigid L. M.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Hotten, Danielle F.; Yu, Yen-Rei A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University	Hogan, BLM (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	brigid.hogan@dm.duke.edu		Bowie, Emily/0000-0002-5694-6044	National Institutes of Health [HL 4R37-HL07103-21]; Ellison Medical Foundation; American Lung Association [R225818-N]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040372] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL071303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); American Lung Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was from the National Institutes of Health (HL 4R37-HL07103-21 to BLMH) and the Ellison Medical Foundation. (www.ellisonfoundation.org). CW was supported by an American Lung Association Fellowship R225818-N (www.lung.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Calvi CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020712; Chilosi M, 2013, TRANSL RES, V162, P156, DOI 10.1016/j.trsl.2013.06.004; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Doles J, 2012, GENE DEV, V26, P2144, DOI 10.1101/gad.192294.112; Driskell RR, 2007, DEV BIOL, V305, P90, DOI 10.1016/j.ydbio.2007.01.038; ENGELHARDT JF, 1995, DEVELOPMENT, V121, P2031; Faner R, 2012, AM J RESP CRIT CARE, V186, P306, DOI 10.1164/rccm.201202-0282PP; Ferrer-Vaquer A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-121; Giangreco A, 2011, J PATHOL, V224, P190, DOI 10.1002/path.2876; HERNANDEZ JA, 1965, J AM GERIATR SOC, V13, P799, DOI 10.1111/j.1532-5415.1965.tb02060.x; Huang JM, 2013, EXP GERONTOL, V48, P717, DOI 10.1016/j.exger.2013.04.001; Ledford JG, 2009, J IMMUNOL, V182, P7818, DOI 10.4049/jimmunol.0900452; Lucchetta EM, 2012, WIRES DEV BIOL, V1, P781, DOI 10.1002/wdev.51; Madsen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064441; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; MAYS PK, 1989, AM REV RESPIR DIS, V140, P410, DOI 10.1164/ajrccm/140.2.410; Mollenhauer J, 2000, CANCER RES, V60, P1704; Muller H, 2008, CLIN EXP IMMUNOL, V151, P123, DOI 10.1111/j.1365-2249.2007.03528.x; NETTESHEIM P, 1970, JNCI-J NATL CANCER I, V44, P687; O'Koren EG, 2013, AM J RESP CELL MOL, V49, P788, DOI 10.1165/rcmb.2012-0369OC; PABST R, 1990, AM J RESP CELL MOL, V3, P131, DOI 10.1165/ajrcmb/3.2.131; Paxson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023232; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Randall TD, 2010, ADV IMMUNOL, V107, P187, DOI [10.1016/S0065-2776(10)07002-1, 10.1016/B978-0-12-381300-8.00007-1]; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Seiler C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001386; Shaykhiev R, 2013, GERONTOLOGY, V59, P481, DOI 10.1159/000354173; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Shore SA, 2003, J APPL PHYSIOL, V95, P938, DOI 10.1152/japplphysiol.00336.2003; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Wallace KN, 2005, DEV CELL, V8, P717, DOI 10.1016/j.devcel.2005.02.015; Wansleeben C, 2010, DEVELOPMENT, V137, P1067, DOI 10.1242/dev.041434; Watanabe H, 2005, GASTROENTEROLOGY, V128, P1391, DOI 10.1053/j.gastro.2005.03.016; Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Zeng N, 2013, AGING CELL	42	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93496	10.1371/journal.pone.0093496	http://dx.doi.org/10.1371/journal.pone.0093496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675804	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677500131
J	Jin, Y; Sun, CJ; Feng, LQ; Li, PC; Xiao, LJ; Ren, YZ; Wang, DM; Li, CF; Chen, L				Jin, Yi; Sun, Caijun; Feng, Liqiang; Li, Pingchao; Xiao, Lijun; Ren, Yizhong; Wang, Dimin; Li, Chufang; Chen, Ling			Regulation of SIV Antigen-Specific CD4+T Cellular Immunity via Autophagosome-Mediated MHC II Molecule-Targeting Antigen Presentation in Mice	PLOS ONE			English	Article							CD4(+) T-CELLS; IMMUNODEFICIENCY-VIRUS TYPE-1; VACCINE-INDUCED IMMUNITY; HIV-1 VACCINE; CROSS-PRESENTATION; AIDS RESEARCH; DOUBLE-BLIND; RESPONSES; INFECTION; EFFICACY	CD4+ T cell-mediated immunity has increasingly received attention due to its contribution in the control of HIV viral replication; therefore, it is of great significance to improve CD4+ T cell responses to enhance the efficacy of HIV vaccines. Recent studies have suggested that macroautophagy plays a crucial role in modulating adaptive immune responses toward CD4+ T cells or CD8+ T cells. In the present study, a new strategy based on a macroautophagy degradation mechanism is investigated to enhance CD4+ T cell responses against the HIV/SIV gag antigen. Our results showed that when fused to the autophagosome-associated LC3b protein, SIVgag protein can be functionally targeted to autophagosomes, processed by autophagy-mediated degradation in autolysosomes/lysosomes, presented to MHC II compartments and elicit effective potential CD4 T cell responses in vitro. Importantly, compared with the SIVgag protein alone, SIVgag-LC3b fusion antigen can induce a stronger antigen-specific CD4+ T cell response in mice, which is characterized by an enhanced magnitude and polyfunctionality. This study provides insight for the immunological modulation between viral and mammalian cells via autophagy, and it also presents an alternative strategy for the design of new antigens in the development of effective HIV vaccines.	[Jin, Yi; Sun, Caijun; Feng, Liqiang; Li, Pingchao; Xiao, Lijun; Ren, Yizhong; Wang, Dimin; Chen, Ling] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China; [Jin, Yi; Xiao, Lijun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ren, Yizhong] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Wang, Dimin] Anhui Univ, Sch Life Sci, Hefei 230039, Peoples R China; [Li, Chufang; Chen, Ling] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Sun, CJ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China.	Sun_caijun@gibh.ac.cn; chen_ling@gibh.ac.cn			National Natural Science Foundation of China [31370923, 81000737, 31200693]; National Science and Technology Major Project "Development of Novel Mucosal Vaccines against HIV-1 Infection" [2012ZX10001-009]; CAS Youth Innovation Promotion Association	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project "Development of Novel Mucosal Vaccines against HIV-1 Infection"; CAS Youth Innovation Promotion Association	This work was supported by the National Natural Science Foundation of China (31370923, 81000737 and 31200693), the National Science and Technology Major Project "Development of Novel Mucosal Vaccines against HIV-1 Infection" (2012ZX10001-009), and the grant of CAS Youth Innovation Promotion Association to Dr. Caijun Sun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2010, CURR OPIN HIV AIDS, V5, P386, DOI 10.1097/COH.0b013e32833cfe4c; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Campbell GR, 2013, CURR OPIN MICROBIOL, V16, P349, DOI 10.1016/j.mib.2013.05.006; Casimiro DR, 2003, J VIROL, V77, P7663, DOI 10.1128/JVI.77.13.7663-7668.2003; Chevalier MF, 2011, J VIROL, V85, P733, DOI 10.1128/JVI.02030-10; Cohen J, 2007, SCIENCE, V318, P28, DOI 10.1126/science.318.5847.28; Cohen J, 2013, SCIENCE, V340, P667, DOI 10.1126/science.340.6133.667; de Souza MS, 2012, J IMMUNOL, V188, P5166, DOI 10.4049/jimmunol.1102756; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dongre AR, 2001, EUR J IMMUNOL, V31, P1485, DOI 10.1002/1521-4141(200105)31:5<1485::AID-IMMU1485>3.0.CO;2-A; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Esparza J, 2013, VACCINE, V31, P3502, DOI 10.1016/j.vaccine.2013.05.018; Gannage Monique, 2013, Methods Mol Biol, V960, P473, DOI 10.1007/978-1-62703-218-6_35; Gauduin MC, 2006, J EXP MED, V203, P2661, DOI 10.1084/jem.20060134; Gilbert PB, 2011, J INFECT DIS, V203, P969, DOI 10.1093/infdis/jiq152; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Heeney Jonathan L, 2006, Nat Immunol, V7, P1281, DOI 10.1038/ni1206-1281; Ireland JM, 2011, J EXP MED, V208, P2625, DOI 10.1084/jem.20110640; Kadowaki Motoni, 2006, Molecular Aspects of Medicine, V27, P426, DOI 10.1016/j.mam.2006.08.010; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Kumamoto Y, 2011, P NATL ACAD SCI USA, V108, P8749, DOI 10.1073/pnas.1100567108; Li YH, 2008, CANCER RES, V68, P6889, DOI 10.1158/0008-5472.CAN-08-0161; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McEnery Regina, 2011, IAVI Rep, V15, P17; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Moog C, 2008, AIDS, V22, P1461, DOI 10.1097/QAD.0b013e3282fdf625; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Nimmerjahn F, 2003, EUR J IMMUNOL, V33, P1250, DOI 10.1002/eji.200323730; Oh JE, 2012, YONSEI MED J, V53, P241, DOI 10.3349/ymj.2012.53.2.241; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Porichis F, 2011, CURR OPIN HIV AIDS, V6, P174, DOI 10.1097/COH.0b013e3283454058; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richetta C, 2013, CELL MICROBIOL, V15, P368, DOI 10.1111/cmi.12043; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; Soghoian DZ, 2010, EXPERT REV VACCINES, V9, P1453, DOI 10.1586/ERV.10.132; Streeck H, 2013, NAT MED, V19, P143, DOI 10.1038/nm.3054; Sun CJ, 2013, J VIROL, V87, P5669, DOI 10.1128/JVI.03247-12; Sun CJ, 2010, J INFECTION, V60, P371, DOI 10.1016/j.jinf.2010.03.005; Sun YX, 2013, IMMUNOLOGY, V138, P370, DOI 10.1111/imm.12049; Sun Y, 2007, J VIROL, V81, P8009, DOI 10.1128/JVI.00482-07; Sun Y, 2006, J VIROL, V80, P10950, DOI 10.1128/JVI.01458-06; Tey SK, 2012, AUTOPHAGY, V8, P1839, DOI 10.4161/auto.21860; Valdor R, 2012, PHARMACOL RES, V66, P475, DOI 10.1016/j.phrs.2012.10.003; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484	53	29	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93143	10.1371/journal.pone.0093143	http://dx.doi.org/10.1371/journal.pone.0093143			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671203	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000120
J	Monteiro, J; Aires, R; Becker, JD; Jacinto, A; Certal, AC; Rodriguez-Leon, J				Monteiro, Joana; Aires, Rita; Becker, Joerg D.; Jacinto, Antonio; Certal, Ana C.; Rodriguez-Leon, Joaquin			V-ATPase Proton Pumping Activity Is Required for Adult Zebrafish Appendage Regeneration	PLOS ONE			English	Article							VERTEBRATE REGENERATION; BLASTEMA FORMATION; MEMBRANE VOLTAGE; VACUOLAR-ATPASE; FIN; PROLIFERATION; EXPRESSION; INDUCTION; MECHANISM; SURVIVAL	The activity of ion channels and transporters generates ion-specific fluxes that encode electrical and/or chemical signals with biological significance. Even though it is long known that some of those signals are crucial for regeneration, only in recent years the corresponding molecular sources started to be identified using mainly invertebrate or larval vertebrate models. We used adult zebrafish caudal fin as a model to investigate which and how ion transporters affect regeneration in an adult vertebrate model. Through the combined use of biophysical and molecular approaches, we show that V-ATPase activity contributes to a regeneration-specific H+ ef'flux. The onset and intensity of both V-ATPase expression and H+ efflux correlate with the different regeneration rate along the proximal-distal axis. Moreover, we show that V-ATPase inhibition impairs regeneration in adult vertebrate. Notably, the activity of this H+ pump is necessary for aldh1a2 and mkp3 expression, blastema cell proliferation and fin innervation. To the best of our knowledge, this is the first report on the role of V-ATPase during adult vertebrate regeneration.	[Monteiro, Joana; Aires, Rita; Becker, Joerg D.; Certal, Ana C.; Rodriguez-Leon, Joaquin] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Monteiro, Joana] Fac Med Lisbon, Inst Med Mol, Lisbon, Portugal; [Jacinto, Antonio] Fac Ciencias Med, Ctr Estudos Doencas Cron, Lisbon, Portugal; [Certal, Ana C.] Champalimaud Fdn, Lisbon, Portugal; [Rodriguez-Leon, Joaquin] Univ Extremadura, Fac Med, Dept Anat Humana Biol Celular & Zool, Badajoz, Spain	Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Universidade Nova de Lisboa; Fundacao Champalimaud; Universidad de Extremadura	Certal, AC (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	catarina.certal@fundacaochampalimaud.pt; jrleon@unex.es	Becker, Jorg/A-5930-2011; Monteiro, Joana F./AAU-9357-2020; Leon, Joaquin Maria Rodriguez/C-6957-2013; Jacinto, Antonio/F-5729-2013; Leon, Joaquin Maria Rodriguez/S-9814-2019; Certal, Ana Catarina/M-4028-2013	Becker, Jorg/0000-0002-6845-6122; Monteiro, Joana F./0000-0002-0057-7307; Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Jacinto, Antonio/0000-0002-4193-6089; Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Certal, Ana Catarina/0000-0002-5091-0083; Aires, Rita/0000-0002-3537-0453	Fundacao para a Ciencia e Tecnologia (FCT), Portugal [SFRH/BD/45131/2008, SFRH/BPD/29957/2006]; european FP6-Cells into Organs, FCT [PTDC/BIA-BCM/100867/2008, POCTI-ISFL-4-664]; Ministerio de Ciencia e Innovacion, Spain [RYC-2008-02753, BFU2009-12279]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/100867/2008] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); european FP6-Cells into Organs, FCT; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundação para a Ciência e a Tecnologia	JJM was supported by a fellowship (SFRH/BD/45131/2008) from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. ACC was supported by a postdocoral fellowship (SFRH/BPD/29957/2006) from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. This work was supported by the following grants: european FP6-Cells into Organs, FCT (Grant PTDC/BIA-BCM/100867/2008 and POCTI-ISFL-4-664) and Ministerio de Ciencia e Innovacion, Spain (Subprograma Ramon y Cajal, reference RYC-2008-02753 and grant BFU2009-12279). JRL is supported by the Subprogram Ramon y Cajal from Ministerio de Ciencia e Innovacion, Spain (RYC-2008-02753). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DS, 2007, DEVELOPMENT, V134, P1323, DOI 10.1242/dev.02812; AKIMENKO MA, 1995, DEVELOPMENT, V121, P347; Beane WS, 2011, CHEM BIOL, V18, P77, DOI 10.1016/j.chembiol.2010.11.012; BECERRA J, 1983, CELL TISSUE RES, V230, P127; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Bjornsson CS, 2004, J EXP BIOL, V207, P2835, DOI 10.1242/jeb.01089; Blum N, 2013, CELL MOL LIFE SCI, V12; Blum N, 2012, DEVELOPMENT, V139, P107, DOI 10.1242/dev.065391; BORGENS RB, 1981, SCIENCE, V213, P611, DOI 10.1126/science.7256258; BORGENS RB, 1979, J EXP ZOOL, V209, P377, DOI 10.1002/jez.1402090304; BORGENS RB, 1977, P NATL ACAD SCI USA, V74, P4528, DOI 10.1073/pnas.74.10.4528; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hyde DR, 2012, JOVE-J VIS EXP, DOI 10.3791/3632; Illingworth C. M., 1980, Clinical Physics and Physiological Measurement, V1, P87, DOI 10.1088/0143-0815/1/1/007; Kawakami A, 2004, DEV DYNAM, V231, P693, DOI 10.1002/dvdy.20181; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Levin M, 2007, TRENDS CELL BIOL, V17, P261, DOI 10.1016/j.tcb.2007.04.007; Li C., 2001, GENOME BIOL, V2, DOI [10.1186/gb-2001-2-8-research0032, DOI 10.1186/GB-2001-2-8-RESEARCH0032]; Lin G, 2008, DEV BIOL, V316, P323, DOI 10.1016/j.ydbio.2008.01.032; Lin LY, 2006, AM J PHYSIOL-CELL PH, V290, pC371, DOI 10.1152/ajpcell.00281.2005; Mateus R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051766; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Nechiporuk A, 2002, DEVELOPMENT, V129, P2607; Nishisho T, 2011, MOL CANCER RES, V9, P845, DOI 10.1158/1541-7786.MCR-10-0449; Nuckels RJ, 2009, INVEST OPHTH VIS SCI, V50, P893, DOI 10.1167/iovs.08-2743; Petzoldt AG, 2013, DIS MODEL MECH, V6, P689, DOI 10.1242/dmm.010660; Poleo G, 2001, DEV DYNAM, V221, P380, DOI 10.1002/dvdy.1152; Reid B, 2011, JOVE-J VIS EXP, DOI 10.3791/2358; Reid B, 2009, DEV BIOL, V335, P198, DOI 10.1016/j.ydbio.2009.08.028; Sasazawa Y, 2009, CANCER SCI, V100, P1460, DOI 10.1111/j.1349-7006.2009.01194.x; Shipley AM, 1999, FERTILIZATION HIGHER, P235; Smith PJS, 1999, MICROSC RES TECHNIQ, V46, P398, DOI 10.1002/(SICI)1097-0029(19990915)46:6<398::AID-JEMT8>3.0.CO;2-H; Song B, 2004, J CELL SCI, V117, P4681, DOI 10.1242/jcs.01341; Sousa S, 2011, DEVELOPMENT, V138, P3897, DOI 10.1242/dev.064717; Stock C, 2005, J PHYSIOL-LONDON, V567, P225, DOI 10.1113/jphysiol.2005.088344; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Sundelacruz S, 2009, STEM CELL REV REP, V5, P231, DOI 10.1007/s12015-009-9080-2; Suzuki M, 2005, DEV BIOL, V286, P361, DOI 10.1016/j.ydbio.2005.08.021; Tal TL, 2010, GERONTOLOGY, V56, P231, DOI 10.1159/000259327; Tseng AS, 2010, J NEUROSCI, V30, P13192, DOI 10.1523/JNEUROSCI.3315-10.2010; Tu S, 2011, DEV CELL, V20, P725, DOI 10.1016/j.devcel.2011.04.013; Vaccari T, 2010, DEVELOPMENT, V137, P1825, DOI 10.1242/dev.045484; Vieira AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017411; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yoshinari N, 2011, BIOL BULL-US, V221, P62, DOI 10.1086/BBLv221n1p62; Yoshinari N, 2009, DEV BIOL, V325, P71, DOI 10.1016/j.ydbio.2008.09.028; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	51	28	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92594	10.1371/journal.pone.0092594	http://dx.doi.org/10.1371/journal.pone.0092594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671205	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000056
J	Pinho, GM; da Silva, AG; Hrbek, T; Venticinque, EM; Farias, IP				Pinho, Gabriela M.; da Silva, Anders Goncalves; Hrbek, Tomas; Venticinque, Eduardo M.; Farias, Izeni P.			Kinship and Social Behavior of Lowland Tapirs (Tapirus terrestris) in a Central Amazon Landscape	PLOS ONE			English	Article							HOME-RANGE OVERLAP; GENETIC-STRUCTURE; POPULATION-STRUCTURE; PAIRWISE RELATEDNESS; COMPUTER-PROGRAM; MATING SYSTEM; DISPERSAL; PATTERNS; DNA; PHILOPATRY	We tested the hypothesis that tapirs tolerate individuals adjacent and overlapping home ranges if they are related. We obtained genetic data from fecal samples collected in the Balbina reservoir landscape, central Amazon. Samples were genotyped at 14 microsatellite loci, of which five produced high quality informative genotypes. Based on an analysis of 32 individuals, we inferred a single panmictic population with high levels of heterozygosity. Kinship analysis identified 10 pairs of full siblings or parent-offspring, 10 pairs of half siblings and 25 unrelated pairs. In 10 cases, the related individuals were situated on opposite margins of he reservoir, suggesting that tapirs are capable of crossing the main river, even after damming. The polygamous model was the most likely mating system for Tapirus terrestris. Moran/index of allele sharing between pairs of individuals geographically close km) was similar to that observed between individual pairs at larger distances (>3 km). Confirming this result, the related individuals were not geographically closer than unrelated ones (W=188.5; p=0.339). Thus, we found no evidence of a preference for being close to relatives and observed a tendency for dispersal. The small importance of relatedness in determining spatial distribution of individuals is unusual in mammals, but unheard of. Finally, non-invasive sampling allowed efficient access to the genetic data, despite the warm and humid climate of the Amazon, which accelerates DNA degradation.	[Pinho, Gabriela M.] INPA, Programa Posgrad Ecol, Manaus, Amazonas, Brazil; [Pinho, Gabriela M.; Hrbek, Tomas; Farias, Izeni P.] Univ Fed Amazonas UFAM, Dept Biol, Lab Evolucao & Genet Anim, Manaus, Amazonas, Brazil; [da Silva, Anders Goncalves] CSIRO, Div Marine & Atmospher Res, Hobart, Tas, Australia; [da Silva, Anders Goncalves] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Venticinque, Eduardo M.] Univ Fed Rio Grande Norte UFRN, Ctr Biociencias, Lab Ecol & Conservacao Biodiversidade, Natal, RN, Brazil	Institute Nacional de Pesquisas da Amazonia; Universidade Federal de Amazonas; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University; Universidade Federal do Rio Grande do Norte	Pinho, GM (corresponding author), INPA, Programa Posgrad Ecol, Manaus, Amazonas, Brazil.	gabriela.m.pinho@gmail.com	Pinho, Gabriela Medeiros de/AAH-2816-2020; Hrbek, Tomas/J-6988-2012; Venticinque, Eduardo M/G-8961-2015; Farias, Izeni Pires/J-3069-2014	Pinho, Gabriela Medeiros de/0000-0003-4671-8221; Hrbek, Tomas/0000-0003-3239-7068; Venticinque, Eduardo M/0000-0002-3455-9107; Farias, Izeni Pires/0000-0002-1416-4351; Goncalves da Silva, Anders/0000-0002-2257-8781	National Council for Scientific and Technological Development (CNPq)/ Sistema Nacional de Pesquisa em Biodiversidade/ BioPHAM [563348/2010-0]; Uatuma Biological Reserve; CNPq [307997/2009-0]	National Council for Scientific and Technological Development (CNPq)/ Sistema Nacional de Pesquisa em Biodiversidade/ BioPHAM(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Uatuma Biological Reserve; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The National Council for Scientific and Technological Development (CNPq)/ Sistema Nacional de Pesquisa em Biodiversidade/ BioPHAM (http://www. cnpq.br/) provided funding for data collection and laboratory analysis (IPF Proc 563348/2010-0). The field logistics were supported by the Uatuma Biological Reserve. GMP received reagents and equipment from IDEA WILD (http://www.ideawild.org/) and a Master's fellowship from CNPq. EMV had funding from CNPq (Proc 307997/2009-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barongi R. A., 1993, International Zoo Yearbook, V32, P7; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beja-Pereira A, 2009, MOL ECOL RESOUR, V9, P1279, DOI 10.1111/j.1755-0998.2009.02699.x; Belkhir K, 2002, MOL ECOL NOTES, V2, P611, DOI 10.1046/j.1471-8286.2002.00273.x; Bellemain E, 2005, CONSERV BIOL, V19, P150, DOI 10.1111/j.1523-1739.2005.00549.x; Bjornstad O. N, 2012, NCF SPATIAL NONPARAM; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Brinkman TJ, 2010, CONSERV GENET, V11, P1547, DOI 10.1007/s10592-009-9928-7; Broquet T, 2007, CONSERV GENET, V8, P249, DOI 10.1007/s10592-006-9146-5; CAUGHLEY G, 1966, ECOLOGY, V47, P906, DOI 10.2307/1935638; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Crawford AM, 1996, GENOME RES, V6, P876, DOI 10.1101/gr.6.9.876; da Silva AG, 2009, CONSERV GENET RESOUR, V1, P39, DOI 10.1007/s12686-009-9009-8; de Thoisy B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-278; de Thoisy Benoit, 2006, Tapir Conservation, V15, P14; DeWoody JA, 2004, BIOTECHNIQUES, V37, P348, DOI 10.2144/04373BM02; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Earl Cranbrook, 2013, INTEGR ZOOL, V8, P95, DOI 10.1111/j.1749-4877.2012.00319.x; EISENBERG J F, 1973, Biotropica, V5, P150, DOI 10.2307/2989807; Environmental Systems Research Institute (ESRI), 2008, ARCGIS 9 3; Epperson BK, 1996, P NATL ACAD SCI USA, V93, P10528, DOI 10.1073/pnas.93.19.10528; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farrell LE, 2000, MOL ECOL, V9, P1583, DOI 10.1046/j.1365-294x.2000.01037.x; Foerster CR, 2002, BIOTROPICA, V34, P423, DOI 10.1111/j.1744-7429.2002.tb00556.x; Garcia MJ, 2012, INTEGR ZOOL, V7, P346, DOI 10.1111/j.1749-4877.2012.00317.x; Garnier JN, 2001, MOL ECOL, V10, P2031, DOI 10.1046/j.0962-1083.2001.01338.x; GEIST V, 1974, AM ZOOL, V14, P205, DOI 10.1093/icb/14.1.205; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Goncalves da Silva A, 2010, J HERED, V101, P581, DOI 10.1093/jhered/esq055; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hirsch BT, 2013, ANIM BEHAV, V85, P463, DOI 10.1016/j.anbehav.2012.12.011; HOLMES WG, 1983, AM SCI, V71, P46; Holzhauer SIJ, 2006, LANDSCAPE ECOL, V21, P891, DOI 10.1007/s10980-005-0438-9; Instituto Brasileiro do Meio Ambiente e dos Recursos Naturais Renovaveis, 1997, PLAN MAN FAS 1 RES B; IUCN, 2019, IUCN RED LIST THREAT; JANIS CM, 1988, TRENDS ECOL EVOL, V3, P291, DOI 10.1016/0169-5347(88)90104-8; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Jordan NR, 2007, ANIM BEHAV, V73, P613, DOI 10.1016/j.anbehav.2006.06.010; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kitchen AM, 2005, J ANIM ECOL, V74, P1173, DOI 10.1111/j.1365-2656.2005.01017.x; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Kuhner MK, 2009, TRENDS ECOL EVOL, V24, P86, DOI 10.1016/j.tree.2008.09.007; Longmire JL, 1988, GENOMICS, V2, P14, DOI 10.1016/0888-7543(88)90104-8; Lucchini V, 2002, MOL ECOL, V11, P857, DOI 10.1046/j.1365-294X.2002.01489.x; Lynch M, 1999, GENETICS, V152, P1753; MacFadden BJ, 2006, TRENDS ECOL EVOL, V21, P157, DOI 10.1016/j.tree.2005.12.003; McEachern MB, 2007, BEHAV ECOL SOCIOBIOL, V61, P1459, DOI 10.1007/s00265-007-0378-2; Medici E. P, 2010, ASSESSING VIABILITY; MELNICK DJ, 1992, INT J PRIMATOL, V13, P379, DOI 10.1007/BF02547824; Norton JE, 2004, ANIM CONSERV, V7, P211, DOI 10.1017/S1367943004001295; Noss A.J., 2003, Tapir Conservation, V12, P24; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; POPE TR, 1992, EVOLUTION, V46, P1112, DOI 10.1111/j.1558-5646.1992.tb00623.x; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; RALLS K, 1971, SCIENCE, V171, P443, DOI 10.1126/science.171.3970.443; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rooney AP, 1999, J MOL EVOL, V49, P682, DOI 10.1007/PL00006589; ROPER TJ, 1993, BEHAVIOUR, V127, P289, DOI 10.1163/156853993X00074; Ross KG, 2001, MOL ECOL, V10, P265, DOI 10.1046/j.1365-294x.2001.01191.x; Rostain RR, 2004, ANIM BEHAV, V68, P703, DOI 10.1016/j.anbehav.2003.10.027; Sanches A, 2009, CONSERV GENET RESOUR, V1, P115, DOI 10.1007/s12686-009-9028-5; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Spong G, 2000, MOL ECOL, V9, P1773, DOI 10.1046/j.1365-294x.2000.01067.x; Storz JF, 1999, J MAMMAL, V80, P553, DOI 10.2307/1383301; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Team R. D. C, 2011, R LANG ENV STAT COMP; Temple HJ, 2006, MOL ECOL, V15, P3449, DOI 10.1111/j.1365-294X.2006.03006.x; Tobler MW., 2008, ECOLOGY LOWLAND TAPI; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van de Casteele T, 2001, MOL ECOL, V10, P1539, DOI 10.1046/j.1365-294X.2001.01288.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; WALDMAN B, 1988, ANNU REV ECOL SYST, V19, P543; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; WASER PM, 1983, Q REV BIOL, V58, P355, DOI 10.1086/413385; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; Wronski T, 2006, BEHAV ECOL SOCIOBIOL, V59, P819, DOI 10.1007/s00265-005-0128-2; Wronski T, 2005, J ZOOL, V266, P227, DOI 10.1017/S0952836905006825	83	10	10	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92507	10.1371/journal.pone.0092507	http://dx.doi.org/10.1371/journal.pone.0092507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671057	Green Published, gold			2022-12-25	WOS:000333677000048
J	Wagner, F; Rossi, V; Aubry-Kientz, M; Bonal, D; Dalitz, H; Gliniars, R; Stahl, C; Trabucco, A; Herault, B				Wagner, Fabien; Rossi, Vivien; Aubry-Kientz, Melaine; Bonal, Damien; Dalitz, Helmut; Gliniars, Robert; Stahl, Clement; Trabucco, Antonio; Herault, Bruno			Pan-Tropical Analysis of Climate Effects on Seasonal Tree Growth	PLOS ONE			English	Article							RAIN-FOREST TREE; SEMI-DECIDUOUS FOREST; CARBON DYNAMICS; INTERANNUAL VARIABILITY; EXPERIMENTAL DROUGHT; CAMBIUM ACTIVITY; CENTRAL AMAZON; DRY SEASON; WATER-USE; PHENOLOGY	Climate models predict a range of changes in tropical forest regions, including increased average temperatures, decreased total precipitation, reduced soil moisture and alterations in seasonal climate variations. These changes are directly related to the increase in anthropogenic greenhouse gas concentrations, primarily CO2. Assessing seasonal forest growth responses to climate is of utmost importance because woody tissues, produced by photosynthesis from atmospheric CO2, water and light, constitute the main component of carbon sequestration in the forest ecosystem. In this paper, we combine intra-annual tree growth measurements from published tree growth data and the corresponding monthly climate data for 25 pan-tropical forest sites. This meta-analysis is designed to find the shared climate drivers of tree growth and their relative importance across pan-tropical forests in order to improve carbon uptake models in a global change context. Tree growth reveals significant intra-annual seasonality at seasonally dry sites or in wet tropical forests. Of the overall variation in tree growth, 28.7% was explained by the site effect, i.e. the tree growth average per site. The best predictive model included four climate variables: precipitation, solar radiation (estimated with extrasolar radiation reaching the atmosphere), temperature amplitude and relative soil water content. This model explained more than 50% of the tree growth variations across tropical forests. Precipitation and solar radiation are the main seasonal drivers of tree growth, causing 19.8% and 16.3% of the tree growth variations. Both have a significant positive association with tree growth. These findings suggest that forest productivity due to tropical tree growth will be reduced in the future if climate extremes, such as droughts, become more frequent.	[Wagner, Fabien] Natl Inst Space Res INPE, Remote Sensing Div, Sao Jose Dos Campos, SP, Brazil; [Wagner, Fabien; Stahl, Clement; Herault, Bruno] Cirad, UMR Ecol Forets Guyane 93, Kourou, France; [Rossi, Vivien] Cirad, UR Biens & Serv Ecosyst Forestiers Trop 105, Montpellier, France; [Rossi, Vivien] Univ Yaounde I, UMI Modelisat Math & Informat Syst Complexes 209, Yaounde, Cameroon; [Aubry-Kientz, Melaine] Univ Antilles Guyane, UMR Ecol Forets Guyane 93, Kourou, France; [Bonal, Damien] INRA, UMR EEF 1137, Champenoux, France; [Dalitz, Helmut; Gliniars, Robert] Univ Hohenheim, Inst Bot, Stuttgart, Germany; [Stahl, Clement] CIRAD, UMR Syst Elevage Milieux Mediterraneens & Trop, Kourou, France; [Trabucco, Antonio] Euromediterranean Ctr Climate Change, Sassari, Italy; [Trabucco, Antonio] Katholieke Univ Leuven, Div Forest Nat & Landscape, Leuven, Belgium	Instituto Nacional de Pesquisas Espaciais (INPE); CIRAD; CIRAD; UDICE-French Research Universities; Sorbonne Universite; Cadi Ayyad University of Marrakech; Hanoi University of Science & Technology; Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; University of Yaounde I; INRAE; Universite de Lorraine; University Hohenheim; CIRAD; Centro Euro-Mediterraneo sui Cambiamenti Climatici (CMCC); KU Leuven	Wagner, F (corresponding author), Natl Inst Space Res INPE, Remote Sensing Div, Sao Jose Dos Campos, SP, Brazil.	wagner.h.fabien@gmail.com	Wagner, Fabien FW/B-8364-2013; Hérault, Bruno/B-2765-2011; Rossi, Vivien/C-9721-2009	Wagner, Fabien FW/0000-0002-9623-1182; Hérault, Bruno/0000-0002-6950-7286; Rossi, Vivien/0000-0001-5458-1523; Trabucco, Antonio/0000-0002-0743-3680	Climfor (Fondation pour la Recherche sur la Biodiversite); Guyasim (European structural fundings, PO-Feder); Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [13/14520-6]; Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-0025]	Climfor (Fondation pour la Recherche sur la Biodiversite); Guyasim (European structural fundings, PO-Feder); Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR))	Funding came from the project Climfor (Fondation pour la Recherche sur la Biodiversite, www.fondationbiodiversite.fr/), from the project Guyasim (European structural fundings, PO-Feder, http://www.europe-guyane.eu/index.php?option = com_content&task= view&id =14&Itemid = 206), and from the Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, processo 13/14520-6, http://www.bv.fapesp.br/pt/bolsas/146751/quantificacao-e-modelagem-da-sazonalidade-da-producao-primaria-liquida-florestal-pantropical-usando-/). This work has also benefited from an "Investissement d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-0025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R.G., 1994, ICID B, V43, P35; Arias PA, 2011, CLIM DYNAM, V37, P1151, DOI 10.1007/s00382-010-0903-2; Baker PJ, 2008, AUST J BOT, V56, P311, DOI 10.1071/BT08040; Baker TR, 2003, PERSPECT PLANT ECOL, V6, P21, DOI 10.1078/1433-8319-00040; Baker TR, 2002, FOREST ECOL MANAG, V171, P261, DOI 10.1016/S0378-1127(01)00787-3; Barnett, 2010, ANAL SEASONAL HLTH D; Bates D., 2013, LME4 LINEAR MIXED EF; Batjes NH, 1997, SOIL USE MANAGE, V13, P9, DOI 10.1111/j.1475-2743.1997.tb00550.x; Batjes NH, 2012, TECHNICAL REPORT; Zanon MLB, 2010, CIENC FLOREST, V20, P467, DOI 10.5902/198050982061; Bonal D, 2008, GLOBAL CHANGE BIOL, V14, P1917, DOI 10.1111/j.1365-2486.2008.01610.x; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Borchert R, 1999, IAWA J, V20, P239, DOI 10.1163/22941932-90000687; Borchert R, 1998, CLIMATIC CHANGE, V39, P381, DOI 10.1023/A:1005383020063; Bradley AV, 2011, GLOBAL CHANGE BIOL, V17, P2245, DOI 10.1111/j.1365-2486.2011.02405.x; Brauning A, 2009, ERDKUNDE, V63, P337, DOI 10.3112/erdkunde.2009.04.04; Brando PM, 2008, PHILOS T R SOC B, V363, P1839, DOI 10.1098/rstb.2007.0031; Brando PM, 2010, P NATL ACAD SCI USA, V107, P14685, DOI 10.1073/pnas.0908741107; Braswell BH, 1997, SCIENCE, V278, P870, DOI 10.1126/science.278.5339.870; Brienen RJW, 2011, TREES-STRUCT FUNCT, V25, P103, DOI 10.1007/s00468-010-0474-1; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cardoso FCG, 2012, PLANT SOIL, V354, P269, DOI 10.1007/s11104-011-1063-9; Chambers JQ, 2004, OECOLOGIA, V141, P596, DOI 10.1007/s00442-004-1676-2; Chave J, 2003, J ECOL, V91, P240, DOI 10.1046/j.1365-2745.2003.00757.x; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Clark DB, 2010, GLOBAL CHANGE BIOL, V16, P747, DOI 10.1111/j.1365-2486.2009.02004.x; Clark DA, 2013, J GEOPHYS RES-BIOGEO, V118, P783, DOI 10.1002/jgrg.20067; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; Couralet C, 2010, BIOTROPICA, V42, P503, DOI 10.1111/j.1744-7429.2009.00613.x; da Silva RP, 2002, FOREST ECOL MANAG, V166, P295, DOI 10.1016/S0378-1127(01)00678-8; DAUBENMIRE R, 1972, J ECOL, V60, P147, DOI 10.2307/2258048; Detienne P, 1988, REV BOIS FORETS TROP; DEVINEAU JL, 1991, REV ECOL-TERRE VIE, V46, P95; Doughty CE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI [10.1029/2007JG000632, 10.1029/2007JG000590]; Doughty CE, 2011, BIOTROPICA, V43, P658, DOI 10.1111/j.1744-7429.2010.00746.x; Ekstrom M, 2007, HYDROL EARTH SYST SC, V11, P1069, DOI 10.5194/hess-11-1069-2007; Enquist BJ, 2001, J TROP ECOL, V17, P41, DOI 10.1017/S0266467401001031; FAO, 2012, TECHNICAL REPORT; Feeley KJ, 2007, P ROY SOC B-BIOL SCI, V274, P2857, DOI 10.1098/rspb.2007.0954; Feng X, 2013, NAT CLIM CHANGE, V3, P811, DOI [10.1038/nclimate1907, 10.1038/NCLIMATE1907]; Field C, 2012, IPCC 2012 MANAGING R, DOI [10.1136/jech-2012-201045, DOI 10.1136/JECH-2012-201045]; Figueira A, 2011, LBA ECO CD 04 DENDRO, DOI [10.3334/ornldaac/989, DOI 10.3334/0RNLDAAC/989]; Franks PJ, 1999, PLANT CELL ENVIRON, V22, P1337, DOI 10.1046/j.1365-3040.1999.00494.x; Gliniars R, 2012, DATA FROM BIOTA E AF; Gliniars R, 2013, TREES-STRUCT FUNCT, V27, P1129, DOI 10.1007/s00468-013-0863-3; Goetz S, 2011, CARBON MANAG, V2, P231, DOI 10.4155/CMT.11.18; Graham EA, 2003, P NATL ACAD SCI USA, V100, P572, DOI 10.1073/pnas.0133045100; Granier A, 1999, ECOL MODEL, V116, P269, DOI 10.1016/S0304-3800(98)00205-1; Grogan J, 2012, BIOTROPICA, V44, P331, DOI 10.1111/j.1744-7429.2011.00825.x; Gurka MJ, 2006, AM STAT, V60, P19, DOI 10.1198/000313006X90396; Harris NL, 2008, ECOL MODEL, V216, P253, DOI 10.1016/j.ecolmodel.2008.04.008; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; Herault B, 2010, J APPL ECOL, V47, P821, DOI 10.1111/j.1365-2664.2010.01826.x; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Hutyra LR, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000365; JANZEN D H, 1974, Biotropica, V6, P260, DOI 10.2307/2989669; Krepkowski J, 2011, TREES-STRUCT FUNCT, V25, P59, DOI 10.1007/s00468-010-0460-7; Susan GWL, 2009, J VEG SCI, V20, P323, DOI 10.1111/j.1654-1103.2009.01044.x; Lewis SL, 2009, ANNU REV ECOL EVOL S, V40, P529, DOI 10.1146/annurev.ecolsys.39.110707.173345; LIEBERMAN D, 1982, J ECOL, V70, P791, DOI 10.2307/2260105; Lisi CS, 2008, IAWA J, V29, P189, DOI 10.1163/22941932-90000179; Lloyd J, 2008, PHILOS T R SOC B, V363, P1811, DOI 10.1098/rstb.2007.0032; da Costa ACL, 2010, NEW PHYTOL, V187, P579, DOI 10.1111/j.1469-8137.2010.03309.x; Lopez-Ayala JL, 2006, AGROCIENCIA-MEXICO, V40, P139; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; MARENGO JA, 1992, INT J CLIMATOL, V12, P853, DOI 10.1002/joc.3370120808; Metcalf CJE, 2009, J TROP ECOL, V25, P1, DOI 10.1017/S0266467408005646; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Nath CD, 2006, J BIOSCIENCES, V31, P651, DOI 10.1007/BF02708418; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Nepstad DC, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000360; Ohashi S, 2009, TREES-STRUCT FUNCT, V23, P813, DOI 10.1007/s00468-009-0322-3; Ohashi Y, 2001, HOLZFORSCHUNG, V55, P151, DOI 10.1515/HF.2001.024; Oliveira JM, 2009, TREES-STRUCT FUNCT, V23, P107, DOI 10.1007/s00468-008-0259-y; Orelien JG, 2008, COMPUT STAT DATA AN, V52, P1896, DOI 10.1016/j.csda.2007.06.006; Orlowsky B, 2012, CLIMATIC CHANGE, V110, P669, DOI 10.1007/s10584-011-0122-9; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pelissier R, 2000, J TROP ECOL, V16, P429, DOI 10.1017/S0266467400001498; Pennec A, 2011, REMOTE SENS LETT, V2, P337, DOI 10.1080/01431161.2010.507610; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Poorter L, 2007, ECOLOGY, V88, P1000, DOI 10.1890/06-0984; Reichstein M, 2002, FUNCT ECOL, V16, P27, DOI 10.1046/j.0269-8463.2001.00597.x; Rozendaal DMA, 2011, TREES-STRUCT FUNCT, V25, P3, DOI 10.1007/s00468-010-0480-3; Ruger N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025330; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; Saleska SR, 2003, SCIENCE, V302, P1554, DOI 10.1126/science.1091165; Schenk H, 2009, ISLSCP INITIATIVE 2, DOI [10.3334/ORNLDAAC/929, 10.3334/ORNLDAAC/929., DOI 10.3334/ORNLDAAC/929]; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sheil D, 2003, CAN J FOREST RES, V33, P2027, DOI 10.1139/X03-121; Smith, 1998, FAO IRRIGATION DRAIN, DOI DOI 10.1016/J.EJA.2010.12.001; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P19; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; Spracklen DV, 2012, NATURE, V489, P282, DOI 10.1038/nature11390; Stahl C, 2010, J TROP ECOL, V26, P393, DOI 10.1017/S0266467410000155; Stark SC, 2012, ECOL LETT, V15, P1406, DOI 10.1111/j.1461-0248.2012.01864.x; Tian HQ, 1998, NATURE, V396, P664, DOI 10.1038/25328; Toledo M, 2011, J ECOL, V99, P254, DOI 10.1111/j.1365-2745.2010.01741.x; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Vieira S, 2004, OECOLOGIA, V140, P468, DOI 10.1007/s00442-004-1598-z; Vincent G, 2012, DATA IRD WORLD AGROF; Volland-Voigt F, 2011, TREES-STRUCT FUNCT, V25, P39, DOI 10.1007/s00468-010-0461-6; Vonesh EF, 1996, BIOMETRICS, V52, P572, DOI 10.2307/2532896; Wagner F, 2013, BIOGEOSCI DISCUSS, V10, P8247; Wagner F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034074; Wagner F, 2011, AGR FOREST METEOROL, V151, P1202, DOI 10.1016/j.agrformet.2011.04.012; Way DA, 2010, TREE PHYSIOL, V30, P669, DOI 10.1093/treephys/tpq015; Worbes M, 1999, J ECOL, V87, P391, DOI 10.1046/j.1365-2745.1999.00361.x; Wright SJ, 2010, ANN NY ACAD SCI, V1195, P1, DOI [10.1111/j.1749-6632.2009.05400.x, 10.1111/j.1749-6632.2010.05455.x]; Wurth MKR, 2005, OECOLOGIA, V143, P11, DOI 10.1007/s00442-004-1773-2; Xiao XM, 2006, REMOTE SENS ENVIRON, V103, P465, DOI 10.1016/j.rse.2006.04.013; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014	118	48	50	4	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92337	10.1371/journal.pone.0092337	http://dx.doi.org/10.1371/journal.pone.0092337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670981	Green Published, gold			2022-12-25	WOS:000333677000040
J	Wickramarathna, LN; Noss, C; Lorke, A				Wickramarathna, Lalith N.; Noss, Christian; Lorke, Andreas			Hydrodynamic Trails Produced by Daphnia: Size and Energetics	PLOS ONE			English	Article							FREELY SWIMMING COPEPOD; STEADY MOTION; FLOW-FIELD; BEHAVIOR; TURBULENCE; EFFICIENCY; ORGANISMS; MODEL; OCEAN	This study focuses on quantifying hydrodynamic trails produced by freely swimming zooplankton. We combined volumetric tracking of swimming trajectories with planar observations of the flow field induced by Daphnia of different size and swimming in different patterns. Spatial extension of the planar flow field along the trajectories was used to interrogate the dimensions (length and volume) and energetics (dissipation rate of kinetic energy and total dissipated power) of the trails. Our findings demonstrate that neither swimming pattern nor size of the organisms affect the trail width or the dissipation rate. However, we found that the trail volume increases with increasing organism size and swimming velocity, more precisely the trail volume is proportional to the third power of Reynolds number. This increase furthermore results in significantly enhanced total dissipated power at higher Reynolds number. The biggest trail volume observed corresponds to about 500 times the body volume of the largest daphnids. Trail-averaged viscous dissipation rate of the swimming daphnids vary in the range of 1.8 x 10(-6) W/kg to 3.4 x 10(-6) W/kg and the observed magnitudes of total dissipated power between 1.3 x 10(-9) W and 1 x 10(-8) W, respectively. Among other zooplankton species, daphnids display the highest total dissipated power in their trails. These findings are discussed in the context of fluid mixing and transport by organisms swimming at intermediate Reynolds numbers.	[Wickramarathna, Lalith N.; Noss, Christian; Lorke, Andreas] Univ Koblenz Landau, Inst Environm Sci, Koblenz Landau, Germany	University of Koblenz & Landau	Wickramarathna, LN (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Koblenz Landau, Germany.	lalith@uni-landau.de	Lorke, Andreas/B-9195-2008	Lorke, Andreas/0000-0001-5533-1817	German Research Foundation [LO 1150/6-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation (URL: www.dfg.de) (grant no. LO 1150/6-1). The proposal prepared by CN and AL based on preliminary work conducted, was submitted to and approved by the listed agency. The agency had no direct say in the methods or outcome of the project beyond providing funding for materials, and did not directly contribute to the writing of this manuscript. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, GUID TEST CHEM 202; Ardekani AM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.084502; BAKER MA, 1987, J PHYS OCEANOGR, V17, P1817, DOI 10.1175/1520-0485(1987)017<1817:STITSO>2.0.CO;2; Borazjani I, 2010, J EXP BIOL, V213, P3019, DOI 10.1242/jeb.043588; Dabiri JO, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043556; Dantec Dynamics A/S, 2012, DYNAMICSTUDIO V3 20; Dewar WK, 2006, J MAR RES, V64, P541, DOI 10.1357/002224006778715720; Doostmohammadi A, 2012, P NATL ACAD SCI USA, V109, P3856, DOI 10.1073/pnas.1116210109; Duren LA, 2003, J EXP BIOL, V206, P255; EAMES I, 1994, J FLUID MECH, V275, P201, DOI 10.1017/S0022112094002338; Elsinga GE, 2006, EXP FLUIDS, V41, P933, DOI 10.1007/s00348-006-0212-z; Fields DM, 1997, J PLANKTON RES, V19, P79, DOI 10.1093/plankt/19.1.79; Gries T, 1999, J PLANKTON RES, V21, P509, DOI 10.1093/plankt/21.3.509; Huntley ME, 2004, MAR ECOL PROG SER, V273, P65, DOI 10.3354/meps273065; Jiang HS, 2011, J EXP BIOL, V214, P476, DOI 10.1242/jeb.049288; Jiang HS, 2004, SURV GEOPHYS, V25, P339, DOI 10.1007/s10712-003-1282-6; Jiang HS, 2002, J PLANKTON RES, V24, P191, DOI 10.1093/plankt/24.3.191; Jiang HS, 2002, J PLANKTON RES, V24, P167, DOI 10.1093/plankt/24.3.167; Katija K, 2009, NATURE, V460, P624, DOI 10.1038/nature08207; Kiorboe T, 2007, LIMNOL OCEANOGR, V52, P1511, DOI 10.4319/lo.2007.52.4.1511; Kiorboe T, 2011, BIOL REV, V86, P311, DOI 10.1111/j.1469-185X.2010.00148.x; Kiorboe T, 2010, P ROY SOC B-BIOL SCI, V277, P3229, DOI 10.1098/rspb.2010.0629; KIRK KL, 1985, LIMNOL OCEANOGR, V30, P679, DOI 10.4319/lo.1985.30.3.0679; Kohlhage K, 1994, ZOOL BEITR, V35, P47; Kundu P.K, 2008, FLUID MECH; Kunze E, 2011, J MAR RES, V69, P591, DOI 10.1357/002224011799849435; Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601; LEAL LG, 1980, ANNU REV FLUID MECH, V12, P435, DOI 10.1146/annurev.fl.12.010180.002251; Leshansky AM, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.025301; Lombard F, 2013, LIMNOL OCEANOGR, V58, P185, DOI 10.4319/lo.2013.58.1.0185; Mathews J. H., 2004, NUMERICAL METHODS US; MORRIS MJ, 1985, MAR BIOL, V86, P283, DOI 10.1007/BF00397515; MORRIS MJ, 1990, MAR BIOL, V107, P83, DOI 10.1007/BF01313245; Noss C, 2013, LIMNOL OCEANOGR-METH, V11, P139, DOI 10.4319/lom.2013.11.139; Noss C, 2014, LIMNOL OCEA IN PRESS; Noss C, 2012, WATER QUAL RES J CAN, V47, P276, DOI 10.2166/wqrjc.2012.135; Penalva-Arana DC, 2007, HYDROBIOLOGIA, V594, P153, DOI 10.1007/s10750-007-9080-7; Pijanowska J, 1997, FRESHWATER BIOL, V37, P649, DOI 10.1046/j.1365-2427.1997.00192.x; PRICE HJ, 1989, LIMNOL OCEANOGR, V34, P649, DOI 10.4319/lo.1989.34.4.0649; RANTA E, 1993, ANN ZOOL FENN, V30, P299; Ringelberg J, 1999, BIOL REV, V74, P397, DOI 10.1017/S0006323199005381; Ringelberg Joop, 1997, Advances in Limnology, V49, P71; Schlichting H, 1977, BOUNDARY LAYER THEOR, P234; Seuront Laurent, 2004, P333; Stamhuis EJ, 2002, EXP FLUIDS, V33, P801, DOI [10.1007/s00348-002-0520-x, 10.1007/s00348-002-0520-X]; Strutton PG, 2007, HDB SCALING METHODS, P338; Tennekes H, 1973, 1 COURSE TURBULENCE; TISELIUS P, 1992, LIMNOL OCEANOGR, V37, P1640, DOI 10.4319/lo.1992.37.8.1640; van Gool E, 1997, J PLANKTON RES, V19, P2041, DOI 10.1093/plankt/19.12.2041; Videler JJ, 2002, INTEGR COMP BIOL, V42, P988, DOI 10.1093/icb/42.5.988; Visser AW, 2009, J PLANKTON RES, V31, P121, DOI 10.1093/plankt/fbn109; Visser AW, 2001, MAR ECOL PROG SER, V222, P1, DOI 10.3354/meps222001; Walker JA, 2002, INTEGR COMP BIOL, V42, P232, DOI 10.1093/icb/42.2.232; Woodson CB, 2007, LIMNOL OCEANOGR, V52, P2701, DOI 10.4319/lo.2007.52.6.2701; WU JS, 1993, AIAA J, V31, P1448, DOI 10.2514/3.11794; Yen J, 1996, INVERTEBR BIOL, V115, P191, DOI 10.2307/3226930; Yen J, 2000, BIOL BULL, V198, P213, DOI 10.2307/1542525	58	34	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92383	10.1371/journal.pone.0092383	http://dx.doi.org/10.1371/journal.pone.0092383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671019	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000042
J	Cartland, SP; Erlich, JH; Kavurma, MM				Cartland, Sian P.; Erlich, Jonathan H.; Kavurma, Mary M.			TRAIL Deficiency Contributes to Diabetic Nephropathy in Fat-Fed ApoE(-/-) Mice	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; NF-KAPPA-B; CYSTATIN-C; KIDNEY-FUNCTION; RENAL-DISEASE; MARKER; ATHEROSCLEROSIS; INFLAMMATION; EXPRESSION; ACTIVATION	Background: We recently demonstrated that TNF-related apoptosis-inducing ligand (TRAIL) is protective of diet-induced diabetes in mice. While TRAIL has been implicated in chronic kidney disease, its role in vivo in diabetic nephropathy is not clear. The present study investigated the role of TRAIL in the pathogenesis of diabetic nephropathy using TRAIL(-/-)ApoE(-/-) mice. Methods: TRAIL(-/-)ApoE(-/-) and ApoE(-/-) mice were fed a high fat diet for 20 w. Plasma glucose and insulin levels were assessed over 0, 5, 8 and 20 w. At 20 w, markers of kidney function including creatinine, phosphate, calcium and cystatin C were measured. Changes in mRNA expression of MMPs, TIMP-1, IL-1 beta and IL-18 were assessed in the kidney. Functional and histological changes in kidneys were examined. Glucose and insulin tolerance tests were performed. Results: TRAIL(-/-)ApoE(-/-) mice had significantly increased urine protein, urine protein: creatinine ratio, plasma phosphorous, and plasma cystatin C, with accelerated nephropathy. Histologically, increased extracellular matrix, mesangial expansion and mesangial cell proliferation in the glomeruli were observed. Moreover, TRAIL(-/-)ApoE(-/-) kidneys displayed loss of the brush border and disorganisation of tubular epithelium, with increased fibrosis. TRAIL-deficient kidneys also had increased expression of MMPs, TIMP-1, PAI-1, IL-1 beta and IL-18, markers of renal injury and inflammation. Compared with ApoE(-/-) mice, TRAIL(-/-)ApoE(-/-) mice displayed insulin resistance and type-2 diabetic features with reduced renal insulin-receptor expression. Conclusions: Here, we show that TRAIL-deficiency in ApoE(-/-) mice exacerbates nephropathy and insulin resistance. Understanding TRAIL signalling in kidney disease and diabetes, may therefore lead to novel strategies for the treatment of diabetic nephropathy.	[Cartland, Sian P.; Kavurma, Mary M.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Erlich, Jonathan H.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Cartland, Sian P.; Kavurma, Mary M.] Heart Res Inst, Sydney, NSW, Australia; [Kavurma, Mary M.] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; Heart Research Institute; University of Sydney	Kavurma, MM (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia.	mary.kavurma@hri.org.au	Erlich, Jonathan/AAJ-6310-2020; Erlich, Jonathan/AAB-7292-2021	Erlich, Jonathan/0000-0002-4447-2179; Cartland, Sian/0000-0003-1723-2679; Kavurma, Mary/0000-0001-7353-0932	Heart Foundation Career Development Fellowship [CR 12S 6833]	Heart Foundation Career Development Fellowship	MMK is supported by a Heart Foundation Career Development Fellowship (CR 12S 6833). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelidis C, 2013, CURR TOP MED CHEM, V13, P164, DOI 10.2174/1568026611313020006; Azahri NSM, 2013, CELL MOL LIFE SCI, V70, P3617, DOI 10.1007/s00018-013-1264-x; Benito-Martin A, 2009, NEFROLOGIA, V29, P13, DOI 10.3265/Nefrologia.2009.29.1.13.1.en.full.pdf; Candido R, 2014, CURR OPIN NEPHROL HY, V23, P69, DOI 10.1097/01.mnh.0000437611.42417.7a; Chan J, 2010, CIRC RES, V106, P1061, DOI 10.1161/CIRCRESAHA.109.206029; Chang YH, 2011, METABOLISM, V60, P1064, DOI 10.1016/j.metabol.2010.11.002; Charlesworth JA, 2005, METABOLISM, V54, P821, DOI 10.1016/j.metabol.2005.01.028; Chasseraud M, 2011, THER APHER DIAL, V15, P140, DOI 10.1111/j.1744-9987.2010.00886.x; Chen Bing, 2008, Zhonghua Yi Xue Za Zhi, V88, P540; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Di Bartolo BA, 2011, DIABETOLOGIA, V54, P3157, DOI 10.1007/s00125-011-2308-0; Di Bartolo BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074211; Di Pietro R, 2004, J CELL PHYSIOL, V201, P331, DOI 10.1002/jcp.20099; Diao ZJ, 2013, CANCER IMMUNOL IMMUN, V62, P653, DOI 10.1007/s00262-012-1370-x; Dorothee G, 2002, J IMMUNOL, V169, P809, DOI 10.4049/jimmunol.169.2.809; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Grubb A, 2011, SCAND J CLIN LAB INV, V71, P145, DOI 10.3109/00365513.2010.546879; Jouan-Lanhouet S, 2012, CELL DEATH DIFFER, V19, P2003, DOI 10.1038/cdd.2012.90; Kavurma MM, 2008, ARTERIOSCL THROM VAS, V28, P1694, DOI 10.1161/ATVBAHA.107.155143; Kavurma MM, 2008, BIOCHEM PHARMACOL, V75, P1441, DOI 10.1016/j.bcp.2007.10.020; Krieg A, 2003, BRIT J CANCER, V88, P918, DOI 10.1038/sj.bjc.6600772; Lamhamedi-Cherradi SE, 2003, DIABETES, V52, P2274, DOI 10.2337/diabetes.52.9.2274; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P2596, DOI 10.1093/ndt/gfq042; Lim AKH, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/146154; Lorz C, 2008, J AM SOC NEPHROL, V19, P904, DOI 10.1681/ASN.2007050581; Lv W, 2013, PHARMACOLOGY, V92, P227, DOI 10.1159/000354600; Maisonneuve P, 2000, AM J KIDNEY DIS, V35, P157, DOI 10.1016/S0272-6386(00)70316-7; Malyszko J, 2011, TRANSPL P, V43, P1877, DOI 10.1016/j.transproceed.2011.03.035; Okura T, 2010, CLIN EXP NEPHROL, V14, P584, DOI 10.1007/s10157-010-0334-8; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Sedger LM, 2002, EUR J IMMUNOL, V32, P2246, DOI 10.1002/1521-4141(200208)32:8<2246::AID-IMMU2246>3.0.CO;2-6; Spierings DC, 2004, J HISTOCHEM CYTOCHEM, V52, P821, DOI 10.1369/jhc.3A6112.2004; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Van Vliet AI, 2001, J PATHOL, V193, P256; Wang PZ, 2011, LIFE SCI, V89, P839, DOI 10.1016/j.lfs.2011.09.003; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Xie Q, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-108; Yu QL, 2009, AM J PHYSIOL-HEART C, V297, pH76, DOI 10.1152/ajpheart.01285.2008; Yu XQ, 1999, AM J PATHOL, V154, P833, DOI 10.1016/S0002-9440(10)65330-8	43	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92952	10.1371/journal.pone.0092952	http://dx.doi.org/10.1371/journal.pone.0092952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667560	Green Submitted, gold, Green Published			2022-12-25	WOS:000333675600108
J	Chang, JW; Kang, SU; Shin, YS; Kim, KI; Seo, SJ; Yang, SS; Lee, JS; Moon, E; Lee, K; Kim, CH				Chang, Jae Won; Kang, Sung Un; Shin, Yoo Seob; Kim, Kang Il; Seo, Seong Jin; Yang, Sang Sik; Lee, Jong-Soo; Moon, Eunpyo; Lee, Keunho; Kim, Chul-Ho			Non-Thermal Atmospheric Pressure Plasma Inhibits Thyroid Papillary Cancer Cell Invasion via Cytoskeletal Modulation, Altered MMP-2/-9/uPA Activity	PLOS ONE			English	Article							FOCAL ADHESION KINASE; MATRIX METALLOPROTEINASES; SIGNALING PATHWAYS; CARCINOMA-CELLS; MELANOMA-CELLS; OVARIAN-CANCER; IN-VITRO; FAK; METASTASIS; MIGRATION	Plasma, the fourth state of matter, is defined as a partially or completely ionized gas that includes a mixture of electrons and ions. Advances in plasma physics have made it possible to use non-thermal atmospheric pressure plasma (NTP) in cancer research. However, previous studies have focused mainly on apoptotic cancer cell death mediated by NTP as a potential cancer therapy. In this study, we investigated the effect of NTP on invasion or metastasis, as well as the mechanism by which plasma induces anti-migration and anti-invasion properties in human thyroid papillary cancer cell lines (BHP10-3 and TPC1). Wound healing, pull-down, and Transwell assays demonstrated that NTP reduced cell migration and invasion. In addition, NTP induced morphological changes and cytoskeletal rearrangements, as detected by scanning electron microscopy and immunocytochemistry. We also examined matrix metalloproteinase (MMP)-2/-9 and urokinase-type plasminogen activator (uPA) activity using gelatin zymography, uPA assays and RT-PCR. FAK, Src, and paxillin expression was detected using Western blot analyses and immunocytochemistry. NTP decreased FAK, Src, and paxillin expression as well as MMP/uPA activity. In conclusion, NTP inhibited the invasion and metastasis of BHP10-3 and TPC1 cells by decreasing MMP-2/-9 and uPA activities and rearranging the cytoskeleton, which is regulated by the FAK/Src complex. These findings suggest novel actions for NTP and may aid in the development of new therapeutic strategies for locally invasive and metastatic cancers.	[Chang, Jae Won; Kang, Sung Un; Shin, Yoo Seob; Seo, Seong Jin; Kim, Chul-Ho] Ajou Univ, Sch Med, Dept Otolaryngol, Suwon 441749, South Korea; [Kim, Kang Il; Yang, Sang Sik] Ajou Univ, Dept Elect & Comp Engn, Suwon 441749, South Korea; [Lee, Jong-Soo; Moon, Eunpyo] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Lee, Jong-Soo; Moon, Eunpyo] Ajou Univ, Dept Life Sci, Suwon 441749, South Korea; [Lee, Keunho] Plasma Syst & Mat PSM Amer Inc, Colorado Springs, CO USA	Ajou University; Ajou University; Ajou University; Ajou University	Kim, CH (corresponding author), Ajou Univ, Sch Med, Dept Otolaryngol, Suwon 441749, South Korea.	ostium@ajou.ac.kr	kang, sung un/AAK-8050-2021; Chang, Jae Won/R-3511-2019	Chang, Jae Won/0000-0002-6596-931X	Bio & Medical Technology Development Program of the NRF; Korean government [2012M3A9B2052870]	Bio & Medical Technology Development Program of the NRF; Korean government(Korean Government)	This research was supported by the Bio & Medical Technology Development Program of the NRF funded by the Korean government (2012M3A9B2052870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Burduk PK, 2014, HEAD NECK; Caccia D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-278; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; Chen BH, 2002, J BIOL CHEM, V277, P33857, DOI 10.1074/jbc.M204429200; Entschladen F, 2004, LANCET ONCOL, V5, P254, DOI 10.1016/S1470-2045(04)01431-7; Gorla L, 2009, MOL CARCINOGEN, V48, P220, DOI 10.1002/mc.20474; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kim CH, 2010, J BIOTECHNOL, V150, P530, DOI 10.1016/j.jbiotec.2010.10.003; Kim CH, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3449575; Kim YS, 2012, OTOLARYNG HEAD NECK, V147, P15, DOI 10.1177/0194599812439277; Kornberg LJ, 2007, MICROVASC RES, V73, P157, DOI 10.1016/j.mvr.2007.02.005; Kramer A, 2008, GMS KRANKENHHYG INTE, V3; Kwiatkowska A, 2011, BBA-MOL CELL RES, V1813, P655, DOI 10.1016/j.bbamcr.2011.01.020; Lee BS, 2012, CANCER LETT, V322, P45, DOI 10.1016/j.canlet.2012.02.007; Lim YC, 2008, CANCER LETT, V271, P140, DOI 10.1016/j.canlet.2008.05.048; Lu ZJ, 2012, TOXICOL LETT, V209, P211, DOI 10.1016/j.toxlet.2011.12.022; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Nomura H, 1996, INT J CANCER, V69, P9, DOI 10.1002/(SICI)1097-0215(19960220)69:1<9::AID-IJC3>3.0.CO;2-8; O'Neill CJ, 2013, ANZ J SURG; Ota I, 2013, ONCOL REP, V30, P1593, DOI 10.3892/or.2013.2659; Owens LV, 1996, ANN SURG ONCOL, V3, P100, DOI 10.1007/BF02409059; Panngom K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.168; Rahmani Nasrin, 2013, Med Glas (Zenica), V10, P164; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Sensenig R, 2011, ANN BIOMED ENG, V39, P674, DOI 10.1007/s10439-010-0197-x; Shibata K, 1998, CANCER RES, V58, P900; Shih YW, 2010, CELL BIOCHEM BIOPHYS, V58, P31, DOI 10.1007/s12013-010-9091-2; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Tong B, 2013, VASC PHARMACOL, V58, P118, DOI 10.1016/j.vph.2012.09.006; Tuhvatulin AI, 2012, ACTA NATURAE, V4, P82, DOI 10.32607/20758251-2012-4-3-82-87; Turner CE, 2000, J CELL SCI, V113, P4139; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Watts AE, 2006, AM J VET RES, V67, P2030, DOI 10.2460/ajvr.67.12.2030; WEINER TM, 1993, LANCET, V342, P1024, DOI 10.1016/0140-6736(93)92881-S; Xiao WB, 2013, MOL MED REP, V8, P703, DOI 10.3892/mmr.2013.1555; Yang YN, 2012, OPHTHALMIC RES, V48, P165, DOI 10.1159/000338819; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001; Zippi M, 2012, CLIN TER, V163, pE435; Zucker SN, 2012, CANCER BIOL THER, V13, P1299, DOI 10.4161/cbt.21787	46	53	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92198	10.1371/journal.pone.0092198	http://dx.doi.org/10.1371/journal.pone.0092198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667444	gold, Green Published, Green Submitted			2022-12-25	WOS:000333675600028
J	Jiang, DH; Li, DY; Cao, LJ; Wang, LL; Zhu, SS; Xu, TD; Wang, C; Pan, DF				Jiang, Dehua; Li, Dongye; Cao, Lijuan; Wang, Lele; Zhu, Shasha; Xu, Tongda; Wang, Cheng; Pan, Defeng			Positive Feedback Regulation of Proliferation in Vascular Smooth Muscle Cells Stimulated by Lipopolysaccharide Is Mediated through the TLR 4/Rac1/Akt Pathway	PLOS ONE			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; TOLL-LIKE-RECEPTOR-4 EXPRESSION; PROINFLAMMATORY PHENOTYPE; ATHEROSCLEROTIC LESIONS; CARDIOVASCULAR-DISEASE; ENDOTHELIAL-CELLS; NADPH OXIDASES; GROWTH-FACTOR; ACTIVATION	Toll-like receptor 4 (TLR4) are important in inflammation and regulating vascular smooth muscle cells (VSMCs) proliferation, which are related to atherosclerosis and restenosis. We have investigated the mechanisms involved in Lipopolysaccharide (LPS)-induced proliferation of VSMCs. Stimulation of rat aortic VSMCs with LPS significantly increases the proliferation of VSMCs. This effect is regulated by Rac1 (Ras-related C3 botulinum toxin substrate l), which mediates the activation of phosphatidylinositol 3-kinase/Akt (PI3K/Akt) signaling pathways. Inhibition of Rac1 activity by NSC23766 is associated with inhibition of Akt activity. Treatment with NSC23766 or LY294002 significantly decreases LPS-induced TLR4 protein and mRNA expression. The data show that positive feedback regulation of proliferation in VSMCs is mediated through the TLR4/Rac1/Akt pathway.	[Jiang, Dehua; Li, Dongye; Cao, Lijuan; Wang, Lele; Zhu, Shasha] Xuzhou Med Coll, Inst Cardiovasc Dis Res, Xuzhou, Jiangsu, Peoples R China; [Li, Dongye; Xu, Tongda; Wang, Cheng; Pan, Defeng] Xuzhou Med Coll, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Li, DY (corresponding author), Xuzhou Med Coll, Inst Cardiovasc Dis Res, Xuzhou, Jiangsu, Peoples R China.	ldy@xzmc.edu.cn; wangcxz@163.com	jiang, dehua/K-3261-2019; 李, 东/GYA-4703-2022; 李, 东野/AAY-6410-2020	jiang, dehua/0000-0001-8517-1623; Xu, Tongda/0000-0002-5594-3992				Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Chen BC, 2009, MOL IMMUNOL, V46, P1179, DOI 10.1016/j.molimm.2008.11.006; de Graaf R, 2006, MICROBES INFECT, V8, P1859, DOI 10.1016/j.micinf.2006.02.024; Devaraj S, 2011, CYTOKINE, V55, P441, DOI 10.1016/j.cyto.2011.03.023; Diebold I, 2008, THROMB HAEMOSTASIS, V100, P1021, DOI 10.1160/TH08-07-0473; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Frantz S, 2007, NAT CLIN PRACT CARD, V4, P444, DOI 10.1038/ncpcardio0938; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Gosu V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049771; Hattori Y, 2003, EUR J PHARMACOL, V481, P153, DOI 10.1016/j.ejphar.2003.09.034; Hayashi C, 2012, J IMMUNOL, V189, P3681, DOI 10.4049/jimmunol.1201541; He ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035926; Katsargyris A, 2008, EXPERT OPIN THER TAR, V12, P1329, DOI [10.1517/14728222.12.11.1329, 10.1517/14728222.12.11.1329 ]; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kong G, 2001, J KOREAN MED SCI, V16, P712, DOI 10.3346/jkms.2001.16.6.712; Kumerz M, 2011, MOL NUTR FOOD RES, V55, P1230, DOI 10.1002/mnfr.201100309; Lee MY, 2009, ARTERIOSCL THROM VAS, V29, P480, DOI 10.1161/ATVBAHA.108.181925; Li HL, 2007, CELL BIOL INT, V31, P831, DOI 10.1016/j.cellbi.2007.01.034; Li SW, 2009, MOL ENDOCRINOL, V23, P901, DOI 10.1210/me.2008-0368; Li XY, 2010, CYTOKINE, V49, P1, DOI 10.1016/j.cyto.2009.08.010; Li XW, 2003, INFECT IMMUN, V71, P4414, DOI 10.1128/IAI.71.8.4414-4420.2003; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2630, DOI 10.1161/01.ATV.0000247259.01257.b3; Lin ML, 2012, MOL CARCINOG; Lu ZY, 2013, J ENDOCRINOL, V216, P61, DOI 10.1530/JOE-12-0338; Maitra U, 2009, J BIOL CHEM, V284, P35403, DOI 10.1074/jbc.M109.059501; Meng D, 2008, CARDIOVASC RES, V80, P299, DOI 10.1093/cvr/cvn173; Miyake H, 2011, CIRC RES, V108, P1170, DOI 10.1161/CIRCRESAHA.110.236174; Miyano K, 2009, BIOCHEM J, V422, P373, DOI 10.1042/BJ20082182; Murga C, 2002, ONCOGENE, V21, P207, DOI 10.1038/sj.onc.1205036; Ohkawara H, 2009, J ATHEROSCLER THROMB, V16, P846; Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090; Pi Y, 2013, LAB INVEST, V93, P880, DOI 10.1038/labinvest.2013.79; Rice JB, 2003, ARTERIOSCL THROM VAS, V23, P1576, DOI 10.1161/01.ATV.0000081741.38087.F9; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Schultz K, 2007, AM J PHYSIOL-HEART C, V292, pH2927, DOI 10.1152/ajpheart.00700.2006; Setacci C, 2012, J CARDIOVASC SURG, V53, P735; Shen YN, 2010, INFECT IMMUN, V78, P2857, DOI 10.1128/IAI.01138-09; Vink A, 2002, CIRCULATION, V106, P1985, DOI 10.1161/01.CIR.0000032146.75113.EE; Weidemann A, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-80; Wu J, 2013, BIOMED PHARMACOTHER, V67, P313, DOI 10.1016/j.biopha.2013.01.011; Yang X, 2005, AM J PHYSIOL-HEART C, V289, pH1069, DOI 10.1152/ajpheart.00143.2005; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894; Zhang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044590; Zhu HQ, 2009, J MOL CELL CARDIOL, V47, P264, DOI 10.1016/j.yjmcc.2009.05.002	47	32	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92398	10.1371/journal.pone.0092398	http://dx.doi.org/10.1371/journal.pone.0092398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667766	Green Submitted, Green Published, gold			2022-12-25	WOS:000333675600036
J	Maier, PJ; Zemoura, K; Acuna, MA; Yevenes, GE; Zeilhofer, HU; Benke, D				Maier, Patrick J.; Zemoura, Khaled; Acuna, Mario A.; Yevenes, Gonzalo E.; Zeilhofer, Hanns Ulrich; Benke, Dietmar			Ischemia-like Oxygen and Glucose Deprivation Mediates Down-regulation of Cell Surface gamma-Aminobutyric Acid(B) Receptors via the Endoplasmic Reticulum (ER) Stress-induced Transcription Factor CCAAT/Enhancer-binding Protein (C/EBP)-homologous Protein (CHOP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Surface; Endoplasmic Reticulum Stress; Endoplasmic Reticulum (ER); G Protein-coupled Receptors (GPCR); GABA Receptors; Neurons; Trafficking; CHOP; Cerebral Ischemia	TRANSIENT FOREBRAIN ISCHEMIA; GABA(B) RECEPTOR; CEREBRAL-ISCHEMIA; PROXIMITY LIGATION; GERBIL HIPPOCAMPUS; IN-SITU; EXPRESSION; DEATH; PHOSPHORYLATION; ACTIVATION	Background: ER stress associated with cerebral ischemia induces the expression of the transcription factor CHOP. Results: Interaction with CHOP down-regulates cell surface GABA(B) receptors and, thus, GABA(B) receptor-mediated neuronal inhibition. Conclusion: Interaction of CHOP with GABA(B) receptors in the ER prevents forward trafficking of the receptors. Significance: This mechanism is expected to contribute to excitotoxicity in cerebral ischemia. Cerebral ischemia frequently leads to long-term disability and death. Excitotoxicity is believed to be the main cause for ischemia-induced neuronal death. Although a role of glutamate receptors in this process has been firmly established, the contribution of metabotropic GABA(B) receptors, which control excitatory neurotransmission, is less clear. A prominent characteristic of ischemic insults is endoplasmic reticulum (ER) stress associated with the up-regulation of the transcription factor CCAAT/enhancer-binding protein-homologous protein (CHOP). After inducing ER stress in cultured cortical neurons by sustained Ca2+ release from intracellular stores or by a brief episode of oxygen and glucose deprivation (in vitro model of cerebral ischemia), we observed an increased expression of CHOP accompanied by a strong reduction of cell surface GABA(B) receptors. Our results indicate that down-regulation of cell surface GABA(B) receptors is caused by the interaction of the receptors with CHOP in the ER. Binding of CHOP prevented heterodimerization of the receptor subunits GABA(B1) and GABA(B2) and subsequent forward trafficking of the receptors to the cell surface. The reduced level of cell surface receptors diminished GABA(B) receptor signaling and, thus, neuronal inhibition. These findings indicate that ischemia-mediated up-regulation of CHOP down-regulates cell surface GABA(B) receptors by preventing their trafficking from the ER to the plasma membrane. This mechanism leads to diminished neuronal inhibition and may contribute to excitotoxicity in cerebral ischemia.	[Maier, Patrick J.; Zemoura, Khaled; Acuna, Mario A.; Yevenes, Gonzalo E.; Zeilhofer, Hanns Ulrich; Benke, Dietmar] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; [Maier, Patrick J.; Zemoura, Khaled; Acuna, Mario A.; Zeilhofer, Hanns Ulrich; Benke, Dietmar] Univ Zurich, Neurosci Ctr Zurich, CH-8057 Zurich, Switzerland; [Maier, Patrick J.; Zemoura, Khaled; Acuna, Mario A.; Zeilhofer, Hanns Ulrich; Benke, Dietmar] Swiss Fed Inst Technol, CH-8057 Zurich, Switzerland; [Zeilhofer, Hanns Ulrich] Swiss Fed Inst Technol, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Benke, D (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	benke@pharma.uzh.ch	Zeilhofer, Hanns Ulrich/A-4600-2008	Zeilhofer, Hanns Ulrich/0000-0001-6954-4629; Acuna, Mario A./0000-0002-0673-5150; Yevenes, Gonzalo/0000-0003-0294-4075	Swiss National Science Foundation [31003A_121963, 31003A_138382]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by Swiss National Science Foundation grants 31003A_121963 and 31003A_138382 (to D.B.).	Babcock AM, 2002, J NEUROSCI RES, V67, P804, DOI 10.1002/jnr.10169; Benke D, 1999, J BIOL CHEM, V274, P27323, DOI 10.1074/jbc.274.38.27323; Benke D, 2002, J RECEPT SIGNAL TR R, V22, P253, DOI 10.1081/RRS-120014600; BENKE D, 1991, J BIOL CHEM, V266, P4478; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; Calver AR, 2001, J NEUROSCI, V21, P1203; Cimarosti H, 2009, NEUROPHARMACOLOGY, V56, P1088, DOI 10.1016/j.neuropharm.2009.03.007; Dave KR, 2005, J NEUROSCI RES, V82, P665, DOI 10.1002/jnr.20674; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Francis J, 1999, J NEUROCHEM, V72, P87, DOI 10.1046/j.1471-4159.1999.0720087.x; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Han D, 2008, FEBS LETT, V582, P1298, DOI 10.1016/j.febslet.2008.02.044; HOSSMANN KA, 1993, PROG BRAIN RES, V96, P161; Im BH, 2012, NEUROSCI LETT, V513, P89, DOI 10.1016/j.neulet.2012.02.014; JacksonFriedman C, 1997, EXP NEUROL, V147, P346, DOI 10.1006/exnr.1997.6637; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim JY, 2011, TRANSL STROKE RES, V2, P195, DOI 10.1007/s12975-011-0082-4; Kostandy BB, 2012, NEUROL SCI, V33, P223, DOI 10.1007/s10072-011-0828-5; Kulinskii VI, 2000, B EXP BIOL MED+, V130, P772, DOI 10.1007/BF02766091; LAL S, 1995, NEUROCHEM RES, V20, P115, DOI 10.1007/BF00970534; Leuchowius KJ, 2010, MOL CELL PROTEOMICS, V9, P178, DOI 10.1074/mcp.M900331-MCP200; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Morimoto N, 2007, NEUROSCIENCE, V147, P957, DOI 10.1016/j.neuroscience.2007.04.017; Oida Y, 2008, NEUROSCIENCE, V151, P111, DOI 10.1016/j.neuroscience.2007.10.047; Osada N, 2010, NEUROCHEM INT, V57, P1, DOI 10.1016/j.neuint.2010.03.017; Osada N, 2009, NEUROCHEM INT, V54, P403, DOI 10.1016/j.neuint.2009.01.010; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Pagano A, 2001, J NEUROSCI, V21, P1189; Paschen W, 1999, ACT NEUR S, V73, P1; Paschen W, 1998, MOL BRAIN RES, V60, P115, DOI 10.1016/S0169-328X(98)00180-6; Pooler AM, 2009, EUR J NEUROSCI, V29, P869, DOI 10.1111/j.1460-9568.2009.06636.x; Ren XH, 2003, J BIOL CHEM, V278, P42006, DOI 10.1074/jbc.M304238200; Sauter K, 2005, J BIOL CHEM, V280, P33566, DOI 10.1074/jbc.M503482200; Schwartz-Bloom RD, 2001, J NEUROCHEM, V77, P353, DOI 10.1046/j.1471-4159.2001.00274.x; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tajiri S, 2004, CELL DEATH DIFFER, V11, P403, DOI 10.1038/sj.cdd.4401365; Tu HJ, 2007, CELL SIGNAL, V19, P1996, DOI 10.1016/j.cellsig.2007.05.004; Vanhoose AM, 2002, J BIOL CHEM, V277, P9049, DOI 10.1074/jbc.M108309200; Vollenweider F, 2006, NEUROSCI LETT, V395, P118, DOI 10.1016/j.neulet.2005.10.079; Xu J, 2008, NEUROPHARMACOLOGY, V54, P1029, DOI 10.1016/j.neuropharm.2008.01.014; Zemoura K, 2014, J BIOL CHEM, V289, P7738, DOI 10.1074/jbc.M113.541987; Zhang F, 2007, NEUROSCIENCE, V150, P938, DOI 10.1016/j.neuroscience.2007.09.070; Zhou C, 2008, J NEUROSCI RES, V86, P2973, DOI 10.1002/jnr.21728; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	48	37	37	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12896	12907		10.1074/jbc.M114.550517	http://dx.doi.org/10.1074/jbc.M114.550517			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24668805	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000335581400058
J	Lind, C; Russell, ML; MacDonald, J; Collins, R; Frank, CJ; Davis, AE				Lind, Candace; Russell, Margaret L.; MacDonald, Judy; Collins, Ramona; Frank, Christine J.; Davis, Amy E.			School-Based Influenza Vaccination: Parents' Perspectives	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; SEASONAL INFLUENZA; HERD-IMMUNITY; CHILDREN; IMPACT; SCHOOLCHILDREN; IMMUNIZATION; ADULTS; HOSPITALIZATION; INFORMATION	Background: School-age children are important drivers of annual influenza epidemics yet influenza vaccination coverage of this population is low despite universal publicly funded influenza vaccination in Alberta, Canada. Immunizing children at school may potentially increase vaccine uptake. As parents are a key stakeholder group for such a program, it is important to consider their concerns. Purpose: We explored parents' perspectives on the acceptability of adding an annual influenza immunization to the immunization program that is currently delivered in Alberta schools, and obtained suggestions for structuring such a program. Participants: Forty-eight parents of children aged 5-18 years participated in 9 focus groups. Participants lived in urban areas of the Alberta Health Services Calgary Zone. Findings: Three major themes emerged: Advantages of school-based influenza vaccination (SBIV), Disadvantages of SBIV, and Implications for program design & delivery. Advantages were perceived to occur for different populations: children (e.g. emotional support), families (e.g. convenience), the community (e.g. benefits for school and multicultural communities), the health sector (e.g. reductions in costs due to burden of illness) and to society at large (e.g. indirect conduit of information about health services, building structure for pandemic preparedness, building healthy lifestyles). Disadvantages, however, might also occur for children (e.g. older children less likely to be immunized), families (e.g. communication challenges, perceived loss of parental control over information, choices and decisions) and the education sector (loss of instructional time). Nine second-level themes emerged within the major theme of Implications for program design & delivery: program goals/objectives, consent process, stakeholder consultation, age-appropriate program, education, communication, logistics, immunizing agent, and clinic process. Conclusions: Parents perceived advantages and disadvantages to delivering annual seasonal influenza immunizations to children at school. Their input gives a framework of issues to address in order to construct robust, acceptable programs for delivering influenza or other vaccines in schools.	[Lind, Candace; Collins, Ramona; Frank, Christine J.] Univ Calgary, Fac Nursing, Calgary, AB, Canada; [Russell, Margaret L.; MacDonald, Judy; Davis, Amy E.] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada; [MacDonald, Judy] Univ Calgary, Fac Med, Alberta Hlth Serv, Calgary, AB, Canada	University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary	Lind, C (corresponding author), Univ Calgary, Fac Nursing, Calgary, AB, Canada.	cylind@ucalgary.ca		MacDonald, Judy/0000-0001-9774-7220	M.S.I. Foundation [859]	M.S.I. Foundation	This research was funded by the M.S.I. Foundation, grant #859 (http://www.msifoundation.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ALB HLTH, 2012, ALB IMM POL GEN GUID; *ALB HLTH SERV, 2013, ALB RESP VIR SURV RE; *ALB HLTH SERV, 2013, 2013 2014 INFL VACC; *ALB HLTH SERV, 2010, DEM ALB HLTH SYST DE; *ALB HLTH SERV, 2013, IMM SCH SERV; Allison MA, 2010, PEDIATR INFECT DIS J, V29, P751, DOI 10.1097/INF.0b013e3181d8562c; ALPHONSO C, 2011, GLOBE MAIL; Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; Basta NE, 2009, AM J EPIDEMIOL, V170, P679, DOI 10.1093/aje/kwp237; Betsch C, 2011, EUROSURVEILLANCE, V16, P15; Betsch C, 2013, HEALTH PSYCHOL, V32, P146, DOI 10.1037/a0027387; Betsch C, 2012, VACCINE, V30, P3727, DOI 10.1016/j.vaccine.2012.02.025; Betsch C, 2011, MED DECIS MAKING, V31, P742, DOI 10.1177/0272989X11400419; Brabin L, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-20; Cawley J, 2010, J SCHOOL HEALTH, V80, P167, DOI 10.1111/j.1746-1561.2009.00482.x; CDC, 1999, MMWR-MORBID MORTAL W, V48, P1; *COMM BRANCH AH, ALB ENC FALL ROUT GE; Cresswell J., 2007, QUAL INQ, V3th; Esposito S, 2003, VACCINE, V21, P3162, DOI 10.1016/S0264-410X(03)00253-6; Flood EM, 2010, CLIN THER, V32, P1448, DOI 10.1016/j.clinthera.2010.06.020; FORS SW, 1989, HEALTH EDUC QUART, V16, P255, DOI 10.1177/109019818901600209; Fraaij PLA, 2011, VACCINE, V29, P7524, DOI 10.1016/j.vaccine.2011.08.010; Gargano LM, 2011, PEDIATRICS, V128, pE1092, DOI 10.1542/peds.2011-0453; Gellin BG, 2000, PEDIATRICS, V106, P1097, DOI 10.1542/peds.106.5.1097; Glezen WP, 2006, J CLIN VIROL, V37, P237, DOI 10.1016/j.jcv.2006.08.020; Grijalva Carlos G, 2010, PLoS One, V5, pe15097, DOI 10.1371/journal.pone.0015097; Guest G., 2011, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Hamilton N., 1996, POPULATION HLTH PROM; Hull HF, 2011, HUM VACCINES, V7, P153, DOI 10.4161/hv.7.2.13668; Kimmel SR, 1996, AM FAM PHYSICIAN, V53, P1648; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; King JC, 2010, VACCINE, V28, P7737, DOI 10.1016/j.vaccine.2010.09.064; KOMARNICKI J, 2013, CALGARY HERALD; KWONG JC, 2008, EVALUATION EFFECT ON; Kwong JC, 2010, VACCINE, V28, P2722, DOI 10.1016/j.vaccine.2010.01.024; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; Loring BJ, 2009, NEW ZEAL MED J, V122, P14; McLaughlin CG, 2002, HEALTH SERV RES, V37, P1441, DOI 10.1111/1475-6773.12171; MCLAUGHLIN JF, 1992, INT J QUALITATIVE ST, V5, P147; Middleman AB, 2012, HUM VACC IMMUNOTHER, V8, P1395, DOI 10.4161/hv.21575; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; Musto R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-640; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 2002, ARCH PEDIAT ADOL MED, V156, P986, DOI 10.1001/archpedi.156.10.986; Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025; Pineda D, 2011, PEDIATRICS, V127, pS134, DOI 10.1542/peds.2010-1722T; Poehling KA, 2009, VACCINE, V27, P2695, DOI 10.1016/j.vaccine.2009.02.043; *PUBL HLTH AG CAN, 2013, PUBL FUND INFL VACC; Public Health Agency of Canada, 2013, PUBL FUND IMM PROGR; Quadri-Sheriff M, 2012, PEDIATRICS, V130, P522, DOI 10.1542/peds.2012-0140; Schanzer DL, 2007, EPIDEMIOL INFECT, V135, P1109, DOI 10.1017/S0950268807007923; Schanzer DL, 2008, INFLUENZA OTHER RESP, V2, P1, DOI 10.1111/j.1750-2659.2008.00035.x; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Schwandt T. A, 2015, SAGE DICT QUALITATIV, V4th; SHORT MB, 2013, HUMAN VACCINES IMMUN, V10; Sim J, 1998, J ADV NURS, V28, P345, DOI 10.1046/j.1365-2648.1998.00692.x; *STAT CAN, 2012, INFL IMM LESS ON YEA; *SURV ASS BRANCH A, 2012, INT HLTH DAT APPL PO; Talbot HK, 2009, VACCINE, V27, P1923, DOI 10.1016/j.vaccine.2009.01.108; Vynnycky E, 2008, VACCINE, V26, P5321, DOI 10.1016/j.vaccine.2008.06.101; ZAZA S, 2005, GUIDE COMMUNITY PREV, P223	64	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93490	10.1371/journal.pone.0093490	http://dx.doi.org/10.1371/journal.pone.0093490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN8GP	24686406	Green Published, Green Submitted, gold			2022-12-25	WOS:000340842300013
J	Schenk, AN; Souza, MJ				Schenk, Ashley N.; Souza, Marcy J.			Major Anthropogenic Causes for and Outcomes of Wild Animal Presentation to a Wildlife Clinic in East Tennessee, USA, 2000-2011	PLOS ONE			English	Article							INFECTIOUS-DISEASES; URBAN ENVIRONMENTS; CONSERVATION; BIODIVERSITY; MANAGEMENT; IMPACTS	To determine the reasons for presentation and outcome of wildlife cases in East Tennessee, a retrospective analysis was performed using 14,303 records from cases presented to the wildlife clinic of the University of Tennessee Veterinary Teaching Hospital between 2000 and 2011. The cases were first categorized into amphibian/non-avian reptile, mammal, or avian and then classified into groups based on the primary admitting/presenting sign. There are a variety of reasons animals were presented to the clinic, and some were directly or indirectly anthropogenic in origin, including cat related, dog related, hit by automobile, and other human encounters leading to trauma; of the cases reviewed, 4,443 (31.1%) presented for one of these 4 reasons. Overall case fatality risk in regard to these 4 admitting/presenting signs was 0.519 for the amphibian/non-avian reptile cases, 0.675 for mammal cases, and 0.687 for avian cases. This study confirms the importance of monitoring wildlife morbidity and mortality and of focusing efforts to reduce the anthropogenic threat on native habitats and resident wildlife populations.	[Schenk, Ashley N.; Souza, Marcy J.] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Souza, MJ (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA.	msouza@utk.edu		Wellehan, Jim/0000-0001-5692-6134				Ament R, 2008, ENVIRON MANAGE, V42, P480, DOI 10.1007/s00267-008-9112-8; Arlettaz R, 2007, P R SOC B, V274, P1219, DOI 10.1098/rspb.2006.0434; Barron OV, 2013, SCI TOTAL ENVIRON, V443, P491, DOI 10.1016/j.scitotenv.2012.10.085; Brown JD, 2002, J WILDLIFE DIS, V38, P699, DOI 10.7589/0090-3558-38.4.699; Cooper CB, 2007, ECOL SOC, V12; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Jenkins PT, 1996, CONSERV BIOL, V10, P300, DOI 10.1046/j.1523-1739.1996.10010300.x; Leu M, 2008, ECOL APPL, V18, P1119, DOI 10.1890/07-0480.1; Lumpkin HA, 2013, CONSERV BIOL, V27, P1069, DOI 10.1111/cobi.12085; Molina-Lopez RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024603; Pavlacky DC, 2012, J ANIM ECOL, V81, P940, DOI 10.1111/j.1365-2656.2012.01975.x; Robertson ID, 1998, AUST VET J, V76, P551, DOI 10.1111/j.1751-0813.1998.tb10214.x; Romano MC, 2010, NEUROIMMUNOMODULAT, V17, P209, DOI 10.1159/000258726; Rosenberg DK, 1997, BIOSCIENCE, V47, P677, DOI 10.2307/1313208; Schrader GM, 2010, J WILDLIFE DIS, V46, P1079, DOI 10.7589/0090-3558-46.4.1079; Segelbacher G, 2008, MOL ECOL, V17, P2356, DOI 10.1111/j.1365-294X.2008.03767.x; Shepherd B, 2006, ECOL SOC, V11; Taylor J, 2011, ENVIRON INT, V37, P1019, DOI 10.1016/j.envint.2011.03.015; Trocme M, 2006, P 6 SWISS TRANSP RES, P1; Tsipoura N, 2011, ENVIRON RES, V111, P775, DOI 10.1016/j.envres.2011.05.013; U.S. Fish and Wildlife Service, 2003, REC PLAN RED COCK WO	23	25	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93517	10.1371/journal.pone.0093517	http://dx.doi.org/10.1371/journal.pone.0093517			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686490	Green Published, gold			2022-12-25	WOS:000340842300016
J	Pollack, AZ; Sjaarda, L; Ahrens, KA; Mumford, SL; Browne, RW; Wactawski-Wende, J; Schisterman, EF				Pollack, Anna Z.; Sjaarda, Lindsey; Ahrens, Katherine A.; Mumford, Sunni L.; Browne, Richard W.; Wactawski-Wende, Jean; Schisterman, Enrique F.			Association of Cadmium, Lead and Mercury with Paraoxonase 1 Activity in Women	PLOS ONE			English	Article							OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; BLOOD CADMIUM; EXPOSURE; RISK; POLYMORPHISMS; PEROXIDATION; SMOKING; ADULTS; Q192R	Background: The activity of paraoxonase 1 (PON1), an antioxidant enzyme whose polymorphisms have been associated with cancer risk, may be associated with metals exposure. Objective: To evaluate PON1 activity in relation to cadmium, lead, and mercury levels in healthy, premenopausal women. Methods: Women from upstate New York were followed for >= two menstrual cycles. Repeated measures linear mixed models estimated the association between cadmium, lead, and mercury levels (by tertile: T1, T2, T3) and PON1 arylesterase (PON1A) and PON1 paraoxonase (PON1P) activity, separately. Analyses were stratified by PON1 Q192R phenotype and unstratified. Results: Median blood cadmium, lead, and mercury concentrations were 0.30 mu g/L, 0.87 mu g/dL, and 1.15 mu g/L. In unstratified analyses cadmium and mercury were associated with decreased PON1A activity (T2 vs. T1; not T3 vs. T1) but metals were not associated with PON1P. Phenotypes were distributed between QQ (n = 99), QR (n = 117), and RR (n = 34). Cadmium was associated with decreased PON1A activity for QR and RR phenotypes comparing T2 vs. T1 (-14.4% 95% confidence interval [CI] [-20.1, -8.4] and -27.9% [-39.5, -14.0],). Lead was associated with decreased PON1A (RR phenotype, T3 vs. T1 -18.9% [-32.5, -2.5]; T2 vs. T1 -19.6% [-32.4, -4.4]). Cadmium was associated with lower PON1P comparing T2 vs. T1 for the RR (-34.9% [-51.5, -12.5]) and QR phenotypes (-9.5% [-18.1, 0.0]) but not comparing T3 vs. T1. Cadmium was associated with increases in PON1P levels (QQ phenotype, T3 vs. T1 24.5% [7.0, 44.9]) and mercury was associated with increased PON1A levels (QQ phenotype, T3 vs. T1 6.2% [0.2, 12.6]). Mercury was associated with decreased PON1P (RR phenotype, T2 vs. T1 -22.8 [-37.8, -4.1]). Conclusion: Blood metals were associated with PON1 activity and these effects varied by phenotype. However, there was not a linear dose-response and these findings await replication.	[Pollack, Anna Z.; Sjaarda, Lindsey; Ahrens, Katherine A.; Mumford, Sunni L.; Schisterman, Enrique F.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Intramural Populat Hlth Res, NIH, Bethesda, MD 20892 USA; [Pollack, Anna Z.] George Mason Univ, Dept Global & Community Hlth, Sch Hlth & Human Serv, Fairfax, VA 22030 USA; [Browne, Richard W.] SUNY Buffalo, Dept Biotech & Clin Lab Sci, Buffalo, NY 14260 USA; [Wactawski-Wende, Jean] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); George Mason University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Schisterman, EF (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Intramural Populat Hlth Res, NIH, Bethesda, MD 20892 USA.	schistee@mail.nih.gov	Wactawski-Wende, Jean/AGH-5457-2022; Pollack, Anna/L-7652-2018	Wactawski-Wende, Jean/0000-0003-3096-9595; Sjaarda, Lindsey/0000-0003-0539-8110; Ahrens, Katherine/0000-0001-5139-9208; Schisterman, Enrique/0000-0003-3757-641X; Pollack, Anna/0000-0002-4313-3298; Mumford, Sunni/0000-0003-0133-3176	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health [HHSN275200403394C]; Long-Range Research Initiative grant of the American Chemistry Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008762] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Long-Range Research Initiative grant of the American Chemistry Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (Contract # HHSN275200403394C). Anna Z. Pollack was partially supported by the Long-Range Research Initiative grant of the American Chemistry Council to Dr. Schisterman, PI, and partially supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayotte P, 2011, ENVIRON HEALTH PERSP, V119, P1077, DOI 10.1289/ehp.1003296; Bayrak A, 2012, J ATHEROSCLER THROMB, V19, P376, DOI 10.5551/jat.11320; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Browne RW, 2007, CLIN CHEM, V53, P310, DOI 10.1373/clinchem.2006.074559; Browne RW, 2000, CLIN CHEM, V46, P829; Cancer IAfRo, 2006, IARC MONOGRAPHS EVAL, V87; CDC, 2009, 4 CDCP; Centers for Disease Control and Prevention (CDC),, 2012, ADV COMM CHILDH LEAD; Davis KA, 2009, ENVIRON HEALTH PERSP, V117, P1226, DOI 10.1289/ehp.0900569; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; ECKERSON HW, 1983, AM J HUM GENET, V35, P1126; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Fang DH, 2012, MOL BIOL REP, V39, P6801, DOI 10.1007/s11033-012-1505-3; Furlong CE, 2002, PHARMACOGENOMICS, V3, P341, DOI 10.1517/14622416.3.3.341; Guallar E, 2002, NEW ENGL J MED, V347, P1747, DOI 10.1056/NEJMoa020157; HAAGEN L, 1992, EUR J CLIN CHEM CLIN, V30, P391; Hernandez AF, 2009, NEUROTOXICOLOGY, V30, P628, DOI 10.1016/j.neuro.2009.04.003; Howards PP, 2009, AM J EPIDEMIOL, V169, P105, DOI 10.1093/aje/kwn287; LEWIS GP, 1972, LANCET, V1, P291; Li WF, 2006, ENV HLTH PERSPECT, V114; Ferramola ML, 2011, ENVIRON TOXICOL PHAR, V32, P17, DOI 10.1016/j.etap.2011.03.002; Mackness B, 2001, ARTERIOSCL THROM VAS, V21, P1451, DOI 10.1161/hq0901.094247; Mackness B, 1998, FEBS LETT, V423, P57, DOI 10.1016/S0014-5793(98)00064-7; Mahaffey KR, 2009, ENVIRON HEALTH PERSP, V117, P47, DOI 10.1289/ehp.11674; McEneny J, 2013, J NUTR BIOCHEM, V24, P163, DOI 10.1016/j.jnutbio.2012.03.015; Milne GL, 2007, NAT PROTOC, V2, P221, DOI 10.1038/nprot.2006.375; Mozaffarian D, 2012, HYPERTENSION, V60, P645, DOI 10.1161/HYPERTENSIONAHA.112.196154; Mozaffarian D, 2011, NEW ENGL J MED, V364, P1116, DOI 10.1056/NEJMoa1006876; Nakanishi Mamoru, 2003, J Atheroscler Thromb, V10, P337; Navas-Acien A, 2004, CIRCULATION, V109, P3196, DOI 10.1161/01.CIR.0000130848.18636.B2; Navas-Acien A, 2007, ENVIRON HEALTH PERSP, V115, P472, DOI 10.1289/ehp.9785; Navas-Acien A, 2009, AM J EPIDEMIOL, V170, P1156, DOI 10.1093/aje/kwp248; Permpongpaiboon T, 2011, HUM EXP TOXICOL, V30, P1196, DOI 10.1177/0960327110388536; Pollack AZ, 2012, AM J EPIDEMIOL, V175, P645, DOI 10.1093/aje/kwr375; Schisterman EF, 2006, AM J EPIDEMIOL, V163, P374, DOI 10.1093/aje/kwj039; She ZG, 2012, ANTIOXID REDOX SIGN, V16, P597, DOI 10.1089/ars.2010.3774; Soran H, 2009, CURR OPIN LIPIDOL, V20, P265, DOI 10.1097/MOL.0b013e32832ec141; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; Wactawski-Wende J, 2009, PAEDIATR PERINAT EP, V23, P171, DOI 10.1111/j.1365-3016.2008.00985.x; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; WHO INT AGCY RES CANC, 1993, IARC MONOG EVAL CARC, V58, P239	42	29	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92152	10.1371/journal.pone.0092152	http://dx.doi.org/10.1371/journal.pone.0092152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682159	Green Submitted, Green Published, gold			2022-12-25	WOS:000333678100007
J	Sengoda, VG; Cooper, WR; Swisher, KD; Henne, DC; Munyaneza, JE				Sengoda, Venkatesan G.; Cooper, W. Rodney; Swisher, Kylie D.; Henne, Donald C.; Munyaneza, Joseph E.			Latent Period and Transmission of "Candidatus Liberibacter solanacearum" by the Potato Psyllid Bactericera cockerelli (Hemiptera: Triozidae)	PLOS ONE			English	Article							ZEBRA CHIP DISEASE; UNITED-STATES; ASSOCIATION; HAPLOTYPES; ASIATICUS; VECTOR; TIME; ACQUISITION; YELLOWS; BIOLOGY	"Candidatus Liberibacter solanacearum'' (Lso) is an economically important pathogen of solanaceous crops and the putative causal agent of zebra chip disease of potato (Solanum tuberosum L.). This pathogen is transmitted to solanaceous species by the potato psyllid, Bactericera cockerelli (Sulc), but many aspects of the acquisition and transmission processes have yet to be elucidated. The present study was conducted to assess the interacting effects of acquisition access period, incubation period, and host plant on Lso titer in psyllids, the movement of Lso from the alimentary canal to the salivary glands of the insect, and the ability of psyllids to transmit Lso to non-infected host plants. Following initial pathogen acquisition, the probability of Lso presence in the alimentary canal remained constant from 0 to 3 weeks, but the probability of Lso being present in the salivary glands increased with increasing incubation period. Lso copy numbers in psyllids peaked two weeks after the initial pathogen acquisition and psyllids were capable of transmitting Lso to non-infected host plants only after a two-week incubation period. Psyllid infectivity was associated with colonization of insect salivary glands by Lso and with Lso copy numbers >10,000 per psyllid. Results of our study indicate that Lso requires a two-week latent period in potato psyllids and suggest that acquisition and transmission of Lso by psyllids follows a pattern consistent with a propagative, circulative, and persistent mode of transmission.	[Sengoda, Venkatesan G.; Cooper, W. Rodney; Swisher, Kylie D.; Munyaneza, Joseph E.] ARS, Yakima Agr Res Lab, USDA, Wapato, WA USA; [Sengoda, Venkatesan G.; Henne, Donald C.] Texas A&M AgriLife Res, Subtrop Pest Management Lab, Dept Entomol, Weslaco, TX USA	United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Munyaneza, JE (corresponding author), ARS, Yakima Agr Res Lab, USDA, Wapato, WA USA.	Joseph.Munyaneza@ars.usda.gov	Cooper, William/ABB-1389-2020	Cooper, William/0000-0001-7983-3627	Frito-Lay Inc.; Washington State Potato Commission; USDA-NIFA-RAMP [2009-51101-05892]; USDA-NIFA-SCRI [2009-51181-20176]	Frito-Lay Inc.; Washington State Potato Commission; USDA-NIFA-RAMP; USDA-NIFA-SCRI	Financial support for this research was partially provided by Frito-Lay Inc., Washington State Potato Commission, USDA-NIFA-RAMP (Project #2009-51101-05892) and USDA-NIFA-SCRI (Project #2009-51181-20176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar ED, 2011, J PHYTOPATHOL, V159, P726, DOI 10.1111/j.1439-0434.2011.01836.x; Casteel CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035191; Chapman R. I., 2010, P 10 ANN ZEBR CHIP R, P64; Cooper WR, 2014, ANN ENTOMOL SOC AM, V107, P204, DOI 10.1603/AN13087; Crosslin JM, 2011, SOUTHWEST ENTOMOL, V36, P125, DOI 10.3958/059.036.0202; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Liefting LW, 2008, PLANT DIS, V92, P1474, DOI 10.1094/PDIS-92-10-1474A; Liefting LW, 2009, PLANT DIS, V93, P208, DOI 10.1094/PDIS-93-3-0208; Lin H, 2012, EUR J PLANT PATHOL, V132, P297, DOI 10.1007/s10658-011-9874-3; Marzachi C, 2005, MOL BIOTECHNOL, V30, P117, DOI 10.1385/MB:30:2:117; Miles GP, 2010, AM J POTATO RES, V87, P337, DOI 10.1007/s12230-010-9140-9; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; MUNYANEZA JE, 2007, SUBTROPICAL PLANT SC, V59, P30; Munyaneza JE, 2012, AM J POTATO RES, V89, P329, DOI 10.1007/s12230-012-9262-3; Munyaneza JE, 2010, J ECON ENTOMOL, V103, P1060, DOI 10.1603/EC10027; Navarre DA, 2009, AM J POTATO RES, V86, P88, DOI 10.1007/s12230-008-9060-0; Nelson WR, 2011, EUR J PLANT PATHOL, V130, P5, DOI 10.1007/s10658-010-9737-3; Ng JCK, 2006, ANNU REV PHYTOPATHOL, V44, P183, DOI 10.1146/annurev.phyto.44.070505.143325; Pastrik KH, 2000, J PHYTOPATHOL, V148, P619, DOI 10.1046/j.1439-0434.2000.00567.x; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Secor GA, 2009, PLANT DIS, V93, P574, DOI 10.1094/PDIS-93-6-0574; Sengoda VG, 2013, J ECON ENTOMOL, V106, P1964, DOI 10.1603/EC13129; Sengoda VG, 2010, AM J POTATO RES, V87, P41, DOI 10.1007/s12230-009-9115-x; Stokes ME, 2000, CATEGORICAL DATA ANA; Swisher K. D., 2014, J INSECT SC IN PRESS; Swisher KD, 2013, AM J POTATO RES, V90, P570, DOI 10.1007/s12230-013-9330-3; Swisher KD, 2013, ENVIRON ENTOMOL, V42, P381, DOI 10.1603/EN12261; Swisher KD, 2012, ENVIRON ENTOMOL, V41, P1019, DOI 10.1603/EN12066; Wen AM, 2013, AM J POTATO RES, V90, P229, DOI 10.1007/s12230-012-9293-9; Zhang YP, 1998, J VIROL METHODS, V71, P45, DOI 10.1016/S0166-0934(97)00190-0	33	47	48	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93475	10.1371/journal.pone.0093475	http://dx.doi.org/10.1371/journal.pone.0093475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682175	Green Submitted, Green Published, gold			2022-12-25	WOS:000333678100049
J	Xu, X; Lv, QM; Shang, JJ; Pang, ZQ; Zhou, ZZ; Wang, J; Jiang, GH; Tao, Y; Xu, Q; Li, XB; Zhao, XF; Li, SG; Xu, JC; Zhu, LH				Xu, Xiao; Lv, Qiming; Shang, Junjun; Pang, Zhiqian; Zhou, Zhuangzhi; Wang, Jing; Jiang, Guanghuai; Tao, Yong; Xu, Qian; Li, Xiaobing; Zhao, Xianfeng; Li, Shigui; Xu, Jichen; Zhu, Lihuang			Excavation of Pid3 Orthologs with Differential Resistance Spectra to Magnaporthe oryzae in Rice Resource	PLOS ONE			English	Article							BLAST RESISTANCE; NUCLEOTIDE-BINDING; RUFIPOGON GRIFF.; FUNCTIONAL-ANALYSIS; DNA POLYMORPHISM; REPEAT CLASS; GENES; PIK; ALLELE; LOCUS	Twenty-six orthologs of the rice blast resistance gene Pid3 from cultivated varieties and wild rice accessions distributed in different areas were cloned by allele mining. Sequence analysis showed that while each of the orthologous genes from indica varieties and most wild accessions encodes a complete NBS-LRR protein, each of the proteins encoded by those from japonica varieties and few wild rice accessions presents a premature termination. Eleven of the 26 orthologs were selected for blast resistance testing by transforming into the blast susceptible rice variety TP309, respectively. Inoculation of 23 M. oryzae strains collected from diverse regions of China to the respective transgenic plants revealed that 6 Pid3 orthologs showed susceptible to all the tested strains, while the other 5 orthologs showed differential resistance spectra in a gradually spectrum-widen order as Pid3-W3, Pid3-W4, Pid3-I3, Pid3-W5 and Pid3-I1. Amino acid sequences alignment of these orthologs indicated that the sequence diversities between the blast resistance orthologs were mostly located in the LRR domain such as the substitutions of Q694H, D856H, Q896R, D899E etc. However, the differences between the resistance orthologs and the susceptible ones were mostly located in the NBS domain. The present experiments provide an example of that the ortholog evaluation of plant R genes could be an efficient way to expand the rice blast resistance and some other plant disease resistance as well for breeding.	[Xu, Xiao; Xu, Qian; Xu, Jichen] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China; [Xu, Xiao; Lv, Qiming; Zhou, Zhuangzhi; Wang, Jing; Jiang, Guanghuai; Li, Xiaobing; Zhao, Xianfeng; Zhu, Lihuang] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Plant Genom, Beijing, Peoples R China; [Lv, Qiming; Li, Shigui] Sichuan Agr Univ, Rice Res Inst, Chengdu, Peoples R China; [Lv, Qiming] Natl Key Lab Hybrid Rice, Changsha, Hunan, Peoples R China; [Shang, Junjun] Nanchang Univ, Coll Life Sci, Key Lab Mol Biol & Gene Engn, Nanchang, Peoples R China; [Pang, Zhiqian; Tao, Yong] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Sichuan Agricultural University; Nanchang University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Li, SG (corresponding author), Sichuan Agr Univ, Rice Res Inst, Chengdu, Peoples R China.	lishigui@sicau.edu.cn; jcxu282@sina.com; lhzhu@genetics.ac.cn			National Basic Research Program of China [2012CB114005, 2011CB100706]; National Transgenic Research Project [2013ZX08009-001, 2013ZX08009-003]; National High Technology Research and Development Program of China [2012AA101101]; Beijing Natural Science Foundation [5122019]; Bill and Melinda Gates Foundation [51587-24]; Special Fund for Agroscientific Research in the Public Interest [201303007]	National Basic Research Program of China(National Basic Research Program of China); National Transgenic Research Project; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Special Fund for Agroscientific Research in the Public Interest	This work was supported by grants from the National Basic Research Program of China (2012CB114005 and 2011CB100706), the National Transgenic Research Project (2013ZX08009-001, 2013ZX08009-003), the National High Technology Research and Development Program of China (2012AA101101), Beijing Natural Science Foundation (5122019), Bill and Melinda Gates Foundation (51587-24), Special Fund for Agroscientific Research in the Public Interest (201303007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; Chen DH, 1996, PLANT DIS, V80, P52, DOI 10.1094/PD-80-0052; Chen Hong-qi, 2008, Zhongguo Shuidao Kexue, V22, P23; Chen J, 2011, J GENET GENOMICS, V38, P209, DOI 10.1016/j.jgg.2011.03.010; Chen XW, 2011, TRENDS PLANT SCI, V16, P451, DOI 10.1016/j.tplants.2011.04.003; Chen Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002595; Das A, 2012, FUNCT INTEGR GENOMIC, V12, P215, DOI 10.1007/s10142-012-0284-1; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Delteil A, 2010, RICE, V3, P56, DOI 10.1007/s12284-009-9035-x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hayashi K, 2009, PLANT J, V57, P413, DOI 10.1111/j.1365-313X.2008.03694.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hittalmani S, 2000, THEOR APPL GENET, V100, P1121, DOI 10.1007/s001220051395; Hua LX, 2012, THEOR APPL GENET, V125, P1047, DOI 10.1007/s00122-012-1894-7; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Jeon JS, 2003, MOL GENET GENOMICS, V269, P280, DOI 10.1007/s00438-003-0834-2; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jiang Nan, 2012, Journal of Hunan Agricultural University, V38, P506, DOI 10.3724/SP.J.1238.2012.00506; Kanzaki H, 2012, PLANT J, V72, P894, DOI 10.1111/j.1365-313X.2012.05110.x; Koide Y, 2010, PLANT BREEDING, V129, P670, DOI 10.1111/j.1439-0523.2010.01781.x; Kumar GR, 2010, BIOTECHNOL ADV, V28, P451, DOI 10.1016/j.biotechadv.2010.02.007; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu G, 2002, MOL GENET GENOMICS, V267, P472, DOI 10.1007/s00438-002-0677-2; Lv QM, 2013, PHYTOPATHOLOGY, V103, P594, DOI 10.1094/PHYTO-10-12-0260-R; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Rai AK, 2011, J PLANT BIOCHEM BIOT, V20, P55, DOI 10.1007/s13562-010-0026-1; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Ravensdale M, 2011, MOL PLANT PATHOL, V12, P93, DOI 10.1111/j.1364-3703.2010.00657.x; RONALD PC, 1992, MOL GEN GENET, V236, P113, DOI 10.1007/BF00279649; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shang J, 2007, THESIS CHINESE ACAD; Shang JJ, 2009, GENETICS, V182, P1303, DOI 10.1534/genetics.109.102871; Shen JD, 2006, GENETICS, V172, P1243, DOI 10.1534/genetics.105.047290; Shen QH, 2003, PLANT CELL, V15, P732, DOI 10.1105/tpc.009258; Skamnioti P, 2009, TRENDS BIOTECHNOL, V27, P141, DOI 10.1016/j.tibtech.2008.12.002; Sun CQ, 2001, THEOR APPL GENET, V102, P157, DOI 10.1007/s001220051631; Sun CQ, 2002, THEOR APPL GENET, V104, P1335, DOI 10.1007/s00122-002-0878-4; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian F, 2006, THEOR APPL GENET, V112, P570, DOI 10.1007/s00122-005-0165-2; Wang L, 2009, PHYTOPATHOLOGY, V99, P900, DOI 10.1094/PHYTO-99-8-0900; Wang ZX, 1999, PLANT J, V19, P55, DOI 10.1046/j.1365-313X.1999.00498.x; Xiao H, 2003, PLANT MOL BIOL, V52, P957, DOI 10.1023/A:1025401611354; Yang SH, 2008, THEOR APPL GENET, V116, P165, DOI 10.1007/s00122-007-0656-4; Yoshida K, 2009, GENES GENET SYST, V84, P121, DOI 10.1266/ggs.84.121; YU ZH, 1991, THEOR APPL GENET, V81, P471, DOI 10.1007/BF00219436; Yuan B, 2011, THEOR APPL GENET, V122, P1017, DOI 10.1007/s00122-010-1506-3; Zhai C, 2011, NEW PHYTOL, V189, P321, DOI 10.1111/j.1469-8137.2010.03462.x; Zhou B, 2006, MOL PLANT MICROBE IN, V19, P1216, DOI 10.1094/MPMI-19-1216; Zhu XY, 2012, THEOR APPL GENET, V124, P1295, DOI 10.1007/s00122-012-1787-9	50	18	24	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93275	10.1371/journal.pone.0093275	http://dx.doi.org/10.1371/journal.pone.0093275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681716	Green Published, gold, Green Submitted			2022-12-25	WOS:000333678100038
J	Auer, R; Gencer, B; Raber, L; Klingenberg, R; Carballo, S; Carballo, D; Nanchen, D; Cornuz, J; Vader, JP; Vogt, P; Juni, P; Matter, CM; Windecker, S; Luscher, TF; Mach, F; Rodondi, N				Auer, Reto; Gencer, Baris; Raeber, Lorenz; Klingenberg, Roland; Carballo, Sebastian; Carballo, David; Nanchen, David; Cornuz, Jacques; Vader, John-Paul; Vogt, Pierre; Jueni, Peter; Matter, Christian M.; Windecker, Stephan; Luescher, Thomas Felix; Mach, Francois; Rodondi, Nicolas			Quality of Care after Acute Coronary Syndromes in a Prospective Cohort with Reasons for Non-Prescription of Recommended Medications	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ST-ELEVATION; GLOBAL REGISTRY; HEART-DISEASE; ASSOCIATION; MANAGEMENT; HOSPITALS; OUTCOMES; THERAPY	Background: Adherence to guidelines is associated with improved outcomes of patients with acute coronary syndrome (ACS). Clinical registries developed to assess quality of care at discharge often do not collect the reasons for nonprescription for proven efficacious preventive medication in Continental Europe. In a prospective cohort of patients hospitalized for an ACS, we aimed at measuring the rate of recommended treatment at discharge, using pre-specified quality indicators recommended in cardiologic guidelines and including systematic collection of reasons for nonprescription for preventive medications. Methods: In a prospective cohort with 1260 patients hospitalized for ACS, we measured the rate of recommended treatment at discharge in 4 academic centers in Switzerland. Performance measures for medication at discharge were pre-specified according to guidelines, systematically collected for all patients and included in a centralized database. Results: Six hundred and eighty eight patients(54.6%) were discharged with a main diagnosis of STEMI, 491(39%) of NSTEMI and 81(6.4%) of unstable angina. Mean age was 64 years and 21.3% were women. 94.6% were prescribed angiotensin converting enzyme inhibitors/angiotensin II receptor blockers at discharge when only considering raw prescription rates, but increased to 99.5% when including reasons non-prescription. For statins, rates increased from 98% to 98.6% when including reasons for non-prescription and for beta-blockers, from 82% to 93%. For aspirin, rates further increased from 99.4% to 100% and from to 99.8% to 100% for P2Y12 inhibitors. Conclusions: We found a very high adherence to ACS guidelines for drug prescriptions at discharge when including reasons for non-prescription to drug therapy. For beta-blockers, prescription rates were suboptimal, even after taking into account reason for non-prescription. In an era of improving quality of care to achieve 100% prescription rates at discharge unless contra-indicated, pre-specification of reasons for non-prescription for cardiovascular preventive medication permits to identify remaining gaps in quality of care at discharge.	[Auer, Reto] UCSF, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Gencer, Baris; Carballo, David; Mach, Francois] Univ Hosp Geneva, Fac Med, Div Cardiol, Geneva, Switzerland; [Raeber, Lorenz; Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Klingenberg, Roland; Matter, Christian M.; Luescher, Thomas Felix] Univ Zurich Hosp, Dept Cardiol, CH-8091 Zurich, Switzerland; [Carballo, Sebastian] Univ Hosp Geneva, Fac Med, Div Internal Med, Geneva, Switzerland; [Nanchen, David; Cornuz, Jacques] Univ Lausanne, Dept Ambulatory & Community Med, Lausanne, Switzerland; [Vader, John-Paul] Univ Lausanne, Inst Social & Prevent Med, Lausanne, Switzerland; [Vogt, Pierre] Univ Lausanne Hosp, Dept Cardiol, Lausanne, Switzerland; [Jueni, Peter] Univ Bern, Dept Clin Res, Inst Social & Prevent Med, Bern, Switzerland; [Jueni, Peter] Univ Bern, Dept Clin Res, Clin Trials Unit, Bern, Switzerland; [Rodondi, Nicolas] Univ Hosp Bern, Dept Gen Internal Med, CH-3010 Bern, Switzerland	University of California System; University of California San Francisco; University of Geneva; University of Bern; University Hospital of Bern; University of Zurich; University Zurich Hospital; University of Geneva; University of Lausanne; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University of Bern; University of Bern; University Hospital of Bern	Auer, R (corresponding author), UCSF, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	reto.auer@ucsf.edu	Juni, Peter/Q-8700-2016; Nanchen, David/AAQ-1118-2021; Gencer, Baris/AAO-2305-2020	Juni, Peter/0000-0002-5985-0670; Nanchen, David/0000-0002-2493-3505; Auer, Reto/0000-0003-4222-4849; Rodondi, Nicolas/0000-0001-9083-6896; Gencer, Baris/0000-0002-8954-9694	Swiss National Science Foundation [SNSF 33CM30-124112, PBLAP3-136774]; Inflammation and acute coronary syndromes (ACS) - Novel strategies for prevention and clinical management; Department of University Medicine and Community Care (DUMSC) of the University of Lausanne, Switzerland; Swiss Heart Foundation; Societe Academique Vaudoise and the SICPA Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Inflammation and acute coronary syndromes (ACS) - Novel strategies for prevention and clinical management; Department of University Medicine and Community Care (DUMSC) of the University of Lausanne, Switzerland; Swiss Heart Foundation; Societe Academique Vaudoise and the SICPA Foundation	The SPUM-ACS cohort is supported by the Swiss National Science Foundation (SNSF 33CM30-124112, Inflammation and acute coronary syndromes (ACS) - Novel strategies for prevention and clinical management). The specific report on quality of care at discharge is supported by a grant from the Department of University Medicine and Community Care (DUMSC) of the University of Lausanne, Switzerland and the Swiss Heart Foundation. The authors acknowledge the cooperation of all participating centers, practicing physicians, referring doctors and institutions. Dr. Auer and Dr Rodondi's research on cardiovascular prevention is supported by grants from the Swiss Heart Foundation. Dr Auer's research on cardiovascular prevention is additionally supported by a grant for prospective researchers from the Swiss National Science Foundation PBLAP3-136774, the Societe Academique Vaudoise and the SICPA Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KP, 2006, EUR HEART J, V27, P1558, DOI 10.1093/eurheartj/ehl067; [Anonymous], HEDIS HLTH PLAN EMPL; Avezum A, 2005, AM HEART J, V149, P67, DOI 10.1016/j.ahj.2004.06.003; Bajaj RR, 2013, AM J CARDIOL, V111, P202, DOI 10.1016/j.amjcard.2012.09.018; Belle L, 2012, AM J MED, V125, P365, DOI 10.1016/j.amjmed.2011.11.015; Butler J, 2002, J AM COLL CARDIOL, V40, P1589, DOI 10.1016/S0735-1097(02)02379-3; Carballo David, 2010, Rev Med Suisse, V6, P520; Ferrieres J, 2009, ATHEROSCLEROSIS, V204, P491, DOI 10.1016/j.atherosclerosis.2008.09.031; Fiore MC, 2012, NEW ENGL J MED, V366, P1172, DOI 10.1056/NEJMp1115176; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Krumholz HM, 2008, CIRCULATION, V118, P2596, DOI 10.1161/CIRCULATIONAHA.108.191099; Levy DE, 2011, ARCH INTERN MED, V171, P1682, DOI 10.1001/archinternmed.2011.451; Luthi JC, 2005, INT J QUAL HEALTH C, V17, P229, DOI 10.1093/intqhc/mzi024; Luthi JC, 2002, SWISS MED WKLY, V132, P461; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; Matter CM, 2010, KARDIOVASKULARE MED, V13, P31; McManus DD, 2011, AM J MED, V124, P40, DOI 10.1016/j.amjmed.2010.07.023; Peterson ED, 2010, HEART, V96, P1798, DOI 10.1136/hrt.2010.200261; Radovanovic D, 2012, EUROPEAN HEART J ACU; Radovanovic D, 2010, SWISS MED WKLY, V140, P314, DOI smw-12986; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Setoguchi S, 2008, J AM COLL CARDIOL, V51, P1247, DOI 10.1016/j.jacc.2007.10.063; Smith CS, 2005, AM HEART J, V149, P444, DOI 10.1016/j.ahj.2004.06.033; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Wieser S, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13655; Zeymer U, 2012, EUR J PREV CARDIOL	28	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93147	10.1371/journal.pone.0093147	http://dx.doi.org/10.1371/journal.pone.0093147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676282	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000333677500082
J	Chen, R; Robinson, A; Chung, SH				Chen, Rong; Robinson, Anna; Chung, Shin-Ho			Mechanism of mu-Conotoxin PIIIA Binding to the Voltage-Gated Na+ Channel Na(V)1.4	PLOS ONE			English	Article							RESISTANT SODIUM-CHANNELS; SOLUTION NMR STRUCTURE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; OUTER VESTIBULE; SKELETAL-MUSCLE; VENOM PEPTIDES; ION CHANNELS; FREE-ENERGY; GIIIA	Several subtypes of voltage-gated Na+ (Na-V) channels are important targets for pain management. mu-Conotoxins isolated from venoms of cone snails are potent and specific blockers of different Na-V channel isoforms. The inhibitory effect of mu-conotoxins on Na-V channels has been examined extensively, but the mechanism of toxin specificity has not been understood in detail. Here the known structure of m-conotoxin PIIIA and a model of the skeletal muscle channel Na(V)1.4 are used to elucidate elements that contribute to the structural basis of m-conotoxin binding and specificity. The model of Na(V)1.4 is constructed based on the crystal structure of the bacterial Na-V channel, Na(V)Ab. Six different binding modes, in which the side chain of each of the basic residues carried by the toxin protrudes into the selectivity filter of Na(V)1.4, are examined in atomic detail using molecular dynamics simulations with explicit solvent. The dissociation constants (K-d) computed for two selected binding modes in which Lys9 or Arg14 from the toxin protrudes into the filter of the channel are within 2 fold; both values in close proximity to those determined from dose response data for the block of Na-V currents. To explore the mechanism of PIIIA specificity, a double mutant of Na(V)1.4 mimicking Na-V channels resistant to m-conotoxins and tetrodotoxin is constructed and the binding of PIIIA to this mutant channel examined. The double mutation causes the affinity of PIIIA to reduce by two orders of magnitude.	[Chen, Rong; Robinson, Anna; Chung, Shin-Ho] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	Australian National University	Chen, R (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	rong.chen@anu.edu.au			Australian Commonwealth Government; National Health and Medical Research Council of Australia; Medical Advances Without Animals Trust (MAWA)	Australian Commonwealth Government(Australian Government); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Medical Advances Without Animals Trust (MAWA)	This research was undertaken on the National Computational Infrastructure in Canberra, Australia, which is supported by the Australian Commonwealth Government. This work was supported by the National Health and Medical Research Council of Australia and The Medical Advances Without Animals Trust (MAWA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriel H, 2007, CARDIOVASC RES, V76, P381, DOI 10.1016/j.cardiores.2007.07.019; ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025; BECKER S, 1992, BIOCHEMISTRY-US, V31, P8229, DOI 10.1021/bi00150a016; Bulaj G, 2005, BIOCHEMISTRY-US, V44, P7259, DOI 10.1021/bi0473408; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chagot B, 2011, J MOL BIOL, V406, P106, DOI 10.1016/j.jmb.2010.11.046; Chagot B, 2009, J BIOL CHEM, V284, P6436, DOI 10.1074/jbc.M807747200; Chen R, 2013, BIOCHEMISTRY-US, V52, P3765, DOI 10.1021/bi4003327; Chen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047253; Chen R, 2012, BIOPHYS J, V102, P483, DOI 10.1016/j.bpj.2011.12.041; Choudhary G, 2007, CHANNELS, V1, P344, DOI 10.4161/chan.5112; Cummins TR, 2002, MOL PHARMACOL, V61, P1192, DOI 10.1124/mol.61.5.1192; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dudley SC, 2000, J GEN PHYSIOL, V116, P679, DOI 10.1085/jgp.116.5.679; Eriksson MAL, 2002, BIOPHYS J, V83, P2595, DOI 10.1016/S0006-3495(02)75270-3; Fallon JL, 2009, P NATL ACAD SCI USA, V106, P5135, DOI 10.1073/pnas.0807487106; Gordon D, 2013, PHYSIOL REV, V93, P767, DOI 10.1152/physrev.00035.2012; Hui KY, 2003, J GEN PHYSIOL, V122, P63, DOI 10.1085/jgp.200308842; Hui KY, 2002, J GEN PHYSIOL, V119, P45, DOI 10.1085/jgp.119.1.45; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khoo KK, 2011, J MED CHEM, V54, P7558, DOI 10.1021/jm200839a; Khoo KK, 2009, BIOCHEMISTRY-US, V48, P1210, DOI 10.1021/bi801998a; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Knapp O, 2012, TOXINS, V4, P1236, DOI 10.3390/toxins4111236; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Lee CH, 2008, CHANNELS, V2, P407, DOI 10.4161/chan.2.6.7429; Leipold E, 2011, NEUROPHARMACOLOGY, V61, P105, DOI 10.1016/j.neuropharm.2011.03.008; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Li RA, 2003, J BIOL CHEM, V278, P8717, DOI 10.1074/jbc.M210882200; Li RA, 2001, J BIOL CHEM, V276, P11072, DOI 10.1074/jbc.M010862200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McArthur JR, 2011, MOL PHARMACOL, V80, P573, DOI 10.1124/mol.111.073460; McArthur JR, 2011, MOL PHARMACOL, V80, P219, DOI 10.1124/mol.111.071779; McArthur JR, 2011, BIOCHEMISTRY-US, V50, P116, DOI 10.1021/bi101316y; Mills JEJ, 1996, J COMPUT AID MOL DES, V10, P607, DOI 10.1007/BF00134183; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nielsen KJ, 2002, J BIOL CHEM, V277, P27247, DOI 10.1074/jbc.M201611200; Norton RS, 2010, MOLECULES, V15, P2825, DOI 10.3390/molecules15042825; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rashid MH, 2013, MAR DRUGS, V11, P848, DOI 10.3390/md11030848; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; SATO K, 1991, J BIOL CHEM, V266, P16989; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shon KJ, 1998, J NEUROSCI, V18, P4473; Smith JJ, 2013, CELL MOL LIFE SCI, V70, P3665, DOI 10.1007/s00018-013-1315-3; Stevens M, 2012, J BIOL CHEM, V287, P31382, DOI 10.1074/jbc.M112.375733; Stevens M, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00071; Tietze AA, 2012, ANGEW CHEM INT EDIT, V51, P4058, DOI 10.1002/anie.201107011; Tikhonov DB, 2012, MOL PHARMACOL, V82, P97, DOI 10.1124/mol.112.078212; WAKAMATSU K, 1992, BIOCHEMISTRY-US, V31, P12577, DOI 10.1021/bi00165a006; West PJ, 2002, BIOCHEMISTRY-US, V41, P15388, DOI 10.1021/bi0265628; Wilson M, 2011, J PETROL, V52, P1, DOI 10.1093/petrology/egq092; Wimley WC, 1996, P NATL ACAD SCI USA, V93, P2985, DOI 10.1073/pnas.93.7.2985; Xia MD, 2013, BIOPHYS J, V104, P2401, DOI 10.1016/j.bpj.2013.04.035; Zhang MM, 2007, J BIOL CHEM, V282, P30699, DOI 10.1074/jbc.M704616200; Zhang MM, 2010, J NEUROPHYSIOL, V104, P88, DOI 10.1152/jn.00145.2010; Zhang MM, 2010, BIOCHEMISTRY-US, V49, P4804, DOI 10.1021/bi100207k; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	62	34	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93267	10.1371/journal.pone.0093267	http://dx.doi.org/10.1371/journal.pone.0093267			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676211	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500100
J	Kumar, B; Yadav, A; Hideg, K; Kuppusamy, P; Teknos, TN; Kumar, P				Kumar, Bhavna; Yadav, Arti; Hideg, Kalman; Kuppusamy, Periannan; Teknos, Theodoros N.; Kumar, Pawan			A Novel Curcumin Analog (H-4073) Enhances the Therapeutic Efficacy of Cisplatin Treatment in Head and Neck Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; SIGNALING INDUCES APOPTOSIS; CONSTITUTIVE ACTIVATION; ANTICANCER EFFICACY; PROSTATE-CANCER; IN-VIVO; STAT3; EXPRESSION; RESISTANCE; SURVIVAL	Chemotherapy constitutes the standard modality of treatment for localized head and neck squamous cell carcinomas (HNSCC). However, many patients fail to respond and relapse after this treatments due to the acquisition of chemoresistance. Therefore, there is an urgent need to develop novel drugs that could reverse the resistant phenotype. Curcumin, the constituent of the spice turmeric has been shown to have anti-inflammatory, anti-oxidant and anti-proliferative properties in several tumor types. However, use of curcumin has been limited due to its poor bio-absorption. Recently, a novel class of curcumin analogs, based on diarylidenylpiperidones (DAP), has been developed by incorporating a piperidone link to the beta-diketone structure and fluoro substitutions on the phenyl groups. In this study, we evaluated the effectiveness of H-4073, a parafluorinated variant of DAP, using both in vitro and in vivo head and neck cancer models. Our results demonstrate that H-4073 is a potent anti-tumor agent and it significantly inhibited cell proliferation in all the HNSCC cell lines tested in a dose-dependent manner. In addition, pretreatment of cisplatin-resistant HNSCC cell lines with H-4073 significantly reversed the chemo-resistance as observed by cell viability assay (MTT), apoptosis assay (Annexin V binding) and cleaved caspase-3 (Western blot). H-4073 mediated its anti-tumor effects by inhibiting JAK/STAT3, FAK, Akt and VEGF signaling pathways that play important roles in cell proliferation, migration, survival and angiogenesis. In the SCID mouse xenograft model, H-4073 significantly enhanced the anti-tumor and anti-angiogenesis effects of cisplatin, with no added systemic toxicity. Interestingly, H-4073 inhibited tumor angiogenesis by blocking VEGF production by tumor cells as well as directly inhibiting endothelial cell function. Taken together, our results suggest that H-4073 is a potent anti-tumor agent and it can be used to overcome chemotherapy resistance in HNSCC.	[Kumar, Bhavna; Teknos, Theodoros N.; Kumar, Pawan] Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA; [Kumar, Bhavna; Yadav, Arti; Teknos, Theodoros N.; Kumar, Pawan] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Hideg, Kalman] Univ Pecs, Inst Organ & Med Chem, Pecs, Hungary; [Kuppusamy, Periannan] Geisel Sch Med, Hanover, NH USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Pecs; Dartmouth College	Teknos, TN (corresponding author), Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA.	Ted.Teknos@osumc.edu; Pawan.Kumar@osumc.edu			National Institutes of Health [NIH/NCI-CA133250]; Joan's Fund Research Grant; Experimental therapeutics seed grant from The Ohio State University Comprehensive Cancer Center; Arthur G. James Cancer Hospital; Richard J. Solove Research Institute; NATIONAL CANCER INSTITUTE [K12CA133250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joan's Fund Research Grant; Experimental therapeutics seed grant from The Ohio State University Comprehensive Cancer Center; Arthur G. James Cancer Hospital; Richard J. Solove Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health (NIH/NCI-CA133250, P. Kumar), Joan's Fund Research Grant (BK P. Kumar), Experimental therapeutics seed grant from The Ohio State University Comprehensive Cancer Center (P. Kumar), Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (TT, P. Kumar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez James V, 2007, Transl Oncogenomics, V2, P99; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Azare J, 2007, MOL CELL BIOL, V27, P4444, DOI 10.1128/MCB.02404-06; Barton BE, 2004, MOL CANCER THER, V3, P11; Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Bradford CR, 2003, HEAD NECK-J SCI SPEC, V25, P654, DOI 10.1002/hed.10274; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Carden CP, 2012, MOL CANC THERAPEUTIC; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; DIMERY IW, 1993, JNCI-J NATL CANCER I, V85, P95, DOI 10.1093/jnci/85.2.95; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Girouard J, 2013, GYNECOL ONCOL, V128, P335, DOI 10.1016/j.ygyno.2012.11.016; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Gu F, 2010, ONCOL REP, V23, P671, DOI 10.3892/or_00000683; Gupta AK, 2003, INT J RADIAT ONCOL, V56, P846, DOI 10.1016/S0360-3016(03)00214-1; Haura EB, 2005, CLIN CANCER RES, V11, P8288, DOI 10.1158/1078-0432.CCR-05-0827; Huang SL, 2012, CANCER LETT, V315, P198, DOI 10.1016/j.canlet.2011.10.011; Jun HJ, 2008, BRIT J CANCER, V99, P167, DOI 10.1038/sj.bjc.6604464; Kalavrezos N, 2010, ORAL ONCOL, V46, P429, DOI 10.1016/j.oraloncology.2010.03.007; Kim DY, 2009, J GASTROEN HEPATOL, V24, P646, DOI 10.1111/j.1440-1746.2008.05671.x; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Kumar B, 2012, MOL CANCER THER, V11, P1988, DOI 10.1158/1535-7163.MCT-12-0167; Kumar P, 2008, MOL CANCER THER, V7, P2060, DOI 10.1158/1535-7163.MCT-08-0287; Lai SY, 2010, DRUG RESIST UPDATE, V13, P67, DOI 10.1016/j.drup.2010.04.001; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Marur S, 2008, MAYO CLIN PROC, V83, P489, DOI 10.4065/83.4.489; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mora LB, 2002, CANCER RES, V62, P6659; Nisi KW, 1998, INT J RADIAT ONCOL, V41, P371, DOI 10.1016/S0360-3016(98)00059-5; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Schlessinger K, 2005, CANCER RES, V65, P5828, DOI 10.1158/0008-5472.CAN-05-0317; Selvendiran K, 2010, MOL CANCER THER, V9, P1169, DOI 10.1158/1535-7163.MCT-09-1207; Selvendiran K, 2010, FREE RADICAL BIO MED, V48, P1228, DOI 10.1016/j.freeradbiomed.2010.02.009; Sen M, 2012, CLIN CANCER RES, V18, P4986, DOI 10.1158/1078-0432.CCR-12-0792; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sturgis EM, 2004, SEMIN ONCOL, V31, P726, DOI 10.1053/j.seminoncol.2004.09.013; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; Takemoto S, 2009, BRIT J CANCER, V101, P967, DOI 10.1038/sj.bjc.6605212; WATSON CJ, 1995, BRIT J CANCER, V71, P840, DOI 10.1038/bjc.1995.162; Worden FP, 2008, J CLIN ONCOL, V26, P3138, DOI 10.1200/JCO.2007.12.7597; Yadav A, 2011, MOL CANC TH IN PRESS; Yadav A, 2011, MOL CANC RES; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang XL, 2007, ONCOL REP, V17, P1377; Zhao M, 2011, LUNG CANCER, V73, P366, DOI 10.1016/j.lungcan.2011.01.002	51	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93208	10.1371/journal.pone.0093208	http://dx.doi.org/10.1371/journal.pone.0093208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675768	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677500089
J	Buhnerkempe, MG; Tildesley, MJ; Lindstrom, T; Grear, DA; Portacci, K; Miller, RS; Lombard, JE; Werkman, M; Keeling, MJ; Wennergren, U; Webb, CT				Buhnerkempe, Michael G.; Tildesley, Michael J.; Lindstrom, Tom; Grear, Daniel A.; Portacci, Katie; Miller, Ryan S.; Lombard, Jason E.; Werkman, Marleen; Keeling, Matt J.; Wennergren, Uno; Webb, Colleen T.			The Impact of Movements and Animal Density on Continental Scale Cattle Disease Outbreaks in the United States	PLOS ONE			English	Article							MOUTH-DISEASE; 2001 FOOT; VACCINATION STRATEGIES; LIVESTOCK MOVEMENTS; SIMULATION-MODEL; GREAT-BRITAIN; EPIDEMIC; DYNAMICS; NETWORK; SPREAD	Globalization has increased the potential for the introduction and spread of novel pathogens over large spatial scales necessitating continental-scale disease models to guide emergency preparedness. Livestock disease spread models, such as those for the 2001 foot-and-mouth disease (FMD) epidemic in the United Kingdom, represent some of the best case studies of large-scale disease spread. However, generalization of these models to explore disease outcomes in other systems, such as the United States's cattle industry, has been hampered by differences in system size and complexity and the absence of suitable livestock movement data. Here, a unique database of US cattle shipments allows estimation of synthetic movement networks that inform a near-continental scale disease model of a potential FMD-like (i.e., rapidly spreading) epidemic in US cattle. The largest epidemics may affect over one-third of the US and 120,000 cattle premises, but cattle movement restrictions from infected counties, as opposed to national movement moratoriums, are found to effectively contain outbreaks. Slow detection or weak compliance may necessitate more severe state-level bans for similar control. Such results highlight the role of large-scale disease models in emergency preparedness, particularly for systems lacking comprehensive movement and outbreak data, and the need to rapidly implement multi-scale contingency plans during a potential US outbreak.	[Buhnerkempe, Michael G.; Grear, Daniel A.; Webb, Colleen T.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Tildesley, Michael J.; Werkman, Marleen; Keeling, Matt J.] Univ Warwick, Math Inst, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England; [Lindstrom, Tom; Wennergren, Uno] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Portacci, Katie; Miller, Ryan S.; Lombard, Jason E.] US Anim & Plant Hlth Inspect Serv, USDA, Ctr Epidemiol, Ft Collins, CO USA; [Portacci, Katie; Miller, Ryan S.; Lombard, Jason E.] US Anim & Plant Hlth Inspect Serv, USDA, Ctr Anim Hlth, Ft Collins, CO USA	Colorado State University; University of Warwick; Linkoping University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Buhnerkempe, MG (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.	michael.buhnerkempe@gmail.com	Buhnerkempe, Michael G./N-2411-2019; Miller, Ryan/H-9848-2019; Keeling, Matt J/J-9280-2012; Lindström, Tom/AAX-6492-2020	Buhnerkempe, Michael G./0000-0002-5996-8927; Miller, Ryan/0000-0003-3892-0251; Keeling, Matt J/0000-0003-4639-4765; Werkman, Marleen/0000-0002-2252-9357; Tildesley, Michael/0000-0002-6875-7232; Grear, Daniel/0000-0002-5478-1549	Research and Policy for Infectious Disease Dynamics (RAPIDD) Program, Science and Technology Directorate, US Department of Homeland Security, and Fogarty International Center, National Institutes of Health; Foreign Animal Disease Modeling Program, Science and Technology Directorate, US Department of Homeland Security [ST-108-000017]; USDA [11-9208-0269-CA 11-1, 09-9208-0235-CA]	Research and Policy for Infectious Disease Dynamics (RAPIDD) Program, Science and Technology Directorate, US Department of Homeland Security, and Fogarty International Center, National Institutes of Health; Foreign Animal Disease Modeling Program, Science and Technology Directorate, US Department of Homeland Security; USDA(United States Department of Agriculture (USDA))	Funding provided by the Research and Policy for Infectious Disease Dynamics (RAPIDD) Program, Science and Technology Directorate, US Department of Homeland Security, and Fogarty International Center, National Institutes of Health; Foreign Animal Disease Modeling Program, Science and Technology Directorate, US Department of Homeland Security (Grant ST-108-000017); and USDA Cooperative Agreements 11-9208-0269-CA 11-1 and 09-9208-0235-CA. Data included in this analysis were provided by the US Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services. However, the views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of USDA-APHIS-Veterinary Services or the US Department of Homeland Security. The authors also acknowledge the National Institute for Mathematical and Biological Synthesis for supporting the Modeling Bovine Tuberculosis working group, where the initial ideas for using ICVI data were developed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajardi P, 2012, J R SOC INTERFACE, V9, P2814, DOI 10.1098/rsif.2012.0289; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019869; Bates TW, 2003, AM J VET RES, V64, P195, DOI 10.2460/ajvr.2003.64.195; Buhnerkempe MG, 2013, PREV VET MED, V112, P318, DOI 10.1016/j.prevetmed.2013.08.002; Csardi N., 2006, INT J COMP SYST, V1695, P1; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Green DM, 2006, P ROY SOC B-BIOL SCI, V273, P2729, DOI 10.1098/rspb.2006.3648; Harvey N, 2007, PREV VET MED, V82, P176, DOI 10.1016/j.prevetmed.2007.05.019; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; Lindstrom T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053432; Lindstrom T, 2012, J R SOC INTERFACE, V9, P1287, DOI 10.1098/rsif.2011.0625; National Agricultural Statistics Service, 2007, CENS AGR; National Agricultural Statistics Service US Department of Agriculture, 2012, QUICK STATS; National Research Council, 2012, EV UPD SIT SPEC RISK; National Research Council, 2010, EV SIT SPEC RISK ASS; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; Ovaskainen O, 2002, AM NAT, V160, P612, DOI 10.1086/342818; Ovaskainen O, 2001, THEOR POPUL BIOL, V60, P281, DOI 10.1006/tpbi.2001.1548; Portacci K, 2013, JAVMA-J AM VET MED A, V243, P555, DOI 10.2460/javma.243.4.555; R Development Core Team, 2012, R LANG ENV STAT COMP; Robinson SE, 2007, J R SOC INTERFACE, V4, P669, DOI 10.1098/rsif.2007.0214; SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B; Shields DA, 2003, LDPM10801 USDA ERS; Smith DL, 2002, P NATL ACAD SCI USA, V99, P3668, DOI [10.1073/pnas.042400799, 10.1073/pnas.132272199]; Speck DE, 2008, LLNLTR404724 US DEP; Ster IC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000502; Ster IC, 2009, EPIDEMICS-NETH, V1, P21, DOI 10.1016/j.epidem.2008.09.001; Thompson D, 2002, REV SCI TECH OIE, V21, P675, DOI 10.20506/rst.21.3.1353; Tildesley MJ, 2008, P ROY SOC B-BIOL SCI, V275, P1459, DOI 10.1098/rspb.2008.0006; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324; United States Department of Agriculture (USDA), 2008, DAIRY 2007 2; US Department of Agriculture, 2011, 5960411 USDAAPHISVS; Vernon MC, 2012, PREV VET MED, V105, P110, DOI 10.1016/j.prevetmed.2011.12.016; Yang PC, 1999, VET REC, V145, P731, DOI 10.1136/vr.145.25.731	39	51	51	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91724	10.1371/journal.pone.0091724	http://dx.doi.org/10.1371/journal.pone.0091724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670977	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000026
J	Grossl, T; Hammer, E; Bien-Moller, S; Geisler, A; Pinkert, S; Roger, C; Poller, W; Kurreck, J; Volker, U; Vetter, R; Fechner, H				Groessl, Tobias; Hammer, Elke; Bien-Moeller, Sandra; Geisler, Anja; Pinkert, Sandra; Roeger, Carsten; Poller, Wolfgang; Kurreck, Jens; Voelker, Uwe; Vetter, Roland; Fechner, Henry			A Novel Artificial MicroRNA Expressing AAV Vector for Phospholamban Silencing in Cardiomyocytes Improves Ca2+ Uptake into the Sarcoplasmic Reticulum.	PLOS ONE			English	Article							CARDIAC GENE-TRANSFER; SHORT HAIRPIN RNA; HEART-FAILURE; DILATED CARDIOMYOPATHY; TRANSGENE EXPRESSION; INTERFERON RESPONSE; COXSACKIEVIRUS B3; MAMMALIAN-CELLS; FAILING HEART; KNOCKDOWN	In failing rat hearts, post-transcriptonal inhibition of phospholamban (PLB) expression by AAV9 vector-mediated cardiac delivery of short hairpin RNAs directed against PLB (shPLBr) improves both impaired SERCA2a controlled Ca2+ cycling and contractile dysfunction. Cardiac delivery of shPLB, however, was reported to cause cardiac toxicity in canines. Thus we developed a new AAV vector, scAAV6-amiR155-PLBr, expressing a novel engineered artificial microRNA (amiR155-PLBr) directed against PLB under control of a heart-specific hybrid promoter. Its PLB silencing efficiency and safety were compared with those of an AAV vector expressing shPLBr (scAAV6-shPLBr) from an ubiquitously active U6 promoter. Investigations were carried out in cultured neonatal rat cardiomyocytes (CM) over a period of 14 days. Compared to shPLBr, amiR155-PLBr was expressed at a significantly lower level, resulting in delayed and less pronounced PLB silencing. Despite decreased knockdown efficiency of scAAV6-amiR155-PLBr, a similar increase of the SERCA2a-catalyzed Ca2+ uptake into sarcoplasmic reticulum (SR) vesicles was observed for both the shPLBr and amiR155-PLBr vectors. Proteomic analysis confirmed PLB silencing of both therapeutic vectors and revealed that shPLBr, but not the amiR155-PLBr vector, increased the proinflammatory proteins STAT3, STAT1 and activated STAT1 phosphorylation at the key amino acid residue Tyr701. Quantitative RT-PCR analysis detected alterations in the expression of several cardiac microRNAs after treatment of CM with scAAV6-shPLBr and scAAV6-amiR155-PLBr, as well as after treatment with its related amiR155- and shRNAs-expressing control AAV vectors. The results demonstrate that scAAV6-amiR155-PLBr is capable of enhancing the Ca2+ transport function of the cardiac SR PLB/SERCA2a system as efficiently as scAAV6-shPLBr while offering a superior safety profile.	[Groessl, Tobias; Geisler, Anja; Pinkert, Sandra; Roeger, Carsten; Kurreck, Jens; Fechner, Henry] Tech Univ Berlin, Inst Biotechnol, Dept Appl Biochem, Berlin, Germany; [Hammer, Elke; Voelker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Bien-Moeller, Sandra] Univ Med Greifswald, Ctr Drug Absorpt & Transport, Dept Pharmacol, Greifswald, Germany; [Poller, Wolfgang] Charite, Dept Cardiol & Pneumol, D-13353 Berlin, Germany; [Vetter, Roland] Charite, Inst Clin Pharmacol & Toxicol, Campus Charite Mitte, D-13353 Berlin, Germany	Technical University of Berlin; Greifswald Medical School; Greifswald Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Fechner, H (corresponding author), Tech Univ Berlin, Inst Biotechnol, Dept Appl Biochem, Berlin, Germany.	henry.fechner@tu-berlin.de	Poller, Wolfgang/AAB-2185-2021; Kurreck, Jens/B-7785-2008	Kurreck, Jens/0000-0002-1469-0052; Volker, Uwe/0000-0002-5689-3448; Poller, Wolfgang/0000-0002-2805-6634; Hammer, Elke/0000-0002-1507-0402	Deutsche Forschungsgemeinschaft through SFB Transregio 19	Deutsche Forschungsgemeinschaft through SFB Transregio 19	This work was supported by the Deutsche Forschungsgemeinschaft through SFB Transregio 19 project grants to HF UV and RV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andino LM, 2008, J GENE MED, V10, P132, DOI 10.1002/jgm.1131; Bish LT, 2011, HUM GENE THER, V22, P969, DOI 10.1089/hum.2011.035; Boden D, 2004, NUCLEIC ACIDS RES, V32, P1154, DOI 10.1093/nar/gkh278; Borel Florie, 2011, J RNAi Gene Silencing, V7, P434; Boudreau RL, 2008, RNA, V14, P1834, DOI 10.1261/rna.1062908; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cernohorsky J, 1998, AM J PHYSIOL-HEART C, V275, pH264, DOI 10.1152/ajpheart.1998.275.1.H264; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; del Monte F, 2001, CIRCULATION, V104, P1424, DOI 10.1161/hc3601.095574; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dieterle T, 2005, CARDIOVASC RES, V67, P678, DOI 10.1016/j.cardiores.2005.04.029; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fechner H, 2007, GENE THER, V14, P960, DOI 10.1038/sj.gt.3302948; Fechner H, 2007, GENE THER, V14, P211, DOI 10.1038/sj.gt.3302872; Fechner H, 2008, J MOL MED, V86, P987, DOI 10.1007/s00109-008-0363-x; Fechner H, 2011, MOLECULES, V16, P8475, DOI 10.3390/molecules16108475; Geisler A, 2011, GENE THER, V18, P199, DOI 10.1038/gt.2010.141; Giering JC, 2008, MOL THER, V16, P1630, DOI 10.1038/mt.2008.144; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hadri L, 2011, CLIN PHARMACOL THER, V90, P620, DOI 10.1038/clpt.2011.161; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Hammer E, 2011, J PROTEOME RES, V10, P2161, DOI 10.1021/pr1008042; Huang Z, 2012, LIFE SCI, V91, P1207, DOI 10.1016/j.lfs.2012.09.015; Hulot JS, 2012, GENE THER, V19, P596, DOI 10.1038/gt.2012.34; Hutson TH, 2012, J GENE MED, V14, P299, DOI 10.1002/jgm.2626; Iwanaga Y, 2004, J CLIN INVEST, V113, P727, DOI 10.1172/JCI200418716; Kawase Y, 2008, J AM COLL CARDIOL, V51, P1112, DOI 10.1016/j.jacc.2007.12.014; Kawase Y, 2011, J AM COLL CARDIOL, V57, P1169, DOI 10.1016/j.jacc.2010.11.023; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kenworthy R, 2009, NUCLEIC ACIDS RES, V37, P6587, DOI 10.1093/nar/gkp714; Kurreck J, 2009, ANGEW CHEM INT EDIT, V48, P1378, DOI 10.1002/anie.200802092; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lompre AM, 2010, CIRCULATION, V121, P822, DOI 10.1161/CIRCULATIONAHA.109.890954; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Maczuga P, 2012, MOL THER; Maczuga P, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-42; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Muller OJ, 2008, GENE THER, V15, P1558, DOI 10.1038/gt.2008.111; Muller OJ, 2006, CARDIOVASC RES, V70, P70, DOI 10.1016/j.cardiores.2005.12.017; Pinkert S, 2009, CIRCULATION, V120, P2358, DOI 10.1161/CIRCULATIONAHA.108.845339; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Shan ZX, 2009, MOL BIOL REP, V36, P1483, DOI 10.1007/s11033-008-9339-8; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Singh S, 2011, PHARM RES-DORDR, V28, P2996, DOI 10.1007/s11095-011-0608-1; Sipo I, 2007, GENE THER, V14, P1319, DOI 10.1038/sj.gt.3302987; Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Varkonyi-Gasic E, 2010, METHODS MOL BIOL, V631, P109, DOI 10.1007/978-1-60761-646-7_10; Vetter R, 1998, MOL CELL BIOCHEM, V188, P177, DOI 10.1023/A:1006850724830; Watanabe A, 2004, J MOL CELL CARDIOL, V37, P691, DOI 10.1016/j.yjmcc.2004.06.009; Xiao SQ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-491; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhang HS, 2012, MOL THER, V20, P1508, DOI 10.1038/mt.2012.80	58	12	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92188	10.1371/journal.pone.0092188	http://dx.doi.org/10.1371/journal.pone.0092188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670775	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000034
J	Hernandez-Avila, I				Hernandez-Avila, Ivan			Patterns of Deep-Water Coral Diversity in the Caribbean Basin and Adjacent Southern Waters: An Approach based on Records from the R/V Pillsbury Expeditions	PLOS ONE			English	Article							GLOBAL HABITAT SUITABILITY; SPECIES RICHNESS; AZOOXANTHELLATE CORALS; CONTINENTAL MARGINS; SEA; ATLANTIC; BIOGEOGRAPHY; COASTAL; SHELF; BIOTA	The diversity of deep-water corals in the Caribbean Sea was studied using records from oceanographic expeditions performed by the R/V Pillsbury. Sampled stations were sorted according to broad depth ranges and ecoregions and were analyzed in terms of species accumulation curves, variance in the species composition and contributions to alpha, beta and gamma diversity. According to the analysis of species accumulation curves using the Chao2 estimator, more diversity occurs on the continental slope (200-2000 m depth) than on the upper continental shelf (60-200 m depth). In addition to the effect of depth sampling, differences in species composition related to depth ranges were detected. However, the differences between ecoregions are dependent on depth ranges, there were fewer differences among ecoregions on the continental slope than on the upper continental shelf. Indicator species for distinctness of ecoregions were, in general, Alcyonaria and Antipatharia for the upper continental shelf, but also the scleractinians Madracis myriabilis and Cladocora debilis. In the continental slope, the alcyonarian Placogorgia and the scleractinians Stephanocyathus and Fungiacyathus were important for the distinction of ecoregions. Beta diversity was the most important component of gamma diversity in the Caribbean Basin. The contribution of ecoregions to alpha, beta and gamma diversity differed with depth range. On the upper continental shelf, the Southern Caribbean ecoregion contributed substantially to all components of diversity. In contrast, the northern ecoregions contributed substantially to the diversity of the Continental Slope. Strategies for the conservation of deep-water coral diversity in the Caribbean Basin must consider the variation between ecoregions and depth ranges.	[Hernandez-Avila, Ivan] Univ Oriente, Nucleo Nueva Esparta, Dept Ciencias, Unidad Cursos Basicos, Margarita Isl, Venezuela; [Hernandez-Avila, Ivan] IFREMER, Unite Rech Etud Ecosyst Profonds, Lab Environm, Plouzane, France	Ifremer	Hernandez-Avila, I (corresponding author), Univ Oriente, Nucleo Nueva Esparta, Dept Ciencias, Unidad Cursos Basicos, Margarita Isl, Venezuela.	ivan.hernandez@ifremer.fr	caputo, carlo/N-3747-2014; Avila, Ivan IHA Hernandez/F-8715-2014	Hernandez, Ivan/0000-0002-6722-5226	Comision de Investigacion, Universidad de Oriente	Comision de Investigacion, Universidad de Oriente	Research visit to RSMAS was partially supported by Comision de Investigacion, Universidad de Oriente. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2008, PERMANOVA PRIMER GUI, P214; Arantes RCM, 2009, MAR ECOL PROG SER, V397, P71, DOI 10.3354/meps08230; Briggs KB, 1996, J MAR RES, V54, P705, DOI 10.1357/0022240963213736; Bryan TL, 2007, MAR ECOL PROG SER, V330, P113, DOI 10.3354/meps330113; Bryan TL, 2006, DEEP-SEA RES PT I, V53, P1865, DOI 10.1016/j.dsr.2006.09.006; CAIRNS S D, 1986, Smithsonian Contributions to Zoology, P1; Cairns S. D., 1979, STUD FAUNA CURACAO, V57, P341; Cairns S.D., 2001, P 1 INT S DEEP SEA C, P30; Cairns SD, 2007, B MAR SCI, V81, P311; Cairns SD, 2007, P BIOL SOC WASH, V120, P1, DOI 10.2988/0006-324X(2007)120[1:SOWAOG]2.0.CO;2; Cairns SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021670; Cairns Stephen D., 2000, Uitgaven Natuurwetenschappelijke Studiekring voor het Caraibisch Gebied, V143, P1; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chazdon RL, 1998, MAN BIOSPH, V20, P285; Clark M.R., 2006, SEAMOUNTS DEEP SEA C; Clark MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029232; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Colwell RK, 2013, ESTIMATES STAT ESTIM; Connelly DP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1636; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Dawson JP, 2002, CORAL REEFS, V21, P27, DOI 10.1007/s00338-001-0207-4; DAYTON PK, 1972, DEEP-SEA RES, V19, P199, DOI 10.1016/0011-7471(72)90031-9; Urriago Juan Diego, 2011, Bol. Invest. Mar. Cost., V40, P89; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; Garcia E, 2011, CIENC MAR, V37, P141, DOI 10.7773/cm.v37i2.1763; German CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023259; GORDON AL, 1967, J GEOPHYS RES, V72, P6207, DOI 10.1029/JZ072i024p06207; Gracia A, 2012, J MAR BIOL ASSOC UK, V92, P1367, DOI 10.1017/S0025315411001421; GRASSLE JF, 1992, AM NAT, V139, P313, DOI 10.1086/285329; GRASSLE JF, 1991, BIOSCIENCE, V41, P464, DOI 10.2307/1311803; Gray JS, 1997, MAR ECOL PROG SER, V159, P97, DOI 10.3354/meps159097; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; Guerra-Castro EJ, 2012, THESIS IVIC VENEZUEL; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Hellweger FL, 2002, J MAR RES, V60, P537, DOI 10.1357/002224002762324202; Henry Lea-Anne, 2011, University of British Columbia Fisheries Centre Research Reports, V19, P120; Hubscher C, 2010, INT J EARTH SCI, V99, pS191, DOI 10.1007/s00531-010-0558-6; Jones DOB, 2012, J MAR BIOL ASSOC UK, V92, P245, DOI 10.1017/S0025315411001123; Kitchingman A, 2005, SEAMOUNTS BIODIVERSI, P7; Leverette TL, 2005, ERLANGEN EARTH C SER, P467, DOI 10.1007/3-540-27673-4_23; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Levin LA, 2009, TRENDS ECOL EVOL, V24, P606, DOI 10.1016/j.tree.2009.04.012; Lu HP, 2007, BASIC APPL ECOL, V8, P1, DOI 10.1016/j.baae.2006.06.004; Lutz MJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003706; Lutz S. J., 2007, STATE DEEP CORAL ECO; MacCready P, 1999, J GEOPHYS RES-OCEANS, V104, P25913, DOI 10.1029/1999JC900206; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; Miller K, 2011, TLS-TIMES LIT SUPPL, P6; Miloslavich P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011916; Mosher CV, 2009, MAR ECOL PROG SER, V397, P81, DOI 10.3354/meps08113; MULLERKARGER FE, 1994, CONT SHELF RES, V14, P199, DOI 10.1016/0278-4343(94)90013-2; Paterson GLJ, 1998, DEEP-SEA RES PT II, V45, P225, DOI 10.1016/S0967-0645(97)00084-2; Priede IG, 2010, MAR ECOL-EVOL PERSP, V31, P247, DOI 10.1111/j.1439-0485.2009.00330.x; Ramirez-Llodra E., 2010, BIOGEOSCI DISCUSS, V7, P2361, DOI DOI 10.5194/BGD-7-2361-2010; Reed JK, 2013, CARIBB J SCI, V47, P13; REX MA, 1973, SCIENCE, V181, P1051, DOI 10.1126/science.181.4104.1051; Reyes J, 2005, ERLANGEN EARTH C SER, P309, DOI 10.1007/3-540-27673-4_15; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Santodomingo N, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P273; Santodomingo N, 2013, MAR BIODIVERS, V43, P7, DOI 10.1007/s12526-012-0131-6; Schmitz Jr W.J., 1996, WHOI9603, V1; Snelgrove PVR, 2002, OCEANOGR MAR BIOL, V40, P311; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Staiger J, 1970, TECHNICAL REPORT; Staiger J, 1968, TECHNICAL REPORT; Staiger J, 1969, TECHNICAL REPORT; Stuart CT, 2003, ECOSY WORLD, V28, P295; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Ugland KI, 2003, J ANIM ECOL, V72, P888, DOI 10.1046/j.1365-2656.2003.00748.x; Voss GL, 1971, TECHNICAL REPORT; Voss GL, 1977, COOPERATIVE INVESTIG; Voss GL, 1966, TECHNICAL REPORT; Watling L, 2013, PROG OCEANOGR, V111, P91, DOI 10.1016/j.pocean.2012.11.003; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109; Woodby D, 2009, MAR ECOL PROG SER, V397, P227, DOI 10.3354/meps08358; Yesson C, 2012, J BIOGEOGR, V39, P1278, DOI 10.1111/j.1365-2699.2011.02681.x	80	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92834	10.1371/journal.pone.0092834	http://dx.doi.org/10.1371/journal.pone.0092834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671156	Green Published, gold			2022-12-25	WOS:000333677000083
J	Jiang, Z; Li, C; Arrick, DM; Yang, S; Baluna, AE; Sun, H				Jiang, Zheng; Li, Chun; Arrick, Denise M.; Yang, Shu; Baluna, Alexandra E.; Sun, Hong			Role of Nitric Oxide Synthases in Early Blood-Brain Barrier Disruption following Transient Focal Cerebral Ischemia	PLOS ONE			English	Article							MITOCHONDRIAL RESPIRATORY-CHAIN; ARTERY OCCLUSION; PROTECTS; PEROXYNITRITE; ARTERIOLES; ACTIVATION; EXPRESSION; GENERATION; REACTIVITY; NEURONS	The role of nitric oxide synthases (NOSs) in early blood-brain barrier (BBB) disruption was determined using a new mouse model of transient focal cerebral ischemia. Ischemia was induced by ligating the middle cerebral artery (MCA) at its M2 segment and reperfusion was induced by releasing the ligation. The diameter alteration of the MCA, arterial anastomoses and collateral arteries were imaged and measured in real time. BBB disruption was assessed by Evans Blue (EB) and sodium fluorescein (Na-F) extravasation at 3 hours of reperfusion. The reperfusion produced an extensive vasodilation and a sustained hyperemia. Although expression of NOSs was not altered at 3 hours of reperfusion, L-NAME (a non-specific NOS inhibitor) abolished reperfusion-induced vasodilation/hyperemia and significantly reduced EB and Na-F extravasation. L-NIO (an endothelial NOS (eNOS) inhibitor) significantly attenuated cerebral vasodilation but not BBB disruption, whereas L-NPA and 7-NI (neuronal NOS (nNOS) inhibitors) significantly reduced BBB disruption but not cerebral vasodilation. In contrast, aminoguanidine (AG) (an inducible NOS (iNOS) inhibitor) had less effect on either cerebral vasodilation or BBB disruption. On the other hand, papaverine (PV) not only increased the vasodilation/hyperemia but also significantly reduced BBB disruption. Combined treatment with L-NAME and PV preserved the vasodilation/hyperemia and significantly reduced BBB disruption. Our findings suggest that nNOS may play a major role in early BBB disruption following transient focal cerebral ischemia via a hyperemia-independent mechanism.	[Jiang, Zheng; Li, Chun; Arrick, Denise M.; Yang, Shu; Baluna, Alexandra E.; Sun, Hong] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Sun, H (corresponding author), Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA.	hsun1@lsuhsc.edu			Louisiana State University Health Sciences Center-Shreveport	Louisiana State University Health Sciences Center-Shreveport	This study was supported by funds from Louisiana State University Health Sciences Center-Shreveport. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CL, 2009, INT J STROKE, V4, P461, DOI 10.1111/j.1747-4949.2009.00387.x; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Bolanos JP, 1999, BBA-BIOENERGETICS, V1411, P415, DOI 10.1016/S0005-2728(99)00030-4; BOLANOS JP, 1995, J NEUROCHEM, V64, P1965; Bouley J, 2007, NEUROSCI LETT, V412, P185, DOI 10.1016/j.neulet.2006.11.003; Chen B, 2009, STROKE, V40, pE666, DOI 10.1161/STROKEAHA.109.551341; Fassbender K, 2000, STROKE, V31, P2208, DOI 10.1161/01.STR.31.9.2208; Grandati M, 1997, BRIT J PHARMACOL, V122, P625, DOI 10.1038/sj.bjp.0701427; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Hartkamp MJ, 1999, STROKE, V30, P2671, DOI 10.1161/01.STR.30.12.2671; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P52, DOI 10.1038/jcbfm.1995.6; Koizumi J., 1986, JPN J STROKE, V8, P1, DOI DOI 10.3995/JSTROKE.8.1; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Lekontseva O, 2011, J PHARM EXPT THERAPE; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; MALINSKI T, 1993, J CEREBR BLOOD F MET, V13, P355, DOI 10.1038/jcbfm.1993.48; Mayhan WG, 2008, MICROCIRCULATION, V15, P225, DOI 10.1080/10739680701641421; Miclescu A, 2010, CRIT CARE MED, V38, P2199, DOI 10.1097/CCM.0b013e3181f26b0c; Mohammadi MT, 2011, PATHOPHYSIOLOGY OFFI; MOORADIAN AD, 1992, MECH AGEING DEV, V64, P247, DOI 10.1016/0047-6374(92)90082-O; MORO MA, 1995, BRIT J PHARMACOL, V116, P1999, DOI 10.1111/j.1476-5381.1995.tb16404.x; Moro MA, 2005, FREE RADICAL BIO MED, V39, P1291, DOI 10.1016/j.freeradbiomed.2005.07.010; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; Mundy AL, 2007, CARDIOVASC RES, V73, P368, DOI 10.1016/j.cardiores.2006.11.019; Perez-Asensio FJ, 2010, J CEREBR BLOOD F MET, V30, P638, DOI 10.1038/jcbfm.2009.237; Peterson EC, 2011, INT J VASC MED, V2011, DOI 10.1155/2011/823525; Rodionov RN, 2010, CIRC RES, V106, P551, DOI 10.1161/CIRCRESAHA.109.200360; Stewart JM, 2011, AM J PHYSIOL-HEART C, V301, pH704, DOI 10.1152/ajpheart.00171.2011; Sun H, 2002, ALCOHOL CLIN EXP RES, V26, P663; Suofu Y, 2010, J NEUROCHEM, V115, P1266, DOI 10.1111/j.1471-4159.2010.07026.x; Toda N, 2009, CAN J PHYSIOL PHARM, V87, P581, DOI [10.1139/Y09-048, 10.1139/y09-048]; TOMINAGA T, 1994, J CEREBR BLOOD F MET, V14, P715, DOI 10.1038/jcbfm.1994.92; Uetsuka S, 2002, J NEUROTRAUM, V19, P1105, DOI 10.1089/089771502760342009; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; ZHANG J, 1995, STROKE, V26, P298, DOI 10.1161/01.STR.26.2.298; ZHANG ZG, 1994, BRAIN RES, V654, P85; ZHANG ZG, 1993, STROKE, V24, P2016, DOI 10.1161/01.STR.24.12.2016; Zhao HG, 2008, BRAIN RES, V1246, P158, DOI 10.1016/j.brainres.2008.08.096	38	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93134	10.1371/journal.pone.0093134	http://dx.doi.org/10.1371/journal.pone.0093134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671193	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000117
J	Muller, LPD; Sargoy, A; Rodriguez, AR; Brecha, NC				Mueller, Luis Perez de Sevilla; Sargoy, Allison; Rodriguez, Allen R.; Brecha, Nicholas C.			Melanopsin Ganglion Cells Are the Most Resistant Retinal Ganglion Cell Type to Axonal Injury in the Rat Retina	PLOS ONE			English	Article							OPTIC-NERVE SECTION; SURVIVAL; PROTEIN; NEURONS; AKT; MORPHOLOGY; RESPONSES; AXOTOMY; DEATH; PTEN	We report that the most common retinal ganglion cell type that remains after optic nerve transection is the M1 melanopsin ganglion cell. M1 ganglion cells are members of the intrinsically photosensitive retinal ganglion cell population that mediates non-image-forming vision, comprising similar to 2.5% of all ganglion cells in the rat retina. In the present study, M1 ganglion cells comprised 1.7 +/- 1%, 28 +/- 14%, 55 +/- 13% and 82 +/- 8% of the surviving ganglion cells 7, 14, 21 and 60 days after optic nerve transection, respectively. Average M1 ganglion cell somal diameter and overall morphological appearance remained unchanged in non-injured and injured retinas, suggesting a lack of injury-induced degeneration. Average M1 dendritic field size increased at 7 and 60 days following optic nerve transection, while average dendritic field size remained similar in non-injured retinas and in retinas at 14 and 21 days after optic nerve transection. These findings demonstrate that M1 ganglion cells are more resistant to injury than other ganglion cell types following optic nerve injury, and provide an opportunity to develop pharmacological or genetic therapeutic approaches to mitigate ganglion cell death and save vision following optic nerve injury.	[Mueller, Luis Perez de Sevilla; Sargoy, Allison; Rodriguez, Allen R.; Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Sargoy, Allison; Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.] Vet Adm Greater Los Angeles Hlth Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Muller, LPD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	luisperez@mednet.ucla.edu			Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD [W81XWH-10-2-0077]; NIH [EY04067]; NIDDK [P30 DK41301]; VA Merit Review; VA Career Research Scientist; NATIONAL EYE INSTITUTE [R56EY004067, T32EY007026, R01EY004067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000764] Funding Source: NIH RePORTER	Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); VA Merit Review(US Department of Veterans Affairs); VA Career Research Scientist; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This research and development project was conducted by the authors at the David Geffen School of Medicine at UCLA and is made possible by a contract agreement that was awarded and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC), at Fort Detrick, MD under Contract Number: W81XWH-10-2-0077. Support for these studies also came from NIH EY04067, NIDDK P30 DK41301 (UCLA Cure Center Core) and a VA Merit Review (NB). NCB is a VA Career Research Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cenni MC, 1996, EUR J NEUROSCI, V8, P1735, DOI 10.1111/j.1460-9568.1996.tb01317.x; Chow DK, 2009, NAT NEUROSCI, V12, P116, DOI 10.1038/nn.2255; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; DeParis SW, 2012, MOL VIS, V18, P2814; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; DRAGER UC, 1984, NATURE, V309, P624, DOI 10.1038/309624a0; DRAGER UC, 1981, INVEST OPHTH VIS SCI, V20, P285; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Estevez ME, 2012, J NEUROSCI, V32, P13608, DOI 10.1523/JNEUROSCI.1422-12.2012; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Hannibal J, 2004, INVEST OPHTH VIS SCI, V45, P4202, DOI 10.1167/iovs.04-0313; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HOLLANDER H, 1984, EXP BRAIN RES, V55, P483; Ingham ES, 2009, J COMP NEUROL, V516, P125, DOI 10.1002/cne.22103; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Joly S, 2008, J NEUROSCI, V28, P13765, DOI 10.1523/JNEUROSCI.5114-08.2008; Joo HR, 2013, VISUAL NEUROSCI, V9, P1; Kameritsch P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.105; Kitaoka Y, 2004, IN VIVO, V18, P311; Kreuzberg MM, 2006, P NATL ACAD SCI USA, V103, P5959, DOI 10.1073/pnas.0508512103; Krysko DV, 2005, APOPTOSIS, V10, P459, DOI 10.1007/s10495-005-1875-2; Kwong JMK, 2010, INVEST OPHTH VIS SCI, V51, P1052, DOI 10.1167/iovs.09-4098; Lai JP, 2009, BRIT J PHARMACOL, V156, P189, DOI 10.1111/j.1476-5381.2008.00020.x; Li RS, 2006, INVEST OPHTH VIS SCI, V47, P2951, DOI 10.1167/iovs.05-1295; Li SY, 2008, CELL MOL NEUROBIOL, V28, P1095, DOI 10.1007/s10571-008-9286-x; LINDEN R, 1982, NEUROSCIENCE, V7, P2813, DOI 10.1016/0306-4522(82)90104-X; LIU ZH, 1986, NEUROSCI LETT, V67, P239, DOI 10.1016/0304-3940(86)90315-0; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; Muller LPD, 2010, VISUAL NEUROSCI, V27, P91, DOI 10.1017/S0952523810000131; Muller LPD, 2010, J COMP NEUROL, V518, P4813, DOI 10.1002/cne.22490; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Ota T, 2002, J OCUL PHARMACOL TH, V18, P241, DOI 10.1089/108076802760116160; Pan F, 2010, J COMP NEUROL, V518, P911, DOI 10.1002/cne.22254; Pang JJ, 2011, INVEST OPHTH VIS SCI, V52, P4886, DOI 10.1167/iovs.10-5921; Perez de Sevilla L, J COMP NEUR IN PRESS; PERRY VH, 1982, NATURE, V297, P683, DOI 10.1038/297683a0; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rane SG, 2000, ONCOGENE, V19, P5662, DOI 10.1038/sj.onc.1203925; Reglodi D, 2012, J MOL NEUROSCI, V48, P482, DOI 10.1007/s12031-012-9762-0; ROBINSON GA, 1994, MOL BRAIN RES, V24, P43, DOI 10.1016/0169-328X(94)90116-3; Robinson GA, 2004, VISION RES, V44, P2667, DOI 10.1016/j.visres.2004.06.010; Rodriguez-Sinovas A, 2007, PROG BIOPHYS MOL BIO, V94, P219, DOI 10.1016/j.pbiomolbio.2007.03.003; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schubert T, 2005, J COMP NEUROL, V490, P29, DOI 10.1002/cne.20621; SHAW G, 1984, EUR J CELL BIOL, V33, P95; SILVEIRA LCL, 1994, J NEUROCYTOL, V23, P75, DOI 10.1007/BF01183863; STRAZNICKY C, 1992, BRAIN RES, V582, P123, DOI 10.1016/0006-8993(92)90325-4; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Sun WZ, 2002, VISUAL NEUROSCI, V19, P483, DOI 10.1017/S0952523802194107; Vaarmann A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.194; VICKERS JC, 1992, NEUROSCIENCE, V49, P73, DOI 10.1016/0306-4522(92)90077-F; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; Vugler AA, 2007, EXP NEUROL, V205, P26, DOI 10.1016/j.expneurol.2007.01.032; Wang L, 2003, INVEST OPHTH VIS SCI, V44, P2, DOI 10.1167/iovs.02-0333; WATANABE M, 1993, J NEUROSCI, V13, P2105; Zhang C, 2008, EXP EYE RES, V86, P991, DOI 10.1016/j.exer.2008.03.020	62	65	65	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93274	10.1371/journal.pone.0093274	http://dx.doi.org/10.1371/journal.pone.0093274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671191	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677000130
J	Reparaz, LB; van Oers, K; Naguib, M; Doutrelant, C; Visser, ME; Caro, SP				Reparaz, Laura B.; van Oers, Kees; Naguib, Marc; Doutrelant, Claire; Visser, Marcel E.; Caro, Samuel P.			Mate Preference of Female Blue Tits Varies with Experimental Photoperiod	PLOS ONE			English	Article							PARUS-CAERULEUS POPULATIONS; EXTRAPAIR PATERNITY; GREAT TITS; PLUMAGE COLORATION; GENETIC-VARIATION; QUALITY MALES; BODY-SIZE; SONG; HERITABILITY; EXPRESSION	Organisms use environmental cues to time their life-cycles and among these cues, photoperiod is the main trigger of reproductive behaviours such as territory defence or song activity. Whether photoperiod is also important for another behaviour closely associated with reproduction, mate choice, is unknown. In many bird species, mate choice occurs at two different times during the annual cycle that strongly differ in daylength: in late winter when photoperiod is short and social mates are chosen, and again around egg-laying when photoperiod is longer and extra-pair mates are chosen. This duality makes the role that photoperiod plays on mate choice behaviours intriguing. We investigated the effect of photoperiod on mate choice using three experimental photoperiodic treatments (9 L:15 D, 14 L:10 D, 18 L:6 D), using blue tits (Cyanistes caeruleus) as a biological model. We show that female choice was stronger under long photoperiods. In addition, female blue tits spent significantly more time near males with long tarsi and long wings. This latter preference was only expressed under long photoperiods, suggesting that some indices of male quality only become significant to females when they are strongly photostimulated, and therefore that females could select their social and extra-pair mates based on different phenotypic traits. These results shed light on the roles that photoperiod may play in stimulating pair-bonding and in refining female selectivity for male traits.	[Reparaz, Laura B.; van Oers, Kees; Visser, Marcel E.; Caro, Samuel P.] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Reparaz, Laura B.; Naguib, Marc] Wageningen Univ WUR, Dept Anim Sci, Behav Ecol Grp, Wageningen, Netherlands; [Doutrelant, Claire; Caro, Samuel P.] CEFE CNRS, Dept Evolutionary Ecol, Montpellier, France	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; Universite de Montpellier	Caro, SP (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands.	samuel.caro@cefe.cnrs.fr	van Oers, Kees/B-2562-2009; P, Samuel/A-5750-2008; Naguib, Marc/C-2650-2009; Visser, Marcel E/A-9151-2009; KNAW, NIOO-KNAW/A-4320-2012	van Oers, Kees/0000-0001-6984-906X; P, Samuel/0000-0002-5405-7753; Visser, Marcel E/0000-0002-1456-1939; Naguib, Marc/0000-0003-0494-4888; KNAW, NIOO-KNAW/0000-0002-3835-159X; Reparaz, Laura/0000-0001-8404-8340	Netherlands Organisation for Scientific Research (NWO); Wallonie-Bruxelles International (WBI)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Wallonie-Bruxelles International (WBI)	This work was supported by the Netherlands Organisation for Scientific Research (NWO) [VICI-grant to M. E. V., VENI-grant to S. P. C.], and by Wallonie-Bruxelles International (WBI) [World-grant to S. P. C.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 1998, AM ZOOL, V38, P166; Andersson Malte, 1994; Baker J. R., 1938, P161; Bentley GE, 2000, HORM BEHAV, V37, P179, DOI 10.1006/hbeh.2000.1573; BIRKHEAD T, 1993, TRENDS ECOL EVOL, V8, P100, DOI 10.1016/0169-5347(93)90060-3; Blondel J, 1999, SCIENCE, V285, P1399, DOI 10.1126/science.285.5432.1399; Blondel J, 2006, BIOSCIENCE, V56, P661, DOI 10.1641/0006-3568(2006)56[661:ATSOPA]2.0.CO;2; Botero CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032311; Bradshaw WE, 2007, ANNU REV ECOL EVOL S, V38, P1, DOI 10.1146/annurev.ecolsys.37.091305.110115; Braillet C, 2002, J AVIAN BIOL, V33, P446, DOI 10.1034/j.1600-048X.2002.02956.x; Bro-Jorgensen J, 2010, TRENDS ECOL EVOL, V25, P292, DOI 10.1016/j.tree.2009.11.003; Buchanan KL, 2011, BEHAV ECOL, V22, P12, DOI 10.1093/beheco/arq083; Chakraborty M, 2009, HORM BEHAV, V55, P106, DOI 10.1016/j.yhbeh.2008.09.001; Challenger WO, 2001, PHYSIOL BIOCHEM ZOOL, V74, P356, DOI 10.1086/320427; Charmantier A, 2004, J AVIAN BIOL, V35, P524, DOI 10.1111/j.0908-8857.2004.03296.x; CLAYTON DH, 1990, AM ZOOL, V30, P251, DOI 10.1093/icb/30.2.251; David M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024778; Davies NB, 2012, INTRO BEHAV ECOLOGY; DAWSON A, 1991, IBIS, V133, P312, DOI 10.1111/j.1474-919X.1991.tb04575.x; DAWSON A, 1983, GEN COMP ENDOCR, V49, P286, DOI 10.1016/0016-6480(83)90146-6; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; DHONDT AA, 1982, EVOLUTION, V36, P418, DOI 10.1111/j.1558-5646.1982.tb05061.x; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Doutrelant C, 2001, ARDEA, V89, P375; Doutrelant C, 2000, J AVIAN BIOL, V31, P360, DOI 10.1034/j.1600-048X.2000.310312.x; Drent PJ, 2003, P ROY SOC B-BIOL SCI, V270, P45, DOI 10.1098/rspb.2002.2168; FERKIN MH, 1991, J REPROD FERTIL, V92, P433; FREEMAN S, 1990, AUK, V107, P69; Garcia-Del-Rey E, 2012, IBIS, V154, P862, DOI 10.1111/j.1474-919X.2012.01241.x; GARNETT MC, 1981, IBIS, V123, P31, DOI 10.1111/j.1474-919X.1981.tb00170.x; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Harper DGC, 1999, ANIM BEHAV, V58, P553, DOI 10.1006/anbe.1999.1154; Hau M, 1998, P ROY SOC B-BIOL SCI, V265, P89, DOI 10.1098/rspb.1998.0268; Hinde RA, 1952, BEHAVIOUR S; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Hunt KE, 2004, GEN COMP ENDOCR, V137, P248, DOI 10.1016/j.ygcen.2004.03.015; Kempenaers B, 1997, BEHAV ECOL, V8, P481, DOI 10.1093/beheco/8.5.481; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; Kurvers RHJM, 2010, IBIS, V152, P393; LAMBRECHTS M, 1986, BEHAV ECOL SOCIOBIOL, V19, P57, DOI 10.1007/BF00303843; Lambrechts MM, 1997, EVOL ECOL, V11, P599, DOI 10.1007/s10682-997-1515-0; Lambrechts MM, 2004, OECOLOGIA, V141, P555, DOI 10.1007/s00442-004-1681-5; Lambrechts MM, 1997, P NATL ACAD SCI USA, V94, P5153, DOI 10.1073/pnas.94.10.5153; Lambrechts MM, 1996, P ROY SOC B-BIOL SCI, V263, P19, DOI 10.1098/rspb.1996.0004; Lambrechts MM, 2000, P ROY SOC B-BIOL SCI, V267, P585, DOI 10.1098/rspb.2000.1041; Leboucher G, 2012, ADV STUD BEHAV, V44, P183, DOI 10.1016/B978-0-12-394288-3.00005-8; Maney DL, 2006, EUR J NEUROSCI, V23, P1523, DOI 10.1111/j.1460-9568.2006.04673.x; Maney DL, 2008, J COMP NEUROL, V511, P173, DOI 10.1002/cne.21830; Meddle SL, 1997, J NEUROSCI, V17, P8909; Merila J, 1998, GENETICS, V148, P1233; MOLLER AP, 1992, AM NAT, V139, P1089, DOI 10.1086/285374; Naguib M, 2008, ETHOLOGY, V114, P255, DOI 10.1111/j.1439-0310.2007.01466.x; Naguib M, 2013, ANIM BEHAV, V85, P949, DOI 10.1016/j.anbehav.2013.02.015; Perfito N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034997; Roney JR, 2008, HORM BEHAV, V53, P14, DOI 10.1016/j.yhbeh.2007.09.008; Safran RJ, 2004, BEHAV ECOL, V15, P455, DOI 10.1093/beheco/arh035; Schielzeth H, 2008, ANIM BEHAV, V76, P1927, DOI 10.1016/j.anbehav.2008.08.014; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Sockman KW, 2009, DEV NEUROBIOL, V69, P339, DOI 10.1002/dneu.20707; Sockman KW, 2004, BIOL REPROD, V71, P979, DOI 10.1095/biolreprod.104.029751; STOKES ALLEN W., 1960, IBIS, V102, P507, DOI 10.1111/j.1474-919X.1960.tb07127.x; Thompson CW, 1997, AM NAT, V149, P270, DOI 10.1086/285990; Titulaer M, 2012, ANIM BEHAV, V83, P723, DOI 10.1016/j.anbehav.2011.12.020; Van Oers K, 2008, ANIM BEHAV, V76, P555, DOI 10.1016/j.anbehav.2008.03.011; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; Williams TD, 2012, GEN COMP ENDOCR, V176, P286, DOI 10.1016/j.ygcen.2011.11.028; Wingfield J.C., 1991, P181; WINGFIELD JC, 1984, GEN COMP ENDOCR, V56, P406, DOI 10.1016/0016-6480(84)90083-2; Woodgate JL, 2011, BEHAV ECOL, V22, P566, DOI 10.1093/beheco/arr006	69	9	10	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92527	10.1371/journal.pone.0092527	http://dx.doi.org/10.1371/journal.pone.0092527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671133	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000051
J	Wander, PL; Hochner, H; Sitlani, CM; Enquobahrie, DA; Lumley, T; Lawrence, GM; Burger, A; Savitsky, B; Manor, O; Meiner, V; Hesselson, S; Kwok, PY; Siscovick, DS; Friedlander, Y				Wander, Pandora L.; Hochner, Hagit; Sitlani, Colleen M.; Enquobahrie, Daniel A.; Lumley, Thomas; Lawrence, Gabriela M.; Burger, Ayala; Savitsky, Bella; Manor, Orly; Meiner, Vardiella; Hesselson, Stephanie; Kwok, Pui Y.; Siscovick, David S.; Friedlander, Yechiel			Maternal Genetic Variation Accounts in Part for the Associations of Maternal Size during Pregnancy with Offspring Cardiometabolic Risk in Adulthood	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; BODY-MASS INDEX; ADIPOSITY; VARIANTS; SEQUENCE; OBESITY; COHORT; BIRTH; DIET	Background: Maternal pre-pregnancy body-mass index (ppBMI) and gestational weight gain (GWG) are associated with cardiometabolic risk (CMR) traits in the offspring. The extent to which maternal genetic variation accounts for these associations is unknown. Methods/Results: In 1249 mother-offspring pairs recruited from the Jerusalem Perinatal Study, we used archival data to characterize ppBMI and GWG and follow-up data from offspring to assess CMR, including body mass index (BMI), waist circumference, glucose, insulin, blood pressure, and lipid levels, at an average age of 32. Maternal genetic risk scores (GRS) were created using a subset of SNPs most predictive of ppBMI, GWG, and each CMR trait, selected among 1384 single-nucleotide polymorphisms (SNPs) characterizing variation in 170 candidate genes potentially related to fetal development and/or metabolic risk. We fit linear regression models to examine the associations of ppBMI and GWG with CMR traits with and without adjustment for GRS. Compared to unadjusted models, the coefficient for the association of a one-standard-deviation (SD) difference in GWG and offspring BMI decreased by 41% (95%CI -81%, -11%) from 0.847 to 0.503 and the coefficient for a 1SD difference in GWG and WC decreased by 63% (95%CI -318%, -11%) from 1.196 to 0.443. For other traits, there were no statistically significant changes in the coefficients for GWG with adjustment for GRS. None of the associations of ppBMI with CMR traits were significantly altered by adjustment for GRS. Conclusions: Maternal genetic variation may account in part for associations of GWG with offspring BMI and WC in young adults.	[Wander, Pandora L.; Enquobahrie, Daniel A.; Siscovick, David S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Wander, Pandora L.; Sitlani, Colleen M.; Siscovick, David S.] Univ Washington, Dept Med, Seattle, WA USA; [Hochner, Hagit; Lawrence, Gabriela M.; Burger, Ayala; Savitsky, Bella; Manor, Orly; Friedlander, Yechiel] Hebrew Univ Jerusalem, Hadassah Med Ctr, Braun Sch Publ Hlth, Jerusalem, Israel; [Sitlani, Colleen M.; Siscovick, David S.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [Meiner, Vardiella] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Human Genet, Jerusalem, Israel; [Hesselson, Stephanie; Kwok, Pui Y.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Kwok, Pui Y.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Kwok, Pui Y.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Washington; University of Washington Seattle; University of Auckland; Hebrew University of Jerusalem; Hadassah University Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wander, PL (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	lwander@u.washington.edu		Savitsky, Bella/0000-0001-8917-8419; Wander, Pandora/0000-0003-3671-1464	National Heart, Lung, and Blood Institute [T32-HL07902, R01-HL088884]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007902, R01HL088884] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the T32-HL07902 training grant and R01-HL088884 from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branum AM, 2011, AM J EPIDEMIOL, V174, P1159, DOI 10.1093/aje/kwr250; Cohen TR, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/787032; Cox J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.041; DAVIES AM, 1969, ISRAEL J MED SCI, V5, P1095; Drake AJ, 2012, CLIN ENDOCRINOL, V77, P808, DOI 10.1111/j.1365-2265.2012.04453.x; Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077; Fan L, 2013, INT J OBESITY, V37, P254, DOI 10.1038/ijo.2012.42; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Guenard F, 2013, P NATL ACAD SCI US; HARLAP S, 1977, ISRAEL J MED SCI, V13, P1073; Harlap S, 2007, PAEDIATR PERINAT EP, V21, P256, DOI 10.1111/j.1365-3016.2007.00799.x; Hochner H, 2012, CIRCULATION; Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Lawlor DA, 2011, AM J CLIN NUTR, V94, P149, DOI 10.3945/ajcn.110.010751; Lawlor DA, 2011, AM J CLIN NUTR, V94, P142, DOI 10.3945/ajcn.110.009324; Lawrence G, 2013, OBESITY SIL IN PRESS; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Ludwig DS, 2010, LANCET, V376, P984, DOI 10.1016/S0140-6736(10)60751-9; Macones G, 2013, WEIGHT GAIN LOSS PRE; May LE, 2012, MED SCI SPORT EXER, V44, P1252, DOI 10.1249/MSS.0b013e318247b324; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; SMITH DE, 1994, JAMA-J AM MED ASSOC, V271, P1747, DOI 10.1001/jama.271.22.1747; Stotland NE, 2006, OBSTET GYNECOL, V108, P635, DOI 10.1097/01.AOG.0000228960.16678.bd; Stuebe AM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.069; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Zaina S, 2010, CURR GENOMICS, V11, P359, DOI 10.2174/138920210791616662	32	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91835	10.1371/journal.pone.0091835	http://dx.doi.org/10.1371/journal.pone.0091835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670385	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677000027
J	Wang, J; Land, D; Ono, K; Galvez, J; Zhao, W; Vempati, P; Steele, JW; Cheng, A; Yamada, M; Levine, S; Mazzola, P; Pasinetti, GM				Wang, Jun; Land, David; Ono, Kenjiro; Galvez, Jorge; Zhao, Wei; Vempati, Prashant; Steele, John W.; Cheng, Alice; Yamada, Masahito; Levine, Samara; Mazzola, Paolo; Pasinetti, Giulio M.			Molecular Topology as Novel Strategy for Discovery of Drugs with A beta Lowering and Anti-Aggregation Dual Activities for Alzheimer's Disease	PLOS ONE			English	Article							MOUSE MODEL; PROTEIN; OLIGOMERS; NEUROPATHOLOGY; TOXICITY	Background and Purpose: In this study, we demonstrate the use of Molecular topology (MT) in an Alzheimer's disease (AD) drug discovery program. MT uses and expands upon the principles governing the molecular connectivity theory of numerically characterizing molecular structures, in the present case, active anti-AD drugs/agents, using topological descriptors to build models. Topological characterization has been shown to embody sufficient molecular information to provide strong correlation to therapeutic efficacy. Experimental Approach: We used MT to include multiple bioactive properties that allows for the identification of multifunctional single agent compounds, in this case, the dual functions of beta-amyloid (A beta) -lowering and anti-oligomerization. Using this technology, we identified and designed novel compounds in chemical classes unrelated to current anti-AD agents that exert dual A beta lowering and anti-A beta oligomerization activities in animal models of AD. AD is a multifaceted disease with different pathological features. Conclusion and Implications: Our study, for the first time, demonstrated that MT can provide novel strategy for discovering drugs with A beta lowering and anti-aggregation dual activities for AD.	[Wang, Jun; Zhao, Wei; Vempati, Prashant; Steele, John W.; Cheng, Alice; Levine, Samara; Mazzola, Paolo; Pasinetti, Giulio M.] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Land, David] Medisyn Technol Inc, Minnetonka, MN USA; [Ono, Kenjiro; Yamada, Masahito] Kanazawa Univ, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan; [Galvez, Jorge] Univ Valencia, Mol Topol & Drug Design Unit, Valencia, Spain; [Wang, Jun; Pasinetti, Giulio M.] James J Peters Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Bronx, NY USA	Icahn School of Medicine at Mount Sinai; Kanazawa University; University of Valencia; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Pasinetti, GM (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA.	giulio.pasinetti@mssm.edu	Mazzola, Paolo/AAC-2448-2019; Zhao, Wei/A-2206-2010	Mazzola, Paolo/0000-0002-0484-1136; Zhao, Wei/0000-0002-3449-2395; Pasinetti, Giulio/0000-0002-1524-5196	Altschul Foundation; Icahn School of Medicine at Mount Sinai; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	Altschul Foundation; Icahn School of Medicine at Mount Sinai; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported in part by the Altschul Foundation and by Discretionary Funds to Giulio Maria Pasinetti from the Icahn School of Medicine at Mount Sinai.	*ALZH ASS, 2006, FACT SHEET ALZH DIS; Alzheimer's Study Group, 2010, NAT ALZH STRAT PLAN; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Boado RJ, 2007, BIOCONJUGATE CHEM, V18, P447, DOI 10.1021/bc060349x; Braak H, 1997, Int Psychogeriatr, V9 Suppl 1, P257, DOI 10.1017/S1041610297004973; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; de Leon MJ, 2007, ANN NY ACAD SCI, V1097, P114, DOI 10.1196/annals.1379.012; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Dudek AZ, 2006, COMB CHEM HIGH T SCR, V9, P213, DOI 10.2174/138620706776055539; Emilien G, 2000, ARCH NEUROL-CHICAGO, V57, P176, DOI 10.1001/archneur.57.2.176; GALVEZ J, 1995, J CHEM INF COMP SCI, V35, P272, DOI 10.1021/ci00024a017; Galvez J, 1996, J MOL GRAPH MODEL, V14, P272, DOI 10.1016/S0263-7855(96)00081-1; Garcia-Domenech R, 2008, CHEM REV, V108, P1127, DOI 10.1021/cr0780006; Giacobini E, 2007, J ALZHEIMERS DIS, V12, P37; HOSOYA H, 1971, B CHEM SOC JPN, V44, P2332, DOI 10.1246/bcsj.44.2332; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jasinski P, 2008, INVEST NEW DRUG, V26, P223, DOI 10.1007/s10637-007-9096-x; Kier L.B., 1986, MOL CONNECTIVITY STR; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087, DOI 10.1093/jnen/62.11.1087; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Morgan D, 2005, NEURODEGENER DIS, V2, P261, DOI 10.1159/000090366; Ono K, 2008, J BIOL CHEM, V283, P32176, DOI 10.1074/jbc.M806154200; RANDIC M, 1975, J AM CHEM SOC, V97, P6609, DOI 10.1021/ja00856a001; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Todeschini R, 2000, HDB MOL DESCRIPTORS, P11; Vollers Sabrina S., 2004, V299, P11; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Wang J, 2008, J NEUROSCI, V28, P6388, DOI 10.1523/JNEUROSCI.0364-08.2008; Wang J, 2006, FASEB J, V20, P2313, DOI 10.1096/fj.06-6281com	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92750	10.1371/journal.pone.0092750	http://dx.doi.org/10.1371/journal.pone.0092750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671215	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677000072
J	Warrilow, D; Watterson, D; Hall, RA; Davis, SS; Weir, R; Kurucz, N; Whelan, P; Allcock, R; Hall-Mendelin, S; O'Brien, CA; Hobson-Peters, J				Warrilow, David; Watterson, Daniel; Hall, Roy A.; Davis, Steven S.; Weir, Richard; Kurucz, Nina; Whelan, Peter; Allcock, Richard; Hall-Mendelin, Sonja; O'Brien, Caitlin A.; Hobson-Peters, Jody			A New Species of Mesonivirus from the Northern Territory, Australia	PLOS ONE			English	Article							ENCEPHALITIS-VIRUS; RNA	Here we describe Casuarina virus (CASV), a new virus in the family Mesoniviridae. This is the first report of a mesonivirus in Australia, which extends the geographical range of this virus family to 3 continents. The virus was isolated in 2010 from Coquillettidia xanthogaster mosquitoes during surveillance in the suburbs of Darwin, the capital of the Northern Territory. Cryo-electron microscopy of the CASV virions revealed spherical particles of 65 nm in size with large club-shaped projections of approximately 15 nm in length. The new virus was most closely related to Alphamesonivirus 1, the only currently recognized species in the family. In 2013 a further 5 putative new mesonivirus species were described: Hana, Meno, Nse, Moumo and Dak Nong viruses. The evolutionary distance between CASV and two of its closest relatives, Cavally and Hana viruses (Jones-Taylor-Thornton distance of 0.151 and 0.224, respectively), along with its isolation from a different genus of mosquitoes captured on a separate continent indicate that CASV is a new species.	[Warrilow, David; Hall-Mendelin, Sonja] Dept Hlth, Forens Serv, Publ Hlth Virol Lab, Archerfield, Qld, Australia; [Warrilow, David; Hall-Mendelin, Sonja] Dept Hlth, Sci Serv, Publ Hlth Virol Lab, Archerfield, Qld, Australia; [Watterson, Daniel; Hall, Roy A.; O'Brien, Caitlin A.; Hobson-Peters, Jody] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia; [Davis, Steven S.; Weir, Richard] Dept Primary Ind & Fisheries, Berrimah Vet Labs, Darwin, NT, Australia; [Kurucz, Nina; Whelan, Peter] Northern Terr Dept Hlth, Hlth Protect Div, Ctr Dis Control, Darwin, NT, Australia; [Allcock, Richard] Univ Western Australia, Sch Pathol & Lab Med, LotteryWest State Biomed Facil, Perth, WA 6009, Australia; [Allcock, Richard] Royal Perth Hosp, Pathwest Lab Med Western Australia, Dept Clin Immunol, Perth, WA 6001, Australia	University of Queensland; University of Western Australia; Royal Perth Hospital	Warrilow, D (corresponding author), Dept Hlth, Forens Serv, Publ Hlth Virol Lab, Archerfield, Qld, Australia.	David_Warrilow@health.qld.gov.au; j.peters2@uq.edu.au		Watterson, Daniel/0000-0001-5957-2853	Australian Infectious Diseases Research Centre; Australian Research Council [DP120103994]	Australian Infectious Diseases Research Centre; Australian Research Council(Australian Research Council)	This work was partially funded by an Australian Infectious Diseases Research Centre support grant and by the Australian Research Council (DP120103994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beniac DR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001082; Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856; Briggs JAG, 2004, J VIROL, V78, P2606, DOI 10.1128/JVI.78.5.2606-2608.2004; Clark DC, 2007, J GEN VIROL, V88, P1175, DOI 10.1099/vir.0.82609-0; CONDREAY LD, 1986, J VIROL, V58, P81, DOI 10.1128/JVI.58.1.81-86.1986; Hall-Mendelin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058026; Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534; Hsu S.H., 1971, ARTHROPOD CELL CULTU, P140; Junglen S, 2009, ECOHEALTH, V6, P239, DOI 10.1007/s10393-009-0260-y; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Kuwata R, 2013, ARCH VIROL; Lauber C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003500; Lauber C, 2012, ARCH VIROL, V157, P1623, DOI 10.1007/s00705-012-1295-x; May FJ, 2006, J GEN VIROL, V87, P329, DOI 10.1099/vir.0.81252-0; Neuman BW, 2006, J VIROL, V80, P7918, DOI 10.1128/JVI.00645-06; Thuy NT, 2013, VIROLOGY, V444, P337, DOI 10.1016/j.virol.2013.06.030; Nga PT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002215; REED L. J., 1938, AMER JOUR HYG, V27, P493; Risco C, 1996, J VIROL, V70, P4773, DOI 10.1128/JVI.70.7.4773-4777.1996; Ritchie SA, 1997, AM J TROP MED HYG, V56, P80, DOI 10.4269/ajtmh.1997.56.80; Rohe D.L., 1979, Bulletin of the Society of Vector Ecologists, V4, P24; Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848; Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861; Voronin D, 2010, J APPL MICROBIOL, V108, P2133, DOI 10.1111/j.1365-2672.2009.04621.x; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whelan P. L., 1993, ARBOVIRUS RES AUST, V6, P270; Zirkel F, 2013, J VIROL, V87, P6346, DOI 10.1128/JVI.00416-13; Zirkel F, 2011, MBIO, V2, DOI 10.1128/mBio.00077-11	28	43	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91103	10.1371/journal.pone.0091103	http://dx.doi.org/10.1371/journal.pone.0091103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670468	gold, Green Submitted, Green Published			2022-12-25	WOS:000333677000016
J	Hayes, BJ; Riehle, KJ; Shimizu-Albergine, M; Bauer, RL; Hudkins, KL; Johansson, F; Yeh, MM; Mahoney, WM; Yeung, RS; Campbell, JS				Hayes, Brian J.; Riehle, Kimberly J.; Shimizu-Albergine, Masami; Bauer, Renay L.; Hudkins, Kelly L.; Johansson, Fredrik; Yeh, Matthew M.; Mahoney, William M., Jr.; Yeung, Raymond S.; Campbell, Jean S.			Activation of Platelet-Derived Growth Factor Receptor Alpha Contributes to Liver Fibrosis	PLOS ONE			English	Article							RAT HEPATIC LIPOCYTES; PDGFR-ALPHA; HEPATOCELLULAR-CARCINOMA; CARBON-TETRACHLORIDE; IN-VIVO; EXPRESSION; BETA; CIRRHOSIS; CELLS; HEPATOTOXICITY	Chronic liver injury leads to fibrosis, cirrhosis, and loss of liver function. Liver cirrhosis is the 12th leading cause of death in the United States, and it is the primary risk factor for developing liver cancer. Fibrosis and cirrhosis result from activation of hepatic stellate cells (HSCs), which are the primary collagen producing cell type in the liver. Here, we show that platelet-derived growth factor receptor alpha (PDGFR alpha) is expressed by human HSCs, and PDGFR alpha expression is elevated in human liver disease. Using a green fluorescent protein (GFP) reporter mouse strain, we evaluated the role of PDGFR alpha in liver disease in mice and found that mouse HSCs express PDGFR alpha and expression is upregulated during carbon tetrachloride (CCl4) induced liver injury and fibrosis injection. This fibrotic response is reduced in Pdgfr alpha heterozygous mice, consistent with the hypothesis that liver fibrosis requires upregulation and activation of PDGFR alpha. These results indicate that Pdgfr alpha expression is important in the fibrotic response to liver injury in humans and mice, and suggest that blocking PDGFR alpha-specific signaling pathways in HSCs may provide therapeutic benefit for patients with chronic liver disease.	[Hayes, Brian J.; Riehle, Kimberly J.; Shimizu-Albergine, Masami; Bauer, Renay L.; Hudkins, Kelly L.; Johansson, Fredrik; Yeh, Matthew M.; Mahoney, William M., Jr.; Yeung, Raymond S.; Campbell, Jean S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Shimizu-Albergine, Masami] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Riehle, Kimberly J.; Yeung, Raymond S.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Mahoney, William M., Jr.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Mahoney, William M., Jr.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Campbell, JS (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	campjs@u.washington.edu	Mahoney, William/GQB-0802-2022	Hayes, Brian J/0000-0002-0930-0160; Campbell, Jean/0000-0002-9187-2204	Herbert S. Coe Foundation; American College of Surgeons Louis C. Argenta Fellowship; American Surgical Association Foundation Fellowship; Howard Hughes Medical Institute program in Molecular Medicine;  [R01CA127228];  [T32HL007312]; NATIONAL CANCER INSTITUTE [R01CA127228] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER	Herbert S. Coe Foundation; American College of Surgeons Louis C. Argenta Fellowship; American Surgical Association Foundation Fellowship; Howard Hughes Medical Institute program in Molecular Medicine; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants R01CA127228 (to J.S. Campbell), the Herbert S. Coe Foundation, American College of Surgeons Louis C. Argenta Fellowship, the American Surgical Association Foundation Fellowship (to K.J. Riehle), and the Howard Hughes Medical Institute program in Molecular Medicine and T32HL007312 (to B.J. Hayes). The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2005, J EXP MED, V201, P925, DOI 10.1084/jem.20041393; Andrae J, 2013, MOL CELL BIOL; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; ANTONIADES HN, 1990, J CLIN INVEST, V86, P1055, DOI 10.1172/JCI114808; Argast GM, 2004, J BIOL CHEM, V279, P34530, DOI 10.1074/jbc.M405703200; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Borkham-Kamphorst E, 2008, LAB INVEST, V88, P1090, DOI 10.1038/labinvest.2008.71; Breitkopf K, 2005, CYTOKINE, V31, P349, DOI 10.1016/j.cyto.2005.06.005; Campbell JS, 2007, DIFFERENTIATION, V75, P843, DOI 10.1111/j.1432-0436.2007.00235.x; Campbell JS, 2006, J IMMUNOL, V176, P2522, DOI 10.4049/jimmunol.176.4.2522; Campbell JS, 2005, P NATL ACAD SCI USA, V102, P3389, DOI 10.1073/pnas.0409722102; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Chen YT, 2011, KIDNEY INT, V80, P1170, DOI 10.1038/ki.2011.208; Chong JJH, 2013, STEM CELLS DEV, V22, P1932, DOI 10.1089/scd.2012.0542; Crosby JR, 1998, NAT GENET, V18, P385, DOI 10.1038/ng0498-385; Czochra P, 2006, J HEPATOL, V45, P419, DOI 10.1016/j.jhep.2006.04.010; Floege J, 2008, J AM SOC NEPHROL, V19, P12, DOI 10.1681/ASN.2007050532; FRIEDMAN SL, 1989, J CLIN INVEST, V84, P1780, DOI 10.1172/JCI114362; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Hasinoff BB, 2010, TOXICOL APPL PHARM, V249, P132, DOI 10.1016/j.taap.2010.08.026; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Ikura Y, 1997, J GASTROENTEROL, V32, P496, DOI 10.1007/BF02934089; Iwayama T, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0304-0; Johnson Simon, 2012, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0939s61; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Krampert M, 2008, LAB INVEST, V88, P1204, DOI 10.1038/labinvest.2008.81; McKinnon RD, 2005, J NEUROSCI, V25, P3499, DOI 10.1523/JNEUROSCI.5049-04.2005; Mellgren AM, 2008, CIRC RES, V103, P1393, DOI 10.1161/CIRCRESAHA.108.176768; Olson LE, 2011, DEV CELL, V20, P815, DOI 10.1016/j.devcel.2011.04.019; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; PIERCE GF, 1995, J CLIN INVEST, V96, P1336, DOI 10.1172/JCI118169; Pinzani M, 1996, AM J PATHOL, V148, P785; ROCKEY DC, 1992, J SUBMICR CYTOL PATH, V24, P193; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Soriano P, 1997, DEVELOPMENT, V124, P2691; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Starr SP, 2011, AM FAM PHYSICIAN, V84, P1353; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; Teo YL, 2013, CANCER TREAT REV, V39, P199, DOI 10.1016/j.ctrv.2012.09.004; Thieringer F, 2008, GENE, V423, P23, DOI 10.1016/j.gene.2008.05.022; TIRIBELLI C, 1989, HEPATOLOGY, V10, P998, DOI 10.1002/hep.1840100618; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; WONG L, 1994, J CLIN INVEST, V94, P1563, DOI 10.1172/JCI117497; Wright J. H., 2013, INT J CANC, DOI 10.1002/ijc.28421; YAMAOKA K, 1993, DIGEST DIS SCI, V38, P1473, DOI 10.1007/BF01308606; Yeh MM, 2007, AM J SURG PATHOL, V31, P681, DOI 10.1097/PAS.0b013e31802ff7aa; Zymek P, 2006, J AM COLL CARDIOL, V48, P2315, DOI 10.1016/j.jacc.2006.07.060	52	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92925	10.1371/journal.pone.0092925	http://dx.doi.org/10.1371/journal.pone.0092925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667490	Green Submitted, gold, Green Published			2022-12-25	WOS:000333675600106
J	Meng, F; Zhang, YY; Liu, F; Guo, XQ; Xu, BH				Meng, Fei; Zhang, Yuanying; Liu, Feng; Guo, Xingqi; Xu, Baohua			Characterization and Mutational Analysis of Omega-Class GST (GSTO1) from Apis cerana cerana, a Gene Involved in Response to Oxidative Stress	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; MOLECULAR CHARACTERIZATION; THIOREDOXIN PEROXIDASE; CATALYTIC MECHANISM; HONEY-BEE; IDENTIFICATION; ENZYME; CELLS; EXPRESSION; RADICALS	The Omega-class of GSTs (GSTOs) is a class of cytosolic GSTs that have specific structural and functional characteristics that differ from those of other GST groups. In this study, we demonstrated the involvement of the GSTO1 gene from A. cerana cerana in the oxidative stress response and further investigated the effects of three cysteine residues of GSTO1 protein on this response. Real-time quantitative PCR (qPCR) showed that AccGSTO1 was highly expressed in larvae and foragers, primarily in the midgut, epidermis, and flight muscles. The AccGSTO1 mRNA was significantly induced by cold and heat at 1 h and 3 h. The TBA (2-Thiobarbituric acid) method indicated that cold or heat resulted in MDA accumulation, but silencing of AccGSTO1 by RNAi in honeybees increased the concentration of MDA. RNAi also increased the temperature sensitivity of honeybees and markedly reduced their survival. Disc diffusion assay indicated that overexpression of AccGSTO1 in E. coli caused the resistance to long-term oxidative stress. Furthermore, AccGSTO1 was active in an in vitro DNA protection assay. Mutations in Cys-28, Cys-70, and Cys-124 affected the catalytic activity and antioxidant activity of AccGSTO1. The predicted three-dimensional structure of AccGSTO1 was also influenced by the replacement of these cysteine residues. These findings suggest that AccGSTO1 plays a protective role in the response to oxidative stress.	[Meng, Fei; Zhang, Yuanying; Guo, Xingqi] Shandong Agr Univ, Coll Life Sci, Tai An, Shandong, Peoples R China; [Liu, Feng; Xu, Baohua] Shandong Agr Univ, Coll Anim Sci & Technol, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Xu, BH (corresponding author), Shandong Agr Univ, Coll Anim Sci & Technol, Tai An, Shandong, Peoples R China.	bhxu@sdau.edu.cn			National Natural Science Foundation in China [31172275]; China Agriculture Research System [CARS-45]	National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	This work was financially supported by the National Natural Science Foundation (No. 31172275) in China and the China Agriculture Research System (No. CARS-45). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Board PG, 2011, DRUG METAB REV, V43, P226, DOI 10.3109/03602532.2011.561353; Burmeister C, 2008, FASEB J, V22, P343, DOI 10.1096/fj.06-7426com; Caccuri AM, 2002, J BIOL CHEM, V277, P18777, DOI 10.1074/jbc.M201137200; Cavallo D, 2003, TOXICOL IN VITRO, V17, P603, DOI 10.1016/S0887-2333(03)00138-3; Chowdhury UK, 2006, TOXICOL APPL PHARM, V216, P446, DOI 10.1016/j.taap.2006.06.014; CHU FF, 1993, J BIOL CHEM, V268, P2571; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; Dugan Laura L, 2005, Sci Aging Knowledge Environ, V2005, ppe20, DOI 10.1126/sageke.2005.26.pe20; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Elias-Neto M, 2010, INSECT BIOCHEM MOLEC, V40, P241, DOI 10.1016/j.ibmb.2010.02.004; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Flanagan SW, 1998, FEBS LETT, V431, P285, DOI 10.1016/S0014-5793(98)00779-0; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; Gustafsson A, 2001, BIOCHEMISTRY-US, V40, P15835, DOI 10.1021/bi010429i; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Harrison JF, 2002, COMP BIOCHEM PHYS A, V133, P323, DOI 10.1016/S1095-6433(02)00163-0; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Kim J, 2006, BIOCHEM J, V398, P451, DOI 10.1042/BJ20060424; Kleinhenz M, 2003, J EXP BIOL, V206, P4217, DOI 10.1242/jeb.00680; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Mahadev K, 2001, J BIOL CHEM, V276, P48662, DOI 10.1074/jbc.M105061200; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; Meng F, 2012, NATURWISSENSCHAFTEN, V99, P343, DOI 10.1007/s00114-012-0905-5; Meng F, 2010, ARCH INSECT BIOCHEM, V75, P121, DOI 10.1002/arch.20386; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Scharlaken B, 2008, DEV COMP IMMUNOL, V32, P883, DOI 10.1016/j.dci.2008.01.010; Story MD, 1999, CANCER CHEMOTH PHARM, V44, P362, DOI 10.1007/s002800050990; Suttiprapa S, 2008, MOL BIOCHEM PARASIT, V160, P116, DOI 10.1016/j.molbiopara.2008.04.010; Tanaka-Kagawa T, 2003, BIOCHEM BIOPH RES CO, V301, P516, DOI 10.1016/S0006-291X(02)03066-8; Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Tsuda M, 2010, FEBS LETT, V584, P3398, DOI 10.1016/j.febslet.2010.06.034; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Vogt G, 1997, FOLD DES, V2, pS40, DOI 10.1016/S1359-0278(97)00062-X; Walters KB, 2009, J HERED, V100, P742, DOI 10.1093/jhered/esp043; Wan Q, 2009, COMP BIOCHEM PHYS C, V150, P558, DOI 10.1016/j.cbpc.2009.08.003; WELLS WW, 1995, METHOD ENZYMOL, V252, P30; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0; Whitbread AK, 2003, PHARMACOGENETICS, V13, P131, DOI 10.1097/00008571-200303000-00003; Winayanuwattikun P, 2005, J BIOL CHEM, V280, P31776, DOI 10.1074/jbc.M502612200; Xun LY, 2010, BIOCHEM J, V428, P419, DOI 10.1042/BJ20091863; Yamamoto K, 2011, INSECT MOL BIOL, V20, P379, DOI 10.1111/j.1365-2583.2011.01073.x; Yan XD, 2007, J PROTEOME RES, V6, P772, DOI 10.1021/pr060402r; Yu F, 2011, INSECT MOL BIOL, V20, P367, DOI 10.1111/j.1365-2583.2011.01071.x; Zhang YY, 2013, CELL STRESS CHAPERON, V18, P503, DOI 10.1007/s12192-013-0406-2	52	25	26	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93100	10.1371/journal.pone.0093100	http://dx.doi.org/10.1371/journal.pone.0093100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667966	Green Submitted, Green Published, gold			2022-12-25	WOS:000333675600138
J	Momot, D; Zheng, CY; Yin, HG; Elbekai, RH; Vallant, M; Chiorini, JA				Momot, Dariya; Zheng, Changyu; Yin, Hongen; Elbekai, Reem H.; Vallant, Molly; Chiorini, John A.			Toxicity and Biodistribution of the Serotype 2 Recombinant Adeno-Associated Viral Vector, Encoding Aquaporin-1, after Retroductal Delivery to a Single Mouse Parotid Gland	PLOS ONE			English	Article							ADENOVIRAL-MEDIATED TRANSFER; RAT SALIVARY-GLANDS; FLUID SECRETION; CDNA	In preparation for testing the safety of using serotype 2 recombinant adeno-associated vector, encoding Aquaporin-1 to treat radiation-induced salivary gland damage in a phase 1 clinical trial, we conducted a 13 week GLP biodistribution and toxicology study using Balb/c mice. To best assess the safety of rAAV2hAQP1 as well as resemble clinical delivery, vector (10(6), 10(9), 10(10), or 4.4x10(10) vector particles/gland) or saline was delivered to the right parotid gland of mice via retroductal cannulation. Very mild surgically induced inflammation was caused by this procedure, seen in 3.6% of animals for the right parotid gland, and 5.3% for the left parotid gland. Long term distribution of vector appeared to be localized to the site of cannulation as well as the right and left draining submandibular lymph nodes at levels >50 copies/mu g in some animals. As expected, there was a dose-related increase in neutralizing antibodies produced by day 29. Overall, animals appeared to thrive, with no differences in mean body weight, food or water consumption between groups. There were no significant adverse effects due to treatment noted by clinical chemistry and pathology evaluations. Hematology assessment of serum demonstrated very limited changes to the white blood cell, segmented neutrophils, and hematocrit levels and were concluded to not be vector-associated. Indicators for liver, kidney, cardiac functions and general tissue damage showed no changes due to treatment. All of these indicators suggest the treatment is clinically safe.	[Momot, Dariya; Zheng, Changyu; Yin, Hongen; Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Elbekai, Reem H.] BioReliance SAFC, Div Toxicol, Rockville, MD USA; [Vallant, Molly] NIEHS, Natl Toxicol Program, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Chiorini, JA (corresponding author), Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA.	jchiorini@dir.nidcr.nih.gov			NTP/NIEHS (National Toxicology Program, National Institute of Environmental Health Sciences) [NO1-ES-55536]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000695] Funding Source: NIH RePORTER	NTP/NIEHS (National Toxicology Program, National Institute of Environmental Health Sciences); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was conducted at BioReliance, supported by NTP/NIEHS (National Toxicology Program, National Institute of Environmental Health Sciences) contract NO1-ES-55536. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Baum BJ, 2012, P NATL ACAD SCI USA, V109, P19403, DOI 10.1073/pnas.1210662109; Braam PM, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-3; Delporte C, 1997, P NATL ACAD SCI USA, V94, P3268, DOI 10.1073/pnas.94.7.3268; Gao R, 2011, GENE THER, V18, P38, DOI 10.1038/gt.2010.128; Johnson PA, 1992, J VIROL, V66, P2652; Kagami H, 1998, HUM GENE THER, V9, P305, DOI 10.1089/hum.1998.9.3-305; Katano H, 2006, GENE THER, V13, P594, DOI 10.1038/sj.gt.3302691; LI J, 1994, PFLUG ARCH EUR J PHY, V428, P455, DOI 10.1007/BF00374565; Voutetakis A, 2007, HUM GENE THER, V18, P1109, DOI 10.1089/hum.2007.072; Zheng CY, 2006, HUM GENE THER, V17, P1122, DOI 10.1089/hum.2006.17.1122	11	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92832	10.1371/journal.pone.0092832	http://dx.doi.org/10.1371/journal.pone.0092832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667436	Green Submitted, Green Published, gold			2022-12-25	WOS:000333675600085
J	Cheng, J; Edin, ML; Hoopes, SL; Li, H; Bradbury, JA; Graves, JP; DeGraff, LM; Lih, FB; Garcia, V; Shaik, JSB; Tomer, KB; Flake, GP; Falck, JR; Lee, CR; Poloyac, SM; Schwartzman, ML; Zeldin, DC				Cheng, Jennifer; Edin, Matthew L.; Hoopes, Samantha L.; Li, Hong; Bradbury, J. Alyce; Graves, Joan P.; DeGraff, Laura M.; Lih, Fred B.; Garcia, Victor; Shaik, Jafar Sadik B.; Tomer, Kenneth B.; Flake, Gordon P.; Falck, John R.; Lee, Craig R.; Poloyac, Samuel M.; Schwartzman, Michal L.; Zeldin, Darryl C.			Vascular characterization of mice with endothelial expression of cytochrome P450 4F2	FASEB JOURNAL			English	Article						CYP4F2; 20-HETE; oxidative stress; cellular proliferation; angiogenesis	URINARY 20-HYDROXYEICOSATETRAENOIC ACID; OXIDATIVE STRESS; 20-HETE SYNTHESIS; ARACHIDONIC-ACID; BLOOD-PRESSURE; NADPH-OXIDASE; RENAL INJURY; DYSFUNCTION; HYPERTENSION; ACTIVATION	Cytochrome P450 (CYP) 4A and 4F enzymes metabolize arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE). Although CYP4A-derived 20-HETE is known to have prohypertensive and proangiogenic properties, the effects of CYP4F-derived metabolites are not well characterized. To investigate the role of CYP4F2 in vascular disease, we generated mice with endothelial expression of human CYP4F2 (Tie2-CYP4F2-Tr). LC/MS/MS analysis revealed 2-fold increases in 20-HETE levels in tissues and endothelial cells (ECs), relative to wild-type (WT) controls. Tie2-CYP4F2-Tr ECs demonstrated increases in growth (267.1 +/- 33.4 vs. 205.0 +/- 13% at 48 h) and tube formation (7.7 +/- 1.1 vs. 1.6 +/- 0.5 tubes/field) that were 20-HETE dependent and associated with up-regulation of prooxidant NADPH oxidase and proangiogenic VEGF. Increases in VEGF and NADPH oxidase levels were abrogated by inhibitors of NADPH oxidase and MAPK, respectively, suggesting the possibility of crosstalk between pathways. Interestingly, IL-6 levels in Tie2-CYP4F2-Tr mice (18.6 +/- 2.7 vs. 7.9 +/- 2.7 pg/ml) were up-regulated via NADPH oxidase-and 20-HETE-dependent mechanisms. Although Tie2-CYP4F2-Tr aortas displayed increased vasoconstriction, vasorelaxation and blood pressure were unchanged. Our findings indicate that human CYP4F2 significantly increases 20-HETE production, CYP4F2-derived 20-HETE mediates EC proliferation and angiogenesis via VEGF-and NADPH oxidase-dependent manners, and the Tie2-CYP4F2-Tr mouse is a novel model for examining the pathophysiological effects of CYP4F2-derived 20-HETE in the vasculature.	[Cheng, Jennifer; Edin, Matthew L.; Hoopes, Samantha L.; Li, Hong; Bradbury, J. Alyce; Graves, Joan P.; DeGraff, Laura M.; Lih, Fred B.; Tomer, Kenneth B.; Flake, Gordon P.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA; [Falck, John R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Garcia, Victor; Schwartzman, Michal L.] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; [Lee, Craig R.] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA; [Shaik, Jafar Sadik B.; Poloyac, Samuel M.] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Texas System; University of Texas Southwestern Medical Center Dallas; New York Medical College; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zeldin, DC (corresponding author), NIEHS, NIH, 111 TW Alexander Dr,Bldg 101,Rm A214, Res Triangle Pk, NC 27709 USA.	zeldin@niehs.nih.gov	SHAIK, JAFAR SADIK/A-9638-2010; Li, Hong/ABE-3959-2021; Edin, Matthew/AAI-1934-2019; Zeldin, Darryl C/Y-7091-2018	SHAIK, JAFAR SADIK/0000-0001-5776-3138; Zeldin, Darryl C/0000-0002-2087-7307; Lee, Craig/0000-0003-3595-5301; Garcia, Victor/0000-0002-1849-8834; Edin, Matthew/0000-0002-7042-500X	U.S. National Institutes of Health (NIH) [DK-38226]; Robert A. Welch Foundation; NIH [GM-088199, HL-34300]; NIH, National Institute of Environmental Health Sciences [Z01 ES050167, Z01 ES025034];  [HL-34300-26A1S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050167, ZIAES025034, ZIAES103005, Z01ES025034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088199] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge the staff at Xenogen Biosciences (Cranberry, NJ, USA) for assistance with pronuclear injections and generation of the Tie2-CYP4F2-Tr mice. This work was made possible by U.S. National Institutes of Health (NIH) grant DK-38226 and support from the Robert A. Welch Foundation (to J.R.F.), NIH grant GM-088199 (to C. R. L), NIH grant HL-34300 (to M. L. S.), Diversity Supplement Award HL-34300-26A1S1 (to V. G.), and funds from the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (Z01 ES050167 to K. B. T. and Z01 ES025034 to D.C.Z.).	Alexanian A, 2012, CANCER GENOM PROTEOM, V9, P163; Alexanian A, 2009, ANTICANCER RES, V29, P3819; Amaral SL, 2003, AM J PHYSIOL-HEART C, V284, pH1528, DOI 10.1152/ajpheart.00406.2002; Athirakul K, 2008, FASEB J, V22, P4096, DOI 10.1096/fj.08-114413; Behrens MM, 2008, J NEUROSCI, V28, P13957, DOI 10.1523/JNEUROSCI.4457-08.2008; Chen P, 2005, AM J PATHOL, V166, P615, DOI 10.1016/S0002-9440(10)62282-1; Chen YM, 2006, AM J PHYSIOL-LUNG C, V291, pL378, DOI 10.1152/ajplung.00424.2005; Cheng J, 2008, AM J PHYSIOL-HEART C, V294, pH1018, DOI 10.1152/ajpheart.01172.2007; Cheng J, 2012, ARTERIOSCL THROM VAS, V32, P1917, DOI 10.1161/ATVBAHA.112.248344; Cheng J, 2010, J PHARMACOL EXP THER, V332, P57, DOI 10.1124/jpet.109.159863; Deng SM, 2010, PROG NEURO-PSYCHOPH, V34, P664, DOI 10.1016/j.pnpbp.2010.03.009; Edin ML, 2011, FASEB J, V25, P3436, DOI 10.1096/fj.11-188300; Guo AM, 2007, J PHARMACOL EXP THER, V321, P18, DOI 10.1124/jpet.106.115360; Guo AM, 2009, AM J PHYSIOL-HEART C, V297, pH602, DOI 10.1152/ajpheart.00874.2008; Hankin JA, 2000, AM J RESP CRIT CARE, V161, pS81, DOI 10.1164/ajrccm.161.supplement_1.ltta-17; Hoff U, 2011, KIDNEY INT, V79, P57, DOI 10.1038/ki.2010.377; Inoue K, 2009, AM J PHYSIOL-RENAL, V297, pF875, DOI 10.1152/ajprenal.00364.2009; Ishizuka T, 2008, J PHARMACOL EXP THER, V324, P103, DOI 10.1124/jpet.107.130336; Jacobs ER, 2006, AM J PHYSIOL-LUNG C, V291, pL369, DOI 10.1152/ajplung.00265.2004; Jiang M, 2004, CIRC RES, V94, P167, DOI 10.1161/01.RES.0000111523.12842.FC; Lasker JM, 2000, J BIOL CHEM, V275, P4118, DOI 10.1074/jbc.275.6.4118; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Lee CR, 2010, FASEB J, V24, P3770, DOI 10.1096/fj.10-160119; Liu H, 2008, J AM SOC NEPHROL, V19, P714, DOI 10.1681/ASN.2007060713; Liu XL, 2012, GENE, V505, P352, DOI 10.1016/j.gene.2012.02.029; Liu XL, 2009, KIDNEY INT, V75, P1288, DOI 10.1038/ki.2009.67; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medhora M, 2008, AM J PHYSIOL-LUNG C, V294, pL902, DOI 10.1152/ajplung.00278.2007; Miyata Noriyuki, 2005, Journal of Smooth Muscle Research, V41, P175, DOI 10.1540/jsmr.41.175; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Park F, 2008, J AM SOC NEPHROL, V19, P1929, DOI 10.1681/ASN.2007070771; Powell PK, 1998, J PHARMACOL EXP THER, V285, P1327; Schuck RN, 2013, ATHEROSCLEROSIS, V227, P442, DOI 10.1016/j.atherosclerosis.2013.01.034; Singh H, 2007, HYPERTENSION, V50, P123, DOI 10.1161/HYPERTENSIONAHA.107.089599; ten Freyhaus H, 2006, CARDIOVASC RES, V71, P331, DOI 10.1016/j.cardiores.2006.01.022; Uddin MR, 1998, HYPERTENSION, V31, P242, DOI 10.1161/01.HYP.31.1.242; Wang JS, 2006, CIRC RES, V98, P962, DOI 10.1161/01.RES.0000217283.98806.a6; Ward NC, 2008, HYPERTENSION, V51, P1393, DOI 10.1161/HYPERTENSIONAHA.107.104463; Ward NC, 2005, FREE RADICAL BIO MED, V38, P1032, DOI 10.1016/j.freeradbiomed.2004.12.024; Ward NC, 2004, CIRCULATION, V110, P438, DOI 10.1161/01.CIR.0000136808.72912.D9; Wassmann S, 2004, CIRC RES, V94, P534, DOI 10.1161/01.RES.0000115557.25127.8D; Yu W, 2011, CANCER CHEMOTH PHARM, V68, P619, DOI 10.1007/s00280-010-1521-8; Zalba G, 2001, HYPERTENSION, V38, P1395, DOI 10.1161/hy1201.099611; Zeng QH, 2010, AM J PHYSIOL-HEART C, V299, pH1109, DOI 10.1152/ajpheart.00067.2010	44	25	27	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2915	2931		10.1096/fj.13-241927	http://dx.doi.org/10.1096/fj.13-241927			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24668751	Green Published, Bronze			2022-12-25	WOS:000337949400016
J	Winardhi, RS; Gulvady, R; Mellies, JL; Yan, J				Winardhi, Ricksen S.; Gulvady, Ranjit; Mellies, Jay L.; Yan, Jie			Locus of Enterocyte Effacement-encoded Regulator ( Ler) of Pathogenic Escherichia coli Competes Off Histone-like Nucleoid-structuring Protein ( H-NS) through Noncooperative DNA Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atomic Force Microscopy; DNA-binding Protein; Gene Regulation; Protein-DNA Interaction; Single Molecule Biophysics; H-NS; Ler; Magnetic Tweezers	TRANSCRIPTIONAL REGULATION; NUCLEOPROTEIN FILAMENT; OLIGOMERIZATION; FORCE; EXPRESSION; MOLECULES; VIRULENCE; DOMAIN; GENES; ORGANIZATION	Background: Ler alleviates H-NS-mediated gene silencing. Results: LerDNA binding properties and Ler effects on H-NSDNA binding are investigated using magnetic tweezers and atomic force microscopy. Conclusion: Ler binds noncooperatively to stiffen and fold DNA, and it can replace prebound H-NS in the conditions tested. Significance: The findings provide new insights into the molecular mechanism of anti-silencing by Ler. The locus of enterocyte effacement-encoded regulator (Ler) of enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC) functions to activate transcription of virulence genes silenced by the histone-like nucleoid-structuring protein (H-NS). Despite its important role in the bacterial gene regulation, the binding mode of Ler to DNA and its mechanism in alleviating genes repressed by H-NS are largely unknown. In this study, we use magnetic tweezers to demonstrate that Ler binds extended DNA through a largely noncooperative process, which results in DNA stiffening and DNA folding depending on protein concentration. We also show that Ler can replace prebound H-NS on DNA over a range of potassium and magnesium concentrations. Our findings reveal the DNA binding properties of Ler and shed light to further understand the anti-silencing activity of Ler.	[Winardhi, Ricksen S.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Winardhi, Ricksen S.; Gulvady, Ranjit; Yan, Jie] Mechanobiol Inst, Singapore 117411, Singapore; [Winardhi, Ricksen S.; Gulvady, Ranjit; Yan, Jie] Natl Univ Singapore, Ctr BioImaging Sci, Singapore 117543, Singapore; [Mellies, Jay L.] Reed Coll, Dept Biol, Portland, OR 97202 USA; [Yan, Jie] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore	National University of Singapore; National University of Singapore; Reed College - Oregon; National University of Singapore	Mellies, JL (corresponding author), Reed Coll, Dept Biol, 3203 SE Woodstock Blvd, Portland, OR 97202 USA.	jay.mellies@reed.edu; phyyj@nus.edu.sg	Yan, Jie/G-2725-2012	Yan, Jie/0000-0002-8555-7291	Ministry of Education of Singapore, National Research Foundation of Singapore [MOE 2013-T2-1-154]; Mechanobiology Institute Singapore	Ministry of Education of Singapore, National Research Foundation of Singapore; Mechanobiology Institute Singapore	This work was supported by the Ministry of Education of Singapore, National Research Foundation of Singapore Grant MOE 2013-T2-1-154, and by the Mechanobiology Institute Singapore (to J.Y.).	Ali SS, 2012, CURR OPIN MICROBIOL, V15, P175, DOI 10.1016/j.mib.2011.12.014; Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; Berdichevsky T, 2005, J BACTERIOL, V187, P349, DOI 10.1128/JB.187.1.349-357.2005; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Bustamante VH, 2001, MOL MICROBIOL, V39, P664, DOI 10.1046/j.1365-2958.2001.02209.x; Ceschini S, 2000, J BIOL CHEM, V275, P729, DOI 10.1074/jbc.275.2.729; CHRISTIAN J, 1961, J GEN MICROBIOL, V25, P97, DOI 10.1099/00221287-25-1-97; Cordeiro TN, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002380; Dame RT, 2000, NUCLEIC ACIDS RES, V28, P3504, DOI 10.1093/nar/28.18.3504; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Dorman CJ, 1999, TRENDS MICROBIOL, V7, P124, DOI 10.1016/S0966-842X(99)01455-9; Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000; Esposito D, 2002, J MOL BIOL, V324, P841, DOI 10.1016/S0022-2836(02)01141-5; Fang FC, 2008, CURR OPIN MICROBIOL, V11, P113, DOI 10.1016/j.mib.2008.02.011; Fu HX, 2013, NUCLEIC ACIDS RES, V41, P924, DOI 10.1093/nar/gks1162; Fu HX, 2011, CHROMOSOMA, V120, P245, DOI 10.1007/s00412-010-0307-4; Garcia J, 2012, NUCLEIC ACIDS RES, V40, P10254, DOI 10.1093/nar/gks846; Hill AV, 1910, J PHYSL, V40, piv, DOI DOI 10.1371/JOURNAL.PONE.0041098; Holbrook JA, 2001, J MOL BIOL, V310, P379, DOI 10.1006/jmbi.2001.4768; Lim CJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00509; Lim CJ, 2012, NUCLEIC ACIDS RES, V40, P3316, DOI 10.1093/nar/gkr1247; Lin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049885; Liu YJ, 2010, GENE DEV, V24, P339, DOI 10.1101/gad.1883510; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; LUSK JE, 1968, J BIOL CHEM, V243, P2618; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Martin-Orozco N, 2006, MOL BIOL CELL, V17, P498, DOI 10.1091/mbc.E04-12-1096; Mellies JL, 2011, MICROBIOL-SGM, V157, P1123, DOI 10.1099/mic.0.046094-0; Qu Y, 2013, NUCLEIC ACIDS RES, V41, P5263, DOI 10.1093/nar/gkt249; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Smyth CP, 2000, MOL MICROBIOL, V36, P962, DOI 10.1046/j.1365-2958.2000.01917.x; Sperandio V, 2000, MOL MICROBIOL, V38, P781, DOI 10.1046/j.1365-2958.2000.02168.x; Steinmann R, 2013, FUTURE MICROBIOL, V8, P85, DOI [10.2217/FMB.12.129, 10.2217/fmb.12.129]; Stoebel DM, 2008, MICROBIOL-SGM, V154, P2533, DOI 10.1099/mic.0.2008/020693-0; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; Torres AG, 2007, J BACTERIOL, V189, P5916, DOI 10.1128/JB.00245-07; Ueguchi C, 1997, J MOL BIOL, V274, P145, DOI 10.1006/jmbi.1997.1381; Umanski T, 2002, MICROBIOL-SGM, V148, P2735, DOI 10.1099/00221287-148-9-2735; Walthers D, 2011, J BIOL CHEM, V286, P1895, DOI 10.1074/jbc.M110.164962; Wang HD, 2002, BIOPHYS J, V83, P3619, DOI 10.1016/S0006-3495(02)75362-9; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Winardhi RS, 2012, NUCLEIC ACIDS RES, V40, P8942, DOI 10.1093/nar/gks669; Yan J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011905; Yerushalmi G, 2008, J BACTERIOL, V190, P7808, DOI 10.1128/JB.00663-08	45	33	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13739	13750		10.1074/jbc.M113.545954	http://dx.doi.org/10.1074/jbc.M113.545954			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24668810	hybrid, Green Published			2022-12-25	WOS:000335984600008
J	Valero, C; Javierre, E; Garcia-Aznar, JM; Gomez-Benito, MJ				Valero, Clara; Javierre, Etelvina; Manuel Garcia-Aznar, Jose; Jose Gomez-Benito, Maria			A Cell-Regulatory Mechanism Involving Feedback between Contraction and Tissue Formation Guides Wound Healing Progression	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; GROWTH-FACTOR-BETA; MECHANOCHEMICAL MODEL; MATRIX CONTRACTION; GRANULATION-TISSUE; FORCE GENERATION; STIFFNESS; COLLAGEN; FIBROBLASTS; MIGRATION	Wound healing is a process driven by cells. The ability of cells to sense mechanical stimuli from the extracellular matrix that surrounds them is used to regulate the forces that cells exert on the tissue. Stresses exerted by cells play a central role in wound contraction and have been broadly modelled. Traditionally, these stresses are assumed to be dependent on variables such as the extracellular matrix and cell or collagen densities. However, we postulate that cells are able to regulate the healing process through a mechanosensing mechanism regulated by the contraction that they exert. We propose that cells adjust the contraction level to determine the tissue functions regulating all main activities, such as proliferation, differentiation and matrix production. Hence, a closed-regulatory feedback loop is proposed between contraction and tissue formation. The model consists of a system of partial differential equations that simulates the evolution of fibroblasts, myofibroblasts, collagen and a generic growth factor, as well as the deformation of the extracellular matrix. This model is able to predict the wound healing outcome without requiring the addition of phenomenological laws to describe the time-dependent contraction evolution. We have reproduced two in vivo experiments to evaluate the predictive capacity of the model, and we conclude that there is feedback between the level of cell contraction and the tissue regenerated in the wound.	[Valero, Clara; Manuel Garcia-Aznar, Jose; Jose Gomez-Benito, Maria] Univ Zaragoza, Aragon Inst Engn Res I3A, Zaragoza, Spain; [Javierre, Etelvina] Ctr Univ Def Zaragoza, Acad Gen Militar, Zaragoza, Spain	University of Zaragoza	Valero, C (corresponding author), Univ Zaragoza, Aragon Inst Engn Res I3A, Zaragoza, Spain.	claraval@unizar.es	Javierre, Etelvina/J-9524-2015; Garcia-Aznar, Jose Manuel/F-8256-2010; Valero, Clara/AAY-9640-2021; Gomez-Benito, Maria Jose/A-5368-2010; Javierre, Etelvina/J-9524-2015	Javierre, Etelvina/0000-0002-8117-1674; Garcia-Aznar, Jose Manuel/0000-0002-9864-7683; Gomez-Benito, Maria Jose/0000-0002-1878-8997; Valero Lazaro, Clara/0000-0001-9318-7107; Javierre, Etelvina/0000-0002-5554-5054	Spanish Ministry of Economy and Competitiveness [DPI2012-32880, BES2010-037281]; European Research Council (ERC) [ERC-2012-StG 306751]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Research Council (ERC)(European Research Council (ERC)European Commission)	This research was supported by the Spanish Ministry of Economy and Competitiveness (Grant DPI2012-32880 and BES2010-037281) (http://www.mineco.gob.es/portal/site/mineco/?lang_choosen = en). Financial support of the European Research Council (ERC) through project ERC-2012-StG 306751 is gratefully acknowledged (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Adam JA, 2000, MATH COMPUT MODEL, V31, P237, DOI 10.1016/S0895-7177(00)00054-6; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Bidan CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036336; Bluestein D, 2008, AM FAM PHYSICIAN, V78, P1186; Borau C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049174; Chiquet M, 2003, MATRIX BIOL, V22, P73, DOI 10.1016/S0945-053X(03)00004-0; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038; Grinnell F, 2000, TRENDS CELL BIOL, V10, P362, DOI 10.1016/S0962-8924(00)01802-X; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; GROTENDORST GR, 1981, P NATL ACAD SCI-BIOL, V78, P3669, DOI 10.1073/pnas.78.6.3669; GUIDRY C, 1992, CANCER METAST REV, V11, P45, DOI 10.1007/BF00047602; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harland B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015011; Hinz B, 2003, CURR OPIN BIOTECH, V14, P538, DOI 10.1016/j.copbio.2003.08.006; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Javierre E, 2009, INT J SOLIDS STRUCT, V46, P3597, DOI 10.1016/j.ijsolstr.2009.06.010; Jones C, 2011, EXP MOL PATHOL, V91, P394, DOI 10.1016/j.yexmp.2011.04.007; Khatyr F, 2004, SKIN RES TECHNOL, V10, P96, DOI 10.1111/j.1600-0846.2004.00057.x; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; MCGRATH MH, 1983, PLAST RECONSTR SURG, V72, P66, DOI 10.1097/00006534-198307000-00015; Mitrossilis D, 2010, P NATL ACAD SCI USA, V107, P16518, DOI 10.1073/pnas.1007940107; Mitrossilis D, 2009, P NATL ACAD SCI USA, V106, P18243, DOI 10.1073/pnas.0903994106; Moreo P, 2008, ACTA BIOMATER, V4, P613, DOI 10.1016/j.actbio.2007.10.014; Murphy KE, 2012, B MATH BIOL, V74, P1143, DOI 10.1007/s11538-011-9712-y; Murphy KE, 2011, J THEOR BIOL, V272, P145, DOI 10.1016/j.jtbi.2010.12.011; Murray JD, 1998, J FRANKLIN I, V335B, P303, DOI 10.1016/S0016-0032(97)00034-3; Ogawa R, 2011, WOUND REPAIR REGEN, V19, pS2, DOI 10.1111/j.1524-475X.2011.00707.x; OLSEN L, 1995, J THEOR BIOL, V177, P113, DOI 10.1006/jtbi.1995.0230; Olsen L, 1996, B MATH BIOL, V58, P787, DOI 10.1016/0092-8240(96)00003-1; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Radovanac K, 2013, EMBO J, V32, P1409, DOI 10.1038/emboj.2013.90; Reina-Romo E, 2010, P I MECH ENG H, V224, P1245, DOI 10.1243/09544119JEIM787; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Roy S, 2009, PHYSIOL GENOMICS, V37, P211, DOI 10.1152/physiolgenomics.90362.2008; Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Serra-Picamal X, 2012, NAT PHYS, V8, P628, DOI [10.1038/NPHYS2355, 10.1038/nphys2355]; SHERRATT JA, 1991, J MATH BIOL, V29, P389, DOI 10.1007/BF00160468; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; TRANQUILLO RT, 1992, J THEOR BIOL, V158, P135, DOI 10.1016/S0022-5193(05)80715-5; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193	51	39	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92774	10.1371/journal.pone.0092774	http://dx.doi.org/10.1371/journal.pone.0092774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681636	gold, Green Published			2022-12-25	WOS:000333678100016
J	Betsch, M; Thelen, S; Santak, L; Herten, M; Jungbluth, P; Miersch, D; Hakimi, M; Wild, M				Betsch, Marcel; Thelen, Simon; Santak, Laila; Herten, Monika; Jungbluth, Pascal; Miersch, Daniel; Hakimi, Mohssen; Wild, Michael			The Role of Erythropoietin and Bone Marrow Concentrate in the Treatment of Osteochondral Defects in Mini-Pigs	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; RECOMBINANT-HUMAN-ERYTHROPOIETIN; BETA-TRICALCIUM PHOSPHATE; CARTILAGE DEFECTS; ANIMAL-MODELS; REPAIR; REGENERATION; PLUG; KNEE; MICROFRACTURE	Background: All available treatment options for osteochondral and chondral defects do not restore hyaline cartilage and are limited to decreasing associated pain, and maintaining or improving joint function. The purpose of this study was to evaluate the potential of erythropoietin (EPO) in combination with bone marrow aspiration concentrate (BMAC) in the treatment of osteochondral defects of mini-pigs. Methods: 14 Goettinger mini-pigs, in which a 6610 mm osteochondral defect in the medial femoral condyle of both knee joints was created, were randomized into four groups: biphasic scaffold alone, scaffold with EPO, scaffold with BMAC and scaffold in combination with EPO and BMAC. After 26 weeks all animals were euthanized and histological slides were evaluated using a modified ODriscoll Score. Results: In the therapy groups, areas of chondrogenic tissue that contained collagen II were present. Adding EPO (p = 0.245) or BMAC (p = 0.099) alone to the scaffold led to a non-significant increase in the score compared to the control group. However, the combination of EPO and BMAC in the implanted scaffold showed a significant improvement (p = 0.02) in the histological score. Conclusion: The results of our study show that in mini-pigs, the combination of EPO and BMAC leads to an enhanced osteochondral healing. However, additional research is necessary to further improve the repair tissue and to define the role of MSCs and EPO in cartilage repair.	[Betsch, Marcel; Thelen, Simon; Santak, Laila; Jungbluth, Pascal; Miersch, Daniel; Hakimi, Mohssen] Univ Hosp Duesseldorf, Dept Trauma & Hand Surg, Dusseldorf, Germany; [Herten, Monika] Univ Hosp Muenster, Dept & Endovasc Surg, Munster, Germany; [Wild, Michael] Klinikum Darmstadt, Dept Trauma & Orthopaed Surg, Darmstadt, Germany	University of Munster; Klinikum Darmstadt	Thelen, S (corresponding author), Univ Hosp Duesseldorf, Dept Trauma & Hand Surg, Dusseldorf, Germany.	simon.thelen@med.uni-duesseldorf.de	Herten, Monika/J-1547-2015; Jungbluth, Pascal/L-6703-2017	Herten, Monika/0000-0001-9697-0287; Wild, Michael/0000-0002-6306-4867	Medical Faculty, Heinrich Heine University Duesseldorf, Germany	Medical Faculty, Heinrich Heine University Duesseldorf, Germany	This study was funded by a research grant of the Medical Faculty, Heinrich Heine University Duesseldorf, Germany. The TRUFIT BGS scaffolds were provided by Smith & Nephew, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Brittberg M, 1999, CLIN ORTHOP RELAT R, pS147; Carmont MR, 2009, ARTHROSCOPY, V25, P810, DOI 10.1016/j.arthro.2009.01.023; CASTROMALASPINA H, 1980, BLOOD, V56, P289; Chen FH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2514; Chen Long, 2008, Zhonghua Xue Ye Xue Za Zhi, V29, P811; Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]; De Spiegelaere W, 2010, MOL CELL BIOCHEM, V337, P287, DOI 10.1007/s11010-009-0310-3; Dennis JE, 2007, STEM CELLS, V25, P2575, DOI 10.1634/stemcells.2007-0204; Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017; DONATH K, 1985, PATHOL RES PRACT, V179, P631, DOI 10.1016/S0344-0338(85)80209-0; Fortier LA, 2010, J BONE JOINT SURG AM, V92A, P1927, DOI 10.2106/JBJS.I.01284; Galeano M, 2006, CRIT CARE MED, V34, P1139, DOI 10.1097/01.CCM.0000206468.18653.EC; Gan YK, 2008, BIOMATERIALS, V29, P3973, DOI 10.1016/j.biomaterials.2008.06.026; Grassel S, 2012, ORTHOPADE, V41, P415, DOI 10.1007/s00132-012-1933-8; Hatzokos I, 2011, J BONE JOINT SURG AM, V93A, P671, DOI 10.2106/JBJS.J.00514; Hendrich C, 2009, ORTHOP REV, V1, P99, DOI 10.4081/or.2009.e32; Hermann PC, 2007, CELL TRANSPLANT, V16, P1059, DOI 10.3727/000000007783472363; Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215; Hernigou P, 2006, J BONE JOINT SURG AM, V88A, P2565, DOI 10.2106/JBJS.E.01455; Hettrich CM, 2008, SPORTS MED ARTHROSC, V16, P230, DOI 10.1097/JSA.0b013e31818cdc98; Holstein JH, 2007, LIFE SCI, V80, P893, DOI 10.1016/j.lfs.2006.11.023; Huang AH, 2008, ANN BIOMED ENG, V36, P1909, DOI 10.1007/s10439-008-9562-4; Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbrc.2004.06.029; Jackson DW, 2001, J BONE JOINT SURG AM, V83A, P53, DOI 10.2106/00004623-200101000-00008; Jager M, 2011, J ORTHOP RES, V29, P173, DOI 10.1002/jor.21230; Joshi N, 2012, AM J SPORT MED, V40, P1289, DOI 10.1177/0363546512441585; Martin DR, 2002, EXP HEMATOL, V30, P879, DOI 10.1016/S0301-472X(02)00864-0; Melton JTK, 2010, EXPERT REV MED DEVIC, V7, P333, DOI 10.1586/ERD.10.15; Mihmanli A, 2009, J ORAL MAXIL SURG, V67, P2337, DOI 10.1016/j.joms.2008.06.082; Moon C, 2005, CARDIOVASC DRUG THER, V19, P243, DOI 10.1007/s10557-005-3189-6; Muschler GF, 2001, J ORTHOP RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3; Pastides P, 2013, OSTEOARTHR CARTILAGE, V21, P646, DOI 10.1016/j.joca.2013.02.008; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rudert M, 2002, CELLS TISSUES ORGANS, V171, P229, DOI 10.1159/000063125; Sauerbier S, 2010, TISSUE ENG PART C-ME, V16, P215, DOI [10.1089/ten.tec.2009.0269, 10.1089/ten.TEC.2009.0269]; Schwarz F, 2007, INT J ORAL MAX SURG, V36, P1198, DOI 10.1016/j.ijom.2007.07.014; Shiozawa Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010853; Smiler Dennis, 2006, Implant Dent, V15, P229, DOI 10.1097/01.id.0000236125.70742.86; Sorg H, 2013, MED RES REV, V33, P637, DOI 10.1002/med.21259; Thiemermann C, 2007, CRIT CARE, V11, DOI 10.1186/cc5912; Thoesen MS, 2006, AM J VET RES, V67, P1655, DOI 10.2460/ajvr.67.10.1655; von Rechenberg B, 2003, OSTEOARTHR CARTILAGE, V11, P265, DOI 10.1016/S1063-4584(03)00006-2; Yen YM, 2008, MED SCI SPORT EXER, V40, P200, DOI 10.1249/mss.0b013e31815cb212; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004	46	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92766	10.1371/journal.pone.0092766	http://dx.doi.org/10.1371/journal.pone.0092766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676029	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500037
J	Jerng, HH; Pfaffinger, PJ				Jerng, Henry H.; Pfaffinger, Paul J.			S-Glutathionylation of an Auxiliary Subunit Confers Redox Sensitivity to Kv4 Channel Inactivation	PLOS ONE			English	Article							N-TYPE INACTIVATION; 2-IODOMELATONIN PREVENTS APOPTOSIS; CEREBELLAR GRANULE NEURONS; CLOSED-STATE INACTIVATION; GATED K+ CHANNELS; FUNCTIONAL-CHARACTERIZATION; MOLECULAR PHYSIOLOGY; BUTYL HYDROPEROXIDE; OXIDATIVE STRESS; BETA-SUBUNIT	Reactive oxygen species (ROS) regulate ion channels, modulate neuronal excitability, and contribute to the etiology of neurodegenerative disorders. ROS differentially suppress fast "ball-and-chain'' N-type inactivation of cloned Kv1 and Kv3 potassium channels but not of Kv4 channels, likely due to a lack of reactive cysteines in Kv4 N-termini. Recently, we discovered that N-type inactivation of Kv4 channel complexes can be independently conferred by certain N-terminal variants of Kv4 auxiliary subunits (DPP6a, DPP10a). Here, we report that both DPP6a and DPP10a, like Kv subunits with redox-sensitive N-type inactivation, contain a highly conserved cysteine in their N-termini (Cys-13). To test if N-type inactivation mediated by DPP6a or DPP10a is redox sensitive, Xenopus oocyte recordings were performed to examine the effects of two common oxidants, tert-butyl hydroperoxide (tBHP) and diamide. Both oxidants markedly modulate DPP6a- or DPP10a-conferred N-type inactivation of Kv4 channels, slowing the overall inactivation and increasing the peak current. These functional effects are fully reversed by the reducing agent dithiothreitol (DTT) and appear to be due to a selective modulation of the N-type inactivation mediated by these auxiliary subunits. Mutation of DPP6a Cys-13 to serine eliminated the tBHP or diamide effects, confirming the importance of Cys-13 to the oxidative regulation. Biochemical studies designed to elucidate the underlying molecular mechanism show no evidence of protein-protein disulfide linkage formation following cysteine oxidation. Instead, using a biotinylated glutathione (BioGEE) reagent, we discovered that oxidation by tBHP or diamide leads to S-glutathionylation of Cys-13, suggesting that S-glutathionylation underlies the regulation of fast N-type inactivation by redox. In conclusion, our studies suggest that Kv4-based A-type current in neurons may show differential redox sensitivity depending on whether DPP6a or DPP10a is highly expressed, and that the S-glutathionylation mechanism may play a previously unappreciated role in mediating excitability changes and neuropathologies associated with ROS.	[Jerng, Henry H.; Pfaffinger, Paul J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Jerng, HH (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	hjerng@cns.bcm.edu			National Institute of Health [R01 GM090029, P30HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090029] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute of Health (R01 GM090029, P30HD024064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahring R, 2001, J PHYSIOL-LONDON, V535, P65, DOI 10.1111/j.1469-7793.2001.00065.x; Barghaan J, 2009, J GEN PHYSIOL, V133, P205, DOI 10.1085/jgp.200810073; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; BRIGELIUS R, 1983, BIOCHEM PHARMACOL, V32, P2529, DOI 10.1016/0006-2952(83)90014-X; BRIGELIUS R, 1983, H-S Z PHYSIOL CHEM, V364, P989, DOI 10.1515/bchm2.1983.364.2.989; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Chen JG, 2000, BIOPHYS J, V78, P174, DOI 10.1016/S0006-3495(00)76583-0; COLLISON MW, 1986, BIOCHIM BIOPHYS ACTA, V885, P58, DOI 10.1016/0167-4889(86)90038-8; Covarrubias M, 2008, NEUROCHEM RES, V33, P1558, DOI 10.1007/s11064-008-9650-8; DUPRAT F, 1995, P NATL ACAD SCI USA, V92, P11796, DOI 10.1073/pnas.92.25.11796; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Gebauer M, 2004, BIOPHYS J, V86, P210, DOI 10.1016/S0006-3495(04)74097-7; GILBERT HF, 1984, METHOD ENZYMOL, V107, P330; Heinemann SH, 1996, J PHYSIOL-LONDON, V493, P625, DOI 10.1113/jphysiol.1996.sp021409; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Hsieh CP, 2008, BIOCHEM BIOPH RES CO, V370, P445, DOI 10.1016/j.bbrc.2008.03.097; Hu CL, 2005, J PINEAL RES, V38, P53, DOI 10.1111/j.1600-079X.2004.00174.x; Jerng HH, 2007, MOL CELL NEUROSCI, V35, P604, DOI 10.1016/j.mcn.2007.03.008; Jerng HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038205; Jerng HH, 2009, CHANNELS, V3, P448, DOI 10.4161/chan.3.6.10216; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jerng HH, 2004, BIOPHYS J, V87, P2380, DOI 10.1529/biophysj.104.042358; Jiao S, 2004, J PINEAL RES, V36, P109, DOI 10.1046/j.1600-079X.2003.00104.x; Keck RG, 1996, ANAL BIOCHEM, V236, P56, DOI 10.1006/abio.1996.0131; Kiehn J, 1996, CIRCULATION, V94, P2572, DOI 10.1161/01.CIR.94.10.2572; Kirichok YV, 1998, NEUROREPORT, V9, P625, DOI 10.1097/00001756-199803090-00012; Kolbe K, 2010, J PHYSIOL-LONDON, V588, P2999, DOI 10.1113/jphysiol.2010.192468; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; KURANTSINMILLS J, 1981, BIOCHIM BIOPHYS ACTA, V641, P129, DOI 10.1016/0005-2736(81)90576-9; Lee TE, 1996, J MEMBRANE BIOL, V151, P225, DOI 10.1007/s002329900073; Leicher T, 1998, J BIOL CHEM, V273, P35095, DOI 10.1074/jbc.273.52.35095; Leicher T, 1996, NEUROPHARMACOLOGY, V35, P787, DOI 10.1016/0028-3908(96)00133-5; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lock JT, 2012, J PHYSL; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Maffie J, 2009, NEUROSCI LETT, V449, P189, DOI 10.1016/j.neulet.2008.10.098; Maffie J, 2008, J PHYSIOL-LONDON, V586, P5609, DOI 10.1113/jphysiol.2008.161620; Marionneau C, 2011, SEMIN CELL DEV BIOL, V22, P145, DOI 10.1016/j.semcdb.2010.10.004; Massaad CA, 2011, ANTIOXID REDOX SIGN, V14, P2013, DOI 10.1089/ars.2010.3208; Muller W, 2002, J NEUROPHYSIOL, V87, P2990, DOI 10.1152/jn.00790.2001; OCHI T, 1993, ARCH TOXICOL, V67, P401, DOI 10.1007/BF01977401; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Rasmusson RL, 1997, ADV EXP MED BIOL, V430, P29; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHUPPE I, 1992, BIOCHEM PHARMACOL, V44, P1757, DOI 10.1016/0006-2952(92)90069-U; SERODIO P, 1994, J NEUROPHYSIOL, V72, P1516, DOI 10.1152/jn.1994.72.4.1516; Sesti F, 2010, TRENDS CELL BIOL, V20, P45, DOI 10.1016/j.tcb.2009.09.008; STEPHENS GJ, 1995, J PHYSIOL-LONDON, V484, P1; Stephens GJ, 1996, PFLUG ARCH EUR J PHY, V431, P435, DOI 10.1007/BF02207283; STEPHENS GJ, 1994, J PHYSIOL-LONDON, V477, P187, DOI 10.1113/jphysiol.1994.sp020183; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; VEGA-SAENZ DE MIERA E, 1992, BIOCHEM BIOPH RES CO, V186, P1681; Wang GY, 2005, J GEN PHYSIOL, V126, P55, DOI 10.1085/jgp.200509288; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wang W, 2005, J GEN PHYSIOL, V125, P127, DOI 10.1085/jgp.200409115; Wang ZG, 1996, J BIOL CHEM, V271, P28311, DOI 10.1074/jbc.271.45.28311; Wissmann R, 1999, J BIOL CHEM, V274, P35521, DOI 10.1074/jbc.274.50.35521; Yang Y, 2010, J BIOL CHEM, V285, P38641, DOI 10.1074/jbc.M110.162578; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zhang ZH, 2004, J BIOL CHEM, V279, P29226, DOI 10.1074/jbc.M403290200; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513	67	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93315	10.1371/journal.pone.0093315	http://dx.doi.org/10.1371/journal.pone.0093315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675763	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677500109
J	Schmitt, C; Kail, D; Mariano, M; Empting, M; Weber, N; Paul, T; Hartmann, RW; Engel, M				Schmitt, Christian; Kail, Dagmar; Mariano, Marica; Empting, Martin; Weber, Nadja; Paul, Tamara; Hartmann, Rolf W.; Engel, Matthias			Design and Synthesis of a Library of Lead-Like 2,4-Bisheterocyclic Substituted Thiophenes as Selective Dyrk/Clk Inhibitors	PLOS ONE			English	Article							PROTEIN-KINASE INHIBITORS; SKELETAL-MUSCLE DIFFERENTIATION; GLYCOGEN-SYNTHASE KINASE; PANCREATIC-CANCER CELLS; CROSS-COUPLING REACTION; DUAL-SPECIFICITY; DOWN-SYNDROME; IN-VITRO; NEUROFIBRILLARY DEGENERATION; TYROSINE PHOSPHORYLATION	The Dyrk family of protein kinases is implicated in the pathogenesis of several diseases, including cancer and neurodegeneration. Pharmacological inhibitors were mainly described for Dyrk1A so far, but in fewer cases for Dyrk1B, Dyrk2 or other isoforms. Herein, we report the development and optimization of 2,4-bisheterocyclic substituted thiophenes as a novel class of Dyrk inhibitors. The optimized hit compounds displayed favorable pharmacokinetic properties and high ligand efficiencies, and inhibited Dyrk1B in intact cells. In a larger selectivity screen, only Clk1 and Clk4 were identified as additional targets of compound 48, but no other kinases frequently reported as off-targets. Interestingly, Dyrk1A is implicated in the regulation of alternative splicing, a function shared with Clk1/Clk4; thus, some of the dual inhibitors might be useful as efficient splicing modulators. A further compound (29) inhibited Dyrk1A and 1B with an IC50 of 130 nM, showing a moderate selectivity over Dyrk2. Since penetration of the central nervous system (CNS) seems possible based on the physicochemical properties, this compound might serve as a lead for the development of potential therapeutic agents against glioblastoma. Furthermore, an inhibitor selective for Dyrk2 (24) was also identified, which might be are suitable as a pharmacological tool to dissect Dyrk2 isoform-mediated functions.	[Schmitt, Christian; Mariano, Marica; Weber, Nadja; Paul, Tamara; Hartmann, Rolf W.; Engel, Matthias] Univ Saarland, Dept Pharmaceut & Med Chem, D-66123 Saarbrucken, Germany; [Kail, Dagmar] PharmBioTec GmbH, Saarbrucken, Germany; [Empting, Martin; Hartmann, Rolf W.] Helmholtz Inst Pharmazeut Forsch Saarland, Dept Drug Design & Optimizat, Saarbrucken, Germany	Saarland University; Helmholtz Association; Helmholtz-Center for Infection Research	Engel, M (corresponding author), Univ Saarland, Dept Pharmaceut & Med Chem, D-66123 Saarbrucken, Germany.	ma.engel@mx.uni-saarland.de	Engel, Matthias/AAH-5823-2021	Engel, Matthias/0000-0001-5065-8634; Empting, Martin/0000-0002-0503-5830	Deutsche Forschungsgemeinschaft (DFG) [EN381/3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de/) for financial support to M.E. (EN381/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akue-Gedu R, 2009, BIOORGAN MED CHEM, V17, P4420, DOI 10.1016/j.bmc.2009.05.017; Alvarez M, 2003, J CELL SCI, V116, P3099, DOI 10.1242/jcs.00618; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Anderson K, 2013, BIOORG MED CHEM LETT, V23, P6610, DOI 10.1016/j.bmcl.2013.10.055; Avrutina O, 2012, ORG BIOMOL CHEM, V10, P7753, DOI 10.1039/c2ob26162f; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bartholome A, 2010, ARCH BIOCHEM BIOPHYS, V501, P58, DOI 10.1016/j.abb.2010.05.024; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Becker W, 2012, CELL CYCLE, V11, P3389, DOI 10.4161/cc.21404; Besselievre F, 2008, J ORG CHEM, V73, P3278, DOI 10.1021/jo7027135; Bey E, 2008, J MED CHEM, V51, P6725, DOI 10.1021/jm8006917; BIRD CW, 1992, TETRAHEDRON, V48, P335, DOI 10.1016/S0040-4020(01)88145-X; Boeira JM, 2001, PHARMACOL TOXICOL, V89, P287, DOI 10.1034/j.1600-0773.2001.d01-162.x; Boeira JM, 2002, MUTAT RES-FUND MOL M, V500, P39, DOI 10.1016/S0027-5107(01)00294-9; Chang HS, 2007, INT J CANCER, V120, P2377, DOI 10.1002/ijc.22573; Cuny GD, 2010, BIOORG MED CHEM LETT, V20, P3491, DOI 10.1016/j.bmcl.2010.04.150; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; de Graaf Katrin, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-7; Debdab M, 2011, J MED CHEM, V54, P4172, DOI 10.1021/jm200274d; Debray J, 2012, MOL DIVERS, V16, P659, DOI 10.1007/s11030-012-9397-7; Deng XB, 2006, CANCER RES, V66, P4149, DOI 10.1158/0008-5472.CAN-05-3089; Deng XB, 2005, J BIOL CHEM, V280, P4894, DOI 10.1074/jbc.M411894200; Deng XB, 2004, J BIOL CHEM, V279, P22498, DOI 10.1074/jbc.M400479200; Deng XB, 2003, J BIOL CHEM, V278, P41347, DOI 10.1074/jbc.M306780200; Deng XB, 2009, CANCER RES, V69, P3317, DOI 10.1158/0008-5472.CAN-08-2903; DONDONI A, 1988, J ORG CHEM, V53, P1748, DOI 10.1021/jo00243a029; Du CP, 2011, CANCER LETT, V309, P54, DOI 10.1016/j.canlet.2011.05.016; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e; Ewton DZ, 2011, MOL CANCER THER, V10, P2104, DOI 10.1158/1535-7163.MCT-11-0498; Fedorov O, 2011, CHEM BIOL, V18, P67, DOI 10.1016/j.chembiol.2010.11.009; Friedman E, 2007, J CELL BIOCHEM, V102, P274, DOI 10.1002/jcb.21451; Frohner W, 2011, J MED CHEM, V54, P6714, DOI 10.1021/jm2005892; Gao JC, 2012, INT J ONCOL, V40, P1203, DOI 10.3892/ijo.2011.1293; Geiger JN, 2001, BLOOD, V97, P901, DOI 10.1182/blood.V97.4.901; Giraud F, 2011, J MED CHEM, V54, P4474, DOI 10.1021/jm200464w; Grzmil M, 2011, CANCER RES, V71, P2392, DOI 10.1158/0008-5472.CAN-10-3112; Hartmann AM, 2001, MOL CELL NEUROSCI, V18, P80, DOI 10.1006/mcne.2001.1000; Hoppstadter J, 2012, EUR J IMMUNOL, V42, P1282, DOI 10.1002/eji.201142081; Hu J, 2011, INT J CANCER, V129, P307, DOI 10.1002/ijc.25692; Jimenez J, 2008, EXP TOXICOL PATHOL, V60, P381, DOI 10.1016/j.etp.2007.12.003; Jin K, 2007, CANCER RES, V67, P7247, DOI 10.1158/0008-5472.can-06-4099; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Jung HY, 2013, J BIOL CHEM, V288, P7252, DOI 10.1074/jbc.M112.416792; KATO R, 1965, J PHARMACOL EXP THER, V150, P279; Kim H, 1997, ARCH BIOCHEM BIOPHYS, V337, P137, DOI 10.1006/abbi.1996.9771; Kimura R, 2007, HUM MOL GENET, V16, P15, DOI 10.1093/hmg/ddl437; Koo KA, 2009, BIOORG MED CHEM LETT, V19, P2324, DOI 10.1016/j.bmcl.2009.02.062; Koon N, 2004, GUT, V53, P235, DOI 10.1136/gut.2003.021238; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Laurence C, 2009, J MED CHEM, V52, P4073, DOI 10.1021/jm801331y; Liu F, 2008, FASEB J, V22, P3224, DOI 10.1096/fj.07-104539; Loidreau Y, 2012, EUR J MED CHEM, V58, P171, DOI 10.1016/j.ejmech.2012.10.006; Lord KA, 2000, BLOOD, V95, P2838, DOI 10.1182/blood.V95.9.2838.009k29_2838_2846; Mazmanian G, 2010, GENESIS, V48, P20, DOI 10.1002/dvg.20578; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Mercer SE, 2005, J BIOL CHEM, V280, P25788, DOI 10.1074/jbc.M413594200; Mercer SE, 2006, CELL BIOCHEM BIOPHYS, V45, P303, DOI 10.1385/CBB:45:3:303; Miller CT, 2003, CANCER RES, V63, P4136; Miralles A, 2005, EUR J PHARMACOL, V518, P234, DOI 10.1016/j.ejphar.2005.06.023; Miyata Y, 2011, BBA-MOL CELL RES, V1813, P1728, DOI 10.1016/j.bbamcr.2011.06.023; MIYAURA N, 1981, SYNTHETIC COMMUN, V11, P513, DOI 10.1080/00397918108063618; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mott BT, 2009, BIOORG MED CHEM LETT, V19, P6700, DOI 10.1016/j.bmcl.2009.09.121; Obach RS, 1999, DRUG METAB DISPOS, V27, P1350; Ogawa Y, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1090; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Pin F, 2011, MEDCHEMCOMM, V2, P899, DOI 10.1039/c1md00141h; Pozo N, 2013, J CLIN INVEST, V123, P2475, DOI 10.1172/JCI63623; Primas N, 2009, TETRAHEDRON, V65, P5739, DOI 10.1016/j.tet.2009.05.013; Rosenthal AS, 2011, BIOORG MED CHEM LETT, V21, P3152, DOI 10.1016/j.bmcl.2011.02.114; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Shi JH, 2008, J BIOL CHEM, V283, P28660, DOI 10.1074/jbc.M802645200; Skurat AV, 2004, J BIOL CHEM, V279, P2490, DOI 10.1074/jbc.M301769200; Slepak TI, 2012, CYTOSKELETON, V69, P514, DOI 10.1002/cm.21021; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; Tahtouh T, 2012, J MED CHEM, V55, P9312, DOI 10.1021/jm301034u; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Taira N, 2012, J CLIN INVEST, V122, P859, DOI 10.1172/JCI60818; Teague SJ, 1999, ANGEW CHEM INT EDIT, V38, P3743, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U; Urbich C, 2009, BLOOD, V113, P5669, DOI 10.1182/blood-2009-01-196485; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Wager TT, 2010, ACS CHEM NEUROSCI, V1, P420, DOI 10.1021/cn100007x; Wang D, 2012, BIOORG MED CHEM LETT, V22, P168, DOI 10.1016/j.bmcl.2011.11.043; Wang K, 2002, ONCOGENE, V21, P7598, DOI 10.1038/sj.onc.1205953; Wegiel J, 2008, ACTA NEUROPATHOL, V116, P391, DOI 10.1007/s00401-008-0419-6; Wegiel J, 2011, J NEUROPATH EXP NEUR, V70, P36, DOI 10.1097/NEN.0b013e318202bfa1; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010; Yamashita SI, 2009, ANTICANCER RES, V29, P2753; Yang C, 2010, CARCINOGENESIS, V31, P552, DOI 10.1093/carcin/bgp330; Yara S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063456; Yin XM, 2012, J BIOL CHEM, V287, P30497, DOI 10.1074/jbc.M112.355412; Zou YL, 2004, J BIOL CHEM, V279, P27790, DOI 10.1074/jbc.M403042200	100	34	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e87851	10.1371/journal.pone.0087851	http://dx.doi.org/10.1371/journal.pone.0087851			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676346	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500002
J	Lin, C; Kuo, FW; Chavanich, S; Viyakarn, V				Lin, Chiahsin; Kuo, Fu-Wen; Chavanich, Suchana; Viyakarn, Voranop			Membrane Lipid Phase Transition Behavior of Oocytes from Three Gorgonian Corals in Relation to Chilling Injury	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; BOVINE OOCYTES; THERMOTROPIC BEHAVIOR; SEASONAL-CHANGES; MOUSE OOCYTES; COLD SHOCK; SENSITIVITY; TEMPERATURE; PRESERVATION; CYTOSKELETAL	The lipid phase transition (LPT) from the fluid liquid crystalline phase to the more rigid gel structure phase that occurs upon exposure to low temperatures can affect physical structure and function of cellular membranes. This study set out to investigate the membrane phase behavior of oocytes of three gorgonian corals; Junceela fragilis, J. juncea and Ellisella robusta, at different developmental stages after exposure to reduced temperatures. Oocytes were chilled to 5 degrees C for 48, 96 or 144 h, and the LPT temperature (LPTT) was determined with Fourier Transform Infrared (FTIR) spectroscopy. The J. fragilis oocytes had a higher LPTT (similar to 23.0-23.7 degrees C) than those of J. juncea and E. robusta oocytes (approximately 18.3-20.3 degrees C). Upon chilling for 96 h at 5 degrees C, the LPTTs of J. juncea and E. robusta oocytes in the early (18.0 +/- 1.0 and 18.3 +/- 0.6 degrees C, respectively) and late (17.3 +/- 0.6 and 17.7 +/- 1.2 degrees C, respectively) stages were significantly lower than those of J. fragilis oocytes (20.3 +/- 2.1 and 19.3 +/- 1.5 degrees C for the early and late stages, respectively). The LPTTs of early stage gorgonian oocytes was significantly lower than those of late stage oocytes. These results suggest that the LPT of three gorgonian oocytes at different developmental stages may have been influenced by the phospholipid composition of their plasma membranes, which could have implications for their low temperature resistance.	[Lin, Chiahsin; Kuo, Fu-Wen] Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan; [Lin, Chiahsin] Natl Dong Hwa Univ, Inst Marine Biotechnol, Checheng, Pingtung, Taiwan; [Chavanich, Suchana; Viyakarn, Voranop] Chulalongkorn Univ, Fac Sci, Dept Marine Sci, Reef Biol Res Grp, Bangkok, Thailand	National Museum of Marine Biology & Aquarium; National Dong Hwa University; Chulalongkorn University	Lin, C (corresponding author), Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan.	chiahsin@nmmba.gov.tw	Viyakarn, Voranop/Q-9182-2019; Chavanich, Suchana/AAU-8266-2020		National Science Council [NSC 102-2313-B-291-002]	National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported by funds from the National Science Council (NSC 102-2313-B-291-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTINI DF, 1995, DEV GENET, V16, P13, DOI 10.1002/dvg.1020160105; ALBERTINI DF, 1992, MUTAT RES, V296, P57, DOI 10.1016/0165-1110(92)90032-5; AMAN RR, 1994, BIOL REPROD, V50, P103, DOI 10.1095/biolreprod50.1.103; Arav A, 1996, CRYOBIOLOGY, V33, P589, DOI 10.1006/cryo.1996.0062; Arav A, 2000, CRYO-LETT, V21, P179; Coull GD, 1998, THERIOGENOLOGY, V49, P179, DOI 10.1016/S0093-691X(98)90532-5; CROWE JH, 1989, CRYOBIOLOGY, V26, P76, DOI 10.1016/0011-2240(89)90035-7; DROBNIS EZ, 1993, J EXP ZOOL, V265, P432, DOI 10.1002/jez.1402650413; Gerelchimeg B, 2009, CRYOBIOLOGY, V59, P54, DOI 10.1016/j.cryobiol.2009.04.005; Ghetler Y, 2005, HUM REPROD, V20, P3385, DOI 10.1093/humrep/dei236; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; HOMA ST, 1986, J REPROD FERTIL, V77, P425, DOI 10.1530/jrf.0.0770425; Imbs AB, 2007, LIPIDS, V42, P1035, DOI 10.1007/s11745-007-3109-6; Kim JY, 2001, REPRODUCTION, V122, P131, DOI 10.1530/rep.0.1220131; Lin C, 2012, THERIOGENOLOGY, V77, P1257, DOI 10.1016/j.theriogenology.2011.09.021; Lin C, 2011, CRYOLETTERS, V32, P141; Lin CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057823; Lin CH, 2013, CRYOBIOLOGY, V66, P3, DOI 10.1016/j.cryobiol.2012.05.005; Lin CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038689; Pang ZG, 2010, CHIN J OCEANOL LIMN, V28, P533, DOI 10.1007/s00343-010-9009-2; Pearl M, 2000, CRYO-LETT, V21, P171; Pielak RM, 2004, DEV BIOL, V269, P421, DOI 10.1016/j.ydbio.2004.01.033; Pielak RM, 2003, BIOL BULL-US, V205, P192, DOI 10.2307/1543247; QUINN PJ, 1985, CRYOBIOLOGY, V22, P128, DOI 10.1016/0011-2240(85)90167-1; Sanina NM, 2002, COMP BIOCHEM PHYS B, V133, P143; Sanina NM, 2001, COMP BIOCHEM PHYS B, V128, P295, DOI 10.1016/S1096-4959(00)00328-6; SATHANANTHAN AH, 1988, HUM REPROD, V3, P968, DOI 10.1093/oxfordjournals.humrep.a136827; SATHANANTHAN AH, 1992, J ASSIST REPROD GEN, V9, P139, DOI 10.1007/BF01203754; Songsasen N, 2002, FERTIL STERIL, V77, P818, DOI 10.1016/S0015-0282(01)03240-X; Thompson JG, 1996, THERIOGENOLOGY, V45, P27, DOI 10.1016/0093-691X(95)00352-9; Treignier C, 2008, LIMNOL OCEANOGR, V53, P2702, DOI 10.4319/lo.2008.53.6.2702; Tsai S, 2009, CRYOBIOLOGY, V58, P279, DOI 10.1016/j.cryobiol.2009.02.002; Ulrich K, 1994, COMP ANIMAL BIOCH; Watson P F, 1987, Symp Soc Exp Biol, V41, P311; WHITE IG, 1993, REPROD FERT DEVELOP, V5, P639, DOI 10.1071/RD9930639; Wu B, 1999, MOL REPROD DEV, V54, P388, DOI 10.1002/(SICI)1098-2795(199912)54:4&lt;388::AID-MRD9&gt;3.0.CO;2-7; Zenes MT, 2001, FERTIL STERIL, V75, P769; Zeron Y, 2002, CRYOBIOLOGY, V45, P143, DOI 10.1016/S0011-2240(02)00123-2; Zeron Y, 2002, MOL REPROD DEV, V61, P271, DOI 10.1002/mrd.1156; Zeron Y, 2001, REPRODUCTION, V121, P447, DOI 10.1530/rep.0.1210447	40	14	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92812	10.1371/journal.pone.0092812	http://dx.doi.org/10.1371/journal.pone.0092812			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671092	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000079
J	Martin, J; Edwards, HH; Bled, F; Fonnesbeck, CJ; Dupuis, JA; Gardner, B; Koslovsky, SM; Aven, AM; Ward-Geiger, LI; Carmichael, RH; Fagan, DE; Ross, MA; Reinert, TR				Martin, Julien; Edwards, Holly H.; Bled, Florent; Fonnesbeck, Christopher J.; Dupuis, Jerome A.; Gardner, Beth; Koslovsky, Stacie M.; Aven, Allen M.; Ward-Geiger, Leslie I.; Carmichael, Ruth H.; Fagan, Daniel E.; Ross, Monica A.; Reinert, Thomas R.			Estimating Upper Bounds for Occupancy and Number of Manatees in Areas Potentially Affected by Oil from the Deepwater Horizon Oil Spill	PLOS ONE			English	Article							ESTIMATING ABUNDANCE	The explosion of the Deepwater Horizon drilling platform created the largest marine oil spill in U. S. history. As part of the Natural Resource Damage Assessment process, we applied an innovative modeling approach to obtain upper estimates for occupancy and for number of manatees in areas potentially affected by the oil spill. Our data consisted of aerial survey counts in waters of the Florida Panhandle, Alabama and Mississippi. Our method, which uses a Bayesian approach, allows for the propagation of uncertainty associated with estimates from empirical data and from the published literature. We illustrate that it is possible to derive estimates of occupancy rate and upper estimates of the number of manatees present at the time of sampling, even when no manatees were observed in our sampled plots during surveys. We estimated that fewer than 2.4% of potentially affected manatee habitat in our Florida study area may have been occupied by manatees. The upper estimate for the number of manatees present in potentially impacted areas (within our study area) was estimated with our model to be 74 (95%CI 46 to 107). This upper estimate for the number of manatees was conditioned on the upper 95%CI value of the occupancy rate. In other words, based on our estimates, it is highly probable that there were 107 or fewer manatees in our study area during the time of our surveys. Because our analyses apply to habitats considered likely manatee habitats, our inference is restricted to these sites and to the time frame of our surveys. Given that manatees may be hard to see during aerial surveys, it was important to account for imperfect detection. The approach that we described can be useful for determining the best allocation of resources for monitoring and conservation.	[Martin, Julien; Edwards, Holly H.; Koslovsky, Stacie M.; Ward-Geiger, Leslie I.; Fagan, Daniel E.; Reinert, Thomas R.] Fish & Wildlife Res Inst, Florida Fish & Wildlife Conservat Commiss, St Petersburg, FL 33701 USA; [Bled, Florent] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA; [Bled, Florent] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Fonnesbeck, Christopher J.] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA; [Dupuis, Jerome A.] Univ Toulouse 3, Lab Stat & Probabilites, F-31062 Toulouse, France; [Gardner, Beth] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Aven, Allen M.; Carmichael, Ruth H.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Aven, Allen M.; Carmichael, Ruth H.] Univ S Alabama, Mobile, AL 36688 USA; [Ross, Monica A.] Sea Shore Alliance, Sarasota, FL USA	Florida Fish & Wildlife Conservation Commission; United States Department of the Interior; United States Geological Survey; Colorado State University; Vanderbilt University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of North Carolina; North Carolina State University; Dauphin Island Sea Lab; University of South Alabama	Martin, J (corresponding author), Fish & Wildlife Res Inst, Florida Fish & Wildlife Conservat Commiss, St Petersburg, FL 33701 USA.	julien.martin@myfwc.com		Carmichael, Ruth/0000-0002-6033-3777; Martin, Julien/0000-0002-7375-129X	Natural Resource Damage Assessment for the Deepwater Horizon oil spill	Natural Resource Damage Assessment for the Deepwater Horizon oil spill	This work was supported by funds provided as part of the Natural Resource Damage Assessment for the Deepwater Horizon oil spill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bled F, 2011, BIODIVERS CONSERV, V20, P1203, DOI 10.1007/s10531-011-0023-2; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Dorazio RM, 2013, ECOLOGY, V94, P1472, DOI 10.1890/0012-9658-94.7.1472; Dupuis JA, 2011, BIOMETRICS, V67, P290, DOI 10.1111/j.1541-0420.2010.01424.x; Edwards HH, 2007, J WILDLIFE MANAGE, V71, P2052, DOI 10.2193/2005-645; Fertl D., 2005, Gulf and Caribbean Research, V17, P69; Gelman A., 2004, BAYESIAN DATA ANAL; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Machlis GE, 2010, SCIENCE, V329, P1018, DOI 10.1126/science.1195382; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; Martin J, 2011, METHODS ECOL EVOL, V2, P595, DOI 10.1111/j.2041-210X.2011.00113.x; Mascarelli A, 2010, NATURE, V467, P22, DOI 10.1038/467022a; Pabody Claire M., 2009, Gulf of Mexico Science, V27, P52; Royle J. A., 2008, HIERARCHICAL MODELIN; Runge M. C., 2007, 20071082 US GEOL SUR; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	16	8	8	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91683	10.1371/journal.pone.0091683	http://dx.doi.org/10.1371/journal.pone.0091683			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670971	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677000025
J	Payne, EGI; Fletcher, TD; Russell, DG; Grace, MR; Cavagnaro, TR; Evrard, V; Deletic, A; Hatt, BE; Cook, PLM				Payne, Emily G. I.; Fletcher, Tim D.; Russell, Douglas G.; Grace, Michael R.; Cavagnaro, Timothy R.; Evrard, Victor; Deletic, Ana; Hatt, Belinda E.; Cook, Perran L. M.			Temporary Storage or Permanent Removal? The Division of Nitrogen between Biotic Assimilation and Denitrification in Stormwater Biofiltration Systems	PLOS ONE			English	Article							POLLUTANT REMOVAL; NUTRIENT RETENTION; NITRATE UPTAKE; BIORETENTION; WATER; NITRIFICATION; GROUNDWATER; ECOSYSTEMS; SATURATION; BIOFILTERS	The long-term efficacy of stormwater treatment systems requires continuous pollutant removal without substantial re-release. Hence, the division of incoming pollutants between temporary and permanent removal pathways is fundamental. This is pertinent to nitrogen, a critical water body pollutant, which on a broad level may be assimilated by plants or microbes and temporarily stored, or transformed by bacteria to gaseous forms and permanently lost via denitrification. Biofiltration systems have demonstrated effective removal of nitrogen from urban stormwater runoff, but to date studies have been limited to a 'black-box' approach. The lack of understanding on internal nitrogen processes constrains future design and threatens the reliability of long-term system performance. While nitrogen processes have been thoroughly studied in other environments, including wastewater treatment wetlands, biofiltration systems differ fundamentally in design and the composition and hydrology of stormwater inflows, with intermittent inundation and prolonged dry periods. Two mesocosm experiments were conducted to investigate biofilter nitrogen processes using the stable isotope tracer (NO3-)-N-15 (nitrate) over the course of one inflow event. The immediate partitioning of (NO3-)-N-15 between biotic assimilation and denitrification were investigated for a range of different inflow concentrations and plant species. Assimilation was the primary fate for NO3- under typical stormwater concentrations (similar to 1-2 mg N/L), contributing an average 89-99% of (NO3-)-N-15 processing in biofilter columns containing the most effective plant species, while only 0-3% was denitrified and 0-8% remained in the pore water. Denitrification played a greater role for columns containing less effective species, processing up to 8% of (NO3-)-N-15, and increased further with nitrate loading. This study uniquely applied isotope tracing to biofiltration systems and revealed the dominance of assimilation in stormwater biofilters. The findings raise important questions about nitrogen release upon plant senescence, seasonally and in the long term, which have implications on the management and design of biofiltration systems.	[Payne, Emily G. I.; Deletic, Ana; Hatt, Belinda E.] Monash Univ, Dept Civil Engn, Monash Water Liveabil, Clayton, Vic 3800, Australia; [Fletcher, Tim D.] Univ Melbourne, Melbourne Sch Land & Environm, Dept Resource Management & Geog, Melbourne, Vic 3010, Australia; [Russell, Douglas G.; Grace, Michael R.; Evrard, Victor; Cook, Perran L. M.] Monash Univ, Sch Chem, Water Studies Ctr, Clayton, Vic 3800, Australia; [Cavagnaro, Timothy R.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia	Monash University; University of Melbourne; Monash University; Monash University	Payne, EGI (corresponding author), Monash Univ, Dept Civil Engn, Monash Water Liveabil, Clayton, Vic 3800, Australia.	emily.payne@monash.edu	Cavagnaro, Timothy/HGC-7768-2022; Grace, Mike/AAE-3073-2022; Fletcher, Tim/AAB-8356-2019; Evrard, Victor/A-9264-2008; Grace, Mike/AAE-3376-2021; Deletic, Ana/CAG-2385-2022	Fletcher, Tim/0000-0001-8819-5567; Evrard, Victor/0000-0001-7650-3534; Grace, Mike/0000-0002-0982-8133; Deletic, Ana/0000-0002-3535-7451; Cook, Perran/0000-0002-0444-3488; Cavagnaro, Timothy/0000-0002-9922-5677	Australian Research Council [LP0990153]; Melbourne Water; Western Australia Department of Water; ARC Future Fellowship [FT100100144]	Australian Research Council(Australian Research Council); Melbourne Water; Western Australia Department of Water; ARC Future Fellowship(Australian Research Council)	This research was supported by funding from the Australian Research Council (LP0990153)(http://www.arc.gov.au/), Melbourne Water (http://www.melbournewater.com.au/Pages/home.aspx), and Western Australia Department of Water (http://www.water.wa.gov.au/). Fletcher is supported by an ARC Future Fellowship (FT100100144). The funders assisted with the study design and discussions of overall project results but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; [Anonymous], 2008, BIOGEOCHEMISTRY WETL; Bedard-Haughn A, 2005, J ENVIRON QUAL, V34, P1651, DOI 10.2134/jeq2005.0033; Bedard-Haughn A, 2004, J ENVIRON QUAL, V33, P2252, DOI 10.2134/jeq2004.2252; Bernot MJ, 2005, ECOSYSTEMS, V8, P442, DOI 10.1007/s10021-003-0143-y; Blecken GT, 2009, ECOL ENG, V35, P769, DOI 10.1016/j.ecoleng.2008.12.009; Bratieres K, 2008, WATER RES, V42, P3930, DOI 10.1016/j.watres.2008.06.009; Cavagnaro TR, 2001, NEW PHYTOL, V149, P105, DOI 10.1046/j.1469-8137.2001.00001.x; Collins KA, 2010, ECOL ENG, V36, P1507, DOI 10.1016/j.ecoleng.2010.03.015; COOPER AB, 1984, NEW ZEAL J MAR FRESH, V18, P441, DOI 10.1080/00288330.1984.9516065; Craft CB, 1996, WETLANDS ECOLOGY MAN, V4, P177, DOI DOI 10.1007/BF01879236; Davis AP, 2009, J ENVIRON ENG, V135, P109, DOI 10.1061/(ASCE)0733-9372(2009)135:3(109); Davis AP, 2006, WATER ENVIRON RES, V78, P284, DOI 10.2175/106143005X94376; Davis AP, 2001, WATER ENVIRON RES, V73, P5, DOI 10.2175/106143001X138624; Duncan H.P., 1999, DATABASE URBAN STORM; Facility for Advancing Water Biofiltration (FAWB), 2009, AD GUID STORMW BIOF; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Gray SR, 2002, URBAN WATER, V4, P331, DOI DOI 10.1016/S1462-0758(02)00033-X; Hatt BE, 2008, ENVIRON SCI TECHNOL, V42, P2535, DOI 10.1021/es071264p; Hunt WF, 2008, J ENVIRON ENG-ASCE, V134, P403, DOI 10.1061/(ASCE)0733-9372(2008)134:5(403); JENKINSON DS, 1990, SOIL USE MANAGE, V6, P56, DOI 10.1111/j.1475-2743.1990.tb00800.x; Kadlec RH, 2005, ECOL ENG, V25, P365, DOI 10.1016/j.ecoleng.2005.06.009; Kim HH, 2003, WATER ENVIRON RES, V75, P355, DOI 10.2175/106143003X141169; Kirk GJD, 2005, ANN BOT-LONDON, V96, P639, DOI 10.1093/aob/mci216; Kreiling RM, 2011, BIOGEOCHEMISTRY, V104, P309, DOI 10.1007/s10533-010-9503-9; Lee CG, 2009, ENG LIFE SCI, V9, P11, DOI 10.1002/elsc.200800049; Lin YF, 2002, ENVIRON POLLUT, V119, P413, DOI 10.1016/S0269-7491(01)00299-8; Lucas WC, 2008, J IRRIG DRAIN ENG, V134, P613, DOI 10.1061/(ASCE)0733-9437(2008)134:5(613); Lucas WC, 2011, WATER ENVIRON RES, V83, P692, DOI 10.2175/106143010X12780288628697; Matheson FE, 2002, ECOL ENG, V19, P249, DOI 10.1016/S0925-8574(02)00093-9; Minett DA, 2013, ECOL ENG, V58, P414, DOI 10.1016/j.ecoleng.2013.06.028; Mitsch W., 2000, WETLANDS, V3rd; Mitsch WJ, 2005, ECOL ENG, V24, P267, DOI 10.1016/j.ecoleng.2005.02.005; NIELSEN LP, 1992, FEMS MICROBIOL ECOL, V86, P357, DOI 10.1016/0378-1097(92)90800-4; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Payne EGI, WATER SCI T IN PRESS; Payne EGI, CRITICAL RE IN PRESS; Pinay G, 1998, J N AM BENTHOL SOC, V17, P179, DOI 10.2307/1467961; POWLSON DS, 1993, SOIL USE MANAGE, V9, P86, DOI 10.1111/j.1475-2743.1993.tb00935.x; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Read J, 2010, INT J PHYTOREMEDIAT, V12, P34, DOI 10.1080/15226510902767114; REDDY KR, 1989, LIMNOL OCEANOGR, V34, P1004, DOI 10.4319/lo.1989.34.6.1004; Ritz C, 2005, J STAT SOFTWARE, V12; Roberts SJ, 2012, 7 INT C WAT SENS URB; SEITZINGER SP, 1988, LIMNOL OCEANOGR, V33, P702, DOI 10.4319/lo.1988.33.4_part_2.0702; Simek M, 2002, SOIL BIOL BIOCHEM, V34, P1227, DOI 10.1016/S0038-0717(02)00059-7; Tanner CC, 1996, ECOL ENG, V7, P59, DOI 10.1016/0925-8574(95)00066-6; Taylor GD, 2005, WATER RES, V39, P1982, DOI 10.1016/j.watres.2005.03.022; URBAN NR, 1988, LIMNOL OCEANOGR, V33, P1611, DOI 10.4319/lo.1988.33.6_part_2.1611; VITOUSEK PM, 1975, BIOSCIENCE, V25, P376, DOI 10.2307/1297148; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vymazal J, 2007, SCI TOTAL ENVIRON, V380, P48, DOI 10.1016/j.scitotenv.2006.09.014; WEISS RF, 1980, MAR CHEM, V8, P347, DOI 10.1016/0304-4203(80)90024-9; Zhu WX, 2004, BIOGEOCHEMISTRY, V71, P177, DOI 10.1007/s10533-004-9683-2; Zinger T, 2007, OPTIMISATION NITROGE; Zinger Y, 2013, ECOL ENG, V51, P75, DOI 10.1016/j.ecoleng.2012.12.007	56	75	87	1	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e90890	10.1371/journal.pone.0090890	http://dx.doi.org/10.1371/journal.pone.0090890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670377	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677000012
J	Smedley, J; Turkbey, B; Bernardo, ML; Del Prete, GQ; Estes, JD; Griffiths, GL; Kobayashi, H; Choyke, PL; Lifson, JD; Keele, BF				Smedley, Jeremy; Turkbey, Baris; Bernardo, Marcelino L.; Del Prete, Gregory Q.; Estes, Jacob D.; Griffiths, Gary L.; Kobayashi, Hisataka; Choyke, Peter L.; Lifson, Jeffrey D.; Keele, Brandon F.			Tracking the Luminal Exposure and Lymphatic Drainage Pathways of Intravaginal and Intrarectal Inocula Used in Nonhuman Primate Models of HIV Transmission	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; RHESUS MACAQUES; BLUE-DYE; INFECTION; SIVMAC251; VARIANTS	Over 80% of sexual HIV-1 transmissions originate from a single viral variant, but the underlying basis for this transmission bottleneck remains to be elucidated. Nonhuman primate models of mucosal virus transmission allow opportunities to gain insight into the basis of this mucosal bottleneck. We used simulated inocula consisting of either non-infectious vital dye or contrast dye with non-invasive magnetic resonance imaging (MRI) to visualize mucosal exposure and passive lymphatic drainage patterns following vaginal and rectal exposures in Indian origin rhesus macaques. Results revealed a limited overall distance of dye coverage from the anal verge following 1 ml (n = 8) intrarectally administered, which greatly increased with a 3 ml (n = 8) volume. Intravaginal dye exposure using 2 ml revealed complete coverage of the mucosa of the vagina and ectocervix, however dye was not detectable in the endocervix, uterus, fallopian tubes or ovaries in nuliparous sexually mature rhesus macaques (n = 9). In addition, following submucosal and intranodal injections of vital dye or MRI contrast dye in the rectum (n = 9), or distal and proximal vagina (n = 4), the lymphatic drainage pathways were identified as first the internal then common iliac chain followed by para-aortic lymph nodes. Drainage from the distal descending colon (n = 8) was via the para-colonic lymph nodes followed by the inferior mesenteric and para-aortic lymph nodes. Analysis after vaginal challenge with infectious SIVmac239 followed by euthanasia at day 3 revealed a pattern of viral dissemination consistent with the imaging results. These results provide insights into potential patterns of viral dissemination that can help guide efforts to better elucidate the earliest events of virus transmission and potential intervention strategies.	[Smedley, Jeremy] Frederick Natl Lab, Leidos Biomed Res Inc, Lab Anim Sci Program, Frederick, MD USA; [Turkbey, Baris; Bernardo, Marcelino L.; Kobayashi, Hisataka; Choyke, Peter L.] NCI, Mol Imaging Program, Bethesda, MD 20892 USA; [Del Prete, Gregory Q.; Estes, Jacob D.; Lifson, Jeffrey D.; Keele, Brandon F.] Frederick Natl Lab, AIDS & Canc Virus Program, Leidos Biomed Res Inc, Frederick, MD 21702 USA; [Griffiths, Gary L.] Frederick Natl Lab, Clin Monitoring Res Program, Leidos Biomed Res Inc, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Keele, BF (corresponding author), Frederick Natl Lab, AIDS & Canc Virus Program, Leidos Biomed Res Inc, Frederick, MD 21702 USA.	keelebf@mail.nih.gov		Smedley, Jeremy/0000-0003-3369-4662	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC010654] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Bostick P, 1999, ARCH SURG-CHICAGO, V134, P43, DOI 10.1001/archsurg.134.1.43; Carias AM, 2013, J VIROL, V87, P11388, DOI 10.1128/JVI.01377-13; CDC, 2011, 23 CDC; Cohen MS, 2007, CLIN INFECT DIS, V45, pS287, DOI 10.1086/522552; Del Prete GQ, 2013, J VIROL, V87, P4584, DOI 10.1128/JVI.03507-12; Gray H., 2000, ANATOMY HUMAN BODY; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Kearney M, 2009, J VIROL, V83, P2715, DOI 10.1128/JVI.01960-08; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2011, BLOOD, V118, P839, DOI 10.1182/blood-2010-12-325860; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Liu JY, 2010, J VIROL, V84, P10406, DOI 10.1128/JVI.01155-10; Ma ZM, 2011, AIDS RES HUM RETROV, V27, P1259, DOI 10.1089/aid.2011.0090; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; PARK JM, 1994, RADIOGRAPHICS, V14, P1309, DOI 10.1148/radiographics.14.6.7855343; Player AN, 2001, J HISTOCHEM CYTOCHEM, V49, P603, DOI 10.1177/002215540104900507; Shaw GM, 2012, HIV TRANSMISSION COL, V2; Shukair SA, 2013, MUCOSAL IMMUNOL, V6, P427, DOI 10.1038/mi.2012.87; Somashekhar SP, 2008, INDIAN J SURG, V70, P111, DOI 10.1007/s12262-008-0033-9; Stone M, 2010, J VIROL, V84, P7083, DOI 10.1128/JVI.00481-10; Thomsen R, 2006, PRIMATES, V47, P272, DOI 10.1007/s10329-005-0171-7; UNAIDS, 2013, AIDS NUMB; Vaccari M, 2013, J VIROL, V87, P3538, DOI 10.1128/JVI.02863-12; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002	26	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92830	10.1371/journal.pone.0092830	http://dx.doi.org/10.1371/journal.pone.0092830			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667371	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600084
J	Terada, K; Kojima, Y; Watanabe, T; Izumo, N; Chiba, K; Karube, Y				Terada, Kazuki; Kojima, Yoshitsugu; Watanabe, Takayuki; Izumo, Nobuo; Chiba, Koji; Karube, Yoshiharu			Inhibition of Nerve Growth Factor-Induced Neurite Outgrowth from PC12 Cells by Dexamethasone: Signaling Pathways through the Glucocorticoid Receptor and Phosphorylated Akt and ERK1/2	PLOS ONE			English	Article							NEUROTROPHIN RECEPTORS; KINASE PATHWAY; MESSENGER-RNA; TRK RECEPTORS; DIFFERENTIATION; EXPRESSION; NGF; TRANSDUCTION; STABILITY; P75	Glucocorticoids are important mediators of the stress response and are commonly employed as drugs for the suppression of immune rejection after organ transplantation. Previous investigations uncovered the possibility of mood depression in patients undergoing long-term treatment with synthetic glucocorticoids, including dexamethasone (DEX). Exogenous glucocorticoids and their synthetic derivatives can also adversely affect the development of the central nervous system. Although neurite extension from rat pheochromocytoma-derived PC12 cells and a variety of primary neurons is stimulated by nerve growth factor (NGF), and signaling pathways triggered by the binding of NGF to tyrosine kinase receptor type 1 (TrkA) function in both neurite outgrowth and neuronal survival, the effect of DEX on the activation of regulatory proteins and pathways downstream of TrkA has not been well characterized. To analyze the influence of DEX on NGF-induced neurite outgrowth and signaling, PC12 cells, a widely utilized model of neuronal differentiation, were pretreated with the glucocorticoid prior to NGF induction. NGF-induced neurite outgrowth was attenuated by pretreatment with DEX, even in the absence of DEX after the addition of NGF. Moreover, DEX suppressed the phosphorylation of Akt and extracellular-regulated kinase 1/2 (ERK1/2) in the neurite outgrowth signaling cascade initiated by NGF. Finally, the glucocorticoid receptor (GR) antagonist, RU38486, counteracted the inhibitory effect of DEX pretreatment, not only on the phosphorylation of Akt and ERK1/2, but also on neurite extension from PC12 cells. These results suggest that DEX binding to the GR impairs NGF-promoted neurite outgrowth by interfering with the activation/phosphorylation of Akt and ERK1/2. These novel findings are likely to be useful for elucidating the central nervous system depressive mechanism(s) of action of DEX and other glucocorticoids.	[Terada, Kazuki; Karube, Yoshiharu] Fukuoka Univ, Fac Pharmaceut Sci, Lab Drug Design & Drug Delivery, Fukuoka 81401, Japan; [Terada, Kazuki; Izumo, Nobuo; Chiba, Koji] Yokohama Coll Pharm, Lab Clin Pharmacol, Yokohama, Kanagawa, Japan; [Kojima, Yoshitsugu; Watanabe, Takayuki] Nippon Sigmax Co Ltd, Res & Dev Dept 2, Tokyo, Japan	Fukuoka University	Chiba, K (corresponding author), Yokohama Coll Pharm, Lab Clin Pharmacol, Yokohama, Kanagawa, Japan.	k.chiba@hamayaku.ac.jp			Nippon Sigmax Co., Ltd.	Nippon Sigmax Co., Ltd.	Nippon Sigmax Co., Ltd., provided support in the form of salaries for authors Y. Kojima & TW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Celano Christopher M, 2011, Dialogues Clin Neurosci, V13, P109; Cerezo-Guisado MI, 2007, BIOCHEM J, V401, P175, DOI 10.1042/BJ20060731; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; Davis EP, 2013, BIOL PSYCHIAT, V74, P647, DOI 10.1016/j.biopsych.2013.03.009; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031; Glick RD, 2000, J PEDIATR SURG, V35, P465, DOI 10.1016/S0022-3468(00)90216-1; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; GREENE LA, 1982, DEV BIOL, V91, P305, DOI 10.1016/0012-1606(82)90037-9; GREENE LA, 1995, CURR OPIN NEUROBIOL, V5, P579, DOI 10.1016/0959-4388(95)80062-X; Guroff G., 1985, CELL CULTURE NEUROSC, P245, DOI 10.1007/978-1-4613-2473-7_8; HALL RCW, 1978, J NERV MENT DIS, V166, P738, DOI 10.1097/00005053-197810000-00007; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Hughes AL, 2000, J BIOL CHEM, V275, P37829, DOI 10.1074/jbc.M003146200; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; Kim Y, 2004, MOL CELLS, V18, P353; KIMURA K, 1994, J BIOL CHEM, V269, P18961; Lecht S., 2007, OPEN PHARM J, V1, P19; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MCEWEN BS, 1986, PHYSIOL REV, V66, P1121, DOI 10.1152/physrev.1986.66.4.1121; Nishina A, 2013, NEUROCHEM RES, V38, P2397, DOI 10.1007/s11064-013-1152-7; PERRONEBIZZOZERO NI, 1993, J CELL BIOL, V120, P1263, DOI 10.1083/jcb.120.5.1263; POLLOCK JD, 1990, J NEUROSCI, V10, P2626; Price RD, 2003, BRIT J PHARMACOL, V140, P825, DOI 10.1038/sj.bjp.0705522; Rossi D, 2013, CHEMMEDCHEM, V8, P1514, DOI 10.1002/cmdc.201300218; Rossner S, 1998, J NEUROCHEM, V71, P757; Schaper C, 2009, REGUL PEPTIDES, V157, P3, DOI 10.1016/j.regpep.2009.07.004; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Wang Q, 2013, NEUROBIOL AGING, V34, P1662, DOI 10.1016/j.neurobiolaging.2012.11.019; Wigerius M, 2013, EUR J CELL BIOL, V92, P213, DOI 10.1016/j.ejcb.2013.07.002; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Yu CW, 2013, J MED CHEM, V56, P6775, DOI 10.1021/jm400564j; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	37	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93223	10.1371/journal.pone.0093223	http://dx.doi.org/10.1371/journal.pone.0093223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667984	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600157
J	Adams, MN; Harrington, BS; He, Y; Davies, CM; Wallace, SJ; Chetty, NP; Crandon, AJ; Oliveira, NB; Shannon, CM; Coward, JI; Lumley, J; Perrin, LC; Armes, JE; Hooper, JD				Adams, M. N.; Harrington, B. S.; He, Y.; Davies, C. M.; Wallace, S. J.; Chetty, N. P.; Crandon, A. J.; Oliveira, N. B.; Shannon, C. M.; Coward, J. I.; Lumley, J. W.; Perrin, L. C.; Armes, J. E.; Hooper, J. D.			EGF inhibits constitutive internalization and palmitoylation-dependent degradation of membrane-spanning procancer CDCP1 promoting its availability on the cell surface	ONCOGENE			English	Article							DOMAIN-CONTAINING PROTEIN-1; CUB-DOMAIN; PKC-DELTA; SRC; RESISTANCE; SURVIVAL; IDENTIFICATION; METASTASIS; INVASION	Many cancers are dependent on inappropriate activation of epidermal growth factor receptor (EGFR), and drugs targeting this receptor can improve patient survival, although benefits are generally short-lived. We reveal a novel mechanism linking EGFR and the membrane-spanning, cancer-promoting protein CDCP1 (CUB domain-containing protein 1). Under basal conditions, cell surface CDCP1 constitutively internalizes and undergoes palmitoylation-dependent degradation by a mechanism in which it is palmitoylated in at least one of its four cytoplasmic cysteines. This mechanism is functional in vivo as CDCP1 is elevated and palmitoylated in high-grade serous ovarian tumors. Interestingly, activation of the EGFR system with EGF inhibits proteasome-mediated, palmitoylation-dependent degradation of CDCP1, promoting recycling of CDCP1 to the cell surface where it is available to mediate its procancer effects. We also show that mechanisms inducing relocalization of CDCP1 to the cell surface, including disruption of its palmitoylation and EGF treatment, promote cell migration. Our data provide the first evidence that the EGFR system can function to increase the lifespan of a protein and also promote its recycling to the cell surface. This information may be useful for understanding mechanisms of resistance to EGFR therapies and assist in the design of treatments for EGFR-dependent cancers.	[Adams, M. N.; Harrington, B. S.; He, Y.; Davies, C. M.; Coward, J. I.; Armes, J. E.; Hooper, J. D.] Univ Queensland, Translat Res Inst, Mater Res Inst, Brisbane, Qld 4102, Australia; [Davies, C. M.; Wallace, S. J.; Chetty, N. P.; Crandon, A. J.; Oliveira, N. B.; Shannon, C. M.; Coward, J. I.; Perrin, L. C.; Armes, J. E.] Mater Hlth Serv, South Brisbane, Qld, Australia; [Lumley, J. W.] Wesley Hosp, Auchenflower, Qld, Australia	Mater Research; University of Queensland; Mater Health Services; Wesley Hospital	Hooper, JD (corresponding author), Univ Queensland, Translat Res Inst, Mater Res Inst, Canc Biol & Management, 37 Kent St, Brisbane, Qld 4102, Australia.	john.hooper@mater.uq.edu.au	Adams, Mark/AAE-1209-2021; Harrington, Brittney/Z-5941-2019; Armes, Jane/D-6396-2012; Harrington, Brittney/P-1687-2016; Coward, Jermaine/C-1779-2012; Hooper, John/C-1481-2016; Coward, Jermaine/F-2903-2016	Adams, Mark/0000-0003-1906-5018; Harrington, Brittney/0000-0001-7083-069X; Armes, Jane/0000-0002-2215-0347; Harrington, Brittney/0000-0001-7083-069X; Hooper, John/0000-0003-1054-8486; Coward, Jermaine/0000-0002-2309-9379; Davies, Claire/0000-0001-8651-0914; Chetty, Naven/0000-0002-7158-7123; HE, Yaowu/0000-0002-7828-263X; Perrin, Lewis/0000-0002-6119-8458	Cancer Council Queensland [614205, 1021827]; Wesley Research Institute [2008/06]; Australian Research Council Future Fellowship [FT120100917]	Cancer Council Queensland(Cancer Council Queensland); Wesley Research Institute; Australian Research Council Future Fellowship(Australian Research Council)	We thank Dr Jon Whitehead for helpful discussions. This work was supported by Cancer Council Queensland Grants 614205 and 1021827 and Wesley Research Institute Grant 2008/06 to JDH. MNA and BSH received Australian Post-Graduate Awards. JDH holds Australian Research Council Future Fellowship FT120100917.	Adams MN, 2012, N-S ARCH PHARMACOL, V385, P861, DOI 10.1007/s00210-012-0783-6; Adams MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028018; Awakura Y, 2008, J CANCER RES CLIN, V134, P1363, DOI 10.1007/s00432-008-0412-4; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Casar B, 2014, ONCOGENE, V33, P255, DOI 10.1038/onc.2012.547; Casar B, 2012, ONCOGENE, V31, P3924, DOI 10.1038/onc.2011.555; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Deryugina EI, 2009, MOL CANCER RES, V7, P1197, DOI 10.1158/1541-7786.MCR-09-0100; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Dong Y, 2012, J BIOL CHEM, V287, P9792, DOI 10.1074/jbc.M111.335448; Emerling BM, 2013, P NATL ACAD SCI USA, V110, P3483, DOI 10.1073/pnas.1222435110; Fukuchi K, 2010, MOL PHARMACEUT, V7, P245, DOI 10.1021/mp900236t; Gao WC, 2013, GASTROENTEROLOGY, V145, P636, DOI 10.1053/j.gastro.2013.05.049; He Y, 2010, J BIOL CHEM, V285, P26162, DOI 10.1074/jbc.M109.096453; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; Joffre C, 2011, NAT CELL BIOL, V13, P827, DOI 10.1038/ncb2257; Kollmorgen G, 2013, MOL ONCOL, V7, P1142, DOI 10.1016/j.molonc.2013.08.009; Kulbe H, 2012, CANCER RES, V72, P66, DOI 10.1158/0008-5472.CAN-11-2178; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Miyazawa Y, 2013, MOL CANCER RES, V11, P628, DOI 10.1158/1541-7786.MCR-12-0544; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Morris DP, 2008, J BIOL CHEM, V283, P2973, DOI 10.1074/jbc.M705795200; Razorenova OV, 2011, P NATL ACAD SCI USA, V108, P1931, DOI 10.1073/pnas.1011777108; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sandilands E, 2008, TRENDS CELL BIOL, V18, P322, DOI 10.1016/j.tcb.2008.05.004; Siva AC, 2008, CANCER RES, V68, P3759, DOI 10.1158/0008-5472.CAN-07-1657; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Uekita T, 2011, CANCER SCI, V102, P1943, DOI 10.1111/j.1349-7006.2011.02052.x; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Wortmann A, 2011, J BIOL CHEM, V286, P42303, DOI 10.1074/jbc.M111.227462; Wortmann A, 2009, IUBMB LIFE, V61, P723, DOI 10.1002/iub.198; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	37	26	26	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 12	2015	34	11					1375	1383		10.1038/onc.2014.88	http://dx.doi.org/10.1038/onc.2014.88			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD1AR	24681947				2022-12-25	WOS:000350806500004
J	Seo, KS; Park, JH; Heo, JY; Jing, K; Han, J; Min, KN; Kim, C; Koh, G; Lim, K; Kang, GY; Lee, JU; Yim, YH; Shong, M; Kwak, TH; Kweon, G				Seo, K-S; Park, J-H; Heo, J-Y; Jing, K.; Han, J.; Min, K-N; Kim, C.; Koh, G. Y.; Lim, K.; Kang, G-Y; Lee, J. Uee; Yim, Y-H; Shong, M.; Kwak, T-H; Kweon, G. R.			SIRT2 regulates tumour hypoxia response by promoting HIF-1 alpha hydroxylation	ONCOGENE			English	Article							INDUCIBLE FACTOR-1-ALPHA; OXIDOREDUCTASE 1; METABOLISM; HIF1-ALPHA; DEGRADATION; ACTIVATION; PROTEIN; ACETYLATION; SUPPRESSION; OXIDATION	Hypoxia-inducible factor-1 alpha (HIF-1 alpha) is a transcription factor that has a central role in the regulation of tumour metabolism under hypoxic conditions. HIF-1 alpha stimulates glycolytic energy production and promotes tumour growth. Sirtuins are NAD(+)-dependent protein deacetylases that regulate cellular metabolism in response to stress; however, their involvement in the hypoxic response remains unclear. In this study, it is shown that SIRT2-mediated deacetylation of HIF-1 alpha regulates its stability in tumour cells. SIRT2 overexpression destabilized HIF-1 alpha under hypoxic conditions, whereas HIF-1 alpha protein levels were high in SIRT2-deficient cells. SIRT2 directly interacted with HIF-1 alpha and deacetylated Lys709 of HIF-1 alpha. Deacetylation of HIF-1 alpha by SIRT2 resulted in increased binding affinity for prolyl hydroxylase 2, a key regulator of HIF-1a stability, and increased HIF-1 alpha hydroxylation and ubiquitination. Moreover, a pharmacological agent that increased the intracellular NAD(+)/NADH ratio led to the degradation of HIF-1 alpha by increasing SIRT2-mediated deacetylation and subsequent hydroxylation. These findings suggest that SIRT2-mediated HIF-1 alpha deacetylation is critical for the destablization of HIF-1 alpha and the hypoxic response of tumour cells.	[Seo, K-S; Park, J-H; Heo, J-Y; Jing, K.; Han, J.; Lim, K.; Kweon, G. R.] Chungnam Natl Univ, Sch Med, Dept Biochem, Taejon 301747, South Korea; [Heo, J-Y; Jing, K.; Han, J.; Lim, K.] Chungnam Natl Univ, Sch Med, Infect Signaling Network Res Ctr, Taejon 301747, South Korea; [Min, K-N; Kwak, T-H] KT&G Life Sci Corp R&D Ctr, Suwon, South Korea; [Kim, C.; Koh, G. Y.] Korea Adv Inst Sci & Technol, Natl Res Lab Vasc Biol, Taejon 305701, South Korea; [Kim, C.; Koh, G. Y.] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Lim, K.] Chungnam Natl Univ, Sch Med, Canc Res Inst, Taejon 301747, South Korea; [Kang, G-Y] Diatech Korea Co Ltd, Seoul, South Korea; [Lee, J. Uee] Catholic Univ, St Marys Hosp, Dept Pathol, Taejon, South Korea; [Yim, Y-H] Korea Res Inst Standard & Sci, Taejon, South Korea; [Shong, M.] Chungnam Natl Univ, Sch Med, Dept Internal Med, Taejon 301747, South Korea	Chungnam National University; Chungnam National University; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University; Catholic University of Korea; Catholic University Korea Hospital; Korea Research Institute of Standards & Science (KRISS); Chungnam National University	Kweon, G (corresponding author), Chungnam Natl Univ, Sch Med, Dept Biochem, Taejon 301747, South Korea.	bioalpha@ktngls.com; mitochondria@cnu.ac.kror	Koh, Gou Young/C-1615-2011; /H-7803-2012	Kim, Chan/0000-0001-9780-6155; Heo, Jun Young/0000-0002-0859-0063; shong, minho/0000-0002-0247-7115; Han, Jeongsu/0000-0001-6524-9841	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2009-1176023, 2011-0011365]; NRF - Ministry of Science, ICT & Future Planning [2007-0054932]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; NRF - Ministry of Science, ICT & Future Planning	We thank Dr HS Kim, Dr JH Lim and Dr JW Park for their skillful methodological assistance, Dr JJ Lee for the HRE luciferase plasmid and Dr KY Lee for the SIRT2 expression plasmids. This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2009-1176023, 2011-0011365) (GRK) and the NRF funded by the Ministry of Science, ICT & Future Planning (2007-0054932).	Berra E, 2006, EMBO REP, V7, P41, DOI 10.1038/sj.embor.7400598; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Chen R, 2011, J BIOL CHEM, V286, P13869, DOI 10.1074/jbc.M110.175414; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Choi HJ, 2008, BRIT J PHARMACOL, V154, P114, DOI 10.1038/bjp.2008.70; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hwang JH, 2009, DIABETES, V58, P965, DOI 10.2337/db08-1183; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Jin Y, 2011, J BIOL CHEM, V286, P22699, DOI 10.1074/jbc.M111.237024; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim SY, 2009, CIRC RES, V104, P842, DOI 10.1161/CIRCRESAHA.108.189837; Kim YH, 2012, FREE RADICAL BIO MED, V52, P880, DOI 10.1016/j.freeradbiomed.2011.12.007; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Kwon SJ, 2005, CLIN CANCER RES, V11, P7607, DOI 10.1158/1078-0432.CCR-05-0981; Laemmle A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033433; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Luthi-Carter R, 2010, P NATL ACAD SCI USA, V107, P7927, DOI 10.1073/pnas.1002924107; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Massudi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042357; Melillo G, 2006, MOL CANCER RES, V4, P601, DOI 10.1158/1541-7786.MCR-06-0235; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; MIETTINEN M, 1994, MODERN PATHOL, V7, P82; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Papadakis AI, 2010, CANCER RES, V70, P7820, DOI 10.1158/0008-5472.CAN-10-0215; Schwer B, 2010, P NATL ACAD SCI USA, V107, P21790, DOI 10.1073/pnas.1016306107; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Tanaka H, 2012, CANCER SCI, V103, P767, DOI 10.1111/j.1349-7006.2011.02192.x; Terzuoli E, 2010, CANCER RES, V70, P6837, DOI 10.1158/0008-5472.CAN-10-1075; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Wang F, 2012, ONCOGENE, V31, P1546, DOI 10.1038/onc.2011.347; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448; Zhang QH, 2006, P NATL ACAD SCI USA, V103, P9029, DOI 10.1073/pnas.0603269103	45	80	84	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 12	2015	34	11					1354	1362		10.1038/onc.2014.76	http://dx.doi.org/10.1038/onc.2014.76			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD1AR	24681946				2022-12-25	WOS:000350806500002
J	Girardot, M; Pecquet, C; Chachoua, I; Van Hees, J; Guibert, S; Ferrant, A; Knoops, L; Baxter, EJ; Beer, PA; Giraudier, S; Moriggl, R; Vainchenker, W; Green, AR; Constantinescu, SN				Girardot, M.; Pecquet, C.; Chachoua, I.; Van Hees, J.; Guibert, S.; Ferrant, A.; Knoops, L.; Baxter, E. J.; Beer, P. A.; Giraudier, S.; Moriggl, R.; Vainchenker, W.; Green, A. R.; Constantinescu, S. N.			Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation	ONCOGENE			English	Article							TYROSINE KINASE JAK2; MYELOPROLIFERATIVE NEOPLASMS; FUNCTION-MUTATION; TRANSCRIPTION; REQUIREMENT; TARGETS; CDNA	STAT (Signal Transducer and Activator of Transcription) transcription factors are constitutively activated in most hematopoietic cancers. We previously identified a target gene, LPP/miR-28 (LIM domain containing preferred translocation partner in lipoma), induced by constitutive activation of STAT5, but not by transient cytokine-activated STAT5. miR-28 exerts negative effects on thrombopoietin receptor signaling and platelet formation. Here, we demonstrate that, in transformed hematopoietic cells, STAT5 and p53 must be synergistically bound to chromatin for induction of LPP/miR-28 transcription. Genome-wide association studies show that both STAT5 and p53 are co-localized on the chromatin at 463 genomic positions in proximal promoters. Chromatin binding of p53 is dependent on persistent STAT5 activation at these proximal promoters. The transcriptional activity of selected promoters bound by STAT5 and p53 was significantly changed upon STAT5 or p53 inhibition. Abnormal expression of several STAT5-p53 target genes (LEP, ATP5J, GTF2A2, VEGFC, NPY1R and NPY5R) is frequently detected in platelets of myeloproliferative neoplasm (MPN) patients, but not in platelets from healthy controls. In conclusion, persistently active STAT5 can recruit normal p53, like in the case of MPN cells, but also p53 mutants, such as p53 M133K in human erythroleukemia cells, leading to pathologic gene expression that differs from canonical STAT5 or p53 transcriptional programs.	[Girardot, M.; Pecquet, C.; Chachoua, I.; Van Hees, J.; Knoops, L.; Constantinescu, S. N.] Ludwig Inst Canc Res, Brussels, Belgium; [Girardot, M.; Pecquet, C.; Chachoua, I.; Van Hees, J.; Knoops, L.; Constantinescu, S. N.] Catholic Univ Louvain, Duve Inst, Brussels, Belgium; [Girardot, M.] Univ Montpellier, CNRS, Inst Mol Genet, UMR5535, F-34059 Montpellier, France; [Guibert, S.] Univ Strasbourg, CNRS, Biotechnol & Cell Signalling, ESBS,UMR 7242, Illkirch Graffenstaden, France; [Ferrant, A.; Knoops, L.] Clin Univ St Luc, Dept Hematol, B-1200 Brussels, Belgium; [Baxter, E. J.; Beer, P. A.; Green, A. R.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Giraudier, S.; Vainchenker, W.] Inst Gustave Roussy, INSERM, U1009, F-94805 Villejuif, France; [Giraudier, S.] Univ Paris 12, Hop Henri Mondor, AP HP, PRB Cellulotheque Hematol,Lab Hematol, F-94010 Creteil, France; [Moriggl, R.] Ludwig Boltzmann Inst Canc Res, Vienna, Austria	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Ludwig Boltzmann Institute	Constantinescu, SN (corresponding author), Univ Louvain Brussels, Signal Transduct Unit, Ludwig Inst Canc Res, B-1200 Brussels, Belgium.	michael.girardot@igmm.cnrs.fr; stefan.constantinescu@bru.licr.org	Moriggl, Richard/H-8118-2019; Chachoua, Ilyas/AAB-3326-2019	Moriggl, Richard/0000-0003-0918-9463; Chachoua, Ilyas/0000-0002-5112-5394; Green, Anthony/0000-0002-9795-0218; Vainchenker, William/0000-0003-4705-202X; Christian, Pecquet/0000-0002-8623-3483; Baxter, Elizabeth Joanna/0000-0002-5946-5238; Constantinescu, Stefan N./0000-0002-8599-2699	FRS-FNRS, Belgium (Mandat d'Impulsion); FRS-FNRS, Belgium (FRSM); Salus Sanguinis Foundation; Action de Recherche Concertee projects of the University catholique de Louvain, Brussels [MEXP31C1, ARC10/15-027]; Fondation contre le Cancer, Brussels; PAI Programs [BCHM61B5]; Belgian Medical Genetics Initiative (BeMG), Belgium; Atlantic Philanthropies, New York; Austrian Science Fund (FWF) [SFB-F2807/SFB-F4707]; Austrian Science Fund (FWF) [F 2807] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish	FRS-FNRS, Belgium (Mandat d'Impulsion); FRS-FNRS, Belgium (FRSM)(Fonds de la Recherche Scientifique - FNRS); Salus Sanguinis Foundation; Action de Recherche Concertee projects of the University catholique de Louvain, Brussels; Fondation contre le Cancer, Brussels; PAI Programs; Belgian Medical Genetics Initiative (BeMG), Belgium; Atlantic Philanthropies, New York; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Cancer Research UK(Cancer Research UK)	We thank Guido Bommer for invaluable p53 reagents and extremely useful criticisms and suggestions. We are grateful for generous support to SNC from the FRS-FNRS, Belgium (Mandat d'Impulsion and FRSM), the Salus Sanguinis Foundation, the Action de Recherche Concertee projects MEXP31C1 and ARC10/15-027 of the University catholique de Louvain, Brussels, the Fondation contre le Cancer, Brussels, the PAI Programs BCHM61B5 and Belgian Medical Genetics Initiative (BeMG), Belgium and the Atlantic Philanthropies, New York (for SNC). RM was supported by SFB-F2807/SFB-F4707 from the Austrian Science Fund (FWF).	BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Casetti L, 2013, CANCER RES, V73, P2052, DOI 10.1158/0008-5472.CAN-12-3955; Chipoy C, 2007, ONCOGENE, V26, P6653, DOI 10.1038/sj.onc.1210492; Constantinescu SN, 2008, TRENDS BIOCHEM SCI, V33, P122, DOI 10.1016/j.tibs.2007.12.002; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; DEJONG J, 1995, P NATL ACAD SCI USA, V92, P3313, DOI 10.1073/pnas.92.8.3313; Fritsche M, 1998, MOL CELL ENDOCRINOL, V143, P143, DOI 10.1016/S0303-7207(98)00140-3; Girardot M, 2010, BLOOD, V116, P437, DOI 10.1182/blood-2008-06-165985; HIGUTI T, 1991, BIOCHEM BIOPH RES CO, V178, P793, DOI 10.1016/0006-291X(91)90178-A; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kramer Oliver H, 2012, JAKSTAT, V1, P203, DOI 10.4161/jkst.21232; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lin YP, 2002, BLOOD, V100, P3990, DOI 10.1182/blood-2002-02-0504; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Moriggl R, 1996, MOL CELL BIOL, V16, P5691; Moucadel V, 2005, J BIOL CHEM, V280, P13364, DOI 10.1074/jbc.M407326200; Mouzaki A, 2009, CYTOKINE, V48, P203, DOI 10.1016/j.cyto.2009.07.006; Nakatake M, 2012, ONCOGENE, V31, P1323, DOI 10.1038/onc.2011.313; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Pecquet C, 2012, BLOOD, V119, P4625, DOI 10.1182/blood-2011-08-372524; Rajala HLM, 2013, BLOOD, V121, P4541, DOI 10.1182/blood-2012-12-474577; Shi S, 2006, NAT GENET, V38, P1071, DOI 10.1038/ng1860; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Townsend PA, 2004, J BIOL CHEM, V279, P5811, DOI 10.1074/jbc.M302637200; Walz C, 2012, BLOOD, V119, P3550, DOI 10.1182/blood-2011-12-397554; Wood TJJ, 1997, MOL CELL ENDOCRINOL, V130, P69, DOI 10.1016/S0303-7207(97)00075-0; Yan DQ, 2012, BLOOD, V119, P3539, DOI 10.1182/blood-2011-03-345215; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	36	21	21	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2015	34	10					1323	1332		10.1038/onc.2014.60	http://dx.doi.org/10.1038/onc.2014.60			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC9JX	24681953	Green Accepted			2022-12-25	WOS:000350687100012
J	Wang, H; Guan, WJ; Yang, WZ; Wang, Q; Zhao, H; Yang, F; Lv, XW; Li, J				Wang, He; Guan, Wenjie; Yang, Wanzhi; Wang, Qi; Zhao, Han; Yang, Feng; Lv, Xiongwen; Li, Jun			Caffeine Inhibits the Activation of Hepatic Stellate Cells Induced by Acetaldehyde via Adenosine A2A Receptor Mediated by the cAMP/PKA/SRC/ERK1/2/P38 MAPK Signal Pathway	PLOS ONE			English	Article							ALCOHOLIC LIVER-DISEASE; PROTEIN-KINASE; COLLAGEN PRODUCTION; METABOLIC SYNDROME; EXPRESSION; PATHOGENESIS; CONSUMPTION; MECHANISMS; FIBROSIS; UPDATE	Hepatic stellate cell (HSC) activation is an essential event during alcoholic liver fibrosis. Evidence suggests that adenosine aggravates liver fibrosis via the adenosine A2A receptor (A2AR). Caffeine, which is being widely consumed during daily life, inhibits the action of adenosine. In this study, we attempted to validate the hypothesis that caffeine influences acetaldehyde-induced HSC activation by acting on A2AR. Acetaldehyde at 50, 100, 200, and 400 mu M significantly increased HSC-T6 cells proliferation, and cell proliferation reached a maximum at 48 h after exposure to 200 mu M acetaldehyde. Caffeine and the A2AR antagonist ZM241385 decreased the cell viability and inhibited the expression of procollagen type I and type III in acetaldehyde-induced HSC-T6 cells. In addition, the inhibitory effect of caffeine on the expression of procollagen type I was regulated by A2AR-mediated signal pathway involving cAMP, PKA, SRC, and ERK1/2. Interestingly, caffeine's inhibitory effect on the expression of procollagen type III may depend upon the A2AR-mediated P38 MAPK-dependent pathway. Conclusions: Caffeine significantly inhibited acetaldehyde-induced HSC-T6 cells activation by distinct A2AR mediated signal pathway via inhibition of cAMP-PKA-SRC-ERK1/2 for procollagen type I and via P38 MAPK for procollagen type III.	[Wang, He; Wang, Qi; Zhao, Han; Yang, Feng; Lv, Xiongwen; Li, Jun] Anhui Med Univ, Sch Pharm, Hefei, Anhui, Peoples R China; [Wang, He; Wang, Qi; Zhao, Han; Yang, Feng; Lv, Xiongwen; Li, Jun] Anhui Med Univ, Inst Liver Dis, Hefei, Anhui, Peoples R China; [Guan, Wenjie] PLA, Hosp 105, Hefei, Anhui, Peoples R China; [Yang, Wanzhi] First Hosp Anqing, Anqing, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Lv, XW (corresponding author), Anhui Med Univ, Sch Pharm, Hefei, Anhui, Peoples R China.	xiongwenlv@gmail.com	lv, xiongwen/ABE-6452-2021	lv, xiongwen/0000-0003-2354-0168	National Science Foundation of China [81270498]; Anhui Provincial Natural Science Foundation [11040606M194]; Anhui Provincial Key Projects of Scientific Research in Universities [KJ2012A148]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Anhui Provincial Key Projects of Scientific Research in Universities	This project was supported by the National Science Foundation of China (No.81270498), Anhui Provincial Natural Science Foundation (No. 11040606M194) and Anhui Provincial Key Projects of Scientific Research in Universities (No.KJ2012A148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala S, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/498232; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; CASINI A, 1991, HEPATOLOGY, V13, P758, DOI 10.1016/0270-9139(91)92576-T; Chan ESL, 2006, BRIT J PHARMACOL, V148, P1144, DOI 10.1038/sj.bjp.0706812; Chan ESL, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4229; Che J, 2007, MOL PHARMACOL, V72, P1626, DOI 10.1124/mol.107.038760; Chen A, 2002, BIOCHEM J, V368, P683, DOI 10.1042/BJ20020949; Chiang DJ, 2014, CLIN LIVER DIS, V18, P157, DOI 10.1016/j.cld.2013.09.006; Chiang DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069114; Cohen DE, 2012, CURRENT DIAGNOSIS TR; Cronstein Bruce N, 2011, F1000 Biol Rep, V3, P21, DOI 10.3410/B3-21; Daly J, 1993, CAFFEINE COFFEE HLTH, P97; Duddempudi AT, 2012, CLIN LIVER DIS, V16, P687, DOI 10.1016/j.cld.2012.08.003; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gessi S, 2011, ADV PHARMACOL, V61, P41, DOI 10.1016/B978-0-12-385526-8.00002-3; Ha MH, 2008, HEPATO-GASTROENTEROL, V55, P1059; Hashmi AZ, 2007, AM J PHYSIOL-GASTR L, V292, pG395, DOI 10.1152/ajpgi.00208.2006; Klinger M, 2002, CELL SIGNAL, V14, P99, DOI 10.1016/S0898-6568(01)00235-2; Li YM, 2011, J DIGEST DIS, V12, P45, DOI 10.1111/j.1751-2980.2010.00477.x; Lin JG, 2011, MOL CELL ENDOCRINOL, V333, P160, DOI 10.1016/j.mce.2010.12.028; Liu YD, 2011, ALCOHOL CLIN EXP RES, V35, P921, DOI 10.1111/j.1530-0277.2010.01422.x; Lv XW, 2010, INFLAMM RES, V59, P635, DOI 10.1007/s00011-010-0176-6; Mandel HG, 2002, FOOD CHEM TOXICOL, V40, P1231, DOI 10.1016/S0278-6915(02)00093-5; Mello T, 2008, MOL ASPECTS MED, V29, P17, DOI 10.1016/j.mam.2007.10.001; Miranda-Mendez A, 2010, INT J ENV RES PUB HE, V7, P1872, DOI 10.3390/ijerph7051872; Modi AA, 2010, HEPATOLOGY, V51, P201, DOI 10.1002/hep.23279; Molloy JW, 2012, HEPATOLOGY, V55, P429, DOI 10.1002/hep.24731; Nakata H, 2007, BIOCHEM BIOPH RES CO, V355, P842, DOI 10.1016/j.bbrc.2007.02.045; Nieto N, 2012, LIVER INT, V32, P189, DOI 10.1111/j.1478-3231.2011.02573.x; Orman ES, 2013, J GASTROEN HEPATOL, V28, P77, DOI 10.1111/jgh.12030; Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013; Peng Z, 2008, FASEB J, V22, P2263, DOI 10.1096/fj.07-100685; Peng Z, 2009, J CLIN INVEST, V119, P582, DOI 10.1172/JCI37409; Perez-Aso M, 2014, FASEB J, V28, P802, DOI 10.1096/fj.13-241646; Purohit V, 2006, HEPATOLOGY, V43, P872, DOI 10.1002/hep.21107; Ramaiah SK, 2004, INT J TOXICOL, V23, P217, DOI 10.1080/10915810490502069; Saab S, 2014, LIVER INT, V34, P495, DOI 10.1111/liv.12304; SAWYNOK J, 1993, PHARMACOL REV, V45, P43; Schulte G, 2000, MOL PHARMACOL, V58, P477, DOI 10.1124/mol.58.3.477; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Siegmund SV, 2005, DIGEST DIS, V23, P264, DOI 10.1159/000090174; Silva E, 2010, TOXICOL APPL PHARM, V245, P159, DOI 10.1016/j.taap.2010.02.015; Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667; Sohail MA, 2009, HEPATOLOGY, V49, P185, DOI 10.1002/hep.22589; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sun CX, 2005, J CLIN INVEST, V115, P35, DOI 10.1172/JCI200522656; Svegliati-Baroni G, 2005, HEPATOLOGY, V42, P343, DOI 10.1002/hep.20798; Svegliati-Baroni G, 2001, HEPATOLOGY, V33, P1130, DOI 10.1053/jhep.2001.23788; Wallacides A, 2012, MOL CELL ENDOCRINOL, V350, P61, DOI 10.1016/j.mce.2011.11.021; Wang JH, 2006, WORLD J GASTROENTERO, V12, P6926, DOI 10.3748/wjg.v12.i43.6926; Yan KF, 2012, MOL MED, V18, P10, DOI 10.2119/molmed.2011.00243; Zhang X, 2014, ARCH ENVIRON CON TOX, V67, P97, DOI 10.1007/s00244-013-9976-3	53	42	47	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92482	10.1371/journal.pone.0092482	http://dx.doi.org/10.1371/journal.pone.0092482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682220	Green Published, Green Submitted, gold			2022-12-25	WOS:000333678100009
J	Kianoush, N; Adler, CJ; Nguyen, KAT; Browne, GV; Simonian, M; Hunter, N				Kianoush, Nima; Adler, Christina J.; Nguyen, Ky-Anh T.; Browne, Gina V.; Simonian, Mary; Hunter, Neil			Bacterial Profile of Dentine Caries and the Impact of pH on Bacterial Population Diversity	PLOS ONE			English	Article							REAL-TIME PCR; STREPTOCOCCUS-MUTANS; MOLECULAR ANALYSIS; PORPHYROMONAS-GINGIVALIS; PYROSEQUENCING ANALYSIS; MICROBIAL DIVERSITY; ORAL MICROFLORA; CARIOUS DENTIN; ACID TOLERANCE; IN-VITRO	Dental caries is caused by the release of organic acids from fermentative bacteria, which results in the dissolution of hydroxyapatite matrices of enamel and dentine. While low environmental pH is proposed to cause a shift in the consortium of oral bacteria, favouring the development of caries, the impact of this variable has been overlooked in microbial population studies. This study aimed to detail the zonal composition of the microbiota associated with carious dentine lesions with reference to pH. We used 454 sequencing of the 16S rRNA gene (V3-V4 region) to compare microbial communities in layers ranging in pH from 4.5-7.8 from 25 teeth with advanced dentine caries. Pyrosequencing of the amplicons yielded 449,762 sequences. Nine phyla, 97 genera and 409 species were identified from the quality-filtered, de-noised and chimera-free sequences. Among the microbiota associated with dentinal caries, the most abundant taxa included Lactobacillus sp., Prevotella sp., Atopobium sp., Olsenella sp. and Actinomyces sp. We found a disparity between microbial communities localised at acidic versus neutral pH strata. Acidic conditions were associated with low diversity microbial populations, with Lactobacillus species including L. fermentum, L. rhamnosus and L. crispatus, being prominent. In comparison, the distinctive species of a more diverse flora associated with neutral pH regions of carious lesions included Alloprevotella tanerrae, Leptothrix sp., Sphingomonas sp. and Streptococcus anginosus. While certain bacteria were affected by the pH gradient, we also found that similar to 60% of the taxa associated with caries were present across the investigated pH range, representing a substantial core. We demonstrated that some bacterial species implicated in caries progression show selective clustering with respect to pH gradient, providing a basis for specific therapeutic strategies.	[Kianoush, Nima; Adler, Christina J.; Nguyen, Ky-Anh T.; Browne, Gina V.; Simonian, Mary; Hunter, Neil] Westmead Ctr Oral Hlth, Inst Dent Res, Sydney, NSW, Australia; [Kianoush, Nima; Adler, Christina J.; Nguyen, Ky-Anh T.; Browne, Gina V.; Simonian, Mary; Hunter, Neil] Westmead Millennium Inst, Sydney, NSW, Australia; [Kianoush, Nima; Adler, Christina J.; Nguyen, Ky-Anh T.; Hunter, Neil] Univ Sydney, Fac Dent, Dept Oral Biol, Sydney, NSW 2006, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney	Kianoush, N (corresponding author), Westmead Ctr Oral Hlth, Inst Dent Res, Sydney, NSW, Australia.	nima.kianoush@sydney.edu.au	Nguyen, Ky-Anh/A-4971-2010	Nguyen, Ky-Anh/0000-0002-1643-6576; Adler, Christina/0000-0002-4731-5291	NIH/NIDCR [R01 DEO15272-07]; Australian National Health and Medical Research Council (NHMRC) [512524.3]; Australian Dental Research Foundation (ADRF) [92-2012]	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Dental Research Foundation (ADRF)	The authors acknowledge funding from NIH/NIDCR (Grant#R01 DEO15272-07), the Australian National Health and Medical Research Council (NHMRC) (Grant# 512524.3), and the Australian Dental Research Foundation (ADRF) (Grant# 92-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Badet MC, 2001, J APPL MICROBIOL, V90, P1015, DOI 10.1046/j.1365-2672.2001.01340.x; Bagramian RA, 2009, AM J DENT, V22, P3; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; Beighton D, 2005, COMMUNITY DENT ORAL, V33, P248, DOI 10.1111/j.1600-0528.2005.00232.x; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; BOYAR RM, 1989, J DENT RES, V68, P1734, DOI 10.1177/00220345890680120301; Bradshaw DJ, 1998, CARIES RES, V32, P456, DOI 10.1159/000016487; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chhour KL, 2005, J CLIN MICROBIOL, V43, P843, DOI 10.1128/JCM.43.2.843-849.2005; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Coenye T, 2007, ANTIMICROB AGENTS CH, V51, P1541, DOI 10.1128/AAC.00999-06; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Downes J, 2013, INT J SYST EVOL MICR, V63, P1214, DOI 10.1099/ijs.0.041376-0; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Gross EL, 2010, J CLIN MICROBIOL, V48, P4121, DOI 10.1128/JCM.01232-10; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; HOJO S, 1994, J DENT RES, V73, P1853, DOI 10.1177/00220345940730121001; HOJO S, 1991, J DENT RES, V70, P182, DOI 10.1177/00220345910700030501; Huang X, 2012, J DENT RES, V91, P1130, DOI 10.1177/0022034512461652; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jiang W, 2013, CURR MICROBIOL, V67, P537, DOI 10.1007/s00284-013-0393-7; Karpievitch YV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007087; Kawasaki K, 1997, J DENT RES, V76, P588, DOI 10.1177/00220345970760011001; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; KLEIN JP, 1988, EUR J EPIDEMIOL, V4, P419; Kleinberg I, 2002, CRIT REV ORAL BIOL M, V13, P108, DOI 10.1177/154411130201300202; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; LOESCHE WJ, 1984, INFECT IMMUN, V46, P765, DOI 10.1128/IAI.46.3.765-772.1984; LOESCHE WJ, 1976, J DENT RES, V55, pA87, DOI 10.1177/002203457605500127011; MACPHERSON LMD, 1990, J DENT RES, V69, P1712, DOI 10.1177/00220345900690110201; Marsh P D, 1994, Adv Dent Res, V8, P263; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Martin FE, 2002, J CLIN MICROBIOL, V40, P1698, DOI 10.1128/JCM.40.5.1698-1704.2002; McLean JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032219; Munson MA, 2004, J CLIN MICROBIOL, V42, P3023, DOI 10.1128/JCM.42.7.3023-3029.2004; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nascimento MM, 2004, CARIES RES, V38, P454, DOI 10.1159/000079627; Petersen PE, 2009, COMMUNITY DENT ORAL, V37, P1, DOI 10.1111/j.1600-0528.2008.00448.x; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; SANSONE C, 1993, J DENT RES, V72, P508, DOI 10.1177/00220345930720020701; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; TAKAHASHI N, 1990, J DENT RES, V69, P1266, DOI 10.1177/00220345900690060801; Takahashi N, 1999, ORAL MICROBIOL IMMUN, V14, P43, DOI 10.1034/j.1399-302X.1999.140105.x; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Takahashi N, 1997, ORAL MICROBIOL IMMUN, V12, P323, DOI 10.1111/j.1399-302X.1997.tb00733.x; TAUBMAN MA, 1974, INFECT IMMUN, V9, P1079, DOI 10.1128/IAI.9.6.1079-1091.1974; VANHOUTE J, 1994, J DENT RES, V73, P672, DOI 10.1177/00220345940730031301; VANHOUTE J, 1991, J DENT RES, V70, P1503, DOI 10.1177/00220345910700120601; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WHILEY RA, 1988, INT J SYST BACTERIOL, V38, P25, DOI 10.1099/00207713-38-1-25; WHO, 2012, FACT SHEET 318; Wolff D, 2013, CARIES RES, V47, P69, DOI 10.1159/000344022; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	71	85	90	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92940	10.1371/journal.pone.0092940	http://dx.doi.org/10.1371/journal.pone.0092940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675997	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677500057
J	Kim, SH; Joung, JY; Chung, J; Park, WS; Lee, KH; Seo, HK				Kim, Sung Han; Joung, Jae Young; Chung, Jinsoo; Park, Weon Seo; Lee, Kang Hyun; Seo, Ho Kyung			Detection of Human Papillomavirus Infection and p16 Immunohistochemistry Expression in Bladder Cancer with Squamous Differentiation	PLOS ONE			English	Article							P53 MUTATION ANALYSIS; CELL CARCINOMAS; HPV GENOTYPES; VIRUS DNA; RISK; METAANALYSIS; TYPE-16; WASHES; SITES	Objectives: To determine the potential association between HPV infection and the squamous cell component of urothelial carcinoma (UC) of the bladder and to validate p16 overexpression as a surrogate marker for HPV infection in these cancers among Koreans. Methods: We analyzed the presence of HPV infection using an HPV-DNA chip and the expression of p16 using immunohistochemistry in 47 subjects between July 2001 and March 2011. The study group (n = 35) included patients with squamous differentiation of UC of the bladder. The control group (n = 12) included patients with squamous metaplasia of the bladder. Results: Baseline characteristics of control and study groups were similar. HPV DNA detection rates were approximately 2-fold higher in the study than the control group (17.1% [6/35] versus 8.3% [1/12], respectively), but the difference was not statistically significant. P16 overexpression was detected in 16/35 (45.7%) study group and 1/12 (8.3%) control group samples (p = 0.034). Both HPV-positivity and p16 overexpression were present in 3/35 (8.8%) study group samples, but none of the control group (p = 0.295). In the study group, the percentage of HPV-positive cases who were non-smokers was 2-fold higher than the percentage of HPV-negative cases who were non-smokers (66.7% [4/6] versus 31.0% [9/29], respectively); however, statistical significance was not achieved due to the small sample size. Conclusions: HPV infection may be associated with UC of the bladder with squamous differentiation, especially in non-smokers. However, p16 expression does not appear to be a strong surrogate marker for evidence of HPV infection in this type of cancer.	[Kim, Sung Han; Joung, Jae Young; Chung, Jinsoo; Park, Weon Seo; Lee, Kang Hyun; Seo, Ho Kyung] Natl Canc Ctr, Ctr Prostate Canc, Goyang, South Korea	National Cancer Center - Korea (NCC)	Seo, HK (corresponding author), Natl Canc Ctr, Ctr Prostate Canc, Goyang, South Korea.	seohk@ncc.re.kr		Seo, Ho Kyung/0000-0003-2601-1093	National Cancer Center, Republic of Korea [NCC-1110510]	National Cancer Center, Republic of Korea	This work was supported by a grant from the National Cancer Center (NCC-1110510), Republic of Korea. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abol-Enein H, 2008, SCAND J UROL NEPHROL, V42, P79, DOI 10.1080/03008880802325309; AGLIANO AM, 1994, UROL INT, V52, P208, DOI 10.1159/000282610; Alexander RE, 2012, MODERN PATHOL, V25, P1526, DOI 10.1038/modpathol.2012.103; ANWAR K, 1992, CANCER-AM CANCER SOC, V70, P1967, DOI 10.1002/1097-0142(19921001)70:7<1967::AID-CNCR2820700726>3.0.CO;2-8; Badawi Hala, 2008, Medscape J Med, V10, P232; Blochin EB, 2012, MODERN PATHOL, V25, P1534, DOI 10.1038/modpathol.2012.112; Boucher N R, 1997, Int Urogynecol J Pelvic Floor Dysfunct, V8, P354, DOI 10.1007/BF02765596; Buitrago-Perez A, 2009, CURR GENOMICS, V10, P26, DOI 10.2174/138920209787581235; Bussu F, 2013, BRIT J CANCER, V108, P1157, DOI 10.1038/bjc.2013.55; Cai T, 2008, EUR UROL, V53, P858, DOI 10.1016/j.eururo.2007.09.041; Cai T, 2011, ONCOL REP, V25, P485, DOI 10.3892/or.2010.1083; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Choi YD, 2005, GYNECOL ONCOL, V98, P369, DOI 10.1016/j.ygyno.2005.04.044; Doxtader EE, 2012, HUM PATHOL, V43, P327, DOI 10.1016/j.humpath.2011.05.010; Freedman ND, 2011, JAMA-J AM MED ASSOC, V306, P737, DOI 10.1001/jama.2011.1142; Grignon DJ, 2004, SQUAMOUS CELL CARCIN; Gutierrez J, 2006, J UROLOGY, V176, P2474, DOI 10.1016/j.juro.2006.07.157; Helal TEA, 2006, PATHOL ONCOL RES, V12, P173, DOI 10.1007/BF02893365; Jimenez-Pacheco A, 2012, KOREAN J UROL, V53, P240, DOI 10.4111/kju.2012.53.4.240; Khaled HM, 2001, TUMORI, V87, P256, DOI 10.1177/030089160108700409; Kim CJ, 2003, GYNECOL ONCOL, V89, P210, DOI 10.1016/S0090-8258(02)00069-0; Lehoux M, 2009, PUBLIC HEALTH GENOM, V12, P268, DOI 10.1159/000214918; LI Y, 1994, CANCER RES, V54, P6078; LopezBeltran A, 1997, BIOMED PHARMACOTHER, V51, P252, DOI 10.1016/S0753-3322(97)83540-8; Moonen PMJ, 2007, EUR UROL, V52, P464, DOI 10.1016/j.eururo.2006.11.017; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Polesel J, 2012, BRIT J CANCER, V106, P222, DOI 10.1038/bjc.2011.519; SANO T, 1995, PATHOL INT, V45, P506, DOI 10.1111/j.1440-1827.1995.tb03493.x; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Shaker OG, 2013, BIOMED PHARMACOTHER, V67, P183, DOI 10.1016/j.biopha.2012.10.019; Shigehara K, 2011, J MED VIROL, V83, P277, DOI 10.1002/jmv.21966; SILVERMAN DT, 1992, HEMATOL ONCOL CLIN N, V6, P1; Steinestel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065189; Um TH, 2011, ANN CLIN LAB SCI, V41, P48; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wiwanitkit Viroj, 2005, Asian Pac J Cancer Prev, V6, P217; Youshya S, 2005, J CLIN PATHOL, V58, P207, DOI 10.1136/jcp.2004.017152; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	38	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93525	10.1371/journal.pone.0093525	http://dx.doi.org/10.1371/journal.pone.0093525			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675970	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500135
J	Li, LQ; Cui, X; Yu, SJ; Zhang, Y; Luo, Z; Yang, H; Zhou, Y; Zheng, XQ				Li, Liqi; Cui, Xiang; Yu, Sanjiu; Zhang, Yuan; Luo, Zhong; Yang, Hua; Zhou, Yue; Zheng, Xiaoqi			PSSP-RFE: Accurate Prediction of Protein Structural Class by Recursive Feature Extraction from PSI-BLAST Profile, Physical-Chemical Property and Functional Annotations	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; PRINCIPAL COMPONENT ANALYSIS; AMINO-ACID-COMPOSITION; SUBCELLULAR-LOCALIZATION; SEQUENCE REPRESENTATION; SECONDARY STRUCTURE; ALGORITHM; CLASSIFICATION; INFORMATION; SIMILARITY	Protein structure prediction is critical to functional annotation of the massively accumulated biological sequences, which prompts an imperative need for the development of high-throughput technologies. As a first and key step in protein structure prediction, protein structural class prediction becomes an increasingly challenging task. Amongst most homological-based approaches, the accuracies of protein structural class prediction are sufficiently high for high similarity datasets, but still far from being satisfactory for low similarity datasets, i.e., below 40% in pairwise sequence similarity. Therefore, we present a novel method for accurate and reliable protein structural class prediction for both high and low similarity datasets. This method is based on Support Vector Machine (SVM) in conjunction with integrated features from position-specific score matrix (PSSM), PROFEAT and Gene Ontology (GO). A feature selection approach, SVM-RFE, is also used to rank the integrated feature vectors through recursively removing the feature with the lowest ranking score. The definitive top features selected by SVM-RFE are input into the SVM engines to predict the structural class of a query protein. To validate our method, jackknife tests were applied to seven widely used benchmark datasets, reaching overall accuracies between 84.61% and 99.79%, which are significantly higher than those achieved by state-of-the-art tools. These results suggest that our method could serve as an accurate and cost-effective alternative to existing methods in protein structural classification, especially for low similarity datasets.	[Li, Liqi; Yang, Hua] Third Mil Med Univ, Xinqiao Hosp, Dept Gen Surg, Chongqing, Peoples R China; [Cui, Xiang; Zhang, Yuan; Zhou, Yue] Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China; [Yu, Sanjiu] Third Mil Med Univ, Xinqiao Hosp, Inst Cardiovasc Dis PLA, Chongqing, Peoples R China; [Luo, Zhong] Chongqing Univ, Coll Bioengn, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 630044, Peoples R China; [Yang, Hua] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI USA; [Zhou, Yue] Shanghai Normal Univ, Dept Math, Shanghai, Peoples R China; [Zheng, Xiaoqi] Harvard Univ, Sch Publ Hlth, Dept Biostat & Computat Biol, Boston, MA USA	Army Medical University; Army Medical University; Army Medical University; Chongqing University; University of Michigan System; University of Michigan; Shanghai Normal University; Harvard University; Harvard T.H. Chan School of Public Health	Yang, H (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Gen Surg, Chongqing, Peoples R China.	Yanghuaxq@163.com; xqzheng@shnu.edu.cn	Luo, Zhong/AAU-2225-2020	Luo, Zhong/0000-0002-9019-3314	National Natural Science Foundation of China [81302134, 31100953]; Innovation Program of Shanghai Municipal Education Commission [12YZ088]; Program of Shanghai Normal University [DZL121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Program of Shanghai Normal University	This work was partially supported by the grants from National Natural Science Foundation of China (No. 81302134 and No. 31100953), Innovation Program of Shanghai Municipal Education Commission (No. 12YZ088) and the Program of Shanghai Normal University (DZL121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck D, 2012, BIOINFORMATICS, V28, P1062, DOI 10.1093/bioinformatics/bts085; Cai YD, 2006, J THEOR BIOL, V238, P172, DOI 10.1016/j.jtbi.2005.05.034; Cao YF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-20; Chen C, 2006, ANAL BIOCHEM, V357, P116, DOI 10.1016/j.ab.2006.07.022; Chen K, 2008, J COMPUT CHEM, V29, P1596, DOI 10.1002/jcc.20918; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Ding SY, 2014, BIOCHIMIE, V97, P60, DOI 10.1016/j.biochi.2013.09.013; Ding SY, 2012, BIOCHIMIE, V94, P1166, DOI 10.1016/j.biochi.2012.01.022; Dong LH, 2006, J BIOMOL STRUCT DYN, V24, P239; Feng KY, 2005, BIOCHEM BIOPH RES CO, V334, P213, DOI 10.1016/j.bbrc.2005.06.075; Gao JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064704; Hu CX, 2013, MED PHYS, V40, DOI 10.1118/1.4804054; Kurgan L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-226; Kurgan L, 2007, BIOCHEM BIOPH RES CO, V357, P453, DOI 10.1016/j.bbrc.2007.03.164; Kurgan LA, 2006, PATTERN RECOGN, V39, P2323, DOI 10.1016/j.patcog.2006.02.014; Lertampaiporn S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks878; Li LQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031057, 10.1371/journal.pone.0045115]; Li ZC, 2008, AMINO ACIDS, V35, P581, DOI 10.1007/s00726-008-0084-z; Li ZC, 2009, AMINO ACIDS, V37, P415, DOI 10.1007/s00726-008-0170-2; Liang CL, 2013, J MED SYST, V37, DOI 10.1007/s10916-013-9932-9; Liu TG, 2012, AMINO ACIDS, V42, P2243, DOI 10.1007/s00726-011-0964-5; Liu TG, 2010, AMINO ACIDS, V38, P721, DOI 10.1007/s00726-009-0276-1; Liu TA, 2010, J THEOR BIOL, V267, P272, DOI 10.1016/j.jtbi.2010.09.007; Million M, 2013, P NATL ACAD SCI USA, V110, pE1, DOI 10.1073/pnas.1218418110; Mizianty MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-414; Niu XH, 2014, J THEOR BIOL, V343, P186, DOI 10.1016/j.jtbi.2013.10.009; Ota K, 2014, J NEUROSCI METH, V221, P139, DOI 10.1016/j.jneumeth.2013.10.003; Paik YK, 2012, NAT BIOTECHNOL, V30, P221, DOI 10.1038/nbt.2152; Park CY, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002957; Qin YF, 2012, PROTEIN PEPTIDE LETT, V19, P388, DOI 10.2174/092986612799789350; Raghuraj R, 2008, COMPUT BIOL CHEM, V32, P302, DOI 10.1016/j.compbiolchem.2008.03.009; Rao HB, 2011, NUCLEIC ACIDS RES, V39, pW385, DOI 10.1093/nar/gkr284; Wan SB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-290; Wang ZX, 2000, PROTEINS, V38, P165, DOI 10.1002/(SICI)1097-0134(20000201)38:2<165::AID-PROT5>3.0.CO;2-V; Xia XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037653; Yang JY, 2009, J THEOR BIOL, V257, P618, DOI 10.1016/j.jtbi.2008.12.027; Zhang JJ, 2011, TALANTA, V83, P1401, DOI 10.1016/j.talanta.2010.11.020; Zhang SL, 2012, J BIOMOL STRUCT DYN, V29, P634, DOI 10.1080/07391102.2011.672627; Zhao B, 2013, J PROTEOMICS, V81, P56, DOI 10.1016/j.jprot.2012.12.021; Zheng XQ, 2010, J COMPUT CHEM, V31, P1201, DOI 10.1002/jcc.21406	40	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92863	10.1371/journal.pone.0092863	http://dx.doi.org/10.1371/journal.pone.0092863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675610	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677500046
J	Palacio, S; Maestro, M; Montserrat-Marti, G				Palacio, Sara; Maestro, Melchor; Montserrat-Marti, Gabriel			Differential Nitrogen Cycling in Semiarid Sub-Shrubs with Contrasting Leaf Habit	PLOS ONE			English	Article							SHOOT GROWTH DYNAMICS; SOUTHERN-CALIFORNIA; DECIDUOUS SHRUBS; SENESCING LEAVES; BUD MORPHOLOGY; NUTRIENT-USE; STORAGE; REMOBILIZATION; RESORPTION; PHENOLOGY	Nitrogen (N) is, after water, the most limiting resource in semiarid ecosystems. However, knowledge on the N cycling ability of semiarid woody plants is still very rudimentary. This study analyzed the seasonal change in the N concentrations and pools of the leaves and woody organs of two species of semiarid sub-shrubs with contrasting leaf habit. The ability of both species to uptake, remobilize and recycle N, plus the main storage organ for N during summer drought were evaluated. We combined an observational approach in the field with experimental N-15 labelling of adult individuals grown in sand culture. Seasonal patterns of N concentrations were different between species and organs and foliar N concentrations of the summer deciduous Lepidium subulatum were almost double those of the evergreen Linum suffruticosum. L. subulatum up took ca. 60% more external N than the evergreen and it also had a higher N resorption efficiency and proficiency. Contrastingly, L. suffruticosum relied more on internal N remobilization for shoot growth. Differently to temperate species, the evergreen stored N preferentially in the main stem and old trunks, while the summer deciduous stored it in the foliage and young stems. The higher ability of L. subulatum to uptake external N can be related to its ability to perform opportunistic growth and exploit the sporadic pulses of N typical of semiarid ecosystems. Such ability may also explain its high foliar N concentrations and its preferential storage of N in leaves and young stems. Finally, L. suffruticosum had a lower ability to recycle N during leaf senescence. These strategies contrast with those of evergreen and deciduous species from temperate and boreal areas, highlighting the need of further studies on semiarid and arid plants.	[Palacio, Sara] CSIC, IPE, Jaca, Huesca, Spain; [Maestro, Melchor; Montserrat-Marti, Gabriel] CSIC, IPE, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Palacio, S (corresponding author), CSIC, IPE, Avda Nuestra Senora Victoria, Jaca, Huesca, Spain.	s.palacio@ipe.csic.es	Palacio, Sara/B-3907-2011	Palacio, Sara/0000-0002-8362-6820	ARBALMONT [786-2012]; Ministerio de Economia y Competitividad, Spain [CGL2011-26654]; Juan de la Cierva from the MEC (Spain);  [GA-LC-011/2008]	ARBALMONT; Ministerio de Economia y Competitividad, Spain; Juan de la Cierva from the MEC (Spain); 	This study was funded by projects GA-LC-011/2008 [DGA], ARBALMONT (786-2012) [Organismo Autonomo de Parques Nacionales], and CGL2011-26654 [Ministerio de Economia y Competitividad, Spain]. SP was funded by a Juan de la Cierva contract from the MEC (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS R, 1993, OIKOS, V66, P144, DOI 10.2307/3545208; Alvarado JJ, 2000, J PLANT PHYSIOL, V156, P612, DOI 10.1016/S0176-1617(00)80220-5; BRAUN-BLANQUET J., 1957, AN ESTAC EXPTL AULA DEI, V5, P1; CHRISTODOULAKIS NS, 1990, ANN BOT-LONDON, V65, P291, DOI 10.1093/oxfordjournals.aob.a087937; COLEMAN GD, 1991, PLANT PHYSIOL, V96, P686, DOI 10.1104/pp.96.3.686; Delgado-Baquerizo M, 2011, PEDOSPHERE, V21, P309, DOI 10.1016/S1002-0160(11)60131-8; Delgado-Baquerizo M, 2013, EFECTOS CAMBIO CLIMA; ESCUDERO A, 1992, VEGETATIO, V100, P225; GALLARDO A, 1993, ECOLOGY, V74, P152, DOI 10.2307/1939510; GRAY JT, 1983, J ECOL, V71, P21, DOI 10.2307/2259961; GRAY JT, 1983, J ECOL, V71, P43, DOI 10.2307/2259962; Grelet GA, 2001, J EXP BOT, V52, P993, DOI 10.1093/jexbot/52.358.993; Guerrero-Campo J, 1999, J ARID ENVIRON, V41, P411, DOI 10.1006/jare.1999.0493; Hodge A, 2009, PLANT SOIL, V321, P153, DOI 10.1007/s11104-009-9929-9; Killingbeck KT, 1996, ECOLOGY, V77, P1716, DOI 10.2307/2265777; MEYER SE, 1992, J VEG SCI, V3, P429, DOI 10.2307/3235799; Milla R, 2005, PLANT SOIL, V278, P303, DOI 10.1007/s11104-005-8770-z; Milla R, 2005, NEW PHYTOL, V168, P167, DOI 10.1111/j.1469-8137.2005.01477.x; Milla R, 2005, PLANT BIOLOGY, V7, P182, DOI 10.1055/s-2005-837469; Milla R, 2004, ANN BOT-LONDON, V93, P671, DOI 10.1093/aob/mch094; MILLARD P, 1992, TREE PHYSIOL, V10, P33, DOI 10.1093/treephys/10.1.33; MILLARD P, 1991, NEW PHYTOL, V117, P587, DOI 10.1111/j.1469-8137.1991.tb00963.x; MILLARD P, 1989, J EXP BOT, V40, P1285, DOI 10.1093/jxb/40.11.1285; Millard P, 1996, Z PFLANZ BODENKUNDE, V159, P1; Millard P, 2010, TREE PHYSIOL, V30, P1083, DOI 10.1093/treephys/tpq042; Mota JF, 2003, PHYTOCOENOLOGIA, V33, P13, DOI 10.1127/0340-269X/2003/0033-0013; Orshan G, 1989, PLANT PHENO MORPHOLO; Palacio S, 2007, J ARID ENVIRON, V68, P522, DOI 10.1016/j.jaridenv.2006.07.008; Palacio S, 2007, PLANT BIOLOGY, V9, P49, DOI 10.1055/s-2006-924224; Palacio S, 2007, ENVIRON EXP BOT, V59, P34, DOI 10.1016/j.envexpbot.2005.10.003; Palacio S, 2005, ANN BOT-LONDON, V95, P949, DOI 10.1093/aob/mci110; Palacio S., 2006, PIRINEOS, V161, P159; Palacio S, 2007, ANN BOT-LONDON, V99, P333, DOI 10.1093/aob/mcl263; Palacio S, 2006, FLORA, V201, P612, DOI 10.1016/j.flora.2006.02.002; Palacio S, 2006, BOT J LINN SOC, V151, P527, DOI 10.1111/j.1095-8339.2006.00542.x; Proe MF, 2000, NEW PHYTOL, V146, P461, DOI 10.1046/j.1469-8137.2000.00658.x; Quirantes J., 1977, ESTUDIO SEDIMENTOLOG; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reynolds JF, 2004, OECOLOGIA, V141, P194, DOI 10.1007/s00442-004-1524-4; Rivas-Martinez S., 1987, MEMORIA MAPA SERIES; Ruiz JM, 2003, INT J PHYTOREMEDIAT, V5, P203, DOI 10.1080/713779220; Schlesinger W.M., 1996, BIOGEOCHEMISTRY ANAL; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Silla F, 2003, OECOLOGIA, V136, P28, DOI 10.1007/s00442-003-1232-5; Silla F, 2008, TREES-STRUCT FUNCT, V22, P785, DOI 10.1007/s00468-008-0239-2; Uscola M, 2013, ECOPHYSIOLOGY NITROG; van der Aart P.J.M., 1988, PLANT FORM VEGETATIO, P211; VANCLEVE B, 1993, PLANTA, V189, P157, DOI 10.1007/BF00201357; Vizoso S, 2008, TREE PHYSIOL, V28, P1729, DOI 10.1093/treephys/28.11.1729; Yuan ZY, 2005, J ARID ENVIRON, V63, P191, DOI 10.1016/j.jaridenv.2005.01.023	50	4	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93184	10.1371/journal.pone.0093184	http://dx.doi.org/10.1371/journal.pone.0093184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675650	Green Published, gold			2022-12-25	WOS:000333677500086
J	Pyles, RB; Vincent, KL; Baum, MM; Elsom, B; Miller, AL; Maxwell, C; Eaves-Pyles, TD; Li, GY; Popov, VL; Nusbaum, RJ; Ferguson, MR				Pyles, Richard B.; Vincent, Kathleen L.; Baum, Marc M.; Elsom, Barry; Miller, Aaron L.; Maxwell, Carrie; Eaves-Pyles, Tonyia D.; Li, Guangyu; Popov, Vsevolod L.; Nusbaum, Rebecca J.; Ferguson, Monique R.			Cultivated Vaginal Microbiomes Alter HIV-1 Infection and Antiretroviral Efficacy in Colonized Epithelial Multilayer Cultures	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BACTERIAL-VAGINOSIS; SIMULTANEOUS DELIVERY; SENSORY GANGLIA; GENITAL-TRACT; TENOFOVIR; RISK; EPIDEMIOLOGY; MICROBICIDES; DISEASE	There is a pressing need for modeling of the symbiotic and at times dysbiotic relationship established between bacterial microbiomes and human mucosal surfaces. In particular clinical studies have indicated that the complex vaginal microbiome (VMB) contributes to the protection against sexually-transmitted pathogens including the life-threatening human immunodeficiency virus (HIV-1). The human microbiome project has substantially increased our understanding of the complex bacterial communities in the vagina however, as is the case for most microbiomes, very few of the community member species have been successfully cultivated in the laboratory limiting the types of studies that can be completed. A genetically controlled ex vivo model system is critically needed to study the complex interactions and associated molecular dialog. We present the first vaginal mucosal culture model that supports colonization by both healthy and dysbiotic VMB from vaginal swabs collected from routine gynecological patients. The immortalized vaginal epithelial cells used in the model and VMB cryopreservation methods provide the opportunity to reproducibly create replicates for lab-based evaluations of this important mucosal/bacterial community interface. The culture system also contains HIV-1 susceptible cells allowing us to study the impact of representative microbiomes on replication. Our results show that our culture system supports stable and reproducible colonization by VMB representing distinct community state types and that the selected representatives have significantly different effects on the replication of HIV-1. Further, we show the utility of the system to predict unwanted alterations in efficacy or bacterial community profiles following topical application of a front line antiretroviral.	[Pyles, Richard B.; Elsom, Barry; Miller, Aaron L.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Pyles, Richard B.; Maxwell, Carrie; Eaves-Pyles, Tonyia D.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Vincent, Kathleen L.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Baum, Marc M.] Oak Crest Inst Sci, Pasadena, CA USA; [Li, Guangyu] E Tennessee State Univ, Dept Internal Med, Div Infect Dis, Johnson City, TN 37614 USA; [Popov, Vsevolod L.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Nusbaum, Rebecca J.] Univ Texas Med Branch, Human Pathophysiol & Translat Med Grad program, Galveston, TX 77555 USA; [Ferguson, Monique R.] Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; East Tennessee State University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Pyles, RB (corresponding author), Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.	rbpyles@utmb.edu		Vincent, Kathleen/0000-0003-3051-9551; Baum, Marc/0000-0003-1558-5649; Nusbaum, Rebecca/0000-0002-8378-8037	Institute for Translational Sciences at the University of Texas Medical Branch; Clinical and Translational Science Award from the National Center for Advancing Translational Sciences, National Institutes of Health (NIH) [UL1TR000071]; National Institute Of Allergy And Infectious Diseases of the NIH [R01AI100744]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100744, P30AI036211] Funding Source: NIH RePORTER	Institute for Translational Sciences at the University of Texas Medical Branch; Clinical and Translational Science Award from the National Center for Advancing Translational Sciences, National Institutes of Health (NIH); National Institute Of Allergy And Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was conducted with the support of the Institute for Translational Sciences at the University of Texas Medical Branch, supported in part by a Clinical and Translational Science Award (UL1TR000071) from the National Center for Advancing Translational Sciences, National Institutes of Health (NIH). This research also was supported by the National Institute Of Allergy And Infectious Diseases of the NIH under Award Number R01AI100744. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum MM, 2012, J PHARM SCI-US, V101, P2833, DOI 10.1002/jps.23208; Bell BA, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046010; Bird MD, 2007, J VIROL, V81, P423, DOI 10.1128/JVI.01455-06; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Brotman RM, 2008, AM J EPIDEMIOL, V168, P188, DOI 10.1093/aje/kwn103; Chu CF, 2008, J REPROD IMMUNOL, V78, P58, DOI 10.1016/j.jri.2007.08.004; Cohen CR, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001251; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Eaves-Pyles T, 2013, MOL MED, V19, P263, DOI 10.2119/molmed.2013.00081; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Givan AL, 1997, AM J REPROD IMMUNOL, V38, P350; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hickey RJ, 2012, TRANSL RES, V160, P267, DOI 10.1016/j.trsl.2012.02.008; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Johnson AJ, 2008, J VIROL, V82, P9678, DOI 10.1128/JVI.01159-08; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keller MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046901; Kenyon C, 2013, AM J OBSTET GYNECOL; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Lambert JA, 2013, APPL ENVIRON MICROB, V79, P4181, DOI 10.1128/AEM.01160-13; Losikoff Phyllis, 2007, Infect Dis Obstet Gynecol, V2007, P92307, DOI 10.1155/2007/92307; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Mayer KH, 2006, AIDS, V20, P543, DOI 10.1097/01.aids.0000210608.70762.c3; Milligan GN, 2005, J VIROL, V79, P11537, DOI 10.1128/JVI.79.17.11537-11540.2005; Mirmonsef P, 2011, AM J REPROD IMMUNOL, V65, P190, DOI 10.1111/j.1600-0897.2010.00943.x; Moss JA, 2012, ANTIMICROB AGENTS CH, V56, P5952, DOI 10.1128/AAC.01198-12; Moss JA, 2012, ANTIMICROB AGENTS CH, V56, P875, DOI 10.1128/AAC.05662-11; Nies AT, 2012, EXPERT OPIN DRUG MET, V8, P1565, DOI 10.1517/17425255.2012.722996; Palmer S, 2001, AIDS RES HUM RETROV, V17, P1167, DOI 10.1089/088922201316912772; Pennock JW, 2009, VACCINE, V27, P5830, DOI 10.1016/j.vaccine.2009.07.052; Petrova MI, 2013, FEMS MICROBIOL REV, V37, P762, DOI 10.1111/1574-6976.12029; Pirrone V, 2011, ANTIVIR RES, V90, P168, DOI 10.1016/j.antiviral.2011.03.176; PYLES RB, 1994, J VIROL, V68, P4514, DOI 10.1128/JVI.68.7.4514-4524.1994; Ramjee Gita, 2007, AIDS Res Ther, V4, P20, DOI 10.1186/1742-6405-4-20; Ravel J, 2012, MBIO, V3, DOI 10.1128/mBio.00370-12; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rose WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032728; Schellenberg JJ, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/131243; Segarra TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027675; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Shattock RJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007385; Sobel JD, 2005, INFECT DIS CLIN N AM, V19, P387, DOI 10.1016/j.idc.2005.03.001; Spear Gregory T, 2007, AIDS Res Ther, V4, P25, DOI 10.1186/1742-6405-4-25; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Thomas S, 1928, J INFECT DIS, V43, P218, DOI 10.1093/infdis/43.3.218; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Verstraelen H, 2013, CURR OPIN INFECT DIS, V26, P86, DOI 10.1097/QCO.0b013e32835c20cd; Verstraelen H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-81; Vincent KL, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.025; Wahren B, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-72; Weinstein L, 1937, Yale J Biol Med, V10, P185; Yeoman CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056111	55	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93419	10.1371/journal.pone.0093419	http://dx.doi.org/10.1371/journal.pone.0093419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676219	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500120
J	Wu, YZ; Yu, YH; Szabo, A; Han, M; Huang, XF				Wu, Yizhen; Yu, Yinghua; Szabo, Alexander; Han, Mei; Huang, Xu-Feng			Central Inflammation and Leptin Resistance Are Attenuated by Ginsenoside Rb1 Treatment in Obese Mice Fed a High-Fat Diet	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; KAPPA-B; ADIPOSE; INHIBITION; ACTIVATION; SECRETION; PTP1B; LIVER; BETA	A low-grade pro-inflammatory state is at the pathogenic core of obesity and type 2 diabetes. We tested the hypothesis that the plant terpenoid compound ginsenoside Rb1 (Rb1), known to exert anti-inflammatory effects, would ameliorate obesity, obesity-associated inflammation and glucose intolerance in the high-fat diet-induced obese mouse model. Furthermore, we examined the effect of Rb1 treatment on central leptin sensitivity and the leptin signaling pathway in the hypothalamus. We found that intraperitoneal injections of Rb1 (14 mg/kg, daily) for 21 days significantly reduced body weight gain, fat mass accumulation, and improved glucose tolerance in obese mice on a HF diet compared to vehicle treatment. Importantly, Rb1 treatment also reduced levels of pro-inflammatory cytokines (TNF-alpha, IL-6 and/or IL-1 beta) and NF-kappa B pathway molecules (p-IKK and p-IkB alpha) in adipose tissue and liver. In the hypothalamus, Rb1 treatment decreased the expression of inflammatory markers (IL-6, IL-1 beta and p-IKK) and negative regulators of leptin signaling (SOCS3 and PTP1B). Furthermore, Rb1 treatment also restored the anorexic effect of leptin in high-fat fed mice as well as leptin pSTAT3 signaling in the hypothalamus. Ginsenoside Rb1 has potential for use as an anti-obesity therapeutic agent that modulates obesity-induced inflammation and improves central leptin sensitivity in HF diet-induced obesity.	[Wu, Yizhen; Yu, Yinghua; Szabo, Alexander; Han, Mei; Huang, Xu-Feng] Univ Wollongong, Illawarra Hlth & Med Res Inst, Sch Med, Wollongong, NSW, Australia; [Yu, Yinghua; Huang, Xu-Feng] Schizophrenia Res Inst, Sydney, NSW, Australia; [Szabo, Alexander] Australian Nucl Sci & Technol Org, ANSTO LifeSci, Sydney, NSW, Australia	University of Wollongong; Australian Nuclear Science & Technology Organisation	Yu, YH (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Sch Med, Wollongong, NSW, Australia.	yinghua@uow.edu.au; xhuang@uow.edu.au	Huang, Xu-Feng/D-6053-2013; Huang, Xu-Feng/H-7408-2015	Huang, Xu-Feng/0000-0002-5895-2253; Huang, Xu-Feng/0000-0002-5895-2253; Yu, Yinghua/0000-0003-2508-7512	Diabetes Australia Research Trust Research Projects; National Health and Medical Research Council of Australia [NHMRC 573441]	Diabetes Australia Research Trust Research Projects; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by Diabetes Australia Research Trust Research Projects to XFH and YHY. YHY is supported by the National Health and Medical Research Council of Australia (NHMRC 573441). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda AP, 2011, ENDOCRINOLOGY, V152, P1314, DOI 10.1210/en.2010-0659; Boey D, 2008, NEUROPEPTIDES, V42, P19, DOI 10.1016/j.npep.2007.11.003; Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Calegari VC, 2011, J BIOL CHEM, V286, P12870, DOI 10.1074/jbc.M110.173021; Chelikani PK, 2004, AM J PHYSIOL-REG I, V287, pR1064, DOI 10.1152/ajpregu.00376.2004; Cho JY, 2004, J CLIN ENDOCR METAB, V89, P3510, DOI 10.1210/jc.2003-031823; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; du Bois TM, 2012, EUROPEAN NEUROPSYCHO; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Joh EH, 2011, BIOCHEM PHARMACOL, V82, P278, DOI 10.1016/j.bcp.2011.05.003; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Li H, 2008, METABOLISM, V57, P1704, DOI 10.1016/j.metabol.2008.07.029; Li QY, 2011, J AGR FOOD CHEM, V59, P6312, DOI 10.1021/jf200424k; Lihn AS, 2005, OBES REV, V6, P13, DOI 10.1111/j.1467-789X.2005.00159.x; Lin N, 2013, CELL BIOCHEM BIOPHYS, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Milanski M, 2012, DIABETES, V61, P1455, DOI 10.2337/db11-0390; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Paget G.E., 1964, EVALUATION DRUG ACTI, P135, DOI DOI 10.1016/B978-1-4832-2845-7.50012-8; Paxinos G, 2002, MOUSE BRAIN STEREOTA, V1st; Pritchard LE, 2002, J ENDOCRINOL, V172, P411, DOI 10.1677/joe.0.1720411; Rigamonti AE, 2011, EUR J ENDOCRINOL, V165, P421, DOI 10.1530/EJE-11-0312; Salminen A, 2008, CELL MOL LIFE SCI, V65, P2979, DOI 10.1007/s00018-008-8103-5; Schmidt PT, 2005, EUR J GASTROEN HEPAT, V17, P207, DOI 10.1097/00042737-200502000-00012; Song JH, 2012, PHYTOTHER RES; Stanton MC, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-8; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174; Washida D, 2003, CHEM PHARM BULL, V51, P1314, DOI 10.1248/cpb.51.1314; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; White CL, 2009, AM J PHYSIOL-ENDOC M, V296, pE291, DOI 10.1152/ajpendo.90513.2008; Wilusz J, 2008, POSTTRANSCRIPTIONAL, P303; Xiong Y, 2010, DIABETES, V59, P2505, DOI 10.2337/db10-0315; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhu J, 2012, NEUROSCIENCE, V202, P342, DOI 10.1016/j.neuroscience.2011.11.070	43	65	70	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92618	10.1371/journal.pone.0092618	http://dx.doi.org/10.1371/journal.pone.0092618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675731	Green Published, gold			2022-12-25	WOS:000333677500029
J	Butz, MV; Kutter, EF; Lorenz, C				Butz, Martin V.; Kutter, Esther F.; Lorenz, Corinna			Rubber Hand Illusion Affects Joint Angle Perception	PLOS ONE			English	Article							BODY; TOUCH; INFORMATION; OWNERSHIP; PLAUSIBILITY; INTEGRATION; OBJECTS; CORTEX; FRAME; FEEL	The Rubber Hand Illusion (RHI) is a well-established experimental paradigm. It has been shown that the RHI can affect hand location estimates, arm and hand motion towards goals, the subjective visual appearance of the own hand, and the feeling of body ownership. Several studies also indicate that the peri-hand space is partially remapped around the rubber hand. Nonetheless, the question remains if and to what extent the RHI can affect the perception of other body parts. In this study we ask if the RHI can alter the perception of the elbow joint. Participants had to adjust an angular representation on a screen according to their proprioceptive perception of their own elbow joint angle. The results show that the RHI does indeed alter the elbow joint estimation, increasing the agreement with the position and orientation of the artificial hand. Thus, the results show that the brain does not only adjust the perception of the hand in body-relative space, but it also modifies the perception of other body parts. In conclusion, we propose that the brain continuously strives to maintain a consistent internal body image and that this image can be influenced by the available sensory information sources, which are mediated and mapped onto each other by means of a postural, kinematic body model.	[Butz, Martin V.; Kutter, Esther F.; Lorenz, Corinna] Univ Tubingen, Fac Sci, Dept Psychol, Dept Comp Sci, Tubingen, Germany	Eberhard Karls University of Tubingen	Butz, MV (corresponding author), Univ Tubingen, Fac Sci, Dept Psychol, Dept Comp Sci, Tubingen, Germany.	martin.butz@uni-tuebingen.de		Lorenz, Corinna/0000-0001-5869-1017	Emmy Noether program of the German Research Foundation (DFG) [BU1335/3-1]; DFG	Emmy Noether program of the German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	Funding from the Emmy Noether program (grant BU1335/3-1) of the German Research Foundation (DFG) is acknowledged. We also acknowledge support by the DFG for the Open Access Publishing Fund of Tubingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Austen EL, 2004, COGN AFFECT BEHAV NE, V4, P170, DOI 10.3758/CABN.4.2.170; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Ehrenfeld S, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00148; Ehrenfeld S, 2013, BIOL CYBERN, V107, P61, DOI 10.1007/s00422-012-0526-2; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Farne A, 2000, BRAIN, V123, P2350, DOI 10.1093/brain/123.11.2350; Folegatti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006920; Gallagher S., 2005, BODY SHAPES MIND; Graziano MSA, 2002, ATTENTION PERFORM, V19, P136; Haggard P., 2005, HIGHER ORDER MOTOR D, P261; Heed T, 2011, ACTA PSYCHOL, V138, P263, DOI [10.1016/j.actpsy.2011.07.003, 10.1016/j.actpsy2011.07.003]; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Ide M, 2013, PERCEPTION, V42, P103, DOI 10.1068/p7322; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kammers MPM, 2010, EXP BRAIN RES, V202, P203, DOI 10.1007/s00221-009-2124-7; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; Lloyd D, 2006, J NEUROPHYSIOL, V95, P205, DOI 10.1152/jn.00614.2005; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Paillard J., 1999, MOTOR CONTROL TODAY, P197, DOI DOI 10.1016/J.NEUROPSYCHOLOGIA.2009.09.022; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; Preston C, 2013, ACTA PSYCHOL, V142, P177, DOI 10.1016/j.actpsy.2012.12.005; Riemer M, 2013, EXP BRAIN RES, V229, P383, DOI 10.1007/s00221-012-3374-3; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Snijders HJ, 2007, NEUROPSYCHOLOGIA, V45, P496, DOI 10.1016/j.neuropsychologia.2006.01.003; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Zopf R, 2011, NEUROPSYCHOLOGIA, V49, P1287, DOI 10.1016/j.neuropsychologia.2011.02.012	31	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92854	10.1371/journal.pone.0092854	http://dx.doi.org/10.1371/journal.pone.0092854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671172	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000084
J	Durairajan, SSK; Huang, YY; Yuen, PY; Chen, LL; Kwok, KY; Liu, LF; Song, JX; Han, QB; Xue, L; Chung, SK; Huang, JD; Baum, L; Senapati, S; Li, M				Durairajan, Siva Sundara Kumar; Huang, Ying-Yu; Yuen, Pui-Yee; Chen, Lei-Lei; Kwok, Ka-Yan; Liu, Liang-Feng; Song, Ju-Xian; Han, Quan-Bin; Xue, Lei; Chung, Sookja K.; Huang, Jian-Dong; Baum, Larry; Senapati, Sanjib; Li, Min			Effects of Huanglian-Jie-Du-Tang and Its Modified Formula on the Modulation of Amyloid-beta Precursor Protein Processing in Alzheimer's Disease Models	PLOS ONE			English	Article							OREN-GEDOKU-TO; SCUTELLARIA-BAICALENSIS GEORGI; TRANSIENT CEREBRAL-ISCHEMIA; TRANSGENIC MOUSE MODEL; PHOSPHORYLATION; EXTRACT; GENERATION; IMPAIRMENT; CELLS; MICE	Huanglian-Jie-Du-Tang (HLJDT) is a famous traditional Chinese herbal formula that has been widely used clinically to treat cerebral ischemia. Recently, we found that berberine, a major alkaloid compound in HLJDT, reduced amyloid-beta (A beta) accumulation in an Alzheimer's disease (AD) mouse model. In this study, we compared the effects of HLJDT, four single component herbs of HLJDT (Rhizoma coptidis (RC), Radix scutellariae (RS), Cortex phellodendri (CP) and Fructus gardenia (FG)) and the modified formula of HLJDT (HLJDT-M, which is free of RS) on the regulatory processing of amyloid-beta precursor protein (APP) in an in vitro model of AD. Here we show that treatment with HLJDT-M and its components RC, CP, and the main compound berberine on N2a mouse neuroblastoma cells stably expressing human APP with the Swedish mutation (N2a-SwedAPP) significantly decreased the levels of full-length APP, phosphorylated APP at threonine 668, C-terminal fragments of APP, soluble APP (sAPP)-alpha and sAPP beta-Swedish and reduced the generation of A beta peptide in the cell lysates of N2a-SwedAPP. HLJDT-M showed more significant APP- and A beta-reducing effects than berberine, RC or CP treatment alone. In contrast, HLJDT, its component RS and the main active compound of RS, baicalein, strongly increased the levels of all the metabolic products of APP in the cell lysates. The extract from FG, however, did not influence APP modulation. Interestingly, regular treatment of TgCRND8 APP transgenic mice with baicalein exacerbated the amyloid plaque burden, APP metabolism and A beta production. Taken together, these data provide convincing evidence that HLJDT and baicalein treatment can increase the amyloidogenic metabolism of APP which is at least partly responsible for the baicalein-mediated A beta plaque increase in the brains of TgCRND8 mice. On the other hand, HLJDT-M significantly decreased all the APP metabolic products including A beta. Further study of HLJDT-M for therapeutic use in treating AD is warranted.	[Durairajan, Siva Sundara Kumar; Huang, Ying-Yu; Yuen, Pui-Yee; Chen, Lei-Lei; Liu, Liang-Feng; Song, Ju-Xian; Li, Min] Hong Kong Baptist Univ, Sch Chinese Med, Neurosci Res Lab, Kowloon Tong, Hong Kong, Peoples R China; [Kwok, Ka-Yan; Han, Quan-Bin] Hong Kong Baptist Univ, Sch Chinese Med, Nat Prod Chem & Anal Lab, Kowloon Tong, Hong Kong, Peoples R China; [Xue, Lei] Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai 200092, Peoples R China; [Chung, Sookja K.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Huang, Jian-Dong] Univ Hong Kong, Li Ka Shing Fac Med, Dept Biochem, Pokfulam, Hong Kong, Peoples R China; [Baum, Larry] Chinese Univ Hong Kong, Sch Pharm, Shatin, Hong Kong, Peoples R China; [Senapati, Sanjib] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Hong Kong Baptist University; Hong Kong Baptist University; Tongji University; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Durairajan, SSK (corresponding author), Hong Kong Baptist Univ, Sch Chinese Med, Neurosci Res Lab, Kowloon Tong, Hong Kong, Peoples R China.	dsskumar@hkbu.edu.hk; limin@hkbu.edu.hk	Durairajan, Siva Sundara Kumar/AAW-4617-2020; Baum, Lawrence/B-1005-2013; /C-4277-2009	Durairajan, Siva Sundara Kumar/0000-0001-7376-7163; Baum, Lawrence/0000-0002-5345-9355; /0000-0001-7531-2816; Li, Min/0000-0002-7113-2700; Song, Ju-Xian/0000-0001-7266-2060; Han, Quanbin/0000-0001-9051-1485	NSFC-RGC from the Hong Kong Government [RGC-N_HKBU 213/11, SCM/10-11/03, IRMS/12-13/1A, FRG1/11-12/045, FRG II/12-13/038, FRG1/12-13/037, HMRF/1112251]; Hong Kong Baptist University [38-40-115]	NSFC-RGC from the Hong Kong Government; Hong Kong Baptist University	This study was partly supported by NSFC-RGC joint research grant (RGC-N_HKBU 213/11) from the Hong Kong Government, research grants SCM/10-11/03, IRMS/12-13/1A, FRG1/11-12/045, FRG II/12-13/038, FRG1/12-13/037, and HMRF/1112251, and RC Start up grant for new academics for Dr. Durairajan Siva Sundara Kumar (38-40-115) from Hong Kong Baptist University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiola N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058837; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Boyd M.R., 1997, ANTICANCER DRUG DEV, P23, DOI [DOI 10.1007/978-1-4615-8152-9_2, 10.1007/978-1-4615-8152-9_2]; Chen GH, 2007, J EMERG TCM, V16, P386; Chen JH, 2008, ANAL CHIM ACTA, V613, P184, DOI 10.1016/j.aca.2008.02.060; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Colombo A, 2009, NEUROBIOL DIS, V33, P518, DOI 10.1016/j.nbd.2008.12.014; De Strooper B, 2000, J CELL SCI, V113, P1857; Durairajan SSK, 2008, NEUROCHEM INT, V52, P741, DOI 10.1016/j.neuint.2007.09.006; Durairajan SSK, 2012, NEUROBIOL AGING, V33, P2903, DOI 10.1016/j.neurobiolaging.2012.02.016; Durairajan SSK, 2011, J ALZHEIMERS DIS, V25, P245, DOI 10.3233/JAD-2011-102085; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hayes CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045841; Hu YH, 2012, J ETHNOPHARMACOL, V141, P728, DOI 10.1016/j.jep.2011.08.011; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Ito E, 1991, GERIATR MED, V29, P303; Khoddami A, 2013, MOLECULES, V18, P2328, DOI 10.3390/molecules18022328; Kondo Y, 2000, NEUROCHEM RES, V25, P205, DOI 10.1023/A:1007515318434; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Lewczuk P, 2010, MOL PSYCHIATR, V15, P138, DOI 10.1038/mp.2008.84; Li Y, 2006, FASEB J, V20, P285, DOI 10.1096/fj.05-4986com; Lleo A, 2006, ANNU REV MED, V57, P513, DOI 10.1146/annurev.med.57.121304.131442; Lu JH, 2011, CHEMBIOCHEM, V12, P615, DOI 10.1002/cbic.201000604; Luo JL, 2012, J FOOD DRUG ANAL, V20, P887, DOI 10.6227/jfda.2012200419; Nam Y, 2013, J TRADIT CHIN MED, V33, P223, DOI 10.1016/S0254-6272(13)60129-6; Okamoto H, 2013, NEUROPSYCH DIS TREAT, V9, P151, DOI 10.2147/NDT.S38318; Otomo E, 1991, GERIAT MED, V29, P121; Paris D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-17; Peng Y, 2007, NEUROSCIENCE, V150, P386, DOI 10.1016/j.neuroscience.2007.09.022; Pham TQ, 2000, J AGR FOOD CHEM, V48, P1455, DOI 10.1021/jf991263j; Qiu Xin, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P1379; Quan QK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059155; Rockenstein E, 2007, J NEUROSCI, V27, P1981, DOI 10.1523/JNEUROSCI.4321-06.2007; Sekiya N, 2005, BIOL PHARM BULL, V28, P294, DOI 10.1248/bpb.28.294; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Shang YZ, 2006, PHYTOTHER RES, V20, P53, DOI 10.1002/ptr.1802; Shao ZH, 1999, J MOL CELL CARDIOL, V31, P1885, DOI 10.1006/jmcc.1999.1021; Silva EFDE, 2003, NEUROCHEM RES, V28, P1553, DOI 10.1023/A:1025630627319; Suzuki T, 2006, J BIOCHEM, V139, P949, DOI 10.1093/jb/mvj121; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Tsai TH, 2002, BRIT J PHARMACOL, V137, P1314, DOI 10.1038/sj.bjp.0704959; Wang GX, 2010, VET PARASITOL, V171, P305, DOI 10.1016/j.vetpar.2010.03.032; Wang L, 2012, MOL NEURODEGENER, V7, pS4; Wang Shan, 2007, Zhongguo Zhong Yao Za Zhi, V32, P2289; Wang XL, 2005, LIFE SCI, V77, P3058, DOI 10.1016/j.lfs.2005.02.033; Xu JH, 2000, J ETHNOPHARMACOL, V73, P405, DOI 10.1016/S0378-8741(00)00303-2; Ye YL, 2012, BIOL PHARM BULL, V35, P355, DOI 10.1248/bpb.35.355; Youmans KL, 2011, J NEUROSCI METH, V196, P51, DOI 10.1016/j.jneumeth.2010.12.025; Yun SM, 2013, NEUROBIOL AGING, V34, P650, DOI 10.1016/j.neurobiolaging.2012.08.005; Zeng HW, 2011, J ETHNOPHARMACOL, V135, P561, DOI 10.1016/j.jep.2011.03.055; Zhang SQ, 2013, J NEUROSCI RES, V91, P1239, DOI 10.1002/jnr.23244; Zhu HX, 2013, PHYTOMEDICINE, V20, P767, DOI 10.1016/j.phymed.2012.11.012	54	31	35	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92954	10.1371/journal.pone.0092954	http://dx.doi.org/10.1371/journal.pone.0092954			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671102	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000094
J	McClure, MC; Bickhart, D; Null, D; VanRaden, P; Xu, LY; Wiggans, G; Liu, G; Schroeder, S; Glasscock, J; Armstrong, J; Cole, JB; Van Tassell, CP; Sonstegard, TS				McClure, Matthew C.; Bickhart, Derek; Null, Dan; VanRaden, Paul; Xu, Lingyang; Wiggans, George; Liu, George; Schroeder, Steve; Glasscock, Jarret; Armstrong, Jon; Cole, John B.; Van Tassell, Curtis P.; Sonstegard, Tad S.			Bovine Exome Sequence Analysis and Targeted SNP Genotyping of Recessive Fertility Defects BH1, HH2, and HH3 Reveal a Putative Causative Mutation in SMC2 for HH3	PLOS ONE			English	Article							CATTLE	The recent discovery of bovine haplotypes with negative effects on fertility in the Brown Swiss, Holstein, and Jersey breeds has allowed producers to identify carrier animals using commercial single nucleotide polymorphism (SNP) genotyping assays. This study was devised to identify the causative mutations underlying defective bovine embryo development contained within three of these haplotypes (Brown Swiss haplotype 1 and Holstein haplotypes 2 and 3) by combining exome capture with next generation sequencing. Of the 68,476,640 sequence variations (SV) identified, only 1,311 genome-wide SNP were concordant with the haplotype status of 21 sequenced carriers. Validation genotyping of 36 candidate SNP identified only 1 variant that was concordant to Holstein haplotype 3 (HH3), while no variants located within the refined intervals for HH2 or BH1 were concordant. The variant strictly associated with HH3 is a non-synonymous SNP (T/C) within exon 24 of the Structural Maintenance of Chromosomes 2 (SMC2) on Chromosome 8 at position 95,410,507 (UMD3.1). This polymorphism changes amino acid 1135 from phenylalanine to serine and causes a non-neutral, non-tolerated, and evolutionarily unlikely substitution within the NTPase domain of the encoded protein. Because only exome capture sequencing was used, we could not rule out the possibility that the true causative mutation for HH3 might lie in a non-exonic genomic location. Given the essential role of SMC2 in DNA repair, chromosome condensation and segregation during cell division, our findings strongly support the non-synonymous SNP (T/C) in SMC2 as the likely causative mutation. The absence of concordant variations for HH2 or BH1 suggests either the underlying causative mutations lie within a non-exomic region or in exome regions not covered by the capture array.	[McClure, Matthew C.; Xu, Lingyang; Liu, George; Schroeder, Steve; Van Tassell, Curtis P.; Sonstegard, Tad S.] ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD 20705 USA; [Bickhart, Derek; Null, Dan; VanRaden, Paul; Wiggans, George; Cole, John B.] ARS, USDA, Anim Improvement Programs Lab, Beltsville, MD USA; [Glasscock, Jarret; Armstrong, Jon] Cofactor Genom, St Louis, MO USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Sonstegard, TS (corresponding author), ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD 20705 USA.	Tad.sonstegard@ars.usda.gov	Xu, Lingyang/W-8664-2019; Liu, George/K-3371-2019; Cole, John B./J-8571-2014; Van Tassell, Curtis P./O-4247-2019; Telezhenko, Liubov/O-8034-2018; Krusir, Galina/F-1312-2016	Liu, George/0000-0003-0192-6705; Cole, John B./0000-0003-1242-4401; Van Tassell, Curtis P./0000-0002-8416-2087; Telezhenko, Liubov/0000-0001-6675-2625; Krusir, Galina/0000-0001-6464-5754; Bickhart, Derek/0000-0003-2223-9285; Schroeder, Steven/0000-0001-9103-5150	Animal Improvement Programs [1245-31000-101-00]; Bovine Functional Genomics Laboratories [1265-31000-104-00]; ARS [ARS-0423740] Funding Source: Federal RePORTER	Animal Improvement Programs; Bovine Functional Genomics Laboratories; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The contribution by scientists in the Animal Improvement Programs and Bovine Functional Genomics Laboratories are supported by appropriated projects 1245-31000-101-00 and 1265-31000-104-00, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams H. A., 2012, PLANT AN GEN 20 C SA; Center for Bioinformatics and Computational Biology, 2013, UMD 3 1 BOST ASS; Charlier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043085; Cole JB, 2009, J DAIRY SCI, V92, P2931, DOI 10.3168/jds.2008-1762; Faculty of Veterinary Science University of Sydney, 2013, ONL MEND INH AN; Fritz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065550; Georgieva L, 2006, P NATL ACAD SCI USA, V103, P12469, DOI 10.1073/pnas.0603029103; Hayes B, 2013, PLANT AN GEM 21 C SA; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Illumina Inc, 2010, BOVINEHD GEN BEADCH; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Schwarzenbacher H., 2012, 63 EAAP M BRAT SLOV, P170; Sonstegard TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054872; VanRaden PM, 2011, J DAIRY SCI, V94, P6153, DOI 10.3168/jds.2011-4624; VanRaden P.M., 2011, FINDHAP F90; VanRaden PM, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-10; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907	19	53	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92769	10.1371/journal.pone.0092769	http://dx.doi.org/10.1371/journal.pone.0092769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667746	gold, Green Published, Green Submitted			2022-12-25	WOS:000333675600072
J	Mohamed, AAM; Wang, QS; Bembenek, J; Ichihara, N; Hiragaki, S; Suzuki, T; Takeda, M				Mohamed, Ahmed A. M.; Wang, Qiushi; Bembenek, Jadwiga; Ichihara, Naoyuki; Hiragaki, Susumu; Suzuki, Takeshi; Takeda, Makio			N-acetyltransferase (nat) Is a Critical Conjunct of Photoperiodism between the Circadian System and Endocrine Axis in Antheraea pernyi	PLOS ONE			English	Article							DROSOPHILA CLOCK GENE; PERIOD PROTEIN; POSTTRANSLATIONAL REGULATION; DOUBLE-TIME; MELATONIN; BRAIN; LIGHT; PHOSPHORYLATION; DIAPAUSE; CRICKET	Since its discovery in 1923, the biology of photoperiodism remains a mystery in many ways. We sought the link connecting the circadian system to an endocrine switch, using Antheraea pernyi. PER-, CLK- and CYC-ir were co-expressed in two pairs of dorsolateral neurons of the protocerebrum, suggesting that these are the circadian neurons that also express melatonin-, NAT- and HIOMT-ir. The results suggest that a melatonin pathway is present in the circadian neurons. Melatonin receptor (MT2 or MEL-1B-R)-ir in PTTH-ir neurons juxtaposing clock neurons suggests that melatonin gates PTTH release. RIA showed a melatonin rhythm with a peak four hours after lights off in adult brain both under LD16:8 (LD) and LD12:12 (SD), and both the peak and the baseline levels were higher under LD than SD, suggesting a photoperiodic influence. When pupae in diapause were exposed to 10 cycles of LD, or stored at 4 degrees C for 4 months under constant darkness, an increase of NAT activity was observed when PTTH released ecdysone. DNA sequence upstream of nat contained E-boxes to which CYC/CLK could bind, and nat transcription was turned off by clk or cyc dsRNA. dsRNA(NAT) caused dysfunction of photoperiodism. dsRNA(PER) upregulated nat transcription as anticipated, based on findings in the Drosophila melanogaster circadian system. Transcription of nat, cyc and clk peaked at ZT12. RIA showed that dsRNA(NAT) decreased melatonin while dsRNA(PER) increased melatonin. Thus nat, a clock controlled gene, is the critical link between the circadian clock and endocrine switch. MT-binding may release PTTH, resulting in termination of diapause. This study thus examined all of the basic functional units from the clock: a photoperiodic counter as an accumulator of mRNA(NAT), to endocrine switch for photoperiodism in A. pernyi showing this system is self-complete without additional device especially for photoperiodism.	[Mohamed, Ahmed A. M.; Wang, Qiushi; Suzuki, Takeshi; Takeda, Makio] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 657, Japan; [Bembenek, Jadwiga; Ichihara, Naoyuki; Hiragaki, Susumu; Takeda, Makio] Kobe Univ, Grad Sch Sci & Technol, Kobe, Hyogo 657, Japan	Kobe University; Kobe University	Takeda, M (corresponding author), Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 657, Japan.	mtakeda@kobe-u.ac.jp	Suzuki, Takeshi/F-7548-2012; Suzuki, Takeshi/G-4845-2014	Suzuki, Takeshi/0000-0002-7930-1425; 	JSPS [B 18380042]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	JSPS Grant-in-Aid for Scientific Research (B 18380042) was provided to Makio Takeda. URL: http://www.jsps.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; BINKLEY S, 1988, J PINEAL RES, V5, P87, DOI 10.1111/j.1600-079X.1988.tb00771.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang DC, 2003, J BIOL CHEM, V278, P38149, DOI 10.1074/jbc.M306937200; Dardente H, 2010, CURR BIOL, V20, P2193, DOI 10.1016/j.cub.2010.10.048; Fang YS, 2007, GENE DEV, V21, P1506, DOI 10.1101/gad.1541607; Foulkes NS, 1996, P NATL ACAD SCI USA, V93, P14140, DOI 10.1073/pnas.93.24.14140; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Hall JC, 2003, ADV GENET, V48, P1, DOI 10.1016/S0065-2660(03)48000-0; Han B, 2009, J INSECT PHYSIOL, V55, P415, DOI 10.1016/j.jinsphys.2009.01.005; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Hiragaki S, 2009, CELL TISSUE RES, V335, P607, DOI 10.1007/s00441-008-0747-9; Hut RA, 2010, CURR BIOL, V21, pR21; Ichihara N, 2000, THESIS KOBE U JAPAN; Ikeno T, 2011, BIOCHEM BIOPH RES CO, V410, P394, DOI 10.1016/j.bbrc.2011.05.142; Ikeno T, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-116; Imaizumi T, 2010, CURR OPIN PLANT BIOL, V13, P83, DOI 10.1016/j.pbi.2009.09.007; ITOH MT, 1995, MOL CELL ENDOCRINOL, V115, P59, DOI 10.1016/0303-7207(95)03670-3; KAPPERS JA, 1978, J NEURAL TRANSM, P13; Kim EY, 2006, P NATL ACAD SCI USA, V103, P6178, DOI 10.1073/pnas.0511215103; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Kobelkova A, 2010, J BIOL RHYTHM, V25, P399, DOI 10.1177/0748730410385283; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Lin JM, 2005, J NEUROSCI, V25, P11175, DOI 10.1523/JNEUROSCI.2159-05.2005; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; LIU X, 1992, J NEUROSCI, V12, P2735; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Masumoto K, 2010, CURR BIOL, V20, P2199, DOI 10.1016/j.cub.2010.11.038; Matsui T, 2009, PHYSIOL BEHAV, V96, P548, DOI 10.1016/j.physbeh.2008.12.009; Matsumoto M, 2002, J INSECT PHYSIOL, V48, P765, DOI 10.1016/S0022-1910(02)00102-6; Mito T, 2011, ENTOMOL SCI, V14, P1, DOI 10.1111/j.1479-8298.2010.00408.x; Pavelka J, 2003, EUR J ENTOMOL, V100, P255, DOI 10.14411/eje.2003.041; Peschel N, 2006, P NATL ACAD SCI USA, V103, P17313, DOI 10.1073/pnas.0606675103; PITTENDRIGH CS, 1972, P NATL ACAD SCI USA, V69, P2734, DOI 10.1073/pnas.69.9.2734; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Richter K, 1999, EUR J ENTOMOL, V96, P341; Rothenfluh A, 2000, NEURON, V26, P505, DOI 10.1016/S0896-6273(00)81182-4; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; Sakamoto T, 2009, J BIOL RHYTHM, V24, P379, DOI 10.1177/0748730409341523; Sandrelli F, 2008, INSECT MOL BIOL, V17, P447, DOI 10.1111/j.1365-2583.2008.00832.x; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Sauman I, 1996, NEURON, V17, P889, DOI 10.1016/S0896-6273(00)80220-2; SAUNDERS DS, 1971, J INSECT PHYSIOL, V17, P801, DOI 10.1016/0022-1910(71)90098-9; Sehadova H, 2004, J BIOL RHYTHM, V19, P466, DOI 10.1177/0748730404269153; Shao QM, 2008, CELL TISSUE RES, V331, P435, DOI 10.1007/s00441-007-0534-z; SOKOLOVE PG, 1975, BRAIN RES, V87, P13, DOI 10.1016/0006-8993(75)90775-1; Stehlik J, 2008, J BIOL RHYTHM, V23, P129, DOI 10.1177/0748730407313364; Takeda Makio, 2011, International Journal of Wild Silkmoth & Silk, V16, P97; Tschuch C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-60; Tsugehara T, 2013, COMP BIOCHEM PHYS C, V157, P93, DOI 10.1016/j.cbpc.2012.10.003; Vafopoulou X, 2010, J COMP NEUROL, V518, P1264, DOI 10.1002/cne.22274; VIVIENROELS B, 1984, NEUROSCI LETT, V49, P153, DOI 10.1016/0304-3940(84)90152-6; Wang Q, 2014, ENTOMOL SCI IN PRESS; Wang QS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079381; Yamada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027493; Yamano H, 2001, J INSECT PHYSIOL, V47, P943, DOI 10.1016/S0022-1910(01)00067-1; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zhang Y, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P513, DOI 10.1016/B978-0-12-384747-8.10015-7; Zheng XZ, 2008, GENETICS, V178, P1147, DOI 10.1534/genetics.107.088658	62	34	37	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92680	10.1371/journal.pone.0092680	http://dx.doi.org/10.1371/journal.pone.0092680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667367	Green Submitted, Green Published, gold			2022-12-25	WOS:000333675600064
J	O'Flanagan, CH; Morais, VA; Wurst, W; De Strooper, B; O'Neill, C				O'Flanagan, C. H.; Morais, V. A.; Wurst, W.; De Strooper, B.; O'Neill, C.			The Parkinson's gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes	ONCOGENE			English	Article							MITOCHONDRIAL FISSION; OXIDATIVE STRESS; DISEASE; APOPTOSIS; MUTATIONS; PROTECTS; DYSFUNCTION; GROWTH; DRP1; PHOSPHORYLATION	PINK1 (phosphatase and tensin homolog deleted on chromosome 10 (PTEN)-induced kinase 1), a Parkinson's disease-associated gene, was identified originally because of its induction by the tumor-suppressor PTEN. PINK1 promotes cell survival and potentially metastatic functions and protects against cell stressors including chemotherapeutic agents. However, the mechanisms underlying PINK1 function in cancer cell biology are unclear. Here, using several model systems, we show that PINK1 deletion significantly reduced cancer-associated phenotypes including cell proliferation, colony formation and invasiveness, which were restored by human PINK1 overexpression. Results show that PINK1 deletion causes major defects in cell cycle progression in immortalized mouse embryonic fibroblasts (MEFs) from PINK1(-/-) mice, and in BE(2)-M17 cells stably transduced with short hairpin RNA against PINK1. Detailed cell cycle analyses of MEF cell lines from several PINK1(-/-) mice demonstrate an increased proportion of cells in G2/M and decreased number of cells in G1 following release from nocodazole block. This was concomitant with increased double and multi-nucleated cells, a reduced ability to undergo cytokinesis and to re-enter G1, and significant alterations in cell cycle markers, including failure to increase cyclin D1, all indicative of mitotic arrest. PINK1(-/-) cells also demonstrated ineffective cell cycle exit following serum deprivation. Cell cycle defects associated with PINK1 deficiency occur at points critical for cell division, growth and stress resistance in cancer cells were rescued by ectopic expression of human PINK1 and demonstrated PINK1 kinase dependence. The importance of PINK1 for cell cycle control is further supported by results showing that cell cycle deficits induced by PINK1 deletion were linked mechanistically to aberrant mitochondrial fission and its regulation by dynamin-related protein-1 (Drp1), known to be critical for progression of mitosis. Our data indicate that PINK1 has tumor-promoting properties and demonstrates a new function for PINK1 as a regulator of the cell cycle.	[O'Flanagan, C. H.; O'Neill, C.] Natl Univ Ireland Univ Coll Cork, Sch Biochem & Cell Biol, BioSci Inst, Cork, Ireland; [Morais, V. A.; De Strooper, B.] VIB, Ctr Biol Dis, Leuven, Belgium; [Morais, V. A.; De Strooper, B.] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium; [Morais, V. A.; De Strooper, B.] Katholieke Univ Leuven, LIND, Leuven, Belgium; [Wurst, W.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Dev Genet, Munich, Germany; [Wurst, W.] Tech Univ Munich, Helmholtz Zentrum Munchen, Lehrstuhl Entwicklungsgenet, Munich, Germany; [Wurst, W.] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [De Strooper, B.] UCL, Inst Neurol, London, England	University College Cork; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of London; University College London	O'Neill, C (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Biochem & Cell Biol, BioSci Inst, Cork, Ireland.	c.oneill@ucc.ie	de+Strooper, Bart/Z-1638-2019	Wurst, Wolfgang/0000-0003-4422-7410; O'Neill, Cora/0000-0001-5386-7415	Health Research Board of Ireland; PhD Scholars' Programme in Cancer Biology; Science Foundation Ireland (SFI); FWO Foundation for Scientific Research Belgium, a Methusalem grant of the Flemish Government; KU Leuven; Helmholtz Alliance for Mental Health in an Ageing Society; SFI Programme Grant	Health Research Board of Ireland; PhD Scholars' Programme in Cancer Biology; Science Foundation Ireland (SFI)(Science Foundation Ireland); FWO Foundation for Scientific Research Belgium, a Methusalem grant of the Flemish Government; KU Leuven(KU Leuven); Helmholtz Alliance for Mental Health in an Ageing Society; SFI Programme Grant(Science Foundation Ireland)	We are grateful to Mark Cookson and Alexandra Beilina, National Institute on Aging, Bethesda, MD, USA for providing us with BE(2)-M17 cells transduced with control and PINK1 shRNA. We thank Rosemary O'Connor, School of Biochemistry and Cell Biology, University College Cork (UCC) for many helpful discussions, Sandra Yeomans UCC for technical assistance and Daniela Vogt-Weisenhorn, Helmholtz Centrum Munchen, for helpful input. This work was funded by the Health Research Board of Ireland, PhD Scholars' Programme in Cancer Biology. Support from Science Foundation Ireland (SFI) (RFP), the FWO Foundation for Scientific Research Belgium, a Methusalem grant of the Flemish Government and the KU Leuven, and the Helmholtz Alliance for Mental Health in an Ageing Society is also gratefully acknowledged. BDS is the Arthur Bax and Anna Vanluffelen Chair for Alzheimer's disease. The Molecular Cell Biology group, UCC, provided access to a Zeiss 510 Confocal microscope, funded by an SFI Programme Grant to Mary W McCaffrey.	Akundi RS, 2012, NEUROBIOL DIS, V45, P469, DOI 10.1016/j.nbd.2011.08.034; Akundi RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016038; Arena G, 2013, CELL DEATH DIFFER, V20, P920, DOI 10.1038/cdd.2013.19; Ayllon V, 2007, ONCOGENE, V26, P3451, DOI 10.1038/sj.onc.1210142; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Barbosa IA, 2012, BBA-REV CANCER, V1826, P238, DOI 10.1016/j.bbcan.2012.04.005; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bernard D, 2002, ONCOGENE, V21, P4392, DOI 10.1038/sj.onc.1205536; Berthier A, 2011, HUM PATHOL, V42, P75, DOI 10.1016/j.humpath.2010.05.016; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Bonda DJ, 2010, NEUROPATH APPL NEURO, V36, P157, DOI 10.1111/j.1365-2990.2010.01064.x; Burgess DJ, 2011, NAT REV CANCER, V11, P692, DOI 10.1038/nrc3142; Cardona F, 2011, HUM MUTAT, V32, P369, DOI 10.1002/humu.21444; Chaiwatanasirikul KA, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.99; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Cho KA, 2004, J BIOL CHEM, V279, P42270, DOI 10.1074/jbc.M402352200; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Dodson MW, 2007, CURR OPIN NEUROBIOL, V17, P331, DOI 10.1016/j.conb.2007.04.010; Favre C, 2010, ONCOGENE, V29, P3964, DOI 10.1038/onc.2010.146; Fujiwara M, 2008, ONCOGENE, V27, P6002, DOI 10.1038/onc.2008.199; Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Grandemange S, 2009, SEMIN CANCER BIOL, V19, P50, DOI 10.1016/j.semcancer.2008.12.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Herrup K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt37; Horn SR, 2011, MOL BIOL CELL, V22, P1207, DOI 10.1091/mbc.E10-07-0567; Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Klinkenberg M, 2010, NEUROSCIENCE, V166, P422, DOI 10.1016/j.neuroscience.2009.12.068; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Marongiu R, 2009, J NEUROCHEM, V108, P1561, DOI 10.1111/j.1471-4159.2009.05932.x; Martin SA, 2011, CANCER RES, V71, P1836, DOI 10.1158/0008-5472.CAN-10-2836; Mei Y, 2009, P NATL ACAD SCI USA, V106, P5153, DOI 10.1073/pnas.0901104106; Michiorri S, 2010, CELL DEATH DIFFER, V17, P962, DOI 10.1038/cdd.2009.200; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Murata H, 2011, J BIOL CHEM, V286, P7182, DOI 10.1074/jbc.M110.179390; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Rakovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016746; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Staropoli JF, 2008, BIOESSAYS, V30, P719, DOI 10.1002/bies.20784; Sun XD, 2013, CELL CYCLE, V12, P1133, DOI 10.4161/cc.24215; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Wang HL, 2007, NEUROBIOL DIS, V28, P216, DOI 10.1016/j.nbd.2007.07.010; Wilhelmus MMM, 2012, FREE RADICAL BIO MED, V53, P983, DOI 10.1016/j.freeradbiomed.2012.05.040; Yamano K, 2011, NAT CELL BIOL, V13, P1026, DOI 10.1038/ncb2334; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	70	49	53	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 12	2015	34	11					1363	1374		10.1038/onc.2014.81	http://dx.doi.org/10.1038/onc.2014.81			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD1AR	24681957	Green Published			2022-12-25	WOS:000350806500003
J	Fachal, L; Blanco, A; Santamarina, M; Carracedo, A; Vega, A				Fachal, Laura; Blanco, Ana; Santamarina, Marta; Carracedo, Angel; Vega, Ana			Large Genomic Rearrangements of BRCA1 and BRCA2 among Patients Referred for Genetic Analysis in Galicia (NW Spain): Delimitation and Mechanism of Three Novel BRCA1 Rearrangements	PLOS ONE			English	Article							BREAST/OVARIAN CANCER FAMILIES; BREAST-CANCER; HEREDITARY BREAST; SPANISH FAMILIES; MUTATIONS; IDENTIFICATION; DELETION; SPECTRUM; MLPA	In the Iberian Peninsula, which includes mainly Spain and Portugal, large genomic rearrangements (LGRs) of BRCA1 and BRCA2 have respectively been found in up to 2.33% and 8.4% of families with hereditary breast and/or ovarian cancer (HBOC) that lack point mutations and small indels. In Galicia (Northwest Spain), the spectrum and frequency of BRCA1/BRCA2 point mutations differs from the rest of the Iberian populations. However, to date there are no Galician frequency reports of BRCA1/BRCA2 LGRs. Here we used multiplex ligation-dependent probe amplification (MLPA) to screen 651 Galician index cases (out of the 830 individuals referred for genetic analysis) without point mutations or small indels. We identified three different BRCA1 LGRs in four families. Two of them have been previously classified as pathogenic LGRs: the complete deletion of BRCA1 (identified in two unrelated families) and the deletion of exons 1 to 13. We also identified the duplication of exons 1 and 2 that is a LGR with unknown pathogenicity. Determination of the breakpoints of the BRCA1 LGRs using CNV/SNP arrays and sequencing identified them as NG_005905.2: g.70536_180359del, NG_005905.2: g.90012_97270dup, and NC_000017.10: g.41230935_41399840delinsAluSx1, respectively; previous observations of BRCA1 exon1-24del, exon1-2dup, and exon1-13del LGRs have not characterized them in such detail. All the BRCA1 LGRs arose from unequal homologous recombination events involving Alu elements. We also detected, by sequencing, one BRCA2 LGR, the Portuguese founder mutation c.156_157insAluYa5. The low frequency of BRCA1 LGRs within BRCA1 mutation carriers in Galicia (2.34%, 95% CI: 0.61-7.22) seems to differ from the Spanish population (9.93%, 95% CI: 6.76-14.27, P-value = 0.013) and from the rest of the Iberian population (9.76%, 95% CI: 6.69-13.94, P-value = 0.014).	[Fachal, Laura; Blanco, Ana; Carracedo, Angel; Vega, Ana] Fdn Publ Galega Med Xen SERGAS, Grp Med Xen, CIBERER, IDIS, Santiago De Compostela, Spain; [Santamarina, Marta] Univ Santiago de Compostela, Grp Med Xen USC, CIBERER, IDIS, Santiago De Compostela, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela	Vega, A (corresponding author), Fdn Publ Galega Med Xen SERGAS, Grp Med Xen, CIBERER, IDIS, Santiago De Compostela, Spain.	ana.vega@usc.es	Carracedo, Angel/D-4257-2012; Fachal, Laura/N-5560-2014; Pérez, Ana/T-4583-2019; Vega, Ana/R-4758-2019	Carracedo, Angel/0000-0003-1085-8986; Fachal, Laura/0000-0002-7256-9752; Blanco Perez, Ana/0000-0002-2535-8311	Xunta de Galicia [10 PXIB 9101 297 PR]; Fundacion Mutua Madrilena; Isabel Barreto programme of the Xunta de Galicia; European Social Fund	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Isabel Barreto programme of the Xunta de Galicia; European Social Fund(European Social Fund (ESF))	This work was supported by grants to AV from the Xunta de Galicia (10 PXIB 9101 297 PR) and the Fundacion Mutua Madrilena. LF is supported by the Isabel Barreto programme of the Xunta de Galicia and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blay P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-243; Bunyan DJ, 2004, BRIT J CANCER, V91, P1155, DOI 10.1038/sj.bjc.6602121; De Brakeleer S, 2013, HUM MUTAT, V34, P785, DOI 10.1002/humu.22297; de la Hoya M, 2006, CLIN CHEM, V52, P1480, DOI 10.1373/clinchem.2006.070110; del Valle J, 2010, BREAST CANCER RES TR, V122, P733, DOI 10.1007/s10549-009-0613-9; Engert S, 2008, HUM MUTAT, V29, P948, DOI 10.1002/humu.20723; Fachal L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033580; Feliubadalo L, 2012, EUR J HUM GENET; Galician Society of Medical Oncology, 2011, GAL HER CANC GUID; Garcia-Casado Z, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-134; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Gutierrez-Enriquez S, 2007, BREAST CANCER RES TR, V103, P103, DOI 10.1007/s10549-006-9376-8; Hartmann Carolin, 2004, Hum Mutat, V24, P534, DOI 10.1002/humu.9291; Juan Jimenez I, 2013, FAM CANCER, P1; Konecny M, 2008, BREAST CANCER RES TR, V109, P581, DOI 10.1007/s10549-007-9670-0; Loidi L, 2006, CLIN ENDOCRINOL, V64, P330, DOI 10.1111/j.1365-2265.2006.02465.x; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Miramar MD, 2008, BREAST CANCER RES TR, V112, P353, DOI 10.1007/s10549-007-9868-1; Palanca S, 2013, FAM CANCER, V12, P119, DOI 10.1007/s10689-012-9579-6; Suela SP, 2008, BREAST CANCER RES TR, V112, P63, DOI 10.1007/s10549-007-9839-6; Peixoto A, 2011, BREAST CANCER RES TR, V127, P671, DOI 10.1007/s10549-010-1036-3; Peixoto A, 2009, BREAST CANCER RES TR, V114, P31, DOI 10.1007/s10549-008-9978-4; Peixoto A, 2006, FAM CANCER, V5, P379, DOI 10.1007/s10689-006-0009-5; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Pylkas K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-146; Rodriguez M, 2010, CLIN GENET, V78, P405, DOI 10.1111/j.1399-0004.2010.01463.x; de Garibay G, 2012, BREAST CANCER RES TR, V133, P273, DOI 10.1007/s10549-011-1909-0; Sluiter MD, 2011, BREAST CANCER RES TR, V125, P325, DOI 10.1007/s10549-010-0817-z; Vega A, 2002, ANN HUM GENET, V66, P29, DOI 10.1017/S0003480001001014; Vega A, 2001, Hum Mutat, V17, P520, DOI 10.1002/humu.1136; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	32	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93306	10.1371/journal.pone.0093306	http://dx.doi.org/10.1371/journal.pone.0093306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686251	Green Published, Green Submitted, gold			2022-12-25	WOS:000340842300007
J	Huang, GH; Zhang, YC; Chen, L; Zhang, N; Huang, T; Cai, YD				Huang, Guohua; Zhang, Yuchao; Chen, Lei; Zhang, Ning; Huang, Tao; Cai, Yu-Dong			Prediction of Multi-Type Membrane Proteins in Human by an Integrated Approach	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; COUPLED RECEPTORS; DRUG DISCOVERY; TOPOLOGY; NETWORKS; SPECTRUM; DATABASE; MODEL	Membrane proteins were found to be involved in various cellular processes performing various important functions, which are mainly associated to their types. However, it is very time-consuming and expensive for traditional biophysical methods to identify membrane protein types. Although some computational tools predicting membrane protein types have been developed, most of them can only recognize one kind of type. Therefore, they are not as effective as one membrane protein can have several types at the same time. To our knowledge, few methods handling multiple types of membrane proteins were reported. In this study, we proposed an integrated approach to predict multiple types of membrane proteins by employing sequence homology and protein-protein interaction network. As a result, the prediction accuracies reached 87.65%, 81.39% and 70.79%, respectively, by the leave-one-out test on three datasets. It outperformed the nearest neighbor algorithm adopting pseudo amino acid composition. The method is anticipated to be an alternative tool for identifying membrane protein types. New metrics for evaluating performances of methods dealing with multi-label problems were also presented. The program of the method is available upon request.	[Huang, Guohua; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Huang, Guohua] Shaoyang Univ, Dept Math, Shaoyang, Hunan, Peoples R China; [Zhang, Yuchao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Zhang, Yuchao] Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci, Shanghai Inst Biol Sci,Inst Hlth Sci,State Key La, Shanghai 200030, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Zhang, Ning] Tianjin Univ, Dept Biomed Engn, Tianjin Key Lab BME Measurement, Tianjin 300072, Peoples R China; [Huang, Tao] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA	Shanghai University; Shaoyang University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Maritime University; Tianjin University; Icahn School of Medicine at Mount Sinai	Chen, L (corresponding author), Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China.	chen_lei1@163.com; zhni@tju.edu.cn; tao.huang@mssm.edu; cai_yud@126.com	Huang, Guohua/A-2215-2019; Chen, Lei/A-2275-2011	Huang, Guohua/0000-0001-6954-3933; Chen, Lei/0000-0003-3068-1583; Zhang, Ning/0000-0002-1559-111X; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510101, 2011CB510102]; National Natural Science Foundation of China [31371335, 81171342, 81201148]; Innovation Program of Shanghai Municipal Education Commission [12ZZ087]; The First-class Discipline of Universities in Shanghai; Scientific Research Fund of Hunan Provincial Science and Technology Department [2011FJ3197]; Hunan National Science Foundation [13JJ3118]; Scientific Research Fund of Hunan Provincial Education Department [11C1125]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); The First-class Discipline of Universities in Shanghai; Scientific Research Fund of Hunan Provincial Science and Technology Department; Hunan National Science Foundation; Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department)	This work was supported by grants from National Basic Research Program of China (2011CB510101, 2011CB510102), National Natural Science Foundation of China (31371335, 81171342, 81201148), Innovation Program of Shanghai Municipal Education Commission (12ZZ087), the grant of "The First-class Discipline of Universities in Shanghai", Scientific Research Fund of Hunan Provincial Science and Technology Department (2011FJ3197), Hunan National Science Foundation (Grant: 13JJ3118), and Scientific Research Fund of Hunan Provincial Education Department (Grant: 11C1125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Arinaminpathy Y, 2009, DRUG DISCOV TODAY, V14, P1130, DOI 10.1016/j.drudis.2009.08.006; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Bourne Philip E, 2003, Methods Biochem Anal, V44, P501; Cai YD, 2004, J THEOR BIOL, V226, P373, DOI 10.1016/j.jtbi.2003.08.015; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Chen L, 2014, MOL BIOSYST, V10, P868, DOI 10.1039/c3mb70490d; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Chen YK, 2013, J THEOR BIOL, V318, P1, DOI 10.1016/j.jtbi.2012.10.033; Chou KC, 2005, J CHEM INF MODEL, V45, P407, DOI 10.1021/ci049686v; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Davey J, 2004, EXPERT OPIN THER TAR, V8, P165, DOI 10.1517/eott.8.2.165.30250; de Ridder D, 2003, LECT NOTES COMPUT SC, V2714, P333; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Ding C, 2012, J PROTEOMICS, V77, P321, DOI 10.1016/j.jprot.2012.09.006; Gao QB, 2010, ANAL BIOCHEM, V398, P52, DOI 10.1016/j.ab.2009.10.040; Guo YZ, 2006, AMINO ACIDS, V30, P397, DOI 10.1007/s00726-006-0332-z; Hayat M, 2012, ANAL BIOCHEM, V424, P35, DOI 10.1016/j.ab.2012.02.007; Hayat M, 2012, AMINO ACIDS, V42, P2447, DOI 10.1007/s00726-011-1053-5; Hayat M, 2012, J THEOR BIOL, V292, P93, DOI 10.1016/j.jtbi.2011.09.026; Hayat M, 2011, J THEOR BIOL, V271, P10, DOI 10.1016/j.jtbi.2010.11.017; Hedman M, 2002, PROTEIN SCI, V11, P652, DOI 10.1110/ps.39402; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jia PL, 2008, J PROTEOME RES, V7, P1131, DOI 10.1021/pr700715c; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Koh IYY, 2003, NUCLEIC ACIDS RES, V31, P3311, DOI 10.1093/nar/gkg619; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033393; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu H, 2005, BIOCHEM BIOPH RES CO, V336, P737, DOI 10.1016/j.bbrc.2005.08.160; Mandavi A, 2011, J THEOR BIOL, V276, P132, DOI 10.1016/j.jtbi.2011.01.048; Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011; Nussinov R, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-2; Petrey D, 2005, MOL CELL, V20, P811, DOI 10.1016/j.molcel.2005.12.005; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Pua X, 2007, J THEOR BIOL, V247, P259, DOI 10.1016/j.jtbi.2007.01.016; Qiu JD, 2010, PROTEIN J, V29, P114, DOI 10.1007/s10930-010-9230-z; Rezaei MA, 2008, J THEOR BIOL, V254, P817, DOI 10.1016/j.jtbi.2008.07.012; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Rychlewski L, 2005, PROTEIN SCI, V14, P240, DOI 10.1110/ps.04888805; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Terstappen GC, 2001, TRENDS PHARMACOL SCI, V22, P23, DOI 10.1016/S0165-6147(00)01584-4; Wang JY, 2012, COMPUT BIOL MED, V42, P564, DOI 10.1016/j.compbiomed.2012.01.012; Wang LP, 2010, IEICE ELECTRON EXPR, V7, P397, DOI 10.1587/elex.7.397; Wang M, 2005, J THEOR BIOL, V232, P7, DOI 10.1016/j.jtbi.2004.07.023; Wang M, 2004, PROTEIN ENG DES SEL, V17, P509, DOI 10.1093/protein/gzh061; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Wang SQ, 2006, J THEOR BIOL, V242, P941, DOI 10.1016/j.jtbi.2006.05.006; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101	56	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93553	10.1371/journal.pone.0093553	http://dx.doi.org/10.1371/journal.pone.0093553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676214	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500140
J	Kelmo, F; Bell, JJ; Moraes, SS; Gomes, RDT; Mariano-Neto, E; Attrill, MJ				Kelmo, Francisco; Bell, James J.; Moraes, Simone Souza; Tourinho Gomes, Rilza da Costa; Mariano-Neto, Eduardo; Attrill, Martin J.			Differential Responses of Emergent Intertidal Coral Reef Fauna to a Large-Scale El-Nino Southern Oscillation Event: Sponge and Coral Resilience	PLOS ONE			English	Article							NORTHERN BAHIA; CNIDARIAN COMMUNITY; CLIMATE-CHANGE; TEMPERATURE; PATTERNS; MORTALITY	There is a paucity of information on the impacts of the 1997-8 El Nino event and subsequent climatic episodes on emergent intertidal coral reef assemblages. Given the environmental variability intertidal reefs experience, such reefs may potentially be more resilient to climatic events and provide important insights into the adaptation of reef fauna to future ocean warming. Here we report the results of a 17-year (1995-2011) biodiversity survey of four emergent coral reef ecosystems in Bahia, Brazil, to assess the impact of a major El Nino event on the reef fauna, and determine any subsequent recovery. The densities of two species of coral, Favia gravida and Siderastrea stellata, did not vary significantly across the survey period, indicating a high degree of tolerance to the El Nino associated stress. However, there were marked decreases in the diversity of other taxa. Molluscs, bryozoans and ascidians suffered severe declines in diversity and abundance and had not recovered to pre-El Nino levels by the end of the study. Echinoderms were reduced to a single species in 1999, Echinometra lucunter, although diversity levels had recovered by 2002. Sponge assemblages were not impacted by the 1997-8 event and their densities had increased by the study end. Multivariate analysis indicated that a stable invertebrate community had re-established on the reefs after the El Nino event, but it has a different overall composition to the pre-El Nino community. It is unclear if community recovery will continue given more time, but our study highlights that any increase in the frequency of large-scale climatic events to more than one a decade is likely to result in a persistent lower-diversity state. Our results also suggest some coral and sponge species are particularly resilient to the El Nino-associated stress and therefore represent suitable models to investigate temperature adaptation in reef organisms.	[Kelmo, Francisco; Mariano-Neto, Eduardo] Univ Fed Bahia, Inst Biol, Salvador, BA, Brazil; [Bell, James J.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Moraes, Simone Souza] Univ Fed Bahia, Inst Geociencias, Salvador, BA, Brazil; [Tourinho Gomes, Rilza da Costa] Fundacao Visconde Cairu, Curso Posgrad Desenvolvimento Humano & Responsabi, Salvador, BA, Brazil; [Attrill, Martin J.] Univ Plymouth, Drake Circus, Inst Marine, Plymouth PL4 8AA, Devon, England	Universidade Federal da Bahia; Victoria University Wellington; Universidade Federal da Bahia; Fundacao Visconde de Cairu; University of Plymouth	Kelmo, F (corresponding author), Univ Fed Bahia, Inst Biol, Campus Univ Ondina, Salvador, BA, Brazil.	kelmo@ufba.br	Moraes, Simone/AAC-6211-2021; Mariano-Neto, Eduardo/F-3441-2010	Moraes, Simone/0000-0002-5432-6781; Mariano-Neto, Eduardo/0000-0002-4204-0882; Attrill, Martin/0000-0002-4039-031X; Bell, James/0000-0001-9996-945X	Plymouth University Marine Institute	Plymouth University Marine Institute	This work is funded by the corresponding author, Francisco Kelmo, with additional support from the Plymouth University Marine Institute to FK. The funders coordinated the overall research objectives and organised the sampling, identification of organisms and data collation throughout the survey, developed sampling methodology, input information on species biology and wrote the paper.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Attrill MJ, 2007, ESTUAR COAST SHELF S, V73, P243, DOI 10.1016/j.ecss.2007.01.007; Attrill MJ, 2004, CLIM RES, V26, P151, DOI 10.3354/cr026151; BARBER RT, 1986, NATURE, V319, P279, DOI 10.1038/319279a0; BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; Bell JJ, 2013, GLOBAL CHANGE BIOL, V19, P2613, DOI 10.1111/gcb.12212; Bittencourt ACDP, 2000, AN ACAD BRAS CIENC, V72, P271, DOI 10.1590/S0001-37652000000200012; Burke L., 2011, REEFS RISK REVISITED; Causey BD, 1988, P ASS IS MAR LAB CAR, V21, P48; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLAUSEN CD, 1975, MAR BIOL, V33, P93, DOI 10.1007/BF00390713; COLES SL, 1977, MAR BIOL, V43, P209, DOI 10.1007/BF00402313; COLES SL, 1976, PAC SCI, V30, P159; Coles SL, 1988, P 6 INT COR REEF S T, V3, P211; Freedman D., 1983, J BUS ECON STAT, V1, P292, DOI [10.2307/1391660, DOI 10.2307/1391660]; Glynn P.W., 1990, Elsevier Oceanography Series, V52, P55; Glynn PW, 2001, B MAR SCI, V69, P79; GLYNN PW, 1988, ANNU REV ECOL SYST, V19, pU309; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Goenaga C., 1988, P ASS ISLAND MAR LAB, V21, P49; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Kelmo F, 2006, HYDROBIOLOGIA, V555, P231, DOI 10.1007/s10750-005-1119-z; Kelmo F, 2003, CORAL REEFS, V22, P541, DOI 10.1007/s00338-003-0343-0; Kelmo F, 2004, BIOL CONSERV, V118, P609, DOI 10.1016/j.biocon.2003.10.010; Kelmo F, 2001, B MAR SCI, V69, P547; Kelmo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076441; Kelmo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065073; Kelmo F, 2013, ECOL INDIC, V30, P148, DOI 10.1016/j.ecolind.2013.02.009; Koplovitz G, 2011, J EXP MAR BIOL ECOL, V407, P48, DOI 10.1016/j.jembe.2011.06.038; Kurn U, 2011, BIOL BULL-US, V221, P43, DOI 10.1086/BBLv221n1p43; Kumar A, 2001, J CLIMATE, V14, P345, DOI 10.1175/1520-0442(2001)014<0345:TSNAWO>2.0.CO;2; Kvitt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028665; Lang JC, 1988, NOAAS UNDERSEA RES P, V88, P30; Leao Z.M.A.N., 1997, P583; Leao ZMAN, 2008, BIOTA NEOTROPICA, V8; Nolasco M. C., 1986, QUATERNARY S AM ANTA, V4, P159; Nozawa Y, 2006, MAR BIOL, V149, P1047, DOI 10.1007/s00227-006-0285-5; Pernice M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016095; Perry CT, 2003, CORAL REEFS, V22, P427, DOI 10.1007/s00338-003-0330-5; Randall CJ, 2009, BIOL BULL-US, V217, P269, DOI 10.1086/BBLv217n3p269; Riegl BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024802; Rodrigues RR, 2011, J CLIMATE, V24, P3402, DOI 10.1175/2011JCLI3983.1; Sanderman IM, 1988, P ASS ISLAND MAR LAB, V21, P50; Vargas-Angel B, 2011, B MAR SCI, V87, P623, DOI 10.5343/bms.2010.1095; Wilkinson C, 1999, AMBIO, V28, P188; Wipf P, 2000, J ORG CHEM, V65, P1037, DOI 10.1021/jo9914566	51	8	8	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93209	10.1371/journal.pone.0093209	http://dx.doi.org/10.1371/journal.pone.0093209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675785	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677500090
J	Zemp, N; Minder, A; Widmer, A				Zemp, Niklaus; Minder, Aria; Widmer, Alex			Identification of Internal Reference Genes for Gene Expression Normalization between the Two Sexes in Dioecious White Campion	PLOS ONE			English	Article							PLANT SILENE-LATIFOLIA; QUANTITATIVE RT-PCR; REAL-TIME PCR; HOUSEKEEPING GENES; SEXUAL-DIMORPHISM; Y-CHROMOSOME; MIQE GUIDELINES; ABIOTIC STRESS; SELECTION; EVOLUTION	Quantitative real time (qRT)-PCR is a precise and efficient method for studying gene expression changes between two states of interest, and is frequently used for validating interesting gene expression patterns in candidate genes initially identified in genome-wide expression analyses, such as RNA-seq experiments. For an adequate normalisation of qRT-PCR data, it is essential to have reference genes available whose expression intensities are constant among the different states of interest. In this study we present and validate a catalogue of traditional and newly identified reference genes that were selected from RNA-seq data from multiple individuals from the dioecious plant Silene latifolia with the aim of studying gene expression differences between the two sexes in both reproductive and vegetative tissues. The catalogue contains more than 15 reference genes with both stable expression intensities and a range of expression intensities in flower buds and leaf tissues. These reference genes were used to normalize expression differences between reproductive and vegetative tissues in eight candidate genes with sex-biased expression. Our results suggest a trend towards a reduced sex-bias in sex-linked gene expression in vegetative tissues. In this study, we report on the systematic identification and validation of internal reference genes for adequate normalization of qRT-PCR-based analyses of gene expression differences between the two sexes in S. latifolia. We also show how RNA-seq data can be used efficiently to identify suitable reference genes in a wide diversity of species.	[Zemp, Niklaus; Widmer, Alex] ETH, Inst Integrat Biol IBZ, Zurich, Switzerland; [Minder, Aria] ETH, Genet Div Ctr, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Widmer, A (corresponding author), ETH, Inst Integrat Biol IBZ, Zurich, Switzerland.	alex.widmer@env.ethz.ch	Zemp, Niklaus/K-7467-2012; Widmer, Alex/B-6841-2009	Zemp, Niklaus/0000-0002-0991-5130; Widmer, Alex/0000-0001-8253-5137	SNF [31003A_141260]	SNF	This study was supported by SNF Grant 31003A_141260 to AW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageez A, 2005, GENES GENET SYST, V80, P403, DOI 10.1266/ggs.80.403; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergero R, 2011, CURR BIOL, V21, P1470, DOI 10.1016/j.cub.2011.07.032; Bernasconi G, 2009, HEREDITY, V103, P5, DOI 10.1038/hdy.2009.34; Blavet N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-376; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cappelli K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-49; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Chibalina MV, 2011, CURR BIOL, V21, P1475, DOI 10.1016/j.cub.2011.07.045; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Delph LF, 2010, EVOLUTION, V64, P2873, DOI 10.1111/j.1558-5646.2010.01048.x; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Fernandez-Aparicio M, 2013, MOL BIOL REP, V40, P3395, DOI 10.1007/s11033-012-2417-y; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Kazama Y, 2009, PLANT CELL PHYSIOL, V50, P1127, DOI 10.1093/pcp/pcp064; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mank JE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-148; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; Marais GAB, 2008, CURR BIOL, V18, P545, DOI 10.1016/j.cub.2008.03.023; Marais GAB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021915; Matsunaga S, 2004, SEX PLANT REPROD, V17, P189, DOI 10.1007/s00497-004-0230-z; Matsunaga S, 2003, MOL BIOL EVOL, V20, P1062, DOI 10.1093/molbev/msg114; Meisel RP, 2012, GENOME RES, V22, P1255, DOI 10.1101/gr.132100.111; Moore RC, 2003, GENETICS, V163, P321; Muyle A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001308; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405; Zluvova J, 2006, P NATL ACAD SCI USA, V103, P18854, DOI 10.1073/pnas.0606622103; Zluvova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-208	51	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92893	10.1371/journal.pone.0092893	http://dx.doi.org/10.1371/journal.pone.0092893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675788	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500051
J	Zhang, Q; Hou, XY; Li, FYH; Niu, JM; Zhou, YL; Ding, Y; Zhao, LQ; Li, X; Ma, WJ; Kang, S				Zhang, Qing; Hou, Xiangyang; Li, Frank Yonghong; Niu, Jianming; Zhou, Yanlin; Ding, Yong; Zhao, Liqing; Li, Xin; Ma, Wenjing; Kang, Sarula			Alpha, Beta and Gamma Diversity Differ in Response to Precipitation in the Inner Mongolia Grassland	PLOS ONE			English	Article							SPECIES-RICHNESS; LATITUDINAL GRADIENTS; AREA RELATIONSHIPS; SPATIAL SCALE; PATTERNS; BIODIVERSITY; CONSEQUENCES; PRODUCTIVITY; COEXISTENCE; SIMILARITY	Understanding the distribution pattern and maintenance mechanism of species diversity along environmental gradients is essential for developing biodiversity conservation strategies under environmental change. We have surveyed the species diversity at 192 vegetation sites across different steppe zones in Inner Mongolia, China. We analysed the total species diversity (gamma diversity) and its composition (alpha diversity and beta diversity) of different steppe types, and their changes along a precipitation gradient. Our results showed that (i) beta diversity contributed more than alpha diversity to the total (gamma) diversity in the Inner Mongolia grassland; the contribution of beta diversity increased with precipitation, thus the species-rich (meadow steppe) grassland had greater contribution of beta diversity than species-poor (desert steppe) grassland. (ii) All alpha, beta and gamma species diversity increased significantly (P < 0.05) with precipitation, but their sensitivity to precipitation (diversity change per mm precipitation increase) was different between the steppe types. The sensitivity of alpha diversity of different steppe community types was negatively (P < 0.05) correlated with mean annual precipitation, whereas the sensitivity of beta and gamma diversity showed no trend along the precipitation gradient (P >= 0.10). (iii) The alpha diversity increased logarithmically, while b diversity increased exponentially, with gamma diversity. Our results suggest that for local species diversity patterns, the site species pool is more important in lower precipitation areas, while local ecological processes are more important in high precipitation areas. In addition, for beta diversity maintenance niche processes and diffusion processes are more important in low and high precipitation areas, respectively. Our results imply that a policy of "multiple small reserves'' is better than one of a "single large reserve'' for conserving species diversity of a steppe ecosystem, and indicate an urgent need to develop management strategies for climate-sensitive desert steppe ecosystem.	[Zhang, Qing; Niu, Jianming; Zhou, Yanlin; Zhao, Liqing; Ma, Wenjing; Kang, Sarula] Inner Mongolia Univ, Sch Life Sci, Hohhot, Peoples R China; [Hou, Xiangyang; Ding, Yong] Chinese Acad Agr Sci, Grassland Res Inst, Hohhot, Peoples R China; [Zhang, Qing; Niu, Jianming; Li, Xin] Inner Mongolia Univ, Sino US Ctr Conservat Energy & Sustainabil Sci, Hohhot, Peoples R China; [Li, Frank Yonghong] AgRes Grasslands Res Ctr, Palmerston North, New Zealand	Inner Mongolia University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Inner Mongolia University; AgResearch - New Zealand	Niu, JM (corresponding author), Inner Mongolia Univ, Sch Life Sci, Hohhot, Peoples R China.	jmniu2005@163.com	Li, Frank Yonghong/AAN-3093-2020; Niu, Jianming/K-3597-2019	Li, Frank Yonghong/0000-0002-5137-8017; 	State Key Basic Research Development Programme of China [2012CB722201, 2014CB138805]; National Basic Research Programme of China [31200414]; Specialised Research Fund for the Doctoral Programme of Higher Education of China [20121501120006]; Inner Mongolia University [125106]	State Key Basic Research Development Programme of China; National Basic Research Programme of China(National Basic Research Program of China); Specialised Research Fund for the Doctoral Programme of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Inner Mongolia University	This study was supported by the State Key Basic Research Development Programme of China (Grant nos. 2012CB722201 and 2014CB138805), The National Basic Research Programme of China (Grant no. 31200414), The Specialised Research Fund for the Doctoral Programme of Higher Education of China (Grant no. 20121501120006), and the Start Research Funding Project of Inner Mongolia University (Grant no. 125106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, OIKOS, V116, P221, DOI [10.1111/j.2006.0030-1299.15327.x, 10.1111/j.0030-1299.2007.15327.x]; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Bai YF, 2007, J APPL ECOL, V44, P1023, DOI 10.1111/j.1365-2664.2007.01351.x; Boieiro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064591; CASE TJ, 1974, P NATL ACAD SCI USA, V71, P3073, DOI 10.1073/pnas.71.8.3073; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chiarucci A, 2010, PERSPECT PLANT ECOL, V12, P83, DOI 10.1016/j.ppees.2010.01.001; Cleland EE, 2013, ECOLOGY, V94, P1687, DOI 10.1890/12-1006.1; CODY ML, 1970, ECOLOGY, V51, P455, DOI 10.2307/1935380; Collins SL, 2012, FUNCT ECOL, V26, P1450, DOI 10.1111/j.1365-2435.2012.01995.x; Colwell RK, 2004, AM NAT, V163, pE1, DOI 10.1086/382056; Crist TO, 2006, ECOL LETT, V9, P923, DOI 10.1111/j.1461-0248.2006.00941.x; de Andrade RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026208; de Juan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065575; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; FANG J-Y, 1990, Ecological Research, V5, P9, DOI 10.1007/BF02348460; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Gering JC, 2002, ECOL LETT, V5, P433, DOI 10.1046/j.1461-0248.2002.00335.x; Green JL, 2003, ECOLOGY, V84, P3090, DOI 10.1890/02-3096; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Inner Mongolia-Ningxia Joint Inspection Group of Chinese Sciences of Academy, 1985, VEG INN MONG; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jurasinski G, 2009, OECOLOGIA, V159, P15, DOI 10.1007/s00442-008-1190-z; Kluge J, 2006, GLOBAL ECOL BIOGEOGR, V15, P358, DOI [10.1111/j.1466-822X.2006.00223.x, 10.1111/j.1466-822x.2006.00223.x]; Koleff P, 2003, GLOBAL ECOL BIOGEOGR, V12, P483, DOI 10.1046/j.1466-822X.2003.00056.x; La Sorte FA, 2008, GLOBAL ECOL BIOGEOGR, V17, P363, DOI 10.1111/j.1466-8238.2007.00369.x; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Leprieur F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042760; Li B, 1962, ACTA SCI NAT U NEIMO, V4, P42; Li Y, 1996, ACTA PHYTOECOLOGICA, V22, P1; Li YH, 2008, RESTOR ECOL, V16, P572, DOI 10.1111/j.1526-100X.2007.00332.x; Loreau M, 2000, ECOL LETT, V3, P73, DOI 10.1046/j.1461-0248.2000.00127.x; Ma YQ, 1995, FLORA INNER MONGOLIA; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Melo AS, 2009, ECOGRAPHY, V32, P226, DOI 10.1111/j.1600-0587.2008.05502.x; Meynard CN, 2011, GLOBAL ECOL BIOGEOGR, V20, P893, DOI 10.1111/j.1466-8238.2010.00647.x; Niu JM, 2001, ACTA ECOL SIN, V21, P1064; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Qian H, 2007, ECOL LETT, V10, P737, DOI 10.1111/j.1461-0248.2007.01066.x; Russell R, 2006, AM NAT, V167, pE158, DOI 10.1086/504603; SALA OE, 1988, ECOLOGY, V69, P40, DOI 10.2307/1943158; Sfenthourakis S, 2012, J BIOGEOGR, V39, P750, DOI 10.1111/j.1365-2699.2011.02639.x; Suttie J. M., 2006, P1; Tang ZY, 2012, ECOGRAPHY, V35, P1083, DOI 10.1111/j.1600-0587.2012.06882.x; Turnbull LA, 2013, ECOL LETT, V16, P116, DOI 10.1111/ele.12056; Veech JA, 2010, ECOLOGY, V91, P1964, DOI 10.1890/08-1727.1; Volder A, 2013, GLOBAL CHANGE BIOL, V19, P843, DOI 10.1111/gcb.12068; Wang ZH, 2009, P NATL ACAD SCI USA, V106, P13388, DOI 10.1073/pnas.0905030106; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Wiersma YF, 2005, CONSERV BIOL, V19, P1262, DOI 10.1111/j.1523-1739.2005.00099.x; Wimp GM, 2001, ECOLOGY, V82, P440, DOI 10.1890/0012-9658(2001)082[0440:BCOPAH]2.0.CO;2; World Conservation Monitoring Centre, 1992, GLOBAL BIODIVERSITY; Zhang PJ, 2011, PLANT SOIL, V347, P79, DOI 10.1007/s11104-011-0813-z; Zhang Q, 2011, ECOL RES, V26, P649, DOI 10.1007/s11284-011-0825-4; ZOBEL M, 1992, OIKOS, V65, P314, DOI 10.2307/3545024	62	25	32	11	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93518	10.1371/journal.pone.0093518	http://dx.doi.org/10.1371/journal.pone.0093518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675900	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500134
J	Apprill, A; Robbins, J; Eren, AM; Pack, AA; Reveillaud, J; Mattila, D; Moore, M; Niemeyer, M; Moore, KMT; Mincer, TJ				Apprill, Amy; Robbins, Jooke; Eren, A. Murat; Pack, Adam A.; Reveillaud, Julie; Mattila, David; Moore, Michael; Niemeyer, Misty; Moore, Kathleen M. T.; Mincer, Tracy J.			Humpback Whale Populations Share a Core Skin Bacterial Community: Towards a Health Index for Marine Mammals?	PLOS ONE			English	Article							DOLPHIN TURSIOPS-TRUNCATUS; SOLE SOLEA-SENEGALENSIS; TIDAL FLAT SEDIMENT; SP-NOV.; MEGAPTERA-NOVAEANGLIAE; NORTH PACIFIC; SEQUENCE DATA; SEA; HALOTOLERANT; MICROBIOTA	Microbes are now well regarded for their important role in mammalian health. The microbiology of skin - a unique interface between the host and environment - is a major research focus in human health and skin disorders, but is less explored in other mammals. Here, we report on a cross-population study of the skin-associated bacterial community of humpback whales (Megaptera novaeangliae), and examine the potential for a core bacterial community and its variability with host (endogenous) or geographic/environmental (exogenous) specific factors. Skin biopsies or freshly sloughed skin from 56 individuals were sampled from populations in the North Atlantic, North Pacific and South Pacific oceans and bacteria were characterized using 454 pyrosequencing of SSU rRNA genes. Phylogenetic and statistical analyses revealed the ubiquity and abundance of bacteria belonging to the Flavobacteria genus Tenacibaculum and the Gammaproteobacteria genus Psychrobacter across the whale populations. Scanning electron microscopy of skin indicated that microbial cells colonize the skin surface. Despite the ubiquity of Tenacibaculum and Psychrobater spp., the relative composition of the skin-bacterial community differed significantly by geographic area as well as metabolic state of the animals (feeding versus starving during migration and breeding), suggesting that both exogenous and endogenous factors may play a role in influencing the skin-bacteria. Further, characteristics of the skin bacterial community from these free-swimming individuals were assembled and compared to two entangled and three dead individuals, revealing a decrease in the central or core bacterial community members (Tenacibaculum and Psychrobater spp.), as well as the emergence of potential pathogens in the latter cases. This is the first discovery of a cross-population, shared skin bacterial community. This research suggests that the skin bacteria may be connected to humpback health and immunity and could possibly serve as a useful index for health and skin disorder monitoring of threatened and endangered marine mammals.	[Apprill, Amy; Moore, Michael; Mincer, Tracy J.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Robbins, Jooke] Ctr Coastal Studies, Provincetown, MA USA; [Eren, A. Murat; Reveillaud, Julie] Josephine Bay Paul Ctr, Marine Biol Lab, Woods Hole, MA USA; [Pack, Adam A.] Univ Hawaii, Hilo, HI 96720 USA; [Pack, Adam A.] Dolphin Inst, Honolulu, HI USA; [Mattila, David] Hawaiian Isl Humpback Whale Natl Marine Sanctuary, Kihei, HI USA; [Niemeyer, Misty; Moore, Kathleen M. T.] Int Fund Anim Welf, Yarmouth Port, MA USA	Woods Hole Oceanographic Institution; Marine Biological Laboratory - Woods Hole; University of Hawaii System; University Hawaii Hilo; National Oceanic Atmospheric Admin (NOAA) - USA	Apprill, A (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	apprill@whoi.edu; tmincer@whoi.edu	Moore, Michael/E-1707-2015; Eren, A. Murat/Q-5497-2019; Eren, A. Murat/J-3408-2014	Moore, Michael/0000-0003-3074-6631; Eren, A. Murat/0000-0001-9013-4827; Eren, A. Murat/0000-0001-9013-4827; Mincer, Tracy/0000-0002-4644-5609; Robbins, Jooke/0000-0002-6382-722X	WHOI Ocean Life Institute; Woods Hole Oceanographic Institution's (WHOI) Marine Mammal Center; Direct For Education and Human Resources [1345247] Funding Source: National Science Foundation	WHOI Ocean Life Institute; Woods Hole Oceanographic Institution's (WHOI) Marine Mammal Center; Direct For Education and Human Resources(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	A.A. was funded by a WHOI Ocean Life Institute post-doctoral scholar award, and this research was supported by a grant to A.A. and T.J.M. from Woods Hole Oceanographic Institution's (WHOI) Marine Mammal Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apprill A, 2013, ENVIRON MICROBIOL, V15, P2063, DOI 10.1111/1462-2920.12107; Apprill A, 2011, ENV MICROBIOL REP, V3, P223, DOI 10.1111/j.1758-2229.2010.00213.x; Ayala-del-Rio HL, 2010, APPL ENVIRON MICROB, V76, P2304, DOI 10.1128/AEM.02101-09; BAKER CS, 1986, MAR ECOL PROG SER, V31, P105, DOI 10.3354/meps031105; Banning EC, 2010, FEMS MICROBIOL ECOL, V73, P254, DOI 10.1111/j.1574-6941.2010.00897.x; Bernhard AE, 2005, FEMS MICROBIOL ECOL, V52, P115, DOI 10.1016/j.femsec.2004.10.016; Berube M, 1996, MOL ECOL, V5, P602, DOI 10.1046/j.1365-294X.1996.00602.x; Bowers RM, 2012, ATMOS ENVIRON, V50, P41, DOI 10.1016/j.atmosenv.2012.01.005; Bowman JP, 1997, SYST APPL MICROBIOL, V20, P209, DOI 10.1016/S0723-2020(97)80067-7; Bowman JP, 1996, INT J SYST BACTERIOL, V46, P841, DOI 10.1099/00207713-46-4-841; BROWN WR, 1983, CAN J ZOOL, V61, P1587, DOI 10.1139/z83-213; Cassoff RM, 2011, DIS AQUAT ORGAN, V96, P175, DOI 10.3354/dao02385; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; Choi DH, 2006, INT J SYST EVOL MICR, V56, P635, DOI 10.1099/ijs.0.64044-0; CLAPHAM PJ, 1993, MAR MAMMAL SCI, V9, P213, DOI 10.1111/j.1748-7692.1993.tb00448.x; Clapham PJ, 2000, CETACEAN SOCIETIES, P173; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Craig AS, 2003, BEHAVIOUR, V140, P981, DOI 10.1163/156853903322589605; Dawbin W.H., 1966, WHALES DOLPHINS PORP, P145; DeLong EF, 1999, APPL ENVIRON MICROB, V65, P5554; Demling RH., 2009, EPLASTY, V9, P9; Denner EBM, 2001, SYST APPL MICROBIOL, V24, P44, DOI 10.1078/0723-2020-00006; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Eren AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026732; Eren AM, 2013, METHODS ECOL EVOL, V4, P1111, DOI 10.1111/2041-210X.12114; Fleming A, 2011, NOAA TECHNICAL MEMOR; Frette L, 2004, INT J SYST EVOL MICR, V54, P519, DOI 10.1099/ijs.0.02398-0; Geraci J.R., 1986, P3; Glockner DA., 1983, COMMUNICATION BEHAV, P447; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Gulland Frances M. D., 2008, Aquatic Mammals, V34, P182, DOI 10.1578/AM.34.2.2008.182; Hanski I, 2012, P NATL ACAD SCI; Harrison R.J., 1974, P45; Heindl H, 2008, INT J SYST EVOL MICR, V58, P542, DOI 10.1099/ijs.0.65383-0; HICKS BD, 1985, J INVEST DERMATOL, V85, P60, DOI 10.1111/1523-1747.ep12275348; Johnson WR, 2009, ENV MICROBIOL REP, V1, P555, DOI 10.1111/j.1758-2229.2009.00080.x; Jung SY, 2006, INT J SYST EVOL MICR, V56, P1577, DOI 10.1099/ijs.0.64302-0; KATONA S. K., 1990, REPORT INT WHALING C, P295; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mathieu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065288; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McLellan SL, 2013, ENVIRON MICROBIOL, V15, P2213, DOI 10.1111/1462-2920.12092; Mouton M., 2012, CUTANEOUS LESIONS CE; MUSCATINE L, 1969, BIOL BULL-US, V137, P506, DOI 10.2307/1540172; Nixon PGF, 1989, CHANGING IDEAS HLTH; Palsboll P.J., 1991, Reports of the International Whaling Commission Special Issue, P71; Pettis HM, 2004, CAN J ZOOL, V82, P8, DOI [10.1139/z03-207, 10.1139/Z03-207]; Pineiro-Vidal M, 2008, INT J SYST EVOL MICR, V58, P881, DOI 10.1099/ijs.0.65539-0; Pineiro-Vidal M, 2008, INT J SYST EVOL MICR, V58, P21, DOI 10.1099/ijs.0.65397-0; Pineiro-Vidal M, 2012, INT J SYST EVOL MICR, V62, P425, DOI 10.1099/ijs.0.025122-0; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Robbins Jooke, 2011, Endangered Species Research, V13, P117, DOI 10.3354/esr00328; Romanenko LA, 2002, INT J SYST EVOL MICR, V52, P1291, DOI [10.1099/ijs.0.02087-0, 10.1099/00207713-52-4-1291]; Scharschmidt Tiffany C, 2013, Drug Discov Today Dis Mech, V10; Scharschmidt TC, 2009, J INVEST DERMATOL, V129, P2435, DOI 10.1038/jid.2009.104; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Wang JT, 2008, INT J SYST EVOL MICR, V58, P761, DOI 10.1099/ijs.0.65437-0; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Yeo SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056207; Yoon JH, 2005, INT J SYST EVOL MICR, V55, P793, DOI 10.1099/ijs.0.63416-0; Zabka TS, 2003, ANAT REC PART A, V273A, P636, DOI 10.1002/ar.a.10077	67	78	78	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e90785	10.1371/journal.pone.0090785	http://dx.doi.org/10.1371/journal.pone.0090785			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671052	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000010
J	Boye, SE; Huang, WC; Roman, AJ; Sumaroka, A; Boye, SL; Ryals, RC; Olivares, MB; Ruan, Q; Tucker, BA; Stone, EM; Swaroop, A; Cideciyan, AV; Hauswirth, WW; Jacobson, SG				Boye, Shannon E.; Huang, Wei-Chieh; Roman, Alejandro J.; Sumaroka, Alexander; Boye, Sanford L.; Ryals, Renee C.; Olivares, Melani B.; Ruan, Qing; Tucker, Budd A.; Stone, Edwin M.; Swaroop, Anand; Cideciyan, Artur V.; Hauswirth, William W.; Jacobson, Samuel G.			Natural History of Cone Disease in the Murine Model of Leber Congenital Amaurosis Due to CEP290 Mutation: Determining the Timing and Expectation of Therapy	PLOS ONE			English	Article							HUMAN GENE-THERAPY; TRANSSPLICING VECTORS EXPAND; ADENOASSOCIATED VIRUS; RETINAL DEGENERATION; VIRAL VECTORS; SUBRETINAL INJECTION; LENTIVIRAL VECTOR; RPE65 MUTATIONS; MOUSE MODEL; PHOTORECEPTORS	Background: Mutations in the CEP290 (cilia-centrosomal protein 290 kDa) gene in Leber congenital amaurosis (LCA) cause early onset visual loss but retained cone photoreceptors in the fovea, which is the potential therapeutic target. A cone-only mouse model carrying a Cep290 gene mutation, rd16;Nrl(-/-), was engineered to mimic the human disease. In the current study, we determined the natural history of retinal structure and function in this murine model to permit design of preclinical proof-of-concept studies and allow progress to be made toward human therapy. Analyses of retinal structure and visual function in CEP290-LCA patients were also performed for comparison with the results in the model. Methods: Rd16;Nrl(-/-) mice were studied in the first 90 days of life with optical coherence tomography (OCT), electroretinography (ERG), retinal histopathology and immunocytochemistry. Structure and function data from a cohort of patients with CEP290-LCA (n = 15; ages 7-48) were compared with those of the model. Results: CEP290-LCA patients retain a central island of photoreceptors with normal thickness at the fovea (despite severe visual loss); the extent of this island declined slowly with age. The rd16; Nrl(-/-) model also showed a relatively slow photoreceptor layer decline in thickness with similar to 80% remaining at 3 months. The number of pseudorosettes also became reduced. By comparison to single mutant Nrl(-/-) mice, UV- and M-cone ERGs of rd16; Nrl(-/-) were at least 1 log unit reduced at 1 month of age and declined further over the 3 months of monitoring. Expression of GNAT2 and S-opsin also decreased with age. Conclusions: The natural history of early loss of photoreceptor function with retained cone cell nuclei is common to both CEP290-LCA patients and the rd16; Nrl(-/-) murine model. Pre-clinical proof-of-concept studies for uniocular therapies would seem most appropriate to begin with intervention at P35-40 and re-study after one month by assaying interocular difference in the UV-cone ERG.	[Boye, Shannon E.; Boye, Sanford L.; Ryals, Renee C.; Ruan, Qing; Hauswirth, William W.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Huang, Wei-Chieh; Roman, Alejandro J.; Sumaroka, Alexander; Olivares, Melani B.; Cideciyan, Artur V.; Jacobson, Samuel G.] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Tucker, Budd A.; Stone, Edwin M.] Univ Iowa, Carver Coll Med, Stephen A Wynn Inst Vis Res, Iowa City, IA USA; [Stone, Edwin M.] Univ Iowa, Howard Hughes Med Inst, Carver Coll Med, Iowa City, IA 52242 USA; [Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA	State University System of Florida; University of Florida; University of Pennsylvania; Pennsylvania Medicine; University of Iowa; Howard Hughes Medical Institute; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Boye, SE (corresponding author), Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA.	shaire@ufl.edu; jacobsos@mail.med.upenn.edu	Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Stone, Edwin M./0000-0003-3343-4414; Boye, Shannon/0000-0002-7312-3197; Tucker, Budd/0000-0003-2178-1742; Swaroop, Anand/0000-0002-1975-1141; hauswirth, william/0000-0002-3244-4947; Jacobson, Samuel/0000-0003-2122-169X	Grousbeck Foundation; NEI intramural research program; Foundation Fighting Blindness; Macula Vision Research Foundation; Hope for Vision; NATIONAL EYE INSTITUTE [P30EY021721, ZIAEY000473, ZIAEY000546] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007483] Funding Source: NIH RePORTER	Grousbeck Foundation; NEI intramural research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness(European Commission); Macula Vision Research Foundation; Hope for Vision; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the Grousbeck Foundation, The Foundation Fighting Blindness, Macula Vision Research Foundation, Hope for Vision, and the NEI intramural research program. AVC is a RPB (Research to Prevent Blindness) Senior Scientific Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; Aleman TS, 2011, INVEST OPHTH VIS SCI, V52, P6898, DOI 10.1167/iovs.11-7701; Alexander JJ, 2007, NAT MED, V13, P685, DOI 10.1038/nm1596; Allocca M, 2008, J CLIN INVEST, V118, P1955, DOI 10.1172/JCI34316; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bainbridge JWB, 2001, GENE THER, V8, P1665, DOI 10.1038/sj.gt.3301574; Balaggan KS, 2006, J GENE MED, V8, P275, DOI 10.1002/jgm.845; Baye LM, 2011, HUM MOL GENET, V20, P1467, DOI 10.1093/hmg/ddr025; Bemelmans AP, 2005, J GENE MED, V7, P1367, DOI 10.1002/jgm.788; Binley K, 2013, INVEST OPHTH VIS SCI, V54, P4061, DOI 10.1167/iovs.13-11871; Boye SL, 2011, INVEST OPHTH VIS SCI, V52, P7098, DOI 10.1167/iovs.11-7867; Boye SE, 2013, MOL THER, V21, P509, DOI 10.1038/mt.2012.280; Boye SE, 2012, HUM GENE THER, V23, P1101, DOI 10.1089/hum.2012.125; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Cheng H, 2006, HUM MOL GENET, V15, P2588, DOI 10.1093/hmg/ddl185; Cideciyan AV, 2007, HUM MUTAT, V28, P1074, DOI 10.1002/humu.20565; Cideciyan AV, 2011, HUM MOL GENET, V20, P1411, DOI 10.1093/hmg/ddr022; Cideciyan AV, 2010, PROG RETIN EYE RES, V29, P398, DOI 10.1016/j.preteyeres.2010.04.002; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Colella P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072027; Conley SM, 2012, BBA-MOL BASIS DIS, V1822, P1169, DOI 10.1016/j.bbadis.2011.10.007; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Dong BA, 2010, MOL THER, V18, P87, DOI 10.1038/mt.2009.258; Drack AV, 2010, AM J OPHTHALMOL, V149, P10, DOI 10.1016/j.ajo.2009.08.038; Drivas TG, 2013, J CLIN INVEST, V123, P4525, DOI 10.1172/JCI69448; Duan Dongsheng, 2003, Methods Mol Med, V76, P287; Duan DS, 2001, MOL THER, V4, P383, DOI 10.1006/mthe.2001.0456; Feathers KL, 2008, INVEST OPHTH VIS SCI, V49, P1126, DOI 10.1167/iovs.07-1234; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; Greenberg KP, 2006, ADV EXP MED BIOL, V572, P255; Halbert CL, 2002, NAT BIOTECHNOL, V20, P697, DOI 10.1038/nbt0702-697; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Huang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075735; Huang WC, 2012, INVEST OPHTH VIS SCI, V53, P5594, DOI 10.1167/iovs.12-10070; Jacobson SG, 2013, CLIN GENET, V84, P175, DOI 10.1111/cge.12165; Jacobson SG, 2008, HUM MOL GENET, V17, P2405, DOI 10.1093/hmg/ddn140; Jacobson SG, 2005, P NATL ACAD SCI USA, V102, P6177, DOI 10.1073/pnas.0500646102; Kapranov P, 2012, HUM GENE THER, V23, P46, DOI 10.1089/hum.2011.160; Khani SC, 2007, INVEST OPHTH VIS SCI, V48, P3954, DOI 10.1167/iovs.07-0257; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; Kong J, 2008, GENE THER, V15, P1311, DOI 10.1038/gt.2008.78; Lai Y, 2005, NAT BIOTECHNOL, V23, P1435, DOI 10.1038/nbt1153; Lai Y, 2010, MOL THER, V18, P75, DOI 10.1038/mt.2009.256; Lai Yi, 2008, V433, P259, DOI 10.1007/978-1-59745-237-3_16; Lopes VS, 2013, GENE THER, V20, P824, DOI 10.1038/gt.2013.3; Lostal W, 2010, HUM MOL GENET, V19, P1897, DOI 10.1093/hmg/ddq065; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; McAnany JJ, 2013, JAMA OPHTHALMOL, V131, P178, DOI 10.1001/2013.jamaophthalmol.354; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; Murga-Zamalloa CA, 2011, J BIOL CHEM, V286, P28276, DOI 10.1074/jbc.M111.237560; Nicoud M, 2007, J GENE MED, V9, P1015, DOI 10.1002/jgm.1115; Pang J, 2013, INVEST OPHTHALMOL VI, V54; Pang JJ, 2006, MOL VIS, V12, P756; Pasadhika S, 2010, INVEST OPHTH VIS SCI, V51, P2608, DOI 10.1167/iovs.09-3734; Rachel Rivka A, 2012, Cilia, V1, P22, DOI 10.1186/2046-2530-1-22; Roger JE, 2012, J NEUROSCI, V32, P528, DOI 10.1523/JNEUROSCI.3591-11.2012; Roman AJ, 2007, MOL VIS, V13, P1701; Ruggeri M, 2007, INVEST OPHTH VIS SCI, V48, P1808, DOI 10.1167/iovs.06-0815; Schafer T, 2008, HUM MOL GENET, V17, P3655, DOI 10.1093/hmg/ddn260; Wenzel A, 2007, INVEST OPHTH VIS SCI, V48, P534, DOI 10.1167/iovs.06-0652; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Yan ZY, 2000, P NATL ACAD SCI USA, V97, P6716, DOI 10.1073/pnas.97.12.6716; Yan ZY, 2002, METHOD ENZYMOL, V346, P334; Yzer S, 2012, MOL VIS, V18, P412; Zhang YD, 2012, HUM GENE THER, V23, P98, DOI 10.1089/hum.2011.131	68	21	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92928	10.1371/journal.pone.0092928	http://dx.doi.org/10.1371/journal.pone.0092928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671090	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000093
J	Close, H; Reilly, J; Mason, JM; Kripalani, M; Wilson, D; Main, J; Hungin, APS				Close, Helen; Reilly, Joe; Mason, James M.; Kripalani, Mukesh; Wilson, Douglas; Main, John; Hungin, A. Pali S.			Renal Failure in Lithium-Treated Bipolar Disorder: A Retrospective Cohort Study	PLOS ONE			English	Article							MOOD DISORDERS; TERM; KIDNEY; RISK; DISEASE; PREVENTION; NEPHROTOXICITY; METAANALYSIS; NEPHROPATHY; WITHDRAWAL	Objective: Lithium users are offered routine renal monitoring but few studies have quantified the risk to renal health. The aim of this study was to assess the association between use of lithium carbonate and incidence of renal failure in patients with bipolar disorder. Methods: This was a retrospective cohort study using the General Practice Research Database (GPRD) and a nested validation study of lithium exposure and renal failure. A cohort of 6360 participants aged over 18 years had a first recorded diagnosis of bipolar disorder between January 1, 1990 and December 31, 2007. Data were examined from electronic primary care records from 418 general practices across the UK. The primary outcome was the hazard ratio for renal failure in participants exposed to lithium carbonate as compared with non-users of lithium, adjusting for age, gender, co-morbidities, and poly-pharmacy. Results: Ever use of lithium was associated with a hazard ratio for renal failure of 2.5 (95% confidence interval 1.6 to 4.0) adjusted for known renal risk factors. Absolute risk was age dependent, with patients of 50 years or older at particular risk of renal failure: Number Needed to Harm (NNH) was 44 (21 to 150). Conclusions: Lithium is associated with an increased risk of renal failure, particularly among the older age group. The absolute risk of renal failure associated with lithium use remains small.	[Close, Helen; Mason, James M.; Wilson, Douglas] Univ Durham, Sch Med Pharm & Hlth, Wolfson Res Inst, Durham Clin Trials Unit, Stockton On Tees, England; [Reilly, Joe; Hungin, A. Pali S.] Univ Durham, Sch Med Pharm & Hlth, Wolfson Res Inst, Stockton On Tees, England; [Reilly, Joe; Kripalani, Mukesh] Tees Esk & Wear Valleys NHS Fdn Trust, West Pk Hosp, Darlington, Durham, England; [Main, John] South Tees Hosp NHS Fdn Trust, Middlesbrough, Cleveland, England	Durham University; Durham University	Reilly, J (corresponding author), Univ Durham, Sch Med Pharm & Hlth, Wolfson Res Inst, Queens Campus, Stockton On Tees, England.	j.g.reilly@durham.ac.uk	Mason, James M/D-9904-2011	Mason, James M/0000-0001-9210-4082; hungin, amritpal Pali/0000-0001-7275-8927	British Renal Society [07/010]	British Renal Society	An unrestricted academic grant from the British Renal Society http://www. britishrenal.org/ (grant no. 07/010). All authors are independent from the funding body. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2002, TREATM PAT BIP DIS, DOI [10.1176/appi.books.9780890423363.50051, DOI 10.1176/APPI.B00KS.9780890423363.50051]; [Anonymous], 2009, STAT VERS 10 0IC; [Anonymous], SPSS VERS 15 WIND; [Anonymous], 2008, WHO DEF DAIL DOS DRU; Bendz H, 1996, NEPHROL DIAL TRANSPL, V11, P457; BENDZ H, 1985, ACTA PSYCHIAT SCAND, V72, P451, DOI 10.1111/j.1600-0447.1985.tb02639.x; Bendz H, 2001, EUR PSYCHIAT, V16, P199, DOI 10.1016/S0924-9338(01)00565-X; Bocchetta A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-33; BOTON R, 1987, AM J KIDNEY DIS, V10, P329, DOI 10.1016/S0272-6386(87)80098-7; Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805; Cipriani A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3646; Communities and Local Government, 2007, IND DEPR; Coskunol H, 1997, J AFFECT DISORDERS, V43, P5, DOI 10.1016/S0165-0327(96)00046-8; COX DR, 1972, J R STAT SOC B, V34, P187; Farres MT, 2003, RADIOLOGY, V229, P570, DOI 10.1148/radiol.2292020758; Geddes JR, 2010, LANCET, V375, P385, DOI 10.1016/S0140-6736(09)61828-6; Gitlin M, 1999, DRUG SAFETY, V20, P231, DOI 10.2165/00002018-199920030-00004; Grunfeld JP, 2009, NAT REV NEPHROL, V5, P270, DOI 10.1038/nrneph.2009.43; HETMAR O, 1987, ACTA PSYCHIAT SCAND, V76, P193, DOI 10.1111/j.1600-0447.1987.tb02883.x; HETMAR O, 1987, J PSYCHIAT RES, V21, P279, DOI 10.1016/0022-3956(87)90029-X; HETMAR O, 1989, J PSYCHIAT RES, V23, P285, DOI 10.1016/0022-3956(89)90034-4; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; HULLIN RP, 1979, BRIT MED J, V1, P1457, DOI 10.1136/bmj.1.6176.1457; KALLNER G, 1995, ACTA PSYCHIAT SCAND, V91, P48, DOI 10.1111/j.1600-0447.1995.tb09741.x; Kripalani M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2452; Lepkifker E, 2004, J CLIN PSYCHIAT, V65, P850; Markowitz GS, 2000, J AM SOC NEPHROL, V11, P1439, DOI 10.1681/ASN.V1181439; McKnight RF, 2012, LANCET, V379, P721, DOI 10.1016/S0140-6736(11)61516-X; National Institute for Health and Clinical Excellence, 2006, MAN BIP DIS AD CHILD, V38; NHS Information Centre, 2007, QUAL OUTC FRAM SUMM; Oakley PW, 2001, AUST NZ J PSYCHIAT, V35, P833, DOI 10.1046/j.1440-1614.2001.00963.x; Paul R, 2010, J PSYCHOPHARMACOL, V24, P1425, DOI 10.1177/0269881109104930; SCHOU M, 1989, PHARMACOPSYCHIATRY, V22, P101, DOI 10.1055/s-2007-1014588; Suissa S, 2008, AM J EPIDEMIOL, V168, P329, DOI 10.1093/aje/kwn135; Turan T, 2002, PROG NEURO-PSYCHOPH, V26, P561, DOI 10.1016/S0278-5846(01)00308-6; Van Staa TP, 2004, GASTROENTEROLOGY, V126, P1733, DOI 10.1053/j.gastro.2004.03.016; Werneke U, 2012, ACTA PSYCHIAT SCAND, V126, P186, DOI 10.1111/j.1600-0447.2012.01847.x	38	59	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e90169	10.1371/journal.pone.0090169	http://dx.doi.org/10.1371/journal.pone.0090169			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670976	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000333677000006
J	Goldberg, JF; Hebblewhite, M; Bardsley, J				Goldberg, Joshua F.; Hebblewhite, Mark; Bardsley, John			Consequences of a Refuge for the Predator-Prey Dynamics of a Wolf-Elk System in Banff National Park, Alberta, Canada	PLOS ONE			English	Article							POPULATION-DYNAMICS; SPATIAL HETEROGENEITY; APPARENT COMPETITION; YELLOWSTONE ASPEN; LANDSCAPE-SCALE; KILL RATES; TRADE-OFFS; RED DEER; CONSERVATION; WOLVES	Refugia can affect predator-prey dynamics via movements between refuge and non-refuge areas. We examine the influence of a refuge on population dynamics in a large mammal predator-prey system. Wolves (Canis lupus) have recolonized much of their former range in North America, and as a result, ungulate prey have exploited refugia to reduce predation risk with unknown impacts on wolf-prey dynamics. We examined the influence of a refuge on elk (Cervus elaphus) and wolf population dynamics in Banff National Park. Elk occupy the Banff townsite with little predation, whereas elk in the adjoining Bow Valley experience higher wolf predation. The Banff refuge may influence Bow Valley predator-prey dynamics through source-sink movements. To test this hypothesis, we used 26 years of wolf and elk population counts and the Delayed Rejection Adaptive Metropolis Markov chain Monte Carlo method to fit five predator-prey models: 1) with no source-sink movements, 2) with elk density-dependent dispersal from the refuge to the non-refuge, 3) with elk predation risk avoidance movements from the non-refuge to the refuge, 4) with differential movement rates between refuge and non-refuge, and 5) with short-term, source-sink wolf movements. Model 1 provided the best fit of the data, as measured by Akaike Information Criterion (AIC). In the top model, Banff and Bow Valley elk had median growth rates of 0.08 and 0.03 (95% credibility intervals [CIs]: 0.027-0.186 and 0.001-0.143), respectively, Banff had a median carrying capacity of 630 elk (95% CI: 471.9-2676.9), Bow Valley elk had a median wolf encounter rate of 0.02 (95% CI: 0.013-0.030), and wolves had a median death rate of 0.23 (95% CI: 0.146-0.335) and a median conversion efficiency of 0.07 (95% CI: 0.031-0.124). We found little evidence for potential source-sink movements influencing the predator-prey dynamics of this system. This result suggests that the refuge was isolated from the non-refuge.	[Goldberg, Joshua F.; Hebblewhite, Mark] Univ Montana, Coll Forestry & Conservat, Dept Ecosyst & Conservat Sci, Wildlife Biol Program, Missoula, MT 59812 USA; [Bardsley, John] Univ Montana, Dept Math & Stat, Missoula, MT 59812 USA	University of Montana System; University of Montana; University of Montana System; University of Montana	Goldberg, JF (corresponding author), Univ Montana, Coll Forestry & Conservat, Dept Ecosyst & Conservat Sci, Wildlife Biol Program, Missoula, MT 59812 USA.	joshua.goldberg@umontana.edu	hebblewhite, mark/G-6164-2013; Hebblewhite, Mark/AAI-8101-2020	Hebblewhite, Mark/0000-0001-5382-1361	Parks Canada; University of Montana; NASA [NNX11AO47G]; Montana Integrative Learning Experience for Students (MILES)	Parks Canada; University of Montana; NASA(National Aeronautics & Space Administration (NASA)); Montana Integrative Learning Experience for Students (MILES)	Funding for this study was provided by Parks Canada, the University of Montana, NASA (grant #NNX11AO47G)and Montana Integrative Learning Experience for Students (MILES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1997, EVOLUTION, V51, P1742, DOI 10.1111/j.1558-5646.1997.tb05098.x; Abrams PA, 1996, ECOLOGY, V77, P1125, DOI 10.2307/2265581; Andreasen AM, 2012, MOL ECOL, V21, P5689, DOI 10.1111/j.1365-294X.2012.05740.x; Bangs EE, 1996, WILDLIFE SOC B, V24, P402; Beyer HL, 2007, ECOL APPL, V17, P1563, DOI 10.1890/06-1254.1; BOUSKILA A, 1995, ECOLOGY, V76, P165, DOI 10.2307/1940639; Boyce MS, 2000, METH C CONS, P253; Brawn JD, 1996, ECOLOGY, V77, P3, DOI 10.2307/2265649; Burcham M, 1999, WILDLIFE SOC B, V27, P833; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Callaghan CJ, 2003, ECOLOGY GRAY WOLF CA; Canada P, 1999, ELK MANAGEMENT STRAT; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Clark J. S, 2007, MODELS ECOLOGICAL DA; Clevenger AP, 2001, WILDLIFE SOC B, V29, P646; COLLINGS JB, 1995, B MATH BIOL, V57, P63, DOI 10.1016/0092-8240(94)00024-7; Cowlishaw G, 1997, ANIM BEHAV, V53, P667, DOI 10.1006/anbe.1996.0298; Creel S, 2009, ECOLOGY, V90, P2454, DOI 10.1890/08-2017.1; CROWLEY PH, 1981, AM NAT, V118, P673, DOI 10.1086/283861; De Valpine P, 2003, ECOLOGY, V84, P3064, DOI 10.1890/02-0039; DICKMAN CR, 1992, ECOLOGY, V73, P313, DOI 10.2307/1938742; Eberhardt LL, 1998, CAN J ZOOL, V76, P380, DOI 10.1139/cjz-76-2-380; Ellner SP, 2001, NATURE, V412, P538, DOI 10.1038/35087580; FESTABIANCHET M, 1988, OECOLOGIA, V75, P580, DOI 10.1007/BF00776423; Fuller Todd K., 2003, P161; Garrott RA, 2005, WILDLIFE SOC B, V33, P1245, DOI 10.2193/0091-7648(2005)33[1245:GWEATG]2.0.CO;2; Gause G. F., 1934, STRUGGLE EXISTENCE; Getz WM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000209; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Gonzalez-Olivares E, 2003, ECOL MODEL, V166, P135, DOI 10.1016/S0304-3800(03)00131-5; Green PJ, 2001, BIOMETRIKA, V88, P1035, DOI 10.1093/biomet/88.4.1035; Gude JA, 2006, ECOL APPL, V16, P285, DOI 10.1890/04-0623; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Haugen TO, 2006, P ROY SOC B-BIOL SCI, V273, P2917, DOI 10.1098/rspb.2006.3659; Hebblewhite M, 2005, ECOLOGY, V86, P2135, DOI 10.1890/04-1269; Hebblewhite M, 2003, WILDLIFE SOC B, V31, P933; Hebblewhite M, 2010, CONSERV BIOL, V24, P341, DOI 10.1111/j.1523-1739.2009.01343.x; Hebblewhite M, 2002, CAN J ZOOL, V80, P789, DOI 10.1139/Z02-058; Hebblewhite M, 2013, POPULATION ECOLOGY; Hebblewhite M., 2000, WOLF ELK PREDATOR PR; Hebblewhite M, 2014, WOLF ELK WINTER COUN; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Higgins SI, 2010, ECOLOGY, V91, P1682, DOI 10.1890/08-1368.1; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; HOLT RD, 1987, AM NAT, V130, P412, DOI 10.1086/284718; IVES AR, 1987, AM NAT, V130, P431, DOI 10.1086/284719; Jost C, 2000, THEOR POPUL BIOL, V57, P325, DOI 10.1006/tpbi.2000.1463; Jost C, 2001, POPUL ECOL, V43, P229, DOI 10.1007/s10144-001-8187-3; Kauffman MJ, 2007, ECOL LETT, V10, P690, DOI 10.1111/j.1461-0248.2007.01059.x; Kauffman MJ, 2010, ECOLOGY, V91, P2742, DOI 10.1890/09-1949.1; Kloppers EL, 2005, ECOL SOC, V10; KOTLER BP, 1991, ECOLOGY, V72, P2249, DOI 10.2307/1941575; Kristan WB, 2004, WILDLIFE SOC B, V32, P244, DOI 10.2193/0091-7648(2004)32[244:DCOCRA]2.0.CO;2; Lame M, 2008, MCMC TOOLBOX MATLAB; Letnic M, 2009, ANIM CONSERV, V12, P302, DOI 10.1111/j.1469-1795.2009.00250.x; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Mathworks T, 2011, MATLAB; McKenzie J., 2001, SELECTIVE ADVANTAGE; MCNAIR JN, 1986, THEOR POPUL BIOL, V29, P38, DOI 10.1016/0040-5809(86)90004-3; MECH LD, 1995, CONSERV BIOL, V9, P270, DOI 10.1046/j.1523-1739.1995.9020270.x; Mira A, 2001, STAT SCI, V16, P340, DOI 10.1214/ss/1015346319; Mira A., 2001, METRON, V59, P231; Muhly TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064311; Musiani M, 2010, ECOL MODEL, V221, P2374, DOI 10.1016/j.ecolmodel.2010.06.019; Naranjo EJ, 2007, BIOL CONSERV, V138, P412, DOI 10.1016/j.biocon.2007.05.010; Orrock JL, 2008, ECOLOGY, V89, P1168, DOI 10.1890/07-0223.1; Orrock JL, 2010, OIKOS, V119, P101, DOI 10.1111/j.1600-0706.2009.17831.x; Pachepsky E, 2008, ECOLOGY, V89, P280, DOI 10.1890/07-0641.1; PERSSON L, 1995, ECOLOGY, V76, P70, DOI 10.2307/1940632; Poggiale JC, 2004, CR BIOL, V327, P1058, DOI 10.1016/j.crvi.2004.06.006; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Putman RJ, 2012, EUR J WILDLIFE RES, V58, P781, DOI 10.1007/s10344-012-0624-4; Rand TA, 2006, CONSERV BIOL, V20, P1720, DOI 10.1111/j.1523-1739.2006.00507.x; Ripple WJ, 2007, BIOL CONSERV, V138, P514, DOI 10.1016/j.biocon.2007.05.006; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; ROBERTSON BA, 2007, CONDOR, V109, P109; Rodewald AD, 2011, ECOL APPL, V21, P936, DOI 10.1890/10-0863.1; Rogala JK, 2011, ECOL SOC, V16, DOI 10.5751/ES-04251-160316; Runge JP, 2006, AM NAT, V167, P925, DOI 10.1086/503531; Sand H, 2008, OECOLOGIA, V156, P53, DOI 10.1007/s00442-008-0969-2; Schauber EM, 2009, ECOLOGY, V90, P240, DOI 10.1890/07-0980.1; SCHMITT RJ, 1987, ECOLOGY, V68, P1887, DOI 10.2307/1939880; Sepulveda AJ, 2011, OECOLOGIA, V166, P1043, DOI 10.1007/s00442-011-1935-y; Shampine LF, 1999, SIAM REV, V41, P538, DOI 10.1137/S003614459933425X; Sharp A, 2011, ECOL APPL, V21, P1024, DOI 10.1890/10-1449.1; SIH A, 1992, AM NAT, V139, P1052, DOI 10.1086/285372; Sinclair ARE, 1998, CONSERV BIOL, V12, P564, DOI 10.1046/j.1523-1739.1998.97030.x; Sinclair ARE, 2006, J ANIM ECOL, V75, P64, DOI 10.1111/j.1365-2656.2006.01036.x; Singh A, 2007, J THEOR BIOL, V247, P733, DOI 10.1016/j.jtbi.2007.04.004; Soetaert K., 2010, J STAT SOFTWARE, V33, P1; Thompson MJ, 1998, WILDLIFE SOC B, V26, P477; Turgeon K, 2012, J ANIM ECOL, V81, P1161, DOI 10.1111/j.1365-2656.2012.01990.x; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; Vucetich JA, 2004, OIKOS, V107, P309, DOI 10.1111/j.0030-1299.2004.13483.x; Vucetich JA, 2002, ECOLOGY, V83, P3003; Waber K, 2013, J WILDLIFE MANAGE, V77, P726, DOI 10.1002/jwmg.530; Wang Y, 2012, NONLINEAR DYNAM, V67, P191, DOI 10.1007/s11071-011-9971-z; Wolfe LL, 2002, J WILDLIFE MANAGE, V66, P564, DOI 10.2307/3803124; Woods J.G., 1991, ECOLOGY PARTIALLY MI	102	16	16	3	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91417	10.1371/journal.pone.0091417	http://dx.doi.org/10.1371/journal.pone.0091417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670632	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000019
J	Ji, K; Luan, J; Liu, CJ; Mu, DL; Mu, LH; Xin, MQ; Sun, JJ; Yin, SL; Chen, L				Ji, Kai; Luan, Jie; Liu, Chunjun; Mu, Dali; Mu, Lanhua; Xin, Minqiang; Sun, Jingjing; Yin, Shilu; Chen, Lin			A Prospective Study of Breast Dynamic Morphological Changes after Dual-plane Augmentation Mammaplasty with 3D Scanning Technique	PLOS ONE			English	Article							IMAGING-SYSTEM; VOLUME; DIMENSIONS; PREVENTION; OUTCOMES; CONTOUR	Background: The dual-plane technique has been widely used in augmentation mammaplasty procedures. However, there are some concerns about aesthetic contour maintenance for long time after muscle releasing. This study aims to track and analyze breast dynamic morphological changes after dual-plane breast augmentation with three-dimensional (3D) scanning technique. Methods: Thirteen dual-plane anatomic implant augmentation patients underwent 3D scanning preoperatively (pre-OP) and postoperatively in four time points (1 month: post-1M, 3 months: post-3M, 6 months: post-6M and 12 months: post-12M). The linear distance, breast projection, nipple position, breast volume and breast surface area were measured and analyzed on the 3D models over time. Results: Compared with post-12M, no significant differences were found in distances of nipple to midline, nipple to inframammary fold and sternal notch to the level of inframammary fold after 6 months in both straight-line distance and its projection on surface. The distances between sternal notch and nipple had no significant difference after post-1M. Breast volume changes had no significant difference after post-3M. The volume and area percentage of upper pole decreased while the lower pole's increased gradually. The surface showed no significant changes after post-1M. The changes of breast projection had no significance after post-1M either. The nipple moved 1.0 +/- 0.6 cm laterally(X axis), 0.6 +/- 0.7 cm upward(Y axis) and 2.3 +/- 1.1 cm anteriorly (Z axis) at post-12M, and the differences were not significant after post-1M. Conclusions: 3D scanning technique provides an objective and effective way to evaluate breast morphological changes after augmentation mammaplasty over time. Dual-plane augmentation optimizes breast shape especially in the lower pole and maintains stable aesthetic outcome during the 12 months follow-up. Most of the contour changes and the interadaptation with the implant have completed 6 months after operation. Therefore, 6 months could be chosen as a relatively stable observing period in the assessment of postoperative outcomes of dual-plane breast augmentation.	[Ji, Kai; Luan, Jie; Liu, Chunjun; Mu, Dali; Mu, Lanhua; Xin, Minqiang; Sun, Jingjing; Yin, Shilu; Chen, Lin] Chinese Acad Med Sci, Breast Plast & Reconstruct Surg Ctr, Plast Surg Hosp, Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Plastic Surgery Hospital - CAMS	Luan, J (corresponding author), Chinese Acad Med Sci, Breast Plast & Reconstruct Surg Ctr, Plast Surg Hosp, Peking Union Med Coll, Beijing 100730, Peoples R China.	doctorluanjie@sina.com		liu, chunjun/0000-0002-4741-058X	Peking Union Medical College Graduate Students Creation Foundation [20121002009]; Beijing Municipal Science & Technology Commission [Z131107002213104]	Peking Union Medical College Graduate Students Creation Foundation; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by the Peking Union Medical College Graduate Students Creation Foundation(20121002009) and the Beijing Municipal Science & Technology Commission No.Z131107002213104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blondeel PN, 2009, PLAST RECONSTR SURG, V124, P372, DOI 10.1097/PRS.0b013e3181aeeb21; Catanuto G, 2009, AESTHET SURG J, V29, P505, DOI 10.1016/j.asj.2009.09.004; Creasman CN, 2011, AESTHET SURG J, V31, P925, DOI 10.1177/1090820X11424147; Creasman CN, 2011, AESTHET SURG J, V31, P914, DOI 10.1177/1090820X11423916; de Chardon VM, 2010, ANN PLAS SURG, V64, P390, DOI 10.1097/SAP.0b013e3181b14284; Eder M, 2013, J PLAST RECONSTR AES, V66, P776, DOI 10.1016/j.bjps.2013.02.008; Eder M, 2012, BREAST, V21, P152, DOI 10.1016/j.breast.2011.07.016; Eder M, 2011, J PLAST RECONSTR AES, V64, P1152, DOI 10.1016/j.bjps.2011.03.037; Esme DL, 2009, AESTHET PLAST SURG, V33, P191, DOI 10.1007/s00266-008-9259-y; Gryskiewicz J, 2013, AESTHET SURG J, V33, P43, DOI 10.1177/1090820X12469534; Hall-Findlay EJ, 2010, PLAST RECONSTR SURG, V125, P1632, DOI 10.1097/PRS.0b013e3181ccdb97; Handel N, 2013, PLAST RECONSTR SURG, V132, P1434, DOI 10.1097/01.prs.0000434405.91316.96; Henseler H, 2011, J PLAST RECONSTR AES, V64, P577, DOI 10.1016/j.bjps.2010.08.044; Isogai N, 2006, ANN PLAS SURG, V56, P237, DOI 10.1097/01.sap.0000200716.82945.b2; Kovacs L, 2006, ANN PLAS SURG, V56, P229, DOI 10.1097/01.sap.0000197774.80832.24; Kovacs L, 2007, BREAST, V16, P137, DOI 10.1016/j.breast.2006.08.001; Kovacs L, 2006, ANN PLAS SURG, V57, P602, DOI 10.1097/01.sap.0000235455.21775.6a; Kovacs L, 2012, AESTHET PLAST SURG, V36, P879, DOI 10.1007/s00266-012-9892-3; Liu CJ, 2012, AESTHET PLAST SURG, V36, P1134, DOI 10.1007/s00266-012-9944-8; Liu CJ, 2010, PLAST RECONSTR SURG, V126, P2125, DOI 10.1097/PRS.0b013e3181f46ec6; Longo B, 2013, PLAST RECONSTR SURG, V132, p1E, DOI 10.1097/PRS.0b013e318290f6bd; Losken A, 2005, ANN PLAS SURG, V54, P471, DOI 10.1097/01.sap.0000155278.87790.a1; Luan J, 2009, J PLAST RECONSTR AES, V62, P1459, DOI 10.1016/j.bjps.2008.05.044; Mohanna PN, 2012, PLAST RECONSTR SURG, V129, p756E, DOI 10.1097/PRS.0b013e318245e8b4; Spear SL, 2006, PLAST RECONSTR SURG, V118, p197S, DOI 10.1097/01.prs.0000247298.27098.7a; Tebbetts JB, 2001, PLAST RECONSTR SURG, V107, P1255, DOI 10.1097/00006534-200104150-00027; Tebbetts JB, 2006, PLAST RECONSTR SURG, V118, p81S, DOI 10.1097/00006534-200612001-00012; Tebbetts JB, 2006, PLAST RECONSTR SURG, V118, p99S, DOI 10.1097/01.prs.0000247256.52442.b9; Tebbetts JB, 2006, PLAST RECONSTR SURG, V118, p53S, DOI 10.1097/01.prs.0000247314.92351.99; Tepper OM, 2009, ANN PLAS SURG, V62, P570, DOI 10.1097/SAP.0b013e31819faff9	30	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93010	10.1371/journal.pone.0093010	http://dx.doi.org/10.1371/journal.pone.0093010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671190	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000101
J	Kennedy, SM; Aiken, EJ; Beres, KA; Hahn, AR; Kamin, SJ; Hagness, SC; Booske, JH; Murphy, WL				Kennedy, Stephen M.; Aiken, Erik J.; Beres, Kaytlyn A.; Hahn, Adam R.; Kamin, Samantha J.; Hagness, Susan C.; Booske, John H.; Murphy, William L.			Cationic Peptide Exposure Enhances Pulsed-Electric-Field-Mediated Membrane Disruption	PLOS ONE			English	Article							BILAYER LIPID-MEMBRANES; IRREVERSIBLE ELECTROPORATION; GENE DELIVERY; STOCHASTIC THEORY; DEFECT FORMATION; MAMMALIAN-CELLS; KINETIC STAGE; I PROCOLLAGEN; BREAKDOWN; DNA	Background: The use of pulsed electric fields (PEFs) to irreversibly electroporate cells is a promising approach for destroying undesirable cells. This approach may gain enhanced applicability if the intensity of the PEF required to electrically disrupt cell membranes can be reduced via exposure to a molecular deliverable. This will be particularly impactful if that reduced PEF minimally influences cells that are not exposed to the deliverable. We hypothesized that the introduction of charged molecules to the cell surfaces would create regions of enhanced transmembrane electric potential in the vicinity of each charged molecule, thereby lowering the PEF intensity required to disrupt the plasma membranes. This study will therefore examine if exposure to cationic peptides can enhance a PEF's ability to disrupt plasma membranes. Methodology/Principal Findings: We exposed leukemia cells to 40 mu s PEFs in media containing varying concentrations of a cationic peptide, polyarginine. We observed the internalization of a membrane integrity indicator, propidium iodide (PI), in real time. Based on an individual cell's PI fluorescence versus time signature, we were able to determine the relative degree of membrane disruption. When using 1-2 kV/cm, exposure to >50 mu g/ml of polyarginine resulted in immediate and high levels of PI uptake, indicating severe membrane disruption, whereas in the absence of peptide, cells predominantly exhibited signatures indicative of no membrane disruption. Additionally, PI entered cells through the anode-facing membrane when exposed to cationic peptide, which was theoretically expected. Conclusions/Significance: Exposure to cationic peptides reduced the PEF intensity required to induce rapid and irreversible membrane disruption. Critically, peptide exposure reduced the PEF intensities required to elicit irreversible membrane disruption at normally sub-electroporation intensities. We believe that these cationic peptides, when coupled with current advancements in cell targeting techniques will be useful tools in applications where targeted destruction of unwanted cell populations is desired.	[Kennedy, Stephen M.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Kennedy, Stephen M.; Aiken, Erik J.; Beres, Kaytlyn A.; Hahn, Adam R.; Kamin, Samantha J.; Hagness, Susan C.; Booske, John H.] Univ Wisconsin, Dept Elect & Comp Engn, Madison, WI 53706 USA; [Murphy, William L.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Murphy, William L.] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI USA	Harvard University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kennedy, SM (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	skennedy@seas.harvard.edu	Murphy, William L/I-4096-2014		Duane H. and Dorothy M. Bleumke endowed professorship; Philip Dunham Reed endowed professorship; National Science Foundation [0745563]; University of Wisconsin Stem Cell and Regenerative Medicine Center; National Institutes (NIH) of Health Ruth L. Kirschstein National Research Service Award (NRSA) [F31 EB007903]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F31EB007903] Funding Source: NIH RePORTER	Duane H. and Dorothy M. Bleumke endowed professorship; Philip Dunham Reed endowed professorship; National Science Foundation(National Science Foundation (NSF)); University of Wisconsin Stem Cell and Regenerative Medicine Center; National Institutes (NIH) of Health Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Duane H. and Dorothy M. Bleumke endowed professorship, the Philip Dunham Reed endowed professorship, the National Science Foundation (CAREER award 0745563), the University of Wisconsin Stem Cell and Regenerative Medicine Center, and a National Institutes (NIH) of Health Ruth L. Kirschstein National Research Service Award (NRSA) for individual predoctoral fellows (F31 EB007903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibor IG, 1979, BIOELECTROCH BIOENER, V6, P37; Aina OH, 2002, BIOPOLYMERS, V66, P184, DOI 10.1002/bip.10257; Al-Sakere B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001135; Andre F, 2004, GENE THER, V11, pS33, DOI 10.1038/sj.gt.3302367; ARAKELYAN VB, 1979, BIOELECTROCH BIOENER, V6, P81, DOI 10.1016/0302-4598(79)85009-6; Bagheri M, 2009, ANTIMICROB AGENTS CH, V53, P1132, DOI 10.1128/AAC.01254-08; BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P1139, DOI 10.1021/bi00274a023; BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P5213, DOI 10.1021/bi00291a023; Binder H, 2003, BIOPHYS J, V85, P982, DOI 10.1016/S0006-3495(03)74537-8; Chang C, 1992, GUIDE ELECTROPORATIO; CHIZMADZHEV YA, 1979, BIOELECTROCH BIOENER, V6, P63, DOI 10.1016/0302-4598(79)85007-2; CONSTANTINOU CD, 1991, MATRIX, V11, P1; De Smedt SC, 2000, PHARMACEUT RES, V17, P113, DOI 10.1023/A:1007548826495; Dev SB, 2000, IEEE T PLASMA SCI, V28, P206, DOI 10.1109/27.842905; Esser AT, 2007, TECHNOL CANCER RES T, V6, P261, DOI 10.1177/153303460700600402; EXPOSITO JY, 1992, J BIOL CHEM, V267, P15559; Ferreira E, 2008, GENE THER, V15, P537, DOI 10.1038/gt.2008.9; Gabriel B, 1997, BIOPHYS J, V73, P2630, DOI 10.1016/S0006-3495(97)78292-4; Gabriel GJ, 2007, MAT SCI ENG R, V57, P28, DOI 10.1016/j.mser.2007.03.002; Gehl J, 2003, ACTA PHYSIOL SCAND, V177, P437, DOI 10.1046/j.1365-201X.2003.01093.x; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Golzio M, 2002, P NATL ACAD SCI USA, V99, P1292, DOI 10.1073/pnas.022646499; HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012; IMAZATO S, 1995, J DENT, V23, P177, DOI 10.1016/0300-5712(95)93576-N; Ivorra A, 2010, PHYS CHEM CHEM PHYS, V12, P10055, DOI 10.1039/c004419a; Joshi RP, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011913; Joshi RP, 2000, PHYS REV E, V62, P1025, DOI 10.1103/PhysRevE.62.1025; Kennedy SM, 2008, BIOPHYS J, V94, P5018, DOI 10.1529/biophysj.106.103218; Kennedy SM, 2009, IEEE T DIELECT EL IN, V16, P1251, DOI 10.1109/TDEI.2009.5293935; Kosciuczuk EM, 2012, MOL BIOL REP, V39, P10957, DOI 10.1007/s11033-012-1997-x; Kunath K, 2003, J CONTROL RELEASE, V89, P113, DOI 10.1016/S0168-3659(03)00076-2; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Li P, 2010, NAT MATER, V12, P1; Lin JQ, 2009, BIOSENS BIOELECTRON, V25, P388, DOI 10.1016/j.bios.2009.07.027; Maor E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004757; Mislick KA, 1996, P NATL ACAD SCI USA, V93, P1249; Miteva M, 1999, FEBS LETT, V462, P155, DOI 10.1016/S0014-5793(99)01520-3; Muller KJ, 2001, J MEMBRANE BIOL, V184, P161, DOI 10.1007/s00232-001-0084-3; NEUMANN E, 1992, BIOELECTROCH BIOENER, V28, P247, DOI 10.1016/0302-4598(92)80017-B; Neumann E., 1989, ELECTROPORATION ELEC; Nishi T, 1996, CANCER RES, V56, P1050; Niu YH, 2013, ORG BIOMOL CHEM, V11, P4283, DOI 10.1039/c3ob40444g; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomova ON, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017100; Palm-Apergi C, 2009, FASEB J, V23, P214, DOI 10.1096/fj.08-110254; PASTUSHENKO VF, 1979, BIOELECTROCH BIOENER, V6, P53, DOI 10.1016/0302-4598(79)85006-0; PASTUSHENKO VF, 1979, BIOELECTROCH BIOENER, V6, P71, DOI 10.1016/0302-4598(79)85008-4; PASTUSHENKO VF, 1979, BIOELECTROCH BIOENER, V6, P97, DOI 10.1016/0302-4598(79)85011-4; PASTUSHENKO VF, 1979, BIOELECTROCH BIOENER, V6, P89, DOI 10.1016/0302-4598(79)85010-2; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Pouton CW, 1998, J CONTROL RELEASE, V53, P289, DOI 10.1016/S0168-3659(98)00015-7; Puc M, 2003, BIOELECTROCHEMISTRY, V60, P1, DOI 10.1016/S1567-5394(03)00021-5; Pucihar G, 2001, BIOELECTROCHEMISTRY, V54, P107, DOI 10.1016/S1567-5394(01)00117-7; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P255, DOI 10.1177/153303460700600401; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Sambhy V, 2008, ANGEW CHEM INT EDIT, V47, P1250, DOI 10.1002/anie.200702287; Schelly ZA, 2007, COLLOID SURFACE B, V56, P281, DOI 10.1016/j.colsurfb.2006.10.031; Stratton TR, 2009, BIOMACROMOLECULES, V10, P2550, DOI 10.1021/bm9005003; Tang MX, 1997, GENE THER, V4, P823, DOI 10.1038/sj.gt.3300454; Tew GN, 2006, BBA-BIOMEMBRANES, V1758, P1387, DOI 10.1016/j.bbamem.2006.03.001; Wadia JS, 2005, ADV DRUG DELIVER REV, V57, P579, DOI 10.1016/j.addr.2004.10.005; Weaver JC, 2000, IEEE T PLASMA SCI, V28, P24, DOI 10.1109/27.842820; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; ZHELEV DV, 1993, BIOCHIM BIOPHYS ACTA, V1147, P89, DOI 10.1016/0005-2736(93)90319-U; ZIMMERMAN U, 1996, ELECTROMANIPULATION	65	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92528	10.1371/journal.pone.0092528	http://dx.doi.org/10.1371/journal.pone.0092528			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671150	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677000052
J	Khan, U; Nicell, JA				Khan, Usman; Nicell, Jim A.			Contraceptive Options and Their Associated Estrogenic Environmental Loads: Relationships and Trade-Offs	PLOS ONE			English	Article							UNITED-STATES; UNINTENDED PREGNANCY; ENDOCRINE DISRUPTION; AQUATIC ENVIRONMENT; COST-EFFECTIVENESS; STEROID ESTROGENS; URINARY-EXCRETION; DRINKING-WATER; WILD FISH; ETHINYLESTRADIOL	This work explores the relationships between a user's choice of a given contraceptive option and the load of steroidal estrogens that can be associated with that choice. Family planning data for the USA served as a basis for the analysis. The results showed that collectively the use of contraception in the USA conservatively averts the release of approximately 4.8 tonnes of estradiol equivalents to the environment. 35% of the estrogenic load released over the course of all experienced pregnancies events and 34% the estrogenic load represented by all resultant legacies are a result of contraception failure and the non-use of contraception. A scenario analysis conducted to explore the impacts of discontinuing the use of ethinylestradiol-based oral contraceptives revealed that this would not only result in a 1.7-fold increase in the estrogenic loading of the users, but the users would also be expected to experience undesired family planning outcomes at a rate that is 3.3 times higher. Additional scenario analyses in which ethinylestradiol-based oral contraceptive users were modeled as having switched entirely to the use of male condoms, diaphragms or copper IUDs suggested that whether a higher or lower estrogenic load can be associated with the switching population depends on the typical failure rates of the options adopted following discontinuation. And, finally, it was estimated that, in the USA, at most 13% of the annual estrogenic load can be averted by fully meeting the contraceptive needs of the population. Therefore, while the issue of estrogen impacts on the environment cannot be addressed solely by meeting the population's contraceptive needs, a significant fraction of the estrogenic mass released to environment can be averted by improving the level with which their contraceptive needs are met.	[Khan, Usman; Nicell, Jim A.] McGill Univ, Dept Civil Engn & Appl Mech, Montreal, PQ H3A 2K6, Canada	McGill University	Nicell, JA (corresponding author), McGill Univ, Dept Civil Engn & Appl Mech, Montreal, PQ H3A 2K6, Canada.	jim.nicell@mcgill.ca		Nicell, Jim/0000-0003-0119-2967	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Natural Sciences and Engineering Research Council of Canada (see www.nserc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerni HR, 2004, ANAL BIOANAL CHEM, V378, P688, DOI 10.1007/s00216-003-2276-4; Anderson PD, 2012, ENVIRON TOXICOL CHEM, V31, P1407, DOI 10.1002/etc.1824; [Anonymous], 2010, MED LETT DRUGS THER, V52, P71; [Anonymous], 2012, FACTS UN PREGN US; [Anonymous], 2012, NATURE, V491, P496; Atkinson SK, 2011, ARCH ENVIRON CON TOX, V60, P1, DOI 10.1007/s00244-010-9515-4; Barber LB, 2011, SCI TOTAL ENVIRON, V409, P4720, DOI 10.1016/j.scitotenv.2011.06.039; BERG FD, 1992, ARCH GYNECOL OBSTET, V251, P17, DOI 10.1007/BF02718274; Caldwell DJ, 2012, ENVIRON TOXICOL CHEM, V31, P1396, DOI 10.1002/etc.1825; Caldwell DJ, 2010, ENVIRON HEALTH PERSP, V118, P338, DOI 10.1289/ehp.0900654; DeQuattro ZA, 2012, ENVIRON TOXICOL CHEM, V31, P851, DOI 10.1002/etc.1754; Desbrow C, 1998, ENVIRON SCI TECHNOL, V32, P1549, DOI 10.1021/es9707973; Desforges JPW, 2010, ENVIRON POLLUT, V158, P3279, DOI 10.1016/j.envpol.2010.07.017; EMA, 2012, IOA ASS REP; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Finer LB, 2012, FERTIL STERIL, V98, P893, DOI 10.1016/j.fertnstert.2012.06.027; Gilbert N, 2012, NATURE, V491, P503, DOI 10.1038/491503a; Goldhaber M K, 1991, Epidemiology, V2, P33; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Institute for Health Metrics and Evaluation, 2010, INF CHILD MORT EST C; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Johnson AC, 2004, ENVIRON SCI TECHNOL, V38, P3649, DOI 10.1021/es035342u; Johnson AC, 2013, ENVIRON SCI TECHNOL, V47, P12297, DOI 10.1021/es4030035; Johnson AC, 2011, ENVIRON SCI TECHNOL, V45, P1028, DOI 10.1021/es103358t; JOHNSON DW, 1979, CLIN CHIM ACTA, V94, P207, DOI 10.1016/0009-8981(79)90015-9; Jurgens MD, 2002, ENVIRON TOXICOL CHEM, V21, P480, DOI 10.1002/etc.5620210302; Kase R, 2011, WASTE WATER EVALUATI; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kiley JW, 2011, INT J WOMENS HEALTH, V3, P281, DOI 10.2147/IJWH.S22645; Kostich M, 2010, SETAC N AM 2010 ANN; McKie R, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4029; Mosher William D, 2010, Vital Health Stat 23, P1; Owen R, 2012, NATURE, V485, P441, DOI 10.1038/485441a; Owens R., 2013, LATE LESSONS EARLY W, p[279, 292]; Paulos PM, 2011, THESIS U N TEXAS; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rosenberg MJ, 1998, AM J OBSTET GYNECOL, V179, P577, DOI 10.1016/S0002-9378(98)70047-X; Runnalls TJ, 2013, ENVIRON SCI TECHNOL, V47, P2077, DOI 10.1021/es3048834; Runnalls TJ, 2010, HUM ECOL RISK ASSESS, V16, P1318, DOI 10.1080/10807039.2010.526503; Sinclair CJ, 2006, ENVIRON SCI TECHNOL, V40, P7283, DOI 10.1021/es0603507; Sumpter JP, 2008, J ENVIRON MONITOR, V10, P1476, DOI 10.1039/b815741n; Tanna RN, 2013, ENVIRON TOXICOL CHEM, V32, P1981, DOI 10.1002/etc.2262; Tetreault GR, 2011, AQUAT TOXICOL, V104, P278, DOI 10.1016/j.aquatox.2011.05.008; Thorpe KL, 2001, ENVIRON SCI TECHNOL, V35, P2476, DOI 10.1021/es001767u; TIKKANEN MJ, 1973, J STEROID BIOCHEM, V4, P57, DOI 10.1016/0022-4731(73)90080-0; Trudeau VL, 2011, FRONT EXP ENDOCRINOL, DOI DOI 10.3389/FEND0.2011.00083/FULL.ACCESSED; Trussell J, 2008, EUR J CONTRACEP REPR, V13, P219, DOI 10.1080/13625180802359263; Trussell J, 2007, CONTRACEPTION, V75, P168, DOI 10.1016/j.contraception.2006.11.009; Trussell J, 2013, CONTRACEPTION, V87, P154, DOI 10.1016/j.contraception.2012.07.016; Trussell J, 2012, CONTRACEPTION, V85, P218, DOI 10.1016/j.contraception.2011.06.011; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021; Trussell J, 2009, CONTRACEPTION, V79, P5, DOI 10.1016/j.contraception.2008.08.003; Vajda AM, 2008, ENVIRON SCI TECHNOL, V42, P3407, DOI 10.1021/es0720661; Vajda AM, 2011, AQUAT TOXICOL, V103, P213, DOI 10.1016/j.aquatox.2011.02.007; Ventura Stephanie J, 2012, Natl Vital Stat Rep, V60, P1; Whidbey CM, 2012, WATER RES, V46, P5287, DOI 10.1016/j.watres.2012.07.016; Williams RJ, 2009, ENVIRON TOXICOL CHEM, V28, P220, DOI 10.1897/08-047.1; Wise A, 2011, ENVIRON SCI TECHNOL, V45, P51, DOI 10.1021/es1014482; Worstall Tim, 2012, FORBES; Yamamoto T. O., 1969, P117; YAMAMOTO TO, 1965, GEN COMP ENDOCR, V5, P527, DOI 10.1016/0016-6480(65)90041-9; Zeilinger J, 2009, ENVIRON TOXICOL CHEM, V28, P2663, DOI 10.1897/08-485.1	62	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92630	10.1371/journal.pone.0092630	http://dx.doi.org/10.1371/journal.pone.0092630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670973	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677000059
J	Sahlean, TC; Gherghel, I; Papes, M; Strugariu, A; Zamfirescu, SR				Sahlean, Tiberiu C.; Gherghel, Iulian; Papes, Monica; Strugariu, Alexandru; Zamfirescu, Stefan R.			Refining Climate Change Projections for Organisms with Low Dispersal Abilities: A Case Study of the Caspian Whip Snake	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; LAND-USE CHANGE; GEOGRAPHIC DISTRIBUTIONS; ECOLOGICAL NICHES; EXTINCTION RATES; ENVELOPE MODELS; IMPACT; PLANT; DIVERSITY; HISTORY	Climate warming is one of the most important threats to biodiversity. Ectothermic organisms such as amphibians and reptiles are especially vulnerable as climatic conditions affect them directly. Ecological niche models (ENMs) are increasingly popular in ecological studies, but several drawbacks exist, including the limited ability to account for the dispersal potential of the species. In this study, we use ENMs to explore the impact of global climate change on the Caspian whip snake (Dolichophis caspius) as model for organisms with low dispersal abilities and to quantify dispersal to novel areas using GIS techniques. Models generated using Maxent 3.3.3 k and GARP for current distribution were projected on future climatic scenarios. A cost-distance analysis was run in ArcGIS 10 using geomorphological features, ecological conditions, and human footprint as "costs'' to dispersal of the species to obtain a Maximum Dispersal Range (MDR) estimate. All models developed were statistically significant (P < 0.05) and recovered the currently known distribution of D. caspius. Models projected on future climatic conditions using Maxent predicted a doubling of suitable climatic area, while GARP predicted a more conservative expansion. Both models agreed on an expansion of suitable area northwards, with minor decreases at the southern distribution limit. The MDR area calculated using the Maxent model represented a third of the total area of the projected model. The MDR based on GARP models recovered only about 20% of the total area of the projected model. Thus, incorporating measures of species' dispersal abilities greatly reduced estimated area of potential future distributions.	[Sahlean, Tiberiu C.] Univ Bucharest, Fac Biol, Bucharest, Romania; [Sahlean, Tiberiu C.] Grigore Antipa Natl Museum Nat Hist, Dept Terr Fauna, Bucharest, Romania; [Gherghel, Iulian; Papes, Monica] Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA; [Strugariu, Alexandru; Zamfirescu, Stefan R.] Alexandru Ioan Cuza Univ, Fac Biol, Iasi, Romania	University of Bucharest; Oklahoma State University System; Oklahoma State University - Stillwater; Alexandru Ioan Cuza University	Gherghel, I (corresponding author), Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA.	iulian.gherghel@okstate.edu	Sahlean, Tiberiu/A-9727-2010; Gherghel, Iulian/C-6478-2009; Gherghel, Iulian/K-8074-2019; Zamfirescu, Stefan Remus/B-8771-2011	Sahlean, Tiberiu/0000-0001-9014-9084; Gherghel, Iulian/0000-0001-7963-6498; Strugariu, Alexandru/0000-0001-7866-6732; Zamfirescu, Stefan/0000-0002-8746-5120				Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], CARTEA ROSIE VERTEBR; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Bombi P, 2009, AMPHIBIA-REPTILIA, V30, P413, DOI 10.1163/156853809788795173; Bonnet X, 1999, BIOL CONSERV, V89, P39, DOI 10.1016/S0006-3207(98)00140-2; Both C, 2005, GLOBAL CHANGE BIOL, V11, P1606, DOI 10.1111/j.1365-2486.2005.01038.x; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Cowling SA, 2001, QUATERNARY RES, V55, P140, DOI 10.1006/qres.2000.2197; Cremene C, 2005, CONSERV BIOL, V19, P1606, DOI 10.1111/j.1523-1739.2005.00084.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; DeMatteo KE, 2008, BIOL CONSERV, V141, P2494, DOI 10.1016/j.biocon.2008.07.010; Doko T, 2011, ECOL MODEL, V222, P748, DOI 10.1016/j.ecolmodel.2010.11.005; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Driscoll DA, 2004, ECOL APPL, V14, P220, DOI 10.1890/02-5248; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; ESRI, 2011, ARCGIS DESKT REL 10; FAO, 2005, GRASSL WORLD; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Foufopoulos J, 2011, AM NAT, V177, P119, DOI 10.1086/657624; Fuhn I. E., 1961, REPTILIA FAUNA PEOPL; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hays GC, 2003, GLOBAL CHANGE BIOL, V9, P642, DOI 10.1046/j.1365-2486.2003.00606.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Ihlow F, 2012, GLOBAL CHANGE BIOL, V18, P1520, DOI 10.1111/j.1365-2486.2011.02623.x; Iverson LR, 1999, ECOL MODEL, V115, P77, DOI 10.1016/S0304-3800(98)00200-2; Jaggi C, 1999, AMPHIBIA-REPTILIA, V20, P25, DOI 10.1163/156853899506870; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Keith K, 2008, CALIF FISH GAME, V94, P75; Kiesecker JM, 2001, NATURE, V410, P681, DOI 10.1038/35070552; Kovacs-Lang E, 2000, PHYTOCOENOLOGIA, V30, P385; Lee DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042466; Malcolm JR, 2002, J BIOGEOGR, V29, P835, DOI 10.1046/j.1365-2699.2002.00702.x; McLaughlin JF, 2002, P NATL ACAD SCI USA, V99, P6070, DOI 10.1073/pnas.052131199; Moreira F, 2007, LANDSCAPE ECOL, V22, P1461, DOI 10.1007/s10980-007-9125-3; Mosier AR, 1997, NUTR CYCL AGROECOSYS, V49, P71, DOI 10.1023/A:1009754207548; Moussalli A, 2009, MOL ECOL, V18, P483, DOI 10.1111/j.1365-294X.2008.04035.x; Nagy ZT, 2010, AMPHIBIA-REPTILIA, V31, P455, DOI 10.1163/017353710X518397; Nix H., 1986, ATLAS ELAPID SNAKES; Owens HL, 2012, BIODIVERS CONSERV, V21, P577, DOI 10.1007/s10531-011-0202-1; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2005, BIOL CONSERV, V123, P389, DOI 10.1016/j.biocon.2004.12.006; Pearson RG, 2002, ECOL MODEL, V154, P289, DOI 10.1016/S0304-3800(02)00056-X; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2001, ECOL MODEL, V144, P21, DOI 10.1016/S0304-3800(01)00345-3; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pitelka LF, 1997, AM SCI, V85, P464; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Ramirez J, 2008, HIGH RESOLUTION STAT; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Reading CJ, 2010, BIOL LETTERS, V6, P777, DOI 10.1098/rsbl.2010.0373; Renner IW, 2013, BIOMETRICS, V69, P274, DOI 10.1111/j.1541-0420.2012.01824.x; Richardson, 2005, WORLDCLIM VERSION 13; RICHMAN AD, 1988, AM NAT, V131, P611, DOI 10.1086/284810; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Scachetti-Pereira R., 2001, DESKTOP GARP; Schcherbak N.N., 1993, HDB REPTILIEN AMPHIB, V3/I, P83; Sillero N, 2011, ECOL MODEL, V222, P1343, DOI 10.1016/j.ecolmodel.2011.01.018; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Sinsch U, 2007, CAN J ZOOL, V85, P665, DOI 10.1139/Z07-046; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Solomon S, 2007, CONTRIBUTION WORKING; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Strugariu A, 2007, HERPETOLOGICA ROMANI, V1, P31; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; Tibu PL, 2007, NORTH-WEST J ZOOL, V3, P62; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wiens JJ, 2004, AM NAT, V163, P914, DOI 10.1086/386552; Wiens JJ, 2011, Q REV BIOL, V86, P75, DOI 10.1086/659883; Wilson JJ, 2010, FOREST POLICY ECON, V12, P94, DOI 10.1016/j.forpol.2009.08.005; Winkler DW, 2002, P NATL ACAD SCI USA, V99, P13595, DOI 10.1073/pnas.212251999; Woodward FI, 1997, GLOBAL ECOL BIOGEOGR, V6, P413, DOI 10.2307/2997350; Zinner H, 1972, SYSTEMATICS EVOLUTIO	103	35	38	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91994	10.1371/journal.pone.0091994	http://dx.doi.org/10.1371/journal.pone.0091994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670422	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677000029
J	Dalenberg, JR; Nanetti, L; Renken, RJ; de Wijk, RA; ter Horst, GJ				Dalenberg, Jelle R.; Nanetti, Luca; Renken, Remco J.; de Wijk, Rene A.; ter Horst, Gert J.			Dealing with Consumer Differences in Liking during Repeated Exposure to Food; Typical Dynamics in Rating Behavior	PLOS ONE			English	Article							IN-HOME CONSUMPTION; K-MEANS; ELDERLY ADULTS; MERE EXPOSURE; ACCEPTANCE; INTENSITY; FLAVOR; YOUNG; PLEASANTNESS; PREFERENCES	Consumers show high interindividual variability in food liking during repeated exposure. To investigate consumer liking during repeated exposure, data is often interpreted on a product level by averaging results over all consumers. However, a single product may elicit inconsistent behaviors in consumers; averaging will mix and hide possible subgroups of consumer behaviors, leading to a misinterpretation of the results. To deal with the variability in consumer liking, we propose to use clustering on data from consumer-product combinations to investigate the nature of the behavioral differences within the complete dataset. The resulting behavioral clusters can then be used to describe product acceptance. To test this approach we used two independent data sets in which young adults were repeatedly exposed to drinks and snacks, respectively. We found that five typical consumer behaviors existed in both datasets. These behaviors differed both in the average level of liking as well as its temporal dynamics. By investigating the distribution of a single product across typical consumer behaviors, we provide more precise insight in how consumers divide in subgroups based on their product liking (i.e. product modality). This work shows that taking into account and using interindividual differences can unveil information about product acceptance that would otherwise be ignored.	[Dalenberg, Jelle R.; Nanetti, Luca; Renken, Remco J.; de Wijk, Rene A.; ter Horst, Gert J.] Top Inst Food & Nutr, Wageningen, Netherlands; [Dalenberg, Jelle R.; Nanetti, Luca; Renken, Remco J.; ter Horst, Gert J.] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr Groningen, NL-9713 AV Groningen, Netherlands; [de Wijk, Rene A.] Univ Wageningen & Res Ctr, Ctr Innovat Consumer Studies, Wageningen, Netherlands	Top Institute Food & Nutrition; University of Groningen; Wageningen University & Research	Dalenberg, JR (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	j.r.dalenberg@umcg.nl		Dalenberg, Jelle R./0000-0001-8580-5358; Renken, Remco Jan/0000-0002-7777-9484	TI Food and Nutrition	TI Food and Nutrition	Funding for this work was realized by TI Food and Nutrition (http://www.tifn.nl/). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The sponsors Danone and FrieslandCampina did have a role in the study design, more specifically: the choice of stimuli, which were produced by these sponsors.	Baayen R. H., 2008, ANAL LINGUISTIC DATA; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; BIRCH LL, 1982, APPETITE, V3, P353, DOI 10.1016/S0195-6663(82)80053-6; BORNSTEIN RF, 1989, PSYCHOL BULL, V106, P265, DOI 10.1037/0033-2909.106.2.265; Cooke L, 2007, J HUM NUTR DIET, V20, P294, DOI 10.1111/j.1365-277X.2007.00804.x; Cox D, 2002, J ACAD MARKET SCI, V30, P119, DOI 10.1177/03079459994371; Essed NH, 2006, PHYSIOL BEHAV, V89, P335, DOI 10.1016/j.physbeh.2006.06.016; Everitt B. S., 2006, HDB STAT ANAL USING; Fraley C, 2006, MCLUST VERSION 3 R N; Fraley C, 2007, J CLASSIF, V24, P155, DOI [10.1007/s00357-007-0004-5, 10.1007/s00357-007-0004-z]; Goutte C, 2001, HUM BRAIN MAPP, V13, P165, DOI 10.1002/hbm.1031; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hetherington MM, 2002, APPETITE, V38, P19, DOI 10.1006/appe.2001.0442; Hoek AC, 2013, FOOD QUAL PREFER, V28, P253, DOI 10.1016/j.foodqual.2012.07.002; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Jonsson P, 2004, 10TH INTERNATIONAL SYMPOSIUM ON SOFTWARE METRICS, PROCEEDINGS, P108, DOI 10.1109/METRIC.2004.1357895; Koster EP, 2003, FOOD QUAL PREFER, V14, P359, DOI 10.1016/S0950-3293(03)00017-X; Koster EP, 2003, FOOD QUAL PREFER, V14, P165, DOI 10.1016/S0950-3293(02)00075-7; Kremer S, 2013, FOOD QUAL PREFER, V27, P179, DOI 10.1016/j.foodqual.2012.06.002; Levy CM, 1999, FOOD QUAL PREFER, V10, P185, DOI 10.1016/S0950-3293(99)00016-6; Liem DG, 2004, PHYSIOL BEHAV, V83, P421, DOI 10.1016/j.physbeh.2004.08.028; Liem DG, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-38; Marks LE, 2012, PHYSIOL BEHAV, V105, P443, DOI 10.1016/j.physbeh.2011.08.039; MCBRIDE RL, 1985, APPETITE, V6, P125, DOI 10.1016/S0195-6663(85)80033-7; Nanetti L, 2013, 19 ANN M ORG HUM BRA; Nanetti L, 2009, NEUROIMAGE, V47, P1666, DOI 10.1016/j.neuroimage.2009.06.014; Pelchat ML, 2000, PHYSIOL BEHAV, V68, P353, DOI 10.1016/S0031-9384(99)00190-0; Pinheiro J, 2001, MIXED EFFECTS MODELS; PLINER P, 1982, APPETITE, V3, P283, DOI 10.1016/S0195-6663(82)80026-3; POULTON EC, 1975, AM J PSYCHOL, V88, P3, DOI 10.2307/1421662; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Steinley D, 2006, BRIT J MATH STAT PSY, V59, P1, DOI 10.1348/000711005X48266; SULLIVAN SA, 1994, PEDIATRICS, V93, P271; Sulmont-Rosse C, 2008, FOOD QUAL PREFER, V19, P412, DOI 10.1016/j.foodqual.2007.12.003; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tremblay A, 2011, MENT LEX, V6, P302, DOI 10.1075/ml.6.2.04tre; van Rijn H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051134; Wardle J, 2003, APPETITE, V40, P155, DOI 10.1016/S0195-6663(02)00135-6; Weijzen PLG, 2008, FOOD QUAL PREFER, V19, P349, DOI 10.1016/j.foodqual.2007.11.003; Witvliet CVO, 2007, COGNITION EMOTION, V21, P3, DOI 10.1080/02699930601000672; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; Zandstra EH, 2000, APPETITE, V35, P113, DOI 10.1006/appe.2000.0342; Zandstra EH, 2004, FOOD QUAL PREFER, V15, P549, DOI 10.1016/j.foodqual.2003.12.001	43	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93350	10.1371/journal.pone.0093350	http://dx.doi.org/10.1371/journal.pone.0093350			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SD	24667832	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600173
J	Fan, Y; Wei, CG; Xiao, WZ; Zhang, WJ; Wang, NS; Chuang, PY; He, JC				Fan, Ying; Wei, Chengguo; Xiao, Wenzhen; Zhang, Weijia; Wang, Niansong; Chuang, Peter Y.; He, John Cijiang			Temporal Profile of the Renal Transcriptome of HIV-1 Transgenic Mice during Disease Progression	PLOS ONE			English	Article							F-SPONDIN; EXPRESSION; GENES; GLOMERULOSCLEROSIS; NEPHROPATHY; VARIANT; INJURY	Profiling of temporal changes of gene expression in the same kidney over the course of renal disease progression is challenging because repeat renal biopsies are rarely indicated in clinical practice. Here, we profiled the temporal change in renal transcriptome of HIV-1 transgenic mice (Tg26), an animal model for human HIV-associated nephropathy (HIVAN), and their littermates at three different time points (4, 8, and 12 weeks of age) representing early, middle, and late stages of renal disease by serial kidney biopsy. We analyzed both static levels of gene expression at three stages of disease and dynamic changes in gene expression between different stages. Analysis of static and dynamic changes in gene expression revealed that up-regulated genes at the early and middle stages are mostly involved in immune response and inflammation, whereas down-regulated genes mostly related to fatty acid and retinoid metabolisms. We validated the expression of a selected panel of genes that are up-regulated at the early stage (CCL2, CCL5, CXCL11, Ubd, Anxa1, and Spon1) by real-time PCR. Among these up-regulated genes, Spon1, which is a previously identified candidate gene for hypertension, was found to be up-regulated in kidney of human with diabetic nephropathy. Immunostaining of human biopsy samples demonstrated that protein expression of Spon1 was also markedly increased in kidneys of patients with both early and late HIVAN and diabetic nephropathy. Our studies suggest that analysis of both static and dynamic changes of gene expression profiles in disease progression avails another layer of information that could be utilized to gain a more comprehensive understanding of disease progression and identify potential biomarkers and drug targets.	[Fan, Ying; Xiao, Wenzhen; Wang, Niansong] Shanghai Jiao Tong Univ, Dept Nephrol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Wei, Chengguo; Zhang, Weijia; Chuang, Peter Y.; He, John Cijiang] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA	Shanghai Jiao Tong University; Icahn School of Medicine at Mount Sinai	He, JC (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA.	cijiang.he@mssm.edu	Xiao, Wenzhen/J-5167-2017		NIH [R01-DK-88541, P01-DK-56492, R01-DK-78897]; Chinese 973 fund [2012CB517601]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088541, R01DK078897, K08DK065495, P01DK056492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 fund(National Basic Research Program of China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is funded by NIH (R01-DK-88541, P01-DK-56492, and R01-DK-78897) http://report.nih.gov/ and Chinese 973 fund (2012CB517601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel LJ, 2008, ARCH INTERN MED, V168, P832, DOI 10.1001/archinte.168.8.832; Araujo LP, 2010, AM J NEPHROL, V31, P527, DOI 10.1159/000309756; Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P2493, DOI 10.1093/bioinformatics/bth283; Berger Dave K., 2007, V382, P177, DOI 10.1007/978-1-59745-304-2_12; Berthier CC, 2009, DIABETES, V58, P469, DOI 10.2337/db08-1328; Bhavnani SK, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S9-S3; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Clemitson JR, 2007, CIRC RES, V100, P992, DOI 10.1161/01.RES.0000261961.41889.9c; DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5; Feng X, 2009, J AM SOC NEPHROL; Gong PF, 2010, J AM SOC NEPHROL, V21, P316, DOI 10.1681/ASN.2009050479; Hodgin JB, 2010, AM J PATHOL, V177, P1674, DOI 10.2353/ajpath.2010.090746; Jahanshad N, 2013, P NATL ACAD SCI USA, V110, P4768, DOI 10.1073/pnas.1216206110; Ju WJ, 2009, AM J PATHOL, V174, P2073, DOI 10.2353/ajpath.2009.080888; KOPP JB, 1992, P NATL ACAD SCI USA, V89, P1577, DOI 10.1073/pnas.89.5.1577; Krensky AM, 2007, NAT CLIN PRACT NEPHR, V3, P164, DOI 10.1038/ncpneph0418; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu TC, 2006, CURR OPIN NEPHROL HY, V15, P233, DOI 10.1097/01.mnh.0000222688.69217.8e; Martini S, 2008, REV ENDOCR METAB DIS, V9, P267, DOI 10.1007/s11154-008-9103-3; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oka H, 2011, J PERIODONTOL, V82, P1776, DOI 10.1902/jop.2011.110111; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ratnam KK, 2011, KIDNEY INT, V79, P624, DOI 10.1038/ki.2010.470; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Sharma P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007751.pub2; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tan K, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-22; Tesch GH, 2008, AM J PHYSIOL-RENAL, V294, pF697, DOI 10.1152/ajprenal.00016.2008; Wang HP, 2010, AM J PHYSIOL-RENAL, V298, pF754, DOI 10.1152/ajprenal.00439.2009; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181	32	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93019	10.1371/journal.pone.0093019	http://dx.doi.org/10.1371/journal.pone.0093019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667548	Green Submitted, Green Published, gold			2022-12-25	WOS:000333675600127
J	Kosiorek, M; Zylinska, L; Zablocki, K; Pikula, S				Kosiorek, Michalina; Zylinska, Ludmila; Zablocki, Krzysztof; Pikula, Slawomir			Calcineurin/NFAT Signaling Represses Genes Vamp1 and Vamp2 via PMCA-Dependent Mechanism during Dopamine Secretion by Pheochromocytoma Cells	PLOS ONE			English	Article							NUCLEAR FACTOR; TRANSCRIPTIONAL REGULATION; CATECHOLAMINE SECRETION; CARDIAC-HYPERTROPHY; NA+/CA2+ EXCHANGER; CALCIUM; NFAT; EXPRESSION; CA2+; PROTEIN	Background: Plasma membrane Ca2+-ATPases (PMCA) extrude Ca2+ ions out of the cell and contribute to generation of calcium oscillations. Calcium signaling is crucial for transcriptional regulation of dopamine secretion by neuroendocrine PC12 cells. Low resting [Ca2+](c) in PC12 cells is maintained mainly by two Ca2+-ATPases, PMCA2 and PMCA3. Recently, we found that Ca2+ dependent phosphatase calcineurin was excessively activated under conditions of experimental downregulation of PMCA2 or PMCA3. Thus, the aim of this study was to explain if, via modulation of the Ca2+/calcineurin-dependent nuclear factor of activated T cells (NFAT) pathway, PMCA2 and PMCA3 affect intracellular signaling in pheochromocytoma/neuronal cells/PC12 cells. Secondly, we tested whether this might influence dopamine secretion by PC12 cells. Results: PMCA2- and PMCA3-deficient cells displayed profound decrease in dopamine secretion accompanied by a permanent increase in [Ca2+](c). Reduction in secretion might result from changes in NFAT signaling, following altered PMCA pattern. Consequently, activation of NFAT1 and NFAT3 transcription factors was observed in PMCA2-or PMCA3-deficient cells. Furthermore, chromatin immunoprecipitation assay indicated that NFATs could be involved in repression of Vamp genes encoding vesicle associated membrane proteins (VAMP). Conclusions: PMCA2 and PMCA3 are crucial for dopamine secretion in PC12 cells. Reduction in PMCA2 or PMCA3 led to calcium-dependent activation of calcineurin/NFAT signaling and, in consequence, to repression of the Vamp gene and deterioration of the SNARE complex formation in PC12 cells.	[Kosiorek, Michalina; Zablocki, Krzysztof; Pikula, Slawomir] PAS, Nencki Inst Expt Biol, Dept Biochem, Warsaw, Poland; [Kosiorek, Michalina] Mossakowski Med Res Ctr PAS, Dept Neurodegenerat Disorders, Neurogenet Lab, Warsaw, Poland; [Zylinska, Ludmila] Med Univ Lodz, Dept Mol Neurochem, Lodz, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Medical University Lodz	Kosiorek, M (corresponding author), PAS, Nencki Inst Expt Biol, Dept Biochem, Warsaw, Poland.	mkosiorek@imdik.pan.pl; s.pikula@nencki.gov.pl	Zylinska, Ludmila/ABE-9113-2020; Wężyk, Michalina Maria/R-2208-2018; Zablocki, Krzysztof/R-4181-2016	Zylinska, Ludmila/0000-0002-3876-8942; Wężyk, Michalina Maria/0000-0001-7498-4610; Zablocki, Krzysztof/0000-0002-9987-1257; Pikula, Slawomir/0000-0003-4640-3094	Polish National Science Center [401533340]; Nencki Instyitute of Experimental Biology	Polish National Science Center; Nencki Instyitute of Experimental Biology	This work is supported by Grant No. 401533340 from the Polish National Science Center and by the Nencki Instyitute of Experimental Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani A, 2006, BIOCHEM SOC T, V34, P696, DOI 10.1042/BST0340696; Abdul Hafiz Mohmmad, 2010, Mol Cell Pharmacol, V2, P7; Ago T, 2010, J CARDIOVASC TRANSL, V3, P304, DOI 10.1007/s12265-010-9182-x; Alberts B, 2002, MOL BIOL CELL; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Asai M, 2004, MOL ENDOCRINOL, V18, P3011, DOI 10.1210/me.2003-0471; Barbado M, 2009, BBA-MOL CELL RES, V1793, P1096, DOI 10.1016/j.bbamcr.2009.02.004; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Belfield JL, 2006, J BIOL CHEM, V281, P27724, DOI 10.1074/jbc.M601485200; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Brini M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004168; Buch MH, 2005, J BIOL CHEM, V280, P29479, DOI 10.1074/jbc.M501326200; BURGOYNE RD, 1995, J PHYSIOL PHARMACOL, V46, P273; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Canellada A, 2008, GLIA, V56, P709, DOI 10.1002/glia.20647; CARAFOLI E, 1992, J BIOL CHEM, V267, P2115; Choo MK, 2009, BONE, V45, P579, DOI 10.1016/j.bone.2009.05.009; Dermitzaki E, 2012, J CELL PHYSIOL, V227, P1861, DOI 10.1002/jcp.22914; Domi T, 2007, ANN NY ACAD SCI, V1099, P237, DOI 10.1196/annals.1387.043; Dubois LA, 2005, WORLD J SURG, V29, P909, DOI 10.1007/s00268-005-7860-7; Duman JG, 2008, J GEN PHYSIOL, V131, P307, DOI 10.1085/jgp.200709915; DUTZ JP, 1993, J IMMUNOL, V150, P2591; Elloumi HZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034172; Gao H, 2012, J MOL CELL CARDIOL, V53, P657, DOI 10.1016/j.yjmcc.2012.08.005; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haberman A, 2012, J CELL BIOL, V196, P261, DOI 10.1083/jcb.201108088; HAMMES A, 1994, FASEB J, V8, P428, DOI 10.1096/fasebj.8.6.8168693; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hernandez-Ochoa EO, 2007, CELL CALCIUM, V41, P559, DOI 10.1016/j.ceca.2006.10.006; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horiba M, 2008, LIFE SCI, V82, P554, DOI 10.1016/j.lfs.2007.11.010; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jena BP, 2011, ADV EXP MED BIOL, V713, P13, DOI 10.1007/978-94-007-0763-4_3; Jordan JA, 2010, J VIROL, V84, P1722, DOI 10.1128/JVI.01918-09; Jordan MC, 2002, ANN NY ACAD SCI, V976, P259; Joyce JN, 1998, NEUROPSYCHOPHARMACOL, V19, P472, DOI 10.1016/S0893-133X(98)00044-X; Kamagate A, 2002, DIABETES, V51, P2773, DOI 10.2337/diabetes.51.9.2773; Kamagate A, 2000, CELL CALCIUM, V27, P231, DOI 10.1054/ceca.2000.0116; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Katanosaka Y, 2005, J BIOL CHEM, V280, P5764, DOI 10.1074/jbc.M410240200; Kim HJ, 2012, J CELL BIOL, V199, P1145, DOI 10.1083/jcb.201204067; Kosiorek M, 2011, BIOCHEM BIOPH RES CO, V411, P235, DOI 10.1016/j.bbrc.2011.06.098; Kubista H, 2004, J CELL SCI, V117, P955, DOI 10.1242/jcs.00941; Lai NS, 2012, CLIN EXP IMMUNOL, V168, P78, DOI 10.1111/j.1365-2249.2012.04563.x; Li L, 2000, J BIOL CHEM, V275, P20903, DOI 10.1074/jbc.M000995200; Li Ruizhao, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1022; Martin R, 2007, BONE, V40, P1203, DOI 10.1016/j.bone.2006.12.060; Meyer MZ, 2006, J BIOL CHEM, V281, P7919, DOI 10.1074/jbc.M600081200; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com; Nguyen T, 2009, J BIOL CHEM, V284, P18816, DOI 10.1074/jbc.M109.015719; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Pan S, 2000, BIOCHEM BIOPH RES CO, V272, P765, DOI 10.1006/bbrc.2000.2831; Rana ZA, 2009, J MUSCLE RES CELL M, V30, P255, DOI 10.1007/s10974-010-9200-2; Ranger AM, 2000, J EXP MED, V191, P9, DOI 10.1084/jem.191.1.9; Reinhardt TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1595, DOI 10.1152/ajpcell.2000.279.5.C1595; Reinhardt TA, 2009, BIOCHEM BIOPH RES CO, V378, P99, DOI 10.1016/j.bbrc.2008.11.004; Ritchie MF, 2012, EMBO J, V31, P1123, DOI 10.1038/emboj.2011.495; Santana LF, 2008, CIRC RES, V103, P681, DOI 10.1161/CIRCRESAHA.108.185090; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Shigekawa M, 2007, ANN NY ACAD SCI, V1099, P53, DOI 10.1196/annals.1387.059; Shirasu M, 2000, NEUROSCI RES, V37, P265, DOI 10.1016/S0168-0102(00)00125-5; Sillitoe RV, 2008, SCHIZOPHRENIA BULL, V34, P212, DOI 10.1093/schbul/sbm170; Ulrich JD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.365197; van Rooij E, 2002, J BIOL CHEM, V277, P48617, DOI 10.1074/jbc.M206532200; Varadi A, 1996, BIOCHEM J, V314, P663, DOI 10.1042/bj3140663; Vashishta A, 2009, J NEUROSCI, V29, P15331, DOI 10.1523/JNEUROSCI.4873-09.2009; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; Wu X, 2009, J CLIN INVEST, V119, P976, DOI 10.1172/JCI36693; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zawawi MSF, 2012, BIOCHEM BIOPH RES CO, V427, P404, DOI 10.1016/j.bbrc.2012.09.077; Zylinska L, 2007, ANN NY ACAD SCI, V1099, P254, DOI 10.1196/annals.1387.008	77	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92176	10.1371/journal.pone.0092176	http://dx.doi.org/10.1371/journal.pone.0092176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667359	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600026
J	Zarubin, M; Farstey, V; Wold, A; Falk-Petersen, S; Genin, A				Zarubin, Margarita; Farstey, Viviana; Wold, Anette; Falk-Petersen, Stig; Genin, Amatzia			Intraspecific Differences in Lipid Content of Calanoid Copepods across Fine-Scale Depth Ranges within the Photic Layer	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; NORTHERN RED-SEA; FEEDING CURRENTS; WAX ESTERS; MESOZOOPLANKTON DISTRIBUTION; BIOLOGICAL PROCESSES; COMMUNITY STRUCTURE; MARINE COPEPODS; ZOOPLANKTON; GULF	Copepods are among the most abundant and diverse groups of mesozooplankton in the world's oceans. Each species has a certain depth range within which different individuals (of the same life stage and sex) are found. Lipids are accumulated in many calanoid copepods for energy storage and reproduction. Lipid content in some species increases with depth, however studies so far focused mostly on temperate and high-latitude seasonal vertically migrating copepods and compared lipid contents among individuals either from coarse layers or between diapausing, deep-dwelling copepods and individuals found in the photic, near-surface layer. Here we examined whether lipid contents of individual calanoid copepods of the same species, life stage/sex differ between finer depth layers within the upper water column of subtropical and Arctic seas. A total of 6 calanoid species were collected from samples taken at precise depths within the photic layer in both cold eutrophic and warm oligotrophic environments using SCUBA diving, MOCNESS and Multinet. Measurements of lipid content were obtained from digitized photographs of the collected individuals. The results revealed significant differences in lipid content across depth differences as small as 12-15 meters for Mecynocera clausi C5 and Ctenocalanus vanus C5 (Red Sea), Clausocalanus furcatus males and two clausocalanid C5s (Mediterranean Sea), and Calanus glacialis C5 (Arctic). We suggest two possible explanations for the differences in lipid content with depth on such a fine scale: predator avoidance and buoyancy.	[Zarubin, Margarita; Farstey, Viviana; Genin, Amatzia] Interuniv Inst Marine Sci, Elat, Israel; [Zarubin, Margarita; Genin, Amatzia] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Ecol Evolut & Behav, Jerusalem, Israel; [Wold, Anette; Falk-Petersen, Stig] Akvaplan Niva, Fram Ctr, Tromso, Norway; [Falk-Petersen, Stig] Univ Tromso, Fac Biosci Fisheries & Econ, Dept Arctic & Marine Biol, Tromso, Norway; [Falk-Petersen, Stig] Norwegian Polar Res Inst, Tromso, Norway	Hebrew University of Jerusalem; Akvaplan-niva; UiT The Arctic University of Tromso; Norwegian Polar Institute	Zarubin, M (corresponding author), Interuniv Inst Marine Sci, Elat, Israel.	margaritazarubin@gmail.com			Israel Science Foundation [ISF 527/10]	Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Science Foundation [grant number ISF 527/10 to AG]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1984, ECOL STUD; AZOV Y, 1991, MAR POLLUT BULL, V23, P225, DOI 10.1016/0025-326X(91)90679-M; BANSE K., 1964, PROGR OCEANOGR, V2, P53, DOI 10.1016/0079-6611(64)90003-5; Berges JA, 1997, LIMNOL OCEANOGR, V42, P1006, DOI 10.4319/lo.1997.42.5.1006; Bjornberg T.K.S., 1981, P587; Bottger-Schnack R, 2008, J PLANKTON RES, V30, P529, DOI 10.1093/plankt/fbn018; BRADFORD JM, 1972, NZ OCEANOGR I MEM, V54, P1; Campbell RW, 2003, MAR ECOL PROG SER, V263, P93, DOI 10.3354/meps263093; Castro LR, 2007, PROG OCEANOGR, V75, P486, DOI 10.1016/j.pocean.2007.08.012; CASTRO LR, 1991, ESTUAR COAST SHELF S, V32, P243, DOI 10.1016/0272-7714(91)90018-7; Cottier FR, 2010, GEOL SOC SPEC PUBL, V344, P35, DOI 10.1144/SP344.4; DAM HG, 1991, MAR ECOL PROG SER, V71, P113, DOI 10.3354/meps071113; Dupont N, 2012, J PLANKTON RES, V34, P263, DOI 10.1093/plankt/fbr096; ECHELMAN T, 1990, MAR BIOL, V107, P179, DOI 10.1007/BF01313255; Falk-Petersen S, 2009, MAR BIOL RES, V5, P18, DOI 10.1080/17451000802512267; Farstey V, 2002, MAR ECOL PROG SER, V238, P91, DOI 10.3354/meps238091; FRAGOPOULU N, 1990, MAR BIOL, V104, P381, DOI 10.1007/BF01314340; Frost B., 1968, Bulletin Scripps Institution of Oceanography Technical Series, V12, P1; Genin A, 2005, SCIENCE, V308, P860, DOI 10.1126/science.1107834; GISKE J, 1990, SARSIA, V75, P65, DOI 10.1080/00364827.1990.10413442; Hays GC, 2001, LIMNOL OCEANOGR, V46, P2050, DOI 10.4319/lo.2001.46.8.2050; Herman W, 1983, LIMNOL OCEANOGR, V28, P709; HOLM S, 1979, SCAND J STAT, V6, P65; HUNTLEY M, 1982, MAR BIOL, V71, P23, DOI 10.1007/BF00396989; Incze LS, 2001, MAR ECOL PROG SER, V213, P229, DOI 10.3354/meps213229; Irigoien X, 2004, J PLANKTON RES, V26, P259, DOI 10.1093/plankt/fbh030; Jiang HS, 2005, J PLANKTON RES, V27, P1003, DOI 10.1093/plankt/fbi087; Jonasdottir Sigrun H., 1999, Fisheries Oceanography, V8, P61, DOI 10.1046/j.1365-2419.1999.00003.x; Jonasdottir SH, 2011, J PLANKTON RES, V33, P85, DOI 10.1093/plankt/fbq085; Kattner G, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P257, DOI 10.1007/978-0-387-89366-2_11; KOEHL MAR, 1981, LIMNOL OCEANOGR, V26, P1062, DOI 10.4319/lo.1981.26.6.1062; Koski M, 2011, J PLANKTON RES, V33, P63, DOI 10.1093/plankt/fbq084; Lagadeuc Y, 1997, J PLANKTON RES, V19, P1183, DOI 10.1093/plankt/19.9.1183; LEE RF, 1971, DEEP-SEA RES, V18, P1147, DOI 10.1016/0011-7471(71)90023-4; LEE RF, 1973, LIMNOL OCEANOGR, V18, P227, DOI 10.4319/lo.1973.18.2.0227; Lee RF, 2006, MAR ECOL PROG SER, V307, P273, DOI 10.3354/meps307273; LEE RF, 1974, MAR BIOL, V26, P313, DOI 10.1007/BF00391515; Leu E, 2011, PROG OCEANOGR, V90, P18, DOI 10.1016/j.pocean.2011.02.004; Lischka S, 2007, MAR BIOL, V150, P443, DOI 10.1007/s00227-006-0359-4; Mauchline J., 1998, ADV MAR BIOL, V33, P1, DOI DOI 10.1163/156854008784513492; Mazzocchi MG, 1997, OCEANOL ACTA, V20, P521; Mazzocchi MG, 1999, J PLANKTON RES, V21, P1501, DOI 10.1093/plankt/21.8.1501; Miller CB, 2000, ICES J MAR SCI, V57, P1786, DOI 10.1006/jmsc.2000.0975; Miller CB, 1998, LIMNOL OCEANOGR, V43, P488, DOI 10.4319/lo.1998.43.3.0488; Ohman MD, 1996, MAR ECOL PROG SER, V130, P295, DOI 10.3354/meps130295; Paffenhofer GA, 2003, J PLANKTON RES, V25, P1139, DOI 10.1093/plankt/25.9.1139; Paffenhofer GA, 1982, MAR BIOL, V67, P193; Pearre S, 2003, BIOL REV, V78, P1, DOI 10.1017/S146479310200595X; Pond DW, 2012, J PLANKTON RES, V34, P443, DOI 10.1093/plankt/fbs027; Pond DW, 2011, LIMNOL OCEANOGR, V56, P1310, DOI 10.4319/lo.2011.56.4.1310; R Development Core Team, 2011, R LANG ENV STAT COMP; Sartoris FJ, 2010, LIMNOL OCEANOGR, V55, P1860, DOI 10.4319/lo.2010.55.5.1860; SiokouFrangou I, 1997, OCEANOL ACTA, V20, P537; Sommer U, 2002, MAR ECOL PROG SER, V239, P251, DOI 10.3354/meps239251; Soreide JE, 2010, GLOBAL CHANGE BIOL, V16, P3154, DOI 10.1111/j.1365-2486.2010.02175.x; STRICKLER JR, 1982, SCIENCE, V218, P158, DOI 10.1126/science.218.4568.158; Visser AW, 2009, J PLANKTON RES, V31, P121, DOI 10.1093/plankt/fbn109; Visser Andre W., 1999, Fisheries Oceanography, V8, P100, DOI 10.1046/j.1365-2419.1999.00001.x; Vogedes D, 2010, J PLANKTON RES, V32, P1471, DOI 10.1093/plankt/fbq068; Wallace MI, 2010, LIMNOL OCEANOGR, V55, P831, DOI 10.4319/lo.2009.55.2.0831; Wheeler B, 2010, IMPERM PERMUTATION T; YACOBI YZ, 1995, J MARINE SYST, V6, P179, DOI 10.1016/0924-7963(94)00028-A; YAYANOS AA, 1978, DEEP-SEA RES, V25, P257, DOI 10.1016/0146-6291(78)90591-X	63	21	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92935	10.1371/journal.pone.0092935	http://dx.doi.org/10.1371/journal.pone.0092935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667529	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600107
J	Nemec, AA; Murphy, DL; Donigan, KA; Sweasy, JB				Nemec, Antonia A.; Murphy, Drew L.; Donigan, Katherine A.; Sweasy, Joann B.			The S229L Colon Tumor- associated Variant of DNA Polymerase beta Induces Cellular Transformation as a Result of Decreased Polymerization Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Base Excision Repair; Cancer; Genetics; Genomic Instability; Mutagenesis	CONSEQUENCES; INSTABILITY; MUTATOR; REPAIR; CELLS; LYASE	Background: The POLB gene is mutated in 40% of human colorectal tumors. Results: The S229L variant is a slow DNA polymerase that leads to the accumulation of BER intermediates and induces cellular transformation. Conclusion: The S229L variant transforms cells by inducing genomic instability. Significance: Tumor-associated variants of DNA polymerase can affect DNA repair efficiency and drive cancer. DNA polymerase (Pol ) plays a key role in base excision repair (BER) by filling in small gaps that are generated after base adducts are excised from the DNA. Pol is mutated in a large number of colorectal tumors, and these mutations may drive carcinogenesis. In the present study, we wished to determine whether the S229L somatic Pol variant identified in a stage 3 colorectal tumor is a driver of carcinogenesis. We show that S229L does not possess any defects in binding to either DNA or nucleotides compared with the WT enzyme, but exhibits a significant loss of polymerization efficiency, largely due to an 8-fold decrease in the polymerization rate. S229L participates in BER, but due to its lower catalytic rate, does so more slowly than WT. Expression of S229L in mammalian cells induces the accumulation of BER intermediate substrates, chromosomal aberrations, and cellular transformation. Our results are consistent with the interpretation that S229L is a driver of carcinogenesis, likely as a consequence of its slow polymerization activity during BER in vivo.	[Sweasy, Joann B.] Yale Univ, Dept Therapeut Radiol, New Haven, CT 06520 USA; Yale Univ, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University	Sweasy, JB (corresponding author), Yale Univ, Dept Therapeut Radiol, POB 208040, New Haven, CT 06520 USA.	joann.sweasy@yale.edu			National Institutes of Health [F32 CA156843]; NCI [T32 CA009259]; NIEHS [ES019179]; NATIONAL CANCER INSTITUTE [T32CA009259, F32CA156843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019179] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants F32 CA156843 and T32 CA009259 from the NCI (to A.A.N.) and ES019179 from the NIEHS (to J.B.S.).	Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Dalal S, 2008, NUCLEIC ACIDS RES, V36, P411, DOI 10.1093/nar/gkm1053; Donigan KA, 2012, J BIOL CHEM, V287, P23830, DOI 10.1074/jbc.M111.324947; Donigan KA, 2012, DNA REPAIR, V11, P381, DOI 10.1016/j.dnarep.2012.01.004; Lang TM, 2007, MOL CELL BIOL, V27, P5587, DOI 10.1128/MCB.01883-06; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LOEB LA, 1974, CANCER RES, V34, P2311; Loeb LA, 2011, NAT REV CANCER, V11, P450, DOI 10.1038/nrc3063; LOWY DR, 1978, J VIROL, V26, P291, DOI 10.1128/JVI.26.2.291-298.1978; Murphy DL, 2008, BIOCHEMISTRY-US, V47, P8048, DOI 10.1021/bi702104y; Murphy DL, 2011, J AM CHEM SOC, V133, P6279, DOI 10.1021/ja111099b; Nemec AA, 2012, J BIOL CHEM, V287, P23840, DOI 10.1074/jbc.M112.362111; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Yamtich J, 2010, BIOCHEMISTRY-US, V49, P2326, DOI 10.1021/bi901735a; Yamtich J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003052; Yamtich J, 2009, DNA REPAIR, V8, P579, DOI 10.1016/j.dnarep.2008.12.005	17	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13708	13716		10.1074/jbc.M114.550400	http://dx.doi.org/10.1074/jbc.M114.550400			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24668809	Green Published, hybrid			2022-12-25	WOS:000335984600005
J	Patterson, JN; Cousteils, K; Lou, JW; Fox, JEM; MacDonald, PE; Joseph, JW				Patterson, Jessica N.; Cousteils, Katelyn; Lou, Jennifer W.; Fox, Jocelyn E. Manning; MacDonald, Patrick E.; Joseph, Jamie W.			Mitochondrial Metabolism of Pyruvate Is Essential for Regulating Glucose-stimulated Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-Cell; Cell Metabolism; Glucose Metabolism; Mitochondria; Pancreatic Islets; Pyruvate	PANCREATIC BETA-CELLS; SENSITIVE K+ CHANNELS; LACTATE-DEHYDROGENASE; MALONYL-COA; CARRIER; ISLETS; RAT; CARBOXYLASE; EXOCYTOSIS; INHIBITION	Background: Pyruvate metabolism plays an essential role in pancreatic -cells. Results: Pharmacological and siRNA-mediated inhibition of mitochondrial pyruvate carrier-1 and -2 inhibit -cell metabolism and insulin secretion. Conclusion: Pyruvate entry into -cell mitochondria is critical for regulating insulin release. Significance: Mitochondrial metabolism of pyruvate plays a key role in generating signals in response to nutrients that control insulin release. It is well known that mitochondrial metabolism of pyruvate is critical for insulin secretion; however, we know little about how pyruvate is transported into mitochondria in -cells. Part of the reason for this lack of knowledge is that the carrier gene was only discovered in 2012. In the current study, we assess the role of the recently identified carrier in the regulation of insulin secretion. Our studies show that -cells express both mitochondrial pyruvate carriers (Mpc1 and Mpc2). Using both pharmacological inhibitors and siRNA-mediated knockdown of the MPCs we show that this carrier plays a key role in regulating insulin secretion in clonal 832/13 -cells as well as rat and human islets. We also show that the MPC is an essential regulator of both the ATP-regulated potassium (K-ATP) channel-dependent and -independent pathways of insulin secretion. Inhibition of the MPC blocks the glucose-stimulated increase in two key signaling molecules involved in regulating insulin secretion, the ATP/ADP ratio and NADPH/NADP(+) ratio. The MPC also plays a role in in vivo glucose homeostasis as inhibition of MPC by the pharmacological inhibitor -cyano--(1-phenylindol-3-yl)-acrylate (UK5099) resulted in impaired glucose tolerance. These studies clearly show that the newly identified mitochondrial pyruvate carrier sits at an important branching point in nutrient metabolism and that it is an essential regulator of insulin secretion.	[Patterson, Jessica N.; Cousteils, Katelyn; Lou, Jennifer W.; Joseph, Jamie W.] Univ Waterloo, Sch Pharm, Waterloo, ON N2G 1C5, Canada; [Fox, Jocelyn E. Manning; MacDonald, Patrick E.] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2E1, Canada; [Fox, Jocelyn E. Manning; MacDonald, Patrick E.] Univ Alberta, Alberta Diabet Inst, Edmonton, AB T6G 2E1, Canada	University of Waterloo; University of Alberta; University of Alberta	Joseph, JW (corresponding author), Univ Waterloo, Sch Pharm, Hlth Sci Campus Bldg A,Rm 4008,10A Victoria St S, Kitchener, ON N2G 1C5, Canada.	j3joseph@uwaterloo.ca		MacDonald, Patrick/0000-0002-5439-6288	Canadian Institute of Health Research [MOP 86638]; Natural Sciences and Engineering Research Council of Canada [RGPIN 371723-2009]; Alberta Diabetes Foundation; University of Alberta; Alberta Innovates-Health Solutions	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Diabetes Foundation; University of Alberta(University of Alberta); Alberta Innovates-Health Solutions	This work was supported in part by Canadian Institute of Health Research Grant MOP 86638 and Natural Sciences and Engineering Research Council of Canada Grant RGPIN 371723-2009. Human islet isolation was funded by the Alberta Diabetes Foundation and the University of Alberta (to P. E. M.).; Supported by a scholarship from Alberta Innovates-Health Solutions and holds the Canada Research Chair in Islet Biology.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; Bertrand G, 2002, J BIOL CHEM, V277, P32883, DOI 10.1074/jbc.M205326200; BEST L, 1991, BIOCHEM PHARMACOL, V41, P405, DOI 10.1016/0006-2952(91)90537-F; BEST L, 1988, BIOCHEM PHARMACOL, V37, P2019, DOI 10.1016/0006-2952(88)90550-3; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Detimary P, 1996, J BIOL CHEM, V271, P20559, DOI 10.1074/jbc.271.34.20559; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; HALESTRAP AP, 1976, BIOCHEM J, V156, P181, DOI 10.1042/bj1560181; HALESTRAP AP, 1975, BIOCHEM J, V148, P97, DOI 10.1042/bj1480097; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; HALESTRAP AP, 1974, BIOCHEM J, V138, P313, DOI 10.1042/bj1380313; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; HALESTRAP AP, 1978, BIOCHEM J, V172, P377, DOI 10.1042/bj1720377; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Hildyard JCW, 2003, BIOCHEM J, V374, P607, DOI 10.1042/BJ20030995; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huypens P, 2011, DIABETOLOGIA, V54, P135, DOI 10.1007/s00125-010-1923-5; Huypens PR, 2012, ISLETS, V4, DOI 10.4161/isl.18338; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Joseph JW, 2002, DIABETES, V51, P3211, DOI 10.2337/diabetes.51.11.3211; JUNTTIBERGGREN L, 1994, J BIOL CHEM, V269, P14391; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kin T, 2010, ISLETS, V2, P265, DOI 10.4161/isl.2.5.13019; Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2011, J BIOL CHEM, V286, P18383, DOI 10.1074/jbc.M111.241182; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 2002, DIABETES, V51, pS99, DOI 10.2337/diabetes.51.2007.S99; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Pi JB, 2010, TOXICOL APPL PHARM, V244, P77, DOI 10.1016/j.taap.2009.05.025; Pigeau GM, 2009, DIABETES, V58, P2084, DOI 10.2337/db08-1371; Pillai R, 2011, J BIOL CHEM, V286, P1014, DOI 10.1074/jbc.M110.149062; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Rocheleau JV, 2002, J BIOL CHEM, V277, P30914, DOI 10.1074/jbc.M202314200; Rorsman P, 1997, DIABETOLOGIA, V40, P487, DOI 10.1007/s001250050706; SATO Y, 1992, DIABETES, V41, P438, DOI 10.2337/diabetes.41.4.438; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Skelly RH, 1998, BIOCHEM J, V331, P553, DOI 10.1042/bj3310553; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; Sugden MC, 2011, ISLETS, V3, P302, DOI 10.4161/isl.3.6.17806; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914; Zhao C, 1998, FEBS LETT, V430, P213, DOI 10.1016/S0014-5793(98)00600-0	56	54	56	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13335	13346		10.1074/jbc.M113.521666	http://dx.doi.org/10.1074/jbc.M113.521666			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24675076	Green Published, hybrid			2022-12-25	WOS:000335522800032
J	Park, S; Stromstedt, AA; Goransson, U				Park, Sungkyu; Stromstedt, Adam A.; Goransson, Ulf			Cyclotide Structure-Activity Relationships: Qualitative and Quantitative Approaches Linking Cytotoxic and Anthelmintic Activity to the Clustering of Physicochemical Forces	PLOS ONE			English	Article							CYCLIC-CYSTINE-KNOT; ANTIMICROBIAL PEPTIDES; PLANT CYCLOTIDES; CIRCULAR PROTEIN; KALATA B1; INSECTICIDAL ACTIVITY; SCANNING MUTAGENESIS; CYCLOVIOLACIN O2; MEMBRANE-BINDING; VIOLA-ODORATA	Cyclotides are a family of plant-derived proteins that are characterized by a cyclic backbone and a knotted disulfide topology. Their cyclic cystine knot (CCK) motif makes them exceptionally resistant to thermal, chemical, and enzymatic degradation. Cyclotides exert much of their biological activity via interactions with cell membranes. In this work, we qualitatively and quantitatively analyze the cytotoxic and anthelmintic membrane activities of cyclotides. The qualitative and quantitative models describe the potency of cyclotides using four simple physicochemical terms relevant to membrane contact. Specifically, surface areas of the cyclotides representing lipophilic and hydrogen bond donating properties were quantified and their distribution across the molecular surface was determined. The resulting quantitative structure-activity relation (QSAR) models suggest that the activity of the cyclotides is proportional to their lipophilic and positively charged surface areas, provided that the distribution of these surfaces is asymmetric. In addition, we qualitatively analyzed the physicochemical differences between the various cyclotide subfamilies and their effects on the cyclotides' orientation on the membrane and membrane activity.	[Park, Sungkyu; Stromstedt, Adam A.; Goransson, Ulf] Uppsala Univ, Div Pharmacognosy, Dept Med Chem, Uppsala, Sweden	Uppsala University	Goransson, U (corresponding author), Uppsala Univ, Div Pharmacognosy, Dept Med Chem, Uppsala, Sweden.	ulf.goransson@fkog.uu.se	Strömstedt, Adam/I-8820-2018	Strömstedt, Adam/0000-0001-9070-6944; Goransson, Ulf/0000-0002-5005-9612	Swedish Research Council [621-2007-5167]; Swedish Foundation for Strategic Research [F06-0058]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	U.G. is supported by the Swedish Research Council (#621-2007-5167) and the Swedish Foundation for Strategic Research (#F06-0058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboye TL, 2012, J MED CHEM, V55, P10729, DOI 10.1021/jm301468k; Accelrys Software Inc, 2007, DISC STUD MOD ENV; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Bhonsle JB, 2007, J MED CHEM, V50, P6545, DOI 10.1021/jm070884y; BLACK SD, 1991, ANAL BIOCHEM, V193, P72, DOI 10.1016/0003-2697(91)90045-U; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Burman R, 2011, BBA-BIOMEMBRANES, V1808, P2665, DOI 10.1016/j.bbamem.2011.07.004; Burman R, 2011, ORG BIOMOL CHEM, V9, P4306, DOI 10.1039/c0ob00966k; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Clark RJ, 2006, BIOCHEM J, V394, P85, DOI 10.1042/BJ20051691; Colgrave ML, 2008, CHEMBIOCHEM, V9, P1939, DOI 10.1002/cbic.200800174; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2004, CURR PROTEIN PEPT SC, V5, P297, DOI 10.2174/1389203043379512; Daly NL, 2006, BIOCHEM J, V393, P619, DOI 10.1042/BJ20051371; Daly NL, 1999, J MOL BIOL, V285, P333, DOI 10.1006/jmbi.1998.2276; de Planque MRR, 2003, BIOCHEMISTRY-US, V42, P5341, DOI 10.1021/bi027000r; Frecer V, 2006, BIOORGAN MED CHEM, V14, P6065, DOI 10.1016/j.bmc.2006.05.005; Gerlach SL, 2010, J NAT PROD, V73, P1207, DOI 10.1021/np9007365; Giang KTN, 2013, J BIOL CHEM, V288, P3370, DOI 10.1074/jbc.M112.415356; Goransson U, 2012, J BIOL CHEM, V287, P27001, DOI 10.1074/jbc.R111.300129; Goransson U, 2009, CHEMBIOCHEM, V10, P2354, DOI 10.1002/cbic.200900342; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Hall L.H., 1991, REV COMPUTATIONAL CH, V2, P367, DOI DOI 10.1002/9780470125793.CH9; Hashempour H, 2013, AMINO ACIDS, V44, P581, DOI 10.1007/s00726-012-1376-x; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Herrmann A, 2006, CELL MOL LIFE SCI, V63, P235, DOI 10.1007/s00018-005-5486-4; Herrmann A, 2008, PHYTOCHEMISTRY, V69, P939, DOI 10.1016/j.phytochem.2007.10.023; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Ireland DC, 2006, BIOCHEM J, V400, P1, DOI 10.1042/BJ20060627; Ireland DC, 2006, J MOL BIOL, V357, P1522, DOI 10.1016/j.jmb.2006.01.051; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Koehbach J, 2013, P NATL ACAD SCI USA, V110, P21183, DOI 10.1073/pnas.1311183110; Koltay A, 2005, INT J PEPT RES THER, V11, P99, DOI 10.1007/s10989-004-1722-2; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Langham AA, 2008, PEPTIDES, V29, P1085, DOI 10.1016/j.peptides.2008.03.018; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lindholm P, 2002, MOL CANCER THER, V1, P365; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Minitab IN, 2010, MINITAB 16 STAT SOFT; MOE, 2012, MOL OP ENV; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Mulvenna JR, 2005, STRUCTURE, V13, P691, DOI 10.1016/j.str.2005.02.013; Ostberg N, 2005, PEPTIDES, V26, P197, DOI 10.1016/j.peptides.2004.09.020; Ovesen RG, 2011, ENVIRON TOXICOL CHEM, V30, P1190, DOI 10.1002/etc.496; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Poth AG, 2012, J BIOL CHEM, V287, P27033, DOI 10.1074/jbc.M112.370841; Poth AG, 2011, ACS CHEM BIOL, V6, P345, DOI 10.1021/cb100388j; ROGERS D, 1994, J CHEM INF COMP SCI, V34, P854, DOI 10.1021/ci00020a020; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Stromstedt AA, 2010, CURR OPIN COLLOID IN, V15, P467, DOI 10.1016/j.cocis.2010.05.006; Svangard E, 2004, J NAT PROD, V67, P144, DOI 10.1021/np030101l; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Trabi M, 2004, PLANT CELL, V16, P2204, DOI 10.1105/tpc.104.021790; VANDEWATERBEEMD H, 1994, AMINO ACIDS, V7, P129, DOI 10.1007/BF00814156; Wang CK, 2009, BIOPHYS J, V97, P1471, DOI 10.1016/j.bpj.2009.06.032; Wang CK, 2009, J BIOL CHEM, V284, P10672, DOI 10.1074/jbc.M900021200; Wang CKL, 2011, BIOCHEMISTRY-US, V50, P4077, DOI 10.1021/bi2004153; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Yeshak MY, 2011, J NAT PROD, V74, P727, DOI 10.1021/np100790f	68	23	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e91430	10.1371/journal.pone.0091430	http://dx.doi.org/10.1371/journal.pone.0091430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682019	Green Published, gold, Green Submitted			2022-12-25	WOS:000333678100003
J	Watanabe, K; Kazama, S; Omura, T; Monaghan, MT				Watanabe, Kozo; Kazama, So; Omura, Tatsuo; Monaghan, Michael T.			Adaptive Genetic Divergence along Narrow Environmental Gradients in Four Stream Insects	PLOS ONE			English	Article							NATURAL-SELECTION; LOCAL ADAPTATION; POPULATION-STRUCTURE; COLOR POLYMORPHISM; GENOME-SCAN; ECOLOGICAL SPECIALIZATION; REPRODUCTIVE ISOLATION; DOMINANT MARKERS; MIXED MODELS; DIFFERENTIATION	A central question linking ecology with evolutionary biology is how environmental heterogeneity can drive adaptive genetic divergence among populations. We examined adaptive divergence of four stream insects from six adjacent catchments in Japan by combining field measures of habitat and resource components with genome scans of non-neutral Amplified Fragment Length Polymorphism (AFLP) loci. Neutral genetic variation was used to measure gene flow and non-neutral genetic variation was used to test for adaptive divergence. We identified the environmental characteristics contributing to divergence by comparing genetic distances at non-neutral loci between sites with Euclidean distances for each of 15 environmental variables. Comparisons were made using partial Mantel tests to control for geographic distance. In all four species, we found strong evidence for non-neutral divergence along environmental gradients at between 6 and 21 loci per species. The relative contribution of these environmental variables to each species' ecological niche was quantified as the specialization index, S, based on ecological data. In each species, the variable most significantly correlated with genetic distance at non-neutral loci was the same variable along which each species was most narrowly distributed (i.e., highest S). These were gradients of elevation (two species), chlorophyll-a, and ammonia-nitrogen. This adaptive divergence occurred in the face of ongoing gene flow (F-st = 0.01-0.04), indicating that selection was strong enough to overcome homogenization at the landscape scale. Our results suggest that adaptive divergence is pronounced, occurs along different environmental gradients for different species, and may consistently occur along the narrowest components of species' niche.	[Watanabe, Kozo; Monaghan, Michael T.] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Berlin, Germany; [Kazama, So] Tohoku Univ, Dept Civil & Environm Engn, Sendai, Miyagi 980, Japan; [Omura, Tatsuo] Tohoku Univ, New Ind Creat Hatchery Ctr NIChe, Sendai, Miyagi 980, Japan	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Tohoku University; Tohoku University	Watanabe, K (corresponding author), Ehime Univ, Dept Civil & Environm Engn, Bunkyo Cho 3, Matsuyama, Ehime, Japan.	watanabe_kozo@cee.ehime-u.ac.jp	Monaghan, Michael T/A-2589-2009; Watanabe, Kozo/F-7388-2010; Kazama, So/T-2641-2019	Monaghan, Michael T/0000-0001-6200-2376; Watanabe, Kozo/0000-0002-7062-595X; 	Japan Society for the Promotion of Science (JSPS) [22360192, 25289172, 24254003, 25303020]; Ministry of Land, Infrastructure and Transport Japan [07052442]; European Commission [237026]; Grants-in-Aid for Scientific Research [25289172] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Land, Infrastructure and Transport Japan; European Commission(European CommissionEuropean Commission Joint Research Centre); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) (grant numbers 22360192, 25289172, 24254003 and 25303020), the Ministry of Land, Infrastructure and Transport Japan (grant number 07052442), and the European Commission (grant number 237026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JK, 2008, MOL ECOL, V17, P1597, DOI 10.1111/j.1365-294X.2007.03641.x; Ackermann M, 2004, EVOLUTION, V58, P2599; Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Andres JA, 2000, EVOLUTION, V54, P2156, DOI 10.1111/j.0014-3820.2000.tb01258.x; Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253; ANTONOVICS J, 1976, ANN MO BOT GARD, V63, P224, DOI 10.2307/2395303; AOYA K, 1987, Japanese Journal of Limnology, V48, P41; Barton NH, 1999, GENET RES, V74, P223, DOI 10.1017/S001667239900422X; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2006, MOL BIOL EVOL, V23, P773, DOI 10.1093/molbev/msj087; Brittain J.E., 2003, ENCY INSECTS, P373; Caballero A, 2008, GENETICS, V179, P539, DOI 10.1534/genetics.107.083246; Carneiro M, 2011, MOL BIOL EVOL, V28, P1801, DOI 10.1093/molbev/msr003; COOK LM, 1992, HEREDITY, V69, P184, DOI 10.1038/hdy.1992.112; Counterman BA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000796; Cousyn C, 2001, P NATL ACAD SCI USA, V98, P6256, DOI 10.1073/pnas.111606798; Cox K, 2011, MOL ECOL, V20, P2724, DOI 10.1111/j.1365-294X.2011.05137.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fischer MC, 2011, MOL ECOL, V20, P1450, DOI 10.1111/j.1365-294X.2011.05015.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Frichot E, 2013, MOL BIOL EVOL, V30, P1687, DOI 10.1093/molbev/mst063; Gillespie RG, 1998, EVOLUTION, V52, P775, DOI [10.2307/2411271, 10.1111/j.1558-5646.1998.tb03701.x]; HALDANE JBS, 1956, PROC R SOC SER B-BIO, V145, P306, DOI 10.1098/rspb.1956.0039; Hauer F. R., 1996, METHODS STREAM ECOLO; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; Hendry AP, 2009, CAN J FISH AQUAT SCI, V66, P1383, DOI 10.1139/F09-074; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hughes JM, 2007, FRESHWATER BIOL, V52, P616, DOI 10.1111/j.1365-2427.2006.01722.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Li YF, 2008, EVOLUTION, V62, P2984, DOI 10.1111/j.1558-5646.2008.00486.x; Lynch M., 1998, GENETICS ANAL QUANTI; Manly BFJ, 1997, RANDOMIZATION BOOTST; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Narum SR, 2010, MOL ECOL, V19, P4622, DOI 10.1111/j.1365-294X.2010.04839.x; NEI M, 1975, GENETICS, V80, P395; Nosil P, 2005, EVOLUTION, V59, P705; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Poisot T, 2011, ECOL LETT, V14, P841, DOI 10.1111/j.1461-0248.2011.01645.x; Raufaste N, 2001, EVOLUTION, V55, P1703, DOI 10.1111/j.0014-3820.2001.tb00689.x; ROBERTSON A, 1975, GENETICS, V80, P396; Saint-Laurent R, 2003, MOL ECOL, V12, P315, DOI 10.1046/j.1365-294X.2003.01735.x; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Spichtig M, 2004, AM NAT, V164, P70, DOI 10.1086/421335; Tollenaere C, 2011, MOL ECOL, V20, P1026, DOI 10.1111/j.1365-294X.2010.04633.x; Van Strien MJ, 2012, MOL ECOL, V21, P4010, DOI 10.1111/j.1365-294X.2012.05687.x; Van VALEN LEIGH, 1965, AMER NATUR, V99, P377, DOI 10.1086/282379; VEKEMANS X, 2002, AFLP SURV VERSION 1; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Ward JV, 1992, AQUATIC INSECT ECOLO; Watanabe K, 2008, SCI TOTAL ENVIRON, V394, P57, DOI 10.1016/j.scitotenv.2008.01.006; Watanabe K, 2010, AQUAT CONSERV, V20, P574, DOI 10.1002/aqc.1124; Wilcock HR, 2007, FRESHWATER BIOL, V52, P1907, DOI 10.1111/j.1365-2427.2007.01818.x; Wong A, 2003, MOL ECOL, V12, P3505, DOI 10.1046/j.1365-294X.2003.02002.x; Yang RC, 2004, EVOLUTION, V58, P1839; Yeaman S, 2006, P ROY SOC B-BIOL SCI, V273, P1587, DOI 10.1098/rspb.2006.3498; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	70	20	20	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93055	10.1371/journal.pone.0093055	http://dx.doi.org/10.1371/journal.pone.0093055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681871	gold, Green Published, Green Submitted			2022-12-25	WOS:000333678100022
J	Grepin, R; Ambrosetti, D; Marsaud, A; Gastaud, L; Amiel, J; Pedeutour, F; Pages, G				Grepin, Renaud; Ambrosetti, Damien; Marsaud, Alexandre; Gastaud, Lauris; Amiel, Jean; Pedeutour, Florence; Pages, Gilles			The Relevance of Testing the Efficacy of Anti-Angiogenesis Treatments on Cells Derived from Primary Tumors: A New Method for the Personalized Treatment of Renal Cell Carcinoma	PLOS ONE			English	Article							CLEAR-CELL; TFE3 GENE; ANTITUMOR-ACTIVITY; GROWTH-FACTOR; C-MET; SORAFENIB; SUNITINIB; CANCER; FUSION; INHIBITION	Despite the numerous available drugs, the most appropriate treatments for patients affected by common or rare renal cell carcinomas (RCC), like those associated with the Xp11.2 translocation/transcription factor for immunoglobulin heavy-chain enhancer 3 (TFE3) gene fusion (TFE3 RCC), are not clearly defined. We aimed to make a parallel between the sensitivity to targeted therapies on living patients and on cells derived from the initial tumor. Three patients diagnosed with a metastatic RCC (one clear cell RCC [ccRCC], two TFE3 RCC) were treated with anti-angiogenesis drugs. The concentrations of the different drugs giving 50% inhibition of cell proliferation (IC50) were determined with the Thiazolyl Blue Tetrazolium Bromide (MTT) assay on cells from the primary tumors and a reference sensitive RCC cell line (786-O). We considered the cells to be sensitive if the IC50 was lower or equal to that in 786-O cells, and insensitive if the IC50 was higher to that in 786-O cells (IC 50 of 6 +/- 1 mu M for sunitinib, 10 +/- 1 mu M for everolimus and 661 mM for sorafenib). Based on this standard, the response in patients and in cells was equivalent. The efficacy of anti-angiogenesis therapies was also tested in cells obtained from five patients with non-metastatic ccRCC, and untreated as recommended by clinical practice in order to determine the best treatment in case of progression toward a metastatic grade. In vitro experiments may represent a method for evaluating the best first-line treatment for personalized management of ccRCC during the period following surgery.	[Grepin, Renaud] Univ Nice Sophia Antipolis, Principal Monaco, Ctr Sci Monaco, Biomed Res Unit, F-06189 Nice, France; [Ambrosetti, Damien] Univ Nice Sophia Antipolis, Nice Univ Hosp, IRCAN, UMR 7284,U1081, F-06189 Nice, France; [Marsaud, Alexandre] Univ Nice Sophia Antipolis, Dept Urol, Nice Univ Hosp, IRCAN UMR U1081 7284, F-06189 Nice, France; [Gastaud, Lauris] Ctr Antoine Lacassagne, Dept Med Oncol, F-06054 Nice, France; [Amiel, Jean] Univ Nice Sophia Antipolis, Dept Urol, Nice Univ Hosp, F-06189 Nice, France; [Pedeutour, Florence] Univ Nice Sophia Antipolis, Lab Solid Tumors Genet, Nice Univ Hosp, IRCAN,UMR U1081 7284, F-06189 Nice, France; [Pages, Gilles] Univ Nice Sophia Antipolis, IRCAN, UMR 7284, U1081, F-06189 Nice, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur	Pages, G (corresponding author), Univ Nice Sophia Antipolis, IRCAN, UMR 7284, U1081, F-06189 Nice, France.	gpages@unice.fr	Pages, Gilles/N-7135-2017; Ambrosetti, Damien/E-2131-2015	Ambrosetti, Damien/0000-0001-8665-0546	Institut National pour la Sante et la Recherche Medicale; Centre National de la Recherche Scientifique; Centre Scientifique de Monaco; National Institute of Cancer; Association for Cancer Research; Fondation de France; Fondation pour la Recherche Medicale; The "Association pour la Recherche sur les Tumeurs du Rein"	Institut National pour la Sante et la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Centre Scientifique de Monaco; National Institute of Cancer; Association for Cancer Research; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); The "Association pour la Recherche sur les Tumeurs du Rein"	This work was supported by institutional national fundings for research ("the Institut National pour la Sante et la Recherche Medicale", the "Centre National de la Recherche Scientifique", the "Centre Scientifique de Monaco", the National Institute of Cancer) and charities (the Association for Cancer Research, the "Fondation de France", the "Fondation pour la Recherche Medicale", The "Association pour la Recherche sur les Tumeurs du Rein"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argani P, 2003, AM J SURG PATHOL, V27, P750, DOI 10.1097/00000478-200306000-00005; Armah HB, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-15; AUERBACH R, 1978, CANCER RES, V38, P1739; Bockorny B, 2013, EXPERT OPIN BIOL TH, V13, P911, DOI 10.1517/14712598.2013.778970; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Burel-Vandenbos F, 2011, J NEURO-ONCOL, V102, P171, DOI 10.1007/s11060-010-0308-4; Cao Y, 2013, CANCER RES, V73, P4579, DOI 10.1158/0008-5472.CAN-13-0529; Cao Y, 2012, CANCER RES, V72, P3912, DOI 10.1158/0008-5472.CAN-11-4058; Choueiri TK, 2012, EUR UROL, V62, P917, DOI 10.1016/j.eururo.2012.05.051; Clark J, 1997, ONCOGENE, V15, P2233, DOI 10.1038/sj.onc.1201394; Davis IJ, 2010, CANCER RES, V70, P639, DOI 10.1158/0008-5472.CAN-09-1121; Escudier B, 2010, J CLIN ONCOL, V28, P2144, DOI 10.1200/JCO.2009.26.7849; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Giangrande PH, 2003, MOL CELL BIOL, V23, P3707, DOI 10.1128/MCB.23.11.3707-3720.2003; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Gotink KJ, 2011, CLIN CANCER RES, V17, P7337, DOI 10.1158/1078-0432.CCR-11-1667; Grepin R, 2012, ONCOGENE, V31, P1683, DOI 10.1038/onc.2011.360; Grepin R, 2013, CANC RES IN PRESS; Hammers HJ, 2010, MOL CANCER THER, V9, P1525, DOI 10.1158/1535-7163.MCT-09-1106; Heimann P, 2001, CANCER RES, V61, P4130; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Kanellis J, 2000, AM J PHYSIOL-RENAL, V278, pF905, DOI 10.1152/ajprenal.2000.278.6.F905; Karam JA, 2011, EUR UROL, V59, P619, DOI 10.1016/j.eururo.2010.11.043; Kuroda N, 2012, HISTOL HISTOPATHOL, V27, P133, DOI 10.14670/HH-27.133; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malouf GG, 2010, ANN ONCOL, V21, P1834, DOI 10.1093/annonc/mdq029; McDermott DF, 2013, SEMIN ONCOL, V40, P492, DOI 10.1053/j.seminoncol.2013.05.008; Medendorp K, 2009, EXP CELL RES, V315, P2399, DOI 10.1016/j.yexcr.2009.04.022; Mestas J, 2005, J IMMUNOL, V175, P5351, DOI 10.4049/jimmunol.175.8.5351; Motzer RJ, 2013, J CLIN ONCOL, V31, P3791, DOI 10.1200/JCO.2012.47.4940; Motzer RJ, 2013, NEW ENGL J MED, V369, P722, DOI 10.1056/NEJMoa1303989; Motzer RJ, 2013, LANCET ONCOL, V14, P552, DOI 10.1016/S1470-2045(13)70093-7; Muller-Hocker J, 2008, PATHOL RES PRACT, V204, P589, DOI 10.1016/j.prp.2008.01.010; Pal SK, 2012, MOL CANCER THER, V11, P526, DOI 10.1158/1535-7163.MCT-11-0806; Ravaud A, 2011, ONCOLOGIST, V16, P32, DOI 10.1634/theoncologist.2011-S2-32; Riesterer O, 2004, ONCOGENE, V23, P4624, DOI 10.1038/sj.onc.1207596; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Ross H, 2012, ARCH PATHOL LAB MED, V136, P391, DOI 10.5858/arpa.2011-0479-RA; Sennino B, 2012, CANCER DISCOV, V2, P270, DOI 10.1158/2159-8290.CD-11-0240; Shiota M, 2010, INT J ONCOL, V37, P509, DOI 10.3892/ijo_00000700; Shiota M, 2010, INT J ONCOL, V36, P1521, DOI 10.3892/ijo_00000639; Sidhar SK, 1996, HUM MOL GENET, V5, P1333, DOI 10.1093/hmg/5.9.1333; Sivanand S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003643; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wang B, 2006, CANCER RES, V66, P3071, DOI 10.1158/0008-5472.CAN-05-2871; Weterman MAJ, 2001, P NATL ACAD SCI USA, V98, P13808, DOI 10.1073/pnas.241304198; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yu K, 2010, CANCER RES, V70, P621, DOI 10.1158/0008-5472.CAN-09-2340; Zhang LB, 2009, NEOPLASIA, V11, P426, DOI 10.1593/neo.09166	52	18	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e89449	10.1371/journal.pone.0089449	http://dx.doi.org/10.1371/journal.pone.0089449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676409	gold, Green Submitted, Green Published			2022-12-25	WOS:000333677500004
J	Liu, ZF; Li, XR; Sun, N; Xu, Y; Meng, YQ; Yang, CX; Wang, YF; Zhang, KR				Liu, Zhifen; Li, Xinrong; Sun, Ning; Xu, Yong; Meng, Yaqin; Yang, Chunxia; Wang, Yanfang; Zhang, Kerang			Microarray Profiling and Co-Expression Network Analysis of Circulating IncRNAs and mRNAs Associated with Major Depressive Disorder	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LONG NONCODING RNAS; GENE-EXPRESSION; PREFRONTAL CORTEX; BIOLOGY; SUSCEPTIBILITY; MECHANISMS; BEHAVIOR; DISEASE; STRESS	LncRNAs, which represent one of the most highly expressed classes of ncRNAs in the brain, are becoming increasingly interesting with regard to brain functions and disorders. However, changes in the expression of regulatory IncRNAs in Major Depressive Disorder (MDD) have not yet been reported. Using microarrays, we profiled the expression of 34834 IncRNAs and 39224 mRNAs in peripheral blood sampled from MDD patients as well as demographically-matched controls. Among these, we found that 2007 IncRNAs and 1667 mRNAs were differentially expressed, 17 of which were documented as depression-related gene in previous studies. Gene Ontology (GO) and pathway analyses indicated that the biological functions of differentially expressed mRNAs were related to fundamental metabolic processes and neurodevelopment diseases. To investigate the potential regulatory roles of the differentially expressed IncRNAs on the mRNAs, we also constructed co-expression networks composed of the IncRNAs and mRNAs, which shows significant correlated patterns of expression. In the MDD-derived network, there were a greater number of nodes and connections than that in the control-derived network. The IncRNAs located at chr10:874695-874794, chr10:75873456-75873642, and chr3:47048304-47048512 may be important factors regulating the expression of mRNAs as they have previously been reported associations with MDD. This study is the first to explore genome-wide IncRNA expression and co-expression with mRNA patterns in MDD using microarray technology. We identified circulating IncRNAs that are aberrantly expressed in MDD and the results suggest that IncRNAs may contribute to the molecular pathogenesis of MDD.	[Liu, Zhifen; Li, Xinrong; Sun, Ning; Xu, Yong; Meng, Yaqin; Yang, Chunxia; Wang, Yanfang; Zhang, Kerang] Shanxi Med Univ, Hosp 1, Dept Psychiat, Taiyuan, Peoples R China	Shanxi Medical University	Zhang, KR (corresponding author), Shanxi Med Univ, Hosp 1, Dept Psychiat, Taiyuan, Peoples R China.	krangzhang_sxmu@vip.163.com	Sun, Ning/AAO-9421-2021	Sun, Ning/0000-0003-3844-2632	National Natural Science Foundation of China [30770770, 30971054, 81171290]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the National Natural Science Foundation of China. (Nos. 30770770, 30971054, and 81171290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge MS, 2007, CURR OPIN PHARMACOL, V7, P8, DOI 10.1016/j.coph.2006.11.006; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barry G, 2013, MOL PSYCHIATR, P1; Bhartiya D, 2012, EXPERT OPIN DRUG DIS, V7, P503, DOI 10.1517/17460441.2012.682055; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Dong C, 2009, MOL PSYCHIATR, V14, P1105, DOI 10.1038/mp.2009.92; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Enache D, 2011, CURR OPIN PSYCHIATR, V24, P461, DOI 10.1097/YCO.0b013e32834bb9d4; FIRST MB, 1995, J PERS DISORD, V9, P92, DOI 10.1521/pedi.1995.9.2.92; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Hauser SR, 2011, PHARMACOL BIOCHEM BE, V100, P253, DOI 10.1016/j.pbb.2011.08.014; Henningsen K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016428; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Lee GL, 2011, NAT REV UROL, V8, P123, DOI 10.1038/nrurol.2011.10; Lee PH, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.95; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Lewis CM, 2010, AM J PSYCHIAT, V167, P949, DOI 10.1176/appi.ajp.2010.09091380; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Lohoff FW, 2010, CURR PSYCHIAT REP, V12, P539, DOI 10.1007/s11920-010-0150-6; Lundh SH, 2013, HUM MOL GENET, V22, P3485, DOI 10.1093/hmg/ddt203; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Marsh L, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0409-5; Mehta D, 2010, CURR PSYCHIAT REP, V12, P135, DOI 10.1007/s11920-010-0100-3; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Mostafavi S., 2013, MOL PSYCHIAT; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Ng SY, 2013, TRENDS GENET, V29, P461, DOI 10.1016/j.tig.2013.03.002; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Sanchez Y, 2013, NUCLEIC ACID THER, V23, P15, DOI 10.1089/nat.2012.0414; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Schroeder M, 2012, CLIN PHARMACOL THER, V91, P310, DOI 10.1038/clpt.2011.282; Segman RH, 2010, MOL PSYCHIATR, V15, P93, DOI 10.1038/mp.2009.65; Seifuddin F, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-213; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Shyn SI, 2011, MOL PSYCHIATR, V16, P202, DOI 10.1038/mp.2009.125; Spadaro Paola A., 2012, Frontiers in Genetics, V3, P132, DOI 10.3389/fgene.2012.00132; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Teyssier JR, 2011, PSYCHIAT RES, V186, P244, DOI 10.1016/j.psychres.2010.07.030; Tiwary BK, 2012, INTEGR BIOL-UK, V4, P1096, DOI 10.1039/c2ib20066j; Tordera RM, 2011, EUR NEUROPSYCHOPHARM, V21, P23, DOI 10.1016/j.euroneuro.2010.06.016; Tsuang MT, 2004, J PSYCHIATR RES, V38, P3, DOI 10.1016/S0022-3956(03)00096-7; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vialou V, 2013, ANNU REV PHARMACOL, V53, P59, DOI 10.1146/annurev-pharmtox-010611-134540; Williams JM, 2009, AM J MED GENET A, V149A, P1758, DOI 10.1002/ajmg.a.32941; Wong ML, 2008, MOL PSYCHIATR, V13, P800, DOI 10.1038/mp.2008.59; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Wuwongse S, 2013, BBA-MOL BASIS DIS, V1832, P2245, DOI 10.1016/j.bbadis.2013.07.022; Xu WH, 2011, P NATL ACAD SCI USA, V108, P3707, DOI 10.1073/pnas.1019753108; Yamada S, 2003, J NEURAL TRANSM, V110, P671, DOI 10.1007/s00702-002-0810-8; Yi M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-30; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	62	82	89	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93388	10.1371/journal.pone.0093388	http://dx.doi.org/10.1371/journal.pone.0093388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676134	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677500118
J	Skaaby, T; Husemoen, LLN; Ahluwalia, TS; Rossing, P; Jorgensen, T; Thuesen, BH; Pisinger, C; Rasmussen, K; Linneberg, A				Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Ahluwalia, Tarunveer Singh; Rossing, Peter; Jorgensen, Torben; Thuesen, Betina Heinsbaek; Pisinger, Charlotta; Rasmussen, Knud; Linneberg, Allan			Cause-Specific Mortality According to Urine Albumin Creatinine Ratio in the General Population	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; BRAIN NATRIURETIC PEPTIDE; KIDNEY-DISEASE MEASURES; STAGE RENAL-DISEASE; COLLABORATIVE METAANALYSIS; SPOT URINE; MICROALBUMINURIA; RISK; ASSOCIATIONS; INDIVIDUALS	Background: Urine albumin creatinine ratio, UACR, is positively associated with all-cause mortality, cardiovascular disease and diabetes in observational studies. Whether a high UACR is also associated with other causes of death is unclear. We investigated the association between UACR and cause-specific mortality. Methods: We included a total of 9,125 individuals from two population-based studies, Monica10 and Inter99, conducted in 1993-94 and 1999-2001, respectively. Urine albumin creatinine ratio was measured from spot urine samples by standard methods. Information on causes of death was obtained from The Danish Register of Causes of Death until 31 December 2010. There were a total of 920 deaths, and the median follow-up was 11.3 years. Results: Multivariable Cox regression analyses with age as underlying time axis showed statistically significant positive associations between UACR status and risk of all-cause mortality, endocrine nutritional and metabolic diseases, mental and behavioural disorders, diseases of the circulatory system, and diseases of the respiratory system with hazard ratios 1.56, 6.98, 2.34, 2.03, and 1.91, for the fourth UACR compared with the first, respectively. Using UACR as a continuous variable, we also found a statistically significant positive association with risk of death caused by diseases of the digestive system with a hazard ratio of 1.02 per 10 mg/g higher UACR. Conclusion: We found statistically significant positive associations between baseline UACR and death from all-cause mortality, endocrine nutritional and metabolic diseases, and diseases of the circulatory system and possibly mental and behavioural disorders, and diseases of the respiratory and digestive system.	[Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Jorgensen, Torben; Thuesen, Betina Heinsbaek; Pisinger, Charlotta; Linneberg, Allan] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Ahluwalia, Tarunveer Singh] Univ Copenhagen, Sect Metab Genet, Copenhagen, Denmark; [Rossing, Peter] Steno Diabet Ctr, Gentofte, Denmark; [Rossing, Peter] Univ Copenhagen, Copenhagen, Denmark; [Rossing, Peter] Univ Aarhus, Aarhus, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, Aalborg, Denmark; [Rasmussen, Knud] Roskilde Univ Hosp, Dept Med, Roskilde, Denmark; [Linneberg, Allan] Glostrup Univ Hosp, Dept Clin Expt Res, Glostrup, Denmark; [Linneberg, Allan] Univ Copenhagen, Dept Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Steno Diabetes Center; University of Copenhagen; Aarhus University; University of Copenhagen; Aalborg University; University of Copenhagen; University of Copenhagen	Skaaby, T (corresponding author), Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark.	tea.skaaby.01@regionh.dk	Jørgensen, Torben/Z-1335-2018; rossing, peter/AAZ-3415-2021; rossing, peter/AAH-7879-2021; Ahluwalia, Tarunveer Singh/C-5549-2009	rossing, peter/0000-0002-1531-4294; Ahluwalia, Tarunveer Singh/0000-0002-7464-3354; Linneberg, Allan/0000-0002-0994-0184; Jorgensen, Torben/0000-0001-9453-2830; Pisinger, Charlotta/0000-0002-7970-3168; Skaaby, Tea/0000-0003-0031-5726; Thuesen, Betina/0000-0001-9772-4344				Aadahl M, 2009, PREV MED, V48, P326, DOI 10.1016/j.ypmed.2009.01.015; Aguilar MI, 2010, NEUROLOGY, V75, P1343, DOI 10.1212/WNL.0b013e3181f73638; Ambye L, 2005, DIABETES RES CLIN PR, V67, P175, DOI 10.1016/j.diabres.2004.06.013; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Babazono T, 2004, DIABETES CARE, V27, P1838, DOI 10.2337/diacare.27.7.1838; Bulcun E, 2013, COPD, V10, P186, DOI 10.3109/15412555.2012.735292; Casanova C, 2010, AM J RESP CRIT CARE, V182, P1004, DOI 10.1164/rccm.201003-0360OC; Cox AJ, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-68; de Borst MH, 2013, J AM SOC NEPHROL; de Zeeuw D, 2004, CIRCULATION, V110, P921, DOI 10.1161/01.CIR.0000139860.33974.28; Drivsholm T, 2001, DIABETIC MED, V18, P126, DOI 10.1046/j.1464-5491.2001.00417.x; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Fried L, 2012, CLIN J AM SOC NEPHRO, V7, P376, DOI 10.2215/CJN.00210112; Friedrich N, 2012, DIABETES CARE, V35, P768, DOI 10.2337/dc11-1833; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Han TZ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/320560; Ibsen H, 2008, J NEPHROL, V21, P566; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Juel K, 1999, DAN MED BULL, V46, P354; Kovesdy CP, 2013, J AM COLL CARDIOL, V61, P1626, DOI 10.1016/j.jacc.2012.11.071; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Martin Helen, 2011, Clin Biochem Rev, V32, P97; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Menne J, 2012, J HYPERTENS, V30, P811, DOI 10.1097/HJH.0b013e328351856d; Olsen MH, 2005, HYPERTENSION, V46, P660, DOI 10.1161/01.HYP.0000179575.13739.72; Olsen MH, 2007, EUR HEART J, V28, P1374, DOI 10.1093/eurheartj/ehl448; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Ruggenenti P, 2012, J AM SOC NEPHROL; Sajjad I, 2012, CLIN J AM SOC NEPHRO, V7, P437, DOI 10.2215/CJN.05330611; Selvin E, 2013, AM J KIDNEY DIS, V61, P716, DOI 10.1053/j.ajkd.2012.11.048; Thyssen JP, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000062; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Wang CCL, 2012, AM J CARDIOL, V110, p58B, DOI 10.1016/j.amjcard.2012.08.036; Witte EC, 2009, J AM SOC NEPHROL, V20, P436, DOI 10.1681/ASN.2008030292	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93212	10.1371/journal.pone.0093212	http://dx.doi.org/10.1371/journal.pone.0093212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675825	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500092
J	Zhang, KS; Liu, YJ; Kong, HJ; Cheng, WW; Shang, YJ; Tian, H; Zheng, HX; Guo, JH; Liu, XT				Zhang, Ke-Shan; Liu, Yong-Jie; Kong, Han-Jin; Cheng, Wei-Wei; Shang, You-Jun; Tian, Hong; Zheng, Hai-Xue; Guo, Jian-Hong; Liu, Xian-Tao			Identification and Analysis of Differential miRNAs in PK-15 Cells after Foot-and-Mouth Disease Virus Infection	PLOS ONE			English	Article							CELLULAR MICRORNAS; SMALL RNAS; BIOGENESIS; SUPPRESSES; EXPRESSION; GENOMICS; REVEALS; PCR	The alterations of MicroRNAs(miRNAs) in host cell after foot-and-mouth disease virus (FMDV) infection is still obscure. To increase our understanding of the pathogenesis of FMDV at the post-transcriptional regulation level, Solexa high-throu MicroRNAs (miRNAs) play an important role both in the post-transcriptional regulation of gene expression and host-virus interactions. Despite investigations of miRNA expression ghput sequencing and bioinformatic tools were used to identify differentially expressed miRNAs and analyze their functions during FMDV infection of PK-15cells. Results indicated that 9,165,674 and 9,230,378 clean reads were obtained, with 172 known and 72 novel miRNAs differently expressed in infected and uninfected groups respectively. Some of differently expressed miRNAs were validated using stem-loop real-time quantitative RT-PCR. The GO annotation and KEGG pathway analysis for target genes revealed that differently expressed miRNAs were involved in immune response and cell death pathways.	[Zhang, Ke-Shan; Liu, Yong-Jie; Kong, Han-Jin; Cheng, Wei-Wei; Shang, You-Jun; Tian, Hong; Zheng, Hai-Xue; Guo, Jian-Hong; Liu, Xian-Tao] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Liu, XT (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China.	hnxiangtao@hotmail.com		zheng, hai xue/0000-0001-6850-1379	The National Natural Science Foundation of China [31201914]; China Postdoctoral Science Foundation [2013M530683]; China Agriculture Research System [CARS-39]	The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); China Agriculture Research System	This work was supported by The National Natural Science Foundation of China (Grant No. 31201914), China Postdoctoral Science Foundation (2013M530683), and China Agriculture Research System (CARS-39). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boss IW, 2009, TRENDS MICROBIOL, V17, P544, DOI 10.1016/j.tim.2009.09.002; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davies G, 2002, RES VET SCI, V73, P195, DOI 10.1016/S0034-5288(02)00105-4; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Grinberg M, 2012, ARCH VIROL, V157, P1719, DOI 10.1007/s00705-012-1366-z; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Ho BC, 2011, CELL HOST MICROBE, V9, P58, DOI 10.1016/j.chom.2010.12.001; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Inoue Kunio, 2007, Tanpakushitsu Kakusan Koso, V52, P197; Ji ZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049463; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lerner M, 2011, CELL CYCLE, V10, P2172, DOI 10.4161/cc.10.13.16248; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li Y, 2010, J VIROL, V84, P3023, DOI 10.1128/JVI.02203-09; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Mahajan VS, 2009, TRENDS IMMUNOL, V30, P1, DOI 10.1016/j.it.2008.08.009; Matskevich AA, 2007, J GEN VIROL, V88, P2627, DOI 10.1099/vir.0.83103-0; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Reese TA, 2010, J VIROL, V84, P10344, DOI 10.1128/JVI.00707-10; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sellers R, 2008, VET J, V177, P159, DOI 10.1016/j.tvjl.2007.03.009; Singh CP, 2012, J VIROL, V86, P7867, DOI 10.1128/JVI.00064-12; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sung TL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000263; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Wu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030988; Ye L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043741; Zhang R, 2008, NUCLEIC ACIDS RES, V36, P4621, DOI 10.1093/nar/gkn431; Zheng ZH, 2013, J VIROL, V87, P5645, DOI 10.1128/JVI.02655-12; Zhou Y, 2013, REPROD DOMEST ANIM, V48, P112, DOI 10.1111/j.1439-0531.2012.02040.x; Zuker M, 1998, RNA, V4, P669, DOI 10.1017/S1355838298980116; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	52	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e90865	10.1371/journal.pone.0090865	http://dx.doi.org/10.1371/journal.pone.0090865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675746	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500010
J	Britton, D; Zen, Y; Quaglia, A; Selzer, S; Mitra, V; Lossner, C; Jung, S; Bohm, G; Schmid, P; Prefot, P; Hoehle, C; Koncarevic, S; Gee, J; Nicholson, R; Ward, M; Castellano, L; Stebbing, J; Zucht, HD; Sarker, D; Heaton, N; Pike, I				Britton, David; Zen, Yoh; Quaglia, Alberto; Selzer, Stefan; Mitra, Vikram; Loessner, Christopher; Jung, Stephan; Boehm, Gitte; Schmid, Peter; Prefot, Petra; Hoehle, Claudia; Koncarevic, Sasa; Gee, Julia; Nicholson, Robert; Ward, Malcolm; Castellano, Leandro; Stebbing, Justin; Zucht, Hans Dieter; Sarker, Debashis; Heaton, Nigel; Pike, Ian			Quantification of Pancreatic Cancer Proteome and Phosphorylome: Indicates Molecular Events Likely Contributing to Cancer and Activity of Drug Targets	PLOS ONE			English	Article							CELL-MIGRATION; TYROSINE PHOSPHORYLATION; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; BETA-CATENIN; KINASE; EXPRESSION; GENE; GROWTH; DOMAIN	Objective: LC-MS/MS phospho-proteomics is an essential technology to help unravel the complex molecular events that lead to and propagate cancer. We have developed a global phospho-proteomic workflow to determine activity of signaling pathways and drug targets in pancreatic cancer tissue for clinical application. Methods: Peptides resulting from tryptic digestion of proteins extracted from frozen tissue of pancreatic ductal adenocarcinoma and background pancreas (n = 12), were labelled with tandem mass tags (TMT 8-plex), separated by strong cation exchange chromatography, then were analysed by LC-MS/MS directly or first enriched for phosphopeptides using IMAC and TiO2, prior to analysis. In-house, commercial and freeware bioinformatic platforms were used to identify relevant biological events from the complex dataset. Results: Of 2,101 proteins identified, 152 demonstrated significant difference in abundance between tumor and non-tumor tissue. They included proteins that are known to be up-regulated in pancreatic cancer (e.g. Mucin-1), but the majority were new candidate markers such as HIPK1 & MLCK. Of the 6,543 unique phosphopeptides identified (6,284 unique phosphorylation sites), 635 showed significant regulation, particularly those from proteins involved in cell migration (Rho guanine nucleotide exchange factors & MRCK alpha) and formation of focal adhesions. Activator phosphorylation sites on FYN, AKT1, ERK2, HDAC1 and other drug targets were found to be highly modulated (>= 2 fold) in different cases highlighting their predictive power. Conclusion: Here we provided critical information enabling us to identify the common and unique molecular events likely contributing to cancer in each case. Such information may be used to help predict more bespoke therapy suitable for an individual case.	[Britton, David; Selzer, Stefan; Mitra, Vikram; Loessner, Christopher; Jung, Stephan; Boehm, Gitte; Schmid, Peter; Prefot, Petra; Hoehle, Claudia; Koncarevic, Sasa; Ward, Malcolm; Zucht, Hans Dieter; Pike, Ian] Proteome Sci Plc, Cobham, England; [Zen, Yoh; Quaglia, Alberto; Sarker, Debashis; Heaton, Nigel] Kings Coll Hosp London, Inst Liver Studies, London SE5 8RX, England; [Castellano, Leandro; Stebbing, Justin] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, London, England; [Gee, Julia; Nicholson, Robert] Cardiff Univ, Cardiff Sch Pharm & Pharmaceut Sci, Cardiff CF10 3AX, S Glam, Wales	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Imperial College London; Cardiff University	Britton, D (corresponding author), Proteome Sci Plc, Cobham, England.	david.britton@proteomics.com	Heaton, Nigel/AAK-8363-2020; Castellano, Leandro/AAE-1366-2021; Gee, Julia MW/N-3995-2014	Gee, Julia MW/0000-0001-6483-2015; Stebbing, Justin/0000-0002-1117-6947; Ward, Malcolm/0000-0003-2164-6938; Pike, Ian/0000-0002-3071-0041; Castellano, Leandro/0000-0002-3059-4829; Sarker, Debashis/0000-0003-4814-8429	Institute of Liver Studies, King's College Hospital; Proteome Sciences plc; Cancer Research UK [14549, 16057] Funding Source: researchfish; Medical Research Council [MR/J006742/1] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-053] Funding Source: researchfish	Institute of Liver Studies, King's College Hospital; Proteome Sciences plc; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	All works carried out in this study were jointly funded by Institute of Liver Studies, King's College Hospital and Proteome Sciences plc. The funders employed the scientists and clinicians who played key roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Berber S, 2013, DEV DYNAM, V242, P1250, DOI 10.1002/dvdy.24023; Bond-Smith G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2476; Bononi A, 2011, ENZYME RES, V2011, DOI [10.4061/2011/329098, DOI 10.4061/2011/329098]; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cook D. R., 2013, ONCOGENE IN PRESS; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; di Magliano MP, 2013, GASTROENTEROLOGY, V144, P1220, DOI 10.1053/j.gastro.2013.01.071; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Engholm-Keller K, 2013, PROTEOMICS, V13, P910, DOI 10.1002/pmic.201200484; Fu L, 2007, CANCER-AM CANCER SOC, V110, P2672, DOI 10.1002/cncr.23110; Germain EC, 2009, MOL BIOL CELL, V20, P56, DOI 10.1091/mbc.E08-06-0646; Goicoechea SM, 2009, ONCOGENE, V28, P587, DOI 10.1038/onc.2008.408; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Hirasawa Y, 2006, ONCOLOGY-BASEL, V71, P77, DOI 10.1159/000100475; Iden S, 2012, J CELL BIOL, V196, P623, DOI 10.1083/jcb.201104143; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Jung CR, 2010, J CLIN INVEST, V120, P4493, DOI 10.1172/JCI42674; Kelly KA, 2008, PLOS MED, V5, P657, DOI 10.1371/journal.pmed.0050085; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; Kondo S, 2003, P NATL ACAD SCI USA, V100, P5431, DOI 10.1073/pnas.0530308100; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Langer T, 2004, CHEMBIOCHEM, V5, P1508, DOI 10.1002/cbic.200400129; Lee D, 2012, EMBO REP, V13, P163, DOI 10.1038/embor.2011.235; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Mayanagi T, 2008, J BIOL CHEM, V283, P31183, DOI 10.1074/jbc.M801606200; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; Michl P, 2013, GUT, V62, P317, DOI 10.1136/gutjnl-2012-303588; Miyasaka KY, 2007, P NATL ACAD SCI USA, V104, P11274, DOI 10.1073/pnas.0702000104; Morohashi Y, 2010, BIOCHEM J, V427, P401, DOI 10.1042/BJ20091681; Ren J, 2002, J BIOL CHEM, V277, P17616, DOI 10.1074/jbc.M200436200; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rinaldo C, 2008, BBA-MOL CELL RES, V1783, P2124, DOI 10.1016/j.bbamcr.2008.06.006; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; Rivera AL, 2010, NEURO-ONCOLOGY, V12, P116, DOI 10.1093/neuonc/nop020; Schramek H, 1997, AM J PHYSIOL-CELL PH, V272, pC383, DOI 10.1152/ajpcell.1997.272.2.C383; Schwappacher R, 2013, J CELL SCI, V126, P1626, DOI 10.1242/jcs.118190; Shin DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007451; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; Wang H, 2010, J PROTEOME RES, V9, P1032, DOI 10.1021/pr900927y; Wei XL, 2007, CANCER RES, V67, P1853, DOI 10.1158/0008-5472.CAN-06-3063; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P95; Werner T, 2012, ANAL CHEM, V84, P7188, DOI 10.1021/ac301553x; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yeo MG, 2011, J CELL PHYSIOL, V226, P236, DOI 10.1002/jcp.22335; Yonezawa S, 2011, PATHOL INT, V61, P697, DOI 10.1111/j.1440-1827.2011.02734.x; Zhang J, 2007, J CLIN INVEST, V117, P2962, DOI 10.1172/JCI30710; Zhang YB, 2010, CANCER SCI, V101, P523, DOI 10.1111/j.1349-7006.2009.01424.x; Zhao LA, 2010, GUT, V59, P1226, DOI 10.1136/gut.2009.202739	54	38	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e90948	10.1371/journal.pone.0090948	http://dx.doi.org/10.1371/journal.pone.0090948			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670416	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000333677000014
J	Dulebohn, DP; Hayes, BM; Rosa, PA				Dulebohn, Daniel P.; Hayes, Beth M.; Rosa, Patricia A.			Global Repression of Host-Associated Genes of the Lyme Disease Spirochete through Post-Transcriptional Modulation of the Alternative Sigma Factor RpoS	PLOS ONE			English	Article							OUTER-SURFACE PROTEIN; BORRELIA-BURGDORFERI OSPC; ESCHERICHIA-COLI; STRESS-RESPONSE; REGULATORY PATHWAY; MAMMALIAN HOST; IMMUNE EVASION; MESSENGER-RNA; FACTOR RSSB; LIFE-CYCLE	Borrelia burgdorferi, the agent of Lyme disease, is a vector-borne pathogen that transits between Ixodes ticks and vertebrate hosts. During the natural infectious cycle, spirochetes must globally adjust their transcriptome to survive in these dissimilar environments. One way B. burgdorferi accomplishes this is through the use of alternative sigma factors to direct transcription of specific genes. RpoS, one of only three sigma factors in B. burgdorferi, controls expression of genes required during tick-transmission and infection of the mammalian host. How spirochetes switch between different sigma factors during the infectious cycle has remained elusive. Here we establish a role for a novel protein, BBD18, in the regulation of the virulence-associated sigma factor RpoS. Constitutive expression of BBD18 repressed transcription of RpoS-dependent genes to levels equivalent to those observed in an rpoS mutant. Consistent with the global loss of RpoS-dependent transcripts, we were unable to detect RpoS protein. However, constitutive expression of BBD18 did not diminish the amount of rpoS transcript, indicating post-transcriptional regulation of RpoS by BBD18. Interestingly, BBD18-mediated repression of RpoS is independent of both the rpoS promoter and the 5' untranslated region, suggesting a mechanism of protein destabilization rather than translational control. We propose that BBD18 is a novel regulator of RpoS and its activity likely represents a first step in the transition from an RpoS-ON to an RpoS-OFF state, when spirochetes transition from the host to the tick vector.	[Dulebohn, Daniel P.; Hayes, Beth M.; Rosa, Patricia A.] NIAID, Lab Zoonot Pathogens, Rocky Mt Labs, Div Intramural Res,NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Dulebohn, DP (corresponding author), NIAID, Lab Zoonot Pathogens, Rocky Mt Labs, Div Intramural Res,NIH, Hamilton, MT USA.	dulebohnd@niaid.nih.gov		Hayes, Beth/0000-0001-6633-751X	Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000917] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades SE, 2008, CURR OPIN MICROBIOL, V11, P535, DOI 10.1016/j.mib.2008.10.004; Akins DR, 1998, J CLIN INVEST, V101, P2240, DOI 10.1172/JCI2325; Archambault L, 2013, BIOCHEM BIOPH RES CO, V433, P73, DOI 10.1016/j.bbrc.2013.02.063; Baker CS, 2002, MOL MICROBIOL, V44, P1599, DOI 10.1046/j.1365-2958.2002.02982.x; BARBOUR AG, 1986, MICROBIOL REV, V50, P381, DOI 10.1128/MMBR.50.4.381-400.1986; BARBOUR AG, 1986, INFECT IMMUN, V52, P549, DOI 10.1128/IAI.52.2.549-554.1986; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Battisti JM, 2008, INFECT IMMUN, V76, P5228, DOI 10.1128/IAI.00410-08; Bestor A, 2012, INFECT IMMUN, V80, P3501, DOI 10.1128/IAI.00521-12; Blevins JS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-82; Bono JL, 2000, J BACTERIOL, V182, P2445, DOI 10.1128/JB.182.9.2445-2452.2000; Bourret TJ, 2011, MOL MICROBIOL, V81, P259, DOI 10.1111/j.1365-2958.2011.07691.x; Boylan JA, 2003, P NATL ACAD SCI USA, V100, P11684, DOI 10.1073/pnas.2032956100; Boylan JA, 2008, MOL MICROBIOL, V68, P786, DOI 10.1111/j.1365-2958.2008.06204.x; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Burtnick MN, 2007, MOL MICROBIOL, V65, P277, DOI 10.1111/j.1365-2958.2007.05813.x; Caimano MJ, 2011, INFECT IMMUN, V79, P3117, DOI 10.1128/IAI.05136-11; Caimano MJ, 2005, J BACTERIOL, V187, P7845, DOI 10.1128/JB.187.22.7845-7852.2005; Caimano MJ, 2004, INFECT IMMUN, V72, P6433, DOI 10.1128/IAI.72.11.6433-6445.2004; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; Casjens SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033280; Chen LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083276; Clifton DR, 2006, MOL MICROBIOL, V61, P243, DOI 10.1111/j.1365-2958.2006.05224.x; de Silva AM, 1998, J INFECT DIS, V177, P395, DOI 10.1086/514200; DeSilva AM, 1997, INFECT IMMUN, V65, P3146, DOI 10.1128/IAI.65.8.3146-3150.1997; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; Dong T, 2009, INFECT IMMUN, V77, P501, DOI 10.1128/IAI.00850-08; Drecktrah D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068799; Dulebohn DP, 2011, INFECT IMMUN, V79, P3510, DOI 10.1128/IAI.05014-11; Dunham-Ems SM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002532; Elias AF, 2000, J BACTERIOL, V182, P2909, DOI 10.1128/JB.182.10.2909-2918.2000; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Fischer JR, 2003, P NATL ACAD SCI USA, V100, P7307, DOI 10.1073/pnas.1231043100; Fisher MA, 2005, P NATL ACAD SCI USA, V102, P5162, DOI 10.1073/pnas.0408536102; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gilmore RD, 2007, INFECT IMMUN, V75, P2753, DOI 10.1128/IAI.00037-07; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Hayes BM, 2010, APPL ENVIRON MICROB, V76, P7407, DOI 10.1128/AEM.01389-10; He M, 2008, MOL MICROBIOL, V70, P1453, DOI 10.1111/j.1365-2958.2008.06491.x; Hengge R, 2009, RES MICROBIOL, V160, P667, DOI 10.1016/j.resmic.2009.08.014; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Karna SLR, 2011, INFECT IMMUN, V79, P732, DOI 10.1128/IAI.00882-10; Kawabata H, 2004, INFECT IMMUN, V72, P7147, DOI 10.1128/IAI.72.12.7147-7154.2004; Kobryn K, 2000, MOL MICROBIOL, V37, P145, DOI 10.1046/j.1365-2958.2000.01981.x; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; Lease RA, 2000, P NATL ACAD SCI USA, V97, P9919, DOI 10.1073/pnas.170281497; Lin T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047532; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Lybecker MC, 2010, MOL MICROBIOL, V78, P622, DOI 10.1111/j.1365-2958.2010.07374.x; MA Y, 1994, INFECT IMMUN, V62, P3663, DOI 10.1128/IAI.62.9.3663-3671.1994; MAGNARELLI LA, 1988, J CLIN MICROBIOL, V26, P1482, DOI 10.1128/JCM.26.8.1482-1486.1988; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; Manganelli R, 2004, J BACTERIOL, V186, P895, DOI 10.1128/JB.186.4.895-902.2004; Miller CL, 2013, MOL MICROBIOL, V88, P105, DOI 10.1111/mmi.12171; Montgomery RR, 2002, J INFECT DIS, V185, P1773, DOI 10.1086/340826; Mulay VB, 2009, J BACTERIOL, V191, P2783, DOI 10.1128/JB.01802-08; Ohnishi J, 2001, P NATL ACAD SCI USA, V98, P670, DOI 10.1073/pnas.98.2.670; Ojaimi C, 2003, INFECT IMMUN, V71, P1689, DOI 10.1128/IAI.71.4.1689-1705.2003; Osterberg S, 2011, ANNU REV MICROBIOL, V65, P37, DOI 10.1146/annurev.micro.112408.134219; Ouyang ZM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-44; Ouyang ZM, 2009, MOL MICROBIOL, V74, P1331, DOI 10.1111/j.1365-2958.2009.06945.x; Pappas CJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002102; Patton TG, 2013, INFECT IMMUN, V81, P2488, DOI 10.1128/IAI.00140-13; PIESMAN J, 1990, AM J TROP MED HYG, V42, P352, DOI 10.4269/ajtmh.1990.42.352; Pruteanu M, 2002, MOL MICROBIOL, V45, P1701, DOI 10.1046/j.1365-2958.2002.03123.x; Rego ROM, 2011, J BACTERIOL, V193, P1161, DOI 10.1128/JB.01176-10; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Rogers EA, 2009, MOL MICROBIOL, V71, P1551, DOI 10.1111/j.1365-2958.2009.06621.x; SADZIENE A, 1993, INFECT IMMUN, V61, P2192, DOI 10.1128/IAI.61.5.2192-2195.1993; Salman-Dilgimen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022168; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Sarkar A, 2011, J BACTERIOL, V193, P5365, DOI 10.1128/JB.01496-10; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Seshu J, 2004, MOL MICROBIOL, V54, P1352, DOI 10.1111/j.1365-2958.2004.04352.x; Shi YL, 2008, INFECT IMMUN, V76, P1239, DOI 10.1128/IAI.00897-07; Smith AH, 2007, J BACTERIOL, V189, P2139, DOI 10.1128/JB.01653-06; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Studemann A, 2003, EMBO J, V22, P4111, DOI 10.1093/emboj/cdg411; Sze CW, 2011, INFECT IMMUN, V79, P1270, DOI 10.1128/IAI.00871-10; Tilly K, 2007, INFECT IMMUN, V75, P1517, DOI 10.1128/IAI.01725-06; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Tokarz R, 2004, INFECT IMMUN, V72, P5419, DOI 10.1128/IAI.72.9.5419-5432.2004; Van Laar TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038171; Vytvytska O, 2000, GENE DEV, V14, P1109; Wang GQ, 2004, FEMS MICROBIOL LETT, V231, P219, DOI 10.1016/S0378-1097(03)00960-1; Weening EH, 2008, INFECT IMMUN, V76, P5694, DOI 10.1128/IAI.00690-08; WINTER RB, 1987, P NATL ACAD SCI USA, V84, P7822, DOI 10.1073/pnas.84.22.7822; Xu HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001104; Xu QL, 2008, MOL MICROBIOL, V69, P15, DOI 10.1111/j.1365-2958.2008.06264.x; Xu QL, 2007, MOL MICROBIOL, V64, P220, DOI 10.1111/j.1365-2958.2007.05636.x; Xu QL, 2006, INFECT IMMUN, V74, P5177, DOI 10.1128/IAI.00713-06; Xu QL, 2008, MICROB PATHOGENESIS, V45, P70, DOI 10.1016/j.micpath.2008.03.002; Xu Q, 2007, INFECT IMMUN, V75, P4272, DOI 10.1128/IAI.00560-07; Xu Q, 2008, MICROBIOL-SGM, V154, P3420, DOI 10.1099/mic.0.2008/019737-0; Yang XFF, 2005, J BACTERIOL, V187, P4822, DOI 10.1128/JB.187.14.4822-4829.2005; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960; Yang XFF, 2003, P NATL ACAD SCI USA, V100, P11001, DOI 10.1073/pnas.1834315100; Young JC, 2003, CELL, V113, P1, DOI 10.1016/S0092-8674(03)00192-2; Zhiming OY, 2008, MICROBIOL-SGM, V154, P2641, DOI 10.1099/mic.0.2008/019992-0	104	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93141	10.1371/journal.pone.0093141	http://dx.doi.org/10.1371/journal.pone.0093141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671196	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000118
J	Miyagawa-Yamaguchi, A; Kotani, N; Honke, K				Miyagawa-Yamaguchi, Arisa; Kotani, Norihiro; Honke, Koichi			Expressed Glycosylphosphatidylinositol-Anchored Horseradish Peroxidase Identifies Co-Clustering Molecules in Individual Lipid Raft Domains	PLOS ONE			English	Article							ENZYME-MEDIATED ACTIVATION; DECAY-ACCELERATING FACTOR; CELL-SURFACE; INTRACELLULAR TRAFFICKING; SIGNAL-TRANSDUCTION; MEMBRANE; PROTEINS; TRANSPORT; OLIGOMERIZATION; MECHANISMS	Lipid rafts that are enriched in glycosylphosphatidylinositol (GPI)-anchored proteins serve as a platform for important biological events. To elucidate the molecular mechanisms of these events, identification of co-clustering molecules in individual raft domains is required. Here we describe an approach to this issue using the recently developed method termed enzyme-mediated activation of radical source (EMARS), by which molecules in the vicinity within 300 nm from horseradish peroxidase (HRP) set on the probed molecule are labeled. GPI-anchored HRP fusion proteins (HRP-GPIs), in which the GPI attachment signals derived from human decay accelerating factor and Thy-1 were separately connected to the C-terminus of HRP, were expressed in HeLa S3 cells, and the EMARS reaction was catalyzed by these expressed HRP-GPIs under a living condition. As a result, these different HRP-GPIs had differences in glycosylation and localization and formed distinct clusters. This novel approach distinguished molecular clusters associated with individual GPI-anchored proteins, suggesting that it can identify co-clustering molecules in individual raft domains.	[Miyagawa-Yamaguchi, Arisa; Kotani, Norihiro; Honke, Koichi] Kochi Univ, Sch Med, Kochi Syst Glycobiol Ctr, Nankoku, Kochi, Japan; [Miyagawa-Yamaguchi, Arisa; Kotani, Norihiro; Honke, Koichi] Kochi Univ, Sch Med, Ctr Innovate & Translat Med, Nankoku, Kochi, Japan; [Kotani, Norihiro] Saitama Med Univ, Dept Biochem, Moroyama, Saitama, Japan; [Honke, Koichi] Kochi Univ, Sch Med, Dept Biochem, Nankoku, Kochi, Japan	Kochi University; Kochi University; Saitama Medical University; Kochi University	Honke, K (corresponding author), Kochi Univ, Sch Med, Kochi Syst Glycobiol Ctr, Nankoku, Kochi, Japan.	khonke@kochi-u.ac.jp		Kotani, Norihiro/0000-0003-3739-6478				Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Chen R, 2002, J CELL BIOCHEM, V84, P68, DOI 10.1002/jcb.1267; CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641; DAVITZ MA, 1986, J EXP MED, V163, P1150, DOI 10.1084/jem.163.5.1150; De Angelis DA, 1998, P NATL ACAD SCI USA, V95, P12312, DOI 10.1073/pnas.95.21.12312; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Fujita A, 2009, BBA-MOL CELL BIOL L, V1791, P388, DOI 10.1016/j.bbalip.2009.01.008; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; Harris TJC, 2002, BIOESSAYS, V24, P996, DOI 10.1002/bies.10172; Hashimoto N, 2012, PROTEOMICS, V12, P3154, DOI 10.1002/pmic.201200279; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Honke K, 2012, SENSORS-BASEL, V12, P16037, DOI 10.3390/s121216037; Honke K, 2011, J NEUROCHEM, V116, P690, DOI 10.1111/j.1471-4159.2010.07027.x; Imjeti NS, 2011, MOL BIOL CELL, V22, P4621, DOI 10.1091/mbc.E11-04-0320; Ishiura Y, 2010, BIOCHEM BIOPH RES CO, V396, P329, DOI 10.1016/j.bbrc.2010.04.092; Jiang SL, 2012, PROTEOMICS, V12, P54, DOI 10.1002/pmic.201100551; Kotani N, 2008, P NATL ACAD SCI USA, V105, P7405, DOI 10.1073/pnas.0710346105; Kotani N, 2012, J BIOL CHEM, V287, P37109, DOI 10.1074/jbc.M112.404178; Kusumi A, 2012, SEMIN CELL DEV BIOL, V23, P126, DOI 10.1016/j.semcdb.2012.01.018; Legler DF, 2004, FASEB J, V18, P73, DOI 10.1096/fj.03-1338fje; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Matsui T, 2003, APPL MICROBIOL BIOT, V62, P517, DOI 10.1007/s00253-003-1273-z; Mayor S, 1998, EMBO J, V17, P4626, DOI 10.1093/emboj/17.16.4626; MORGAN BP, 1993, EUR J IMMUNOL, V23, P2841, DOI 10.1002/eji.1830231118; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; Paladino S, 2008, J CELL SCI, V121, P4001, DOI 10.1242/jcs.036038; Schikorski T, 2007, J NEUROSCI METH, V165, P210, DOI 10.1016/j.jneumeth.2007.06.004; SHENOYSCARIA AM, 1992, J IMMUNOL, V149, P3535; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Solomon KR, 1996, P NATL ACAD SCI USA, V93, P6053, DOI 10.1073/pnas.93.12.6053; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Vereb G, 2003, P NATL ACAD SCI USA, V100, P8053, DOI 10.1073/pnas.1332550100; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; WELINDER KG, 1976, FEBS LETT, V72, P19, DOI 10.1016/0014-5793(76)80804-6; Yamashita R, 2011, J BIOCHEM, V149, P347, DOI 10.1093/jb/mvq148; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939	45	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93054	10.1371/journal.pone.0093054	http://dx.doi.org/10.1371/journal.pone.0093054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671047	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000108
J	Head, GA; Andrianopoulos, N; McGrath, BP; Martin, CA; Carrington, MJ; Lukoshkova, EV; Davern, PJ; Jennings, GL; Reid, CM				Head, Geoffrey A.; Andrianopoulos, Nick; McGrath, Barry P.; Martin, Catherine A.; Carrington, Melinda J.; Lukoshkova, Elena V.; Davern, Pamela J.; Jennings, Garry L.; Reid, Christopher M.			Predictors of Mean Arterial Pressure Morning Rate of Rise and Power Function in Subjects Undergoing Ambulatory Blood Pressure Recording	PLOS ONE			English	Article							DOUBLE-LOGISTIC ANALYSIS; RECEPTOR KNOCKOUT MICE; CIRCADIAN VARIATION; OXIDATIVE STRESS; CEREBROVASCULAR-DISEASE; CHOLESTEROL LEVELS; SURGE; SILENT; LIPIDS; ONSET	Background: We determined clinical predictors of the rate of rise (RoR) in blood pressure in the morning as well as a novel measure of the power of the BP surge (BPpower) derived from ambulatory blood pressure recordings. Methods: BPpower and RoR were calculated from 409 ambulatory blood pressure (ABP) recordings from subjects attending a cardiovascular risk clinic. Anthropometric data, blood biochemistry, and history were recorded. The 409 subjects were 20-82 years old (average 57, SD = 13), 46% male, 9% with hypertension but not on medication and 34% on antihypertensive medication. Results: Average RoR was 11.1 mmHg/hour (SD = 8) and BPpower was 273 mmHg(2)/hour (SD = 235). Only cholesterol, low density lipoprotein and body mass index (BMI) were associated with higher BPpower and RoR (P < 0.05) from 25 variables assessed. BPpower was lower in those taking beta-blockers or diuretics. Multivariate analysis identified that only BMI was associated with RoR (4.2% increase/unit BMI, P = 0.020) while cholesterol was the only remaining associated variable with BPpower (17.5% increase/mmol/L cholesterol, P = 0.047). A follow up of 213 subjects with repeated ABP after an average 1.8 years identified that baseline cholesterol was the only predictor for an increasing RoR and BPpower (P < 0.05). 37 patients who commenced statin subsequently had lower BPpower whereas 90 age and weight matched controls had similar BPpower on follow-up. Conclusions: Cholesterol is an independent predictor of a greater and more rapid rise in morning BP as well as of further increases over several years. Reduction of cholesterol with statin therapy is very effective in reducing the morning blood pressure surge.	[Head, Geoffrey A.; Carrington, Melinda J.; Davern, Pamela J.; Jennings, Garry L.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Head, Geoffrey A.; Carrington, Melinda J.; Davern, Pamela J.; Jennings, Garry L.] Alfred Hosp, Dept Cardiovasc Med, Melbourne, Vic, Australia; [Andrianopoulos, Nick; Reid, Christopher M.] Monash Univ, NHMRC Ctr Clin Res Excellence Therapeut, Melbourne, Vic 3004, Australia; [McGrath, Barry P.; Martin, Catherine A.] Monash Hlth Dandenong Australia, Melbourne, Vic, Australia; [McGrath, Barry P.; Martin, Catherine A.] Monash Univ, Melbourne, Vic 3004, Australia; [Martin, Catherine A.] Australian Catholic Univ, Fitzroy, Vic, Australia; [Lukoshkova, Elena V.] Natl Cardiol Res Ctr, Moscow, Russia	Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; Australian Catholic University; National Medical Research Center of Cardiology	Head, GA (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	geoff.head@baker.edu.au	Reid, Christopher M/AAP-8135-2021; Lukoshkova, Elena/ABG-1274-2020; Head, Geoffrey A./B-2177-2010; Jennings, Garry/B-3914-2009	Head, Geoffrey A./0000-0002-7623-137X; Lukoshkova, Elena/0000-0002-1564-3469; Carrington, Melinda J/0000-0003-3865-1645; Jennings, Garry/0000-0002-7865-5483; Reid, Christopher/0000-0001-9173-3944	National Health & Medical Research Council of Australia (NHMRC) [317826, 1049610, 546272]; Baker IDI Heart and Diabetes Institute; Victorian Government's OIS Program; NHMRC [1002186, 1045862, 1032934]; NHMRC/NHF [1012881]	National Health & Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Baker IDI Heart and Diabetes Institute; Victorian Government's OIS Program; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC/NHF(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health & Medical Research Council of Australia (NHMRC, www.nhmrc.gov.au) (project grant 317826 and 1049610; program grant 546272), the Baker IDI Heart and Diabetes Institute, and in part by the Victorian Government's OIS Program (http://www.business.vic.gov.au/industries/science-technology-and-innovation/programs/medical-research-operational-infrastructure-program). Investigators were supported by a NHMRC Principal Research Fellowship (1002186 to GAH), Senior Research Fellowship (1045862 to CMR), NHMRC/NHF Postdoctoral Fellowship 1012881 to PJD, and NHMRC career development award 1032934 to MJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGENTINO C, 1990, STROKE, V21, P387, DOI 10.1161/01.STR.21.3.387; BEVAN AT, 1969, CLIN SCI, V36, P329; BONAA KH, 1991, CIRCULATION, V83, P1305, DOI 10.1161/01.CIR.83.4.1305; Borghi C, 2007, J HYPERTENS, V25, P2051, DOI 10.1097/HJH.0b013e32827759a6; Campos RR, 2011, CLIN EXP PHARMACOL P, V38, P144, DOI 10.1111/j.1440-1681.2010.05437.x; de Oliveira J, 2011, NEUROSCIENCE, V197, P99, DOI 10.1016/j.neuroscience.2011.09.009; Ekstedt M, 2004, PSYCHOSOM MED, V66, P925, DOI 10.1097/01.psy.0000145821.25453.f7; Elliott WJ, 1998, STROKE, V29, P992, DOI 10.1161/01.STR.29.5.992; Evangelho JS, 2011, AUTON NEUROSCI-BASIC, V159, P98, DOI 10.1016/j.autneu.2010.07.010; Fujita M, 2005, HYPERTENSION, V45, P1165, DOI 10.1161/01.HYP.0000165690.85505.37; Fujita M, 2007, HYPERTENSION, V50, P360, DOI 10.1161/HYPERTENSIONAHA.107.091009; Head GA, 2005, J APPL PHYSIOL, V98, P1511, DOI 10.1152/japplphysiol.00647.2004; Head GA, 2004, J HYPERTENS, V22, P2075, DOI 10.1097/00004872-200411000-00008; Head GA, 2008, CLIN EXP PHARMACOL P, V35, P516, DOI 10.1111/j.1440-1681.2008.04908.x; Head GA, 2006, AM J HYPERTENS, V19, P1010, DOI 10.1016/j.amjhyper.2006.03.014; Head GA, 2010, AM J HYPERTENS, V23, P1074, DOI 10.1038/ajh.2010.126; KANNEL WB, 1985, AM HEART J, V110, P1100, DOI 10.1016/0002-8703(85)90224-8; Kario K, 1996, ARTERIOSCL THROM VAS, V16, P734, DOI 10.1161/01.ATV.16.6.734; Kario K, 2004, AM J HYPERTENS, V17, P668, DOI 10.1016/j.amjhyper.2004.04.001; Kario K, 2003, J CARDIOVASC PHARM, V41, pS61; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Kario K, 2006, AM J HYPERTENS, V19, P1018, DOI 10.1016/j.amjhyper.2006.05.014; Kario K, 2010, HYPERTENSION, V56, P765, DOI 10.1161/HYPERTENSIONAHA.110.157149; Kishi T, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/406897; Lambert E, 2013, AM J HYPERT IN PRESS; Lambert E, 2013, AM J HYPERTENS, V26, P250, DOI 10.1093/ajh/hps016; MACMAHON SW, 1985, ARTERIOSCLEROSIS, V5, P391, DOI 10.1161/01.ATV.5.4.391; Marques FZ, 2011, PHYSIOL GENOMICS, V43, P766, DOI 10.1152/physiolgenomics.00009.2011; Martin CA, 2013, J HUM HYPERTENS, V27, P315, DOI 10.1038/jhh.2012.44; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; NADEMANEE K, 1987, AM J CARDIOL, V60, P494, DOI 10.1016/0002-9149(87)90292-X; Nagae A, 2009, CIRCULATION, V119, P978, DOI 10.1161/CIRCULATIONAHA.108.824730; Nakazato T, 1998, J AUTONOM NERV SYST, V70, P32, DOI 10.1016/S0165-1838(98)00024-1; Nickenig G, 1997, AM J PHYSIOL-HEART C, V272, pH2701, DOI 10.1152/ajpheart.1997.272.6.H2701; Oliveira-Sales EB, 2009, AM J HYPERTENS, V22, P484, DOI 10.1038/ajh.2009.17; Paim BA, 2008, FREE RADICAL BIO MED, V44, P444, DOI 10.1016/j.freeradbiomed.2007.10.005; PANZA JA, 1991, NEW ENGL J MED, V325, P986, DOI 10.1056/NEJM199110033251402; Shaw JA, 2001, CIRCULATION, V103, P806, DOI 10.1161/01.CIR.103.6.806; SIRGO MA, 1988, ARCH INTERN MED, V148, P2547, DOI 10.1001/archinte.148.12.2547; Strehlow K, 2000, ANN MED, V32, P386, DOI 10.3109/07853890008995944; WILLICH SN, 1990, AM J CARDIOL, V66, pG15, DOI 10.1016/0002-9149(90)90387-G; WILLICH SN, 1987, AM J CARDIOL, V60, P801, DOI 10.1016/0002-9149(87)91027-7	42	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93186	10.1371/journal.pone.0093186	http://dx.doi.org/10.1371/journal.pone.0093186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667944	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600156
J	Jamin, Y; Glass, L; Hallsworth, A; George, R; Koh, DM; Pearson, ADJ; Chesler, L; Robinson, SP				Jamin, Yann; Glass, Laura; Hallsworth, Albert; George, Rani; Koh, Dow-Mu; Pearson, Andrew D. J.; Chesler, Louis; Robinson, Simon P.			Intrinsic Susceptibility MRI Identifies Tumors with ALK(F1174L) Mutation in Genetically-Engineered Murine Models of High-Risk Neuroblastoma	PLOS ONE			English	Article							VASCULAR ARCHITECTURE; ACTIVATING MUTATIONS; ALK KINASE; MYCN; ANGIOGENESIS; HYPOXIA; CANCER; RECEPTOR; BIOLOGY	The early identification of children presenting ALK(F1174L)-mutated neuroblastoma, which are associated with resistance to the promising ALK inhibitor crizotinib and a marked poorer prognosis, has become a clinical priority. In comparing the radiology of the novel Th-ALK(F1174L)/Th-MYCN and the well-established Th-MYCN genetically-engineered murine models of neuroblastoma using MRI, we have identified a marked ALK(F1174L)-driven vascular phenotype. We demonstrate that quantitation of the transverse relaxation rate R-2* (s(-1)) using intrinsic susceptibility-MRI under baseline conditions and during hyperoxia, can robustly discriminate this differential vascular phenotype, and identify MYCN-driven tumors harboring the ALK(F1174L) mutation with high specificity and selectivity. Intrinsic susceptibility-MRI could thus potentially provide a non-invasive and clinically-exploitable method to help identifying children with MYCN-driven neuroblastoma harboring the ALK(F1174L) mutation at the time of diagnosis.	[Jamin, Yann; Glass, Laura; Koh, Dow-Mu; Chesler, Louis; Robinson, Simon P.] Inst Canc Res, Div Radiotherapy & Imaging, London SW3 6JB, England; [Jamin, Yann; Glass, Laura; Koh, Dow-Mu; Chesler, Louis; Robinson, Simon P.] Royal Marsden NHS Fdn Trust, London, England; [Glass, Laura; Hallsworth, Albert; Chesler, Louis] Inst Canc Res, Div Canc Therapeut, London SW3 6JB, England; [Glass, Laura; Chesler, Louis] Inst Canc Res, Div Mol Pathol, London SW3 6JB, England; [Glass, Laura; Pearson, Andrew D. J.; Chesler, Louis] Inst Canc Res, Div Clin Studies, London SW3 6JB, England; [George, Rani] Dana Farber Canc Inst, Dept Pediat Haematol & Oncol, Boston, MA 02115 USA; [George, Rani] Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard Medical School	Jamin, Y (corresponding author), Inst Canc Res, Div Radiotherapy & Imaging, London SW3 6JB, England.	yann.jamin@icr.ac.uk	George, Rani/AAG-7635-2019	Jamin, yann/0000-0003-0350-3757; Koh, Dow-Mu/0000-0001-7654-8011; Robinson, Simon/0000-0003-4101-7274; Chesler, Louis/0000-0001-7842-2068; Glass, Laura/0000-0003-2072-7365	Institute of Cancer Research CR-UK; EPSRC Cancer Imaging Centre; MRC; Department of Health (England) [C1060/A10334]; NHS; Cancer Research-UK project grants [C16412/A6269]; Wellcome Trust [091763Z/10/Z]; Medical Research Council [G1000391]; Neuroblastoma Society; SPARKS charity; Medical Research Council NC3R [G1000121/94513]; National Institutes of Health [R01 CA148688]; Cancer Research UK [14610, 16464] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H046526/1] Funding Source: researchfish; Medical Research Council [G0701533] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA148688] Funding Source: NIH RePORTER; EPSRC [EP/H046526/1] Funding Source: UKRI; MRC [G0701533] Funding Source: UKRI	Institute of Cancer Research CR-UK(Cancer Research UK); EPSRC Cancer Imaging Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (England); NHS; Cancer Research-UK project grants; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Neuroblastoma Society; SPARKS charity; Medical Research Council NC3R(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge support received for The Institute of Cancer Research CR-UK (http://www.cancerresearchuk.org/) and EPSRC (http://www.epsrc.ac.uk) Cancer Imaging Centre, in association with the MRC (http://www.epsrc.ac.uk) and Department of Health (England) (https://www.gov.uk/government/organisations/department-of-health) grant C1060/A10334, and NHS funding to the NIHR Biomedical Research Centre. This work was supported by Cancer Research-UK project grants C16412/A6269, The Wellcome Trust (grant #091763Z/10/Z) (http://www.wellcome.ac.uk), and the Medical Research Council (grant #G1000391). Pre-clinical development of the TH-ALKF1174L/TH-MYCN model was funded by grants from The Neuroblastoma Society (http://www.nsoc.co.uk), the SPARKS charity (http://www.sparks.org.uk), Medical Research Council NC3R (grant #G1000121/94513)(http://www.nc3rs.org.uk/), and the National Institutes of Health (R01 CA148688) (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsson A, 2002, CIRCULATION, V105, P112, DOI 10.1161/hc0102.101437; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Berry T, 2012, CANCER CELL, V22, P117, DOI 10.1016/j.ccr.2012.06.001; Bresler SC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002950; Brisse HJ, 2011, RADIOLOGY, V261, P243, DOI 10.1148/radiol.11101352; Carpenter EL, 2012, ONCOGENE, V31, P4888, DOI 10.1038/onc.2012.208; Carpenter EL, 2012, NAT REV CLIN ONCOL, V9, P391, DOI 10.1038/nrclinonc.2012.72; Chantrain CF, 2004, CANCER RES, V64, P1675, DOI 10.1158/0008-5472.CAN-03-0160; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chesler L, 2011, SEMIN CANCER BIOL, V21, P245, DOI 10.1016/j.semcancer.2011.09.011; Christen T, 2012, RADIOLOGY, V262, P495, DOI 10.1148/radiol.11110518; Comstock JM, 2009, AM J CLIN PATHOL, V132, P69, DOI 10.1309/AJCPN76VTIGWPOAG; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; Di Paolo D, 2011, MOL THER, V19, P2201, DOI 10.1038/mt.2011.142; Fox E, 2010, J CLIN ONCOL, V28, P5174, DOI 10.1200/JCO.2010.30.9674; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Goo HW, 2010, EUR J RADIOL, V75, P306, DOI 10.1016/j.ejrad.2009.09.014; Heukamp LC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003967; Hoskin PJ, 2007, INT J RADIAT ONCOL, V68, P1065, DOI 10.1016/j.ijrobp.2007.01.018; Jamin Y, 2013, RADIOLOGY, V266, P130, DOI 10.1148/radiol.12120128; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; McDonald DM, 2003, NAT MED, V9, P713, DOI 10.1038/nm0603-713; McPhail LD, 2010, RADIOLOGY, V254, P110, DOI 10.1148/radiol.2541090395; Meitar D, 1996, J CLIN ONCOL, V14, P405, DOI 10.1200/JCO.1996.14.2.405; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Robinson SP, 2003, J MAGN RESON IMAGING, V17, P445, DOI 10.1002/jmri.10274; Robinson SP, 2006, NEW TECHNIQUES ONCOL, P257; Sasaki T, 2010, EUR J CANCER, V46, P1773, DOI 10.1016/j.ejca.2010.04.002; Stephens MA, 1986, GOODNESS OF FIT TECH; Tatum JL, 2006, INT J RADIAT BIOL, V82, P699, DOI 10.1080/09553000601002324; Walker-Samuel S, 2010, MAGN RESON MED, V64, P914, DOI 10.1002/mrm.22478; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010	35	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92886	10.1371/journal.pone.0092886	http://dx.doi.org/10.1371/journal.pone.0092886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667968	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600099
J	Laurence, A; Lumineau, S; Calandreau, L; Arnould, C; Leterrier, C; Boissy, A; Houdelier, C				Laurence, Agathe; Lumineau, Sophie; Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine; Boissy, Alain; Houdelier, Cecilia			Short- and Long-Term Effects of Unpredictable Repeated Negative Stimuli on Japanese Quail's Fear of Humans	PLOS ONE			English	Article							DOMESTIC CHICKS FEAR; HUMAN-BEINGS; CHRONIC STRESS; COTURNIX-COTURNIX; EMOTIONAL REACTIVITY; BEHAVIORAL-RESPONSES; MODIFY RESPONSES; TONIC IMMOBILITY; HUMAN CONTACT; LAYING HENS	Numerous aversive events occur in poultry production, and if repeated and unpredictable, can result in an impaired welfare. Some events such as handling can be perceived negatively and it is of interest to understand how humans' behaviour could affect poultry's behaviours and especially its avoidance of humans. Our aim was to evaluate short-and long-lasting effects of a 3-week procedure involving unpredictable repeated negative stimuli (URNS) applied during the post-juvenile period on quail's reactivity to humans. We compared the reactions of two sets of quail: URNS was applied to one set (treated quail) and the other set was left undisturbed (control quail). When two weeks old, treated quail were exposed to a variety of negative stimuli, either applied automatically or involving human presence. One and seven weeks after the termination of the procedure, the reactivity of control and treated quail to a passive human being was evaluated. Furthermore, the experimenter with her hand on a trough containing a mealworm assessed the propensity of quail of both groups to habituate to feed close to a human being. In the presence of a seated observer, treated quail were more inhibited and more alert than control quail. Likewise, seven weeks after the end of the URNS procedure, more treated than control quail adopted a fear posture. Moreover, whereas control quail spent as much time in the different areas of their cages, treated quail spent more time in the rear part of their cages. Finally, whereas control quail habituated gradually to feed near the experimenter's hand, treated quail did not. All these tests evidence negative short-and long-term effects on treated quail's reactivity to a passive human being and on their habituation to a human being when her presence is positively reinforced. This highlights the importance of young poultry's experience with humans in production.	[Laurence, Agathe; Lumineau, Sophie; Houdelier, Cecilia] Univ Rennes 1, CNRS, UMR 6552, Ethos, Rennes, France; [Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine] INRA, UMR Physiol Reprod & Comportements 85, F-37380 Nouzilly, France; [Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine] CNRS, UMR 6175, Nouzilly, France; [Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine] Univ Tours, Tours, France; [Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine] IFCE, Nouzilly, France; [Boissy, Alain] INRA Vet Agro Sup, INRA UMR 1213, Unite Rech Herbivores, St Genes Champanelle, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Universite de Tours; INRAE	Lumineau, S (corresponding author), Univ Rennes 1, CNRS, UMR 6552, Ethos, Rennes, France.	sophie.lumineau@univ-rennes1.fr	Leterrier, Christine/AAY-7201-2020	Lumineau, Sophie/0000-0002-2076-9947	French National Research Agency (ANR), Emofarm Program [ANR-09BLAN-0339]	French National Research Agency (ANR), Emofarm Program(French National Research Agency (ANR))	This work was supported by the French National Research Agency (ANR), Emofarm Program (ANR-09BLAN-0339). Website: http://www.agence-nationale-recherche.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNETT JL, 1994, APPL ANIM BEHAV SCI, V41, P87, DOI 10.1016/0168-1591(94)90054-X; BARNETT JL, 1993, APPL ANIM BEHAV SCI, V37, P139, DOI 10.1016/0168-1591(93)90106-Y; BARNETT JL, 1992, BRIT POULTRY SCI, V33, P699, DOI 10.1080/00071669208417510; Bertin A, 2004, APPL ANIM BEHAV SCI, V89, P215, DOI 10.1016/j.applanim.2004.06.004; BLOKHUIS HJ, 1984, APPL ANIM BEHAV SCI, V12, P289, DOI 10.1016/0168-1591(84)90121-7; BLOKHUIS HJ, 1983, WORLD POULTRY SCI J, V39, P33, DOI 10.1079/WPS19830003; Bredbacka P., 1988, Proceedings of the International Congress on Applied Ethology in Farm Animals, Skara, 1988., P74; Calandreau L, 2011, BEHAV BRAIN RES, V225, P505, DOI 10.1016/j.bbr.2011.08.010; Calandreau L, 2011, BEHAV BRAIN RES, V217, P104, DOI 10.1016/j.bbr.2010.10.004; Cransberg PH, 2000, BRIT POULTRY SCI, V41, P272, DOI 10.1080/713654939; Davis H, 2001, BRIT POULTRY SCI, V42, P276, DOI 10.1080/00071660120048564; Destrez A, 2013, APPL ANIM BEHAV SCI, V148, P28, DOI 10.1016/j.applanim.2013.07.016; DUNCAN IJH, 1990, CURR T VET, V53, P121; Fairhurst GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017663; HEMSWORTH PH, 1994, APPL ANIM BEHAV SCI, V41, P101, DOI 10.1016/0168-1591(94)90055-8; Henry S, 2006, DEV PSYCHOBIOL, V48, P712, DOI 10.1002/dev.20189; HUGHES BO, 1976, BRIT POULTRY SCI, V17, P135, DOI 10.1080/00071667608416258; Jones R. B., 1995, INT J COMP PSYCHOL, V8, P88; JONES RB, 1993, ANIM BEHAV, V46, P991, DOI 10.1006/anbe.1993.1280; Jones RB, 1996, WORLD POULTRY SCI J, V52, P131, DOI 10.1079/WPS19960013; JONES RB, 1994, APPL ANIM BEHAV SCI, V42, P129, DOI 10.1016/0168-1591(94)90153-8; JONES RB, 1993, APPL ANIM BEHAV SCI, V36, P185, DOI 10.1016/0168-1591(93)90009-E; Laurence A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047475; Le Neindre P, 1994, RUMINANTS HOMME VIEU, P91; Martin LB, 2005, CAN J ZOOL, V83, P780, DOI 10.1139/Z05-062; Mignon-Grasteau S, 2003, BEHAV PROCESS, V61, P69, DOI 10.1016/S0376-6357(02)00162-6; MILLS AD, 1991, J COMP PSYCHOL, V105, P25, DOI 10.1037/0735-7036.105.1.25; Mills AD, 2000, APPL ANIM BEHAV SCI, V69, P125, DOI 10.1016/S0168-1591(00)00126-X; MURPHY LB, 1978, APPL ANIM ETHOL, V4, P5, DOI 10.1016/0304-3762(78)90089-5; MURPHY LB, 1977, APPL ANIM ETHOL, V3, P321, DOI 10.1016/0304-3762(77)90057-8; MURPHY ME, 1992, ORNIS SCAND, V23, P304, DOI 10.2307/3676654; Nazar FN, 2011, STRESS, V14, P166, DOI 10.3109/10253890.2010.523093; Piato AL, 2011, PROG NEURO-PSYCHOPH, V35, P561, DOI 10.1016/j.pnpbp.2010.12.018; Rich EL, 2005, AM J PHYSIOL-REG I, V288, pR1628, DOI 10.1152/ajpregu.00484.2004; Richard S, 2010, BEHAV PROCESS, V85, P18, DOI 10.1016/j.beproc.2010.05.009; Rushen J, 1999, APPL ANIM BEHAV SCI, V65, P285, DOI 10.1016/S0168-1591(99)00089-1; Saint-Dizier H, 2008, APPL ANIM BEHAV SCI, V112, P297, DOI 10.1016/j.applanim.2007.09.005; SAINTJALME M, 1995, IBIS, V137, P570; Satterlee DG, 1997, POULTRY SCI, V76, P469, DOI 10.1093/ps/76.3.469; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; WINGFIELD JC, 1986, HORM BEHAV, V20, P405, DOI 10.1016/0018-506X(86)90003-6; Zulkifli I, 2004, APPL ANIM BEHAV SCI, V88, P77, DOI 10.1016/j.applanim.2004.02.014	43	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93259	10.1371/journal.pone.0093259	http://dx.doi.org/10.1371/journal.pone.0093259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24668017	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600159
J	Rodriguez-Menocal, L; Salgado, M; Davis, S; Waibel, J; Shabbir, A; Cox, A; Badiavas, EV				Rodriguez-Menocal, Luis; Salgado, Marcela; Davis, Stephen; Waibel, Jill; Shabbir, Arsalan; Cox, Audrey; Badiavas, Evangelos V.			Percutaneous Bone Marrow Transplantation Using Fractional Ablative Erbium:YAG Laser	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; DRUG-DELIVERY; HUMAN SKIN	Topical application of therapeutic agents has been a mainstay in Dermatology for the treatment of skin disorders but is not commonly used for systemic delivery. For a topically applied agent to reach distant body sites it must first overcome the barrier function of the skin and then penetrate into deeper structures before reaching the systemic circulation. This has limited the use of topically applied agents to those having specific charge, solubility and size restrictions. Pretreatment of the skin with ablative fractional laser appears to enhance the uptake of some topically applied drugs but the ability to effectively deliver agents to distant sites is largely unproven. In this report we used a fractional ablative Erb:YAG (Erbium/Yttrium Aluminum Garnet) laser to facilitate the transfer of bone marrow stem cells through the skin in a murine bone marrow transplant model. Chimerism could be detected in the peripheral blood of recipient C57BL/6 mice that were pretreated with ablative fractional laser and had topically applied enhanced green fluorescent protein (GFP) labeled bone marrow cells from syngeneic donor transgenic mice. This study indicates that fractional laser can be used to deliver stem cells through the skin and remain functionally intact.	[Rodriguez-Menocal, Luis; Salgado, Marcela; Davis, Stephen; Waibel, Jill; Shabbir, Arsalan; Cox, Audrey; Badiavas, Evangelos V.] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA; [Rodriguez-Menocal, Luis; Salgado, Marcela; Badiavas, Evangelos V.] Univ Miami, Miller Sch Med, Interdiscipinary Stem Cell Inst, Miami, FL 33136 USA	University of Miami; University of Miami	Badiavas, EV (corresponding author), Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA.	ebadiavas@med.miami.edu	Rodriguez-Menocal, Luis/AGL-5931-2022		internal University of Miami funding sources	internal University of Miami funding sources	This work was supported by internal University of Miami funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiavas AR, 2011, EXPERT OPIN BIOL TH, V11, P1447, DOI 10.1517/14712598.2011.606212; Badiavas EV, 2007, WOUND REPAIR REGEN, V15, P856, DOI 10.1111/j.1524-475X.2007.00305.x; Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812; Genina EA, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.111406; Haak CS, 2012, J CONTROL RELEASE, V163, P335, DOI 10.1016/j.jconrel.2012.09.008; Hunzeker CM, 2009, AESTHET SURG J, V29, P317, DOI 10.1016/j.asj.2009.05.004; Kim JE, 2013, DERMATOL SURG, V39, P1033, DOI 10.1111/dsu.12170; Laubach HJ, 2006, LASER SURG MED, V38, P142, DOI 10.1002/lsm.20254; Lee WR, 2011, J CONTROL RELEASE, V153, P240, DOI 10.1016/j.jconrel.2011.03.015; Quesenberry PJ, 2010, STEM CELLS DEV, V19, P453, DOI 10.1089/scd.2009.0283; Reilly MJ, 2010, ARCH FACIAL PLAST S, V12, P321, DOI 10.1001/archfacial.2010.38; Waibel J, 2008, J DRUGS DERMATOL, V7, P59; Waibel Jill, 2009, J Drugs Dermatol, V8, P294; Waibel JS, 2013, LASER SURG MED, V45, P135, DOI 10.1002/lsm.22120; Wognum AW, 2003, ARCH MED RES, V34, P461, DOI 10.1016/j.arcmed.2003.09.008; Zelickson BD, 2009, LASER SURG MED, V41, P634, DOI 10.1002/lsm.20843	16	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93004	10.1371/journal.pone.0093004	http://dx.doi.org/10.1371/journal.pone.0093004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667438	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600124
J	Zhang, K; Duan, LT; Ong, QX; Lin, ZL; Varman, PM; Sung, KJ; Cui, BX				Zhang, Kai; Duan, Liting; Ong, Qunxiang; Lin, Ziliang; Varman, Pooja Mahendra; Sung, Kijung; Cui, Bianxiao			Light-Mediated Kinetic Control Reveals the Temporal Effect of the Raf/MEK/ERK Pathway in PC12 Cell Neurite Outgrowth	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; LIVING CELLS; NEURONAL DIFFERENTIATION; SIGNALING PATHWAYS; MAP KINASE; PHEOCHROMOCYTOMA CELLS; NUCLEAR TRANSLOCATION; MAMMALIAN-CELLS; PLASMA-MEMBRANE	It has been proposed that differential activation kinetics allows cells to use a common set of signaling pathways to specify distinct cellular outcomes. For example, nerve growth factor (NGF) and epidermal growth factor (EGF) induce different activation kinetics of the Raf/MEK/ERK signaling pathway and result in differentiation and proliferation, respectively. However, a direct and quantitative linkage between the temporal profile of Raf/MEK/ERK activation and the cellular outputs has not been established due to a lack of means to precisely perturb its signaling kinetics. Here, we construct a light-gated protein-protein interaction system to regulate the activation pattern of the Raf/MEK/ERK signaling pathway. Light-induced activation of the Raf/MEK/ERK cascade leads to significant neurite outgrowth in rat PC12 pheochromocytoma cell lines in the absence of growth factors. Compared with NGF stimulation, light stimulation induces longer but fewer neurites. Intermittent on/off illumination reveals that cells achieve maximum neurite outgrowth if the off-time duration per cycle is shorter than 45 min. Overall, light-mediated kinetic control enables precise dissection of the temporal dimension within the intracellular signal transduction network.	[Zhang, Kai; Duan, Liting; Ong, Qunxiang; Varman, Pooja Mahendra; Cui, Bianxiao] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Lin, Ziliang] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Sung, Kijung] Stanford Univ, Biophys Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Cui, BX (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	bcui@stanford.edu	Zhang, Kai/ABD-1498-2021; Zhang, Kai/G-6437-2010	Zhang, Kai/0000-0002-6687-4558; Zhang, Kai/0000-0002-6687-4558	US National Institute of Health [DP2-NS082125]; Searle Scholar Award; Packard Science and Engineering Fellowship; Dreyfus New Faculty Award; American Cancer Society [PF-13-030-01-DDC]; Pre-doctoral Fellowship from the Agency for Science, Technology and Research (A*STAR) Singapore	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar Award; Packard Science and Engineering Fellowship; Dreyfus New Faculty Award; American Cancer Society(American Cancer Society); Pre-doctoral Fellowship from the Agency for Science, Technology and Research (A*STAR) Singapore	B. Cui is supported by the US National Institute of Health (DP2-NS082125), Searle Scholar Award, the Packard Science and Engineering Fellowship, and the Dreyfus New Faculty Award. K. Zhang, PhD was supported by a Postdoctoral Fellowship, PF-13-030-01-DDC from the American Cancer Society. Q. Ong was supported by a Pre-doctoral Fellowship from the Agency for Science, Technology and Research (A*STAR) Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Bugaj LJ, 2013, NAT METHODS, V10, P249, DOI 10.1038/nmeth.2360; Castellano F, 2000, METHOD ENZYMOL, V325, P285; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chen X, 2001, J BIOL CHEM, V276, P34617, DOI 10.1074/jbc.M103995200; Cheung Eric C C, 2004, Sci STKE, V2004, pPE45; Chung JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009011; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Ganesan A, 2012, PROTEIN SCI, V21, P918, DOI 10.1002/pro.2089; Gautier A, 2011, J AM CHEM SOC, V133, P2124, DOI 10.1021/ja1109979; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; HEASLEY LE, 1992, MOL BIOL CELL, V3, P545, DOI 10.1091/mbc.3.5.545; Herbst KJ, 2011, MOL CELL BIOL, V31, P4063, DOI 10.1128/MCB.05459-11; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; HUFF K, 1981, J CELL BIOL, V88, P189, DOI 10.1083/jcb.88.1.189; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Karginov AV, 2010, NAT BIOTECHNOL, V28, P743, DOI 10.1038/nbt.1639; Karginov AV, 2010, J AM CHEM SOC; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; New LG, 2001, J CELL BIOCHEM, V83, P585, DOI 10.1002/jcb.1253; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; Pollock R, 2002, CURR OPIN BIOTECH, V13, P459, DOI 10.1016/S0958-1669(02)00373-7; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Ren HY, 2010, DEV BIOL, V345, P144, DOI 10.1016/j.ydbio.2010.07.002; Saito TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057037; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; SEEDORF K, 1995, METABOLISM, V44, P24, DOI 10.1016/0026-0495(95)90217-1; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Strickland D, 2010, NAT METHODS, V7, P623, DOI [10.1038/NMETH.1473, 10.1038/nmeth.1473]; Subramaniam S, 2004, J CELL BIOL, V165, P357, DOI 10.1083/jcb.200403028; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wang L, 2011, MOL BIOL CELL, V22, P3853, DOI 10.1091/mbc.E11-03-0277; Watanabe K, 2012, J CELL SCI, V125, P2198, DOI 10.1242/jcs.097709; Wend S., 2013, ACS SYNTH BIOL; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WOOD KW, 1993, P NATL ACAD SCI USA, V90, P5016, DOI 10.1073/pnas.90.11.5016; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	62	61	64	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92917	10.1371/journal.pone.0092917	http://dx.doi.org/10.1371/journal.pone.0092917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667437	gold, Green Submitted, Green Published			2022-12-25	WOS:000333675600105
J	Bharadwaj, U; Eckols, TK; Kolosov, M; Kasembeli, MM; Adam, A; Torres, D; Zhang, X; Dobrolecki, LE; Wei, W; Lewis, MT; Dave, B; Chang, JC; Landis, MD; Creighton, CJ; Mancini, MA; Tweardy, DJ				Bharadwaj, U.; Eckols, T. K.; Kolosov, M.; Kasembeli, M. M.; Adam, A.; Torres, D.; Zhang, X.; Dobrolecki, L. E.; Wei, W.; Lewis, M. T.; Dave, B.; Chang, J. C.; Landis, M. D.; Creighton, C. J.; Mancini, M. A.; Tweardy, D. J.			Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer	ONCOGENE			English	Article							EPIDERMAL-GROWTH-FACTOR; UNPHOSPHORYLATED STAT3; TYROSINE PHOSPHORYLATION; SIGNAL TRANSDUCER; GENE-EXPRESSION; DOWN-REGULATION; STEM-CELL; TRANSCRIPTION; BINDING; ACTIVATION	Signal transducer and activator of transcription (STAT) 3 regulates many cardinal features of cancer including cancer cell growth, apoptosis resistance, DNA damage response, metastasis, immune escape, tumor angiogenesis, the Warburg effect and oncogene addiction and has been validated as a drug target for cancer therapy. Several strategies have been used to identify agents that target Stat3 in breast cancer but none has yet entered into clinical use. We used a high-throughput fluorescence microscopy search strategy to identify compounds in a drug-repositioning library (Prestwick library) that block ligand-induced nuclear translocation of Stat3 and identified piperlongumine (PL), a natural product isolated from the fruit of the pepper Piper longum. PL inhibited Stat3 nuclear translocation, inhibited ligand-induced and constitutive Stat3 phosphorylation, and modulated expression of multiple Stat3-regulated genes. Surface plasmon resonance assay revealed that PL directly inhibited binding of Stat3 to its phosphotyrosyl peptide ligand. Phosphoprotein antibody array analysis revealed that PL does not modulate kinases known to activate Stat3 such as Janus kinases, Src kinase family members or receptor tyrosine kinases. PL inhibited anchorage-independent and anchorage-dependent growth of multiple breast cancer cell lines having increased pStat3 or total Stat3, and induced apoptosis. PL also inhibited mammosphere formation by tumor cells from patient-derived xenografts. PL's antitumorigenic function was causally linked to its Stat3-inhibitory effect. PL was non-toxic in mice up to a dose of 30 mg/kg/day for 14 days and caused regression of breast cancer cell line xenografts in nude mice. Thus, PL represents a promising new agent for rapid entry into the clinic for use in treating breast cancer, as well as other cancers in which Stat3 has a role.	[Bharadwaj, U.; Eckols, T. K.; Kolosov, M.; Kasembeli, M. M.; Adam, A.; Torres, D.; Tweardy, D. J.] Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA; [Zhang, X.; Dobrolecki, L. E.; Wei, W.; Lewis, M. T.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Wei, W.; Lewis, M. T.; Mancini, M. A.; Tweardy, D. J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Lewis, M. T.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Lewis, M. T.; Tweardy, D. J.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Dave, B.; Chang, J. C.; Landis, M. D.] Methodist Hosp, Res Inst, Methodist Canc Ctr, Houston, TX 77030 USA; [Creighton, C. J.] Baylor Coll Med, Dept Med, Hematol Oncol Sect, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine	Tweardy, DJ (corresponding author), Baylor Coll Med, Dept Med, Infect Dis Sect, BCM 286,Room N-1319,1 Baylor Plaza, Houston, TX 77030 USA.	dtweardy@bcm.edu	Tweardy, David/L-3929-2019; Lewis, Michael T/A-9572-2009; Dave, Bhuvanesh/ABF-8334-2020	Dave, Bhuvanesh/0000-0001-6741-1363	National Institutes of Health [CA149783, P50-CA058183, U54-CA149196]; BCM Cancer Center [P30 CA125123]; John S Dunn Gulf Coast Consortium for Chemical Genomics Screening Grant Program; NCRR [S10RR024574]; NIAID [AI036211]; NCI [P30 CA125123]; NATIONAL CANCER INSTITUTE [R41CA153658, P30CA125123, R21CA149783, U54CA149196, P50CA058183] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BCM Cancer Center; John S Dunn Gulf Coast Consortium for Chemical Genomics Screening Grant Program; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank various BCM core facilities for providing the infrastructure, instrumentation and expertise for performing many of our experiments; the Integrated Microscopy core (Director: Michael Mancini, PhD) for assistance with the HTFM screening assay; the Cytometry and Cell Sorting Core (Director: Joel M Sederstrom, MBS/Christine Beeton, PhD) for the Phosphoflow experiments; the Protein and Antibody Array Proteomics Core (Director: Shixia Huang, PhD) for the phosphoproteomic analysis. This project was supported, in part, by the following grants: National Institutes of Health grant CA149783 (DJT), P50-CA058183 (MTL), U54-CA149196 (MTL), the BCM Cancer Center Support Grant P30 CA125123, research grants from the John S Dunn Gulf Coast Consortium for Chemical Genomics Screening Grant Program (DJT), NCRR grant S10RR024574, NIAID AI036211 and NCI P30 CA125123 (BCM Cytometry and Cell Sorting Core funding).	Adams DJ, 2012, P NATL ACAD SCI USA, V109, P15115, DOI 10.1073/pnas.1212802109; Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Barry SP, 2010, INT J EXP PATHOL, V91, P506, DOI 10.1111/j.1365-2613.2010.00734.x; Barry SP, 2009, BIOCHEM BIOPH RES CO, V385, P324, DOI 10.1016/j.bbrc.2009.05.051; Bezerra DP, 2007, TOXICOL IN VITRO, V21, P1, DOI 10.1016/j.tiv.2006.07.007; Bolli R, 2011, J MOL CELL CARDIOL, V50, P589, DOI 10.1016/j.yjmcc.2011.01.002; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dave B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030207; Demaria M, 2010, AGING-US, V2, P823, DOI 10.18632/aging.100232; Doucette TA, 2012, NEURO-ONCOLOGY, V14, P1136, DOI 10.1093/neuonc/nos139; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haviland R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024923; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Huang Y, 2007, J BIOL CHEM, V282, P34958, DOI 10.1074/jbc.M704548200; Jang JH, 2012, ANTIOXID REDOX SIGN, V16, P383, DOI 10.1089/ars.2011.4134; Jarnicki A, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-14; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Johnston PA, 2011, MOL INTERV, V11, P18, DOI 10.1124/mi.11.1.4; Jung JE, 2009, J NEUROSCI, V29, P7003, DOI 10.1523/JNEUROSCI.1110-09.2009; Kim BK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2247; Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200; Kim SW, 2007, J NEUROSCI RES, V85, P1252, DOI 10.1002/jnr.21236; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Lee SM, 2001, BIOCHIMIE, V83, P1057, DOI 10.1016/S0300-9084(01)01351-7; Litzenburger BC, 2011, CLIN CANCER RES, V17, P2314, DOI 10.1158/1078-0432.CCR-10-1903; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Oshima Y, 2005, CARDIOVASC RES, V65, P428, DOI 10.1016/j.cardiores.2004.10.021; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Ram PT, 2001, ONCOGENE, V20, P1601, DOI 10.1038/sj.onc.1204186; Redell MS, 2005, CURR PHARM DESIGN, V11, P2873, DOI 10.2174/1381612054546699; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shao H, 2004, J BIOL CHEM, V279, P18967, DOI 10.1074/jbc.M314037200; Shao H, 2001, BLOOD, V98, P3853, DOI 10.1182/blood.V98.13.3853; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Song LX, 2011, MOL CANCER THER, V10, P481, DOI 10.1158/1535-7163.MCT-10-0502; Timofeeva OA, 2012, J BIOL CHEM, V287, P14192, DOI 10.1074/jbc.M111.323899; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Xiong H, 2012, J BIOL CHEM, V287, P5819, DOI 10.1074/jbc.M111.295964; Xu XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004783; Yang J, 2005, CANCER RES, V65, P939; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhou HK, 2011, BONE, V49, P404, DOI 10.1016/j.bone.2011.04.020	60	108	111	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 12	2015	34	11					1341	1353		10.1038/onc.2014.72	http://dx.doi.org/10.1038/onc.2014.72			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD1AR	24681959	Green Accepted			2022-12-25	WOS:000350806500001
J	Omairi-Nasser, A; Haselkorn, R; Austin, J				Omairi-Nasser, Amin; Haselkorn, Robert; Austin, Jotham, II			Visualization of channels connecting cells in filamentous nitrogen-fixing cyanobacteria	FASEB JOURNAL			English	Article						Anabaena; heterocysts; communication; tomography	HETEROCYST-FORMING CYANOBACTERIUM; ANABAENA-SP PCC-7120; INTERCELLULAR MOLECULAR-EXCHANGE; PATTERN-FORMATION; PROTEIN; MUTANTS; DIFFERENTIATION; INTEGRITY; HETR; LOCALIZATION	Cyanobacteria, formerly called blue-green algae, are abundant bacteria that carry out green plant photosynthesis, fixing CO2 and generating O-2. Many species can also fix N-2 when reduced nitrogen sources are scarce. Many studies imply the existence of intracellular communicating channels in filamentous cyanobacteria, in particular, the nitrogen-fixing species. In a species such as Anabaena, growth in nitrogendepleted medium, in which similar to 10% of the cells differentiate into anaerobic factories for nitrogen fixation (heterocysts), requires the transport of amino acids from heterocysts to vegetative cells, and reciprocally, the transport of sugar from vegetative cells to heterocysts. Convincing physical evidence for such channels has been slim. Using improved preservation of structure by high-pressure rapid freezing of samples for electron microscopy, coupled with high-resolution 3D tomography, it has been possible to visualize and measure the dimensions of channels that breach the peptidoglycan between vegetative cells and between heterocysts and vegetative cells. The channels appear to be straight tubes, 21 nm long and 14 nm in diameter for the latter and 12 nm long and 12 nm in diameter for the former.	[Omairi-Nasser, Amin; Haselkorn, Robert; Austin, Jotham, II] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Austin, Jotham, II] Univ Chicago, Adv Electron Microscopy Facil, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Haselkorn, R (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 East 58th St, Chicago, IL 60637 USA.	rh01@uchicago.edu			Ellison Medical Foundation; University of Chicago	Ellison Medical Foundation(Lawrence Ellison Foundation); University of Chicago(University of Chicago)	This work was supported by the Ellison Medical Foundation and the University of Chicago. The authors thank the Electron Microscopy Core Facility at the University of Chicago, and David Mastronarde (University of Colorado, Boulder, CO, USA) for providing essential application software and support (IMOD and Serial EM). Birgitta Bergman (Stockholm University, Stockholm, Sweden) provided useful advice. Author contributions: A.O.-N. and J.A. performed the experiments, analyzed the results, and wrote the article; R. H. suggested the project, supervised the work, and contributed to the article.	Austin JR, 2014, METHODS MOL BIOL, V1062, P473, DOI 10.1007/978-1-62703-580-4_25; BAUER CC, 1995, J BACTERIOL, V177, P1520, DOI 10.1128/jb.177.6.1520-1526.1995; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Buikema WJ, 2001, P NATL ACAD SCI USA, V98, P2729, DOI 10.1073/pnas.051624898; BUIKEMA WJ, 1991, J BACTERIOL, V173, P1879, DOI 10.1128/jb.173.6.1879-1885.1991; Callahan SM, 2001, MOL MICROBIOL, V40, P941, DOI 10.1046/j.1365-2958.2001.02437.x; Cumino AC, 2007, PLANT PHYSIOL, V143, P1385, DOI 10.1104/pp.106.091736; Flores E, 2007, J BACTERIOL, V189, P3884, DOI 10.1128/JB.00085-07; GIDDINGS TH, 1978, CYTOBIOLOGIE, V16, P235; GIDDINGS TH, 1981, ARCH MICROBIOL, V129, P295, DOI 10.1007/BF00414700; GILKEY JC, 1986, J ELECTRON MICR TECH, V3, P177, DOI 10.1002/jemt.1060030206; Golden JW, 2003, CURR OPIN MICROBIOL, V6, P557, DOI 10.1016/j.mib.2003.10.004; Haselkorn R, 2008, MOL MICROBIOL, V70, P783, DOI 10.1111/j.1365-2958.2008.06475.x; Higa KC, 2012, MOL MICROBIOL, V83, P682, DOI 10.1111/j.1365-2958.2011.07949.x; Huang X, 2004, P NATL ACAD SCI USA, V101, P4848, DOI 10.1073/pnas.0400429101; JUTTNER F, 1983, J BACTERIOL, V155, P628; Khudyakov IY, 2004, P NATL ACAD SCI USA, V101, P16040, DOI 10.1073/pnas.0405572101; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; KUMAR A, 1981, Z ALLG MIKROBIOL, V21, P353, DOI 10.1002/jobm.3630210502; Li JH, 2003, MICROBIOL-SGM, V149, P3257, DOI 10.1099/mic.0.26462-0; Mariscal V, 2007, MOL MICROBIOL, V65, P1139, DOI 10.1111/j.1365-2958.2007.05856.x; Martin-Figueroa E, 2000, FEBS LETT, V476, P282, DOI 10.1016/S0014-5793(00)01722-1; Merino-Puerto V, 2011, MOL MICROBIOL, V82, P87, DOI 10.1111/j.1365-2958.2011.07797.x; Merino-Puerto V, 2010, MOL MICROBIOL, V75, P1159, DOI 10.1111/j.1365-2958.2009.07031.x; Mullineaux CW, 2008, EMBO J, V27, P1299, DOI 10.1038/emboj.2008.66; Nayar AS, 2007, MICROBIOL-SGM, V153, P601, DOI 10.1099/mic.0.2006/002535-0; Olive J, 1997, BBA-BIOENERGETICS, V1319, P275, DOI 10.1016/S0005-2728(96)00168-5; Sherman DM, 2000, J PHYCOL, V36, P932, DOI 10.1046/j.1529-8817.2000.99132.x; Ughy B, 2004, MICROBIOL-SGM, V150, P4147, DOI 10.1099/mic.0.27498-0; Valladares A, 2003, MOL MICROBIOL, V47, P1239, DOI 10.1046/j.1365-2958.2003.03372.x; Valladares A, 2007, J BACTERIOL, V189, P4425, DOI 10.1128/JB.00220-07; Vargas WA, 2011, PLANTA, V233, P153, DOI 10.1007/s00425-010-1288-5; WILCOX M, 1973, J CELL SCI, V13, P637; Wilk L, 2011, CELL MICROBIOL, V13, P1744, DOI 10.1111/j.1462-5822.2011.01655.x; Yoon HS, 1998, SCIENCE, V282, P935, DOI 10.1126/science.282.5390.935; Yoon HS, 2001, J BACTERIOL, V183, P2605, DOI 10.1128/JB.183.8.2605-2613.2001; Zhang LC, 2008, MOL MICROBIOL, V70, P814, DOI 10.1111/j.1365-2958.2008.06476.x	37	20	20	0	33	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3016	3022		10.1096/fj.14-252007	http://dx.doi.org/10.1096/fj.14-252007			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24675362				2022-12-25	WOS:000337949400024
J	Strachan, RT; Sun, JP; Rominger, DH; Violin, JD; Ahn, S; Thomsen, ARB; Zhu, X; Kleist, A; Costa, T; Lefkowitz, RJ				Strachan, Ryan T.; Sun, Jin-peng; Rominger, David H.; Violin, Jonathan D.; Ahn, Seungkirl; Thomsen, Alex Rojas Bie; Zhu, Xiao; Kleist, Andrew; Costa, Tommaso; Lefkowitz, Robert J.			Divergent Transducer-specific Molecular Efficacies Generate Biased Agonism at a G Protein-coupled Receptor ( GPCR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiotensin II; Drug Discovery; G Protein-coupled Receptors (GPCR); Molecular Pharmacology; Signal Transduction	BETA-ADRENERGIC-RECEPTOR; ALPHA FUSION PROTEINS; TERNARY COMPLEX MODEL; FUNCTIONAL SELECTIVITY; BETA(2)-ADRENERGIC RECEPTOR; 7-TRANSMEMBRANE RECEPTORS; SIGNAL-TRANSDUCTION; LIGAND-BINDING; DRUG DISCOVERY; HEART-FAILURE	Background: Biased agonism is an incompletely understood phenomenon describing the unequal activation of different signal transduction pathways by a G protein-coupled receptor (GPCR). Results: A cell-free approach using GPCR-transducer fusion proteins (G-protein or -arrestin) quantifies signaling in vitro to elucidate the molecular basis of biased agonism. Conclusion: Differences in ligand-receptor-transducer coupling account for biased agonism in cells. Significance: Biased agonism is a bona fide molecular property of GPCR ligands. The concept of biased agonism arises from the recognition that the ability of an agonist to induce a receptor-mediated response (i.e. efficacy) can differ across the multiple signal transduction pathways (e.g. G protein and -arrestin (arr)) emanating from a single GPCR. Despite the therapeutic promise of biased agonism, the molecular mechanism(s) whereby biased agonists selectively engage signaling pathways remain elusive. This is due in large part to the challenges associated with quantifying ligand efficacy in cells. To address this, we developed a cell-free approach to directly quantify the transducer-specific molecular efficacies of balanced and biased ligands for the angiotensin II type 1 receptor (AT(1)R), a prototypic GPCR. Specifically, we defined efficacy in allosteric terms, equating shifts in ligand affinity (i.e. K-Lo/K-Hi) at AT(1)R-G(q) and AT(1)R-arr2 fusion proteins with their respective molecular efficacies for activating G(q) and arr2. Consistent with ternary complex model predictions, transducer-specific molecular efficacies were strongly correlated with cellular efficacies for activating G(q) and arr2. Subsequent comparisons across transducers revealed that biased AT(1)R agonists possess biased molecular efficacies that were in strong agreement with the signaling bias observed in cellular assays. These findings not only represent the first measurements of the thermodynamic driving forces underlying differences in ligand efficacy between transducers but also support a molecular mechanism whereby divergent transducer-specific molecular efficacies generate biased agonism at a GPCR.	[Strachan, Ryan T.; Ahn, Seungkirl; Thomsen, Alex Rojas Bie; Zhu, Xiao; Kleist, Andrew; Lefkowitz, Robert J.] Duke Univ, Dept Med, Med Ctr, Durham, NC 27710 USA; [Sun, Jin-peng] Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Key Lab Expt Teratol,Minist Educ, Jinan 250012, Shandong, Peoples R China; [Rominger, David H.; Violin, Jonathan D.] Trevena Inc, King Of Prussia, PA 19406 USA; [Costa, Tommaso] Ist Super Sanita, Dipartimento Farmaco, I-00161 Rome, Italy; [Lefkowitz, Robert J.] Duke Univ, Dept Biochem, Med Ctr, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Howard Hughes Med Inst, Med Ctr, Durham, NC 27710 USA	Duke University; Shandong University; Istituto Superiore di Sanita (ISS); Duke University; Duke University; Howard Hughes Medical Institute	Costa, T (corresponding author), Ist Super Sanita, Dip Farmaco, Viale Regina Elena 299, I-00161 Rome, Italy.	tommaso.costa@iss.it; lefko001@receptor-biol.duke.edu	costa, tommaso/AAD-3714-2019; sun, Jinpeng/AAR-9196-2020; Lefkowitz, Robert/AAW-2649-2021	costa, tommaso/0000-0002-8729-3357; Thomsen, Alex/0000-0003-1638-8911	National Institutes of Health [HL16037, HL70631]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070631, R01HL016037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL16037 and HL70631. R. J. L. is a co-founder of Trevena, Inc., a privately held clinical stage pharmaceutical company dedicated to the discovery and development of biased GPCR ligands. J. D. V. and D. H. R. are both employed by Trevena, Inc.	Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Berg KA, 1998, MOL PHARMACOL, V54, P94, DOI 10.1124/mol.54.1.94; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Boerrigter G, 2011, CIRC-HEART FAIL, V4, P770, DOI 10.1161/CIRCHEARTFAILURE.111.962571; Bohinc BN, 2012, MINI-REV MED CHEM, V12, P856; Burnier M, 2000, LANCET, V355, P637, DOI 10.1016/S0140-6736(99)10365-9; DELEAN A, 1980, J BIOL CHEM, V255, P7108; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; DeWire SM, 2011, CIRC RES, V109, P205, DOI 10.1161/CIRCRESAHA.110.231308; EHLERT FJ, 1985, MOL PHARMACOL, V28, P410; Fenton AW, 2008, TRENDS BIOCHEM SCI, V33, P420, DOI 10.1016/j.tibs.2008.05.009; Figueroa KW, 2009, J PHARMACOL EXP THER, V328, P331, DOI 10.1124/jpet.108.145219; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, DOI 10.1038/nrd3954-c2; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2013, BRIT J PHARMACOL, V168, P554, DOI 10.1111/j.1476-5381.2012.02223.x; Kenakin T, 2012, BMC PHARMACOL TOXICO, V13, DOI 10.1186/2050-6511-13-3; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kenakin TP, 2012, BRIT J PHARMACOL, V165, P1659, DOI 10.1111/j.1476-5381.2011.01749.x; KENT RS, 1980, MOL PHARMACOL, V17, P14; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Mary S, 2012, P NATL ACAD SCI USA, V109, P8304, DOI 10.1073/pnas.1119881109; Molinari P, 2003, J BIOL CHEM, V278, P15778, DOI 10.1074/jbc.M300731200; Monasky MM, 2013, AM J PHYSIOL-HEART C, V305, pH856, DOI 10.1152/ajpheart.00327.2013; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Onaran HO, 2012, NAT CHEM BIOL, V8, P674, DOI 10.1038/nchembio.1024; Onaran HO, 1997, ANN NY ACAD SCI, V812, P98, DOI 10.1111/j.1749-6632.1997.tb48150.x; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Rajagopal S, 2013, NAT REV DRUG DISCOV, V12, DOI 10.1038/nrd3954-c1; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Seifert R, 1999, TRENDS PHARMACOL SCI, V20, P383, DOI 10.1016/S0165-6147(99)01368-1; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Soergel DG, 2013, J CLIN PHARMACOL, V53, P892, DOI 10.1002/jcph.111; STEPHENSON RP, 1956, BRIT J PHARM CHEMOTH, V11, P379, DOI 10.1111/j.1476-5381.1956.tb00006.x; Strachan RT, 2010, MOL PHARMACOL, V77, P327, DOI 10.1124/mol.109.061440; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Violin JD, 2013, TRENDS CARDIOVAS MED, V23, P242, DOI 10.1016/j.tcm.2013.01.002; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801	63	77	78	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14211	14224		10.1074/jbc.M114.548131	http://dx.doi.org/10.1074/jbc.M114.548131			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24668815	hybrid, Green Published			2022-12-25	WOS:000335984600047
J	Lutz, D; Loers, G; Kleene, R; Oezen, I; Kataria, H; Katagihallimath, N; Braren, I; Harauz, G; Schachner, M				Lutz, David; Loers, Gabriele; Kleene, Ralf; Oezen, Iris; Kataria, Hardeep; Katagihallimath, Nainesh; Braren, Ingke; Harauz, George; Schachner, Melitta			Myelin Basic Protein Cleaves Cell Adhesion Molecule L1 and Promotes Neuritogenesis and Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate; Carbohydrate-binding Protein; Cell Adhesion; Cell Death; Cell Surface; Myelin; Neurite Outgrowth; Neurobiology; Protease; Protein Processing	SPINAL-CORD-INJURY; NEURITE OUTGROWTH; MULTIPLE-SCLEROSIS; NERVOUS-SYSTEM; IMMUNOGLOBULIN-SUPERFAMILY; RECOGNITION MOLECULES; NEURONAL MIGRATION; RAT-BRAIN; EXPRESSION; GENE	Background: The cell adhesion molecule L1 plays important roles in the developing and adult nervous system. Results: L1 is cleaved by myelin basic protein (MBP) yielding a L1 fragment that promotes L1-dependent functions. Conclusion: L1 functions in the nervous system depend on MBP. Significance: Study of the L1 and MBP functions may contribute to understanding the pathogenesis of demyelinating and neurodegenerative diseases. The cell adhesion molecule L1 is a Lewis(x)-carrying glycoprotein that plays important roles in the developing and adult nervous system. Here we show that myelin basic protein (MBP) binds to L1 in a Lewis(x)-dependent manner. Furthermore, we demonstrate that MBP is released by murine cerebellar neurons as a sumoylated dynamin-containing protein upon L1 stimulation and that this MBP cleaves L1 as a serine protease in the L1 extracellular domain at Arg(687) yielding a transmembrane fragment that promotes neurite outgrowth and neuronal survival in cell culture. L1-induced neurite outgrowth and neuronal survival are reduced in MBP-deficient cerebellar neurons and in wild-type cerebellar neurons in the presence of an MBP antibody or L1 peptide containing the MBP cleavage site. Genetic ablation of MBP in shiverer mice and mutagenesis of the proteolytically active site in MBP or of the MBP cleavage site within L1 as well as serine protease inhibitors and an L1 peptide containing the MBP cleavage site abolish generation of the L1 fragment. Our findings provide evidence for novel functions of MBP in the nervous system.	[Lutz, David; Loers, Gabriele; Kleene, Ralf; Oezen, Iris; Kataria, Hardeep; Katagihallimath, Nainesh; Schachner, Melitta] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Braren, Ingke] Univ Klinikum Hamburg Eppendorf, Inst Expt Pharmakol & Toxikol, Hamburg Zentrum Expt Therapieforsch HEXT, Vector Core Unit, D-20246 Hamburg, Germany; [Harauz, George] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Guelph; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Schachner, M (corresponding author), Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Martinistr 52, D-20246 Hamburg, Germany.	melitta.schachner@zmnh.uni-hamburg.de	Kataria, Hardeep/AAI-8411-2020; Lutz, David/AAX-1607-2021	Kataria, Hardeep/0000-0001-8413-0600; Lutz, David/0000-0001-9171-4081; Harauz, George/0000-0002-6114-9947	Deutsche Forschungsgemeinschaft [KL1378/2-2, SFB470/C3]; New Jersey Commission for Spinal Cord Research; Li Ka-Shing Foundation at Shantou University Medical College	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); New Jersey Commission for Spinal Cord Research; Li Ka-Shing Foundation at Shantou University Medical College	This work was supported by the Deutsche Forschungsgemeinschaft (KL1378/2-2 and SFB470/C3).; Supported by the New Jersey Commission for Spinal Cord Research and the Li Ka-Shing Foundation at Shantou University Medical College.	APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Barbin G, 2004, NEURON GLIA BIOL, V1, P65, DOI 10.1017/s1740925x04000092; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Brito C, 2007, J NEUROSCI RES, V85, P1260, DOI 10.1002/jnr.21230; Capello E, 1997, ANN NEUROL, V41, P797, DOI 10.1002/ana.410410616; Chen J, 2007, BRAIN, V130, P954, DOI 10.1093/brain/awm049; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; Chignola R, 2000, CLIN EXP IMMUNOL, V122, P429, DOI 10.1046/j.1365-2249.2000.01363.x; Cui YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017126; D'Souza CA, 2005, BIOCHEMISTRY-US, V44, P12905, DOI 10.1021/bi051152f; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; DeBruin LS, 2006, BIOCHEM CELL BIOL, V84, P993, DOI 10.1139/O06-180; Derfuss T, 2012, CURR OPIN NEUROL, V25, P231, DOI 10.1097/WCO.0b013e3283533a64; Feng JM, 2007, NEUROCHEM RES, V32, P273, DOI 10.1007/s11064-006-9164-1; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Guerriero C, 2003, J NEUROIMMUNOL, V141, P83, DOI 10.1016/S0165-5728(03)00226-1; Guseva D, 2011, EXP NEUROL, V229, P339, DOI 10.1016/j.expneurol.2011.02.018; Harauz G, 2013, J NEUROCHEM, V125, P334, DOI 10.1111/jnc.12195; Heller M, 2003, J NEUROCHEM, V84, P557, DOI 10.1046/j.1471-4159.2003.01537.x; Hosono H, 2008, BIOL PHARM BULL, V31, P834, DOI 10.1248/bpb.31.834; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Katagihallimath N, 2010, EUR J CELL BIOL, V89, P77, DOI 10.1016/j.ejcb.2009.10.007; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; Kurumaji A, 2001, AM J MED GENET, V105, P99; Landry CF, 1996, J NEUROSCI, V16, P2452; Lavdas AA, 2010, EXP NEUROL, V221, P206, DOI 10.1016/j.expneurol.2009.10.024; Liao MC, 2009, J BIOL CHEM, V284, P28917, DOI 10.1074/jbc.M109.050856; Lieberoth A, 2009, J NEUROSCI, V29, P6677, DOI 10.1523/JNEUROSCI.4361-08.2009; Loers G, 2005, J NEUROCHEM, V92, P1463, DOI 10.1111/j.1471-4159.2004.02983.x; Loers G, 2012, J NEUROSCI, V32, P3917, DOI 10.1523/JNEUROSCI.6165-11.2012; Lutz D, 2014, J NEUROCHEM, V128, P713, DOI 10.1111/jnc.12473; Lutz D, 2012, J BIOL CHEM, V287, P17161, DOI 10.1074/jbc.M112.346759; Makhina T, 2009, MOL CELL NEUROSCI, V41, P206, DOI 10.1016/j.mcn.2009.02.010; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Matsumoto-Miyai K, 2003, J NEUROSCI, V23, P7727; MIKOSHIBA K, 1983, DEV BRAIN RES, V7, P71, DOI 10.1016/0165-3806(83)90082-2; MILLER SL, 1989, J NEUROSCI RES, V22, P262, DOI 10.1002/jnr.490220305; Musse AA, 2007, INT REV NEUROBIOL, V79, P149, DOI 10.1016/S0074-7742(07)79007-4; Nagasato K, 1997, J NEUROIMMUNOL, V72, P21, DOI 10.1016/S0165-5728(96)00137-3; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Pedraza L, 1997, NEURON, V18, P579, DOI 10.1016/S0896-6273(00)80299-8; POLTORAK M, 1995, EXP NEUROL, V131, P266, DOI 10.1016/0014-4886(95)90048-9; READHEAD C, 1990, ANN NY ACAD SCI, V605, P280; READHEAD C, 1990, BEHAV GENET, V20, P213, DOI 10.1007/BF01067791; Roonprapunt C, 2003, J NEUROTRAUM, V20, P871, DOI 10.1089/089771503322385809; Sajdel-Sulkowska EM, 1998, ACTA BIOCHIM POL, V45, P781, DOI 10.18388/abp.1998_4272; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Smith GST, 2011, J NEUROSCI RES, V89, P467, DOI 10.1002/jnr.22570; STAUGAITIS SM, 1990, J CELL BIOL, V110, P1719, DOI 10.1083/jcb.110.5.1719; Streit A, 1996, J NEUROCHEM, V66, P834; Strekalova H, 2006, NEUROBIOL AGING, V27, P1, DOI 10.1016/j.neurobiolaging.2004.11.013; Tosic M, 2002, GLIA, V37, P219, DOI 10.1002/glia.10028; URSELL MRM, 1995, J NEUROSCI RES, V42, P41, DOI 10.1002/jnr.490420106; Wakabayashi Y, 2008, PROG NEURO-PSYCHOPH, V32, P1199, DOI 10.1016/j.pnpbp.2008.03.005; WING DR, 1992, BIOCHEM SOC T, V20, P386, DOI 10.1042/bst0200386; WOLF MK, 1984, ADV EXP MED BIOL, V181, P115; Woodruff RH, 1998, J NEUROCYTOL, V27, P683, DOI 10.1023/A:1006972316697; Xu JC, 2011, J NEUROTRAUM, V28, P1921, DOI 10.1089/neu.2011.1783; Zhang AM, 1999, J BIOL CHEM, V274, P10439, DOI 10.1074/jbc.274.15.10439; Zhang Y, 2005, P NATL ACAD SCI USA, V102, P14883, DOI 10.1073/pnas.0505164102; Zhang YQ, 2008, BIOCHEM BIOPH RES CO, V374, P673, DOI 10.1016/j.bbrc.2008.07.109	67	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13503	13518		10.1074/jbc.M113.530238	http://dx.doi.org/10.1074/jbc.M113.530238			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24671420	Green Published, hybrid			2022-12-25	WOS:000335522800046
J	Chen, M; Ye, TR; Krumholz, LR; Jiang, HL				Chen, Mo; Ye, Tian-Ran; Krumholz, Lee R.; Jiang, He-Long			Temperature and Cyanobacterial Bloom Biomass Influence Phosphorous Cycling in Eutrophic Lake Sediments	PLOS ONE			English	Article							FE(III) OXIDE REDUCTION; SOIL ORGANIC-MATTER; FRESH-WATER; SULFATE REDUCTION; PROFUNDAL SEDIMENTS; LARGE SHALLOW; IRON; SULFUR; PHOSPHATE; RELEASE	Cyanobacterial blooms frequently occur in freshwater lakes, subsequently, substantial amounts of decaying cyanobacterial bloom biomass (CBB) settles onto the lake sediments where anaerobic mineralization reactions prevail. Coupled Fe/S cycling processes can influence the mobilization of phosphorus (P) in sediments, with high releases often resulting in eutrophication. To better understand eutrophication in Lake Taihu (PRC), we investigated the effects of CBB and temperature on phosphorus cycling in lake sediments. Results indicated that added CBB not only enhanced sedimentary iron reduction, but also resulted in a change from net sulfur oxidation to sulfate reduction, which jointly resulted in a spike of soluble Fe(II) and the formation of FeS/FeS2. Phosphate release was also enhanced with CBB amendment along with increases in reduced sulfur. Further release of phosphate was associated with increases in incubation temperature. In addition, CBB amendment resulted in a shift in P from the Fe-adsorbed P and the relatively unreactive Residual-P pools to the more reactive Al-adsorbed P, Ca-bound P and organic-P pools. Phosphorus cycling rates increased on addition of CBB and were higher at elevated temperatures, resulting in increased phosphorus release from sediments. These findings suggest that settling of CBB into sediments will likely increase the extent of eutrophication in aquatic environments and these processes will be magnified at higher temperatures.	[Chen, Mo; Ye, Tian-Ran; Jiang, He-Long] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China; [Chen, Mo] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Krumholz, Lee R.] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Oklahoma System; University of Oklahoma - Norman	Jiang, HL (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Jiangsu, Peoples R China.	hljiang@niglas.ac.cn	Jiang, Helong/H-2709-2015	Jiang, He-Long/0000-0001-5528-423X	National Natural Science Foundation of China [51079139]; Innovation Program of the Chinese Academy of Sciences [KZCX2-EW-314]; 135 project of Nanjing Institute of Geography and Limnology, CAS [NIGLAS2012135008]; Chinese Academy of Sciences [2011T1Z37]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); 135 project of Nanjing Institute of Geography and Limnology, CAS; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Natural Science Foundation of China (51079139), the Innovation Program of the Chinese Academy of Sciences (KZCX2-EW-314), 135 project of Nanjing Institute of Geography and Limnology, CAS (No. NIGLAS2012135008), and Chinese Academy of Sciences visiting professorship for senior international scientists (2011T1Z37). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen FO, 1999, HYDROBIOLOGIA, V408, P175, DOI 10.1023/A:1017027818233; Bai XL, 2009, ENVIRON POLLUT, V157, P2507, DOI 10.1016/j.envpol.2009.03.018; BAK F, 1991, FEMS MICROBIOL ECOL, V85, P31, DOI 10.1016/0378-1097(91)90629-O; Bullock AL, 2013, ESTUAR COAST, V36, P482, DOI 10.1007/s12237-012-9536-5; Carey CC, 2012, WATER RES, V46, P1394, DOI 10.1016/j.watres.2011.12.016; Chacon N, 2006, BIOGEOCHEMISTRY, V78, P67, DOI 10.1007/s10533-005-2343-3; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Conant RT, 2008, GLOBAL CHANGE BIOL, V14, P868, DOI 10.1111/j.1365-2486.2008.01541.x; Condron LM, 2011, J SOIL SEDIMENT, V11, P830, DOI 10.1007/s11368-011-0363-2; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Correll DL, 1998, J ENVIRON QUAL, V27, P261, DOI 10.2134/jeq1998.00472425002700020004x; Gachter R, 2003, LIMNOL OCEANOGR, V48, P929; GACHTER R, 1993, HYDROBIOLOGIA, V253, P103, DOI 10.1007/BF00050731; Genkai-Kato M, 2005, ECOLOGY, V86, P210, DOI 10.1890/03-0545; Gonsiorczyk T, 1998, WATER SCI TECHNOL, V37, P51, DOI 10.1016/S0273-1223(98)00055-9; Gunnars A, 1997, BIOGEOCHEMISTRY, V37, P203, DOI 10.1023/A:1005744610602; Handley KM, 2013, ISME J, V7, P800, DOI 10.1038/ismej.2012.148; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Holmer M, 2001, FRESHWATER BIOL, V46, P431, DOI 10.1046/j.1365-2427.2001.00687.x; Holmkvist L, 2011, GEOCHIM COSMOCHIM AC, V75, P3581, DOI 10.1016/j.gca.2011.03.033; Hsieh YP, 1997, CHEM GEOL, V137, P255, DOI 10.1016/S0009-2541(96)00159-3; Hu WP, 2006, ECOL MODEL, V190, P367, DOI 10.1016/j.ecolmodel.2005.02.024; INGVORSEN K, 1981, APPL ENVIRON MICROB, V42, P1029, DOI 10.1128/AEM.42.6.1029-1036.1981; Jiang X, 2008, WATER RES, V42, P2251, DOI 10.1016/j.watres.2007.12.003; Jilbert T, 2011, BIOGEOSCIENCES, V8, P1699, DOI 10.5194/bg-8-1699-2011; Jost G, 2010, FEMS MICROBIOL ECOL, V71, P226, DOI 10.1111/j.1574-6941.2009.00798.x; Karlson AML, 2008, LIMNOL OCEANOGR, V53, P2754, DOI 10.4319/lo.2008.53.6.2754; Kelton N, 2005, LAKE RESERV MANAGE, V21, P223, DOI 10.1080/07438140509354432; Kim LH, 2004, SCI TOTAL ENVIRON, V321, P115, DOI 10.1016/j.scitotenv.2003.08.018; Kraal P, 2013, ENVIRON SCI TECHNOL, V47, P3114, DOI 10.1021/es304868t; Li DP, 2010, ECOL ENG, V36, P958, DOI 10.1016/j.ecoleng.2010.04.014; Li JH, 1996, HYDROBIOLOGIA, V333, P201, DOI 10.1007/BF00013434; Li KY, 2010, WATER RES, V44, P1591, DOI 10.1016/j.watres.2009.11.007; LOVLEY DR, 1987, APPL ENVIRON MICROB, V53, P1536, DOI 10.1128/AEM.53.7.1536-1540.1987; MCLAUGHLIN JR, 1981, J SOIL SCI, V32, P365, DOI 10.1111/j.1365-2389.1981.tb01712.x; Michalak AM, 2013, P NATL ACAD SCI USA, V110, P6448, DOI 10.1073/pnas.1216006110; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; North RL, 2007, LIMNOL OCEANOGR, V52, P315, DOI 10.4319/lo.2007.52.1.0315; Pace Michael L., 2005, P103, DOI 10.1093/acprof:oso/9780198527084.003.0007; Peng JF, 2007, ECOL ENG, V31, P92, DOI 10.1016/j.ecoleng.2007.06.005; Pester M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00072; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; Reddy KR, 1999, CRIT REV ENV SCI TEC, V29, P83, DOI 10.1080/10643389991259182; Robador A, 2009, ENVIRON MICROBIOL, V11, P1692, DOI 10.1111/j.1462-2920.2009.01896.x; Roden EE, 1997, ARCH HYDROBIOL, V139, P347; Roden EE, 1996, LIMNOL OCEANOGR, V41, P1733, DOI 10.4319/lo.1996.41.8.1733; Rozan TF, 2002, LIMNOL OCEANOGR, V47, P1346, DOI 10.4319/lo.2002.47.5.1346; Rydin E, 1998, WATER RES, V32, P2969, DOI 10.1016/S0043-1354(98)00055-4; Shao KQ, 2013, J BASIC MICROB, V53, P549, DOI 10.1002/jobm.201100532; Smith SJ, 2005, CLIMATIC CHANGE, V73, P267, DOI 10.1007/s10584-005-6887-y; Song N, 2013, HYDROBIOLOGIA, V714, P131, DOI 10.1007/s10750-013-1529-2; Spears BM, 2007, HYDROBIOLOGIA, V584, P37, DOI 10.1007/s10750-007-0610-0; Strosser Eduard, 2010, Journal of Agrobiology, V27, P49, DOI 10.2478/s10146-009-0008-x; Taillefert M, 2000, ENVIRON SCI TECHNOL, V34, P2169, DOI 10.1021/es990120a; Tang XM, 2009, MICROB ECOL, V58, P307, DOI 10.1007/s00248-008-9482-8; Ternan NG, 1998, WORLD J MICROB BIOT, V14, P635, DOI 10.1023/A:1008848401799; Turner AM, 2010, ECOL APPL, V20, P2089, DOI 10.1890/10-0208.1; Vahtera E, 2007, AMBIO, V36, P186, DOI 10.1579/0044-7447(2007)36[186:IEFENC]2.0.CO;2; VANCAPPELLEN P, 1988, AM J SCI, V288, P289, DOI 10.2475/ajs.288.4.289; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wilhelm S, 2008, FRESHWATER BIOL, V53, P226, DOI 10.1111/j.1365-2427.2007.01887.x; Zhu YR, 2013, ENVIRON SCI TECHNOL, V47, P7679, DOI 10.1021/es305277g	62	73	82	14	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93130	10.1371/journal.pone.0093130	http://dx.doi.org/10.1371/journal.pone.0093130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682039	Green Published, Green Submitted, gold			2022-12-25	WOS:000333678100026
J	Brown, AD; Sager, BW; Gorthi, A; Tonapi, SS; Brown, EJ; Bishop, AJR				Brown, Adam D.; Sager, Brian W.; Gorthi, Aparna; Tonapi, Sonal S.; Brown, Eric J.; Bishop, Alexander J. R.			ATR Suppresses Endogenous DNA Damage and Allows Completion of Homologous Recombination Repair	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; EARLY EMBRYONIC LETHALITY; S-PHASE CHECKPOINT; CELL-CYCLE; MAMMALIAN-CELLS; IN-VIVO; ATAXIA-TELANGIECTASIA; INCREASED FREQUENCY; REPLICATION FORKS; SECKEL-SYNDROME	DNA replication fork stalling or collapse that arises from endogenous damage poses a serious threat to genome stability, but cells invoke an intricate signaling cascade referred to as the DNA damage response (DDR) to prevent such damage. The gene product ataxia telangiectasia and Rad3-related (ATR) responds primarily to replication stress by regulating cell cycle checkpoint control, yet it's role in DNA repair, particularly homologous recombination (HR), remains unclear. This is of particular interest since HR is one way in which replication restart can occur in the presence of a stalled or collapsed fork. Hypomorphic mutations in human ATR cause the rare autosomal-recessive disease Seckel syndrome, and complete loss of Atr in mice leads to embryonic lethality. We recently adapted the in vivo murine pink-eyed unstable (p(un)) assay for measuring HR frequency to be able to investigate the role of essential genes on HR using a conditional Cre/loxP system. Our system allows for the unique opportunity to test the effect of ATR loss on HR in somatic cells under physiological conditions. Using this system, we provide evidence that retinal pigment epithelium (RPE) cells lacking ATR have decreased density with abnormal morphology, a decreased frequency of HR and an increased level of chromosomal damage.	[Brown, Adam D.; Sager, Brian W.; Gorthi, Aparna; Tonapi, Sonal S.; Bishop, Alexander J. R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Brown, Adam D.; Sager, Brian W.; Gorthi, Aparna; Tonapi, Sonal S.; Bishop, Alexander J. R.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Brown, Eric J.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; [Bishop, Alexander J. R.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Pennsylvania; Pennsylvania Medicine; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Bishop, AJR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	bishopa@uthscsa.edu		Gorthi, Aparna/0000-0001-5935-4098; Bishop, Alexander/0000-0002-5742-4387	National Institute of Environmental Health Sciences [K22ES012264]; American Cancer Society Institutional Research Grant [ACS-IRG-00-173-04]; GCCRI Ambassador's Circle Research Support Award; National Institute of Aging [T32AG021890]; Medical Student Summer Research Program, School of Medicine, UTHSCSA; Cancer Prevention Research Institute of Texas [RP101491]; UT System Graduate Programs Initiative; National Cancer Institute [T32CA148724-2]; Greehey Children's Cancer Research Institute; NATIONAL CANCER INSTITUTE [T32CA148724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES012264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027376, T32AG021890] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Cancer Society Institutional Research Grant(American Cancer Society); GCCRI Ambassador's Circle Research Support Award; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Student Summer Research Program, School of Medicine, UTHSCSA; Cancer Prevention Research Institute of Texas; UT System Graduate Programs Initiative; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Greehey Children's Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Environmental Health Sciences [grant K22ES012264 to A.J.R.B.]; American Cancer Society Institutional Research Grant [ACS-IRG-00-173-04 to A.J.R.B.]; GCCRI Ambassador's Circle Research Support Award [to A.J.R.B.]; the National Institute of Aging [grant T32AG021890 to A. D. B.], the Medical Student Summer Research Program, School of Medicine, UTHSCSA [to B. W. S.], the Cancer Prevention Research Institute of Texas [grant RP101491 to A. G.], a Translational Science Training Across Disciplines Scholarship from the UT System Graduate Programs Initiative [to A. G.], a National Cancer Institute [grant T32CA148724-2 to SST] and Greehey Children's Cancer Research Institute endowment funds to defray the costs of publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335; Bishop AJR, 2003, CANCER RES, V63, P5335; Bishop AJR, 2000, CANCER RES, V60, P395; Bishop AJR, 2001, CARCINOGENESIS, V22, P641, DOI 10.1093/carcin/22.4.641; BRILLIANT MH, 1991, SCIENCE, V252, P566, DOI 10.1126/science.1673574; Brilliant MH, 2001, PIGM CELL RES, V14, P86, DOI 10.1034/j.1600-0749.2001.140203.x; Brown AD, 2011, MOL CELL BIOL, V31, P3593, DOI 10.1128/MCB.00848-10; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Chanoux RA, 2009, J BIOL CHEM, V284, P5994, DOI 10.1074/jbc.M806739200; Claybon A, 2011, JOVE-J VIS EXP, DOI 10.3791/2563; Claybon A, 2010, NUCLEIC ACIDS RES, V38, P7538, DOI 10.1093/nar/gkq624; Davies SL, 2004, MOL CELL BIOL, V24, P1279, DOI 10.1128/MCB.24.3.1279-1291.2004; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Eykelenboom JK, 2013, CELL REP, V5, P1095, DOI 10.1016/j.celrep.2013.10.027; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Friedberg EC, 2006, DNA REPAIR, V5, P189, DOI 10.1016/j.dnarep.2005.09.009; GALLI A, 1995, MOL GEN GENET, V248, P301, DOI 10.1007/BF02191597; Garg R, 2004, MOL CANCER RES, V2, P362; Gunn A, 2011, J BIOL CHEM, V286, P42470, DOI 10.1074/jbc.M111.309252; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Hu BC, 2005, CANCER RES, V65, P8613, DOI 10.1158/0008-5472.CAN-05-1966; Karia B, 2013, DNA REPAIR AMST; Li WH, 2004, J CELL BIOL, V165, P801, DOI 10.1083/jcb.200402095; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Mori M, 2002, INVEST OPHTH VIS SCI, V43, P1384; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Oetting WS, 1999, HUM MUTAT, V13, P99, DOI 10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.3.CO;2-3; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Pichierri P, 2003, ONCOGENE, V22, P1491, DOI 10.1038/sj.onc.1206169; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Polo SE, 2012, MOL CELL, V45, P505, DOI 10.1016/j.molcel.2011.12.035; Reliene R, 2004, DNA REPAIR, V3, P103, DOI 10.1016/j.dnarep.2003.09.010; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Thanos A, 2012, AM J PATHOL, V180, P1917, DOI 10.1016/j.ajpath.2012.01.017; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Wang HY, 2004, CANCER RES, V64, P7139, DOI 10.1158/0008-5472.CAN-04-1289; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yeung PL, 2012, J CELL BIOCHEM, V113, P1787, DOI 10.1002/jcb.24050	47	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e91222	10.1371/journal.pone.0091222	http://dx.doi.org/10.1371/journal.pone.0091222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675793	gold, Green Submitted, Green Published			2022-12-25	WOS:000333677500012
J	Chen, L; Wu, JJ; Chen, XH; Cao, L; Wu, Y; Zhu, LJ; Lv, KT; Ji, CB; Guo, XR				Chen, Ling; Wu, Jing-Jing; Chen, Xiao-Hui; Cao, Li; Wu, Yun; Zhu, Li-Jun; Lv, Kang-Tai; Ji, Chen-Bo; Guo, Xi-Rong			Measurement of Fetal Abdominal and Subscapular Subcutaneous Tissue Thickness during Pregnancy to Predict Macrosomia: A Pilot Study	PLOS ONE			English	Article							GESTATIONAL-DIABETES-MELLITUS; BODY-COMPOSITION; NEWBORN-INFANTS; GROWTH; WEIGHT; ULTRASOUND; OUTCOMES; WOMEN; DELIVERY; RISK	This study assessed the growth trends and reference ranges of the ultrasound parameters, fetal abdominal subcutaneous tissue thickness (ASTT) and subscapular subcutaneous tissue thickness (SSTT), in the last two trimesters of normal pregnancy in a Chinese population. We recruited 744 healthy women with singleton pregnancies. The ASTT and SSTT were evaluated at different times between 21 and 36 weeks of gestation. The correlations between these parameters and fetal gestational weeks were assessed using linear regression analysis. Both ASTT and SSTT increased with gestation, and both parameters showed a strong correlation with gestation (ASTT vs. GA, R-2 = 0.792; P < 0.0001; SSTT vs. GA, R-2 = 0.302; P < 0.0001). Time-specific reference ranges, including 5th, 50th and 95th percentiles and means +/- SD, were constructed for ASTT and SSTT. These results provide a preliminary reference range to evaluate whether fetal development and maternal metabolic health is normal or not in a Chinese population.	[Chen, Ling; Wu, Jing-Jing; Chen, Xiao-Hui; Cao, Li; Wu, Yun; Zhu, Li-Jun; Lv, Kang-Tai; Ji, Chen-Bo; Guo, Xi-Rong] Nanjing Med Univ, Nanjing Maternal & Child Hlth Hosp, Nanjing, Jiangsu, Peoples R China; [Chen, Ling; Guo, Xi-Rong] Nanjing Med Univ, Inst Pediat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Ji, CB (corresponding author), Nanjing Med Univ, Nanjing Maternal & Child Hlth Hosp, Nanjing, Jiangsu, Peoples R China.	chenboji@njmu.edu.cn; xrguo@njmu.edu.cn			National Key Basic Research Program of China [2013CB530604]; National Natural Science Foundation of China [81270928, 81200642]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Medical Innovation Team Project of Jiangsu province [LJ201108]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Medical Innovation Team Project of Jiangsu province	This work was supported by grants from the National Key Basic Research Program of China (2013CB530604), the National Natural Science Foundation of China (Grant Nos. 81270928 and 81200642), the Priority Academic Program Development of Jiangsu Higher Education Institutions, and the Medical Innovation Team Project of Jiangsu province (LJ201108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein IM, 1997, AM J OBSTET GYNECOL, V176, P28, DOI 10.1016/S0002-9378(97)80006-3; BERNSTEIN IM, 1994, OBSTET GYNECOL, V83, P462; Buchanan TA, 1999, DIABETES, V48, P2430, DOI 10.2337/diabetes.48.12.2430; Buhling KJ, 2012, ULTRASOUND OBST GYN, V39, P558, DOI 10.1002/uog.10092; CATALANO PM, 1992, OBSTET GYNECOL, V79, P46; Cetin I, 2008, SEMIN ULTRASOUND CT, V29, P136, DOI 10.1053/j.sult.2008.01.002; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Dashe JS, 2000, OBSTET GYNECOL, V96, P321, DOI 10.1016/S0029-7844(00)00943-1; de Groot LCPGM, 1999, NUTR REV, V57, P62; Edwards LE, 1996, OBSTET GYNECOL, V87, P389, DOI 10.1016/0029-7844(95)00446-7; Galan HL, 2001, AM J OBSTET GYNECOL, V185, P839, DOI 10.1067/mob.2001.117350; Gardosi J, 2006, HORM RES, V65, P15, DOI 10.1159/000091501; Gillmer MD, 1975, BRIT MED J, V3, P402; Gojnic M, 2012, CLIN EXP OBSTET GYN, V39, P512; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; Larciprete G, 2005, ULTRASOUND OBST GYN, V26, P258, DOI 10.1002/uog.1980; Larciprete G, 2003, ULTRASOUND OBST GYN, V22, P591, DOI 10.1002/uog.926; Li Shengli, 2004, PRENATAL ULTRASOUNDG; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; MINTZ MC, 1989, AM J PERINAT, V6, P240, DOI 10.1055/s-2007-999585; Rigano S, 2000, CROAT MED J, V41, P240; ROSATI P, 1992, ULTRASOUND OBST GYN, V2, P23, DOI 10.1046/j.1469-0705.1992.02010023.x; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; SHEPARD MJ, 1982, AM J OBSTET GYNECOL, V142, P47; WEN SW, 1990, AM J OBSTET GYNECOL, V162, P53; WHITELAW A, 1977, LANCET, V1, P15	27	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93077	10.1371/journal.pone.0093077	http://dx.doi.org/10.1371/journal.pone.0093077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675769	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677500070
J	Hamblin, J; Stefanova, K; Angessa, TT				Hamblin, John; Stefanova, Katia; Angessa, Tefera Tolera			Variation in Chlorophyll Content per Unit Leaf Area in Spring Wheat and Implications for Selection in Segregating Material	PLOS ONE			English	Article							PHOTOSYNTHESIS	Reduced levels of leaf chlorophyll content per unit leaf area in crops may be of advantage in the search for higher yields. Possible reasons include better light distribution in the crop canopy and less photochemical damage to leaves absorbing more light energy than required for maximum photosynthesis. Reduced chlorophyll may also reduce the heat load at the top of canopy, reducing water requirements to cool leaves. Chloroplasts are nutrient rich and reducing their number may increase available nutrients for growth and development. To determine whether this hypothesis has any validity in spring wheat requires an understanding of genotypic differences in leaf chlorophyll content per unit area in diverse germplasm. This was measured with a SPAD 502 as SPAD units. The study was conducted in series of environments involving up to 28 genotypes, mainly spring wheat. In general, substantial and repeatable genotypic variation was observed. Consistent SPAD readings were recorded for different sampling positions on leaves, between different leaves on single plant, between different plants of the same genotype, and between different genotypes grown in the same or different environments. Plant nutrition affected SPAD units in nutrient poor environments. Wheat genotypes DBW 10 and Transfer were identified as having consistent and contrasting high and low average SPAD readings of 52 and 32 units, respectively, and a methodology to allow selection in segregating populations has been developed.	[Hamblin, John; Stefanova, Katia] Univ Western Australia, Inst Agr, Crawley, WA, Australia; [Angessa, Tefera Tolera] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Hamblin, J (corresponding author), Univ Western Australia, Inst Agr, Crawley, WA, Australia.	hamway2@gmail.com	Angessa, Tefera/GLU-7090-2022	Angessa, Tefera Tolera/0000-0002-2400-1732	The University of Western Australia; SuperSeed Technologies Pty Ltd (SST)	The University of Western Australia(University of Melbourne); SuperSeed Technologies Pty Ltd (SST)	The University of Western Australia funded the salaries of Drs. Stefanove and Angessa. Dr. Hamblin is retired and self funded. The operating and publishing costs were supplied from SuperSeed Technologies Pty Ltd (SST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen X, 2007, PLANT SCI, V173, P397, DOI 10.1016/j.plantsci.2007.06.012; DONALD CM, 1976, ADV AGRON, V28, P361, DOI 10.1016/S0065-2113(08)60559-3; Giunta F, 2002, EUPHYTICA, V125, P197, DOI 10.1023/A:1015878719389; Li Y, 2013, J AGRON CROP SCI, V199, P49, DOI 10.1111/j.1439-037X.2012.00519.x; Murdock L, 2004, COMP USE CHLOROPHYLL; PETTIGREW WT, 1989, CROP SCI, V29, P1025, DOI 10.2135/cropsci1989.0011183X002900040040x; Robertson DW, 1937, GENETICS, V22, P104; USUDA H, 1984, AUST J PLANT PHYSIOL, V11, P509, DOI 10.1071/PP9840509; Zhang KP, 2009, J GENET, V88, P183, DOI 10.1007/s12041-009-0026-x; Zhao CJ, 2007, NEW ZEAL J AGR RES, V50, P735; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	11	29	30	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92529	10.1371/journal.pone.0092529	http://dx.doi.org/10.1371/journal.pone.0092529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676338	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677500023
J	Hergueta-Redondo, M; Sarrio, D; Molina-Crespo, A; Megias, D; Mota, A; Rojo-Sebastian, A; Garcia-Sanz, P; Morales, S; Abril, S; Cano, A; Peinado, H; Moreno-Bueno, G				Hergueta-Redondo, Marta; Sarrio, David; Molina-Crespo, Angela; Megias, Diego; Mota, Alba; Rojo-Sebastian, Alejandro; Garcia-Sanz, Pablo; Morales, Saleta; Abril, Sandra; Cano, Amparo; Peinado, Hector; Moreno-Bueno, Gema			Gasdermin-B Promotes Invasion and Metastasis in Breast Cancer Cells	PLOS ONE			English	Article							MOUSE-CHROMOSOME 11; H LTR ELEMENT; MESENCHYMAL TRANSITION; GASTROINTESTINAL-TRACT; GASTRIC-CANCER; GSDML GENE; EXPRESSION; CARCINOMA; FAMILY; GROWTH	Gasdermin B (GSDMB) belongs to the Gasdermin protein family that comprises four members (GSDMA-D). Gasdermin B expression has been detected in some tumor types such as hepatocarcinomas, gastric and cervix cancers; and its overexpression has been related to tumor progression. At least four splicing isoforms of GSDMB have been identified, which may play differential roles in cancer. However, the implication of GSDMB in carcinogenesis and tumor progression is not well understood. Here, we uncover for the first time the functional implication of GSDMB in breast cancer. Our data shows that high levels of GSDMB expression is correlated with reduced survival and increased metastasis in breast cancer patients included in an expression dataset (>1,000 cases). We demonstrate that GSDMB is upregulated in breast carcinomas compared to normal breast tissue, being the isoform 2 (GSDMB-2) the most differentially expressed. In order to evaluate the functional role of GSDMB in breast cancer two GSDMB isoforms were studied (GSDMB-1 and GSDMB-2). The overexpression of both isoforms in the MCF7 breast carcinoma cell line promotes cell motility and invasion, while its silencing in HCC1954 breast carcinoma cells decreases the migratory and invasive phenotype. Importantly, we demonstrate that both isoforms have a differential role on the activation of Rac-1 and Cdc-42 Rho-GTPases. Moreover, our data support that GSMDB-2 induces a pro-tumorigenic and pro-metastatic behavior in mouse xenograft models as compared to GSDMB-1. Finally, we observed that although both GSDMB isoforms interact in vitro with the chaperone Hsp90, only the GSDMB-2 isoform relies on this chaperone for its stability. Taken together, our results provide for the first time evidences that GSDMB-2 induces invasion, tumor progression and metastasis in MCF7 cells and that GSDMB can be considered as a new potential prognostic marker in breast cancer.	[Hergueta-Redondo, Marta; Sarrio, David; Molina-Crespo, Angela; Mota, Alba; Morales, Saleta; Cano, Amparo; Moreno-Bueno, Gema] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols,CSIC, IdiPAZ, Dept Bioquim, Madrid, Spain; [Megias, Diego; Abril, Sandra] CNIO, Madrid, Spain; [Abril, Sandra] Hosp MD Anderson Canc Ctr, Madrid, Spain; [Garcia-Sanz, Pablo; Moreno-Bueno, Gema] Fdn MD Anderson Internac, Madrid, Spain; [Peinado, Hector] Weill Cornell Med Coll, Dept Pediat, Dept Cell & Dev Biol, Childrens Canc & Blood Fdn Labs, New York, NY USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Centro Nacional de Investigaciones Oncologicas (CNIO); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Cornell University	Moreno-Bueno, G (corresponding author), Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols,CSIC, IdiPAZ, Dept Bioquim, Madrid, Spain.	gmoreno@iib.uam.es	SARRIO, DAVID/Y-8903-2019; Peinado, Hector/A-6417-2013; Jimenez, Alba Mota/M-5710-2014; Megías, Diego/L-6008-2014; Rojo, Alejandro/Y-9674-2019; Moreno-Bueno, Gema/K-9354-2016	Peinado, Hector/0000-0002-4256-3413; Jimenez, Alba Mota/0000-0001-9148-3965; Rojo, Alejandro/0000-0001-6439-3518; Moreno-Bueno, Gema/0000-0002-5030-6687; Megias, Diego/0000-0003-0755-0518; Sarrio, David/0000-0003-4886-8290	Spanish Ministry of Science and Innovation; MICINN [SAF2007-63075, SAF2010-20175]; AVON Foundation; Comunidad de Madrid [S2010/BMD-2302]; AECC network; Instituto de Salud Carlos III (ISCIII) [PI13_00132]; Breast Network from ISCIII [RD12036/0007]; AECC Scientific Foundation; MECD; ISCIII [RD12036/0007]; Melanoma Research Alliance; Pediatric Oncology Experimental Therapeutics Investigators Consortium; The Nancy C. and Daniel P. Paduano Foundation; The Manning Foundation; NCI [U01 CA169538, RO1 CA169416-01]; DoD [BC123187, BC121988];  [S2010/BMD23]; NATIONAL CANCER INSTITUTE [R01CA169416, U01CA169538] Funding Source: NIH RePORTER	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); AVON Foundation; Comunidad de Madrid(Comunidad de Madrid); AECC network; Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Breast Network from ISCIII; AECC Scientific Foundation; MECD; ISCIII(Instituto de Salud Carlos III); Melanoma Research Alliance; Pediatric Oncology Experimental Therapeutics Investigators Consortium; The Nancy C. and Daniel P. Paduano Foundation; The Manning Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DoD(United States Department of Defense); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Spanish Ministry of Science and Innovation, MICINN (SAF2007-63075 and SAF2010-20175), AVON Foundation 2012, Comunidad de Madrid (S2010/BMD-2302), AECC network 2011, Instituto de Salud Carlos III (ISCIII) (PI13_00132) to GMB and Breast Network from ISCIII RD12036/0007 to AC. MHR has been funded by a predoctoral contract associated to SAF2007-63075 and now has a postdoc contract from S2010/BMD23. DS and PGS are funded by postdoc contracts from the AECC Scientific Foundation, AM is funded by a predoctoral fellowship from MECD; ACM is funded by ISCIII RD12036/0007. Dr HP's work is supported by the Melanoma Research Alliance, Pediatric Oncology Experimental Therapeutics Investigators Consortium, The Nancy C. and Daniel P. Paduano Foundation, The Manning Foundation, NCI (U01 CA169538, RO1 CA169416-01) and the DoD (BC123187, BC121988). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carl-Mcgrath S, 2008, PATHOLOGY, V40, P13, DOI 10.1080/00313020701716250; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gimona M, 2006, INT J BIOCHEM CELL B, V38, P1875, DOI 10.1016/j.biocel.2006.05.003; Harrell JC, 2006, CANCER RES, V66, P9308, DOI 10.1158/0008-5472.CAN-06-1769; Huh JW, 2008, ARCH VIROL, V153, P1201, DOI 10.1007/s00705-008-0105-y; Iorns E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047995; Katoh M, 2004, INT J ONCOL, V24, P757; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Komiyama H, 2010, GENES GENET SYST, V85, P75, DOI 10.1266/ggs.85.75; KUREBAYASHI J, 1993, CANCER RES, V53, P2178; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Lunny DP, 2005, J INVEST DERMATOL, V124, P615, DOI 10.1111/j.0022-202X.2005.23623.x; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Moreno-Bueno G, 2011, EMBO MOL MED, V3, P528, DOI 10.1002/emmm.201100156; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Nascimento CF, 2011, EXP CELL RES, V317, P2562, DOI 10.1016/j.yexcr.2011.08.022; Olmeda D, 2007, CANCER RES, V67, P11721, DOI 10.1158/0008-5472.CAN-07-2318; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Saeki N, 2007, ONCOGENE, V26, P6488, DOI 10.1038/sj.onc.1210475; Saeki N, 2000, MAMM GENOME, V11, P718, DOI 10.1007/s003350010138; Saeki N, 2009, GENE CHROMOSOME CANC, V48, P261, DOI 10.1002/gcc.20636; Sato H, 1998, MAMM GENOME, V9, P20, DOI 10.1007/s003359900673; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Sin HS, 2006, ARCH VIROL, V151, P1985, DOI 10.1007/s00705-006-0764-5; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sun Q, 2008, TRANSL ONCOL, V1, P73, DOI 10.1593/tlo.08112; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tamura M, 2007, GENOMICS, V89, P618, DOI 10.1016/j.ygeno.2007.01.003; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; van Horssen R, 2006, J CELL BIOCHEM, V99, P1536, DOI 10.1002/jcb.20994; Wang HB, 2009, CLIN CHEM LAB MED, V47, P811, DOI 10.1515/CCLM.2009.186; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Watabe E, 2001, JPN J CANCER RES, V92, P140, DOI 10.1111/j.1349-7006.2001.tb01076.x; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; YONEDA T, 1994, BREAST CANCER RES TR, V32, P73, DOI 10.1007/BF00666208; Yu J, 2011, PEDIATR PULM, V46, P701, DOI 10.1002/ppul.21424	42	87	92	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e90099	10.1371/journal.pone.0090099	http://dx.doi.org/10.1371/journal.pone.0090099			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675552	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677500006
J	Bui-Klimke, TR; Guclu, H; Kensler, TW; Yuan, JM; Wu, F				Bui-Klimke, Travis R.; Guclu, Hasan; Kensler, Thomas W.; Yuan, Jian-Min; Wu, Felicia			Aflatoxin Regulations and Global Pistachio Trade: Insights from Social Network Analysis	PLOS ONE			English	Article							EXPOSURE; RISK	Aflatoxins, carcinogenic toxins produced by Aspergillus fungi, contaminate maize, peanuts, and tree nuts in many regions of the world. Pistachios are the main source of human dietary aflatoxins from tree nuts worldwide. Over 120 countries have regulations for maximum allowable aflatoxin levels in food commodities. We developed social network models to analyze the association between nations' aflatoxin regulations and global trade patterns of pistachios from 1996-2010. The main pistachio producing countries are Iran and the United States (US), which together contribute to nearly 75% of the total global pistachio market. Over this time period, during which many nations developed or changed their aflatoxin regulations in pistachios, global pistachio trade patterns changed; with the US increasingly exporting to countries with stricter aflatoxin standards. The US pistachio crop has had consistently lower levels of aflatoxin than the Iranian crop over this same time period. As similar trading patterns have also been documented in maize, public health may be affected if countries without aflatoxin regulations, or with more relaxed regulations, continually import crops with higher aflatoxin contamination. Unlike the previous studies on maize, this analysis includes a dynamic element, examining how trade patterns change over time with introduction or adjustment of aflatoxin regulations.	[Bui-Klimke, Travis R.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Guclu, Hasan] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Guclu, Hasan] Univ Pittsburgh, Publ Hlth Dynam Lab, Pittsburgh, PA USA; [Kensler, Thomas W.] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; [Kensler, Thomas W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Yuan, Jian-Min] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Wu, Felicia] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Wu, Felicia] Michigan State Univ, Dept Agr Food & Resource Econ, E Lansing, MI 48824 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Michigan State University; Michigan State University	Wu, F (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.	fwu@msu.edu	Bui, Travis/AAX-1983-2020; Kensler, Thomas W/D-8686-2014; Guclu, Hasan/B-7080-2008	Kensler, Thomas W/0000-0002-6676-261X; Guclu, Hasan/0000-0003-3582-9460; Yuan, Jian-Min/0000-0002-4620-3108	National Cancer Institute (NCI) of the National Institutes of Health (NIH) [5R01CA153073-2]; NATIONAL CANCER INSTITUTE [R01CA153073] Funding Source: NIH RePORTER	National Cancer Institute (NCI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Cancer Institute (NCI) of the National Institutes of Health (NIH), Grant No. 5R01CA153073-2. The content is solely the responsibility of the authors and does not necessarily represent the official views of NCI or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay R, 2007, FOOD ADDIT CONTAM A, V24, P1109, DOI 10.1080/02652030701553251; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; De Nooy W., 2005, EXPLORATORY SOCIAL N; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; FAO, 1997, WORLDW REG MYC 1995; FAO, 2004, WORLDW REG MYC FOOD; FAOSTAT, 2011, TOP PROD PIST 2010; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Groopman JD, 2008, ANNU REV PUBL HEALTH, V29, P187, DOI 10.1146/annurev.publhealth.29.020907.090859; IARC, 2002, IARC MON EV CARC RIS, V82, P171, DOI DOI 10.1016/J.CHEMOSPHERE.2009.12.012; JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2007, WHO TECHN REP SER, V947; Kadushin C., 2012, UNDERSTANDING SOCIAL; Liu Y, 2012, EUR J CANCER, V48, P2125, DOI 10.1016/j.ejca.2012.02.009; Strosnider H, 2006, ENVIRON HEALTH PERSP, V114, P1898, DOI 10.1289/ehp.9302; [WHO] World Health Organization, 2013, GLOB HLTH OBS; Williams JH, 2004, AM J CLIN NUTR, V80, P1106, DOI 10.1093/ajcn/80.5.1106; Wu F, 2008, WORLD MYCOTOXIN J, V1, P95, DOI 10.3920/WMJ2008.x011; Wu F, 2004, ENVIRON SCI TECHNOL, V38, P4049, DOI 10.1021/es035353n; Wu F, 2013, RISK ANAL IN PRESS; Wu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045151	22	36	37	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92149	10.1371/journal.pone.0092149	http://dx.doi.org/10.1371/journal.pone.0092149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670581	Green Published, Green Accepted, gold			2022-12-25	WOS:000333677000032
J	Burnett, WE; Heinze, J				Burnett, William E.; Heinze, Juergen			Sperm Bundles in the Seminal Vesicles of Sexually Mature Lasius Ant Males	PLOS ONE			English	Article							FIRE ANT; BEES HYMENOPTERA; ATTA-COLOMBICA; SOCIAL INSECTS; FORMICIDAE; ULTRASTRUCTURE; SPERMATOZOA; EVOLUTION; QUEENS; LENGTH	In many insects, sperm cells are produced in bundles with their heads being held together by a glycoprotein matrix secreted by a cyst cell. Mature sperm cells in the seminal vesicles are usually free, but in sawflies and several other insects, such structures (spermatodesmata) remain intact and sperm cells may be ejaculated as bundles. Here we report the occurrence of spermatodesmata in mature males of the ant Lasius pallitarsis. Microscopic investigations of the abdominal contents of males immediately prior to their nuptial flights showed that the anterior ends of numerous sperm cells were embedded in an oval-shaped 20 by 30 micrometer extracellular fibrous cap. Individual sperm ranged in length from 55 to 75 micrometers with an average overall length of 65 micrometers. The bulb-shaped heads of the sperm were relatively small, only about 1.5 micrometers in length and about 1.1 micrometers in diameter. The diameter of the sperm tails was approximately 1 micrometer. Observations of live preparations of the spermatodesmata showed increasingly active undulating wave-like movement of the sperm tails as the slide preparations aged. This appears to be the first case of sperm bundles being present in the seminal vesicles of mature ant males - males that are immediately poised to complete their nuptial mating flight.	[Burnett, William E.] Bitterroot Environm Serv Co, Hamilton, MT USA; [Heinze, Juergen] Univ Regensburg, D-93053 Regensburg, Germany	University of Regensburg	Burnett, WE (corresponding author), Bitterroot Environm Serv Co, Hamilton, MT USA.	cescoweb@aol.com						Baer B, 2005, APIDOLOGIE, V36, P187, DOI 10.1051/apido:2005013; Baer B, 2003, INSECT SOC, V50, P101, DOI 10.1007/s00040-003-0641-0; Baer B, 2009, BEHAV ECOL, V20, P38, DOI 10.1093/beheco/arn112; Baer B, 2006, J MORPHOL, V267, P1165, DOI 10.1002/jmor.10467; BARTELS PJ, 1985, AM MIDL NAT, V113, P190, DOI 10.2307/2425361; Boomsma JJ, 2005, ANNU REV ENTOMOL, V50, P395, DOI 10.1146/annurev.ento.50.071803.130416; Burnett WE, 2013, SPERM BUNDLES MALE A; den Boer SPA, 2008, BEHAV ECOL SOCIOBIOL, V62, P1843, DOI 10.1007/s00265-008-0613-5; den Boer SPA, 2010, SCIENCE, V327, P1506, DOI 10.1126/science.1184709; den Boer SPA, 2009, P ROY SOC B-BIOL SCI, V276, P3945, DOI 10.1098/rspb.2009.1184; Fjerdingstad EJ, 2003, J EVOLUTION BIOL, V16, P844, DOI 10.1046/j.1420-9101.2003.00589.x; Hayashi F, 1998, FUNCT ECOL, V12, P347, DOI 10.1046/j.1365-2435.1998.00205.x; Higginson DM, 2011, BIOL REV, V86, P249, DOI 10.1111/j.1469-185X.2010.00147.x; HOLLDOBLER B, 1985, EXPT BEHAV ECOLOGY S, P237; Lino-Neto J, 2002, TISSUE CELL, V34, P124, DOI 10.1016/S0040-8166(02)00026-5; Lino-Neto J, 2008, TISSUE CELL, V40, P185, DOI 10.1016/j.tice.2007.11.004; Moja J, 2007, ACTA ZOOLOGICA, V88, P181; Moreira Jane, 2004, Brazilian Journal of Morphological Sciences, V21, P185; Oppelt A, 2007, NATURWISSENSCHAFTEN, V94, P781, DOI 10.1007/s00114-007-0249-8; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P69, DOI 10.1016/B978-0-12-372568-4.00003-3; Pizzari T, 2008, PLOS BIOL, V6, P925, DOI 10.1371/journal.pbio.0060130; QUICKE DLJ, 1992, ZOOL SCR, V21, P381, DOI 10.1111/j.1463-6409.1992.tb00339.x; Schiff A, 2001, J HYMENOPT RES, V10, P119; THOMPSON TE, 1967, ANN ENTOMOL SOC AM, V60, P632, DOI 10.1093/aesa/60.3.632; TSCHINKEL WR, 1988, ANN ENTOMOL SOC AM, V81, P777, DOI 10.1093/aesa/81.5.777; VANDERHAVE TM, 1988, EVOLUTION, V42, P160, DOI 10.1111/j.1558-5646.1988.tb04116.x; WHEELER DE, 1990, J MORPHOL, V206, P343, DOI 10.1002/jmor.1052060311; WHEELER DE, 1992, J MORPHOL, V211, P307, DOI 10.1002/jmor.1052110308; Zama U, 2005, INSECT SOC, V52, P122, DOI 10.1007/s00040-005-0789-x; Zama U, 2004, TISSUE CELL, V36, P29, DOI 10.1016/j.tice.2003.08.003; Zama Uyra, 2001, Journal of Hymenoptera Research, V10, P261	31	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93383	10.1371/journal.pone.0093383	http://dx.doi.org/10.1371/journal.pone.0093383			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671307	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000138
J	da Silva, VM; Colussi, F; Neto, MD; Braz, ASK; Squina, FM; Oliveira, CLP; Garcia, W				da Silva, Viviam M.; Colussi, Francieli; Neto, Mario de Oliveira; Braz, Antonio S. K.; Squina, Fabio M.; Oliveira, Cristiano L. P.; Garcia, Wanius			Modular Hyperthermostable Bacterial Endo-beta-1, 4-Mannanase: Molecular Shape, Flexibility and Temperature-Dependent Conformational Changes	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; BIOLOGICAL MACROMOLECULES; STRUCTURE PREDICTION; SOLUTION SCATTERING; MANNANASES; RESOLUTION; SERVER	Endo-beta-1,4-mannanase from Thermotoga petrophila (TpMan) is a hyperthermostable enzyme that catalyzes the hydrolysis of beta-1,4-mannoside linkages in various mannan-containing polysaccharides. A recent study reported that TpMan is composed of a GH5 catalytic domain joined by a linker to a carbohydrate-binding domain. However, at this moment, there is no three-dimensional structure determined for TpMan. Little is known about the conformation of the TpMan as well as the role of the length and flexibility of the linker on the spatial arrangement of the constitutive domains. In this study, we report the first structural characterization of the entire TpMan by small-angle X-ray scattering combined with the three-dimensional structures of the individual domains in order to shed light on the low-resolution model, overall dimensions, and flexibility of this modular enzyme at different temperatures. The results are consistent with a linker with a compact structure and that occupies a small volume with respect to its large number of amino acids. Furthermore, at 20 degrees C the results are consistent with a model where TpMan is a molecule composed of three distinct domains and that presents some level of molecular flexibility in solution. Even though the full enzyme has some degree of molecular flexibility, there might be a preferable conformation, which could be described by the rigid-body modeling procedure. Finally, the results indicate that TpMan undergoes a temperature-driven transition between conformational states without a significant disruption of its secondary structure. Our results suggest that the linker can optimize the geometry between the other two domains with respect to the substrate at high temperatures. These studies should provide a useful basis for future biophysical studies of entire TpMan.	[da Silva, Viviam M.; Colussi, Francieli; Braz, Antonio S. K.; Garcia, Wanius] Univ Fed ABC UFABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil; [Neto, Mario de Oliveira] Univ Estadual Paulista, Inst Biociencias, Dept Fis & Biofis, Sao Paulo, Brazil; [Squina, Fabio M.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Ciencia & Tecnol Bioetanol, Sao Paulo, Brazil; [Oliveira, Cristiano L. P.] Univ Sao Paulo, Inst Fis, BR-01498 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo	Garcia, W (corresponding author), Univ Fed ABC UFABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil.	wanius.garcia@ufabc.edu.br	Oliveira, Cristiano L P/B-4403-2008; Squina, Fabio/J-8130-2012; Silva, Wanius J. G./L-3948-2016; Neto, Mario Oliveira/F-2717-2013; Colussi, Francieli/J-9166-2016	Oliveira, Cristiano L P/0000-0002-3426-6507; Squina, Fabio/0000-0002-8154-7459; Colussi, Francieli/0000-0002-4392-767X; Oliveira Neto, Mario/0000-0002-6226-7419	Fundacao de Amparo a pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [2012/21054-9, 478900/2012-0, 2012/03503-0, 501037/2012-8]	Fundacao de Amparo a pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to thank Fundacao de Amparo a pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for the financial support for this work via grants #2012/21054-9 and #478900/2012-0; and fellowships #2012/03503-0 (VMS) and #501037/2012-8 (FC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado P, 2010, EUR BIOPHYS J BIOPHY, V39, P769, DOI 10.1007/s00249-009-0549-3; Boraston AB, 2003, STRUCTURE, V11, P665, DOI 10.1016/S0969-2126(03)00100-X; Brunecky R, 2012, ACTA CRYSTALLOGR D, V68, P292, DOI 10.1107/S0907444912001680; Chang MCY, 2007, CURR OPIN CHEM BIOL, V11, P677, DOI 10.1016/j.cbpa.2007.08.039; Cota J, 2011, BIOCHEM BIOPH RES CO, V406, P590, DOI 10.1016/j.bbrc.2011.02.098; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; dos Santos CR, 2011, BIOTECHNOL LETT, V33, P131, DOI 10.1007/s10529-010-0409-3; GILKES NR, 1991, MICROBIOL REV, V55, P303, DOI 10.1128/MMBR.55.2.303-315.1991; Girio FM, 2010, BIORESOURCE TECHNOL, V101, P4775, DOI 10.1016/j.biortech.2010.01.088; Hall M, 2011, J BIOTECHNOL, V155, P370, DOI 10.1016/j.jbiotec.2011.07.016; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Lima MA, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-75; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Montiel MD, 2002, APPL MICROBIOL BIOT, V58, P67, DOI 10.1007/s00253-001-0866-7; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Randall A, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-52; Rezende CA, 2011, BIOTECHNOL BIOFUELS, V4, P1, DOI 10.1186/1754-6834-4-54; Rost B, 1996, METHOD ENZYMOL, V266, P525; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANTOS CR, 2012, J STRUCT BIOL, V177, P469, DOI DOI 10.1016/J.JSB.2011.11.021; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takahata Y, 2001, INT J SYST EVOL MICR, V51, P1901, DOI 10.1099/00207713-51-5-1901; Tenkanen M, 1997, J BIOTECHNOL, V57, P191, DOI 10.1016/S0168-1656(97)00099-0; van Zyl WH, 2010, PROCESS BIOCHEM, V45, P1203, DOI 10.1016/j.procbio.2010.05.011; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268	42	6	6	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92996	10.1371/journal.pone.0092996	http://dx.doi.org/10.1371/journal.pone.0092996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671161	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000097
J	Hanson, AM; Gambill, J; Phomakay, V; Staten, CT; Kelley, MD				Hanson, Amanda M.; Gambill, Jessica; Phomakay, Venusa; Staten, C. Tyler; Kelley, Melissa D.			9-cis-Retinoic Acid and Troglitazone Impacts Cellular Adhesion, Proliferation, and Integrin Expression in K562 Cells	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; NF-KAPPA-B; RETINOIC ACID; ALL-TRANS; VITAMIN-A; EXTRACELLULAR-MATRIX; NUCLEAR RECEPTOR; T-CELLS; C-MYC; DIFFERENTIATION	Retinoids are established pleiotropic regulators of both adaptive and innate immune responses. Recently, troglitazone, a PPAR gamma agonist, has been demonstrated to have anti-inflammatory effects. Separately, retinoids and troglitazone are implicated in immune related processes; however, their combinatory role in cellular adhesion and proliferation has not been well established. In this study, the effect of 9-cis-retinoic acid (9-cis-RA) and troglitazone on K562 cellular adhesion and proliferation was investigated. Troglitazone exposure decreased K562 cellular adhesion to RGD containing extracellular matrix proteins fibronectin, FN-120, and vitronectin in a concentration and time-dependent manner. In the presence of troglitazone, 9-cis-retinoic acid restores cellular adhesion to levels comparable to vehicle treatment alone on fibronectin, FN-120, and vitronectin substrates within 72 hours. Due to the prominent role of integrins in attachment to extracellular matrix proteins, we evaluated the level of integrin alpha 5 subunit expression. Troglitazone treatment results in decrease in alpha 5 subunit expression on the cell surface. In the presence of both agonists, cell surface alpha 5 subunit expression was restored to levels comparable to vehicle treatment alone. Additionally, troglitazone and 9-cis-RA mediated cell adhesion was decreased in the presence of a function blocking integrin alpha 5 inhibitor. Further, through retinoid metabolic profiling and HPLC analysis, our study demonstrates that troglitazone augments retinoid availability in K562 cells. Finally, we demonstrate that troglitazone and 9-cis-retinoic acid synergistically dampen cellular proliferation in K562 cells. Our study is the first to report that the combination of troglitazone and 9-cis-retinoic acid restores cellular adhesion, alters retinoid availability, impacts integrin expression, and dampens cellular proliferation in K562 cells.	[Hanson, Amanda M.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA; [Gambill, Jessica; Phomakay, Venusa] Univ Arkansas Med Sci, Coll Med, Little Rock, AR USA; [Staten, C. Tyler] Harding Univ, Coll Pharm, Searcy, AR USA; [Kelley, Melissa D.] Univ Cent Arkansas, Dept Chem, Conway, AR 72035 USA	University of Arizona; University of Arkansas System; University of Arkansas Medical Sciences; University of Central Arkansas	Kelley, MD (corresponding author), Univ Cent Arkansas, Dept Chem, Conway, AR 72035 USA.	mkelley@uca.edu			National Center for Research Resources [5P20RR016460-11]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GM103429-11]; National Science Foundation [0959209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103429] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The National Center for Research Resources (5P20RR016460-11) and the National Institute of General Medical Sciences (8 P20 GM103429-11) from the National Institutes of Health. The National Science Foundation Award ID 0959209. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baroni A, 2003, BRIT J DERMATOL, V148, P424, DOI 10.1046/j.1365-2133.2003.05165.x; Blomhoff HK, 2004, BIOCHEM SOC T, V32, P982, DOI 10.1042/BST0320982; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; Bridges LC, 2008, BIOCHEMISTRY-US, V47, P4544, DOI 10.1021/bi702447u; Brown DC, 1999, BRIT J HAEMATOL, V107, P86, DOI 10.1046/j.1365-2141.1999.01671.x; Cariati R, 2000, INT J CANCER, V86, P375, DOI 10.1002/(SICI)1097-0215(20000501)86:3<375::AID-IJC12>3.0.CO;2-Z; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Clark RB, 2002, J LEUKOCYTE BIOL, V71, P388; Cooper JP, 2011, BRIT J PHARMACOL, V163, P1263, DOI 10.1111/j.1476-5381.2011.01310.x; DILLEHAY DL, 1987, CELL IMMUNOL, V107, P130, DOI 10.1016/0008-8749(87)90273-5; Ertesvag A, 2002, J IMMUNOL, V169, P5555, DOI 10.4049/jimmunol.169.10.5555; Ertesvag A, 2009, SEMIN IMMUNOL, V21, P36, DOI 10.1016/j.smim.2008.06.005; Escribese Maria M, 2007, BMC Nephrol, V8, P3, DOI 10.1186/1471-2369-8-3; FAULL RJ, 1993, J CELL BIOL, V121, P155, DOI 10.1083/jcb.121.1.155; Feng Y, 2001, J EXP CLIN CANC RES, V20, P429; Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785; Gardsvoll H, 2007, J BIOL CHEM, V282, P13561, DOI 10.1074/jbc.M610184200; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Gorrasi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086352; Gu XS, 2006, J BIOL CHEM, V281, P17882, DOI 10.1074/jbc.M601302200; Han SW, 2005, AM J RESP CELL MOL, V32, P350, DOI 10.1165/rcmb.2004-0345OC; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Idres N, 2001, CANCER RES, V61, P700; Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iwata M, 2009, SEMIN IMMUNOL, V21, P8, DOI 10.1016/j.smim.2008.09.002; Iwata M, 2009, SEMIN IMMUNOL, V21, P1, DOI 10.1016/j.smim.2008.09.001; JARVINEN M, 1993, CELL BIOL INT, V17, P399, DOI 10.1006/cbir.1993.1078; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kinashi T, METHODS MOL BIOL, V757, P261; LEO MA, 1989, ARCH BIOCHEM BIOPHYS, V269, P305, DOI 10.1016/0003-9861(89)90112-4; Lerga A, 1999, CELL GROWTH DIFFER, V10, P639; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; Loi CM, 1999, CLIN PHARMACOKINET, V37, P91, DOI 10.2165/00003088-199937020-00001; Ludbrook SB, 2003, BIOCHEM J, V369, P311, DOI 10.1042/BJ20020809; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Marchetti MN, 1997, DRUG METAB DISPOS, V25, P637; MARTINI R, 1993, ARCH BIOCHEM BIOPHYS, V303, P57, DOI 10.1006/abbi.1993.1255; Massimi M, 2007, LIVER INT, V27, P128, DOI 10.1111/j.1478-3231.2006.01391.x; Medhora MM, 2000, AM J PHYSIOL-HEART C, V279, pH382, DOI 10.1152/ajpheart.2000.279.1.H382; Mellanby E, 1929, BMJ-BRIT MED J, V1929, P984; Molla A, 2000, CELL GROWTH DIFFER, V11, P83; Moore T, 1930, BIOCHEM J, V24, P692, DOI 10.1042/bj0240692; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Nakajima H, 1996, LEUKEMIA RES, V20, P665, DOI 10.1016/0145-2126(96)00020-3; Okazaki T, 2009, AM J PATHOL, V174, P2378, DOI 10.2353/ajpath.2009.080942; PASQUALINI R, 1993, J CELL SCI, V105, P101; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Pinaire JA, 2007, PPAR RES, V2007, DOI 10.1155/2007/94156; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Sahi J, 2003, DRUG METAB DISPOS, V31, P439, DOI 10.1124/dmd.31.4.439; Sasaki Makoto, 2005, BMC Physiol, V5, P3, DOI 10.1186/1472-6793-5-3; Schlezinger JJ, 2006, TOXICOL SCI, V92, P433, DOI 10.1093/toxsci/kfl003; Schlezinger JJ, 2004, J IMMUNOL, V173, P3165, DOI 10.4049/jimmunol.173.5.3165; Schlezinger JJ, 2002, J IMMUNOL, V169, P6831, DOI 10.4049/jimmunol.169.12.6831; Scrimshaw N S, 1968, Monogr Ser World Health Organ, V57, P3; Segara D, 2005, CLIN CANCER RES, V11, P3587, DOI 10.1158/1078-0432.CCR-04-1813; Semba RD, 1999, J NUTR, V129, P783, DOI 10.1093/jn/129.4.783; Semba RD, 1998, NUTR REV, V56, pS38, DOI 10.1111/j.1753-4887.1998.tb01643.x; Seta N, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/820827; Shirley MA, 1996, DRUG METAB DISPOS, V24, P293; SIDELL N, 1981, EXP CELL BIOL, V49, P239; Sonnenberg A, 1993, Curr Top Microbiol Immunol, V184, P7; Sporn M.B., 1994, RETINOIDS BIOL CHEM; Sun Z, 2008, AM J PHYSIOL-CELL PH, V295, pC268, DOI 10.1152/ajpcell.00516.2007; Svobodova H, 2009, PHYSIOL RES, V58, P701, DOI 10.33549/physiolres.931573; Tanaka R, 2009, J BIOL CHEM, V284, P19817, DOI 10.1074/jbc.M109.009860; Tarui T, 2003, J BIOL CHEM, V278, P29863, DOI 10.1074/jbc.M304694200; VARNER JA, 1995, MOL BIOL CELL, V6, P725, DOI 10.1091/mbc.6.6.725; Weber C, 1996, J CELL BIOL, V134, P1063, DOI 10.1083/jcb.134.4.1063; Whelan JT, J NUTR BIOCH, V24, P832; White JA, 1997, J BIOL CHEM, V272, P18538, DOI 10.1074/jbc.272.30.18538; WILLIAMS JB, 1985, P NATL ACAD SCI USA, V82, P4658, DOI 10.1073/pnas.82.14.4658; Worm M, 1998, BLOOD, V92, P1713, DOI 10.1182/blood.V92.5.1713.417k20_1713_1720; Wu Y, 2011, CELL IMMUNOL, V268, P68, DOI 10.1016/j.cellimm.2011.03.002; Zhang Y., IMMUNOLOGY, V135, P268	79	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93005	10.1371/journal.pone.0093005	http://dx.doi.org/10.1371/journal.pone.0093005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671180	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677000099
J	Ignac, TM; Skupin, A; Sakhanenko, NA; Galas, DJ				Ignac, Tomasz M.; Skupin, Alexander; Sakhanenko, Nikita A.; Galas, David J.			Discovering Pair-Wise Genetic Interactions: An Information Theory-Based Approach	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MISSING HERITABILITY; EXPRESSION; PHENOTYPE; TRAIT	Phenotypic variation, including that which underlies health and disease in humans, results in part from multiple interactions among both genetic variation and environmental factors. While diseases or phenotypes caused by single gene variants can be identified by established association methods and family-based approaches, complex phenotypic traits resulting from multi-gene interactions remain very difficult to characterize. Here we describe a new method based on information theory, and demonstrate how it improves on previous approaches to identifying genetic interactions, including both synthetic and modifier kinds of interactions. We apply our measure, called interaction distance, to previously analyzed data sets of yeast sporulation efficiency, lipid related mouse data and several human disease models to characterize the method. We show how the interaction distance can reveal novel gene interaction candidates in experimental and simulated data sets, and outperforms other measures in several circumstances. The method also allows us to optimize case/control sample composition for clinical studies.	[Ignac, Tomasz M.; Skupin, Alexander; Galas, David J.] Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [Ignac, Tomasz M.; Sakhanenko, Nikita A.; Galas, David J.] Pacific Northwest Diabet Res Inst, Seattle, WA USA; [Skupin, Alexander] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA	University of Luxembourg; Pacific Northwest Diabetes Research Institute (PNDRI); University of California System; University of California San Diego	Ignac, TM (corresponding author), Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg.	tmignac@gmail.com		Sakhanenko, Nikita/0000-0001-6256-4643; SKUPIN, Alexander/0000-0002-8955-8304	"le plan Technologies de la Sante par le Gouvernment du Grand-Duche de Luxembourg" through Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg; NSF [IIS-1340619]	"le plan Technologies de la Sante par le Gouvernment du Grand-Duche de Luxembourg" through Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg; NSF(National Science Foundation (NSF))	This work has been funded by "le plan Technologies de la Sante par le Gouvernment du Grand-Duche de Luxembourg" through Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, and supported by NSF grant IIS-1340619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Carter GW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100137; Carter GW, 2011, ENCY COMPLEXITY SYST, P9105; Chanda P, 2008, GENETICS, V180, P1191, DOI 10.1534/genetics.108.088542; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Guthery SL, 2007, AM J HUM GENET, V81, P1221, DOI 10.1086/522239; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Ignac T, 2012, P 9 INT WORKSH COMP, P39; Jakulin A., 2004, P 21 INT C MACH LEAR, P409; Li M, 2004, IEEE T INFORM THEORY, V50, P3250, DOI 10.1109/TIT.2004.838101; Li WT, 2000, HUM HERED, V50, P334, DOI 10.1159/000022939; Lorenz K, 2012, GENETICS, V192, P1123, DOI 10.1534/genetics.112.143107; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McGill WJ., 1954, PSYCHOMETRIKA, V19, P97, DOI 10.1007/BF02289159; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Sakhanenko N. A., 2011, P 8 INT WORKSH COMP, P161; Sakhanenko NA, 2010, J COMPUT BIOL, V17, P1491, DOI 10.1089/cmb.2010.0044; Tabangin Meredith E, 2009, BMC Proc, V3 Suppl 7, pS41, DOI 10.1186/1753-6561-3-S7-S41; TSUJISHITA T, 1995, ADV APPL MATH, V16, P269, DOI 10.1006/aama.1995.1013; Wang S, 2006, PLOS GENET, V2, P148, DOI 10.1371/journal.pgen.0020015; Wang SS, 2007, CIRC RES, V101, pE11, DOI 10.1161/CIRCRESAHA.107.152975; Zhu QQ, 2012, AM J HUM GENET, V91, P422, DOI 10.1016/j.ajhg.2012.07.010; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	29	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							c92310	10.1371/journal.pone.0092310	http://dx.doi.org/10.1371/journal.pone.0092310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670935	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000038
J	Lin, J; Yuan, YB; Zhang, MY				Lin, Jing; Yuan, Yongbo; Zhang, Mingyuan			Improved FTA Methodology and Application to Subsea Pipeline Reliability Design	PLOS ONE			English	Article								An innovative logic tree, Failure Expansion Tree (FET), is proposed in this paper, which improves on traditional Fault Tree Analysis (FTA). It describes a different thinking approach for risk factor identification and reliability risk assessment. By providing a more comprehensive and objective methodology, the rather subjective nature of FTA node discovery is significantly reduced and the resulting mathematical calculations for quantitative analysis are greatly simplified. Applied to the Useful Life phase of a subsea pipeline engineering project, the approach provides a more structured analysis by constructing a tree following the laws of physics and geometry. Resulting improvements are summarized in comparison table form.	[Lin, Jing; Yuan, Yongbo; Zhang, Mingyuan] Dalian Univ Technol, Dept Construct Management, Dalian, Peoples R China	Dalian University of Technology	Zhang, MY (corresponding author), Dalian Univ Technol, Dept Construct Management, Dalian, Peoples R China.	myzhang@dlut.edu.cn	ZHANG, Mingyuan/AAJ-4616-2020		National Natural Science Foundation of China [51208081]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This paper was funded by the National Natural Science Foundation of China under Grant No. 51208081. The authors also gratefully acknowledge the helpful comments and suggestions of the reviewers, which have improved the presentation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, 57605 BS; [Anonymous], 1992, PROC SAF MAN HIGHL H; Bhote KR, 2004, WORLD CLASS RELIABIL, P155; Ding YH, 2005, J LOSS PREVENT PROC, V18, P83, DOI 10.1016/j.jlp.2004.12.003; Ericson Clifton, 1999, 17 INT SYST SAF C; Gabaix X, 2006, Q J ECON, V121, P3; Heikkila AM, 1999, INHERENT SAFETY PROC, P32; Hoyle D, 2012, ISO 9000 QUALITY SYS; Javadi MS, 2011, INT J MULTIDISCIPLIN, V2, P6; Lin J, 2013, 2013 INT C IND ENG M; Morris D.V, 1991, P INT WORKSH OFFSH P; Muhlbauer W.K., 2004, PIPELINE RISK MANAGE; Peng D, 2008, RES SAFETY RELIABILI, P116; Peng k, 2007, APPL HUMAN ERROR ANA, P36; Rausand M, 2004, WILEY SERIES PROBABI, P50; Rausand M., 2004, WILEY SERIES PROBABI; Sarbes A, 1990, NUREG1150; Shingo S., 1986, ZERO QUALITY CONTROL; Wang Q, 2008, NATUR GASIND, V28, P5; Xie Y, 2007, RES RISK ASSESSMENT, p[12, 23]; Xie Yunjie, 2006, CHINA OFFSHORE OIL G, V18, P214; Xie Yunjie, 2007, RES RISK ASSESSMENT, P59; Xu PD, 2007, METHODOLOGY APPL RIS, P135; Zhou Q, 2012, FAILURE CAUSE EFFECT	24	8	8	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93042	10.1371/journal.pone.0093042	http://dx.doi.org/10.1371/journal.pone.0093042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667681	gold, Green Published, Green Submitted			2022-12-25	WOS:000333675600130
J	Sharma, R; Panigrahi, P; Suresh, CG				Sharma, Ranu; Panigrahi, Priyabrata; Suresh, C. G.			In-Silico Analysis of Binding Site Features and Substrate Selectivity in Plant Flavonoid-3-O Glycosyltransferases (F3GT) through Molecular Modeling, Docking and Dynamics Simulation Studies	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURES; ANTHOCYANIN BIOSYNTHESIS; UDP-GLUCOSE; AMINO-ACID; CLONING; CLASSIFICATION; EXPRESSION	Flavonoids are a class of plant secondary metabolites that act as storage molecules, chemical messengers, as well as participate in homeostasis and defense processes. They possess pharmaceutical properties important for cancer treatment such as antioxidant and anti-tumor activities. The drug-related properties of flavonoids can be improved by glycosylation. The enzymes glycosyltransferases (GTs) glycosylate acceptor molecules in a regiospecific manner with the help of nucleotide sugar donor molecules. Several plant GTs have been characterized and their amino acid sequences determined. However, three-dimensional structures of only a few are reported. Here, phylogenetic analysis using amino acid sequences have identified a group of GTs with the same regiospecific activity. The structures of these closely related GTs were modeled using homologous GT structures. Their substrate binding sites were elaborated by docking flavonoid acceptor and UDP-sugar donor molecules in the modeled structures. Eight regions near the acceptor binding site in the N- and C-terminal domain of GTs have been identified that bind and specifically glycosylate the 3-OH group of acceptor flavonoids. Similarly, a conserved motif in the C-terminal domain is known to bind a sugar donor substrate. In certain GTs, the substitution of a specific glutamine by histidine in this domain changes the preference of sugar from glucose to galactose as a result of changed pattern of interactions. The molecular modeling, docking, and molecular dynamics simulation studies have revealed the chemical and topological features of the binding site and thus provided insights into the basis of acceptor and donor recognition by GTs.	[Sharma, Ranu; Panigrahi, Priyabrata; Suresh, C. G.] Natl Chem Lab, CSIR, Div Biochem Sci, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Suresh, CG (corresponding author), Natl Chem Lab, CSIR, Div Biochem Sci, Pune, Maharashtra, India.	cg.suresh@ncl.res.in		Panigrahi, Priyabrata/0000-0002-2307-6337	Council of Scientific and Industrial Research (CSIR), New Delhi; CSIR-National Chemical Laboratory Centre of Excellence in Scientific Computing (CoESC)	Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India); CSIR-National Chemical Laboratory Centre of Excellence in Scientific Computing (CoESC)	1) Council of Scientific and Industrial Research (CSIR), New Delhi. 2) CSIR-National Chemical Laboratory Centre of Excellence in Scientific Computing (CoESC). The funding agencies have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2012, SUIT 2012 LIGPREP VE; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gong ZZ, 1997, PLANT MOL BIOL, V35, P915, DOI 10.1023/A:1005959203396; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hirotani M, 2000, PLANTA, V210, P1006, DOI 10.1007/s004250050710; Hu YN, 2002, CHEM BIOL, V9, P1287, DOI 10.1016/S1074-5521(02)00295-8; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikegami A, 2009, PLANTA, V230, P841, DOI 10.1007/s00425-009-0989-0; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kanadaswami C, 2005, IN VIVO, V19, P895; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li LN, 2007, J MOL BIOL, V370, P951, DOI 10.1016/j.jmb.2007.05.036; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Martonak R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.075503; Masada S, 2007, FEBS LETT, V581, P2605, DOI 10.1016/j.febslet.2007.05.002; Mato M, 1998, PLANT CELL PHYSIOL, V39, P1145, DOI 10.1093/oxfordjournals.pcp.a029315; Miller KD, 1999, J BIOL CHEM, V274, P34011, DOI 10.1074/jbc.274.48.34011; Montefiori M, 2011, PLANT J, V65, P106, DOI 10.1111/j.1365-313X.2010.04409.x; Ogata J., 2004, PLANT BIOTECHNOL, V21, P367, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.21.367; Osmani SA, 2009, PHYTOCHEMISTRY, V70, P325, DOI 10.1016/j.phytochem.2008.12.009; Schrodinger Suite, 2011, SCHROD SUIT 2011 PRO; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka Y, 1996, PLANT CELL PHYSIOL, V37, P711, DOI 10.1093/oxfordjournals.pcp.a029004; Taniguchi N, 2003, HDB GLYCOSYLTRANSFER, V68, P707; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang XQ, 2009, FEBS LETT, V583, P3303, DOI 10.1016/j.febslet.2009.09.042; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yoshihara N, 2005, PLANT SCI, V169, P496, DOI 10.1016/j.plantsci.2005.04.007; Zhang ZD, 2003, PROTEIN SCI, V12, P2291, DOI 10.1110/ps.03131303	44	12	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92636	10.1371/journal.pone.0092636	http://dx.doi.org/10.1371/journal.pone.0092636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667893	Green Submitted, gold, Green Published			2022-12-25	WOS:000333675600057
J	Galan-Moya, EM; Treps, L; Oliver, L; Chneiweiss, H; Vallette, FM; Bidere, N; Gavard, J				Galan-Moya, Eva Maria; Treps, Lucas; Oliver, Lisa; Chneiweiss, Herve; Vallette, Francois M.; Bidere, Nicolas; Gavard, Julie			Endothelial Secreted Factors Suppress Mitogen Deprivation-Induced Autophagy and Apoptosis in Glioblastoma Stem-Like Cells	PLOS ONE			English	Article							CANCER-CELLS; BECLIN 1; TUMORS; NICHE; INHIBITION; THERAPY; NETWORK; KINASE; GROWTH; DEATH	Rapidly growing and highly vascularized tumors, such as glioblastoma multiforme, contain heterogeneous areas within the tumor mass, some of which are inefficiently supplied with nutrients and oxygen. While the cell death rate is elevated in such zones, tumor cells are still suspected to grow and survive independently of extracellular growth factors. In line with this, glioblastoma stem-like cells (GSCs) are found closely associated with brain vasculature in situ, and as such are most likely in a protected microenvironment. However, the behavior of GSCs under deprived conditions has not been explored in detail. Using a panel of 14 patient-derived GSCs, we report that ex vivo mitogen deprivation impaired self-renewal capability, abolished constitutive activation of the mTor pathway, and impinged on GSC survival via the engagement of autophagic and apoptotic cascades. Moreover, pharmacological inhibition of the mTor pathway recapitulated the mitogen deprivation scenario. In contrast, blocking either apoptosis or autophagy, or culturing GSCs with endothelial-secreted factors partly restored mTor pathway activation and rescued GSC survival. Overall, our data suggest that GSCs are addicted to mTor, as their survival and self-renewal are profoundly dependent on this signaling axis. Thus, as mTor governs the fate of GSCs under both deprivation conditions and in the presence of endothelial factors, it could be a key target for therapeutic purposes.	[Galan-Moya, Eva Maria; Treps, Lucas; Gavard, Julie] Ctr Natl Rech Sci, UMR 8104, Paris, France; [Galan-Moya, Eva Maria; Treps, Lucas; Gavard, Julie] Inst Natl Sante & Rech Med, U1016, Paris, France; [Galan-Moya, Eva Maria; Treps, Lucas; Gavard, Julie] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Oliver, Lisa; Vallette, Francois M.] Inst Natl Sante & Rech Med, UMR 892, Nantes, France; [Oliver, Lisa; Vallette, Francois M.] Ctr Natl Rech Sci, UMR 6299, Nantes, France; [Oliver, Lisa; Vallette, Francois M.] Univ Nantes, Fac Med, Nantes, France; [Oliver, Lisa; Vallette, Francois M.] Inst Cancerol Ouest, Nantes, France; [Oliver, Lisa; Vallette, Francois M.; Bidere, Nicolas] Equipe Labellisee Ligue Canc, Paris, France; [Chneiweiss, Herve] Inst Natl Sante & Rech Med, Neurosci Paris Seine, UMRS 1130, Paris, France; [Chneiweiss, Herve] Ctr Natl Rech Sci, UMR 8246, Paris, France; [Chneiweiss, Herve] Univ Paris 06, UMCR18, Paris, France; [Bidere, Nicolas] Inst Natl Sante & Rech Med, UMR S1014, Villejuif, France; [Bidere, Nicolas] Univ Paris 11, Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Gavard, J (corresponding author), Ctr Natl Rech Sci, UMR 8104, Paris, France.	julie.gavard@inserm.fr	Oliver, Lisa J/L-3070-2015; Gavard, Julie/I-5487-2012; Treps, Lucas/AAF-2499-2020; Vallette, Francois/N-2361-2018; Bidère, Nicolas/K-8887-2015; Vallette, Francois M/K-9047-2015; Galan-Moya, Eva M/I-2912-2015; herve, chneiweiss/Q-6818-2019; Gavard, Julie/I-5487-2012	Oliver, Lisa J/0000-0002-5588-7564; Gavard, Julie/0000-0002-7985-9007; Treps, Lucas/0000-0003-0735-9000; Bidère, Nicolas/0000-0001-9177-0008; Vallette, Francois M/0000-0002-3296-8572; Galan-Moya, Eva M/0000-0001-5758-7592; herve, chneiweiss/0000-0001-7675-5061; Gavard, Julie/0000-0003-3107-2026; Vallette, Francois/0000-0003-0802-0519	Ligue Nationale Contre le Cancer; Association des NeuroOncologues d'Expression Francaise (ANOCEF); Fondation pour la Recherche Medicale (FRM); Fondation Association pour la Recherche sur le Cancer (ARC); Agence Nationale pour la Recherche Programme Jeunes Chercheuses-Jeunes Chercheurs (ANR JCJC); Institut National du Cancer [INCA 6508]; Marie Curie International Reintegration Grant within The Seventh Framework Program; Universite Paris Descartes	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association des NeuroOncologues d'Expression Francaise (ANOCEF); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation Association pour la Recherche sur le Cancer (ARC); Agence Nationale pour la Recherche Programme Jeunes Chercheuses-Jeunes Chercheurs (ANR JCJC)(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); Marie Curie International Reintegration Grant within The Seventh Framework Program; Universite Paris Descartes	This research was funded by Ligue Nationale Contre le Cancer, Association des NeuroOncologues d'Expression Francaise (ANOCEF), Fondation pour la Recherche Medicale (FRM), Fondation Association pour la Recherche sur le Cancer (ARC), Agence Nationale pour la Recherche Programme Jeunes Chercheuses-Jeunes Chercheurs (ANR JCJC), Institut National du Cancer (INCA 6508) and by a Marie Curie International Reintegration Grant within The Seventh Framework Program. EMGM is supported by a post-doctoral fellowship from Ligue Nationale contre le Cancer and LT is supported by doctoral fellowship from Universite Paris Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Charles NA, 2012, GLIA, V60, P502, DOI 10.1002/glia.21264; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dwyer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045562; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Galan-Moya EM, 2011, CELL CYCLE, V10, P2403, DOI 10.4161/cc.10.15.16198; Galan-Moya EM, 2011, EMBO REP, V12, P470, DOI 10.1038/embor.2011.39; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Jiang H, 2009, METHOD ENZYMOL, V453, P273, DOI 10.1016/S0076-6879(08)04013-5; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Le Guelte A, 2012, J CELL SCI; Lefranc Florence, 2006, Neurosurg Focus, V20, pE7, DOI 10.3171/foc.2006.20.4.4; Levine B, 2010, NATURE, V466, P38, DOI 10.1038/466038a; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Naik E, 2011, J EXP MED, V208, P1351, DOI 10.1084/jem.20100951; Oliver L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019820; Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66; Persano L, 2013, BIOCHEM PHARMACOL, V85, P612, DOI 10.1016/j.bcp.2012.10.001; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Priault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008755; Selvakumaran M, 2013, CLIN CANCER RES, V19, P2995, DOI 10.1158/1078-0432.CCR-12-1542; Singh SK, 2003, CANCER RES, V63, P5821; Sini P, 2010, AUTOPHAGY, V6, P553, DOI 10.4161/auto.6.4.11671; Sneddon JB, 2009, METHODS MOL BIOL, V568, P217, DOI 10.1007/978-1-59745-280-9_14; Thirant C, 2012, STEM CELLS, V30, P845, DOI 10.1002/stem.1062; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	33	12	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93505	10.1371/journal.pone.0093505	http://dx.doi.org/10.1371/journal.pone.0093505			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682219	Green Published, gold, Green Submitted			2022-12-25	WOS:000333678100050
J	Topper, SM; Aguilar, SC; Topper, VY; Elbel, E; Pierce-Shimomura, JT				Topper, Stephen M.; Aguilar, Sara C.; Topper, Viktoria Y.; Elbel, Erin; Pierce-Shimomura, Jonathan T.			Alcohol Disinhibition of Behaviors in C. elegans	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; RAT NUCLEUS-ACCUMBENS; CAENORHABDITIS-ELEGANS; DOPAMINE-RECEPTOR; ETHANOL; RELEASE; ANXIETY; RESPONSES; STRESS; SENSITIZATION	Alcohol has a wide variety of effects on physiology and behavior. One of the most well-recognized behavioral effects is disinhibition, where behaviors that are normally suppressed are displayed following intoxication. A large body of evidence has shown that alcohol-induced disinhibition in humans affects attention, verbal, sexual, and locomotor behaviors. Similar behavioral disinhibition is also seen in many animal models of ethanol response, from invertebrates to mammals and primates. Here we describe several examples of disinhibition in the nematode C. elegans. The nematode displays distinct behavioral states associated with locomotion (crawling on land and swimming in water) that are mediated by dopamine. On land, animals crawl and feed freely, but these behaviors are inhibited in water. We found that additional behaviors, including a variety of escape responses are also inhibited in water. Whereas alcohol non-specifically impaired locomotion, feeding, and escape responses in worms on land, alcohol specifically disinhibited these behaviors in worms immersed in water. Loss of dopamine signaling relieved disinhibition of feeding behavior, while loss of the D1-like dopamine receptor DOP-4 impaired the ethanol-induced disinhibition of crawling. The powerful genetics and simple nervous system of C. elegans may help uncover conserved molecular mechanisms that underlie alcohol-induced disinhibition of behaviors in higher animals.	[Topper, Stephen M.; Aguilar, Sara C.; Topper, Viktoria Y.; Elbel, Erin; Pierce-Shimomura, Jonathan T.] Univ Texas Austin, Dept Neurosci, Waggoner Ctr Alcohol & Addict Res Cell & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Pierce-Shimomura, JT (corresponding author), Univ Texas Austin, Dept Neurosci, Waggoner Ctr Alcohol & Addict Res Cell & Mol Biol, Austin, TX 78712 USA.	jonps@austin.utexas.edu			National Institutes of Health grants from NIAAA [R01AA020992]; NINDS, Waggoner Center for Alcohol and Addiction Research [R01NS075541]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020992] Funding Source: NIH RePORTER	National Institutes of Health grants from NIAAA; NINDS, Waggoner Center for Alcohol and Addiction Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding was provided by National Institutes of Health grants from NIAAA (R01AA020992) and NINDS (R01NS075541), Waggoner Center for Alcohol and Addiction Research (http://www.utexas.edu/research/wcaar/) to JTP as well as a Bruce Jones Fellowship to ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao KP, 2011, INT J NEUROPSYCHOPH, V14, P175, DOI 10.1017/S1461145710000441; AHLENIUS S, 1974, J NEURAL TRANSM, V35, P175, DOI 10.1007/BF01250743; Alaimo JT, 2012, ALCOHOL CLIN EXP RES, V36, P1840, DOI 10.1111/j.1530-0277.2012.01799.x; BABOR TF, 1983, PSYCHOPHARMACOLOGY, V80, P53, DOI 10.1007/BF00427496; Bahi A, 2012, BEHAV BRAIN RES, V226, P250, DOI 10.1016/j.bbr.2011.09.024; BRENNER S, 1974, GENETICS, V77, P71; Broadbent J, 2005, ALCOHOL, V35, P137, DOI 10.1016/j.alcohol.2005.03.006; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; COLOMBO G, 1995, PHYSIOL BEHAV, V57, P1181, DOI 10.1016/0031-9384(94)00382-F; Davies AG, 2004, NEURON, V42, P731, DOI 10.1016/j.neuron.2004.05.004; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; DEBOER MC, 1993, ADDICT BEHAV, V18, P117, DOI 10.1016/0306-4603(93)90041-7; DUNCAN HM, 1966, J BIOL CHEM, V241, P1694; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Gomez JL, 2012, ALCOHOL, V46, P499, DOI 10.1016/j.alcohol.2011.12.005; Gonzales RA, 2004, PHARMACOL THERAPEUT, V103, P121, DOI 10.1016/j.pharmthera.2004.06.002; HERWEIJER MA, 1985, BIOCHIM BIOPHYS ACTA, V809, P81, DOI 10.1016/0005-2728(85)90170-7; Hodge CW, 1997, ALCOHOL CLIN EXP RES, V21, P1083, DOI 10.1111/j.1530-0277.1997.tb04257.x; IMPERATO A, 1986, J PHARMACOL EXP THER, V239, P219; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Lee HG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001391; Lee J, 2009, GENES BRAIN BEHAV, V8, P578, DOI 10.1111/j.1601-183X.2009.00513.x; Marinkovic K, 2000, J STUD ALCOHOL, V61, P24, DOI 10.15288/jsa.2000.61.24; Melendez RI, 2002, ALCOHOL CLIN EXP RES, V26, P318; Mitchell PH, 2007, PHARMACOGENOMICS J, V7, P411, DOI 10.1038/sj.tpj.6500440; Mitchell P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010422; Moberg CA, 2009, J ABNORM PSYCHOL, V118, P335, DOI 10.1037/a0015636; Mongan NP, 2002, PROTEIN SCI, V11, P1162, DOI 10.1110/ps.3040102; Pandey SC, 2005, J CLIN INVEST, V115, P2762, DOI 10.1172/JCI24381; Pisu MG, 2011, EUR NEUROPSYCHOPHARM, V21, P414, DOI 10.1016/j.euroneuro.2010.07.006; Pohorecky LA, 2008, PHYSIOL BEHAV, V94, P432, DOI 10.1016/j.physbeh.2008.02.010; Prause N, 2011, ARCH SEX BEHAV, V40, P373, DOI 10.1007/s10508-010-9718-9; RASSNICK S, 1992, PSYCHOPHARMACOLOGY, V109, P92, DOI 10.1007/BF02245485; Rose AK, 2007, ALCOHOL ALCOHOLISM, V42, P544, DOI 10.1093/alcalc/agm073; SAMSON HH, 1993, BRAIN RES BULL, V30, P133, DOI 10.1016/0361-9230(93)90049-H; Sayette MA, 2012, PSYCHOL SCI, V23, P869, DOI 10.1177/0956797611435134; Sprengel R, 2001, TRENDS PHARMACOL SCI, V22, P7, DOI 10.1016/S0165-6147(00)01588-1; Stoner SA, 2007, AIDS BEHAV, V11, P227, DOI 10.1007/s10461-006-9137-z; Sugiura M, 2005, J NEUROCHEM, V94, P1146, DOI 10.1111/j.1471-4159.2005.03268.x; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Suo S, 2003, J NEUROCHEM, V86, P869, DOI 10.1046/j.1471-4159.2003.01896.x; Suo S, 2002, NEUROSCI LETT, V319, P13, DOI 10.1016/S0304-3940(01)02477-6; Varlinskaya EI, 2012, PHARMACOL BIOCHEM BE, V100, P440, DOI 10.1016/j.pbb.2011.10.010; Vidal-Gadea A, 2011, P NATL ACAD SCI USA, V108, P17504, DOI 10.1073/pnas.1108673108; Vidal-Gadea Andres G, 2012, Worm, V1, P5; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; Weafer J, 2012, DRUG ALCOHOL DEPEN, V126, P176, DOI 10.1016/j.drugalcdep.2012.05.010; WEIGHT FF, 1992, ADV BIOCHEM PSYCHOPH, V47, P335; WEISS F, 1993, J PHARMACOL EXP THER, V267, P250; Wintle RF, 2001, PARKINSONISM RELAT D, V7, P177, DOI 10.1016/S1353-8020(00)00055-9; Yang YH, 1999, ALCOHOL CLIN EXP RES, V23, P983; Yassin L, 2001, MOL CELL NEUROSCI, V17, P589, DOI 10.1006/mcne.2000.0944; Yim HJ, 2000, ALCOHOL, V22, P107, DOI 10.1016/S0741-8329(00)00121-X	55	18	18	8	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92965	10.1371/journal.pone.0092965	http://dx.doi.org/10.1371/journal.pone.0092965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681782	Green Published, gold, Green Submitted			2022-12-25	WOS:000333678100020
J	Aquino, D; Di Stefano, AL; Scotti, A; Cuppini, L; Anghileri, E; Finocchiaro, G; Bruzzone, MG; Eoli, M				Aquino, Domenico; Di Stefano, Anna Luisa; Scotti, Alessandro; Cuppini, Lucia; Anghileri, Elena; Finocchiaro, Gaetano; Bruzzone, Maria Grazia; Eoli, Marica			Parametric Response Maps of Perfusion MRI May Identify Recurrent Glioblastomas Responsive to Bevacizumab and Irinotecan	PLOS ONE			English	Article							ANTI-ANGIOGENIC THERAPY; CEREBRAL BLOOD-VOLUME; HISTOGRAM ANALYSIS; BRAIN-TUMOR; GLIOMAS; SURVIVAL; GRADE; PROGRESSION; MULTIFORME; BIOMARKERS	Background: Perfusion weighted imaging (PWI) can be used to measure key aspects of tumor vascularity in vivo and recent studies suggest that perfusion imaging may be useful in the early assessment of response to angiogenesis inhibitors. Aim of this work is to compare Parametric Response Maps (PRMs) with the Region Of Interest (ROI) approach in the analysis of tumor changes induced by bevacizumab and irinotecan in recurrent glioblastomas (rGBM), and to evaluate if changes in tumor blood volume measured by perfusion MRI may predict clinical outcome. Methods: 42 rGBM patients with KPS >= 50 were treated until progression, as defined by MRI with RANO criteria. Relative cerebral blood volume (rCBV) variation after 8 weeks of treatment was calculated through semi-automatic ROI placement in the same anatomic region as in baseline. Alternatively, rCBV variations with respect to baseline were calculated into the evolving tumor region using a voxel-by-voxel difference. PRMs were created showing where rCBV significantly increased, decreased or remained unchanged. Results: An increased blood volume in PRM (PRMCBV+) higher than 18% (first quartile) after 8 weeks of treatment was associated with increased progression free survival (PFS; 24 versus 13 weeks, p = 0.045) and overall survival (OS; 38 versus 25 weeks, p = 0.016). After 8 weeks of treatment ROI analysis showed that mean rCBV remained elevated in non responsive patients (4.8 +/- 60.9 versus 5.1 +/- 1.2, p = 0.38), whereas decreased in responsive patients (4.2 +/- 1.3 versus 3.8 +/- 1.6 p = 0.04), and re-increased progressively when patients approached tumor progression. Conclusions: Our data suggest that PRMs can provide an early marker of response to antiangiogenic treatment and warrant further confirmation in a larger cohort of GBM patients.	[Aquino, Domenico; Scotti, Alessandro; Bruzzone, Maria Grazia] Fdn IRCCS Ist Neurol C Besta, Neuroradiol Unit, Milan, Italy; [Di Stefano, Anna Luisa] Fdn IRCCS Ist Neurol C Besta, Gen Neurol Unit, Milan, Italy; [Cuppini, Lucia; Anghileri, Elena; Finocchiaro, Gaetano; Eoli, Marica] Fdn IRCCS Ist Neurol C Besta, Mol Neurooncol Unit, Milan, Italy	IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta	Eoli, M (corresponding author), Fdn IRCCS Ist Neurol C Besta, Mol Neurooncol Unit, Milan, Italy.	eoli@istituto-besta.it	Aquino, Domenico/AAK-3047-2021; Bruzzone, Maria/AAM-4478-2021; Di Stefano, Anna Luisa/AAS-7836-2020; Finocchiaro, Gaetano/AAG-6791-2020; Eoli, Marica/K-7748-2016; Anghileri, Elena/AAK-4180-2021	Aquino, Domenico/0000-0002-1289-9573; Bruzzone, Maria/0000-0002-2786-1471; Di Stefano, Anna Luisa/0000-0003-1746-0647; Eoli, Marica/0000-0003-4744-9377; Anghileri, Elena/0000-0001-7383-3108; Finocchiaro, Gaetano/0000-0003-3583-4040	Italian Ministry of Health [RF-INN-2008-1142520]; MIUR [RBAP1183B5]	Italian Ministry of Health(Ministry of Health, Italy); MIUR(Ministry of Education, Universities and Research (MIUR))	This work was partially supported by a grant from the Italian Ministry of Health [RF-INN-2008-1142520 to GF]. Drugs were supplied by Roche S. p. A. (Monza, Italy) and Hospira (Napoli, Italy). This work was partially funded by MIUR, FIRB project "Materiali fluorurati nanostrutturati come mezzi di contrasto intelligenti in 19F-RMN (FLUORIMAGING)'' project no. RBAP1183B5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barajas RF, 2012, PROG NEUROL SURG, V25, P55, DOI 10.1159/000331174; Batchelor TT, 2013, P NATL ACAD SCI USA, V110, P19059, DOI 10.1073/pnas.1318022110; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cha S, 2000, AM J NEURORADIOL, V21, P881; Chamberlain MC, 2011, J NEURO-ONCOL, V101, P319, DOI 10.1007/s11060-010-0251-4; Cuppini L, 2013, PLOS ONE IN PRESS; Galban CJ, 2011, CLIN CANCER RES, V17, P4751, DOI 10.1158/1078-0432.CCR-10-2098; Galban CJ, 2009, NAT MED, V15, P572, DOI 10.1038/nm.1919; Hashimoto M, 2004, ONCOGENE, V23, P3716, DOI 10.1038/sj.onc.1207418; Hu LS, 2012, AM J NEURORADIOL, V33, P69, DOI 10.3174/ajnr.A2743; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Law M, 2007, AM J NEURORADIOL, V28, P761; Law M, 2008, RADIOLOGY, V247, P490, DOI 10.1148/radiol.2472070898; Lu Kan V, 2013, CNS Oncol, V2, P49; Maier SE, 2010, NMR BIOMED, V23, P849, DOI 10.1002/nbm.1544; Maru D, 2013, CLIN CANCER RES, V19, P2824, DOI 10.1158/1078-0432.CCR-12-3409; McNamara MG, 2012, EXPERT REV ANTICANC, V12, P643, DOI [10.1586/ERA.12.35, 10.1586/era.12.35]; Mills SJ, 2010, AM J NEURORADIOL, V31, P726, DOI 10.3174/ajnr.A1925; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Pope WB, 2011, AM J NEURORADIOL, V32, P882, DOI 10.3174/ajnr.A2385; Pope WB, 2012, J NEURO-ONCOL, V108, P491, DOI 10.1007/s11060-012-0847-y; Ratai EM, 2013, NEURO-ONCOLOGY, V15, P936, DOI 10.1093/neuonc/not044; Sawlani RN, 2010, RADIOLOGY, V255, P622, DOI 10.1148/radiol.10091341; Sorensen AG, 2012, CANCER RES, V72, P402, DOI 10.1158/0008-5472.CAN-11-2464; Specenier P, 2012, EXPERT REV ANTICANC, V12, P9, DOI [10.1586/ERA.11.179, 10.1586/era.11.179]; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sugahara T, 2000, AM J NEURORADIOL, V21, P901; Takano Shingo, 2013, Acta Neurochir Suppl, V118, P185, DOI 10.1007/978-3-7091-1434-6_34; Tsien C, 2010, J CLIN ONCOL, V28, P2293, DOI 10.1200/JCO.2009.25.3971; Van Meter MEM, 2010, CURR OPIN ONCOL, V22, P586, DOI 10.1097/CCO.0b013e32833edc0c; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Young R, 2007, J MAGN RESON IMAGING, V26, P1053, DOI 10.1002/jmri.21064; Zulfiqar M, 2013, AM J ROENTGENOL, V200, P624, DOI 10.2214/AJR.12.8679	33	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e90535	10.1371/journal.pone.0090535	http://dx.doi.org/10.1371/journal.pone.0090535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675671	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677500008
J	Raghunath, S; Rajagopalan, S; Karwoski, RA; Maldonado, F; Peikert, T; Moua, T; Ryu, JH; Bartholmai, BJ; Robb, RA				Raghunath, Sushravya; Rajagopalan, Srinivasan; Karwoski, Ronald A.; Maldonado, Fabien; Peikert, Tobias; Moua, Teng; Ryu, Jay H.; Bartholmai, Brian J.; Robb, Richard A.			Quantitative Stratification of Diffuse Parenchymal Lung Diseases	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; NONSPECIFIC INTERSTITIAL PNEUMONIA; COMPUTED-TOMOGRAPHY; PREDICTS SURVIVAL; CLINICAL-TRIALS; EMPHYSEMA; CT; CLASSIFICATION; DIAGNOSIS; PATTERNS	Diffuse parenchymal lung diseases (DPLDs) are characterized by widespread pathological changes within the pulmonary tissue that impair the elasticity and gas exchange properties of the lungs. Clinical-radiological diagnosis of these diseases remains challenging and their clinical course is characterized by variable disease progression. These challenges have hindered the introduction of robust objective biomarkers for patient-specific prediction based on specific phenotypes in clinical practice for patients with DPLD. Therefore, strategies facilitating individualized clinical management, staging and identification of specific phenotypes linked to clinical disease outcomes or therapeutic responses are urgently needed. A classification schema consistently reflecting the radiological, clinical (lung function and clinical outcomes) and pathological features of a disease represents a critical need in modern pulmonary medicine. Herein, we report a quantitative stratification paradigm to identify subsets of DPLD patients with characteristic radiologic patterns in an unsupervised manner and demonstrate significant correlation of these self-organized disease groups with clinically accepted surrogate endpoints. The proposed consistent and reproducible technique could potentially transform diagnostic staging, clinical management and prognostication of DPLD patients as well as facilitate patient selection for clinical trials beyond the ability of current radiological tools. In addition, the sequential quantitative stratification of the type and extent of parenchymal process may allow standardized and objective monitoring of disease, early assessment of treatment response and mortality prediction for DPLD patients.	[Raghunath, Sushravya; Rajagopalan, Srinivasan; Karwoski, Ronald A.; Robb, Richard A.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Maldonado, Fabien; Peikert, Tobias; Moua, Teng; Ryu, Jay H.] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA; [Bartholmai, Brian J.] Mayo Clin, Dept Radiol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Robb, RA (corresponding author), Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.	robb.richard@mayo.edu	Moua, Teng/AAG-7445-2019	Bartholmai, Brian/0000-0001-7834-6579; Ryu, Jay/0000-0002-9576-2272	Mayo Graduate School, Mayo Clinic College of Medicine;  [HHSN268201100022C]; NATIONAL CANCER INSTITUTE [K23CA159391] Funding Source: NIH RePORTER	Mayo Graduate School, Mayo Clinic College of Medicine; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Brian J. Bartholmai is the PI of NIH/NHLBI Radiology core lab for LTRC (HHSN268201100022C) and was partially funded by this contract. Sushravya Raghunath was funded by Mayo Graduate School, Mayo Clinic College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Akira M, 2009, RADIOLOGY, V251, P271, DOI 10.1148/radiol.2511080917; Bartholmai BJ, 2013, J THORAC IMAG, V28, P298, DOI 10.1097/RTI.0b013e3182a21969; Best AC, 2008, RADIOLOGY, V246, P935, DOI 10.1148/radiol.2463062200; Castaldi PJ, 2013, AM J RESP CRIT CARE, V188, P1083, DOI 10.1164/rccm.201305-0873OC; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Cesuroglu T, 2012, PERS MED, V9, P115, DOI 10.2217/pme.12.16; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dirksen A, 2013, AM J RESP CRIT CARE, V188, P1045, DOI 10.1164/rccm.201309-1649ED; Flaherty KR, 2003, AM J RESP CRIT CARE, V168, P543, DOI 10.1164/rccm.200209-1112OC; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gietema HA, 2011, ACAD RADIOL, V18, P661, DOI 10.1016/j.acra.2011.01.011; Goldin JG, 2013, J THORAC IMAG, V28, P291, DOI 10.1097/RTI.0b013e3182a1d93d; Hansell DM, 2013, RADIOLOGY, V268, P628, DOI 10.1148/radiol.13120908; HAYHURST MD, 1984, LANCET, V2, P320; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Kim SS, 2013, RADIOLOGY, V266, P626, DOI 10.1148/radiol.12120385; Lederer DJ, 2013, EUROPEAN RESP J, V42, P1442; Ley B, 2012, ANN INTERN MED, V156, P684, DOI 10.7326/0003-4819-156-10-201205150-00004; Luppi F, 2012, CURR OPIN PULM MED, V18, P428, DOI 10.1097/MCP.0b013e3283567ff9; Lynch DA, 2005, AM J RESP CRIT CARE, V172, P488, DOI 10.1164/rccm.200412-1756OC; Lynch DA, 2005, RADIOLOGY, V236, P10, DOI 10.1148/radiol.2361031674; MacDonald SLS, 2001, RADIOLOGY, V221, P600, DOI 10.1148/radiol.2213010158; Maldonado F, 2014, EUR RESPIR J, V43, P204, DOI 10.1183/09031936.00071812; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mooney JJ, 2013, CHEST, V144, P586, DOI 10.1378/chest.12-2623; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Raghunath Sushravya, 2012, Stud Health Technol Inform, V173, P362; Ryerson CJ, 2013, CHEST, V144, P234, DOI 10.1378/chest.12-2403; Schuster DP, 2007, AM J RESP CRIT CARE, V176, P224, DOI 10.1164/rccm.200703-462PP; Sullivan DC, 2008, RADIOLOGY, V248, P328, DOI 10.1148/radiol.2482080242; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Trusheim MR, 2007, NAT REV DRUG DISCOV, V6, P287, DOI 10.1038/nrd2251; Uppaluri R, 1999, AM J RESP CRIT CARE, V159, P519, DOI 10.1164/ajrccm.159.2.9707145; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Xaubet A, 1998, AM J RESP CRIT CARE, V158, P431, DOI 10.1164/ajrccm.158.2.9709008; Xu Y, 2006, IEEE T MED IMAGING, V25, P464, DOI 10.1109/TMI.2006.870889	39	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93229	10.1371/journal.pone.0093229	http://dx.doi.org/10.1371/journal.pone.0093229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676019	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677500096
J	Ravetto, A; Wyss, HM; Anderson, PD; den Toonder, JMJ; Bouten, CVC				Ravetto, Agnese; Wyss, Hans M.; Anderson, Patrick D.; den Toonder, Jaap M. J.; Bouten, Carlijn V. C.			Monocytic Cells Become Less Compressible but More Deformable upon Activation	PLOS ONE			English	Article							POLYMORPHONUCLEAR LEUKOCYTES; MECHANICAL DEFORMATION; NARROW CHANNELS; NEUTROPHILS; CYTOSKELETON; RETENTION; CAPILLARIES	Aims: Monocytes play a significant role in the development of atherosclerosis. During the process of inflammation, circulating monocytes become activated in the blood stream. The consequent interactions of the activated monocytes with the blood flow and endothelial cells result in reorganization of cytoskeletal proteins, in particular of the microfilament structure, and concomitant changes in cell shape and mechanical behavior. Here we investigate the full elastic behavior of activated monocytes in relation to their cytoskeletal structure to obtain a better understanding of cell behavior during the progression of inflammatory diseases such as atherosclerosis. Methods and Results: The recently developed Capillary Micromechanics technique, based on exposing a cell to a pressure difference in a tapered glass microcapillary, was used to measure the deformation of activated and non-activated monocytic cells. Monitoring the elastic response of individual cells up to large deformations allowed us to obtain both the compressive and the shear modulus of a cell from a single experiment. Activation by inflammatory chemokines affected the cytoskeletal organization and increased the elastic compressive modulus of monocytes with 73-340%, while their resistance to shape deformation decreased, as indicated by a 25-88% drop in the cell's shear modulus. This decrease in deformability is particularly pronounced at high strains, such as those that occur during diapedesis through the vascular wall. Conclusion: Overall, monocytic cells become less compressible but more deformable upon activation. This change in mechanical response under different modes of deformation could be important in understanding the interplay between the mechanics and function of these cells. In addition, our data are of direct relevance for computational modeling and analysis of the distinct monocytic behavior in the circulation and the extravascular space. Lastly, an understanding of the changes of monocyte mechanical properties will be important in the development of diagnostic tools and therapies concentrating on circulating cells.	[Ravetto, Agnese; Bouten, Carlijn V. C.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Wyss, Hans M.; Anderson, Patrick D.; den Toonder, Jaap M. J.] Eindhoven Univ Technol, Dept Mech Engn, NL-5600 MB Eindhoven, Netherlands; [Wyss, Hans M.; Anderson, Patrick D.; den Toonder, Jaap M. J.] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Eindhoven University of Technology	Ravetto, A (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, POB 513, NL-5600 MB Eindhoven, Netherlands.	a.ravetto@tue.nl	Bouten, Carlijn/AAT-5187-2020; Anderson, Patrick D/E-6046-2011; Wyss, Hans/A-9404-2008	Bouten, Carlijn/0000-0003-1035-5094; Wyss, Hans/0000-0001-6564-3398; den Toonder, Jaap/0000-0002-5923-4456; Anderson, Patrick/0000-0001-9157-0858	CTMM, the Center for Translational Molecular Medicine, project CIRCULATING CELLS [01C-102]; Dutch Heart Foundation	CTMM, the Center for Translational Molecular Medicine, project CIRCULATING CELLS; Dutch Heart Foundation(Netherlands Heart Foundation)	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project CIRCULATING CELLS (grant 01C-102), and supported by the Dutch Heart Foundation. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The manuscript had to be submitted to the funders for Clearance on IP issues.	BOYD AW, 1984, LEUKEMIA RES, V8, P27, DOI 10.1016/0145-2126(84)90029-8; BUTTRUM SM, 1994, J APPL PHYSIOL, V77, P1801, DOI 10.1152/jappl.1994.77.4.1801; CHIEN S, 1987, ANN NY ACAD SCI, V516, P333, DOI 10.1111/j.1749-6632.1987.tb33054.x; DOHERTY DE, 1994, J IMMUNOL, V153, P241; DOWNEY GP, 1990, J APPL PHYSIOL, V69, P1767, DOI 10.1152/jappl.1990.69.5.1767; DOWNEY GP, 1991, J CELL BIOL, V114, P1179, DOI 10.1083/jcb.114.6.1179; EVANS E, 1989, BIOPHYS J, V56, P151, DOI 10.1016/S0006-3495(89)82660-8; Gabriele S, 2009, BIOPHYS J, V96, P4308, DOI 10.1016/j.bpj.2009.02.037; Gossett DR, 2012, P NATL ACAD SCI USA, V109, P7630, DOI 10.1073/pnas.1200107109; Guo MY, 2011, MACROMOL MATER ENG, V296, P223, DOI 10.1002/mame.201000359; HOWARD TH, 1985, J CELL BIOL, V101, P1078, DOI 10.1083/jcb.101.3.1078; Kitagawa Y, 1997, J APPL PHYSIOL, V82, P1397, DOI 10.1152/jappl.1997.82.5.1397; NEEDHAM D, 1992, BIOPHYS J, V61, P1664, DOI 10.1016/S0006-3495(92)81970-7; Nishino M, 2005, J TRAUMA, V59, P1425, DOI 10.1097/01.ta.0000197356.83144.72; Nossal R, 1998, BIOPHYS J, V75, P1541, DOI 10.1016/S0006-3495(98)74073-1; Preira P, 2013, LAB CHIP, V13, P161, DOI [10.1039/c2lc40847c, 10.1039/c2lc40847]; Rinker KD, 2004, ATHEROSCLEROSIS, V177, P275, DOI 10.1016/j.atherosclerosis.2004.07.017; Rosenbluth MJ, 2006, BIOPHYS J, V90, P2994, DOI 10.1529/biophysj.105.067496; Sefah K, 2009, LEUKEMIA, V23, P235, DOI 10.1038/leu.2008.335; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Simon SI, 1999, J IMMUNOL, V163, P2891; Singh V, 2009, CURR VASC PHARMACOL, V7, P75, DOI 10.2174/157016109787354097; TSAI MA, 1993, BIOPHYS J, V65, P2078, DOI 10.1016/S0006-3495(93)81238-4; Tseng Y, 2004, J BIOL CHEM, V279, P1819, DOI 10.1074/jbc.M306090200; VERMES I, 1987, DIABETOLOGIA, V30, P434, DOI 10.1007/BF00292548; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; WORTHEN GS, 1989, SCIENCE, V245, P183, DOI 10.1126/science.2749255; Wyss HM, 2011, AM J PHYSIOL-CELL PH, V300, pC397, DOI 10.1152/ajpcell.00438.2010; Wyss HM, 2010, SOFT MATTER, V6, P4550, DOI 10.1039/c003344h; Yap B, 2005, J APPL PHYSIOL, V99, P2323, DOI 10.1152/japplphysiol.00503.2005; Yap B, 2005, J APPL PHYSIOL, V98, P1930, DOI 10.1152/japplphysiol.01226.2004	31	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92814	10.1371/journal.pone.0092814	http://dx.doi.org/10.1371/journal.pone.0092814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676335	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500043
J	Sun, W; Li, J; Han, PF; Yang, YH; Kang, XP; Li, YC; Li, JM; Zhang, Y; Wu, XY; Jiang, T; Qin, CF; Hu, Y; Zhu, QY				Sun, Wei; Li, Jing; Han, Pengfei; Yang, Yinhui; Kang, Xiaoping; Li, Yuchang; Li, Jiaming; Zhang, Yu; Wu, Xiaoyan; Jiang, Tao; Qin, Chengfeng; Hu, Yi; Zhu, Qingyu			U-4 at the 3 ' UTR of PB1 Segment of H5N1 Influenza Virus Promotes RNA Polymerase Activity and Contributes to Viral Pathogenicity	PLOS ONE			English	Article							MIGRATORY WATERFOWL; SECONDARY STRUCTURE; PANHANDLE RNA; HUMAN AIRWAY; REPLICATION; TRANSCRIPTION; NUCLEOTIDE; INFECTION; HEMAGGLUTININ; NUCLEOPROTEIN	The viral RNA-dependent RNA polymerase has been found to contribute to efficient replication in mammalian systems and to the high pathogenicity of H5N1 influenza A virus in humans and other mammals. The terminal untranslated regions of the viral segments perform functions such as polyadenylation and contain signals for genomic packaging and initiation of RNA synthesis. These sequences are highly conserved, apart from a U/C polymorphism at position 4 of the 39 end, most often seen in the polymerase gene segments. However, no study has yet tested whether the untranslated regions of H5N1 make any contribution to its high pathogenicity. Herein, the association of the fourth nucleotide at the 39 end of the untranslated region in segment 2 (PB1), of A/Vietnam/1194/2004 (H5N1), with pathogenicity was examined in mice. To this end, an RNA polymerase reporter system was constructed, and viruses with mutations at this site were rescued. Results showed the U-4 in PB1 was found to contribute to greater amounts of RNA-dependent RNA polymerase activity and differentially regulate genomic transcription and replication. Although a recombinant H5N1 virus with the rarer C-4 sequence in all eight segments was viable and replicated to high titers in vitro, replacing a single U-4 at the 39 termini of the PB1 gene segment enhanced viral reproduction and more pathogenesis. In this way, these data showed the importance of untranslated regions of H5N1 influenza virus to pathogenicity.	[Sun, Wei; Li, Jing; Han, Pengfei; Yang, Yinhui; Kang, Xiaoping; Li, Yuchang; Li, Jiaming; Zhang, Yu; Wu, Xiaoyan; Jiang, Tao; Qin, Chengfeng; Hu, Yi; Zhu, Qingyu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Hu, Y (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China.	qingyzh@aliyun.com; huyi-amms@163.com	Qin, Cheng-Feng/I-6839-2019; Li, Jing/AAE-6038-2019; Tao, Jiang/AAE-6623-2019	Qin, Cheng-Feng/0000-0002-0632-2807; Tao, Jiang/0000-0003-1908-2926	973 High-Tech Projects Plan [2011CB504706]; National Nature Science Foundation of China [31200119]; Major National Science and Technology Projects [2012ZX10004-502]	973 High-Tech Projects Plan(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major National Science and Technology Projects	This study was supported by the grant from the 973 High-Tech Projects Plan (No. 2011CB504706) (http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm), the grant from the National Nature Science Foundation of China (No. 31200119) (http://www.nsfc.gov.cn/Portal0/default166.htm) and the grant from Major National Science and Technology Projects (No. 2012ZX10004-502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; BOSCH FX, 1979, VIROLOGY, V95, P197, DOI 10.1016/0042-6822(79)90414-8; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Chen Y, 2013, LANCET, V6736, P3; Cheong HK, 1996, NUCLEIC ACIDS RES, V24, P4197, DOI 10.1093/nar/24.21.4197; Davis JM, 2008, AM J PHYSIOL-REG I, V295, pR505, DOI 10.1152/ajpregu.90319.2008; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; DESSELBERGER U, 1980, GENE, V8, P315, DOI 10.1016/0378-1119(80)90007-4; FODOR E, 1994, J VIROL, V68, P4092, DOI 10.1128/JVI.68.6.4092-4096.1994; Fujii K, 2005, J VIROL, V79, P3766, DOI 10.1128/JVI.79.6.3766-3774.2005; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jiang HB, 2010, VIROLOGY, V408, P190, DOI 10.1016/j.virol.2010.09.022; Kawakami E, 2011, J VIROL METHODS, V173, P1, DOI 10.1016/j.jviromet.2010.12.014; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Lee KH, 1998, J GEN VIROL, V79, P1923, DOI 10.1099/0022-1317-79-8-1923; Lee MK, 2003, NUCLEIC ACIDS RES, V31, P1216, DOI 10.1093/nar/gkg214; Li J, 2011, J GEN VIROL, V92, P1435, DOI 10.1099/vir.0.030718-0; Li J, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-93; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Resa-Infante P, 2011, RNA BIOL, V8, P207, DOI 10.4161/rna.8.2.14513; ROBERTSON JS, 1979, NUCLEIC ACIDS RES, V6, P3745, DOI 10.1093/nar/6.12.3745; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Twu KY, 2007, J VIROL, V81, P8112, DOI 10.1128/JVI.00006-07; WEBSTER RG, 1987, CELL, V50, P665, DOI 10.1016/0092-8674(87)90321-7; Zheng HY, 1996, VIROLOGY, V217, P242, DOI 10.1006/viro.1996.0111	33	6	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93366	10.1371/journal.pone.0093366	http://dx.doi.org/10.1371/journal.pone.0093366			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676059	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677500117
J	Cruz-Ramirez, N; Acosta-Mesa, HG; Mezura-Montes, E; Guerra-Hernandez, A; Hoyos-Rivera, GD; Barrientos-Martinez, RE; Gutierrez-Fragoso, K; Nava-Fernandez, LA; Gonzalez-Gaspar, P; Novoa-del-Toro, EM; Aguilera-Rueda, VJ; Ameca-Alducin, MY				Cruz-Ramirez, Nicandro; Gabriel Acosta-Mesa, Hector; Mezura-Montes, Efren; Guerra-Hernandez, Alejandro; de Jesus Hoyos-Rivera, Guillermo; Erandi Barrientos-Martinez, Rocio; Gutierrez-Fragoso, Karina; Alonso Nava-Fernandez, Luis; Gonzalez-Gaspar, Patricia; Maria Novoa-del-Toro, Elva; Josue Aguilera-Rueda, Vicente; Yaneli Ameca-Alducin, Maria			How Good Is Crude MDL for Solving the Bias-Variance Dilemma? An Empirical Investigation Based on Bayesian Networks	PLOS ONE			English	Article							MODEL SELECTION; PROBABILISTIC NETWORKS; CLASSIFIERS; INFORMATION; DISCRETIZATION; DISTRIBUTIONS; ALGORITHMS; KNOWLEDGE; VARIABLES	The bias-variance dilemma is a well-known and important problem in Machine Learning. It basically relates the generalization capability (goodness of fit) of a learning method to its corresponding complexity. When we have enough data at hand, it is possible to use these data in such a way so as to minimize overfitting (the risk of selecting a complex model that generalizes poorly). Unfortunately, there are many situations where we simply do not have this required amount of data. Thus, we need to find methods capable of efficiently exploiting the available data while avoiding overfitting. Different metrics have been proposed to achieve this goal: the Minimum Description Length principle (MDL), Akaike's Information Criterion (AIC) and Bayesian Information Criterion (BIC), among others. In this paper, we focus on crude MDL and empirically evaluate its performance in selecting models with a good balance between goodness of fit and complexity: the so-called bias-variance dilemma, decomposition or tradeoff. Although the graphical interaction between these dimensions (bias and variance) is ubiquitous in the Machine Learning literature, few works present experimental evidence to recover such interaction. In our experiments, we argue that the resulting graphs allow us to gain insights that are difficult to unveil otherwise: that crude MDL naturally selects balanced models in terms of bias-variance, which not necessarily need be the gold-standard ones. We carry out these experiments using a specific model: a Bayesian network. In spite of these motivating results, we also should not overlook three other components that may significantly affect the final model selection: the search procedure, the noise rate and the sample size.	[Cruz-Ramirez, Nicandro; Gabriel Acosta-Mesa, Hector; Mezura-Montes, Efren; Guerra-Hernandez, Alejandro; de Jesus Hoyos-Rivera, Guillermo; Erandi Barrientos-Martinez, Rocio; Gonzalez-Gaspar, Patricia; Maria Novoa-del-Toro, Elva; Josue Aguilera-Rueda, Vicente; Yaneli Ameca-Alducin, Maria] Univ Veracruzana, Fac Fis & Inteligencia Artificial, Xalapa 91000, Veracruz, Mexico; [Gutierrez-Fragoso, Karina] Univ Veracruzana, Ctr Invest Biomed, Xalapa 91000, Veracruz, Mexico; [Alonso Nava-Fernandez, Luis] UNAM, Ctr Alta Tecnol Educ Distancia, Tlaxcala, Mexico	Universidad Veracruzana; Universidad Veracruzana; Universidad Nacional Autonoma de Mexico	Cruz-Ramirez, N (corresponding author), Univ Veracruzana, Fac Fis & Inteligencia Artificial, Xalapa 91000, Veracruz, Mexico.	ncruz@uv.mx	Acosta-Mesa, Hector Gabriel/GQP-3005-2022; Mezura-Montes, Efrén/R-3926-2019	Mezura-Montes, Efrén/0000-0002-1565-5267; Gonzalez-Gaspar, Patricia/0000-0003-2062-3697; Guerra-Hernandez, Alejandro/0000-0002-4856-4011	PROMEP (Programa de Mejoramiento del Profesorado) [PROMEP/103.5/06/0585]	PROMEP (Programa de Mejoramiento del Profesorado)	The first author thanks PROMEP (Programa de Mejoramiento del Profesorado), project number PROMEP/103.5/06/0585, for the economic support given for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acid S, 2013, DATA MIN KNOWL DISC, V26, P174, DOI 10.1007/s10618-011-0247-5; Allen T.V., 2000, P 17 INT C MACH LEAR, P1047; Alonso-Barba JI, 2011, SOFT COMPUT, V15, P1881, DOI 10.1007/s00500-010-0623-x; Bouckaert R. R., 1993, Symbolic and Quantitative Approaches to Reasoning and Uncertainty. European Conference ECSQARU '93 Proceedings, P41, DOI 10.1007/BFb0028180; Boulle M, 2007, J MACH LEARN RES, V8, P1659; Bozdogan H, 2000, J MATH PSYCHOL, V44, P62, DOI 10.1006/jmps.1999.1277; Buntine W, 1996, IEEE T KNOWL DATA EN, V8, P195, DOI 10.1109/69.494161; Carvalho AM, 2007, LECT NOTES COMPUT SC, V4830, P16; Castillo G, 2005, LECT NOTES COMPUT SC, V3735, P70; Cheng J, 2002, ARTIF INTELL, V137, P43, DOI 10.1016/S0004-3702(02)00191-1; Cheng J, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P101; Chickering D.M., 1996, LEARNING DATA ARTIFI, P121, DOI [DOI 10.1007/978-1-4612-2404-4_12, DOI 10.1007/978-1-4612-2404-412]; Chickering David Maxwell, 1997, P 13 C UNC ART INT P, P80; CHOW CK, 1968, IEEE T INFORM THEORY, V14, P462, DOI 10.1109/TIT.1968.1054142; Clarke EJ, 2000, INT J INTELL SYST, V15, P61, DOI 10.1002/(SICI)1098-111X(200001)15:1<61::AID-INT4>3.0.CO;2-O; Cooper GF, 1999, COMPUTATION, CAUSATION, AND DISCOVERY, P3; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; de Campos C.P., 2009, P 26 ANN INT C MACHI, P113; de Campos LM, 2006, J MACH LEARN RES, V7, P2149; Diez FJ, 1997, ARTIF INTELL MED, V10, P59, DOI 10.1016/S0933-3657(97)00384-9; Drugan MM, 2010, INT J APPROX REASON, V51, P695, DOI 10.1016/j.ijar.2010.02.001; Flores MJ, 2011, APPL INTELL, V34, P372, DOI 10.1007/s10489-011-0286-z; Francois OCH, 2008, EUR WORKSH PROB GRAP, V4, P121; Freno A, 2011, INTEL SYST REF LIBR, V15, P1, DOI 10.1007/978-3-642-20308-4; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Friedman JH, 1997, DATA MIN KNOWL DISC, V1, P55, DOI 10.1023/A:1009778005914; Friedman N, 1998, NATO ADV SCI I D-BEH, V89, P421; Friedman N., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P157; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Friedman N, 1996, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, P274; Friedman N, 1998, LEARNING BAYESIAN NE, V15; Geiger D, 1998, NATO ADV SCI I D-BEH, V89, P461; GEMAN S, 1992, NEURAL COMPUT, V4, P1, DOI 10.1162/neco.1992.4.1.1; Glymour C., 1999, COMPUTATION CAUSATIO; Grossman D., 2004, P 21 INT C MACH LEAR, P46; Grunwald P, 2000, J MATH PSYCHOL, V44, P133, DOI 10.1006/jmps.1999.1280; Grunwald P.D., 2005, ADV MINIMUM DESCRIPT; Grunwald P. D., 2007, MINIMUM DESCRIPTION; Heckerman D, 1998, NATO ADV SCI I D-BEH, V89, P301; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Ide JS, 2002, LECT NOTES ARTIF INT, V2507, P366; Isozaki T, 2012, NEW GENERAT COMPUT, V30, P17, DOI 10.1007/s00354-012-0103-1; Jing Y, 2005, P 22 INT C MACH LEAR, V22, P369; Jing YS, 2008, MACH LEARN, V73, P155, DOI 10.1007/s10994-008-5065-7; Flores MJ, 2011, ARTIF INTELL MED, V53, P181, DOI 10.1016/j.artmed.2011.08.004; Kearns M, 1997, MACH LEARN, V27, P7, DOI 10.1023/A:1007344726582; Kelner R, 2012, INT J APPROX REASON, V53, P248, DOI 10.1016/j.ijar.2011.10.006; Kleiner A., 2000, Artificial Intelligence and Soft Computing. Proceedings of the IASTED International Conference, P191; Kontkanen P, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P334; Kontkanen P, 2000, STAT COMPUT, V10, P39, DOI 10.1023/A:1008984400380; Langseth H, 2006, MACH LEARN, V63, P135, DOI 10.1007/s10994-006-6136-2; Larranaga P, 2013, INFORM SCIENCES, V233, P109, DOI 10.1016/j.ins.2012.12.051; Lee N, 2010, COMPUT STAT DATA AN, V54, P1247, DOI 10.1016/j.csda.2009.11.003; Lima CF, 2011, SOFT COMPUT, V15, P1351, DOI 10.1007/s00500-010-0675-y; Liu Y, 2010, FRONT BIOL, V5, P98; Madden M, 2003, P EUR C MACH LEARN W, V14, P59; Madden MG, 2002, LECT NOTES ARTIF INT, V2464, P203; Madden MG, 2009, KNOWL-BASED SYST, V22, P489, DOI 10.1016/j.knosys.2008.10.006; Myung IJ, 2000, J MATH PSYCHOL, V44, P190, DOI 10.1006/jmps.1999.1283; Neapolitan R.E., 1990, PROBABILISTIC REASON; Neapolitan R.E., 2004, LEARNING BAYESIAN NE; O'Donnell RT, 2006, LECT NOTES COMPUT SC, V4304, P192; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Press W. H., 1999, NUMERICAL RECIPES C; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Robinson RW., 1977, LECT NOTES MATH, P28, DOI DOI 10.1007/BFB0069178; Roos T, 2005, MACH LEARN, V59, P267; Russell S. J., 2010, ARTIF INTELL, V3rd; Sahin F, 2004, P SOC PHOTO-OPT INS, V5433, P88, DOI 10.1117/12.542371; Santos E., 2004, P 17 INT FLOR ART IN, P538; Scheines R., 2000, CAUSATION PREDICTION; Silander T, 2010, INT J APPROX REASON, V51, P544, DOI 10.1016/j.ijar.2010.01.012; Spirtes P., 1995, KDD-95 Proceedings. First International Conference on Knowledge Discovery and Data Mining, P294; Su J., 2006, P 23 INT C MACH LEAR, P897, DOI DOI 10.1145/1143844.1143957; Suzuki J, 1999, IEICE T FUND ELECTR, VE82A, P2237; Suzuki J., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P462; Wai Lam, 1994, Computational Intelligence, V10, P269, DOI 10.1111/j.1467-8640.1994.tb00166.x; Wasserman L, 2000, J MATH PSYCHOL, V44, P92, DOI 10.1006/jmps.1999.1278; Whittaker J., 1990, GRAPHICAL MODELS APP; Wong ML, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P498, DOI 10.1109/ICDM.2002.1183994; Wong ML, 2002, GECCO, V2, P214; Yang Y, 2007, MACH LEARN, V69, P35, DOI 10.1007/s10994-007-5020-z; Yehezkel R, 2006, LECT NOTES COMPUT SC, V4109, P154; Zucchini W, 2000, J MATH PSYCHOL, V44, P41, DOI 10.1006/jmps.1999.1276	86	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92866	10.1371/journal.pone.0092866	http://dx.doi.org/10.1371/journal.pone.0092866			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671204	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677000087
J	Kuo, PL; Huang, YL; Hsieh, CCJ; Lee, JC; Lin, BW; Hung, LY				Kuo, Pao-Lin; Huang, Yung-Ling; Hsieh, Christine Chin-Jung; Lee, Jenq-Chang; Lin, Bo-Wen; Hung, Liang-Yi			STK31 Is a Cell-Cycle Regulated Protein That Contributes to the Tumorigenicity of Epithelial Cancer Cells	PLOS ONE			English	Article							SPINDLE CHECKPOINT; GENE-EXPRESSION; CENTROSOME; IDENTIFICATION; INSTABILITY; MITOSIS; IMMUNOTHERAPY; DESTRUCTION; MEIOSIS; OPINION	Serine/threonine kinase 31 (STK31) is one of the novel cancer/testis antigens for which its biological functions remain largely unclear. Here, we demonstrate that STK31 is overexpressed in many human colorectal cancer cell lines and tissues. STK31 co-localizes with pericentrin in the centrosomal region throughout all phases of the cell cycle. Interestingly, when cells undergo mitosis, STK31 also localizes to the centromeres, central spindle, and midbody. This localization behavior is similar to that of chromosomal passenger proteins, which are known to be the important players of the spindle assembly checkpoint. The expression of STK31 is cell cycle-dependent through the regulation of a putative D-box near its C-terminal region. Ectopically-expressed STK31-GFP increases cell migration and invasive ability without altering the proliferation rate of cancer cells, whereas the knockdown expression of endogenous STK31 by lentivirus-derived shRNA results in microtubule assembly defects that prolong the duration of mitosis and lead to apoptosis. Taken together, our results suggest that the aberrant expression of STK31 contributes to tumorigenicity in somatic cancer cells. STK31 might therefore act as a potential therapeutic target in human somatic cancers.	[Kuo, Pao-Lin; Huang, Yung-Ling; Hsieh, Christine Chin-Jung] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci BioTechnol, Tainan 70101, Taiwan; [Hung, Liang-Yi] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan 70101, Taiwan; [Hung, Liang-Yi] Natl Cheng Kung Univ, Ctr Infect Dis & Signal Transduct Res, Tainan 70101, Taiwan; [Kuo, Pao-Lin] Natl Cheng Kung Univ Hosp, Dept Obstet & Gynecol, Tainan 70428, Taiwan; [Lee, Jenq-Chang; Lin, Bo-Wen] Natl Cheng Kung Univ Hosp, Dept Surg, Tainan 70428, Taiwan; [Hung, Liang-Yi] Taipei Med Univ, Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Taipei Medical University	Hung, LY (corresponding author), Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan 70101, Taiwan.	lyhung@mail.ncku.edu.tw	Hung, Liang-Yi/AAG-4174-2019	, Liang-Yi/0000-0002-7284-2608	National Science Council [NSC101-2325-B-006-001, NSC102-2325-B-006-001]; Academia Sinica, Project of Promoting Academic Excellence and Developing World Class Research Centers [IBMS-CRC100-P01]; Center for Infectious Disease and Signaling Transduction Research, National Cheng Kung University	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Project of Promoting Academic Excellence and Developing World Class Research Centers; Center for Infectious Disease and Signaling Transduction Research, National Cheng Kung University	This work was supported by grants NSC101-2325-B-006-001 and NSC102-2325-B-006-001 from the National Science Council, grant IBMS-CRC100-P01 from Academia Sinica, Project of Promoting Academic Excellence and Developing World Class Research Centers, and the Center for Infectious Disease and Signaling Transduction Research, National Cheng Kung University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderhub SJ, 2012, CANCER LETT, V322, P8, DOI 10.1016/j.canlet.2012.02.006; Andersen SSL, 1999, INT REV CYTOL, V187, P51; Avidor-Reiss T, 2013, CURR OPIN CELL BIOL, V25, P72, DOI 10.1016/j.ceb.2012.10.016; Baillet A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-436; Bakhoum SF, 2012, J CLIN INVEST, V122, P1138, DOI 10.1172/JCI59954; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Campos SM, 2012, HEMATOL ONCOL CLIN N, V26, P607, DOI 10.1016/j.hoc.2012.01.007; Carmena M, 2009, CURR OPIN CELL BIOL, V21, P796, DOI 10.1016/j.ceb.2009.09.008; Duensing S, 2001, BBA-REV CANCER, V1471, pM81, DOI 10.1016/S0304-419X(00)00025-1; Fok KL, 2012, CARCINOGENESIS, V33, P2044, DOI 10.1093/carcin/bgs246; Hames RS, 2001, EMBO J, V20, P7117, DOI 10.1093/emboj/20.24.7117; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; Kollareddy M, 2012, INVEST NEW DRUG, V30, P2411, DOI 10.1007/s10637-012-9798-6; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Lange BMH, 2002, CURR OPIN CELL BIOL, V14, P35, DOI 10.1016/S0955-0674(01)00291-5; Lin YH, 2006, FERTIL STERIL, V86, P1650, DOI 10.1016/j.fertnstert.2006.04.039; Mahen R, 2012, CURR OPIN CELL BIOL, V24, P14, DOI 10.1016/j.ceb.2011.12.012; Malumbres Marcos, 2006, Clin Transl Oncol, V8, P399, DOI 10.1007/s12094-006-0193-7; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; Olesen C, 2007, CELL TISSUE RES, V328, P207, DOI 10.1007/s00441-006-0205-5; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Schmidt M, 2007, DRUG RESIST UPDATE, V10, P162, DOI 10.1016/j.drup.2007.06.003; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Tyler RK, 2007, CELL CYCLE, V6, P2846, DOI 10.4161/cc.6.22.4940; van Leuken R, 2008, BBA-REV CANCER, V1786, P49, DOI 10.1016/j.bbcan.2008.05.002; Vitre BD, 2012, CURR OPIN CELL BIOL, V24, P809, DOI 10.1016/j.ceb.2012.10.006; Vogt E, 2008, MUTAT RES-GEN TOX EN, V651, P14, DOI 10.1016/j.mrgentox.2007.10.015; Wasch R, 2010, RECENT RESULTS CANC, V184, P215, DOI 10.1007/978-3-642-01222-8_15; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106; Yee C, 2002, NAT REV CANCER, V2, P409, DOI 10.1038/nrc820; Yokoe T, 2008, CANCER RES, V68, P1074, DOI 10.1158/0008-5472.CAN-07-0964; Zang ZJ, 2011, CANCER RES, V71, P29, DOI 10.1158/0008-5472.CAN-10-1749	39	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93303	10.1371/journal.pone.0093303	http://dx.doi.org/10.1371/journal.pone.0093303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667656	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600167
J	Tryfona, T; Theys, TE; Wagner, T; Stott, K; Keegstra, K; Dupree, P				Tryfona, Theodora; Theys, Tina E.; Wagner, Tanya; Stott, Katherine; Keegstra, Kenneth; Dupree, Paul			Characterisation of FUT4 and FUT6 alpha-(1 -> 2)-Fucosyltransferases Reveals that Absence of Root Arabinogalactan Fucosylation Increases Arabidopsis Root Growth Salt Sensitivity	PLOS ONE			English	Article							MALDI-TOF/TOF-MS/MS; CELL-WALL; STRUCTURAL-ANALYSIS; CRUCIFEROUS PLANTS; YARIV REAGENT; ROSE CELLS; PROTEINS; THALIANA; POLYSACCHARIDE; LEAVES	Plant type II arabinogalactan (AG) polysaccharides are attached to arabinogalactan proteins (AGPs) at hydroxyproline residues, and they are very diverse and heterogeneous structures. The AG consists of a beta-(1 -> 3)-linked galactan backbone with beta-(1 -> 6)-galactan side chains that are modified mainly with arabinose, but they may also contain glucuronic acid, rhamnose or other sugars. Here, we studied the positions of fucose substitutions in AGPs, and we investigated the functions of this fucosylation. Monosaccharide analysis of Arabidopsis leaf AGP extracts revealed a significant reduction in L-Fucose content in the fut4 mutant, but not in the fut6 mutant. In addition, Fucose was reduced in the fut4 mutant in root AGP extracts and was absent in the fut4/fut6 mutant. Curiously, in all cases reduction of fucose was accompanied with a reduction in xylose levels. The fucosylated AGP structures in leaves and roots in wild type and fut mutant plants were characterised by sequential digestion with AG specific enzymes, analysis by Polysaccharide Analysis using Carbohydrate gel Electrophoresis, and Matrix Assisted Laser Desorption/Ionisation (MALDI)-Time of Flight Mass spectrometry (MS). We found that FUT4 is solely responsible for the fucosylation of AGPs in leaves. The Arabidopsis thaliana FUT4 and FUT6 genes have been previously proposed to be non-redundant AG-specific fucosyltransferases. Unexpectedly, FUT4 and FUT6 enzymes both fucosylate the same AGP structures in roots, suggesting partial redundancy to each other. Detailed structural characterisation of root AGPs with high energy MALDI-Collision Induced Dissociation MS and NMR revealed an abundant unique AG oligosaccharide structure consisting of terminal xylose attached to fucose. The loss of this structure in fut4/fut6 mutants explains the reduction of both fucose and xylose in AGP extracts. Under salt-stress growth conditions the fut4/fut6 mutant lacking AGP fucosylation exhibited a shorter root phenotype than wild type plants, implicating fucosylation of AGPs in maintaining proper cell expansion under these conditions.	[Tryfona, Theodora; Theys, Tina E.; Stott, Katherine; Dupree, Paul] Univ Cambridge, Dept Biochem, Sch Biol Sci, Cambridge CB2 1QW, England; [Wagner, Tanya; Keegstra, Kenneth] Michigan State Univ, DOE Plant Res Lab, E Lansing, MI 48824 USA	University of Cambridge; Michigan State University; United States Department of Energy (DOE)	Dupree, P (corresponding author), Univ Cambridge, Dept Biochem, Sch Biol Sci, Tennis Court Rd, Cambridge CB2 1QW, England.	p.dupree@bioc.cam.ac.uk	Dupree, Paul/T-2568-2018	Dupree, Paul/0000-0001-9270-6286; Stott, Katherine/0000-0002-4014-1188; Tryfona, Theodora/0000-0002-1618-3521	United Kingdom BBSRC Sustainable Bioenergy Centre (BSBEC) [BB/G016240/1]; BioMASS Programme of the centre [BB/G016216/1]; Plant Genome Research Program at the National Science Foundation; Energy Biosciences Program at the U.S. Department of Energy; BBSRC [BB/G016216/1, BB/G016240/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G016216/1, BB/G016240/1] Funding Source: researchfish	United Kingdom BBSRC Sustainable Bioenergy Centre (BSBEC); BioMASS Programme of the centre; Plant Genome Research Program at the National Science Foundation; Energy Biosciences Program at the U.S. Department of Energy; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful for the financial support for this research from the United Kingdom BBSRC Sustainable Bioenergy Centre (BSBEC, http://www.bbsrc.ac.uk/), working within the Cell Wall Sugars Programme (Grant BB/G016240/1), and the BioMASS Programme of the centre (Grant BB/G016216/1). This work was supported in part by grants from the Plant Genome Research Program at the National Science Foundation and the Energy Biosciences Program at the U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACIC A, 1986, PLANT PHYSIOL, V80, P771, DOI 10.1104/pp.80.3.771; BASKIN TI, 1992, AUST J PLANT PHYSIOL, V19, P427, DOI 10.1071/PP9920427; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; Borner GHH, 2003, PLANT PHYSIOL, V132, P568, DOI 10.1104/pp.103.021170; Cavanagh J., 1996, PROTEIN NMR SPECTROS; CHEUNG AY, 1995, CELL, V82, P383, DOI 10.1016/0092-8674(95)90427-1; Chun H, 2001, BIOL PHARM BULL, V24, P941, DOI 10.1248/bpb.24.941; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; CLARKE AE, 1979, PHYTOCHEMISTRY, V18, P521, DOI 10.1016/S0031-9422(00)84255-7; Currie HA, 2006, J CHROMATOGR A, V1128, P90, DOI 10.1016/j.chroma.2006.06.045; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; DONALDSON SP, 1993, PHYSIOL MOL PLANT P, V42, P177, DOI 10.1006/pmpp.1993.1016; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; FINCHER GB, 1974, BIOCHEM J, V139, P535, DOI 10.1042/bj1390535; GANE AM, 1995, CARBOHYD RES, V277, P67, DOI 10.1016/0008-6215(95)00197-2; Gibeaut DM, 1997, PLANT PHYSIOL, V115, P317, DOI 10.1104/pp.115.2.317; Goubet F, 2002, ANAL BIOCHEM, V300, P53, DOI 10.1006/abio.2001.5444; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Kitazawa K, 2013, PLANT PHYSIOL, V161, P1117, DOI 10.1104/pp.112.211722; Konishi T, 2008, CARBOHYD RES, V343, P1191, DOI 10.1016/j.carres.2008.03.004; Kotake T, 2004, BIOCHEM J, V377, P749, DOI 10.1042/bj20031145; Lamport DTA, 2012, NEW PHYTOLOGIST; Liang Y, 2013, J EXP BOT, V64, P5537, DOI 10.1093/jxb/ert321; Lin LY, 2011, PHARM BIOL, V49, P319, DOI 10.3109/13880209.2010.516753; Maslen SL, 2007, CARBOHYD RES, V342, P724, DOI 10.1016/j.carres.2006.12.007; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAKAMURA K, 1984, AGR BIOL CHEM TOKYO, V48, P753, DOI 10.1080/00021369.1984.10866213; Nguema-Ona E, 2012, ANN BOT-LONDON, V110, P383, DOI 10.1093/aob/mcs143; Nyberg NT, 2005, J AM CHEM SOC, V127, P6154, DOI 10.1021/ja050878w; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; Ridlova G, 2008, RAPID COMMUN MASS SP, V22, P2723, DOI 10.1002/rcm.3665; Roy SS, 2002, ANN BOT-LONDON, V89, P293, DOI 10.1093/aob/mcf040; Sarria R, 2001, PLANT PHYSIOL, V127, P1595, DOI 10.1104/pp.010596; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Seifert GJ, 2002, CURR BIOL, V12, P1840, DOI 10.1016/S0960-9822(02)01260-5; SERPE MD, 1995, PLANT PHYSIOL, V109, P1007, DOI 10.1104/pp.109.3.1007; Serpe MD, 1996, PLANT PHYSIOL, V112, P1261, DOI 10.1104/pp.112.3.1261; Shi HZ, 2003, PLANT CELL, V15, P19, DOI 10.1105/tpc.007872; Spina E, 2004, RAPID COMMUN MASS SP, V18, P392, DOI 10.1002/rcm.1350; STEVENSON TT, 1988, CARBOHYD RES, V182, P207, DOI 10.1016/0008-6215(88)84004-7; Takata R, 2010, CARBOHYD RES, V345, P2516, DOI 10.1016/j.carres.2010.09.006; Tan L, 2004, J BIOL CHEM, V279, P13156, DOI 10.1074/jbc.M311864200; Tan L, 2013, PLANT CELL ONLINE; Tan L, 2010, J BIOL CHEM, V285, P24575, DOI 10.1074/jbc.M109.100149; Tryfona T, 2012, PLANT PHYSIOL, V160, P653, DOI 10.1104/pp.112.202309; Tryfona T, 2010, CARBOHYD RES, V345, P2648, DOI 10.1016/j.carres.2010.09.018; Tryfona T, 2010, METHODS MOL BIOL, V658, P137, DOI 10.1007/978-1-60761-780-8_8; TSUMURAYA Y, 1984, AGR BIOL CHEM TOKYO, V48, P2915, DOI 10.1080/00021369.1984.10866619; TSUMURAYA Y, 1984, CARBOHYD RES, V134, P215, DOI 10.1016/0008-6215(84)85039-9; TSUMURAYA Y, 1990, J BIOL CHEM, V265, P7207; TSUMURAYA Y, 1988, PLANT PHYSIOL, V86, P155, DOI 10.1104/pp.86.1.155; van Hengel AJ, 2002, PHYSIOL PLANTARUM, V114, P637, DOI 10.1034/j.1399-3054.2002.1140418.x; van Hengel AJ, 2002, PLANT J, V32, P105, DOI 10.1046/j.1365-313X.2002.01406.x; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Willats WGT, 1996, PLANT J, V9, P919, DOI 10.1046/j.1365-313X.1996.9060919.x; Wu YY, 2010, J BIOL CHEM, V285, P13638, DOI 10.1074/jbc.M110.102715	56	43	44	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93291	10.1371/journal.pone.0093291	http://dx.doi.org/10.1371/journal.pone.0093291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667545	Green Submitted, Green Published, gold			2022-12-25	WOS:000333675600165
J	Kuo, PY; Leshchenko, VV; Fazzari, MJ; Perumal, D; Gellen, T; He, T; Iqbal, J; Baumgartner-Wennerholm, S; Nygren, L; Zhang, F; Zhang, W; Suh, KS; Goy, A; Yang, DT; Chan, WC; Kahl, BS; Verma, AK; Gascoyne, RD; Kimby, E; Sander, B; Ye, BH; Melnick, AM; Parekh, S				Kuo, P-Y; Leshchenko, V. V.; Fazzari, M. J.; Perumal, D.; Gellen, T.; He, T.; Iqbal, J.; Baumgartner-Wennerholm, S.; Nygren, L.; Zhang, F.; Zhang, W.; Suh, K. S.; Goy, A.; Yang, D. T.; Chan, W-C; Kahl, B. S.; Verma, A. K.; Gascoyne, R. D.; Kimby, E.; Sander, B.; Ye, B. H.; Melnick, A. M.; Parekh, S.			High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma	ONCOGENE			English	Article							TRANSCRIPTION FACTOR SOX11; BETA-CATENIN DEGRADATION; DEPENDENT PHOSPHORYLATION; PROTEIN-KINASE; FOLLOW-UP; EXPRESSION; PROLIFERATION; ACTIVATION; PATHWAY; GENE	Sex determining region Y-box 11 (SOX11) expression is specific for mantle cell lymphoma ( MCL) as compared with other non-Hodgkin's lymphomas. However, the function and direct-binding targets of SOX11 in MCL are largely unknown. We used high-resolution chromatin immunoprecipitation sequencing to identify the direct target genes of SOX11 in a genome-wide, unbiased manner and elucidate its functional significance. Pathway analysis identified WNT, PKA and TGF-beta signaling pathways as significantly enriched by SOX11-target genes. Quantitative chromatin immunoprecipitation sequencing and promoter reporter assays confirmed that SOX11 directly binds to individual genes and modulates their transcription activities in these pathways in MCL. Functional studies using RNA interference demonstrate that SOX11 directly regulates WNT in MCL. We analyzed SOX11 expression in three independent well-annotated tissue microarrays from the University of Wisconsin (UW), Karolinska Institute and British Columbia Cancer Agency. Our findings suggest that high SOX11 expression is associated with improved survival in a subset of MCL patients, particularly those treated with intensive chemotherapy. Transcriptional regulation of WNT and other biological pathways affected by SOX11-target genes may help explain the impact of SOX11 expression on patient outcomes.	[Kuo, P-Y; Leshchenko, V. V.; Perumal, D.; He, T.; Parekh, S.] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, New York, NY 10029 USA; [Fazzari, M. J.] Yeshiva Univ, Albert Einstein Coll Med, Dept Populat Hlth, Bronx, NY USA; [Fazzari, M. J.] Yeshiva Univ, Albert Einstein Coll Med, Dept Genet, Bronx, NY USA; [Gellen, T.; Verma, A. K.] Yeshiva Univ, Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY USA; [Iqbal, J.; Chan, W-C] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Baumgartner-Wennerholm, S.; Kimby, E.] Karolinska Inst, Ctr Haematol, Dept Med, Stockholm, Sweden; [Baumgartner-Wennerholm, S.; Nygren, L.; Kimby, E.; Sander, B.] Karolinska Univ Hosp, Stockholm, Sweden; [Nygren, L.; Sander, B.] Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden; [Zhang, F.; Zhang, W.] Icahn Sch Med Mt Sinai, Dept Med, Bioinformat Lab, New York, NY 10029 USA; [Suh, K. S.; Goy, A.] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Genom & Biomarkers Program, Hackensack, NJ USA; [Yang, D. T.; Kahl, B. S.] Univ Wisconsin, Dept Pathol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Kahl, B. S.] Univ Wisconsin, UW Carbone Canc Ctr, Madison, WI USA; [Gascoyne, R. D.] British Columbia Canc Agcy, Dept Pathol & Expt Therapeut, Vancouver, BC V5Z 4E6, Canada; [Ye, B. H.] Yeshiva Univ, Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY USA; [Melnick, A. M.] Weill Cornell Med Coll, Div Hematol & Oncol, New York, NY USA; [Melnick, A. M.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA	Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Nebraska System; University of Nebraska Medical Center; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Icahn School of Medicine at Mount Sinai; Hackensack University Medical Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; British Columbia Cancer Agency; Yeshiva University; Albert Einstein College of Medicine; Cornell University; Cornell University	Parekh, S (corresponding author), Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, 1470 Madison Ave 5-114,Box 1079, New York, NY 10029 USA.	samir.parekh@mssm.edu	Goy, Andre/AHC-0473-2022; Melnick, Ari/AAA-5763-2020; Goy, Andre/AAS-4464-2020; Gascoyne, Randy D/A-6009-2013	Goy, Andre/0000-0001-5125-6522; Goy, Andre/0000-0001-5125-6522; Gascoyne, Randy D/0000-0002-2610-5690; Fazzari, Melissa/0000-0002-5674-3589; Iqbal, Javeed/0000-0003-3668-0629; He, Tianfang/0000-0003-3307-3110; Kimby, Eva/0000-0003-3078-6131	Chemotherapy Foundation; NATIONAL CANCER INSTITUTE [P30CA013330, P30CA014520, K12CA132783] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER	Chemotherapy Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the Epigenomics cores at Weil Cornell Medical College and Albert Einstein College of Medicine for the service support in next generation sequencing. We would also like to thank Eugenia (Jenny) Giannopoulou, PhD, and Olivier Elemento, PhD, for the assistance in ChIP-seq analysis and Chris Benner, PhD, for the support in motif analysis. We are grateful for Stuart A Aaronson, MD, for the expert consultation on WNT signaling pathway and the DN-TCF4 construct and Thomas J Kelly, MD, PhD for the SMAD3 reporter construct. This project was funded in part by the Chemotherapy Foundation (SP), Gabrielle's Angel Foundation (SP), Leukemia and Lymphoma Society Translational Research Project Grant (SP), Paul Calabresi Career Development Award K12-CA132783-01 (SP), the Swedish Cancer Society (BS), the Swedish Research Council (BS), the Cancer Society in Stockholm (BS), the Karolinska Institutet Funds (BS) and the Stockholm County Council (BS). DTY is supported by the Clinical and Translational Science Award (CTSA) program, previously through the National Center for Research Resources grant 1UL1RR025011, and now by the National Center for Advancing Translational Sciences (NCATS), grant 9U54TR000021 (DTY), grant P30 CA014520 from the National Cancer Institute and Forward Lymphoma (DTY).	Asciutti S, 2011, ONCOGENE, V30, P956, DOI 10.1038/onc.2010.475; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; BODRUG SE, 1994, EMBO J, V13, P2124, DOI 10.1002/j.1460-2075.1994.tb06488.x; Brennana DJ, 2009, EUR J CANCER, V45, P1510, DOI 10.1016/j.ejca.2009.01.028; Vegliante MC, 2013, BLOOD, V121, P2175, DOI 10.1182/blood-2012-06-438937; Vegliante MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021382; Carvajal-Cuenca A, 2012, HAEMATOL-HEMATOL J, V97, P270, DOI 10.3324/haematol.2011.052621; Chen YH, MOD PATHOL, V23, P105; Chung EJ, 2002, BLOOD, V100, P982, DOI 10.1182/blood.V100.3.982; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; Dictor M, 2009, HAEMATOL-HEMATOL J, V94, P1563, DOI 10.3324/haematol.2009.008474; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; Fernandez V, 2010, CANCER RES, V70, P1408, DOI 10.1158/0008-5472.CAN-09-3419; Geisler CH, 2012, BRIT J HAEMATOL, V158, P355, DOI 10.1111/j.1365-2141.2012.09174.x; Gelebart P, 2008, BLOOD, V112, P5171, DOI 10.1182/blood-2008-02-139212; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Greiner TC, 1996, BLOOD, V87, P4302, DOI 10.1182/blood.V87.10.4302.bloodjournal87104302; Grumolato L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003603; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Kimura Y, 2013, INT J ONCOL, V43, P457, DOI 10.3892/ijo.2013.1982; Kormish JD, 2010, DEV DYNAM, V239, P56, DOI 10.1002/dvdy.22046; Kridel R, 2012, BLOOD, V119, P1963, DOI 10.1182/blood-2011-11-391474; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lee JY, 2004, AM J RESP CELL MOL, V31, P234, DOI 10.1165/rcmb.2003-0447OC; Leshchenko VV, 2010, BLOOD, V116, P1025, DOI 10.1182/blood-2009-12-257485; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murugan S, 2012, EXP CELL RES, V318, P1134, DOI 10.1016/j.yexcr.2012.03.008; Nygren L, 2012, BLOOD, V119, P4215, DOI 10.1182/blood-2011-12-400580; Oberley MJ, 2013, HISTOPATHOLOGY, V63, P499, DOI 10.1111/his.12207; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Rhind N, 2012, COLD SPRING HARB PER, V4, P1; RIABOWOL K, 1989, CELL, V57, P393, DOI 10.1016/0092-8674(89)90914-8; Romaguera JE, 2010, BRIT J HAEMATOL, V150, P200, DOI 10.1111/j.1365-2141.2010.08228.x; Sakamoto I, 2000, J BIOL CHEM, V275, P32871, DOI 10.1074/jbc.M004089200; Sernbo S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-405; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Taketo MM, 2004, NAT GENET, V36, P320, DOI 10.1038/ng0404-320; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wang X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014085; Weigle B, 2005, ONCOL REP, V13, P139; Wiestner A, 2007, BLOOD, V109, P4599, DOI 10.1182/blood-2006-08-039859; Witzig TE, 2005, J CLIN ONCOL, V23, P6409, DOI 10.1200/JCO.2005.55.017; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zhang M, 2010, J BIOL CHEM, V285, P8703, DOI 10.1074/jbc.M109.093526; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	55	47	48	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2015	34	10					1231	1240		10.1038/onc.2014.44	http://dx.doi.org/10.1038/onc.2014.44			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC9JX	24681958	Green Accepted			2022-12-25	WOS:000350687100003
J	Davis, MI; Gross, S; Shen, M; Straley, KS; Pragani, R; Lea, WA; Popovici-Muller, J; DeLaBarre, B; Artin, E; Thorne, N; Auld, DS; Li, ZY; Dang, L; Boxer, MB; Simeonov, A				Davis, Mindy I.; Gross, Stefan; Shen, Min; Straley, Kimberly S.; Pragani, Rajan; Lea, Wendy A.; Popovici-Muller, Janeta; DeLaBarre, Byron; Artin, Erin; Thorne, Natasha; Auld, Douglas S.; Li, Zhuyin; Dang, Lenny; Boxer, Matthew B.; Simeonov, Anton			Biochemical, Cellular, and Biophysical Characterization of a Potent Inhibitor of Mutant Isocitrate Dehydrogenase IDH1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dehydrogenase; Drug Discovery; Enzyme Inhibitors; Glioblastoma; Small Molecules; AML; IDH1; Isocitrate Dehydrogenase; Enzyme	ONCOMETABOLITE 2-HYDROXYGLUTARATE; MUTATION; LEUKEMIA	Background: IDH1 R132H, implicated in glioblastoma and AML, produces the oncometabolite 2-HG. Results: A detailed binding mechanism of a small molecule inhibitor (ML309) is proposed. Conclusion: ML309 competes with -KG but is uncompetitive with NADPH and rapidly and reversibly affects cellular 2-HG levels. Significance: Understanding IDH1 R132H inhibition sets the stage for targeting IDH1 R132H for the treatment of cancer. Two mutant forms (R132H and R132C) of isocitrate dehydrogenase 1 (IDH1) have been associated with a number of cancers including glioblastoma and acute myeloid leukemia. These mutations confer a neomorphic activity of 2-hydroxyglutarate (2-HG) production, and 2-HG has previously been implicated as an oncometabolite. Inhibitors of mutant IDH1 can potentially be used to treat these diseases. In this study, we investigated the mechanism of action of a newly discovered inhibitor, ML309, using biochemical, cellular, and biophysical approaches. Substrate binding and product inhibition studies helped to further elucidate the IDH1 R132H catalytic cycle. This rapidly equilibrating inhibitor is active in both biochemical and cellular assays. The (+) isomer is active (IC50 = 68 nm), whereas the (-) isomer is over 400-fold less active (IC50 = 29 m) for IDH1 R132H inhibition. IDH1 R132C was similarly inhibited by (+)-ML309. WT IDH1 was largely unaffected by (+)-ML309 (IC50 >36 m). Kinetic analyses combined with microscale thermophoresis and surface plasmon resonance indicate that this reversible inhibitor binds to IDH1 R132H competitively with respect to -ketoglutarate and uncompetitively with respect to NADPH. A reaction scheme for IDH1 R132H inhibition by ML309 is proposed in which ML309 binds to IDH1 R132H after formation of the IDH1 R132H NADPH complex. ML309 was also able to inhibit 2-HG production in a glioblastoma cell line (IC50 = 250 nm) and had minimal cytotoxicity. In the presence of racemic ML309, 2-HG levels drop rapidly. This drop was sustained until 48 h, at which point the compound was washed out and 2-HG levels recovered.	[Davis, Mindy I.; Shen, Min; Pragani, Rajan; Lea, Wendy A.; Thorne, Natasha; Auld, Douglas S.; Li, Zhuyin; Boxer, Matthew B.; Simeonov, Anton] NIH, NIH Chem Genom Ctr, Natl Ctr Adv Translat Sci, Rockville, MD 20892 USA; [Gross, Stefan; Straley, Kimberly S.; Popovici-Muller, Janeta; DeLaBarre, Byron; Artin, Erin; Dang, Lenny] Agios Pharmaceut Inc, Cambridge, MA 02139 USA; [Auld, Douglas S.] Ctr Prote Chem, Novartis Inst Biomed Res, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Agios Pharmaceuticals; Novartis	Simeonov, A (corresponding author), NIH, NIH Chem Genom Ctr, Natl Ctr Adv Translat Sci, 9800 Med Ctr Dr, Rockville, MD 20892 USA.	asimeono@mail.nih.gov		Dang, Lenny/0000-0002-2073-6109	Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research, National Institutes of Health [U54 MH084681]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by the Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research, National Institutes of Health (U54 MH084681).	Avdeef A, 2001, PHARMACOKINETIC OPTIMIZATION IN DRUG RESEARCH, P305, DOI 10.1002/9783906390437.ch18; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Copeland R. A., 2005, EVALUATION ENZYME IN, P125; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Di L, 2006, INT J PHARMACEUT, V317, P54, DOI 10.1016/j.ijpharm.2006.03.007; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Korfmacher WA, 2009, MINI-REV MED CHEM, V9, P703, DOI 10.2174/138955709788452694; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Mardis ER, 2009, HUM MOL GENET, V18, pR163, DOI 10.1093/hmg/ddp396; Miyata S, 2013, NEUROL MED-CHIR, V53, P645, DOI 10.2176/nmc.oa2012-0409; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Pietrak B, 2011, BIOCHEMISTRY-US, V50, P4804, DOI 10.1021/bi200499m; Popovici-Muller J, 2012, ACS MED CHEM LETT, V3, P850, DOI 10.1021/ml300225h; Rendina AR, 2013, BIOCHEMISTRY-US, V52, P4563, DOI 10.1021/bi400514k; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Schneider SW, 2004, ACTA NEUROPATHOL, V107, P272, DOI 10.1007/s00401-003-0810-2; Thompson CB, 2009, NEW ENGL J MED, V360, P813, DOI 10.1056/NEJMe0810213; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Zheng BS, 2013, ACS MED CHEM LETT, V4, P542, DOI 10.1021/ml400036z	24	65	83	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13717	13725		10.1074/jbc.M113.511030	http://dx.doi.org/10.1074/jbc.M113.511030			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24668804	Green Published, hybrid			2022-12-25	WOS:000335984600006
J	Villinger, S; Giller, K; Bayrhuber, M; Lange, A; Griesinger, C; Becker, S; Zweckstetter, M				Villinger, Saskia; Giller, Karin; Bayrhuber, Monika; Lange, Adam; Griesinger, Christian; Becker, Stefan; Zweckstetter, Markus			Nucleotide Interactions of the Human Voltage-dependent Anion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; Membrane Proteins; NMR; Nucleotide; Organic Anion Channels; Interactions	MITOCHONDRIAL OUTER-MEMBRANE; ESCHERICHIA-COLI; VDAC CHANNELS; SUGAR TRANSLOCATION; MOLECULAR-DYNAMICS; DETERGENT MICELLES; CRYSTAL-STRUCTURES; SELECTIVE CHANNEL; NEUROSPORA-CRASSA; STRUCTURAL BASIS	Background: Human VDAC1 mediates and controls the transport of metabolites across the outer mitochondrial membrane. Results: The N-terminal helix of hVDAC1 is involved in binding to charged forms of ATP, UTP, and GTP with an important contribution from lysine 20. Conclusion: Weak binding of ATP confers specificity for ATP transport. Significance: ATP interaction mapped at residue resolution supports metabolite selectivity of VDAC. The voltage-dependent anion channel (VDAC) mediates and gates the flux of metabolites and ions across the outer mitochondrial membrane and is a key player in cellular metabolism and apoptosis. Here we characterized the binding of nucleotides to human VDAC1 (hVDAC1) on a single-residue level using NMR spectroscopy and site-directed mutagenesis. We find that hVDAC1 possesses one major binding region for ATP, UTP, and GTP that partially overlaps with a previously determined NADH binding site. This nucleotide binding region is formed by the N-terminal -helix, the linker connecting the helix to the first -strand and adjacent barrel residues. hVDAC1 preferentially binds the charged forms of ATP, providing support for a mechanism of metabolite transport in which direct binding to the charged form exerts selectivity while at the same time permeation of the Mg2+-complexed ATP form is possible.	[Villinger, Saskia; Giller, Karin; Bayrhuber, Monika; Lange, Adam; Griesinger, Christian; Becker, Stefan; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, D-37077 Gottingen, Germany; [Zweckstetter, Markus] Univ Med Gottingen, Ctr Mol Physiol Brain, D-37073 Gottingen, Germany	Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Gottingen	Zweckstetter, M (corresponding author), German Ctr Neurodegenerat Dis DZNE, D-37077 Gottingen, Germany.	Markus.Zweckstetter@dzne.de		Lange, Adam/0000-0002-7534-5973; Zweckstetter, Markus/0000-0002-2536-6581	Fonds der Chemischen Industrie; Deutsche Forschungsgemeinschaft (DFG); DFG collaborative research center SFB803; ERC [282008]	Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG collaborative research center SFB803; ERC(European Research Council (ERC)European Commission)	This work was supported by a Fonds der Chemischen Industrie scholarship (to S. V.), a Deutsche Forschungsgemeinschaft (DFG) Emmy Noether Fellowship (to A. L.), DFG collaborative research center SFB803 (to A. L., C. G., and M. Z.), and the ERC Grant Agreement 282008 (to M. Z.).	Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; AKERBOOM TPM, 1978, EUR J BIOCHEM, V84, P413, DOI 10.1111/j.1432-1033.1978.tb12182.x; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; BENZ R, 1990, BIOCHIM BIOPHYS ACTA, V1022, P311, DOI 10.1016/0005-2736(90)90279-W; BENZ R, 1988, FEBS LETT, V231, P75, DOI 10.1016/0014-5793(88)80706-3; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; BENZ R, 1988, EUR J BIOCHEM, V176, P699, DOI 10.1111/j.1432-1033.1988.tb14333.x; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; De Stefano C, 2006, BIOPHYS CHEM, V121, P121, DOI 10.1016/j.bpc.2005.12.016; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dutzler R, 1996, STRUCTURE, V4, P127, DOI 10.1016/S0969-2126(96)00016-0; FEENEY J, 1979, J MAGN RESON, V33, P519, DOI 10.1016/0022-2364(79)90163-X; FLORKE H, 1994, BIOL CHEM H-S, V375, P513, DOI 10.1515/bchm3.1994.375.8.513; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; GELLERICH FN, 1993, BIOCHIM BIOPHYS ACTA, V1142, P217, DOI 10.1016/0005-2728(93)90150-E; Goddard T. D., 2006, SPARKY 3; Goncalves RP, 2007, J MOL BIOL, V369, P413, DOI 10.1016/j.jmb.2007.03.063; GUO XW, 1993, BIOPHYS J, V64, P545, DOI 10.1016/S0006-3495(93)81399-7; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2009, CURR OPIN STRUC BIOL, V19, P396, DOI 10.1016/j.sbi.2009.07.013; Kim BH, 2002, J MEMBRANE BIOL, V187, P239, DOI 10.1007/s00232-001-0167-1; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; KOBAYASHI Y, 1985, EUR J BIOCHEM, V151, P231, DOI 10.1111/j.1432-1033.1985.tb09093.x; LEE AC, 1994, J BIOL CHEM, V269, P30974; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; LIU MY, 1992, BIOCHIM BIOPHYS ACTA, V1098, P255, DOI 10.1016/S0005-2728(05)80344-5; Lou HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025825; Malia T. J., 2006, THESIS MIT; MANNELLA CA, 1982, J CELL BIOL, V94, P680, DOI 10.1083/jcb.94.3.680; Mertins B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047938; Meyer JEW, 1997, PROTEIN SCI, V6, P1084, DOI 10.1002/pro.5560060515; Nestorovich EM, 2002, P NATL ACAD SCI USA, V99, P9789, DOI 10.1073/pnas.152206799; PENG S, 1992, BIOPHYS J, V62, P123, DOI 10.1016/S0006-3495(92)81799-X; Pongprayoon P, 2009, P NATL ACAD SCI USA, V106, P21614, DOI 10.1073/pnas.0907315106; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Rostovtseva TK, 2002, BIOPHYS J, V82, P193, DOI 10.1016/S0006-3495(02)75386-1; Rostovtseva TK, 2002, J MEMBRANE BIOL, V187, P147, DOI 10.1007/s00232-001-0159-1; Runke G, 2000, J BIOENERG BIOMEMBR, V32, P563, DOI 10.1023/A:1005618510502; SCHEIN SJ, 1976, J MEMBRANE BIOL, V30, P99, DOI 10.1007/BF01869662; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; SCHULEIN K, 1990, MOL MICROBIOL, V4, P625, DOI 10.1111/j.1365-2958.1990.tb00631.x; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Song JM, 1998, BIOPHYS J, V74, P2926, DOI 10.1016/S0006-3495(98)78000-2; Sukhan A, 1996, J BIOL CHEM, V271, P21239, DOI 10.1074/jbc.271.35.21239; Teijido O, 2012, J BIOL CHEM, V287, P11437, DOI 10.1074/jbc.M111.314229; THOMAS L, 1993, P NATL ACAD SCI USA, V90, P5446, DOI 10.1073/pnas.90.12.5446; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Villinger S, 2010, P NATL ACAD SCI USA, V107, P22546, DOI 10.1073/pnas.1012310108; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yehezkel G, 2006, J BIOL CHEM, V281, P5938, DOI 10.1074/jbc.M510104200; Yehezkel G, 2007, J CELL PHYSIOL, V212, P551, DOI 10.1002/jcp.21048; Yu TY, 2012, BBA-BIOMEMBRANES, V1818, P1562, DOI 10.1016/j.bbamem.2011.11.012; Zachariae U, 2006, J BIOL CHEM, V281, P7413, DOI 10.1074/jbc.M510939200; Zachariae U, 2012, STRUCTURE, V20, P1540, DOI 10.1016/j.str.2012.06.015; ZIMMERBERG J, 1986, NATURE, V323, P36, DOI 10.1038/323036a0; ZIZI M, 1994, J BIOL CHEM, V269, P1614; Zou HJ, 2008, J PHYS CHEM B, V112, P13070, DOI 10.1021/jp710964x	64	27	27	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13397	13406		10.1074/jbc.M113.524173	http://dx.doi.org/10.1074/jbc.M113.524173			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24668813	Green Published, hybrid			2022-12-25	WOS:000335522800038
J	Kim, A; Rivera, S; Shprung, D; Limbrick, D; Gabayan, V; Nemeth, E; Ganz, T				Kim, Airie; Rivera, Seth; Shprung, Dana; Limbrick, Donald; Gabayan, Victoria; Nemeth, Elizabeta; Ganz, Tomas			Mouse Models of Anemia of Cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; EPOETIN ALPHA; HEPCIDIN; CHEMOTHERAPY; INFLAMMATION; PREVALENCE; MANAGEMENT; ONCOLOGY; SURVIVAL; OUTCOMES	Anemia of cancer (AC) may contribute to cancer-related fatigue and impair quality of life. Improved understanding of the pathogenesis of AC could facilitate better treatment, but animal models to study AC are lacking. We characterized four syngeneic C57BL/6 mouse cancers that cause AC. Mice with two different rapidly-growing metastatic lung cancers developed the characteristic findings of anemia of inflammation (AI), with dramatically different degrees of anemia. Mice with rapidly-growing metastatic melanoma also developed a severe anemia by 14 days, with hematologic and inflammatory parameters similar to AI. Mice with a slow-growing peritoneal ovarian cancer developed an iron-deficiency anemia, likely secondary to chronically impaired nutrition and bleeding into the peritoneal cavity. Of the four models, hepcidin mRNA levels were increased only in the milder lung cancer model. Unlike in our model of systemic inflammation induced by heat-killed Brucella abortus, ablation of hepcidin in the ovarian cancer and the milder lung cancer mouse models did not affect the severity of anemia. Hepcidin-independent mechanisms play an important role in these murine models of AC.	[Kim, Airie; Rivera, Seth; Shprung, Dana; Limbrick, Donald; Gabayan, Victoria; Nemeth, Elizabeta; Ganz, Tomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Ganz, Tomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kim, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	airiekim@mednet.ucla.edu	Ganz, Tomas/AAN-3308-2020; Ganz, Tomas/D-4567-2009	Nemeth, Elizabeta/0000-0002-3477-2397; Ganz, Tomas/0000-0002-2830-5469	NIH [HL072752]; Roche Foundation for Anemia Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072752] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roche Foundation for Anemia Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH Pulmonary & Critical Care Institutional Training Grant T32 (HL072752) to AK, 09/2008 - 06/2011; and Roche Foundation for Anemia Research to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapro M, 2009, ONCOLOGIST, V14, P6, DOI 10.1634/theoncologist.2009-S1-6; Adamson John W, 2008, Hematology Am Soc Hematol Educ Program, P159, DOI 10.1182/asheducation-2008.1.159; Butterfield AM, 2010, CLIN CHEM, V56, P1725, DOI 10.1373/clinchem.2010.151522; Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P; Crawford J, 2002, CANCER-AM CANCER SOC, V95, P888, DOI 10.1002/cncr.10763; Demetri GD, 1998, J CLIN ONCOL, V16, P3412, DOI 10.1200/JCO.1998.16.10.3412; Demetri GD, 2001, BRIT J CANCER, V84, P31, DOI 10.1054/bjoc.2001.1750; Dicato M, 2010, ANN ONCOL, V21, P167, DOI 10.1093/annonc/mdq284; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Glaspy J, 1997, J CLIN ONCOL, V15, P1218, DOI 10.1200/JCO.1997.15.3.1218; Goodnough JB, 2012, HEPATOLOGY, V56, P291, DOI 10.1002/hep.25615; Hagihara K, 2004, BIOCHEM BIOPH RES CO, V314, P363, DOI 10.1016/j.bbrc.2003.12.096; Kim A, 2014, BLOOD, V123, P1129, DOI 10.1182/blood-2013-08-521419; Knight K, 2004, AM J MED, V116, P11, DOI 10.1016/j.amjmed.2003.12.008; Kosmidis P, 2005, LUNG CANCER, V50, P401, DOI 10.1016/j.lungcan.2005.08.004; Lesbordes-Brion JC, 2006, BLOOD, V108, P1402, DOI 10.1182/blood-2006-02-003376; Ludwig H, 2004, EUR J CANCER, V40, P2293, DOI 10.1016/j.ejca.2004.06.019; Lynch EC, 1990, CLIN METHODS HIST PH; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; Ramos E, 2012, BLOOD, V120, P3829, DOI 10.1182/blood-2012-07-440743; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Sasu BJ, 2010, BLOOD CELL MOL DIS, V45, P238, DOI 10.1016/j.bcmd.2010.07.013; Sharma S, 2008, CLIN CANCER RES, V14, P3262, DOI 10.1158/1078-0432.CCR-07-4153; Songur N, 2004, TUMORI J, V90, P196, DOI 10.1177/030089160409000207; Spivak JL, 2009, ONCOLOGIST, V14, P43, DOI 10.1634/theoncologist.2009-S1-43; Stasi R, 2003, CANCER-AM CANCER SOC, V98, P1786, DOI 10.1002/cncr.11742; Ukarma L, 2009, CLIN CHEM, V55, P1354, DOI 10.1373/clinchem.2008.121285; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Wong SS, 1996, CLIN CHIM ACTA, V244, P91; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Zakrzewska I, 2001, Pol Merkur Lekarski, V11, P210; Zhang ZZ, 2012, HEPATOLOGY, V56, P961, DOI 10.1002/hep.25746	38	15	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93283	10.1371/journal.pone.0093283	http://dx.doi.org/10.1371/journal.pone.0093283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681760	Green Published, gold, Green Submitted			2022-12-25	WOS:000333678100039
J	Weeda, S; Zhang, N; Zhao, XL; Ndip, G; Guo, YD; Buck, GA; Fu, CG; Ren, SX				Weeda, Sarah; Zhang, Na; Zhao, Xiaolei; Ndip, Grace; Guo, Yangdong; Buck, Gregory A.; Fu, Conggui; Ren, Shuxin			Arabidopsis Transcriptome Analysis Reveals Key Roles of Melatonin in Plant Defense Systems	PLOS ONE			English	Article							GROWTH-STIMULATING COMPOUND; PV. TOMATO DC3000; REACTIVE OXYGEN; EXOGENOUS MELATONIN; PEROXIDASE-ACTIVITY; TRANSGENIC RICE; SIGNAL-TRANSDUCTION; ROOT REGENERATION; OXIDATIVE STRESS; RESISTANCE	Melatonin is a ubiquitous molecule and exists across kingdoms including plant species. Studies on melatonin in plants have mainly focused on its physiological influence on growth and development, and on its biosynthesis. Much less attention has been drawn to its affect on genome-wide gene expression. To comprehensively investigate the role(s) of melatonin at the genomics level, we utilized mRNA-seq technology to analyze Arabidopsis plants subjected to a 16-hour 100 pM (low) and 1 mM (high) melatonin treatment. The expression profiles were analyzed to identify differentially expressed genes. 100 pM melatonin treatment significantly affected the expression of only 81 genes with 51 down-regulated and 30 up-regulated. However, 1 mM melatonin significantly altered 1308 genes with 566 up-regulated and 742 down-regulated. Not all genes altered by low melatonin were affected by high melatonin, indicating different roles of melatonin in regulation of plant growth and development under low and high concentrations. Furthermore, a large number of genes altered by melatonin were involved in plant stress defense. Transcript levels for many stress receptors, kinases, and stress-associated calcium signals were up-regulated. The majority of transcription factors identified were also involved in plant stress defense. Additionally, most identified genes in ABA, ET, SA and JA pathways were up-regulated, while genes pertaining to auxin responses and signaling, peroxidases, and those associated with cell wall synthesis and modifications were mostly down-regulated. Our results indicate critical roles of melatonin in plant defense against various environmental stresses, and provide a framework for functional analysis of genes in melatonin-mediated signaling pathways.	[Weeda, Sarah; Ren, Shuxin] Virginia State Univ, ARS, Petersburg, VA 23806 USA; [Zhang, Na; Guo, Yangdong] China Agr Univ, Coll Agr & Biotechnol, Beijing 100094, Peoples R China; [Zhao, Xiaolei; Fu, Conggui] Tianjin Acad Agr Sci, Tianjin Crop Sci Inst, Tianjin, Peoples R China; [Ndip, Grace] Virginia State Univ, Dept Chem, Petersburg, VA 23806 USA; [Buck, Gregory A.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA	Virginia State University; China Agricultural University; Virginia State University; Virginia Commonwealth University	Guo, YD (corresponding author), China Agr Univ, Coll Agr & Biotechnol, Beijing 100094, Peoples R China.	yaguo@cau.edu.cn; sren@vsu.edu	zhang, na/M-6968-2016		USDA Evans Allen Fund	USDA Evans Allen Fund	This work is partially supported by USDA Evans Allen Fund. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afreen F, 2006, J PINEAL RES, V41, P108, DOI 10.1111/j.1600-079X.2006.00337.x; Arnao MB, 2009, J PINEAL RES, V46, P58, DOI 10.1111/j.1600-079X.2008.00625.x; Arnao MB, 2007, J PINEAL RES, V42, P147, DOI 10.1111/j.1600-079X.2006.00396.x; Arnao MB, 2006, PLANT SIGNAL BEHAV, V1, P89, DOI 10.4161/psb.1.3.2640; Arnao MB, 2013, J PINEAL RES, V55, P149, DOI 10.1111/jpi.12055; Arnao MB, 2009, J PINEAL RES, V46, P295, DOI 10.1111/j.1600-079X.2008.00660.x; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Banas AK, 2011, PLANT PHYSIOL, V157, P1497, DOI 10.1104/pp.111.185504; Arnao MB, 2013, FOOD CHEM, V138, P1212, DOI 10.1016/j.foodchem.2012.10.077; Boccalandro HE, 2011, J PINEAL RES, V51, P226, DOI 10.1111/j.1600-079X.2011.00884.x; Brunskill EW, 2012, DEV BIOL, V368, P4, DOI 10.1016/j.ydbio.2012.05.030; Byeon Y, 2013, J PINEAL RES, V55, P357, DOI 10.1111/jpi.12077; Byeon Y, 2012, J PINEAL RES, V53, P107, DOI 10.1111/j.1600-079X.2012.00976.x; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Carrillo-Vico A, 2005, ENDOCRINE, V27, P189, DOI 10.1385/ENDO:27:2:189; Cartieaux F, 2008, MOL PLANT MICROBE IN, V21, P244, DOI 10.1094/MPMI-21-2-0244; Catinot J, 2008, FEBS LETT, V582, P473, DOI 10.1016/j.febslet.2007.12.039; Chen Q, 2009, J PLANT PHYSIOL, V166, P324, DOI 10.1016/j.jplph.2008.06.002; Cuypers A, 2001, PLANT PHYSIOL BIOCH, V39, P657, DOI 10.1016/S0981-9428(01)01276-1; Danquah A, 2014, BIOTECHNOL ADV, V32, P40, DOI 10.1016/j.biotechadv.2013.09.006; DUBBELS R, 1995, J PINEAL RES, V18, P28, DOI 10.1111/j.1600-079X.1995.tb00136.x; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; EDGERTON MD, 1994, PHYTOCHEMISTRY, V35, P1111, DOI 10.1016/S0031-9422(00)94807-6; Ellis C, 2002, PLANT CELL, V14, P1557, DOI 10.1105/tpc.002022; Espino J, 2010, J MEMBRANE BIOL, V233, P105, DOI 10.1007/s00232-010-9230-0; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; Hamann T, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00077; Hardeland R, 1999, REPROD NUTR DEV, V39, P399, DOI 10.1051/rnd:19990311; HATTORI A, 1995, BIOCHEM MOL BIOL INT, V35, P627; Hernandez-Ruiz J, 2008, J AGR FOOD CHEM, V56, P10567, DOI 10.1021/jf8022063; Hernandez-Ruiz J, 2005, J PINEAL RES, V39, P137, DOI 10.1111/j.1600-079X.2005.00226.x; Hernandez-Ruiz J, 2004, PLANTA, V220, P140, DOI 10.1007/s00425-004-1317-3; Hernandez-Ruiz J, 2008, PLANT GROWTH REGUL, V55, P29, DOI 10.1007/s10725-008-9254-y; Iglesias MJ, 2011, PLANT SIGNAL BEHAV, V6, P452, DOI 10.4161/psb.6.3.14676; Jung JH, 2011, PLANT SIGNAL BEHAV, V6, P1198, DOI 10.4161/psb.6.8.15792; Kang K, 2010, J PINEAL RES, V49, P176, DOI 10.1111/j.1600-079X.2010.00783.x; Kedziora-Kornatowska K, 2007, J PINEAL RES, V42, P153, DOI 10.1111/j.1600-079X.2006.00394.x; Kolar J, 1997, PHYTOCHEMISTRY, V44, P1407, DOI 10.1016/S0031-9422(96)00568-7; Kolar J, 2003, PHYSIOL PLANTARUM, V118, P605, DOI 10.1034/j.1399-3054.2003.00114.x; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kwak JM, 2006, PLANT PHYSIOL, V141, P323, DOI 10.1104/pp.106.079004; Lei XY, 2004, J PINEAL RES, V36, P126, DOI 10.1046/j.1600-079X.2003.00106.x; LERNER AB, 1958, J AM CHEM SOC, V80, P2587, DOI 10.1021/ja01543a060; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; Ma SS, 2006, J EXP BOT, V57, P1097, DOI 10.1093/jxb/erj098; Manchester LC, 1995, CELL MOL BIOL RES, V41, P391; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; McMullan CJ, 2013, JAMA-J AM MED ASSOC, V309, P1388, DOI 10.1001/jama.2013.2710; Melchiorri D, 1996, BIOCHEM PHARMACOL, V51, P1095, DOI 10.1016/0006-2952(96)00055-X; MELCHIORRI D, 1994, LIFE SCI, V56, P83, DOI 10.1016/0024-3205(94)00928-7; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Murch SJ, 2002, NATURWISSENSCHAFTEN, V89, P555, DOI 10.1007/s00114-002-0376-1; Murch SJ, 2000, PLANT CELL REP, V19, P698, DOI 10.1007/s002990000206; Nickkholgh A, 2011, J PINEAL RES, V50, P381, DOI 10.1111/j.1600-079X.2011.00854.x; Nishida S, 2005, ENDOCRINE, V27, P131, DOI 10.1385/ENDO:27:2:131; Paredes SD, 2009, J EXP BOT, V60, P57, DOI 10.1093/jxb/ern284; Park S, 2013, J PINEAL RES, V54, P258, DOI [10.1111/j.1600-079X.2011.00930.x, 10.1111/j.1600-079X.2012.01029.x]; Park S, 2013, J PINEAL RES, V55, P40, DOI 10.1111/jpi.12021; Park S, 2012, J PINEAL RES, V53, P385, DOI 10.1111/j.1600-079X.2012.01008.x; Park WJ, 2011, J PLANT BIOL, V54, P143, DOI 10.1007/s12374-011-9159-6; Pelagio-Flores R, 2012, J PINEAL RES, V53, P279, DOI 10.1111/j.1600-079X.2012.00996.x; Perez-Ruiz JM, 2006, PLANT CELL, V18, P2356, DOI 10.1105/tpc.106.041541; Peters JL, 2005, J COMP NEUROL, V493, P370, DOI 10.1002/cne.20779; POEGGELER B, 1993, J PINEAL RES, V14, P151, DOI 10.1111/j.1600-079X.1993.tb00498.x; Posmyk MM, 2008, J PINEAL RES, V45, P24, DOI 10.1111/j.1600-079X.2007.00552.x; Posmyk MM, 2009, J PINEAL RES, V46, P214, DOI 10.1111/j.1600-079X.2008.00652.x; Raghavan Chitra, 2006, Functional & Integrative Genomics, V6, P60, DOI 10.1007/s10142-005-0012-1; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; REITER RJ, 1993, EXPERIENTIA, V49, P654, DOI 10.1007/BF01923947; Reiter RJ, 2001, CELL BIOCHEM BIOPHYS, V34, P237, DOI 10.1385/CBB:34:2:237; Ren S. X., 2012, Journal of Biotech Research, V4, P80; REUVENI R, 1992, PHYTOPATHOLOGY, V82, P749, DOI 10.1094/Phyto-82-749; REUVENI R, 1985, PHYTOPATHOL Z, V112, P193; REUVENI R, 1985, PHYTOPATHOL Z, V114, P260; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Rodriguez C, 2013, INT J MOL SCI, V14, P6597, DOI 10.3390/ijms14046597; Sarropoulou V, 2012, PLANT PHYSIOL BIOCH, V61, P162, DOI 10.1016/j.plaphy.2012.10.001; Sasidharan R, 2011, CRIT REV PLANT SCI, V30, P548, DOI 10.1080/07352689.2011.615706; Singhal NK, 2011, J PINEAL RES, V50, P97, DOI 10.1111/j.1600-079X.2010.00819.x; Sjoblom M, 2003, AM J PHYSIOL-GASTR L, V284, pG1034, DOI 10.1152/ajpgi.00500.2002; Tal O, 2011, J EXP BOT, V62, P1903, DOI 10.1093/jxb/erq378; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Tan DX, 2007, FASEB J, V21, P1724, DOI 10.1096/fj.06-7745com; Tan Dun-Xian, 2002, Current Topics in Medicinal Chemistry, V2, P181, DOI 10.2174/1568026023394443; Tan DX, 2012, J EXP BOT, V63, P577, DOI 10.1093/jxb/err256; Tan DX, 2007, PLANT SIGNAL BEHAV, V2, P514, DOI 10.4161/psb.2.6.4639; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; Tettamanti C., 2000, ACTA PHYTOTHERAPEUTI, V3, P2000; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsutsui T, 2009, J PLANT RES, V122, P633, DOI 10.1007/s10265-009-0252-6; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P79, DOI 10.4161/psb.2.2.4176; Vadassery J, 2012, PLANT PHYSIOL, V159, P1159, DOI 10.1104/pp.112.198150; Valerio L, 2004, PHYTOCHEMISTRY, V65, P1331, DOI 10.1016/j.phytochem.2004.04.017; Van Tassel DL, 2001, J PINEAL RES, V31, P8, DOI 10.1034/j.1600-079X.2001.310102.x; Wang P, 2013, J PINEAL RES, V54, P292, DOI [10.1111/j.1600-079X.2012.00999.x, 10.1111/jpi.12017]; Wang P, 2012, J PINEAL RES, V53, P11, DOI 10.1111/j.1600-079X.2011.00966.x; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Yin LH, 2013, J PINEAL RES, V54, P426, DOI 10.1111/jpi.12038; Yoo SD, 2008, PLANT SIGNAL BEHAV, V3, P848, DOI 10.4161/psb.3.10.5995; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Zhang L, 2012, PLOS ONE, DOI [10.1371/journal.pone.0031229, DOI 10.1371/J0URNAL.P0NE.0031229]; Zhang LJ, 2012, IN VITRO CELL DEV-PL, V48, P275, DOI 10.1007/s11627-011-9413-0; Zhang N, 2014, J PINEAL RES, V56, P39, DOI 10.1111/jpi.12095; Zhang N, 2013, J PINEAL RES, V54, P15, DOI 10.1111/j.1600-079X.2012.01015.x; Zhao Y, 2013, J PINEAL RES, V55, P79, DOI 10.1111/jpi.12044	110	193	202	8	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93462	10.1371/journal.pone.0093462	http://dx.doi.org/10.1371/journal.pone.0093462			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682084	Green Published, gold, Green Submitted			2022-12-25	WOS:000333678100047
J	Fichtner, D; Lorenz, B; Engin, S; Deichmann, C; Oelkers, M; Janshoff, A; Menke, A; Wedlich, D; Franz, CM				Fichtner, Dagmar; Lorenz, Baerbel; Engin, Sinem; Deichmann, Christina; Oelkers, Marieelen; Janshoff, Andreas; Menke, Andre; Wedlich, Doris; Franz, Clemens M.			Covalent and Density-Controlled Surface Immobilization of E-Cadherin for Adhesion Force Spectroscopy	PLOS ONE			English	Article							CELL-CELL ADHESION; SELF-ASSEMBLED MONOLAYERS; MEMBRANE TETHERS; FUSION PROTEINS; STEM-CELLS; BINDING; COOPERATIVITY; BENZYLGUANINE; ACTIVATION; MECHANISMS	E-cadherin is a key cell-cell adhesion molecule but the impact of receptor density and the precise contribution of individual cadherin ectodomains in promoting cell adhesion are only incompletely understood. Investigating these mechanisms would benefit from artificial adhesion substrates carrying different cadherin ectodomains at defined surface density. We therefore developed a quantitative E-cadherin surface immobilization protocol based on the SNAP-tag technique. Extracellular (EC) fragments of E-cadherin fused to the SNAP-tag were covalently bound to self-assembled monolayers (SAM) of thiols carrying benzylguanine (BG) head groups. The adhesive functionality of the different E-cadherin surfaces was then assessed using cell spreading assays and single-cell (SCSF) and single-molecule (SMSF) force spectroscopy. We demonstrate that an E-cadherin construct containing only the first and second outmost EC domain (E1-2) is not sufficient for mediating cell adhesion and yields only low single cadherin-cadherin adhesion forces. In contrast, a construct containing all five EC domains (E1-5) efficiently promotes cell spreading and generates strong single cadherin and cell adhesion forces. By varying the concentration of BG head groups within the SAM we determined a lateral distance of 5-11 nm for optimal E-cadherin functionality. Integrating the results from SCMS and SMSF experiments furthermore demonstrated that the dissolution of E-cadherin adhesion contacts involves a sequential unbinding of individual cadherin receptors rather than the sudden rupture of larger cadherin receptor clusters. Our method of covalent, oriented and density-controlled E-cadherin immobilization thus provides a novel and versatile platform to study molecular mechanisms underlying cadherin-mediated cell adhesion under defined experimental conditions.	[Fichtner, Dagmar; Engin, Sinem; Deichmann, Christina; Wedlich, Doris; Franz, Clemens M.] Karlsruhe Inst Technol, DFG Ctr Funct Nanostruct, D-76021 Karlsruhe, Germany; [Lorenz, Baerbel; Oelkers, Marieelen; Janshoff, Andreas] Univ Gottingen, Inst Phys Chem, D-37073 Gottingen, Germany; [Menke, Andre] Univ Giessen, D-35390 Giessen, Germany	German Research Foundation (DFG); Helmholtz Association; Karlsruhe Institute of Technology; University of Gottingen; Justus Liebig University Giessen	Franz, CM (corresponding author), Karlsruhe Inst Technol, DFG Ctr Funct Nanostruct, D-76021 Karlsruhe, Germany.	clemens.franz@kit.edu		Franz, Clemens/0000-0003-0104-4841; Janshoff, Andreas/0000-0002-0773-2963	DFG-Center for Functional Nanostructures [E2.2, E2.4]; DFG [FOR 1756]; Open Access Publishing Fund of Karlsruhe Institute of Technology	DFG-Center for Functional Nanostructures(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Open Access Publishing Fund of Karlsruhe Institute of Technology	This study is partially supported by grants E2.2 and E2.4 from the DFG-Center for Functional Nanostructures. Andreas Janshoff and Clemens Franz gratefully acknowledge further financial support from DFG (FOR 1756). The authors also acknowledge support from the Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; Bayas MV, 2006, BIOPHYS J, V90, P1385, DOI 10.1529/biophysj.105.069583; Becker SF, 2012, ARCH BIOCHEM BIOPHYS, V524, P30, DOI 10.1016/j.abb.2012.02.013; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Bruns M, 2012, SURF INTERFACE ANAL, V44, P909, DOI 10.1002/sia.4876; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chien YH, 2008, J BIOL CHEM, V283, P1848, DOI 10.1074/jbc.M708044200; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; del Valle I, 2013, DEVELOPMENT, V140, P1684, DOI 10.1242/dev.088690; Engin S, 2010, LANGMUIR, V26, P6097, DOI 10.1021/la904829y; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Franz CM, 2007, SCI STKE, V2007, P15; FRANZ CM, 2007, SCI STKE, pPL5; Franz CM, 2012, AFM BASED SINGLE CEL, P307; Friedrichs J, 2010, NAT PROTOC, V5, P1353, DOI 10.1038/nprot.2010.89; Ganz A, 2006, BIOL CELL, V98, P721, DOI 10.1042/BC20060039; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Karpowicz P, 2009, J NEUROSCI, V29, P3885, DOI 10.1523/JNEUROSCI.0037-09.2009; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kindermann M, 2003, J AM CHEM SOC, V125, P7810, DOI 10.1021/ja034145s; Korner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054749; Kraft B, 2012, J CELL BIOL, V198, P695, DOI 10.1083/jcb.201110076; Lambert M, 2002, J CELL BIOL, V157, P469, DOI 10.1083/jcb.200107104; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Leckband D, 2012, CURR OPIN CELL BIOL, V24, P620, DOI 10.1016/j.ceb.2012.05.014; MCNEILL H, 1993, J CELL BIOL, V120, P1217, DOI 10.1083/jcb.120.5.1217; Muller MA, 2013, J MOL BIOL, V425, P2988, DOI 10.1016/j.jmb.2013.05.020; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Niessen CM, 2002, J CELL BIOL, V156, P389, DOI 10.1083/jcb.200108040; OZAWA M, 1990, CELL, V63, P1033, DOI 10.1016/0092-8674(90)90506-A; OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; Puech PH, 2006, ULTRAMICROSCOPY, V106, P637, DOI 10.1016/j.ultramic.2005.08.003; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Richter B, 2013, ADV MAT; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Schmitz J, 2008, BIOPHYS J, V95, P1448, DOI 10.1529/biophysj.107.124289; Selhuber-Unkel C, 2008, BIOPHYS J, V95, P5424, DOI 10.1529/biophysj.108.139584; Stemmler MP, 2008, MOL BIOSYST, V4, P835, DOI 10.1039/b719215k; Sun MZ, 2005, BIOPHYS J, V89, P4320, DOI 10.1529/biophysj.104.058180; Taubenberger A, 2007, MOL BIOL CELL, V18, P1634, DOI 10.1091/mbc.E06-09-0777; Thie M, 1998, HUM REPROD, V13, P3211, DOI 10.1093/humrep/13.11.3211; Thiery JP, 2012, CURR OPIN CELL BIOL, V24, P614, DOI 10.1016/j.ceb.2012.06.007; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013; Wu YH, 2011, NATURE, V475, P510, DOI 10.1038/nature10183; Wu YH, 2010, P NATL ACAD SCI USA, V107, P17592, DOI 10.1073/pnas.1011247107; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106	56	30	30	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93123	10.1371/journal.pone.0093123	http://dx.doi.org/10.1371/journal.pone.0093123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675966	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677500075
J	Hidalgo-Tenorio, C; Rivero-Rodriguez, M; Gil-Anguita, C; De Hierro, ML; Palma, P; Ramirez-Taboada, J; Esquivias, J; Lopez-Ruz, MA; Javier-Martinez, R; Pasquau-Liano, J				Hidalgo-Tenorio, Carmen; Rivero-Rodriguez, Mar; Gil-Anguita, Concepcion; Lopez De Hierro, Mercedes; Palma, Pablo; Ramirez-Taboada, Jessica; Esquivias, Javier; Angel Lopez-Ruz, Miguel; Javier-Martinez, Rosario; Pasquau-Liano, Juan			Antiretroviral Therapy as a Factor Protective against Anal Dysplasia in HIV-Infected Males Who Have Sex with Males	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; AIDS-DEFINING CANCERS; NATURAL-HISTORY; RISK; MEN; LESIONS; HPV; EPIDEMIOLOGY; TERMINOLOGY; GUIDELINES	Objectives: Chronic infection with oncogenic HPV genotype is associated with the development of anal dysplasia. Antiretroviral therapy (ART) has been shown to decrease the incidence of cervical carcinoma in women with HIV. We sought to: 1) describe the prevalence and grade of anal dysplasia and HPV infection in our study subjects; 2) analyze the grade of correlation between anal cytology, PCR of high-risk HPV, and histology; 3) identify the factors associated with the appearance of >= AIN2 lesions. Design: Cross-sectional, prospective study. Methods: A cohort of HIV-positive males (n = 140, mean age = 37 years) who have sex with males (MSM) had epidemiological, clinical and analytical data collected. Anal mucosa samples were taken for cytology, HPV PCR genotyping, and anoscopy for histological analysis. Results: Within the cohort, 77.1% were being treated with ART, 8.5% anoscopy findings were AIN2, and 11.4% carcinoma in situ; 74.2% had high-risk (HR), 59.7% low-risk (LR) HPV genotypes and 46.8% had both. The combination of cytology with PCR identifying HR-HPV better predicts the histology findings than either of these factors alone. Logistic regression highlighted ART as a protective factor against >= AIN2 lesions (OR: 0.214; 95% CI: 0.054-0.84). Anal/genital condylomas (OR: 4.26; 95% CI: 1.27-14.3), and HPV68 genotype (OR: 10.6; 95% CI: 1.23-91.47) were identified as risk factors. Conclusions: In our cohort, ART has a protective effect against dysplastic anal lesions. Anal/genital warts and HPV68 genotype are predictors of >= AIN2 lesions. Introducing PCR HPV genotype evaluation improves screening success over that of cytology alone.	[Hidalgo-Tenorio, Carmen; Rivero-Rodriguez, Mar; Gil-Anguita, Concepcion; Ramirez-Taboada, Jessica; Angel Lopez-Ruz, Miguel; Javier-Martinez, Rosario; Pasquau-Liano, Juan] Univ Hosp Virgen Nieves, Infect Dis Unit, Granada, Spain; [Lopez De Hierro, Mercedes] Univ Hosp Virgen Nieves, Gastroenterol Serv, Granada, Spain; [Palma, Pablo] Univ Hosp Virgen Nieves, Gen Surg Serv, Granada, Spain; [Esquivias, Javier] Univ Hosp Virgen Nieves, Pathol Serv, Granada, Spain	Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen de las Nieves	Hidalgo-Tenorio, C (corresponding author), Univ Hosp Virgen Nieves, Infect Dis Unit, Granada, Spain.	chidalgo72@hotmail.com		Palma, Pablo/0000-0003-1084-5982				Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Andres AM, 2005, STAT METHODS MED RES, V14, P473, DOI 10.1191/0962280205sm412oa; Blitz S, 2013, J INFECT DIS, V208, P454, DOI 10.1093/infdis/jit181; CHAN SY, 1992, J VIROL, V66, P5714, DOI 10.1128/JVI.66.10.5714-5725.1992; D'Souza G, 2008, JAIDS-J ACQ IMM DEF, V48, P491, DOI 10.1097/QAI.0b013e31817aebfe; Darragh TM, 2012, J LOW GENIT TRACT DI, V16, P205, DOI 10.1097/PGP.0b013e31826916c7; Darwich L, 2013, DIS COLON RECTUM, V56, P1043, DOI 10.1097/DCR.0b013e31829c654f; de Pokomandy A, 2011, CLIN INFECT DIS, V52, P1174, DOI 10.1093/cid/cir064; Diamond C, 2005, SEX TRANSM DIS, V32, P314, DOI 10.1097/01.olq.0000162366.60245.02; Franceschi S, 2010, BRIT J CANCER, V103, P416, DOI 10.1038/sj.bjc.6605756; Freeman D, 1987, APPL CATEGORICAL DAT; GESIDA & PNS, 2011, ENFERM INFEC MICR CL, V29, P286, DOI 10.1016/j.eimc.2010.10.002; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Heard I, 2005, MED MALADIES INFECT, V35, P302, DOI 10.1016/j.medmal.2005.02.008; Tenorio CH, 2013, MED CLIN-BARCELONA, V140, P193, DOI 10.1016/j.medcli.2012.05.044; Hleyhel M, 2013, CLIN INFECT DIS, V57, P1638, DOI 10.1093/cid/cit497; Kojic EM, 2011, SEX TRANSM DIS, V38, P253, DOI 10.1097/OLQ.0b013e3181f70253; Kutlubay Z, 2013, CLIN DERMATOL, V31, P362, DOI 10.1016/j.clindermatol.2013.01.003; Mooij SH, 2013, CANCER EPIDEM BIOMAR, V22, P1698, DOI 10.1158/1055-9965.EPI-13-0460; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Oon SF, 2010, J MED SCREEN, V17, P44, DOI 10.1258/jms.2009.009058; Palefsky JM, 2009, OBSTET GYN CLIN N AM, V36, P187, DOI 10.1016/j.ogc.2009.02.003; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; Pinzone MR, 2012, EUR REV MED PHARMACO, V16, P1377; Salati SA, 2012, INT J HEALTH SCI-IJH, V6, P206, DOI 10.12816/0006000; Scholefield JH, 2011, COLORECTAL DIS, V13, P3, DOI 10.1111/j.1463-1318.2010.02494.x; Schwartz LM, 2013, J INFECT DIS, V208, P1768, DOI 10.1093/infdis/jit374; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; van der Snoek EM, 2012, SEX TRANSM DIS, V39, P495, DOI 10.1097/OLQ.0b013e31825aa764; Videla S, 2013, SEX TRANSM DIS, V40, P3, DOI 10.1097/OLQ.0b013e31827e87bd; Yang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035983	33	15	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92376	10.1371/journal.pone.0092376	http://dx.doi.org/10.1371/journal.pone.0092376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676139	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500020
J	Wen, YX; Wu, WR				Wen, Yongxian; Wu, Weiren			Mapping of Imprinted Quantitative Trait Loci Using Immortalized F-2 Populations	PLOS ONE			English	Article							BODY-COMPOSITION; MATERNAL CONTROL; GENE; CROSSES; PIGS; QTL; ARABIDOPSIS; PHENOTYPE; ENDOSPERM; GROWTH	Mapping of imprinted quantitative trait loci (iQTLs) is helpful for understanding the effects of genomic imprinting on complex traits in animals and plants. At present, the experimental designs and corresponding statistical methods having been proposed for iQTL mapping are all based on temporary populations including F-2 and BC1, which can be used only once and suffer some other shortcomings respectively. In this paper, we propose a framework for iQTL mapping, including methods of interval mapping (IM) and composite interval mapping (CIM) based on conventional low-density genetic maps and point mapping (PM) and composite point mapping (CPM) based on ultrahigh-density genetic maps, using an immortalized F-2 (imF(2)) population generated by random crosses between recombinant inbred lines or doubled haploid lines. We demonstrate by simulations that imF(2) populations are very desirable and the proposed statistical methods (especially CIM and CPM) are very powerful for iQTL mapping, with which the imprinting effects as well as the additive and dominance effects of iQTLs can be unbiasedly estimated.	[Wen, Yongxian; Wu, Weiren] Fujian Agr & Forestry Univ, Key Lab Educ, Minist Genet Breeding & Multiple Utilizat Crops, Fuzhou, Fujian, Peoples R China; [Wen, Yongxian] Fujian Agr & Forestry Univ, Sch Comp & Informat Sci, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Wu, WR (corresponding author), Fujian Agr & Forestry Univ, Key Lab Educ, Minist Genet Breeding & Multiple Utilizat Crops, Fuzhou, Fujian, Peoples R China.	wuwr@fafu.edu.cn			National Natural Science Foundation of China [31171448]; Natural Science Foundation of Fujian Province [2012J01069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work was supported by the National Natural Science Foundation of China ( project no.: 31171448) and the Natural Science Foundation of Fujian Province (project no. 2012J01069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Chen W, 2007, THEOR APPL GENET, V115, P849, DOI 10.1007/s00122-007-0613-2; Cheverud JM, 2008, P NATL ACAD SCI USA, V105, P4253, DOI 10.1073/pnas.0706562105; CHURCHILL GA, 1994, GENETICS, V138, P963; Cruz-Correa M, 2004, GASTROENTEROLOGY, V126, P964, DOI 10.1053/j.gastro.2003.12.051; Cui YH, 2006, GENOMICS, V87, P543, DOI 10.1016/j.ygeno.2005.11.021; Cui YH, 2007, GENETICA, V130, P227, DOI 10.1007/s10709-006-9101-x; Cui YH, 2007, J THEOR BIOL, V244, P115, DOI 10.1016/j.jtbi.2006.07.009; Cui YH, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-6; de Koning DJ, 2002, GENETICS, V161, P931; de Koning DJ, 2000, P NATL ACAD SCI USA, V97, P7947, DOI 10.1073/pnas.140216397; Dilkes BP, 2002, GENETICS, V160, P1163; Falls JG, 1999, AM J PATHOL, V154, P635, DOI 10.1016/S0002-9440(10)65309-6; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HALEY CS, 1994, GENETICS, V136, P1195; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Kelsey G, 1997, BIOESSAYS, V19, P361, DOI 10.1002/bies.950190502; KERMICLE JL, 1970, GENETICS, V66, P69; Kinoshita T, 1999, PLANT CELL, V11, P1945, DOI 10.1105/tpc.11.10.1945; Knott SA, 1998, GENETICS, V149, P1069; Lawson HA, 2013, NAT REV GENET, V14, P608, DOI 10.1038/nrg3543; Li ZK, 2010, J GENET, V89, P409, DOI 10.1007/s12041-010-0059-1; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; SAPIENZA C, 1995, DEV GENET, V17, P185, DOI 10.1002/dvg.1020170302; Tang JH, 2010, THEOR APPL GENET, V120, P333, DOI 10.1007/s00122-009-1213-0; Threadgill DW, 2011, ILAR J, V52, P24, DOI 10.1093/ilar.52.1.24; Wang CG, 2012, BRIEF BIOINFORM, V13, P34, DOI 10.1093/bib/bbr023; Waters AJ, 2011, PLANT CELL, V23, P4221, DOI 10.1105/tpc.111.092668; Wolf JB, 2008, EPIGENETICS-US, V3, P295, DOI 10.4161/epi.3.6.7257; Wu RL, 2002, GENET RES, V79, P85, DOI 10.1017/S0016672301005389; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; ZENG ZB, 1994, GENETICS, V136, P1457; Zou F, 2005, GENETICS, V170, P1299, DOI 10.1534/genetics.104.035709	38	1	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92989	10.1371/journal.pone.0092989	http://dx.doi.org/10.1371/journal.pone.0092989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676330	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500063
J	Ainalem, ML; Bartles, A; Muck, J; Dias, RS; Carnerup, AM; Zink, D; Nylander, T				Ainalem, Marie-Louise; Bartles, Andrew; Muck, Joscha; Dias, Rita S.; Carnerup, Anna M.; Zink, Daniele; Nylander, Tommy			DNA Compaction Induced by a Cationic Polymer or Surfactant Impact Gene Expression and DNA Degradation	PLOS ONE			English	Article							COIL-GLOBULE TRANSITION; TRANSCRIPTIONAL ACTIVITY; PAMAM DENDRIMERS; ETHIDIUM-BROMIDE; LIGHT-SCATTERING; PHASE-BEHAVIOR; CHROMATIN; PEPTIDE; CONDENSATION; ACTIVATION	There is an increasing interest in achieving gene regulation in biotechnological and biomedical applications by using synthetic DNA-binding agents. Most studies have so far focused on synthetic sequence-specific DNA-binding agents. Such approaches are relatively complicated and cost intensive and their level of sophistication is not always required, in particular for biotechnological application. Our study is inspired by in vivo data that suggest that DNA compaction might contribute to gene regulation. This study exploits the potential of using synthetic DNA compacting agents that are not sequence-specific to achieve gene regulation for in vitro systems. The semi-synthetic in vitro system we use include common cationic DNA-compacting agents, poly(amido amine) (PAMAM) dendrimers and the surfactant hexadecyltrimethylammonium bromide (CTAB), which we apply to linearized plasmid DNA encoding for the luciferase reporter gene. We show that complexing the DNA with either of the cationic agents leads to gene expression inhibition in a manner that depends on the extent of compaction. This is demonstrated by using a coupled in vitro transcription-translation system. We show that compaction can also protect DNA against degradation in a dose-dependent manner. Furthermore, our study shows that these effects are reversible and DNA can be released from the complexes. Release of DNA leads to restoration of gene expression and makes the DNA susceptible to degradation by Dnase. A highly charged polyelectrolyte, heparin, is needed to release DNA from dendrimers, while DNA complexed with CTAB dissociates with the non-ionic surfactant C12E5. Our results demonstrate the relation between DNA compaction by non-specific DNA-binding agents and gene expression and gene regulation can be achieved in vitro systems in a reliable dose-dependent and reversible manner.	[Ainalem, Marie-Louise; Bartles, Andrew; Dias, Rita S.; Carnerup, Anna M.; Nylander, Tommy] Lund Univ, Ctr Chem & Chem Engn, S-22100 Lund, Sweden; [Muck, Joscha; Zink, Daniele] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany	Lund University; University of Munich	Ainalem, ML (corresponding author), Lund Univ, Ctr Chem & Chem Engn, S-22100 Lund, Sweden.	marie-louise.ainalem@esss.se	de Sousa Dias, Rita/C-2224-2008; Zink, Daniele/A-8181-2015	de Sousa Dias, Rita/0000-0001-9600-0934; Nylander, Tommy/0000-0001-9420-2217	EU [12967]; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BPD/24203/2005]	EU(European Commission); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	The sixth EU framework program is greatly acknowledged for funding this work as being a part of a EU-STREP project with NEST program (NEONUCLEI, Contract no. 12967). RD acknowledges the Fundacao para a Ciencia e a Tecnologia, Portugal (SFRH/BPD/24203/2005 and the programme Ciencia 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainalem ML, 2011, SOFT MATTER, V7, P4577, DOI 10.1039/c0sm01171a; Ainalem ML, 2009, SOFT MATTER, V5, P2310, DOI 10.1039/b821629k; Bednarski D, 2006, CHEMBIOCHEM, V7, P1715, DOI 10.1002/cbic.200600141; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; BELLARE JR, 1988, J ELECTRON MICR TECH, V10, P87, DOI 10.1002/jemt.1060100111; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Besch R, 2004, J INVEST DERMATOL, V122, P1114, DOI 10.1111/j.0022-202X.2004.22521.x; Bielinska A, 1996, NUCLEIC ACIDS RES, V24, P2176, DOI 10.1093/nar/24.11.2176; Bielinska AU, 1997, BBA-GENE STRUCT EXPR, V1353, P180, DOI 10.1016/S0167-4781(97)00069-9; Bitton R, 2005, LANGMUIR, V21, P11888, DOI 10.1021/la051811p; Blagbrough IS, 2003, BIOCHEM SOC T, V31, P397, DOI 10.1042/BST0310397; Cakara D, 2003, MACROMOLECULES, V36, P4201, DOI 10.1021/ma0300241; Cardenas M, 2008, INTERACTION DNA SURF, P291; Carlson ED, 2012, BIOTECHNOL ADV, V30, P1185, DOI 10.1016/j.biotechadv.2011.09.016; Carnerup AM, 2009, LANGMUIR, V25, P12466, DOI 10.1021/la903068v; Carnerup AM, 2011, SOFT MATTER, V7, P760, DOI 10.1039/c0sm00644k; Chen W, 2000, LANGMUIR, V16, P15, DOI 10.1021/la981429v; Cogoi S, 2005, BIOCHEMISTRY-US, V44, P10510, DOI 10.1021/bi0505215; Corbyn CP, 2009, PHYS CHEM CHEM PHYS, V11, P11568, DOI 10.1039/b916116c; Corsi J, 2008, CHEM COMMUN, P2307, DOI 10.1039/b801199k; Dexter AF, 2008, IND ENG CHEM RES, V47, P6391, DOI 10.1021/ie800127f; Dias R, 2000, LANGMUIR, V16, P9577, DOI 10.1021/la000640f; Dias R.S., 2008, DNA INTERACT POLYM S, P89, DOI DOI 10.1002/9780470286364.CH4; Dias RS, 2005, ELECTROPHORESIS, V26, P2908, DOI 10.1002/elps.200400182; Dias RS, 2005, J PHYS CHEM B, V109, P10458, DOI 10.1021/jp0444464; Dufes C, 2005, ADV DRUG DELIVER REV, V57, P2177, DOI 10.1016/j.addr.2005.09.017; El-Sayed M, 2001, PHARM RES-DORDR, V18, P23, DOI 10.1023/A:1011066408283; Fant K, 2008, BIOCHEMISTRY-US, V47, P1732, DOI 10.1021/bi7017199; Fox KR, 2000, CURR MED CHEM, V7, P17, DOI 10.2174/0929867003375506; Ghosh MK, 2005, MOL CELL BIOCHEM, V278, P147, DOI 10.1007/s11010-005-7283-7; GODDARD ED, 1977, J AM OIL CHEM SOC, V54, P561, DOI 10.1007/BF03027636; Gonzalez-Perez A, 2008, BIOMACROMOLECULES, V9, P772, DOI 10.1021/bm7012907; Graslund T, 2005, J BIOL CHEM, V280, P3707, DOI 10.1074/jbc.M406809200; HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012; Hedman J, 2013, BIOSECUR BIOTERROR, V11, pS87, DOI 10.1089/bsp.2012.0090; Holmberg K., 2003, SURFACTANTS POLYM AQ, P39; Izumrudov VA, 2002, LANGMUIR, V18, P10348, DOI 10.1021/la020592u; Janowski BA, 2005, NAT CHEM BIOL, V1, P210, DOI 10.1038/nchembio724; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jorge AF, 2012, BIOMACROMOLECULES, V13, P3151, DOI 10.1021/bm300934p; Joseph J, 1997, NUCLEIC ACIDS RES, V25, P2182, DOI 10.1093/nar/25.11.2182; Klug A, 2005, FEBS LETT, V579, P892, DOI 10.1016/j.febslet.2004.10.104; KukowskaLatallo JF, 1996, P NATL ACAD SCI USA, V93, P4897, DOI 10.1073/pnas.93.10.4897; Lai YM, 2005, J PHARMACOL EXP THER, V315, P571, DOI 10.1124/jpet.105.089086; Leal C, 2004, J PHYS CHEM B, V108, P3044, DOI 10.1021/jp030850b; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lindemose S, 2005, NUCLEIC ACIDS RES, V33, P1790, DOI 10.1093/nar/gki319; Liu ZH, 2010, PROG POLYM SCI, V35, P1144, DOI 10.1016/j.progpolymsci.2010.04.007; Lleres D, 2002, LANGMUIR, V18, P10340, DOI 10.1021/la025845y; Lu YJ, 2001, BIOPOLYMERS, V61, P261, DOI 10.1002/bip.10151; Mapp AK, 2000, P NATL ACAD SCI USA, V97, P3930, DOI 10.1073/pnas.97.8.3930; Milhem OM, 2000, INT J PHARM, V197, P239, DOI 10.1016/S0378-5173(99)00463-9; MOLLEGAARD NE, 1994, P NATL ACAD SCI USA, V91, P3892, DOI 10.1073/pnas.91.9.3892; Orberg ML, 2007, BIOMACROMOLECULES, V8, P1557, DOI 10.1021/bm061194z; Page C., 2013, ISRN PHARM, V2013, P1, DOI [DOI 10.1155/2013/910743, 10.1155/2013/910743]; Pavlov G, 2003, EUR BIOPHYS J BIOPHY, V32, P437, DOI 10.1007/s00249-003-0316-9; Piculell L, 1998, SURF SCI SERIES, V77, P65; Potschke D, 2000, MACROMOL CHEM PHYS, V201, P330; Prasad TK, 2003, BBA-GEN SUBJECTS, V1619, P59, DOI 10.1016/S0304-4165(02)00442-7; Qamhieh K, 2009, BIOMACROMOLECULES, V10, P1720, DOI 10.1021/bm9000662; Raspaud E, 2005, BIOPHYS J, V88, P392, DOI 10.1529/biophysj.104.040113; Ritchie S, 2000, J BIOL CHEM, V275, P847, DOI 10.1074/jbc.275.2.847; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Ronsin G, 2001, CHEM COMMUN, P2234, DOI 10.1039/b105936j; Rosenfeldt S, 2002, MACROMOL CHEM PHYS, V203, P1995, DOI 10.1002/1521-3935(200209)203:13<1995::AID-MACP1995>3.0.CO;2-6; Ryan AJ, 2004, BIOCHEM J, V382, P741, DOI 10.1042/BJ20040105; Santoso SS, 2002, CURR OPIN COLLOID IN, V7, P262, DOI 10.1016/S1359-0294(02)00072-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takahashi M, 1997, J PHYS CHEM B, V101, P9396, DOI 10.1021/jp9716391; Tsumoto K, 2003, BIOPHYS CHEM, V106, P23, DOI 10.1016/S0301-4622(03)00138-8; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Wang XH, 1999, MACROMOLECULES, V32, P4299, DOI 10.1021/ma9902450; Waterhouse JE, 2005, CHEMBIOCHEM, V6, P1212, DOI 10.1002/cbic.200400408; Xu YH, 1996, BIOCHEMISTRY-US, V35, P5616, DOI 10.1021/bi9602019; Yoshikawa Y, 2013, ANGEW CHEM INT EDIT, V52, P3712, DOI 10.1002/anie.201209144	76	31	31	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92692	10.1371/journal.pone.0092692	http://dx.doi.org/10.1371/journal.pone.0092692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671109	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000064
J	Aydin, U; Vorwerk, J; Kupper, P; Heers, M; Kugel, H; Galka, A; Hamid, L; Wellmer, J; Kellinghaus, C; Rampp, S; Wolters, CH				Aydin, Uemit; Vorwerk, Johannes; Kuepper, Philipp; Heers, Marcel; Kugel, Harald; Galka, Andreas; Hamid, Laith; Wellmer, Joerg; Kellinghaus, Christoph; Rampp, Stefan; Wolters, Carsten Hermann			Combining EEG and MEG for the Reconstruction of Epileptic Activity Using a Calibrated Realistic Volume Conductor Model	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; FOCAL CORTICAL DYSPLASIA; ELEMENT HEAD MODEL; SOURCE LOCALIZATION; HUMAN BRAIN; HUMAN SKULL; IN-VIVO; INTRINSIC EPILEPTOGENICITY; PRESURGICAL EVALUATION; EQUIVALENT DIPOLE	To increase the reliability for the non-invasive determination of the irritative zone in presurgical epilepsy diagnosis, we introduce here a new experimental and methodological source analysis pipeline that combines the complementary information in EEG and MEG, and apply it to data from a patient, suffering from refractory focal epilepsy. Skull conductivity parameters in a six compartment finite element head model with brain anisotropy, constructed from individual MRI data, are estimated in a calibration procedure using somatosensory evoked potential (SEP) and field (SEF) data. These data are measured in a single run before acquisition of further runs of spontaneous epileptic activity. Our results show that even for single interictal spikes, volume conduction effects dominate over noise and need to be taken into account for accurate source analysis. While cerebrospinal fluid and brain anisotropy influence both modalities, only EEG is sensitive to skull conductivity and conductivity calibration significantly reduces the difference in especially depth localization of both modalities, emphasizing its importance for combining EEG and MEG source analysis. On the other hand, localization differences which are due to the distinct sensitivity profiles of EEG and MEG persist. In case of a moderate error in skull conductivity, combined source analysis results can still profit from the different sensitivity profiles of EEG and MEG to accurately determine location, orientation and strength of the underlying sources. On the other side, significant errors in skull modeling are reflected in EEG reconstruction errors and could reduce the goodness of fit to combined datasets. For combined EEG and MEG source analysis, we therefore recommend calibrating skull conductivity using additionally acquired SEP/SEF data.	[Aydin, Uemit; Vorwerk, Johannes; Kuepper, Philipp; Wolters, Carsten Hermann] Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany; [Kuepper, Philipp; Kellinghaus, Christoph] Klinikum Osnabruck, Dept Neurol, Osnabruck, Germany; [Heers, Marcel; Wellmer, Joerg] Univ Klinikum Knappschaftskrankenhaus Bochum, Ruhr Epileptol Dept Neurol, Bochum, Germany; [Kugel, Harald] Univ Klinikum Munster, Dept Clin Radiol, Munster, Germany; [Galka, Andreas; Hamid, Laith] Univ Klinikum Schleswig Holstein, Dept Neuropediat, Kiel, Germany; [Rampp, Stefan] Univ Klinikum Erlangen, Dept Neurol, Epilepsy Ctr, Erlangen, Germany	University of Munster; Ruhr University Bochum; University of Munster; University of Kiel; Schleswig Holstein University Hospital; University of Erlangen Nuremberg	Aydin, U (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany.	umitaydin@ieee.org	Heers, Marcel/AAF-9364-2019; Heers, Marcel/GRS-2648-2022; Wolters, Carsten H/R-4234-2016; Rampp, Stefan/J-9386-2019; Aydin, Ümit/HII-7669-2022	Heers, Marcel/0000-0001-5545-7014; Wolters, Carsten H/0000-0001-6233-424X; Rampp, Stefan/0000-0002-4826-1520; Kugel, Harald/0000-0002-4349-1984; Aydin, Umit/0000-0002-6327-7811; Vorwerk, Johannes/0000-0003-3597-4203	German Research Foundation (DFG) [WO1425/2-1, STE380/14-1, SFB 855]; Medical Faculty, Ruhr University Bochum; FoRUM research grant [K062-11]	German Research Foundation (DFG)(German Research Foundation (DFG)); Medical Faculty, Ruhr University Bochum; FoRUM research grant	This research has been supported by the German Research Foundation (DFG) through projects WO1425/2-1, STE380/14-1 and SFB 855 (http://dfg.de), and by the Medical Faculty, Ruhr University Bochum, by a FoRUM research grant (K062-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar ZA, 2013, BRAIN TOPOGR, V26, P378, DOI 10.1007/s10548-012-0274-6; Akhtari M, 2000, BRAIN TOPOGR, V13, P29, DOI 10.1023/A:1007882102297; Akhtari M, 2002, BRAIN TOPOGR, V14, P151, DOI 10.1023/A:1014590923185; Baillet S, 1999, IEEE T BIO-MED ENG, V46, P522, DOI 10.1109/10.759053; Barkley GL, 2003, J CLIN NEUROPHYSIOL, V20, P163, DOI 10.1097/00004691-200305000-00002; Bast T, 2004, EPILEPSIA, V45, P621, DOI 10.1111/j.0013-9580.2004.56503.x; Bast T, 2006, J CLIN NEUROPHYSIOL, V23, P487, DOI 10.1097/01.wnp.0000232208.14060.c7; BAUMGARTNER C, 1995, NEUROLOGY, V45, P118, DOI 10.1212/WNL.45.1.118; Baysal U, 2004, PHYSIOL MEAS, V25, P737, DOI 10.1088/0967-3334/25/3/013; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bertrand O, 1991, 3D FINITE ELEMENT ME, P154; Boon P, 2002, J CLIN NEUROPHYSIOL, V19, P461, DOI 10.1097/00004691-200210000-00009; Buchner H, 1997, ELECTROEN CLIN NEURO, V102, P267, DOI 10.1016/S0013-4694(96)95698-9; Buchner Helmut, 1994, Brain Topography, V6, P299, DOI 10.1007/BF01211175; Camacho DLA, 1997, J BIOMECH, V30, P1067, DOI 10.1016/S0021-9290(97)00073-0; Chitoku S, 2003, BRAIN DEV-JPN, V25, P14, DOI 10.1016/S0387-7604(02)00104-3; COHEN D, 1987, PHYS MED BIOL, V32, P85, DOI 10.1088/0031-9155/32/1/013; Dannhauer M, 2011, HUM BRAIN MAPP, V32, P1383, DOI 10.1002/hbm.21114; DASILVA FHL, 1991, BRAIN TOPOGR, V4, P133; Dassios G, 2007, INVERSE PROBL, V23, P2541, DOI 10.1088/0266-5611/23/6/016; Degen R, 2003, ACTA NEUROL SCAND, V108, P309, DOI 10.1034/j.1600-0404.2003.00153.x; Ebersole JS, 2010, J CLIN NEUROPHYSIOL, V27, P360, DOI 10.1097/WNP.0b013e318201ffc4; Ebersole JS, 1999, EEG CL N SU, V50, P167; Fuchs M, 1998, ELECTROEN CLIN NEURO, V107, P93, DOI 10.1016/S0013-4694(98)00046-7; Gavaret M, 2004, J CLIN NEUROPHYSIOL, V21, P267, DOI 10.1097/01.WNP.0000139929.06455.82; Goncalves S, 2003, IEEE T BIO-MED ENG, V50, P1124, DOI 10.1109/TBME.2003.816072; Goncalves S, 2000, PHYSIOL MEAS, V21, P379, DOI 10.1088/0967-3334/21/3/304; Gullmar D, 2010, NEUROIMAGE, V51, P145, DOI 10.1016/j.neuroimage.2010.02.014; Hallez H, 2008, PHYS MED BIOL, V53, P1877, DOI 10.1088/0031-9155/53/7/005; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; Heers M, 2011, SEIZURE, V21, P128; Hoekema R, 2003, BRAIN TOPOGR, V16, P29, DOI 10.1023/A:1025606415858; HOMMA S, 1995, NEUROSCI RES, V22, P51, DOI 10.1016/0168-0102(95)00880-3; Huang MX, 2007, NEUROIMAGE, V37, P731, DOI 10.1016/j.neuroimage.2007.06.002; Huiskamp G, 1999, IEEE T BIO-MED ENG, V46, P1281, DOI 10.1109/10.797987; Iwasaki M, 2005, EPILEPSIA, V46, P59, DOI 10.1111/j.0013-9580.2005.21104.x; Janszky J, 2000, NEUROLOGY, V54, P1470, DOI 10.1212/WNL.54.7.1470; Jenkinson M, 2005, BET2 MR BASED ESTIMA; Jerbi K, 2004, NEUROIMAGE, V22, P779, DOI 10.1016/j.neuroimage.2004.02.010; Knake S, 2006, EPILEPSY RES, V69, P80, DOI 10.1016/j.eplepsyres.2006.01.001; Kohling R, 2000, J NEUROPHYSIOL, V84, P2161, DOI 10.1152/jn.2000.84.4.2161; Kupper P, 2012, THESIS BEUTH HOCHSCH; Lai Y, 2005, CLIN NEUROPHYSIOL, V116, P456, DOI 10.1016/j.clinph.2004.08.017; Lanfer B, 2012, NEUROIMAGE, V62, P418, DOI 10.1016/j.neuroimage.2012.05.006; Lanfer B, 2013, BRAIN TOPOGR, V26, P212, DOI 10.1007/s10548-012-0251-0; Lantz G, 2003, J CLIN NEUROPHYSIOL, V20, P311, DOI 10.1097/00004691-200309000-00003; Lau S., 2011, INT J BIOELECTROMAGN, V13, P228; Lee SK, 2005, ANN NEUROL, V58, P525, DOI 10.1002/ana.20569; Lew S, 2009, HUM BRAIN MAPP, V30, P2862, DOI 10.1002/hbm.20714; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; Luders HO, 2006, EPILEPTIC DISORD, V8, pS1; Meno FM, 1997, IEEE T BIOMED ENG, V3, P220, DOI DOI 10.1109/10.554770; Montes-Restrepo V, 2014, BRAIN TOPOGR, V27, P95, DOI 10.1007/s10548-013-0313-y; Morioka T, 1999, EPILEPSY RES, V33, P177, DOI 10.1016/S0920-1211(98)00096-5; Munck JCD, 2012, EEG MEG FORWARD MODE, P192; Ollikainen JO, 1999, MED ENG PHYS, V21, P143, DOI 10.1016/S1350-4533(99)00038-7; Oozeer M, 2005, MED BIOL ENG COMPUT, V43, P608, DOI 10.1007/BF02351034; Ossenblok P, 2007, EPILEPSIA, V48, P2139, DOI 10.1111/j.1528-1167.2007.01223.x; Otsubo H, 2001, EPILEPSIA, V42, P1523, DOI 10.1046/j.1528-1157.2001.16701.x; Pataraia E, 2005, NEUROIMAGE, V24, P607, DOI 10.1016/j.neuroimage.2004.09.031; Ramon C, 2004, BRAIN TOPOGR, V16, P245; Ramon C., 2012, INT J BIOELECTROMAGN, V14, P27; Rampp S, 2007, EXPERT REV MED DEVIC, V4, P335, DOI 10.1586/17434440.4.3.335; Rice JK, 2013, NEUROIMAGE, V64, P476, DOI 10.1016/j.neuroimage.2012.09.041; Rullmann M, 2009, NEUROIMAGE, V44, P399, DOI 10.1016/j.neuroimage.2008.09.009; Ruthotto L, 2012, PHYS MED BIOL, V57, P5715, DOI 10.1088/0031-9155/57/18/5715; Salayev KA, 2006, CLIN NEUROPHYSIOL, V117, P1836, DOI 10.1016/j.clinph.2006.05.003; Scherg M, 2002, J CLIN NEUROPHYSIOL, V19, P91, DOI 10.1097/00004691-200203000-00001; Schimpf PH, 2002, IEEE T BIO-MED ENG, V49, P409, DOI 10.1109/10.995679; Slutzky MW, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026004; Speckmann EJ, 2012, NIEDERMEYERS ELECTRO; Stefan H, 2003, BRAIN, V126, P2396, DOI 10.1093/brain/awg239; Sutherling WW, 2008, NEUROLOGY, V71, P990, DOI 10.1212/01.wnl.0000326591.29858.1a; Tuch DS, 2001, P NATL ACAD SCI USA, V98, P11697, DOI 10.1073/pnas.171473898; Van't Ent D, 2003, CLIN NEUROPHYSIOL, V114, P1948, DOI 10.1016/S1388-2457(03)00156-1; Vorwerk J, 2012, BIOMED ENG TECH; Weinstein D, 2000, ANN BIOMED ENG, V28, P1059, DOI 10.1114/1.1310220; Wendel K, 2008, IEEE T BIO-MED ENG, V55, P1454, DOI 10.1109/TBME.2007.912427; Wennberg R, 2014, CLIN NEUROPHYSIOL, V125, P903, DOI 10.1016/j.clinph.2013.08.032; Wennberg R, 2011, CLIN NEUROPHYSIOL, V122, P1295, DOI 10.1016/j.clinph.2010.11.019; Wolters C.H., 2010, BIOMED TECHNIK BIOME, V55, P64; Wolters CH, 2007, IEEE T BIO-MED ENG, V54, P1446, DOI 10.1109/TBME.2007.890736; Wolters CH, 2006, NEUROIMAGE, V30, P813, DOI 10.1016/j.neuroimage.2005.10.014; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	85	58	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93154	10.1371/journal.pone.0093154	http://dx.doi.org/10.1371/journal.pone.0093154			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671208	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000121
J	Soema, PC; Willems, GJ; van Twillert, K; van de Wijdeven, G; Boog, CJ; Kersten, GFA; Amorij, JP				Soema, Peter C.; Willems, Geert-Jan; van Twillert, Klaas; van de Wijdeven, Gijsbert; Boog, Claire J.; Kersten, Gideon F. A.; Amorij, Jean-Pierre			Solid Bioneedle-Delivered Influenza Vaccines Are Highly Thermostable and Induce Both Humoral and Cellular Immune Responses	PLOS ONE			English	Article							INACTIVATED VIRUS-VACCINE; SUBUNIT VACCINE; POWDER; IMMUNIZATION; MICE; IMMUNOGENICITY; QUANTIFICATION; HEMAGGLUTININ; CARRIERS; STORAGE	The potential of bioneedles to deliver influenza vaccines was investigated. Four influenza vaccine formulations were screened to determine the optimal formulation for use with bioneedles. The stability of the formulations after freeze-drying was checked to predict the stability of the influenza vaccines in the bioneedles. Subunit, split, virosomal and whole inactivated influenza (WIV) vaccine were formulated and lyophilized in bioneedles, and subsequently administered to C57BL/6 mice. Humoral and cellular immune responses were assessed after vaccination. The thermostability of lyophilized vaccines was determined after one-month storage at elevated temperatures. Bioneedle influenza vaccines induced HI titers that are comparable to those induced by intramuscular WIV vaccination. Delivery by bioneedles did not alter the type of immune response induced by the influenza vaccines. Stability studies showed that lyophilized influenza vaccines have superior thermostability compared to conventional liquid vaccines, and remained stable after one-month storage at 60 degrees C. Influenza vaccines delivered by bioneedles are a viable alternative to conventional liquid influenza vaccines. WIV was determined to be the most potent vaccine formulation for administration by bioneedles. Lyophilized influenza vaccines in bioneedles are independent of a cold-chain, due to their increased thermostability, which makes distribution and stockpiling easier.	[Soema, Peter C.; Willems, Geert-Jan; van Twillert, Klaas; Boog, Claire J.; Kersten, Gideon F. A.; Amorij, Jean-Pierre] Inst Translat Vaccinol Intravacc, Bilthoven, Netherlands; [van de Wijdeven, Gijsbert] Bioneedle Technol Grp BV, Eindhoven, Netherlands		Soema, PC (corresponding author), Inst Translat Vaccinol Intravacc, Bilthoven, Netherlands.	petersoema@gmail.com			Dutch Ministry of Health, Welfare and Sport	Dutch Ministry of Health, Welfare and Sport	This work was funded by the Dutch Ministry of Health, Welfare and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorij JP, 2007, VACCINE, V25, P6447, DOI 10.1016/j.vaccine.2007.06.054; Amorij JP, 2008, PHARM RES-DORDR, V25, P1256, DOI 10.1007/s11095-008-9559-6; Amorij JP, 2010, LANCET INFECT DIS, V10, P699, DOI 10.1016/S1473-3099(10)70157-2; Bodewes R, 2010, J GEN VIROL, V91, P1743, DOI 10.1099/vir.0.020784-0; Budimir N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063163; BUDOWSKY EI, 1991, VACCINE, V9, P398, DOI 10.1016/0264-410X(91)90125-P; Chen DX, 2003, VACCINE, V21, P2830, DOI 10.1016/S0264-410X(03)00175-0; Choi HJ, 2013, J CONTROL RELEASE, V166, P159, DOI 10.1016/j.jconrel.2012.12.002; de Jonge J, 2007, EUR J PHARM SCI, V32, P33, DOI 10.1016/j.ejps.2007.05.112; de Jonge J, 2006, BBA-BIOMEMBRANES, V1758, P527, DOI 10.1016/j.bbamem.2006.03.011; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Geeraedts F, 2010, AAPS J, V12, P215, DOI 10.1208/s12248-010-9179-z; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Geeraedts F, 2008, INFLUENZA OTHER RESP, V2, P41, DOI 10.1111/j.1750-2659.2008.00038.x; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Hagenaars N, 2008, VACCINE, V26, P6555, DOI 10.1016/j.vaccine.2008.09.057; Hillaire MLB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/939860; Hirschberg HJHB, 2008, VACCINE, V26, P2389, DOI 10.1016/j.vaccine.2008.02.067; Hirschberg HJHB, 2010, J CONTROL RELEASE, V147, P211, DOI 10.1016/j.jconrel.2010.06.028; Kapteyn JC, 2009, VACCINE, V27, P1468, DOI 10.1016/j.vaccine.2008.11.113; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; Mitragotri S, 2006, NAT REV DRUG DISCOV, V5, P543, DOI 10.1038/nrd2076; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nilsson CE, 2010, VACCINE, V28, P759, DOI 10.1016/j.vaccine.2009.10.070; Taddio A, 2012, VACCINE, V30, P4807, DOI 10.1016/j.vaccine.2012.05.011; The Committee for Proprietary Medicinal Products (CHMP), CHMPBWP21496; van de Wijdeven GGP, 2002, J CONTROL RELEASE, V85, P145, DOI 10.1016/S0168-3659(02)00283-3	28	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92806	10.1371/journal.pone.0092806	http://dx.doi.org/10.1371/journal.pone.0092806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671048	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000078
J	Bargiela, A; Llamusi, B; Cerro-Herreros, E; Artero, R				Bargiela, Ariadna; Llamusi, Beatriz; Cerro-Herreros, Estefania; Artero, Ruben			Two Enhancers Control Transcription of Drosophila muscleblind in the Embryonic Somatic Musculature and in the Central Nervous System	PLOS ONE			English	Article							MYOTONIC-DYSTROPHY TYPE-1; GENE-EXPRESSION; NUCLEAR FOCI; PROTEINS; RNA; SPECIFICATION; LOCALIZATION; PROMOTERS; ELEMENT; CELLS	The phylogenetically conserved family of Muscleblind proteins are RNA-binding factors involved in a variety of gene expression processes including alternative splicing regulation, RNA stability and subcellular localization, and miRNA biogenesis, which typically contribute to cell-type specific differentiation. In humans, sequestration of Muscleblind-like proteins MBNL1 and MBNL2 has been implicated in degenerative disorders, particularly expansion diseases such as myotonic dystrophy type 1 and 2. Drosophila muscleblind was previously shown to be expressed in embryonic somatic and visceral muscle subtypes, and in the central nervous system, and to depend on Mef2 for transcriptional activation. Genomic approaches have pointed out candidate gene promoters and tissue-specific enhancers, but experimental confirmation of their regulatory roles was lacking. In our study, luciferase reporter assays in S2 cells confirmed that regions P1 (515 bp) and P2 (573 bp), involving the beginning of exon 1 and exon 2, respectively, were able to initiate RNA transcription. Similarly, transgenic Drosophila embryos carrying enhancer reporter constructs supported the existence of two regulatory regions which control embryonic expression of muscleblind in the central nerve cord (NE, neural enhancer; 830 bp) and somatic (skeletal) musculature (ME, muscle enhancer; 3.3 kb). Both NE and ME were able to boost expression from the Hsp70 heterologous promoter. In S2 cell assays most of the ME enhancer activation could be further narrowed down to a 1200 bp subregion (ME.3), which contains predicted binding sites for the Mef2 transcription factor. The present study constitutes the first characterization of muscleblind enhancers and will contribute to a deeper understanding of the transcriptional regulation of the gene.	[Bargiela, Ariadna; Llamusi, Beatriz; Cerro-Herreros, Estefania; Artero, Ruben] Univ Valencia, Dept Genet, Translat Genom Grp, Valencia, Spain; [Bargiela, Ariadna; Llamusi, Beatriz; Cerro-Herreros, Estefania; Artero, Ruben] INCLIVA Hlth Res Inst, Valencia, Spain	University of Valencia	Artero, R (corresponding author), Univ Valencia, Dept Genet, Translat Genom Grp, Valencia, Spain.	ruben.artero@uv.es	Bargiela, Ariadna/ABF-9125-2020; Herreros, Estefanía Cerro/AAD-6166-2021; llamusi, Beatriz/M-4449-2015; Artero, Ruben/K-6815-2014	Herreros, Estefanía Cerro/0000-0003-3247-5900; llamusi, Beatriz/0000-0002-2694-1293; Artero, Ruben/0000-0003-1596-047X; Bargiela, Ariadna/0000-0003-4336-2522	Genoma Espana Foundation; Generalitat Valenciana [Prometeo/2010/081]; Ministerio de Ciencia e Innovacion [BFU2009-10940]; Ministerio de Economia y Competitividad [SAF2012-36854]; Generalitat Valenciana; Genoma Espana; Geronimo Forteza grant from Generalitat Valenciana; Plan E; FEDER	Genoma Espana Foundation; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Genoma Espana; Geronimo Forteza grant from Generalitat Valenciana; Plan E; FEDER(European Commission)	This work was supported by research grants from Genoma Espana Foundation, Generalitat Valenciana (Prometeo/2010/081), Ministerio de Ciencia e Innovacion (BFU2009-10940, including funds from Plan E), and Ministerio de Economia y Competitividad (SAF2012-36854, including funds from FEDER) to R. A. A. B. was supported by a Prometeo contract and a predoctoral fellowship from Generalitat Valenciana. B. L. was funded through Genoma Espana. E. C. H. was supported by a Geronimo Forteza grant from Generalitat Valenciana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adereth Y, 2005, NAT CELL BIOL, V7, P1240, DOI 10.1038/ncb1335; Artero R, 1998, DEV BIOL, V195, P131, DOI 10.1006/dbio.1997.8833; AWGULEWITSCH A, 1992, NATURE, V358, P341, DOI 10.1038/358341a0; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Begemann G, 1997, DEVELOPMENT, V124, P4321; BERMINGHAM JR, 1990, DEVELOPMENT, V109, P553; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROOK, 1992, CELL, V69, P385; Carlson JM, 2007, NUCLEIC ACIDS RES, V35, pW259, DOI 10.1093/nar/gkm310; Charizanis K, 2012, NEURON, V75, P437, DOI 10.1016/j.neuron.2012.05.029; Cunha PMF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001014; De Graeve F, 2004, DEV BIOL, V270, P122, DOI 10.1016/j.ydbio.2004.02.014; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fernandez-Costa JM, 2011, BIOL REV, V86, P947, DOI 10.1111/j.1469-185X.2011.00180.x; Fernandez-Costa JM, 2010, MOL CELLS, V30, P65, DOI 10.1007/s10059-010-0089-9; Fiszer A, 2013, J MOL MED, V91, P683, DOI 10.1007/s00109-013-1016-2; Goers ES, 2008, BIOCHEMISTRY-US, V47, P7284, DOI 10.1021/bi702252d; Han H, 2013, NATURE, V498, P241, DOI 10.1038/nature12270; Houseley JM, 2005, HUM MOL GENET, V14, P873, DOI 10.1093/hmg/ddi080; Irion U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034248; JAGLA K, 1993, GENE, V127, P165, DOI 10.1016/0378-1119(93)90715-F; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; Juni N, 2009, J NEUROGENET, V23, P329, DOI 10.1080/01677060802471601; Kanadia RN, 2003, GENE EXPR PATTERNS, V3, P459, DOI 10.1016/S1567-133X(03)00064-4; KANIA A, 1995, GENETICS, V139, P1663; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lee KS, 2007, BIOCHEM BIOPH RES CO, V361, P151, DOI 10.1016/j.bbrc.2007.06.165; Lee KS, 2010, J BIOL CHEM, V285, P33779, DOI 10.1074/jbc.M110.124255; Li LB, 2010, TRENDS NEUROSCI, V33, P292, DOI 10.1016/j.tins.2010.03.004; Lin X, 2006, HUM MOL GENET; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Machuca-Tzili L, 2006, HUM GENET, V120, P487, DOI 10.1007/s00439-006-0228-8; Masuda A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00209; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mykowska A, 2011, NUCLEIC ACIDS RES, V39, P8938, DOI 10.1093/nar/gkr608; Novotny T, 2002, DEVELOPMENT, V129, P1027; Ohler U, 2006, NUCLEIC ACIDS RES, V34, P5943, DOI 10.1093/nar/gkl608; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; Picchio L, 2013, HUM MOL GENET, V22, P2795, DOI 10.1093/hmg/ddt127; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Poulos MG, 2013, HUM MOL GENET, V22, P3547, DOI 10.1093/hmg/ddt209; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; Romani S, 1996, MECH DEVELOP, V60, P95, DOI 10.1016/S0925-4773(96)00603-X; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Squillace RM, 2002, DEV BIOL, V250, P218, DOI 10.1006/dbio.2002.0798; Tabebordbar M, 2013, ANNU REV PATHOL-MECH, V8, P441, DOI 10.1146/annurev-pathol-011811-132450; Vicente M, 2007, DIFFERENTIATION, V75, P427, DOI 10.1111/j.1432-0436.2006.00156.x; Vicente-Crespo M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001613; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	58	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93125	10.1371/journal.pone.0093125	http://dx.doi.org/10.1371/journal.pone.0093125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667536	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600145
J	Miyazaki, S; Okada, Y; Miyakawa, H; Tokuda, G; Cornette, R; Koshikawa, S; Maekawa, K; Miura, T				Miyazaki, Satoshi; Okada, Yasukazu; Miyakawa, Hitoshi; Tokuda, Gaku; Cornette, Richard; Koshikawa, Shigeyuki; Maekawa, Kiyoto; Miura, Toru			Sexually Dimorphic Body Color Is Regulated by Sex-Specific Expression of Yellow Gene in Ponerine Ant, Diacamma Sp.	PLOS ONE			English	Article							EVOLUTION; PIGMENTATION; MECHANISMS; PROTEINS; PATTERNS; TRAITS; TAN	Most hymenopteran species exhibit conspicuous sexual dimorphism due to ecological differences between the sexes. As hymenopteran genomes, under the haplodiploid genetic system, exhibit quantitative differences between sexes while remaining qualitatively identical, sexual phenotypes are assumed to be expressed through sex-specific gene usage. In the present study, the molecular basis for expression of sexual dimorphism in a queenless ant, Diacamma sp., which exhibits a distinct color dimorphism, was examined. Worker females of the species appear bluish-black, while winged males exhibit a yellowish-brown body color. Initially, observations of the pigmentation processes during pupal development revealed that black pigmentation was present in female pupae but not in males, suggesting that sex-specific melanin synthesis was responsible for the observed color dimorphism. Therefore, five orthologs of the genes involved in the insect melanin synthesis (yellow, ebony, tan, pale and dopa decarboxylase) were subcloned and their spatiotemporal expression patterns were examined using real-time quantitative RT-PCR. Of the genes examined, yellow, which plays a role in black melanin synthesis in insects, was expressed at higher levels in females than in males throughout the entire body during the pupal stage. RNA interference of yellow was then carried out in order to determine the gene function, and produced females with a more yellowish, brighter body color similar to that of males. It was concluded that transcriptional regulation of yellow was responsible for the sexual color dimorphism observed in this species.	[Miyazaki, Satoshi; Okada, Yasukazu; Miyakawa, Hitoshi; Cornette, Richard; Koshikawa, Shigeyuki; Miura, Toru] Hokkaido Univ, Grad Sch Environm Sci, Lab Ecol Genet, Sapporo, Hokkaido, Japan; [Miyazaki, Satoshi; Maekawa, Kiyoto] Toyama Univ, Grad Sch Sci & Engn, Toyama 930, Japan; [Okada, Yasukazu] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Miyakawa, Hitoshi] Natl Inst Basic Biol, Okazaki Inst Integrat Biosci, Okazaki, Aichi 444, Japan; [Tokuda, Gaku] Univ Ryukyus, Ctr Mol Biosci, Okinawa, Japan; [Cornette, Richard] Natl Inst Agrobiol Sci, Insect Mimet Res Unit, Tsukuba, Ibaraki, Japan; [Koshikawa, Shigeyuki] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	Hokkaido University; University of Toyama; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); University of the Ryukyus; National Institute of Agrobiological Sciences - Japan; University of Wisconsin System; University of Wisconsin Madison	Miyazaki, S (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Lab Ecol Genet, Sapporo, Hokkaido, Japan.	ihsotasm@gmail.com	Tokuda, Gaku/I-3686-2013; Miura, Toru/P-2456-2019; Okada, Yasukazu/B-1590-2014; Koshikawa, Shigeyuki/D-3052-2012; Miyazaki, Satoshi/AAX-4796-2021	Tokuda, Gaku/0000-0003-0645-6191; Miura, Toru/0000-0002-7456-4402; Okada, Yasukazu/0000-0003-4528-2980; Koshikawa, Shigeyuki/0000-0003-2831-555X; Miyazaki, Satoshi/0000-0003-3309-1618; Maekawa, Kiyoto/0000-0002-2354-1059	Japan Society for the Promotion of Science Research Fellowships for Young Scientists; Ministry of Education, Culture, Sports, Science and Technology of Japan;  [25251041]; Grants-in-Aid for Scientific Research [25251041, 11J09207] Funding Source: KAKEN	Japan Society for the Promotion of Science Research Fellowships for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The present study was supported by a Grant-in-Aid for Scientific Research (No. 25251041 to TM) awarded by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The first author was supported by the Japan Society for the Promotion of Science Research Fellowships for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane Y, 2010, INSECT BIOCHEM MOLEC, V40, P259, DOI 10.1016/j.ibmb.2010.01.012; Arakane Y, 2009, J BIOL CHEM, V284, P16584, DOI 10.1074/jbc.M901629200; BAKER BS, 1980, GENETICS, V94, P383; Chapman R.F., 2012, INSECTS STRUCTURE FU; Cho S, 2007, GENETICS, V177, P1733, DOI 10.1534/genetics.107.078980; COSCHIGANO KT, 1993, GENE DEV, V7, P42, DOI 10.1101/gad.7.1.42; Drapeau MD, 2003, J NEUROBIOL, V55, P53, DOI 10.1002/neu.10196; Friggi-Grelin F, 2003, GENESIS, V35, P260, DOI 10.1002/gene.1082; Futahashi R, 2010, EVOL DEV, V12, P157, DOI 10.1111/j.1525-142X.2010.00401.x; Gempe T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000222; Gibert JM, 2007, PLOS GENET, V3, P266, DOI 10.1371/journal.pgen.0030030; Gompel N, 2003, NATURE, V424, P931, DOI 10.1038/nature01787; Hoffman EA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-23; Holldobler B., 1990, pi; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; Hunt BG, 2011, P NATL ACAD SCI USA, V108, P15936, DOI 10.1073/pnas.1104825108; Jeong S, 2006, CELL, V125, P1387, DOI 10.1016/j.cell.2006.04.043; Johnson JK, 2001, INSECT BIOCHEM MOLEC, V31, P1125, DOI 10.1016/S0965-1748(01)00072-8; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Majerus M, 1998, MELANISM EVOLUTION A; Nakata K, 1998, J INSECT BEHAV, V11, P869, DOI 10.1023/A:1020816227912; Ninomiya Y, 2007, FEBS J, V274, P1768, DOI 10.1111/j.1742-4658.2007.05724.x; Okada Y, 2006, SOCIOBIOLOGY, V48, P527; Ometto L, 2011, MOL BIOL EVOL, V28, P1381, DOI 10.1093/molbev/msq322; PEETERS C, 1989, NATURWISSENSCHAFTEN, V76, P177, DOI 10.1007/BF00366404; Reed RD, 2008, P R SOC B, V275, P37, DOI 10.1098/rspb.2007.1115; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168; Shukla JN, 2012, SCI REPORTS, V2, P10; Stubblefield J. William, 1994, P71; Suzuki MG, 2005, EVOL DEV, V7, P58, DOI 10.1111/j.1525-142X.2005.05007.x; TAKAMIZAWA K, 2005, JAPANESE SOCIAL WASP; True JR, 2005, PLOS GENET, V1, P551, DOI 10.1371/journal.pgen.0010063; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Tsuji K, 1996, NATURWISSENSCHAFTEN, V83, P577; van Wilgenburg Ellen, 2006, Frontiers in Zoology, V3, P1, DOI 10.1186/1742-9994-3-1; Verhulst EC, 2010, CURR OPIN GENET DEV, V20, P376, DOI 10.1016/j.gde.2010.05.001; Verhulst EC, 2010, SCIENCE, V328, P620, DOI 10.1126/science.1185805; Walter MF, 1996, ARCH INSECT BIOCHEM, V31, P219, DOI 10.1002/(SICI)1520-6327(1996)31:2&lt;219::AID-ARCH9&gt;3.0.CO;2-U; WALTER MF, 1991, DEV BIOL, V147, P32, DOI 10.1016/S0012-1606(05)80005-3; Wheeler W. M., 1922, Psyche Boston Mass, V29, P203, DOI 10.1155/1922/80849; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Williams TM, 2009, NAT REV GENET, V10, P797, DOI 10.1038/nrg2687; Wittkopp PJ, 2009, SEMIN CELL DEV BIOL, V20, P65, DOI 10.1016/j.semcdb.2008.10.002; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849	46	18	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92875	10.1371/journal.pone.0092875	http://dx.doi.org/10.1371/journal.pone.0092875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667821	Green Published, gold			2022-12-25	WOS:000333675600095
J	Zahiri, R; Lafontaine, D; Schmidt, BC; deWaard, JR; Zakharov, EV; Hebert, PDN				Zahiri, Reza; Lafontaine, Donald; Schmidt, B. Christian; deWaard, Jeremy R.; Zakharov, Evgeny V.; Hebert, Paul D. N.			A Transcontinental Challenge - A Test of DNA Barcode Performance for 1,541 Species of Canadian Noctuoidea (Lepidoptera)	PLOS ONE			English	Article							LEVEL CLASSIFICATION; CRYPTIC DIVERSITY; MOTHS LEPIDOPTERA; NATURAL-HISTORY; AMERICA NORTH; MITOCHONDRIAL; BIODIVERSITY; DELIMITATION; HYMENOPTERA; BUTTERFLIES	This study provides a first, comprehensive, diagnostic use of DNA barcodes for the Canadian fauna of noctuoids or "owlet" moths (Lepidoptera: Noctuoidea) based on vouchered records for 1,541 species (99.1% species coverage), and more than 30,000 sequences. When viewed from a Canada-wide perspective, DNA barcodes unambiguously discriminate 90% of the noctuoid species recognized through prior taxonomic study, and resolution reaches 95.6% when considered at a provincial scale. Barcode sharing is concentrated in certain lineages with 54% of the cases involving 1.8% of the genera. Deep intraspecific divergence exists in 7.7% of the species, but further studies are required to clarify whether these cases reflect an overlooked species complex or phylogeographic variation in a single species. Non-native species possess higher Nearest-Neighbour (NN) distances than native taxa, whereas generalist feeders have lower NN distances than those with more specialized feeding habits. We found high concordance between taxonomic names and sequence clusters delineated by the Barcode Index Number (BIN) system with 1,082 species (70%) assigned to a unique BIN. The cases of discordance involve both BIN mergers and BIN splits with 38 species falling into both categories, most likely reflecting bidirectional introgression. One fifth of the species are involved in a BIN merger reflecting the presence of 158 species sharing their barcode sequence with at least one other taxon, and 189 species with low, but diagnostic COI divergence. A very few cases (13) involved species whose members fell into both categories. Most of the remaining 140 species show a split into two or three BINs per species, while Virbia ferruginosa was divided into 16. The overall results confirm that DNA barcodes are effective for the identification of Canadian noctuoids. This study also affirms that BINs are a strong proxy for species, providing a pathway for a rapid, accurate estimation of animal diversity.	[Zahiri, Reza; deWaard, Jeremy R.; Zakharov, Evgeny V.; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Lafontaine, Donald] Agr & Agri Food Canada, Canadian Natl Collect Insects Arachnids & Nematod, Ottawa, ON, Canada; [Schmidt, B. Christian] Canadian Food Inspect Agcy, Canadian Natl Collect Insects Arachnids & Nematod, Ottawa, ON, Canada	University of Guelph; Agriculture & Agri Food Canada; Canadian Food Inspection Agency	Zahiri, R (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	rzahiri@uoguelph.ca	Hebert, Paul DN/C-4161-2013; Schmidt, Christian/AAE-3069-2019; Zahiri, Reza/G-5797-2018; Zakharov, Evgeny/G-9587-2014; deWaard, Jeremy R/G-8112-2014	Hebert, Paul DN/0000-0002-3081-6700; Zahiri, Reza/0000-0001-6274-6973; Schmidt, Christian/0000-0003-4160-7629	Genome Canada; Ontario Genomics Institute; NSERC; Canada Foundation for Innovation	Genome Canada(Genome Canada); Ontario Genomics Institute; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	The work was funded by the following: Genome Canada, Ontario Genomics Institute, NSERC, Canada Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes W., 1918, Mem Amer mus NH New York, V3; Butcher BA, 2012, ZOOTAXA, P7; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Crabo LG, 2013, ZOOKEYS, P85, DOI 10.3897/zookeys.264.4304; Dewaard JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018290; deWaard JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014280; DeWaard Jeremy R., 2008, V410, P275; Dinca V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1329; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Franclemont JG, 1983, CHECK LIST LEPIDOPTE, p[120, xxiv]; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Gall LF, 2010, ZOOKEYS, P37, DOI 10.3897/zookeys.39.425; Gwiazdowski RA, 2013, ANN ENTOMOL SOC AM, V106, P143, DOI 10.1603/AN12033; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Handfield L, 2011, PAPILLONS QUEBEC; Hanner R, 2005, CONSORTIUM BARCODE L; Hausmann A, 2011, SPIXIANA, V34, P47; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huemer P, 2011, ECO MONT, V3, P11, DOI 10.1553/eco.mont-3-1s11; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kvie KS, 2013, ECOL EVOL, V3, P126, DOI 10.1002/ece3.434; Lafontaine J.D., 2010, P489; Lafontaine J.D., 1997, Biological Survey of Canada Monograph Series, V2, P723; Lafontaine J Donald, 2013, Zookeys, P209, DOI 10.3897/zookeys.264.4441; Lafontaine JD, 2011, ZOOKEYS, P145, DOI 10.3897/zookeys.149.1805; Lafontaine JD, 2010, ZOOKEYS, P6, DOI 10.3897/zookeys.40.414; Linnen CR, 2007, EVOLUTION, V61, P1417, DOI 10.1111/j.1558-5646.2007.00114.x; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Miller SE, 2013, P ENTOMOL SOC WASH, V115, P107, DOI 10.4289/0013-8797.115.1.107; Mitchell A, 2006, SYST ENTOMOL, V31, P21, DOI 10.1111/j.1365-3113.2005.00306.x; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Pohl GR, 2010, ZOOKEYS, P1; Poole RW, 1995, THE MOTHS OF AMERICA, V26; Powell J. A., 2009, MOTHS W N AM; Prentice RM, 1962, USITC PUBL, V2, P77; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Riedel A, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-15; Riedel A, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.280.3906; Riotte JCE, 1992, ANNOTATED LIST ONTAR; Rougerie R, 2013, J BIOGEOGRA IN PRESS; Rougerie R, 2010, ANN SOC ENTOMOL FR, V46, P477, DOI 10.1080/00379271.2010.10697684; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Schmidt BC, 2008, SYST ENTOMOL, V33, P613, DOI 10.1111/J.1365-3113.2008.00433.x; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036514; STEINER WWM, 1977, AM NAT, V111, P1037, DOI 10.1086/283236; Valade R, 2009, MOL ECOL, V18, P3458, DOI 10.1111/j.1365-294X.2009.04290.x; van Nieukerken EJ, 2012, CONTRIB ZOOL, V81, P1; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; Wagner D. L, 2011, OWLET CATERPILLARS E; Wilson John James, 2011, BMC Ecology, V11, P18, DOI 10.1186/1472-6785-11-18; Zahiri R, 2011, ZOOL SCR, V40, P158, DOI 10.1111/j.1463-6409.2010.00459.x; Zaspel J. M., 2008, Bulletin of the Florida Museum of Natural History, V48, P59; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	62	78	90	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92797	10.1371/journal.pone.0092797	http://dx.doi.org/10.1371/journal.pone.0092797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667847	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600077
J	Wu, TS; Tan, CT; Chang, CC; Lin, BR; Lai, WT; Chen, ST; Kuo, MYP; Rau, CL; Jaw, FS; Chang, HH				Wu, T-S; Tan, C-T; Chang, C-C; Lin, B-R; Lai, W-T; Chen, S-T; Kuo, M. Yen-Ping; Rau, C-L; Jaw, F-S; Chang, H-H			B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway	ONCOGENE			English	Article							NF-KAPPA-B; S100 PROTEINS; PANCREATIC-CANCER; EPITHELIAL-CELLS; GENE-EXPRESSION; NECK-CANCER; ACTIVATION; BCL10; BINDING; METASTASIS	B-cell lymphoma/leukemia 10 (BCL10) is an apoptotic regulatory protein related to advanced TNM stage and disease recurrence in oral squamous cell carcinoma (OSCC). However, the regulatory mechanism of BCL10 in OSCC progression is still unknown. Here, we showed that knockdown of endogenous BCL10 could significantly reduce cell migration and invasion abilities, retard cell proliferation by G(0)/G(1) phase accumulation and inhibit tumorigenicity in vivo. In molecular level, we identified S100P as a crucial downstream effector of BCL10-inhibited OSCC progression by high-throughput microarray analysis. S100P messenger RNA and protein expression levels were significantly diminished in silenced-BCL10 clones, and transfected S100P expression plasmids restored migration, invasion, proliferation abilities and tumorigenicity in shBCL10 transfectants. Furthermore, we provided evidence that BCL10 regulated S100P expression through signal transducers and activators of transcription 1 (STAT1) and activating transcription factor 4 (ATF4). Knockdown of BCL10 decreased S100P promoter activity, but showed no effect in truncated STAT1/ATF4 S100P promoter. In addition, we also found that the P50/P65 signaling pathway was involved in BCL10-enhanced OSCC progression. Restored S100P in silenced-BCL10 clones could markedly reverse P65 activation via outside-in signaling. Taken together, we discovered a novel axis of BCL10-regulated OSCC progression via STAT1/ATF4/S100P/P65 signaling, which could predict the prognosis of OSCC and will be beneficial for developing therapeutic strategy against advanced OSCC.	[Wu, T-S; Chang, C-C; Lai, W-T] Natl Taiwan Univ, Sch Dent, Grad Inst Oral Biol, Taipei 100, Taiwan; [Tan, C-T] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Lin, B-R] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Chen, S-T] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Chen, S-T] Natl Taiwan Univ Hosp, Dept Pediat, YunLin Branch, Taipei 10016, Taiwan; [Kuo, M. Yen-Ping; Chang, H-H] Natl Taiwan Univ, Sch Dent, Dept Dent, Taipei 100, Taiwan; [Kuo, M. Yen-Ping; Chang, H-H] Natl Taiwan Univ, Sch Dent, Grad Inst Clin Dent, Taipei 100, Taiwan; [Rau, C-L; Jaw, F-S] Natl Taiwan Univ, Inst Biomed Engn, Taipei 100, Taiwan; [Rau, C-L] Taipei Med Univ, Shuang Ho Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; Taipei Medical University; Shuang Ho Hospital	Chang, HH (corresponding author), Natl Taiwan Univ, Sch Dent, Dept Dent, 1 Chang Te St, Taipei 100, Taiwan.	changhh@ntu.edu.tw		LIN, BEEN-REN/0000-0001-8354-1758; Chen, Szu-Ta/0000-0002-9715-1221; Tan, Ching-Ting/0000-0001-8317-2235	National Science Council, Taiwan [NSC-100-2314-B-002-097, NSC-101-2314-B-002-102]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from National Science Council, Taiwan NSC-100-2314-B-002-097 (to C-CC), NSC-101-2314-B-002-102 (to H-HC).	Arumugam T, 2004, J BIOL CHEM, V279, P5059, DOI 10.1074/jbc.M310124200; Austermann J, 2008, J BIOL CHEM, V283, P29331, DOI 10.1074/jbc.M806145200; Averboukh L, 1996, PROSTATE, V29, P350; Bertram J, 1998, ANTI-CANCER DRUG, V9, P311, DOI 10.1097/00001813-199804000-00004; Bhattacharyya S, 2008, J BIOL CHEM, V283, P10550, DOI 10.1074/jbc.M708833200; BOYLE P, 1995, EUR J CANCER, V31A, P1395, DOI 10.1016/0959-8049(95)00334-F; Cancemi P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-476; Chang HH, 2009, ORAL ONCOL, V45, P589, DOI 10.1016/j.oraloncology.2008.08.003; Da Silva IDCG, 2000, INT J ONCOL, V16, P231; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Holzmann K, 2004, CANCER RES, V64, P4428, DOI 10.1158/0008-5472.CAN-04-0431; Huttunen HJ, 2002, CANCER RES, V62, P4805; Jiang T, 2011, CANCER RES, V71, P2183, DOI 10.1158/0008-5472.CAN-10-3626; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Koltzscher M, 2003, MOL BIOL CELL, V14, P2372, DOI 10.1091/mbc.E02-09-0553; Lee SH, 1999, CANCER RES, V59, P5674; Logsdon CD, 2003, CANCER RES, V63, P2649; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; NEGRI E, 1993, CANCER EPIDEM BIOMAR, V2, P189; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkkila S, 2008, BMC CLIN PATHOL, V8, DOI 10.1186/1472-6890-8-2; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Sato N, 2002, ANAT REC, V267, P60, DOI 10.1002/ar.10085; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shyu RY, 2003, J BIOMED SCI, V10, P313, DOI 10.1159/000070096; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Whiteman HJ, 2007, CANCER RES, V67, P8633, DOI 10.1158/0008-5472.CAN-07-0545; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Wutzl A, 2007, J ORAL MAXIL SURG, V65, P255, DOI 10.1016/j.joms.2006.09.007; Yao R, 2007, HISTOL HISTOPATHOL, V22, P1025, DOI 10.14670/HH-22.1025; Yeh PY, 2006, J BIOL CHEM, V281, P167, DOI 10.1074/jbc.M511014200	39	10	11	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2015	34	10					1207	1219		10.1038/onc.2014.43	http://dx.doi.org/10.1038/onc.2014.43			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC9JX	24681956				2022-12-25	WOS:000350687100001
J	Yeung, F; Ramsey, CS; Popko-Scibor, AE; Allison, DF; Gray, LG; Shin, M; Kumar, M; Li, D; McCubrey, JA; Mayo, MW				Yeung, F.; Ramsey, C. S.; Popko-Scibor, A. E.; Allison, D. F.; Gray, L. G.; Shin, M.; Kumar, M.; Li, D.; McCubrey, J. A.; Mayo, M. W.			Regulation of the mitogen-activated protein kinase kinase (MEK)-1 by NAD(+)-dependent deacetylases	ONCOGENE			English	Article							HIGH EXPRESSION; CANCER; SIRT1; TRANSCRIPTION; TUMORIGENESIS; METABOLISM; PROGNOSIS; SIRTUINS; SIGNAL; CELLS	Sirtuins are class III deacetylases that regulate many essential processes, including cellular stress, genome stability and metabolism. Although these NAD(+)-dependent deacetylases control adaptive cellular responses, identification of sirtuin-regulated signaling targets remain under-studied. Here, we demonstrate that acetylation of the mitogen-activated protein kinase kinase-1 (MEK1) stimulates its kinase activity, and that acetylated MEK1 is under the regulatory control of the sirtuin family members SIRT1 and SIRT2. Treatment of cells with sirtuin inhibitors, or siRNA knockdown of SIRT1 or SIRT2 proteins, increases MEK1 acetylation and subsequent phosphorylation of the extracellular signal-regulated kinase. Generation of an acetyl-specific MEK1 antibody demonstrates that endogenous acetylated MEK1 is extensively enriched in the nucleus following epidermal growth factor stimulation. An acetyl-mimic of MEK1 increases inappropriate growth properties, suggesting that acetylation of MEK1 has oncogenic potential.	[Yeung, F.; Ramsey, C. S.; Popko-Scibor, A. E.; Allison, D. F.; Gray, L. G.; Shin, M.; Kumar, M.; Li, D.; Mayo, M. W.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [McCubrey, J. A.] E Carolina Univ, Dept Microbiol & Immunol, Greenville, NC USA	University of Virginia; University of North Carolina; East Carolina University	Mayo, MW (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Box 800733, Charlottesville, VA 22908 USA.	mwm3y@virginia.edu		McCubrey, James/0000-0001-6027-3156	National Cancer Institute [CA132580, CA104397];  [CA110552]; NATIONAL CANCER INSTITUTE [R01CA132580, R01CA104397, F32CA110552, T32CA009156] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs JS Smith, PT Stukenberg, JJ Wamsley and Ms A Sherman for scientific and editorial review. HA-MEK1, HA-MEK1(S218/222D) and Flag-ERK1 were gifts from Dr M Weber, University of Virginia. p300 was provided by Dr D Livingston, Dana-Farber Cancer Institute. Gal4-ELK1 was a gift from Dr C Der, University of North Carolina. V5-SIRT1 and Flag-SIRT2 were gifts from E Verdin, Gladstone Institute. The pBabe-puro vector was provided by Dr Robert Weinberg, Whitehead Institute, MIT. Work was supported by the National Cancer Institute (CA132580 and CA104397) to MWM, and CA110552 awarded to FY.	Allison DF, 2012, P NATL ACAD SCI USA, V109, P16888, DOI 10.1073/pnas.1208468109; Bajpe PK, 2015, ONCOGENE, V34, P531, DOI 10.1038/onc.2013.588; Blalock WL, 2000, ONCOGENE, V19, P526, DOI 10.1038/sj.onc.1203337; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Catalanotti F, 2009, NAT STRUCT MOL BIOL, V16, P294, DOI 10.1038/nsmb.1564; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Duffy A, 2009, TARGET ONCOL, V4, P267, DOI 10.1007/s11523-009-0125-x; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Huang PY, 2010, PROTEIN CELL, V1, P218, DOI 10.1007/s13238-010-0019-9; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lawrence MC, 2008, P NATL ACAD SCI USA, V105, P13315, DOI 10.1073/pnas.0806465105; Li M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-5; Park ER, 2007, CELL SIGNAL, V19, P1488, DOI 10.1016/j.cellsig.2007.01.018; RESING KA, 1995, BIOCHEMISTRY-US, V34, P2610, DOI 10.1021/bi00008a027; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Xiao XS, 2011, CHINESE J CANCER RES, V23, P201, DOI 10.1007/s11670-011-0201-5; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	26	10	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2015	34	6					798	804		10.1038/onc.2014.39	http://dx.doi.org/10.1038/onc.2014.39			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DG	24681949	Green Accepted, Green Submitted			2022-12-25	WOS:000348853800013
J	Abbas, M; Shanmugam, I; Bsaili, M; Hromas, R; Shaheen, M				Abbas, Mohammad; Shanmugam, Ilanchezhian; Bsaili, Manal; Hromas, Robert; Shaheen, Monte			The Role of the Human Psoralen 4 ( hPso4) Protein Complex in Replication Stress and Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						BRCA1; DNA Damage; DNA Repair; DNA Replication; Homologous Recombination	DOUBLE-STRAND BREAKS; CROSS-LINK REPAIR; DNA-REPAIR; CELL-CYCLE; U-BOX; SACCHAROMYCES-CEREVISIAE; IONIZING-RADIATION; DIRECTED REPAIR; BRCA1; DAMAGE	Background: hPso4 has been implicated in the resistance to interstrand cross-linking DNA-damaging agents. Results: hPso4 complex is involved in normal replication, and it has a role in DNA repair by homologous recombination through the regulation of DNA strand resection. Conclusion: hPso4 has a function in DNA double strand break repair by homologous recombination. Significance: hPso4 complex levels could predict sensitivity of cancer cells to PARP inhibitors. Psoralen 4 (Pso4) is an evolutionarily conserved protein that has been implicated in a variety of cellular processes including RNA splicing and resistance to agents that cause DNA interstrand cross-links. Here we show that the hPso4 complex is required for timely progression through S phase and transition through the G(2)/M checkpoint, and it functions in the repair of DNA lesions that arise during replication. Notably, hPso4 depletion results in delayed resumption of DNA replication after hydroxyurea-induced stalling of replication forks, reduced repair of spontaneous and hydroxyurea-induced DNA double strand breaks (DSBs), and increased sensitivity to a poly(ADP-ribose) polymerase inhibitor. Furthermore, we show that hPso4 is involved in the repair of DSBs by homologous recombination, probably by regulating the BRCA1 protein levels and the generation of single strand DNA at DSBs. Together, our results demonstrate that hPso4 participates in cell proliferation and the maintenance of genome stability by regulating homologous recombination. The involvement of hPso4 in the recombinational repair of DSBs provides an explanation for the sensitivity of Pso4-deficient cells to DNA interstrand cross-links.	[Abbas, Mohammad; Shanmugam, Ilanchezhian; Bsaili, Manal; Shaheen, Monte] Univ New Mexico, Dept Internal Med, Div Hematol Oncol, Albuquerque, NM 87131 USA; [Hromas, Robert] Univ Florida, Dept Med, Gainesville, FL 32611 USA	University of New Mexico; State University System of Florida; University of Florida	Shaheen, M (corresponding author), Univ New Mexico, Ctr Canc, 1201 Camino Salud NE, Albuquerque, NM 87131 USA.	moshaheen@salud.unm.edu			National Institutes of Health [5K01HL103182-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL103182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5K01HL103182-03 (to M. S.).	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Beck BD, 2008, J BIOL CHEM, V283, P9023, DOI 10.1074/jbc.M800150200; Brendel M, 2001, MUTAT RES-REV MUTAT, V489, P79, DOI 10.1016/S1383-5742(01)00066-7; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Choudhury AD, 2004, J BIOL CHEM, V279, P33909, DOI 10.1074/jbc.M403646200; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng ZH, 2012, NUCLEIC ACIDS RES, V40, P726, DOI 10.1093/nar/gkr748; Fortschegger K, 2007, MOL CELL BIOL, V27, P3123, DOI 10.1128/MCB.01188-06; FOTEDAR R, 1992, EMBO J, V11, P2177, DOI 10.1002/j.1460-2075.1992.tb05277.x; Grey M, 1996, NUCLEIC ACIDS RES, V24, P4009, DOI 10.1093/nar/24.20.4009; Grote M, 2010, MOL CELL BIOL, V30, P2105, DOI 10.1128/MCB.01505-09; Groth P, 2012, NUCLEIC ACIDS RES, V40, P6585, DOI 10.1093/nar/gks315; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Kleinridders A, 2009, MOL CELL BIOL, V29, P3173, DOI 10.1128/MCB.01807-08; Lleres D, 2010, EMBO REP, V11, P445, DOI 10.1038/embor.2010.64; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Lu XY, 2008, MOL CANCER RES, V6, P937, DOI 10.1158/1541-7786.MCR-07-2115; Maass N, 2002, CANCER LETT, V185, P219, DOI 10.1016/S0304-3835(02)00286-0; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Reid LJ, 2008, P NATL ACAD SCI USA, V105, P20876, DOI 10.1073/pnas.0811203106; Schlegel BP, 2006, CANCER RES, V66, P5181, DOI 10.1158/0008-5472.CAN-05-3209; Sedelnikova OA, 2003, CANCER BIOL THER, V2, P233; Shaheen M, 2011, BLOOD, V117, P6074, DOI 10.1182/blood-2011-01-313734; Silver DP, 2012, CANCER DISCOV, V2, P679, DOI 10.1158/2159-8290.CD-12-0221; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Vander Kooi CW, 2006, BIOCHEMISTRY-US, V45, P121, DOI 10.1021/bi051787e; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Yang ES, 2010, FEBS J, V277, P3079, DOI 10.1111/j.1742-4658.2010.07734.x; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhang NX, 2009, EMBO REP, V10, P1029, DOI 10.1038/embor.2009.122; Zhang NX, 2005, J BIOL CHEM, V280, P40559, DOI 10.1074/jbc.M508453200	43	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14009	14019		10.1074/jbc.M113.520056	http://dx.doi.org/10.1074/jbc.M113.520056			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24675077	Green Published, hybrid			2022-12-25	WOS:000335984600031
J	Berkut, AA; Usmanova, DR; Peigneur, S; Oparin, PB; Mineev, KS; Odintsova, TI; Tytgat, J; Arseniev, AS; Grishin, EV; Vassilevski, AA				Berkut, Antonina A.; Usmanova, Dinara R.; Peigneur, Steve; Oparin, Peter B.; Mineev, Konstantin S.; Odintsova, Tatyana I.; Tytgat, Jan; Arseniev, Alexander S.; Grishin, Eugene V.; Vassilevski, Alexander A.			Structural Similarity between Defense Peptide from Wheat and Scorpion Neurotoxin Permits Rational Functional Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antimicrobial Peptides; Plant Defense; Potassium Channels; Protein Design; Protein Engineering; Protein Folding; Hairpin; Hefutoxin	HELICAL HAIRPIN STRUCTURE; CHANNEL-BLOCKING ACTIVITY; DE-NOVO PROTEIN; K+ CHANNEL; ANTIMICROBIAL PEPTIDES; COUPLING-CONSTANTS; TRYPSIN-INHIBITOR; CRYSTAL-STRUCTURE; NMR STRUCTURE; SHK TOXIN	Background: Protein folds differ in size and complexity and hence in their utility for engineering purposes. Results: The three-dimensional structure of wheat antifungal peptide Tk-AMP-X2 was investigated, and a new functionality was engineered based on its -hairpin scaffold. Conclusion: -Hairpinins are an attractive simple structural template for functional engineering and drug design. Significance: The repertoire of available scaffolds for protein engineering is broadened. In this study, we present the spatial structure of the wheat antimicrobial peptide (AMP) Tk-AMP-X2 studied using NMR spectroscopy. This peptide was found to adopt a disulfide-stabilized -helical hairpin fold and therefore belongs to the -hairpinin family of plant defense peptides. Based on Tk-AMP-X2 structural similarity to cone snail and scorpion potassium channel blockers, a mutant molecule, Tk-hefu, was engineered by incorporating the functionally important residues from -hefutoxin 1 onto the Tk-AMP-X2 scaffold. The designed peptide contained the so-called essential dyad of amino acid residues significant for channel-blocking activity. Electrophysiological studies showed that although the parent peptide Tk-AMP-X2 did not present any activity against potassium channels, Tk-hefu blocked Kv1.3 channels with similar potency (IC50 approximate to 35 m) to -hefutoxin 1 (IC50 approximate to 40 m). We conclude that -hairpinins are attractive in their simplicity as structural templates, which may be used for functional engineering and drug design.	[Berkut, Antonina A.; Usmanova, Dinara R.; Oparin, Peter B.; Mineev, Konstantin S.; Arseniev, Alexander S.; Grishin, Eugene V.; Vassilevski, Alexander A.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia; [Berkut, Antonina A.; Usmanova, Dinara R.] State Univ, Moscow Inst Phys & Technol, Moscow 117303, Russia; [Peigneur, Steve; Tytgat, Jan] Katholieke Univ Leuven, Lab Toxicol & Pharmacol, B-3000 Louvain, Belgium; [Odintsova, Tatyana I.] Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow 119991, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Moscow Institute of Physics & Technology; KU Leuven; Russian Academy of Sciences; Vavilov Institute of General Genetics	Vassilevski, AA (corresponding author), Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia.	avas@ibch.ru	Mineev, Konstantin S/Q-3948-2018; Oparin, Peter/M-3305-2017; Usmanova, Dinara Ravilevna/I-9370-2014; Berkut, Antonina/AAE-4247-2019; Mineev, Konstantin/E-4151-2010; Vassilevski, Alexander/S-3824-2016; Mineev, Konstantin/AAC-6662-2019	Mineev, Konstantin S/0000-0002-2418-9421; Oparin, Peter/0000-0002-5713-0960; Mineev, Konstantin/0000-0002-2418-9421; Vassilevski, Alexander/0000-0002-1359-0076; Mineev, Konstantin/0000-0002-2418-9421; Peigneur, Steve/0000-0003-0504-5702; Tytgat, Jan/0000-0003-1778-6022	Russian Foundation for Basic Research [11-04-00190]; Molecular and Cell Biology Program of the Russian Academy of Sciences; Russian Federation [1924.2014.4]; F.W.O. Vlaanderen [G.0433.12, G.A071.10N, G.0257.08]; Inter-University Attraction Poles Program from Belgian State, Belgian Science Policy [IUAP 7/10]; KU Leuven [OT/12/081]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Molecular and Cell Biology Program of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Federation(Russian Federation); F.W.O. Vlaanderen(FWO); Inter-University Attraction Poles Program from Belgian State, Belgian Science Policy; KU Leuven(KU Leuven)	This work was supported in part by Russian Foundation for Basic Research Grant 11-04-00190, the Molecular and Cell Biology Program of the Russian Academy of Sciences, and Grant 1924.2014.4 from the President of Russian Federation.; Supported by F.W.O. Vlaanderen Grants G.0433.12, G.A071.10N, and G.0257.08; Inter-University Attraction Poles Program Grant IUAP 7/10 from Belgian State, Belgian Science Policy; and KU Leuven Grant OT/12/081.	Barnham KJ, 1997, J MOL BIOL, V268, P886, DOI 10.1006/jmbi.1997.0980; Camargos TS, 2011, PEPTIDES, V32, P1509, DOI 10.1016/j.peptides.2011.05.017; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chagot B, 2005, BIOCHEM J, V388, P263, DOI 10.1042/BJ20041705; Chen TF, 2013, METHOD ENZYMOL, V523, P303, DOI 10.1016/B978-0-12-394292-0.00014-X; Conners R, 2007, J BIOL CHEM, V282, P27760, DOI 10.1074/jbc.M703871200; DeLano WL, 2002, PYMOL USERS MANUAL; Diego-Garcia E, 2012, PROTEOMICS, V12, P313, DOI 10.1002/pmic.201100409; DOLGIKH DA, 1991, DOKL AKAD NAUK SSSR+, V320, P1266; Dolgikh DA, 1996, PROTEIN ENG, V9, P195, DOI 10.1093/protein/9.2.195; DUVICK JP, 1992, J BIOL CHEM, V267, P18814; Dux P, 1997, J BIOMOL NMR, V10, P301, DOI 10.1023/A:1018393225804; EFREMOV RG, 1995, J BIOMOL STRUCT DYN, V12, P971, DOI 10.1080/07391102.1995.10508791; Egorov Ts A, 2012, Bioorg Khim, V38, P7; FEDOROV AN, 1992, J MOL BIOL, V225, P927, DOI 10.1016/0022-2836(92)90092-X; Gasparian ME, 2003, PROTEIN EXPRES PURIF, V31, P133, DOI 10.1016/S1046-5928(03)00159-1; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; Gracy J, 2011, CURR PHARM DESIGN, V17, P4337, DOI 10.2174/138161211798999339; HANDLOSER CS, 1973, J CHEM EDUC, V50, P510, DOI 10.1021/ed050p510; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Huys I, 2004, J BIOL CHEM, V279, P2781, DOI 10.1074/jbc.M311029200; Juers DH, 1999, PROTEIN SCI, V8, P122; Jurgens C, 2000, P NATL ACAD SCI USA, V97, P9925, DOI 10.1073/pnas.160255397; Keller R., 2004, COMPUTER AIDED RESON, V1; Koide A, 2007, METH MOL B, V352, P95; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laederach A, 2002, BIOCHEMISTRY-US, V41, P12359, DOI 10.1021/bi026185z; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LINDAHL M, 1994, EMBO J, V13, P1249, DOI 10.1002/j.1460-2075.1994.tb06376.x; Lipovsek D, 2011, PROTEIN ENG DES SEL, V24, P3, DOI 10.1093/protein/gzq097; Lombardo A, 1996, PROTEIN SCI, V5, P1934, DOI 10.1002/pro.5560050922; Mandard N, 2002, EUR J BIOCHEM, V269, P1190, DOI 10.1046/j.0014-2956.2002.02760.x; Marcus JP, 1999, PLANT J, V19, P699, DOI 10.1046/j.1365-313x.1999.00569.x; McCoy J., 2001, CURR PROTOC MOL BIOL, V16, P18; Moller C, 2005, BIOCHEMISTRY-US, V44, P15986, DOI 10.1021/bi0511181; Mouhat S, 2005, J PEPT SCI, V11, P65, DOI 10.1002/psc.630; Mouhat S, 2004, BIOCHEM J, V377, P25, DOI 10.1042/BJ20030115; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Ng YM, 2011, J STRUCT BIOL, V174, P164, DOI 10.1016/j.jsb.2010.12.007; Nicastro G, 2009, PROTEIN SCI, V18, P1786, DOI 10.1002/pro.168; Nirthanan S, 2005, BIOCHEM PHARMACOL, V69, P669, DOI 10.1016/j.bcp.2004.10.018; Nolde SB, 2011, J BIOL CHEM, V286, P25145, DOI 10.1074/jbc.M110.200378; Oparin PB, 2012, BIOCHEM J, V446, P69, DOI 10.1042/BJ20120548; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Peigneur S, 2013, TOXICON, V71, P25, DOI 10.1016/j.toxicon.2013.05.010; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rashid MH, 2012, J PHYS CHEM B, V116, P4812, DOI 10.1021/jp300639x; Rogozhin EA, 2012, PEPTIDES, V38, P33, DOI 10.1016/j.peptides.2012.08.009; Saucedo AL, 2012, J BIOL CHEM, V287, P12321, DOI 10.1074/jbc.M111.329607; Shlyapnikov YM, 2008, PROTEIN EXPRES PURIF, V60, P89, DOI 10.1016/j.pep.2008.03.011; Silva ECN, 2009, TOXICON, V54, P252, DOI 10.1016/j.toxicon.2009.04.010; Slavokhotova AA, 2014, PLANT MOL BIOL, V84, P189, DOI 10.1007/s11103-013-0127-z; Song JX, 1997, BIOCHEMISTRY-US, V36, P3760, DOI 10.1021/bi962720h; Spelbrink RG, 2004, PLANT PHYSIOL, V135, P2055, DOI 10.1104/pp.104.040873; Srinivasan KN, 2002, J BIOL CHEM, V277, P30040, DOI 10.1074/jbc.M111258200; Tudor JE, 1996, NAT STRUCT BIOL, V3, P317, DOI 10.1038/nsb0496-317; Utkina LL, 2013, FEBS J, V280, P3594, DOI 10.1111/febs.12349; Vandendriessche T, 2012, BIOCHEM PHARMACOL, V83, P1307, DOI 10.1016/j.bcp.2012.01.021; Vassilevski AA, 2010, METHODS MOL BIOL, V615, P87, DOI 10.1007/978-1-60761-535-4_7; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yamada K, 1999, J BIOL CHEM, V274, P2563, DOI 10.1074/jbc.274.4.2563; Zhu LM, 2012, TOXICON, V59, P402, DOI 10.1016/j.toxicon.2011.11.016; Zhu S, 2005, CELL MOL LIFE SCI, V62, P2257, DOI 10.1007/s00018-005-5200-6	68	20	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14331	14340		10.1074/jbc.M113.530477	http://dx.doi.org/10.1074/jbc.M113.530477			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24671422	Green Published, hybrid			2022-12-25	WOS:000335984600058
J	Ersahin, T; Carkacioglu, L; Can, T; Konu, O; Atalay, V; Cetin-Atalay, R				Ersahin, Tulin; Carkacioglu, Levent; Can, Tolga; Konu, Ozlen; Atalay, Volkan; Cetin-Atalay, Rengul			Identification of Novel Reference Genes Based on MeSH Categories	PLOS ONE			English	Article							SUITABLE REFERENCE GENES; REAL-TIME PCR; HEPATOCELLULAR-CARCINOMA; HOUSEKEEPING GENES; EXPRESSION; NORMALIZATION; VARIANCE; MODEL	Transcriptome experiments are performed to assess protein abundance through mRNA expression analysis. Expression levels of genes vary depending on the experimental conditions and the cell response. Transcriptome data must be diverse and yet comparable in reference to stably expressed genes, even if they are generated from different experiments on the same biological context from various laboratories. In this study, expression patterns of 9090 microarray samples grouped into 381 NCBI-GEO datasets were investigated to identify novel candidate reference genes using randomizations and Receiver Operating Characteristic (ROC) curves. The analysis demonstrated that cell type specific reference gene sets display less variability than a united set for all tissues. Therefore, constitutively and stably expressed, origin specific novel reference gene sets were identified based on their coefficient of variation and percentage of occurrence in all GEO datasets, which were classified using Medical Subject Headings (MeSH). A large number of MeSH grouped reference gene lists are presented as novel tissue specific reference gene lists. The most commonly observed 17 genes in these sets were compared for their expression in 8 hepatocellular, 5 breast and 3 colon carcinoma cells by RT-qPCR to verify tissue specificity. Indeed, commonly used housekeeping genes GAPDH, Actin and EEF2 had tissue specific variations, whereas several ribosomal genes were among the most stably expressed genes in vitro. Our results confirm that two or more reference genes should be used in combination for differential expression analysis of large-scale data obtained from microarray or next generation sequencing studies. Therefore context dependent reference gene sets, as presented in this study, are required for normalization of expression data from diverse technological backgrounds.	[Ersahin, Tulin; Konu, Ozlen; Cetin-Atalay, Rengul] Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey; [Carkacioglu, Levent; Can, Tolga; Atalay, Volkan] Middle E Tech Univ, Dept Comp Engn, TR-06531 Ankara, Turkey	Ihsan Dogramaci Bilkent University; Middle East Technical University	Cetin-Atalay, R (corresponding author), Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey.	rengul@bilkent.edu.tr	Can, Tolga/D-1395-2010; Cetin-Atalay, Rengul/F-5780-2013; Cetin-Atalay, Rengul/O-9826-2014; Atalay, Volkan/M-2256-2016	Can, Tolga/0000-0002-5532-0154; Cetin-Atalay, Rengul/0000-0003-2408-6606; Cetin-Atalay, Rengul/0000-0003-2408-6606; Atalay, Volkan/0000-0001-7850-0601	Scientific and Technical Research Council of Turkey, (TUBITAK) [110S338]; Bilkent University; Middle East Technical University	Scientific and Technical Research Council of Turkey, (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Bilkent University(Ihsan Dogramaci Bilkent University); Middle East Technical University(Middle East Technical University)	This work was supported by grants from The Scientific and Technical Research Council of Turkey, (TUBITAK-project #110S338), Bilkent University and Middle East Technical University local funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carkacioglu L, 2010, INT J DATA MIN BIOIN, V4, P701, DOI 10.1504/IJDMB.2010.037548; CHANG C, 2011, FILM COMMENT, V47, P6, DOI DOI 10.1371/J0URNAL.P0NE.0022859; Chen ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054082; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Eisenberg E, 2013, TRENDS GENET, P1; Fu LY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-49; Gao Q, 2008, J CANCER RES CLIN, V134, P979, DOI 10.1007/s00432-008-0369-3; HE L, 1984, IN VITRO CELL DEV B, V20, P493, DOI 10.1007/BF02619623; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Jin P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-55; Jung M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-47; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; OEFINGER PE, 1981, J GEN VIROL, V53, P105, DOI 10.1099/0022-1317-53-1-105; Ohl F, 2005, J MOL MED, V83, P1014, DOI 10.1007/s00109-005-0703-z; Popovici V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-42; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Sikand K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047510; Srivastava S, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq670; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041659; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Valenti MT, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-49; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Waxman S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-243; Zimonjic DB, 2009, J CELL MOL MED, V13, P3985, DOI 10.1111/j.1582-4934.2009.00769.x	36	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93341	10.1371/journal.pone.0093341	http://dx.doi.org/10.1371/journal.pone.0093341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682035	Green Published, gold, Green Submitted			2022-12-25	WOS:000333678100045
J	Doi, H; Heeren, A; Maurage, P				Doi, Hideyuki; Heeren, Alexandre; Maurage, Pierre			Scientific Activity Is a Better Predictor of Nobel Award Chances than Dietary Habits and Economic Factors	PLOS ONE			English	Article							CHOCOLATE CONSUMPTION; CONSERVATION BIOLOGY; REGRESSION; ECOLOGY	Several recent studies have described a strong correlation between nutritional or economic data and the number of Nobel awards obtained across a large range of countries. This sheds new light on the intriguing question of the key predictors of Nobel awards chances. However, all these studies have been focused on a single predictor and were only based on simple correlation and/or linear model analysis. The main aim of the present study was thus to clarify this debate by simultaneously exploring the influence of food consumption (cacao, milk, and wine), economic variables (gross domestic product) and scientific activity (number of publications and research expenditure) on Nobel awards. An innovative statistical analysis, hierarchical partitioning, has been used because it enables us to reduce collinearity problems by determining and comparing the independent contribution of each factor. Our results clearly indicate that a country's number of Nobel awards can be mainly predicted by its scientific achievements such as number of publications and research expenditure. Conversely, dietary habits and the global economy variable are only minor predictors; this finding contradicts the conclusions of previous studies. Dedicating a large proportion of the GDP to research and to the publication of a high number of scientific papers would thus create fertile ground for obtaining Nobel awards.	[Doi, Hideyuki] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 724, Japan; [Heeren, Alexandre; Maurage, Pierre] Catholic Univ Louvain, Psychol Sci Res Inst, Lab Expt Psychopathol, B-1348 Louvain, Belgium	Hiroshima University; Universite Catholique Louvain	Doi, H (corresponding author), Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 724, Japan.	doih@hiroshima-u.ac.jp	Doi, Hideyuki/D-2012-2010; Heeren, Alexandre/U-9748-2019	Doi, Hideyuki/0000-0002-2701-3982; Heeren, Alexandre/0000-0003-0553-6149; Maurage, Pierre/0000-0003-0197-0810	Belgian Fund for Scientific Research (F.R.S.-FNRS, Belgium)	Belgian Fund for Scientific Research (F.R.S.-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS)	Alexandre Heeren (Post-doctoral Research Fellow) and Pierre Maurage (Research Associate) are funded by the Belgian Fund for Scientific Research (F.R.S.-FNRS, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Golomb BA, 2013, NATURE, V499, P409, DOI 10.1038/499409a; Kayser Manfred, 2012, Investig Genet, V3, P26, DOI 10.1186/2041-2223-3-26; Li J, 2013, PRACT NEURO IN PRESS; Lintwaithe S, 2012, PRACT NEUROL, V13, P63; Loney Tom, 2013, Evid Based Med, V18, P120, DOI 10.1136/eb-2013-101288; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; Maurage P, 2013, J NUTR, V143, P931, DOI 10.3945/jn.113.174813; Messerli FH, 2012, NEW ENGL J MED, V367, P1562, DOI 10.1056/NEJMon1211064; Olea PP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011698; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Shulman T, 2012, PED ANN, V41, P486; Walsh C, 2013, HIER PART HIER PART; [No title captured]	15	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92612	10.1371/journal.pone.0092612	http://dx.doi.org/10.1371/journal.pone.0092612			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675712	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677500028
J	He, JH; Lai, HF; Engle, M; Gorlatov, S; Gruber, C; Steinkellner, H; Diamond, MS; Chen, Q				He, Junyun; Lai, Huafang; Engle, Michael; Gorlatov, Sergey; Gruber, Clemens; Steinkellner, Herta; Diamond, Michael S.; Chen, Qiang			Generation and Analysis of Novel Plant-Derived Antibody-Based Therapeutic Molecules against West Nile Virus	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; DEPENDENT ENHANCEMENT; N-GLYCOSYLATION; INFECTION; EXPRESSION; VECTORS; PARTICLES; INDUCTION; DISEASE; SYSTEM	Previously, our group engineered a plant-derived monoclonal antibody (MAb) (pHu-E16) that efficiently treated West Nile virus (WNV) infection in mice. In this study, we developed several pHu-E16 variants to improve its efficacy. These variants included a single-chain variable fragment (scFv) of pHu-E16 fused to the heavy chain (HC) constant domains (C-H(1-3)) of human IgG (pHu-E16scFv-C-H(1-3)) and a tetravalent molecule (Tetra pHu-E16) assembled from pHu-E16scFv-C-H(1-3) with a second pHu-E16scFv fused to the light chain (LC) constant region. pHu-E16scFv-C-H(1-3) and Tetra pHu-E16 were efficiently expressed and assembled in plants. To assess the impact of differences in N-linked glycosylation on pHu-E16 variant assembly and function, we expressed additional pHu-E16 variants with various combinations of HC and LC components. Our study revealed that proper pairing of HC and LC was essential for the complete N-glycan processing of antibodies in both plant and animal cells. Associated with their distinct N-glycoforms, pHu-E16, pHu-E16scFv-C-H(1-3) and Tetra pHu-E16 exhibited differential binding to C1q and specific Fc gamma receptors (Fc gamma R). Notably, none of the plant-derived Hu-E16 variants showed antibody-dependent enhancement (ADE) activity in CD32A(+) human cells, suggesting the potential of plant-produced antibodies to minimize the adverse effect of ADE. Importantly, all plant-derived MAb variants exhibited at least equivalent in vitro neutralization and in vivo protection in mice compared to mammalian cell-produced Hu-E16. This study demonstrates the capacity of plants to express and assemble a large, complex and functional IgG-like tetravalent mAb variant and also provides insight into the relationship between MAb N-glycosylation, Fc gamma R and C1q binding, and ADE. These new insights may allow the development of safer and cost effective MAb-based therapeutics for flaviviruses, and possibly other pathogens.	[He, Junyun; Lai, Huafang; Chen, Qiang] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Chen, Qiang] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Engle, Michael; Diamond, Michael S.] Arizona State Univ, Coll Technol & Innovat, Mesa, AZ USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Gruber, Clemens] Univ Nat Resources & Appl Life Sci, Dept Chem, Vienna, Austria; [Steinkellner, Herta] Univ Nat Resources & Appl Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria; [Gorlatov, Sergey] MacroGenics Inc, Rockville, MD USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Chen, Q (corresponding author), Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA.	qiang.chen.4@asu.edu	Diamond, Michael/AAH-1733-2019; he, junyun/H-6461-2011; Steinkellner, Herta/N-4267-2016	Diamond, Michael/0000-0002-8791-3165; Steinkellner, Herta/0000-0003-4823-1505; Grunwald-Gruber, Clemens/0000-0002-6097-8348; chen, qiang/0000-0003-1498-7013	NIAID [U01 AI075549, R21 AI101329]; Laura Bassi Centers of Expertise PlantBioP [822757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075549, R21AI101329, R33AI101329] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Laura Bassi Centers of Expertise PlantBioP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID grants number U01 AI075549 and R21 AI101329 to Q. C., and by a Laura Bassi Centers of Expertise PlantBioP grant number 822757 to H. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256; Boado RJ, 2007, BIOTECHNOL BIOENG, V96, P381, DOI 10.1002/bit.21120; Bode AV, 2006, CLIN INFECT DIS, V42, P1234, DOI 10.1086/503038; Bosch D, 2013, CURR PHARM DESIGN, V19, P5503, DOI 10.2174/1381612811319310006; Chen Q., 2013, MOL VACCINES, V1, P153, DOI [10.1007/978-3-7091-1419-3_8, DOI 10.1007/978-3-7091-1419-3_8]; Chen Q., 2008, BIOL ENG, V1, P291, DOI DOI 10.13031/201326854; Chen Qiang, 2013, Adv Tech Biol Med, V1; Chen Q, 2011, TRANSGENIC HORTICULTURAL CROPS: CHALLENGES AND OPPORTUNITIES, P83; Chen Q, 2011, HUM VACCINES, V7, P331, DOI 10.4161/hv.7.3.14262; De Muynck B, 2010, PLANT BIOTECHNOL J, V8, P529, DOI 10.1111/j.1467-7652.2009.00494.x; Diamond MS, 2006, TRENDS MICROBIOL, V14, P287, DOI 10.1016/j.tim.2006.05.004; Engle MJ, 2003, J VIROL, V77, P12941, DOI 10.1128/JVI.77.24.12941-12949.2003; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Fuchs A, 2011, VIROLOGY, V412, P101, DOI 10.1016/j.virol.2011.01.003; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; He J, 2014, BIOMED RES IN PRESS; He JY, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/106783; HIATT A, 1989, NATURE, V342, P76, DOI 10.1038/342076a0; Houde D, 2010, MOL CELL PROTEOMICS, V9, P1716, DOI 10.1074/mcp.M900540-MCP200; Huang Z, 2010, BIOTECHNOL BIOENG, V106, P9, DOI 10.1002/bit.22652; Huang Z, 2009, BIOTECHNOL BIOENG, V103, P706, DOI 10.1002/bit.22299; Huisman W, 2009, VACCINE, V27, P505, DOI 10.1016/j.vaccine.2008.10.087; Lai HF, 2012, PLANT CELL REP, V31, P573, DOI 10.1007/s00299-011-1196-6; Lai HF, 2012, PLANT BIOTECHNOL J, V10, P95, DOI 10.1111/j.1467-7652.2011.00649.x; Lai HF, 2010, P NATL ACAD SCI USA, V107, P2419, DOI 10.1073/pnas.0914503107; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; Leuzinger K, 2013, JOVE-J VIS EXP, DOI 10.3791/50521; Lico C, 2008, J CELL PHYSIOL, V216, P366, DOI 10.1002/jcp.21423; Lim JK, 2008, J INFECT DIS, V197, P262, DOI 10.1086/524691; Loos A, 2012, ARCH BIOCHEM BIOPHYS, V526, P167, DOI 10.1016/j.abb.2012.05.011; Loos A, 2011, PLANT PHYSIOL, V155, P2036, DOI 10.1104/pp.110.171330; Mehlhop E, 2007, CELL HOST MICROBE, V2, P417, DOI 10.1016/j.chom.2007.09.015; MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042; Phoolcharoen W, 2011, P NATL ACAD SCI USA, V108, P20695, DOI 10.1073/pnas.1117715108; Phoolcharoen W, 2011, PLANT BIOTECHNOL J, V9, P807, DOI 10.1111/j.1467-7652.2011.00593.x; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; Santi L, 2008, VACCINE, V26, P1846, DOI 10.1016/j.vaccine.2008.01.053; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Williams KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003157; Zeitlin L, 2011, P NATL ACAD SCI USA, V108, P20690, DOI 10.1073/pnas.1108360108	48	44	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93541	10.1371/journal.pone.0093541	http://dx.doi.org/10.1371/journal.pone.0093541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675995	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500136
J	Reimers, AK; Wagner, M; Alvanides, S; Steinmayr, A; Reiner, M; Schmidt, S; Woll, A				Reimers, Anne K.; Wagner, Matthias; Alvanides, Seraphim; Steinmayr, Andreas; Reiner, Miriam; Schmidt, Steffen; Woll, Alexander			Proximity to Sports Facilities and Sports Participation for Adolescents in Germany	PLOS ONE			English	Article							PHYSICAL-ACTIVITY LEVELS; HEALTH INTERVIEW; SOCIOECONOMIC-STATUS; BUILT ENVIRONMENT; CHILDREN; AVAILABILITY; KIGGS; ASSOCIATIONS; BEHAVIORS; YOUTH	Objectives: To assess the relationship between proximity to specific sports facilities and participation in the corresponding sports activities for adolescents in Germany. Methods: A sample of 1,768 adolescents aged 11-17 years old and living in 161 German communities was examined. Distances to the nearest sports facilities were calculated as an indicator of proximity to sports facilities using Geographic Information Systems (GIS). Participation in specific leisure-time sports activities in sports clubs was assessed using a self-report questionnaire and individual-level socio-demographic variables were derived from a parent questionnaire. Community-level socio-demographics as covariates were selected from the INKAR database, in particular from indicators and maps on land development. Logistic regression analyses were conducted to examine associations between proximity to the nearest sports facilities and participation in the corresponding sports activities. Results: The logisitic regression analyses showed that girls residing longer distances from the nearest gym were less likely to engage in indoor sports activities; a significant interaction between distances to gyms and level of urbanization was identified. Decomposition of the interaction term showed that for adolescent girls living in rural areas participation in indoor sports activities was positively associated with gym proximity. Proximity to tennis courts and indoor pools was not associated with participation in tennis or water sports, respectively. Conclusions: Improved proximity to gyms is likely to be more important for female adolescents living in rural areas.	[Reimers, Anne K.; Wagner, Matthias] Univ Konstanz, Dept Sport Sci, Constance, Germany; [Reimers, Anne K.; Reiner, Miriam; Schmidt, Steffen; Woll, Alexander] Karlsruhe Inst Technol, Inst Sport & Sport Sci, D-76021 Karlsruhe, Germany; [Steinmayr, Andreas] Northumbria Univ, Dept Geog & Built Environm, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Steinmayr, Andreas] Univ St Gallen, Swiss Inst Empir Econ Res SEW, St Gallen, Switzerland	University of Konstanz; Helmholtz Association; Karlsruhe Institute of Technology; Northumbria University; University of St Gallen	Reimers, AK (corresponding author), Univ Konstanz, Dept Sport Sci, Constance, Germany.	anne.reimers@uni-konstanz.de	Reimers, Anne/AAH-5735-2021; Steinmayr, Andreas/AAF-4741-2019; Reimers, Anne/M-8519-2018; Alvanides, S./H-1057-2019	Steinmayr, Andreas/0000-0002-2491-5032; Reimers, Anne/0000-0003-4053-1378; Alvanides, S./0000-0003-4905-4109	German Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research); German Bundesministerium fur Gesundheit (Federal Ministry of Health) [01ER0810]; Brigitte Schlieben-Lange-Programm from the Ministry of Science of the German State of Baden-Wurttemberg; Economic and Social Research Council [ES/I035206/1] Funding Source: researchfish; ESRC [ES/I035206/1] Funding Source: UKRI	German Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); German Bundesministerium fur Gesundheit (Federal Ministry of Health); Brigitte Schlieben-Lange-Programm from the Ministry of Science of the German State of Baden-Wurttemberg; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was funded by a project grant from the German Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research) and by the German Bundesministerium fur Gesundheit (Federal Ministry of Health) (grant number: 01ER0810). The content of this article reflects only the authors' views and the funders were not liable for any use that may be made of the information contained therein. The contribution of AKR was funded by a grant scholarship of the Brigitte Schlieben-Lange-Programm from the Ministry of Science of the German State of Baden-Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ADJUSTMENT SOCIAL CL; Ball K, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-33; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; BIK Aschpurwis und Behrens GmbH, 2001, BIK REG BALL STADTR; Brettschneider W-D, 2001, EUR J SPORT SCI, V1, P1, DOI DOI 10.1080/17461390100071201; Brug J, 2012, PEDIATR OBES, V7, P399, DOI 10.1111/j.2047-6310.2012.00067.x; Burgoine T, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-33; Davison KK, 2009, MED SCI SPORT EXER, V41, P1816, DOI 10.1249/MSS.0b013e3181a278e2; Federal Office for Building and Regional Planning, 2012, INF FORSCH BBSR; Giles-Corti B, 2005, EXERC SPORT SCI REV, V33, P175, DOI 10.1097/00003677-200510000-00005; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058; Grow HM, 2008, MED SCI SPORT EXER, V40, P2071, DOI 10.1249/MSS.0b013e3181817baa; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hanson MD, 2007, J BEHAV MED, V30, P263, DOI 10.1007/s10865-007-9098-3; Hayes A.F., 2012, MODERAT COND PROCESS; Brodersen NH, 2007, BRIT J SPORT MED, V41, P140, DOI 10.1136/bjsm.2006.031138; Holling H, 2007, BUNDESGESUNDHEITSBLA, V50, P557, DOI 10.1007/s00103-007-0216-8; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Jekauc D, 2014, INT J EPIDE IN PRESS; Jekauc D, 2013, J PUBLIC HEALTH-HEID, V21, P505, DOI 10.1007/s10389-013-0579-2; Jekauc D, 2013, DIAGNOSTICA, V59, P100, DOI 10.1026/0012-1924/a000083; Jekauc D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-714; Jones A, 2010, OBESOGENIC ENV, P41; Kamtsiuris P, 2007, BUNDESGESUNDHEITSBLA, V50, P547, DOI 10.1007/s00103-007-0215-9; Kurth BM, 2007, BUNDESGESUNDHEITSBLA, V50, P533, DOI 10.1007/s00103-007-0214-x; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Lampert T, 2002, GESUNDHEITSWESEN, V64, pS48; Macintyre S, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-32; Moore JB, 2010, HEALTH EDUC RES, V25, P355, DOI 10.1093/her/cyq004; Niclasen B, 2012, SCAND J PUBLIC HEALT, V40, P614, DOI 10.1177/1403494812459815; Owen CG, 2009, INT J EPIDEMIOL, V38, P1082, DOI 10.1093/ije/dyp176; Owen N, 2000, Exerc Sport Sci Rev, V28, P153; Pikora T, 2003, SOC SCI MED, V56, P1693, DOI 10.1016/S0277-9536(02)00163-6; Powell LM, 2007, AM J PREV MED, V33, pS292, DOI 10.1016/j.amepre.2007.07.002; Prins RG, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-90; Prins RG, 2010, HEALTH EDUC RES, V25, P489, DOI 10.1093/her/cyq024; Prins RG, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-70; Prins RG, 2011, HEALTH PLACE, V17, P1228, DOI 10.1016/j.healthplace.2011.07.012; Roux AVD, 2007, AM J PUBLIC HEALTH, V97, P493, DOI 10.2105/AJPH.2006.087734; Sagatun A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-419; Sallis JF, 2008, HLTH BEHAV HLTH ED T, V260, P465; Schenk L, 2007, BUNDESGESUNDHEITSBLA, V50, P590, DOI 10.1007/s00103-007-0220-z; Spence JC, 2003, PSYCHOL SPORT EXERC, V4, P7, DOI 10.1016/S1469-0292(02)00014-6; Steinmayr A, 2011, EUR REV AGING PHYS A, V8, P67, DOI 10.1007/s11556-011-0090-0; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Telama R, 2009, PEDIATR EXERC SCI, V21, P462, DOI 10.1123/pes.21.4.462; Thornton Lukar E, 2011, Int J Behav Nutr Phys Act, V8, P71, DOI 10.1186/1479-5868-8-71; Woll A, 2011, EUR J PEDIATR, V170, P1129, DOI 10.1007/s00431-010-1391-4; Wong BYM, 2010, INT J PEDIATR OBES, V5, P169, DOI 10.3109/17477160903159432; Xiaolin Yang, 1996, International Review for the Sociology of Sport, V31, P273	51	30	30	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93059	10.1371/journal.pone.0093059	http://dx.doi.org/10.1371/journal.pone.0093059			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SW	24675689	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000333677500067
J	Sun, L; Qiang, R; Yang, Y; Jiang, ZL; Wang, GH; Zhao, GW; Ren, TJ; Jiang, R; Xu, LH				Sun, Li; Qiang, Ren; Yang, Yao; Jiang, Zheng-Lin; Wang, Guo-Hua; Zhao, Guang-Wei; Ren, Tao-Jie; Jiang, Rui; Xu, Li-Hua			L-Serine Treatment May Improve Neurorestoration of Rats after Permanent Focal Cerebral Ischemia Potentially Through Improvement of Neurorepair	PLOS ONE			English	Article							NEURAL STEM-CELLS; PROMOTES NEURITE OUTGROWTH; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; TENASCIN-C; NEURONAL MIGRATION; NOGO-A; STROKE; MECHANISMS; GDNF	The present study was conducted to clarify whether treatment with L-serine can improve the brain repair and neurorestoration of rats after permanent middle cerebral artery occlusion (pMCAO). After pMCAO, the neurological functions, brain lesion volume, and cortical injury were determined. GDNF, NGF, NCAM L1, tenascin-C, and Nogo-A levels were measured. Proliferation and differentiation of the neural stem cells (NSCs) and proliferation of the microvessels in the ischemic boundary zone of the cortex were evaluated. Treatment with L-serine (168 mg/kg body weight, i.p.) began 3 h after pMCAO and was repeated every 12 h for 7 days or until the end of the experiment. L-Serine treatment: 1) reduced the lesion volume and neuronal loss; 2) improved the recovery of neurological functions; 3) elevated the expression of nerve growth-related factors; and 4) facilitated the proliferation of endogenous NSCs and microvessels activated after pMCAO and increased the number of new-born neurons. 5) D-cycloserine, an inhibitor of serine hydroxymethyltransferase, blunted the effects of L-serine on NSC proliferation, differentiation, microvascular proliferation. In conclusions, L-serine treatment in pMCAO rats can reduce brain injury and facilitate neurorestoration which is partly associated with the improvement of proliferation of NSCs and microvessels, reconstruction of neurovascular units and resultant neurorepair. The effects of L-serine on endogenous NSC proliferation and microvascular proliferation are partly mediated by the action of L-serine as a substrate for the production of one-carbon groups used for purine and pyrimidine synthesis and modulation of the expression of some nerve growth-related factors.	[Sun, Li; Yang, Yao; Jiang, Zheng-Lin; Wang, Guo-Hua; Zhao, Guang-Wei; Ren, Tao-Jie; Jiang, Rui; Xu, Li-Hua] Nantong Univ, Dept Neuropharmacol, Inst Naut Med, Nantong, Jiangsu, Peoples R China; [Qiang, Ren] Third Peoples Hosp Nantong, Dept Infect Dis, Nantong, Jiangsu, Peoples R China; [Jiang, Zheng-Lin; Zhao, Guang-Wei; Ren, Tao-Jie] Nantong Univ, Dept Neurol, Affiliated Hosp, Nantong, Jiangsu, Peoples R China	Nantong University; Nantong University	Yang, Y (corresponding author), Nantong Univ, Dept Neuropharmacol, Inst Naut Med, Nantong, Jiangsu, Peoples R China.	jsyangyao@126.com; jiangzl@ntu.edu.cn	Wang, Guohua/AAD-8992-2022	Wang, Guohua/0000-0002-4810-8534	National Natural Science Foundation of China [81000497, 81071614, 81372131]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Nantong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Nantong University	This work was supported partly by grants from the National Natural Science Foundation of China (81000497, 81071614 and 81372131), by project funding from the Priority Academic Program Development of Jiangsu Higher Education Institutions, and by the Project for Innovation Development of Graduate Student of Nantong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaskharoun M, 2010, ASN NEURO, V2, DOI 10.1042/AN20100001; Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Andrews MR, 2009, J NEUROSCI, V29, P5546, DOI 10.1523/JNEUROSCI.0759-09.2009; Bednar MM, 2012, NEUROL RES, V34, P129, DOI 10.1179/1743132811Y.0000000069; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Chen B, 2009, BRAIN RES, V1284, P1, DOI 10.1016/j.brainres.2009.05.100; Chen J, 2005, J NEUROTRAUM, V22, P896, DOI 10.1089/neu.2005.22.896; Chen JA, 2010, MOL THER, V18, P1769, DOI 10.1038/mt.2010.133; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chiu SC, 2009, J MOL MED, V87, P1179, DOI 10.1007/s00109-009-0528-2; Cui YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017126; de Koning TJ, 2004, CURR OPIN NEUROL, V17, P197, DOI 10.1097/00019052-200404000-00019; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; Duan SR, 2010, NEUROL RES, V32, P835, DOI 10.1179/016164109X12581096870159; Duarte EP, 2012, GROWTH FACTORS, V30, P242, DOI 10.3109/08977194.2012.691478; GERMANO AF, 1994, J NEUROTRAUM, V11, P345, DOI 10.1089/neu.1994.11.345; Gogel S, 2011, GENE THER, V18, P1, DOI 10.1038/gt.2010.130; He XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046223; Ichim G, 2012, EXP CELL RES, V318, P1221, DOI 10.1016/j.yexcr.2012.03.006; Jablonska A, 2011, ACTA NEUROBIOL EXP, V71, P74; Joester A, 2001, MATRIX BIOL, V20, P13, DOI 10.1016/S0945-053X(00)00136-0; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Joshi CN, 2004, BRAIN RES PROTOC, V13, P11, DOI 10.1016/j.brainresprot.2003.12.001; Kameda M, 2007, EUR J NEUROSCI, V26, P1462, DOI 10.1111/j.1460-9568.2007.05776.x; Kramer M, 2010, J NEUROSCI METH, V187, P84, DOI 10.1016/j.jneumeth.2009.12.020; Leker RR, 2009, EXPERT OPIN BIOL TH, V9, P1117, DOI 10.1517/14712590903130558; Macrae IM, 2011, BRIT J PHARMACOL, V164, P1062, DOI 10.1111/j.1476-5381.2011.01398.x; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MANOHAR R, 1984, BIOCHEMISTRY-US, V23, P4116, DOI 10.1021/bi00313a016; Meiners S, 1999, J NEUROSCI, V19, P8443; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Pandya Rachna S., 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P81; Pernet V, 2012, CELL DEATH DIFFER, V19, P1096, DOI 10.1038/cdd.2011.191; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; RAMESH KS, 1980, BIOCHEM J, V187, P623, DOI 10.1042/bj1870623; Ren TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067044; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Rigato F, 2002, J NEUROSCI, V22, P6596; Sahota P, 2011, NEUROTHERAPEUTICS, V8, P434, DOI 10.1007/s13311-011-0040-6; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Schulz F, 2013, NANOSCALE, V5, P10605, DOI 10.1039/c3nr02707d; Seo JH, 2012, YONSEI MED J, V53, P1059, DOI 10.3349/ymj.2012.53.6.1059; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Stout RW, 2001, COMPARATIVE MED, V51, P524; Sun CR, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-77; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Vaquero J, 2011, PROG NEUROBIOL, V93, P341, DOI 10.1016/j.pneurobio.2010.12.002; Wang GH, 2010, J NEUROSCI RES, V88, P2035, DOI 10.1002/jnr.22365; Wang T, 2012, BRAIN RES BULL, V87, P499, DOI 10.1016/j.brainresbull.2012.02.011; Wang XK, 2004, MOL PHARMACOL, V65, P890, DOI 10.1124/mol.65.4.890; Xiong Y, 2010, DISCOV MED, V10, P434; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yoneyama M, 2011, J PHARMACOL SCI, V115, P425, DOI 10.1254/jphs.11R02CP	54	15	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93405	10.1371/journal.pone.0093405	http://dx.doi.org/10.1371/journal.pone.0093405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671106	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677000140
J	Hartman, ME; Librande, JR; Medvedev, IO; Ahmad, RN; Moussavi-Harami, F; Gupta, PP; Chien, WM; Chin, MT				Hartman, Matthew E.; Librande, Jason R.; Medvedev, Ivan O.; Ahmad, Rabiah N.; Moussavi-Harami, Farid; Gupta, Pritha P.; Chien, Wei-Ming; Chin, Michael T.			An Optimized and Simplified System of Mouse Embryonic Stem Cell Cardiac Differentiation for the Assessment of Differentiation Modifiers	PLOS ONE			English	Article							CONDUCTION SYSTEM; PROGENITOR CELLS; GENE-EXPRESSION; RAT BLASTOCYSTS; SELF-RENEWAL; CARDIOMYOCYTES; HEART; LINES; SPECIFICATION; MYOCARDIUM	Generating cardiomyocytes from embryonic stem cells is an important technique for understanding cardiovascular development, the origins of cardiovascular diseases and also for providing potential reagents for cardiac repair. Numerous methods have been published but often are technically challenging, complex, and are not easily adapted to assessment of specific gene contributions to cardiac myocyte differentiation. Here we report the development of an optimized protocol to induce the differentiation of mouse embryonic stem cells to cardiac myocytes that is simplified and easily adapted for genetic studies. Specifically, we made four critical findings that distinguish our protocol: 1) mouse embryonic stem cells cultured in media containing CHIR99021 and PD0325901 to maintain pluripotency will efficiently form embryoid bodies containing precardiac mesoderm when cultured in these factors at a reduced dosage, 2) low serum conditions promote cardiomyocyte differentiation and can be used in place of commercially prepared StemPro nutrient supplement, 3) the Wnt inhibitor Dkk-1 is dispensable for efficient cardiac differentiation and 4) tracking differentiation efficiency may be done with surface expression of PDGFR alpha alone. In addition, cardiac mesodermal precursors generated by this system can undergo lentiviral infection to manipulate the expression of specific target molecules to assess effects on cardiac myocyte differentiation and maturation. Using this approach, we assessed the effects of CHF1/Hey2 on cardiac myocyte differentiation, using both gain and loss of function. Overexpression of CHF1/Hey2 at the cardiac mesoderm stage had no apparent effect on cardiac differentiation, while knockdown of CHF1/Hey2 resulted in increased expression of atrial natriuretic factor and connexin 43, suggesting an alteration in the phenotype of the cardiomyocytes. In summary we have generated a detailed and simplified protocol for generating cardiomyocytes from mES cells that is optimized for investigating factors that affect cardiac differentiation.	[Hartman, Matthew E.; Librande, Jason R.; Medvedev, Ivan O.; Ahmad, Rabiah N.; Moussavi-Harami, Farid; Gupta, Pritha P.; Chien, Wei-Ming; Chin, Michael T.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Chin, MT (corresponding author), Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98195 USA.	mtchin@u.washington.edu	Moussavi-Harami, Farid/AAD-4608-2020	Moussavi-Harami, Farid/0000-0002-0189-7214; Hartman, Matt/0000-0002-6238-1887	NIH [T32 HL07828]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007828] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Work in this manuscript was supported by a training grant T32 HL07828 from the NIH (www.nih.gov) to M. E. H., F. M. AND I.O.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Batlle-Morera L, 2008, GENESIS, V46, P758, DOI 10.1002/dvg.20442; Bezzina CR, 2013, NAT GENET, V45, P1044, DOI 10.1038/ng.2712; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cao N, 2011, CELL RES, V21, P1316, DOI 10.1038/cr.2011.48; David R, 2011, CARDIOVASC RES, V92, P115, DOI 10.1093/cvr/cvr158; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001; Franco D, 1998, CARDIOVASC RES, V38, P25, DOI 10.1016/S0008-6363(97)00321-0; GOURDIE RG, 1993, J CELL SCI, V105, P985; Greener ID, 2011, J MOL CELL CARDIOL, V50, P642, DOI 10.1016/j.yjmcc.2010.12.017; Gutstein DE, 2001, CIRCULATION, V104, P1194, DOI 10.1161/hc3601.093990; Haigh J. J, 2008, ORGANOGENESIS, V4, P247, DOI DOI 10.4161/0RG.4.4.7415; Hirai H, 2011, BIOCHEM J, V438, P11, DOI 10.1042/BJ20102152; Hsiao EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002532; Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; KELLY RG, 1999, HEART DEV, P333; Koibuchi N, 2007, CIRC RES, V100, P850, DOI 10.1161/01.RES.0000261693.13269.bf; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Monfredi O, 2010, PACE, V33, P1392, DOI 10.1111/j.1540-8159.2010.02838.x; Moorman AFM, 1998, CIRC RES, V82, P629, DOI 10.1161/01.RES.82.6.629; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Potta SP, 2010, CELL PHYSIOL BIOCHEM, V25, P595, DOI 10.1159/000315078; Telugu BPVL, 2010, INT J DEV BIOL, V54, P1703, DOI 10.1387/ijdb.103200bt; Thomas SA, 1998, CIRCULATION, V97, P686, DOI 10.1161/01.CIR.97.7.686; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yamamoto H, 2007, GENES CELLS, V12, P1215, DOI 10.1111/j.1365-2443.2007.01128.x; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhou BY, 2007, STEM CELLS, V25, P779, DOI 10.1634/stemcells.2006-0128	43	10	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93033	10.1371/journal.pone.0093033	http://dx.doi.org/10.1371/journal.pone.0093033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667642	gold, Green Published, Green Submitted			2022-12-25	WOS:000333675600129
J	Dwivedi, N; Neeli, I; Schall, N; Wan, H; Desiderio, DM; Csernok, E; Thompson, PR; Dali, H; Briand, JP; Muller, S; Radic, M				Dwivedi, Nishant; Neeli, Indira; Schall, Nicolas; Wan, Haibao; Desiderio, Dominic M.; Csernok, Elena; Thompson, Paul R.; Dali, Hayet; Briand, Jean-Paul; Muller, Sylviane; Radic, Marko			Deimination of linker histones links neutrophil extracellular trap release with autoantibodies in systemic autoimmunity	FASEB JOURNAL			English	Article						inflammation; autoimmune disorders; peptidylarginine deiminase; chromatin	LUPUS-ERYTHEMATOSUS; CLASSIFICATION CRITERIA; INTERACTION SURFACE; ARGININE DEIMINASE; H1 VARIANTS; CITRULLINATION; ANTIBODIES; PHOSPHORYLATION; NUCLEOSOME; PAD4	Autoantibodies to nuclear antigens arise in human autoimmune diseases, but a unifying pathogenetic mechanism remains elusive. Recently we reported that exposure of neutrophils to inflammatory conditions induces the citrullination of core histones by peptidylarginine deiminase 4 (PAD4) and that patients with autoimmune disorders produce autoantibodies that recognize such citrullinated histones. Here we identify histone H1 as an additional substrate of PAD4, localize H1 within neutrophil extracellular traps, and detect autoantibodies to citrullinated H1 in 6% of sera from patients with systemic lupus erythematosus and Sjogren's syndrome. No preference for deiminated H1 was observed in healthy control sera and sera from patients with scleroderma or rheumatoid arthritis. We map binding to the winged helix of H1 and determine that citrulline 53 represents a key determinant of the autoantibody epitope. In addition, we quantitate RNA for H1 histone subtypes in mature human neutrophils and identify citrulline residues by liquid chromatography and tandem mass spectrometry. Our results indicate that deimination of linker histones generates new autoantibody epitopes with enhanced potential for stimulating autoreactive human B cells.	[Dwivedi, Nishant; Neeli, Indira; Radic, Marko] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Wan, Haibao; Desiderio, Dominic M.] Univ Tennessee, Ctr Hlth Sci, Dept Neurol, Charles B Stout Neurosci Mass Spectrometry Lab, Memphis, TN 38163 USA; [Schall, Nicolas; Dali, Hayet; Briand, Jean-Paul; Muller, Sylviane] CNRS, Inst Biol Mol & Cellulaire, Lab Excellence Medalis, F-67084 Strasbourg, France; [Csernok, Elena] Med Univ Lubeck, Dept Rheumatol, Klinikum Bad Bramstedt, Bad Bramstedt, Germany; [Thompson, Paul R.] Scripps Res Inst Florida, Jupiter, FL USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Lubeck; Scripps Research Institute	Radic, M (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, 858 Madison Ave, Memphis, TN 38163 USA.	mradic@uthsc.edu	Muller, Sylviane/J-5319-2014	Radic, Marko/0000-0002-8004-282X; Dwivedi, Nishant/0000-0003-3812-4917	Lupus Research Institute of New York; Dana Foundation Program in Human Immunology; French Centre National de la Recherche Scientifique; Laboratory of Excellence Medalis [ANR-10-LABX-0034]; Initiative of Excellence (IdEx); Strasbourg University; ImmuPharma France; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079357] Funding Source: NIH RePORTER	Lupus Research Institute of New York; Dana Foundation Program in Human Immunology; French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Laboratory of Excellence Medalis; Initiative of Excellence (IdEx); Strasbourg University; ImmuPharma France; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge Dr. Jean-Francois Kleinmann (Strasbourg University Hospitals, Strasbourg, France), for providing patient sera used in these studies; the insightful and critical comments of Dr. Marc Monestier (Temple University, Philadelphia, PA, USA); and the technical expertise of Tim Higgins (Senior Illustrator, University of Tennessee Health Science Center, Memphis, TN, USA). This work was supported by research funding provided by the Lupus Research Institute of New York and the Dana Foundation Program in Human Immunology. Research was supported in part by the French Centre National de la Recherche Scientifique, the Laboratory of Excellence Medalis (ANR-10-LABX-0034), Initiative of Excellence (IdEx), Strasbourg University, and ImmuPharma France.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Andrade F, 2010, ARTHRITIS RHEUM-US, V62, P1630, DOI 10.1002/art.27439; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Brinkmann V, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00413; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Christophorou MA, 2014, NATURE, V507, P104, DOI 10.1038/nature12942; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Daigo K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00378; Dwivedi N, 2014, ANN RHEUM DIS, V73, P483, DOI 10.1136/annrheumdis-2013-203844; Dwivedi N, 2012, ARTHRITIS RHEUM-US, V64, P982, DOI 10.1002/art.33432; el-Azhary RA, 2006, INT J DERMATOL, V45, P1296, DOI 10.1111/j.1365-4632.2006.02891.x; Fauchais AL, 2010, AUTOIMMUN REV, V9, P595, DOI 10.1016/j.autrev.2010.05.004; Froy O, 2009, ANN NY ACAD SCI, V1173, P365, DOI 10.1111/j.1749-6632.2009.04622.x; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; George EM, 2010, J BIOL CHEM, V285, P20891, DOI 10.1074/jbc.M110.108639; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Hemmers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022043; Kearney PL, 2005, BIOCHEMISTRY-US, V44, P10570, DOI 10.1021/bi050292m; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kim K, 2008, J BIOL CHEM, V283, P9113, DOI 10.1074/jbc.M708205200; Knight JS, 2013, J CLIN INVEST, V123, P2981, DOI 10.1172/JCI67390; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Leshner M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00307; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Li YQ, 2011, SURGERY, V150, P442, DOI 10.1016/j.surg.2011.07.003; Mackey-Cushman SL, 2011, GENES IMMUN, V12, P559, DOI 10.1038/gene.2011.31; Manolova I, 2001, RHEUMATOL INT, V20, P197; Millan-Arino L, 2014, NUCLEIC ACIDS RES, V42, P4474, DOI 10.1093/nar/gku079; MULLER S, 1984, EMBO J, V3, P2431, DOI 10.1002/j.1460-2075.1984.tb02150.x; Muller S, 2008, LUPUS, V17, P431, DOI 10.1177/0961203308090030; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Neeli I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00038; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Polyanichko A, 2005, BIOPOLYMERS, V78, P329, DOI 10.1002/bip.20299; Pradhan Vandana D, 2004, J Assoc Physicians India, V52, P533; Pratesi F, 2014, ANN RHEUM DIS, V73, P1414, DOI 10.1136/annrheumdis-2012-202765; Proost P, 2008, J EXP MED, V205, P2085, DOI 10.1084/jem.20080305; Radic M, 2013, GENET EPIGENETICS, V5, P63, DOI 10.4137/GEG.S12144; Radic M, 2013, SEMIN IMMUNOPATHOL, V35, P465, DOI 10.1007/s00281-013-0376-6; Rohrbach AS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00360; Schett G, 2002, LUPUS, V11, P704, DOI 10.1191/0961203302lu247oa; SENSHU T, 1995, J INVEST DERMATOL, V105, P163, DOI 10.1111/1523-1747.ep12317070; Sokolove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035296; STEMMER C, 1994, MOL IMMUNOL, V31, P1037, DOI 10.1016/0161-5890(94)90099-X; Sun XY, 2008, J CLIN LAB ANAL, V22, P271, DOI 10.1002/jcla.20248; Syed SH, 2010, P NATL ACAD SCI USA, V107, P9620, DOI 10.1073/pnas.1000309107; Tamiya H, 2006, RHEUMATOL INT, V27, P147, DOI 10.1007/s00296-006-0173-9; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Vogler C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001234; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018; Vossenaar ER, 2003, ARTHRITIS RHEUM-US, V48, P2489, DOI 10.1002/art.11229; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Wei LH, 2013, J MED CHEM, V56, P1715, DOI 10.1021/jm301755q; Willis V, 2011, J IMMUNOL, V186, P4396, DOI 10.4049/jimmunol.1001620; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Zhang XS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002112; Zheng YP, 2010, J CELL BIOL, V189, P407, DOI 10.1083/jcb.201001148	65	49	50	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2840	2851		10.1096/fj.13-247254	http://dx.doi.org/10.1096/fj.13-247254			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24671707	Green Published			2022-12-25	WOS:000337949400010
J	Lin, XY; Ruiz, J; Bajraktari, I; Ohman, R; Banerjee, S; Gribble, K; Kaufman, JD; Wingfield, PT; Griggs, RC; Fischbeck, KH; Mankodi, A				Lin, Xiaoyan; Ruiz, Janelle; Bajraktari, Ilda; Ohman, Rachel; Banerjee, Soojay; Gribble, Katherine; Kaufman, Joshua D.; Wingfield, Paul T.; Griggs, Robert C.; Fischbeck, Kenneth H.; Mankodi, Ami			Z-disc-associated, Alternatively Spliced, PDZ Motif-containing Protein ( ZASP) Mutations in the Actin-binding Domain Cause Disruption of Skeletal Muscle Actin Filaments in Myofibrillar Myopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Muscular Dystrophy; Protein Complex; Protein-Protein Interaction; Skeletal Muscle; Actinin; Myofibrillar Myopathy; Myotilin; Z-disc; ZASP	GIRDLE MUSCULAR-DYSTROPHY; ONSET DISTAL MYOPATHY; ALPHA-ACTININ; DILATED CARDIOMYOPATHY; LIM PROTEIN; Z-BAND; DESMIN POSITIVITY; SEVERE FORM; IN-VIVO; Z-LINE	Background: The binding partners of the ZASP internal region that is mutated in zaspopathy are not yet known. Results: The internal region of ZASP binds to skeletal muscle -actin, and zaspopathy mutations cause actin disruption. Conclusion: ZASP mutations in the actin-binding domain are deleterious to the muscle Z-disc structure. Significance: ZASP-actin interaction expands the role of ZASP and defines the mechanism of zaspopathy. The core of skeletal muscle Z-discs consists of actin filaments from adjacent sarcomeres that are cross-linked by -actinin homodimers. Z-disc-associated, alternatively spliced, PDZ motif-containing protein (ZASP)/Cypher interacts with -actinin, myotilin, and other Z-disc proteins via the PDZ domain. However, these interactions are not sufficient to maintain the Z-disc structure. We show that ZASP directly interacts with skeletal actin filaments. The actin-binding domain is between the modular PDZ and LIM domains. This ZASP region is alternatively spliced so that each isoform has unique actin-binding domains. All ZASP isoforms contain the exon 6-encoded ZASP-like motif that is mutated in zaspopathy, a myofibrillar myopathy (MFM), whereas the exon 8-11 junction-encoded peptide is exclusive to the postnatal long ZASP isoform (ZASP-Lex10). MFM is characterized by disruption of skeletal muscle Z-discs and accumulation of myofibrillar degradation products. Wild-type and mutant ZASP interact with -actin, -actinin, and myotilin. Expression of mutant, but not wild-type, ZASP leads to Z-disc disruption and F-actin accumulation in mouse skeletal muscle, as in MFM. Mutations in the actin-binding domain of ZASP-Lex10, but not other isoforms, cause disruption of the actin cytoskeleton in muscle cells. These isoform-specific mutation effects highlight the essential role of the ZASP-Lex10 isoform in F-actin organization. Our results show that MFM-associated ZASP mutations in the actin-binding domain have deleterious effects on the core structure of the Z-discs in skeletal muscle.	[Lin, Xiaoyan; Ruiz, Janelle; Bajraktari, Ilda; Ohman, Rachel; Banerjee, Soojay; Gribble, Katherine; Fischbeck, Kenneth H.; Mankodi, Ami] NINDS, NIH, Neurogenet Branch, Bethesda, MD 20892 USA; [Kaufman, Joshua D.; Wingfield, Paul T.] NIAMS, NIH, Prot Express Lab, Bethesda, MD 20892 USA; [Griggs, Robert C.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Rochester	Mankodi, A (corresponding author), NINDS, NIH, Neurogenet Branch, 35 Convent Dr,Bldg 35,Rm 2A-1002, Bethesda, MD 20892 USA.	ami.mankodi@nih.gov		Griggs, Robert/0000-0001-7988-4854; Gribble, Katherine/0000-0001-7050-5184; Wingfield, Paul/0000-0002-9515-4752; Mankodi, Ami/0000-0002-5131-7767	NINDS, National Institute of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003038, ZIANS003131] Funding Source: NIH RePORTER	NINDS, National Institute of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institute of Health intramural research funds, including the Henry F. McFarland Transition to Independence Award (to A. M.).	Arimura T, 2009, CARDIOVASC RES, V83, P80, DOI 10.1093/cvr/cvp119; Au YH, 2004, STRUCTURE, V12, P611, DOI 10.1016/j.str.2004.02.019; Cheng HQ, 2011, HUM MOL GENET, V20, P1751, DOI 10.1093/hmg/ddr050; Conover GM, 2011, J CELL SCI, V124, P3464, DOI 10.1242/jcs.087080; Crawford K, 2002, MOL CELL BIOL, V22, P5887, DOI 10.1128/MCB.22.16.5887-5896.2002; DeBleecker JL, 1996, J NEUROPATH EXP NEUR, V55, P563, DOI 10.1097/00005072-199605000-00009; Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Fujita M, 2012, DEV BIOL, V361, P79, DOI 10.1016/j.ydbio.2011.10.008; Griggs R, 2007, BRAIN, V130, P1477, DOI 10.1093/brain/awm006; Griggs RC, 2011, NEUROMOL MED, V13, P27, DOI 10.1007/s12017-010-8134-6; Hishiya A, 2010, CIRC RES, V107, P1220, DOI 10.1161/CIRCRESAHA.110.225649; Huang CQ, 2003, J BIOL CHEM, V278, P7360, DOI 10.1074/jbc.M211875200; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; Klaavuniemi T, 2006, EXP CELL RES, V312, P1299, DOI 10.1016/j.yexcr.2005.12.036; Klaavuniemi T, 2004, J BIOL CHEM, V279, P26402, DOI 10.1074/jbc.M401871200; KNAPPEIS GG, 1962, J CELL BIOL, V13, P323, DOI 10.1083/jcb.13.2.323; LAZARIDES E, 1975, CELL, V6, P289, DOI 10.1016/0092-8674(75)90180-4; LUTHER PK, 1991, J CELL BIOL, V113, P1043, DOI 10.1083/jcb.113.5.1043; Luther PK, 2000, J STRUCT BIOL, V129, P1, DOI 10.1006/jsbi.1999.4207; MARKESBERY WR, 1974, NEUROLOGY, V24, P127, DOI 10.1212/WNL.24.2.127; MCGOUGH A, 1994, J CELL BIOL, V126, P433, DOI 10.1083/jcb.126.2.433; Nakano S, 1996, J NEUROPATH EXP NEUR, V55, P549, DOI 10.1097/00005072-199605000-00008; Nowak KJ, 2009, J CELL BIOL, V185, P903, DOI 10.1083/jcb.200812132; Passier R, 2000, MECH DEVELOP, V92, P277, DOI 10.1016/S0925-4773(99)00330-5; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pomies P, 1999, J BIOL CHEM, V274, P29242, DOI 10.1074/jbc.274.41.29242; Salmikangas P, 1999, HUM MOL GENET, V8, P1329, DOI 10.1093/hmg/8.7.1329; Salmikangas P, 2003, HUM MOL GENET, V12, P189, DOI 10.1093/hmg/ddg020; Sanger JM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.132pe37; Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376; Selcen Duygu, 2011, Neuromuscul Disord, V21, P161, DOI [10.1016/B978-0-08-045031-5.00011-6, 10.1016/j.nmd.2010.12.007]; Singh BN, 2007, J MOL BIOL, V366, P756, DOI 10.1016/j.jmb.2006.12.012; VANDEKERCKHOVE J, 1986, J BIOL CHEM, V261, P1838; VANDEKERCKHOVE J, 1979, DIFFERENTIATION, V14, P123, DOI 10.1111/j.1432-0436.1979.tb01021.x; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; von Nandelstadh P, 2009, MOL CELL BIOL, V29, P822, DOI 10.1128/MCB.01454-08; Xia HH, 1997, J CELL BIOL, V139, P507, DOI 10.1083/jcb.139.2.507; Zheng M, 2009, HUM MOL GENET, V18, P701, DOI 10.1093/hmg/ddn400; Zhou Q, 1999, J BIOL CHEM, V274, P19807, DOI 10.1074/jbc.274.28.19807; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	41	30	30	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13615	13626		10.1074/jbc.M114.550418	http://dx.doi.org/10.1074/jbc.M114.550418			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24668811	Green Published, hybrid			2022-12-25	WOS:000335522800055
J	Pessoa, R; Watanabe, JT; Nukui, Y; Pereira, J; Kasseb, J; de Oliveira, ACP; Segurado, AC; Sanabani, SS				Pessoa, Rodrigo; Watanabe, Jaqueline Tomoko; Nukui, Youko; Pereira, Juliana; Kasseb, Jorge; Penalva de Oliveira, Augusto Cesar; Segurado, Aluisio Cotrim; Sanabani, Sabri Saeed			Molecular Characterization of Human T-Cell Lymphotropic Virus Type 1 Full and Partial Genomes by Illumina Massively Parallel Sequencing Technology	PLOS ONE			English	Article							I HTLV-I; LEUKEMIA-VIRUS; BLOOD-DONORS; STRAINS; AFRICAN; BRAZIL; SOUTH; IDENTIFICATION; EPIDEMIOLOGY; RETROVIRUS	Background: Here, we report on the partial and full-length genomic (FLG) variability of HTLV-1 sequences from 90 well-characterized subjects, including 48 HTLV-1 asymptomatic carriers (ACs), 35 HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and 7 adult T-cell leukemia/lymphoma (ATLL) patients, using an Illumina paired-end protocol. Methods: Blood samples were collected from 90 individuals, and DNA was extracted from the PBMCs to measure the proviral load and to amplify the HTLV-1 FLG from two overlapping fragments. The amplified PCR products were subjected to deep sequencing. The sequencing data were assembled, aligned, and mapped against the HTLV-1 genome with sufficient genetic resemblance and utilized for further phylogenetic analysis. Results: A high-throughput sequencing-by-synthesis instrument was used to obtain an average of 3210-and 5200-fold coverage of the partial (n = 14) and FLG (n = 76) data from the HTLV-1 strains, respectively. The results based on the phylogenetic trees of consensus sequences from partial and FLGs revealed that 86 (95.5%) individuals were infected with the transcontinental sub-subtypes of the cosmopolitan subtype (aA) and that 4 individuals (4.5%) were infected with the Japanese sub-subtypes (aB). A comparison of the nucleotide and amino acids of the FLG between the three clinical settings yielded no correlation between the sequenced genotype and clinical outcomes. The evolutionary relationships among the HTLV sequences were inferred from nucleotide sequence, and the results are consistent with the hypothesis that there were multiple introductions of the transcontinental subtype in Brazil. Conclusions: This study has increased the number of subtype aA full-length genomes from 8 to 81 and HTLV-1 aB from 2 to 5 sequences. The overall data confirmed that the cosmopolitan transcontinental sub-subtypes were the most prevalent in the Brazilian population. It is hoped that this valuable genomic data will add to our current understanding of the evolutionary history of this medically important virus.	[Pessoa, Rodrigo; Watanabe, Jaqueline Tomoko] Sao Paulo Inst Trop Med, Dept Virol, Sao Paulo, Brazil; [Nukui, Youko; Pereira, Juliana] Univ Sao Paulo, Fac Med, Dept Hematol, Sao Paulo, Brazil; [Kasseb, Jorge; Penalva de Oliveira, Augusto Cesar] Inst Infectol Emilio Ribas, Dept Neurol, Sao Paulo, Brazil; [Segurado, Aluisio Cotrim] Univ Sao Paulo, Fac Med, Dept Infect Dis, Sao Paulo, Brazil; [Sanabani, Sabri Saeed] Univ Sao Paulo, Sch Med, Hosp Clin, Clin Lab,Dept Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Sanabani, SS (corresponding author), Univ Sao Paulo, Sch Med, Hosp Clin, Clin Lab,Dept Pathol, Sao Paulo, Brazil.	sabyem_63@yahoo.com	PEREIRA, JULIANA/C-2742-2014; Segurado, Aluisio C/K-2229-2012; Pessôa, Rodrigo/B-7206-2018; Sanabani, Sabri Saeed/F-5600-2012	PEREIRA, JULIANA/0000-0002-0655-2821; Segurado, Aluisio C/0000-0002-6311-8036; Sanabani, Sabri Saeed/0000-0002-8876-8262	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/12297-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported with funding from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2011/12297-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara LCJ, 2006, AIDS, V20, P780, DOI 10.1097/01.aids.0000216383.14808.13; Mota ACA, 2007, AIDS RES HUM RETROV, V23, P503, DOI 10.1089/aid.2006.0203; Balcazar N, 2003, MEM I OSWALDO CRUZ, V98, P641, DOI 10.1590/S0074-02762003000500010; Bimber BN, 2010, J VIROL, V84, P12087, DOI 10.1128/JVI.01378-10; Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09; Carneiro-Proietti ABF, 2012, AIDS RES HUM RETROV, V28, P1265, DOI 10.1089/aid.2011.0143; Catalan-Soares Bernadette, 2005, Cad. Saúde Pública, V21, P926, DOI 10.1590/S0102-311X2005000300027; Da--Costa AC, 2011, VIROL J, V8, P535; Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Edlich RF, 2000, J EMERG MED, V18, P109, DOI 10.1016/S0736-4679(99)00173-0; Eirin ME, 2008, AIDS RES HUM RETROV, V24, P1237, DOI 10.1089/aid.2008.0024; Franchini G, 2003, INT J HEMATOL, V78, P280, DOI 10.1007/BF02983552; Furukawa Y, 2000, J INFECT DIS, V182, P1343, DOI 10.1086/315897; GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x; GESSAIN A, 1985, LANCET, V2, P407; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; HENEINE W, 1992, J CLIN MICROBIOL, V30, P1605, DOI 10.1128/JCM.30.6.1605-1607.1992; HUANG YQ, 1992, LANCET, V339, P1110; Kashima S, 2006, AIDS RES HUM RETROV, V22, P953, DOI 10.1089/aid.2006.22.953; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KOMURIAN F, 1991, J VIROL, V65, P3770, DOI 10.1128/JVI.65.7.3770-3778.1991; LEITNER T, 2002, MOL EPIDEMIOLOGY HUM; LONGO DL, 1984, NATURE, V310, P505, DOI 10.1038/310505a0; Magri MC, 2012, AIDS RES HUM RETROV, V28, P110, DOI [10.1089/AID.2011.0117, 10.1089/aid.2011.0117]; Mahieux R, 1997, J VIROL, V71, P1317, DOI 10.1128/JVI.71.2.1317-1333.1997; Matsuoka M, 2003, ONCOGENE, V22, P5131, DOI 10.1038/sj.onc.1206551; Naderi M, 2012, J CLIN VIROL, V53, P302, DOI 10.1016/j.jcv.2011.12.033; NISHIOKA K, 1989, LANCET, V1, P441; OSAME M, 1986, LANCET, V1, P1031; OSAME M, 1990, HUMAN RETROVIROLOGY : HTLV, P191; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Segurado AAC, 2002, MEM I OSWALDO CRUZ, V97, P329, DOI 10.1590/S0074-02762002000300009; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; SONG KJ, 1995, AM J TROP MED HYG, V52, P101, DOI 10.4269/ajtmh.1995.52.101; SUGIMOTO M, 1987, LANCET, V2, P1220; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Dooren S, 1998, J GEN VIROL, V79, P2695, DOI 10.1099/0022-1317-79-11-2695; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; VIDAL AU, 1994, J GEN VIROL, V75, P3655, DOI 10.1099/0022-1317-75-12-3655; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Willerth SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013564; Yamashita M, 2001, AIDS RES HUM RETROV, V17, P783, DOI 10.1089/088922201750237068; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031	47	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93374	10.1371/journal.pone.0093374	http://dx.doi.org/10.1371/journal.pone.0093374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686382	Green Published, gold, Green Submitted			2022-12-25	WOS:000340842300010
J	Wierenga, ATJ; Vellenga, E; Schuringa, JJ				Wierenga, Albertus T. J.; Vellenga, Edo; Schuringa, Jan Jacob			Convergence of Hypoxia and TGF beta Pathways on Cell Cycle Regulation in Human Hematopoietic Stem/Progenitor Cells	PLOS ONE			English	Article							BONE-MARROW NICHE; STEM-CELLS; INDUCIBLE FACTORS; TRANSCRIPTION FACTOR; SELF-RENEWAL; OXYGEN; PROLIFERATION; NRF2; STRESS; LOCALIZATION	Although it has been shown that HIF1 and 2 fulfill essential roles within the hematopoietic system and in the regulation of HSC fate, little is currently known about the specific mechanisms that are involved. We identified transcriptome changes induced by hypoxia, constitutively active HIF1((P402/564)) and HIF2((P405/531)) in human cord blood CD34(+) cells. Thus, we were able to identify common hypoxia-HIF1-HIF2 gene signatures, but we also identified specific target genes that were exclusively regulated by HIF1, HIF2 or hypoxia. Geneset enrichment analysis (GSEA) revealed that, besides known pathways associated with "hypoxia-induced signaling'', also significant enrichment for the Transforming Growth Factor beta (TGF beta) pathway was observed within the hypoxia/HIF1/HIF2 transcriptomes. One of the most significantly upregulated genes in both gene sets was the cyclin dependent kinase inhibitor CDKN1C (p57kip2). Combined hypoxia treatment or HIF overexpression together with TGF beta stimulation resulted in enhanced expression of CDKN1C and enhanced cell cycle arrest within the CD34(+)/CD38(-) stem cell compartment. Interestingly, we observed that CD34(+) cells cultured under hypoxic conditions secreted high levels of latent TGF beta, suggesting an auto-or paracrine role of TGF beta in the regulation of quiescence of these cells. However, knockdown of SMAD4 could not rescue the hypoxia induced cell cycle arrest, arguing against direct effects of hypoxia-induced secreted TGF beta. Finally, the Ga-coupled receptor GTPase RGS1 was identified as a HIF-dependent hypoxia target that dampens SDF1-induced migration and signal transduction in human CD34(+) stem/progenitor cells.	[Wierenga, Albertus T. J.; Vellenga, Edo; Schuringa, Jan Jacob] Univ Groningen, Univ Med Ctr Groningen, Dept Expt Hematol, Groningen, Netherlands; [Wierenga, Albertus T. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands	University of Groningen; University of Groningen	Schuringa, JJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Expt Hematol, Groningen, Netherlands.	j.j.schuringa@umcg.nl			UMCG	UMCG	These studies were supported by internal funds from the UMCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; ALLALUNISTURNER MJ, 1987, INT J CELL CLONING, V5, P315, DOI 10.1002/stem.5530050406; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Argiropoulos B, 2008, EXP HEMATOL, V36, P845, DOI 10.1016/j.exphem.2008.02.011; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; BRADLEY TR, 1978, J CELL PHYSIOL, V97, P517, DOI 10.1002/jcp.1040970327; Cao YA, 2008, BLOOD, V112, P4494, DOI 10.1182/blood-2007-12-127621; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Eliasson P, 2010, EXP HEMATOL, V38, P301, DOI 10.1016/j.exphem.2010.01.005; Fahling M, 2009, J CELL MOL MED, V13, P2770, DOI 10.1111/j.1582-4934.2009.00875.x; Forristal CE, 2013, BLOOD, V121, P759, DOI 10.1182/blood-2012-02-408419; Guitart AV, 2013, BLOOD, V122, P1741, DOI 10.1182/blood-2013-02-484923; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Han JI, 2006, J LEUKOCYTE BIOL, V79, P1357, DOI 10.1189/jlb.1105693; Ivanovic Z, 2000, TRANSFUSION, V40, P1482, DOI 10.1046/j.1537-2995.2000.40121482.x; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karlsson G, 2007, J EXP MED, V204, P467, DOI 10.1084/jem.20060465; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Krause DS, 2013, CYTOM PART B-CLIN CY, V84B, P7, DOI 10.1002/cyto.b.21066; Kuang LH, 2013, INT J BIOL SCI, V9, P656, DOI 10.7150/ijbs.5887; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Moratz C, 2004, MOL CELL BIOL, V24, P5767, DOI 10.1128/MCB.24.13.5767-5775.2004; Nakamura-Ishizu A, 2013, BBA-GEN SUBJECTS, V1830, P2404, DOI 10.1016/j.bbagen.2012.08.023; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Rouault-Pierre K, 2013, CELL STEM CELL, V13, P549, DOI 10.1016/j.stem.2013.08.011; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Smirnova NA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1108, DOI 10.1134/S0006297912100033; Smith JNP, 2013, STEM CELLS, V31, P1044, DOI 10.1002/stem.1370; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699; Wierenga ATJ, 2008, MOL CELL BIOL, V28, P6668, DOI 10.1128/MCB.01025-08; Wierenga ATJ, 2006, BLOOD, V107, P4326, DOI 10.1182/blood-2005-11-4608; Wierenga ATJ, 2010, BLOOD, V115, P4367, DOI 10.1182/blood-2009-10-250894; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480	48	37	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93494	10.1371/journal.pone.0093494	http://dx.doi.org/10.1371/journal.pone.0093494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686421	Green Published, Green Submitted, gold			2022-12-25	WOS:000340842300014
J	Shin, HM; McKone, TE; Sohn, MD; Bennett, DH				Shin, Hyeong-Moo; McKone, Thomas E.; Sohn, Michael D.; Bennett, Deborah H.			Tracking Contributions to Human Body Burden of Environmental Chemicals by Correlating Environmental Measurements with Biomarkers	PLOS ONE			English	Article							ORGANOPHOSPHATE PESTICIDE EXPOSURE; IN-HOUSE DUST; SERUM; CHILDREN; PBDES; CHARACTERIZE; ASSOCIATIONS; VARIABILITY; HANDWIPES; URINE	The work addresses current knowledge gaps regarding causes for correlations between environmental and biomarker measurements and explores the underappreciated role of variability in disaggregating exposure attributes that contribute to biomarker levels. Our simulation-based study considers variability in environmental and food measurements, the relative contribution of various exposure sources (indoors and food), and the biological half-life of a compound, on the resulting correlations between biomarker and environmental measurements. For two hypothetical compounds whose half-lives are on the order of days for one and years for the other, we generate synthetic daily environmental concentrations and food exposures with different day-to-day and population variability as well as different amounts of home-and food-based exposure. Assuming that the total intake results only from home-based exposure and food ingestion, we estimate time-dependent biomarker concentrations using a one-compartment pharmacokinetic model. Box plots of modeled R-2 values indicate that although the R-2 correlation between wipe and biological (e. g., serum) measurements is within the same range for the two compounds, the relative contribution of the home exposure to the total exposure could differ by up to 20%, thus providing the relative indication of their contribution to body burden. The novel method introduced in this paper provides insights for evaluating scenarios or experiments where sample, exposure, and compound variability must be weighed in order to interpret associations between exposure data.	[Shin, Hyeong-Moo; Bennett, Deborah H.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [McKone, Thomas E.; Sohn, Michael D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Environm Energy Technol Div, Berkeley, CA 94720 USA; [McKone, Thomas E.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Shin, HM (corresponding author), Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA.	hmshin@ucdavis.edu	Shin, Hyeong-Moo/T-2127-2017; Shin, Hyeong-Moo/AAI-5229-2021; Sohn, Michael/HHM-5790-2022	Shin, Hyeong-Moo/0000-0002-7001-2555; 	American Chemistry Council [3-DBACC01]	American Chemistry Council	This research is funded by the American Chemistry Council (Grant#: 3-DBACC01, http://www.americanchemistry.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartell S, 2003, STAT METHODS NONSTEA; Bradman A, 2007, J EXPO SCI ENV EPID, V17, P331, DOI 10.1038/sj.jes.7500507; Centers for Disease Control and Prevention, 2009, 4 CDCP; Centers for Disease Control and Prevention (CDC), 2005, 3 CDC; Chen CC, 2004, STOCH ENV RES RISK A, V18, P377, DOI 10.1007/s00477-004-0208-2; Coronado GD, 2006, ENVIRON HEALTH PERSP, V114, P999, DOI 10.1289/ehp.8620; Curwin BD, 2007, ANN OCCUP HYG, V51, P53, DOI [10.1093/annhug/mel062, 10.1093/annhyg/mel062]; Fraser AJ, 2012, ENVIRON SCI TECHNOL, V46, P1209, DOI 10.1021/es2038257; Geens T, 2012, FOOD CHEM TOXICOL, V50, P3725, DOI 10.1016/j.fct.2012.07.059; Griffith W, 2011, ENVIRON RES, V111, P751, DOI 10.1016/j.envres.2011.05.008; Hubal EAC, 2000, ENVIRON HEALTH PERSP, V108, P475, DOI 10.2307/3454607; Johnson PI, 2010, ENVIRON SCI TECHNOL, V44, P5627, DOI 10.1021/es100697q; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Loomis D, 2004, AM J IND MED, V45, P113, DOI 10.1002/ajim.10324; Lorber M, 2011, ENVIRON SCI TECHNOL, V45, P8006, DOI 10.1021/es103718h; Quiros-Alcala L, 2012, J EXPO SCI ENV EPID, V22, P559, DOI 10.1038/jes.2012.46; Ramaswami A, 2005, INTEGRATED ENV MODEL; RAPPAPORT SM, 1995, ENVIRON HEALTH PERSP, V103, P49, DOI 10.2307/3432560; Rothlein J, 2006, ENVIRON HEALTH PERSP, V114, P691, DOI 10.1289/ehp.8182; Shin HM, 2013, ATMOS ENVIRON, V69, P148, DOI 10.1016/j.atmosenv.2012.12.027; Shin HM, 2013, ENVIRON SCI TECHNOL, V47, P859, DOI 10.1021/es303316d; Shin HM, 2012, ENVIRON SCI TECHNOL, V46, P10063, DOI 10.1021/es3018286; Shin HM, 2011, ENVIRON HEALTH PERSP, V119, P1760, DOI 10.1289/ehp.1103729; Stapleton HM, 2012, ENVIRON HEALTH PERSP, V120, P1049, DOI 10.1289/ehp.1104802; Watkins DJ, 2012, ENVIRON SCI TECHNOL, V46, P1192, DOI 10.1021/es203314e; Watkins DJ, 2011, ENVIRON HEALTH PERSP, V119, P1247, DOI 10.1289/ehp.1003271; Weschler CJ, 2012, INDOOR AIR, V22, P356, DOI 10.1111/j.1600-0668.2012.00772.x; Wu N, 2007, ENVIRON SCI TECHNOL, V41, P1584, DOI 10.1021/es0620282; Xu ZL, 2013, SCI TOTAL ENVIRON, V443, P485, DOI 10.1016/j.scitotenv.2012.10.089	29	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93678	10.1371/journal.pone.0093678	http://dx.doi.org/10.1371/journal.pone.0093678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681626	gold, Green Submitted, Green Published			2022-12-25	WOS:000333678100054
J	Koslik, HJ; Hamilton, G; Golomb, BA				Koslik, Hayley J.; Hamilton, Gavin; Golomb, Beatrice A.			Mitochondrial Dysfunction in Gulf War Illness Revealed by 31Phosphorus Magnetic Resonance Spectroscopy: A Case-Control Study	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; OXIDATIVE STRESS; VETERANS; ASSOCIATION; SYMPTOMS; QUANTIFICATION; RECOVERY; EXERCISE; SPECTRA; BRAIN	Background: Approximately 1/3 of 1990-1 Gulf War veterans developed chronic multisymptom health problems. Implicated exposures bear mechanisms that adversely affect mitochondria. Symptoms emphasize fatigue, cognition and muscle (brain and muscle are aerobically demanding); with protean additional domains affected, compatible with mitochondrial impairment. Recent evidence supports treatments targeting cell bioenergetics (coenzyme10) to benefit Gulf War illness symptoms. However, no evidence has directly documented mitochondrial or bioenergetic impairment in Gulf War illness. Objective: We sought to objectively assess for mitochondrial dysfunction, examining post-exercise phosphocreatine-recovery time constant (PCr-R) using (31)Phosphorus Magnetic Resonance Spectroscopy (P-31-MRS), in Gulf War veterans with Gulf War illness compared to matched healthy controls. PCr-R has been described as a "robust and practical" index of mitochondrial status. Design and Participants: Case-control study from 2012-2013. Fourteen community-dwelling Gulf War veterans and matched controls from the San Diego area comprised 7 men meeting CDC and Kansas criteria for Gulf War illness, and 7 non-deployed healthy controls matched 1: 1 to cases on age, sex, and ethnicity. Outcome Measure: Calf muscle phosphocreatine was evaluated by P-31-MRS at rest, through 5 minutes of foot pedal depression exercise, and in recovery, to assess PCr-R. Paired t-tests compared cases to matched controls. Results: PCr-R was significantly prolonged in Gulf War illness cases vs their matched controls: control values, mean +/- SD, 29.0 +/- 8.7 seconds; case values 46.1 +/- 18.0 seconds; difference 17.1 +/- 14.9 seconds; p = 0.023. PCr-R was longer for cases relative to their matched controls for all but one pair; moreover while values clustered under 31 seconds for all but one control, they exceeded 35 seconds (with a spread up to 70 seconds) for all but one case. Discussion: These data provide the first direct evidence supporting mitochondrial dysfunction in Gulf War illness. Findings merit replication in a larger study and/or corroboration with additional mitochondrial assessment tools.	[Koslik, Hayley J.; Golomb, Beatrice A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Hamilton, Gavin] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Golomb, Beatrice A.] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Golomb, BA (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	bgolomb@ucsd.edu		Hamilton, Gavin/0000-0001-9302-5546	University of California, San Diego, Academic Senate Award [MED126M]; Department of Defense Congressionally Directed Medical Research Program [GW120071]	University of California, San Diego, Academic Senate Award; Department of Defense Congressionally Directed Medical Research Program(United States Department of Defense)	This study was funded by a University of California, San Diego, Academic Senate Award (MED126M) and the Department of Defense Congressionally Directed Medical Research Program (GW120071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouDonia MB, 1996, FUND APPL TOXICOL, V34, P201, DOI 10.1006/faat.1996.0190; Binns J., 2004, SCI PROGR UNDERSTAND; Binns JH, 2008, GULF WARE ILLNESS HL; Broderick G, 2013, BRAIN BEHAV IMMUN, V28, P159, DOI 10.1016/j.bbi.2012.11.007; Cecchine G., 2000, REV SCI LIT PERTAINS, V8; Chan JYH, 2006, NEUROPHARMACOLOGY, V51, P1109, DOI 10.1016/j.neuropharm.2006.06.024; Coffman CJ, 2005, NEUROEPIDEMIOLOGY, V24, P141, DOI 10.1159/000083297; Department of Defense, 2003, ENV EXP REP PEST; Fricker RD, 2000, MR101812OSD RAND, V12; General Accounting Office, 2004, GAO04159; Genova ML, 2004, ANN NY ACAD SCI, V1011, P86, DOI 10.1196/annals.1293.010; Gillert DJ, 1997, DOD SAYS 98910 EXPOS; GOLOMB B, 1999, REV SCI LIT PERTAINS, V2; Golomb B, 2012, OXIDATIVE STRESS MIT; Golomb BA, 2014, NEURAL COMP IN PRESS; Golomb BA, 2013, J CHILD NEUROL; Golomb BA, 2009, DRUG SAFETY, V32, P649, DOI 10.2165/00002018-200932080-00004; Golomb BA, 2008, P NATL ACAD SCI USA, V105, P4295, DOI 10.1073/pnas.0711986105; Haley RW, 2003, NEUROLOGY, V61, P750, DOI 10.1212/WNL.61.6.750; Hamilton G, 2006, J MAGN RESON IMAGING, V23, P459, DOI 10.1002/jmri.20524; Hamilton G, 2003, NMR BIOMED, V16, P168, DOI 10.1002/nbm.821; Horner RD, 2003, NEUROLOGY, V61, P742, DOI 10.1212/01.WNL.0000069922.32557.CA; Hotopf M, 2003, BRIT MED J, V327, P1370, DOI 10.1136/bmj.327.7428.1370; KEMP GJ, 1993, NMR BIOMED, V6, P66, DOI 10.1002/nbm.1940060111; Kroenke K, 1998, J OCCUP ENVIRON MED, V40, P520, DOI 10.1097/00043764-199806000-00004; Lee HC, 1997, J BIOMED SCI, V4, P319, DOI 10.1007/BF02258357; Milatovic D, 2006, THESCIENTIFICWORLDJO, V6, P295, DOI 10.1100/tsw.2006.38; MURPHY EJ, 1989, MAGNET RESON MED, V12, P282, DOI 10.1002/mrm.1910120218; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Ozakinci G, 2006, ENVIRON HEALTH PERSP, V114, P1553, DOI 10.1289/ehp.9251; Pena-Llopis S, 2003, DIS AQUAT ORGAN, V55, P237, DOI 10.3354/dao055237; Pena-Llopis S, 2003, AQUAT TOXICOL, V65, P337, DOI 10.1016/S0166-445X(03)00148-6; Rayhan RU, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058493, 10.1371/journal.pone.0063903]; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; THOMPSON CH, 1995, J APPL PHYSIOL, V78, P2131, DOI 10.1152/jappl.1995.78.6.2131; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wei YH, 1998, P SOC EXP BIOL MED, V217, P53; Whistler T, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-12	38	59	61	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92887	10.1371/journal.pone.0092887	http://dx.doi.org/10.1371/journal.pone.0092887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675771	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677500050
J	Lorent, N; Choun, K; Thai, S; Kim, T; Huy, S; Pe, R; van Griensven, J; Buyze, J; Colebunders, R; Rigouts, L; Lynen, L				Lorent, Natalie; Choun, Kimcheng; Thai, Sopheak; Kim, Tharin; Huy, Sopheaktra; Pe, Reaksmey; van Griensven, Johan; Buyze, Jozefien; Colebunders, Robert; Rigouts, Leen; Lynen, Lutgarde			Community-Based Active Tuberculosis Case Finding in Poor Urban Settlements of Phnom Penh, Cambodia: A Feasible and Effective Strategy	PLOS ONE			English	Article							TREATMENT SUCCESS; DIAGNOSIS; TB	Background: In light of the limitations of the current case finding strategies and the global urgency to improve tuberculosis (TB) case-detection, a renewed interest in active case finding (ACF) has risen. The WHO calls for more evidence on innovative ways of TB screening, especially from low-income countries, to inform global guideline development. We aimed to assess the feasibility of community-based ACF for TB among the urban poor in Cambodia and determine its impact on case detection, treatment uptake and outcome. Methods: Between 9/2/2012-31/3/2013 the Sihanouk Hospital Center of HOPE conducted a door-to-door survey for TB in deprived communities of Phnom Penh. TB workers and community health volunteers performed symptom screening, collected sputum and facilitated specimen transport to the laboratories. Fluorescence microscopy was introduced at three referral hospitals. The GeneXpert MTB/RIF assay (Xpert) was performed at tertiary level for individuals at increased risk of HIV-associated, drug-resistant or smear-negative TB. Mobile phone/short message system (SMS) was used for same-day issuing of positive results. TB workers contacted diagnosed patients and referred them for care at their local health centre. Results: In 14 months, we screened 315.874 individuals; we identified 12.201 aged >= 15 years with symptoms suggestive of TB; 84% provided sputum. We diagnosed 783, including 737 bacteriologically confirmed, TB cases. Xpert testing yielded 41% and 48% additional diagnoses among presumptive HIV-associated and multidrug-resistant TB cases, respectively. The median time from sputum collection to notification (by SMS) of the first positive (microscopy or Xpert) result was 3 days (IQR 2-6). Over 94% commenced TB treatment and 81% successfully completed it. Conclusion: Our findings suggest that among the urban poor ACF for TB, using a sensitive symptom screen followed by smear-microscopy and targeted Xpert, contributed to improved case detection of drug-susceptible and drug-resistant TB, shortening the diagnostic delay, and successfully bringing patients into care.	[Lorent, Natalie; Choun, Kimcheng; Thai, Sopheak; Huy, Sopheaktra; Pe, Reaksmey; van Griensven, Johan] Sihanouk Hosp, Ctr HOPE, Dept Infect Dis, Phnom Penh, Cambodia; [Kim, Tharin] Sihanouk Hosp, Ctr HOPE, Mycobacteriol Lab, Phnom Penh, Cambodia; [Rigouts, Leen] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Lorent, Natalie; van Griensven, Johan; Buyze, Jozefien; Colebunders, Robert; Lynen, Lutgarde] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Colebunders, Robert] Univ Antwerp, B-2020 Antwerp, Belgium; [Rigouts, Leen] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); University of Antwerp; University of Antwerp	Lorent, N (corresponding author), Sihanouk Hosp, Ctr HOPE, Dept Infect Dis, Phnom Penh, Cambodia.	nlorent@itg.be	Lynen, Lutgarde/AAT-9180-2020; Lynen, Lutgarde/A-1212-2014; Buyze, Jozefien/B-8550-2014	Lynen, Lutgarde/0000-0001-7183-4895; Lynen, Lutgarde/0000-0001-7183-4895; Buyze, Jozefien/0000-0001-6780-380X; Colebunders, Robert/0000-0002-1919-1340	TB REACH Initiative (wave 2) of the Stop TB partnership [T9-370-114CAM]; Directorate General for Development Cooperation, Belgium, through the Institute of Tropical Medicine, Belgium [FA3/II 2.08]; Research Foundation - Flanders [G.0322.10]	TB REACH Initiative (wave 2) of the Stop TB partnership; Directorate General for Development Cooperation, Belgium, through the Institute of Tropical Medicine, Belgium; Research Foundation - Flanders(FWO)	The study was funded by the TB REACH Initiative (wave 2) of the Stop TB partnership, grant number: T9-370-114CAM (http://www.stoptb.org/global/awards/tbreach/wave2.asp); the Directorate General for Development Cooperation, Belgium, through the Institute of Tropical Medicine, Belgium, grant number: FA3/II 2.08 (http://diplomatie.belgium.be/en/policy/development_cooperation/partnerships/non_governmental/scientific_cooperation/); and the Research Foundation - Flanders, programme grant G.0322.10 (http://www.fwo.be/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Darraji HAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073717; Ayles H, 2013, LANCET; Chadha VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042625; Claassens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058689; Cobelens F, 2012, J INFECT DIS, V205, pS191, DOI 10.1093/infdis/jis188; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Den Boon S, 2008, EPIDEMIOL INFECT, V136, P1342, DOI 10.1017/S0950268807000106; Dorman SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043307; Dowdy DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070485; Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109; Eang MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-469; Getahun H, 2010, LANCET, V376, P1205, DOI 10.1016/S0140-6736(10)61503-6; Golub JE, 2013, INT J TUBERC LUNG D, V17, P856, DOI 10.5588/ijtld.13.0059; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Hossain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044980; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Kranzer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001281; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Long Q, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-202; McCord GC, 2013, B WORLD HEALTH ORGAN, V91, P244, DOI 10.2471/BLT.12.109660; Miller AC, 2010, INT J TUBERC LUNG D, V14, P720; National Centre for Tuberculosis and Leprosy Control C Ministry of Health, 2013, SECOND NATIONAL TUBE; National Institute of Statistics DGfHaIM2, 2013, CAMBODIA DEMOGRAPHIC; National Tuberculosis and Leprosy Control Programme C, 2012, NATIONAL REPORT ON T; National Tuberculosis and Leprosy Control Programme C, 2013, NATIONAL REPORT ON T; National Tuberculosis and leprosy Programme C, 2011, NATIONAL REPORT ON T; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Ntinginya EN, 2012, INT J TUBERC LUNG D, V16, P1468, DOI 10.5588/ijtld.12.0127; Obermeyer Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001721; Raviglione M, 2013, LANCET; Santha T, 2003, INT J TUBERC LUNG D, V7, P258; Schuurman MWE, 1996, TUBERCLE LUNG DIS, V77, P549, DOI 10.1016/S0962-8479(96)90054-4; Sekandi JN, 2009, INT J TUBERC LUNG D, V13, P508; Shapiro AE, 2012, AM J RESP CRIT CARE, V185, P1110, DOI 10.1164/rccm.201111-1941OC; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2011, TECHNICAL AND OPERAT; WHO, 2010, TREATMENT FOR TUBERC; WHO, 2013, PRINCIPLES AND RECOM; Williams Virginia, 2013, Int J Tuberc Lung Dis, V17, P1, DOI 10.5588/ijtld.13.0447; World Health Organization, 2013, DEFINITIONS REPORTIN; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174; Zachariah R, 2012, INT J TUBERC LUNG D, V16, P714, DOI 10.5588/ijtld.11.0635	47	71	71	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92754	10.1371/journal.pone.0092754	http://dx.doi.org/10.1371/journal.pone.0092754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675985	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677500036
J	Hermes, R; Goritz, F; Saragusty, J; Stoops, MA; Hildebrandt, TB				Hermes, Robert; Goeritz, Frank; Saragusty, Joseph; Stoops, Monica A.; Hildebrandt, Thomas B.			Reproductive Tract Tumours: The Scourge of Woman Reproduction Ails Indian Rhinoceroses	PLOS ONE			English	Article							ARTIFICIAL-INSEMINATION; UTERINE LEIOMYOMA; FIBROIDS; PREGNANCY; WOMEN; SIMUM; ULTRASONOGRAPHY; EMBOLIZATION	In Indian rhinoceros, extensive leiomyoma, a benign smooth muscle tumour, was sporadically diagnosed post mortem and commonly thought of as contributing factor for reduced fecundity of this species in captivity. However, to date, the prevalence of reproductive tract tumours and their relevance for fecundity are unknown. Our analysis of the international studbook now reveals that females cease reproducing at the age of 18.1 +/- 1.2 years; equivalent to a reproductive lifespan of just 9.5 +/- 1.3 years. This short reproductive life is in sharp contrast to their longevity in captivity of over 40 years. Here we show, after examining 42% of the captive female population, that age-related genital tract tumours are highly prevalent in this endangered species. Growth and development of these tumours was found to be age-related, starting from the age of 10 years. All females older than 12 years had developed genital tumours, just 7-9 years past maturity. Tumour sizes ranged from 1.5-10 cm. With age, tumours became more numerous, sometimes merging into one large diffuse tumour mass. These tumours, primarily vaginal and cervical, presumably cause widespread young-age infertility by the age of 18 years. In few cases, tumour necrosis suggested possible malignancy of tumours. Possible consequences of such genital tract tumour infestation are hindered intromission, pain during mating, hampered sperm passage, risk of ascending infection during pregnancy, dystocia, or chronic vaginal bleeding. In humans, leiomyoma affect up to 80% of pre-menopause women. While a leading cause for infertility, pregnancy is known to reduce the risk of tumour development. However, different from human, surgical intervention is not a viable treatment option in rhinoceroses. Thus, in analogy to humans, we suggest early onset and seamless consecutive pregnancies to help reduce prevalence of this disease, better maintain a self-sustained captive population and improve animal welfare.	[Hermes, Robert; Goeritz, Frank; Saragusty, Joseph; Hildebrandt, Thomas B.] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany; [Stoops, Monica A.] Cincinnati Zoo & Bot Garden, Ctr Conservat & Res Endangered Wildlife, Cincinnati, OH USA	Leibniz Institut fur Zoo und Wildtierforschung	Hermes, R (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany.	hermes@izw-berlin.de	Saragusty, Joseph/M-5030-2016	Saragusty, Joseph/0000-0002-9274-7800				Aballi Neninger OL, 2002, ANN C AM ASS ZOO VET, P428; Aupperle H, 2008, J ZOO WILDLIFE MED, V39, P107, DOI 10.1638/2006-0045.1; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Burek KA, 2000, ANN C AM ASS ZOO VET, P468; Burns R., 2006, P AM ASS ZOO VET, P154; Cook H, 2010, Minerva Ginecol, V62, P225; Cooper NP, 2005, OBSTET GYNECOL SURV, V60, P132, DOI 10.1097/01.ogx.0000154688.02423.68; CRAMER SF, 1990, AM J CLIN PATHOL, V94, P435, DOI 10.1093/ajcp/94.4.435; Dejuste de Paula C, 2002, ANN C AM ASS ZOO VET, P435; Dinerstein E., 2003, RETURN UNICORNS NATU; Foose Thomas J., 1997, pi; Ford E.W., 1986, American Association of Zoo Veterinarians Annual Proceedings, V1986, P155; Galateanu G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068493; Gamble KC, 2004, ANN C AM ASS ZOO VET, P561; Goldberg J, 2006, CURR OPIN OBSTET GYN, V18, P402, DOI 10.1097/01.gco.0000233934.13684.cb; Goltenboth R., 1995, P209; Guldenschuh G, 2002, HUSBANDRY MANUAL GRE; Hermes R, 2006, THERIOGENOLOGY, V65, P1492, DOI 10.1016/j.theriogenology.2005.09.002; Hermes R, 2004, ANIM REPROD SCI, V82-3, P49, DOI 10.1016/j.anireprosci.2004.05.015; Hermes R, 2009, THERIOGENOLOGY, V72, P959, DOI 10.1016/j.theriogenology.2009.06.014; Hermes Robert, 2012, P546; Hernandez-Lopez L, 2007, THERIOGENOLOGY, V67, P399, DOI 10.1016/j.theriogenology.2006.06.016; Hildebrandt TB, 2007, THERIOGENOLOGY, V67, P1473, DOI 10.1016/j.theriogenology.2007.03.005; Hildebrandt TB, 2000, ZOO BIOL, V19, P321, DOI 10.1002/1098-2361(2000)19:5&lt;321::AID-ZOO4&gt;3.0.CO;2-K; Hlavacek G, 2002, INT STUDBOOK GREATER; IUCN, 2013, AFR RHIN WONT HOLD O; JONES ML, 1977, ZOO ANVERS, V42, P124; King NW, 1973, UTERUS, P548; Klein LV, 1997, ANN C AM ASS ZOO VET, P127; Kroon B, 2011, AUST NZ J OBSTET GYN, V51, P289, DOI 10.1111/j.1479-828X.2011.01300.x; Lueders I, 2010, REPROD FERT DEVELOP, V22, P1159, DOI 10.1071/RD09305; Mikaelian I, 2000, J VET DIAGN INVEST, V12, P371, DOI 10.1177/104063870001200414; Montali RJ, 1982, INT S ERKRANKUNGEN Z, V24, P117; Montali RJ, 1997, INT S ERKRANKUNGEN Z, P253; MYLNICZENKO ND, 2008, P AM ASS ZOO VET, P149; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; Owston MA, 2005, ANN C AM ASS ZOO VET, P100; Parazzini F, 1996, EPIDEMIOLOGY, V7, P440, DOI 10.1097/00001648-199607000-00018; PARAZZINI F, 1988, OBSTET GYNECOL, V72, P853, DOI 10.1097/00006250-198812000-00008; Pashov BN, 1990, ANN C AM ASS ZOO VET, P53; Rachlow JL, 1998, ANIM CONSERV, V1, P101, DOI 10.1111/j.1469-1795.1998.tb00017.x; Radcliffe RM, 2000, J ZOO WILDLIFE MED, V31, P201, DOI 10.1638/1042-7260(2000)031[0201:SLGUBI]2.0.CO;2; Radcliffe Robin W., 2007, P543, DOI 10.1002/9780470376478.ch48; Roberts J., 1986, American Association of Zoo Veterinarians Annual Proceedings, V1986, P173; Sabry M, 2012, REPROD SCI, V19, P339, DOI 10.1177/1933719111432867; Sapundzhiev E, 2007, J VET MED A, V54, P499, DOI 10.1111/j.1439-0442.2007.00949.x; Schaffer N.E. M., 2001, INT EL RHIN RES S 7; SCHAFFER NE, 1994, J ZOO WILDLIFE MED, V25, P337; Steck B, 2012, EUR ASS ZOOS AQ ANN; Steck B, 2010, EUR ASS ZOOS AQ ANN; Stoops MA, 2004, REPRODUCTION, V128, P843, DOI 10.1530/rep.1.00328; Viswanathan Meera, 2007, Evid Rep Technol Assess (Full Rep), P1; von Houwald F, 2012, GREATER ONE HORNED I; von Houwald FF, 2001, FOOT PROBLEMS INDIAN; Walker WJ, 2002, BJOG-INT J OBSTET GY, V109, P1262, DOI 10.1046/j.1471-0528.2002.01449.x; Wilson M, 2010, J ZOO WILDLIFE MED, V41, P111, DOI 10.1638/2009-0128.1; World Health Organization, 2003, TUMOURS BREAST FEMAL; WWF, 2010, JAV RHIN FOUND DEAD; Young LA, 1996, J ZOO WILDLIFE MED, V27, P96; Zimmermann A, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-6; Zschokke Samuel, 1998, IZN (International Zoo News), V45, P261	61	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92595	10.1371/journal.pone.0092595	http://dx.doi.org/10.1371/journal.pone.0092595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671211	Green Published, gold			2022-12-25	WOS:000333677000057
J	Magnhagen, C; Wacker, S; Forsgren, E; Myhre, LC; Espy, E; Amundsen, T				Magnhagen, Carin; Wacker, Sebastian; Forsgren, Elisabet; Myhre, Lise Cats; Espy, Elizabeth; Amundsen, Trond			Context Consistency and Seasonal Variation in Boldness of Male Two-Spotted Gobies	PLOS ONE			English	Article							STICKLEBACKS GASTEROSTEUS-ACULEATUS; GOBIUSCULUS-FLAVESCENS FABRICIUS; FALSE DISCOVERY RATE; ANIMAL PERSONALITY; PREDATION RISK; POECILIA-RETICULATA; PUMPKINSEED SUNFISH; BEHAVIORAL SYNDROME; NATURAL-SELECTION; TRADE-OFF	In order to attribute the behaviour of an animal to its personality it is important to study whether certain behavioural traits show up consistently across a variety of contexts. The aim of this study was to investigate whether breeding state males of the two-spotted goby, Gobiusculus flavescens, showed consistent degree of boldness when tested in four different behaviour assays. We also wanted to investigate whether boldness varied over the breeding season in accordance with changes in male-male competition for matings. We used two standard assays (the emergence test and the open field test), and two simple assays related to threat response. Repeated runs of each of the tests were highly correlated, and we found significant correlations between all four assays. Thus, we have documented both a within and a between-context consistency in risk-taking behaviour. Furthermore, we found that goby males studied during the middle of the breeding season were bolder than males studied at the end of the season. Since male two-spotted gobies face strongly decreasing male-male competition as the season progresses, the benefit of being bold for the mating success of the males may differ over the time of the breeding season. The difference in behaviour found over the season thus corresponds well with the sexual dynamics of this model species.	[Magnhagen, Carin] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Wacker, Sebastian; Myhre, Lise Cats; Espy, Elizabeth; Amundsen, Trond] Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway; [Forsgren, Elisabet] Norwegian Inst Nat Res NINA, Trondheim, Norway	Swedish University of Agricultural Sciences; Norwegian University of Science & Technology (NTNU); Norwegian Institute Nature Research	Magnhagen, C (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden.	carin.magnhagen@slu.se	Magnhagen, Carin/ABA-4968-2021	Amundsen, Trond/0000-0003-4261-0555	Royal Swedish Academy of Science, ASSEMBLE [227799]; Nordic Marine Academy; German Academic Exchange Service (DAAD)	Royal Swedish Academy of Science, ASSEMBLE; Nordic Marine Academy; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The study was financially supported by the Royal Swedish Academy of Science, ASSEMBLE (grant agreement no. 227799), Nordic Marine Academy (grants to LCM and SW), and the German Academic Exchange Service (DAAD; grant to SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens B, 2013, ECOL LETT, V16, P47, DOI 10.1111/ele.12011; Amundsen T, 2001, P NATL ACAD SCI USA, V98, P13155, DOI 10.1073/pnas.211439298; Beckmann C, 2013, ETHOLOGY, V119, P937, DOI 10.1111/eth.12137; Bell AM, 2012, BEHAVIOUR, V149, P1339, DOI 10.1163/1568539X-00003019; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjelvenmark J, 2003, BEHAVIOUR, V140, P55, DOI 10.1163/156853903763999890; Brown C, 2004, ANIM BEHAV, V68, P1325, DOI 10.1016/j.anbehav.2004.04.004; Brown C, 2007, BEHAV ECOL SOCIOBIOL, V62, P237, DOI 10.1007/s00265-007-0458-3; Burns JG, 2008, J COMP PSYCHOL, V122, P344, DOI 10.1037/0735-7036.122.4.344; Candolin U, 1998, P ROY SOC B-BIOL SCI, V265, P1171, DOI 10.1098/rspb.1998.0415; Carter AJ, 2013, BIOL REV, V88, P465, DOI 10.1111/brv.12007; Carter AJ, 2012, ANIM BEHAV, V83, P1051, DOI 10.1016/j.anbehav.2012.01.033; Castanheira MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062037; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Dammhahn M, 2012, P ROY SOC B-BIOL SCI, V279, P2645, DOI 10.1098/rspb.2012.0212; De Jong K., 2011, THESIS NORWEGIAN U S; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Forsgren E, 2004, NATURE, V429, P551, DOI 10.1038/nature02562; Garamszegi LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002647; Godin JGJ, 1996, P NATL ACAD SCI USA, V93, P10262, DOI 10.1073/pnas.93.19.10262; GORDON JCD, 1983, OPHELIA, V22, P173, DOI 10.1080/00785326.1983.10426593; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; King AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081116; Kortet R, 2007, EVOL ECOL RES, V9, P185; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MAGNHAGEN C, 1991, BEHAV ECOL, V2, P351, DOI 10.1093/beheco/2.4.351; Miller KA, 2006, ANIM BEHAV, V71, P1323, DOI 10.1016/j.anbehav.2005.08.018; Mobley KB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-6; Montiglio PO, 2012, ANIM BEHAV, V84, P1071, DOI 10.1016/j.anbehav.2012.08.010; Myhre LC, 2012, AM NAT, V179, P741, DOI 10.1086/665651; Nicolaus M, 2012, P ROY SOC B-BIOL SCI, V279, P4885, DOI 10.1098/rspb.2012.1936; Nyqvist MJ, 2013, ETHOLOGY, V119, P156, DOI 10.1111/eth.12049; Oosten JE, 2010, BEHAV ECOL SOCIOBIOL, V64, P793, DOI 10.1007/s00265-009-0896-1; Pelabon C, 2003, BEHAV ECOL, V14, P787, DOI 10.1093/beheco/arg074; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; SALVANES AGV, 1993, SARSIA, V78, P221, DOI 10.1080/00364827.1993.10413536; Schuett W, 2011, ETHOLOGY, V117, P908, DOI 10.1111/j.1439-0310.2011.01945.x; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Skolbekken R, 2001, J EXP MAR BIOL ECOL, V261, P137, DOI 10.1016/S0022-0981(01)00249-0; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Stamps JA, 2012, ANIM BEHAV, V83, P1325, DOI 10.1016/j.anbehav.2012.02.017; UTNE ACW, 1993, J EXP MAR BIOL ECOL, V166, P203, DOI 10.1016/0022-0981(93)90219-E; Waite TA, 2006, ECOSCIENCE, V13, P439, DOI 10.2980/1195-6860(2006)13[439:CTFDRA]2.0.CO;2; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; Wheeler A.C., 1969, FISHES BRIT ISLES N; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson AJW, 2005, MARINERS MIRROR, V91, P111; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wolf M, 2008, P NATL ACAD SCI USA, V105, P15825, DOI 10.1073/pnas.0805473105; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835	54	11	11	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93354	10.1371/journal.pone.0093354	http://dx.doi.org/10.1371/journal.pone.0093354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671255	gold, Green Published			2022-12-25	WOS:000333677000135
J	Zhu, YJ; Bu, QX; Liu, XY; Hu, WH; Wang, YY				Zhu, Yuanjun; Bu, Qixin; Liu, Xiaoyan; Hu, Wenhui; Wang, Yinye			Neuroprotective Effect of TAT-14-3-3 epsilon Fusion Protein against Cerebral Ischemia/Reperfusion Injury in Rats	PLOS ONE			English	Article							ISCHEMIC BRAIN-INJURY; TRANSDUCED TAT-DJ-1 PROTEIN; TAT-MEDIATED DELIVERY; CELL-DEATH; REPERFUSION INJURY; FUTURE PERSPECTIVES; OXIDATIVE STRESS; NEURON DEATH; AUTOPHAGY; STROKE	Stroke is the major cause of death and disability worldwide, and the thrombolytic therapy currently available was unsatisfactory. 14-3-3 epsilon is a well characterized member of 14-3-3 family, and has been reported to protect neurons against apoptosis in cerebral ischemia. However, it cannot transverse blood brain barrier (BBB) due to its large size. A protein transduction domain (PTD) of HIV TAT protein, is capable of delivering a large variety of proteins into the brain. In this study, we generated a fusion protein TAT-14-3-3 epsilon, and evaluated its potential neuroprotective effect in rat focal ischemia/reperfusion (I/R) model. Western blot analysis validated the efficient transduction of TAT-14-3-3 epsilon fusion protein into brain via a route of intravenous injection. TAT-14-3-3 epsilon pre-treatment 2 h before ischemia significantly reduced cerebral infarction volume and improved neurologic score, while post-treatment 2 h after ischemia was less effective. Importantly, pre- or post-ischemic treatment with TAT-14-3-3 epsilon significantly increased the number of surviving neurons as determined by Nissl staining, and attenuated I/R-induced neuronal apoptosis as showed by the decrease in apoptotic cell numbers and the inhibition of caspase-3 activity. Moreover, the introduction of 14-3-3 epsilon into brain by TAT-mediated delivering reduced the formation of autophagosome, attenuated LC3B-II upregulation and reversed p62 downregulation induced by ischemic injury. Such inhibition of autophagy was reversed by treatment with an autophagy inducer rapamycin (RAP), which also attenuated the neuroprotective effect of TAT-14-3-3 epsilon. Conversely, autophagy inhibitor 3-methyladenine (3-MA) inhibited I/R-induced the increase in autophagic activity, and attenuated I/R-induced brain infarct. These results suggest that TAT-14-3-3 epsilon can be efficiently transduced into brain and exert significantly protective effect against brain ischemic injury through inhibiting neuronal apoptosis and autophagic activation.	[Zhu, Yuanjun; Bu, Qixin; Liu, Xiaoyan; Wang, Yinye] Peking Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Beijing 100871, Peoples R China; [Hu, Wenhui] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA	Peking University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Wang, YY (corresponding author), Peking Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Beijing 100871, Peoples R China.	wangyinye@bjmu.edu.cn			Natural Science Foundation of China [61071002, 81302763]; Beijing Natural Science Foundation [7144218]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the Natural Science Foundation of China (61071002 and 81302763) and Beijing Natural Science Foundation (7144218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami F, 2007, AUTOPHAGY, V3, P42, DOI 10.4161/auto.3412; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Asoh S, 2008, ADV DRUG DELIVER REV, V60, P499, DOI 10.1016/j.addr.2007.09.011; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Cai B, 2011, EXP NEUROL, V227, P224, DOI 10.1016/j.expneurol.2010.11.009; Cao GD, 2002, J NEUROSCI, V22, P5423; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Chen RL, 2010, NAT REV NEUROL, V6, P256, DOI 10.1038/nrneurol.2010.36; Denicourt C, 2003, TRENDS PHARMACOL SCI, V24, P216, DOI 10.1016/S0165-6147(03)00074-9; Doeppner TR, 2010, NEUROBIOL DIS, V40, P265, DOI 10.1016/j.nbd.2010.05.033; Duncan PW, 2005, STROKE, V36, pE100, DOI 10.1161/01.STR.0000180861.54180.FF; Fujimura M, 1999, J NEUROSCI, V19, P3414; Gao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046092; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Gou XC, 2011, J DRUG TARGET, V19, P86, DOI 10.3109/10611861003733961; Grotta J, 2007, SURG NEUROL, V68, pS12, DOI 10.1016/j.surneu.2007.07.079; Guegan C, 2006, NEUROBIOL DIS, V22, P177, DOI 10.1016/j.nbd.2005.10.014; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; Hata R, 1999, METAB BRAIN DIS, V14, P117, DOI 10.1023/A:1020709814456; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Hu XM, 2006, J PROTEOME RES, V5, P2396, DOI 10.1021/pr060209x; Hu ZY, 2013, BRAIN RES, V1491, P204, DOI 10.1016/j.brainres.2012.11.004; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Jeong HJ, 2012, EXP MOL MED, V44, P586, DOI 10.3858/emm.2012.44.10.067; Jeong HJ, 2012, MOL CELLS, V33, P471, DOI 10.1007/s10059-012-2255-8; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kilic E, 2006, FRONT BIOSCI-LANDMRK, V11, P1716, DOI 10.2741/1917; Kilic U, 2003, STROKE, V34, P1304, DOI 10.1161/01.STR.0000066869.45310.50; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Lai Y, 2005, J NEUROCHEM, V94, P360, DOI 10.1111/j.1471-4159.2005.03212.x; Li WL, 2013, NEUROSCIENCE; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Love S, 2000, NEUROPATH APPL NEURO, V26, P55, DOI 10.1046/j.1365-2990.2000.00218.x; Love S, 2003, PROG NEURO-PSYCHOPH, V27, P267, DOI 10.1016/S0278-5846(03)00022-8; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Minnerup J, 2012, INT J MOL SCI, V13, P11753, DOI 10.3390/ijms130911753; Misra A, 2003, J PHARM PHARM SCI, V6, P252; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nijboer CH, 2008, STROKE, V39, P2578, DOI 10.1161/STROKEAHA.108.516401; Pan J, 2007, NEURORADIOLOGY, V49, P93, DOI 10.1007/s00234-006-0183-z; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; Pozuelo-Rubio M, 2011, AUTOPHAGY, V7, P240, DOI 10.4161/auto.7.2.14286; Qin AP, 2010, AUTOPHAGY, V6, P738, DOI 10.4161/auto.6.6.12573; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Rojas JI, 2007, EUR J NEUROL, V14, P895, DOI 10.1111/j.1468-1331.2007.01841.x; Rosenquist M, 2003, BRAZ J MED BIOL RES, V36, P403, DOI 10.1590/S0100-879X2003000400001; Sairanen T, 2006, BRAIN, V129, P189, DOI 10.1093/brain/awh645; Schulz JB, 1999, ANN NEUROL, V45, P421, DOI 10.1002/1531-8249(199904)45:4<421::AID-ANA2>3.0.CO;2-Q; Sheng R, 2010, AUTOPHAGY, V6, P482, DOI 10.4161/auto.6.4.11737; Shi RY, 2012, CNS NEUROSCI THER, V18, P250, DOI 10.1111/j.1755-5949.2012.00295.x; Smrcka M, 2003, PHYSIOL RES, V52, P117; Soane L, 2005, J NEUROCHEM, V95, P230, DOI 10.1111/j.1471-4159.2005.03359.x; Steinacker P, 2011, SEMIN CELL DEV BIOL, V22, P696, DOI 10.1016/j.semcdb.2011.08.005; Sugawara Taku, 2004, NeuroRx, V1, P17, DOI 10.1602/neurorx.1.1.17; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; van der Kooij MA, 2010, NEUROBIOL DIS, V38, P266, DOI 10.1016/j.nbd.2010.01.016; Wang JY, 2011, J NEUROPATH EXP NEUR, V70, P314, DOI 10.1097/NEN.0b013e31821352bd; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048247; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Won J, 2003, J BIOL CHEM, V278, P19347, DOI 10.1074/jbc.M213098200; Wu JS, 2009, CIRCULATION, V119, P1124, DOI 10.1161/CIRCULATIONAHA.108.812537; Xu F, 2012, NEUROSCI BULL, V28, P658, DOI 10.1007/s12264-012-1268-9; Ye NH, 2011, LIFE SCI, V89, P868, DOI 10.1016/j.lfs.2011.09.015; Yin W, 2006, NEUROBIOL DIS, V21, P358, DOI 10.1016/j.nbd.2005.07.015; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhong JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039378	70	37	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93334	10.1371/journal.pone.0093334	http://dx.doi.org/10.1371/journal.pone.0093334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671253	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677000134
J	Zhu, M; Yin, F; Fan, X; Jing, W; Chen, R; Liu, L; Zhang, L; Liu, Y; Liang, Y; Bu, F; Tong, X; Zheng, H; Zhao, J; Guo, Y				Zhu, M.; Yin, F.; Fan, X.; Jing, W.; Chen, R.; Liu, L.; Zhang, L.; Liu, Y.; Liang, Y.; Bu, F.; Tong, X.; Zheng, H.; Zhao, J.; Guo, Y.			Decreased TIP30 promotes Snail-mediated epithelial-mesenchymal transition and tumor-initiating properties in hepatocellular carcinoma	ONCOGENE			English	Article							DEPENDENT UP-REGULATION; E-CADHERIN EXPRESSION; NF-KAPPA-B; POOR-PROGNOSIS; NUCLEAR IMPORT; CANCER CELLS; STEM-CELLS; TGF-BETA; METASTASIS; TRANSCRIPTION	The poor prognosis of hepatocellular carcinoma (HCC) is mainly due to tumor recurrence and metastases. Recently, epithelial-mesenchymal transition (EMT) has been implicated in tumor invasion and metastasis. However, the underlying molecular mechanisms are yet to be elucidated. Here, we show that 30-kDa Tat-interacting protein (TIP30), also called CC3, is significantly downregulated during transforming growth factor-beta-induced EMT. In our in vitro and in vivo studies, we show that decreased TIP30 expression leads to EMT, as well as enhanced motility and invasion of HCC cells. Also, increased self-renewal ability and chemotherapeutic resistance are observed with TIP30 depletion. Moreover, Snail is one of the key transcription factors promoting EMT, and overexpression of TIP30 greatly decreased nucleic accumulation in Snail through the regulation of intracellular localization. Small interfering RNAs targeting Snail attenuated EMT and tumor-initiating properties induced by TIP30 deficiency. We further confirmed that TIP30 competitively interrupted the interaction of Snail with importin-beta 2 to block the nuclear import of Snail. Consistently, TIP30 expression significantly correlates with E-cadherin expression in HCC patients. TIP30 or combination of E-cadherin is a powerful marker in predicting the prognosis of HCC. Taken together, our results suggest a novel and critical role of TIP30 involved in HCC progression and aggressiveness.	[Zhu, M.; Yin, F.; Fan, X.; Chen, R.; Zhang, L.; Liu, Y.; Liang, Y.; Bu, F.; Tong, X.; Zhao, J.; Guo, Y.] Second Mil Med Univ, Int Joint Canc Res Inst, Shanghai 200433, Peoples R China; [Zhu, M.; Jing, W.; Liu, L.; Zheng, H.] Second Mil Med Univ, Changhai Hosp, Shanghai 200433, Peoples R China; [Yin, F.; Zhao, J.; Guo, Y.] Peoples Liberat Army Gen Hosp, Ctr Canc, PLA Postgrad Sch Med, Beijing, Peoples R China	Naval Medical University; Naval Medical University; Chinese People's Liberation Army General Hospital	Zheng, H (corresponding author), Second Mil Med Univ, Changhai Hosp, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	zheng_hl2004@163.com; zhaojian@smmu.edu.cn			Ministry of Science and Technology of China [2010CB945600, 2010CB833600, 2011CB966200]; National Nature Science Foundation of China; State Key Project for Infection Disease and New Drug Development and Programs of Shanghai Subject Chief Scientists; Municipal Commission of Education; Municipal Commission of Science and Technology	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Project for Infection Disease and New Drug Development and Programs of Shanghai Subject Chief Scientists; Municipal Commission of Education; Municipal Commission of Science and Technology	This work is supported in part by grants from Ministry of Science and Technology of China '973' and '863' programs (2010CB945600, 2010CB833600, 2011CB966200), National Nature Science Foundation of China, State Key Project for Infection Disease and New Drug Development and Programs of Shanghai Subject Chief Scientists, Municipal Commission of Education and Municipal Commission of Science and Technology.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Banerjee SK, 2012, J CELL COMMUN SIGNAL, V6, P63, DOI 10.1007/s12079-012-0158-2; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen XB, 2010, DIGEST DIS SCI, V55, P2219, DOI 10.1007/s10620-009-0992-0; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Coleman WB, 2003, CURR MOL MED, V3, P573, DOI 10.2174/1566524033479546; Dang HE, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-396; Fujiki K, 2013, ARCH TOXICOL, V87, P2119, DOI 10.1007/s00204-013-1077-6; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hwang WL, 2011, GASTROENTEROLOGY, V141, P279, DOI 10.1053/j.gastro.2011.04.008; Ito M, 2003, CANCER RES, V63, P8763; Jiang C, 2007, CANCER RES, V67, P3574, DOI 10.1158/0008-5472.CAN-06-0831; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim MS, 2013, MOL CELLS, V36, P177, DOI 10.1007/s10059-013-0061-6; King FW, 2004, MOL CELL BIOL, V24, P7091, DOI 10.1128/MCB.24.16.7091-7101.2004; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Li A, 2013, ONCOGENE, V32, P2273, DOI 10.1038/onc.2012.253; Lu B, 2008, CLIN CANCER RES, V14, P7405, DOI 10.1158/1078-0432.CCR-08-0409; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nakahara J, 2009, J CLIN INVEST, V119, P169, DOI 10.1172/JCI35440; NicAmhlaoibh R, 2001, ONCOGENE, V20, P270, DOI 10.1038/sj.onc.1204075; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Pecha J, 2007, ONCOGENE, V26, P7423, DOI 10.1038/sj.onc.1210548; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Poon RTP, 2001, J CLIN ONCOL, V19, P3037, DOI 10.1200/JCO.2001.19.12.3037; Shtivelman E, 1997, ONCOGENE, V14, P2167, DOI 10.1038/sj.onc.1201059; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tong X, 2009, AM J PATHOL, V174, P1931, DOI 10.2353/ajpath.2009.080846; Wang HT, 2013, PSYCHOPHARMACOLOGY, V228, P129, DOI 10.1007/s00213-013-3017-9; Wu KJ, 2012, CELL SIGNAL, V24, P2273, DOI 10.1016/j.cellsig.2012.08.004; Xue GD, 2012, CANCER DISCOV, V2, P248, DOI 10.1158/2159-8290.CD-11-0270; Yamasaki H, 2005, GENES CELLS, V10, P455, DOI 10.1111/j.1365-2443.2005.00850.x; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang XR, 2009, CLIN CANCER RES, V15, P5518, DOI 10.1158/1078-0432.CCR-09-0151; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Zhang CL, 2010, CANCER RES, V70, P10224, DOI 10.1158/0008-5472.CAN-10-3057; Zhang W, 2012, GASTROENTEROLOGY, V143, P1641, DOI 10.1053/j.gastro.2012.08.032; Zhao J, 2008, HEPATOLOGY, V48, P265, DOI 10.1002/hep.22280; Zhao J, 2008, CANCER RES, V68, P4133, DOI 10.1158/0008-5472.CAN-08-0432; Zhao J, 2007, HUM PATHOL, V38, P293, DOI 10.1016/j.humpath.2006.08.005	51	22	26	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 12	2015	34	11					1420	1431		10.1038/onc.2014.73	http://dx.doi.org/10.1038/onc.2014.73			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD1AR	24681951				2022-12-25	WOS:000350806500008
J	Fukunaga, T; Zou, W; Warren, JT; Teitelbaum, SL				Fukunaga, Tomohiro; Zou, Wei; Warren, Julia T.; Teitelbaum, Steven L.			Vinculin Regulates Osteoclast Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Cell Biology; Cytoskeleton; Integrins; Osteoclast; Vinculin	ALPHA-V-BETA-3 INTEGRIN; RESORBING OSTEOCLASTS; FOCAL ADHESIONS; ACTIN DYNAMICS; CYTOSKELETON; ACTIVATION; LIGAND; SYK; MACROPHAGES; PHENOTYPE	Background: Vinculin, an actin-binding protein, is essential for cytoskeletal organization. Results: Vinculin deficiency in osteoclasts impairs osteoclast function, not differentiation, leading to increased bone mass in vivo. Conclusion: Vinculin expression regulates osteoclast function in a talin-dependent, v3 integrin-independent manner. Significance: This is the first demonstration that vinculin regulates osteoclast function. Osteoclastic bone resorption depends upon the cell's ability to organize its cytoskeleton. Because vinculin (VCL) is an actin-binding protein, we asked whether it participates in skeletal degradation. Thus, we mated VCLfl/fl mice with those expressing cathepsin K-Cre (CtsK-VCL) to delete the gene in mature osteoclasts or lysozyme M-Cre (LysM-VCL) to target all osteoclast lineage cells. VCL-deficient osteoclasts differentiate normally but, reflecting cytoskeletal disorganization, form small actin rings and fail to effectively resorb bone. In keeping with inhibited resorptive function, CtsK-VCL and LysM-VCL mice exhibit a doubling of bone mass. Despite cytoskeletal disorganization, the capacity of VCL-/- osteoclastic cells to normally phosphorylate c-Src in response to v3 integrin ligand is intact. Thus, integrin-activated signals are unrelated to the means by which VCL organizes the osteoclast cytoskeleton. WT VCL completely rescues actin ring formation and bone resorption, as does VCLP878A, which is incapable of interacting with Arp2/3. As expected, deletion of the VCL tail domain (VCL1-880), which binds actin, does not normalize VCL-/- osteoclasts. The same is true regarding VCLI997A, which also prevents VCL/actin binding, and VCLA50I and VCL811-1066, both of which arrest talin association. Thus, VCL binding talin, but not Arp2/3, is critical for osteoclast function, and its selective inhibition retards physiological bone loss.	[Fukunaga, Tomohiro; Zou, Wei; Warren, Julia T.; Teitelbaum, Steven L.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Teitelbaum, Steven L.] Washington Univ, Sch Med, Dept Med, Div Bone & Mineral Dis, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Teitelbaum, SL (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Campus Box 8118,660 S Euclid Ave, St Louis, MO 63110 USA.	teitelbs@wustl.edu	Fukunaga, Tomohiro/T-4339-2019	Fukunaga, Tomohiro/0000-0003-0533-6454; Zou, Wei/0000-0001-8081-268X; Warren, Julia/0000-0003-2017-6444; Teitelbaum, Steven/0000-0002-4054-6679	National Institutes of Health [R01 AR032788, R01 AR057037, R01 AR046523, P30 AR057235]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057037, R01AR046523, R01AR032788, P30AR057235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR032788, R01 AR057037, R01 AR046523, and P30 AR057235.	Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Croke M, 2011, J CELL SCI, V124, P3811, DOI 10.1242/jcs.086280; Diez G, 2009, BIOPHYS J, V97, P3105, DOI 10.1016/j.bpj.2009.09.039; Dumbauld DW, 2013, P NATL ACAD SCI USA, V110, P9788, DOI 10.1073/pnas.1216209110; Faccio R, 2003, J CELL BIOL, V162, P499, DOI 10.1083/jcb.200212082; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Faccio R, 2002, J CELL SCI, V115, P2919; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hurst IR, 2004, J BONE MINER RES, V19, P499, DOI 10.1359/JBMR.0301238; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Pollard TD, 2001, J CELL SCI, V114, P3; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Thievessen I, 2013, J CELL BIOL, V202, P163, DOI 10.1083/jcb.201303129; Xu WM, 1998, DEVELOPMENT, V125, P327; Xu WM, 1998, J CELL SCI, V111, P1535; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; Zou W, 2008, MOL CELL, V31, P422, DOI 10.1016/j.molcel.2008.06.023; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083; Zou W, 2013, J CELL BIOCHEM, V114, P1871, DOI 10.1002/jcb.24531; Zou W, 2013, MOL CELL BIOL, V33, P830, DOI 10.1128/MCB.00790-12; Zou W, 2012, J BONE MINER RES, V27, P2490, DOI 10.1002/jbmr.1706	36	33	35	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13554	13564		10.1074/jbc.M114.550731	http://dx.doi.org/10.1074/jbc.M114.550731			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24675074	hybrid, Green Published			2022-12-25	WOS:000335522800050
J	Vo, N; Taga, A; Inaba, Y; Yoshida, H; Cotterill, S; Yamaguchi, M				Vo, Nicole; Taga, Ayano; Inaba, Yasuhiro; Yoshida, Hideki; Cotterill, Sue; Yamaguchi, Masamitsu			Drosophila Mcm10 Is Required for DNA Replication and Differentiation in the Compound Eye	PLOS ONE			English	Article							POLYMERASE-ALPHA; SACCHAROMYCES-CEREVISIAE; CHROMATIN ASSOCIATION; CATALYTIC SUBUNIT; FISSION YEAST; BINDING; MELANOGASTER; EXPRESSION; INITIATION; COMPLEX	Mini chromosome maintenance 10 (Mcm10) is an essential protein, which is conserved from S. cerevisiae to Drosophila and human, and is required for the initiation of DNA replication. Knockdown of Drosophila Mcm10 (dMcm10) by RNA interference in eye imaginal discs induces abnormal eye morphology (rough eye phenotype), and the number of ommatidia is decreased in adult eyes. We also observed a delay in the S phase and M phase in eye discs of dMcm10 knockdown fly lines. These results show important roles for dMcm10 in the progression of S and M phases. Furthermore, genome damage and apoptosis were induced by dMcm10 knockdown in eye imaginal discs. Surprisingly, when we used deadpan-lacZ and klingon-lacZ enhancer trap lines to monitor the photoreceptor cells in eye discs, knockdown of dMcm10 by the GMR-GAL4 driver reduced the signals of R7 photoreceptor cells. These data suggest an involvement of dMcm10 in R7 cell differentiation. This involvement appears to be independent of the apoptosis induced by dMcm10 knockdown. Together, these results suggest that dMcm10 knockdown has an effect on DNA replication and R7 cell differentiation.	[Vo, Nicole; Taga, Ayano; Inaba, Yasuhiro; Yoshida, Hideki; Yamaguchi, Masamitsu] Kyoto Inst Technol, Dept Appl Biol, Kyoto 606, Japan; [Vo, Nicole; Taga, Ayano; Inaba, Yasuhiro; Yoshida, Hideki; Yamaguchi, Masamitsu] Kyoto Inst Technol, Insect Biomed Res Ctr, Kyoto 606, Japan; [Cotterill, Sue] St Georges Univ London, Dept Basic Med Sci, London, England	Kyoto Institute of Technology; Kyoto Institute of Technology; St Georges University London	Yamaguchi, M (corresponding author), Kyoto Inst Technol, Dept Appl Biol, Kyoto 606, Japan.	myamaguc@kit.ac.jp		Yamaguchi, Masamitsu/0000-0002-6321-9750	JSPS; Ministry of Education, Culture, Sports, Science and Technology of Japan	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid from JSPS and the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Apger J, 2010, GENETICS, V185, P1151, DOI 10.1534/genetics.110.117234; Chattopadhyay S, 2007, MOL BIOL CELL, V18, P4085, DOI 10.1091/mbc.E06-12-1148; Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; Cook CR, 2003, J BIOL CHEM, V278, P36051, DOI 10.1074/jbc.M306049200; Douglas NL, 2005, MOL BIOL REP, V32, P197, DOI 10.1007/s11033-005-2312-x; Du Wenyue, 2012, Subcell Biochem, V62, P197, DOI 10.1007/978-94-007-4572-8_11; Du WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070518; Gregan J, 2003, MOL BIOL CELL, V14, P3876, DOI 10.1091/mbc.E03-02-0090; Hayashi Y, 2006, BBA-GENE STRUCT EXPR, V1759, P359, DOI 10.1016/j.bbaexp.2006.07.002; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Hirose F, 2001, MOL CELL BIOL, V21, P7231, DOI 10.1128/MCB.21.21.7231-7242.2001; Izumi M, 2004, J BIOL CHEM, V279, P32569, DOI 10.1074/jbc.M314017200; Kanke M, 2012, EMBO J, V31, P2182, DOI 10.1038/emboj.2012.68; Knott SRV, 2009, GENE DEV, V23, P1077, DOI 10.1101/gad.1784309; Liachko I, 2005, GENETICS, V171, P503, DOI 10.1534/genetics.105.042333; Liachko I, 2009, GENETICS, V181, P379, DOI 10.1534/genetics.108.099101; Reichhart JM, 2002, GENESIS, V34, P160, DOI 10.1002/gene.10122; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Ricke RM, 2006, J BIOL CHEM, V281, P18414, DOI 10.1074/jbc.M513551200; ROBERTSON HM, 1988, GENETICS, V118, P461; Robertson PD, 2008, J BIOL CHEM, V283, P3338, DOI 10.1074/jbc.M706267200; Robertson PD, 2010, J BIOL CHEM, V285, P22942, DOI 10.1074/jbc.M110.131276; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; Sun JT, 1999, MOL CELL BIOL, V19, P216; Thu YM, 2013, TRENDS BIOCHEM SCI, V38, P184, DOI 10.1016/j.tibs.2012.12.003; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Warren EM, 2008, STRUCTURE, V16, P1892, DOI 10.1016/j.str.2008.10.005; Warren EM, 2009, J BIOL CHEM, V284, P24662, DOI 10.1074/jbc.M109.020438; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Wolff Tanya, 1993, P1277; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Yamaguchi M, 1995, BIOL CELL, V85, P147, DOI 10.1016/0248-4900(96)85275-0; Yang XW, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-13; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	35	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93450	10.1371/journal.pone.0093450	http://dx.doi.org/10.1371/journal.pone.0093450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686397	Green Published, gold, Green Submitted			2022-12-25	WOS:000340842300011
J	Shen, JH; Nair, A; Saxena, R; Zhang, CC; Borrelli, J; Tang, LP				Shen, Jinhui; Nair, Ashwin; Saxena, Ramesh; Zhang, Cheng Cheng; Borrelli, Joseph, Jr.; Tang, Liping			Tissue Engineering Bone Using Autologous Progenitor Cells in the Peritoneum	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ACUTE INFLAMMATORY RESPONSES; IN-VIVO; OSTEOGENIC DIFFERENTIATION; MORPHOGENETIC PROTEIN-2; GROWTH-FACTOR; SCAFFOLDS; REGENERATION; RECRUITMENT; ADHESION	Despite intensive research efforts, there remains a need for novel methods to improve the ossification of scaffolds for bone tissue engineering. Based on a common phenomenon and known pathological conditions of peritoneal membrane ossification following peritoneal dialysis, we have explored the possibility of regenerating ossified tissue in the peritoneum. Interestingly, in addition to inflammatory cells, we discovered a large number of multipotent mesenchymal stem cells (MSCs) in the peritoneal lavage fluid from mice with peritoneal catheter implants. The osteogenic potential of these peritoneal progenitor cells was demonstrated by their ability to easily infiltrate decalcified bone implants, produce osteocalcin and form mineralized bone in 8 weeks. Additionally, when poly(l-lactic acid) scaffolds loaded with bone morphogenetic protein-2 (a known osteogenic differentiation agent) were implanted into the peritoneum, signs of osteogenesis were seen within 8 weeks of implantation. The results of this investigation support the concept that scaffolds containing BMP-2 can stimulate the formation of bone in the peritoneum via directed autologous stem and progenitor cell responses.	[Shen, Jinhui; Nair, Ashwin; Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA; [Saxena, Ramesh] Univ Texas SW Med Ctr Dallas, Div Nephrol, Dallas, TX 75390 USA; [Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Borrelli, Joseph, Jr.] Texas Hlth Arlington Mem Hosp, Texas Hlth Phys Grp, Arlington, TX USA; [Tang, Liping] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan	University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Kaohsiung Medical University	Tang, LP (corresponding author), Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.	ltang@uta.edu	Zhang, Cheng/GRS-8698-2022; Nair, Ashwin/B-8307-2011	Nair, Ashwin/0000-0002-7334-3114	National Institutes of Health [EB007271, CA172268]; NATIONAL CANCER INSTITUTE [R01CA172268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This works was supported by National Institutes of Health grants EB007271 and CA172268. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2004, AM J ROENTGENOL, V182, P441, DOI 10.2214/ajr.182.2.1820441; Arpornmaeklong P, 2009, STEM CELLS DEV, V18, P955, DOI 10.1089/scd.2008.0310; Bellon JM, 2002, AM J SURG, V184, P154, DOI 10.1016/S0002-9610(02)00907-8; Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P1, DOI 10.1002/term.63; Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Campbell GR, 2008, J TISSUE ENG REGEN M, V2, P50, DOI 10.1002/term.66; Campbell JH, 2000, ANN NY ACAD SCI, V902, P224; Cao Y, 2008, J BIOMED MATER RES A, V87A, P719, DOI 10.1002/jbm.a.31781; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chartoff EH, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/586586; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Chue WL, 2004, J VASC SURG, V39, P859, DOI 10.1016/j.jvs.2003.03.003; Crisostomo PR, 2006, SHOCK, V26, P575, DOI 10.1097/01.shk.0000235087.45798.93; Di Paolo N, 2004, PERITON DIALYSIS INT, V24, P471; Diao HJ, 2009, TISSUE ENG PT A, V15, P2687, DOI [10.1089/ten.tea.2008.0621, 10.1089/ten.TEA.2008.0621]; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dudek AZ, 2003, BLOOD, V101, P4687, DOI 10.1182/blood-2002-08-2363; Fadare O, 2002, MODERN PATHOL, V15, P777, DOI 10.1097/01.MP.0000017565.19341.63; GANDHI VC, 1980, ARCH INTERN MED, V140, P1201, DOI 10.1001/archinte.140.9.1201; Garosi G, 2001, PERITON DIALYSIS INT, V21, P417; Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008; GUO W, 1993, INT J ARTIF ORGANS, V16, P276, DOI 10.1177/039139889301600508; Gupta B, 2007, PROG POLYM SCI, V32, P455, DOI 10.1016/j.progpolymsci.2007.01.005; Hakki SS, 2014, J BIOMED MATER RES B, V102, P119, DOI 10.1002/jbm.b.32988; Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6; Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019; Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009; Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231; Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226; Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124; Ioannidis O, 2012, J RES MED SCI, V17, P92; King RD, 2010, NEUROIMAGE, V53, P471, DOI 10.1016/j.neuroimage.2010.06.050; Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093; Le SJ, 2010, DIFFERENTIATION, V79, P232, DOI 10.1016/j.diff.2010.03.001; Libetta C, 1996, KIDNEY INT, V49, P506, DOI 10.1038/ki.1996.72; LORD BI, 1995, BLOOD, V85, P3412, DOI 10.1182/blood.V85.12.3412.bloodjournal85123412; Matthews BD, 2005, J SURG RES, V123, P227, DOI 10.1016/j.jss.2004.08.012; Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4; Mizutani H, 1996, Nagoya J Med Sci, V59, P37; Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063; Nair A, 2011, ACTA BIOMATER, V7, P3887, DOI 10.1016/j.actbio.2011.06.050; Nair AM, 2013, BIOMATERIALS, V34, P7364, DOI 10.1016/j.biomaterials.2013.06.031; Najman S, 2004, BIO-MED MATER ENG, V14, P61; Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L; Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019; Pelus LM, 2006, EXP HEMATOL, V34, P1010, DOI 10.1016/j.exphem.2006.04.004; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Riser BL, 2011, NEPHROL DIAL TRANSPL, V26, P3349, DOI 10.1093/ndt/gfr039; SAMPATH TK, 1992, J BIOL CHEM, V267, P20352; Shen JH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00067; Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Song I, 2011, BIOCHEM BIOPH RES CO, V408, P126, DOI 10.1016/j.bbrc.2011.03.135; Spinella-Jaegle S, 2001, BONE, V29, P323, DOI 10.1016/S8756-3282(01)00580-4; Stocum DL, 2008, DEV DYNAM, V237, P3648, DOI 10.1002/dvdy.21774; Takahashi S, 1987, Nihon Seikeigeka Gakkai Zasshi, V61, P197; TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147; Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549; Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841; Thevenot P, 2008, TISSUE ENG PART C-ME, V14, P319, DOI 10.1089/ten.tec.2008.0221; Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144; TULI SM, 1978, J BONE JOINT SURG BR, V60, P116, DOI 10.1302/0301-620X.60B1.342532; URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601; Vranken I, 2008, BIOMATERIALS, V29, P797, DOI 10.1016/j.biomaterials.2007.10.041; Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953; WLODARSKI KH, 1991, CLIN ORTHOP RELAT R, P8; Yaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712; Zhang F, 2009, J BIOL CHEM, V284, P17564, DOI 10.1074/jbc.M109.013987; Zhang J, 2004, LEUKEMIA RES, V28, P631, DOI 10.1016/j.leukres.2003.10.028; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095	71	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93514	10.1371/journal.pone.0093514	http://dx.doi.org/10.1371/journal.pone.0093514			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681529	Green Published, Green Submitted, gold			2022-12-25	WOS:000333678100051
J	Dia, N; Sarr, FD; Thiam, D; Sarr, TF; Espie, E; OmarBa, I; Coly, M; Niang, M; Richard, V				Dia, Ndongo; Sarr, Fatoumata Diene; Thiam, Diamilatou; Sarr, Tening Faye; Espie, Emmanuelle; OmarBa, Ibrahim; Coly, Malang; Niang, Mbayame; Richard, Vincent		4S Network Grp	Influenza-Like Illnesses in Senegal: Not Only Focus on Influenza Viruses	PLOS ONE			English	Article							SENTINEL SURVEILLANCE; VIRAL ETIOLOGY; MADAGASCAR	Influenza surveillance in African countries was initially restricted to the identification of circulating strains. In Senegal, the network has recently been enhanced (i) to include epidemiological data from Dakar and other regions and (ii) to extend virological surveillance to other respiratory viruses. Epidemiological data from the sentinel sites is transmitted daily by mobile phone. The data include those for other febrile syndromes similar to influenza- like illnesses (ILI), corresponding to integrated approach. Also, clinical samples are randomly selected and analyzed for influenza and other respiratory viruses. There were 101,640 declared visits to the 11 sentinel sites between week 11-2012 and week 35-2013; 22% of the visits were for fever syndromes and 23% of the cases of fever syndrome were ILI. Influenza viruses were the second most frequent cause of ILI (20%), after adenoviruses (21%) and before rhinoviruses (18%) and enteroviruses (15%). Co-circulation and co-infection were frequent and were responsible for ILI peaks. The first months of implementation of the enhanced surveillance system confirmed that viruses other the influenza make large contributions to influenza- like illnesses. It is therefore important to consider these etiologies in the development of strategies to reduce respiratory infections. More informative tools and research studies are required to assess the burden of respiratory infections in developing countries.	[Dia, Ndongo; Niang, Mbayame] Pasteur Inst Dakar, Virol Unit, Dakar, Senegal; [Sarr, Fatoumata Diene; Thiam, Diamilatou; Sarr, Tening Faye; Espie, Emmanuelle; Richard, Vincent] Pasteur Inst Dakar, Epidemiol Unit, Dakar, Senegal; [OmarBa, Ibrahim] Minist Hlth, Dakar, Senegal; [Coly, Malang] World Hlth Org, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; World Health Organization	Richard, V (corresponding author), Pasteur Inst Dakar, Epidemiol Unit, Dakar, Senegal.	vrichard@pasteur.sn		Vincent, RICHARD/0000-0002-6961-1753	Department of Health and Human Service via the International Network of Pasteur Institutes [IDSEP 110011-01-00]	Department of Health and Human Service via the International Network of Pasteur Institutes	This network was supported by the Department of Health and Human Service (Grant Number: IDSEP 110011-01-00) via the International Network of Pasteur Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dosseh A, 2000, AM J TROP MED HYG, V62, P639, DOI 10.4269/ajtmh.2000.62.639; El Moussi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074064; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Heraud JM, 2012, J INFECT DIS, V206, pS5, DOI 10.1093/infdis/jis541; Kebede S, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-22; Kim HK, 2013, J CLIN MICROBIOL, V51, P1137, DOI 10.1128/JCM.02958-12; Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380; Monto AS, 2004, INT CONGR SER, V1263, P3, DOI 10.1016/j.ics.2004.02.049; Niang MN, 2012, J INFECT DIS, V206, pS129, DOI 10.1093/infdis/jis576; Niang MN, 2010, J MED VIROL, V82, P866, DOI 10.1002/jmv.21665; Njouom R, 2012, J INFECT DIS, V206, pS29, DOI 10.1093/infdis/jis573; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Rajatonirina S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072839; Rajatonirina S, 2012, B WORLD HEALTH ORGAN, V90, P385, DOI 10.2471/BLT.11.097816; Randrianasolo L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-31; Razanajatovo NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017579; Schoub Barry D, 2010, Expert Rev Respir Med, V4, P167, DOI 10.1586/ers.10.10; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Yazdanbakhsh M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000182	19	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93227	10.1371/journal.pone.0093227	http://dx.doi.org/10.1371/journal.pone.0093227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675982	Green Published, gold			2022-12-25	WOS:000333677500095
J	Jagielski, AC; Brown, A; Hosseini-Araghi, M; Thomas, GN; Taheri, S				Jagielski, Alison C.; Brown, Adrian; Hosseini-Araghi, Marzieh; Thomas, G. Neil; Taheri, Shahrad			The Association between Adiposity, Mental Well-Being, and Quality of Life in Extreme Obesity	PLOS ONE			English	Article							BODY-MASS INDEX; HOSPITAL ANXIETY; HEALTH-STATUS; DEPRESSION; POPULATION; DISORDERS; EUROQOL; SCALE; MOOD	Objectives: To explore the cross-sectional association between adiposity, mental well-being, and quality of life in extreme obese individuals entering a UK specialist weight management service prior to treatment commencement. Methods: The sample comprised 263 extreme obese individuals who were referred to the service as a result of having a body mass index (BMI) >= 40 kg/m(2) or >= 35 kg/m(2) with a co-morbid health condition. In a retrospective analysis, routinely collected baseline clinical examination data and self-report questionnaires (Impact of Weight on Quality of Life: IWQOL-Lite, EQ5D-3L, and Hospital Anxiety and Depression Scale: HADS) were analysed to examine the cross-sectional association between adiposity and quality of life. Results: The sample was predominantly female (74.8%) with mean BMI 47.0 +/- 7.9 kg/m(2). Increasing adiposity was significantly negatively associated with quality of life, with an increase of 1 BMI unit associated with decreases of 1.93 in physical function (95% CI -2.86 + -1.00, p<0.001), 1.62 in self-esteem (95% CI -2.67 + -0.57, p<0.05), 2.69 in public distress (95% CI -3.75 + -1.62, p<0.001), 1.33 in work (95% CI -2.63 + -0.02, p<0.05), and 1.79 in total IWQOL-Lite scores (95% CI -2.65 + -0.93, p<0.001). Adiposity was associated with significantly increased risk of problems in mobility (OR = 3.44, 95% CI 1.4728.05), and performing usual activities (OR = 2.45, 95% CI 1.10-5.46) in highest relative to lowest BMI tertile. The prevalence of experience of symptoms of anxiety (70.3%) and depression (66.2%) as measured by HADS was consistently high. Conclusions: We identified a high prevalence of psychological co-morbidity, including widespread experience of symptoms of anxiety and depressive disorders and reduced quality of life among these extreme obese individuals seeking weight management treatment. Clinical implications include the need for the incorporation of strategies to improve mental wellbeing into multi-disciplinary weight management interventions.	[Jagielski, Alison C.; Hosseini-Araghi, Marzieh; Thomas, G. Neil; Taheri, Shahrad] Birmingham & Black Country NIHR CLAHRC, Birmingham, W Midlands, England; [Brown, Adrian; Taheri, Shahrad] Heart England NHS Fdn Trust, Specialist Weight Management Serv, Birmingham, W Midlands, England; [Thomas, G. Neil] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Thomas, G. Neil] Heidelberg Univ, Mannheim Med Fac, Inst Publ Hlth Social & Prevent Med, Mannheim, Germany; [Taheri, Shahrad] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Taheri, Shahrad] Kings Coll London, Dept Med, London, England	Heart of England NHS Foundation Trust; University of Birmingham; Ruprecht Karls University Heidelberg; Cornell University; University of London; King's College London	Thomas, GN (corresponding author), Birmingham & Black Country NIHR CLAHRC, Birmingham, W Midlands, England.	gneilthomas@yahoo.co.uk; staheri@me.com	Taheri, Shahrad/O-9721-2016; Thomas, G. Neil/A-1879-2013	Taheri, Shahrad/0000-0001-8314-1500; Thomas, G. Neil/0000-0002-2777-1847	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme	National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme(National Institute for Health Research (NIHR))	AJ, MHA and ST were supported by the National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC) programme. NIHR disclaimer: This paper presents independent work supported by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlantis E, 2008, INT J OBESITY, V32, P881, DOI 10.1038/ijo.2008.54; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Bruffaerts R, 2008, CAN J PSYCHIAT, V53, P679, DOI 10.1177/070674370805301007; Butler GS, 1999, INT J OBESITY, V23, P505, DOI 10.1038/sj.ijo.0800850; Cox TL, 2012, APPL RES QUAL LIFE, V7, P309, DOI 10.1007/s11482-011-9160-8; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Dixon JB, 2002, OBES SURG, V12, P65, DOI 10.1381/096089202321144612; Doll HA, 2000, OBES RES, V8, P160, DOI 10.1038/oby.2000.17; Fabricatore AN, 2005, OBES SURG, V15, P304, DOI 10.1381/0960892053576578; Fettich KC, 2012, OBESITY, V20, P1118, DOI 10.1038/oby.2012.12; FITZGIBBON ML, 1993, HEALTH PSYCHOL, V12, P342, DOI 10.1037/0278-6133.12.5.342; Fontaine KR, 1996, J FAM PRACTICE, V43, P265; Gariepy G, 2010, INT J OBESITY, V34, P407, DOI 10.1038/ijo.2009.252; Health and Social Care Information Centre, 2012, HLTH SURV ENGL 2012; Health and Social Care Information Centre, 2012, HLTH SURV ENGL 2011; Heo M, 2003, OBES RES, V11, P209, DOI 10.1038/oby.2003.33; Jia HM, 2005, J PUBLIC HEALTH-UK, V27, P156, DOI 10.1093/pubmed/fdi025; Karlsson J, 2007, INT J OBESITY, V31, P1248, DOI 10.1038/sj.ijo.0803573; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Kolotkin RL, 2002, OBES RES, V10, P748, DOI 10.1038/oby.2002.102; Kolotkin RL, 2001, OBES RES, V9, P564, DOI 10.1038/oby.2001.73; Kolotkin RL, 2001, OBES RES, V9, P102, DOI 10.1038/oby.2001.13; Kolotkin RL, 2006, OBESITY, V14, P472, DOI 10.1038/oby.2006.62; Korhonen PE, 2014, QUAL LIFE RES, V23, P67, DOI 10.1007/s11136-013-0433-6; Mannucci E, 1999, ADDICT BEHAV, V24, P345, DOI 10.1016/S0306-4603(98)00055-0; McElroy SL, 2004, J CLIN PSYCHIAT, V65, P634; Murphy JM, 2009, INT J OBESITY, V33, P335, DOI 10.1038/ijo.2008.273; National Patient Safety Agency, 2009, DEF RES NRES GUID HE; Onyike CU, 2003, AM J EPIDEMIOL, V158, P1139, DOI 10.1093/aje/kwg275; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Sach TH, 2007, INT J OBESITY, V31, P189, DOI 10.1038/sj.ijo.0803365; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Sturm R, 2013, INT J OBESITY, V37, P889, DOI 10.1038/ijo.2012.159; Tessier A, 2011, QUAL LIFE RES, V20, P467, DOI 10.1007/s11136-010-9787-1; Thomas DM, 2013, OBESITY, DOI [10.1002/oby.20520, DOI 10.1002/0BY.20520]; WADDEN TA, 1985, ANN INTERN MED, V103, P1062, DOI 10.7326/0003-4819-103-6-1062; Zhao G, 2009, INT J OBESITY, V33, P257, DOI 10.1038/ijo.2008.268; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	39	38	38	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92859	10.1371/journal.pone.0092859	http://dx.doi.org/10.1371/journal.pone.0092859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24671197	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000086
J	Kim, MY; Finch, AM; Lumbers, ER; Boyce, AC; Gibson, KJ; Eiby, YA; Lingwood, BE				Kim, Min Young; Finch, Angela M.; Lumbers, Eugenie R.; Boyce, Amanda C.; Gibson, Karen J.; Eiby, Yvonne A.; Lingwood, Barbara E.			Expression of Adrenoceptor Subtypes in Preterm Piglet Heart Is Different to Term Heart	PLOS ONE			English	Article							BETA-ADRENERGIC-RECEPTORS; VENA-CAVA FLOW; ALPHA-1-ADRENERGIC RECEPTOR; BINDING-SITES; INFANTS; MECHANISMS; OVEREXPRESSION; HEMORRHAGE; INOTROPES; DOPAMINE	preterm delivery increases the risk of inadequate systemic blood flow and hypotension and many preterm infants fail to respond to conventional inotrope treatments. If the profile of cardiac adrenoceptor subtypes in the preterm neonate is different to that at term this may contribute to these clinical problems. This study measured mRNA expression of beta(1), beta(2), alpha(1A,) alpha(2A) and alpha(2B)-adrenoceptor subtypes by real time PCR in term (113d), preterm (91d) and preterm piglets (91d) exposed to maternal glucocorticoid treatment. Abundance of beta(1)-adrenoceptor binding sites in the left ventricle was measured using saturation binding assays. Relative abundance of beta(1)-adrenoceptor mRNA in untreated Preterm hearts was similar to 50% term abundance in both left and right ventricles (P<0.001). Trends in receptor binding site density measurements supported this observation (P=0.07). Glucocorticoid exposure increased beta(1)-adrenoceptor mRNA levels in the right ventricle of preterm hearts (P=0.008) but did not alter expression in the left ventricle (P>0.1). Relative abundance of alpha(1A) adrenoceptor rnRNA was the same in preterm and term piglet hearts (P= >0.1) but was reduced by maternal glucocorticoid treatment (P<0.01); alpha(2A)-adrenoceptor mRNA abundance was higher in untreated and glucocorticoid exposed preterm piglet hearts than in term piglets (P < 0.001). There was no difference between male and female piglets in mRNA abundance of any of he genes studied. In conclusion, there is reduced mRNA abundance of beta(1)-adrenoceptors in he preterm pig heart. If this lower expression of beta-adrenoceptars occurs in human preterm infants, it could explain their poor cardiovascular function and their frequent failure to respond to commonly used inotropes.	[Kim, Min Young; Lumbers, Eugenie R.; Eiby, Yvonne A.; Lingwood, Barbara E.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Finch, Angela M.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia; [Lumbers, Eugenie R.; Boyce, Amanda C.; Gibson, Karen J.] Univ New S Wales, Sch Med Sci, Dept Physiol, Sydney, NSW, Australia; [Lumbers, Eugenie R.] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia	University of Queensland; University of New South Wales Sydney; University of New South Wales Sydney; University of Newcastle	Lingwood, BE (corresponding author), Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia.	b.lingwood@uq.edu.au	Finch, Angela M/F-5962-2012; Lingwood, Barbara E/F-1398-2010; Eiby, Yvonne/F-2772-2010; Lumbers, Eugenie/AAS-4930-2020	Finch, Angela M/0000-0002-4598-6745; Eiby, Yvonne/0000-0003-0079-7796; 	National Health and Medical Research Council of Australia [5696351]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia [grant number 5696351 (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adigun AA, 2010, NEUROTOXICOL TERATOL, V32, P193, DOI 10.1016/j.ntt.2009.10.002; Akhter SA, 1997, J BIOL CHEM, V272, P21253, DOI 10.1074/jbc.272.34.21253; BAKER SP, 1980, BRIT J PHARMACOL, V68, P65, DOI 10.1111/j.1476-5381.1980.tb10699.x; BEINLICH CJ, 1995, J MOL CELL CARDIOL, V27, P273, DOI 10.1016/S0022-2828(08)80026-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carron J, 2005, DOMEST ANIM ENDOCRIN, V28, P257, DOI 10.1016/j.domaniend.2004.10.001; CHEN FCM, 1979, EUR J PHARMACOL, V58, P255, DOI 10.1016/0014-2999(79)90474-6; Cox DJ, 2012, ACTA PAEDIATR, V101, P17, DOI 10.1111/j.1651-2227.2011.02545.x; De Matteo R, 2010, REPROD SCI, V17, P724, DOI 10.1177/1933719110369182; Eiby YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068763; Eiby YA, 2012, AM J PHYSIOL-REG I, V303, pR769, DOI 10.1152/ajpregu.00010.2012; Elsmen E, 2004, ACTA PAEDIATR, V93, P529, DOI 10.1080/08035250410024998; FOWDEN AL, 1995, EXP PHYSIOL, V80, P457, DOI 10.1113/expphysiol.1995.sp003860; Gilsbach R, 2010, CARDIOVASC RES, V86, P432, DOI 10.1093/cvr/cvq014; Giraud GD, 2006, ENDOCRINOLOGY, V147, P3643, DOI 10.1210/en.2006-0061; Grupp IL, 1998, AM J PHYSIOL-HEART C, V275, pH1338, DOI 10.1152/ajpheart.1998.275.4.H1338; HATJIS C G, 1982, Journal of Developmental Physiology (Eynsham), V4, P327; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Kawano F, 2009, J PHYSIOL SCI, V59, P383, DOI 10.1007/s12576-009-0046-6; Kim MY, 2014, PLOS ONE IN PRESS; Kluckow M, 2000, ARCH DIS CHILD-FETAL, V82, pF188, DOI 10.1136/fn.82.3.F188; Kluckow M, 2004, NEOREVIEWS, V5, pe98; Lin G, 2001, CIRC RES, V89, P343, DOI 10.1161/hh1601.095912; Lumbers ER, 2005, AM J PHYSIOL-REG I, V288, pR567, DOI 10.1152/ajpregu.00556.2004; McMullen JR, 2002, REGUL PEPTIDES, V105, P83, DOI 10.1016/S0167-0115(02)00002-2; Metz LD, 1996, J MOL CELL CARDIOL, V28, P1033, DOI 10.1006/jmcc.1996.0096; Mohl MC, 2011, CARDIOVASC RES, V91, P310, DOI 10.1093/cvr/cvr081; MOISE AA, 1995, PEDIATRICS, V95, P845; Myslivecek J, 2003, N-S ARCH PHARMACOL, V368, P366, DOI 10.1007/s00210-003-0825-1; NAKADA MT, 1987, MOL PHARMACOL, V31, P377; NOGUCHI A, 1981, DEV PHARMACOL THERAP, V3, P179, DOI 10.1159/000457439; Osborn D, 2002, J PEDIATR-US, V140, P183, DOI 10.1067/mpd.2002.120834; Osborn DA, 2003, PEDIATRICS, V112, P33, DOI 10.1542/peds.112.1.33; Osborn DA, 2007, PEDIATRICS, V120, P372, DOI 10.1542/peds.2006-3398; Porter AC, 2003, LIFE SCI, V72, P1455, DOI 10.1016/S0024-3205(02)02381-0; Pradidarcheep W, 2009, N-S ARCH PHARMACOL, V379, P397, DOI 10.1007/s00210-009-0393-0; ROCKSON SG, 1981, J CLIN INVEST, V67, P319, DOI 10.1172/JCI110038; SCHMID G, 1985, VIRCHOWS ARCH B, V48, P59, DOI 10.1007/BF02890115; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seri I, 2001, Semin Neonatol, V6, P85, DOI 10.1053/siny.2000.0034; SLOTKIN TA, 1986, TOXICOLOGY, V41, P95, DOI 10.1016/0300-483X(86)90107-1; SMOLICH JJ, 1995, REPROD FERT DEVELOP, V7, P451, DOI 10.1071/RD9950451; Stark MJ, 2009, AM J PHYSIOL-REG I, V297, pR510, DOI 10.1152/ajpregu.00175.2009; Stevenson DK, 2000, ARCH DIS CHILD-FETAL, V83, pF182, DOI 10.1136/fn.83.3.F182; van der Voort CR, 2000, J NEUROIMMUNOL, V108, P82, DOI 10.1016/S0165-5728(00)00253-8; WHITSETT JA, 1981, PEDIATR RES, V15, P1363, DOI 10.1203/00006450-198110000-00013; Woodcock EA, 2007, CLIN EXP PHARMACOL P, V34, P884, DOI 10.1111/j.1440-1681.2007.04707.x; Zhang J, 1999, ARCH DIS CHILD-FETAL, V81, pF99, DOI 10.1136/fn.81.2.F99	48	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92167	10.1371/journal.pone.0092167	http://dx.doi.org/10.1371/journal.pone.0092167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670668	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000033
J	Muller-Nordhorn, J; Muckelbauer, R; Englert, H; Grittner, U; Berger, H; Sonntag, F; Voller, H; Prugger, C; Wegscheider, K; Katus, HA; Willich, SN				Mueller-Nordhorn, Jacqueline; Muckelbauer, Rebecca; Englert, Heike; Grittner, Ulrike; Berger, Hendrike; Sonntag, Frank; Voeller, Heinz; Prugger, Christof; Wegscheider, Karl; Katus, Hugo A.; Willich, Stefan N.			Longitudinal Association between Body Mass Index and Health-Related Quality of Life	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; OLDER-ADULTS; US POPULATION; WEIGHT-LOSS; PHYSICAL-ACTIVITY; CHRONIC ILLNESS; HEART-FAILURE; WHITEHALL II; PRIMARY-CARE; OBESITY	Objective: Health-related quality of life (HRQoL) is an important outcome in individuals with a high risk for cardiovascular diseases. We investigated the association of HRQoL and body mass index (BMI) as an indicator for obesity. Design: Secondary longitudinal analysis of the ORBITAL study, an intervention study which included high-risk cardiovascular primary care patients with hypercholesterolemia and an indication for statin therapy. Methods: HRQoL was determined with the generic Short Form (SF)-12 health status instrument. Body weight and height were assessed at baseline and at months 6, 12, 18, 24, 30, and 36. We used a linear and a linear mixed-effects regression model to investigate the association between BMI and SF-12 summary scores at baseline as well as between change in BMI and SF-12 summary scores over 3 years. We adjusted for age, sex, smoking status, and in the longitudinal analysis also for the study arm and its interaction term with time. Results: Of the 7640 participants who completed the baseline questionnaire, 6726 participants (mean age: 61 years) were analyzed. The baseline BMI was inversely associated with physical and mental SF-12 summary scores (beta [95% CI] per 1 kg/ m(2) : -0.36 [-0.41; -0.30] and -0.05 [-0.11; -0.00], respectively). A significant association between the change in BMI and physical SF-12 summary scores over time was only present in women (-0.18 [-0.27; -0.09]) and only in obese participants (-0.19 [-0.29; -0.10]). A change in BMI was directly associated with mental SF-12 summary scores (0.12 [0.06; 0.19]) in the total population. Conclusion: Increases in BMI were associated with decreases in physical HRQoL, particularly in obese individuals and in women. In contrast, the mental HRQoL seemed to increase with increasing BMI over time. Thus, body weight management with respect to the HRQoL should be evaluated differentially by sex and body weight status.	[Mueller-Nordhorn, Jacqueline; Willich, Stefan N.] Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany; [Mueller-Nordhorn, Jacqueline; Muckelbauer, Rebecca] Charite, Berlin Sch Publ Hlth, D-13353 Berlin, Germany; [Englert, Heike] Univ Appl Sci, Munster, Germany; [Grittner, Ulrike] Charite, Dept Biostat & Clin Epidemiol, D-13353 Berlin, Germany; [Berger, Hendrike] Univ Appl Sci, Osnabruck, Germany; [Voeller, Heinz] Univ Potsdam, Rehabil Res Ctr, Potsdam, Germany; [Prugger, Christof] Univ Paris 05, Sorbonne Paris Cite, Paris Cardiovasc Res Ctr, UMR S970, Paris, France; [Wegscheider, Karl] Univ Hamburg, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Katus, Hugo A.] Heidelberg Univ, Dept Cardiol Angiol & Pneumol, Heidelberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Applied Sciences, Muenster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Potsdam; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Hamburg; Ruprecht Karls University Heidelberg	Muller-Nordhorn, J (corresponding author), Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany.	jacqueline.mueller-nordhorn@charite.de	Grittner, Ulrike/I-2026-2019	Grittner, Ulrike/0000-0003-2595-0224; Prugger, Christof/0000-0003-1845-0950; Muckelbauer, Rebecca/0000-0001-5979-2469	AstraZeneca	AstraZeneca(AstraZeneca)	The original intervention study was supported by an unconditional grant from AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The present analysis was supported exclusively by the Berlin School of Public Health, Charite University Medical Center Berlin.	ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Aranceta J, 2009, NUTR REV, V67, pS83, DOI 10.1111/j.1753-4887.2009.00166.x; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bottone FG, 2013, J NUTR HEALTH AGING, V17, P495, DOI 10.1007/s12603-013-0022-y; Brown WJ, 1998, INT J OBESITY, V22, P520, DOI 10.1038/sj.ijo.0800617; Brown WJ, 2000, INT J OBESITY, V24, P1360, DOI 10.1038/sj.ijo.0801384; BULLINGER M., 1998, HDB DEUTSCHSPRACHIGE; Cameron AJ, 2012, INT J OBESITY, V36, P295, DOI 10.1038/ijo.2011.103; Zuluaga MC, 2010, EUR J HEART FAIL, V12, P1372, DOI 10.1093/eurjhf/hfq163; Doll HA, 2000, OBES RES, V8, P160, DOI 10.1038/oby.2000.17; Fine JT, 1999, JAMA-J AM MED ASSOC, V282, P2136, DOI 10.1001/jama.282.22.2136; Finkelstein MM, 2000, J FAM PRACTICE, V49, P734; Flegal KM, 2007, AM J EPIDEMIOL, V166, P975, DOI 10.1093/aje/kwm152; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Ford ES, 2001, OBES RES, V9, P21, DOI 10.1038/oby.2001.4; Franco OH, 2012, EUR J EPIDEMIOL, V27, P255, DOI 10.1007/s10654-012-9664-z; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Groessl EJ, 2004, AM J PREV MED, V26, P126, DOI 10.1016/j.amepre.2003.10.007; Han TS, 1998, AM J PUBLIC HEALTH, V88, P1814, DOI 10.2105/AJPH.88.12.1814; Hassan MK, 2003, INT J OBESITY, V27, P1227, DOI 10.1038/sj.ijo.0802396; Heo M, 2003, OBES RES, V11, P209, DOI 10.1038/oby.2003.33; Herman KM, 2012, MED SCI SPORT EXER, V44, P625, DOI 10.1249/MSS.0b013e31823a90ae; Hernandez JL, 2003, AM J MED, V114, P631, DOI 10.1016/S0002-9343(03)00115-3; Huang IC, 2006, INT J OBESITY, V30, P1250, DOI 10.1038/sj.ijo.0803250; Hunger M, 2012, J DIABETES COMPLICAT, V26, P413, DOI 10.1016/j.jdiacomp.2012.05.008; Jia HM, 2005, J PUBLIC HEALTH-UK, V27, P156, DOI 10.1093/pubmed/fdi025; Kato N, 2011, CIRC J, V75, P1661, DOI 10.1253/circj.CJ-10-1308; Katz DA, 2000, J GEN INTERN MED, V15, P789, DOI 10.1046/j.1525-1497.2000.90906.x; Kinge JM, 2010, SOC SCI MED, V71, P1864, DOI 10.1016/j.socscimed.2010.09.001; Kocalevent RD, 2013, GEN HOSP PSYCHIAT; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Landman GWD, 2010, DIABETES CARE, V33, P2378, DOI 10.2337/dc10-0979; Larsson U, 2002, INT J OBESITY, V26, P417, DOI 10.1038/sj.ijo.0801919; Le Pen C, 1998, J EPIDEMIOL COMMUN H, V52, P445, DOI 10.1136/jech.52.7.445; Lean MEJ, 1999, ARCH INTERN MED, V159, P837, DOI 10.1001/archinte.159.8.837; Lean MEJ, 1998, LANCET, V351, P853, DOI 10.1016/S0140-6736(97)10004-6; Lenz M, 2009, DTSCH ARZTEBL INT, V106, P641, DOI 10.3238/arztebl.2009.0641; Maatouk I, 2012, J HYPERTENS, V30, P1364, DOI 10.1097/HJH.0b013e328353d81b; Maatouk I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031088; Maciejewski ML, 2005, J CLIN EPIDEMIOL, V58, P568, DOI 10.1016/j.jclinepi.2004.10.015; McMinn J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1732; Moriel G, 2010, ARQ BRAS CARDIOL, V95, P691, DOI 10.1590/S0066-782X2010001600004; Myint PK, 2007, NEUROLOGY, V69, P2243, DOI 10.1212/01.wnl.0000296010.21252.78; Onyike CU, 2003, AM J EPIDEMIOL, V158, P1139, DOI 10.1093/aje/kwg275; Osthus TBH, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-46; Osthus TBH, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-78; Sach TH, 2007, INT J OBESITY, V31, P189, DOI 10.1038/sj.ijo.0803365; Stafford M, 1998, INT J OBESITY, V22, P23, DOI 10.1038/sj.ijo.0800539; Tapp R, 2010, DIABETES CARE, V33, P757, DOI 10.2337/dc09-1107; ter Horst R, 2012, INTERACT CARDIOV TH, V15, P651, DOI 10.1093/icvts/ivs184; Ul-Haq Z, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-143; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wee HL, 2008, VALUE HEALTH, V11, pS105, DOI 10.1111/j.1524-4733.2008.00374.x; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Willich SN, 2004, AM HEART J, V148, P1060, DOI 10.1016/j.ahj.2004.05.032; Willich SN, 2009, EUR J CARDIOV PREV R, V16, P180, DOI 10.1097/HJR.0b013e3283262ac3; World Health Organization, 2000, OB PREV MAN GLOB EP, pi; Yan LJL, 2004, OBES RES, V12, P69, DOI 10.1038/oby.2004.10; Yancy WS, 2002, OBES RES, V10, P1057, DOI 10.1038/oby.2002.143	60	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93071	10.1371/journal.pone.0093071	http://dx.doi.org/10.1371/journal.pone.0093071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24671104	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000110
J	Paulsson, JF; Ludvigsson, J; Carlsson, A; Casas, R; Forsander, G; Ivarsson, SA; Kockum, I; Lernmark, A; Marcus, C; Lindblad, B; Westermark, GT				Paulsson, Johan F.; Ludvigsson, Johnny; Carlsson, Annelie; Casas, Rosaura; Forsander, Gun; Ivarsson, Sten A.; Kockum, Ingrid; Lernmark, Ake; Marcus, Claude; Lindblad, Bengt; Westermark, Gunilla T.			High Plasma Levels of Islet Amyloid Polypeptide in Young with New-Onset of Type 1 Diabetes Mellitus	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; INSULIN-SECRETION; AUTOANTIBODIES; EXPRESSION; DEPOSITION; PANCREAS; PROTEIN; AMYLIN	Aims/Hypothesis: Islet amyloid polypeptide (IAPP) is a beta cell hormone secreted together with insulin upon glucose stimulation. IAPP participates in normal glucose regulation, but IAPP is also known for its ability to misfold and form islet amyloid. Amyloid fibrils form through smaller cell toxic intermediates and deposited amyloid disrupts normal islet architecture. Even though IAPP and amyloid formation are much discussed in type 2 diabetes, our aim was to study the significance of IAPP in type 1 diabetes. Results: Plasma IAPP levels in children and adolescents with newly diagnosed type 1 diabetes (n = 224) were analysed and concentrations exceeding 100 pmol/L (127.2 - 888.7 pmol/L) were found in 11% (25/224). The IAPP increase did not correlate with C-peptide levels. Conclusions/Interpretation: Plasma levels of IAPP and insulin deviate in a subpopulation of young with newly-diagnosed type 1 diabetes. The determined elevated levels of IAPP might increase the risk for IAPP misfolding and formation of cell toxic amyloid in beta cells. This finding add IAPP-aggregation to the list over putative pathological factors causing type 1 diabetes.	[Paulsson, Johan F.; Ludvigsson, Johnny; Casas, Rosaura] Linkoping Univ Hosp, Dept Clin & Expt Med, Div Pediat, S-58185 Linkoping, Sweden; [Paulsson, Johan F.; Ludvigsson, Johnny; Casas, Rosaura] Linkoping Univ Hosp, Diabet Res Ctr, S-58185 Linkoping, Sweden; [Carlsson, Annelie] Univ Lund Hosp, Dept Pediat, S-22185 Lund, Sweden; [Forsander, Gun; Lindblad, Bengt] Queen Silvia Childrens Hosp, Dept Pediat, Gothenburg, Sweden; [Ivarsson, Sten A.] Univ Hosp MAS, Dept Pediat, Malmo, Sweden; [Kockum, Ingrid] Karolinska Inst, Dept Mol Med, Stockholm, Sweden; [Lernmark, Ake] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Marcus, Claude] Karolinska Univ Hosp, Dept Pediat, Huddinge, Sweden; [Westermark, Gunilla T.] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	Linkoping University; Linkoping University; Lund University; Skane University Hospital; Queen Silvia Children's Hospital; Lund University; Skane University Hospital; Karolinska Institutet; Lund University; Karolinska Institutet; Karolinska University Hospital; Uppsala University	Westermark, GT (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	Gunilla.Westermark@mcb.uu.se	Ludvigsson, Johnny/AAI-2051-2020; Kockum, Ingrid/O-8781-2018; Marcus, Claude/ABE-1177-2020; Lernmark, Åke/F-8140-2015	Ludvigsson, Johnny/0000-0003-1695-5234; Kockum, Ingrid/0000-0002-0867-4726; Marcus, Claude/0000-0003-0890-2650; Lernmark, Åke/0000-0003-1735-0499; Paulsson, Johan F/0000-0001-6601-8383; Forsander, Gun A/0000-0002-0266-9651	Swedish Research Council [GTW-1767]; Swedish Diabetes Association; Swedish Child Diabetes Foundation; Family Ernfors Fund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Swedish Child Diabetes Foundation; Family Ernfors Fund	The work was funded by Swedish Research Council GTW-1767, Swedish Diabetes Association, the Swedish Child Diabetes Foundation, and Family Ernfors Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly T, 2004, DIABETES CARE, V27, P1205, DOI 10.2337/diacare.27.5.1205; Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; Bjerner J, 2002, CLIN CHEM, V48, P613; BOTTAZZO GF, 1985, NEW ENGL J MED, V313, P353, DOI 10.1056/NEJM198508083130604; CLARK A, 1991, DIABETIC MED, V8, P668, DOI 10.1111/j.1464-5491.1991.tb01675.x; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Gebre-Medhin S, 1998, BIOCHEM BIOPH RES CO, V250, P271, DOI 10.1006/bbrc.1998.9308; GORUS FK, 1992, DIABETOLOGIA, V35, P1080, DOI 10.1007/BF02221685; In't Veld P, 2007, DIABETES, V56, P2400, DOI 10.2337/db07-0416; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; KAHN SE, 1993, DIABETOLOGIA, V36, P570, DOI 10.1007/BF02743276; KAHN SE, 1991, HORM METAB RES, V23, P577, DOI 10.1055/s-2007-1003759; Kricka LJ, 1999, CLIN CHEM, V45, P942; Lernmark A, 1999, CLIN CHEM, V45, P1331; Martin S, 2001, NEW ENGL J MED, V345, P1036, DOI 10.1056/NEJMoa010465; Martinez A, 2000, ENDOCRINOLOGY, V141, P406, DOI 10.1210/en.141.1.406; Mather KJ, 2002, DIABETES-METAB RES, V18, P118, DOI 10.1002/dmrr.263; Matveyenko AV, 2006, DIABETES, V55, P2106, DOI 10.2337/db05-1672; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Mulder H, 1996, AM J PHYSIOL-ENDOC M, V271, pE1008, DOI 10.1152/ajpendo.1996.271.6.E1008; Paulsson JF, 2005, DIABETES, V54, P2117, DOI 10.2337/diabetes.54.7.2117; Paulsson JF, 2008, EXP DIABETES RES, DOI 10.1155/2008/865850; Pihoker C, 2005, DIABETES, V54, pS52, DOI 10.2337/diabetes.54.suppl_2.S52; Rivera JF, 2011, CELL DEATH DIFFER, V18, P415, DOI 10.1038/cdd.2010.111; STRIDSBERG M, 1993, DIABETOLOGIA, V36, P843, DOI 10.1007/BF00400360; TOSHIMORI H, 1991, VIRCHOWS ARCH A, V418, P411, DOI 10.1007/BF01605927; TUCK AB, 1992, DIABETIC MED, V9, P781; Westermark GT, 2008, NEW ENGL J MED, V359, P977, DOI 10.1056/NEJMc0802893; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Westermark P, 1996, FEBS LETT, V379, P203, DOI 10.1016/0014-5793(95)01512-4; WESTERMARK P, 1986, BIOCHEM BIOPH RES CO, V140, P827, DOI 10.1016/0006-291X(86)90708-4; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Williams AJK, 1997, J AUTOIMMUN, V10, P473, DOI 10.1006/jaut.1997.0154; Yoon Ji-Won, 2005, Am J Ther, V12, P580, DOI 10.1097/01.mjt.0000178767.67857.63	34	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93053	10.1371/journal.pone.0093053	http://dx.doi.org/10.1371/journal.pone.0093053			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671002	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677000107
J	Carre, N; Solomon, G; Gertler, A; Binart, N				Carre, Nadege; Solomon, Gili; Gertler, Arieh; Binart, Nadine			Effects of High Affinity Leptin Antagonist on Prolactin Receptor Deficient Male Mouse	PLOS ONE			English	Article							HIGH-FAT-DIET; BODY-WEIGHT; MICE; INSULIN; EXPRESSION; LACTATION; HORMONE; OBESITY	Hyperprolactinemia occurs during gestation and lactation with marked hyperphagia associated with leptin resistance. Prolactin (PRL) induces the expression of orexigenic neuropeptide Y (NPY) in hypothalamic dorsomedial nucleus (DMH) leading to hyperphagia. Along this line prolactin receptor deficient (PRLR-/-) mice are resistant to obesity under high fat diet due to increased energy expenditure. As these mice have an altered food intake, our objective was to test whether leptin is responsible for these characteristics. PRLR-/- male mice and control littermates were injected subcutaneously every other day with 12 mg/kg pegylated superactive mouse leptin antagonist (PEG-SMLA) for 3 weeks. We tested the effect of PEG-SMLA on body weight, food intake and metabolic parameters. The antagonist led to a rapid increase in body weight (20%) but increased adipose mass in PEG-SMLA treated mice was less pronounced in PRLR-/- than in WT mice. Food intake of PEG-SMLA-injected animals increased during the first week period of the experiment but then declined to a similar level of the control animals during the second week. Interestingly, PRLR-/- mice were found to have the same bone volume than those of control mice although PEG-SMLA increased bone mass by 7% in both strains. In addition, PEG-SMLA led to insulin resistance and glucose intolerance as well as an altered lipid profile in treated mice. Altogether, these results suggest that PRLR-/- mice respond to leptin antagonist similarly to the control mice, indicating no interaction between the actions of the two hormones.	[Carre, Nadege; Binart, Nadine] INSERM, U693, F-94275 Le Kremlin Bicetre, France; [Carre, Nadege; Binart, Nadine] Univ Paris 11, Fac Med Paris Sud, UMR S693, Le Kremlin Bicetre, France; [Solomon, Gili; Gertler, Arieh] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel; [Binart, Nadine] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Hebrew University of Jerusalem; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Binart, N (corresponding author), INSERM, U693, F-94275 Le Kremlin Bicetre, France.	nadine.binart@inserm.fr	Binart, Nadine/F-2949-2013	Binart, Nadine/0000-0002-5606-3866	Agence Nationale de la Recherche [09-BLAN-0246]; Institut National de la Sante et de la Recherche Medicale, Universite Paris-Sud	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale, Universite Paris-Sud	This work was supported by grants from Agence Nationale de la Recherche (09-BLAN-0246), Institut National de la Sante et de la Recherche Medicale, Universite Paris-Sud. N.B. was awarded an Institut National de la Sante et de la Recherche Medicale-Assistance Publique-Hopitaux de Paris Interface contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikopoulos S, 2005, J ENDOCRINOL, V187, P45, DOI 10.1677/joe.1.06333; Auffret J, 2012, FASEB J, V26, P3728, DOI 10.1096/fj.12-204958; Ben-Jonathan N, 2006, TRENDS ENDOCRIN MET, V17, P110, DOI 10.1016/j.tem.2006.02.005; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Chapnik N, 2013, J ENDOCRINOL, V217, P283, DOI 10.1530/JOE-13-0033; Chen PL, 2004, ENDOCRINOLOGY, V145, P823, DOI 10.1210/en.2003-1255; Elinav E, 2009, ENDOCRINOLOGY, V150, P3083, DOI 10.1210/en.2008-1706; Freemark M, 2001, ENDOCRINOLOGY, V142, P532, DOI 10.1210/en.142.2.532; Goffin V, 2002, ANNU REV PHYSIOL, V64, P47, DOI 10.1146/annurev.physiol.64.081501.131049; Greenman Y, 1998, CLIN ENDOCRINOL, V48, P547, DOI 10.1046/j.1365-2265.1998.00403.x; GUSTAFSON AB, 1980, J CLIN ENDOCR METAB, V51, P242, DOI 10.1210/jcem-51-2-242; Ling C, 2000, ENDOCRINOLOGY, V141, P3564, DOI 10.1210/en.141.10.3564; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Naliato ECO, 2007, CLIN ENDOCRINOL, V67, P845, DOI 10.1111/j.1365-2265.2007.02973.x; Nilsson L, 2011, MOL GENET METAB, V102, P78, DOI 10.1016/j.ymgme.2010.08.017; Sauve D, 2000, BRAIN RES, V868, P306, DOI 10.1016/S0006-8993(00)02344-1; Shpilman M, 2011, J BIOL CHEM, V286, P4429, DOI 10.1074/jbc.M110.196402; Solomon G, 2013, AM J PHYSIOL-ENDOC M, DOI [10.1152/ajpendo.00155.2013, DOI 10.1152/AJPEND0.00155.2013]; Syberg S, 2012, J OSTEOPOROS, V2012, DOI 10.1155/2012/637986; Viengchareun S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001535	20	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e91422	10.1371/journal.pone.0091422	http://dx.doi.org/10.1371/journal.pone.0091422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667351	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600007
J	Garcia-Armisen, T; Inceoglu, O; Ouattara, NK; Anzil, A; Verbanck, MA; Brion, N; Servais, P				Garcia-Armisen, Tamara; Inceoglu, Ozgul; Ouattara, Nouho Koffi; Anzil, Adriana; Verbanck, Michel A.; Brion, Natacha; Servais, Pierre			Seasonal Variations and Resilience of Bacterial Communities in a Sewage Polluted Urban River	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; SP-NOV.; WATER; LAKE; DIVERSITY; BACTERIOPLANKTON; TEMPERATURE; SYNCHRONY; ABUNDANCE; SEDIMENTS	The Zenne River in Brussels (Belgium) and effluents of the two wastewater treatment plants (WWTPs) of Brussels were chosen to assess the impact of disturbance on bacterial community composition (BCC) of an urban river. Organic matters, nutrients load and oxygen concentration fluctuated highly along the river and over time because of WWTPs discharge. Tag pyrosequencing of bacterial 16S rRNA genes revealed the significant effect of seasonality on the richness, the bacterial diversity (Shannon index) and BCC. The major grouping: -winter/fall samples versus spring/summer samples-could be associated with fluctuations of in situ bacterial activities (dissolved and particulate organic carbon biodegradation associated with oxygen consumption and N transformation). BCC of the samples collected upstream from the WWTPs discharge were significantly different from BCC of downstream samples and WWTPs effluents, while no significant difference was found between BCC of WWTPs effluents and the downstream samples as revealed by ANOSIM. Analysis per season showed that allochthonous bacteria brought by WWTPs effluents triggered the changes in community composition, eventually followed by rapid post-disturbance return to the original composition as observed in April (resilience), whereas community composition remained altered after the perturbation by WWTPs effluents in the other seasons.	[Garcia-Armisen, Tamara; Inceoglu, Ozgul; Ouattara, Nouho Koffi; Anzil, Adriana; Servais, Pierre] Univ Libre Bruxelles, Brussels, Belgium; [Verbanck, Michel A.] Univ Libre Bruxelles, Dept Water Pollut Control, Brussels, Belgium; [Brion, Natacha] Vrije Univ Brussels, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Servais, P (corresponding author), Univ Libre Bruxelles, Campus Plaine, Brussels, Belgium.	pservais@ulb.ac.be	Brion, Natacha/H-3565-2017; OUATTARA, KOFFI NOUHO/AAF-3109-2019	Brion, Natacha/0000-0002-3021-1445; 	Belgian Federal Science Policy Office (BELSPO); FNRS (Fonds National de la Recherche Scientifique, Belgium) grant	Belgian Federal Science Policy Office (BELSPO)(Belgian Federal Science Policy Office); FNRS (Fonds National de la Recherche Scientifique, Belgium) grant(Fonds de la Recherche Scientifique - FNRS)	This study was mainly performed in the scope of the GESZ research project (Towards the Good Ecological Status of River Zenne: Reevaluating Brussels wastewater management) from the "Impulse Environment 2008" program of the Brussels Institute for Research and Innovation (Innoviris). A part of the work was also performed in the scope of the project "Tracing and Integrated Modelling of Natural and Anthropogenic effects on Hydrosystems" (TIMOTHY), an Interuniversity Attraction Pole (IAP6.13) funded by the Belgian Federal Science Policy Office (BELSPO). O Ynceolu benefits from a FNRS (Fonds National de la Recherche Scientifique, Belgium) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WR, 2010, INT J MICROBIOL, V2011; Ademoroti CMA, 1996, ENV CHEM TOXICOLOGY, P70; Allison G, 2004, ECOL MONOGR, V74, P117, DOI 10.1890/02-0681; Araya R, 2003, J HEALTH SCI, V49, P379, DOI 10.1248/jhs.49.379; Barra Caracciolo A, 2011, CHEM ECOL, V27, P43, DOI 10.1080/02757540.2010.534082; Belanche L, 2000, ARTIF INTELL ENG, V14, P307, DOI 10.1016/S0954-1810(00)00012-1; Berga M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036959; Brion N, 2012, BRIDGE TROUBLED WATE, P241; Callaway TR, 2009, POULTRY SCI, V88, P298, DOI 10.3382/ps.2008-00222; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; Crump BC, 2005, LIMNOL OCEANOGR, V50, P1718, DOI 10.4319/lo.2005.50.6.1718; David R, 2010, LABDSV ORDINATION MU; Drury B, 2013, APPL ENVIRON MICROB, V79, P1897, DOI 10.1128/AEM.03527-12; Echeveste P, 2010, CHEMOSPHERE, V81, P161, DOI 10.1016/j.chemosphere.2010.06.072; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; EIKELBOOM DH, 1975, WATER RES, V9, P365, DOI 10.1016/0043-1354(75)90182-7; EVISON LM, 1988, WATER SCI TECHNOL, V20, P309, DOI 10.2166/wst.1988.0300; Finneran KT, 2003, INT J SYST EVOL MICR, V53, P669, DOI 10.1099/ijs.0.02298-0; Gamier J, 1992, ARCH HYDROBIOL ERGEB, V37, P83; GARNIER J, 1992, CAN J MICROBIOL, V38, P56, DOI 10.1139/m92-009; Ghiglione JF, 2012, ENVIRON MICROBIOL, V14, P617, DOI 10.1111/j.1462-2920.2011.02601.x; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Hu M, 2012, BIORESOURCE TECHNOL, V117, P72, DOI 10.1016/j.biortech.2012.04.061; Huerta B, 2013, SCI TOTAL ENVIRON, V456, P161, DOI 10.1016/j.scitotenv.2013.03.071; Ibekwe AM, 2012, FEMS MICROBIOL ECOL, V79, P155, DOI 10.1111/j.1574-6941.2011.01205.x; JAFFE R, 1991, ENVIRON POLLUT, V69, P237, DOI 10.1016/0269-7491(91)90147-O; Kent AD, 2007, ISME J, V1, P38, DOI 10.1038/ismej.2007.6; Kenzaka T, 2001, J HEALTH SCI, V47, P353, DOI 10.1248/jhs.47.353; KIRCHMAN DL, 1994, MICROBIAL ECOL, V28, P255, DOI 10.1007/BF00166816; Kostanjsek R, 2005, ENVIRON SCI POLLUT R, V12, P361, DOI 10.1065/espr2005.07.271; Kotay SM, 2011, WATER RES, V45, P694, DOI 10.1016/j.watres.2010.08.038; Lamy D, 2009, AQUAT MICROB ECOL, V58, P95, DOI 10.3354/ame01359; Li D, 2008, FEMS MICROBIOL ECOL, V65, P494, DOI 10.1111/j.1574-6941.2008.00540.x; Lliros M, 2008, FEMS MICROBIOL ECOL, V66, P331, DOI 10.1111/j.1574-6941.2008.00583.x; Methe BA, 1998, LIMNOL OCEANOGR, V43, P368, DOI 10.4319/lo.1998.43.2.0368; Moreno Y, 2003, APPL ENVIRON MICROB, V69, P1181, DOI 10.1128/AEM.69.2.1181-1186.2003; Murray AE, 1998, APPL ENVIRON MICROB, V64, P2585; Murray KS, 2001, J GREAT LAKES RES, V27, P220, DOI 10.1016/S0380-1330(01)70635-1; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Nielsen PH, 2010, WATER RES, V44, P5070, DOI 10.1016/j.watres.2010.07.036; Okpokwasili GC, 1996, ENVIRON TOXIC WATER, V11, P77; Oksanen J., 2011, VEGAN COMMUNITY ECOL; Ouattara NK, 2011, ENVIRON MONIT ASSESS, V183, P243, DOI 10.1007/s10661-011-1918-9; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; R Development Core Team, 2011, R LANG ENV STAT COMP; Servais P, 2007, SCI TOTAL ENVIRON, V375, P152, DOI 10.1016/j.scitotenv.2006.12.010; Shade A., 2010, MICROB ECOL, V59, P546, DOI [10.1007/s00248-009-9589-6, DOI 10.1007/s00248-009-9589-6]; Shanks OC, 2013, APPL ENVIRON MICROB, V79, P2906, DOI 10.1128/AEM.03448-12; Smith DM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-41; Spring S, 2005, INT J SYST EVOL MICR, V55, P621, DOI 10.1099/ijs.0.63356-0; Starliper CE, 2011, J ADV RES, V2, P97, DOI 10.1016/j.jare.2010.04.001; United Nations (UN), 2009, REV WORLD URB PROSP; Van der Gucht K, 2001, ENVIRON MICROBIOL, V3, P680, DOI 10.1046/j.1462-2920.2001.00242.x; Wakelin SA, 2008, APPL ENVIRON MICROB, V74, P2659, DOI 10.1128/AEM.02348-07; WEITHMAN AS, 1984, T AM FISH SOC, V113, P109, DOI 10.1577/1548-8659(1984)113<109:EODDOT>2.0.CO;2; Winter C, 2007, APPL ENVIRON MICROB, V73, P421, DOI 10.1128/AEM.01849-06; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9; Zhang ML, 2012, AQUAT SCI, V74, P113, DOI 10.1007/s00027-011-0201-z; Zhu J, 2013, MAR POLLUT B	65	39	43	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92579	10.1371/journal.pone.0092579	http://dx.doi.org/10.1371/journal.pone.0092579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667680	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600050
J	Ibanez, J; de la Aleja, JG; Gallego, JA; Romero, JP; Saiz-Diaz, RA; Benito-Leon, J; Rocon, E				Ibanez, Jaime; Gonzalez de la Aleja, Jesus; Gallego, Juan A.; Romero, Juan P.; Saiz-Diaz, Rosana A.; Benito-Leon, Julian; Rocon, Eduardo			Effects of Alprazolam on Cortical Activity and Tremors in Patients with Essential Tremor	PLOS ONE			English	Article							SENSORIMOTOR-CORTEX; MOTOR CORTEX; EEG; NETWORK; UPDATE; PHARMACODYNAMICS; SYNCHRONIZATION; IDENTIFICATION; OSCILLATIONS; POTENTIALS	Background: Essential tremor (ET) is characterised by postural and action tremors with a frequency of 4-12 Hz. Previous studies suggest that the tremor activity originates in the cerebello-thalamocortical pathways. Alprazolam is a short-acting benzodiazepine that attenuates tremors in ET. The mechanisms that mediate the therapeutic action of alprazolam are unknown; however, in healthy subjects, benzodiazepines increase cortical beta activity. In this study, we investigated the effect of alprazolam both on beta and tremor-related cortical activity and on alterations in tremor presentation in ET patients. Therefore, we characterised the dynamics of tremor and cortical activity in ET patients after alprazolam intake. Methods: We recorded hand tremors and contralateral cortical activity in four recordings before and after a single dose of alprazolam. We then computed the changes in tremors, cortico-muscular coherence, and cortical activity at the tremor frequency and in the beta band. Results: Alprazolam significantly attenuated tremors (EMG: 76.2 +/- 22.68%), decreased cortical activity in the tremor frequency range and increased cortical beta activity in all patients (P<0.05). At the same time, the cortico-muscular coherence at the tremor frequency became non-significant (P<0.05). We also found a significant correlation (r = 0.757, P<0.001) between the reduction in tremor severity and the increased ratio of cortical activity in the beta band to the activity observed in the tremor frequency range. Conclusions: This study provides the first quantitative analysis of tremor reduction following alprazolam intake. We observed that the tremor severity decreased in association with an increased ratio of beta to tremor-related cortical activity. We hypothesise that the increase in cortical beta activity may act as a blocking mechanism and may dampen the pathological oscillatory activity, which in turn attenuates the observed tremor.	[Ibanez, Jaime; Gallego, Juan A.; Rocon, Eduardo] Consejo Super Invest Cientif, Bioengn Grp, Arganda Del Rey, Spain; [Gonzalez de la Aleja, Jesus; Romero, Juan P.; Saiz-Diaz, Rosana A.; Benito-Leon, Julian] Univ Hosp 12 Octubre, Dept Neurol, Madrid, Spain; [Gonzalez de la Aleja, Jesus; Saiz-Diaz, Rosana A.; Benito-Leon, Julian] Univ Complutense, Fac Med, Dept Med, E-28040 Madrid, Spain; [Benito-Leon, Julian] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Romero, Juan P.] Univ Francisco Vitoria, Pozuelo De Alarcon, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Hospital Universitario 12 de Octubre; Complutense University of Madrid; CIBERNED; Universidad Francisco de Vitoria	Ibanez, J (corresponding author), Consejo Super Invest Cientif, Bioengn Grp, Arganda Del Rey, Spain.	jaime.ibanez@csic.es	Ibáñez, Jaime/G-2123-2015; Romero, Juan Pablo/Y-6765-2018; Benito-León, Julián/AAA-1331-2019; Rocon, Eduardo/F-4866-2011	Ibáñez, Jaime/0000-0001-8439-151X; Romero, Juan Pablo/0000-0002-3190-1296; Benito-León, Julián/0000-0002-1769-4809; Rocon, Eduardo/0000-0001-9618-2176; Gallego, Juan Alvaro/0000-0003-2146-0703; Gonzalez de la Aleja Tejera, Jesus/0000-0001-8197-1519; saiz diaz, rosa ana/0000-0002-0457-0516	CSIC [CSIC-201050I040]; EU Commission [EU-FP7-2011-287739]	CSIC; EU Commission(European CommissionEuropean Commission Joint Research Centre)	This work has been partially funded by CSIC, through the program for the incorporation of tenure researches CSIC-201050I040, "Development and clinical validation of a neuroprosthesis for tremor suppression", and by the EU Commission through the grant EU-FP7-2011-287739, "NeuroTREMOR". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babij R, 2013, BRAIN, V136, P3051, DOI 10.1093/brain/awt238; Baker MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049088; Baker MR, 2003, J PHYSIOL-LONDON, V546, P931, DOI 10.1113/jphysiol.2002.029553; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; Bazzigaluppi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046360; Benito-Leon J, 2011, MINERVA MED, V102, P417; Benito-Leon J, 2006, NAT CLIN PRACT NEURO, V2, P666, DOI 10.1038/ncpneuro0347; Benito-Leon J, 2009, J NEUROL SCI, V287, P138, DOI 10.1016/j.jns.2009.08.037; Boecker H, 1996, ANN NEUROL, V39, P650, DOI 10.1002/ana.410390515; Brown P, 2000, PROG NEUROBIOL, V60, P97, DOI 10.1016/S0301-0082(99)00029-5; Chakarov V, 2009, J NEUROPHYSIOL, V102, P1115, DOI 10.1152/jn.91095.2008; CONNORS BW, 1988, J PHYSIOL-LONDON, V406, P443, DOI 10.1113/jphysiol.1988.sp017390; Conway BA, 1995, J PHYSIOL-LONDON, V489, P917, DOI 10.1113/jphysiol.1995.sp021104; de Lima ER, 2006, MED BIOL ENG COMPUT, V44, P569, DOI 10.1007/s11517-006-0065-x; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Deuschl G, 2011, LANCET NEUROL, V10, P148, DOI 10.1016/S1474-4422(10)70322-7; Elble RJ, 2009, CURR NEUROL NEUROSCI, V9, P273, DOI 10.1007/s11910-009-0041-6; Farina D, 2013, J PHYSIOL-LONDON, V591, P2403, DOI 10.1113/jphysiol.2012.246082; Gallego JA, 2010, SENSORS-BASEL, V10, P2129, DOI 10.3390/s100302129; GROWDON JH, 1975, NEUROLOGY, V25, P259, DOI 10.1212/WNL.25.3.259; Gunal DI, 2000, NEUROL SCI, V21, P315, DOI 10.1007/s100720070069; Hall SD, 2010, HUM BRAIN MAPP, V31, P581, DOI 10.1002/hbm.20889; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Halliday DM, 1998, NEUROSCI LETT, V241, P5, DOI 10.1016/S0304-3940(97)00964-6; Hellwig B, 2003, CLIN NEUROPHYSIOL, V114, P1462, DOI 10.1016/S1388-2457(03)00116-0; Hellwig B, 2001, LANCET, V357, P519, DOI 10.1016/S0140-6736(00)04044-7; HJORTH B, 1975, ELECTROEN CLIN NEURO, V39, P526, DOI 10.1016/0013-4694(75)90056-5; Hua SE, 1998, J NEUROL NEUROSUR PS, V64, P273, DOI 10.1136/jnnp.64.2.273; HUBER SJ, 1988, NEUROLOGY, V38, P241, DOI 10.1212/WNL.38.2.241; Ilan AB, 2001, ALCOHOL, V25, P137, DOI 10.1016/S0741-8329(01)00191-4; JENKINS IH, 1993, ANN NEUROL, V34, P82, DOI 10.1002/ana.410340115; Jensen O, 2005, NEUROIMAGE, V26, P347, DOI 10.1016/j.neuroimage.2005.02.008; Kaplan GB, 1998, J CLIN PHARMACOL, V38, P14, DOI 10.1002/j.1552-4604.1998.tb04370.x; Kilner JM, 2000, J NEUROSCI, V20, P8838; Lindhardt K, 2001, BRIT J CLIN PHARMACO, V52, P521, DOI 10.1046/j.0306-5251.2001.01486.x; Louis ED, 2013, MOVEMENT DISORD, V28, P779, DOI 10.1002/mds.25400; Minc D, 2010, NEUROSCI LETT, V469, P145, DOI 10.1016/j.neulet.2009.11.062; Muthuraman M, 2012, NEUROIMAGE, V60, P1331, DOI 10.1016/j.neuroimage.2012.01.088; Negro F, 2011, J PHYSIOL-LONDON, V589, P629, DOI 10.1113/jphysiol.2010.202473; Niedermeyer E., 2005, ELECTROEN CLIN NEURO; Pahapill PA, 1999, ANN NEUROL, V46, P249, DOI 10.1002/1531-8249(199908)46:2<249::AID-ANA15>3.0.CO;2-C; Paris-Robidas S, 2012, BRAIN, V135, P105, DOI 10.1093/brain/awr301; Park YG, 2010, P NATL ACAD SCI USA, V107, P10731, DOI 10.1073/pnas.1002995107; Petersen TH, 2012, J PHYSIOL-LONDON, V590, P2443, DOI 10.1113/jphysiol.2012.227397; Raethjen J, 2007, J NEUROPHYSIOL, V97, P3219, DOI 10.1152/jn.00477.2006; Raethjen J, 2012, CLIN NEUROPHYSIOL, V123, P61, DOI 10.1016/j.clinph.2011.09.024; Rangaswamy M, 2002, BIOL PSYCHIAT, V52, P831, DOI 10.1016/S0006-3223(02)01362-8; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; Schnitzler A, 2009, MOVEMENT DISORD, V24, P1629, DOI 10.1002/mds.22633; Sommerlade L, 2011, J NEUROSCI METH, V196, P182, DOI 10.1016/j.jneumeth.2010.12.019; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wilms H, 1999, MOVEMENT DISORD, V14, P557, DOI 10.1002/1531-8257(199907)14:4<557::AID-MDS1004>3.0.CO;2-G; Zesiewicz TA, 2011, NEUROLOGY, V77, P1752, DOI 10.1212/WNL.0b013e318236f0fd	54	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93159	10.1371/journal.pone.0093159	http://dx.doi.org/10.1371/journal.pone.0093159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667763	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000333675600150
J	Liu, J; Wei, W; Kuang, H; Tsien, JZ; Zhao, F				Liu, Jun; Wei, Wei; Kuang, Hui; Tsien, Joe Z.; Zhao, Fang			Heart Rate and Heart Rate Variability Assessment Identifies Individual Differences in Fear Response Magnitudes to Earthquake, Free Fall, and Air Puff in Mice	PLOS ONE			English	Article							ACOUSTIC STARTLE STIMULUS; CARDIOVASCULAR-RESPONSES; CONDITIONED FEAR; POTENTIATED STARTLE; STRESS-RESPONSE; MEMORY; BEHAVIOR; EMOTION; NEUROBIOLOGY; HABITUATION	Fear behaviors and fear memories in rodents have been traditionally assessed by the amount of freezing upon the presentation of conditioned cues or unconditioned stimuli. However, many experiences, such as encountering earthquakes or accidental fall from tree branches, may produce long-lasting fear memories but are behaviorally difficult to measure using freezing parameters. Here, we have examined changes in heartbeat interval dynamics as physiological readout for assessing fearful reactions as mice were subjected to sudden air puff, free-fall drop inside a small elevator, and a laboratory-version earthquake. We showed that these fearful events rapidly increased heart rate (HR) with simultaneous reduction of heart rate variability (HRV). Cardiac changes can be further analyzed in details by measuring three distinct phases: namely, the rapid rising phase in HR, the maximum plateau phase during which HRV is greatly decreased, and the recovery phase during which HR gradually recovers to baseline values. We showed that durations of the maximum plateau phase and HR recovery speed were quite sensitive to habituation over repeated trials. Moreover, we have developed the fear resistance index based on specific cardiac response features. We demonstrated that the fear resistance index remained largely consistent across distinct fearful events in a given animal, thereby enabling us to compare and rank individual mouse's fear responsiveness among the group. Therefore, the fear resistance index described here can represent a useful parameter for measuring personality traits or individual differences in stress-susceptibility in both wild-type mice and post-traumatic stress disorder (PTSD) models.	[Liu, Jun; Wei, Wei] E China Normal Univ, Key Lab Brain Funct Genom, Minist Educ, Inst Brain Funct Genom, Shanghai 200062, Peoples R China; [Kuang, Hui; Tsien, Joe Z.; Zhao, Fang] Xi Shuang Ban Na Prefecture, Banna Biomed Res Inst, Xishuangbanna, Yunnan, Peoples R China; [Liu, Jun; Wei, Wei; Kuang, Hui; Tsien, Joe Z.; Zhao, Fang] Georgia Regents Univ, Brain & Behav Discovery Inst, Med Coll Georgia, Augusta, GA USA; [Liu, Jun; Wei, Wei; Kuang, Hui; Tsien, Joe Z.; Zhao, Fang] Georgia Regents Univ, Dept Neurol, Med Coll Georgia, Augusta, GA USA	East China Normal University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Tsien, JZ (corresponding author), Xi Shuang Ban Na Prefecture, Banna Biomed Res Inst, Xishuangbanna, Yunnan, Peoples R China.	jtsien@gru.edu; zhaofang.magic@gmail.com			National Institutes of Health [NS079774, AG034663-01, MH060236]; Shanghai Commission of Science and Technology [10140900500]; Yunnan Province Department of Science and Technology [2012BA009]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); Yunnan Province Department of Science and Technology	This work was supported by grants from National Institutes of Health (NS079774, AG034663-01, and MH060236), Shanghai Commission of Science and Technology (Grant # 10140900500), and Yunnan Province Department of Science and Technology (Grant # 2012BA009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Villaca Y, 2006, BEHAV BRAIN RES, V167, P175, DOI 10.1016/j.bbr.2005.09.003; Adolphs R, 2000, LEARN MEMORY, V7, P180, DOI 10.1101/lm.7.3.180; Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; Baudrie V, 2001, CLIN EXP PHARMACOL P, V28, P1096, DOI 10.1046/j.1440-1681.2001.03593.x; Baudrie V, 1997, J AUTON PHARMACOL, V17, P303, DOI 10.1046/j.1365-2680.1997.00465.x; BERGER TW, 1978, P NATL ACAD SCI USA, V75, P1572, DOI 10.1073/pnas.75.3.1572; BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; Bradley M. M., 1999, STARTLE MODIFICATION, P157, DOI [10.1017/CBO9780511665523.010, DOI 10.1017/CBO9780511665523.010]; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; BROWN JS, 1951, J EXP PSYCHOL, V41, P317, DOI 10.1037/h0060166; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; CASTO R, 1989, AM J PHYSIOL, V256, pR1121, DOI 10.1152/ajpregu.1989.256.5.R1121; CHI CC, 1965, PSYCHOPHARMACOLOGIA, V7, P115, DOI 10.1007/BF00403634; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; DAVIS M, 1982, J NEUROSCI, V2, P791; Davis M., 1984, P287; DAVIS M, 1993, BEHAV BRAIN RES, V58, P175, DOI 10.1016/0166-4328(93)90102-V; Eder DN, 2009, INT J PSYCHOPHYSIOL, V71, P149, DOI 10.1016/j.ijpsycho.2008.09.001; Ellis BJ, 2006, DEV REV, V26, P175, DOI 10.1016/j.dr.2006.02.004; Fang FSC, 1997, ENTROPY OPTIMIZATION; FANSELOW MS, 1984, TRENDS NEUROSCI, V7, P460; Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038; Gaburro S, 2011, INT J NEUROPSYCHOPH, V14, P1341, DOI 10.1017/S1461145711000058; Holmes A, 2005, NEUROSCI BIOBEHAV R, V29, P1335, DOI 10.1016/j.neubiorev.2005.04.012; Islam S, 2006, EUR J OPER RES, V173, P387, DOI 10.1016/j.ejor.2005.01.050; Jakovcevski M, 2008, GENES BRAIN BEHAV, V7, P235, DOI 10.1111/j.1601-183X.2007.00345.x; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Landis C, 1939, STARTLE PATTERN FARR; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Lathe R, 2004, GENES BRAIN BEHAV, V3, P317, DOI 10.1111/j.1601-183X.2004.00083.x; LEDOUX JE, 1994, SCI AM, V270, P50, DOI 10.1038/scientificamerican0694-50; Lin LN, 2005, P NATL ACAD SCI USA, V102, P6125, DOI 10.1073/pnas.0408233102; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063590; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McCauley Mark D, 2010, J Vis Exp, DOI 10.3791/1739; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Osan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016507; Palmer AA, 1999, NEUROSCIENCE, V89, P965, DOI 10.1016/S0306-4522(98)00333-9; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; RETTIG R, 1986, PHYSIOL BEHAV, V36, P1123, DOI 10.1016/0031-9384(86)90489-0; Ruiz-Padial E, 2003, PSYCHOPHYSIOLOGY, V40, P306, DOI 10.1111/1469-8986.00032; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Stiedl O, 2004, AUTON NEUROSCI-BASIC, V115, P15, DOI 10.1016/j.autneu.2004.07.006; Stiedl O, 1997, BEHAV NEUROSCI, V111, P703, DOI 10.1037/0735-7044.111.4.703; Stiedl O, 1999, BEHAV BRAIN RES, V104, P1, DOI 10.1016/S0166-4328(99)00047-9; Stiedl O, 2009, NEUROSCI BIOBEHAV R, V33, P181, DOI 10.1016/j.neubiorev.2008.08.015; Taylor BK, 1996, PHYSIOL BEHAV, V60, P919; Tovote P, 2005, BEHAV NEUROSCI, V119, P55, DOI 10.1037/0735-7044.119.1.55; Tsien JZ, 2013, NEUROBIOL LEARN MEM, V105, P200, DOI 10.1016/j.nlm.2013.06.019; Vogel EH, 2005, PHYSIOL BEHAV, V86, P516, DOI 10.1016/j.physbeh.2005.08.042; Wahlsten D, 2003, J NEUROBIOL, V54, P283, DOI 10.1002/neu.10173; Wang DV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017047; Weible AP, 2003, J NEUROPHYSIOL, V90, P599, DOI 10.1152/jn.01097.2002; Xie K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064907; YOUNG BJ, 1994, BEHAV NEUROSCI, V108, P1065, DOI 10.1037/0735-7044.108.6.1065; Zhang WN, 2004, BEHAV BRAIN RES, V154, P199, DOI 10.1016/j.bbr.2004.02.016	60	22	23	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93270	10.1371/journal.pone.0093270	http://dx.doi.org/10.1371/journal.pone.0093270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667366	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600160
J	Marolt, D; Rode, M; Kregar-Velikonja, N; Jeras, M; Knezevic, M				Marolt, Darja; Rode, Matjaz; Kregar-Velikonja, Nevenka; Jeras, Matjaz; Knezevic, Miomir			Primary Human Alveolar Bone Cells Isolated from Tissue Samples Acquired at Periodontal Surgeries Exhibit Sustained Proliferation and Retain Osteogenic Phenotype during In Vitro Expansion	PLOS ONE			English	Article							MARROW STROMAL CELLS; MESENCHYMAL STEM-CELLS; OSTEOBLAST-LIKE CELLS; ENGINEERED BONE; SINUS AUGMENTATION; QUANTITATIVE-ANALYSIS; PERIOSTEAL CELLS; GENE-EXPRESSION; DIFFERENTIATION; REGENERATION	Objectives: Bone tissue regeneration requires a source of viable, proliferative cells with osteogenic differentiation capacity. Periodontal surgeries represent an opportunity to procure small amounts of autologous tissues for primary cell isolation. Our objective was to assess the potential of human alveolar bone as a source of autologous osteogenic cells for tissue engineering and biomaterials and drug testing studies. Materials and Methods: Alveolar bone tissue was obtained from 37 patients undergoing routine periodontal surgery. Tissue harvesting and cell isolation procedures were optimized to isolate viable cells. Primary cells were subcultured and characterized with respect to their growth characteristics, gene expression of osteogenic markers, alkaline phosphatase activity and matrix mineralization, under osteogenic stimulation. Results: Alveolar bone cells were successfully isolated from 28 of the 30 samples harvested with bone forceps, and from 2 of the 5 samples obtained by bone drilling. The yield of cells in primary cultures was variable between the individual samples, but was not related to the site of tissue harvesting and the patient age. In 80% of samples (n = 5), the primary cells proliferated steadily for eight subsequent passages, reaching cumulative numbers over 10(10) cells. Analyses confirmed stable gene expression of alkaline phosphatase, osteopontin and osteocalcin in early and late cell passages. In osteogenic medium, the cells from late passages increased alkaline phosphatase activity and accumulated mineralized matrix, indicating a mature osteoblastic phenotype. Conclusions: Primary alveolar bone cells exhibited robust proliferation and retained osteogenic phenotype during in vitro expansion, suggesting that they can be used as an autologous cell source for bone regenerative therapies and various in vitro studies.	[Marolt, Darja; Jeras, Matjaz; Knezevic, Miomir] Blood Transfus Ctr Slovenia, Ljubljana, Slovenia; [Marolt, Darja; Kregar-Velikonja, Nevenka; Knezevic, Miomir] Educell Doo, Trzin, Slovenia; [Rode, Matjaz] Ctr Community Hlth, Ljubljana, Slovenia; [Kregar-Velikonja, Nevenka] Fac Hlth Sci, Novo Mesto, Slovenia; [Jeras, Matjaz] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Jeras, Matjaz] Celica Doo Biomed Ctr, Ljubljana, Slovenia	University of Ljubljana	Marolt, D (corresponding author), Blood Transfus Ctr Slovenia, Ljubljana, Slovenia.	darjamarolt@gmail.com	Velikonja, Nevenka Kregar/AAR-1166-2020	Velikonja, Nevenka Kregar/0000-0002-0479-3779; Marolt Presen, Darja/0000-0003-3638-4619	Republic of Slovenia Ministry of Education, Science and Sport [L4-6325-0311-04/4.06, 3311-01-831/476, P3-0371]; Slovene Human Resources Development and Scholarship Fund [11013-73/2012]	Republic of Slovenia Ministry of Education, Science and Sport; Slovene Human Resources Development and Scholarship Fund	This work was supported by Republic of Slovenia Ministry of Education, Science and Sport (grants L4-6325-0311-04/4.06, 3311-01-831/476, P3-0371) and Slovene Human Resources Development and Scholarship Fund (grant 11013-73/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akintoye SO, 2006, BONE, V38, P758, DOI 10.1016/j.bone.2005.10.027; Alves H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042908; Barlic A, 2008, J ORTHOP RES, V26, P847, DOI 10.1002/jor.20559; Beaumont C, 2008, J PERIODONTOL, V79, P541, DOI [10.1902/jop.2008.070255, 10.1902/jop.2008.070255 ]; Benisch P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045142; Bruder SP, 1999, CLIN ORTHOP RELAT R, pS68; Clausen C, 2006, CLIN ORAL IMPLAN RES, V17, P533, DOI 10.1111/j.1600-0501.2006.01254.X; Declercq H, 2004, BIOMATERIALS, V25, P757, DOI 10.1016/S0142-9612(03)00580-5; Dolan EB, 2012, J R SOC INTERFACE, V9, P3503, DOI 10.1098/rsif.2012.0520; Fekete N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043255; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029; Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210; Hutmacher DW, 2003, TISSUE ENG, V9, pS45, DOI 10.1089/10763270360696978; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Janssen NG, 2013, CLIN ORAL INVESTIG; Jaquiery C, 2005, ANN SURG, V242, P859, DOI 10.1097/01.sla.0000189572.02554.2c; Jonsson KB, 1999, ACTA ORTHOP SCAND, V70, P365, DOI 10.3109/17453679908997826; Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010; Kregar Velikonja N, 2012, BONE REGENERATION; Landesberg R, 2011, ANN NY ACAD SCI, V1218, P62, DOI 10.1111/j.1749-6632.2010.05835.x; Mailhot JM, 1998, CLIN ORAL IMPLAN RES, V9, P43, DOI 10.1034/j.1600-0501.1998.090106.x; Majors AK, 1997, J ORTHOPAED RES, V15, P546, DOI 10.1002/jor.1100150410; Malicev E, 2008, BIOTECHNOL BIOENG, V100, P773, DOI 10.1002/bit.21815; Mangano Carlo, 2009, Clin Implant Dent Relat Res, V11 Suppl 1, pe92, DOI 10.1111/j.1708-8208.2009.00227.x; Marolt D, 2012, J ORAL MAXIL SURG, V70, P1081, DOI 10.1016/j.joms.2011.05.002; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366; McMahon RE, 2013, J BIOMED MATER RES B, V101B, P387, DOI 10.1002/jbm.b.32823; Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029; Muschler GF, 1997, J BONE JOINT SURG AM, V79A, P1699, DOI 10.2106/00004623-199711000-00012; Piek E, 2010, BONE, V46, P613, DOI 10.1016/j.bone.2009.10.024; Pradel W, 2006, ORAL SURG ORAL MED O, V101, P285, DOI 10.1016/j.tripleo.2005.06.001; Pradel W, 2008, J PHYSIOL PHARMACOL, V59, P47; Pradel W, 2012, ANN ANAT, V194, P545, DOI 10.1016/j.aanat.2012.06.002; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Schimming R, 2004, J ORAL MAXIL SURG, V62, P724, DOI 10.1016/j.joms.2004.01.009; Schmelzeisen R, 2003, J CRANIO MAXILL SURG, V31, P34, DOI 10.1016/S1010-5182(02)00163-4; Shui CX, 2001, J BONE MINER RES, V16, P731, DOI 10.1359/jbmr.2001.16.4.731; Siggelkow H, 1999, J CELL BIOCHEM, V75, P22, DOI 10.1002/(SICI)1097-4644(19991001)75:1<22::AID-JCB3>3.0.CO;2-6; Sodek J, 2000, PERIODONTOL 2000, V24, P99, DOI 10.1034/j.1600-0757.2000.2240106.x; Springer IN, 2006, TISSUE ENG, V12, P2649, DOI 10.1089/ten.2006.12.2649; Stefanik D, 2008, ORAL DIS, V14, P465, DOI 10.1111/j.1601-0825.2007.01402.x; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Suga H, 2007, CYTOTHERAPY, V9, P738, DOI 10.1080/14653240701679873; Voegele TJ, 2000, ANTICANCER RES, V20, P3575; Xiao Y, 2004, CELL TRANSPLANT, V13, P15, DOI 10.3727/000000004772664851; Xiao Y, 2003, TISSUE ENG, V9, P1167, DOI 10.1089/10763270360728071; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	50	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92969	10.1371/journal.pone.0092969	http://dx.doi.org/10.1371/journal.pone.0092969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667745	gold, Green Published, Green Submitted			2022-12-25	WOS:000333675600112
J	Resende, PC; Motta, FC; Oliveira, MDA; Gregianini, TS; Fernandes, SB; Cury, ALF; Rosa, MDD; Souza, TML; Siqueira, MM				Resende, Paola Cristina; Motta, Fernando C.; Oliveira, Maria de Lourdes A.; Gregianini, Tatiana S.; Fernandes, Sandra B.; Cury, Ana Luisa F.; Rosa, Maria do Carmo D.; Souza, Thiago Moreno L.; Siqueira, Marilda M.			Polymorphisms at Residue 222 of the Hemagglutinin of Pandemic Influenza A(H1N1)pdm09: Association of Quasi-Species to Morbidity and Mortality in Different Risk Categories	PLOS ONE			English	Article							SUBSTITUTION; D222G; VIRUS; H1N1	The D222G substitution in the hemagglutinin (HA) gene of the pandemic influenza A(H1N1)pdm09 virus has been identified as a potential virulence marker, because this change allows for virus invasion deeper into the respiratory tract. In this study, we analyzed D, G and N polymorphisms at residue 222 by pyrosequencing (PSQ). We initially analyzed 401 samples from Brazilian patients. These were categorized with respect to clinical conditions due to influenza infection (mild, serious or fatal) and sub-stratified by risky factors. The frequency of mixed population of virus, with more than one polymorphism at residue 222, was significantly higher in serious (10.6%) and fatal (46.7%) influenza cases, whereas those who showed mild influenza infections were all infected by D222 wild-type. Mixtures of quasi-species showed a significant association of mortality, especially for those with risk factors, in special pregnant women. These results not only reinforce the association between D222G substitution and influenza A(H1N1)pdm09-associated morbidity and mortality, but also add the perspective that a worse clinical prognosis is most likely correlated with mixtures of quasi-species at this HA residue. Therefore, quasi-species may have a critical and underestimated role in influenza-related clinical outcomes.	[Resende, Paola Cristina; Motta, Fernando C.; Oliveira, Maria de Lourdes A.; Souza, Thiago Moreno L.; Siqueira, Marilda M.] Fiocruz MS, Inst Oswaldo Cruz, Lab Virus Resp & Sarampo, BR-21045900 Rio De Janeiro, Brazil; [Gregianini, Tatiana S.] Fundacao Estadual Prod & Pesquisa Saude Secao, Lab Cent Saude Publ Estado Rio Grande do Sul, Porto Alegre, RS, Brazil; [Fernandes, Sandra B.] Lab Cent Saude Publ Estado Santa Catarina, Florianopolis, SC, Brazil; [Cury, Ana Luisa F.] Inst Octavio Magalhaes, Lab Cent Saude Publ Estado Minas Gerais, Belo Horizonte, MG, Brazil; [Cury, Ana Luisa F.] Fundacao Ezequiel Dias, Belo Horizonte, MG, Brazil; [Rosa, Maria do Carmo D.] Lab Cent Saude Publ Estado Parana, Curitiba, Parana, Brazil	Fundacao Oswaldo Cruz	Resende, PC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Virus Resp & Sarampo, BR-21045900 Rio De Janeiro, Brazil.	paola@ioc.fiocruz.br	DE LOURDES A OLIVEIRA, MARIA/H-2474-2018; Resende, Paola Cristina/P-5002-2015; de Lourdes Aguiar Oliveira, Maria/AAI-8473-2021; Souza, Thiago Moreno L./G-2900-2012; Motta, Fernando/AAJ-2647-2021	Resende, Paola Cristina/0000-0002-2884-3662; de Lourdes Aguiar Oliveira, Maria/0000-0002-2472-5263; Souza, Thiago Moreno L./0000-0003-2212-3899; 	Brazilian Ministry of Health and Ministry of Technology and Science; CNPq; FAPERJ	Brazilian Ministry of Health and Ministry of Technology and Science; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Brazilian Ministry of Health and Ministry of Technology and Science, CNPq and FAPERJ provided funding to conduct this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P21; Baldanti F, 2011, CLIN MICROBIOL INFEC, V17, P1166, DOI 10.1111/j.1469-0691.2010.03403.x; Belser JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025091; Chan KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013757; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; Cheng VCC, 2012, CLIN MICROBIOL REV, V25, P223, DOI 10.1128/CMR.05012-11; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Houng HSH, 2012, J CLIN VIROL, V53, P12, DOI 10.1016/j.jcv.2011.09.004; Kilander A, 2010, EUROSURVEILLANCE, V15, P1, DOI DOI 10.1128/JVI.01136-10; Kuroda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010256; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Ledesma J, 2011, J CLIN VIROL, V51, P75, DOI 10.1016/j.jcv.2011.01.020; Levine M, 2011, J CLIN MICROBIOL, V49, P1307, DOI 10.1128/JCM.02424-10; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; MILLER RR, 2010, EURO SURVEILL, V15; Mosby LG, 2011, AM J OBSTET GYNECOL, V205, P10, DOI 10.1016/j.ajog.2010.12.033; Orczyk-Pawilowicz M, 2013, GLYCOCONJUGATE J, V30, P599, DOI 10.1007/s10719-012-9460-8; Puzelli S, 2010, EMERG INFECT DIS, V16, P863, DOI [10.3201/eid1605.091858, 10.3201/eid1605.091815]; Rykkvin R, 2013, EUROSURVEILLANCE, V18, P18; Sdve Saude, 2010, INFL PAND H1N1 2009, P21; Selleri M., 2012, CLIN MICROBIOL INFEC; Souza TML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014158; Vazquez-Perez JA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-41; Wang B., 2011, J CLIN VIROL; Wedde M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057059; WHO Global Influenza Surveillance Network, 2011, MAN LAB DIAGN VIR SU; World Health Organization, 2010, PAND H1N1 2009 UPD 1; Yasugi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030946	29	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92789	10.1371/journal.pone.0092789	http://dx.doi.org/10.1371/journal.pone.0092789			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667815	Green Submitted, Green Published, gold			2022-12-25	WOS:000333675600074
J	Tsukiyama, T; Kato-Itoh, M; Nakauchi, H; Ohinata, Y				Tsukiyama, Tomoyuki; Kato-Itoh, Megumi; Nakauchi, Hiromitsu; Ohinata, Yasuhide			A Comprehensive System for Generation and Evaluation of Induced Pluripotent Stem Cells Using piggyBac Transposition	PLOS ONE			English	Article							MAMMALIAN-CELLS; SOMATIC-CELLS; MOUSE SPERM; EXPRESSION; FIBROBLASTS; INJECTION; STATE; MICE	The most stringent criterion for evaluating pluripotency is generation of chimeric animals with germline transmission ability. Because the quality of induced pluripotent stem cell (iPSC) lines is heterogeneous, an easy and accurate system to evaluate these abilities would be useful. In this study, we describe a simple but comprehensive system for generating and evaluating iPSCs by single transfection of multiple piggyBac (PB) plasmid vectors encoding Tet-inducible polycistronic reprogramming factors, a pluripotent-cell-specific reporter, a constitutively active reporter, and a sperm-specific reporter. Using this system, we reprogrammed 129 and NOD mouse embryonic fibroblasts into iPSCs, and then evaluated the molecular and functional properties of the resultant iPSCs by quantitative RT-PCR analysis and chimera formation assays. The iPSCs contributed extensively to chimeras, as indicated by the constitutively active TagRFP reporter, and also differentiated into sperm, as indicated by the late-spermatogenesis-specific Acr (acrosin)-EGFP reporter. Next, we established secondary MEFs from E13.5 chimeric embryos and efficiently generated secondary iPSCs by simple addition of doxycycline. Finally, we applied this system to establishment and evaluation of rat iPSCs and production of rat sperm in mouse-rat interspecific chimeras. By monitoring the fluorescence of Acr-EGFP reporter, we could easily detect seminiferous tubules containing rat iPSC-derived spermatids and sperm. And, we succeeded to obtain viable offspring by intracytoplasmic sperm injection (ICSI) using these haploid male germ cells. We propose that this system will enable robust strategies for induction and evaluation of iPSCs, not only in rodents but also in other mammals. Such strategies will be especially valuable in non-rodent species, in which verification of germline transmission by mating is inefficient and time-consuming.	[Tsukiyama, Tomoyuki; Kato-Itoh, Megumi; Ohinata, Yasuhide] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan; [Tsukiyama, Tomoyuki; Ohinata, Yasuhide] RIKEN Ctr Dev Biol CDB, Lab Pluripotent Stem Cell Studies, Kobe, Hyogo, Japan; [Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Ctr Stem Cell Biol & Regenerat Med,Minato Ku, Tokyo, Japan; [Kato-Itoh, Megumi; Nakauchi, Hiromitsu] JST, ERATO, Nakauchi Stem Cell & Organ Regenerat Project, Chiyoda Ku, Tokyo, Japan; [Ohinata, Yasuhide] Univ Yamanashi, Fac Life & Environm Sci, Dept Biotechnol, Life Sci Expt Facil, Kofu, Yamanashi, Japan	Japan Science & Technology Agency (JST); RIKEN; University of Tokyo; Japan Science & Technology Agency (JST); University of Yamanashi	Ohinata, Y (corresponding author), Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan.	yasuhideohinata@gmail.com	TSUKIYAMA, Tomoyuki/AAI-3082-2020	TSUKIYAMA, Tomoyuki/0000-0002-2657-7719	PRESTO of the Japan Science and Technology Agency; Research Fellowship Program of the Japan Society for the Promotion of Science	PRESTO of the Japan Science and Technology Agency; Research Fellowship Program of the Japan Society for the Promotion of Science	This study was supported by grants from PRESTO of the Japan Science and Technology Agency (to Y.O.) and the Research Fellowship Program of the Japan Society for the Promotion of Science (to Y.O. and T. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Hasuwa H, 2010, EXP ANIM TOKYO, V59, P105, DOI 10.1538/expanim.59.105; Hirabayashi M, 2002, TRANSGENIC RES, V11, P221, DOI 10.1023/A:1015210604906; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Isotani A, 2011, GENES CELLS, V16, P397, DOI 10.1111/j.1365-2443.2011.01495.x; KASHIWABARA S, 1990, BIOCHEM BIOPH RES CO, V173, P240, DOI 10.1016/S0006-291X(05)81047-2; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsukiyama T, 2011, GENES CELLS, V16, P815, DOI 10.1111/j.1365-2443.2011.01528.x; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780	30	19	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92973	10.1371/journal.pone.0092973	http://dx.doi.org/10.1371/journal.pone.0092973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667806	Green Submitted, gold, Green Published			2022-12-25	WOS:000333675600114
J	Estrada, DF; Skinner, AL; Laurence, JS; Scott, EE				Estrada, D. Fernando; Skinner, Andria L.; Laurence, Jennifer S.; Scott, Emily E.			Human Cytochrome P450 17A1 Conformational Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytochrome P450; Membrane Proteins; NMR; Protein Structure; Steroidogenesis; Cytochrome b5	NMR-SPECTROSCOPY; LIGAND-BINDING; B(5); STATE; HETEROGENEITY; ABIRATERONE; MODULATION; DYNAMICS; COMPLEX; MODEL	Background: Crystallography provides a static structure of cytochrome P450 17A1 (CYP17A1). Results: Solution NMR reveals an ensemble of CYP17A1 conformational substates. Conclusion: Ligand, cytochrome b(5), or temperature alters the conformational CYP17A1 substates present. Significance: Changes in conformations probably modulate human steroidogenesis by CYP17A1. Crystallographic studies of different membrane cytochrome P450 enzymes have provided examples of distinct structural conformations, suggesting protein flexibility. It has been speculated that conformational selection is an integral component of substrate recognition and access, but direct evidence of such substate interconversion has thus far remained elusive. In the current study, solution NMR revealed multiple and exchanging backbone conformations for certain structural features of the human steroidogenic cytochrome P450 17A1 (CYP17A1). This bifunctional enzyme is responsible for pregnenolone C17 hydroxylation, followed by a 17,20-lyase reaction to produce dehydroepiandrosterone, the key intermediate in human synthesis of androgen and estrogen sex steroids. The distribution of CYP17A1 conformational states was influenced by temperature, binding of these two substrates, and binding of the soluble domain of cytochrome b(5) (b(5)). Notably, titration of b(5) to CYP17A1pregnenolone induced a set of conformational states closely resembling those of CYP17A1<bold>17</bold>-hydroxypregnenolone without b(5,) providing structural evidence consistent with the reported ability of b(5) to selectively enhance 17,20-lyase activity. Solution NMR thus revealed a set of conformations likely to modulate human steroidogenesis by CYP17A1, demonstrating that this approach has the potential to make similar contributions to understanding the functions of other membrane P450 enzymes involved in drug metabolism and disease states.	[Estrada, D. Fernando; Skinner, Andria L.; Scott, Emily E.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Laurence, Jennifer S.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA	University of Kansas; University of Kansas	Laurence, JS (corresponding author), Univ Kansas, Dept Pharmaceut Chem, 2095 Constant Ave, Lawrence, KS 66047 USA.	laurencj@ku.edu; eescott@ku.edu	Chadwick, Jennifer/N-8027-2013	Chadwick, Jennifer/0000-0002-1686-5979	National Institutes of Health [T32 GM08545]; Center of Biomedical Research Excellence in Protein Structure and Function (National Institutes of Health) [RR01778, GM103420]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM076343, R01GM076343, F32GM103069, T32GM008545, P20GM103420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Biomedical Research Excellence in Protein Structure and Function (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Abiraterone was a gift synthesized by Charlie Fehl (supported by National Institutes of Health Grant T32 GM08545) in the laboratory of Dr. Jeff Aube, University of Kansas Department of Medicinal Chemistry. NMR data were collected at the University of Kansas Biomolecular NMR Laboratory, supported in part by the Center of Biomedical Research Excellence in Protein Structure and Function (National Institutes of Health Grants RR01778 and GM103420).	Ahuja S, 2013, J BIOL CHEM, V288, P22080, DOI 10.1074/jbc.M112.448225; Akhtar MK, 2005, J ENDOCRINOL, V187, P267, DOI 10.1677/joe.1.06375; Asciutto EK, 2012, BIOCHEMISTRY-US, V51, P3383, DOI 10.1021/bi300007r; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Ciaccio NA, 2008, PROTEIN EXPRES PURIF, V62, P235, DOI 10.1016/j.pep.2008.07.011; Davydov DR, 2003, BIOCHEM BIOPH RES CO, V312, P121, DOI 10.1016/j.bbrc.2003.09.247; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 2009, CHEM BIOL, V16, P1215, DOI 10.1016/j.chembiol.2009.12.002; Haider SM, 2010, J MOL BIOL, V400, P1078, DOI 10.1016/j.jmb.2010.05.069; HILDEBRANDT P, 1994, BIOCHEMISTRY-US, V33, P12920, DOI 10.1021/bi00209a024; Hiruma Y, 2013, J MOL BIOL, V425, P4353, DOI 10.1016/j.jmb.2013.07.006; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Johnson EF, 2014, DRUG METAB DISPOS, V42, P9, DOI 10.1124/dmd.113.054627; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; Jovanovic T, 2005, J AM CHEM SOC, V127, P13816, DOI 10.1021/ja0438314; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; Khatri Y, 2014, BIOCHEM BIOPH RES CO, V443, P179, DOI 10.1016/j.bbrc.2013.11.094; Kim D, 2004, BIOCHEMISTRY-US, V43, P981, DOI 10.1021/bi035593f; Kim D, 2004, ARCH BIOCHEM BIOPHYS, V432, P102, DOI 10.1016/j.abb.2004.09.001; Lampe JN, 2010, J BIOL CHEM, V285, P9594, DOI 10.1074/jbc.M109.087593; Lampe JN, 2008, J AM CHEM SOC, V130, P16168, DOI 10.1021/ja8071463; LANGE R, 1992, EUR J BIOCHEM, V207, P75, DOI 10.1111/j.1432-1033.1992.tb17022.x; LEEROBICHAUD P, 1995, BIOCHEM J, V308, P901, DOI 10.1042/bj3080901; Lian LY, 2001, PROG NUCL MAG RES SP, V39, P171, DOI 10.1016/S0079-6565(01)00034-6; Luthra A, 2011, ARCH BIOCHEM BIOPHYS, V507, P26, DOI 10.1016/j.abb.2010.12.008; Miller WL, 1998, ENDOCR RES, V24, P817, DOI 10.3109/07435809809032692; Perret A, 1998, BIOCHEMISTRY-US, V37, P11412, DOI 10.1021/bi980908q; Pochapsky TC, 2010, ANTIOXID REDOX SIGN, V13, P1273, DOI 10.1089/ars.2010.3109; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Roberts AG, 2006, BIOCHEMISTRY-US, V45, P1673, DOI 10.1021/bi0518895; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Shi RW, 2011, J MOL MODEL, V17, P1941, DOI 10.1007/s00894-010-0903-5; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tripathi S, 2013, SCIENCE, V340, P1227, DOI 10.1126/science.1235797; Villali J, 2010, CURR OPIN CHEM BIOL, V14, P636, DOI 10.1016/j.cbpa.2010.08.007; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wilderman PR, 2012, FEBS J, V279, P1607, DOI 10.1111/j.1742-4658.2011.08411.x; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Yang YC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087749, 10.1371/journal.pone.0100677, 10.1371/journal.pone.0085863, 10.1371/journal.pone.0102942]; Zhang ZG, 2009, J BIOTECHNOL, V139, P12, DOI 10.1016/j.jbiotec.2008.09.010	44	48	48	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14310	14320		10.1074/jbc.M114.560144	http://dx.doi.org/10.1074/jbc.M114.560144			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24671419	hybrid, Green Published			2022-12-25	WOS:000335984600056
J	Rosenbaek, LL; Kortenoeven, MLA; Aroankins, TS; Fenton, RA				Rosenbaek, Lena L.; Kortenoeven, Marleen L. A.; Aroankins, Takwa S.; Fenton, Robert A.			Phosphorylation Decreases Ubiquitylation of the Thiazide-sensitive Cotransporter NCC and Subsequent Clathrin-mediated Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endocytosis; Epithelium; Phosphorylation; Plasma Membrane; Trafficking; Ubiquitylation	NA+-CL-COTRANSPORTER; SODIUM-CHLORIDE COTRANSPORTER; NACL COTRANSPORTER; PLASMA-MEMBRANE; DIETARY SALT; LOCALIZATION; EXPRESSION; MUTATIONS; WNK4; STIMULATION	Background: The sodium chloride cotransporter NCC mediates NaCl reabsorption in the kidney distal convoluted tubule. Results: NCC internalization from the plasma membrane is clathrin-mediated and regulated by NCC phosphorylation and ubiquitylation. Conclusion: Phosphorylation of NCC can regulate NCC internalization and ubiquitylation. Significance: Impaired NCC endocytosis could be implicated in salt-sensitive hypertension in vivo. The thiazide-sensitive sodium chloride cotransporter, NCC, is the major NaCl transport protein in the distal convoluted tubule (DCT). The transport activity of NCC can be regulated by phosphorylation, but knowledge of modulation of NCC trafficking by phosphorylation is limited. In this study, we generated novel tetracycline-inducible Madin-Darby canine kidney type I (MDCKI) cell lines expressing NCC to examine the role of NCC phosphorylation and ubiquitylation on NCC endocytosis. In MDCKI-NCC cells, NCC was highly glycosylated at molecular weights consistent with NCC monomers and dimers. NCC constitutively cycles to the apical plasma membrane of MDCKI-NCC cells, with 20-30% of the membrane pool of NCC internalized within 30 min. The use of dynasore, PitStop2, methyl--cyclodextrin, nystatin, and filipin (specific inhibitors of either clathrin-dependent or -independent endocytosis) demonstrated that NCC is internalized via a clathrin-mediated pathway. Reduction of endocytosis resulted in greater levels of NCC in the plasma membrane. Immunogold electron microscopy confirmed the association of NCC with the clathrin-mediated internalization pathway in rat DCT cells. Compared with controls, inducing phosphorylation of NCC via low chloride treatment or mimicking phosphorylation by replacing Thr-53, Thr-58, and Ser-71 residues with Asp resulted in increased membrane abundance and reduced rates of NCC internalization. NCC ubiquitylation was lowest in the conditions with greatest NCC phosphorylation, thus providing a mechanism for the reduced endocytosis. In conclusion, our data support a model where NCC is constitutively cycled to the plasma membrane, and upon stimulation, it can be phosphorylated to both increase NCC activity and decrease NCC endocytosis, together increasing NaCl transport in the DCT.	[Fenton, Robert A.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; Aarhus Univ, Ctr Interact Prot Epithelial Transport, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Fenton, RA (corresponding author), Aarhus Univ, Dept Biomed, Bldg 1233,Rm 213, DK-8000 Aarhus, Denmark.	ROFE@ana.au.dk	Fenton, Robert A/ABD-9824-2021; Fenton, Robert/AFR-6983-2022; Kortenoeven, Marleen/B-8565-2014	Fenton, Robert/0000-0003-1623-199X; Kortenoeven, Marleen/0000-0001-9962-8276	Danish Medical Research Council; Lundbeck Foundation; Novo Nordisk Foundation; Carlsberg Foundation; Aarhus University Research Foundation; Lundbeck Foundation [R44-2009-4252] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); Aarhus University Research Foundation; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Danish Medical Research Council, the Lundbeck Foundation, the Novo Nordisk Foundation, the Carlsberg Foundation, and the Aarhus University Research Foundation.	Ares GR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386425; Ares GR, 2010, AM J PHYSIOL-RENAL, V299, pF1193, DOI 10.1152/ajprenal.00307.2010; Cai H, 2006, KIDNEY INT, V69, P2162, DOI 10.1038/sj.ki.5000333; Chiga M, 2008, KIDNEY INT, V74, P1403, DOI 10.1038/ki.2008.451; Chow CW, 1999, J BIOL CHEM, V274, P37551, DOI 10.1074/jbc.274.53.37551; de Jong JC, 2003, J BIOL CHEM, V278, P24302, DOI 10.1074/jbc.M303101200; De Jong JC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017904.77985.03; Dutta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045799; Fang L, 2009, J CLIN INVEST, V119, P3278, DOI 10.1172/JCI37950; Fenton RA, 2007, AM J PHYSIOL-RENAL, V293, pF748, DOI 10.1152/ajprenal.00316.2006; Frohlich O, 2004, AM J PHYSIOL-CELL PH, V286, pC1264, DOI 10.1152/ajpcell.00499.2003; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GAMBA G, 1994, J BIOL CHEM, V269, P17713; GESEK FA, 1992, J CLIN INVEST, V90, P429, DOI 10.1172/JCI115878; Glover M, 2010, CAN J PHYSIOL PHARM, V88, P986, DOI [10.1139/y10-080, 10.1139/Y10-080]; Hoover RS, 2003, J AM SOC NEPHROL, V14, P271, DOI 10.1097/01.ASN.0000043903.93452.D0; Huang HD, 2010, AM J PHYSIOL-RENAL, V299, pF1389, DOI 10.1152/ajprenal.00718.2009; Khan MZH, 2012, BIOCHEM BIOPH RES CO, V425, P456, DOI 10.1016/j.bbrc.2012.07.124; Kim GH, 1998, P NATL ACAD SCI USA, V95, P14552, DOI 10.1073/pnas.95.24.14552; Ko B, 2007, P NATL ACAD SCI USA, V104, P20120, DOI 10.1073/pnas.0709506104; Ko B, 2012, AM J PHYSIOL-RENAL, V303, pF700, DOI 10.1152/ajprenal.00139.2012; Ko B, 2010, AM J PHYSIOL-RENAL, V299, pF300, DOI 10.1152/ajprenal.00441.2009; Kunchaparty S, 1999, AM J PHYSIOL-RENAL, V277, pF643, DOI 10.1152/ajprenal.1999.277.4.F643; Lemmink HH, 1998, KIDNEY INT, V54, P720, DOI 10.1046/j.1523-1755.1998.00070.x; Lu H, 2004, AM J PHYSIOL-RENAL, V286, pF233, DOI 10.1152/ajprenal.00179.2003; Markadieu N, 2012, AM J PHYSIOL-RENAL, V303, pF886, DOI 10.1152/ajprenal.00114.2012; Mastroianni N, 1996, AM J HUM GENET, V59, P1019; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McCormick JA, 2011, CELL METAB, V14, P352, DOI 10.1016/j.cmet.2011.07.009; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Monkawa T, 2000, J AM SOC NEPHROL, V11, P65, DOI 10.1681/ASN.V11165; Mutig K, 2010, AM J PHYSIOL-RENAL, V298, pF502, DOI 10.1152/ajprenal.00476.2009; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Pedersen NB, 2010, KIDNEY INT, V78, P160, DOI 10.1038/ki.2010.130; Peng KC, 1999, J HISTOCHEM CYTOCHEM, V47, P757, DOI 10.1177/002215549904700605; Plotkin MD, 1996, KIDNEY INT, V50, P174, DOI 10.1038/ki.1996.300; Rice WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032843; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Rosenbaek LL, 2012, J PHYSIOL-LONDON, V590, P6121, DOI 10.1113/jphysiol.2012.240986; Sandberg MB, 2007, AM J PHYSIOL-RENAL, V293, pF662, DOI 10.1152/ajprenal.00064.2007; Sandberg MB, 2006, AM J PHYSIOL-RENAL, V291, pF503, DOI 10.1152/ajprenal.00482.2005; Shi HK, 2002, EUR J BIOCHEM, V269, P4551, DOI 10.1046/j.1432-1033.2002.03154.x; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Sorensen MV, 2013, KIDNEY INT, V83, P811, DOI 10.1038/ki.2013.14; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; Sun TX, 2002, AM J PHYSIOL-RENAL, V282, pF998, DOI 10.1152/ajprenal.00257.2001; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Vallon V, 2009, AM J PHYSIOL-RENAL, V297, pF704, DOI 10.1152/ajprenal.00030.2009; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Yang SS, 2005, BIOCHEM BIOPH RES CO, V330, P410, DOI 10.1016/j.bbrc.2005.02.172; Zhou B, 2010, J AM SOC NEPHROL, V21, P82, DOI 10.1681/ASN.2008121275	54	50	50	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13347	13361		10.1074/jbc.M113.543710	http://dx.doi.org/10.1074/jbc.M113.543710			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24668812	Green Published, hybrid			2022-12-25	WOS:000335522800033
J	Xu, HF; Abe, T; Liu, JKH; Zalivina, I; Hohenester, E; Leitinger, B				Xu, Huifang; Abe, Takemoto; Liu, Justin K. H.; Zalivina, Irina; Hohenester, Erhard; Leitinger, Birgit			Normal Activation of Discoidin Domain Receptor 1 Mutants with Disulfide Cross-links, Insertions, or Deletions in the Extracellular Juxtamembrane Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Mutagenesis Site-specific; Receptor Regulation; Receptor Structure-Function; Receptor Tyrosine Kinase; Signal Transduction; Activation Mechanism; Cysteine Scanning	GROWTH-FACTOR RECEPTOR; TYROSINE KINASES; TRANSMEMBRANE DOMAINS; LIGAND-BINDING; EGF RECEPTOR; ERYTHROPOIETIN RECEPTOR; COLLAGEN RECOGNITION; STRUCTURAL BASIS; MEMBRANE; DDR2	Background: DDR1 is a constitutively dimeric receptor tyrosine kinase that is activated by collagen. The mechanism of transmembrane signaling is unknown. Results: DDR1 activation is unaffected by disulfide cross-links, insertions, or deletions in the extracellular juxtamembrane region. Conclusion: The extracellular juxtamembrane region of DDR1 does not transmit a conformational change across the cell membrane. Significance: The activation mechanism of DDR1 appears to be unique among receptor tyrosine kinases. The discoidin domain receptors, DDR1 and DDR2, are receptor tyrosine kinases that are activated by collagen. DDR activation does not appear to occur by the common mechanism of ligand-induced receptor dimerization: the DDRs form stable noncovalent dimers in the absence of ligand, and ligand-induced autophosphorylation of cytoplasmic tyrosines is unusually slow and sustained. Here we sought to identify functionally important dimer contacts within the extracellular region of DDR1 by using cysteine-scanning mutagenesis. Cysteine substitutions close to the transmembrane domain resulted in receptors that formed covalent dimers with high efficiency, both in the absence and presence of collagen. Enforced covalent dimerization did not result in constitutive activation and did not affect the ability of collagen to induce receptor autophosphorylation. Cysteines farther away from the transmembrane domain were also cross-linked with high efficiency, but some of these mutants could no longer be activated. Furthermore, the extracellular juxtamembrane region of DDR1 tolerated large deletions as well as insertions of flexible segments, with no adverse effect on activation. These findings indicate that the extracellular juxtamembrane region of DDR1 is exceptionally flexible and does not constrain the basal or ligand-activated state of the receptor. DDR1 transmembrane signaling thus appears to occur without conformational coupling through the juxtamembrane region, but requires specific receptor interactions farther away from the cell membrane. A plausible mechanism to explain these findings is signaling by DDR1 clusters.	[Xu, Huifang; Abe, Takemoto; Liu, Justin K. H.; Zalivina, Irina; Leitinger, Birgit] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Hohenester, Erhard] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	Imperial College London; Imperial College London	Leitinger, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Mol Med Sect, NHLI, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	b.leitinger@imperial.ac.uk		Liu, Justin/0000-0002-4665-737X	Biotechnology and Biological Sciences Research Council United Kingdom [BB/I011226/1]; Biotechnology and Biological Sciences Research Council [BB/I011226/1] Funding Source: researchfish; BBSRC [BB/I011226/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grant BB/I011226/1 from the Biotechnology and Biological Sciences Research Council United Kingdom.	Adar R, 2002, J BONE MINER RES, V17, P860, DOI 10.1359/jbmr.2002.17.5.860; Ali BR, 2010, HUM MOL GENET, V19, P2239, DOI 10.1093/hmg/ddq103; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Bargal R, 2009, AM J HUM GENET, V84, P80, DOI 10.1016/j.ajhg.2008.12.004; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Burke CL, 1998, MOL CELL BIOL, V18, P5371, DOI 10.1128/MCB.18.9.5371; Carafoli F, 2013, BBA-PROTEINS PROTEOM, V1834, P2187, DOI 10.1016/j.bbapap.2012.10.014; Carafoli F, 2012, STRUCTURE, V20, P688, DOI 10.1016/j.str.2012.02.011; Carafoli F, 2009, STRUCTURE, V17, P1573, DOI 10.1016/j.str.2009.10.012; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Finger C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000547; Foehr ED, 2000, FASEB J, V14, P973, DOI 10.1096/fasebj.14.7.973; Fu HL, 2014, J BIOL CHEM, V289, P9275, DOI 10.1074/jbc.M113.541102; Fu HL, 2013, J BIOL CHEM, V288, P12114, DOI 10.1074/jbc.M112.409599; Fu HL, 2013, J BIOL CHEM, V288, P7430, DOI 10.1074/jbc.R112.444158; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Ichikawa O, 2007, EMBO J, V26, P4168, DOI 10.1038/sj.emboj.7601833; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Kjaer S, 2006, ONCOGENE, V25, P7086, DOI 10.1038/sj.onc.1209698; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Kubatzky KF, 2005, J BIOL CHEM, V280, P14844, DOI 10.1074/jbc.M411251200; Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Leitinger B, 2014, INT REV CEL MOL BIO, V310, P39, DOI 10.1016/B978-0-12-800180-6.00002-5; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mangasarian K, 1997, J CELL PHYSIOL, V172, P117, DOI 10.1002/(SICI)1097-4652(199707)172:1<117::AID-JCP13>3.3.CO;2-S; Mi LZ, 2011, NAT STRUCT MOL BIOL, V18, P984, DOI 10.1038/nsmb.2092; Mihai C, 2009, J MOL BIOL, V385, P432, DOI 10.1016/j.jmb.2008.10.067; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; Oka OBV, 2013, BBA-MOL CELL RES, V1833, P2425, DOI 10.1016/j.bbamcr.2013.02.007; Parat M, 2010, BIOCHEMISTRY-US, V49, P4601, DOI 10.1021/bi901711w; RIEDEL H, 1986, NATURE, V324, P68, DOI 10.1038/324068a0; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Siegel PM, 1996, P NATL ACAD SCI USA, V93, P8878, DOI 10.1073/pnas.93.17.8878; Slack BE, 2006, J CELL BIOCHEM, V98, P672, DOI 10.1002/jcb.20812; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Vilar M, 2009, J CELL SCI, V122, P3351, DOI 10.1242/jcs.055061; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel WF, 2002, FEBS LETT, V514, P175, DOI 10.1016/S0014-5793(02)02360-8; Vogel WF, 2001, MOL CELL BIOL, V21, P2906, DOI 10.1128/MCB.21.8.2906-2917.2001; Ward CW, 2013, BIOESSAYS, V35, P945, DOI 10.1002/bies.201300065; Xu HF, 2011, MATRIX BIOL, V30, P16, DOI 10.1016/j.matbio.2010.10.004	51	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13565	13574		10.1074/jbc.M113.536144	http://dx.doi.org/10.1074/jbc.M113.536144			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24671415	Green Published, hybrid			2022-12-25	WOS:000335522800051
J	Lu, DF; Wang, Y; Su, ZZ; Zeng, ZH; Xing, XW; He, ZY; Zhang, CX				Lu, Dong-feng; Wang, Ying; Su, Zi-zhuo; Zeng, Zhao-hua; Xing, Xiao-wen; He, Zhi-yu; Zhang, Chunxiang			Knockdown of the HDAC1 Promotes the Directed Differentiation of Bone Mesenchymal Stem Cells into Cardiomyocytes	PLOS ONE			English	Article								Failure of the directed differentiation of the transplanted stem cells into cardiomyocytes is still a major challenge of cardiac regeneration therapy. Our recent study has demonstrated that the expression of histone deacetylase 1 (HDAC1) is decreased in bone mesenchymal stem cells (BMSCs) during their differentiation into cardiomyocytes. However, the potential roles of HDAC1 in cardiac cell differentiation of BMSCs, as well as the mechanisms involved are still unclear. In current study, the expression of HDAC1 in cultured rat BMSCs is knocked down by lentiviral vectors expressing HDAC1-RNAi. The directed differentiation of BMSCs into cardiomyocytes is evaluated by the expression levels of cardiomyocyte-related genes such as GATA-binding protein 4 (GATA-4), Nirenberg, Kim gene 2 homeobox 5 (Nkx2.5), cardiac troponin T (CTnT), myosin heavy chain (MHC), and connexin-43. Compared with that in control BMSCs, the expression of these cardiomyocyte-related genes is significantly increased in these HDAC1 deficient stem cells. The results suggest that HDAC1 is involved in the cardiomyocyte differentiation of BMSCs. Knockdown of the HDAC1 may promote the directed differentiation of BMSCs into cardiomyocytes.	[Lu, Dong-feng; Wang, Ying; Su, Zi-zhuo; Zeng, Zhao-hua; Xing, Xiao-wen; He, Zhi-yu] Guangzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Zhang, Chunxiang] Rush Univ, Dept Pharmacol, Rush Med Coll, Chicago, IL 60612 USA; [Zhang, Chunxiang] Rush Univ, Cardiovasc Res Ctr, Rush Med Coll, Chicago, IL 60612 USA	Guangzhou Medical University; Rush University; Rush University	Lu, DF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	497440817@qq.com; chunxiang_zhang@rush.edu	zhang, xiang chun/HCH-7063-2022	zhang, xiang chun/0000-0001-8303-6495	Scientific Foundation of Guangdong, China [2009B030801358, 10151009504000008, 2012A030400028, 7003080]	Scientific Foundation of Guangdong, China	This research was supported by the Scientific Foundation of Guangdong, China (No. 2009B030801358; No. 10151009504000008; No. 2012A030400028; No. 7003080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.		0	11	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e92179	10.1371/journal.pone.0092179	http://dx.doi.org/10.1371/journal.pone.0092179			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TJ	24686813	gold, Green Submitted, Green Published			2022-12-25	WOS:000333678800002
J	Hu, KZ; Du, K; Tang, GH; Yao, SB; Wang, HL; Liang, X; Yao, BG; Huang, TT; Zang, LQ				Hu, Kongzhen; Du, Kan; Tang, Ganghua; Yao, Shaobo; Wang, Hongliang; Liang, Xiang; Yao, Baoguo; Huang, Tingting; Zang, Linquan			Radiosynthesis and Biological Evaluation of N-[F-18]Labeled Glutamic Acid as a Tumor Metabolic Imaging Tracer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; X(C)(-) TRANSPORTER ACTIVITY; PET; GLUTAMINOLYSIS; CARCINOMA; FDG	We have previously reported that N-(2-[F-18]fluoropropionyl)-L-methionine ([F-18]FPMET) selectively accumulates in tumors. However, due to the poor pharmacokinetics of [F-18]FPMET in vivo, the potential clinical translation of this observation is hampered. In this study, we rationally designed and synthesized [F-18] or [C-11]labeled N-position L-glutamic acid analogues for tumor imaging. N-(2-[F-18]fluoropropionyl)-L-glutamic acid ([F-18]FPGLU) was synthesized with a 30 +/- 10% (n = 10, decay-corrected) overall radiochemical yield and a specific activity of 40 +/- 25 GBq/mu mol (n = 10) after 130 min of radiosynthesis. In vitro cell experiments showed that [F-18]FPGLU was primarily transported through the X-AG system and was not incorporated into protein. [F-18]FPGLU was stable in urine, tumor tissues, and blood. We were able to use [F-18]FPGLU in PET imaging and obtained high tumor to background ratios when visualizing tumors tissues in animal models.	[Hu, Kongzhen; Tang, Ganghua; Yao, Shaobo; Wang, Hongliang; Liang, Xiang; Yao, Baoguo; Huang, Tingting] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nucl Med, PET CT Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Du, Kan; Zang, Linquan] Guangdong Pharmaceut Univ, Sch Pharm, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangdong Pharmaceutical University	Tang, GH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nucl Med, PET CT Ctr, Guangzhou 510275, Guangdong, Peoples R China.	gtang0224@126.com	Yao, Shaobo/AAR-3740-2021	Yao, Shaobo/0000-0003-2245-871X; Hu, Kongzhen/0000-0002-7889-9576	National High Technology Research and Development Program of China (863 Program) [2008AA02Z430, 81371584]; National Natural Science Foundation [81371584, 30970856]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [[2010]609]; Science and Technology Planning Project of Guangzhou [2011J5200025]; Sun Yat-Sen University [80000-3126132]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Science and Technology Planning Project of Guangzhou; Sun Yat-Sen University	National High Technology Research and Development Program of China (863 Program, No. 2008AA02Z430, NO. 81371584), the National Natural Science Foundation (No. 30970856, No. 81371584), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry ([2010]609), Science and Technology Planning Project of Guangzhou (2011J5200025), and Sun Yat-Sen University (No. 80000-3126132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek S, 2013, J NUCL MED, V54, P117, DOI 10.2967/jnumed.112.108704; Bourdier T, 2011, J MED CHEM, V54, P1860, DOI 10.1021/jm101513q; DALLASTA V, 1983, J BIOL CHEM, V258, P6371; Deng HF, 2011, J NUCL MED, V52, P287, DOI 10.2967/jnumed.110.081349; Dimitrakopoulou-Strauss A, 2001, J NUCL MED, V42, P248; Hautzel H, 2002, UROLOGE A, V41, P569, DOI 10.1007/s00120-002-0244-9; Hu KZ, 2014, J RADIOANAL NUCL CH, V299, P271, DOI 10.1007/s10967-013-2736-z; Hu KZ, 2013, NUCL MED BIOL, V40, P926, DOI 10.1016/j.nucmedbio.2013.06.006; Hughes AB, 2000, AUST J CHEM, V53, P237, DOI 10.1071/CH99182; Hultsch C, 2005, AMINO ACIDS, V29, P405, DOI 10.1007/s00726-005-0204-y; Ide M, 2006, Q J NUCL MED MOL IM, V50, P23; Kanai Yoshikatsu, 2003, J Toxicol Sci, V28, P1, DOI 10.2131/jts.28.1; Kansal Vinod K., 2000, Indian Journal of Experimental Biology, V38, P1097; Koglin N, 2011, CLIN CANCER RES, V17, P6000, DOI 10.1158/1078-0432.CCR-11-0687; Krasikova RN, 2011, J MED CHEM, V54, P406, DOI 10.1021/jm101068q; Lang LX, 2011, BIOCONJUGATE CHEM, V22, P2415, DOI 10.1021/bc200197h; Langen KJ, 2002, NUCL MED BIOL, V29, P685, DOI 10.1016/S0969-8051(02)00327-X; Lieberman BP, 2011, J NUCL MED, V52, P1947, DOI 10.2967/jnumed.111.093815; Machtens S, 2004, UROLOGE A, V43, P1397, DOI 10.1007/s00120-004-0714-3; Nagren K, 2000, J LABELLED COMPD RAD, V43, P1013, DOI 10.1002/1099-1344(200009)43:10<1013::AID-JLCR387>3.0.CO;2-H; Pekkala S, 2009, BIOCHEM J, V424, P211, DOI 10.1042/BJ20090888; Pillarsetty NV, 2009, J NUCL MED, V50, P1709, DOI 10.2967/jnumed.109.064212; Ploessl K, 2012, J NUCL MED, V53, P1616, DOI 10.2967/jnumed.111.101279; Prenant C, 1996, NUCL MED BIOL, V23, P359, DOI 10.1016/0969-8051(96)00016-9; Rajagopalan KN, 2011, J NUCL MED, V52, P1005, DOI 10.2967/jnumed.110.084244; Shanware NP, 2011, J MOL MED, V89, P229, DOI 10.1007/s00109-011-0731-9; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Tang Ganghua, 2006, Nuclear Techniques, V29, P531; Wang XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053938, 10.1371/journal.pone.0050627]; Weber WA, 2000, EUR J NUCL MED, V27, P542, DOI 10.1007/s002590050541; Wester HJ, 1999, J NUCL MED, V40, P205; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wu SF, 1980, SCI CHINA, P913	33	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93262	10.1371/journal.pone.0093262	http://dx.doi.org/10.1371/journal.pone.0093262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681642	Green Published, Green Submitted, gold			2022-12-25	WOS:000333678100036
J	Lauten, A; Gerhard-Garcia, A; Suhr, F; Fischer, JH; Figulla, HR; Bloch, W				Lauten, Alexander; Gerhard-Garcia, Alexandra; Suhr, Frank; Fischer, Juergen H.; Figulla, Hans R.; Bloch, Wilhelm			Impact of Ischemia-Reperfusion on Extracellular Matrix Processing and Structure of the Basement Membrane of the Heart	PLOS ONE			English	Article							ANGIOGENESIS; METALLOPROTEINASES; ENDOSTATIN; INFARCTION; CONDUCTION; ENDOREPELLIN; PROTEOLYSIS; INHIBITION; TUMSTATIN; FRAGMENT	Purpose: Acute ischemic injury is a strong inductor of cardiac remodelling, resulting in structural changes of the extracellular matrix (ECM) and basement membrane (BM). In a large animal model of ischemia-reperfusion (I/R) we investigated the post-ischemic liberation of the collagen-IV-fragments Tumstatin (TUM; 28 kDa-fragment of collagen-IV-alpha-3), Arresten (ARR; 26 kDa-fragment of collagen-IV-alpha-1) and Endorepellin (LG3, 85 kDa-fragment of perlecan) which are biologically active in angiogenesis and vascularization in the post-ischemic myocardium. Methods and Results: In this blinded study, 30 pigs were randomized to 60 min of global I/R at either 4 degrees C or 32 degrees C or served as control. Three transmyocardial tissue samples were collected prior to ischemia and within 30 min and 150 min of reperfusion. Tissue content of TUM, ARR and LG3 was analyzed by western blotting and immunostaining. Within 150 min of mild hypothermic I/R a significantly increased tissue content of ARR (0.17+/-0.14 vs. 0.56+/-0.56; p = 0.001) and LG3 (1.13+/-0.34 vs. 2.51+/-1.71, p<0.001) was observed. In contrast, deep hypothermic I/R was not associated with a significant release of cleavage products. Cleavage of TUM remained unchanged irrespective of temperature. Increased matrix processing following mild hypothermia I/R is further supported by a>11 fold elevation of creatine kinase (2075+/-2595 U/l vs. 23248+/-6551 U/l; p<0.001) in the coronary sinus plasma samples. Immunostaining demonstrated no changes for ARR and LG3 presentation irrespective of temperature. In contrast, TUM significantly decreased in the BM surrounding cardiomyocytes and capillaries after mild and deep hypothermic I/R, thus representing structural alterations of the BM in these groups. Conclusion: The study demonstrates an early temperature-dependent processing of Col-IV as major component of the BM of cardiomyocytes and vascular endothelium. These observations support the protective effects of deep hypothermia during I/R. Furthermore, the results suggest an increased structural remodelling of the myocardial basement membrane with potential functional impairment during mild hypothermic I/R which may contribute to the progression to post-ischemic heart failure.	[Lauten, Alexander; Figulla, Hans R.] Univ Jena, Dept Internal Med Cardiol Angiol Pneumol 1, Jena, Germany; [Lauten, Alexander; Gerhard-Garcia, Alexandra; Suhr, Frank; Bloch, Wilhelm] German Sports Univ, Inst Cardiovasc Res & Sports Med, Cologne, Germany; [Fischer, Juergen H.] Univ Cologne, Inst Expt Med, D-50931 Cologne, Germany	Friedrich Schiller University of Jena; German Sport University Cologne; University of Cologne	Lauten, A (corresponding author), Univ Jena, Dept Internal Med Cardiol Angiol Pneumol 1, Jena, Germany.	alexander.lauten@med.uni-jena.de	Lauten, Alexander/GLT-9500-2022; Suhr, Frank/AAU-5080-2021	Suhr, Frank/0000-0002-9013-3944				Bendrik C, 2010, CANCER LETT, V292, P32, DOI 10.1016/j.canlet.2009.11.002; Cailhier JF, 2008, J BIOL CHEM, V283, P27220, DOI 10.1074/jbc.M801164200; Cleutjens JPM, 1996, CARDIOVASC RES, V32, P816; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Falk V, 2002, EUR J CARDIO-THORAC, V22, P53, DOI 10.1016/S1010-7940(02)00207-5; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; He KJ, 2004, CARDIOVASC RES, V64, P72, DOI 10.1016/j.cardiores.2004.06.007; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x; Laplante P, 2006, J BIOL CHEM, V281, P30383, DOI 10.1074/jbc.M606412200; Lauten A, 2009, CATHETER CARDIO INTE, V74, P514, DOI 10.1002/ccd.22093; Lauten A, 2009, BASIC RES CARDIOL, V104, P559, DOI 10.1007/s00395-009-0013-7; LERMAN RH, 1983, CIRC RES, V53, P378, DOI 10.1161/01.RES.53.3.378; Maeshima Y, 2000, J BIOL CHEM, V275, P23745, DOI 10.1074/jbc.C000186200; Malan D, 2009, STEM CELLS, V27, P88, DOI 10.1634/stemcells.2008-0335; MARAGOUDAKIS ME, 1995, MICROVASC RES, V50, P215, DOI 10.1006/mvre.1995.1054; MARAGOUDAKIS ME, 1993, KIDNEY INT, V43, P147, DOI 10.1038/ki.1993.24; Mellon MJ, 2008, HUM GENE THER, V19, P487, DOI 10.1089/hum.2007.135; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Morley GE, 1999, J CARDIOVASC ELECTR, V10, P1361, DOI 10.1111/j.1540-8167.1999.tb00192.x; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Raymond MA, 2004, FASEB J, V18, P705, DOI 10.1096/fj.03-0573fje; Roell W, 2002, CIRCULATION, V105, P2435, DOI 10.1161/01.CIR.0000016063.66513.BB; Sabbah HN, 2003, CIRC RES, V93, P1095, DOI 10.1161/01.RES.0000101932.70443.FE; Sasse P, 2008, CARDIOVASC RES, V80, P435, DOI 10.1093/cvr/cvn225; Schmidt A, 2004, DEV DYNAM, V230, P468, DOI 10.1002/dvdy.20072; Schrickel JW, 2007, CARDIOVASC RES, V76, P257, DOI 10.1016/j.cardiores.2007.07.001; Shamhart PE, 2010, J MOL CELL CARDIOL, V48, P530, DOI 10.1016/j.yjmcc.2009.06.017; Spinale FG, 2008, CIRCULATION, V118, pS16, DOI 10.1161/CIRCULATIONAHA.108.786640; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Suhr F, 2009, SCAND J MED SCI SPOR; TAKAHASHI S, 1990, BIOCHEM J, V265, P233, DOI 10.1042/bj2650233; van Rijen HVM, 2004, CIRCULATION, V109, P1048, DOI 10.1161/01.CIR.0000117402.70689.75; Wenzel D, 2006, CIRC RES, V98, P1203, DOI 10.1161/01.RES.0000219899.93384.ed	34	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92833	10.1371/journal.pone.0092833	http://dx.doi.org/10.1371/journal.pone.0092833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681713	gold, Green Published, Green Submitted			2022-12-25	WOS:000333678100018
J	Arner, E; Forrest, ARR; Ehrlund, A; Mejhert, N; Itoh, M; Kawaji, H; Lassmann, T; Laurencikiene, J; Ryden, M; Arner, P				Arner, Erik; Forrest, Alistair R. R.; Ehrlund, Anna; Mejhert, Niklas; Itoh, Masayoshi; Kawaji, Hideya; Lassmann, Timo; Laurencikiene, Jurga; Ryden, Mikael; Arner, Peter		Fantom Consortium	Ceruloplasmin Is a Novel Adipokine Which Is Overexpressed in Adipose Tissue of Obese Subjects and in Obesity-Associated Cancer Cells	PLOS ONE			English	Article							BODY-WATER; ADIPOCYTES	Obesity confers an increased risk of developing specific cancer forms. Although the mechanisms are unclear, increased fat cell secretion of specific proteins (adipokines) may promote/facilitate development of malignant tumors in obesity via cross-talk between adipose tissue(s) and the tissues prone to develop cancer among obese. We searched for novel adipokines that were overexpressed in adipose tissue of obese subjects as well as in tumor cells derived from cancers commonly associated with obesity. For this purpose expression data from human adipose tissue of obese and non-obese as well as from a large panel of human cancer cell lines and corresponding primary cells and tissues were explored. We found expression of ceruloplasmin to be the most enriched in obesity-associated cancer cells. This gene was also significantly up-regulated in adipose tissue of obese subjects. Ceruloplasmin is the body's main copper carrier and is involved in angiogenesis. We demonstrate that ceruloplasmin is a novel adipokine, which is produced and secreted at increased rates in obesity. In the obese state, adipose tissue contributed markedly (up to 22%) to the total circulating protein level. In summary, we have through bioinformatic screening identified ceruloplasmin as a novel adipokine with increased expression in adipose tissue of obese subjects as well as in cells from obesity-associated cancers. Whether there is a causal relationship between adipose overexpression of ceruloplasmin and cancer development in obesity cannot be answered by these cross-sectional comparisons.	[Arner, Erik; Forrest, Alistair R. R.; Itoh, Masayoshi; Kawaji, Hideya; Lassmann, Timo] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; [Arner, Erik; Ehrlund, Anna; Mejhert, Niklas; Laurencikiene, Jurga; Ryden, Mikael; Arner, Peter] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Huddinge, Sweden; [Itoh, Masayoshi; Kawaji, Hideya] RIKEN Prevent Med & Diag Innovat Program, Wako, Saitama, Japan; [Arner, Erik; Forrest, Alistair R. R.; Itoh, Masayoshi; Kawaji, Hideya; Lassmann, Timo] RIKEN Om Sci Ctr, Yokohama, Kanagawa, Japan	RIKEN; Karolinska Institutet; Karolinska University Hospital; RIKEN; RIKEN	Arner, E (corresponding author), RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan.	arner@gsc.riken.jp; peter.arner@ki.se	Lassmann, Timo/HCH-4313-2022; Ohno, Hiroshi/L-7899-2014; Ravasi, Timothy/B-8777-2008; Mackay-Sim, Alan/C-3431-2008; Kawaji, Hideya/N-5116-2015; Arner, Erik/A-1895-2010; Daub, Carsten O/A-7436-2010; Itoh, Masayoshi/N-5363-2015; Kere, Juha/A-9179-2008; Hide, Winston A/V-2727-2017; Hide, Winston Hide/C-7217-2009; Hide, Winston/R-3815-2019; Kenna, Tony/A-6035-2011; Bodega, Beatrice/I-4644-2018; Katayama, Shintaro/F-2958-2010; Wolvetang, Ernst jurgen/D-6644-2017; Lassmann, Timo/A-8271-2008; Wells, Christine/A-5071-2010	Lassmann, Timo/0000-0002-0138-2691; Ohno, Hiroshi/0000-0001-8776-9661; Mackay-Sim, Alan/0000-0003-4446-5371; Kawaji, Hideya/0000-0002-0575-0308; Arner, Erik/0000-0003-1225-4908; Daub, Carsten O/0000-0002-3295-8729; Itoh, Masayoshi/0000-0002-1772-318X; Kere, Juha/0000-0003-1974-0271; Hide, Winston A/0000-0002-8621-3271; Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston/0000-0002-8621-3271; Bodega, Beatrice/0000-0003-0527-9234; Katayama, Shintaro/0000-0001-7581-5157; Wolvetang, Ernst jurgen/0000-0002-2146-6614; Lassmann, Timo/0000-0002-0138-2691; Valen, Eivind/0000-0003-1840-6108; Moro, Kazuyo/0000-0002-7377-1303; Burroughs, A. Max/0000-0002-2229-8771; Knox, Alan/0000-0002-5906-4143; Wasserman, Wyeth/0000-0001-6098-6412; Wells, Christine/0000-0003-3133-3628; Heutink, Peter/0000-0001-5218-1737; Sajantila, Antti/0000-0003-4117-5248; Lenhard, Boris/0000-0002-1114-1509; Arner, Peter/0000-0002-6208-6220; IIDA, Kei/0000-0001-7130-8705; Forrest, Alistair/0000-0003-4543-1675; Winteringham, Louise/0000-0002-8117-5069; Mejhert, Niklas/0000-0003-1785-833X; Fisher, Malcolm/0000-0003-1074-8103; , Jurga/0000-0002-7032-2924; Meehan, Terrence/0000-0003-1980-3228; Ekwall, Karl/0000-0002-3029-4041	MEXT; MEXT, Japan; Swedish Research Council; Swedish Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA076674] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF12OC1016371, NNF14OC0010187] Funding Source: researchfish	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Novo Nordisk Fonden(Novo Nordisk Foundation)	FANTOM5 was made possible by a Research Grant for RIKEN Omics Science Center from MEXT to Yoshihide Hayashizaki and a Grant of the Research Program of Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from MEXT, Japan to Yoshihide Hayashizaki. This study was also supported by grants from the Swedish Research Council and the Swedish Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner E, 2012, DIABETES, V61, P1986, DOI 10.2337/db11-1508; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen J, 2011, OBES REV, V12, P1063, DOI 10.1111/j.1467-789X.2011.00917.x; Cignarelli M, 1996, INT J OBESITY, V20, P809; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Healy J, 2007, J NEURAL TRANSM, V114, P777, DOI 10.1007/s00702-007-0687-7; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Kim OY, 2011, CLIN BIOCHEM, V44, P351, DOI 10.1016/j.clinbiochem.2011.01.014; Laurencikiene J, 2011, J CLIN ENDOCR METAB, V96, pE2045, DOI 10.1210/jc.2011-1702; Lehr S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010504; Lonnqvist F, 1997, J CLIN INVEST, V99, P2398, DOI 10.1172/JCI119422; Mayi TH, 2012, J BIOL CHEM, V287, P21904, DOI 10.1074/jbc.M111.315200; Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; RAISON J, 1983, AM J CARDIOL, V51, P165, DOI 10.1016/S0002-9149(83)80030-7; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Ribeiro R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-108; Ritz P, 2008, CLIN NUTR, V27, P740, DOI 10.1016/j.clnu.2008.07.010; WCRF/ AICR, 2007, FOOD NUTR PHYS ACT P; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595; Zhang Y, 2012, CANCER RES, V72, P5198, DOI 10.1158/0008-5472.CAN-12-0294	23	39	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e80274	10.1371/journal.pone.0080274	http://dx.doi.org/10.1371/journal.pone.0080274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676332	gold, Green Published, Green Accepted			2022-12-25	WOS:000333677500001
J	Tanaka, Y; Tiest, WMB; Kappers, AML; Sano, A				Tanaka, Yoshihiro; Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.; Sano, Akihito			Contact Force and Scanning Velocity during Active Roughness Perception	PLOS ONE			English	Article							TACTILE ROUGHNESS; GROOVED SURFACES; TEMPORAL CUES	Haptic perception is bidirectionally related to exploratory movements, which means that exploration influences perception, but perception also influences exploration. We can optimize or change exploratory movements according to the perception and/or the task, consciously or unconsciously. This paper presents a psychophysical experiment on active roughness perception to investigate movement changes as the haptic task changes. Exerted normal force and scanning velocity are measured in different perceptual tasks (discrimination or identification) using rough and smooth stimuli. The results show that humans use a greater variation in contact force for the smooth stimuli than for the rough stimuli. Moreover, they use higher scanning velocities and shorter break times between stimuli in the discrimination task than in the identification task. Thus, in roughness perception humans spontaneously use different strategies that seem effective for the perceptual task and the stimuli. A control task, in which the participants just explore the stimuli without any perceptual objective, shows that humans use a smaller contact force and a lower scanning velocity for the rough stimuli than for the smooth stimuli. Possibly, these strategies are related to aversiveness while exploring stimuli.	[Tanaka, Yoshihiro; Sano, Akihito] Nagoya Inst Technol, Grad Sch Engn, Dept Engn Phys Elect & Mech, Nagoya, Aichi, Japan; [Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands	Nagoya Institute of Technology; Utrecht University	Tanaka, Y (corresponding author), Nagoya Inst Technol, Grad Sch Engn, Dept Engn Phys Elect & Mech, Nagoya, Aichi, Japan.	tanaka.yoshihiro@nitech.ac.jp		Kappers, Astrid/0000-0003-4101-7717	Netherlands Organisation for Scientific Research (NWO); European Commission [248587, FP7-ICT-2009-4-2-1]; JSPS [22686026, 25289060]; Grants-in-Aid for Scientific Research [25289060] Funding Source: KAKEN	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Commission(European CommissionEuropean Commission Joint Research Centre); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded in part by grants from the Netherlands Organisation for Scientific Research (NWO), the European Commission with the Collaborative Project no. 248587, "THE Hand Embodied'', within the FP7-ICT-2009-4-2-1 program "Cognitive Systems and Robotics'', the JSPS Institutional Program for Young Researcher Overseas Visits, the JSPS Grant-in-Aid for Young Scientists (A) (No. 22686026), and the JSPS Grant-in-Aid for Scientific Research (B) (No. 25289060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros S, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P166, DOI 10.1109/WHC.2009.4810901; Cascio CJ, 2001, J NEUROSCI, V21, P5289, DOI 10.1523/JNEUROSCI.21-14-05289.2001; Coren S, 1992, LEFT HANDER SYNDROME; Drewing K., 2011, 2011 IEEE World Haptics Conference (WHC 2011), P215, DOI 10.1109/WHC.2011.5945488; EKMAN G, 1965, J EXP PSYCHOL, V70, P18, DOI 10.1037/h0021985; Gamzu E, 2001, J NEUROSCI, V21, P7416, DOI 10.1523/JNEUROSCI.21-18-07416.2001; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P695, DOI 10.3758/BF03206916; Hollins M, 2002, BEHAV BRAIN RES, V135, P51, DOI 10.1016/S0166-4328(02)00154-7; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P1534, DOI 10.3758/BF03212154; Hollins M, 2007, CAN J EXP PSYCHOL, V61, P184, DOI 10.1037/cjep2007020; JOHANSSON RS, 1990, ATTENTION PERFORM, V8, P677; Kaim LR, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P565, DOI 10.1109/WHC.2009.4810830; Kitada R, 2005, NEUROIMAGE, V25, P90, DOI 10.1016/j.neuroimage.2004.11.026; LEDERMAN SJ, 1981, B PSYCHONOMIC SOC, V18, P253; LEDERMAN SJ, 1974, PERCEPT PSYCHOPHYS, V16, P385, DOI 10.3758/BF03203958; LEDERMAN SJ, 1972, PERCEPT PSYCHOPHYS, V12, P401, DOI 10.3758/BF03205850; LEDERMAN SJ, 1982, PERCEPT PSYCHOPHYS, V32, P109, DOI 10.3758/BF03204270; Lederman SJ, 1998, CLIN DEV MED, P16; Meftah E, 2000, EXP BRAIN RES, V132, P351, DOI 10.1007/s002210000348; MORLEY JW, 1983, EXP BRAIN RES, V49, P291; Roland PE, 1998, P NATL ACAD SCI USA, V95, P3295, DOI 10.1073/pnas.95.6.3295; Sinapov J, 2011, IEEE T ROBOT, V27, P488, DOI 10.1109/TRO.2011.2127130; Smith AM, 2002, EXP BRAIN RES, V144, P211, DOI 10.1007/s00221-002-1015-y; Smith AM, 2002, EXP BRAIN RES, V147, P209, DOI 10.1007/s00221-002-1240-4; Smith AM, 1996, J NEUROPHYSIOL, V75, P1957, DOI 10.1152/jn.1996.75.5.1957; STEVENS SS, 1962, J EXP PSYCHOL, V64, P489, DOI 10.1037/h0042621; Tanaka Yoshihiro, 2012, Haptics: Perception, Devices, Mobility, and Communication. Proceedings International Conference (EuroHaptics 2012), P169, DOI 10.1007/978-3-642-31404-9_29; Tanaka Yoshihiro, 2012, Haptics: Perception, Devices, Mobility, and Communication. Proceedings International Conference (EuroHaptics 2012), P163, DOI 10.1007/978-3-642-31404-9_28; Tanaka Y., 2011, 2011 IEEE World Haptics Conference (WHC 2011), P621, DOI 10.1109/WHC.2011.5945557; TAYLOR MM, 1975, PERCEPT PSYCHOPHYS, V17, P23, DOI 10.3758/BF03203993	30	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93363	10.1371/journal.pone.0093363	http://dx.doi.org/10.1371/journal.pone.0093363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676036	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500116
J	Chiu, HC; Hannemann, H; Heesom, KJ; Matthews, DA; Davidson, AD				Chiu, Han-Chen; Hannemann, Holger; Heesom, Kate J.; Matthews, David A.; Davidson, Andrew D.			High-Throughput Quantitative Proteomic Analysis of Dengue Virus Type 2 Infected A549 Cells	PLOS ONE			English	Article							GENE TRANSCRIPT ABUNDANCE; WEST-NILE-VIRUS; NF-KAPPA-B; NUCLEAR-LOCALIZATION; PERIPHERAL-BLOOD; HOST RESPONSES; CYCLE ARREST; WILD-TYPE; PROTEIN; EXPRESSION	Disease caused by dengue virus is a global health concern with up to 390 million individuals infected annually worldwide. There are no vaccines or antiviral compounds available to either prevent or treat dengue disease which may be fatal. To increase our understanding of the interaction of dengue virus with the host cell, we analyzed changes in the proteome of human A549 cells in response to dengue virus type 2 infection using stable isotope labelling in cell culture (SILAC) in combination with high-throughput mass spectrometry (MS). Mock and infected A549 cells were fractionated into nuclear and cytoplasmic extracts before analysis to identify proteins that redistribute between cellular compartments during infection and reduce the complexity of the analysis. We identified and quantified 3098 and 2115 proteins in the cytoplasmic and nuclear fractions respectively. Proteins that showed a significant alteration in amount during infection were examined using gene enrichment, pathway and network analysis tools. The analyses revealed that dengue virus infection modulated the amounts of proteins involved in the interferon and unfolded protein responses, lipid metabolism and the cell cycle. The SILAC-MS results were validated for a select number of proteins over a time course of infection by Western blotting and immunofluorescence microscopy. Our study demonstrates for the first time the power of SILAC-MS for identifying and quantifying novel changes in cellular protein amounts in response to dengue virus infection.	[Chiu, Han-Chen; Hannemann, Holger; Matthews, David A.; Davidson, Andrew D.] Univ Bristol, Sch Cellular & Mol Med, Fac Med & Vet Sci, Bristol, Avon, England; [Heesom, Kate J.] Univ Bristol, Prote Facil, Fac Med & Vet Sci, Bristol, Avon, England	University of Bristol; University of Bristol	Davidson, AD (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Fac Med & Vet Sci, Bristol, Avon, England.	andrew.davidson@bristol.ac.uk		Matthews, David/0000-0003-4611-8795	Medical Research Council, UK [G0801973]; Medical Research Council [G0801973] Funding Source: researchfish; MRC [G0801973] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council, UK (www.mrc.ac.uk) Grant G0801973 to ADD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque LM, 2009, J PROTEOME RES, V8, P5431, DOI 10.1021/pr900236f; Altindis E, 2013, CURR TOP MED CHEM; Arrington DD, 2008, AM J PHYSIOL-CELL PH, V294, pC641, DOI 10.1152/ajpcell.00400.2007; Balas C, 2011, J INFECT DIS, V203, P103, DOI 10.1093/infdis/jiq022; Behera B, 2010, J INFECT DEV COUNTR, V4, P48, DOI 10.3855/jidc.535; Bhatia VN, 2009, ANAL CHEM, V81, P9819, DOI 10.1021/ac901335x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brasier AR, 2012, CTS-CLIN TRANSL SCI, V5, P8, DOI 10.1111/j.1752-8062.2011.00377.x; Bunyaratvej A, 1997, Southeast Asian J Trop Med Public Health, V28 Suppl 3, P32; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Chukkapalli V, 2012, CURR OPIN MICROBIOL, V15, P512, DOI 10.1016/j.mib.2012.05.013; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Davy C, 2007, VIROLOGY, V368, P219, DOI 10.1016/j.virol.2007.05.043; De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407; Devignot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011671; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Fehr AR, 2013, J VIROL; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Fischl W, 2011, CURR OPIN MICROBIOL; Fo CS, 2006, GENE, V371, P154, DOI 10.1016/j.gene.2005.12.009; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Grigoriev I, 2011, CURR BIOL, V21, P967, DOI 10.1016/j.cub.2011.04.030; Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437; Hannemann H, 2013, J BIOL CHEM; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Helt AM, 2005, J VIROL, V79, P13218, DOI 10.1128/JVI.79.21.13218-13230.2005; Hoang LT, 2010, J VIROL; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005; Kanlaya R, 2010, J PROTEOME RES; Kanlaya R, 2009, J PROTEOME RES, V8, P2551, DOI 10.1021/pr900060g; Kannan RP, 2011, J VIROL, V85, P7989, DOI 10.1128/JVI.00280-11; Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kroschewski H, 2008, J BIOL CHEM, V283, P19410, DOI 10.1074/jbc.M800613200; Le Breton M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-234; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Loke P, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000710; Long HT, 2009, J INFECT DIS, V199, P537, DOI 10.1086/596507; Mairiang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053535; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Marianneau P, 1997, J VIROL, V71, P3244, DOI 10.1128/JVI.71.4.3244-3249.1997; Mason DA, 2009, J MOL EVOL, V68, P351, DOI 10.1007/s00239-009-9215-8; Munday DC, 2012, PROTEOMICS; Munday DC, 2010, MOL CELL PROTEOMICS, V9, P2438, DOI 10.1074/mcp.M110.001859; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Munoz-Jordan JL, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P121; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007892; Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012; Paradkar PN, 2010, BIOSCI REP; Pastorino B, 2009, MOL CELL PROTEOMICS; Patramool S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-138; Pattanakitsakul S, 2007, J PROTEOME RES, V6, P4592, DOI 10.1021/pr070366b; Pattanakitsakul SN, 2010, J PROTEOME RES, V9, P4640, DOI 10.1021/pr100357f; Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584; Pettersson M, 2000, GENOMICS, V68, P351, DOI 10.1006/geno.2000.6278; Phoolcharoen W, 2004, J MED VIROL, V74, P434, DOI 10.1002/jmv.20195; Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x; Rasmussen AL, 2011, J VIROL, V85, P11646, DOI 10.1128/JVI.05605-11; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Rothwell C, 2009, VIROLOGY; Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0; Sanson M, 2008, CELL DEATH DIFFER, V15, P1255, DOI 10.1038/cdd.2008.36; Schussek S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077811; Schweneker M, 2005, FEBS LETT, V579, P1751, DOI 10.1016/j.febslet.2005.02.037; Sessions OM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002107; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; Silveira GF, 2011, J VIROL, V85, P5374, DOI 10.1128/JVI.01915-10; Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tanabe K, 2013, PARASITOL INT; Tchankouo-Nguetcheu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013149; Tolfvenstam T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-209; Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699; Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91; Vento MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015636; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; Walther TC, 2010, J CELL BIOL, V190, P491, DOI 10.1083/jcb.201004052; Warke RV, 2008, J VIROL, V82, P555, DOI 10.1128/JVI.01694-06; Warke RV, 2003, J VIROL, V77, P11822, DOI 10.1128/JVI.77.21.11822-11832.2003; Wati S, 2009, J VIROL, V83, P12871, DOI 10.1128/JVI.01419-09; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; World Health Organization, 2009, DENGUE GUIDELINES DI; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06; Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780; Zhang LK, 2013, J PROTEOME RES, V12, P2666, DOI 10.1021/pr400011k	100	55	57	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93305	10.1371/journal.pone.0093305	http://dx.doi.org/10.1371/journal.pone.0093305			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671231	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677000133
J	Souto, GR; Queiroz, CM; de Abreu, MHNG; Costa, FO; Mesquita, RA				Souto, Giovanna Ribeiro; Queiroz-Junior, Celso Martins; Nogueira Guimaraes de Abreu, Mauro Henrique; Costa, Fernando Oliveira; Mesquita, Ricardo Alves			Pro-inflammatory, Th1, Th2, Th17 Cytokines and Dendritic Cells: A Cross-sectional Study in Chronic Periodontitis	PLOS ONE			English	Article							CD34(+) HEMATOPOIETIC PROGENITORS; CORD BLOOD DIFFERENTIATE; T-CELLS; GINGIVAL TISSUES; LANGERHANS CELLS; INTERLEUKIN-6; PATHWAYS; DISEASE; ANTIGEN; LYMPHOCYTES	There are a limited number of studies correlating the different stages of dendritic cells (DC) maturation with cytokines in individuals presented chronic periodontitis (CP). The aim of the study was to evaluate the correlation among the expression of IL-2, IL-10, IL-4, IL-6, IFN-gamma, TNF-alpha, and IL-17A with the presence of DC and mild-moderate or advanced CP. Gingival samples were obtained from 24 individuals with CP and six samples of normal mucosa (NM) overlapping third molar for controls of the levels of cytokines. Periodontal examination was performed. Immunohistochemical staining was carried out, revealing CD1a+ immature, Fator XIIIa+ immature, and CD83+ mature DCs. The inflammatory infiltrate was counted, and the cytokines were measured by flow cytometry. Densities of DCs and inflammatory infiltrate, cytokines, subtypes of CP, and clinical periodontal parameters were correlated and compared. IL-6 expression was correlated positively with the increased numbers of CD1a+ immature DCs. Levels of IL-2, TNF-alpha, IFN-gamma, IL-10, and IL-17A were increased when compared with NM. The percentage of sites with clinical attachment level (CAL)>3 were positively correlated with densities of inflammatory infiltrate and negatively correlated with densities of immature DCs. IL-6 can contribute to the increase of the immature DCs in the CP. Higher levels of IL-2, TNF-alpha, IFN-gamma, IL-10, and IL-17A cytokines were observed in CP. Higher densities of inflammatory infiltrate as well as lower densities of immature DCs can result in a more severe degree of human CP.	[Souto, Giovanna Ribeiro; Queiroz-Junior, Celso Martins; Costa, Fernando Oliveira; Mesquita, Ricardo Alves] Univ Fed Minas Gerais, Sch Dent, Dept Oral Surg & Pathol, Belo Horizonte, MG, Brazil; [Nogueira Guimaraes de Abreu, Mauro Henrique] Univ Fed Minas Gerais, Sch Dent, Dept Social & Prevent Dent, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Souto, GR (corresponding author), Univ Fed Minas Gerais, Sch Dent, Dept Oral Surg & Pathol, Belo Horizonte, MG, Brazil.	grsouto@hotmail.com	Abreu, Mauro Henrique/G-6502-2012; Queiroz-Junior, Celso/L-5438-2013; Mesquita, Ricardo Alves/H-3256-2014; Souto, Giovanna R/B-1702-2019	Abreu, Mauro Henrique/0000-0001-8794-5725; Queiroz-Junior, Celso/0000-0002-7884-7709; Mesquita, Ricardo Alves/0000-0003-3207-4007; Souto, Giovanna R/0000-0003-3617-8794; COSTA, FERNANDO/0000-0002-7687-1238	CNPq	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors wish to thank the National Council for Scientific and Technological Development (CNPq) (309209/2010-2; 472045/2011-3). RA Mesquita, MH de Abreu and FO Costa are researchers funded by CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Allam JP, 2011, J CLIN PERIODONTOL, V38, P879, DOI 10.1111/j.1600-051X.2011.01752.x; Anjana R, 2012, ORAL DIS, V18, P778, DOI 10.1111/j.1601-0825.2012.01945.x; Armitage GC, 2004, PERIODONTOL 2000, V34, P9, DOI 10.1046/j.0906-6713.2002.003421.x; Baker PJ, 1999, INFECT IMMUN, V67, P2804, DOI 10.1128/IAI.67.6.2804-2809.1999; Behfarnia Parichehr, 2010, Dent Res J (Isfahan), V7, P45; Bratke K, 2008, AM J RESP CELL MOL, V38, P655, DOI 10.1165/rcmb.2007-0400OC; BRIDGES RB, 1977, INFECT IMMUN, V16, P240, DOI 10.1128/IAI.16.1.240-248.1977; Cardoso CR, 2009, ORAL MICROBIOL IMMUN, V24, P1, DOI 10.1111/j.1399-302X.2008.00463.x; Caux C, 1997, BLOOD, V90, P1458, DOI 10.1182/blood.V90.4.1458.1458_1458_1470; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Cohen J., 1988, STAT POWER ANAL BEHA, P140; Cury Patricia Ramos, 2008, Braz. oral res., V22, P258, DOI 10.1590/S1806-83242008000300012; Cutler CW, 2004, PERIODONTOL 2000, V35, P135, DOI 10.1111/j.0906-6713.2004.003560.x; Dereka XE, 2004, J PERIODONTAL RES, V39, P447, DOI 10.1111/j.1600-0765.2004.00764.x; Frick JS, 2010, INT J MED MICROBIOL, V300, P19, DOI 10.1016/j.ijmm.2009.08.010; Garlet GP, 2008, MICROBES INFECT, V10, P489, DOI 10.1016/j.micinf.2008.01.010; Gemmell E, 2007, PERIODONTOL 2000, V43, P14, DOI 10.1111/j.1600-0757.2006.00173.x; Goutoudi P, 2012, INT J DENT, V2012, DOI 10.1155/2012/362905; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; GUILLOT JL, 1995, J PERIODONTOL, V66, P667, DOI 10.1902/jop.1995.66.8.667; Hegde S, 2004, FASEB J, V18, P1439, DOI 10.1096/fj.03-0969fje; Huang CB, 2011, INFLAMM RES, V60, P119, DOI 10.1007/s00011-010-0242-0; ISHIMI Y, 1990, J IMMUNOL, V145, P3297; Jankovic D, 2001, TRENDS IMMUNOL, V22, P450, DOI 10.1016/S1471-4906(01)01975-5; JILKA RL, 1992, SCIENCE, V257, P88, DOI 10.1126/science.1621100; Jotwani R, 2001, J IMMUNOL, V167, P4693, DOI 10.4049/jimmunol.167.8.4693; Jotwani R, 2010, ANN NY ACAD SCI, V1192, P278, DOI 10.1111/j.1749-6632.2009.05247.x; Kawashima N, 1999, ARCH ORAL BIOL, V44, P55, DOI 10.1016/S0003-9969(98)00094-6; Lannes N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060893; Lappin DF, 2001, CLIN EXP IMMUNOL, V123, P294, DOI 10.1046/j.1365-2249.2001.01448.x; Laurence A, 2007, NAT IMMUNOL, V8, P903, DOI 10.1038/ni0907-903; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Liu YCG, 2010, PERIODONTOL 2000, V52, P163, DOI 10.1111/j.1600-0757.2009.00321.x; Lopez NJ, 2005, J PERIODONTOL, V76, P2144, DOI 10.1902/jop.2005.76.11-S.2144; Lunz JG, 2007, HEPATOLOGY, V46, P1946, DOI 10.1002/hep.21906; Moutsopoulos NM, 2012, J AUTOIMMUN, V39, P294, DOI 10.1016/j.jaut.2012.03.003; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; NEWCOMB GM, 1982, J CLIN PERIODONTOL, V9, P297, DOI 10.1111/j.1600-051X.1982.tb02096.x; Rezavandi K, 2002, J ORAL PATHOL MED, V31, P59, DOI 10.1046/j.0904-2512.2001.joptest.doc.x; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Schmidt SV, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00274; Seguier S, 2000, ARCH ORAL BIOL, V45, P441, DOI 10.1016/S0003-9969(00)00018-2; Smyth LJC, 2008, CLIN EXP IMMUNOL, V154, P56, DOI 10.1111/j.1365-2249.2008.03729.x; Sousa CRE, 2001, IMMUNITY, V14, P495; Souto GR, 2011, J PERIODONTOL, V82, P619, DOI 10.1902/jop.2010.100488; Tew JG, 2012, J DENT RES, V91, P8, DOI 10.1177/0022034511407338; Thunell DH, 2010, J PERIODONTAL RES, V45, P148, DOI 10.1111/j.1600-0765.2009.01204.x; Tonetti MS, 2005, J CLIN PERIODONTOL, V32, P210, DOI 10.1111/j.1600-051X.2005.00822.x; Trombone AP, 2010, GENES IMMUN, V11, P479, DOI 10.1038/gene.2010.13; Tymkiw KD, 2011, J CLIN PERIODONTOL, V38, P219, DOI 10.1111/j.1600-051X.2010.01684.x; Vassallo R, 2008, MOL IMMUNOL, V45, P3321, DOI 10.1016/j.molimm.2008.04.014; Wykes M, 1998, J IMMUNOL, V161, P1313; Yu JJ, 2008, INFECT IMMUN, V76, P4206, DOI 10.1128/IAI.01209-07; Zhao L, 2011, J CLIN PERIODONTOL, V38, P509, DOI 10.1111/j.1600-051X.2011.01712.x	55	35	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91636	10.1371/journal.pone.0091636	http://dx.doi.org/10.1371/journal.pone.0091636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670840	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000022
J	Wang, XH; Xia, Y; Wen, XH; Yang, YF; Zhou, JZ				Wang, Xiaohui; Xia, Yu; Wen, Xianghua; Yang, Yunfeng; Zhou, Jizhong			Microbial Community Functional Structures in Wastewater Treatment Plants as Characterized by GeoChip	PLOS ONE			English	Article							ACTIVATED-SLUDGE; BACTERIAL COMMUNITY; GENE DIVERSITY; DYNAMICS; TEMPERATURE; NITRIFICATION; INSTABILITY; BIOREACTOR; REMOVAL; REVEALS	Background: Biological WWTPs must be functionally stable to continuously and steadily remove contaminants which rely upon the activity of complex microbial communities. However, knowledge is still lacking in regard to microbial community functional structures and their linkages to environmental variables. Aims: To investigate microbial community functional structures of activated sludge in wastewater treatment plants (WWTPs) and to understand the effects of environmental factors on their structure. Methods: 12 activated sludge samples were collected from four WWTPs in Beijing. A comprehensive functional gene array named GeoChip 4.2 was used to determine the microbial functional genes involved in a variety of biogeochemical processes such as carbon, nitrogen, phosphorous and sulfur cycles, metal resistance, antibiotic resistance and organic contaminant degradation. Results: High similarities of the microbial community functional structures were found among activated sludge samples from the four WWTPs, as shown by both diversity indices and the overlapped genes. For individual gene category, such as egl, amyA, lip, nirS, nirK, nosZ, ureC, ppx, ppk, aprA, dsrA, sox and benAB, there were a number of microorganisms shared by all 12 samples. Canonical correspondence analysis (CCA) showed that the microbial functional patterns were highly correlated with water temperature, dissolved oxygen (DO), ammonia concentrations and loading rate of chemical oxygen demand (COD). Based on the variance partitioning analyses (VPA), a total of 53% of microbial community variation from GeoChip data can be explained by wastewater characteristics (25%) and operational parameters (23%), respectively. Conclusions: This study provided an overall picture of microbial community functional structures of activated sludge in WWTPs and discerned the linkages between microbial communities and environmental variables in WWTPs.	[Wang, Xiaohui; Xia, Yu; Wen, Xianghua; Yang, Yunfeng; Zhou, Jizhong] Tsinghua Univ, Sch Environm, Environm Simulat & Pollut Control State Key Joint, Beijing 100084, Peoples R China; [Wang, Xiaohui] Beijing Univ Chem Technol, Dept Environm Sci & Engn, Beijing 100029, Peoples R China; [Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [Zhou, Jizhong] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Zhou, Jizhong] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA	Tsinghua University; Beijing University of Chemical Technology; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Wen, XH (corresponding author), Tsinghua Univ, Sch Environm, Environm Simulat & Pollut Control State Key Joint, Beijing 100084, Peoples R China.	xhwen@tsinghua.edu.cn	Yang, Yunfeng/H-9853-2013; 吴, 昊/AAB-1620-2020; wen, xianghua/A-7551-2015	Yang, Yunfeng/0000-0001-8274-6196; 	National Natural Science Foundation of China [51078207, 51178239]; special fund of State Key Joint Laboratory of Environment Simulation and Pollution Control [12L03ESPC]; ENIGMA-Ecosystems; Networks Integrated with Genes and Molecular Assemblies through the Office of Science, Office of Biological and Environmental Research; U.S. Department of Energy [DE-AC02-05CH11231]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special fund of State Key Joint Laboratory of Environment Simulation and Pollution Control; ENIGMA-Ecosystems; Networks Integrated with Genes and Molecular Assemblies through the Office of Science, Office of Biological and Environmental Research; U.S. Department of Energy(United States Department of Energy (DOE))	This study was supported by National Natural Science Foundation of China funds (51078207 and 51178239) and the special fund of State Key Joint Laboratory of Environment Simulation and Pollution Control (12L03ESPC). This study made use of the GeoChip and associated computational pipelines funded by ENIGMA-Ecosystems and Networks Integrated with Genes and Molecular Assemblies through the Office of Science, Office of Biological and Environmental Research, the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsubasi AT, 2009, ENVIRON SCI TECHNOL, V43, P2950, DOI 10.1021/es8026488; Association AAPH, 2012, STANDARD METHODS EXA; Bergaust L, 2011, BIOCHEM SOC T, V39, P207, DOI 10.1042/BST0390207; Briones A, 2003, CURR OPIN BIOTECH, V14, P270, DOI 10.1016/S0958-1669(03)00065-X; Curtis TP, 2006, WATER SCI TECHNOL, V54, P227, DOI 10.2166/wst.2006.391; Dytczak MA, 2008, WATER RES, V42, P2320, DOI 10.1016/j.watres.2007.12.018; Ebie Y, 2002, WATER SCI TECHNOL, V46, P105, DOI 10.2166/wst.2002.0724; Ebrahimi S, 2010, APPL MICROBIOL BIOT, V87, P1555, DOI 10.1007/s00253-010-2621-4; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gentile ME, 2007, APPL ENVIRON MICROB, V73, P680, DOI 10.1128/AEM.01519-06; Graham DW, 2007, ISME J, V1, P385, DOI 10.1038/ismej.2007.45; Gregory SP, 2010, ECOL ENG, V36, P1485, DOI 10.1016/j.ecoleng.2010.06.031; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; He ZL, 2010, ECOL LETT, V13, P564, DOI 10.1111/j.1461-0248.2010.01453.x; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Huang ZH, 2010, WATER RES, V44, P4351, DOI 10.1016/j.watres.2010.05.037; Kunin V, 2008, GENOME RES, V18, P293, DOI 10.1101/gr.6835308; Li TL, 2012, BIORESOURCE TECHNOL, V108, P28, DOI 10.1016/j.biortech.2011.12.141; Lopez-Vazquez CM, 2008, WATER RES, V42, P2349, DOI 10.1016/j.watres.2008.01.001; Lu ZM, 2012, ISME J, V6, P451, DOI 10.1038/ismej.2011.91; Lydmark P, 2007, ENVIRON MICROBIOL, V9, P2220, DOI 10.1111/j.1462-2920.2007.01336.x; Miura Y, 2007, WATER RES, V41, P627, DOI 10.1016/j.watres.2006.11.005; Nogales B, 2001, APPL ENVIRON MICROB, V67, P1874, DOI 10.1128/AEM.67.4.1874-1884.2001; Ofiteru ID, 2010, P NATL ACAD SCI USA, V107, P15345, DOI 10.1073/pnas.1000604107; Park HD, 2004, WATER RES, V38, P3275, DOI 10.1016/j.watres.2004.04.047; Petropoulos P, 2005, CAN J MICROBIOL, V51, P791, DOI [10.1139/W05-069, 10.1139/w05-069]; Pholchan MK, 2010, WATER RES, V44, P1341, DOI 10.1016/j.watres.2009.11.005; Rittmann BE, 2006, ENVIRON SCI TECHNOL, V40, P1096, DOI 10.1021/es062631k; Sanapareddy N, 2009, APPL ENVIRON MICROB, V75, P1688, DOI 10.1128/AEM.01210-08; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Szukics U, 2010, FEMS MICROBIOL ECOL, V72, P395, DOI 10.1111/j.1574-6941.2010.00853.x; ter B, 2002, CANOCO REFERENCE MAN; Urakawa H, 2008, APPL ENVIRON MICROB, V74, P894, DOI 10.1128/AEM.01529-07; Van Nostrand JD, 2011, APPL ENVIRON MICROB, V77, P3860, DOI 10.1128/AEM.01981-10; Wang FP, 2009, P NATL ACAD SCI USA, V106, P4840, DOI 10.1073/pnas.0810418106; Wang XH, 2012, APPL ENVIRON MICROB, V78, P7042, DOI 10.1128/AEM.01617-12; Wang XH, 2011, FRONT ENVIRON SCI EN, V5, P92, DOI 10.1007/s11783-010-0254-6; Wang XH, 2011, BIORESOURCE TECHNOL, V102, P2352, DOI 10.1016/j.biortech.2010.10.095; Wang XH, 2010, J ENVIRON SCI-CHINA, V22, P627, DOI 10.1016/S1001-0742(09)60155-8; Wells GF, 2009, ENVIRON MICROBIOL, V11, P2310, DOI 10.1111/j.1462-2920.2009.01958.x; Wu L, 2008, APPL ENVIRON MICROB, V74, P4516, DOI 10.1128/AEM.02751-07; Xia SQ, 2010, ENVIRON SCI TECHNOL, V44, P7391, DOI 10.1021/es101554m; Xie JP, 2011, APPL ENVIRON MICROB, V77, P991, DOI 10.1128/AEM.01798-10; Ye L, 2012, ENVIRON SCI TECHNOL, V46, P13244, DOI 10.1021/es303454k; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhou JZ, 2008, P NATL ACAD SCI USA, V105, P7768, DOI 10.1073/pnas.0709016105; Zhou JZ, 2002, APPL ENVIRON MICROB, V68, P326, DOI 10.1128/AEM.68.1.326-334.2002; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	49	34	36	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93422	10.1371/journal.pone.0093422	http://dx.doi.org/10.1371/journal.pone.0093422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671164	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677000143
J	Blango, MG; Ott, EM; Erman, A; Veranic, P; Mulvey, MA				Blango, Matthew G.; Ott, Elizabeth M.; Erman, Andreja; Veranic, Peter; Mulvey, Matthew A.			Forced Resurgence and Targeting of Intracellular Uropathogenic Escherichia coli Reservoirs	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; UROTHELIAL CELLS; HOST DEFENSES; BACTERIAL COMMUNITIES; EPITHELIAL-CELLS; BLADDER; PERSISTENCE; CHITOSAN; DIFFERENTIATION; PERMEABILITY	Intracellular quiescent reservoirs of uropathogenic Escherichia coli (UPEC), which can seed the bladder mucosa during the acute phase of a urinary tract infection (UTI), are protected from antibiotic treatments and are extremely difficult to eliminate. These reservoirs are a potential source for recurrent UTIs that affect millions annually. Here, using murine infection models and the bladder cell exfoliant chitosan, we demonstrate that intracellular UPEC populations shift within the stratified layers of the urothelium during the course of a UTI. Following invasion of the terminally differentiated superficial layer of epithelial cells that line the bladder lumen, UPEC can multiply and disseminate, eventually establishing reservoirs within underlying immature host cells. If given access, UPEC can invade the superficial and immature bladder cells equally well. As infected immature host cells differentiate and migrate towards the apical surface of the bladder, UPEC can reinitiate growth and discharge into the bladder lumen. By inducing the exfoliation of the superficial layers of the urothelium, chitosan stimulates rapid regenerative processes and the reactivation and efflux of quiescent intracellular UPEC reservoirs. When combined with antibiotics, chitosan treatment significantly reduces bacterial loads within the bladder and may therefore be of therapeutic value to individuals with chronic, recurrent UTIs.	[Blango, Matthew G.; Ott, Elizabeth M.; Mulvey, Matthew A.] Univ Utah, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA; [Erman, Andreja; Veranic, Peter] Univ Ljubljana, Inst Cell Biol, Fac Med, Ljubljana, Slovenia	Utah System of Higher Education; University of Utah; University of Ljubljana	Mulvey, MA (corresponding author), Univ Utah, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA.	mulvey@path.utah.edu	Blango, Matthew/AAY-2384-2020; Veranic, Peter/I-6276-2015	Blango, Matthew/0000-0001-8015-9019; Veranic, Peter/0000-0003-1999-9988; Mulvey, Matthew/0000-0002-6016-7510	NIH [AI095647, AI090369, AI088086, T32AI055434]; Slovenian Ministry of Higher Education, Science and Technology [P3-0108]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088086, R01AI095647, T32AI055434, R21AI090369] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Slovenian Ministry of Higher Education, Science and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research in the Mulvey lab was funded by NIH grants AI095647, AI090369, and AI088086. M. G. B. was supported by NIH microbial pathogenesis training grant T32AI055434. AE and PV were supported by Slovenian Ministry of Higher Education, Science and Technology (grant no. P3-0108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber AE, 2013, CLIN INFECT DIS, V57, P719, DOI 10.1093/cid/cit284; Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Dhakal BK, 2009, J BIOL CHEM, V284, P446, DOI 10.1074/jbc.M805010200; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; Erman A, 2013, HISTOCHEM CELL BIOL; Eto DS, 2007, PLOS PATHOG, V3, P949, DOI 10.1371/journal.ppat.0030100; Eto DS, 2006, CELL MICROBIOL, V8, P704, DOI 10.1111/j.1462-5822.2006.00691.x; Gotoh H, 2010, Biofouling, V26, P603, DOI 10.1080/08927014.2010.501895; Horvath DJ, 2011, MICROBES INFECT, V13, P426, DOI 10.1016/j.micinf.2010.12.004; HULTGREN SJ, 1986, INFECT IMMUN, V54, P613, DOI 10.1128/IAI.54.3.613-620.1986; Hvidberg H, 2000, ANTIMICROB AGENTS CH, V44, P156, DOI 10.1128/AAC.44.1.156-163.2000; Jabbal-Gill I, 2012, EXPERT OPIN DRUG DEL, V9, P1051, DOI 10.1517/17425247.2012.697455; Justice SS, 2006, INFECT IMMUN, V74, P4793, DOI 10.1128/IAI.00355-06; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; Kerec M, 2005, EUR J PHARM SCI, V25, P113, DOI 10.1016/j.ejps.2005.02.003; Kerrn MB, 2005, J ANTIMICROB CHEMOTH, V55, P383, DOI 10.1093/jac/dki002; Khasriya R, 2013, J CLIN MICROBIOL, V51, P2054, DOI 10.1128/JCM.03314-12; Kreft ME, 2010, PROTOPLASMA, V246, P3, DOI 10.1007/s00709-010-0112-1; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Lavelle J, 2002, AM J PHYSIOL-RENAL, V283, pF242, DOI 10.1152/ajprenal.00307.2001; Liu H, 2004, INT J FOOD MICROBIOL, V95, P147, DOI 10.1016/j.ijfoodmicro.2004.01.022; Lorian V., 2005, ANTIBIOTICS LAB MED; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Mysorekar IU, 2002, J BIOL CHEM, V277, P7412, DOI 10.1074/jbc.M110560200; PARSONS CL, 1988, INFECT IMMUN, V56, P1341, DOI 10.1128/IAI.56.5.1341-1343.1988; Patel MP, 2010, J PHARM PHARM SCI, V13, P536, DOI 10.18433/J3JC7C; Robino L, 2013, PATHOG DIS, V68, P78, DOI 10.1111/2049-632X.12047; Romih R, 1999, HISTOCHEM CELL BIOL, V112, P375, DOI 10.1007/s004180050419; Rosen DA, 2007, PLOS MED, V4, P1949, DOI 10.1371/journal.pmed.0040329; Schilling JD, 2002, INFECT IMMUN, V70, P7042, DOI 10.1128/IAI.70.12.7042-7049.2002; Soto SM, 2006, CLIN MICROBIOL INFEC, V12, P1034, DOI 10.1111/j.1469-0691.2006.01543.x; Ulett GC, 2013, CURR OPIN MICROBIOL, V16, P100, DOI 10.1016/j.mib.2013.01.005; Veranic P, 2009, HISTOCHEM CELL BIOL, V131, P129, DOI 10.1007/s00418-008-0492-x; Zhou G, 2001, J CELL SCI, V114, P4095	39	42	42	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93327	10.1371/journal.pone.0093327	http://dx.doi.org/10.1371/journal.pone.0093327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667805	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600171
J	Gaykalova, DA; Mambo, E; Choudhary, A; Houghton, J; Buddavarapu, K; Sanford, T; Darden, W; Adai, A; Hadd, A; Latham, G; Danilova, LV; Bishop, J; Li, RJ; Westra, WH; Hennessey, P; Koch, WM; Ochs, MF; Califano, JA; Sun, W				Gaykalova, Daria A.; Mambo, Elizabeth; Choudhary, Ashish; Houghton, Jeffery; Buddavarapu, Kalyan; Sanford, Tiffany; Darden, Will; Adai, Alex; Hadd, Andrew; Latham, Gary; Danilova, Ludmila V.; Bishop, Justin; Li, Ryan J.; Westra, William H.; Hennessey, Patrick; Koch, Wayne M.; Ochs, Michael F.; Califano, Joseph A.; Sun, Wenyue			Novel Insight into Mutational Landscape of Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							SOMATIC MUTATIONS; ONCOGENIC MUTATIONS; GROWTH-INHIBITION; TYROSINE KINASE; CANCER; RECEPTOR; GENE; TARGET; ACTIVATION; LEUKEMIA	Development of head and neck squamous cell carcinoma (HNSCC) is characterized by accumulation of mutations in several oncogenes and tumor suppressor genes. We have formerly described the mutation pattern of HNSCC and described NOTCH signaling pathway alterations. Given the complexity of the HNSCC, here we extend the previous study to understand the overall HNSCC mutation context and to discover additional genetic alterations. We performed high depth targeted exon sequencing of 51 highly actionable cancer-related genes with a high frequency of mutation across many cancer types, including head and neck. DNA from primary tumor tissues and matched normal tissues was analyzed for 37 HNSCC patients. We identified 26 non-synonymous or stop-gained mutations targeting 11 of 51 selected genes. These genes were mutated in 17 out of 37 (46%) studied HNSCC patients. Smokers harbored 3.2-fold more mutations than non-smokers. Importantly, TP53 was mutated in 30%, NOTCH1 in 8% and FGFR3 in 5% of HNSCC. HPV negative patients harbored 4-fold more TP53 mutations than HPV positive patients. These data confirm prior reports of the HNSCC mutational profile. Additionally, we detected mutations in two new genes, CEBPA and FES, which have not been previously reported in HNSCC. These data extend the spectrum of HNSCC mutations and define novel mutation targets in HNSCC carcinogenesis, especially for smokers and HNSCC without HPV infection.	[Gaykalova, Daria A.; Li, Ryan J.; Westra, William H.; Hennessey, Patrick; Koch, Wayne M.; Califano, Joseph A.; Sun, Wenyue] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Mambo, Elizabeth; Choudhary, Ashish; Houghton, Jeffery; Buddavarapu, Kalyan; Sanford, Tiffany; Darden, Will; Adai, Alex; Hadd, Andrew; Latham, Gary] Asuragen Inc, Austin, TX USA; [Bishop, Justin; Westra, William H.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Danilova, Ludmila V.; Ochs, Michael F.] Johns Hopkins Med Inst, Dept Oncol & Hlth Sci Informat, Baltimore, MD 21205 USA; [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Asuragen; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center	Califano, JA (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jcalifa@jhmi.edu; wenyue.sun@nih.gov		Sun, Wenyue/0000-0003-1673-0895	National Institute of Dental and Craniofacial Research (NIDCR); NIH [RC1DE020324, RC2DE020789]; NCI [P50 DE 019032]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P50DE019032, R01DE013152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020789, RC1DE020324] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported by National Institute of Dental and Craniofacial Research (NIDCR) and NIH Challenge Grant RC1DE020324 and RC2DE020789, and NCI P50 DE 019032 Head and Neck Cancer SPORE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Asthagiri AR, 2009, LANCET, V373, P1974, DOI 10.1016/S0140-6736(09)60259-2; Astier AL, 2003, BLOOD, V101, P1118, DOI 10.1182/blood-2002-05-1519; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Califano J, 1996, CANCER RES, V56, P2488; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen YX, 2006, P NATL ACAD SCI USA, V103, P1018, DOI 10.1073/pnas.0510347103; Chocarro-Calvo A, 2013, MOL CELL, V49, P474, DOI 10.1016/j.molcel.2012.11.022; Chung CH, 2006, J CLIN ONCOL, V24, P4170, DOI 10.1200/JCO.2006.07.2587; COOPER GM, 1982, SCIENCE, V217, P801, DOI 10.1126/science.6285471; Della Rocca GJ, 1999, J BIOL CHEM, V274, P13978, DOI 10.1074/jbc.274.20.13978; Demokan S, 2012, HEAD NECK-J SCI SPEC, V34, P1470, DOI 10.1002/hed.21949; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P682, DOI 10.1210/jc.2007-1714; Elnaggar MM, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-23; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Gaykalova D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040389; Ha PK, 2006, LANCET ONCOL, V7, P77, DOI 10.1016/S1470-2045(05)70540-4; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Harari PM, 2007, J CLIN ONCOL, V25, P4057, DOI 10.1200/JCO.2007.11.8984; Hardisson D, 2003, EUR ARCH OTO-RHINO-L, V260, P502, DOI 10.1007/s00405-003-0581-3; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hill Stephen J., 2001, Current Opinion in Pharmacology, V1, P526, DOI 10.1016/S1471-4892(01)00091-1; Hornberg JJ, 2005, ONCOGENE, V24, P5533, DOI 10.1038/sj.onc.1208817; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Jagani Z, 2010, NAT MED, V16, P1429, DOI 10.1038/nm.2251; Jain P, 2013, CURR TREAT OPTION ON, V14, P127, DOI 10.1007/s11864-013-0234-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kawamura J, 2005, ONCOL REP, V14, P47; Kent D, 2008, CLIN CANCER RES, V14, P1926, DOI 10.1158/1078-0432.CCR-07-5134; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kikkawa N, 2010, BRIT J CANCER, V103, P877, DOI 10.1038/sj.bjc.6605811; Lechner M, 2013, GENOME MED, V5, DOI 10.1186/gm453; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; Luzzatto L, 2002, NATURE, V417, P703, DOI 10.1038/417703a; MacFarlane M, 2004, EMBO REP, V5, P674, DOI 10.1038/sj.embor.7400191; Maestro R, 1996, CANCER RES, V56, P1146; MCCORMICK F, 1995, MOL REPROD DEV, V42, P500, DOI 10.1002/mrd.1080420419; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moliterno AR, 1998, NEW ENGL J MED, V338, P572, DOI 10.1056/NEJM199802263380903; Murugan AK, 2008, INT J ONCOL, V32, P101; Nichols AC, 2012, ARCH OTOLARYNGOL, V138, P732, DOI 10.1001/archoto.2012.1558; Nordstrom-O'Brien M, 2010, HUM MUTAT, V31, P521, DOI 10.1002/humu.21219; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; Okami K, 1998, CANCER RES, V58, P509; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Ono T, 2011, LEUKEMIA RES, V35, P598, DOI 10.1016/j.leukres.2010.12.006; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Poeta ML, 2009, CLIN CANCER RES, V15, P7658, DOI 10.1158/1078-0432.CCR-09-1433; Psyrri A, 2011, ANTI-CANCER DRUG, V22, P586, DOI 10.1097/CAD.0b013e328344ec44; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Qiu W, 2006, ONCOGENE, V25, P2937, DOI 10.1038/sj.onc.1209325; Rand V, 2005, P NATL ACAD SCI USA, V102, P14344, DOI 10.1073/pnas.0507200102; ROSNET O, 1991, GENOMICS, V9, P380, DOI 10.1016/0888-7543(91)90270-O; Ruckert F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012243; Schindler CW, 2002, J CLIN INVEST, V109, P1133, DOI 10.1172/JCI200215644; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Scully C, 2000, ORAL ONCOL, V36, P404, DOI 10.1016/S1368-8375(00)00023-3; Seiwert TY, 2009, CANCER RES, V69, P3021, DOI 10.1158/0008-5472.CAN-08-2881; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Shao CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048582; Shioda T, 1998, P NATL ACAD SCI USA, V95, P9785, DOI 10.1073/pnas.95.17.9785; Smith IM, 2007, INT J CANCER, V121, P1724, DOI 10.1002/ijc.22889; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; STEHELIN D, 1977, VIROLOGY, V76, P675, DOI 10.1016/0042-6822(77)90250-1; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sun WY, 2014, CANCER RES, V74, P1091, DOI 10.1158/0008-5472.CAN-13-1259; Sun WY, 2009, CLIN CANCER RES, V15, P476, DOI 10.1158/1078-0432.CCR-08-0930; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Weber A, 2003, ONCOGENE, V22, P4757, DOI 10.1038/sj.onc.1206705; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhang Y, 2005, INT J CANCER, V117, P166, DOI 10.1002/ijc.21145	89	62	63	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93102	10.1371/journal.pone.0093102	http://dx.doi.org/10.1371/journal.pone.0093102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667986	gold, Green Published, Green Submitted			2022-12-25	WOS:000333675600139
J	Quandt, D; Rothe, K; Scholz, R; Baerwald, CW; Wagner, U				Quandt, Dagmar; Rothe, Kathrin; Scholz, Roger; Baerwald, Christoph W.; Wagner, Ulf			Peripheral CD4CD8 Double Positive T Cells with a Distinct Helper Cytokine Profile Are Increased in Rheumatoid Arthritis	PLOS ONE			English	Article							CITRULLINATED PEPTIDE ANTIBODIES; ANTI-CD4 MONOCLONAL-ANTIBODY; LYMPHOCYTES; EXPRESSION; ATHEROSCLEROSIS; IMMUNITY; DISEASE	Peripheral CD4CD8 double positive (DP) T cells have been reported to play a role in several autoimmune diseases, virus infections and cancer. In rheumatoid arthritis (RA), both CD4 and CD8 single positive (SP) T cells are known to be involved in the pathogenesis, but the role of peripheral CD4CD8 DP T cells has not been investigated in detail. Anti cyclic citrullinated antibodies (ACPA) positive and ACPA negative RA patients, patients with systemic lupus erythematodes (SLE) and age matched healthy donors (HD) were enrolled in the analysis. The frequencies and phenotype of DP T cells in PBMC were investigated. In addition, DP T cells were quantified in biopsies from rheumatoid synovium. After in vitro restimulation, the cytokine production of DP T cells was investigated in cultures of PBMC. CMV specific cytokine secretion as well as proliferation was analyzed following antigen specific restimulation after an appropriate culture duration. DP T cells were found more frequently in RA patients than in healthy controls or patients with SLE. These DP T cells express ab TCRs, are of a memory phenotype and share features of both CD4 as well as CD8 SP T cells. Importantly, DP T cells were found to also be present in the rheumatoid synovium. Further characterization of DP T cells from RA patients revealed increased production of IL-21 and IL-4, implying a possible role as T helper cells. In addition, DP T cells in RA seem to contribute to the inflammatory process, because they produce significantly more IFN gamma than counterparts from HD and are increased in CMV+ RA patients. Given their capacity to produce a variety of cytokines (IL4, IL21 and IFN gamma), their association with ACPA positive RA and their presence in the synovium, we suggest an important role of double positive T cells in the pathogenesis of rheumatoid arthritis.	[Wagner, Ulf] Univ Leipzig, Gastroenterol Clin, Div Rheumatol, D-04109 Leipzig, Saxony, Germany; Univ Leipzig, Clin Rheumatol, Div Rheumatol, D-04109 Leipzig, Saxony, Germany	Leipzig University; Leipzig University	Wagner, U (corresponding author), Univ Leipzig, Gastroenterol Clin, Div Rheumatol, D-04109 Leipzig, Saxony, Germany.	ulf.wagner@medizin.uni-leipzig.de	Baerwald, Christoph/T-7107-2019; Rothe, Kathrin/AAQ-2842-2020; Baerwald, Christoph/AAD-9013-2020; Wagner, Ulf/F-4351-2016	Baerwald, Christoph/0000-0002-1406-3024; Quandt, Dagmar/0000-0001-6666-6874	German Research Foundation [WA 2765/3-1]; German Research Foundation (DFG); Leipzig University	German Research Foundation(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	This study was supported by the German Research Foundation (WA 2765/3-1). The author(s) acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho BA, 2012, J CLIN IMMUNOL, V32, P709, DOI 10.1007/s10875-012-9674-3; Claude L, 2005, J CLIN IMMUNOL, V25, P418, DOI 10.1007/s10875-005-5257-x; Daridon C, 2009, CURR OPIN RHEUMATOL, V21, P205, DOI 10.1097/BOR.0b013e32832a0760; Desfrancois J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008437; Dorner T, 2009, NAT REV RHEUMATOL, V5, P433, DOI 10.1038/nrrheum.2009.141; DURIE FH, 1994, IMMUNOL TODAY, V15, P406, DOI 10.1016/0167-5699(94)90269-0; Frahm MA, 2012, J IMMUNOL, V188, P4289, DOI 10.4049/jimmunol.1103701; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Gerli R, 2008, ANN RHEUM DIS, V67, P724, DOI 10.1136/ard.2007.073718; Gerli R, 2009, ARTHRITIS RHEUM, V60, P631, DOI 10.1002/art.24297; Ghia P, 2007, BRIT J HAEMATOL, V139, P780, DOI 10.1111/j.1365-2141.2007.06867.x; Holling TM, 2002, J IMMUNOL, V168, P763, DOI 10.4049/jimmunol.168.2.763; HORNEFF G, 1991, ARTHRITIS RHEUM, V34, P129, DOI 10.1002/art.1780340202; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Kelly-Rogers J, 2006, HUM IMMUNOL, V67, P863, DOI 10.1016/j.humimm.2006.08.292; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Maxwell LJ, 2010, J RHEUMATOL, V37, P234, DOI 10.3899/jrheum.091066; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Nascimbeni M, 2004, BLOOD, V104, P478, DOI 10.1182/blood-2003-12-4395; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; PALIARD X, 1988, NATURE, V335, P642, DOI 10.1038/335642a0; Parel Y, 2004, AUTOIMMUN REV, V3, P215, DOI 10.1016/j.autrev.2003.09.001; Parel Y, 2007, ARTHRITIS RHEUM-US, V56, P3459, DOI 10.1002/art.22927; Pierer M, 2012, ARTHRITIS RHEUM-US, V64, P1740, DOI 10.1002/art.34346; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Scheerens H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3502; Schmidt D, 1996, MOL MED, V2, P608, DOI 10.1007/BF03401644; Suni MA, 2001, EUR J IMMUNOL, V31, P2512, DOI 10.1002/1521-4141(200108)31:8<2512::AID-IMMU2512>3.0.CO;2-M; Wagner U, 2003, EUR J IMMUNOL, V33, P79, DOI 10.1002/immu.200390010; Zloza A, 2006, J LEUKOCYTE BIOL, V79, P4, DOI 10.1189/jlb.0805455	35	55	55	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93293	10.1371/journal.pone.0093293	http://dx.doi.org/10.1371/journal.pone.0093293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667579	gold, Green Published, Green Submitted			2022-12-25	WOS:000333675600166
J	Li, TJ; Wang, S; Meng, XS; Bao, YR; Guan, SS; Liu, B; Chen, L; Wang, L; Ran, XR				Li Tianjiao; Wang Shuai; Meng Xiansheng; Bao Yongrui; Guan Shanshan; Liu Bo; Chen Lu; Wang Lei; Ran Xiaorong			Metabolomics Coupled with Multivariate Data and Pathway Analysis on Potential Biomarkers in Gastric Ulcer and Intervention Effects of Corydalis yanhusuo Alkaloid	PLOS ONE			English	Article							MASS-SPECTROMETRY; CHINESE; METABONOMICS; RECOGNITION; MEDICINE; SURFACE; PLASMA	Metabolomics, the systematic analysis of potential metabolites in a biological specimen, has been increasingly applied to discovering biomarkers, identifying perturbed pathways, measuring therapeutic targets, and discovering new drugs. By analyzing and verifying the significant difference in metabolic profiles and changes of metabolite biomarkers, metabolomics enables us to better understand substance metabolic pathways which can clarify the mechanism of Traditional Chinese Medicines (TCM). Corydalis yanhusuo alkaloid (CA) is a major component of Qizhiweitong (QZWT) prescription which has been used for treating gastric ulcer for centuries and its mechanism remains unclear completely. Metabolite profiling was performed by high-performance liquid chromatography combined with time-of-flight mass spectrometry (HPLC/ESI-TOF-MS) and in conjunction with multivariate data analysis and pathway analysis. The statistic software Mass Profiller Prossional (MPP) and statistic method including ANOVA and principal component analysis (PCA) were used for discovering novel potential biomarkers to clarify mechanism of CA in treating acid injected rats with gastric ulcer. The changes in metabolic profiling were restored to their base-line values after CA treatment according to the PCA score plots. Ten different potential biomarkers and seven key metabolic pathways contributing to the treatment of gastric ulcer were discovered and identified. Among the pathways, sphingophospholipid metabolism and fatty acid metabolism related network were acutely perturbed. Quantitative real time polymerase chain reaction (RT-PCR) analysis were performed to evaluate the expression of genes related to the two pathways for verifying the above results. The results show that changed biomarkers and pathways may provide evidence to insight into drug action mechanisms and enable us to increase research productivity toward metabolomics drug discovery.	[Li Tianjiao; Wang Shuai; Meng Xiansheng; Bao Yongrui; Guan Shanshan; Liu Bo; Chen Lu] Liaoning Univ Tradit Chinese Med, Dalian, Peoples R China; [Wang Lei; Ran Xiaorong] Agilent Technol Co Ltd, Beijing, Peoples R China; [Wang Shuai; Meng Xiansheng; Wang Lei; Ran Xiaorong] Liaoning Univ Tradit Chinese Med, Agilent Technol Modern TCM & Multiom Res Collabor, Dalian, Peoples R China	Liaoning University of Traditional Chinese Medicine; Agilent Technologies; Liaoning University of Traditional Chinese Medicine	Meng, XS (corresponding author), Liaoning Univ Tradit Chinese Med, Dalian, Peoples R China.	mxsvvv@163.com; xiaorong-ran@aglient.com			Natural Science Foundation of the State [81241111]	Natural Science Foundation of the State	This work was supported by grants from the Key Program of the Natural Science Foundation of the State (No. 81241111). The Aglient and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2008, DIGEST DIS SCI, V53, P933, DOI 10.1007/s10620-007-9965-3; Cheng Xing-ye, 2009, Yaoxue Xuebao, V44, P167; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Eamlamnam K, 2006, WORLD J GASTROENTERO, V12, P2034, DOI 10.3748/wjg.v12.i13.2034; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Gao W, 2012, J CHROMATOGR A, V1245, P109, DOI 10.1016/j.chroma.2012.05.027; Griffin JL, 2006, PHILOS T R SOC B, V361, P147, DOI 10.1098/rstb.2005.1734; HAKOMORI S, 1995, J BIOCHEM, V118, P1091, DOI 10.1093/oxfordjournals.jbchem.a124992; Idle JR, 2007, CELL METAB, V6, P348, DOI 10.1016/j.cmet.2007.10.005; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Ji CX, 2012, EUR J PHARMACOL, V691, P46, DOI 10.1016/j.ejphar.2012.06.041; Konturek PC, 2012, J PHYSIOL PHARMACOL, V50, P211; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Lee TH, 2010, BIOL PHARM BULL, V33, P958, DOI 10.1248/bpb.33.958; Lee U, 2012, XENOBIOTICA, V42, P310, DOI 10.3109/00498254.2011.619014; Li Y, 2005, J ETHNOPHARMACOL, V98, P329, DOI 10.1016/j.jep.2005.01.020; Lin G, 2012, J NUTR, V142, P990, DOI 10.3945/jn.111.153411; Liu JL, 2011, BIOL PHARM BULL, V34, P871, DOI 10.1248/bpb.34.871; Murata K, 2012, PHYTOTHER RES, V26, P1126, DOI 10.1002/ptr.3681; Nakashita M, 2013, DIGEST DIS SCI, V58, P354, DOI 10.1007/s10620-012-2350-x; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Nie HG, 2010, J LIPID RES, V51, P2833, DOI 10.1194/jlr.D007567; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.188; OKABE S, 1971, AM J DIG DIS, V16, P277, DOI 10.1007/BF02235252; OKABE S, 1972, AM J DIG DIS, V17, P619, DOI 10.1007/BF02231748; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Sacca R, 1997, CURR OPIN IMMUNOL, V9, P851, DOI 10.1016/S0952-7915(97)80189-6; Shu MH, 2013, BMC COMPLEM ALTERN M, V13, P1; Soji Y, 1969, Nihon Yakurigaku Zasshi, V65, P196; Stone R, 2008, SCIENCE, V319, P709, DOI 10.1126/science.319.5864.709; Sun H, 2012, PHYTOTHER RES, V26, P1466, DOI 10.1002/ptr.4613; Suzuki H, 2000, J GASTROEN HEPATOL, V15, pD46; UCHIDA M, 1990, DIGEST DIS SCI, V35, P80, DOI 10.1007/BF01537227; Wang XJ, 2012, J PROTEOME RES, V11, P1284, DOI 10.1021/pr200963e; Zhang AH, 2012, ANALYST, V137, P293, DOI 10.1039/c1an15605e; Zhang QH, 2013, INT WOUND J, V10, P221, DOI 10.1111/j.1742-481X.2012.00969.x	38	38	45	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e82499	10.1371/journal.pone.0082499	http://dx.doi.org/10.1371/journal.pone.0082499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24671209	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100005
J	Li, Y; Surya, W; Claudine, S; Torres, J				Li, Yan; Surya, Wahyu; Claudine, Stephanie; Torres, Jaume			Structure of a Conserved Golgi Complex-targeting Signal in Coronavirus Envelope Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Analytical Ultracentrifugation; Nuclear Magnetic Resonance (NMR); Protein Structure; Structural Biology; Viral Protein; Virus Assembly; Golgi Targeting; SARS; Coronavirus; Envelope Protein	RESPIRATORY SYNDROME CORONAVIRUS; INFECTIOUS-BRONCHITIS-VIRUS; NUCLEAR-MAGNETIC-RESONANCE; TORSION ANGLE DYNAMICS; SARS-CORONAVIRUS; MEMBRANE-PROTEIN; MUTATIONAL ANALYSIS; MURINE CORONAVIRUS; CYTOPLASMIC TAIL; TERMINAL DOMAIN	Background: Coronavirus envelope (CoV E) proteins have a predicted -coil- motif reported to target the Golgi complex. Results: This conserved domain forms -structure on its own but is -helical in the context of full-length SARS-CoV E protein. Conclusion: This domain is potentially involved in large conformational transitions. Significance: This is the first structural data of the extramembrane domain of any coronavirus E protein. Coronavirus envelope (CoV E) proteins are approximate to 100-residue polypeptides with at least one channel-forming -helical transmembrane (TM) domain. The extramembrane C-terminal tail contains a completely conserved proline, at the center of a predicted -coil- motif. This hydrophobic motif has been reported to constitute a Golgi-targeting signal or a second TM domain. However, no structural data for this or other extramembrane domains in CoV E proteins is available. Herein, we show that the E protein in the severe acute respiratory syndrome virus has only one TM domain in micelles, whereas the predicted -coil- motif forms a short membrane-bound -helix connected by a disordered loop to the TM domain. However, complementary results suggest that this motif is potentially poised for conformational change or in dynamic exchange with other conformations.	[Li, Yan; Surya, Wahyu; Claudine, Stephanie; Torres, Jaume] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Torres, J (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	jtorres@ntu.edu.sg	Torres, Jaume/A-2179-2011; Li, Yan/G-4642-2013; Torres, Jaume/AAJ-4510-2020	Torres, Jaume/0000-0002-1282-9727; Li, Yan/0000-0003-1963-839X; Surya, Wahyu/0000-0001-9240-371X				Abdul-Gader A, 2011, BIOINFORMATICS, V27, P1630, DOI 10.1093/bioinformatics/btr234; Al-Ahdal MN, 2012, J INFECT DEV COUNTR, V6, P692, DOI 10.3855/jidc.3084; Alvarez E, 2010, VIROLOGY, V402, P281, DOI 10.1016/j.virol.2010.03.015; Anderson LJ, 2012, NEW ENGL J MED, V367, P1850, DOI 10.1056/NEJMe1212300; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Baudoux P, 1998, J VIROL, V72, P8636, DOI 10.1128/JVI.72.11.8636-8643.1998; Bos ECW, 1996, VIROLOGY, V218, P52, DOI 10.1006/viro.1996.0165; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cohen JR, 2011, J VIROL, V85, P5794, DOI 10.1128/JVI.00060-11; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Corman VM, 2012, EUROSURVEILLANCE, V17, P2; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Corse E, 2000, J VIROL, V74, P4319, DOI 10.1128/JVI.74.9.4319-4326.2000; Corse E, 2003, VIROLOGY, V312, P25, DOI 10.1016/S0042-6822(03)00175-2; Corse E, 2002, J VIROL, V76, P1273, DOI 10.1128/JVI.76.3.1273-1284.2002; Curtis KM, 2002, J VIROL, V76, P1422, DOI 10.1128/JVI.76.3.1422-1434.2002; de Haan CAM, 2000, J VIROL, V74, P4967, DOI 10.1128/JVI.74.11.4967-4978.2000; DeDiego ML, 2008, VIROLOGY, V376, P379, DOI 10.1016/j.virol.2008.03.005; DeDiego ML, 2007, J VIROL, V81, P1701, DOI 10.1128/JVI.01467-06; DeDiego ML, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002315; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Enjuanes L, 2011, BIRKHAUSER ADV INFEC, P73, DOI 10.1007/978-3-0346-0277-8_4; Fauquet C.M., 2000, VIRUS TAXONOMY CLASS, P835; Fischer F, 1998, J VIROL, V72, P7885, DOI 10.1128/JVI.72.10.7885-7894.1998; Fleming KG, 2002, J MOL BIOL, V323, P563, DOI 10.1016/S0022-2836(02)00920-8; Gan SW, 2011, ANAL BIOCHEM, V416, P100, DOI 10.1016/j.ab.2011.05.007; Gonzaalez JM, 2003, ARCH VIROL, V148, P2207, DOI 10.1007/s00705-003-0162-1; Gorbalenya AE, 2004, J VIROL, V78, P7863, DOI 10.1128/JVI.78.15.7863-7866.2004; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hernandez LD, 1998, J VIROL, V72, P3259, DOI 10.1128/JVI.72.4.3259-3267.1998; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hogue BG, 2008, NIDOVIRUSES, P179; Ito H, 1999, J VIROL, V73, P8907, DOI 10.1128/JVI.73.10.8907-8912.1999; Kasai T., 2007, JAPAN MED ASS J, V50, P117; KAUPPINEN JK, 1981, APPL OPTICS, V20, P1866, DOI 10.1364/AO.20.001866; Kochendoerfer GG, 1999, BIOCHEMISTRY-US, V38, P11905, DOI 10.1021/bi990720m; Kuo LL, 2007, J VIROL, V81, P2249, DOI 10.1128/JVI.01577-06; Kuo LL, 2010, J VIROL, V84, P12872, DOI 10.1128/JVI.01850-10; Lamirande EW, 2008, J VIROL, V82, P7721, DOI 10.1128/JVI.00304-08; Liang BY, 2006, J AM CHEM SOC, V128, P4389, DOI 10.1021/ja0574825; Lim KP, 2001, J BIOL CHEM, V276, P17515, DOI 10.1074/jbc.M009731200; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Mortola E, 2004, FEBS LETT, V576, P174, DOI 10.1016/j.febslet.2004.09.009; Muller MA, 2012, MBIO, V3, DOI 10.1128/mBio.00515-12; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Netland J, 2010, VIROLOGY, V399, P120, DOI 10.1016/j.virol.2010.01.004; Nieto-Torres JL, 2011, VIROLOGY, V415, P69, DOI 10.1016/j.virol.2011.03.029; Ortego J, 2002, J VIROL, V76, P11518, DOI 10.1128/JVI.76.22.11518-11529.2002; Parthasarathy K, 2008, BIOPHYS J, V95, pL39, DOI 10.1529/biophysj.108.133041; Parthasarathy K, 2012, PROTEIN EXPRES PURIF, V85, P133, DOI 10.1016/j.pep.2012.07.005; Pervushin K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000511; Ruch TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002674; Ruch TR, 2011, J VIROL, V85, P675, DOI 10.1128/JVI.01570-10; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schneidman-Duhovny D, 2005, PROTEINS, V60, P224, DOI 10.1002/prot.20562; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Serrano P, 2007, J VIROL, V81, P12049, DOI 10.1128/JVI.00969-07; SIDDELL SG, 1995, CORONAVIRIDAE INTRO; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Surya W., 2013, RESP DIS INFECT NEW, DOI [10.5772/53957, DOI 10.5772/53957]; Teoh KT, 2010, MOL BIOL CELL, V21, P3838, DOI 10.1091/mbc.E10-04-0338; Torres J, 2005, BIOPHYS J, V88, P1283, DOI 10.1529/biophysj.104.051730; Torres J, 2007, PROTEIN SCI, V16, P2065, DOI 10.1110/ps.062730007; Torres J, 2006, BIOPHYS J, V91, P938, DOI 10.1529/biophysj.105.080119; Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q; Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; Van Horn WD, 2010, BBA-BIOMEMBRANES, V1798, P140, DOI 10.1016/j.bbamem.2009.08.022; Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x; Verdia-Baguena C, 2012, VIROLOGY, V432, P485, DOI 10.1016/j.virol.2012.07.005; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wilson L, 2004, VIROLOGY, V330, P322, DOI 10.1016/j.virol.2004.09.033; Wilson L, 2006, VIROLOGY, V353, P294, DOI 10.1016/j.virol.2006.05.028; WOLFSBERG TG, 1995, DEV BIOL, V169, P378, DOI 10.1006/dbio.1995.1152; Xu XP, 2001, J BIOMOL NMR, V21, P321, DOI 10.1023/A:1013324104681; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	79	64	65	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12535	12549		10.1074/jbc.M114.560094	http://dx.doi.org/10.1074/jbc.M114.560094			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24668816	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000335581400028
J	N'Dilimabaka, N; Taoufiq, Z; Zougbede, S; Bonnefoy, S; Lorthiois, A; Couraud, PO; Rebollo, A; Snounou, G; Mazier, D; Sabater, AM				N'Dilimabaka, Nadine; Taoufiq, Zacharie; Zougbede, Sergine; Bonnefoy, Serge; Lorthiois, Audrey; Couraud, Pierre Oliver; Rebollo, Angelita; Snounou, Georges; Mazier, Dominique; Sabater, Alicia Moreno			P-falciparum Isolate-Specific Distinct Patterns of Induced Apoptosis in Pulmonary and Brain Endothelial Cells	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; HUMAN CEREBRAL MALARIA; INFECTED ERYTHROCYTES; MODEL; CYTOADHERENCE; TRANSCRIPTION; PATHOGENESIS; DYSFUNCTION; ACTIVATION; EXPRESSION	The factors implicated in the transition from uncomplicated to severe clinical malaria such as pulmonary oedema and cerebral malaria remain unclear. It is known that alterations in vascular integrity due to endothelial cell (EC) activation and death occur during severe malaria. In this study, we assessed the ability of different P. falciparum clinical isolates to induce apoptosis in ECs derived from human lung and brain. We observed that induction of EC apoptosis was sensitive to the environmental pH and required direct contact between the parasite and the cell, though it was not correlated to the ability of the parasite to cytoadhere. Moreover, the extent of induced apoptosis in the two EC types varied with the isolate. Analysis of parasite genes transcript led us to propose that the activation of different pathways, such as Plasmodium apoptosis-linked pathogenicity factors (PALPF), PALPF-2, PALPF-5 and PF11_0521, could be implied in EC death. These observations provide an experimental framework to decipher the molecular mechanism implicated in the genesis of severe malaria.	[N'Dilimabaka, Nadine; Taoufiq, Zacharie; Zougbede, Sergine; Lorthiois, Audrey; Rebollo, Angelita; Snounou, Georges; Mazier, Dominique; Sabater, Alicia Moreno] Univ Paris 06, UMRS 945, Paris, France; [N'Dilimabaka, Nadine; Taoufiq, Zacharie; Zougbede, Sergine; Lorthiois, Audrey; Rebollo, Angelita; Snounou, Georges; Mazier, Dominique; Sabater, Alicia Moreno] INSERM, UMRS 945, Paris, France; [Bonnefoy, Serge] Inst Pasteur, CNRS, URA 2581, Unite Immunol Mol Parasites, Paris, France; [Couraud, Pierre Oliver] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Couraud, Pierre Oliver] CNRS, UMR8104, Paris, France; [Couraud, Pierre Oliver] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Mazier, Dominique] Hop La Pitie Salpetriere, AP HP, Lab Parasitol Mycol, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Sabater, AM (corresponding author), Univ Paris 06, UMRS 945, Paris, France.	alicia.moreno-sabater@upmc.fr	Rebollo, Angelita/P-2118-2017; Bonnefoy, Serge/B-2466-2014; Snounou, Georges/F-3352-2011; Moreno Sabater, Alicia/P-3536-2017	Bonnefoy, Serge/0000-0001-9148-0123; Taoufiq, Zacharie/0000-0003-4893-0322; Snounou, Georges/0000-0002-6133-6398; Moreno Sabater, Alicia/0000-0002-7571-9533; Rebollo, Angelita/0000-0002-1293-9686	Ministere des Affaires Etrangeres through the Ambassade de France at Libreville, Gabon	Ministere des Affaires Etrangeres through the Ambassade de France at Libreville, Gabon	NN was supported by a fellowship from the Ministere des Affaires Etrangeres through the Ambassade de France at Libreville, Gabon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; [Anonymous], LANCET; Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Chakravorty SJ, 2007, INT J PARASITOL, V37, P975, DOI 10.1016/j.ijpara.2007.02.006; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; CLARK IA, 1994, PARASITOL TODAY, V10, P410, DOI 10.1016/0169-4758(94)90237-2; Combes V, 2004, JAMA-J AM MED ASSOC, V291, P2542, DOI 10.1001/jama.291.21.2542-b; Craig A, 2001, MOL BIOCHEM PARASIT, V115, P129, DOI 10.1016/S0166-6851(01)00275-4; Day NPJ, 2000, CRIT CARE MED, V28, P1833, DOI 10.1097/00003246-200006000-00025; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Elias RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044004; Gardner JP, 1996, P NATL ACAD SCI USA, V93, P3503, DOI 10.1073/pnas.93.8.3503; Gerardin P, 2002, AM J TROP MED HYG, V66, P686, DOI 10.4269/ajtmh.2002.66.686; Gillrie MR, 2007, BLOOD, V110, P3426, DOI 10.1182/blood-2007-04-084582; Gillrie MR, 2012, AM J PATHOL, V180, P1028, DOI 10.1016/j.ajpath.2011.11.037; GOODYER ID, 1994, ANN TROP MED PARASIT, V88, P209, DOI 10.1080/00034983.1994.11812859; GRAU GE, 1994, PARASITOL TODAY, V10, P408, DOI 10.1016/0169-4758(94)90236-4; Hanson J, 2012, J INFECT DIS, V206, P571, DOI 10.1093/infdis/jis400; Hemmer CJ, 2011, TROP MED INT HEALTH, V16, P906, DOI 10.1111/j.1365-3156.2011.02788.x; Hemmer CJ, 2005, INFECT IMMUN, V73, P1764, DOI 10.1128/IAI.73.3.1764-1770.2005; HEMMER CJ, 1991, AM J MED, V91, P37, DOI 10.1016/0002-9343(91)90071-5; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Jambou R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001021; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Marchiafava E, 1894, 2 MONOGRAPHS MALARIA; McKenzie FE, 2008, ADV PARASIT, V66, P1, DOI 10.1016/S0065-308X(08)00201-7; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mita-Mendoza NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054481; Montgomery J, 2007, MOL MICROBIOL, V65, P959, DOI 10.1111/j.1365-2958.2007.05837.x; Muanza K, 1996, RES IMMUNOL, V147, P149, DOI 10.1016/0923-2494(96)83167-1; Peters JM, 2007, J INFECT DIS, V195, P748, DOI 10.1086/511436; Pino P, 2003, ANN NY ACAD SCI, V1010, P582, DOI 10.1196/annals.1299.109; Prato M, 2011, CELL MICROBIOL, V13, P1275, DOI 10.1111/j.1462-5822.2011.01620.x; Punsawad C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-260; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schofield L, 2002, NATURE, V418, P785, DOI 10.1038/nature00937; Schofield L, 1996, J IMMUNOL, V156, P1886; Siau A, 2007, J INFECT DIS, V196, P1603, DOI 10.1086/522012; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Taoufiq Z, 2008, J INFECT DIS, V197, P1062, DOI 10.1086/528988; Taoufiq Z, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-52; Taylor WRJ, 2012, CHEST, V142, P492, DOI 10.1378/chest.11-2655; Toure FS, 2008, PARASITE IMMUNOL, V30, P47; Tripathi AK, 2007, J INFECT DIS, V195, P942, DOI 10.1086/512083; Tripathi AK, 2009, BLOOD, V114, P4243, DOI 10.1182/blood-2009-06-226415; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Wassmer SC, 2006, INFECT IMMUN, V74, P645, DOI 10.1128/IAI.74.1.645-653.2006; Wassmer SC, 2006, J IMMUNOL, V176, P1180, DOI 10.4049/jimmunol.176.2.1180; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; White NJ, 2013, J INFECT DIS, V208, P192, DOI 10.1093/infdis/jit116; WHO, 2000, T R SOC TROP MED HYG, P94; Zang-Edou ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013221; Zougbede S, 2011, J CEREBR BLOOD F MET, V31, P514, DOI 10.1038/jcbfm.2010.121	57	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e90692	10.1371/journal.pone.0090692	http://dx.doi.org/10.1371/journal.pone.0090692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TJ	24686750	gold, Green Published, Green Submitted			2022-12-25	WOS:000333678800001
J	DuVal, MG; Oel, AP; Allison, WT				DuVal, Michele G.; Oel, A. Phillip; Allison, W. Ted			gdf6a Is Required for Cone Photoreceptor Subtype Differentiation and for the Actions of tbx2b in Determining Rod Versus Cone Photoreceptor Fate	PLOS ONE			English	Article							RETINAL DEVELOPMENT; ZEBRAFISH BRAIN; PRECURSOR CELLS; OPTIC-NERVE; OPSIN GENE; REGENERATION; EXPRESSION; TRANSPLANTATION; DEGENERATION; GOLDFISH	Functional vision restoration is within reach via stem cell therapy, but one of the largest obstacles is the derivation of colour-sensitive cone photoreceptors that are required for high-acuity daytime vision. To enhance progress made using nocturnal murine models, we instead utilize cone-rich zebrafish and herein investigate relationships between gdf6a and tbx2b in cone photoreceptor development. Growth/differentiation factor 6a (gdf6a), a bone morphogenetic protein family ligand, is an emerging factor in photoreceptor degenerative diseases. The T-box transcription factor tbx2b is required to specify UV cone photoreceptor fate instead of rod photoreceptor fate. Interactions between these factors in cone development would be unanticipated, considering the discrete phenotypes in their respective mutants. However, gdf6a positively modulates the abundance of tbx2b transcript during early eye morphogenesis, and we extended this conclusion to later stages of retinal development comprising the times when photoreceptors differentiate. Despite this, gdf6a(-/-) larvae possess a normal relative number of UV cones and instead present with a low abundance of blue cone photoreceptors, approximately half that of siblings (p<0.001), supporting a differential role for gdf6a amongst the spectral subtypes of cone photoreceptors. Further, gdf6a(-/-) larvae from breeding of compound heterozygous gdf6a(+/-); tbx2b(+/-) mutants exhibit the recessive lots-of-rods phenotype (which also shows a paucity of UV cones) at significantly elevated rates (44% or 48% for each of two tbx2b alleles, chi(2) p <= 0.007 for each compared to expected Mendelian 25%). Thus the gdf6a(-/-) background sensitizes fish such that the recessive lots-of-rods phenotype can appear in heterozygous tbx2b(+/-) fish. Overall, this work establishes a novel link between tbx2b and gdf6a in determining photoreceptor fates, defining the nexus of an intricate pathway influencing the abundance of cone spectral subtypes and specifying rod vs. cone photoreceptors. Understanding this interaction is a necessary step in the refinement of stem cell-based restoration of daytime vision in humans.	[DuVal, Michele G.; Oel, A. Phillip; Allison, W. Ted] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Allison, W. Ted] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Allison, W. Ted] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Allison, WT (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	ted.allison@ualberta.ca	Allison, W. Ted/A-2612-2014; Allison, W. Ted/K-5228-2012	Allison, W. Ted/0000-0002-8461-4864; DuVal, Michele/0000-0001-6975-8117	NSERC; CIHR	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	The work was funded by NSERC (www.nserc-crsng.gc.ca) Discovery Grant to WTA, CGSM Studentship from NSERC to APO, and MD/PhD Studentship from CIHR (www.cihr-irsc.gc.ca) to MGD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison WT, 2006, J COMP NEUROL, V499, P702, DOI 10.1002/cne.21164; Allison WT, 2006, MOL VIS, V12, P655; Allison WT, 2010, J COMP NEUROL, V518, P4182, DOI 10.1002/cne.22447; Allison WT, 2004, VISUAL NEUROSCI, V21, P945, DOI 10.1017/S0952523804216145; Allison WT, 2003, J COMP NEUROL, V461, P294, DOI 10.1002/cne.10682; Allison WT, 2004, THESIS U VICTORIA VI; Alvarez-Delfin K, 2009, P NATL ACAD SCI USA, V106, P2023, DOI 10.1073/pnas.0809439106; Asai-Coakwell M, 2007, AM J HUM GENET, V80, P306, DOI 10.1086/511280; Asai-Coakwell M, 2013, HUM MOL GENET, V22, P1432, DOI 10.1093/hmg/dds560; Asai-Coakwell M, 2009, HUM MOL GENET, V18, P1110, DOI 10.1093/hmg/ddp008; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Becker T, 1998, J NEUROSCI, V18, P5789; Behesti H, 2009, DEV BIOL, V333, P360, DOI 10.1016/j.ydbio.2009.06.026; Bilican B, 2006, EXP CELL RES, V312, P2358, DOI 10.1016/j.yexcr.2006.03.033; BROWMAN HI, 1994, J EXP BIOL, V193, P191; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Clanton JA, 2013, DEVELOPMENT, V140, P323, DOI 10.1242/dev.083709; Dann SG, 2004, J MOL EVOL, V58, P400, DOI 10.1007/s00239-003-2562-y; den Hollander AI, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-102; DuVal MG, 2013, PLOS ONE, V9, DOI [10.1371/journal.pone.0089183, DOI 10.1371/J0URNAL.P0NE.0089183]; Duval MG, 2013, MOL VIS, V19, P1082; Easter SS, 2000, NEUROSCIENTIST, V6, P454, DOI 10.1177/107385840000600608; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fleisch VC, 2011, BBA-MOL BASIS DIS, V1812, P364, DOI 10.1016/j.bbadis.2010.10.012; Fraser B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055410; French CR, 2010, THESIS U ALBERTA EDM; French CR, 2013, INVEST OPHTH VIS SCI, V54, P4636, DOI 10.1167/iovs.13-11674; French CR, 2009, DEV BIOL, V333, P37, DOI 10.1016/j.ydbio.2009.06.018; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012; Gonzalez-Rodriguez J, 2010, BRIT J OPHTHALMOL, V94, P1100, DOI 10.1136/bjo.2009.173500; Gosse NJ, 2009, P NATL ACAD SCI USA, V106, P2236, DOI 10.1073/pnas.0803202106; Gross JM, 2005, P NATL ACAD SCI USA, V102, P4371, DOI 10.1073/pnas.0501061102; Hanel ML, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-43; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lakowski J, 2011, STEM CELLS, V29, P1391, DOI 10.1002/stem.694; Lakowski J, 2010, HUM MOL GENET, V19, P4545, DOI 10.1093/hmg/ddq378; Lamba D, 2008, CELL STEM CELL, V2, P538, DOI 10.1016/j.stem.2008.05.002; Lenkowski JR, 2013, GLIA, V61, P1687, DOI 10.1002/glia.22549; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Mansergh FC, 2010, EXP EYE RES, V91, P500, DOI 10.1016/j.exer.2010.07.003; Martin N, 2012, EMBO J, V31, P95, DOI 10.1038/emboj.2011.370; Matsukawa T, 2004, BIOL PHARM BULL, V27, P445, DOI 10.1248/bpb.27.445; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Milam AH, 2002, P NATL ACAD SCI USA, V99, P473, DOI 10.1073/pnas.022533099; Morris AC, 2005, INVEST OPHTH VIS SCI, V46, P4762, DOI 10.1167/iovs.05-0797; Ng L, 2001, HUM MOL GENET, V10, P2701, DOI 10.1093/hmg/10.23.2701; Ng L, 2011, J NEUROSCI, V31, P11118, DOI 10.1523/JNEUROSCI.1709-11.2011; Okada I, 2011, AM J HUM GENET, V88, P30, DOI 10.1016/j.ajhg.2010.11.012; RAYMOND PA, 1993, NEURON, V10, P1161, DOI 10.1016/0896-6273(93)90064-X; Raymond PA, 2004, INT J DEV BIOL, V48, P935, DOI 10.1387/ijdb.041873pr; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; Satoh S, 2009, J NEUROSCI, V29, P12401, DOI 10.1523/JNEUROSCI.0951-09.2009; Seko Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035611; Senut MC, 2004, J NEUROSCI, V24, P7663, DOI 10.1523/JNEUROSCI.2281-04.2004; Sharon D, 2003, ARCH OPHTHALMOL-CHIC, V121, P1316, DOI 10.1001/archopht.121.9.1316; Snelson CD, 2008, DEVELOPMENT, V135, P1693, DOI 10.1242/dev.016576; Srinivas M, 2006, MOL ENDOCRINOL, V20, P1728, DOI 10.1210/me.2005-0505; Stenkamp DL, 1997, J COMP NEUROL, V382, P272, DOI 10.1002/(SICI)1096-9861(19970602)382:2<272::AID-CNE10>3.0.CO;2-U; Stenkamp DL, 1996, INVEST OPHTH VIS SCI, V37, P363; Suzuki SC, 2013, P NATL ACAD SCI USA, V110, P15109, DOI 10.1073/pnas.1303551110; Takechi M, 2005, J EXP BIOL, V208, P1337, DOI 10.1242/jeb.01532; Takechi M, 2003, FEBS LETT, V553, P90, DOI 10.1016/S0014-5793(03)00977-3; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Veldhoen K, 2006, VISUAL NEUROSCI, V23, P169, DOI 10.1017/S0952523806232139; Vihtelic TS, 1999, VISUAL NEUROSCI, V16, P571, DOI 10.1017/S0952523899163168; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Zhang L, 2012, J BIOL CHEM, V287, P1520, DOI 10.1074/jbc.M111.275990	72	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92991	10.1371/journal.pone.0092991	http://dx.doi.org/10.1371/journal.pone.0092991			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681822	Green Published, gold, Green Submitted			2022-12-25	WOS:000333678100021
J	Usselman, RJ; Hill, I; Singel, DJ; Martino, CF				Usselman, Robert J.; Hill, Iain; Singel, David J.; Martino, Carlos F.			Spin Biochemistry Modulates Reactive Oxygen Species (ROS) Production by Radio Frequency Magnetic Fields	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; PAIR MECHANISM; NADPH OXIDASES; SMOOTH-MUSCLE; MAGNETORECEPTION; SUPEROXIDE; ACTIVATION; BIOLOGY	The effects of weak magnetic fields on the biological production of reactive oxygen species (ROS) from intracellular superoxide (O-2(center dot-)) and extracellular hydrogen peroxide (H2O2) were investigated in vitro with rat pulmonary arterial smooth muscle cells (rPASMC). A decrease in O-2(center dot-) and an increase in H2O2 concentrations were observed in the presence of a 7 MHz radio frequency (RF) at 10 mu T-RMS and static 45 mu T magnetic fields. We propose that O-2(center dot-) and H2O2 production in some metabolic processes occur through singlet-triplet modulation of semiquinone flavin (FADH(center dot)) enzymes and O-2(center dot-) spin-correlated radical pairs. Spin-radical pair products are modulated by the 7 MHz RF magnetic fields that presumably decouple flavin hyperfine interactions during spin coherence. RF flavin hyperfine decoupling results in an increase of H2O2 singlet state products, which creates cellular oxidative stress and acts as a secondary messenger that affects cellular proliferation. This study demonstrates the interplay between O-2(center dot-) and H2O2 production when influenced by RF magnetic fields and underscores the subtle effects of low-frequency magnetic fields on oxidative metabolism, ROS signaling, and cellular growth.	[Usselman, Robert J.] NIST, Electromagnet Div, Boulder, CO 80309 USA; [Singel, David J.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Hill, Iain; Martino, Carlos F.] Univ Nevada, Dept Mech Engn, Reno, NV 89557 USA	National Institute of Standards & Technology (NIST) - USA; Montana State University System; Montana State University Bozeman; Nevada System of Higher Education (NSHE); University of Nevada Reno	Usselman, RJ (corresponding author), NIST, Electromagnet Div, Boulder, CO 80309 USA.	robert.usselman@gmail.com; cmartino@unr.edu	Martino, Carlos F/C-6597-2016	Martino, Carlos F/0000-0002-0560-2604	United States government	United States government	This work was partially supported by the United States government but is not protected by US copyright. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair RK, 1999, BIOELECTROMAGNETICS, V20, P255, DOI 10.1002/(SICI)1521-186X(1999)20:4<255::AID-BEM6>3.0.CO;2-W; [Anonymous], 2005, C951 IEEE; Ball P, 2011, NATURE, V474, P272, DOI 10.1038/474272a; Barnes F. S., 2006, HDB BIOL EFFECTS ELE, P67; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BLANKENSHIP RE, 1977, BIOCHIM BIOPHYS ACTA, V461, P297, DOI 10.1016/0005-2728(77)90179-7; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Bucci M, 2010, NAT CHEM BIOL, V6, P847, DOI 10.1038/nchembio.489; Buchachenko AL, 2005, P NATL ACAD SCI USA, V102, P10793, DOI 10.1073/pnas.0504876102; Buetler TM, 2004, NEWS PHYSIOL SCI, V19, P120, DOI 10.1152/nips.01514.2003; CANFIELD JM, 1994, CHEM PHYS, V182, P1, DOI 10.1016/0301-0104(93)E0442-X; Cespedes O, 2010, BIOELECTROMAGNETICS, V31, P311, DOI 10.1002/bem.20564; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Challis LJ, 2005, BIOELECTROMAGNETICS, pS98, DOI 10.1002/bem.20119; Chen K, 2009, ANTIOXID REDOX SIGN, V11, P2467, DOI [10.1089/ars.2009.2594, 10.1089/ARS.2009.2594]; Cintolesi F, 2003, CHEM PHYS, V294, P385, DOI 10.1016/S0301-0104(03)00320-3; Cohen AE, 2009, J PHYS CHEM A, V113, P11084, DOI 10.1021/jp907113p; Crotty D, 2012, P NATL ACAD SCI USA, V109, P1437, DOI 10.1073/pnas.1117840108; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Dikalov SI, 2011, FREE RADICAL RES, V45, P417, DOI 10.3109/10715762.2010.540242; Engstrom S, 2006, HDB BIOL EFFECTS ELE, P157; Fisher AB, 2009, ANTIOXID REDOX SIGN, V11, P1349, DOI [10.1089/ars.2008.2378, 10.1089/ARS.2008.2378]; Forrest AS, 2012, AM J PHYSIOL-CELL PH, V303, pC1229, DOI 10.1152/ajpcell.00044.2012; FRIX WM, 1994, IEEE T POWER DELIVER, V9, P100, DOI 10.1109/61.277684; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; GRISSOM CB, 1995, CHEM REV, V95, P3, DOI 10.1021/cr00033a001; HOFF AJ, 1977, BIOCHIM BIOPHYS ACTA, V460, P547, DOI 10.1016/0005-2728(77)90094-9; Hogben HJ, 2009, CHEM PHYS LETT, V480, P118, DOI 10.1016/j.cplett.2009.08.051; Hore PJ, 2012, P NATL ACAD SCI USA, V109, P1357, DOI 10.1073/pnas.1120531109; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Jones AR, 2009, J AM CHEM SOC, V131, P17246, DOI 10.1021/ja9059238; Kominis IK, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056115; Lacy-Hulbert A, 1998, FASEB J, V12, P395, DOI 10.1096/fasebj.12.6.395; Lambert N, 2013, NAT PHYS, V9, P10, DOI [10.1038/nphys2474, 10.1038/NPHYS2474]; Leszczynski D, 2002, DIFFERENTIATION, V70, P120, DOI 10.1046/j.1432-0436.2002.700207.x; Maeda K, 2008, NATURE, V453, P387, DOI 10.1038/nature06834; Martino CF, 2010, BIOELECTROMAGNETICS, V31, P296, DOI 10.1002/bem.20565; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mates JM, 2008, ARCH TOXICOL, V82, P273, DOI 10.1007/s00204-008-0304-z; MCLAUCHLAN K, 1992, PHYS WORLD, V5, P41; Miller RL, 2007, BRAIN RES, V1167, P129, DOI 10.1016/j.brainres.2007.06.046; Minaev B. F., 2008, UKR BIOORG ACTA, V2, P56; Minaev BF, 2012, HDB COMPUTATIONAL CH, P1067; Niessner C, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0638; Okano H, 2008, FRONT BIOSCI-LANDMRK, V13, P6106, DOI 10.2741/3141; OKAZAKI M, 1987, J CHEM PHYS, V86, P6792, DOI 10.1063/1.452378; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Portelli LA, 2013, BIOELECTROMAGNETICS, V34, P337, DOI 10.1002/bem.21787; Prabhakar R, 2002, J PHYS CHEM B, V106, P3742, DOI 10.1021/jp014013q; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Schleicher E, 2010, APPL MAGN RESON, V37, P339, DOI 10.1007/s00723-009-0101-8; SCHULTEN K, 1978, J CHEM PHYS, V68, P3292, DOI 10.1063/1.436135; Solov'yov IA, 2009, BIOPHYS J, V96, P4804, DOI 10.1016/j.bpj.2009.03.048; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; Swanson MA, 2008, BIOCHEMISTRY-US, V47, P8894, DOI 10.1021/bi800507p; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P808, DOI 10.1001/jama.2011.186; Vorst A. V., 2006, RF MICROWAVE INTERAC; Wedge CJ, 2013, PHYS CHEM CHEM PHYS, V15, P16043, DOI 10.1039/c3cp52019f; Yakunin IN, 2010, RUSS J PHYS CHEM B+, V4, P210, DOI 10.1134/S1990793110020053; Yu YB, 2008, CELL RES, V18, P1233, DOI 10.1038/cr.2008.306	68	50	51	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93065	10.1371/journal.pone.0093065	http://dx.doi.org/10.1371/journal.pone.0093065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681944	Green Published, Green Submitted, gold			2022-12-25	WOS:000333678100023
J	Zhang, JB; An, M; Wu, HW; Liu, DL; Stanton, R				Zhang, Jinbiao; An, Min; Wu, Hanwen; Liu, De Li; Stanton, Rex			Phytotoxic Activity and Chemical Composition of Aqueous Volatile Fractions from Eucalyptus Species	PLOS ONE			English	Article							ESSENTIAL OIL; MONOTERPENES	The essential oils from four Eucalyptus species (E. spathulata, E. salubris, E. brockwayii and E. dundasii) have been previously confirmed to have stronger inhibitory effects on germination and seedling growth of silverleaf nightshade (Solanum elaeagnifolium Cav.). The aqueous volatile fractions (AVFs) were the water soluble volatile fractions produced together with the essential oils (water insoluble fractions) during the steam distillation process. The aim of this study was to further assess the phytotoxicity of AVFs from the four Eucalyptus species and their chemical composition. The fresh leaves of the four Eucalyptus species were used for the extraction of AVFs. The AVFs were tested for their phytotoxic effects on the perennial weed, silverleaf nightshade under laboratory conditions. The chemical compositions of the AVFs were determined by gas chromatograph-mass spectrometry (GC-MS). Our results showed that the AVFs had strong inhibition on the germination and seedling growth of silverleaf nightshade. The inhibition index increased with the increasing concentrations of AVFs. The inhibitory effects of the AVFs varied between different Eucalyptus species. The AVF from E. salubris demonstrated the highest inhibitory activity on the weed tested, with complete inhibition on germination and seedling growth at a concentration of 75%. The GC-MS analysis revealed that 1,8-cineole, isopentyl isovalerate, isomenthol, pinocarvone, trans-pinocarveol, alpha-terpineol and globulol were the main compounds in the AVFs. These results indicated that all AVFs tested had differential inhibition on the germination and seedling growth of silverleaf nightshade, which could be due to the joint effects of compounds present in the AVFs as these compounds were present in different quantities and ratio between Eucalyptus species.	[Zhang, Jinbiao] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China; [Zhang, Jinbiao] Fujian Agr & Forestry Univ, Sch Life Sci, Fuzhou, Peoples R China; [An, Min] Charles Sturt Univ, Fac Sci, Environm & Analyt Labs, Wagga Wagga, NSW, Australia; [Wu, Hanwen; Liu, De Li; Stanton, Rex] Wagga Wagga Agr Inst, EH Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Charles Sturt University	Zhang, JB (corresponding author), Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China.	jbzhangfj@yahoo.com	Wu, Hanwen/B-7901-2010; , De Li Liu/Y-4656-2019	Wu, Hanwen/0000-0001-5157-4977; Liu, De Li/0000-0003-2574-1908	Meat and Livestock of Australia	Meat and Livestock of Australia	This work was supported by Meat and Livestock of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 1995, IDENTIFICATION ESSEN; An Min, 2005, Nonlinearity in Biology Toxicology and Medicine, V3, P245, DOI 10.2201/nonlin.003.02.006; Anonymous, 2007, Bulletin OEPP, V37, P236, DOI 10.1111/j.1365-2338.2007.01112.x; AWC (Australian Weeds Committee), 2012, WEEDS NAT SIGN; Babu RC, 1997, J AGRON CROP SCI, V179, P123, DOI 10.1111/j.1439-037X.1997.tb00507.x; Batish DR, 2006, Z NATURFORSCH C, V61, P52; Baum SF, 1998, J PLANT GROWTH REGUL, V17, P107, DOI 10.1007/PL00007015; Cuevas-Glory LF, 2007, FOOD CHEM, V103, P1032, DOI 10.1016/j.foodchem.2006.07.068; DELMORAL R, 1978, AUST J BOT, V26, P203; Deng CH, 2004, J CHROMATOGR A, V1059, P149, DOI 10.1016/j.chroma.2004.10.005; Kaur S, 2011, J PLANT INTERACT, V6, P297, DOI 10.1080/17429145.2010.539709; Khan M. A., 2008, Pakistan Journal of Weed Science Research, V14, P201; Li XF, 2011, PLANT SOIL, V341, P383, DOI 10.1007/s11104-010-0652-3; Liu DL, 2007, ALLELOPATHY J, V19, P203; Martins C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061233; Romagni JG, 2000, J CHEM ECOL, V26, P303, DOI 10.1023/A:1005414216848; Setia N, 2007, J ENVIRON BIOL, V28, P63; Singh HP, 2005, ANN APPL BIOL, V146, P89, DOI 10.1111/j.1744-7348.2005.04018.x; Singh HP, 2002, CROP PROT, V21, P347, DOI 10.1016/S0261-2194(01)00096-5; Stanton R, 2008, P 16 AUSTR WEEDS C C, P330; Stanton R, 2012, WEED SCI, V60, P42, DOI 10.1614/WS-D-11-00105.1; USDA-NRCS, 2005, PLANTS DAT VERS 35; Van Vuuren SF, 2007, FLAVOUR FRAG J, V22, P540, DOI 10.1002/ffj.1843; VAUGHN SF, 1993, WEED SCI, V41, P114, DOI 10.1017/S0043174500057672; Wu H, 1999, WEED RES, V39, P171, DOI 10.1046/j.1365-3180.1999.00136.x; Wu HW, 2011, ALLELOPATHY J, V28, P87; Zhang JB, 2012, PLANT GROWTH REGUL, V68, P231, DOI 10.1007/s10725-012-9711-5; Zhang JB, 2010, ALLELOPATHY J, V25, P313	28	30	31	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93189	10.1371/journal.pone.0093189	http://dx.doi.org/10.1371/journal.pone.0093189			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681490	gold, Green Published, Green Submitted			2022-12-25	WOS:000333678100031
J	Bergamini, A; Chimenti, MS; Baffari, E; Guarino, MD; Gigliucci, G; Perricone, C; Perricone, R				Bergamini, Alberto; Chimenti, Maria Sole; Baffari, Eleonora; Guarino, Maria Domenica; Gigliucci, Gianfranco; Perricone, Carlo; Perricone, Roberto			Downregulation of Immunoglobulin-Like Transcript-4 (ILT4) in Patients with Psoriatic Arthritis	PLOS ONE			English	Article							INHIBITORY RECEPTOR ILT4; DENDRITIC CELLS; T-CELLS; ENDOTHELIAL-CELLS; DIFFERENTIAL EXPRESSION; RHEUMATOID-ARTHRITIS; PERIPHERAL-BLOOD; SYNOVIAL-FLUID; UP-REGULATION; KAPPA-B	Objective: The immunoglobulin-like transcript-4 (ILT4) is an inhibitory receptor that modulates the activity of innate immune agents. We determined the expression of ILT4 and analysed the relationship with the expression of costimulatory proteins and tumor necrosis factor-alpha (TNF-alpha) production in monocytes from patients with psoriatic arthritis (PsA) starting anti-TNF treatment. Methods: Peripheral blood monocytes from 15 healthy controls and from 16 patients with PsA were activated in vitro by CD40 ligand (CD40L) and analyzed for ILT4, CD40, CD80 and CD86 expression, and spontaneous lipopolysaccharide (LPS)-induced TNF-alpha production by flow cytometry, before and after treatment with adalimumab. Results: The percentage of ILT4-negative monocytes was greater in PsA patients compared to controls and negatively correlated with DAS44. Normal monocytes treated with sera of PsA patients showed a reduced expression of ILT4 compared with monocytes exposed to sera from controls. CD40, CD80 and CD86 expression was higher in patients compared to controls. Both spontaneous and LPS-induced TNF-alpha production was restricted to ILT4-negative monocytes and was greater in PsA patients compared to controls. Finally, twelve weeks-treatment with adalimumab resulted in a significant increase of ILT4 expression and a decrease of costimulatory molecules expression in PsA patients, compared to pre-therapy levels. Conclusions: These data support the possibility that changes in the immunophenotype of monocytes play a role in the pathogenesis of PSA. Thus, modulation of the expression of ILT4 may represent an enticing new therapeutic target.	[Bergamini, Alberto; Chimenti, Maria Sole; Baffari, Eleonora; Guarino, Maria Domenica; Gigliucci, Gianfranco; Perricone, Roberto] Univ Roma Tor Vergata, Dept Internal Med, Rheumatol Unit, Rome, Italy; [Perricone, Carlo] Sapienza Univ Roma, Dipartimento Med Interna & Specialita Med, Rome, Italy	University of Rome Tor Vergata; Sapienza University Rome	Perricone, C (corresponding author), Sapienza Univ Roma, Dipartimento Med Interna & Specialita Med, Rome, Italy.	carlo.perricone@gmail.com	Chimenti, Maria Sole/ABG-3165-2020	Chimenti, Maria Sole/0000-0002-1343-1729; Perricone, Carlo/0000-0003-4771-6981; Perricone, Roberto/0000-0002-2368-9766				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ALDERSON MR, 1993, J EXP MED, V178, P669, DOI 10.1084/jem.178.2.669; Allen RL, 2004, CURR MOL MED, V4, P59, DOI 10.2174/1566524043479329; Baffari E, 2013, HUM IMMUNOL, V74, P1244, DOI 10.1016/j.humimm.2013.07.012; Borghi A, 2008, ARCH DERMATOL RES, V300, P551, DOI 10.1007/s00403-008-0886-6; Brossart P, 1998, BLOOD, V92, P4238, DOI 10.1182/blood.V92.11.4238.423k16_4238_4247; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chang CC, 2009, J IMMUNOL, V182, P5208, DOI 10.4049/jimmunol.0804048; Chimenti MS, 2013, AUTOIMMUN REV, V12, P599, DOI 10.1016/j.autrev.2012.10.002; Christophers E, 2001, CLIN EXP DERMATOL, V26, P314, DOI 10.1046/j.1365-2230.2001.00832.x; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Contini C, 2011, RHEUMATOL INT, V31, P1307, DOI 10.1007/s00296-010-1460-z; Cortesini NSF, 2004, TRANSPL IMMUNOL, V13, P73, DOI 10.1016/j.trim.2004.06.001; Curran SA, 2004, J IMMUNOL, V172, P1935, DOI 10.4049/jimmunol.172.3.1935; Danning CL, 2000, ARTHRITIS RHEUM-US, V43, P1244, DOI 10.1002/1529-0131(200006)43:6<1244::AID-ANR7>3.0.CO;2-2; Daoussis D, 2007, RHEUMATOLOGY, V46, P227, DOI 10.1093/rheumatology/kel229; Dietrich J, 2001, J IMMUNOL, V166, P2514, DOI 10.4049/jimmunol.166.4.2514; Dulphy N, 2002, INT IMMUNOL, V14, P471, DOI 10.1093/intimm/14.5.471; GRAF D, 1992, EUR J IMMUNOL, V22, P3191, DOI 10.1002/eji.1830221226; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; HELLIWELL P, 1991, BRIT J RHEUMATOL, V30, P339; Huynh OA, 2007, RHEUMATOLOGY, V46, P742, DOI 10.1093/rheumatology/kel405; Iannone F, 2012, J RHEUMATOL, V39, P100, DOI 10.3899/jrheum.120257; KIENER PA, 1995, J IMMUNOL, V155, P4917; Kollnberger S, 2002, ARTHRITIS RHEUM, V46, P2972, DOI 10.1002/art.10605; Konig A, 1997, RHEUMATOL INT, V17, P159, DOI 10.1007/s002960050028; Lehtonen A, 2005, J IMMUNOL, V175, P6570, DOI 10.4049/jimmunol.175.10.6570; Merlo A, 2001, INFECT IMMUN, V69, P6022, DOI 10.1128/IAI.69.10.6022-6029.2001; Moen K, 2006, CLIN EXP RHEUMATOL, V24, P656; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; Murakami K, 1999, J IMMUNOL, V163, P2667; Nakajima H, 2003, J IMMUNOL, V171, P6611, DOI 10.4049/jimmunol.171.12.6611; Neumann M, 2000, BLOOD, V95, P277; O'Sullivan B, 2003, CRIT REV IMMUNOL, V23, P83, DOI 10.1615/CritRevImmunol.v23.i12.50; PICKER LJ, 1995, BLOOD, V86, P1408, DOI 10.1182/blood.V86.4.1408.bloodjournal8641408; Placido R, 1997, J PATHOL, V181, P31, DOI 10.1002/(SICI)1096-9896(199701)181:1<31::AID-PATH722>3.0.CO;2-G; Prigione I, 2011, RHEUMATOLOGY, V50, P966, DOI 10.1093/rheumatology/keq418; Ristich V, 2005, EUR J IMMUNOL, V35, P1133, DOI 10.1002/eji.200425741; Ritchlin C, 1998, J RHEUMATOL, V25, P1544; Ritchlin CT, 2009, ANN RHEUM DIS, V68, P1387, DOI 10.1136/ard.2008.094946; Rojas D, 2010, IMMUNOL LETT, V132, P31, DOI 10.1016/j.imlet.2010.05.003; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; Seitz Michael, 1999, Current Opinion in Rheumatology, V11, P226, DOI 10.1097/00002281-199905000-00012; Stuber E, 1996, J EXP MED, V183, P693, DOI 10.1084/jem.183.2.693; Svajger U, 2010, IMMUNOLOGY, V129, P525, DOI 10.1111/j.1365-2567.2009.03205.x; Tassiulas I, 1999, HUM IMMUNOL, V60, P479, DOI 10.1016/S0198-8859(99)00034-8; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; van Kuijk AWR, 2006, ANN RHEUM DIS, V65, P1551, DOI 10.1136/ard.2005.050963; VANDERHEIJDE DMFM, 1993, J RHEUMATOL, V20, P579; Vlad G, 2003, HUM IMMUNOL, V64, P483, DOI 10.1016/S0198-8859(03)00040-5; Wang QM, 1999, ARTHRITIS RHEUM, V42, P2055, DOI 10.1002/1529-0131(199910)42:10<2055::AID-ANR5>3.0.CO;2-A; Wijngaarden S, 2005, RHEUMATOLOGY, V44, P729, DOI 10.1093/rheumatology/keh583; YELLIN MJ, 1995, J EXP MED, V182, P1857, DOI 10.1084/jem.182.6.1857; Young NT, 2008, BLOOD, V111, P3090, DOI 10.1182/blood-2007-05-089771	55	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92018	10.1371/journal.pone.0092018	http://dx.doi.org/10.1371/journal.pone.0092018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676037	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677500018
J	Mei, LL; Xue, G; Lu, ZL; He, QH; Zhang, MX; Wei, M; Xue, F; Chen, CS; Dong, Q				Mei, Leilei; Xue, Gui; Lu, Zhong-Lin; He, Qinghua; Zhang, Mingxia; Wei, Miao; Xue, Feng; Chen, Chuansheng; Dong, Qi			Artificial Language Training Reveals the Neural Substrates Underlying Addressed and Assembled Phonologies	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; READING ALOUD; DUAL-ROUTE; KANA WORDS; FUNCTIONAL-ANATOMY; CEREBRAL-CORTEX; BRAIN; FMRI; PSEUDOWORDS; METAANALYSIS	Although behavioral and neuropsychological studies have suggested two distinct routes of phonological access, their neural substrates have not been clearly elucidated. Here, we designed an artificial language (based on Korean Hangul) that can be read either through addressed (i.e., whole word mapping) or assembled (i.e., grapheme-to-phoneme mapping) phonology. Two matched groups of native English-speaking participants were trained in one of the two conditions, one hour per day for eight days. Behavioral results showed that both groups correctly named more than 90% of the trained words after training. At the neural level, we found a clear dissociation of the neural pathways for addressed and assembled phonologies: There was greater involvement of the anterior cingulate cortex, posterior cingulate cortex, right orbital frontal cortex, angular gyrus and middle temporal gyrus for addressed phonology, but stronger activation in the left precentral gyrus/inferior frontal gyrus and supramarginal gyrus for assembled phonology. Furthermore, we found evidence supporting the strategy-shift hypothesis, which postulates that, with practice, reading strategy shifts from assembled to addressed phonology. Specifically, compared to untrained words, trained words in the assembled phonology group showed stronger activation in the addressed phonology network and less activation in the assembled phonology network. Our results provide clear brain-imaging evidence for the dual-route models of reading.	[Mei, Leilei] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Mei, Leilei] Univ Calif Irvine, Sch Psychol, Irvine, CA USA; [Mei, Leilei; Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA 92697 USA; [Zhang, Mingxia; Dong, Qi] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Mingxia; Dong, Qi] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Lu, Zhong-Lin] Ohio State Univ, Ctr Cognit & Behav Brain Imaging, Columbus, OH 43210 USA; [Lu, Zhong-Lin] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [He, Qinghua; Wei, Miao; Xue, Feng] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA	South China Normal University; University of California System; University of California Irvine; University of California System; University of California Irvine; Beijing Normal University; Beijing Normal University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Southern California	Chen, CS (corresponding author), Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA 92697 USA.	cschen@uci.edu; dongqi@bnu.edu.cn	Xue, Feng/B-2304-2010; Xue, Gui/A-1762-2009; He, Qinghua/B-2573-2008	Xue, Feng/0000-0001-8286-3552; Xue, Gui/0000-0001-7891-8151; He, Qinghua/0000-0001-6396-6273; Chen, Chuansheng/0000-0002-8224-1005; Lu, Zhong-Lin/0000-0002-7295-727X; zhang, ming xia/0000-0003-1512-2513	National Natural Science Foundation of China [31130025, 31221003]; National Science Foundation [BCS 0823624, BCS 0823495]; National Institute of Health [HD057884-01A2]; 111 Project [B0700]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057884] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 111 Project(Ministry of Education, China - 111 Project); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Natural Science Foundation of China (31130025, 31221003), National Science Foundation (grant numbers BCS 0823624 and BCS 0823495), the National Institute of Health (grant number HD057884-01A2), and the 111 Project (B0700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, WOODCOCK READING MAS; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Binder JR, 2005, NEUROIMAGE, V27, P677, DOI 10.1016/j.neuroimage.2005.04.029; Bolger DJ, 2005, HUM BRAIN MAPP, V25, P92, DOI 10.1002/hbm.20124; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; Burton H, 2003, J NEUROPHYSIOL, V90, P1965, DOI 10.1152/jn.00279.2003; Carreiras M, 2007, J COGNITIVE NEUROSCI, V19, P433, DOI 10.1162/jocn.2007.19.3.433; Cattinelli I, 2013, J NEUROLINGUIST, V26, P214, DOI 10.1016/j.jneuroling.2012.08.001; Chen CS, 2007, NEUROPSYCHOLOGIA, V45, P741, DOI 10.1016/j.neuropsychologia.2006.08.018; Chen CS, 2009, PROG BRAIN RES, V178, P159, DOI 10.1016/S0079-6123(09)17811-1; Chen YP, 2002, J COGNITIVE NEUROSCI, V14, P1088, DOI 10.1162/089892902320474535; Church JA, 2008, CEREB CORTEX, V18, P2054, DOI 10.1093/cercor/bhm228; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037/0033-295X.100.4.589; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Fiebach CJ, 2002, J COGNITIVE NEUROSCI, V14, P11, DOI 10.1162/089892902317205285; Fiez JA, 1999, NEURON, V24, P205, DOI 10.1016/S0896-6273(00)80833-8; Fu SM, 2002, NEUROIMAGE, V17, P1538, DOI 10.1006/nimg.2002.1155; Graves WW, 2010, CEREB CORTEX, V20, P1799, DOI 10.1093/cercor/bhp245; Hagoort P, 1999, J COGNITIVE NEUROSCI, V11, P383, DOI 10.1162/089892999563490; Hartwigsen G, 2010, P NATL ACAD SCI USA, V107, P16494, DOI 10.1073/pnas.1008121107; Heim S, 2005, COGNITIVE BRAIN RES, V25, P982, DOI 10.1016/j.cogbrainres.2005.09.022; Herbster AN, 1997, HUM BRAIN MAPP, V5, P84, DOI 10.1002/(SICI)1097-0193(1997)5:2<84::AID-HBM2>3.0.CO;2-I; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Joubert S, 2004, BRAIN LANG, V89, P9, DOI 10.1016/S0093-934X(03)00403-6; Lee H, 2007, J NEUROSCI, V27, P1184, DOI 10.1523/JNEUROSCI.4442-06.2007; Levy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006675; Maloney E, 2009, Q J EXP PSYCHOL, V62, P858, DOI 10.1080/17470210802578385; MARSHALL JC, 1973, J PSYCHOLINGUIST RES, V2, P175, DOI 10.1007/BF01067101; McDermott KB, 2003, NEUROPSYCHOLOGIA, V41, P293, DOI 10.1016/S0028-3932(02)00162-8; Mechelli A, 2005, J COGNITIVE NEUROSCI, V17, P1753, DOI 10.1162/089892905774589190; Mechelli A, 2003, J COGNITIVE NEUROSCI, V15, P260, DOI 10.1162/089892903321208196; Mumford J., 2007, GUIDE CALCULAT UNPUB; Nakamura K, 2005, J COGNITIVE NEUROSCI, V17, P954, DOI 10.1162/0898929054021166; Nosarti C, 2010, CEREB CORTEX, V20, P315, DOI 10.1093/cercor/bhp101; PAAP KR, 1991, PSYCHOL RES-PSYCH FO, V53, P13, DOI 10.1007/BF00867328; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; Perry C, 2007, NESTED INCREMENTAL M; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Price CJ, 1998, TRENDS COGN SCI, V2, P281, DOI 10.1016/S1364-6613(98)01201-7; Pugh KR, 2001, J COMMUN DISORD, V34, P479, DOI 10.1016/S0021-9924(01)00060-0; Rastle K, 2002, Q J EXP PSYCHOL-A, V55, P1339, DOI 10.1080/02724980244000099; Raven J.C, 1990, ADV PROGR MATRICES S; Richlan F, 2009, HUM BRAIN MAPP, V30, P3299, DOI 10.1002/hbm.20752; Sakurai Y, 2000, COGNITIVE BRAIN RES, V9, P111, DOI 10.1016/S0926-6410(99)00052-X; Seghier ML, 2010, J NEUROSCI, V30, P16809, DOI 10.1523/JNEUROSCI.3377-10.2010; SEIDENBERG MS, 1984, J VERB LEARN VERB BE, V23, P383, DOI 10.1016/S0022-5371(84)90270-6; SHALLICE T, 1975, Q J EXP PSYCHOL, V27, P187, DOI 10.1080/14640747508400479; Simos PG, 2002, CEREB CORTEX, V12, P297, DOI 10.1093/cercor/12.3.297; SNYDER PJ, 1993, CORTEX, V29, P115, DOI 10.1016/S0010-9452(13)80216-X; Tagamets MA, 2000, J COGNITIVE NEUROSCI, V12, P281, DOI 10.1162/089892900562101; Tan LH, 2005, HUM BRAIN MAPP, V25, P83, DOI 10.1002/hbm.20134; TARABAN R, 1987, J MEM LANG, V26, P608, DOI 10.1016/0749-596X(87)90105-7; Thuy DHD, 2004, NEUROIMAGE, V23, P878, DOI 10.1016/j.neuroimage.2004.07.059; Tohka J, 2008, NEUROIMAGE, V39, P1227, DOI 10.1016/j.neuroimage.2007.10.013; Torgesen J.K., 1999, TOWRE TEST WORD READ; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2002, CURR OPIN NEUROBIOL, V12, P574, DOI 10.1016/S0959-4388(02)00361-6; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Xu B, 2001, CEREB CORTEX, V11, P267, DOI 10.1093/cercor/11.3.267; Xue G, 2006, NEUROIMAGE, V31, P1315, DOI 10.1016/j.neuroimage.2005.11.055; Zorzi M, 1998, J EXP PSYCHOL HUMAN, V24, P1131, DOI 10.1037/0096-1523.24.4.1131	69	22	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93548	10.1371/journal.pone.0093548	http://dx.doi.org/10.1371/journal.pone.0093548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SW	24676060	Green Published, gold			2022-12-25	WOS:000333677500138
J	Plischke, M; Kohl, M; Bankir, L; Shayganfar, S; Handisurya, A; Heinze, G; Haas, M				Plischke, Max; Kohl, Maria; Bankir, Lise; Shayganfar, Sascha; Handisurya, Ammon; Heinze, Georg; Haas, Martin			Urine Osmolarity and Risk of Dialysis Initiation in a Chronic Kidney Disease Cohort - a Possible Titration Target?	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; WATER-INTAKE; RECEPTOR ANTAGONISM; ANTIDIURETIC ACTION; COMPETING RISK; VASOPRESSIN; RATS; PROGRESSION; VOLUME; PROTEIN	Background: Increasing evidence is linking fluid intake, vasopressin suppression and osmotic control with chronic kidney disease progression. Interestingly, the association between urine volume, urine osmolarity and risk of dialysis initiation has not been studied in chronic kidney disease patients before. Objective: To study the relationship between urine volume, urine osmolarity and the risk of initiating dialysis in chronic kidney disease. Design: In a retrospective cohort analysis of 273 patients with chronic kidney disease stage 1-4 we assessed the association between urine volume, urine osmolarity and the risk of dialysis by a multivariate proportional sub-distribution hazards model for competing risk data according to Fine and Gray. Co-variables were selected via the purposeful selection algorithm. Results: Dialysis was reached in 105 patients over a median follow-up period of 92 months. After adjustment for age, baseline creatinine clearance, other risk factors and diuretics, a higher risk for initiation of dialysis was found in patients with higher urine osmolarity. The adjusted sub-distribution hazard ratio for initiation of dialysis was 2.04 ( 95% confidence interval, 1.06 to 3.92) for each doubling of urine osmolarity. After 72 months, the estimated adjusted cumulative incidence probabilities of dialysis were 15%, 24%, and 34% in patients with a baseline urine osmolarity of 315, 510, and 775 mosm/ L, respectively. Conclusions: We conclude that higher urine osmolarity is associated with a higher risk of initiating dialysis. As urine osmolarity is a potentially modifiable risk factor, it thus deserves further, prospective research as a potential target in chronic kidney disease progression.	[Plischke, Max; Handisurya, Ammon; Haas, Martin] Med Univ Vienna, Dept Internal Med 3, Div Nephrol & Dialysis, Vienna, Austria; [Kohl, Maria; Heinze, Georg] Med Univ Vienna, Sect Clin Biometr, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Bankir, Lise] Ctr Rech Cordeliers, INSERM UMRS 1138, Equipe 2, Paris, France; [Shayganfar, Sascha] Univ Hosp Dusseldorf, Fac Med, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany	Medical University of Vienna; Medical University of Vienna; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Haas, M (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Nephrol & Dialysis, Vienna, Austria.	martin.haas@meduniwien.ac.at	BANKIR, Lise/AAK-2733-2020	BANKIR, Lise/0000-0002-3321-0819; Heinze, Georg/0000-0003-1147-8491; Plischke, Max/0000-0002-7410-2611	European Community [241544]	European Community(European Commission)	Maria Kohl (statistician) was supported by the European Community's Seventh Framework Programme, grant number 241544. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Maria Kohl was involved in study design, analysis, and preparation of the manuscript. Mortality data, obtained via Statistics Austria, was payed for using the authors' departments (Department of Internal Med. III, Division of Nephrology and Dialysis, Medical University Vienna) research budget, which is not tied to any external funding institution. As this was a retrospective study, other expenses (laboratory, etc) were fully covered by routine patient care at the authors' outpatient department.	Anastasio P, 2001, KIDNEY INT, V60, P748, DOI 10.1046/j.1523-1755.2001.060002748.x; Bankir L, 2001, CARDIOVASC RES, V51, P372, DOI 10.1016/S0008-6363(01)00328-5; BANKIR L, 1991, AM J KIDNEY DIS, V17, P661, DOI 10.1016/S0272-6386(12)80346-5; Bankir L, 2013, NAT REV NEPHROL, V9, P223, DOI 10.1038/nrneph.2013.22; Bardoux P, 2003, NEPHROL DIAL TRANSPL, V18, P1755, DOI 10.1093/ndt/gfg277; Bouby N, 1996, J AM SOC NEPHROL, V7, P842; Bouby N, 2003, EUR J CLIN NUTR, V57, pS39, DOI 10.1038/sj.ejcn.1601900; BOUBY N, 1990, AM J PHYSIOL, V258, pF973, DOI 10.1152/ajprenal.1990.258.4.F973; Clark WF, 2011, CLIN J AM SOC NEPHRO, V6, P2634, DOI 10.2215/CJN.01990211; FEINFELD DA, 1987, AM J KIDNEY DIS, V10, P231, DOI 10.1016/S0272-6386(87)80179-8; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GELLAI M, 1984, AM J PHYSIOL, V246, pF819, DOI 10.1152/ajprenal.1984.246.6.F819; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hebert LA, 2003, AM J KIDNEY DIS, V41, P962, DOI 10.1016/S0272-6386(03)00193-8; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; LUFT FC, 1983, J LAB CLIN MED, V101, P605; Meijer E, 2010, KIDNEY INT, V77, P29, DOI 10.1038/ki.2009.397; Meijer E, 2009, TRANSPLANTATION, V88, P561, DOI 10.1097/TP.0b013e3181b11ae4; Nagao S, 2006, J AM SOC NEPHROL, V17, P2220, DOI 10.1681/ASN.2006030251; Perico N, 2009, KIDNEY INT, V76, P960, DOI 10.1038/ki.2009.267; Perucca J, 2007, AM J PHYSIOL-REG I, V292, pR700, DOI 10.1152/ajpregu.00500.2006; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Strippoli GFM, 2011, NEPHROLOGY, V16, P326, DOI 10.1111/j.1440-1797.2010.01415.x; Sugiura T, 1999, KIDNEY INT, V55, P1800, DOI 10.1046/j.1523-1755.1999.00443.x; Thomas MC, 2011, DIABETES CARE, V34, P861, DOI 10.2337/dc10-1722; Torres VE, 2011, CLIN J AM SOC NEPHRO, V6, P640, DOI 10.2215/CJN.03250410; Wang CJ, 2013, KIDNEY INT, V84, P45, DOI 10.1038/ki.2013.23; Wang CJ, 2011, CLIN J AM SOC NEPHRO, V6, P192, DOI 10.2215/CJN.03950510; Wang XL, 2006, J AM SOC NEPHROL, V17, P2900, DOI 10.1681/ASN.2005101106	29	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93226	10.1371/journal.pone.0093226	http://dx.doi.org/10.1371/journal.pone.0093226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675963	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500094
J	Yamashita, H; Kotani, T; Park, JH; Murata, Y; Okazawa, H; Ohnishi, H; Ku, Y; Matozaki, T				Yamashita, Hironori; Kotani, Takenori; Park, Jung-ha; Murata, Yoji; Okazawa, Hideki; Ohnishi, Hiroshi; Ku, Yonson; Matozaki, Takashi			Role of the Protein Tyrosine Phosphatase Shp2 in Homeostasis of the Intestinal Epithelium	PLOS ONE			English	Article							STEM-CELLS; EXPRESSION; DIFFERENTIATION; ALPHA; CRYPT; RAS; PROLIFERATION; INFLAMMATION; PROGRESSION; DEFENSINS	Protein tyrosine phosphorylation is thought to be important for regulation of the proliferation, differentiation, and rapid turnover of intestinal epithelial cells (IECs). The role of protein tyrosine phosphatases in such homeostatic regulation of IECs has remained largely unknown, however. Src homology 2-containing protein tyrosine phosphatase (Shp2) is a ubiquitously expressed cytoplasmic protein tyrosine phosphatase that functions as a positive regulator of the Ras-mitogen-activated protein kinase (MAPK) signaling pathway operative downstream of the receptors for various growth factors and cytokines, and it is thereby thought to contribute to the regulation of cell proliferation and differentiation. We now show that mice lacking Shp2 specifically in IECs (Shp2 CKO mice) develop severe colitis and die as early as 3 to 4 weeks after birth. The number of goblet cells in both the small intestine and colon of Shp2 CKO mice was markedly reduced compared with that for control mice. Furthermore, Shp2 CKO mice showed marked impairment of both IEC migration along the crypt-villus axis in the small intestine and the development of intestinal organoids from isolated crypts. The colitis as well as the reduction in the number of goblet cells apparent in Shp2 CKO mice were normalized by expression of an activated form of K-Ras in IECs. Our results thus suggest that Shp2 regulates IEC homeostasis through activation of Ras and thereby protects against the development of colitis.	[Yamashita, Hironori; Kotani, Takenori; Park, Jung-ha; Murata, Yoji; Okazawa, Hideki; Matozaki, Takashi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling, Kobe, Hyogo 657, Japan; [Yamashita, Hironori; Ku, Yonson] Kobe Univ, Grad Sch Med, Dept Surg, Div Hepato Biliary Pancreat Surg, Kobe, Hyogo 657, Japan; [Ohnishi, Hiroshi] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci, Maebashi, Gunma, Japan; [Matozaki, Takashi] Gunma Univ, Inst Mol & Cellular Regulat, Lab Biosignal Sci, Maebashi, Gunma, Japan	Kobe University; Kobe University; Gunma University; Gunma University	Kotani, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling, Kobe, Hyogo 657, Japan.	kotani@med.kobe-u.ac.jp; matozaki@med.kobe-u.ac.jp		Kotani, Takenori/0000-0001-8571-4210; Murata, Yoji/0000-0002-9576-7030	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23370061, 25114709]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (B) (23370061) and a Grant-in-Aid for Scientific Research on Innovative Area (25114709) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N., 2010, CURR PROTOC STEM CEL; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Coulombe G, 2013, MOL CELL BIOL, V33, P2275, DOI 10.1128/MCB.00043-13; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; Feng Y, 2011, GASTROENTEROLOGY, V141, P1003, DOI 10.1053/j.gastro.2011.05.007; Fornaro M, 2006, J CELL BIOL, V175, P87, DOI 10.1083/jcb.200602029; Grossmann KS, 2009, P NATL ACAD SCI USA, V106, P16704, DOI 10.1073/pnas.0904336106; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; HALL PA, 1994, J CELL SCI, V107, P3569; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kanazawa Y, 2010, GENES CELLS, V15, P1189, DOI 10.1111/j.1365-2443.2010.01453.x; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Matozaki T, 2009, CANCER SCI, V100, P1786, DOI 10.1111/j.1349-7006.2009.01257.x; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Murata Y, 2010, GENES CELLS, V15, P513, DOI 10.1111/j.1365-2443.2010.01398.x; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; Noguchi T, 2001, J BIOL CHEM, V276, P15216, DOI 10.1074/jbc.M007208200; Ouellette AJ, 2005, SPRINGER SEMIN IMMUN, V27, P133, DOI 10.1007/s00281-005-0202-x; Sadakata H, 2009, GENES CELLS, V14, P295, DOI 10.1111/j.1365-2443.2008.01270.x; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Schoenwaelder SM, 2000, CURR BIOL, V10, P1523, DOI 10.1016/S0960-9822(00)00831-9; Shi JS, 2007, INFLAMM BOWEL DIS, V13, P1284, DOI 10.1002/ibd.20197; Siegmund B, 2004, J LEUKOCYTE BIOL, V76, P782, DOI 10.1189/jlb.0404239; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takahashi A, 2011, MOL CELL, V43, P45, DOI 10.1016/j.molcel.2011.05.014; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581	37	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92904	10.1371/journal.pone.0092904	http://dx.doi.org/10.1371/journal.pone.0092904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675817	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677500053
J	Zhang, Q; Liu, L; Zhu, F; Ning, ZH; Hincke, MT; Yang, N; Hou, ZC				Zhang, Quan; Liu, Long; Zhu, Feng; Ning, ZhongHua; Hincke, Maxwell T.; Yang, Ning; Hou, ZhuoCheng			Integrating De Novo Transcriptome Assembly and Cloning to Obtain Chicken Ovocleidin-17 Full-Length cDNA	PLOS ONE			English	Article							LECTIN-LIKE PROTEINS; EGG-WHITE PROTEOME; MATRIX PROTEINS; RNA-SEQ; EGGSHELL MATRIX; SEQUENCE; BIOMINERALIZATION; MINERALIZATION; ALIGNMENT	Efficiently obtaining full-length cDNA for a target gene is the key step for functional studies and probing genetic variations. However, almost all sequenced domestic animal genomes are not 'finished'. Many functionally important genes are located in these gapped regions. It can be difficult to obtain full-length cDNA for which only partial amino acid/EST sequences exist. In this study we report a general pipeline to obtain full-length cDNA, and illustrate this approach for one important gene (Ovocleidin-17, OC-17) that is associated with chicken eggshell biomineralization. Chicken OC-17 is one of the best candidates to control and regulate the deposition of calcium carbonate in the calcified eggshell layer. OC-17 protein has been purified, sequenced, and has had its three-dimensional structure solved. However, researchers still cannot conduct OC-17 mRNA related studies because the mRNA sequence is unknown and the gene is absent from the current chicken genome. We used RNA-Seq to obtain the entire transcriptome of the adult hen uterus, and then conducted de novo transcriptome assembling with bioinformatics analysis to obtain candidate OC-17 transcripts. Based on this sequence, we used RACE and PCR cloning methods to successfully obtain the full-length OC-17 cDNA. Temporal and spatial OC-17 mRNA expression analyses were also performed to demonstrate that OC-17 is predominantly expressed in the adult hen uterus during the laying cycle and barely at immature developmental stages. Differential uterine expression of OC-17 was observed in hens laying eggs with weak versus strong eggshell, confirming its important role in the regulation of eggshell mineralization and providing a new tool for genetic selection for eggshell quality parameters. This study is the first one to report the full-length OC-17 cDNA sequence, and builds a foundation for OC-17 mRNA related studies. We provide a general method for biologists experiencing difficulty in obtaining candidate gene full-length cDNA sequences.	[Zhang, Quan; Liu, Long; Ning, ZhongHua; Yang, Ning; Hou, ZhuoCheng] China Agr Univ, Dept Anim Genet & Breeding, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China; [Zhang, Quan; Liu, Long; Ning, ZhongHua; Yang, Ning; Hou, ZhuoCheng] China Agr Univ, Dept Anim Genet & Breeding, MOA Key Lab Anim Genet & Breeding, Beijing 100094, Peoples R China; [Zhu, Feng] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Peoples R China; [Hincke, Maxwell T.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	China Agricultural University; China Agricultural University; Sichuan Agricultural University; University of Ottawa	Hou, ZC (corresponding author), China Agr Univ, Dept Anim Genet & Breeding, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China.	zchou@cau.edu.cn		Zhang, Quan/0000-0002-6123-9512; Yang, Ning/0000-0001-5772-3320	Chinese Agricultural Research System [CARS-41]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]; Fundamental Research Funds for the Central Universities [2011JS003]; National Scientific Supporting Projects of China [2011BAD28B03]; Natural Sciences and Engineering Research Council of Canada (NSERC) [210015]	Chinese Agricultural Research System; Program for Changjiang Scholar and Innovation Research Team in University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Scientific Supporting Projects of China; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by the Chinese Agricultural Research System (CARS-41), and the Program for Changjiang Scholar and Innovation Research Team in University (IRT1191) to NY, the Fundamental Research Funds for the Central Universities (2011JS003) and the National Scientific Supporting Projects of China (2011BAD28B03) to ZCH, Natural Sciences and Engineering Research Council of Canada (NSERC, 210015) to MTH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Colfen H, 2010, NAT MATER, V9, P960, DOI 10.1038/nmat2911; D'Ambrosio C, 2008, J PROTEOME RES, V7, P3461, DOI 10.1021/pr800193y; English AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047768; Freeman CL, 2012, PHYS CHEM CHEM PHYS, V14, P7287, DOI 10.1039/c2cp23987f; Garg R, 2013, METHODS MOL BIOL, V1069, P43, DOI 10.1007/978-1-62703-613-9_4; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hincke MT, 2012, FRONT BIOSCI-LANDMRK, V17, P1266, DOI 10.2741/3985; HINCKE MT, 1995, CALCIFIED TISSUE INT, V56, P578, DOI 10.1007/BF00298593; Hoeijmakers Wieteke A M, 2013, Methods Mol Biol, V923, P221; Hou Z, 2009, GENOMICS, V93, P33, DOI 10.1016/j.ygeno.2008.09.005; Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101; Lakshminarayanan R, 2002, P NATL ACAD SCI USA, V99, P5155, DOI 10.1073/pnas.072658899; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li CQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-552; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mann K, 2006, COMP BIOCHEM PHYS B, V143, P160, DOI 10.1016/j.cbpb.2005.11.003; Mann K, 2004, BBA-PROTEINS PROTEOM, V1696, P41, DOI 10.1016/j.bbapap.2003.09.006; Mann K, 2008, PROTEOMICS, V8, P2322, DOI 10.1002/pmic.200800032; Mann K, 2008, PROTEOMICS, V8, P178, DOI 10.1002/pmic.200700790; Mann K, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-7; MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286; Nys Y, 2004, CR PALEVOL, V3, P549, DOI 10.1016/j.crpv.2004.08.002; Panheleux M, 2000, POULTRY SCI, V79, P580, DOI 10.1093/ps/79.4.580; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Reyes-Grajeda JP, 2004, J BIOL CHEM, V279, P40876, DOI 10.1074/jbc.M406033200; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rose MLH, 2009, CELL MOL LIFE SCI, V66, P2707, DOI 10.1007/s00018-009-0046-y; Zhang Y, 2011, POULTRY SCI, V90, P2718, DOI 10.3382/ps.2011-01751	30	13	14	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93452	10.1371/journal.pone.0093452	http://dx.doi.org/10.1371/journal.pone.0093452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676480	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500125
J	Wang, HH; Xu, SY; Sun, LY; Pan, XD; Yang, SW; Wang, LY				Wang, Haihong; Xu, Shengyuan; Sun, Liyuan; Pan, Xiaodong; Yang, Shiwei; Wang, Luya			Functional Characterization of Two Low-Density Lipoprotein Receptor Gene Mutations in Two Chinese Patients with Familial Hypercholesterolemia	PLOS ONE			English	Article							DOMAIN; PREVALENCE; DIAGNOSIS; PROTEINS; DATABASE; BINDING; DISEASE; VARIANT; UPDATE	Background: Familial hypercholesterolemia (FH) is an autosomal dominant disease that primarily results from mutations in the low-density lipoprotein receptor (LDLR) gene. We investigated two unrelated Chinese FH patients using gene screening and functional analysis to reveal the pathogenicity and the mechanism by which these mutations cause FH. Methods: First, the LDLR gene was sequenced in these patients. Then, mutant receptors were transfected into human embryo kidney 293(HEK-293) cells, and a confocal laser-scanning microscope was used to observe the localization of mutant proteins. Further, the expression and the internalization activity were analyzed by flow cytometry. Finally, LDLR protein expression and stability was detected by western blot. Results: Two different LDLR class 2B mutations were detected in two patients. The C201F mutation is a known mutation. However, the G615V mutation is novel. Flow cytometry showed that the expression and internalization activity of the mutant LDLRs were reduced to 73.6% and 82.6% for G615V and 33.2% and 33.5% for C201F, respectively. Conclusions: This study identified two LDLR mutations in Chinese patients with FH and analyzed the relationship between the genotype and phenotype of these patients. We found that these mutant LDLRs were defective in transport, which led to a reduction in cholesterol clearance. These results increase our understanding of the mutational spectrum of FH in the Chinese population.	[Wang, Haihong; Xu, Shengyuan; Sun, Liyuan; Pan, Xiaodong; Yang, Shiwei; Wang, Luya] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Atherosclerosis, Beijing, Peoples R China	Capital Medical University	Wang, LY (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Atherosclerosis, Beijing, Peoples R China.	wangluya@126.com			National Natural Science Foundation of China [81170810, 81271923]; Beijing Natural Science Foundation [7112022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by grants from the National Natural Science Foundation of China (81170810, 81271923) and the Beijing Natural Science Foundation (7112022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin MA, 2004, AM J EPIDEMIOL, V160, P407, DOI 10.1093/aje/kwh236; Benn M, 2012, J CLIN ENDOCR METAB, V97, P3956, DOI 10.1210/jc.2012-1563; Beuret N, 2004, J BIOL CHEM, V279, P20242, DOI 10.1074/jbc.M310613200; Civeira F, 2008, AM J CARDIOL, V102, P1187, DOI 10.1016/j.amjcard.2008.06.056; ESSER V, 1988, J BIOL CHEM, V263, P13282; Fouchier SW, 2001, HUM GENET, V109, P602, DOI 10.1007/s00439-001-0628-8; Gent J, 2004, CELL MOL LIFE SCI, V61, P2461, DOI 10.1007/s00018-004-4090-3; Goldstein J.L, 2001, METABOLIC MOL BASES, V3, P2863; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Leigh SEA, 2008, ANN HUM GENET, V72, P485, DOI 10.1111/j.1469-1809.2008.00436.x; Leren TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016721; Lin J, 2008, CHINESE MED J-PEKING, V121, P776, DOI 10.1097/00029330-200805010-00002; Marais A David, 2004, Clin Biochem Rev, V25, P49; MOORJANI S, 1989, ARTERIOSCLEROSIS, V9, P211, DOI 10.1161/01.ATV.9.2.211; Naoumova RP, 2004, ATHEROSCLEROSIS, V174, P67, DOI 10.1016/j.atherosclerosis.2004.01.001; Nordestgaard BG, 2013, EUR HEART J; Palacios L, 2012, ATHEROSCLEROSIS, V221, P137, DOI 10.1016/j.atherosclerosis.2011.12.021; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Rudenko G, 2003, CURR OPIN STRUC BIOL, V13, P683, DOI 10.1016/j.sbi.2003.10.001; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Silva S, 2012, ATHEROSCLEROSIS, V225, P128, DOI 10.1016/j.atherosclerosis.2012.08.017; Sorensen S, 2006, J BIOL CHEM, V281, P468, DOI 10.1074/jbc.M507071200; Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836; Usifo E, 2012, ANN HUM GENET, V76, P387, DOI 10.1111/j.1469-1809.2012.00724.x; Wang L, 2009, NUTR METAB CARDIOVAS, V19, P391, DOI 10.1016/j.numecd.2008.07.011	29	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92703	10.1371/journal.pone.0092703	http://dx.doi.org/10.1371/journal.pone.0092703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671153	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000066
J	Joldybayeva, B; Prorok, P; Grin, IR; Zharkov, DO; Ishenko, AA; Tudek, B; Bissenbaev, AK; Saparbaev, M				Joldybayeva, Botagoz; Prorok, Paulina; Grin, Inga R.; Zharkov, Dmitry O.; Ishenko, Alexander A.; Tudek, Barbara; Bissenbaev, Amangeldy K.; Saparbaev, Murat			Cloning and Characterization of a Wheat Homologue of Apurinic/Apyrimidinic Endonuclease Ape1L	PLOS ONE			English	Article							ACTIVE DNA DEMETHYLATION; BASE EXCISION-REPAIR; STRUCTURAL CHEMISTRY; METAL SITES; DAMAGE; NUCLEOTIDE; PATHWAY; PURIFICATION; RECOGNITION; GLYCOSYLASE	Background: Apurinic/apyrimidinic (AP) endonucleases are key DNA repair enzymes involved in the base excision repair (BER) pathway. In BER, an AP endonuclease cleaves DNA at AP sites and 39-blocking moieties generated by DNA glycosylases and/or oxidative damage. A Triticum aestivum cDNA encoding for a putative homologue of ExoIII family AP endonucleases which includes E. coli Xth, human APE1 and Arabidopsis thaliana AtApe1L has been isolated and its protein product purified and characterized. Methodology/Principal Findings: We report that the putative wheat AP endonuclease, referred here as TaApe1L, contains AP endonuclease, 3'-repair phosphodiesterase, 3'-phosphatase and 3'-> 5' exonuclease activities. Surprisingly, in contrast to bacterial and human AP endonucleases, addition of Mg2+ and Ca2+ (5-10 mM) to the reaction mixture inhibited TaApe1L whereas the presence of Mn2+, Co2+ and Fe2+ cations (0.1-1.0 mM) strongly stimulated all its DNA repair activities. Optimization of the reaction conditions revealed that the wheat enzyme requires low divalent cation concentration (0.1 mM), mildly acidic pH (6-7), low ionic strength (20 mM KCl) and has a temperature optimum at around 20 degrees C. The steady-state kinetic parameters of enzymatic reactions indicate that TaApe1L removes 39-blocking sugar-phosphate and 3'-phosphate groups with good efficiency (k(cat)/K-M = 630 and 485 mu M-1.min(-1), respectively) but possesses a very weak AP endonuclease activity as compared to the human homologue, APE1. Conclusions/Significance: Taken together, these data establish the DNA substrate specificity of the wheat AP endonuclease and suggest its possible role in the repair of DNA damage generated by endogenous and environmental factors.	[Joldybayeva, Botagoz; Bissenbaev, Amangeldy K.] al Farabi Kazakh Natl Univ, Fac Biol, Dept Mol Biol & Genet, Alma Ata, Kazakhstan; [Prorok, Paulina; Grin, Inga R.; Ishenko, Alexander A.; Saparbaev, Murat] Univ Paris 11, Inst Gustave Roussy, CNRS UMR8200, Grp Reparat ADN, Villejuif, France; [Prorok, Paulina; Tudek, Barbara] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Grin, Inga R.; Zharkov, Dmitry O.] SB RAS Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Grin, Inga R.; Zharkov, Dmitry O.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Tudek, Barbara] Univ Warsaw, Inst Genet & Biotechnol, Warsaw, Poland	Al-Farabi Kazakh National University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; University of Warsaw	Bissenbaev, AK (corresponding author), al Farabi Kazakh Natl Univ, Fac Biol, Dept Mol Biol & Genet, Alma Ata, Kazakhstan.	Amangeldy.Bisenbaev@kaznu.kz; smurat@igr.fr	Ishchenko, Alexander/D-4133-2013; Grin, Inga/I-8188-2014; Saparbaev, Murat/AAC-5478-2020; Saparbaev, Murat K/N-3225-2015; Zharkov, Dmitry/K-2158-2012; Grin, Inga/U-8737-2019; Bissenbaev, Amangeldy/B-1767-2015	Ishchenko, Alexander/0000-0002-0488-8858; Grin, Inga/0000-0002-5685-1248; Saparbaev, Murat/0000-0002-4630-1074; Saparbaev, Murat K/0000-0002-4630-1074; Zharkov, Dmitry/0000-0001-5013-0194; Grin, Inga/0000-0002-5685-1248; Joldybayeva, Botagoz/0000-0003-1682-4947; Prorok, Paulina/0000-0002-1427-1528; Bissenbaev, Amangeldy/0000-0001-7837-8685	Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan [0145/GF, 0738GF]; Agence Nationale pour la Recherche [ANR-09-GENO-000]; Electricite de France Contract Radioprotection [RB 2013-23]; Centre National de la Recherche Scientifique [PICS N5479-Russie]; CNRS-INCA-MSHE Franco-Pologne [3037987]; Fondation de France [2012 00029161]; Polish-French collaborative grants [346/N-INCA/2008/0, 303 819540]; Russian Academy of Sciences [MKB 6.12]; Russian Foundation for Basic Research [12-04-33231-mol_a_ved]; International PhD Projects Programme of Foundation for Polish Science: "Studies of nucleic acids and proteins - from basic to applied research''; European Union - Regional Development Fund	Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Electricite de France Contract Radioprotection; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); CNRS-INCA-MSHE Franco-Pologne; Fondation de France(Fondation de France); Polish-French collaborative grants; Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); International PhD Projects Programme of Foundation for Polish Science: "Studies of nucleic acids and proteins - from basic to applied research''; European Union - Regional Development Fund	This work was supported by grants from Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan [grants No 0145/GF and No 0738GF] to A. K. B. and from Agence Nationale pour la Recherche [ANR Blanc 2010 Projet ANR-09-GENO-000 to M. S.] (http://www.agence-nationale-recherche.fr), Electricite de France (http://www.edf.fr) Contract Radioprotection [RB 2013-23 to M. S.]; Centre National de la Recherche Scientifique (http://www.cnrs.fr) [PICS N5479-Russie, and CNRS-INCA-MSHE Franco-Pologne #3037987 to M. S.] and by Fondation de France (http://www.fondationdefrance.org) [#2012 00029161 to A. A. I.] and by Polish-French collaborative grants No346/N-INCA/2008/0 and No303 819540 [to B. T.] and by Russian Academy of Sciences [MKB 6.12 to D.O.Z.]; Russian Foundation for Basic Research [12-04-33231-mol_a_ved to I. R. G.]; P. P. was supported by the fellowship from International PhD Projects Programme of Foundation for Polish Science: "Studies of nucleic acids and proteins - from basic to applied research''. The project is co-financed by European Union - Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreini C, 2013, NUCLEIC ACIDS RES, V41, pD312, DOI 10.1093/nar/gks1063; BABIYCHUK E, 1994, P NATL ACAD SCI USA, V91, P3299, DOI 10.1073/pnas.91.8.3299; Beernink PT, 2001, J MOL BIOL, V307, P1023, DOI 10.1006/jmbi.2001.4529; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bissenbaev AK, 2011, PLANT PHYSIOL BIOCH, V49, P1155, DOI 10.1016/j.plaphy.2011.07.017; BLAISDELL P, 1983, J BIOL CHEM, V258, P1603; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; Cordoba-Canero D, 2011, PLANT J, V68, P693, DOI 10.1111/j.1365-313X.2011.04720.x; Cordoba-Canero D, 2009, PLANT J, V60, P716, DOI 10.1111/j.1365-313X.2009.03994.x; Couve S, 2009, J BIOL CHEM, V284, P11963, DOI 10.1074/jbc.M900746200; CUNNINGHAM RP, 1986, J BACTERIOL, V168, P1120, DOI 10.1128/jb.168.3.1120-1127.1986; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEMPLE B, 1986, P NATL ACAD SCI USA, V83, P7731, DOI 10.1073/pnas.83.20.7731; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gelin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012241; Georgiadis MM, 2008, MUTAT RES-FUND MOL M, V643, P54, DOI 10.1016/j.mrfmmm.2008.04.008; Gorman MA, 1997, EMBO J, V16, P6548, DOI 10.1093/emboj/16.21.6548; Gros L, 2004, NUCLEIC ACIDS RES, V32, P73, DOI 10.1093/nar/gkh165; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Hsin K, 2008, J APPL CRYSTALLOGR, V41, P963, DOI 10.1107/S002188980802476X; Martinez-Macias MI, 2012, MOL CELL, V45, P357, DOI 10.1016/j.molcel.2011.11.034; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Ishchenko AA, 2005, MOL CELL BIOL, V25, P6380, DOI 10.1128/MCB.25.15.6380-6390.2005; Ishchenko AA, 2003, NUCLEIC ACIDS RES, V31, P6344, DOI 10.1093/nar/gkg812; KANE CM, 1981, J BIOL CHEM, V256, P3405; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Manvilla BA, 2013, ACTA CRYSTALLOGR D, V69, P2555, DOI 10.1107/S0907444913027042; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Murphy TM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004297; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P1087, DOI 10.1093/nar/19.5.1087; Rogers S G, 1980, Methods Enzymol, V65, P201; Schmiedel R, 2009, DNA REPAIR, V8, P219, DOI 10.1016/j.dnarep.2008.10.009; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tsutakawa SE, 2013, J BIOL CHEM, V288, P8445, DOI 10.1074/jbc.M112.422774; Vanyushin BF, 2011, BBA-GENE REGUL MECH, V1809, P360, DOI 10.1016/j.bbagrm.2011.04.006; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	45	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92963	10.1371/journal.pone.0092963	http://dx.doi.org/10.1371/journal.pone.0092963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667595	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600109
J	Klompmaker, AA; Artal, P; van Bakel, BWM; Fraaije, RHB; Jagt, JWM				Klompmaker, Adiel A.; Artal, Pedro; van Bakel, Barry W. M.; Fraaije, Rene H. B.; Jagt, John W. M.			Parasites in the Fossil Record: A Cretaceous Fauna with Isopod-Infested Decapod Crustaceans, Infestation Patterns through Time, and a New Ichnotaxon	PLOS ONE			English	Article							CRABS CRUSTACEA; SQUAT LOBSTERS; BRACHYURA GLAESSNEROPSOIDEA; ANOMURA GALATHEOIDEA; TRACE FOSSILS; REVISION; BOPYRIDAE; GALATHEIDAE; DIVERSITY; ERNSTBRUNN	Parasites are common in modern ecosystems and are also known from the fossil record. One of the best preserved and easily recognisable examples of parasitism in the fossil record concerns isopod-induced swellings in the branchial chamber of marine decapod crustaceans. However, very limited quantitative data on the variability of infestation percentages at the species, genus, and family levels are available. Here we provide this type of data for a mid-Cretaceous (upper Lower Cretaceous, upper Albian) reef setting at Koskobilo, northern Spain, on the basis of 874 specimens of anomurans and brachyurans. Thirty-seven specimens (4.2%), arranged in ten species, are infested. Anomurans are more heavily infested than brachyurans, variability can be high within genera, and a relationship may exist between the number of specimens and infestation percentage per taxon, possibly suggesting host-specificity. We have also investigated quantitative patterns of infestation through geological time based on 88 infested species (25 anomurans, 55 brachyurans, seven lobsters, and one shrimp), to show that the highest number of infested species can be found in the Late Jurassic, also when corrected for the unequal duration of epochs. The same Late Jurassic peak is observed for the percentage of infested decapod species per epoch. This acme is caused entirely by infested anomurans and brachyurans. Biases (taphonomic and otherwise) and causes of variability with regard to the Koskobilo assemblage and infestation patterns through time are discussed. Finally, a new ichnogenus and -species, Kanthyloma crusta, are erected to accommodate such swellings or embedment structures (bioclaustrations).	[Klompmaker, Adiel A.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Klompmaker, Adiel A.] Kent State Univ, Dept Geol, Kent, OH 44242 USA; [Artal, Pedro] Museo Geol Seminario Barcelona, Barcelona, Spain; [van Bakel, Barry W. M.; Fraaije, Rene H. B.] Oertijdmuseum Groene Poort, Boxtel, Netherlands; [van Bakel, Barry W. M.] Naturalis Biodivers Ctr, Leiden, Netherlands; [Jagt, John W. M.] Nat Hist Museum Maastricht, Maastricht, Netherlands	State University System of Florida; University of Florida; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Naturalis Biodiversity Center	Klompmaker, AA (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	adielklompmaker@gmail.com	Artal, Pablo/AGV-7547-2022; Artal, Pablo/AAG-4485-2020	Artal, Pablo/0000-0003-1284-6591; Artal, Pablo/0000-0003-1284-6591	Molengraaff Fonds; Amoco Alumni Scholarship; Graduate Student Senate (Kent State University) research grant; Sigma Gamma Epsilon (Gamma Zeta Chapter) research grant; NSF [EF-0531670]; Jon L. and Beverly A. Thompson Endowment Fund (Florida Museum of Natural History, University of Florida)	Molengraaff Fonds; Amoco Alumni Scholarship; Graduate Student Senate (Kent State University) research grant; Sigma Gamma Epsilon (Gamma Zeta Chapter) research grant; NSF(National Science Foundation (NSF)); Jon L. and Beverly A. Thompson Endowment Fund (Florida Museum of Natural History, University of Florida)	Fieldwork at Koskobilo was in part supported by the Molengraaff Fonds, an Amoco Alumni Scholarship, a Graduate Student Senate (Kent State University) research grant, and a Sigma Gamma Epsilon (Gamma Zeta Chapter) research grant to AAK, as well as an NSF grant (EF-0531670) to Feldmann and Schweitzer. This work was further supported by the Jon L. and Beverly A. Thompson Endowment Fund (Florida Museum of Natural History, University of Florida) to AAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamid Marouf A. M., 1999, Revue de Paleobiologie, V18, P69; ABELE LG, 1976, MAR BIOL, V38, P263, DOI 10.1007/BF00388939; ALCOCK A, 1895, J ASIATIC SOC BENGAL, V64, P157, DOI DOI 10.5962/BHL.TITLE.16033; [Anonymous], 1972, ACTA GEOL POL; [Anonymous], GEOLOGICA HUNGARICA; Artal P, 2012, REV MEX CIENC GEOL, V29, P398; Baba K, 2008, ZOOTAXA, P1; BACHMAYER F., 1950, ANN NATURHIST STAATSMUS WIEN, V57, P133; Bachmayer F., 1955, Sitzungsberichte der Oesterreichischen Akademie der Wissenschaften Abt I, V164, P255; BACHMAYER F., 1955, PALAEONTOL ZEITSCHR, V29, P5; Bachmayer F., 1948, Sitzungsberichte der Oesterreichischen Akademie der Wissenschaften Wien Abt I, V157, P263; Bachmayer F, 1945, JB GEOLOGISCHEN BUND, V1945, P35; Bauer R.T., 1989, Crustacean Issues, V6, P49; BAUER R T, 1981, Journal of Crustacean Biology, V1, P153, DOI 10.2307/1548154; Baumiller Tomasz K., 2002, Paleontological Society Papers, V8, P195; Bell T., 1858, MONOGRAPH PALAEONTOG, V10, P1; Bell T., 1863, PALAEONTOGRAPHICAL S, P1, DOI DOI 10.5962/BHL.TITLE.11701; Bertling Markus, 2007, P81, DOI 10.1016/B978-044452949-7/50131-5; Bertling M, 2006, LETHAIA, V39, P265, DOI 10.1080/00241160600787890; Beschin C., 2007, MUSEO ARCHEOLOGIA SC, V2007, P9; Beurlen K., 1929, Zentralblatt fuer Mineralogie Geologie und Palaeontologie Stuttgart, V1929B, P125; BISHOP G A, 1974, Crustaceana (Leiden), V26, P212, DOI 10.1163/156854074X00578; BISHOP GA, 1983, CRUSTACEANA, V44, P23, DOI 10.1163/156854083X00028; Bittner, 1883, DENKSCHRIFTEN KAISER, V46, P299; Bittner A., 1875, DENKSCHRIFTEN KAISER, V34, P63; BLASCHKE F., 1911, ANN KAISERLICH KONIG, V25, P143; BOADA L V, 1981, Geobios (Villeurbanne), V14, P247; Bohaty J, 2012, J PALEONTOL, V86, P282, DOI 10.1666/11-007.1; Boucot A. J., 2011, FOSSIL BEHAV COMPEND; Boyko CB, 2013, SYST BIODIVERS, V11, P495, DOI 10.1080/14772000.2013.865679; Boyko CB, 2012, ZOOTAXA, P1; Boyko CB, 2011, BIOLOGY OF SQUAT LOBSTERS, P271; Boyko Christopher B., 2009, Crustacean Issues, V18, P197; Bradford-Grieve JM, 2002, HYDROBIOLOGIA, V485, P223, DOI 10.1023/A:1021373412738; Breton G, 2010, MUSEUM NATL HIST NAT, V2, P332; BRETT CE, 1985, J PALEONTOL, V59, P625; BROMLEY R. G, 1970, TRACE FOSSILS, P49; Bromley RG, 2004, GEOL SOC SPEC PUBL, V228, P455, DOI 10.1144/GSL.SP.2004.228.01.20; Bromley RG, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P361, DOI 10.1007/978-3-540-77598-0_18; BURSEY CR, 1978, B MAR SCI, V28, P566; CECCON L., 2013, LAVORI SOC VEN SCI N, V38, P83; Collins J.S.H., 1992, Gronlands Geologiske Undersogelse Bulletin, P1; Collins Joe S. H., 1995, Acta Palaeontologica Polonica, V40, P165; Combes C., 2004, PARASITISM ECOLOGY E; Console-Gonella C, 2014, LETHAIA, V47, P107, DOI 10.1111/let.12043; Dana JD, 1852, CRUSTACEA 1, V13, P1; Dana JD, 1851, P ACAD NAT SCI PHILA, V5, P247; De Angeli A., 2003, MEM SOC ITAL SCI NAT, V30, P1, DOI [10.1163/18759866-0720203006, DOI 10.1163/18759866-0720203006]; De Haan F, 1833, CRUSTACEA, p[i, i, ix, 1]; Eudes-Deslongchamps J.A., 1835, MEMOIRE SOC LINNEENN, V5, P37; Fabricius J.C., 1793, ENTOMOLOGIA SYSTEMAT, V3, P1; Feldmann R.M., 1993, PALEONTOLOGICAL SOC, V28, p[i, 1]; Feldmann RM, 1998, J PALEONTOL, V72, P493, DOI 10.1017/S0022336000024264; Feldmann Rodney M., 2009, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V111A, P183; Forster R., 1969, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V9, P45; Fraaije HB, 2013, NETH J GEOSCI, V92, P109, DOI 10.1017/S0016774600000032; Fraaije R. H. B., 2009, B SOC GEOL MEX, V61, P13, DOI DOI 10.18268/BSGM2009V61N1A2; Fraaije RHB, 2012, NEUES JAHRB GEOL P-A, V263, P85, DOI 10.1127/0077-7749/2012/0213; Frantescu Ovidiu D., 2014, Bulletin of the Mizunami Fossil Museum, V40, P13; Gatt M, 2010, PALAEONTOLOGY, V53, P1315, DOI 10.1111/j.1475-4983.2010.01008.x; Gibbes L.R, 1850, P AM ASS ADV SCI, V3, P165; GLAESSNER M F, 1980, Transactions of the Royal Society of South Australia, V104, P171; Glaessner MF, 1960, NZ GEOLOGICAL SURVEY, V31, P3; Gonzalez MT, 2004, J CRUSTACEAN BIOL, V24, P618, DOI 10.1651/C-2482; Hartnoll R.G., 1985, Crustacean Issues, V3, P101; Hartnoll R.G., 1982, P111; Hernaez P, 2010, J MAR BIOL ASSOC UK, V90, P691, DOI 10.1017/S0025315409991093; Hess H, 2010, J PALEONTOL, V84, P1031, DOI 10.1666/10-036.1; Hosie AM, 2008, ZOOTAXA, P1; Houssa V., 1963, Sbornik Geol Ust Csl, V28, P101; Howell BF, 1962, TREATISE INVERTEBR W, pF144; Hyzny Matus, 2011, Bulletin of the Mizunami Fossil Museum, V37, P37; Jacquinot H, 1842, VOYAGE POLE SUD OCEA; Jagt JWM, 2009, NATUURHISTORISCH MAA, V98, P108; Jakobsen SL, 1997, B GEOL SOC DENMARK, V44, P89; Jones A., 2013, THESIS KENT STATE U; Karasawa H., 2008, B MIZUNAMI FOSSIL MU, V34, P23; Kiessling W, 2009, ANNU REV ECOL EVOL S, V40, P173, DOI 10.1146/annurev.ecolsys.110308.120251; Kiessling Wolfgang, 2002, P625; Klompmaker AA, 2013, GEOLOGICAL SOC AM AB, V45, P460; Klompmaker AA, 2012, THESIS KENT STATE U, DOI 10.1666/0022-3360(2006)080[0083:P0SHDC]2.0.CO;2; Klompmaker AA, 2013, GEOLOGY, V41, P1179, DOI 10.1130/G34768.1; Klompmaker AA, 2013, CRETACEOUS RES, V41, P150, DOI 10.1016/j.cretres.2012.12.003; Klompmaker AA, 2013, PALAEOGEOGR PALAEOCL, V374, P256, DOI 10.1016/j.palaeo.2013.01.024; Klompmaker AA, 2012, J CRUSTACEAN BIOL, V32, P780, DOI 10.1163/193724012X635340; Klompmaker AA, 2012, CRETACEOUS RES, V36, P125, DOI 10.1016/j.cretres.2012.03.003; Klompmaker AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031893; Klompmaker AA, 2011, PALAEONTOLOGY, V54, P1199, DOI 10.1111/j.1475-4983.2011.01072.x; Klompmaker AA, 2011, NEUES JAHRB GEOL P-A, V260, P191, DOI 10.1127/0077-7749/2011/0170; Klompmaker AA, 2011, J PALEONTOL, V85, P226, DOI 10.1666/10-028.1; Knaust D., 2012, DEV SEDIMENTOL, P79; Kobayashi Nobuaki, 2008, Bulletin of the Mizunami Fossil Museum, V34, P111; Konig C., 1825, ICONES FOSSILIUM SEC, P1; Labandeira Conrad C., 2002, Paleontological Society Papers, V8, P211; Lorenthey E. u., 1929, Geologica Hungarica Ser Palaeont, V3, P1; M'Coy F., 1854, ANN MAG NAT HIST, V44, P116, DOI DOI 10.1080/037454809494314; Mantell GA, 1844, MEDALS CREATION 1 2, V1-2, P1; MARKHAM JC, 1986, CRUSTACEAN BIOGEOGRA, P143, DOI DOI 10.1201/9781315140674-7; MCDERMOTT JJ, 1991, OPHELIA, V33, P71, DOI 10.1080/00785326.1991.10429731; McKinney F, 2009, ICHNOS, V16, P193, DOI 10.1080/10420940802686160; Mercier J., 1936, B SOCIETE GEOLOGIQUE, V6, P149; Milne Edwards A., 1865, B SOC SCI HIST NATUR, V19, P341; Milne-Edwards A, 1886, GEOLOGIE DEP SARTHE; Miyashita Y., 1941, Japanese Journal of Zoology, V9, P251; Moericke W., 1889, PALAEONTOGRAPHICA S, V3, P43; Morris S.F., 1991, Bulletin of the British Museum (Natural History) Geology, V47, P1; MORRIS SC, 1981, PARASITOLOGY, V82, P489, DOI 10.1017/S0031182000067020; Muller P., 1991, Contributions to Tertiary and Quaternary Geology, V28, P47; O'Brien J., 1985, Crustacean Issues, V3, P191; ORTMANN A. E., 1892, ZOOLOGISCHE JB ABTHE, V6, P532, DOI DOI 10.5962/BHL.PART.26456; PALMER TJ, 1988, PALAEONTOLOGY, V31, P939; Patrulius D., 1959, Revue de Geologie et de Geographie Bucarest, V3, P249; Petric M, 2010, J MAR BIOL ASSOC UK, V90, P1395, DOI 10.1017/S0025315409991615; Pickerill Ron K., 1994, P3; Porter C. E, 1903, REV CHIL HIST NAT, V7, P274; Poulin R., 2004, PARASITE BIODIVERSIT; Radwanska U, 2005, ACTA GEOL POL, V55, P109; Radwanska U, 2010, ACTA GEOL POL, V60, P549; Rathbun M.J., 1917, P US NATL MUSEUM, V52, P385, DOI DOI 10.5479/SI.00963801.52-2182.385; Rathbun M. J., 1935, GEOLOGICAL SOC AM, V2, P1; Rathbun M. J., 1926, US GEOLOGICAL SURVEY, P184; RATHBUN MARY J., 1928, PROC U S NATION MUS, V73, P1; RAYNER G. W., 1935, DISCOVERY REPTS [GOV DEPEND FALKLAND IS], V10, P209; Remes M., 1923, Bul Intern Acad Prag, V23, P36; Remes M., 1895, B INT ACAD SCI BOHEM, V2, P200; Reuss, 1858, SITZUNGSBERICHTE MN, V31, P5; ROBERTS H.B., 1962, CRETACEOUS FOSSILS N, V61, P163; Robins Cristina M., 2013, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V115, P167; Robins Cristina M., 2012, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V114A, P289; Roccatagliata D, 1999, J CRUSTACEAN BIOL, V19, P720, DOI 10.2307/1549296; Roemer, 1887, NEUES JB MINERALOGIE, V1, P173; Roemer F. A., 1841, VERSTEINERUNGEN NORD; Roman J., 1952, Bulletin de la Societe Geologique de France Ser 6, V2, P3; Ruiz de Gaona M., 1943, B REAL SOC ESPANOLA, V40, P425; Schotte M., 2008, WORLD LIST MARINE FR; Schweitzer C. E., 2009, ANN NATURHISTORISC A, V110, P55; Schweitzer Carrie E., 2007, Senckenbergiana Lethaea, V87, P119; Schweitzer CE, 2010, NEUES JAHRB GEOL P-A, V258, P243, DOI 10.1127/0077-7749/2010/0096; Schweitzer CE, 2010, NEUES JAHRB GEOL P-A, V258, P51, DOI 10.1127/0077-7749/2010/0084; Schweitzer Carrie E., 2010, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V112A, P169; Schweitzer CE, 2010, NEUES JAHRB GEOL P-A, V256, P363, DOI 10.1127/0077-7749/2010/0059; Schweitzer Carrie E., 2001, Bulletin of the Mizunami Fossil Museum, V28, P173; Schweitzer CE, 2009, NEUES JAHRB GEOL P-A, V253, P357, DOI 10.1127/0077-7749/2009/0253-0357; Schweitzer CE, 2009, NEUES JAHRB GEOL P-A, V252, P1, DOI 10.1127/0077-7749/2009/0252-0001; Schweitzer CE, 2008, NEUES JAHRB GEOL P-A, V250, P273, DOI 10.1127/0077-7749/2008/0250-0273; Schweitzer Carrie E., 2009, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V111A, P207; Schweitzer CE, 2009, ANN CARNEGIE MUS, V77, P403, DOI 10.2992/0097-4463-77.4.403; Segerberg K.O., 1900, GEOLOGISKA F RENINGE, V22, P347; Selden PA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1049; Sepkoski JJ, 2000, CONTRIB ZOOL, V69, P213, DOI 10.1163/18759866-06904001; SHIELDS JD, 1985, J INVERTEBR PATHOL, V45, P122, DOI 10.1016/0022-2011(85)90060-6; Soergel W, 1913, NEUES HB MINERALOGIE, V36, P586; Stimpson W, 1860, ANN LYCEUM NATURAL H, V7, P177, DOI [10.1111/j.1749-6632.1862.tb00153.x, DOI 10.1111/J.1749-6632.1862.TB00153.X]; Tapanila L, 2005, LETHAIA, V38, P89, DOI 10.1080/00241160510013123; Tapanila Leif, 2007, P345, DOI 10.1016/B978-044452949-7/50145-5; Tapanila L, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P3, DOI 10.1007/978-3-540-77598-0_1; Todd Jonathan A., 2005, Bulletin of the Mizunami Fossil Museum, V32, P53; Van Bakel BWM, 2012, ZOOTAXA, P1; Van Straelen V., 1940, Bull Mus Hist nat Belg, V16, P1; Van Straelen V., 1944, B MUSEE ROYAL HIST N, V20, P1; VANWYK PM, 1982, PARASITOLOGY, V85, P459, DOI 10.1017/S0031182000056249; Voigt E., 1967, Palaeontologische Zeitschrift, V41, P86; Voigt E., 1959, PALAEONTOL Z, V33, P211, DOI DOI 10.1007/BF02987935; von Graff L, 1885, PALAEONTOGRAPHICA, V31, P183; von Meyer H., 1851, NEUES JB MINERALOGIE, V1851, P677; von Meyer H., 1857, NEUES JB MINERALOGIE, V1857, P556; von Meyer H., 1860, PALAEONTOGRAPHICA, V7, P183; von Meyer H., 1840, NEUE GATTUNGEN FOSSI; von Meyer H., 1842, BEITRAGE PETREFAKTEN, V5, P70; Ward M., 1942, Mauritius Institute Bulletin, V2, P49; Waugh DA, 2009, J CRUSTACEAN BIOL, V29, P141, DOI 10.1651/08-3105.1; Wehner G., 1988, THESIS LUDWIG MAXIMI; WELCH JR, 1976, J PALEONTOL, V50, P218; Wienberg Rasmussen H., 2008, B MIZUNAMI FOSSIL MU, V34, P31; Williams JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035350; Wolff Matthias, 1995, Revista de Biologia Marina, V30, P57; WRIGHT C. W., 1950, PROC GEOL ASSOC, V61, P13; WRIGHT C W, 1972, Palaeontographical Society Monographs (London), V126, P1; ZELDIS JR, 1985, MAR ECOL PROG SER, V22, P77, DOI 10.3354/meps022077	179	49	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92551	10.1371/journal.pone.0092551	http://dx.doi.org/10.1371/journal.pone.0092551			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667587	Green Submitted, Green Published, gold			2022-12-25	WOS:000333675600049
J	Ruyssinck, J; Van, AHT; Geurts, P; Dhaene, T; Demeester, P; Saeys, Y				Ruyssinck, Joeri; Van Anh Huynh-Thu; Geurts, Pierre; Dhaene, Tom; Demeester, Piet; Saeys, Yvan			NIMEFI: Gene Regulatory Network Inference using Multiple Ensemble Feature Importance Algorithms	PLOS ONE			English	Article							SELECTION	One of the long-standing open challenges in computational systems biology is the topology inference of gene regulatory networks from high-throughput omics data. Recently, two community-wide efforts, DREAM4 and DREAM5, have been established to benchmark network inference techniques using gene expression measurements. In these challenges the overall top performer was the GENIE3 algorithm. This method decomposes the network inference task into separate regression problems for each gene in the network in which the expression values of a particular target gene are predicted using all other genes as possible predictors. Next, using tree-based ensemble methods, an importance measure for each predictor gene is calculated with respect to the target gene and a high feature importance is considered as putative evidence of a regulatory link existing between both genes. The contribution of this work is twofold. First, we generalize the regression decomposition strategy of GENIE3 to other feature importance methods. We compare the performance of support vector regression, the elastic net, random forest regression, symbolic regression and their ensemble variants in this setting to the original GENIE3 algorithm. To create the ensemble variants, we propose a subsampling approach which allows us to cast any feature selection algorithm that produces a feature ranking into an ensemble feature importance algorithm. We demonstrate that the ensemble setting is key to the network inference task, as only ensemble variants achieve top performance. As second contribution, we explore the effect of using rankwise averaged predictions of multiple ensemble algorithms as opposed to only one. We name this approach NIMEFI (Network Inference using Multiple Ensemble Feature Importance algorithms) and show that this approach outperforms all individual methods in general, although on a specific network a single method can perform better. An implementation of NIMEFI has been made publicly available.	[Ruyssinck, Joeri; Dhaene, Tom; Demeester, Piet] Ghent Univ iMinds, Dept Informat Technol, Ghent, Belgium; [Van Anh Huynh-Thu; Geurts, Pierre] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium; [Van Anh Huynh-Thu; Geurts, Pierre] Univ Liege, GIGA R, Liege, Belgium; [Van Anh Huynh-Thu] Univ Edinburgh, Sch Informat, Edinburgh, Midlothian, Scotland; [Saeys, Yvan] Univ Ghent VIB, Immunoregulat Lab, Inflammat Res Ctr, Ghent, Belgium; [Saeys, Yvan] Univ Ghent, Dept Resp Med, B-9000 Ghent, Belgium	Ghent University; IMEC; University of Liege; University of Liege; University of Edinburgh; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Ruyssinck, J (corresponding author), Ghent Univ iMinds, Dept Informat Technol, Ghent, Belgium.	joeri.ruyssinck@intec.ugent.be	Dhaene, Tom/A-4541-2009; Saeys, Yvan/C-1311-2009	Dhaene, Tom/0000-0003-2899-4636; Saeys, Yvan/0000-0002-0415-1506	Interuniversity Attraction Poles Programme [IAP P6/25 BIOMAGNET]; Belgian State, Science Policy Office; French Community of Belgium (ARC REFRACT, ULg); European Commission [FP7-PEOPLE-2011, CardiomiR-285991]; Ghent University Multidisciplinary Research Partnership Bioinformatics: from nucleotides to networks; Ghent University; Hercules Foundation; Flemish Government department EWI	Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian State, Science Policy Office(Belgian Federal Science Policy Office); French Community of Belgium (ARC REFRACT, ULg); European Commission(European CommissionEuropean Commission Joint Research Centre); Ghent University Multidisciplinary Research Partnership Bioinformatics: from nucleotides to networks(Ghent University); Ghent University(Ghent University); Hercules Foundation; Flemish Government department EWI	This work was partially supported by the Interuniversity Attraction Poles Programme (IAP P6/25 BIOMAGNET), initiated by the Belgian State, Science Policy Office, by the French Community of Belgium (ARC REFRACT, ULg), and by a grant from the European Commission (FP7-PEOPLE-2011; CardiomiR-285991; Dr. Heymans). This work is supported by Ghent University Multidisciplinary Research Partnership Bioinformatics: from nucleotides to networks. This work was carried out using the Stevin Supercomputer Infrastructure at Ghent University, funded by Ghent University, the Hercules Foundation and the Flemish Government department EWI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2009, BIOINFORMATICS, V25, pI313, DOI 10.1093/bioinformatics/btp191; Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; Bach FR., 2008, P 25 INT C MACHINE L, V33, P40, DOI [10.1145/1390156.1390161, DOI 10.1145/1390156.1390161]; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Butte A J, 2000, Pac Symp Biocomput, P418; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; de Matos Simoes Ricardo, 2012, PLoS One, V7, pe33624, DOI 10.1371/journal.pone.0033624; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon Isabelle, 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hache H, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/617281; Haury AC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-145; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Kuffner R, 2012, BIOINFORMATICS, V28, P1376, DOI 10.1093/bioinformatics/bts143; Madhamshettiwar PB, 2012, GENOME MED, V4, DOI 10.1186/gm340; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Meyer PE, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/79879; Michoel T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-49; Narendra V, 2011, GENOMICS, V97, P7, DOI 10.1016/j.ygeno.2010.10.003; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Saeys Y, 2008, LECT NOTES ARTIF INT, V5212, P313, DOI 10.1007/978-3-540-87481-2_21; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Smits GF, 2005, GENET PROGR SER, V8, P283, DOI 10.1007/0-387-23254-0_17; Soranzo N, 2007, BIOINFORMATICS, V23, P1640, DOI 10.1093/bioinformatics/btm163; Van den Bulcke T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-43; Vladislavleva K, 2010, GECCO 10, P941, DOI DOI 10.1145/1830483.1830651; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	36	38	38	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92709	10.1371/journal.pone.0092709	http://dx.doi.org/10.1371/journal.pone.0092709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667482	Green Published, gold			2022-12-25	WOS:000333675600066
J	Biyanee, A; Ohnheiser, J; Singh, P; Klempnauer, KH				Biyanee, A.; Ohnheiser, J.; Singh, P.; Klempnauer, K-H			A novel mechanism for the control of translation of specific mRNAs by tumor suppressor protein Pdcd4: inhibition of translation elongation	ONCOGENE			English	Article							A-MYB PROTEIN; C-MYB; CODING REGION; BINDING-PROTEIN; EUKARYOTIC TRANSLATION; STRUCTURAL BASIS; GENE-EXPRESSION; CANCER; TRANSFORMATION; TRANSCRIPTION	The tumor suppressor gene Pdcd4 (programmed cell death gene 4) has drawn considerable attention because its downregulation is involved in the development of several types of cancer. Because Pdcd4 interacts with the translation initiation factor eIF4A and inhibits its helicase activity, Pdcd4 has been implicated in the translational suppression of cellular mRNAs containing structured 5'-untranslated regions. However, Pdcd4's role in translation regulation is still poorly understood, because only very few physiological Pdcd4 target mRNAs are known. By using a Pdcd4-deficient clone of the chicken B-cell line DT40, we have discovered that the mRNA of the A-myb proto-oncogene is a novel Pdcd4 target RNA whose translation is suppressed by Pdcd4. Interestingly, the inhibitory effect of Pdcd4 is independent of the Pdcd4-eIF4A interaction, but is dependent on an RNA-binding domain at the N terminus of Pdcd4 and on sequences located within the coding region of A-myb mRNA, indicating that Pdcd4 suppresses A-myb translation by a novel mechanism. Our data show that the Pdcd4 RNA-binding domain preferentially recognizes an RNA secondary structure element formed by the part of the A-myb coding region that mediates Pdcd4-dependent suppression. Previously, we have shown that Pdcd4 also suppresses the translation of the c-myb mRNA by a similar mechanism involving binding of Pdcd4 to RNA secondary structure formed by the c-myb coding region. Surprisingly, our data show that Pdcd4 exerts its inhibitory activity only when the target region of Pdcd4 in A-myb and c-myb mRNA is itself translated, consistent with a mechanism in which Pdcd4 suppresses translation by interfering with translation elongation. Taken together, our work reveals a novel mechanism by which Pdcd4 affects the translational of cellular RNAs. Furthermore, as c-myb and A-myb are members of the Myb proto-oncogene family whose deregulation has been implicated in tumorigenesis, inhibiting their translation might contribute to the tumor-suppressive activity of Pdcd4.	[Biyanee, A.; Ohnheiser, J.; Singh, P.; Klempnauer, K-H] Univ Munster, Inst Biochem, D-48149 Munster, Germany; [Biyanee, A.] Univ Munster, GSC MS, D-48149 Munster, Germany	University of Munster; University of Munster	Klempnauer, KH (corresponding author), Univ Munster, Inst Biochem, Wilhelm Klemm Str 2, D-48149 Munster, Germany.	klempna@uni-muenster.de	Singh, Priyanka/N-1372-2018; Singh, Priyanka/GRF-6098-2022	Singh, Priyanka/0000-0003-0841-1544; Singh, Priyanka/0000-0002-5928-6280	Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft; Graduate School of Chemistry (GSC-MS) at the University of Munster	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate School of Chemistry (GSC-MS) at the University of Munster	We thank J Golay for the human A-Myb expression vector. This work was supported by a grant from the Deutsche Krebshilfe and the Deutsche Forschungsgemeinschaft. AB and PS were supported by fellowships from the Graduate School of Chemistry (GSC-MS) at the University of Munster.	Afonja O, 2004, ONCOGENE, V23, P8135, DOI 10.1038/sj.onc.1207983; Appl H, 2002, ONCOGENE, V21, P3076, DOI 10.1038/sj.onc.1205427; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Biroccio A, 2001, AM J PATHOL, V158, P1289, DOI 10.1016/S0002-9440(10)64080-1; Bitomsky N, 2008, ONCOGENE, V27, P4820, DOI 10.1038/onc.2008.115; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Bohm M, 2003, ONCOGENE, V22, P4905, DOI 10.1038/sj.onc.1206710; Brummer A, 2013, RNA, V19, P1317, DOI 10.1261/rna.037531.112; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Drabsch Y, 2007, P NATL ACAD SCI USA, V104, P13762, DOI 10.1073/pnas.0700104104; ErcikanAbali EA, 1997, BIOCHEMISTRY-US, V36, P12317, DOI 10.1021/bi971026e; FOOS G, 1994, ONCOGENE, V9, P2481; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; GOLAY J, 1994, ONCOGENE, V9, P2469; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; KLEMPNAUER KH, 1986, EMBO J, V5, P1903, DOI 10.1002/j.1460-2075.1986.tb04443.x; Kumar N, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2012.37; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; LaRonde-LeBlanc N, 2007, MOL CELL BIOL, V27, P147, DOI 10.1128/MCB.00867-06; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Lin XK, 2000, NUCLEIC ACIDS RES, V28, P1381, DOI 10.1093/nar/28.6.1381; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Perez-Leal O, 2012, MOL CELL BIOL, V32, P1453, DOI 10.1128/MCB.06444-11; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Prechtel AT, 2006, J BIOL CHEM, V281, P10912, DOI 10.1074/jbc.M510306200; Ramkissoon LA, 2013, P NATL ACAD SCI USA, V110, P8188, DOI 10.1073/pnas.1300252110; Schlichter U, 2001, ONCOGENE, V20, P231, DOI 10.1038/sj.onc.1204071; Schlichter U, 2001, BBA-GENE STRUCT EXPR, V1520, P99, DOI 10.1016/S0167-4781(01)00252-4; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; Shiota M, 2009, CANCER RES, V69, P3148, DOI 10.1158/0008-5472.CAN-08-2334; Singh P, 2011, ONCOGENE, V30, P4864, DOI 10.1038/onc.2011.202; Singh P, 2009, ONCOGENE, V28, P3758, DOI 10.1038/onc.2009.239; SLEEMAN JP, 1993, ONCOGENE, V8, P1931; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; Wedeken L, 2011, J BIOL CHEM, V286, P42855, DOI 10.1074/jbc.M111.269456; Wedeken Lena, 2010, Genes Cancer, V1, P293, DOI 10.1177/1947601910364227; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zhang YY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010618	57	27	27	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 12	2015	34	11					1384	1392		10.1038/onc.2014.83	http://dx.doi.org/10.1038/onc.2014.83			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CD1AR	24681950				2022-12-25	WOS:000350806500005
J	Sweigard, JH; Yanai, R; Gaissert, P; Saint-Geniez, M; Kataoka, K; Thanos, A; Stahl, GL; Lambris, JD; Connor, KM				Sweigard, J. Harry; Yanai, Ryoji; Gaissert, Philipp; Saint-Geniez, Magali; Kataoka, Keiko; Thanos, Aristomenis; Stahl, Gregory L.; Lambris, John D.; Connor, Kip M.			The alternative complement pathway regulates pathological angiogenesis in the retina	FASEB JOURNAL			English	Article						neovascularization; innate immune system; factor b; Cd55; oxygen-induced retinopathy	ENDOTHELIAL GROWTH-FACTOR; DECAY-ACCELERATING FACTOR; CHOROIDAL NEOVASCULARIZATION; RETINOPATHY; INHIBITION; EXPRESSION; MOUSE; MODEL; ACTIVATION; PATHOGENESIS	A defining feature in proliferative retinopathies is the formation of pathological neovessels. In these diseases, the balance between neovessel formation and regression determines blindness, making the modulation of neovessel growth highly desirable. The role of the immune system in these retinopathies is of increasing interest, but it is not completely understood. We investigated the role of the alternative complement pathway during the formation and resolution of aberrant neovascularization. We used alternative complement pathway-deficient (Fb(-/-)) mice and age- and strain-matched control mice to assess neovessel development and regression in an oxygen-induced retinopathy (OIR) mouse model. In the control mice, we found increased transcription of Fb after OIR treatment. In the Fb(-/-) mice, we prepared retinal flat-mounts and identified an increased number of neovessels, peaking at postnatal day 17 (P17; P = 0.001). Subjecting human umbilical vein endothelial cells (HUVECs) to low oxygen, mimicking a characteristic of neovessels, decreased the expression of the complement inhibitor Cd55. Finally, using laser capture microdissection (LCM) to isolate the neovessels after OIR, we found decreased expression of Cd55 (P = 0.005). Together, our data implicate the alternative complement pathway in facilitating neovessel clearance by down-regulating the complement inhibitor Cd55 specifically on neovessels, allowing for their targeted removal while leaving the established vasculature intact.	[Sweigard, J. Harry; Yanai, Ryoji; Gaissert, Philipp; Kataoka, Keiko; Thanos, Aristomenis; Connor, Kip M.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Angiogenesis Lab,Dept Ophthalmol, Boston, MA 02114 USA; [Saint-Geniez, Magali] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA; [Stahl, Gregory L.] Harvard Univ, Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Sch Med,Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02114 USA; [Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pennsylvania	Connor, KM (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, 243 Charles St, Boston, MA 02114 USA.	kip_connor@meei.harvard.edu	Lambris, John/Q-5633-2018; SAINT-GENIEZ, MAGALI/P-3509-2019; Kataoka, Keiko/B-2806-2016	Lambris, John/0000-0002-9370-5776; SAINT-GENIEZ, MAGALI/0000-0001-9897-138X; Kataoka, Keiko/0000-0002-8795-6536; Stahl, Gregory/0000-0002-4805-8119; Connor, Kip/0000-0002-2048-9080	National Eye Institute of the U.S. National Institutes of Health (NIH) [R01EY022084-01/S1, EY020633-02, AI068730, T32EY007145, P30EY014104]; Howe Laboratory endowment of the Massachusetts Eye and Ear Infirmary; March of Dimes Foundation [5-FY09-535]; Research to Prevent Blindness; Massachusetts Lions Eye Research Fund, Inc.; Japan Eye Bank Association; NATIONAL EYE INSTITUTE [P30EY014104, R01EY020633, R01EY023682, T32EY007145, R01EY022084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068730] Funding Source: NIH RePORTER	National Eye Institute of the U.S. National Institutes of Health (NIH); Howe Laboratory endowment of the Massachusetts Eye and Ear Infirmary; March of Dimes Foundation(March of Dimes); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Massachusetts Lions Eye Research Fund, Inc.; Japan Eye Bank Association; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Eye Institute of the U.S. National Institutes of Health (NIH) under award numbers R01EY022084-01/S1 (K.M.C.), EY020633-02 and AI068730 (J.D.L.), T32EY007145 (J.H.S.), and P30EY014104. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Additional support was provided by the Howe Laboratory endowment of the Massachusetts Eye and Ear Infirmary; March of Dimes Foundation (5-FY09-535); a Research to Prevent Blindness unrestricted grant; Massachusetts Lions Eye Research Fund, Inc. (K.M.C.); and an award from the Japan Eye Bank Association (to R.Y.).	Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; Brodsky SV, 2009, TRANSPLANTATION, V88, P457, DOI 10.1097/TP.0b013e3181b0517d; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Gardiner TA, 2005, AM J PATHOL, V166, P637, DOI 10.1016/S0002-9440(10)62284-5; HAMILTON KK, 1990, BLOOD, V76, P2572; Harris CL, 1999, BIOCHEM J, V341, P821, DOI 10.1042/0264-6021:3410821; Harris CL, 2007, J IMMUNOL, V178, P352, DOI 10.4049/jimmunol.178.1.352; Hoang MV, 2011, BBA-MOL BASIS DIS, V1812, P549, DOI 10.1016/j.bbadis.2010.08.008; Hoang MV, 2010, ANGIOGENESIS, V13, P269, DOI 10.1007/s10456-010-9184-y; Hourcade D, 2000, IMMUNOPHARMACOLOGY, V49, P103, DOI 10.1016/S0162-3109(00)80296-9; Kemper C, 2001, CLIN EXP IMMUNOL, V124, P180, DOI 10.1046/j.1365-2249.2001.01458.x; Kim DD, 2006, CLIN IMMUNOL, V118, P127, DOI 10.1016/j.clim.2005.10.014; Langer HF, 2010, BLOOD, V116, P4395, DOI 10.1182/blood-2010-01-261503; Mechoulam Hadas, 2003, Am J Pharmacogenomics, V3, P261, DOI 10.2165/00129785-200303040-00004; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; Moulton KS, 2006, CURR OPIN LIPIDOL, V17, P548, DOI 10.1097/01.mol.0000245261.71129.f0; Nauta AJ, 2002, EUR J IMMUNOL, V32, P783, DOI 10.1002/1521-4141(200203)32:3<783::AID-IMMU783>3.0.CO;2-Q; Nilsson B, 2012, IMMUNOBIOLOGY, V217, P1106, DOI 10.1016/j.imbio.2012.07.008; Okroj M, 2009, CANCER IMMUNOL IMMUN, V58, P1771, DOI 10.1007/s00262-009-0685-8; Ozaki H, 2000, AM J PATHOL, V156, P697, DOI 10.1016/S0002-9440(10)64773-6; Pedersen ED, 2007, MOL IMMUNOL, V44, P2459, DOI 10.1016/j.molimm.2006.10.022; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Pierce EA, 1996, ARCH OPHTHALMOL-CHIC, V114, P1219, DOI 10.1001/archopht.1996.01100140419009; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Ramaglia V, 2009, MOL IMMUNOL, V46, P1892, DOI 10.1016/j.molimm.2009.01.017; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; Roumenina LT, 2011, J IMMUNOL METHODS, V365, P8, DOI 10.1016/j.jim.2010.12.020; Rus H, 2006, AUTOIMMUNITY, V39, P395, DOI 10.1080/08916930600739605; Saishin Y, 2003, J CELL PHYSIOL, V195, P241, DOI 10.1002/jcp.10246; Sasidharan C K, 2003, Indian J Pediatr, V70, P359, DOI 10.1007/BF02723597; Seo MS, 1999, AM J PATHOL, V154, P1743, DOI 10.1016/S0002-9440(10)65430-2; Song WC, 2004, CURR DIRECT AUTOIMMU, V7, P181; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Stem MS, 2013, CURR MED CHEM, V20, P3241, DOI 10.2174/09298673113209990027; Suzuki H, 2013, J IMMUNOL, V191, P4431, DOI 10.4049/jimmunol.1202242; Vakeva A, 1998, APMIS, V106, P1149; VANDERSCHOOT CE, 1990, BLOOD, V76, P1853; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Weidemann A, 2010, GLIA, V58, P1177, DOI 10.1002/glia.20997; Yanai R, 2012, ADV EXP MED BIOL, V946, P161, DOI 10.1007/978-1-4614-0106-3_10; Zhang L, 2003, CANCER RES, V63, P3403; ZIMMERMANN A, 1990, VIRCHOWS ARCH A, V417, P299, DOI 10.1007/BF01605780	50	30	31	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3171	3182		10.1096/fj.14-251041	http://dx.doi.org/10.1096/fj.14-251041			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24668752	Green Published			2022-12-25	WOS:000337949400037
J	Shi, S; Leites, C; He, DL; Schwartz, D; Moy, W; Shi, JX; Duan, JB				Shi, Sandra; Leites, Catherine; He, Deli; Schwartz, Daniel; Moy, Winton; Shi, Jianxin; Duan, Jubao			MicroRNA-9 and MicroRNA-326 Regulate Human Dopamine D2 Receptor Expression, and the MicroRNA-mediated Expression Regulation Is Altered by a Genetic Variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dopamine Receptors; Gene Expression; Gene Regulation; Genetic Polymorphism; MicroRNA; Pharmacogenetics; DRD2	C957T POLYMORPHISM; PREFRONTAL CORTEX; MESSENGER-RNA; NT2 CELLS; DRD2 GENE; EXPERIMENTAL VALIDATION; ASSOCIATION ANALYSIS; ANTIPSYCHOTIC-DRUGS; WORKING-MEMORY; SCHIZOPHRENIA	Background: Regulation of dopamine D2 receptor (DRD2) is pathophysiologically and pharmacologically important. Results: miR-9 and miR-326 target to the 3-UTR of DRD2, and endogenously inhibit DRD2 expression. A functional single nucleotide polymorphism alters such regulation. Conclusion:DRD2 is post-transcriptionally regulated by miR-326 and miR-9. Significance: The study suggests a pathophysiological and pharmacological role of miR-9 and miR-326 in neuropsychiatric disorders. The human dopamine receptor D2 (DRD2) has been implicated in the pathophysiology of schizophrenia and other neuropsychiatric disorders. Most antipsychotic drugs influence dopaminergic transmission through blocking dopamine receptors, primarily DRD2. We report here the post-transcriptional regulation of DRD2 expression by two brain-expressed microRNAs (miRs), miR-326 and miR-9, in an ex vivo mode, and show the relevance of miR-mediated DRD2 expression regulation in human dopaminergic neurons and in developing human brains. Both miRs targeted the 3-UTR (untranslated region) of DRD2 in NT2 (neuron-committed teratocarcinoma, which endogenously expresses DRD2) and CHO (Chinese hamster ovary) cell lines, decreasing luciferase activity measured by a luciferase reporter gene assay. miR-326 overexpression reduced DRD2 mRNA and DRD2 receptor synthesis. Both antisense miR-326 and antisense miR-9 increased DRD2 protein abundance, suggesting an endogenous repression of DRD2 expression by both miRs. Furthermore, a genetic variant (rs1130354) within the DRD2 3-UTR miR-targeting site interferes with miR-326-mediated repression of DRD2 expression. Finally, co-expression analysis identified an inverse correlation of DRD2 expression with both miR-326 and miR-9 in differentiating dopaminergic neurons derived from human induced pluripotent stem cells (iPSCs) and in developing human brain regions implicated in schizophrenia. Our study provides empirical evidence suggesting that miR-326 and miR-9 may regulate dopaminergic signaling, and miR-326 and miR-9 may be considered as potential drug targets for the treatment of disorders involving abnormal DRD2 function, such as schizophrenia.	[Shi, Sandra; Leites, Catherine; He, Deli; Schwartz, Daniel; Moy, Winton; Duan, Jubao] NorthShore Univ HealthSyst, Dept Psychiat & Behav Sci, Evanston, IL 60201 USA; [Shi, Sandra; Duan, Jubao] Univ Chicago, Dept Psychiat & Behav Sci, Chicago, IL 60637 USA; [Shi, Jianxin] NCI, Biostat Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA	NorthShore University Health System; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Duan, JB (corresponding author), NorthShore Univ HealthSyst, Res Inst, 1001 Univ Pl, Evanston, IL 60201 USA.	jduan@uchicago.edu			National Institutes of Health [R21MH102685]; Brain and Behavior Research Foundation Young Investigator Award; NorthShore University HealthSystem Research Career Development Award; NorthShore University HealthSystem Pilot Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH102685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain and Behavior Research Foundation Young Investigator Award; NorthShore University HealthSystem Research Career Development Award; NorthShore University HealthSystem Pilot Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant R21MH102685 (to J.D.). This work was also supported by a Brain and Behavior Research Foundation (formerly NARSAD) Young Investigator Award, NorthShore University HealthSystem Research Career Development Award, and the NorthShore University HealthSystem 2011 Pilot Award (all to J.D.).	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761; Abi-Dargham A, 2005, EUR PSYCHIAT, V20, P15, DOI 10.1016/j.eurpsy.2004.11.003; Arinami T, 1997, HUM MOL GENET, V6, P577, DOI 10.1093/hmg/6.4.577; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Breier A, 1997, P NATL ACAD SCI USA, V94, P2569, DOI 10.1073/pnas.94.6.2569; CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cravchik A, 1996, J BIOL CHEM, V271, P26013, DOI 10.1074/jbc.271.42.26013; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Duan JB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01318; Fang H, 2003, J BIOL CHEM, V278, P26401, DOI 10.1074/jbc.M211539200; Farde L, 1997, NATURE, V385, P590, DOI 10.1038/385590a0; FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; GEJMAN PV, 1994, JAMA-J AM MED ASSOC, V271, P204, DOI 10.1001/jama.271.3.204; Gennarino VA, 2012, GENOME RES, V22, P1163, DOI 10.1101/gr.130435.111; Girgenti MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032404; Glatt SJ, 2003, MOL PSYCHIATR, V8, P911, DOI 10.1038/sj.mp.4001321; Goldsmith SK, 1997, ARCH GEN PSYCHIAT, V54, P649; Guella I, 2013, J PSYCHIATR RES, V47, P1215, DOI 10.1016/j.jpsychires.2013.05.021; Gunter KK, 2006, NEUROBIOL AGING, V27, P1816, DOI 10.1016/j.neurobiolaging.2005.10.003; Hirvonen M, 2004, MOL PSYCHIATR, V9, P1060, DOI 10.1038/sj.mp.4001561; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; Jacobsen LK, 2006, PSYCHOPHARMACOLOGY, V188, P530, DOI 10.1007/s00213-006-0469-1; Jonsson EG, 2003, BIOL PSYCHIAT, V53, P577, DOI 10.1016/S0006-3223(02)01732-8; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kim AH, 2012, SCHIZOPHR RES, V141, P60, DOI 10.1016/j.schres.2012.06.038; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kuhn DE, 2008, METHODS, V44, P47, DOI 10.1016/j.ymeth.2007.09.005; Kwon E, 2013, MOL PSYCHIATR, V18, P11, DOI 10.1038/mp.2011.170; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Laruelle M, 1996, P NATL ACAD SCI USA, V93, P9235, DOI 10.1073/pnas.93.17.9235; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YC, 2011, P NATL ACAD SCI USA, V108, P12107, DOI 10.1073/pnas.1109718108; LIEBERMAN JA, 1987, PSYCHOPHARMACOLOGY, V91, P415, DOI 10.1007/BF00216006; MACKAY AVP, 1982, ARCH GEN PSYCHIAT, V39, P991; Misiuta IE, 2006, J NEUROSCI RES, V83, P668, DOI 10.1002/jnr.20718; MITA T, 1986, BIOL PSYCHIAT, V21, P1407, DOI 10.1016/0006-3223(86)90332-X; Moyer RA, 2011, NEUROPSYCHOPHARMACOL, V36, P753, DOI 10.1038/npp.2010.208; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Park In-Hyun, 2009, Curr Protoc Stem Cell Biol, VChapter 4, DOI 10.1002/9780470151808.sc04a01s8; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rodriguez-Jimenez R, 2006, NEUROPSYCHOBIOLOGY, V54, P166, DOI 10.1159/000098652; Sanders AR, 2008, AM J PSYCHIAT, V165, P497, DOI 10.1176/appi.ajp.2007.07101573; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Seeman P, 2000, P NATL ACAD SCI USA, V97, P7673, DOI 10.1073/pnas.97.14.7673; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; SEEMAN P, 1975, SCIENCE, V188, P1217, DOI 10.1126/science.1145194; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Sipila T, 2010, BIOL PSYCHIAT, V67, P1163, DOI 10.1016/j.biopsych.2009.12.011; SNYDER S H, 1974, Psychopharmacology Bulletin, V10, P4; SNYDER SH, 1976, AM J PSYCHIAT, V133, P197; Sodja C, 2002, MOL BRAIN RES, V99, P83, DOI 10.1016/S0169-328X(01)00324-2; Sommer CA, 2010, STEM CELLS, V28, P64, DOI 10.1002/stem.255; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Sullivan D, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.146; Sun GQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1532; Tallerico T, 2001, MOL BRAIN RES, V87, P160, DOI 10.1016/S0169-328X(00)00293-X; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Voisey J, 2010, PSYCHIAT RES, V177, P367, DOI 10.1016/j.psychres.2010.02.015; Volk DW, 2010, CURR TOP BEHAV NEURO, V4, P485, DOI 10.1007/7854_2010_44; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; Whitmer AJ, 2012, COGN AFFECT BEHAV NE, V12, P741, DOI 10.3758/s13415-012-0112-z; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Yuva-Aydemir Y, 2011, RNA BIOL, V8, P557, DOI 10.4161/rna.8.4.16019; Zakzanis KK, 1998, SCHIZOPHR RES, V32, P201, DOI 10.1016/S0920-9964(98)00041-3; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; ZHANG LJ, 1994, MOL PHARMACOL, V45, P878; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104; Zhao CN, 2013, SCI REP-UK, V3, DOI 10.1038/srep01329	83	46	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13434	13444		10.1074/jbc.M113.535203	http://dx.doi.org/10.1074/jbc.M113.535203			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24675081	Green Published, hybrid			2022-12-25	WOS:000335522800041
J	Cavaco-Silva, J; Abecasis, A; Miranda, AC; Pocas, J; Narciso, J; Aguas, MJ; Maltez, F; Almeida, I; Germano, I; Diniz, A; Goncalves, MDF; Gomes, P; Cunha, C; Camacho, RJ				Cavaco-Silva, Joana; Abecasis, Ana; Miranda, Ana Claudia; Pocas, Jose; Narciso, Jorge; Aguas, Maria Joao; Maltez, Fernando; Almeida, Isabel; Germano, Isabel; Diniz, Antonio; de Fatima Goncalves, Maria; Gomes, Perpetua; Cunha, Celso; Camacho, Ricardo Jorge		Portuguese HIV-2 Resistance Study	HIV-2 Integrase Polymorphisms and Longitudinal Genotypic Analysis of HIV-2 Infected Patients Failing a Raltegravir-Containing Regimen	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VITRO PHENOTYPIC SUSCEPTIBILITY; MULTIPLE SEQUENCE ALIGNMENT; CARBOXYL-TERMINAL DOMAINS; DNA-BINDING REGION; RESISTANCE MUTATIONS; DRUG-RESISTANCE; VIRAL FITNESS; CORE DOMAIN; PROTEIN	To characterize the HIV-2 integrase gene polymorphisms and the pathways to resistance of HIV-2 patients failing a raltegravir-containing regimen, we studied 63 integrase strand transfer inhibitors (INSTI)-naive patients, and 10 heavily pretreated patients exhibiting virological failure while receiving a salvage raltegravir-containing regimen. All patients were infected by HIV-2 group A. 61.4% of the integrase residues were conserved, including the catalytic motif residues. No INSTI-major resistance mutations were detected in the virus population from naive patients, but two amino acids that are secondary resistance mutations to INSTIs in HIV-1 were observed. The 10 raltegravir-experienced patients exhibited resistance mutations via three main genetic pathways: N155H, Q148R, and eventually E92Q - T97A. The 155 pathway was preferentially used (7/10 patients). Other mutations associated to raltegravir resistance in HIV-1 were also observed in our HIV-2 population (V151I and D232N), along with several novel mutations previously unreported. Data retrieved from this study should help build a more robust HIV-2-specific algorithm for the genotypic interpretation of raltegravir resistance, and contribute to improve the clinical monitoring of HIV-2-infected patients.	[Cavaco-Silva, Joana; Cunha, Celso] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol Med, Ctr Malaria & Outras Doencas Tropicais, P-1200 Lisbon, Portugal; [Abecasis, Ana] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Saude Publ Int & Bioestat, Ctr Malaria & Outras Doencas Tropicais, P-1200 Lisbon, Portugal; [Miranda, Ana Claudia] Ctr Hosp Lisboa Ocidental, Serv Doencas Infecciosas, Lisbon, Portugal; [Pocas, Jose] Ctr Hosp Setubal, Hosp Sao Bernardo, Setubal, Portugal; [Narciso, Jorge] Hosp SAMS, Lisbon, Portugal; [Aguas, Maria Joao] Hosp Garcia de Orta, Almada, Portugal; [Maltez, Fernando] Ctr Hosp Lisboa Cent, Hosp Curry Cabral, Lisbon, Portugal; [Almeida, Isabel] Ctr Hosp Porto, Hosp Santo Antonio, Oporto, Portugal; [Germano, Isabel] Ctr Hosp Lisboa Cent, Hosp Sao Jose, Lisbon, Portugal; [Diniz, Antonio] Ctr Hosp Lisboa Norte, Hosp Pulido Valente, Lisbon, Portugal; [de Fatima Goncalves, Maria; Gomes, Perpetua] Ctr Hosp Lisboa Ocidental, Serv Patol Clin SPC, Lab Microbiol Clin & Biol Mol, Lisbon, Portugal; [Gomes, Perpetua; Camacho, Ricardo Jorge] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Tropicais, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal; [Gomes, Perpetua] Inst Super Ciencias Saude Sul, Ctr Invest Interdisciplinar Egas Moniz CiiEM, Caparica, Portugal; [Camacho, Ricardo Jorge] Katholieke Univ Leuven KU Leuven, Rega Inst Med Res, Leuven, Belgium	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade de Lisboa; Hospital Garcia de Orta; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; Universidade de Lisboa; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade de Lisboa; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Instituto Superior de Ciencias da Saude Egas Moniz; KU Leuven	Cavaco-Silva, J (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol Med, Ctr Malaria & Outras Doencas Tropicais, P-1200 Lisbon, Portugal.	jo.cvsilva@gmail.com	Abecasis, Ana/B-6295-2009; Cunha, Celso/I-2371-2012; Abecasis, Ana/ABF-6657-2020; Gomes, Perpetua/I-5652-2012; Camacho, Ricardo J/I-7629-2012	Abecasis, Ana/0000-0002-3903-5265; Cunha, Celso/0000-0003-4745-3819; Abecasis, Ana/0000-0002-3903-5265; Gomes, Perpetua/0000-0003-3271-8255; Camacho, Ricardo J/0000-0002-9129-3237; Almeida, Isabel/0000-0002-8867-1540; Vasconcelos, Carlos/0000-0002-8073-5028	Merck & Co., Inc., Whitehouse Station, N.J., USA; European Commission [223131]; Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/61141/2009]	Merck & Co., Inc., Whitehouse Station, N.J., USA(Merck & Company); European Commission(European CommissionEuropean Commission Joint Research Centre); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by a research grant from Merck & Co., Inc., Whitehouse Station, N.J., USA, and by the European Commission's Seventh Framework Programme (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network" (CHAIN, grant 223131). J.C.-S. was supported by Fundacao para a Ciencia e Tecnologia (FCT) with a PhD grant no. SFRH/BD/61141/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram ME, 2013, ANTIMICROB AGENTS CH, V57, P2654, DOI 10.1128/AAC.02568-12; Appa RS, 2001, J BIOL CHEM, V276, P45848, DOI 10.1074/jbc.M107365200; Armstrong-James D, 2010, ANTIVIR RES, V86, P224, DOI 10.1016/j.antiviral.2010.02.324; Bercoff DP, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-98; Borrego P, 2012, ANTIVIR THER, V17, P565, DOI 10.3851/IMP1996; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; Buzon MJ, 2008, ANTIVIR THER, V13, P881; Ceccherini-Silberstein F, 2010, J ANTIMICROB CHEMOTH, V65, P2305, DOI 10.1093/jac/dkq326; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Charpentier C, 2011, ANTIVIR THER, V16, P937, DOI 10.3851/IMP1826; Charpentier C, 2011, ANTIMICROB AGENTS CH, V55, P1293, DOI 10.1128/AAC.00942-10; Charpentier C, 2010, AIDS, V24, P2753, DOI 10.1097/QAD.0b013e32833f9e36; Colson P, 2004, J CLIN MICROBIOL, V42, P570, DOI 10.1128/JCM.42.2.570-577.2004; Damond F, 2008, AIDS, V22, P665, DOI 10.1097/QAD.0b013e3282f51203; Dar MJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-94; de Silva TI, 2008, TRENDS MICROBIOL, V16, P588, DOI 10.1016/j.tim.2008.09.003; DeAnda F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077448; Departamento de Doencas Infecciosas do INSA. Unidade de Referencia e Vigilancia Laboratorial Epidemiologica. Nucleo de Vigilancia Laboratorial de Doencas Infecciosas, 2013, 144 SIDA DEP DOENC I; Desbois D, 2008, ANTIMICROB AGENTS CH, V52, P1545, DOI 10.1128/AAC.01284-07; DRELICH M, 1992, VIROLOGY, V188, P459, DOI 10.1016/0042-6822(92)90499-F; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ENGELMAN A, 1994, J VIROL, V68, P5911, DOI 10.1128/JVI.68.9.5911-5917.1994; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; Eron JJ, 2013, J INFECT DIS, V207, P740, DOI 10.1093/infdis/jis750; Esposito D, 1999, ADV VIRUS RES, V52, P319, DOI 10.1016/S0065-3527(08)60304-8; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Fransen S, 2009, ANTIMICROB AGENTS CH, V53, P4522, DOI 10.1128/AAC.00651-09; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Garrett N, 2008, AIDS, V22, P1091, DOI 10.1097/QAD.0b013e3282f9b165; Gerton JL, 1997, J BIOL CHEM, V272, P25809, DOI 10.1074/jbc.272.41.25809; Gomes P, 2009, ALGORITHM INTERPRETA; Gottlieb GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022204; Hansmann A, 2005, JAIDS-J ACQ IMM DEF, V38, P335; Harper AL, 2001, J VIROL, V75, P7756, DOI 10.1128/JVI.75.16.7756-7762.2001; HICKMAN AB, 1994, J BIOL CHEM, V269, P29279; Hu ZX, 2010, JAIDS-J ACQ IMM DEF, V55, P148, DOI 10.1097/QAI.0b013e3181e9a87a; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Buzon MJ, 2010, AIDS, V24, P17, DOI 10.1097/QAD.0b013e328331c81e; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; Lataillade M, 2007, ANTIVIR THER, V12, P563; Lee SP, 1997, BIOCHEMISTRY-US, V36, P173, DOI 10.1021/bi961849o; Low A, 2009, ANTIMICROB AGENTS CH, V53, P4275, DOI 10.1128/AAC.00397-09; Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07; Malet I, 2009, J ANTIMICROB CHEMOTH, V63, P795, DOI 10.1093/jac/dkp014; Matheron S, 2006, AIDS, V20, P459, DOI 10.1097/01.aids.0000199829.57112.2f; McColl DJ, 2007, ANTIVIR THER, V12, pS11; Mesplede T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-22; Ni XJ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-68; Ntemgwa M, 2007, ANTIMICROB AGENTS CH, V51, P604, DOI 10.1128/AAC.00870-06; Poveda E, 2004, AIDS RES HUM RETROV, V20, P347, DOI 10.1089/088922204322996590; Quashie PK, 2012, J VIROL, V86, P2696, DOI 10.1128/JVI.06591-11; Rodes B, 2006, J ANTIMICROB CHEMOTH, V57, P709, DOI 10.1093/jac/dkl034; Rodes B, 2006, AIDS, V20, P127, DOI 10.1097/01.aids.0000196171.35056.6c; Roquebert B, 2008, J ANTIMICROB CHEMOTH, V62, P914, DOI 10.1093/jac/dkn335; Roquebert B, 2008, AIDS, V22, P2045, DOI 10.1097/QAD.0b013e32830f4c7d; Salgado M, 2009, J CLIN VIROL, V46, P173, DOI 10.1016/j.jcv.2009.06.020; Smith RA, 2011, AIDS, V25, P2235, DOI 10.1097/QAD.0b013e32834d8e52; Smith RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045372; Smith RA, 2009, J INFECT DIS, V199, P1323, DOI 10.1086/597802; Trevino A, 2011, J ANTIMICROB CHEMOTH, V66, P1484, DOI 10.1093/jac/dkr164; Tuaillon E, 2004, JAIDS-J ACQ IMM DEF, V37, P1543, DOI 10.1097/00126334-200412150-00001; *UNAIDS, 2006, AIDS EP UPD DEC 2006; van Rossum Guido, 2011, PYTHON LANGUAGE WEBS; VANGENT DC, 1992, P NATL ACAD SCI USA, V89, P9598, DOI 10.1073/pnas.89.20.9598; VINK C, 1993, NUCLEIC ACIDS RES, V21, P1419, DOI 10.1093/nar/21.6.1419; Wandeler G, 2011, AIDS, V25, P2306, DOI 10.1097/QAD.0b013e32834cdb89; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Witvrouw M, 2004, ANTIVIR THER, V9, P57; WOERNER AM, 1993, NUCLEIC ACIDS RES, V21, P3507, DOI 10.1093/nar/21.15.3507; Xu L, 2008, AIDS RES HUM RETROV, V24, P1003, DOI 10.1089/aid.2007.0303; Xu L, 2009, AIDS RES HUM RETROV, V25, P843, DOI 10.1089/aid.2009.0039; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659	75	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92747	10.1371/journal.pone.0092747	http://dx.doi.org/10.1371/journal.pone.0092747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681625	Green Published, gold, Green Submitted			2022-12-25	WOS:000333678100015
J	Furubayashi, M; Ikezumi, M; Kajiwara, J; Iwasaki, M; Fujii, A; Li, L; Saito, K; Umeno, D				Furubayashi, Maiko; Ikezumi, Mayu; Kajiwara, Jun; Iwasaki, Miki; Fujii, Akira; Li, Ling; Saito, Kyoichi; Umeno, Daisuke			A High-Throughput Colorimetric Screening Assay for Terpene Synthase Activity Based on Substrate Consumption	PLOS ONE			English	Article							SESQUITERPENE CYCLASE; DIRECTED MUTAGENESIS; DIPHOSPHATE SYNTHASE; TAXADIENE SYNTHASE; PSEUDOMATURE FORM; ESCHERICHIA-COLI; GENE FAMILY; BIOSYNTHESIS; EXPRESSION; EVOLUTION	Terpene synthases catalyze the formation of a variety of terpene chemical structures. Systematic mutagenesis studies have been effective in providing insights into the characteristic and complex mechanisms of C-C bond formations and in exploring the enzymatic potential for inventing new chemical structures. In addition, there is growing demand to increase terpene synthase activity in heterologous hosts, given the maturation of metabolic engineering and host breeding for terpenoid synthesis. We have developed a simple screening method for the cellular activities of terpene synthases by scoring their substrate consumption based on the color loss of the cell harboring carotenoid pathways. We demonstrate that this method can be used to detect activities of various terpene synthase or prenyltransferase genes in a high-throughput manner, irrespective of the product type, enabling the mutation analysis and directed evolution of terpene synthases. We also report the possibility for substrate-specific screening system of terpene synthases by taking advantage of the substrate-size specificity of C-30 and C-40 carotenoid pathways.	[Furubayashi, Maiko; Ikezumi, Mayu; Kajiwara, Jun; Iwasaki, Miki; Fujii, Akira; Li, Ling; Saito, Kyoichi; Umeno, Daisuke] Chiba Univ, Dept Appl Chem & Biotechnol, Chiba, Japan; [Umeno, Daisuke] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan	Chiba University; Japan Science & Technology Agency (JST)	Umeno, D (corresponding author), Chiba Univ, Dept Appl Chem & Biotechnol, Chiba, Japan.	umeno@faculty.chiba-u.jp	Furubayashi, Maiko/E-1457-2011; Li, Ling/F-9769-2018	Furubayashi, Maiko/0000-0001-5215-523X; Li, Ling/0000-0003-2192-4678	JSPS; PRESTO (JST); MEXT/JSPS [23108507]; Mishima-Kaiun Memorial Foundation; Futaba Electronics Memorial Foundation; Shorai Foundation for Science and Technology	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); PRESTO (JST)(Japan Science & Technology Agency (JST)); MEXT/JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mishima-Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Futaba Electronics Memorial Foundation; Shorai Foundation for Science and Technology	M.F. is supported by a JSPS fellowship for young scientists. D.U. is supported by the PRESTO (JST) and the MEXT/JSPS Grant-in-Aid for Scientific Research on Innovative Areas 23108507, Biosynthetic Machinery. This work have been financially supported by the Mishima-Kaiun Memorial Foundation, the Futaba Electronics Memorial Foundation, and the Shorai Foundation for Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony JR, 2009, METAB ENG, V11, P13, DOI 10.1016/j.ymben.2008.07.007; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Austin MB, 2008, NAT CHEM BIOL, V4, P217, DOI 10.1038/nchembio0408-217; Bar-Even A, 2013, CURR OPIN BIOTECH, V24, P310, DOI 10.1016/j.copbio.2012.10.006; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Burke C, 2002, ARCH BIOCHEM BIOPHYS, V405, P130, DOI 10.1016/S0003-9861(02)00335-1; Cane D.E., 1999, COMPR NAT PROD CHEM, V2, P155, DOI [10.1016/B978-0-08-091283-7.00039-4, DOI 10.1016/B978-0-08-091283-7.00039-4]; Cane DE, 2000, ARCH BIOCHEM BIOPHYS, V376, P354, DOI 10.1006/abbi.2000.1734; Chen APC, 2005, BIOCHEM J, V386, P169, DOI 10.1042/BJ20040785; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Christianson DW, 2008, CURR OPIN CHEM BIOL, V12, P141, DOI 10.1016/j.cbpa.2007.12.008; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; CUNNINGHAM FX, 1994, PLANT CELL, V6, P1107, DOI 10.1105/tpc.6.8.1107; Diaz JE, 2011, PROTEIN SCI, V20, P1597, DOI 10.1002/pro.691; Dudareva N, 2003, PLANT CELL, V15, P1227, DOI 10.1105/tpc.011015; Dumelin CE, 2012, NAT CHEM BIOL, V8, P913, DOI [10.1038/nchembio.1070, 10.1038/NCHEMBIO.1070]; FACCHINI PJ, 1992, P NATL ACAD SCI USA, V89, P11088, DOI 10.1073/pnas.89.22.11088; Furubayashi M, 2014, FEBS LETT, V588, P436, DOI 10.1016/j.febslet.2013.12.003; Huang QL, 2000, TETRAHEDRON LETT, V41, P9701, DOI 10.1016/S0040-4039(00)01733-0; Iijima Y, 2004, PLANT PHYSIOL, V134, P370, DOI 10.1104/pp.103.032946; Kirby J, 2009, ANNU REV PLANT BIOL, V60, P335, DOI 10.1146/annurev.arplant.043008.091955; Kotera I, 2008, J BIOTECHNOL, V137, P1, DOI 10.1016/j.jbiotec.2008.07.1816; Lange BM, 2013, PLANT BIOTECHNOL J, V11, P169, DOI 10.1111/pbi.12022; Lauchli R, 2013, ANGEW CHEM INT EDIT, V52, P5571, DOI 10.1002/anie.201301362; Little DB, 2002, ARCH BIOCHEM BIOPHYS, V402, P120, DOI 10.1016/S0003-9861(02)00068-1; Marienhagen J, 2013, J BIOTECHNOL, V163, P166, DOI 10.1016/j.jbiotec.2012.06.001; Martin DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-226; Martin VJJ, 2001, BIOTECHNOL BIOENG, V75, P497, DOI 10.1002/bit.10037; McAndrew RP, 2011, STRUCTURE, V19, P1876, DOI 10.1016/j.str.2011.09.013; McCaskill D, 1997, Adv Biochem Eng Biotechnol, V55, P107; Misawa N, 2011, CURR OPIN BIOTECH, V22, P627, DOI 10.1016/j.copbio.2011.01.002; Nieuwenhuizen NJ, 2009, J EXP BOT, V60, P3203, DOI 10.1093/jxb/erp162; O'Maille PE, 2008, NAT CHEM BIOL, V4, P617, DOI 10.1038/nchembio.113; Ohnuma S, 1996, J BIOL CHEM, V271, P30748, DOI 10.1074/jbc.271.48.30748; Pelz A, 2005, J BIOL CHEM, V280, P32493, DOI 10.1074/jbc.M505070200; Reiling KK, 2004, BIOTECHNOL BIOENG, V87, P200, DOI 10.1002/bit.20128; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Seemann M, 2002, J AM CHEM SOC, V124, P7681, DOI 10.1021/ja026058q; Segura MJR, 2003, NAT PROD REP, V20, P304, DOI 10.1039/b008338k; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Tarshis LC, 1996, P NATL ACAD SCI USA, V93, P15018, DOI 10.1073/pnas.93.26.15018; Umeno D, 2004, J BACTERIOL, V186, P1531, DOI 10.1128/JB.186.5.1531-1536.2004; Umeno D, 2002, J BACTERIOL, V184, P6690, DOI 10.1128/JB.184.23.6690-6699.2002; Vedula LS, 2008, ARCH BIOCHEM BIOPHYS, V469, P184, DOI 10.1016/j.abb.2007.10.015; VOGELI U, 1990, PLANT PHYSIOL, V93, P182, DOI 10.1104/pp.93.1.182; WHITEHEAD IM, 1989, PHYTOCHEMISTRY, V28, P775, DOI 10.1016/0031-9422(89)80114-1; WIELAND B, 1994, J BACTERIOL, V176, P7719, DOI 10.1128/JB.176.24.7719-7726.1994; Wildung MR, 1996, J BIOL CHEM, V271, P9201, DOI 10.1074/jbc.271.16.9201; Williams DC, 2000, ARCH BIOCHEM BIOPHYS, V379, P137, DOI 10.1006/abbi.2000.1865; Williams DC, 1998, BIOCHEMISTRY-US, V37, P12213, DOI 10.1021/bi980854k; Wise M. L., 1999, COMPREHENSIVE NATURA, P97, DOI DOI 10.1016/B978-0-08-091283-7.00038-2; Withers ST, 2007, APPL ENVIRON MICROB, V73, P6277, DOI 10.1128/AEM.00861-07; Yoshikuni Y, 2006, CHEM BIOL, V13, P91, DOI 10.1016/j.chembiol.2005.10.016	54	35	38	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93317	10.1371/journal.pone.0093317	http://dx.doi.org/10.1371/journal.pone.0093317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681801	gold, Green Published, Green Submitted			2022-12-25	WOS:000333678100040
J	Cao, PH; Wang, X; Fang, SS; Cheng, XW; Chan, KP; Wang, XL; Lu, X; Wu, CL; Tang, XJ; Zhang, RL; Ma, HW; Cheng, JQ; Wong, CM; Yang, L				Cao, Pei-Hua; Wang, Xin; Fang, Shi-Song; Cheng, Xiao-Wen; Chan, King-Pan; Wang, Xi-Ling; Lu, Xing; Wu, Chun-Li; Tang, Xiu-Juan; Zhang, Ren-Li; Ma, Han-Wu; Cheng, Jin-Quan; Wong, Chit-Ming; Yang, Lin			Forecasting Influenza Epidemics from Multi-Stream Surveillance Data in a Subtropical City of China	PLOS ONE			English	Article							OUTBREAK DETECTION	Background: Influenza has been associated with heavy burden of mortality and morbidity in subtropical regions. However, timely forecast of influenza epidemic in these regions has been hindered by unclear seasonality of influenza viruses. In this study, we developed a forecasting model by integrating multiple sentinel surveillance data to predict influenza epidemics in a subtropical city Shenzhen, China. Methods: Dynamic linear models with the predictors of single or multiple surveillance data for influenza-like illness (ILI) were adopted to forecast influenza epidemics from 2006 to 2012 in Shenzhen. Temporal coherence of these surveillance data with laboratory-confirmed influenza cases was evaluated by wavelet analysis and only the coherent data streams were entered into the model. Timeliness, sensitivity and specificity of these models were also evaluated to compare their performance. Results: Both influenza virology data and ILI consultation rates in Shenzhen demonstrated a significant annual seasonal cycle (p < 0.05) during the entire study period, with occasional deviations observed in some data streams. The forecasting models that combined multi-stream ILI surveillance data generally outperformed the models with single-stream ILI data, by providing more timely, sensitive and specific alerts. Conclusions: Forecasting models that combine multiple sentinel surveillance data can be considered to generate timely alerts for influenza epidemics in subtropical regions like Shenzhen.	[Cao, Pei-Hua; Chan, King-Pan; Wang, Xi-Ling; Wong, Chit-Ming; Yang, Lin] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Wang, Xin; Fang, Shi-Song; Cheng, Xiao-Wen; Wu, Chun-Li; Tang, Xiu-Juan; Zhang, Ren-Li; Ma, Han-Wu; Cheng, Jin-Quan] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Yang, Lin] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Shenzhen Center for Disease Control & Prevention (SZCDC); Hong Kong Polytechnic University	Cheng, JQ (corresponding author), Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China.	Cjinquan@vip.sohu.com; hrmrwcm@hku.hk	Cao, Peihua/GYU-4280-2022; YANG, Lin/F-9601-2014	YANG, Lin/0000-0002-5964-3233				Alonso WJ, 2007, AM J EPIDEMIOL, V165, P9; [Anonymous], 2002, Wkly Epidemiol Rec, V77, P191; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Centers for Disease Control and Prevention (CDC), 2012, OV INFL SURV US; Cheng XW, 2013, J INFECT DIS, V207, P106, DOI 10.1093/infdis/jis526; Chowell G, 2010, P ROY SOC B-BIOL SCI, V277, P1857, DOI 10.1098/rspb.2009.1897; COSTAGLIOLA D, 1991, AM J PUBLIC HEALTH, V81, P97, DOI 10.2105/AJPH.81.1.97; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; Hutwagner LC, 1997, EMERG INFECT DIS, V3, P395, DOI 10.3201/eid0303.970322; Kleinman KP, 2006, STAT METHODS MED RES, V15, P445, DOI 10.1177/0962280206071641; Lau EHY, 2008, EMERG INFECT DIS, V14, P1154, DOI 10.3201/eid1407.080060; Li J, 2010, J ROY STAT SOC, V59, P20; Maraun D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016707; Monto AS, 2000, ARCH INTERN MED, V160, P5; OBrien SJ, 1997, PUBLIC HEALTH, V111, P255, DOI 10.1016/S0033-3506(97)00044-9; Peiris G, 2010, J STAT SOFTW, V36, P16; Petris G, 2009, USE R, P1, DOI 10.1007/b135794_1; Petris G, 2011, J STAT SOFTW, V41, P1; R Core Team, 2021, R LANG ENV STAT COMP; Stern L, 1999, EPIDEMIOL INFECT, V122, P103, DOI 10.1017/S0950268898001939; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tusell F, 2011, J STAT SOFTW, V39, P1; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Wang X, 2011, EPIDEMIOL INFECT, V139, P1551, DOI 10.1017/S0950268810002694; Widdowson MA, 2003, EMERG INFECT DIS, V9, P1046; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315	28	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92945	10.1371/journal.pone.0092945	http://dx.doi.org/10.1371/journal.pone.0092945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676091	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500059
J	Hyde, ER; Andrade, F; Vaksman, Z; Parthasarathy, K; Jiang, H; Parthasarathy, DK; Torregrossa, AC; Tribble, G; Kaplan, HB; Petrosino, JF; Bryan, NS				Hyde, Embriette R.; Andrade, Fernando; Vaksman, Zalman; Parthasarathy, Kavitha; Jiang, Hong; Parthasarathy, Deepa K.; Torregrossa, Ashley C.; Tribble, Gena; Kaplan, Heidi B.; Petrosino, Joseph F.; Bryan, Nathan S.			Metagenomic Analysis of Nitrate-Reducing Bacteria in the Oral Cavity: Implications for Nitric Oxide Homeostasis	PLOS ONE			English	Article							INCIDENT CARDIOVASCULAR EVENTS; FLOW-MEDIATED DILATION; DIETARY NITRATE; BLOOD-PRESSURE; ENDOTHELIAL FUNCTION; INORGANIC NITRATE; DYSFUNCTION; GENERATION; PHYSIOLOGY; DISEASE	The microbiota of the human lower intestinal tract helps maintain healthy host physiology, for example through nutrient acquisition and bile acid recycling, but specific positive contributions of the oral microbiota to host health are not well established. Nitric oxide (NO) homeostasis is crucial to mammalian physiology. The recently described entero-salivary nitrate-nitrite-nitric oxide pathway has been shown to provide bioactive NO from dietary nitrate sources. Interestingly, this pathway is dependent upon oral nitrate-reducing bacteria, since humans lack this enzyme activity. This pathway appears to represent a newly recognized symbiosis between oral nitrate-reducing bacteria and their human hosts in which the bacteria provide nitrite and nitric oxide from nitrate reduction. Here we measure the nitrate-reducing capacity of tongue-scraping samples from six healthy human volunteers, and analyze metagenomes of the bacterial communities to identify bacteria contributing to nitrate reduction. We identified 14 candidate species, seven of which were not previously believed to contribute to nitrate reduction. We cultivated isolates of four candidate species in single-and mixed-species biofilms, revealing that they have substantial nitrate-and nitrite-reduction capabilities. Colonization by specific oral bacteria may thus contribute to host NO homeostasis by providing nitrite and nitric oxide. Conversely, the lack of specific nitrate-reducing communities may disrupt the nitrate-nitrite-nitric oxide pathway and lead to a state of NO insufficiency. These findings may also provide mechanistic evidence for the oral systemic link. Our results provide a possible new therapeutic target and paradigm for NO restoration in humans by specific oral bacteria.	[Hyde, Embriette R.] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Hyde, Embriette R.; Petrosino, Joseph F.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [Andrade, Fernando; Vaksman, Zalman; Kaplan, Heidi B.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Parthasarathy, Kavitha; Tribble, Gena] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Periodont, Houston, TX 77030 USA; [Petrosino, Joseph F.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Jiang, Hong; Parthasarathy, Deepa K.; Torregrossa, Ashley C.; Bryan, Nathan S.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, Texas Therapeut Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Petrosino, JF (corresponding author), Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA.	jpetrosi@bcm.edu; Nathan.Bryan@uth.tmc.edu	Tribble, Gena/A-8755-2011; Petrosino, Joseph F./AAF-1621-2019	Tribble, Gena/0000-0002-6468-2851	Alkek Foundation; National Institute of Dental and Cranial Research of the NIH [R01 DE021394]; National Human Genome Research Institute [U54 HG004973]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008231] Funding Source: NIH RePORTER	Alkek Foundation; National Institute of Dental and Cranial Research of the NIH; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research reported here was supported in part by grants from The Alkek Foundation to JFP and the National Institute of Dental and Cranial Research of the NIH under award number R01 DE021394 to HBK. The authors would like to thank the Human Genome Sequencing Center at BCM, where DNA sequence data generation for this manuscript took place, especially Ginger Metcalf and Richard Gibbs and The National Human Genome Research Institute grant (U54 HG004973) to Richard Gibbs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Bryan NS, 2008, FREE RADICAL BIO MED, V45, P468, DOI 10.1016/j.freeradbiomed.2008.04.040; Bryan NS, 2007, P NATL ACAD SCI USA, V104, P19144, DOI 10.1073/pnas.0706579104; Bryan NS, 2007, FREE RADICAL BIO MED, V43, P645, DOI 10.1016/j.freeradbiomed.2007.04.026; Bugiardini R, 2004, CIRCULATION, V109, P2518, DOI 10.1161/01.CIR.0000128208.22378.E3; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlstrom M, 2011, CARDIOVASC RES, V89, P574, DOI 10.1093/cvr/cvq366; Carlstrom M, 2010, P NATL ACAD SCI USA, V107, P17716, DOI 10.1073/pnas.1008872107; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Doel JJ, 2005, EUR J ORAL SCI, V113, P14, DOI 10.1111/j.1600-0722.2004.00184.x; DUNCAN C, 1995, NAT MED, V1, P546, DOI 10.1038/nm0695-546; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Hendgen-Cotta UB, 2012, CIRCULATION, V126, P1983, DOI 10.1161/CIRCULATIONAHA.112.112912; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Joshipura K, 2000, COMPEND CONTIN ED S, V12-23; Kapil V, 2013, FREE RADICAL BIO MED, V55, P93, DOI 10.1016/j.freeradbiomed.2012.11.013; Kleinbongard P, 2006, FREE RADICAL BIO MED, V40, P295, DOI 10.1016/j.freeradbiomed.2005.08.025; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Lundberg JO, 2004, FREE RADICAL BIO MED, V37, P395, DOI 10.1016/j.freeradbiomed.2004.04.027; Lundberg JO, 2004, NAT REV MICROBIOL, V2, P593, DOI 10.1038/nrmicro929; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MONCADA S, 1991, PHARMACOL REV, V43, P109; Petersson J, 2009, FREE RADICAL BIO MED, V46, P1068, DOI 10.1016/j.freeradbiomed.2009.01.011; Alonso VR, 2013, BRIT J NUTR, V109, pS21, DOI 10.1017/S0007114512005235; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; STACKEBRANDT E, 1991, APPL ENVIRON MICROB, V57, P1468, DOI 10.1128/AEM.57.5.1468-1477.1991; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276; Yeboah J, 2009, CIRCULATION, V120, P502, DOI 10.1161/CIRCULATIONAHA.109.864801	32	125	131	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e88645	10.1371/journal.pone.0088645	http://dx.doi.org/10.1371/journal.pone.0088645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670812	Green Published, gold			2022-12-25	WOS:000333677000002
J	Victorio, CBL; Xu, YS; Ng, Q; Chow, VTK; Chua, KB				Victorio, Carla Bianca Luena; Xu, Yishi; Ng, Qimei; Chow, Vincent T. K.; Chua, Kaw Bing			Phenotypic and Genotypic Characteristics of Novel Mouse Cell Line (NIH/3T3)-Adapted Human Enterovirus 71 Strains (EV71:TLLm and EV71:TLLmv)	PLOS ONE			English	Article							NEUROGENIC PULMONARY-EDEMA; POLIOMYELITIS-LIKE DISEASE; MOUTH-DISEASE; SWISS-MODEL; INFECTION; OUTBREAK; FOOT; EPIDEMIC; HAND; VIRUS	Since its identification in 1969, Enterovirus 71 (EV71) has been causing periodic outbreaks of infection in children worldwide and most prominently in the Asia-Pacific Region. Understanding the pathogenesis of Enterovirus 71 (EV71) is hampered by the virus's inability to infect small animals and replicate in their derived in vitro cultured cells. This manuscript describes the phenotypic and genotypic characteristics of two selected EV71 strains (EV71:TLLm and EV71:TLLmv), which have been adapted to replicate in mouse-derived NIH/3T3 cells, in contrast to the original parental virus which is only able to replicate in primate cell lines. The EV71: TLLm strain exhibited productive infection in all primate and rodent cell lines tested, while EV71: TLLmv exhibited greater preference for mouse cell lines. EV71: TLLmv displayed higher degree of adaptation and temperature adaptability in NIH/3T3 cells than in Vero cells, suggesting much higher fitness in NIH/3T3 cells. In comparison with the parental EV71:BS strain, the adapted strains accumulated multiple adaptive mutations in the genome resulting in amino acid substitutions, most notably in the capsid-encoding region (P1) and viral RNA-dependent RNA polymerase (3D). Two mutations, E167D and L169F, were mapped to the VP1 canyon that binds the SCARB2 receptor on host cells. Another two mutations, S135T and K140I, were located in the VP2 neutralization epitope spanning amino acids 136-150. This is the first report of human EV71 with the ability to productively infect rodent cell lines in vitro.	[Victorio, Carla Bianca Luena; Xu, Yishi; Ng, Qimei; Chua, Kaw Bing] Natl Univ Singapore, Temasek Lifesci Lab, Singapore 117548, Singapore; [Victorio, Carla Bianca Luena; Xu, Yishi; Chow, Vincent T. K.] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Host & Pathogen Interact Lab,Dept Microbiol, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Chua, KB (corresponding author), Natl Univ Singapore, Temasek Lifesci Lab, 1 Res Link, Singapore 117548, Singapore.	chuakb@tll.org.sg	Victorio, Bianca/AAF-5227-2021	Victorio, Bianca/0000-0002-1161-5006; Chow, Vincent/0000-0003-2634-6213	Temasek LifeSciences Laboratory (TLL)	Temasek LifeSciences Laboratory (TLL)	The research was fully funded by Temasek LifeSciences Laboratory (TLL). The funder had no role in study design, data collection and analysis, or preparation of the manuscript. The authors have obtained permission from the institute to publish these results.	ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Arita M, 2005, J GEN VIROL, V86, P1391, DOI 10.1099/vir.0.80784-0; Arita M, 2008, J VIROL, V82, P1787, DOI 10.1128/JVI.01798-07; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bible JM, 2008, J CLIN MICROBIOL, V46, P3192, DOI 10.1128/JCM.00628-08; Biebricher CK, 2006, CURR TOP MICROBIOL, V299, P1; BLOMBERG J, 1974, LANCET, V2, P112; BORREGO B, 1993, J VIROL, V67, P6071, DOI 10.1128/JVI.67.10.6071-6079.1993; Burch CL, 1999, GENETICS, V151, P921; Chang LY, 1998, LANCET, V352, P367, DOI 10.1016/S0140-6736(98)24031-1; Chen P, 2012, J BIOL CHEM, V287, P6406, DOI 10.1074/jbc.M111.301622; Chen YC, 2004, J GEN VIROL, V85, P69, DOI 10.1099/vir.0.19423-0; CHONMAITREE T, 1981, PEDIATRICS, V67, P489; Chua BH, 2008, J GEN VIROL, V89, P1622, DOI 10.1099/vir.0.83676-0; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; DEIBEL R, 1975, P SOC EXP BIOL MED, V148, P203, DOI 10.3181/00379727-148-38506; Domingo E, 2002, J VIROL, V76, P463, DOI 10.1128/JVI.76.1.463-465.2002; Domingo E, 1997, REV MED VIROL, V7, P87, DOI 10.1002/(SICI)1099-1654(199707)7:2<87::AID-RMV188>3.0.CO;2-0; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1993, GENE, V135, P37, DOI 10.1016/0378-1119(93)90047-7; Eigen M., 1988, RNA GENETICS, V3, P211; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAGIWARA A, 1978, INTERVIROLOGY, V9, P60, DOI 10.1159/000148922; HAGIWARA A, 1983, J GEN VIROL, V64, P491, DOI 10.1099/0022-1317-64-2-499; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HAYWARD JC, 1989, PEDIATR INFECT DIS J, V8, P611, DOI 10.1097/00006454-198909000-00009; ISHIMARU Y, 1980, ARCH DIS CHILD, V55, P583, DOI 10.1136/adc.55.8.583; KENNETT ML, 1974, B WORLD HEALTH ORGAN, V51, P609; Khong WX, 2012, J VIROL, V86, P2121, DOI 10.1128/JVI.06103-11; Lin JY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Lum LCS, 1998, LANCET, V352, P1391, DOI 10.1016/S0140-6736(05)60789-1; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; Melnick J.L., 1996, FIELDS VIROLOGY, Vthird, P655; Miyamura K, 2011, J GEN VIROL, V92, P287, DOI 10.1099/vir.0.022418-0; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; REED L. J., 1938, AMER JOUR HYG, V27, P493; SAMUDA GM, 1987, PEDIATR INFECT DIS J, V6, P206, DOI 10.1097/00006454-198702000-00013; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; SHINDAROV LM, 1979, J HYG EPID MICROB IM, V23, P284; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C; TAGAYA I, 1981, JPN J MED SCI BIOL, V34, P191, DOI 10.7883/yoken1952.34.191; The Central People's Government of the People's Republic of China, 2008, HAND FOOT MOUTH DIS; Wang JR, 2000, J CLIN VIROL, V17, P91, DOI 10.1016/S1386-6532(00)00079-2; Wang W, 2011, MICROBES INFECT, V13, P862, DOI 10.1016/j.micinf.2011.04.004; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Yamayoshi S, 2013, J VIROL, V87, P3335, DOI 10.1128/JVI.02070-12; Yamayoshi S, 2011, J VIROL, V85, P4937, DOI 10.1128/JVI.02358-10; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yan JJ, 2000, J CLIN VIROL, V17, P13, DOI 10.1016/S1386-6532(00)00067-6; Yang F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-508; Yao PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051996; Zaini Z, 2012, J GEN VIROL, V93, P1935, DOI 10.1099/vir.0.043893-0; Zaini Z, 2012, VIRUS RES, V167, P86, DOI 10.1016/j.virusres.2012.04.009; Zaini Z, 2012, VIRUS RES, V165, P151, DOI 10.1016/j.virusres.2012.02.009; Zeng M, 2012, J CLIN VIROL, V53, P285, DOI 10.1016/j.jcv.2011.12.025; Zhang Y, 2011, LAB INVEST, V91, P1337, DOI 10.1038/labinvest.2011.82	64	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92719	10.1371/journal.pone.0092719	http://dx.doi.org/10.1371/journal.pone.0092719			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671184	gold, Green Submitted, Green Published			2022-12-25	WOS:000333677000069
J	Abramowski, P; Otto, B; Martin, R				Abramowski, Pierre; Otto, Benjamin; Martin, Roland			The Orally Available, Synthetic Ether Lipid Edelfosine Inhibits T Cell Proliferation and Induces a Type I Interferon Response	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; GENE-EXPRESSION; HOMEOSTATIC PROLIFERATION; ET-18-OCH3 EDELFOSINE; SELECTIVE INDUCTION; CANCER-CELLS; APOPTOSIS; BETA; RISK; INVOLVEMENT	The drug edelfosine is a synthetic analog of 2-lysophosphatidylcholine. Edelfosine is incorporated by highly proliferating cells, e. g. activated immune cells. It acts on cellular membranes by selectively aggregating the cell death receptor Fas in membrane rafts and interference with phosphatidylcholine (PC) synthesis with subsequent induction of apoptosis. Edelfosine has been proposed for the treatment of autoimmune diseases like multiple sclerosis (MS). Earlier studies on the animal model of MS, experimental autoimmune encephalomyelitis (EAE), have generated first evidence for the efficacy of edelfosine treatment. However, it is unknown if the previously described mechanisms for edelfosine action, which are derived from in vitro studies, are solely responsible for the amelioration of EAE or if edelfosine may exert additional effects, which may be beneficial in the context of autoimmunity. Since it was the purpose of our studies to assess the potential usefulness of edelfosine for the treatment of MS, we examined its mechanism/s of action on immune functions in human T cells. Low doses of edelfosine led to a decrease in homeostatic proliferation, and further studies of the mechanism/s of action by genome-wide transcriptional profiling showed that edelfosine reduces the expression of MHC class II molecules, of molecules involved in MHC class II-associated processing and presentation, and finally upregulated a series of type I interferon-associated genes. The inhibition of homeostatic proliferation, as well as the effects on MHC class II expression and -presentation, and the induction of type I interferon-associated genes are novel and interesting in the context of developing edelfosine for clinical use in MS and possibly also other T cell-mediated autoimmune diseases.	[Abramowski, Pierre; Martin, Roland] Univ Med Ctr Hamburg Eppendorf, ZMNH, Inst Neuroimmunol & Clin Multiple Sclerosis Res I, Hamburg, Germany; [Abramowski, Pierre] Univ Med Ctr Hamburg Eppendorf, Clin Stem Cell Transplantat, Res Dept Cell & Gene Therapy, Hamburg, Germany; [Otto, Benjamin] Univ Med Ctr Hamburg Eppendorf, Ctr Internal Med, Dept Internal Med 1, Hamburg, Germany; [Otto, Benjamin] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Ctr Diagnost, Hamburg, Germany; [Martin, Roland] Univ Zurich Hosp, Dept Neurol, Neuroimmunol & MS Res, CH-8091 Zurich, Switzerland	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zurich; University Zurich Hospital	Martin, R (corresponding author), Univ Med Ctr Hamburg Eppendorf, ZMNH, Inst Neuroimmunol & Clin Multiple Sclerosis Res I, Hamburg, Germany.	roland.martin@usz.ch		Abramowski, Pierre/0000-0002-7121-6912	Gemeinnuetzige Hertie Stiftung	Gemeinnuetzige Hertie Stiftung	This work and the inims were supported by the Gemeinnuetzige Hertie Stiftung (http://www.ghst.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREESEN R, 1980, IMMUNOBIOLOGY, V156, P498, DOI 10.1016/S0171-2985(80)80083-0; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; BOGGS KP, 1995, J BIOL CHEM, V270, P7757, DOI 10.1074/jbc.270.13.7757; BOGGS KP, 1995, J BIOL CHEM, V270, P11612, DOI 10.1074/jbc.270.19.11612; BRINKMANN V, 1993, J EXP MED, V178, P1655, DOI 10.1084/jem.178.5.1655; Cabaner C, 1999, BRIT J PHARMACOL, V127, P813, DOI 10.1038/sj.bjp.0702606; Chawla-Sarkar M, 2001, CLIN CANCER RES, V7, P1821; Cousens LP, 1999, J EXP MED, V189, P1315, DOI 10.1084/jem.189.8.1315; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; FUJIWARA K, 1994, CANCER CHEMOTH PHARM, V34, P472, DOI 10.1007/s002800050175; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; Gajate C, 1998, MOL PHARMACOL, V53, P602, DOI 10.1124/mol.53.4.602; Gajate C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005044; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Hilpert J, 2008, J NEUROIMMUNOL, V199, P115, DOI 10.1016/j.jneuroim.2008.04.036; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JERSILD C, 1973, LANCET, V2, P1221; Jones JL, 2013, P NATL ACAD SCI USA, V110, P20200, DOI 10.1073/pnas.1313654110; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kiss Z, 1997, FEBS LETT, V412, P313, DOI 10.1016/S0014-5793(97)00817-X; KLEINFRANKE A, 1992, J AUTOIMMUN, V5, P83, DOI 10.1016/S0896-8411(05)80053-8; Kny G, 1969, LYSOLECITHIN ANALOGA; Kondo T, 2001, NAT IMMUNOL, V2, P932, DOI 10.1038/ni711; Laplaud DA, 2004, BRAIN, V127, P981, DOI 10.1093/brain/awh119; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Lunemann JD, 2008, J EXP MED, V205, P1763, DOI 10.1084/jem.20072397; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; MCRAE BL, 1995, J EXP MED, V182, P75, DOI 10.1084/jem.182.1.75; Micali OC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-52; Mohme M, 2013, BRAIN, V136, P1783, DOI 10.1093/brain/awt108; Mollinedo F, 1997, CANCER RES, V57, P1320; Mollinedo F, 2004, CURR MED CHEM, V11, P3163, DOI 10.2174/0929867043363703; MOLLINEDO F, 1993, BIOCHEM BIOPH RES CO, V192, P603, DOI 10.1006/bbrc.1993.1458; MUNDER PG, 1990, CHEM IMMUNOL, V49, P206; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Muraro PA, 2004, J NEUROIMMUNOL, V150, P123, DOI 10.1016/j.jneuroim.2004.01.002; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; Riise T, 2003, NEUROLOGY, V61, P1122, DOI 10.1212/01.WNL.0000081305.66687.D2; ROOS G, 1986, LEUKEMIA RES, V10, P195, DOI 10.1016/0145-2126(86)90042-1; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sellebjerg F, 2008, MULT SCLER J, V14, P615, DOI 10.1177/1352458507085976; Selleri C, 1997, BLOOD, V89, P957, DOI 10.1182/blood.V89.3.957; Serrano-Fernandez P, 2010, AUTOIMMUNITY, V43, P172, DOI 10.3109/08916930903219040; Singh MK, 2007, J NEUROL SCI, V258, P52, DOI 10.1016/j.jns.2007.02.034; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Sturzebecher S, 2003, BRAIN, V126, P1419, DOI 10.1093/brain/awg147; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; van Baarsen LGM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001927; van der Luit AH, 2002, J BIOL CHEM, V277, P39541, DOI 10.1074/jbc.M203176200; van der Luit AH, 2007, MOL CANCER THER, V6, P2337, DOI 10.1158/1535-7163.MCT-07-0202; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Zerp SF, 2008, ANTI-CANCER DRUG, V19, P65, DOI 10.1097/CAD.0b013e3282f16d36	57	12	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e91970	10.1371/journal.pone.0091970	http://dx.doi.org/10.1371/journal.pone.0091970			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667731	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000333675600015
J	Charrier, O; Dupont, P; Pornon, A; Escaravage, N				Charrier, Olivia; Dupont, Pierre; Pornon, Andre; Escaravage, Nathalie			Microsatellite Marker Analysis Reveals the Complex Phylogeographic History of Rhododendron ferrugineum (Ericaceae) in the Pyrenees	PLOS ONE			English	Article							GENETIC DIVERSITY; GLACIAL REFUGIA; L.; DIFFERENTIATION; POPULATIONS; SOFTWARE; GENOTYPE; NORTHERN; SURVIVAL; PLANTS	Genetic variation within plant species is determined by a number of factors such as reproductive mode, breeding system, life history traits and climatic events. In alpine regions, plants experience heterogenic abiotic conditions that influence the population's genetic structure. The aim of this study was to investigate the genetic structure and phylogeographic history of the subalpine shrub Rhododendron ferrugineum across the Pyrenees and the links between the populations in the Pyrenees, the Alps and Jura Mountains. We used 27 microsatellite markers to genotype 645 samples from 29 Pyrenean populations, three from the Alps and one from the Jura Mountains. These data were used to estimate population genetics statistics such as allelic richness, observed heterozygosity, expected heterozygosity, fixation index, inbreeding coefficient and number of migrants. Genetic diversity was found to be higher in the Alps than in the Pyrenees suggesting colonization waves from the Alps to the Pyrenees. Two separate genetic lineages were found in both the Alps and Pyrenees, with a substructure of five genetic clusters in the Pyrenees where a loss of genetic diversity was noted. The strong differentiation among clusters is maintained by low gene flow across populations. Moreover, some populations showed higher genetic diversity than others and presented rare alleles that may indicate the presence of alpine refugia. Two lineages of R. ferrugineum have colonized the Pyrenees from the Alps. Then, during glaciation events R. ferrugineum survived in the Pyrenees in different refugia such as lowland refugia at the eastern part of the chain and nunataks at high elevations leading to a clustered genetic pattern.	[Charrier, Olivia; Dupont, Pierre; Pornon, Andre; Escaravage, Nathalie] Univ Toulouse 3, Lab Evolut & Divers Biol EDB, F-31062 Toulouse, France; [Charrier, Olivia; Dupont, Pierre; Pornon, Andre; Escaravage, Nathalie] CNRS, EDB, UMR 5174, F-31062 Toulouse, France	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA)	Charrier, O (corresponding author), Univ Toulouse 3, Lab Evolut & Divers Biol EDB, F-31062 Toulouse, France.	olcharrier@gmail.com	Dupont, Pierre/AAD-5659-2021	Dupont, Pierre/0000-0002-7438-7995; Dupont, Pierre-Yves/0000-0002-7384-5181	UniversitA(C) Paul Sabatier Toulouse - CNRS	UniversitA(C) Paul Sabatier Toulouse - CNRS	Funding provided by UniversitA (c) Paul Sabatier Toulouse - CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEgisdottir HH, 2009, ANN BOT-LONDON, V104, P1313, DOI 10.1093/aob/mcp242; AITKEN SN, 1994, EVOLUTION, V48, P1009, DOI [10.2307/2410362, 10.1111/j.1558-5646.1994.tb05289.x]; Alberto F, 2010, MOL ECOL, V19, P2626, DOI 10.1111/j.1365-294X.2010.04631.x; [Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Belkhir K, 2004, GENETIX 4 0 LAB GENO; Beniston M, 1997, CLIMATIC CHANGE, V36, P281, DOI 10.1023/A:1005310214361; BRAUN-BLANQUET J., 1948, COLLECT BOT, V2, P1; Bruni I, 2012, PLANT BIOSYST, V146, P24, DOI 10.1080/11263504.2011.557093; Burga C., 1998, VEGETATION KLIMA SCH; Byars SG, 2009, ANN BOT-LONDON, V103, P885, DOI 10.1093/aob/mcp018; Charrier O, 2013, CONSERV GENET RESOUR, V5, P473, DOI 10.1007/s12686-012-9831-2; Delmas CEL, 2013, PLANT BIOL IN PRESS, DOI 10.111/plb.12039; Delmas CEL, 2011, AM J BOT, V98, pE120, DOI 10.3732/ajb.1000533; DEMESURE B, 1995, MOL ECOL, V4, P129, DOI 10.1111/j.1365-294X.1995.tb00201.x; Dzialuk A, 2009, PLANT SYST EVOL, V277, P197, DOI 10.1007/s00606-008-0123-y; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Escaravage N, 1997, CAN J BOT, V75, P736, DOI 10.1139/b97-084; Escaravage N, 1998, MOL ECOL, V7, P975, DOI 10.1046/j.1365-294x.1998.00415.x; Escaravage N, 2004, PLANT BIOL, V6; Escaravage N, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr029; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Frankel O.H., 1995, CONSERVATION PLANT B; Freeman S, 2007, EVOLUTIONARY ANAL, V4; Goetsch L, 2005, SYST BOT, V30, P616, DOI 10.1600/0363644054782170; Hadado TT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-121; Hahn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041608; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hensen I, 2010, PLANT BIOLOGY, V12, P526, DOI 10.1111/j.1438-8677.2009.00227.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Holderegger R, 2002, MOL ECOL, V11, P1409, DOI 10.1046/j.1365-294X.2002.01548.x; Holleley CE, 2009, BIOTECHNIQUES, V46, P511, DOI 10.2144/000113156; Iserbyt S, 2008, ANN SOC ENTOMOL FR, V44, P211, DOI 10.1080/00379271.2008.10697558; JALUT G, 1992, QUATERNARY SCI REV, V11, P449, DOI 10.1016/0277-3791(92)90027-6; Jeannel R, 1946, REV FRANCAISE ENTOMO, V14, P53; Koelling VA, 2012, HEREDITY, V106, P310; Kropf M, 2006, NEW PHYTOL, V172, P169, DOI 10.1111/j.1469-8137.2006.01795.x; Lauga B, 2009, ACTA BOT GALLICA, V156, P317, DOI 10.1080/12538078.2009.10516162; Ledig FT, 2000, J HERED, V91, P307, DOI 10.1093/jhered/91.4.307; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; MANTEL N, 1967, CANCER RES, V27, P209; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Ohsawa T, 2008, GLOBAL ECOL BIOGEOGR, V17, P152, DOI 10.1111/j.1466-8238.2007.00357.x; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pornon A, 2000, MOL ECOL, V9, P1099, DOI 10.1046/j.1365-294x.2000.00976.x; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Segarra-Moragues JG, 2007, J BIOGEOGR, V34, P1893, DOI 10.1111/j.1365-2699.2007.01740.x; Serrat D, 1993, 1386E2 US GEOL SURV; Stehlik I, 2002, BIOL J LINN SOC, V77, P87, DOI 10.1046/j.1095-8312.2002.00094.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wolf PG, 2004, J HERED, V95, P301, DOI 10.1093/jhered/esh053	61	33	34	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92976	10.1371/journal.pone.0092976	http://dx.doi.org/10.1371/journal.pone.0092976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667824	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600116
J	Kennard, JTT; Guevremont, D; Mason-Parker, SE; Abraham, WC; Williams, JM				Kennard, Jeremy T. T.; Guevremont, Diane; Mason-Parker, Sara E.; Abraham, Wickliffe C.; Williams, Joanna M.			Redistribution of Ionotropic Glutamate Receptors Detected by Laser Microdissection of the Rat Dentate Gyrus 48 h following LTP Induction In Vivo	PLOS ONE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL SYNAPTIC PLASTICITY; NR2B-CONTAINING NMDA RECEPTORS; GLUR2-LACKING AMPA RECEPTORS; PERFORANT PATH; CAPTURE MICRODISSECTION; PROTEIN-SYNTHESIS; DIFFERENTIAL ROLES; MOLECULAR ANALYSIS; LATE-PHASE	The persistence and input specificity of long-term potentiation (LTP) make it attractive as a mechanism of information storage. In its initial phase, both in vivo and in vitro studies have shown that LTP is associated with increased membrane localization of AMPA receptor subunits, but the molecular basis of LTP maintenance over the long-term is still unclear. We have previously shown that expression of AMPA and NMDA receptor subunits is elevated in whole homogenates prepared from dentate gyrus 48 h after LTP induction in vivo. In the present study, we utilized laser microdissection (LMD) techniques to determine whether AMPA and NMDA receptor upregulation occurs specifically in the stimulated regions of the dentate gyrus dendritic arbor. Receptor proteins GluN1, GluA1 and GluA2, as well as postsynaptic density protein of 95 kDa and tubulin were detected by Western blot analysis in microdissected samples. Gradients of expression were observed for GluN1 and GluA2, decreasing from the inner to the outer zones of the molecular layer, and were independent of LTP. When induced at medial perforant path synapses, LTP was associated with an apparent specific redistribution of GluA1 and GluN1 to the middle molecular layer that contains these synapses. These data indicate that glutamate receptor proteins are delivered specifically to dendritic regions possessing LTP-expressing synapses, and that these changes are preserved for at least 48 h.	[Kennard, Jeremy T. T.; Guevremont, Diane; Mason-Parker, Sara E.; Abraham, Wickliffe C.; Williams, Joanna M.] Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand; [Kennard, Jeremy T. T.; Guevremont, Diane; Williams, Joanna M.] Otago Sch Med Sci, Dept Anat, Dunedin, New Zealand; [Kennard, Jeremy T. T.; Mason-Parker, Sara E.; Abraham, Wickliffe C.] Univ Otago, Dept Psychol, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Williams, JM (corresponding author), Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand.	joanna.williams@anatomy.otago.ac.nz			New Zealand Health Research Council [99/275]; Department of Anatomy, Postgraduate Support	New Zealand Health Research Council(Health Research Council of New Zealand); Department of Anatomy, Postgraduate Support	Funder: New Zealand Health Research Council; Grant Number: 99/275; Department of Anatomy, Postgraduate Support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2006, NEUROBIOL LEARN MEM, V86, P82, DOI 10.1016/j.nlm.2005.12.007; Abraham WC, 2002, J NEUROSCI, V22, P9626; ABRAHAM WC, 1995, MOL BRAIN RES, V30, P367, DOI 10.1016/0169-328X(95)00026-O; Abraham WC, 2001, P NATL ACAD SCI USA, V98, P10924, DOI 10.1073/pnas.181342098; ABRAHAM WC, 1988, BRAIN RES, V462, P40, DOI 10.1016/0006-8993(88)90582-3; ABRAHAM WC, 1983, NATURE, V305, P717, DOI 10.1038/305717a0; Abraham WC, 1994, P NATL ACAD SCI USA, V91, P10053; Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; Barco A, 2008, NEUROSCI BIOBEHAV R, V32, P831, DOI 10.1016/j.neubiorev.2008.01.002; Bartlett TE, 2007, NEUROPHARMACOLOGY, V52, P60, DOI 10.1016/j.neuropharm.2006.07.013; BAUDE A, 1995, NEUROSCIENCE, V69, P1031, DOI 10.1016/0306-4522(95)00350-R; Bear MF, 1996, PROG BRAIN RES, V108, P205, DOI 10.1016/S0079-6123(08)62541-8; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bohm M, 1997, AM J PATHOL, V151, P63; Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Catania MV, 1998, EUR J NEUROSCI, V10, P3479, DOI 10.1046/j.1460-9568.1998.00356.x; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150, DOI 10.1152/jn.1993.69.4.1150; Davies KD, 2008, J BIOL CHEM, V283, P33138, DOI 10.1074/jbc.M803431200; Doyere V, 1997, J NEUROPHYSIOL, V77, P571, DOI 10.1152/jn.1997.77.2.571; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Fox CJ, 2006, HIPPOCAMPUS, V16, P907, DOI 10.1002/hipo.20230; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; HANSE E, 1992, EUR J NEUROSCI, V4, P1191, DOI 10.1111/j.1460-9568.1992.tb00144.x; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Kennard JTT, 2009, NEUROPHARMACOLOGY, V56, P66, DOI 10.1016/j.neuropharm.2008.07.044; KNEISLER TB, 1995, HIPPOCAMPUS, V5, P151, DOI 10.1002/hipo.450050302; Kosuge Y, 2008, NEUROCHEM INT, V52, P1204, DOI 10.1016/j.neuint.2007.12.010; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Lee SH, 2001, NEUROPHARMACOLOGY, V41, P680, DOI 10.1016/S0028-3908(01)00124-1; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mallon AP, 2005, EXP BRAIN RES, V162, P374, DOI 10.1007/s00221-004-2193-6; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; Mezey S, 2004, EUR J NEUROSCI, V19, P2310, DOI 10.1111/j.0953-816X.2004.03334.x; Mockett BG, 2007, J NEUROSCI, V27, P2918, DOI 10.1523/JNEUROSCI.0838-06.2007; Moga DE, 2006, HIPPOCAMPUS, V16, P990, DOI 10.1002/hipo.20227; Murray GI, 2007, ACTA HISTOCHEM, V109, P171, DOI 10.1016/j.acthis.2007.02.001; OTANI S, 1989, NEUROSCIENCE, V28, P519, DOI 10.1016/0306-4522(89)90001-8; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; RACINE RJ, 1983, BRAIN RES, V260, P217, DOI 10.1016/0006-8993(83)90676-5; Redondo RL, 2010, J NEUROSCI, V30, P4981, DOI 10.1523/JNEUROSCI.3140-09.2010; Reymann KG, 2007, NEUROPHARMACOLOGY, V52, P24, DOI 10.1016/j.neuropharm.2006.07.026; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Simone NL, 1998, TRENDS GENET, V14, P272, DOI 10.1016/S0168-9525(98)01489-9; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; von Eggeling F, 2007, PROTEOMICS, V7, P2729, DOI 10.1002/pmic.200700079; Weitlauf C, 2005, J NEUROSCI, V25, P8386, DOI 10.1523/JNEUROSCI.2388-05.2005; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Williams JM, 1998, MOL BRAIN RES, V60, P21, DOI 10.1016/S0169-328X(98)00154-5; Williams JM, 2003, NEUROSCIENCE, V118, P1003, DOI 10.1016/S0306-4522(03)00028-9; Williams JM, 2007, J NEUROSCI, V27, P14171, DOI 10.1523/JNEUROSCI.2348-07.2007; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Yang YL, 2010, P NATL ACAD SCI USA, V107, P11999, DOI 10.1073/pnas.0913004107	66	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92972	10.1371/journal.pone.0092972	http://dx.doi.org/10.1371/journal.pone.0092972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667777	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600113
J	Kiwanuka, J; Mulogo, E; Haberer, JE				Kiwanuka, Julius; Mulogo, Edgar; Haberer, Jessica E.			Caregiver Perceptions and Motivation for Disclosing or Concealing the Diagnosis of HIV Infection to Children Receiving HIV Care in Mbarara, Uganda: A Qualitative Study	PLOS ONE			English	Article							SOUTH-AFRICA; ADOLESCENTS; INTERVENTION; MORTALITY; HIV/AIDS; HEALTH	Background: Disclosure of the diagnosis of HIV to HIV-infected children is challenging for caregivers. Despite current recommendations, data suggest that levels of disclosure of HIV status to HIV-infected children receiving care in resource-limited settings are very low. Few studies describe the disclosure process for children in these settings, particularly the motivators, antecedent goals, and immediate outcomes of disclosure to HIV-infected children. This study examined caregivers' perception of the disclosure concept prior to disclosure, their motivation towards or away from disclosure, and their short-and long-term intentions for disclosure to their HIV-infected children. Methods: In-depth interviews were conducted with primary caregivers of 40 HIV-infected children (ages 5-15 years) who were receiving HIV care but did not know their HIV status. Results: Caregivers of HIV-infected children mainly perceived disclosure as a single event rather than a process of gradual delivery of information about the child's illness. They viewed disclosure as potentially beneficial both to children and themselves, as well as an opportunity to explain the parents' role in the transmission of HIV to the children. Caregivers desired to personally conduct the disclosure; however, most reported being over-whelmed with fear of negative outcomes and revealed a lack of self-efficacy towards managing the disclosure process. Consequently, most cope by deception to avoid or delay disclosure until they perceive their own readiness to disclose. Conclusions: Interventions for HIV disclosure should consider that caregivers may desire to be directly responsible for disclosure to children under their care. They, however, need to be empowered with practical skills to recognize opportunities to initiate the disclosure process early, as well as supported to manage it in a phased, developmentally appropriate manner. The potential role for peer counselors in the disclosure process deserves further study.	[Kiwanuka, Julius] Mbarara Univ Sci & Technol, Dept Paediat & Child Hlth, Mbarara, Uganda; [Mulogo, Edgar] Mbarara Univ Sci & Technol, Dept Community Hlth, Mbarara, Uganda; [Haberer, Jessica E.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Haberer, Jessica E.] Harvard Univ, Sch Med, Boston, MA USA	Mbarara University of Science & Technology; Mbarara University of Science & Technology; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kiwanuka, J (corresponding author), Mbarara Univ Sci & Technol, Dept Paediat & Child Hlth, Mbarara, Uganda.	jpkiwanuka@gmail.com	Haberer, Jessica/AAH-7976-2019	Haberer, Jessica/0000-0001-5845-3190	Canada-Africa Prevention Trials (CAPT) Network; US National Institutes of Health [K23MH087228]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH087228] Funding Source: NIH RePORTER	Canada-Africa Prevention Trials (CAPT) Network; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was funded by a mentorship grant from the Canada-Africa Prevention Trials (CAPT) Network (captnetwork.org). Dr. Haberer was supported by the US National Institutes of Health (K23MH087228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwiine B, 2012, THESIS MBARARA U SCI; Biadgilign S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017572; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Butler AM, 2009, PEDIATRICS, V123, P935, DOI 10.1542/peds.2008-1290; Chaudoir SR, 2011, SOC SCI MED, V72, P1618, DOI 10.1016/j.socscimed.2011.03.028; DEMATTEO D, 2002, PSYCHOL HEALTH MED, V7, P339, DOI DOI 10.1080/13548500220139395; Flanagan-Klygis E, 2001, J CLIN ETHIC, V12, P150; FunckBrentano I, 1997, ARCH PEDIAT ADOL MED, V151, P978, DOI 10.1001/archpedi.1997.02170470012002; Gerson A C, 2001, J Pediatr Health Care, V15, P161, DOI 10.1067/mph.2001.114835; Heeren GA, 2012, VULNERABLE CHILD YOU, V7, P47, DOI 10.1080/17450128.2012.656733; Hejoaka F, 2009, SOC SCI MED, V69, P869, DOI 10.1016/j.socscimed.2009.05.041; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Judd A, 2007, CLIN INFECT DIS, V45, P918, DOI 10.1086/521167; Kallem S, 2011, AIDS BEHAV, V15, P1121, DOI 10.1007/s10461-010-9741-9; Kouyoumdjian FG, 2005, J TROP PEDIATRICS, V51, P285, DOI 10.1093/tropej/fmi014; Kyaddondo D, 2013, SAHARA J-J SOC ASP H, V10, pS37, DOI 10.1080/02664763.2012.755323; Ledlie SW, 1999, NURS RES, V48, P141, DOI 10.1097/00006199-199905000-00004; Lee CL, 1999, AIDS PATIENT CARE ST, V13, P41, DOI 10.1089/apc.1999.13.41; LESTER P, 2002, CLIN CHILD PSYCHOL P, V7, P85, DOI DOI 10.1177/1359104502007001007; Madiba S, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/402403; Marston M, 2005, JAIDS-J ACQ IMM DEF, V38, P219, DOI 10.1097/00126334-200502010-00015; Medley A, 2013, AIDS BEHAV, V17, P224, DOI 10.1007/s10461-012-0344-5; Melvin D, 1999, J HIV THERAPY, V4, P77; Menon A, 2007, JAIDS-J ACQ IMM DEF, V46, P349, DOI 10.1097/QAI.0b013e3181565df0; Ministry of Health Uganda, 2012, UG AIDS IND SURV; Ministry of Health (Uganda), 2005, UG NAT POL GUID HIV; Nor B, 2012, MATERN CHILD NUTR, V8, P448, DOI 10.1111/j.1740-8709.2011.00332.x; Oberdorfer P, 2006, J PAEDIATR CHILD H, V42, P283, DOI 10.1111/j.1440-1754.2006.00855.x; Petersen I, 2010, AIDS CARE, V22, P970, DOI 10.1080/09540121003623693; Pinzon-Iregui MC, 2013, J TROP PEDIATRICS, V59, P84, DOI 10.1093/tropej/fms052; Riekert KA, 1999, CHILD HEALTH CARE, V28, P201, DOI 10.1207/s15326888chc2803_1; Ryan G.W., 2003, FIELD METHOD, V15, P85, DOI [DOI 10.1177/1525822X02239569, 10.1177/1525822X02239569]; Strauss AL, 1998, BASICS QUALITATIVE R, V2nd; Vaz LME, 2011, J DEV BEHAV PEDIATR, V32, P307, DOI 10.1097/DBP.0b013e31820f7a47; Vaz LME, 2010, AIDS PATIENT CARE ST, V24, P247, DOI 10.1089/apc.2009.0217; Vreeman RC, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18466; Waugh S, 2003, AIDS CARE, V15, P169, DOI 10.1080/0954012031000068317; WHO, 2013, GLOB UPD HIV TREATM; Wiener L, 2007, J DEV BEHAV PEDIATR, V28, P155, DOI 10.1097/01.DBP.0000267570.87564.cd; Wiener LS, 1996, PEDIATR AIDS HIV INF, V7, P310; Wilfert C, 1999, PEDIATRICS, V103, P164; World Health Organization, 2011, GUID HIV DISCL COUNS; World Health Organization, 2010, ANT THER HIV INF INF	43	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93276	10.1371/journal.pone.0093276	http://dx.doi.org/10.1371/journal.pone.0093276			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SD	24667407	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600161
J	Scharinger, C; Rabl, U; Kasess, CH; Meyer, BM; Hofmaier, T; Diers, K; Bartova, L; Pail, G; Huf, W; Uzelac, Z; Hartinger, B; Kalcher, K; Perkmann, T; Haslacher, H; Meyer-Lindenberg, A; Kasper, S; Freissmuth, M; Windischberger, C; Willeit, M; Lanzenberger, R; Esterbauer, H; Brocke, B; Moser, E; Sitte, HH; Pezawas, L				Scharinger, Christian; Rabl, Ulrich; Kasess, Christian H.; Meyer, Bernhard M.; Hofmaier, Tina; Diers, Kersten; Bartova, Lucie; Pail, Gerald; Huf, Wolfgang; Uzelac, Zeljko; Hartinger, Beate; Kalcher, Klaudius; Perkmann, Thomas; Haslacher, Helmuth; Meyer-Lindenberg, Andreas; Kasper, Siegfried; Freissmuth, Michael; Windischberger, Christian; Willeit, Matthaeus; Lanzenberger, Rupert; Esterbauer, Harald; Brocke, Burkhard; Moser, Ewald; Sitte, Harald H.; Pezawas, Lukas			Platelet Serotonin Transporter Function Predicts Default-Mode Network Activity	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; SCALE BRAIN NETWORKS; ANTIDEPRESSANT TREATMENT; TRYPTOPHAN DEPLETION; AMYGDALA REACTIVITY; GENETIC-VARIATION; ACUTE CITALOPRAM; BLOOD-PLATELETS; STATE; FMRI	Background: The serotonin transporter (5-HTT) is abundantly expressed in humans by the serotonin transporter gene SLC6A4 and removes serotonin (5-HT) from extracellular space. A blood-brain relationship between platelet and synaptosomal 5-HT reuptake has been suggested, but it is unknown today, if platelet 5-HT uptake can predict neural activation of human brain networks that are known to be under serotonergic influence. Methods: A functional magnetic resonance study was performed in 48 healthy subjects and maximal 5-HT uptake velocity (V-max) was assessed in blood platelets. We used a mixed-effects multilevel analysis technique (MEMA) to test for linear relationships between whole-brain, blood-oxygen-level dependent (BOLD) activity and platelet V-max. Results: The present study demonstrates that increases in platelet V-max significantly predict default-mode network (DMN) suppression in healthy subjects independent of genetic variation within SLC6A4. Furthermore, functional connectivity analyses indicate that platelet V-max is related to global DMN activation and not intrinsic DMN connectivity. Conclusion: This study provides evidence that platelet V-max predicts global DMN activation changes in healthy subjects. Given previous reports on platelet-synaptosomal V-max coupling, results further suggest an important role of neuronal 5-HT reuptake in DMN regulation.	[Scharinger, Christian; Rabl, Ulrich; Kasess, Christian H.; Meyer, Bernhard M.; Bartova, Lucie; Pail, Gerald; Huf, Wolfgang; Hartinger, Beate; Kalcher, Klaudius; Kasper, Siegfried; Willeit, Matthaeus; Lanzenberger, Rupert; Pezawas, Lukas] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria; [Hofmaier, Tina; Perkmann, Thomas; Haslacher, Helmuth; Esterbauer, Harald] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Kasess, Christian H.; Huf, Wolfgang; Kalcher, Klaudius; Windischberger, Christian; Moser, Ewald] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Hofmaier, Tina; Uzelac, Zeljko; Freissmuth, Michael; Sitte, Harald H.] Med Univ Vienna, Ctr Biomol Med & Pharmacol, Vienna, Austria; [Diers, Kersten; Brocke, Burkhard] Tech Univ Dresden, Dept Psychol, Dresden, Germany; [Huf, Wolfgang; Kalcher, Klaudius] Vienna Univ Technol, Dept Stat & Probabil Theory, A-1040 Vienna, Austria; [Meyer-Lindenberg, Andreas] Heidelberg Univ, Cent Inst Mental Hlth, Mannheim, Germany	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Technische Universitat Dresden; Technische Universitat Wien; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Pezawas, L (corresponding author), Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria.	lukas.pezawas@meduniwien.ac.at	Haslacher, Helmuth/D-4233-2013; Moser, Ewald/B-3666-2013; Bartova, Lucie/ABC-1857-2021; Lanzenberger, Rupert/I-5438-2019; Pezawas, Lukas/A-2367-2011; Perkmann, Thomas/F-3074-2012; Sitte, Harald/O-7025-2019; Meyer-Lindenberg, Andreas/H-1076-2011	Haslacher, Helmuth/0000-0003-4605-2503; Moser, Ewald/0000-0001-8278-9583; Bartova, Lucie/0000-0002-1769-8025; Lanzenberger, Rupert/0000-0003-4641-9539; Pezawas, Lukas/0000-0002-1329-6352; Sitte, Harald/0000-0002-1339-7444; Kasper, Siegfried/0000-0001-8278-191X; Meyer-Lindenberg, Andreas/0000-0001-5619-1123; Kasess, Christian/0000-0002-5644-7229; Meyer, Bernhard M./0000-0002-9772-0471; Rabl, Ulrich/0000-0001-5285-7223; Kalcher, Klaudius/0000-0003-4558-7987; Freissmuth, Michael/0000-0001-9398-1765; Windischberger, Christian/0000-0002-9944-0190; Willeit, Matthaeus/0000-0001-8418-6188; Perkmann, Thomas/0000-0002-7976-0285; Esterbauer, Harald/0000-0001-7343-7455	Austrian Science Fund (FWF) [SFB-35, F3514-B11, F3510-B11, F3506-B11]; Institute for Study of Affective Neuroscience (ISAN); Austrian National Bank [OeNB P11903, OeNB P13214]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Institute for Study of Affective Neuroscience (ISAN); Austrian National Bank	This work was supported by the Special Research Project SFB-35 (Project No. F3514-B11, F3510-B11 and F3506-B11 to LP, MF and HHS, respectively) of the Austrian Science Fund (FWF) and the Institute for Study of Affective Neuroscience (ISAN) as well as by grants of the Austrian National Bank (OeNB P11903 to L. Pezawas and OeNB P13214 to R. Lanzenberger). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; Alasaari JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045813; Anderson GM, 2004, PEDIATR RES, V56, P418, DOI 10.1203/01.PDR.0000136278.23672.A0; Anderson GM, 2002, MOL PSYCHIATR, V7, P831, DOI 10.1038/sj.mp.4001099; Anderson IM, 2011, EUR NEUROPSYCHOPHARM, V21, P140, DOI 10.1016/j.euroneuro.2010.06.008; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; APA, 2000, DIAGN STAT MAN MENT, V4th, DOI [DOI 10.1176/APPI.BOOKS.9780890423349, 10.1176/appi.books.9780890423349]; Audhya T, 2012, BBA-GEN SUBJECTS, V1820, P1496, DOI 10.1016/j.bbagen.2012.05.012; Bauer M, 2013, WORLD J BIOL PSYCHIA, V14, P334, DOI 10.3109/15622975.2013.804195; Baune BT, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.18; Bigos KL, 2008, NEUROPSYCHOPHARMACOL, V33, P3221, DOI 10.1038/npp.2008.52; Boubela RN, 2012, MAGN RESON MATER PHY, V25, P313, DOI 10.1007/s10334-011-0290-7; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Bruchas MR, 2011, NEURON, V71, P498, DOI 10.1016/j.neuron.2011.06.011; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carhart-Harris RL, 2012, P NATL ACAD SCI USA, V109, P2138, DOI 10.1073/pnas.1119598109; Carneiro AMD, 2008, J CLIN INVEST, V118, P1544, DOI 10.1172/JCI33374; Chen G, 2012, NEUROIMAGE, V60, P747, DOI 10.1016/j.neuroimage.2011.12.060; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Collins CM, 2012, J PSYCHOPHARMACOL; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dang LC, 2012, J NEUROSCI, V32, P9582, DOI 10.1523/JNEUROSCI.0909-12.2012; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; El-Kasaby A, 2010, J BIOL CHEM, V285, P39201, DOI 10.1074/jbc.M110.118000; ELLIS PM, 1994, BIOL PSYCHIAT, V36, P292, DOI 10.1016/0006-3223(94)90626-2; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fisher PM, 2009, CEREB CORTEX, V19, P2499, DOI 10.1093/cercor/bhp022; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friesen E., 1978, FACIAL ACTION CODING, V3, P5; Frokjaer VG, 2009, NEUROIMAGE, V46, P360, DOI 10.1016/j.neuroimage.2009.02.008; Fu CHY, 2004, ARCH GEN PSYCHIAT, V61, P877, DOI 10.1001/archpsyc.61.9.877; Graham J, 2013, J AFFECT DISORDERS, V151, P423, DOI 10.1016/j.jad.2013.07.002; Greenberg BD, 1999, AM J MED GENET, V88, P83, DOI 10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.3.CO;2-S; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hahn A, 2012, P NATL ACAD SCI USA, V109, P2619, DOI 10.1073/pnas.1117104109; Hamilton JP, 2011, BIOL PSYCHIAT, V70, P327, DOI 10.1016/j.biopsych.2011.02.003; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hardwick RM, 2013, NEUROIMAGE, V67, P283, DOI 10.1016/j.neuroimage.2012.11.020; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hayashi-Takagi A, 2013, BIOL PSYCHIAT; Hoflich A, 2012, REV NEUROSCIENCE, V23, P227, DOI 10.1515/revneuro-2012-0038; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Hyman SE, 2008, NATURE, V455, P890, DOI 10.1038/nature07454; JERNEJ B, 1990, PSYCHIAT RES, V32, P167, DOI 10.1016/0165-1781(90)90083-H; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; Kinnally EL, 2010, GENES BRAIN BEHAV, V9, P45, DOI 10.1111/j.1601-183X.2009.00533.x; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Klomp A, 2012, JOVE-J VIS EXP, DOI 10.3791/3956; Kraus C, 2014, NEUROIMAGE, V84, P236, DOI 10.1016/j.neuroimage.2013.08.036; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Kunisato Y, 2011, NEUROSCI RES, V69, P129, DOI 10.1016/j.neures.2010.11.005; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Lang PJ, 1997, TECHNICAL REPORT; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McKie S, 2005, PSYCHOPHARMACOLOGY, V180, P680, DOI 10.1007/s00213-005-2270-y; MELTZER HY, 1981, ARCH GEN PSYCHIAT, V38, P1322; MELTZER HY, 1988, PSYCHIAT RES, V24, P263, DOI 10.1016/0165-1781(88)90108-4; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Mercado CP, 2010, MOL INTERV, V10, P231, DOI 10.1124/mi.10.4.6; Minzenberg MJ, 2011, PSYCHOPHARMACOLOGY, V215, P23, DOI 10.1007/s00213-010-2111-5; Murphy DL, 2008, NEUROPHARMACOLOGY, V55, P932, DOI 10.1016/j.neuropharm.2008.08.034; Neumeister A, 2004, ARCH GEN PSYCHIAT, V61, P765, DOI 10.1001/archpsyc.61.8.765; Nobile M, 1999, J AM ACAD CHILD PSY, V38, P1396, DOI 10.1097/00004583-199911000-00014; Olsson CA, 2010, BIOL PSYCHOL, V83, P159, DOI 10.1016/j.biopsycho.2009.12.003; Passamonti L, 2012, BIOL PSYCHIAT, V71, P36, DOI 10.1016/j.biopsych.2011.07.033; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Posner J, 2013, JAMA PSYCHIAT, V70, P373, DOI 10.1001/jamapsychiatry.2013.455; Preece MA, 2009, NEUROSCIENCE, V159, P751, DOI 10.1016/j.neuroscience.2008.12.032; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rausch J, 2005, PSYCHOPHARMACOLOGY, V180, P391, DOI 10.1007/s00213-005-2178-6; Rhodes RA, 2007, J NEUROSCI, V27, P9233, DOI 10.1523/JNEUROSCI.1175-07.2007; Savli M, 2013, NEUROIMAGE; Savli M, 2012, NEUROIMAGE, V63, P447, DOI 10.1016/j.neuroimage.2012.07.001; Scharinger C, 2011, WORLD J BIOL PSYCHIA, V12, P474, DOI 10.3109/15622975.2011.596220; Scholze P, 2001, NEUROSCI LETT, V309, P173, DOI 10.1016/S0304-3940(01)02058-4; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Singh YS, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.2; Singh YS, 2010, ACS CHEM NEUROSCI, V1, P49, DOI 10.1021/cn900012y; Steiger H, 2006, NEUROPSYCHOPHARMACOL, V31, P1785, DOI 10.1038/sj.npp.1301011; Tibshirani R., 1993, INTRO BOOTSTRAP, DOI 10.1007/978-1-4899-4541-9; Uebelback R, 2006, NEUROSCI LETT, V406, P153, DOI 10.1016/j.neulet.2006.06.004; van de Ven V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068355; van Ijzendoorn MH, 2010, BIOL PSYCHIAT, V68, P405, DOI 10.1016/j.biopsych.2010.05.008; van Wingen GA, 2014, NEUROIMAGE, V88, P47, DOI 10.1016/j.neuroimage.2013.11.022; Varnas K, 2004, HUM BRAIN MAPP, V22, P246, DOI 10.1002/hbm.20035; Vul E, 2012, NEUROIMAGE, V62, P945, DOI 10.1016/j.neuroimage.2012.01.027; Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789; Willeit M, 2008, NEUROPSYCHOPHARMACOL, V33, P1503, DOI 10.1038/sj.npp.1301560; Windischberger C, 2010, NEUROIMAGE, V49, P1161, DOI 10.1016/j.neuroimage.2009.10.013; Yubero-Lahoz S, 2013, CURR MED CHEM, V20, P1382, DOI 10.2174/0929867311320110003; Yubero-Lahoz S, 2012, EUR J PHARMACOL, V674, P337, DOI 10.1016/j.ejphar.2011.10.033; Ziegelstein RC, 2009, INTERN MED J, V39, P38, DOI 10.1111/j.1445-5994.2008.01794.x	99	19	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92543	10.1371/journal.pone.0092543	http://dx.doi.org/10.1371/journal.pone.0092543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667541	gold, Green Submitted, Green Published			2022-12-25	WOS:000333675600048
J	Nam, S; Chang, HR; Kim, KT; Kook, MC; Hong, D; Kwon, CH; Jung, HR; Park, HS; Powis, G; Liang, H; Park, T; Kim, YH				Nam, S.; Chang, H. R.; Kim, K-T; Kook, M-C; Hong, D.; Kwon, C. H.; Jung, H. R.; Park, H. S.; Powis, G.; Liang, H.; Park, T.; Kim, Y. H.			PATHOME: an algorithm for accurately detecting differentially expressed subpathways	ONCOGENE			English	Article							SET ENRICHMENT ANALYSIS; GASTRIC-CANCER; INTEGRATIVE ANALYSIS; SIGNALING PATHWAY; DATABASE; GENOME; NETWORK; TRANSCRIPTION; MEDICINE; ONTOLOGY	The translation of high-throughput gene expression data into biologically meaningful information remains a bottleneck. We developed a novel computational algorithm, PATHOME, for detecting differentially expressed biological pathways. This algorithm employs straightforward statistical tests to evaluate the significance of differential expression patterns along subpathways. Applying it to gene expression data sets of gastric cancer (GC), we compared its performance with those of other leading programs. Based on a literature-driven reference set, PATHOME showed greater consistency in identifying known cancer-related pathways. For the WNT pathway uniquely identified by PATHOME, we validated its involvement in gastric carcinogenesis through experimental perturbation of both cell lines and animal models. We identified HNF4 alpha-WNT5A regulation in the cross-talk between the AMPK metabolic pathway and the WNT signaling pathway, and further identified WNT5A as a potential therapeutic target for GC. We have demonstrated PATHOME to be a powerful tool, with improved sensitivity for identifying disease-related dysregulated pathways.	[Nam, S.; Hong, D.; Kwon, C. H.] Natl Canc Ctr Korea, Canc Genom Branch, Goyang Si 410769, Gyeonggi Do, South Korea; [Chang, H. R.; Jung, H. R.; Park, H. S.; Kim, Y. H.] Natl Canc Ctr Korea, New Expt Therapeut Branch, Goyang Si 410769, Gyeonggi Do, South Korea; [Kim, K-T] Natl Canc Ctr Korea, Mol Epidemiol Branch, Goyang Si 410769, Gyeonggi Do, South Korea; [Kook, M-C] Natl Canc Ctr Korea, Dept Pathol, Goyang Si 410769, Gyeonggi Do, South Korea; [Powis, G.] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA USA; [Liang, H.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Park, T.] Seoul Natl Univ, Dept Stat, Seoul, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Sanford Burnham Prebys Medical Discovery Institute; University of Texas System; UTMD Anderson Cancer Center; Seoul National University (SNU)	Liang, H (corresponding author), Natl Canc Ctr Korea, New Expt Therapeut Branch, Goyang Si 410769, Gyeonggi Do, South Korea.	hliang1@mdanderson.org; tspark@stats.snu.ac.kr; yhkim@ncc.re.kr	Nam, Seungyoon/ACO-0914-2022	Nam, Seungyoon/0000-0002-0966-7915	National Cancer Center of the Republic of Korea [NCC-1210350-2, NCC-1210460]; National Research Foundation of Korea (NRF) - Republic of Korea (MSIP) [2012R1A3A2026438, 2008-0062618, 2013M3A9C4078158]; US National Institutes of Health [CA95060, CA129616, CA17094, CA98920, CA143883]; University of Texas MD Anderson Cancer Center-GS Hogan Gastrointestinal Research Fund; Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine; NATIONAL CANCER INSTITUTE [P50CA098258, R01CA129616, P50CA095060, P30CA016672, R01CA098920, R01CA163541, P01CA017094, U24CA143883] Funding Source: NIH RePORTER	National Cancer Center of the Republic of Korea; National Research Foundation of Korea (NRF) - Republic of Korea (MSIP); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson Cancer Center-GS Hogan Gastrointestinal Research Fund; Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the National Cancer Center of the Republic of Korea, NCC-1210350-2 (to YHK), NCC-1210460 (to SN); the National Research Foundation of Korea (NRF) grant funded by the Republic of Korea (MSIP) 2012R1A3A2026438, 2008-0062618, 2013M3A9C4078158 (to TP); grants from the US National Institutes of Health, CA95060, CA129616, CA17094 and CA98920 (to GP), CA143883 (to HL); the University of Texas MD Anderson Cancer Center-GS Hogan Gastrointestinal Research Fund and the Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine (to HL). The Korea Institute of Science and Technology Information provided SN with a high-performance computing resource. We thank LeeAnn Chastain for editorial assistance.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen XJ, 2011, BIOINFORMATICS, V27, P649, DOI 10.1093/bioinformatics/btq714; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; Colletti M, 2009, GASTROENTEROLOGY, V137, P660, DOI 10.1053/j.gastro.2009.05.038; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huerta AM, 1998, NUCLEIC ACIDS RES, V26, P55, DOI 10.1093/nar/26.1.55; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P59, DOI 10.1093/nar/30.1.59; Kato K, 2012, MOL CANCER THER, V11, P549, DOI 10.1158/1535-7163.MCT-11-0594; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Khatri P, 2004, NUCLEIC ACIDS RES, V32, pW449, DOI 10.1093/nar/gkh409; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kim YH, 2012, CANCER RES, V72, P2512, DOI 10.1158/0008-5472.CAN-11-3870; Kim YH, 2011, CANCER CHEMOTH PHARM, V68, P405, DOI 10.1007/s00280-010-1500-0; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; Nam S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031685; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Soon WW, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.61; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeno A, 2010, ANN SURG ONCOL, V17, P1033, DOI 10.1245/s10434-009-0854-1; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	34	55	55	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 9	2014	33	41					4941	4951		10.1038/onc.2014.80	http://dx.doi.org/10.1038/onc.2014.80			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR7OA	24681952	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000343767900007
J	Haji-Ghassemi, O; Muller-Loennies, S; Saldova, R; Muniyappa, M; Brade, L; Rudd, PM; Harvey, DJ; Kosma, P; Brade, H; Evans, SV				Haji-Ghassemi, Omid; Mueller-Loennies, Sven; Saldova, Radka; Muniyappa, Mohankumar; Brade, Lore; Rudd, Pauline M.; Harvey, David J.; Kosma, Paul; Brade, Helmut; Evans, Stephen V.			Groove-type Recognition of Chlamydiaceae-specific Lipopolysaccharide Antigen by a Family of Antibodies Possessing an Unusual Variable Heavy Chain N-Linked Glycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENUS-SPECIFIC EPITOPE; MOUSE MONOCLONAL-ANTIBODIES; LASER-DESORPTION IONIZATION; CHLAMYDOPHILA-PSITTACI 6BC; FACTOR-VIII ANTIBODY; ACID KDO RESIDUES; SOMATIC HYPERMUTATION; STRUCTURAL-ANALYSIS; MASS-SPECTROMETRY; GLYCOSYLATION DETERMINES	The structure of the antigen binding fragment ofmAb S25-26, determined to 1.95 angstrom resolution in complex with the Chlamydiaceae family-specific trisaccharide antigen Kdo(2 -> 8) Kdo-(2 -> 4) Kdo (Kdo = 3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid), displays a germ-line-coded paratope that differs significantly from previously characterized Chlamydiaceae-specific mAbs despite being raised against the identical immunogen. Unlike the terminal Kdo recognition pocket that promotes cross-reactivity in S25-2-type antibodies, S25-26 and the closely related S25-23 utilize a groove composed of germ-line residues to recognize the entire trisaccharide antigen and so confer strict specificity. Interest in S25-23 was sparked by its rare high mu M affinity and strict specificity for the family-specific trisaccharide antigen; however, only the related antibody S25-26 proved amenable to crystallization. The structures of three unliganded forms of S25-26 have a labile complementary-determining region H3 adjacent to significant glycosylation of the variable heavy chain on asparagine 85 in Framework Region 3. Analysis of the glycan reveals a heterogeneous mixture with a common root structure that contains an unusually high number of terminal alpha Gal-Gal moieties. One of the few reported structures of glycosylated mAbs containing these epitopes is the therapeutic antibody Cetuximab; however, unlike Cetuximab, one of the unliganded structures in S25-26 shows significant order in the glycan with appropriate electron density for nine residues. The elucidation of the three-dimensional structure of an alpha Gal-containing N-linked glycan on a mAb variable heavy chain has potential clinical interest, as it has been implicated in allergic response in patients receiving therapeutic antibodies.	[Haji-Ghassemi, Omid; Evans, Stephen V.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8P 3P6, Canada; [Mueller-Loennies, Sven; Brade, Lore; Brade, Helmut] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany; [Saldova, Radka; Muniyappa, Mohankumar; Rudd, Pauline M.] NIBRT, GlycoSci Grp, Dublin 4, Ireland; [Kosma, Paul] Univ Nat Resources & Life Sci, Vienna, Austria; [Harvey, David J.] Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England	University of Victoria; Forschungszentrum Borstel; University of Natural Resources & Life Sciences, Vienna; University of Oxford	Muller-Loennies, S (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Pk Allee 22, D-23845 Borstel, Germany.	sml@fz-borstel.de; svevans@uvic.ca	Harvey, David/A-5579-2013; Kosma, Paul/Y-7443-2019	Kosma, Paul/0000-0001-5342-7161; Evans, Stephen/0000-0002-0366-4027; Haji-Ghassemi, Omid/0000-0003-0116-005X; Fahey (Saldova), Radka/0000-0001-5085-5080; Harvey, David/0000-0003-0544-771X	Natural Sciences and Engineering Research Council of Canada; European Union [260600]; Fonds zur Forderung der wissenschaftlichen Forschung [P22909]; Michael Smith Foundation for Health Research Senior Scholarship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); European Union(European Commission); Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Michael Smith Foundation for Health Research Senior Scholarship(Michael Smith Foundation for Health Research)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (to S. V. E.), European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 260600 ("GlycoHIT") (to R. S.), and by Fonds zur Forderung der wissenschaftlichen Forschung Grant P22909 (to P. K.).; Recipient of a Michael Smith Foundation for Health Research Senior Scholarship.	ANDERSSON B, 1971, CELL IMMUNOL, V2, P411, DOI 10.1016/0008-8749(71)90052-9; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Blackler R. J., 2012, ANTICARBOHYDRATE ANT, P75; Blackler RJ, 2011, BIOCHEMISTRY-US, V50, P3357, DOI 10.1021/bi101886v; Bogart JA, 2006, CLIN LUNG CANCER, V7, P285, DOI 10.3816/CLC.2006.n.009; BORNSEN KO, 1995, RAPID COMMUN MASS SP, V9, P1031, DOI 10.1002/rcm.1290091112; BORREBAECK CAK, 1993, IMMUNOL TODAY, V14, P477, DOI 10.1016/0167-5699(93)90259-N; BRADE H, 1987, P NATL ACAD SCI USA, V84, P2508, DOI 10.1073/pnas.84.8.2508; Brade L, 1997, GLYCOBIOLOGY, V7, P819, DOI 10.1093/glycob/7.6.819; Brade L, 2002, J ENDOTOXIN RES, V8, P357, DOI 10.1179/096805102125000687; BRADE L, 1994, FEMS IMMUNOL MED MIC, V8, P27, DOI 10.1111/j.1574-695X.1994.tb00422.x; Brade L, 2000, J ENDOTOXIN RES, V6, P361, DOI 10.1179/096805100101532289; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Brooks CL, 2008, J MOL BIOL, V377, P450, DOI 10.1016/j.jmb.2008.01.018; Brooks CL, 2013, ACTA CRYSTALLOGR F, V69, P2, DOI 10.1107/S1744309112047422; Brooks CL, 2010, BIOCHEMISTRY-US, V49, P570, DOI 10.1021/bi9011308; CYGLER M, 1991, SCIENCE, V253, P442, DOI 10.1126/science.1713710; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans DW, 2011, GLYCOBIOLOGY, V21, P1049, DOI 10.1093/glycob/cwr041; FU YC, 1992, INFECT IMMUN, V60, P1314, DOI 10.1128/IAI.60.4.1314-1321.1992; Garcia-Ojeda PA, 2004, INFECT IMMUN, V72, P3451, DOI 10.1128/IAI.72.6.3451-3460.2004; Gaspal FMC, 2006, EUR J IMMUNOL, V36, P1665, DOI 10.1002/eji.200535339; Gerstenbruch S, 2010, GLYCOBIOLOGY, V20, P461, DOI 10.1093/glycob/cwp198; GREENSPAN NS, 1988, J IMMUNOL, V141, P4276; Harvey DJ, 2008, ANAL BIOCHEM, V376, P44, DOI 10.1016/j.ab.2008.01.025; Harvey DJ, 2011, J AM SOC MASS SPECTR, V22, P568, DOI 10.1007/s13361-010-0053-0; Harvey DJ, 2009, PROTEOMICS, V9, P3796, DOI 10.1002/pmic.200900096; Heine H, 2003, EUR J BIOCHEM, V270, P440, DOI 10.1046/j.1432-1033.2003.03392.x; HELLSTROM I, 1990, CANCER RES, V50, P2183; HOLST O, 1995, EUR J BIOCHEM, V229, P194, DOI 10.1111/j.1432-1033.1995.tb20455.x; HOLST O, 1993, EUR J BIOCHEM, V214, P703, DOI 10.1111/j.1432-1033.1993.tb17971.x; HOLST O, 1994, EUR J BIOCHEM, V222, P183, DOI 10.1111/j.1432-1033.1994.tb18856.x; Igietseme JU, 2011, EXPERT REV VACCINES, V10, P1585, DOI [10.1586/erv.11.139, 10.1586/ERV.11.139]; Jacquemin M, 2006, J THROMB HAEMOST, V4, P1047, DOI 10.1111/j.1538-7836.2006.01900.x; Jacquemin M, 2010, HAEMOPHILIA, V16, P16, DOI 10.1111/j.1365-2516.2010.02233.x; KIMURA H, 1989, EUR J IMMUNOL, V19, P1741, DOI 10.1002/eji.1830190932; KOSMA P, 1987, CARBOHYD RES, V167, P39, DOI 10.1016/0008-6215(87)80266-5; Kosma P, 1999, BBA-MOL BASIS DIS, V1455, P387, DOI 10.1016/S0925-4439(99)00061-7; KOSMA P, 1994, CARBOHYD RES, V254, P105, DOI 10.1016/0008-6215(94)84246-9; KOSMA P, 1989, CARBOHYD RES, V190, P191, DOI 10.1016/0008-6215(89)84125-4; KOSMA P, 1988, CARBOHYD RES, V183, P183, DOI 10.1016/0008-6215(88)84073-4; KOSMA P, 1990, CARBOHYD RES, V208, P37, DOI 10.1016/0008-6215(90)80083-F; Kosma P, 2000, J ENDOTOXIN RES, V6, P57, DOI 10.1177/09680519000060010801; Kosma P., 2008, CARBOHYDRATE BASED V, V989, P211; Leibiger H, 1999, BIOCHEM J, V338, P529, DOI 10.1042/0264-6021:3380529; Li ZQ, 2004, GENE DEV, V18, P1, DOI 10.1101/gad.1161904; Mariotti SP, 2009, BRIT J OPHTHALMOL, V93, P563, DOI 10.1136/bjo.2008.148494; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Muller-Loennies S, 2006, GLYCOBIOLOGY, V16, P184, DOI 10.1093/glycob/cwj055; Muller-Loennies S, 2002, J ENDOTOXIN RES, V8, P295, DOI 10.1179/096805102125000506; Muller-Loennies S, 2000, GLYCOBIOLOGY, V10, P121, DOI 10.1093/glycob/10.2.121; Murase T, 2009, J MOL BIOL, V392, P381, DOI 10.1016/j.jmb.2009.06.074; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; Nguyen HP, 2001, ACTA CRYSTALLOGR D, V57, P1872, DOI 10.1107/S0907444901014536; PASCUAL V, 1992, J IMMUNOL, V149, P2337; PATEL TP, 1992, BIOCHEM J, V285, P839, DOI 10.1042/bj2850839; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qian J, 2007, ANAL BIOCHEM, V364, P8, DOI 10.1016/j.ab.2007.01.023; Royle L., 2006, GLYCOBIOLOGY PROTOCO; Royle L, 2008, ANAL BIOCHEM, V376, P1, DOI 10.1016/j.ab.2007.12.012; Rund S, 2000, EUR J BIOCHEM, V267, P5717, DOI 10.1046/j.1432-1327.2000.01635.x; SHARON J, 1990, P NATL ACAD SCI USA, V87, P4814, DOI 10.1073/pnas.87.12.4814; Sheeley DM, 1997, ANAL BIOCHEM, V247, P102, DOI 10.1006/abio.1997.2036; Sheriff S, 1996, J MOL BIOL, V259, P938, DOI 10.1006/jmbi.1996.0371; SIGURSKJOLD BW, 1992, J BIOL CHEM, V267, P8371; Stein K. E., 1992, J INFECT DIS S1, V165, pS49; Teng G, 2007, ANNU REV GENET, V41, P107, DOI 10.1146/annurev.genet.41.110306.130340; Theillet FX, 2009, J MOL BIOL, V388, P839, DOI 10.1016/j.jmb.2009.03.057; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Xie KF, 2005, ACTA CRYSTALLOGR D, V61, P1386, DOI 10.1107/S0907444905023851; Zhou JH, 2004, INFECT IMMUN, V72, P3505, DOI 10.1128/IAI.72.6.3505-3514.2004	74	11	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16644	16661		10.1074/jbc.M113.528224	http://dx.doi.org/10.1074/jbc.M113.528224			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24682362	Green Published, hybrid			2022-12-25	WOS:000338016200006
J	Dotterl, S; Gluck, U; Jurgens, A; Woodring, J; Aas, G				Doetterl, Stefan; Glueck, Ulrike; Juergens, Andreas; Woodring, Joseph; Aas, Gregor			Floral Reward, Advertisement and Attractiveness to Honey Bees in Dioecious Salix caprea	PLOS ONE			English	Article							POLLEN LIMITATION; REPRODUCTIVE SUCCESS; POLLINATOR SELECTIVITY; PLANT REPRODUCTION; NECTAR PRODUCTION; CHEMICAL ECOLOGY; WIND POLLINATION; SEX-DIFFERENCES; FEMALE FLOWERS; OLFACTORY CUES	In dioecious, zoophilous plants potential pollinators have to be attracted to both sexes and switch between individuals of both sexes for pollination to occur. It often has been suggested that males and females require different numbers of visits for maximum reproductive success because male fertility is more likely limited by access to mates, whereas female fertility is rather limited by resource availability. According to sexual selection theory, males therefore should invest more in pollinator attraction (advertisement, reward) than females. However, our knowledge on the sex specific investment in floral rewards and advertisement, and its effects on pollinator behaviour is limited. Here, we use an approach that includes chemical, spectrophotometric, and behavioural studies i) to elucidate differences in floral nectar reward and advertisement (visual, olfactory cues) in dioecious sallow, Salix caprea, ii) to determine the relative importance of visual and olfactory floral cues in attracting honey bee pollinators, and iii) to test for differential attractiveness of female and male inflorescence cues to honey bees. Nectar amount and sugar concentration are comparable, but sugar composition varies between the sexes. Olfactory sallow cues are more attractive to honey bees than visual cues; however, a combination of both cues elicits the strongest behavioural responses in bees. Male flowers are due to the yellow pollen more colourful and emit a higher amount of scent than females. Honey bees prefer the visual but not the olfactory display of males over those of females. In all, the data of our multifaceted study are consistent with the sexual selection theory and provide novel insights on how the model organism honey bee uses visual and olfactory floral cues for locating host plants.	[Doetterl, Stefan] Univ Bayreuth, Dept Plant Systemat, Bayreuth, Germany; [Glueck, Ulrike; Aas, Gregor] Univ Bayreuth, Ecol Bot Garden, Bayreuth, Germany; [Juergens, Andreas] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Pietermaritzburg, South Africa; [Woodring, Joseph] Univ Bayreuth, Dept Anim Ecol, Bayreuth, Germany	University of Bayreuth; University of Bayreuth; University of Kwazulu Natal; University of Bayreuth	Dotterl, S (corresponding author), Salzburg Univ, A-5020 Salzburg, Austria.	stefan.doetterl@sbg.ac.at	Juergens, Andreas/E-9479-2010	Juergens, Andreas/0000-0002-5288-0498; Dotterl, Stefan/0000-0001-5228-1332	German Research Foundation (Research Training Group 678) [C5]	German Research Foundation (Research Training Group 678)	This work was supported by German Research Foundation (Research Training Group 678, Project C5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN J, 1986, OECOLOGIA, V70, P332, DOI 10.1007/BF00379493; Amirav A, 1997, EUR MASS SPECTROM, V3, P105, DOI 10.1255/ejms.27; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Armstrong JE, 1997, AM J BOT, V84, P1266, DOI 10.2307/2446051; Ashman TL, 2009, FUNCT ECOL, V23, P852, DOI 10.1111/j.1365-2435.2009.01590.x; Ashman TL, 2000, OIKOS, V90, P347, DOI 10.1034/j.1600-0706.2000.900216.x; Ashman TL, 2005, ECOLOGY, V86, P2099, DOI 10.1890/04-1161; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; Ashman TL, 2000, ECOLOGY, V81, P2577, DOI 10.1890/0012-9658(2000)081[2577:PSAIIF]2.0.CO;2; Balkenius A, 2006, J COMP PHYSIOL A, V192, P431, DOI 10.1007/s00359-005-0081-6; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BAWA KS, 1980, ANNU REV ECOL SYST, V11, P15, DOI 10.1146/annurev.es.11.110180.000311; BAWA KS, 1980, EVOLUTION, V34, P467, DOI 10.1111/j.1558-5646.1980.tb04836.x; BAWA KS, 1975, EVOLUTION, V29, P167, DOI 10.2307/2407150; BIERZYCHUDEK P, 1987, ECOLOGY, V68, P444, DOI 10.2307/1939276; Blair AC, 2007, CAN J BOT, V85, P414, DOI 10.1139/B07-025; BURD M, 1994, BOT REV, V60, P83, DOI 10.1007/BF02856594; Burger H, 2010, FUNCT ECOL, V24, P1234, DOI 10.1111/j.1365-2435.2010.01744.x; BUTLER CG, 1951, PROC R SOC SER B-BIO, V138, P403, DOI 10.1098/rspb.1951.0032; CHARLESWORTH D, 1993, AM NAT, V141, P481, DOI 10.1086/285485; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; Chittka L., 2005, PRACTICAL POLLINATIO, P157; Clarke KR, 2006, PRIMER V6 USER MANUA, P1; COLLISON CH, 1979, J APICULT RES, V18, P184, DOI 10.1080/00218839.1979.11099965; Costich DE, 2001, BIOL J LINN SOC, V74, P475, DOI 10.1111/j.1095-8312.2001.tb01406.x; Delph LF, 2006, INTEGR COMP BIOL, V46, P465, DOI 10.1093/icb/icj038; Dotterl S, 2010, CAN J ZOOL, V88, P668, DOI 10.1139/Z10-031; Dotterl S, 2011, J COMP PHYSIOL A, V197, P1119, DOI 10.1007/s00359-011-0673-2; Dotterl S, 2005, PHYTOCHEMISTRY, V66, P203, DOI 10.1016/j.phytochem.2004.12.002; Dotterl S, 2005, J CHEM ECOL, V31, P2993, DOI 10.1007/s10886-005-9152-y; Dyer AG, 2004, J COMP PHYSIOL A, V190, P105, DOI 10.1007/s00359-003-0475-2; FOX JF, 1992, OECOLOGIA, V90, P283, DOI 10.1007/BF00317187; Fussel U, 2007, J CHEM ECOL, V33, P749, DOI 10.1007/s10886-007-9257-6; Fussel U., 2007, THESIS U BAYREUTH BA; GALEN C, 1980, AM MIDL NAT, V104, P281, DOI 10.2307/2424867; GIURFA M, 1995, J COMP PHYSIOL A, V177, P247; Golonka AM, 2013, AM MIDL NAT, V169, P235, DOI 10.1674/0003-0031-169.2.235; Goukon K, 1976, SAISHU TO SHIIKU, V38, P111; Greco CF, 1996, CAN ENTOMOL, V128, P355, DOI 10.4039/Ent128355-3; HARDER LD, 1994, EVOL ECOL, V8, P542, DOI 10.1007/BF01238257; HEINRICH B, 1977, BEHAV ECOL SOCIOBIOL, V2, P247, DOI 10.1007/BF00299738; Herrera CM, 2008, ECOLOGY, V89, P2369, DOI 10.1890/08-0241.1; Heuschen B, 2005, PLANT SYST EVOL, V252, P121, DOI 10.1007/s00606-004-0249-5; Howe Henry F., 1997, P262; Johnson SD, 2009, AM J BOT; Jurgens A, 2004, AM J BOT, V91, P1969, DOI 10.3732/ajb.91.12.1969; Karrenberg S, 2002, PLANT SYST EVOL, V235, P181, DOI 10.1007/s00606-002-0231-z; KATOH N, 1985, Science Reports of the Tohoku University Fourth Series (Biology), V39, P45; KAY QON, 1984, NEW PHYTOL, V98, P515, DOI 10.1111/j.1469-8137.1984.tb04145.x; KEVAN PG, 1972, J ECOL, V60, P831, DOI 10.2307/2258569; Laporte MM, 1996, OECOLOGIA, V106, P63, DOI 10.1007/BF00334408; LEPAGE M, 1968, LIPIDS, V3, P530, DOI 10.1007/BF02530897; LUNAU K, 1992, CAN J ZOOL, V70, P2139, DOI 10.1139/z92-288; Lunau K, 2000, PLANT SYST EVOL, V222, P89, DOI 10.1007/BF00984097; Lunau K, 2007, BOT JB SYSTEMATIK PF, V127, P13; Menzel R, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P21, DOI 10.1017/CBO9780511542268.003; Milet-Pinheiro P, 2012, BEHAV ECOL, V23, P531, DOI 10.1093/beheco/arr219; Nepi M, 1996, ACTA BOT NEERL, V45, P41; Omura H, 2005, OECOLOGIA, V142, P588, DOI 10.1007/s00442-004-1761-6; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; PERCIVAL MARY S., 1961, NEW PHYTOL, V60, P235, DOI 10.1111/j.1469-8137.1961.tb06255.x; PICHERSKY E, 1994, PLANT PHYSIOL, V106, P1533, DOI 10.1104/pp.106.4.1533; Pohl M, 2008, BEHAV ECOL SOCIOBIOL, V63, P295, DOI 10.1007/s00265-008-0661-x; Raguso RA, 2005, ANIM BEHAV, V69, P407, DOI 10.1016/j.anbehav.2004.04.015; Raguso RA, 2002, ANIM BEHAV, V64, P685, DOI 10.1006/anbe.2002.4010; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; RIBBANDS CR, 1949, J ANIM ECOL, V18, P47, DOI 10.2307/1581; Richard A.J, 1997, PLANT BREEDING SYSTE; Roy BA, 1997, OECOLOGIA, V109, P414, DOI 10.1007/s004420050101; Schaffler I, 2011, APIDOLOGIE, V42, P409, DOI 10.1007/s13592-011-0010-3; Shykoff JA, 1997, CAN J BOT, V75, P1407, DOI 10.1139/b97-855; Skvortsov A.K., 1999, FACULTY MATH NATURAL; Soler CCL, 2012, ECOL LETT, V15, P978, DOI 10.1111/j.1461-0248.2012.01818.x; STANTON ML, 1986, SCIENCE, V232, P1625, DOI 10.1126/science.232.4758.1625; StatSoft Inc, 2008, STAT DAT AN SOFTW SY; Svensson GP, 2010, NEW PHYTOL, V186, P995, DOI 10.1111/j.1469-8137.2010.03227.x; Theis N, 2007, INT J PLANT SCI, V168, P587, DOI 10.1086/513481; TOLLSTEN L, 1992, PLANT SYST EVOL, V182, P229, DOI 10.1007/BF00939189; Totland O, 2001, AM J BOT, V88, P1011, DOI 10.2307/2657082; Urban Claudia, 2004, Senckenbergiana Biologica, V84, P81; van der Werf F, 1982, BEITR BIOL PFLANZ, V56, P105; Vaughton G, 1998, OECOLOGIA, V115, P93, DOI 10.1007/s004420050495; von Frisch Karl, 1919, ZOOL JB, V37, P1; VROEGE PW, 1990, ISRAEL J BOT, V39, P125; Waelti MO, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-190; WILSON P, 1994, AM NAT, V143, P283, DOI 10.1086/285604; Wright GA, 2005, J COMP PHYSIOL A, V191, P105, DOI 10.1007/s00359-004-0576-6; WYKES GR, 1952, J EXP BIOL, V29, P511; Zhen-Fu F., 1987, J SYST EVOL, V25, P307	90	52	56	3	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93421	10.1371/journal.pone.0093421	http://dx.doi.org/10.1371/journal.pone.0093421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676333	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677500121
J	Dostal, A; Gagnon, M; Chassard, C; Zimmermann, MB; O'Mahony, L; Lacroix, C				Dostal, Alexandra; Gagnon, Melanie; Chassard, Christophe; Zimmermann, Michael Bruce; O'Mahony, Liam; Lacroix, Christophe			Salmonella Adhesion, Invasion and Cellular Immune Responses Are Differentially Affected by Iron Concentrations in a Combined In Vitro Gut Fermentation-Cell Model	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; LACTIC-ACID BACTERIA; KAPPA-B ACTIVATION; COCULTURE MODEL; CACO-2; RESISTANCE; EXPRESSION; MICROBIOTA; INFECTION; GROWTH	In regions with a high infectious disease burden, concerns have been raised about the safety of iron supplementation because higher iron concentrations in the gut lumen may increase risk of enteropathogen infection. The aim of this study was to investigate interactions of the enteropathogen Salmonella enterica ssp. enterica Typhimurium with intestinal cells under different iron concentrations encountered in the gut lumen during iron deficiency and supplementation using an in vitro colonic fermentation system inoculated with immobilized child gut microbiota combined with Caco-2/HT29-MTX co-culture monolayers. Colonic fermentation effluents obtained during normal, low (chelation by 2,2'-dipyridyl) and high iron (26.5 mg iron/L) fermentation conditions containing Salmonella or pure Salmonella cultures with similar iron conditions were applied to cellular monolayers. Salmonella adhesion and invasion capacity, cellular integrity and immune response were assessed. Under high iron conditions in pure culture, Salmonella adhesion was 8-fold increased compared to normal iron conditions while invasion was not affected leading to decreased invasion efficiency (-86%). Moreover, cellular cytokines IL-1 beta, IL-6, IL-8 and TNF-alpha secretion as well as NF-kappa B activation in THP-1 cells were attenuated under high iron conditions. Low iron conditions in pure culture increased Salmonella invasion correlating with an increase in IL-8 release. In fermentation effluents, Salmonella adhesion was 12-fold and invasion was 428-fold reduced compared to pure culture. Salmonella in high iron fermentation effluents had decreased invasion efficiency (-77.1%) and cellular TNF-alpha release compared to normal iron effluent. The presence of commensal microbiota and bacterial metabolites in fermentation effluents reduced adhesion and invasion of Salmonella compared to pure culture highlighting the importance of the gut microbiota as a barrier during pathogen invasion. High iron concentrations as encountered in the gut lumen during iron supplementation attenuated Salmonella invasion efficiency and cellular immune response suggesting that high iron concentrations alone may not lead to an increased Salmonella invasion.	[Dostal, Alexandra; Gagnon, Melanie; Chassard, Christophe; Lacroix, Christophe] ETH, Inst Food Nutr & Hlth, Lab Food Biotechnol, Zurich, Switzerland; [Zimmermann, Michael Bruce] ETH, Inst Food Nutr & Hlth, Human Nutr Lab, Zurich, Switzerland; [O'Mahony, Liam] Univ Zurich, Swiss Inst Allergy & Asthma Res, Davos, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Allergy & Asthma Research; University of Zurich	Lacroix, C (corresponding author), ETH, Inst Food Nutr & Hlth, Lab Food Biotechnol, Zurich, Switzerland.	christophe.lacroix@hest.ethz.ch	Lacroix, Christophe/B-5139-2016; O'Mahony, Liam/AAG-5838-2019; Zimmermann, Michael B/C-3062-2016	Lacroix, Christophe/0000-0003-4360-2020; O'Mahony, Liam/0000-0003-4705-3583; 	Swiss National Science Foundation, Bern, Switzerland [310030_127272]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01HD0 64921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD064921] Funding Source: NIH RePORTER	Swiss National Science Foundation, Bern, Switzerland(Swiss National Science Foundation (SNSF)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Swiss National Science Foundation (project number: 310030_127272, Bern, Switzerland) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (award number: U01HD0 64921). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrami B, 2011, J APPL MICROBIOL, V110, P353, DOI 10.1111/j.1365-2672.2010.04889.x; Bahrami B, 2011, APPL ENVIRON MICROB, V77, P2934, DOI 10.1128/AEM.02244-10; Bermudez-Brito M, 2013, BRIT J NUTR, V109, pS27, DOI 10.1017/S0007114512004023; Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003; Burkholder KM, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-14; Chen CY, 2012, POULTRY SCI, V91, P2139, DOI 10.3382/ps.2012-02237; Collado MC, 2007, CURR MICROBIOL, V55, P260, DOI 10.1007/s00284-007-0144-8; Collins HL, 2008, EUR J IMMUNOL, V38, P1803, DOI 10.1002/eji.200838505; Collins HL, 2003, IMMUNOL LETT, V85, P193, DOI 10.1016/S0165-2478(02)00229-8; Collins HL, 2002, J IMMUNOL, V168, P3458, DOI 10.4049/jimmunol.168.7.3458; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Dostal A, 2013, FEMS MICROBIOL ECOL, V83, P161, DOI 10.1111/j.1574-6941.2012.01461.x; Dostal A, 2012, J NUTR, V142, P271, DOI 10.3945/jn.111.148643; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Fang HW, 2010, J MED MICROBIOL, V59, P573, DOI 10.1099/jmm.0.009662-0; Ferreira RBR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020338; Foster SL, 2001, J NUTR, V131, P1452, DOI 10.1093/jn/131.5.1452; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gagnon M, 2013, J MICROBIOL METH, V94, P274, DOI 10.1016/j.mimet.2013.06.027; Gantois I, 2006, APPL ENVIRON MICROB, V72, P946, DOI 10.1128/AEM.72.1.946-949.2006; Gera T, 2002, BMJ-BRIT MED J, V325, P1142, DOI 10.1136/bmj.325.7373.1142; Haller D, 2004, IMMUNOLOGY, V112, P310, DOI 10.1111/j.1365-2567.2004.01874.x; Haller D, 2000, GUT, V47, P79, DOI 10.1136/gut.47.1.79; Iannotti LL, 2006, AM J CLIN NUTR, V84, P1261, DOI 10.1093/ajcn/84.6.1261; Janakiraman A, 2000, MOL MICROBIOL, V35, P1146, DOI 10.1046/j.1365-2958.2000.01783.x; Kortman GAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029968; Lakhdari O, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/282356; Laparra JM, 2009, LETT APPL MICROBIOL, V49, P695, DOI 10.1111/j.1472-765X.2009.02729.x; Laparra JM, 2009, CELL BIOL INT, V33, P971, DOI 10.1016/j.cellbi.2009.06.001; Layton AN, 2010, FEMS MICROBIOL LETT, V302, P114, DOI 10.1111/j.1574-6968.2009.01847.x; Lee SH, 2008, BIOL TRACE ELEM RES, V126, pS57, DOI 10.1007/s12011-008-8209-5; LESUFFLEUR T, 1990, CANCER RES, V50, P6334; Mahler GJ, 2009, J NUTR BIOCHEM, V20, P494, DOI 10.1016/j.jnutbio.2008.05.006; Nairz M, 2008, EUR J IMMUNOL, V38, P1923, DOI 10.1002/eji.200738056; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; O'Mahony D, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-63; Parlesak A, 2004, SCAND J IMMUNOL, V60, P477, DOI 10.1111/j.0300-9475.2004.01495.x; Pieracci Fredric M, 2005, Surg Infect (Larchmt), V6 Suppl 1, pS41, DOI 10.1089/sur.2005.6.s1-41; PUSCHMANN M, 1977, INFECT IMMUN, V17, P663, DOI 10.1128/IAI.17.3.663-664.1977; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Simovich M, 2003, AM J HEMATOL, V74, P32, DOI 10.1002/ajh.10383; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Stoidis CN, 2010, NUTR RES REV, P1; Teixido L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019711; Tsai CC, 2011, FEMS IMMUNOL MED MIC, V63, P44, DOI 10.1111/j.1574-695X.2011.00826.x; Van Immerseel F, 2004, POULTRY SCI, V83, P69, DOI 10.1093/ps/83.1.69; Van Immerseel F, 2003, INT J FOOD MICROBIOL, V85, P237, DOI 10.1016/S0168-1605(02)00542-1; Viswanathan VK, 2009, NAT REV MICROBIOL, V7, P110, DOI 10.1038/nrmicro2053; Wang LJ, 2008, J IMMUNOL, V181, P2723, DOI 10.4049/jimmunol.181.4.2723; Wang LJ, 2009, J CLIN INVEST, V119, P3322, DOI 10.1172/JCI39939; Zaharik ML, 2002, P NATL ACAD SCI USA, V99, P15705, DOI 10.1073/pnas.252415599; Zihler A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-264; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564	57	38	38	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93549	10.1371/journal.pone.0093549	http://dx.doi.org/10.1371/journal.pone.0093549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676135	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000333677500139
J	Lu, KL; Xu, WN; Wang, LN; Zhang, DD; Zhang, CN; Liu, WB				Lu, Kang-Le; Xu, Wei-Na; Wang, Li-Na; Zhang, Ding-Dong; Zhang, Chun-Nuan; Liu, Wen-Bin			Hepatic beta-Oxidation and Regulation of Carnitine Palmitoyltransferase (CPT) I in Blunt Snout Bream Megalobrama amblycephala Fed a High Fat Diet	PLOS ONE			English	Article							CARP CTENOPHARYNGODON-IDELLA; SALMON SALMO-SALAR; GENE-EXPRESSION; LIPID-COMPOSITION; MITOCHONDRIAL DYSFUNCTION; GROWTH-PERFORMANCE; LIVER HISTOLOGY; PRACTICAL DIETS; INDUCED OBESITY; ACID OXIDATION	High-fat diets may promote growth, partly through their protein-sparing effects. However, high-fat diets often lead to excessive fat deposition, which may have a negative impact on fish such as poor growth and suppressive immune. Therefore, this study investigated the effects of a fat-rich diet on the mechanisms of fat deposition in the liver. Three-hundred blunt snout bream (Megalobrama amblycephala) juveniles (initial mass 18.00 +/- 0.05 g) were fed with one of two diets (5% or 15% fat) for 8 weeks. beta-Oxidation capacity and regulation of rate-limiting enzymes were assessed. Large fat droplets were present in hepatocytes of fish fed the high-fat diet. This observation is thought to be largely owing to the reduced capacity for mitochondrial and peroxisomal beta-oxidation in the livers of fish fed the high-fat diet, as well as the decreased activities of carnitine palmitoyltransferase (CPT) I and acyl-CoA oxidase (ACO), which are enzymes involved in fatty-acid metabolism. Study of CPT I kinetics showed that CPT I had a low affinity for its substrates and a low catalytic efficiency in fish fed the high-fat diet. Expression of both CPT I and ACO was significantly down-regulated in fish fed the high-fat diet. Moreover, the fatty-acid composition of the mitochondrial membrane varied between the two groups. In conclusion, the attenuated beta-oxidation capacity observed in fish fed a high-fat diet is proposed to be owing to decreased activity and/or catalytic efficiency of the rate-limiting enzymes CPT I and ACO, via both genetic and non-genetic mechanisms.	[Lu, Kang-Le; Xu, Wei-Na; Wang, Li-Na; Zhang, Ding-Dong; Zhang, Chun-Nuan; Liu, Wen-Bin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Liu, WB (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	wbliu@njau.edu.cn	Lu, Kang-le/I-6284-2019	Lu, Kang-le/0000-0002-6548-4291	National Natural Science Foundation of China [31172418, 31202005]; China Agriculture Research System [CARS-46-20]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	The project was supported by the National Natural Science Foundation of China (31172418 and 31202005) and China Agriculture Research System (CARS-46-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIEBER LL, 1986, METHOD ENZYMOL, V123, P276; Blanchard G, 2008, BRIT J NUTR, V100, P317, DOI 10.1017/S0007114508926532; Bolla S, 2011, AQUACULTURE, V312, P117, DOI 10.1016/j.aquaculture.2010.12.019; Caballero MJ, 1999, AQUACULTURE, V179, P277, DOI 10.1016/S0044-8486(99)00165-9; Colquhoun A, 2002, BBA-MOL CELL BIOL L, V1583, P74, DOI 10.1016/S1388-1981(02)00162-2; DEMOZ A, 1995, J CHROMATOGR B, V667, P148, DOI 10.1016/0378-4347(94)00595-V; Du ZY, 2008, AQUACULT NUTR, V14, P77, DOI 10.1111/j.1365-2095.2007.00507.x; Du ZY, 2006, BRIT J NUTR, V95, P905, DOI 10.1079/BJN20061733; Du ZY, 2012, BIOCHIM BIOPHYS ACTA, V1831, P291; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fraser F, 2001, J BIOL CHEM, V276, P20182, DOI 10.1074/jbc.M101078200; Froyland L, 1995, J LIPID RES, V36, P2529; Froyland L, 2000, AQUACULT NUTR, V6, P85; Grove TJ, 2004, COMP BIOCHEM PHYS B, V139, P53, DOI 10.1016/j.cbpc.2004.06.005; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hansen JO, 2008, AQUACULTURE, V284, P159, DOI 10.1016/j.aquaculture.2008.07.043; HOFSTEE BHJ, 1952, SCIENCE, V116, P329, DOI 10.1126/science.116.3013.329; Kennedy SR, 2007, AQUACULTURE, V272, P489, DOI 10.1016/j.aquaculture.2007.06.033; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; KIESSLING KH, 1993, CAN J ZOOL, V71, P248, DOI 10.1139/z93-035; Kim JH, 2005, J PHARMACOL SCI, V97, P124, DOI 10.1254/jphs.FP0040184; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Kjaer MA, 2008, LIPIDS, V43, P813, DOI 10.1007/s11745-008-3208-z; Kjaer MA, 2009, AQUACULTURE, V288, P325, DOI 10.1016/j.aquaculture.2008.12.022; KOLODZIEJ MP, 1990, BIOCHEM J, V272, P421, DOI 10.1042/bj2720421; Leaver MJ, 2007, J MOL ENDOCRINOL, V38, P391, DOI 10.1677/JME-06-0043; Leaver MJ, 2005, ENDOCRINOLOGY, V146, P3150, DOI 10.1210/en.2004-1638; Li XF, 2012, FISH SHELLFISH IMMUN, V33, P316, DOI 10.1016/j.fsi.2012.05.007; Li XF, 2010, AQUACULTURE, V303, P65, DOI 10.1016/j.aquaculture.2010.03.014; Li XF, 2012, FISH PHYSIOL BIOCHEM, V38, P529, DOI 10.1007/s10695-011-9533-9; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu KL, 2013, AQUACULTURE, V408, P160, DOI 10.1016/j.aquaculture.2013.06.003; Lu KL, 2013, FISHERIES SCI, V79, P661, DOI 10.1007/s12562-013-0635-4; MCCORMICK SD, 1995, J COMP PHYSIOL B, V165, P245, DOI 10.1007/BF00367308; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Morais S, 2001, AQUACULTURE, V203, P101, DOI 10.1016/S0044-8486(01)00618-4; Morais S, 2007, PHYSIOL GENOMICS, V28, P239, DOI 10.1152/physiolgenomics.00136.2006; Morash AJ, 2008, BBA-BIOMEMBRANES, V1778, P1382, DOI 10.1016/j.bbamem.2008.02.013; Morash AJ, 2009, COMP BIOCHEM PHYS B, V152, P85, DOI 10.1016/j.cbpb.2008.10.005; MURTHY MSR, 1987, P NATL ACAD SCI USA, V84, P378, DOI 10.1073/pnas.84.2.378; NAKANO M, 1990, METHOD ENZYMOL, V186, P227; Nanton DA, 2006, AQUACULT NUTR, V12, P363, DOI 10.1111/j.1365-2095.2006.00435.x; Nanton DA, 2003, COMP BIOCHEM PHYS B, V135, P95, DOI 10.1016/S1096-4959(03)0002-6; PHILIP GH, 1995, ECOTOX ENVIRON SAFE, V31, P173, DOI 10.1006/eesa.1995.1059; Power GW, 1997, LIPIDS, V32, P31, DOI 10.1007/s11745-997-0005-4; Price PT, 2000, CURR OPIN LIPIDOL, V11, P3, DOI 10.1097/00041433-200002000-00002; Rasmussen BB, 1999, ANNU REV NUTR, V19, P463, DOI 10.1146/annurev.nutr.19.1.463; Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030; Reddy JK, 2001, AM J PHYSIOL-GASTR L, V281, pG1333, DOI 10.1152/ajpgi.2001.281.6.G1333; Richards JG, 2002, AM J PHYSIOL-REG I, V282, pR89, DOI 10.1152/ajpregu.00238.2001; Roberts R. J, 1989, FISH PATHOLOGY; Robinson-Rechavi M, 2001, GENOME RES, V11, P781, DOI 10.1101/gr.165601; Rueda-Jasso R, 2004, AQUACULTURE, V231, P417, DOI 10.1016/S0044-8486(03)00537-4; Ruyter B, 2006, AQUACULTURE, V252, P441, DOI 10.1016/j.aquaculture.2005.07.014; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; SUAREZ RK, 1981, J COMP PHYSIOL, V143, P269; Tan XY, 2013, LIPIDS, V48, P505, DOI 10.1007/s11745-013-3759-5; Torstensen BE, 2009, AQUACULT NUTR, V15, P440, DOI 10.1111/j.1365-2095.2008.00609.x; Turchini GM, 2003, AQUACULTURE, V225, P251, DOI 10.1016/S0044-8486(03)00294-1; Walczak R, 2002, J LIPID RES, V43, P177; Watanabe T, 2002, FISHERIES SCI, V68, P242, DOI 10.1046/j.1444-2906.2002.00418.x; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Zheng JL, 2013, CHEMOSPHERE, V92, P616, DOI 10.1016/j.chemosphere.2013.04.013; Zheng JL, 2013, GENOMICS, V101, P195, DOI 10.1016/j.ygeno.2012.12.002; Zhou Z, 2008, AQUACULT NUTR, V14, P153, DOI 10.1111/j.1365-2095.2007.00515.x	66	116	119	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93135	10.1371/journal.pone.0093135	http://dx.doi.org/10.1371/journal.pone.0093135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676148	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677500080
J	Peng, HC; Kaloshian, I				Peng, Hsuan-Chieh; Kaloshian, Isgouhi			The Tomato Leucine-Rich Repeat Receptor-Like Kinases SlSERK3A and SlSERK3B Have Overlapping Functions in Bacterial and Nematode Innate Immunity	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; PAMP-TRIGGERED IMMUNITY; CELL-DEATH; MI-1-MEDIATED RESISTANCE; DEFENSE RESPONSES; EFFECTORS TARGET; STRUCTURAL BASIS; EARLY EVENTS; ARABIDOPSIS; BAK1	The Somatic Embryogenesis Receptor Kinase 3 (SERK3)/Brassinosteroid (BR) Insensitive 1-Associated Kinase 1 (BAK1) is required for pattern-triggered immunity (PTI) in Arabidopsis thaliana and Nicotiana benthamiana. Tomato (Solanum lycopersicum) has three SlSERK members. Two of them exhibit particularly high levels of sequence similarity to AtSERK3 and, therefore, were named SlSERK3A and SlSERK3B. To characterize a role for SlSERK3A and SlSERK3B in defense, we suppressed each gene individually or co-silenced both using virus-induced gene silencing (VIGS) in the tomato cv. Moneymaker. Co-silencing SlSERK3A and SlSERK3B resulted in spontaneous necrotic lesions and reduced sensitivity to exogenous BR treatment. Silencing either SlSERK3A or SlSERK3B resulted in enhanced susceptibility to root knot-nematode and to nonpathogenic Pseudomonas syringae pv. tomato (Pst) DC3000 hrcC indicating that both SlSERK3s are positive regulators of defense. Interestingly, silencing SlSERK3B, but not SlSERK3A, resulted in enhanced susceptibility to the pathogenic strain Pst DC3000 indicating distinct roles for these two SlSERK3 paralogs. SlSERK3A and SlSERK3B are active kinases, localized to the plasma membrane, and interact in vivo with the Flagellin Sensing 2 receptor in a flg22-dependent manner. Complementation of the Atserk3/bak1-4 mutant with either SlSERK3A or SlSERK3B partially rescued the mutant phenotype. Thus, SlSERK3A and SlSERK3B are likely to constitute tomato orthologs of BAK1.	[Peng, Hsuan-Chieh; Kaloshian, Isgouhi] Univ Calif Riverside, Ctr Plant Cell Biol, Dept Nematol, Grad Program Bot & Plant Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside	Kaloshian, I (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Dept Nematol, Grad Program Bot & Plant Sci, Riverside, CA 92521 USA.	Isgouhi.kaloshian@ucr.edu			University of California Agricultural Experiment Station	University of California Agricultural Experiment Station(University of California System)	This research was supported by the University of California Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2008, PLANT PHYSIOL, V148, P611, DOI 10.1104/pp.108.123216; Allemandou F, 2003, J BIOMED BIOTECHNOL, P202; Anderson JC, 2006, PLANT CELL, V18, P502, DOI 10.1105/tpc.105.036590; Bajwa VS, 2013, PLANT PHYSIOL, V163, P30, DOI 10.1104/pp.113.221465; Bar M, 2010, PLANT J, V63, P791, DOI 10.1111/j.1365-313X.2010.04282.x; Bhattarai KK, 2007, PLANT PHYSIOL, V144, P312, DOI 10.1104/pp.107.097246; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bucherl CA, 2013, PLANT PHYSIOL, V162, P1911, DOI 10.1104/pp.113.220152; Chaparro-Garcia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016608; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; de Ilarduya OM, 2003, MOL PLANT MICROBE IN, V16, P699, DOI 10.1094/MPMI.2003.16.8.699; de Ilarduya OM, 2001, PLANT J, V27, P417, DOI 10.1046/j.1365-313X.2001.01112.x; Fradin EF, 2011, PLANT PHYSIOL, V156, P2255, DOI 10.1104/pp.111.180067; Fradin EF, 2009, PLANT PHYSIOL, V150, P320, DOI 10.1104/pp.109.136762; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gou XP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002452; Haegeman A, 2012, GENE, V492, P19, DOI 10.1016/j.gene.2011.10.040; Hann DR, 2007, PLANT J, V49, P607, DOI 10.1111/j.1365-313X.2006.02981.x; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaloshian I, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P309, DOI 10.1007/978-94-007-0434-3_15; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Karlova R, 2009, PROTEOMICS, V9, P368, DOI 10.1002/pmic.200701059; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; Kim JG, 2009, PLANT CELL, V21, P1305, DOI 10.1105/tpc.108.063123; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; LIANG XW, 1992, P NATL ACAD SCI USA, V89, P11046, DOI 10.1073/pnas.89.22.11046; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Mantelin S, 2011, PLANT J, V67, P459, DOI 10.1111/j.1365-313X.2011.04609.x; Mathur J, 1998, PLANT J, V14, P593, DOI 10.1046/j.1365-313X.1998.00158.x; Millet YA, 2010, PLANT CELL, V22, P973, DOI 10.1105/tpc.109.069658; Monaghan J, 2012, CURR OPIN PLANT BIOL, V15, P349, DOI 10.1016/j.pbi.2012.05.006; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nguyen HP, 2010, MOL PLANT MICROBE IN, V23, P991, DOI 10.1094/MPMI-23-8-0991; Ntoukakis V, 2011, PLANT CELL, V23, P3871, DOI 10.1105/tpc.111.090779; Quentin M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00053; Robatzek S, 2007, PLANT MOL BIOL, V64, P539, DOI 10.1007/s11103-007-9173-8; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Sakamoto T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-229; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Shah H, 2001, J MOL BIOL, V309, P641, DOI 10.1006/jmbi.2001.4706; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Smant G, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P273, DOI 10.1007/978-94-007-0434-3_13; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; Tornero P, 1997, MOL PLANT MICROBE IN, V10, P624, DOI 10.1094/MPMI.1997.10.5.624; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang Z, 2011, PLANT J, V67, P1081, DOI 10.1111/j.1365-313X.2011.04659.x; Williamson VM, 2006, TRENDS GENET, V22, P396, DOI 10.1016/j.tig.2006.05.003; Yang DH, 2011, J EXP BOT, V62, P641, DOI 10.1093/jxb/erq298; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003	65	40	42	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93302	10.1371/journal.pone.0093302	http://dx.doi.org/10.1371/journal.pone.0093302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675749	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677500108
J	Volis, S				Volis, Sergei			Dormancy-Related Seed Positional Effect in Two Populations of an Annual Grass from Locations of Contrasting Aridity	PLOS ONE			English	Article							OATS AVENA-FATUA; PURE LINES; GERMINATION; DEMOGRAPHY; CONSEQUENCES; TEMPERATURE; DYNAMICS; BANKING; WINTER; TIME	In grasses, variation in seed size and dormancy often results from a seed's position within a dispersal unit. In this paper, I asked whether seed positional effect within a spikelet contributes to ecotypic differentiation between two populations of Avena sterilis having different species range position and associated aridity. I created experimental seed banks in which germination of seeds (florets) having different positions within a spikelet was examined over three years. In addition, two germination tests were conducted under controlled conditions. The two populations were found to have a short-living soil seed bank due to sequential germination of the florets. Although positional seed dormancy effect in A. sterilis does not appear to be a specific desert adaptation against unpredictability of rainfall events, this trait does contribute to ecotypic differentiation between desert and Mediterranean populations. Consistent with bet hedging buffering against rainfall unpredictability, germination fractions in the first year were higher in the Mediterranean than in the desert population, while seeds of the desert origin had stronger dormancy and more sequential germination of florets.	Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Volis, S (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Peoples R China.	volis@mail.kib.ac.cn	Volis, Sergei/GLU-5848-2022					ADKINS SW, 1988, PHYSIOL PLANTARUM, V73, P15, DOI 10.1111/j.1399-3054.1988.tb09186.x; ADKINS SW, 1987, WEED SCI, V35, P169; ADKINS SW, 1986, WEED SCI, V34, P859; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; BEATLEY JC, 1967, ECOLOGY, V48, P745, DOI 10.2307/1933732; CAMPBELL CS, 1983, ANNU REV ECOL SYST, V14, P411, DOI 10.1146/annurev.es.14.110183.002211; Childs DZ, 2010, P ROY SOC B-BIOL SCI, V277, P3055, DOI 10.1098/rspb.2010.0707; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; DelArco MJS, 1995, WEED RES, V35, P477, DOI 10.1111/j.1365-3180.1995.tb01645.x; Dyer AR, 2004, PLANT ECOL, V172, P211, DOI 10.1023/B:VEGE.0000026339.61069.33; Evans MEK, 2007, AM NAT, V169, P184, DOI 10.1086/510599; Evans MEK, 2005, Q REV BIOL, V80, P431, DOI 10.1086/498282; FREAS KE, 1983, J ECOL, V71, P211, DOI 10.2307/2259973; GOSLING PG, 1981, J EXP BOT, V32, P621, DOI 10.1093/jxb/32.3.621; Gutterman Y, 1998, PLANT SOIL, V204, P223, DOI 10.1023/A:1004314017674; Horovitz A, 1998, CENTRAL RES I FIELD, P185; Imbert E, 2002, PERSPECT PLANT ECOL, V5, P13, DOI 10.1078/1433-8319-00021; Inouye R., 1991, ECOLOGY DESERT COMMU, P27; JOHNSON L. P. V., 1935, CANADIAN JOUR RES SEC C BOT SCI, V13, P283; KALISZ S, 1992, ECOLOGY, V73, P1082, DOI 10.2307/1940182; ORZACK SH, 1989, AM NAT, V133, P901, DOI 10.1086/284959; Pake CE, 1996, ECOLOGY, V77, P1427, DOI 10.2307/2265540; PHANEENDRANATH BR, 1978, CROP SCI, V18, P683, DOI 10.2135/cropsci1978.0011183X001800040040x; PITT MD, 1978, ECOLOGY, V59, P336, DOI 10.2307/1936378; Polis GA, 1995, ECOLOGY DESERT COMMU, P1; Schwendiman Alvin, 1943, JOUR AMER SOC AGRON, V35, P681; Simpson G. M., 1990, SEED DORMANCY GRASSE; *STATSOFT INC, 2004, STATISTICA DAT AN SO; Stocklin J, 1999, OECOLOGIA, V120, P539, DOI 10.1007/s004420050888; Sugawara S, 1959, B FACULTY AGR NIIGAT, V11, P9; TEVIS L, 1958, ECOLOGY, V39, P681, DOI 10.2307/1931608; Tuljapurkar S, 2000, ECOL MODEL, V133, P143, DOI 10.1016/S0304-3800(00)00288-X; Valleriani A, 2006, THEOR POPUL BIOL, V70, P255, DOI 10.1016/j.tpb.2006.07.008; van der Aart P.J.M., 1988, PLANT FORM VEGETATIO, P211; Venable D. Lawrence, 1999, P115; Volis S, 2004, BASIC APPL ECOL, V5, P53, DOI 10.1078/1439-1791-00192; Volis S, 2012, PERSPECT PLANT ECOL, V14, P335, DOI 10.1016/j.ppees.2012.07.002; Wang AB, 2010, ANN BOT-LONDON, V106, P95, DOI 10.1093/aob/mcq089; WURZBURGER J, 1976, PLANT PHYSIOL, V57, P670, DOI 10.1104/pp.57.4.670; ZOHARY D, 1983, ISRAEL J BOT, V32, P97	40	6	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93061	10.1371/journal.pone.0093061	http://dx.doi.org/10.1371/journal.pone.0093061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675719	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500068
J	Wu, J; Xu, YQ; Mo, DP; Huang, PJ; Sun, RH; Huang, L; Pan, SY; Xu, J				Wu, Jing; Xu, Yuqiao; Mo, Dongping; Huang, Peijun; Sun, Ruihong; Huang, Lei; Pan, Shiyang; Xu, Jian			Kaposi's Sarcoma-Associated Herpesvirus (KSHV) vIL-6 Promotes Cell Proliferation and Migration by Upregulating DNMT1 via STAT3 Activation	PLOS ONE			English	Article							VIRUS-X PROTEIN; DNA METHYLTRANSFERASE-1; GENE; EXPRESSION; GROWTH; CANCER; METHYLATION; SEQUENCES; HOMOLOG	Kaposi's sarcoma-associated herpesvirus (KSHV) is etiologically associated with Kaposi's sarcoma (KS), the most common AIDS-related malignancy. KSHV vIL-6 promotes KS development, but the exact mechanisms remain unclear. Here, we reported that KSHV vIL-6 enhanced the expression of DNA methyltransferase 1 (DNMT1) in endothelial cells, increased the global genomic DNA methylation, and promoted cell proliferation and migration. And this effect could be blocked by the DNA methyltransferase inhibitor, 5-azadeoxycytidine. We also showed that vIL-6 induced up-regulation of DNMT1 was dependent on STAT3 activation. Therefore, the present study suggests that vIL-6 plays a role in KS tumorigenesis partly by activating DNMT1 and inducing aberrant DNA methylation, and it might be a potential target for KS therapy.	[Wu, Jing] Nanjing Chest Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China; [Xu, Yuqiao; Mo, Dongping; Huang, Peijun; Sun, Ruihong; Huang, Lei; Pan, Shiyang; Xu, Jian] Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China; [Huang, Peijun; Pan, Shiyang; Xu, Jian] Natl Key Clin Dept Lab Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Pan, SY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China.	sypan@njmu.edu.cn; xu_jian79@163.com			National Natural Science Foundation of China [30901262, 81371894]; Key Laboratory for Laboratory Medicine of Jiangsu Province of China [XK201114]; Medical Science and Technology Development Foundation, Nanjing Department of Health [QYK11143]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory for Laboratory Medicine of Jiangsu Province of China; Medical Science and Technology Development Foundation, Nanjing Department of Health; Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by National Natural Science Foundation of China (No. 30901262, 81371894), Key Laboratory for Laboratory Medicine of Jiangsu Province of China (No. XK201114), Medical Science and Technology Development Foundation, Nanjing Department of Health (No. QYK11143), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 1999, BLOOD, V93, P4034, DOI 10.1182/blood.V93.12.4034.412k38_4034_4043; Bigey P, 2000, GENE, V242, P407, DOI 10.1016/S0378-1119(99)00501-6; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Detich N, 2001, J BIOL CHEM, V276, P24881, DOI 10.1074/jbc.M103056200; Dhe-Paganon Sirano, 2011, Int J Biochem Mol Biol, V2, P58; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Flanagan JM, 2007, BRIT J CANCER, V96, P183, DOI 10.1038/sj.bjc.6603516; Foran E, 2010, MOL CANCER RES, V8, P471, DOI 10.1158/1541-7786.MCR-09-0496; Gasche JA, 2011, INT J CANCER, V129, P1053, DOI 10.1002/ijc.25764; Hodge David R., 2007, Cancer Genomics & Proteomics, V4, P387; Hodge DR, 2005, CANCER RES, V65, P4673, DOI 10.1158/0008-5472.CAN-04-3589; Hodge DR, 2001, J BIOL CHEM, V276, P39508, DOI 10.1074/jbc.C100343200; Jenner RG, 2002, BBA-REV CANCER, V1602, P1, DOI 10.1016/S0304-419X(01)00040-3; Jin BL, 2013, ADV EXP MED BIOL, V754, P3, DOI 10.1007/978-1-4419-9967-2_1; Jung JK, 2007, CANCER RES, V67, P5771, DOI 10.1158/0008-5472.CAN-07-0529; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Lee JO, 2005, ONCOGENE, V24, P6617, DOI 10.1038/sj.onc.1208827; Marshall V, 2007, J INFECT DIS, V195, P645, DOI 10.1086/511434; McLemore ML, 2001, IMMUNITY, V14, P193, DOI 10.1016/S1074-7613(01)00101-7; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Moody R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003857; Morris VA, 2012, VIROLOGY, V428, P112, DOI 10.1016/j.virol.2012.03.013; Neipel F, 1997, J VIROL, V71, P839, DOI 10.1128/JVI.71.1.839-842.1997; Pan SY, 2009, BIOMED PHARMACOTHER, V63, P463, DOI 10.1016/j.biopha.2008.09.006; RIEBER AJ, 1993, THROMB HAEMOSTASIS, V69, P476; Sakakibara S, 2011, J INTERF CYTOK RES, V31, P791, DOI 10.1089/jir.2011.0043; Shamay M, 2006, P NATL ACAD SCI USA, V103, P14554, DOI 10.1073/pnas.0604469103; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Suthaus J, 2011, EUR J CELL BIOL, V90, P495, DOI 10.1016/j.ejcb.2010.10.016; Tsai CL, 2006, CANCER RES, V66, P11668, DOI 10.1158/0008-5472.CAN-06-2194; Wan XY, 1999, J VIROL, V73, P8268, DOI 10.1128/JVI.73.10.8268-8278.1999; Wehbe H, 2006, CANCER RES, V66, P10517, DOI 10.1158/0008-5472.CAN-06-2130; WU JJ, 1993, P NATL ACAD SCI USA, V90, P8891, DOI 10.1073/pnas.90.19.8891; Yeung CLA, 2010, ONCOL REP, V24, P1599, DOI 10.3892/or_00001023; Zhang Q, 2006, BLOOD, V108, P1058, DOI 10.1182/blood-2005-08-007377; Zhu X, 2014, ONCOGENE, V33, P1986, DOI 10.1038/onc.2013.136	38	25	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93478	10.1371/journal.pone.0093478	http://dx.doi.org/10.1371/journal.pone.0093478			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675762	gold, Green Submitted, Green Published			2022-12-25	WOS:000333677500129
J	Delgado, MM; Nicholas, M; Petrie, DJ; Jacobs, LF				Delgado, Mikel M.; Nicholas, Molly; Petrie, Daniel J.; Jacobs, Lucia F.			Fox Squirrels Match Food Assessment and Cache Effort to Value and Scarcity	PLOS ONE			English	Article							GREY SQUIRRELS; SEX-DIFFERENCES; FUTURE VALUE; SCIURUS; HIPPOCAMPUS; EVOLUTION; BEHAVIOR; HABITS; MODEL; NUTS	Scatter hoarders must allocate time to assess items for caching, and to carry and bury each cache. Such decisions should be driven by economic variables, such as the value of the individual food items, the scarcity of these items, competition for food items and risk of pilferage by conspecifics. The fox squirrel, an obligate scatter-hoarder, assesses cacheable food items using two overt movements, head flicks and paw manipulations. These behaviors allow an examination of squirrel decision processes when storing food for winter survival. We measured wild squirrels' time allocations and frequencies of assessment and investment behaviors during periods of food scarcity (summer) and abundance (fall), giving the squirrels a series of 15 items (alternating five hazelnuts and five peanuts). Assessment and investment per cache increased when resource value was higher (hazelnuts) or resources were scarcer (summer), but decreased as scarcity declined (end of sessions). This is the first study to show that assessment behaviors change in response to factors that indicate daily and seasonal resource abundance, and that these factors may interact in complex ways to affect food storing decisions. Food-storing tree squirrels may be a useful and important model species to understand the complex economic decisions made under natural conditions.	[Delgado, Mikel M.; Nicholas, Molly; Petrie, Daniel J.; Jacobs, Lucia F.] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Delgado, MM (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	mikeldelgado@berkeley.edu		Delgado, Mikel/0000-0002-3252-2618	University of California at Berkeley Chancellor's Fellowship; National Science Foundation Graduate Research Fellowship; National Science Foundation Electrical, Communications and Cyber Systems [1028319]	University of California at Berkeley Chancellor's Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation Electrical, Communications and Cyber Systems	This work was funded by the University of California at Berkeley Chancellor's Fellowship and the National Science Foundation Graduate Research Fellowship to MD and the National Science Foundation Electrical, Communications and Cyber Systems Grant 1028319 to LJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1978, ANIM BEHAV, V26, P707, DOI 10.1016/0003-3472(78)90137-9; [Anonymous], 2012, USDA NAT NUTR DAT ST; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brown J. S., 1992, ANN ZOOL FENN, V29, P1; Burger DK, 2013, BEHAV BRAIN RES, V236, P131, DOI 10.1016/j.bbr.2012.08.044; COCKRELL R. A., 1976, TREES BERKELEY CAMPU; Coxe S, 2009, J PERS ASSESS, V91, P121, DOI 10.1080/00223890802634175; Eibl-Eibesfeldt I., 1963, Zeitschrift fuer Tierpsychologie, V20, P705; Fowells HA, 1956, 1150 USDA; Gerber LR, 2004, ECOL MODEL, V175, P77, DOI 10.1016/j.ecolmodel.2003.10.022; GOODRUM PD, 1972, J WILDLIFE MANAGE, V36, P159, DOI 10.2307/3799203; HadjChikh LZ, 1996, ANIM BEHAV, V52, P941, DOI 10.1006/anbe.1996.0242; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Hopewell LJ, 2008, ETHOLOGY, V114, P1061, DOI 10.1111/j.1439-0310.2008.01554.x; HORWICH R H, 1972, P103; Jacobs LF, 1999, J COMP PSYCHOL, V113, P116, DOI 10.1037/0735-7036.113.2.116; Kislalioglu M., 1976, Journal of exp mar Biol Ecol, V25, P151, DOI 10.1016/0022-0981(76)90016-2; Koenig WD, 2008, CALIFORNIA ACORN SUR; Kotler BP, 1999, AM MIDL NAT, V142, P77, DOI 10.1674/0003-0031(1999)142[0077:FSATFB]2.0.CO;2; KRAUS B, 1983, ECOLOGY, V64, P608, DOI 10.2307/1939982; Langen TA, 1998, ANIM BEHAV, V55, P1245, DOI 10.1016/S0003-3472(98)90000-8; Langen Tom A., 1999, Animal Cognition, V2, P223, DOI 10.1007/s100710050043; Lavenex P, 2000, J COMP NEUROL, V425, P152; Leaver LA, 2007, ANIM COGN, V10, P23, DOI 10.1007/s10071-006-0026-7; LEWIS AR, 1982, AM MIDL NAT, V107, P250, DOI 10.2307/2425376; Lichti N. I., 2012, THESIS; LIGON JD, 1974, ANIM BEHAV, V22, P421, DOI 10.1016/S0003-3472(74)80040-0; LOEWENSTEIN G, 1987, ECON J, V97, P666, DOI 10.2307/2232929; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; McDonald PM, 1969, SILVICAL CHARACTERIS, V53; MCQUADE DB, 1986, ETHOLOGY, V72, P22; Melin AD, 2009, INT J PRIMATOL, V30, P753, DOI 10.1007/s10764-009-9383-9; Moore JE, 2007, ECOLOGY, V88, P2529, DOI 10.1890/07-0247.1; MUUL I, 1969, J MAMMAL, V50, P542, DOI 10.2307/1378781; NIXON CM, 1991, AM MIDL NAT, V125, P168, DOI 10.2307/2426380; NIXON CM, 1968, J WILDLIFE MANAGE, V32, P294, DOI 10.2307/3798974; Preston SD, 2009, J MAMMAL, V90, P787, DOI 10.1644/08-MAMM-A-254.1; Rockwell C, 2013, ANIM BEHAV, V86, P783, DOI 10.1016/j.anbehav.2013.07.018; Schmidt KA, 2008, AM NAT, V171, P386, DOI 10.1086/527497; SHORT HL, 1971, J WILDLIFE MANAGE, V35, P435, DOI 10.2307/3799694; Skaug H., 2006, GLMMADMB GEN LINEAR; SMITH CC, 1984, ANNU REV ECOL SYST, V15, P329, DOI 10.1146/annurev.es.15.110184.001553; STAPANIAN MA, 1978, ECOLOGY, V59, P884, DOI 10.2307/1938541; STAPANIAN MA, 1984, ECOLOGY, V65, P1387, DOI 10.2307/1939119; Steele MA, 2008, ANIM BEHAV, V75, P705, DOI 10.1016/j.anbehav.2007.07.026; Steele MA, 2014, BEHAV ECOL, V25, P206, DOI 10.1093/beheco/art107; Stephens D.W., 1986, pi; THOMPSON DC, 1980, CAN J ZOOL, V58, P701, DOI 10.1139/z80-101; Valone TJ, 2006, OIKOS, V112, P252; Vander Wall SB, 1990, FOOD HOARDING ANIMAL, P453; Waisman AS, 2008, ANIM COGN, V11, P625, DOI 10.1007/s10071-008-0152-5; Waisman AS, 2011, P 33 ANN C COGN SCI; Wang B, 2013, OIKOS, V122, P1027, DOI 10.1111/j.1600-0706.2012.20823.x; Wood M, 1998, J ECON PSYCHOL, V19, P295, DOI 10.1016/S0167-4870(98)00009-9	55	9	9	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92892	10.1371/journal.pone.0092892	http://dx.doi.org/10.1371/journal.pone.0092892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671221	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000089
J	Huber, A; Lui, F; Duzzi, D; Pagnoni, G; Porro, CA				Huber, Alexa; Lui, Fausta; Duzzi, Davide; Pagnoni, Giuseppe; Porro, Carlo Adolfo			Structural and Functional Cerebral Correlates of Hypnotic Suggestibility	PLOS ONE			English	Article							RESTING-STATE FMRI; HUMAN BRAIN; COGNITIVE CONTROL; HYPNOTIZABILITY; HYPNOSIS; SUSCEPTIBILITY; CONFLICT; PAIN; INTEGRATION; ABSORPTION	Little is known about the neural bases of hypnotic suggestibility, a cognitive trait referring to the tendency to respond to hypnotic suggestions. In the present magnetic resonance imaging study, we performed regression analyses to assess hypnotic suggestibility-related differences in local gray matter volume, using voxel-based morphometry, and in waking resting state functional connectivity of 10 resting state networks, in 37 healthy women. Hypnotic suggestibility was positively correlated with gray matter volume in portions of the left superior and medial frontal gyri, roughly overlapping with the supplementary and pre-supplementary motor area, and negatively correlated with gray matter volume in the left superior temporal gyrus and insula. In the functional connectivity analysis, hypnotic suggestibility was positively correlated with functional connectivity between medial posterior areas, including bilateral posterior cingulate cortex and precuneus, and both the lateral visual network and the left fronto-parietal network; a positive correlation was also found with functional connectivity between the executive-control network and a right postcentral/parietal area. In contrast, hypnotic suggestibility was negatively correlated with functional connectivity between the right fronto-parietal network and the right lateral thalamus. These findings demonstrate for the first time a correlation between hypnotic suggestibility, the structural features of specific cortical regions, and the functional connectivity during the normal resting state of brain structures involved in imagery and self-monitoring activity.	[Huber, Alexa; Lui, Fausta; Duzzi, Davide; Pagnoni, Giuseppe; Porro, Carlo Adolfo] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy	Universita di Modena e Reggio Emilia	Porro, CA (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy.	carlo.porro@unimore.it	Porro, Carlo Adolfo/N-2580-2015; Lui, Fausta/P-3816-2015; Pagnoni, Giuseppe/F-3398-2015	Porro, Carlo Adolfo/0000-0003-2345-5852; Lui, Fausta/0000-0001-6577-059X; Pagnoni, Giuseppe/0000-0002-8272-8091; Mullner-Huber, Alexa/0000-0003-2372-7942	Fondazione Cassa di Risparmio di Modena (FCRM); FCRM International grant [A0FF-0AAB-9711-FA30]	Fondazione Cassa di Risparmio di Modena (FCRM); FCRM International grant	The authors thank the Fondazione Cassa di Risparmio di Modena (FCRM) for its financial support to the Modena MR center. A. H. is supported by a FCRM International grant 2010 (code: A0FF-0AAB-9711-FA30) to C. A. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Carli G., 2008, CONT HYPNOSIS, V25, P65, DOI [DOI 10.1002/CH.356, 10.1002/ch.v25:210.1002/ch.356, DOI 10.1002/CH.V25:210.1002/CH.356]; Carli G, 2008, COGN NEUROPSYCHOL, V25, P1065, DOI 10.1080/02643290801913712; Castellani E, 2011, INT J CLIN EXP HYP, V59, P250, DOI 10.1080/00207144.2011.546269; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; De Pascalis V, 2000, INT J CLIN EXP HYP, V48, P315, DOI 10.1080/00207140008415249; De Pascalis V, 2008, PAIN, V134, P197, DOI 10.1016/j.pain.2007.09.005; Dienes Z, 2013, CORTEX, V49, P386, DOI 10.1016/j.cortex.2012.07.009; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Egner T, 2005, NEUROIMAGE, V27, P969, DOI 10.1016/j.neuroimage.2005.05.002; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Garcia-Larrea L, 2012, NEUROPHYSIOL CLIN, V42, P299, DOI 10.1016/j.neucli.2012.06.001; GLISKY ML, 1995, INT J CLIN EXP HYP, V43, P34, DOI 10.1080/00207149508409374; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gotts SJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00356; Green JP, 2011, INT J CLIN EXP HYP, V59, P103, DOI 10.1080/00207144.2011.522914; Gruzelier J, 2010, CONT HYPNOSIS, V28, P116; Hoeft F, 2012, ARCH GEN PSYCHIAT, V69, P1064, DOI 10.1001/archgenpsychiatry.2011.2190; Horton JE, 2004, BRAIN, V127, P1741, DOI 10.1093/brain/awh196; Huber A, 2013, PAIN, V154, P1509, DOI 10.1016/j.pain.2013.03.031; Aguilar EJ, 2008, EUR J RADIOL, V67, P434, DOI 10.1016/j.ejrad.2008.02.046; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Kirsch I, 2001, CURR DIR PSYCHOL SCI, V10, P57, DOI 10.1111/1467-8721.00115; LYNN SJ, 1986, J PERS SOC PSYCHOL, V51, P404, DOI 10.1037/0022-3514.51.2.404; Maquet P, 1999, BIOL PSYCHIAT, V45, P327, DOI 10.1016/S0006-3223(97)00546-5; McGeown WJ, 2012, CONSCIOUS COGN, V21, P100, DOI 10.1016/j.concog.2011.10.015; McGeown WJ, 2009, CONSCIOUS COGN, V18, P848, DOI 10.1016/j.concog.2009.09.001; Menzocchi M, 2010, INT J CLIN EXP HYP, V58, P122, DOI 10.1080/00207140903316169; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Molinari E, 2013, CEREB CORTEX, V23, P178, DOI 10.1093/cercor/bhr393; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Oakley DA, 2013, NAT REV NEUROSCI, V14, P565, DOI 10.1038/nrn3538; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pedrabissi L, 1989, INVENTARIO ANSIA STA; PICCIONE C, 1989, J PERS SOC PSYCHOL, V56, P289, DOI 10.1037/0022-3514.56.2.289; Pochon JB, 2008, J NEUROSCI, V28, P3468, DOI 10.1523/JNEUROSCI.4195-07.2008; Preacher KJ, 2005, PSYCHOL METHODS, V10, P178, DOI 10.1037/1082-989X.10.2.178; Pyka M, 2011, NEUROIMAGE, V56, P2173, DOI 10.1016/j.neuroimage.2011.03.078; Raz A, 2005, P NATL ACAD SCI USA, V102, P9978, DOI 10.1073/pnas.0503064102; Raz A, 2008, INT J CLIN EXP HYP, V56, P99, DOI 10.1080/00207140701506482; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; Terhune DB, 2011, PSYCHOPHYSIOLOGY, V48, P1444, DOI 10.1111/j.1469-8986.2011.01211.x; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Weitzenhoffer A., 1959, STANFORD HYPNOTIC SU; Whittingstall K, 2013, STRUCTURAL NETWORK U; Woody EZ, 2005, PSYCHOL ASSESSMENT, V17, P200, DOI 10.1037/1040-3590.17.2.200; Wylie KP, 2010, SCHIZOPHR RES, V123, P93, DOI 10.1016/j.schres.2010.08.027	52	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93187	10.1371/journal.pone.0093187	http://dx.doi.org/10.1371/journal.pone.0093187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671130	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677000126
J	Paredes, R; Orben, RA; Suryan, RM; Irons, DB; Roby, DD; Harding, AMA; Young, RC; Benoit-Bird, K; Ladd, C; Renner, H; Heppell, S; Phillips, RA; Kitaysky, A				Paredes, Rosana; Orben, Rachael A.; Suryan, Robert M.; Irons, David B.; Roby, Daniel D.; Harding, Ann M. A.; Young, Rebecca C.; Benoit-Bird, Kelly; Ladd, Carol; Renner, Heather; Heppell, Scott; Phillips, Richard A.; Kitaysky, Alexander			Foraging Responses of Black-Legged Kittiwakes to Prolonged Food-Shortages around Colonies on the Bering Sea Shelf	PLOS ONE			English	Article							POLLOCK THERAGRA-CHALCOGRAMMA; DIEL VERTICAL MIGRATION; PRIBILOF ISLANDS; PISCIVOROUS SEABIRDS; POPULATION PROCESSES; MYCTOPHID FISHES; EL-NINO; PREY; AVAILABILITY; STRESS	We hypothesized that changes in southeastern Bering Sea foraging conditions for black-legged kittiwakes (Rissa tridactyla) have caused shifts in habitat use with direct implications for population trends. To test this, we compared at-sea distribution, breeding performance, and nutritional stress of kittiwakes in three years (2008-2010) at two sites in the Pribilof Islands, where the population has either declined (St. Paul) or remained stable (St. George). Foraging conditions were assessed from changes in (1) bird diets, (2) the biomass and distribution of juvenile pollock (Theragra chalcogramma) in 2008 and 2009, and (3) eddy kinetic energy (EKE; considered to be a proxy for oceanic prey availability). In years when biomass of juvenile pollock was low and patchily distributed in shelf regions, kittiwake diets included little or no neritic prey and a much higher occurrence of oceanic prey (e.g. myctophids). Birds from both islands foraged on the nearby shelves, or made substantially longer-distance trips overnight to the basin. Here, feeding was more nocturnal and crepuscular than on the shelf, and often occurred near anticyclonic, or inside cyclonic eddies. As expected from colony location, birds from St. Paul used neritic waters more frequently, whereas birds from St. George typically foraged in oceanic waters. Despite these distinctive foraging patterns, there were no significant differences between colonies in chick feeding rates or fledging success. High EKE in 2010 coincided with a 63% increase in use of the basin by birds from St. Paul compared with 2008 when EKE was low. Nonetheless, adult nutritional stress, which was relatively high across years at both colonies, peaked in birds from St. Paul in 2010. Diminishing food resources in nearby shelf habitats may have contributed to kittiwake population declines at St Paul, possibly driven by increased adult mortality or breeding desertion due to high foraging effort and nutritional stress.	[Paredes, Rosana; Heppell, Scott] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Orben, Rachael A.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Suryan, Robert M.] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Newport, OR 97365 USA; [Irons, David B.] US Fish & Wildlife Serv, Anchorage, AK USA; [Roby, Daniel D.] Oregon State Univ, US Geol Survey, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA; [Harding, Ann M. A.] Alaska Pacific Univ, Dept Environm Sci, Anchorage, AK USA; [Young, Rebecca C.; Kitaysky, Alexander] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Benoit-Bird, Kelly] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Ladd, Carol] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Renner, Heather] US Fish & Wildlife Serv, Alaska Maritime Natl Wildlife Refuge, Homer, AK USA; [Phillips, Richard A.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England	Oregon State University; University of California System; University of California Santa Cruz; Oregon State University; United States Department of the Interior; US Fish & Wildlife Service; Oregon State University; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; US Fish & Wildlife Service; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Paredes, R (corresponding author), Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA.	rparedes.insley@gmail.com	Orben, Rachael A./H-9460-2019; Ladd, Carol/M-6159-2014	Orben, Rachael A./0000-0002-0802-407X; Ladd, Carol/0000-0003-1065-430X; Suryan, Robert/0000-0003-0755-8317	North Pacific Research Board as part of the Bering Sea Project; Oregon State University; Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	North Pacific Research Board as part of the Bering Sea Project; Oregon State University; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by the North Pacific Research Board as part of the Bering Sea Project [http://bsierp.nprb.org/1, Fish and Wildlife Service (http:// alaska;fws.gov/) and Oregon State University (http://fw.oregonstate.edu/). BSIERP projects were granted to David Irons and Daniel Roby (B63 and B77), Heather Renner (B77), Alexander Kitaysky (B77), and to Scott Heppell and Kelly Benoit-Bird (B67 and B77). The funders facilitated indersciplinary partnerships as part of the program but had no role in the specifics of the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 2003, ECOLOGY, V84, P709, DOI 10.1890/0012-9658(2003)084[0709:PRCAGS]2.0.CO;2; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Atwood E, 2010, FISH OCEANOGR, V19, P493, DOI 10.1111/j.1365-2419.2010.00559.x; Beamish RJ, 1999, PROG OCEANOGR, V43, P399, DOI 10.1016/S0079-6611(99)00017-8; Benoit-Bird KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053348; Benoit-Bird KJ, 2011, MAR ECOL PROG SER, V443, P217, DOI 10.3354/meps09408; Benowitz-Fredericks ZM, 2008, DEEP-SEA RES PT II, V55, P1868, DOI 10.1016/j.dsr2.2008.04.007; Bertrand S, 2012, J APPL ECOL, V49, P1168, DOI 10.1111/j.1365-2664.2012.02190.x; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; BRAUN BM, 1983, AUK, V100, P469, DOI 10.1093/auk/100.2.469; Burger AE, 2008, AUK, V125, P253, DOI 10.1525/auk.2008.1408; Byrd GV, 2008, DEEP-SEA RES PT II, V55, P1846, DOI 10.1016/j.dsr2.2008.04.004; CHAURAND T, 1994, J ANIM ECOL, V63, P275, DOI 10.2307/5546; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; CLARK CW, 1990, EVOL ECOL, V4, P21, DOI 10.1007/BF02270712; Cotte C, 2007, P R SOC B, V274, P2385, DOI 10.1098/rspb.2007.0775; Coyle KO, 2011, FISH OCEANOGR, V20, P139, DOI 10.1111/j.1365-2419.2011.00574.x; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Dell J, 2011, FISH OCEANOGR, V20, P383, DOI 10.1111/j.1365-2419.2011.00591.x; Dias MP, 2012, MAR ECOL PROG SER, V467, P245, DOI 10.3354/meps09966; Drazen JC, 2011, DEEP-SEA RES PT I, V58, P557, DOI 10.1016/j.dsr.2011.03.002; DRENT RH, 1980, ARDEA, V68, P225; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Erikstad KE, 1998, ECOLOGY, V79, P1781; Erikstad KE, 2009, ECOLOGY, V90, P3197, DOI 10.1890/08-1778.1; Frederiksen M, 2004, J APPL ECOL, V41, P1129, DOI 10.1111/j.0021-8901.2004.00966.x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Furuhashi M, 1989, P NIPR S POLAR BIOL, V2, P94; Garthe S, 2007, MAR BIOL, V151, P687, DOI 10.1007/s00227-006-0523-x; Godo OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030161; Golet GH, 1998, J ANIM ECOL, V67, P827, DOI 10.1046/j.1365-2656.1998.00233.x; Gonzalez-Solis J, 2007, AQUAT CONSERV, V17, pS22, DOI 10.1002/aqc.911; Gonzalez-Solis J, 2009, MAR ECOL PROG SER, V391, P117, DOI 10.3354/meps08282; Goutte A, 2010, GEN COMP ENDOCR, V167, P246, DOI 10.1016/j.ygcen.2010.03.018; Gremillet D, 2004, FUNCT ECOL, V18, P793, DOI 10.1111/j.0269-8463.2004.00914.x; Harding AMA, 2009, FUNCT ECOL, V23, P348, DOI 10.1111/j.1365-2435.2008.01488.x; Hatch SA, 2013, MAR ECOL PROG SER, V477, P271, DOI 10.3354/meps10161; Haynes Trevor B., 2011, Marine Ornithology, V39, P151; HAYS C, 1986, BIOL CONSERV, V36, P169, DOI 10.1016/0006-3207(86)90005-4; Hollowed AB, 2012, DEEP-SEA RES PT II, V65-70, P230, DOI 10.1016/j.dsr2.2012.02.008; Hunt GL, 2011, ICES J MAR SCI, V68, P1230, DOI 10.1093/icesjms/fsr036; HUNT GL, 1986, AUK, V103, P306, DOI 10.1093/auk/103.2.306; Irons DB, 2008, GLOBAL CHANGE BIOL, V14, P1455, DOI 10.1111/j.1365-2486.2008.01581.x; Jahncke J, 2008, DEEP-SEA RES PT II, V55, P1809, DOI 10.1016/j.dsr2.2008.04.003; Jodice PGR, 2000, WATERBIRDS, V23, P405, DOI 10.2307/1522177; Karpouzi VS, 2007, MAR ECOL PROG SER, V343, P87, DOI 10.3354/meps06860; Kitaysky AS, 2007, MAR ECOL PROG SER, V352, P245, DOI 10.3354/meps07074; Kitaysky AS, 2010, FUNCT ECOL, V24, P625, DOI 10.1111/j.1365-2435.2009.01679.x; Kitaysky AS, 1999, FUNCT ECOL, V13, P577, DOI 10.1046/j.1365-2435.1999.00352.x; Klostermann MR, 2013, 201308 AMNWR US FISH; Kotzerka J, 2010, J ORNITHOL, V151, P459, DOI 10.1007/s10336-009-0479-y; Ladd C, 2012, DEEP-SEA RES PT I, V66, P67, DOI 10.1016/j.dsr.2012.04.003; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; LOBEL PS, 1988, J PLANKTON RES, V10, P1209, DOI 10.1093/plankt/10.6.1209; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Mizobata K, 2002, PROG OCEANOGR, V55, P65, DOI 10.1016/S0079-6611(02)00070-8; Mueter FJ, 2011, ICES J MAR SCI, V68, P1284, DOI 10.1093/icesjms/fsr022; Muhling BA, 2007, DEEP-SEA RES PT II, V54, P1113, DOI 10.1016/j.dsr2.2006.05.045; Navarro J, 2007, OECOLOGIA, V151, P150, DOI 10.1007/s00442-006-0559-0; Navarro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062897; Nel DC, 2001, MAR ECOL PROG SER, V217, P15, DOI 10.3354/meps217015; Nordstrom CA, 2013, DEEP-SEA RES PT II, V88-89, P78, DOI 10.1016/j.dsr2.2012.07.010; Orians G.H., 1979, P155; Oro D, 2002, ECOLOGY, V83, P2516; Paredes R, 2012, MAR ECOL PROG SER, V471, P253, DOI 10.3354/meps10034; REID WV, 1987, OECOLOGIA, V74, P458, DOI 10.1007/BF00378945; Renner HM, 2012, DEEP-SEA RES PT II, V65-70, P273, DOI 10.1016/j.dsr2.2012.02.014; RICKLEFS RE, 1987, AUK, V104, P750, DOI 10.1093/auk/104.4.750; RICKLEFS RE, 1991, ACT 20 ORN C TRUST B, P992; Romero LM, 2001, P NATL ACAD SCI USA, V98, P7366, DOI 10.1073/pnas.131091498; Romero LM, 2000, GEN COMP ENDOCR, V118, P113, DOI 10.1006/gcen.1999.7446; Sassa C, 2004, MAR BIOL, V144, P417, DOI 10.1007/s00227-003-1214-5; Satterthwaite WH, 2012, MAR ECOL PROG SER, V454, P221, DOI 10.3354/meps09539; Satterthwaite WH, 2010, EVOL ECOL RES, V12, P779; Schabetsberger R, 2000, ICES J MAR SCI, V57, P1283, DOI 10.1006/jmsc.2000.0814; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Schumacher J.D., 1994, Fisheries Oceanography, V3, P182, DOI 10.1111/j.1365-2419.1994.tb00095.x; Sigler MF, 2012, DEEP-SEA RES PT II, V65-70, P292, DOI 10.1016/j.dsr2.2012.02.017; Sinclair EH, 2008, DEEP-SEA RES PT II, V55, P1897, DOI 10.1016/j.dsr2.2008.04.031; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P31, DOI 10.1016/j.dsr2.2012.02.020; Sterling J.T., 2009, NO SEAL FORAGING BEH; Suryan RM, 2002, MAR ECOL PROG SER, V236, P273, DOI 10.3354/meps236273; Suryan RM, 2000, CONDOR, V102, P374, DOI 10.1650/0010-5422(2000)102[0374:PSAVFS]2.0.CO;2; Suryan RM, 2012, MAR ECOL PROG SER, V451, P213, DOI 10.3354/meps09597; Thomson G, 2013, 201310 AMNWR US FISH; Traynor JJ, 1996, ICES J MAR SCI, V53, P253, DOI 10.1006/jmsc.1996.0031; Vacquie-Garcia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043565; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077; Watanabe H, 1999, FISH OCEANOGR, V8, P115, DOI 10.1046/j.1365-2419.1999.00103.x; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Weimerskirch H, 2012, MAR ECOL PROG SER, V458, P231, DOI 10.3354/meps09752; Whitman L, 2010, THESIS OREGON STATE; Wingfield JC, 2002, INTEGR COMP BIOL, V42, P600, DOI 10.1093/icb/42.3.600; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191; Zainuddin M, 2006, DEEP-SEA RES PT II, V53, P419, DOI 10.1016/j.dsr2.2006.01.007; Zavalaga CB, 2007, MAR ECOL PROG SER, V336, P291, DOI 10.3354/meps336291	97	39	40	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							c92520	10.1371/journal.pone.0092520	http://dx.doi.org/10.1371/journal.pone.0092520			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671108	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000333677000050
J	Restrepo, BI; Twahirwa, M; Rahbar, MH; Schlesinger, LS				Restrepo, Blanca I.; Twahirwa, Marcel; Rahbar, Mohammad H.; Schlesinger, Larry S.			Phagocytosis via Complement or Fc-Gamma Receptors Is Compromised in Monocytes from Type 2 Diabetes Patients with Chronic Hyperglycemia	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RISK; MACROPHAGES; INCREASES; MICE	Type 2 diabetes patients (DM2) have a higher risk of tuberculosis (TB) that may be attributed to functional defects in their mononuclear phagocytes given the critical role of these cells in Mycobacterium tuberculosis containment. Our previous findings suggest that monocytes from DM2 have reduced association with serum-opsonized M. tuberculosis. To determine if this alteration is due to defects in phagocytosis via complement or Fc-gamma receptors (Fc gamma Rs), in this study we evaluated the uptake of sheep red blood cells coated with IgG or complement, respectively, by monocytes from individuals with and without DM2. We found that chronic hyperglycemia was significantly associated with reduced phagocytosis via either receptor by univariable and multivariable analyses. This defect was independent of host serum opsonins and flow cytometry data indicated this was not attributed to reduced expression of these phagocytic receptors on DM2 monocytes. The positive correlation between both pathways (R = 0.64; p = 0.003) indicate that monocytes from individuals with chronic hyperglycemia have a defect in the two predominant phagocytic pathways of these cells. Given that phagocytosis is linked to activation of effector mechanisms for bacterial killing, it is likely that this defect is one factor contributing to the higher susceptibility of DM2 patients to pathogens like M. tuberculosis.	[Restrepo, Blanca I.] UTHlth Houston, Sch Publ Hlth Brownsville, Div Epidemiol, Brownsville, TX USA; [Twahirwa, Marcel] Joslin Diabet Ctr Doctors Hosp Renaissance, Edinburg, TX USA; [Rahbar, Mohammad H.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Internal Med, Div Clin & Translat Sci, Houston, TX 77030 USA; [Schlesinger, Larry S.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Schlesinger, Larry S.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	University of Texas System; University of Texas Health Science Center Houston; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Restrepo, BI (corresponding author), UTHlth Houston, Sch Publ Hlth Brownsville, Div Epidemiol, Brownsville, TX USA.	blanca.i.restrepo@uth.tmc.edu		Restrepo, Blanca I/0000-0002-3743-9098	National Institute of Allergy and Infectious Diseases at the National Institutes of Health [R21AI079624-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079624] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (grant number R21AI079624-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; CHANG FY, 1995, DIABETES RES CLIN PR, V28, P137, DOI 10.1016/0168-8227(95)00168-8; COOPER NR, 1991, IMMUNOL TODAY, V12, P327, DOI 10.1016/0167-5699(91)90010-Q; Dai SP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003114; Dandona P, 2007, CURR OPIN CLIN NUTR, V10, P511, DOI 10.1097/MCO.0b013e3281e38774; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Feng B, 2011, BBA-MOL BASIS DIS, V1812, P1130, DOI 10.1016/j.bbadis.2011.05.007; GEISLER C, 1982, ACTA PATH MICRO IM C, V90, P33; Gomez DI, 2013, TUBERCULOSIS, V93, P192, DOI 10.1016/j.tube.2012.10.003; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Guirado E, 2013, SEMIN IMMUNOPATHOL, V35, P563, DOI 10.1007/s00281-013-0388-2; Hair PS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-35; Harries AD, 2011, INT J TUBERC LUNG D, V15, P1436, DOI 10.5588/ijtld.11.0503; Hodgson KA, 2011, MICROBES INFECT, V13, P1177, DOI 10.1016/j.micinf.2011.07.008; HORWITZ MA, 1980, J CLIN INVEST, V65, P82, DOI 10.1172/JCI109663; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; KATZ S, 1983, DIABETES CARE, V6, P479, DOI 10.2337/diacare.6.5.479; Labuzek K, 2010, N-S ARCH PHARMACOL, V381, P171, DOI 10.1007/s00210-009-0477-x; Liu BF, 1999, DIABETES, V48, P2074, DOI 10.2337/diabetes.48.10.2074; LOIKE JD, 1979, J BIOL CHEM, V254, P9558; Martens GW, 2007, AM J RESP CELL MOL, V37, P518, DOI 10.1165/rcmb.2006-0478OC; Mathews CE, 2012, CLIN VACCINE IMMUNOL, V19, P1360, DOI 10.1128/CVI.00268-12; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; Rajaram MVS, 2010, J IMMUNOL, V185, P929, DOI 10.4049/jimmunol.1000866; Restrepo BI, 2008, CLIN INFECT DIS, V47, P634, DOI 10.1086/590565; Restrepo BI, 2013, TUBERCULOSIS, V93, pS10, DOI 10.1016/S1472-9792(13)70004-0; Restrepo BI, 2011, B WORLD HEALTH ORGAN, V89, P352, DOI 10.2471/BLT.10.085738; Schlesinger LS, 1996, CURR TOP MICROBIOL, V215, P71; SCHLESINGER LS, 1990, J IMMUNOL, V144, P2771; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Stalenhoef JE, 2008, EUR J CLIN MICROBIOL, V27, P97, DOI 10.1007/s10096-007-0395-0; Stevenson CR, 2007, CHRONIC ILLN, V3, P228, DOI 10.1177/1742395307081502; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Vallerskog T, 2010, J IMMUNOL, V184, P6275, DOI 10.4049/jimmunol.1000304; Walsh MC, 2011, INT J TUBERC LUNG D, V15, P179; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; ZIEGLERHEITBROCK HWL, 1993, EUR J IMMUNOL, V23, P2053, DOI 10.1002/eji.1830230902; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	41	52	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92977	10.1371/journal.pone.0092977	http://dx.doi.org/10.1371/journal.pone.0092977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671137	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000096
J	Wurpel, DJ; Totsika, M; Allsopp, LP; Hartley-Tassell, LE; Day, CJ; Peters, KM; Sarkar, S; Ulett, GC; Yang, J; Tiralongo, J; Strugnell, RA; Jennings, MP; Schembri, MA				Wurpel, Daniel J.; Totsika, Makrina; Allsopp, Luke P.; Hartley-Tassell, Lauren E.; Day, Christopher J.; Peters, Kate M.; Sarkar, Sohinee; Ulett, Glen C.; Yang, Ji; Tiralongo, Joe; Strugnell, Richard A.; Jennings, Michael P.; Schembri, Mark A.			F9 Fimbriae of Uropathogenic Escherichia coli Are Expressed at Low Temperature and Recognise Gal beta 1-3GlcNAc-Containing Glycans	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; H-NS; MOLECULAR CHARACTERIZATION; AUTOTRANSPORTER PROTEINS; BIOFILM FORMATION; CLONING VEHICLES; S-FIMBRIAE; E.-COLI; IDENTIFICATION; COMMENSAL	Uropathogenic Escherichia coli (UPEC) is the leading causative agent of urinary tract infections (UTI) in the developed world. Among the major virulence factors of UPEC, surface expressed adhesins mediate attachment and tissue tropism. UPEC strains typically possess a range of adhesins, with type 1 fimbriae and P fimbriae of the chaperone-usher class the best characterised. We previously identified and characterised F9 as a new chaperone-usher fimbrial type that mediates biofilm formation. However, the regulation and specific role of F9 fimbriae remained to be determined in the context of wild-type clinical UPEC strains. In this study we have assessed the distribution and genetic context of the f9 operon among diverse E. coli lineages and pathotypes and demonstrated that f9 genes are significantly more conserved in a UPEC strain collection in comparison to the well-defined E. coli reference (ECOR) collection. In the prototypic UPEC strain CFT073, the global regulator protein H-NS was identified as a transcriptional repressor of f9 gene expression at 37 degrees C through its ability to bind directly to the f9 promoter region. F9 fimbriae expression was demonstrated at 20 degrees C, representing the first evidence of functional F9 fimbriae expression by wild-type E. coli. Finally, glycan array analysis demonstrated that F9 fimbriae recognise and bind to terminal Gal beta 1-3GlcNAc structures.	[Wurpel, Daniel J.; Totsika, Makrina; Allsopp, Luke P.; Peters, Kate M.; Sarkar, Sohinee; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Hartley-Tassell, Lauren E.; Day, Christopher J.; Tiralongo, Joe; Jennings, Michael P.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Ulett, Glen C.] Griffith Univ, Ctr Med & Oral Hlth, Sch Med Sci, Southport, Qld 4215, Australia; [Yang, Ji; Strugnell, Richard A.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	University of Queensland; Griffith University; Griffith University; University of Melbourne	Totsika, M (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.	m.totsika@uq.edu.au; m.schembri@uq.edu.au	Schembri, Mark A/C-7262-2009; Totsika, Makrina/A-8993-2011; Allsopp, Luke/AAG-2488-2020; Jennings, Michael P/G-4822-2013	Schembri, Mark A/0000-0003-4863-9260; Totsika, Makrina/0000-0003-2468-0293; Allsopp, Luke/0000-0002-0313-9265; Jennings, Michael P/0000-0002-1027-4684; Sarkar, Sohinee/0000-0001-9364-1920; Day, Christopher/0000-0001-7953-4408; Tiralongo, Joe/0000-0002-3529-6310; Strugnell, Richard/0000-0003-0614-5641; Ulett, Glen/0000-0002-9638-8091	Australian National Health and Medical Research Council [631654, APP1012076]; Australian Research Council (ARC) [FT100100662, FT110101048]; ARC [DE130101169]; NHMRC Program [565526]; Smart Futures Fund Research Partnerships Program Grant	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); ARC(Australian Research Council); NHMRC Program(National Health and Medical Research Council (NHMRC) of Australia); Smart Futures Fund Research Partnerships Program Grant	This work was supported by grants from the Australian National Health and Medical Research Council (631654 and APP1012076). MAS and GCU are supported by Australian Research Council (ARC) Future Fellowships (FT100100662 and FT110101048). MT is supported by an ARC Discovery Early Career Researcher Award (DE130101169). MPJ is supported by a NHMRC Program Grant 565526 and a Smart Futures Fund Research Partnerships Program Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp LP, 2012, INFECT IMMUN, V80, P321, DOI 10.1128/IAI.05322-11; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez RA, 2006, METHOD ENZYMOL, V415, P292, DOI 10.1016/S0076-6879(06)15018-1; Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; [Anonymous], 2005, Nat Methods, V2, P629; Archer CT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-9; Avasthi TS, 2011, J BACTERIOL, V193, P4272, DOI 10.1128/JB.05413-11; Beloin C, 2003, MOL MICROBIOL, V47, P825, DOI 10.1046/j.1365-2958.2003.03347.x; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Day CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004927; Dorman CJ, 2007, NAT REV MICROBIOL, V5, P157, DOI 10.1038/nrmicro1598; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Dziva F, 2004, MICROBIOL-SGM, V150, P3631, DOI 10.1099/mic.0.27448-0; Easton DM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00120; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; Foxman B, 2002, AM J MED, V113, p5S; Fricke WF, 2008, J BACTERIOL, V190, P6779, DOI 10.1128/JB.00661-08; Garnett JA, 2012, P NATL ACAD SCI USA, V109, P3950, DOI 10.1073/pnas.1106733109; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Grote A, 2009, NUCLEIC ACIDS RES, V37, pD61, DOI 10.1093/nar/gkn837; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; KALLENIUS G, 1981, LANCET, V2, P1369; Khan AS, 2000, INFECT IMMUN, V68, P3541, DOI 10.1128/IAI.68.6.3541-3547.2000; Kjaergaard K, 2000, ENVIRON MICROBIOL, V2, P695, DOI 10.1046/j.1462-2920.2000.00152.x; Klemm P, 2000, INT J MED MICROBIOL, V290, P27; Korea CG, 2010, ENVIRON MICROBIOL, V12, P1957, DOI 10.1111/j.1462-2920.2010.02202.x; KORHONEN TK, 1986, INFECT IMMUN, V54, P322, DOI 10.1128/IAI.54.2.322-327.1986; Krause DO, 2011, J BACTERIOL, V193, P583, DOI 10.1128/JB.01290-10; Kulasekara BR, 2009, INFECT IMMUN, V77, P3713, DOI 10.1128/IAI.00198-09; Kyle JL, 2012, J BACTERIOL, V194, P1885, DOI 10.1128/JB.00120-12; LEFFLER H, 1981, INFECT IMMUN, V34, P920, DOI 10.1128/IAI.34.3.920-929.1981; Lehti TA, 2013, MOL MICROBIOL, V87, P1200, DOI 10.1111/mmi.12161; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Low AS, 2006, INFECT IMMUN, V74, P2233, DOI 10.1128/IAI.74.4.2233-2244.2006; Lu ST, 2011, J BACTERIOL, V193, P7005, DOI 10.1128/JB.06284-11; MARRE R, 1990, INFECT IMMUN, V58, P3434, DOI 10.1128/IAI.58.10.3434-3437.1990; Miquel S, 2010, J BACTERIOL, V192, P1832, DOI 10.1128/JB.01679-09; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Moriel DG, 2010, P NATL ACAD SCI USA, V107, P9072, DOI 10.1073/pnas.0915077107; Muller CM, 2006, J BACTERIOL, V188, P5428, DOI 10.1128/JB.01956-05; MURPHY TF, 1989, MICROB PATHOGENESIS, V6, P159, DOI 10.1016/0882-4010(89)90066-1; Nash JHE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-667; NILSSON P, 1991, MOL MICROBIOL, V5, P1791, DOI 10.1111/j.1365-2958.1991.tb01928.x; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; Oelschlaeger Tobias A, 2002, Curr Opin Urol, V12, P33, DOI 10.1097/00042307-200201000-00007; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; Ono S, 2005, BIOCHEM J, V391, P203, DOI 10.1042/BJ20050453; Oshima K, 2008, DNA RES, V15, P375, DOI 10.1093/dnares/dsn026; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pouttu R, 2001, J BACTERIOL, V183, P4727, DOI 10.1128/JB.183.16.4727-4736.2001; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rendon MA, 2007, P NATL ACAD SCI USA, V104, P10637, DOI 10.1073/pnas.0704104104; Schembri MA, 2001, INFECT IMMUN, V69, P1322, DOI 10.1128/IAI.69.3.1322-1328.2001; STAHL B, 1994, ANAL BIOCHEM, V223, P218, DOI 10.1006/abio.1994.1577; STAMM WE, 1991, AM J MED, V91, pS65, DOI 10.1016/0002-9343(91)90345-X; STROMBERG N, 1990, EMBO J, V9, P2001, DOI 10.1002/j.1460-2075.1990.tb08328.x; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Teneberg S, 2002, J BIOL CHEM, V277, P19709, DOI 10.1074/jbc.M201113200; Toh H, 2010, J BACTERIOL, V192, P1165, DOI 10.1128/JB.01543-09; Totsika M, 2012, APPL ENVIRON MICROB, V78, P2179, DOI 10.1128/AEM.06680-11; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Ulett GC, 2007, MICROBIOL-SGM, V153, P2321, DOI 10.1099/mic.0.2006/004648-0; van Diemen PA, 2005, INFECT IMMUN, V73, P1735, DOI 10.1128/IAI.73.3.1735-1743.2005; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wu XR, 1996, P NATL ACAD SCI USA, V93, P9630, DOI 10.1073/pnas.93.18.9630; Wurpel DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052835; Xiong YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036144; Zdziarski J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001078; Zhou ZM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008700	88	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93177	10.1371/journal.pone.0093177	http://dx.doi.org/10.1371/journal.pone.0093177			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671091	Green Published, gold			2022-12-25	WOS:000333677000124
J	Zhao, Q; Zhang, W; Ning, ZF; Zhuang, XF; Lu, HZ; Liang, J; Li, J; Zhang, Y; Dong, Y; Zhang, YH; Zhang, SR; Liu, SM; Liu, BL				Zhao, Qian; Zhang, Wen; Ning, Zhifeng; Zhuang, Xiufen; Lu, Haizhen; Liang, Jing; Li, Jie; Zhang, Yu; Dong, Ying; Zhang, Youhui; Zhang, Shuren; Liu, Shangmei; Liu, Binlei			A Novel Oncolytic Herpes Simplex Virus Type 2 Has Potent Anti-Tumor Activity	PLOS ONE			English	Article							OVARIAN-CANCER; TUMOR CELLS; DOXORUBICIN; REPLICATION; IMMUNITY; THERAPY; DEATH; CHEMOTHERAPY; INDUCTION; CARCINOMA	Oncolytic viruses are promising treatments for many kinds of solid tumors. In this study, we constructed a novel oncolytic herpes simplex virus type 2: oHSV2. We investigated the cytopathic effects of oHSV2 in vitro and tested its antitumor efficacy in a 4T1 breast cancer model. We compared its effect on the cell cycle and its immunologic impact with the traditional chemotherapeutic agent doxorubicin. In vitro data showed that oHSV2 infected most of the human and murine tumor cell lines and was highly oncolytic. oHSV2 infected and killed 4T1 tumor cells independent of their cell cycle phase, whereas doxorubicin mainly blocked cells that were in S and G2/M phase. In vivo study showed that both oHSV2 and doxorubicin had an antitumor effect, though the former was less toxic. oHSV2 treatment alone not only slowed down the growth of tumors without causing weight loss but also induced an elevation of NK cells and mild decrease of Tregs in spleen. In addition, combination therapy of doxorubicin followed by oHSV2 increased survival with weight loss than oHSV2 alone. The data showed that the oncolytic activity of oHSV2 was similar to oHSV1 in cell lines examined and in vivo. Therefore, we concluded that our virus is a safe and effective therapeutic agent for 4T1 breast cancer and that the sequential use of doxorubicin followed by oHSV2 could improve antitumor activity without enhancing doxorubicin's toxicity.	[Zhao, Qian; Lu, Haizhen; Liang, Jing; Liu, Shangmei] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100730, Peoples R China; [Zhao, Qian; Zhang, Wen; Zhuang, Xiufen; Lu, Haizhen; Liang, Jing; Li, Jie; Zhang, Yu; Dong, Ying; Zhang, Youhui; Zhang, Shuren; Liu, Shangmei; Liu, Binlei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Wen; Zhuang, Xiufen; Li, Jie; Zhang, Yu; Dong, Ying; Zhang, Youhui; Zhang, Shuren; Liu, Binlei] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Immunol, Beijing 100730, Peoples R China; [Ning, Zhifeng; Liu, Binlei] Hubei Univ Sci & Technol, Sch Pharmacol, Xianning, Hubei, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Hubei University of Science & Technology	Liu, SM (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100730, Peoples R China.	liu_shangmei@sina.com; liubinlei@cicams.ac.cn	Zhang, Wen/AAX-4530-2021; Zhang, Wen/ABE-6422-2021	Zhang, Wen/0000-0003-3150-2751; Zhang, Wen/0000-0003-3150-2751; Liu, Binlei/0000-0002-2852-600X	National Basic Research Program of China (973 Program) [2012CB917100]; National Natural Sciene Foundation of China [81172160]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Sciene Foundation of China	This work was supported by grants from the National Basic Research Program of China (973 Program) granted (No. 2012CB917100) and National Natural Sciene Foundation of China (No. 81172160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagalkot V, 2009, MOL PHARMACEUT, V6, P1019, DOI 10.1021/mp800177f; Betaman AR, 2002, CANCER RES, V62, P6566; Chernajovsky Y, 2006, BRIT MED J, V332, P170, DOI 10.1136/bmj.332.7534.170; Colunga AG, 2010, GENE THER, V17, P315, DOI 10.1038/gt.2009.126; Cross D, 2006, CLIN MED RES, V4, P218, DOI 10.3121/cmr.4.3.218; Davydova J, 2010, CANCER SCI, V101, P474, DOI 10.1111/j.1349-7006.2009.01407.x; FORNARI FA, 1994, MOL PHARMACOL, V45, P649; Fu X, 2007, CANCER GENE THER, V14, P480, DOI 10.1038/sj.cgt.7701033; Fu XP, 2007, INT J ONCOL, V30, P1561; Fu XP, 2006, MOL THER, V13, P882, DOI 10.1016/j.ymthe.2006.02.007; Fu XP, 2002, CANCER RES, V62, P2306; Hardcastle J, 2010, MOL THER, V18, P285, DOI 10.1038/mt.2009.232; Hu JCC, 2006, CLIN CANCER RES, V12, P6737, DOI 10.1158/1078-0432.CCR-06-0759; Huszthy PC, 2010, GENE THER, V17, P202, DOI 10.1038/gt.2009.130; Ishida D, 2010, CANCER LETT, V288, P17, DOI 10.1016/j.canlet.2009.06.014; Israyelyan A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-68; Jennings VA, 2014, INT J CANCER, V134, P1091, DOI 10.1002/ijc.28450; Kaufman HL, 2010, ANN SURG ONCOL, V17, P718, DOI 10.1245/s10434-009-0809-6; Laginha KM, 2005, CLIN CANCER RES, V11, P6944, DOI 10.1158/1078-0432.CCR-05-0343; Li C, 2012, MOL MED REP, V6, P977, DOI 10.3892/mmr.2012.1066; Li HT, 2007, J GENE MED, V9, P161, DOI 10.1002/jgm.1005; Loudon PT, 2003, J GENE MED, V5, P407, DOI 10.1002/jgm.354; MOMPARLER RL, 1976, CANCER RES, V36, P2891; Nagano S, 2008, CANCER RES, V68, P3795, DOI 10.1158/0008-5472.CAN-07-6193; Nakamori M, 2004, MOL THER, V9, P658, DOI 10.1016/j.ymthe.2004.02.019; Nowak R, 2013, J PHARM PHARMACOL, V65, P855, DOI 10.1111/jphp.12042; Prados J, 2012, ANTI-CANCER AGENT ME, V12, P1058, DOI 10.2174/187152012803529646; Sheridan C, 2013, NAT BIOTECHNOL, V31, P471, DOI 10.1038/nbt0613-471; Smith KD, 2006, J VIROL, V80, P1110, DOI 10.1128/JVI.80.3.1110-1120.2006; THOMAS D, 2003, MANAGE TODAY     JAN, P8; Toda M, 1999, HUM GENE THER, V10, P385, DOI 10.1089/10430349950018832; Wong HH, 2008, PANCREATOLOGY, V8, P431, DOI 10.1159/000151536; Zhuang Xiu-fen, 2012, Zhonghua Zhong Liu Za Zhi, V34, P187, DOI 10.3760/cma.j.issn.0253-3766.2012.03.006; Zhuang XF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-549; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	35	26	29	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93103	10.1371/journal.pone.0093103	http://dx.doi.org/10.1371/journal.pone.0093103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671154	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000113
J	Cai, H; Xie, ZY; Liu, GH; Sun, XM; Peng, GT; Lin, BQ; Liao, QF				Cai, Hao; Xie, Zhiyong; Liu, Guanghui; Sun, Xiuman; Peng, Guangtian; Lin, Baoqin; Liao, Qiongfeng			Isolation, Identification and Activities of Natural Antioxidants from Callicarpa kwangtungensis Chun	PLOS ONE			English	Article							PHENOLIC CONTENTS; PEPTIDES; CAPACITY; TRANSITION; ACTEOSIDE; RADICALS; TANNINS; BARLEY; FRUITS; L.	Reactive oxygen species leads to some diseases associated with oxidative stress. Callicarpa kwangtungensis Chun (CK) is a common remedy in traditional Chinese medicine and possesses diverse biological activities involving antioxidant properties; its main compounds phenylethanoid glycosides (PG) and flavonoids are always reported as antioxidants. In order to develop CK as a safe and activated antioxidant, our investigation was performed to validate antioxidant properties and assess which types of compounds (similar polarity or similar structure), even which compounds, played the role of antioxidants. The extracted compounds of CK were analyzed qualitatively and quantitatively by HPLC-DAD-ESI-Trap MS and UV for their contents and antioxidant activities. The correlations between antioxidant activities and known contents were respectively counted and a semi-quantitative experiment was designed to screen antioxidant compounds of CK with HPLC-UV. The n-butanol fraction (BF) showed the highest total phenolic and flavonoid contents (TPC, TFC), and three PG (forsythiaside B, poliumoside and acteoside) contents. BF showed the significantly best (P<0.05) activities in most assays. There were significant correlations (P<0.05) between DPPH center dot, ABTS(+)center dot, center dot O-2(-) scavenging, Cu2+-chelating, anti-lipidperoxidation activities and TPC. BF also has significant antioxidant activities on CCl4-induced acute liver injury Mice and TBHP-reduced HepG2 cells. Nine PG (forsythiaside B, poliumoside, acteoside, alyssonoside, brandioside and their derivatives) and one flavone (rhamnazin) were screened out as antioxidants. BF in CK contained abundant polyphenolic, which reflected some definite antioxidant properties. The antioxidant compounds consisted at the least of nine PG and one flavone.	[Cai, Hao; Liu, Guanghui; Sun, Xiuman; Peng, Guangtian; Lin, Baoqin; Liao, Qiongfeng] Guangzhou Univ Chinese Med, Sch Chinese Mat Med, Guangzhou, Guangdong, Peoples R China; [Cai, Hao; Xie, Zhiyong] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Sun Yat Sen University	Xie, ZY (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China.	xiezy2074@yahoo.com; liaoqf2075@yahoo.com		Xie, Zhi/0000-0002-5589-4836	National Natural Science Foundation of China [81173564, 81274028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Nos. 81173564 and 81274028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarowicz R, 2004, FOOD CHEM, V84, P551, DOI 10.1016/S0308-8146(03)00278-4; Bourgou S, 2008, CR BIOL, V331, P48, DOI 10.1016/j.crvi.2007.11.001; Cai H, 2013, CHIN J EXP TRADIT ME, V19, P63; Celep E, 2012, FOOD CHEM TOXICOL, V50, P3329, DOI 10.1016/j.fct.2012.06.010; Chao J, 2013, INT J MOL SCI, V14, P2928, DOI 10.3390/ijms14022928; Chen DJ, 2012, FOOD CHEM, V134, P2126, DOI 10.1016/j.foodchem.2012.04.011; Chung KT, 1998, CRIT REV FOOD SCI, V38, P421, DOI 10.1080/10408699891274273; Eder K, 2002, J NUTR, V132, P3400, DOI 10.1093/jn/132.11.3400; Hagerman AE, 1998, J AGR FOOD CHEM, V46, P1887, DOI 10.1021/jf970975b; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HALLIWELL B, 1990, FREE RADICAL RES COM, V9, P1, DOI 10.3109/10715769009148569; Huang MH, 2011, J ETHNOPHARMACOL, V133, P743, DOI 10.1016/j.jep.2010.11.005; Huang X, 1998, CHINESE TRADITIONAL, V29, P246; Iturbe-Ormaetxe I, 1998, PLANT PHYSIOL, V116, P173, DOI 10.1104/pp.116.1.173; Jiang H, 1999, CHINESE TRADITIONAL, V22, P139; Koo KA, 2006, LIFE SCI, V79, P709, DOI 10.1016/j.lfs.2006.02.019; Kumar NSS, 2012, AMINO ACIDS, V42, P1641, DOI 10.1007/s00726-011-0858-6; Lee KY, 2006, BIOL PHARM BULL, V29, P71, DOI 10.1248/bpb.29.71; Lee YR, 2007, FOOD SCI BIOTECHNOLO, V16; Li XC, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-140; Li XC, 2012, MOLECULES, V17, P13457, DOI 10.3390/molecules171113457; Li XC, 2009, MOLECULES, V14, P5349, DOI 10.3390/molecules14125349; [林朝展 LIN Chao-zhan], 2009, [热带亚热带植物学报, Journal of Tropical and Subtropical Botany], V17, P401; Liu LX, 2009, FOOD CHEM, V112, P35, DOI 10.1016/j.foodchem.2008.05.038; Morkunaite-Haimi S, 2003, BIOCHEM PHARMACOL, V65, P43, DOI 10.1016/S0006-2952(02)01450-8; Nie W., 2011, MODERN CHINESE MED, V13, P37; Ning D, 2012, GUIHAIA, V32, P845; Ozsoy N, 2009, FOOD CHEM, V116, P867, DOI 10.1016/j.foodchem.2009.03.036; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Prochazkova D, 2011, FITOTERAPIA, V82, P513, DOI 10.1016/j.fitote.2011.01.018; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; Saiga A, 2003, J AGR FOOD CHEM, V51, P3661, DOI 10.1021/jf021156g; Sharma P, 2012, FOOD CHEM, V131, P1406, DOI 10.1016/j.foodchem.2011.10.009; Singh A, 2012, INT RES J PHARM, V3, P452; Tu YH, 2013, J ETHNOPHARMACOL, V146, P465, DOI 10.1016/j.jep.2012.12.051; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wiriyaphan C, 2012, FOOD CHEM, V132, P104, DOI 10.1016/j.foodchem.2011.10.040; Xie ZJ, 2008, FOOD CHEM, V111, P370, DOI 10.1016/j.foodchem.2008.03.078; Yamasaki T, 2007, J NAT MED, V61, P318, DOI 10.1007/s11418-007-0135-x; Yan H., 2006, CHINA PHARM, V15, P3; Yesilada E, 2000, J ETHNOPHARMACOL, V73, P471, DOI 10.1016/S0378-8741(00)00327-5; Zhao HF, 2008, FOOD CHEM, V107, P296, DOI 10.1016/j.foodchem.2007.08.018; Zheng Q, 2012, STUDIES MED MAT QUAL, P1; Zhu XW, 2004, BRAIN RES, V1000, P32, DOI 10.1016/j.brainres.2004.01.012; Zou YP, 2011, J AGR FOOD CHEM, V59, P2268, DOI 10.1021/jf104640k	46	42	49	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93000	10.1371/journal.pone.0093000	http://dx.doi.org/10.1371/journal.pone.0093000			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667350	Green Submitted, Green Published, gold			2022-12-25	WOS:000333675600122
J	Glaeser, SP; Berghoff, BA; Stratmann, V; Grossart, HP; Glaeser, J				Glaeser, Stefanie P.; Berghoff, Bork A.; Stratmann, Verena; Grossart, Hans-Peter; Glaeser, Jens			Contrasting Effects of Singlet Oxygen and Hydrogen Peroxide on Bacterial Community Composition in a Humic Lake	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; PHOTOCHEMICAL FORMATION; GENUS POLYNUCLEOBACTER; ULTRAVIOLET-RADIATION; SEASONAL DYNAMICS; SURFACE WATERS; UV-RADIATION; DIVERSITY; SEQUENCE; CARBON	Light excitation of humic matter generates reactive oxygen species (ROS) in surface waters of aquatic ecosystems. Abundant ROS generated in humic matter rich lakes include singlet oxygen (O-1(2)) and hydrogen peroxide (H2O2). Because these ROS differ in half-life time and toxicity, we compared their effects on microbial activity (C-14-Leucine incorporation) and bacterial community composition (BCC) in surface waters of humic Lake Grosse Fuchskuhle (North-eastern Germany). For this purpose, experiments with water samples collected from the lake were conducted in July 2006, September 2008 and August 2009. Artificially increased O-1(2) and H2O2 concentrations inhibited microbial activity in water samples to a similar extent, but the effect of the respective ROS on BCC varied strongly. BCC analysis by 16S rRNA gene clone libraries and RT-PCR DGGE revealed ROS specific changes in relative abundance and activity of major bacterial groups and composition of dominating phylotypes. These changes were consistent in the three experiments performed in different years. The relative abundance of Polynucleobacter necessarius, Limnohabitans-related phylotypes (Betaproteobacteria), and Novosphingobium acidiphilum (Alphaproteobacteria) increased or was not affected by photo-sensitized O-1(2) exposure, but decreased after H2O2 exposure. The opposite pattern was found for Actinobacteria of the freshwater AcI-B cluster which were highly sensitive to O-1(2) but not to H2O2 exposure. Furthermore, group-specific RT-PCR DGGE analysis revealed that particle-attached P. necessarius and Limnohabitans-related phylotypes exhibit higher resistance to O-1(2) exposure compared to free-living populations. These results imply that O-1(2) acts as a factor in niche separation of closely affiliated Polynucleobacter and Limnohabitans-related phylotypes. Consequently, oxidative stress caused by photochemical ROS generation should be regarded as an environmental variable determining abundance, activity, and phylotype composition of environmentally relevant bacterial groups, in particular in illuminated and humic matter rich waters.	[Glaeser, Stefanie P.; Berghoff, Bork A.; Stratmann, Verena; Glaeser, Jens] Univ Giessen, Inst Microbiol & Mol Biol, D-35390 Giessen, Germany; [Glaeser, Stefanie P.] Univ Giessen, Inst Appl Microbiol, D-35390 Giessen, Germany; [Berghoff, Bork A.] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden; [Grossart, Hans-Peter] Leibniz Inst Freshwater Ecol & Inland Fisheries, Stechlin, Germany; [Grossart, Hans-Peter] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Uppsala University; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Potsdam	Grossart, HP (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Stechlin, Germany.	hgrossart@igb-berlin.de; jens.glaeser@mikro.bio.uni-giessen.de	Glaeser, Stefanie/ABI-5518-2020		German Science Foundation (DFG) [JG-620/2-1, GR-1540/17-1, PA- 1655/1-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by funds of the German Science Foundation (DFG) given to JG (JG-620/2-1) and to HPG (GR-1540/17-1 and PA- 1655/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2006, APPL ENVIRON MICROB, V72, P3489, DOI 10.1128/AEM.72.5.3489-3497.2006; Allgaier M, 2006, AQUAT MICROB ECOL, V45, P115, DOI 10.3354/ame045115; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anesio AM, 2005, APPL ENVIRON MICROB, V71, P6267, DOI 10.1128/AEM.71.10.6267-6275.2005; BAXTER RM, 1983, NATURE, V306, P575, DOI 10.1038/306575a0; Bertilsson S, 2000, LIMNOL OCEANOGR, V45, P753, DOI 10.4319/lo.2000.45.4.0753; BROSIUS J, 1978, P NATL ACAD SCI USA, V75, P4801, DOI 10.1073/pnas.75.10.4801; Buck U, 2008, AQUAT MICROB ECOL, V51, P97, DOI 10.3354/ame01188; Buck U, 2009, ENVIRON MICROBIOL, V11, P1854, DOI 10.1111/j.1462-2920.2009.01910.x; Burkert U, 2003, APPL ENVIRON MICROB, V69, P6550, DOI 10.1128/AEM.69.11.6550-6559.2003; Carlos L, 2011, PHOTOCH PHOTOBIO SCI, V10, P1080, DOI 10.1039/c1pp00003a; Cooper W.J., 1989, ADV CHEM SER, P333; COOPER WJ, 1989, ENVIRON SCI TECHNOL, V23, P1425, DOI 10.1021/es00069a017; Cory RM, 2010, ENVIRON SCI TECHNOL, V44, P3683, DOI 10.1021/es902989y; Dalrymple RM, 2010, ENVIRON SCI TECHNOL, V44, P5824, DOI 10.1021/es101005u; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Dufour YS, 2008, J MOL BIOL, V383, P713, DOI 10.1016/j.jmb.2008.08.017; Eichler S, 2004, MOL MICROBIAL ECOLOG, P103; Garcia SL, 2013, ISME J, V7, P137, DOI 10.1038/ismej.2012.86; Glaeser J, 2011, ADV MICROB PHYSIOL, V58, P141, DOI 10.1016/B978-0-12-381043-4.00004-0; Glaeser SP, 2010, ENVIRON MICROBIOL, V12, P3124, DOI 10.1111/j.1462-2920.2010.02285.x; Glaeser SP, 2009, INT J SYST EVOL MICR, V59, P323, DOI 10.1099/ijs.0.65852-0; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Goldstone JV, 2002, ENVIRON SCI TECHNOL, V36, P364, DOI 10.1021/es0109646; Grandbois M, 2008, ENVIRON SCI TECHNOL, V42, P9184, DOI 10.1021/es8017094; Grossart HP, 2008, ENVIRON MICROBIOL, V10, P635, DOI 10.1111/j.1462-2920.2007.01487.x; Grossart HP, 2010, ENV MICROBIOL REP, V2, P706, DOI 10.1111/j.1758-2229.2010.00179.x; Grossart HP, 1997, LIMNOL OCEANOGR, V42, P1651, DOI 10.4319/lo.1997.42.8.1651; HAAG WR, 1986, ENVIRON SCI TECHNOL, V20, P341, DOI 10.1021/es00146a005; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P2002, DOI 10.1099/ijs.0.005801-0; Hakkinen PJ, 2004, CAN J FISH AQUAT SCI, V61, P1520, DOI 10.1139/F04-098; Hutalle-Schmelzer KML, 2010, FEMS MICROBIOL ECOL, V72, P58, DOI 10.1111/j.1574-6941.2009.00831.x; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jones SE, 2009, ENVIRON MICROBIOL, V11, P2463, DOI 10.1111/j.1462-2920.2009.01977.x; Joux F, 2009, PHOTOCHEM PHOTOBIOL, V85, P783, DOI 10.1111/j.1751-1097.2008.00474.x; Judd KE, 2007, AQUAT SCI, V69, P96, DOI 10.1007/s00027-006-0908-4; KEIL RG, 1994, MAR CHEM, V45, P187, DOI 10.1016/0304-4203(94)90002-7; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Latch DE, 2006, SCIENCE, V311, P1743, DOI 10.1126/science.1121636; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lourenco RF, 2009, MOL MICROBIOL, V72, P1159, DOI 10.1111/j.1365-2958.2009.06714.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Minella M, 2011, CHEMOSPHERE, V83, P1480, DOI 10.1016/j.chemosphere.2011.02.093; Moran MA, 1997, LIMNOL OCEANOGR, V42, P1307, DOI 10.4319/lo.1997.42.6.1307; Morris JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016805; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Ogilby PR, 2010, CHEM SOC REV, V39, P3181, DOI 10.1039/b926014p; Perez MT, 2007, ENVIRON MICROBIOL, V9, P2200, DOI 10.1111/j.1462-2920.2007.01334.x; Petasne RG, 1997, MAR CHEM, V56, P215, DOI 10.1016/S0304-4203(96)00072-2; Piccini C, 2009, PHOTOCH PHOTOBIO SCI, V8, P1321, DOI 10.1039/b905040j; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ryter SW, 1998, FREE RADICAL BIO MED, V24, P1520, DOI 10.1016/S0891-5849(97)00461-9; Salka I, 2011, ENVIRON MICROBIOL, V13, P2865, DOI 10.1111/j.1462-2920.2011.02562.x; Scully NM, 1996, LIMNOL OCEANOGR, V41, P540, DOI 10.4319/lo.1996.41.3.0540; Simek K, 2010, APPL ENVIRON MICROB, V76, P1406, DOI 10.1128/AEM.02517-09; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tranvik L, 1998, AQUAT MICROB ECOL, V14, P301, DOI 10.3354/ame014301; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe K, 2009, FEMS MICROBIOL ECOL, V67, P57, DOI 10.1111/j.1574-6941.2008.00606.x; ZEPP RG, 1977, NATURE, V267, P421, DOI 10.1038/267421a0; Ziegelhoffer EC, 2009, NAT REV MICROBIOL, V7, P856, DOI 10.1038/nrmicro2237	63	17	17	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92518	10.1371/journal.pone.0092518	http://dx.doi.org/10.1371/journal.pone.0092518			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667441	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600046
J	Ma, JJ; Yang, BY; Yu, SF; Zhang, YN; Zhang, XL; Lao, SH; Chen, XC; Li, BQ; Wu, CY				Ma, Jiangjun; Yang, Binyan; Yu, Sifei; Zhang, Yannan; Zhang, Xianlan; Lao, Suihua; Chen, Xinchun; Li, Baiqing; Wu, Changyou			Tuberculosis antigen-induced expression of IFN-alpha in tuberculosis patients inhibits production of IL-1 beta	FASEB JOURNAL			English	Article						BCG; TB-Ag; PFMCs	MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; I INTERFERONS; INFLAMMASOME ACTIVATION; HUMAN MACROPHAGES; PLEURAL FLUID; INFECTION; CELLS; INTERLEUKIN-1; INDUCTION	The mechanism by which IFN-alpha regulates the host response to Mycobacterium tuberculosis (M. tb) infection in humans is poorly understood. In the present study, we found that freshly isolated pleural fluid mononuclear cells (PFMCs) from tuberculous pleural effusion but not peripheral blood mononuclear cells (PBMCs) spontaneously expressed IFN-alpha and IL-1 beta in vivo. In addition, exogenous IFN-alpha significantly inhibited production of IL-1 beta in PFMCs after stimulation with Bacillus Calmette-Guerin (BCG). To further evaluate the effect of endogenous IFN-alpha on BCG-induced IL-1 beta production, a neutralizing antibody to IFN-alpha was added to the cultures of BCG-stimulated PFMCs. As expected, neutralization of IFN-alpha by antibody significantly enhanced the production of IL-1 beta. Notably, we showed that IFN-alpha inhibited production of IL-1 beta through 2 distinct mechanisms: IFN-alpha signaling, via the STAT1 transcription factor, suppressed caspase-1-dependent IL-1 beta maturation, and IFN-alpha induced the production of IL-10 in a STAT1-dependent manner in which IL-10 reduced the abundance of IL-1 beta. In contrast, we found that IFN-alpha enhanced the production of IFN-gamma, and IFN-gamma also suppressed IL-1 beta production in the PFMCs during BCG stimulation. Our findings demonstrate that IFN-alpha employs distinct pathways for regulating IL-1 beta production and reveal that in the case of M. tb infection, the induction of IFN-alpha and IFN-gamma might be associated with M. tb immune escape and disease progression in infected humans.	[Ma, Jiangjun; Yang, Binyan; Yu, Sifei; Zhang, Yannan; Wu, Changyou] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Immunol, Guangzhou 510080, Guangdong, Peoples R China; [Ma, Jiangjun; Yang, Binyan; Yu, Sifei; Zhang, Yannan; Wu, Changyou] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control Res, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Xianlan; Lao, Suihua] Chest Hosp Guangzhou, Guangzhou, Guangdong, Peoples R China; [Chen, Xinchun] Guangdong Med Coll, Shenzhen Peoples Hosp 3, Shenzhen Key Lab Infect & Immun, Shenzhen, Peoples R China; [Li, Baiqing] Bengbu Med Coll, Immunol Res Ctr, Dept Immunol, Bengbu, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangdong Medical University; Bengbu Medical College	Wu, CY (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Inst Immunol, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	changyou_wu@yahoo.com			Program of China [2013ZX10003007-002-003]; National Nature Science Foundation of China [31170833]; Guangdong Provincial Department of Science and Technology Plan Projects of China [2012B040304008]	Program of China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Department of Science and Technology Plan Projects of China	This work was supported by the Program of China during the Twelfth Five-Year Plan Period (2013ZX10003007-002-003), National Nature Science Foundation of China (31170833), and Guangdong Provincial Department of Science and Technology Plan Projects of China (2012B040304008). The authors declare no conflicts of interest.	Apte RN, 2008, IMMUNOL REV, V222, P222, DOI 10.1111/j.1600-065X.2008.00615.x; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bouchonnet F, 2002, INFECT IMMUN, V70, P3020, DOI 10.1128/IAI.70.6.3020-3025.2002; Carlsson F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000895; Cooper AM, 2011, MUCOSAL IMMUNOL, V4, P252, DOI 10.1038/mi.2011.13; Cooper AM, 2000, INFECT IMMUN, V68, P6879, DOI 10.1128/IAI.68.12.6879-6882.2000; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; Desvignes L, 2012, J IMMUNOL, V188, P6205, DOI 10.4049/jimmunol.1200255; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2010, ARTHRITIS RHEUM-US, V62, P3140, DOI 10.1002/art.27663; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Garlanda C, 2007, J IMMUNOL, V179, P3119, DOI 10.4049/jimmunol.179.5.3119; Giosue S, 1998, AM J RESP CRIT CARE, V158, P1156, DOI 10.1164/ajrccm.158.4.9803065; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guler R, 2011, VACCINE, V29, P1339, DOI 10.1016/j.vaccine.2010.10.045; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Li L, 2011, IMMUNOBIOLOGY, V216, P477, DOI 10.1016/j.imbio.2010.09.003; Li Q, 2011, IMMUNOL LETT, V138, P113, DOI 10.1016/j.imlet.2011.03.008; Li Q, 2011, CELL MOL IMMUNOL, V8, P172, DOI 10.1038/cmi.2010.80; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Monroe KM, 2010, CELL MICROBIOL, V12, P881, DOI 10.1111/j.1462-5822.2010.01478.x; Novikov A, 2011, J IMMUNOL, V187, P2540, DOI 10.4049/jimmunol.1100926; Palmero D, 1999, INT J TUBERC LUNG D, V3, P214; Prabhakar S, 2003, INFECT IMMUN, V71, P2487, DOI 10.1128/IAI.71.5.2487-2497.2003; Qiao D, 2011, SCAND J IMMUNOL, V73, P330, DOI 10.1111/j.1365-3083.2011.02512.x; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Remoli ME, 2002, J IMMUNOL, V169, P366, DOI 10.4049/jimmunol.169.1.366; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Stern JNH, 2009, IMMUNOL RES, V45, P1, DOI 10.1007/s12026-008-8024-2; Taki S, 2002, CYTOKINE GROWTH F R, V13, P379, DOI 10.1016/S1359-6101(02)00023-0; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Ward CM, 2007, EUR J PEDIATR, V166, P981, DOI 10.1007/s00431-006-0339-1	48	17	19	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3238	3248		10.1096/fj.13-247056	http://dx.doi.org/10.1096/fj.13-247056			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24675363				2022-12-25	WOS:000337949400043
J	dela Sena, C; Riedl, KM; Narayanasamy, S; Curley, RW; Schwartz, SJ; Harrison, EH				dela Sena, Carlo; Riedl, Kenneth M.; Narayanasamy, Sureshbabu; Curley, Robert W., Jr.; Schwartz, Steven J.; Harrison, Earl H.			The Human Enzyme That Converts Dietary Provitamin A Carotenoids to Vitamin A Is a Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carotenoid; Dioxygenase; Enzyme Catalysis; Enzyme Mechanisms; Oxidation-Reduction; Retinoid; Vitamin A; Monooxygenase; Oxygenase	PSEUDOMONAS-PAUCIMOBILIS TMY1009; BETA-CAROTENE; LIGNOSTILBENE-ALPHA,BETA-DIOXYGENASE GENE; INTESTINAL-ABSORPTION; CLEAVAGE; CLONING; BIOSYNTHESIS	Background: The human enzyme -carotene 15-15-oxygenase (BCO1) has been thought to be a monooxygenase. Results: Incubation of BCO1 and -carotene in (H2O)-O-18-O-16(2) or (H2O)-O-16-O-18(2) medium yields two retinals both of which contain oxygen atoms originating solely from O-2 gas. Conclusion: BCO1 is a dioxygenase. Significance: It is important to clearly establish the reaction mechanism of an enzyme, especially when the name reflects the mechanism. -Carotene 15-15-oxygenase (BCO1) catalyzes the oxidative cleavage of dietary provitamin A carotenoids to retinal (vitamin A aldehyde). Aldehydes readily exchange their carbonyl oxygen with water, making oxygen labeling experiments challenging. BCO1 has been thought to be a monooxygenase, incorporating oxygen from O-2 and H2O into its cleavage products. This was based on a study that used conditions that favored oxygen exchange with water. We incubated purified recombinant human BCO1 and -carotene in either O-16(2)-(H2O)-O-18 or O-18(2)-(H2O)-O-16 medium for 15 min at 37 degrees C, and the relative amounts of O-18-retinal and O-16-retinal were measured by liquid chromatography-tandem mass spectrometry. At least 79% of the retinal produced by the reaction has the same oxygen isotope as the O-2 gas used. Together with the data from O-18-retinal-(H2O)-O-16 and O-16-retinal-(H2O)-O-18 incubations to account for nonenzymatic oxygen exchange, our results show that BCO1 incorporates only oxygen from O-2 into retinal. Thus, BCO1 is a dioxygenase.	[dela Sena, Carlo; Narayanasamy, Sureshbabu; Harrison, Earl H.] Ohio State Univ, Dept Human Nutr, Columbus, OH 43210 USA; [dela Sena, Carlo; Curley, Robert W., Jr.; Harrison, Earl H.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Riedl, Kenneth M.; Schwartz, Steven J.] Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA; [Curley, Robert W., Jr.; Harrison, Earl H.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Harrison, EH (corresponding author), 314 Campbell Hall,1787 Neil Ave, Columbus, OH 43210 USA.	harrison.304@osu.edu	NARAYANASAMY, SURESHBABU/AAN-6604-2021; Harrison, Earl H/AAN-5378-2021; riedl, ken/G-8621-2014; Riedl, Ken/K-1881-2019	riedl, ken/0000-0002-9020-3471; Schwartz, Steven/0000-0002-1427-5780; Narayanasamy, Sureshbabu/0000-0002-5846-3230	National Institutes of Health (NHLBI) [R01-HL49879]; National Institutes of Health (National Institutes of Health Office of Dietary Supplements); Ohio State University Food Innovation Center; Ohio Agricultural Research Development Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049879] Funding Source: NIH RePORTER	National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (National Institutes of Health Office of Dietary Supplements)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University Food Innovation Center; Ohio Agricultural Research Development Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL49879 (NHLBI and the National Institutes of Health Office of Dietary Supplements). This work was also supported by grants from The Ohio State University Food Innovation Center and the Ohio Agricultural Research Development Center. The mass spectrometry experiments were done at the Nutrient and Phytochemical Analytic Shared Resource of the Ohio State University Comprehensive Cancer Center.	BYRN M, 1966, J AM CHEM SOC, V88, P1916, DOI 10.1021/ja00961a013; CREELMAN RA, 1984, PLANT PHYSIOL, V75, P166, DOI 10.1104/pp.75.1.166; dela Sena C, 2013, J BIOL CHEM, V288, P37094, DOI 10.1074/jbc.M113.507160; dePee S, 1996, EUR J CLIN NUTR, V50, pS38; During A, 2004, ARCH BIOCHEM BIOPHYS, V430, P77, DOI 10.1016/j.abb.2004.03.024; GOODMAN DS, 1965, SCIENCE, V149, P879, DOI 10.1126/science.149.3686.879; GOODMAN DS, 1966, J BIOL CHEM, V241, P1929; Harrison EH, 2012, BBA-MOL CELL BIOL L, V1821, P70, DOI 10.1016/j.bbalip.2011.06.002; HENEHAN GTM, 1993, BIOCHEMISTRY-US, V32, P736, DOI 10.1021/bi00054a001; Holger S, 2006, J BIOL CHEM, V281, P9845, DOI 10.1074/jbc.M511668200; JUTTNER F, 1985, ARCH MICROBIOL, V141, P337, DOI 10.1007/BF00428846; KAMODA S, 1993, BIOSCI BIOTECH BIOCH, V57, P926, DOI 10.1271/bbb.57.926; KAMODA S, 1995, BIOSCI BIOTECH BIOCH, V59, P1866, DOI 10.1271/bbb.59.1866; Kamoda S, 1997, BIOSCI BIOTECH BIOCH, V61, P1575, DOI 10.1271/bbb.61.1575; KAMODA S, 1991, AGR BIOL CHEM TOKYO, V55, P1411, DOI 10.1080/00021369.1991.10870789; KAMODA S, 1993, BIOSCI BIOTECH BIOCH, V57, P931, DOI 10.1271/bbb.57.931; Kawanishi Y, 2011, CHEM ENG J, V167, P531, DOI 10.1016/j.cej.2010.10.052; Kim YS, 2009, J BIOL CHEM, V284, P15781, DOI 10.1074/jbc.M109.002618; Kloer DP, 2006, CELL MOL LIFE SCI, V63, P2291, DOI 10.1007/s00018-006-6176-6; Leuenberger MG, 2001, ANGEW CHEM INT EDIT, V40, P2614, DOI 10.1002/1521-3773(20010716)40:14<2613::AID-ANIE2613>3.0.CO;2-Z; Lide D. R., 2013, HDB CHEM PHYS, p[11, 11]; Marasco EK, 2008, CHEMBIOCHEM, V9, P1450, DOI 10.1002/cbic.200700724; Moss G. P., 2014, ENZYME NOMENCLATURE; Mutti FG, 2012, BIOINORG CHEM APPL, V2012, DOI 10.1155/2012/626909; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872	25	51	52	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13661	13666		10.1074/jbc.M114.557710	http://dx.doi.org/10.1074/jbc.M114.557710			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24668807	hybrid, Green Published			2022-12-25	WOS:000335522800059
J	Eichstaedt, CA; Antao, T; Pagani, L; Cardona, A; Kivisild, T; Mormina, M				Eichstaedt, Christina A.; Antao, Tiago; Pagani, Luca; Cardona, Alexia; Kivisild, Toomas; Mormina, Maru			The Andean Adaptive Toolkit to Counteract High Altitude Maladaptation: Genome-Wide and Phenotypic Analysis of the Collas	PLOS ONE			English	Article							ARTERIAL OXYGEN-SATURATION; RECENT POSITIVE SELECTION; GRAN-CHACO POPULATIONS; HUMAN ADAPTATION; HEMOGLOBIN CONCENTRATION; GENETIC ADAPTATION; GROWTH-FACTOR; NITRIC-OXIDE; TIBETAN; MOUNTAIN	During their migrations out of Africa, humans successfully colonised and adapted to a wide range of habitats, including extreme high altitude environments, where reduced atmospheric oxygen (hypoxia) imposes a number of physiological challenges. This study evaluates genetic and phenotypic variation in the Colla population living in the Argentinean Andes above 3500 m and compares it to the nearby lowland Wichi group in an attempt to pinpoint evolutionary mechanisms underlying adaptation to high altitude hypoxia. We genotyped 730,525 SNPs in 25 individuals from each population. In genome-wide scans of extended haplotype homozygosity Collas showed the strongest signal around VEGFB, which plays an essential role in the ischemic heart, and ELTD1, another gene crucial for heart development and prevention of cardiac hypertrophy. Moreover, pathway enrichment analysis showed an overrepresentation of pathways associated with cardiac morphology. Taken together, these findings suggest that Colla highlanders may have evolved a toolkit of adaptative mechanisms resulting in cardiac reinforcement, most likely to counteract the adverse effects of the permanently increased haematocrit and associated shear forces that characterise the Andean response to hypoxia. Regulation of cerebral vascular flow also appears to be part of the adaptive response in Collas. These findings are not only relevant to understand the evolution of hypoxia protection in high altitude populations but may also suggest new avenues for medical research into conditions where hypoxia constitutes a detrimental factor.	[Eichstaedt, Christina A.; Pagani, Luca; Cardona, Alexia; Kivisild, Toomas; Mormina, Maru] Univ Cambridge, Div Biol Anthropol, Cambridge, England; [Antao, Tiago] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Pagani, Luca] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Mormina, Maru] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England	University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; University of East Anglia	Eichstaedt, CA (corresponding author), Univ Cambridge, Div Biol Anthropol, Cambridge, England.	cae31@cam.ac.uk; mem50@cam.ac.uk	Kivisild, Toomas/P-5889-2017; Antao, Tiago/C-3615-2009; Mormina, Maru/HGC-2853-2022; Pagani, Luca/G-8511-2017	Kivisild, Toomas/0000-0002-6297-7808; Antao, Tiago/0000-0002-7269-5513; Pagani, Luca/0000-0002-6639-524X; Mormina, Maru/0000-0002-5836-8989; Cardona, Alexia/0000-0002-7877-5565	European Research Council [FP7-261213]; University of East Anglia [RC-158]; National Geographic Society [8900-11]	European Research Council(European Research Council (ERC)European Commission); University of East Anglia; National Geographic Society(National Geographic Society)	This work was supported by European Research Council Starting Investigator grant http://erc.europa.eu/starting-grants (FP7-261213, TK), a starting investigator grant from the University of East Anglia (RC-158, MM) and the Young Explorers Grant from the National Geographic Society http://www.nationalgeographic.co.uk/explorers/grants-programs/young-explorers/ (8900-11, CE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acreche N, 2004, CUADERNOS FHYCS UNJU, V22, P171; Albeza MV, 2002, CHUNGARA, V34, P119; Aldashev AA, 2005, THORAX, V60, P683, DOI 10.1136/thx.2005.041954; Aldenderfer MS, 2003, AM SCI, V91, P542; Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alkorta-Aranburu G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003110; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Bauer M, 2010, J PSYCHIATR RES, V44, P1170, DOI 10.1016/j.jpsychires.2010.04.009; Beall CM, 2006, INTEGR COMP BIOL, V46, P18, DOI 10.1093/icb/icj004; Beall CM, 1997, AM J PHYS ANTHROPOL, V104, P427, DOI 10.1002/(SICI)1096-8644(199712)104:4<427::AID-AJPA1>3.0.CO;2-P; Beall CM, 2001, NATURE, V414, P411, DOI 10.1038/35106641; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bigham AW, 2008, HIGH ALT MED BIOL, V9, P167, DOI 10.1089/ham.2007.1066; Bigham Abigail W., 2009, Human Genomics, V4, P79; Bigham AW, 2013, AM J HUM BIOL; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; Braunstein J, 2001, PEOPLES GRAN CHACO; Brutsaert TD, 2000, AM J PHYS ANTHROPOL, V113, P169, DOI 10.1002/1096-8644(200010)113:2<169::AID-AJPA3>3.3.CO;2-0; Brutsaert TD, 1999, AM J HUM BIOL, V11, P383, DOI 10.1002/(SICI)1520-6300(1999)11:3<383::AID-AJHB9>3.0.CO;2-X; Cabana GS, 2006, AM J PHYS ANTHROPOL, V131, P108, DOI 10.1002/ajpa.20410; Cameron N, 1981, PRACTICAL HUMAN BIOL, P27; Center for International Earth Science Information Network (CIESIN)/Columbia University, 2012, NAT AGGR GEOSP DAT P; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Corach D, 2010, ANN HUM GENET, V74, P65, DOI 10.1111/j.1469-1809.2009.00556.x; de Simone G, 1999, HYPERTENSION, V33, P800, DOI 10.1161/01.HYP.33.3.800; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Demarchi DA, 2004, HUM BIOL, V76, P413, DOI 10.1353/hub.2004.0043; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dorward DA, 2007, RESP MED, V101, P587, DOI 10.1016/j.rmed.2006.06.014; Egan JR, 2008, J THORAC CARDIOV SUR, V136, P1265, DOI 10.1016/j.jtcvs.2008.04.002; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Frank S., 2008, PUEBLOS ORIGINARIOS; Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FRISANCHO AR, 1975, HUM BIOL, V47, P233; Frisancho AR, 2008, ANTHROPOMETRIC STAND, pviii; Gaya-Vidal M, 2011, AM J PHYS ANTHROPOL, V145, P215, DOI 10.1002/ajpa.21487; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Giussani DA, 2001, PEDIATR RES, V49, P490, DOI 10.1203/00006450-200104000-00009; Hawks J, 2007, P NATL ACAD SCI USA, V104, P20753, DOI 10.1073/pnas.0707650104; Heath D, 1995, HIGH ALTITUDE MED PA, px; Heggarty P, 2010, CURR ANTHR, V51; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huerta-Sanchez E, 2013, MOL BIOL EVOL, V30, P1877, DOI 10.1093/molbev/mst089; Igwe EI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-408; Jansen GFA, 2011, J CEREBR BLOOD F MET, V31, P706, DOI 10.1038/jcbfm.2010.150; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Levett DZ, 2012, FASEB J, V26, P1431, DOI 10.1096/fj.11-197772; Levett DZH, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-98; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li X, 2008, ARTERIOSCL THROM VAS, V28, P1614, DOI 10.1161/ATVBAHA.107.158725; Lundby C, 2004, AM J PHYSIOL-REG I, V287, pR1202, DOI 10.1152/ajpregu.00725.2003; Mao XY, 2007, AM J HUM GENET, V80, P1171, DOI 10.1086/518564; Martin D, 2008, POSTGRAD MED J, V84, P622, DOI 10.1136/pgmj.2008.068296; Monge C, 1982, HYPOXIA MAN ALTITUDE, P51; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; Nechiporuk T, 2001, J BIOL CHEM, V276, P4150, DOI 10.1074/jbc.M004814200; Nei M., 1987, MOL EVOLUTIONARY GEN; Nordstrom DK, 2002, SCIENCE, V296, P2143, DOI 10.1126/science.1072375; Pagani L, 2012, HUM GENET, V131, P423, DOI 10.1007/s00439-011-1084-8; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Penaloza D, 2007, CIRCULATION, V115, P1132, DOI 10.1161/CIRCULATIONAHA.106.624544; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinque D, 2006, ANAL BIOCHEM, V353, P272, DOI 10.1016/j.ab.2006.03.021; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; ROTHHAMMER F, 1989, AM J PHYS ANTHROPOL, V78, P403, DOI 10.1002/ajpa.1330780308; Rothhammer F, 2001, LAT AM ANTIQ, V12, P59, DOI 10.2307/971757; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rupert JL, 2001, J EXP BIOL, V204, P3151; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sala A, 1998, HUM BIOL, V70, P937; Scheinfeldt LB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r1; Sevini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064054; Shriver MD, 2004, HUM GENOMICS, V1, P274; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Simonson TS, 2010, SCIENCE; SYKES B, 1995, AM J HUM GENET, V57, P1463; TAJIMA F, 1983, GENETICS, V105, P437; Tajima N, 2006, J PHYSIOL-LONDON, V571, P349, DOI 10.1113/jphysiol.2005.096818; Tarazona-Santos E, 2000, AM J PHYS ANTHROPOL, V111, P165, DOI 10.1002/(SICI)1096-8644(200002)111:2<165::AID-AJPA3>3.3.CO;2-7; Thornton KR, 2007, GENETICS, V175, P737, DOI 10.1534/genetics.106.064642; U.S. Department of Agriculture, 2008, USDA FOOD SEARCH REL; Villafuerte FC, 2004, J APPL PHYSIOL, V96, P1581, DOI 10.1152/japplphysiol.00328.2003; Virues-Ortega J, 2006, DEVELOPMENTAL SCI, V9, P400, DOI 10.1111/j.1467-7687.2006.00505.x; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017002; West JB, 2007, HIGH ALTITUDE MED PH, pxii; Xing GQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002342; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhou D, 2013, AM J HUM GENET	106	46	48	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2014	9	3							e93314	10.1371/journal.pone.0093314	http://dx.doi.org/10.1371/journal.pone.0093314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GP	24686296	gold, Green Submitted, Green Published			2022-12-25	WOS:000340842300008
J	Vanni, T; Mesa-Frias, M; Sanchez-Garcia, R; Roesler, R; Schwartsmann, G; Goldani, MZ; Foss, AM				Vanni, Tazio; Mesa-Frias, Marco; Sanchez-Garcia, Ruben; Roesler, Rafael; Schwartsmann, Gilberto; Goldani, Marcelo Z.; Foss, Anna M.			International Scientific Collaboration in HIV and HPV: A Network Analysis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS TYPES; WOMEN; AIDS; LESIONS; CANCER; PREVALENCE; INFECTION; NEOPLASIA; CERVIX	Research endeavours require the collaborative effort of an increasing number of individuals. International scientific collaborations are particularly important for HIV and HPV co-infection studies, since the burden of disease is rising in developing countries, but most experts and research funds are found in developed countries, where the prevalence of HIV is low. The objective of our study was to investigate patterns of international scientific collaboration in HIV and HPV research using social network analysis. Through a systematic review of the literature, we obtained epidemiological data, as well as data on countries and authors involved in co-infection studies. The collaboration network was analysed in respect to the following: centrality, density, modularity, connected components, distance, clustering and spectral clustering. We observed that for many low-and middle-income countries there were no epidemiological estimates of HPV infection of the cervix among HIV-infected individuals. Most studies found only involved researchers from the same country (64%). Studies derived from international collaborations including high-income countries and either low-or middle-income countries had on average three times larger sample sizes than those including only high-income countries or low-income countries. The high global clustering coefficient (0.9) coupled with a short average distance between researchers (4.34) suggests a "small-world phenomenon.'' Researchers from high-income countries seem to have higher degree centrality and tend to cluster together in densely connected communities. We found a large well-connected community, which encompasses 70% of researchers, and 49 other small isolated communities. Our findings suggest that in the field of HIV and HPV, there seems to be both room and incentives for researchers to engage in collaborations between countries of different income-level. Through international collaboration resources available to researchers in high-income countries can be efficiently used to enroll more participants in low-and middle-income countries.	[Vanni, Tazio; Roesler, Rafael; Foss, Anna M.] Hosp Clin Porto Alegre, Natl Inst Sci & Technol Translat Med, Porto Alegre, RS, Brazil; [Vanni, Tazio; Mesa-Frias, Marco] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England; [Sanchez-Garcia, Ruben] Univ Southhampton, Southampton, England; [Roesler, Rafael] Univ Fed Rio Grande do Sul, Dept Pharmacol, Inst Basic Hlth Sci, Lab Neuropharmacol & Neural Tumor Biol, Porto Alegre, RS, Brazil; [Roesler, Rafael; Schwartsmann, Gilberto] Univ Fed Rio Grande do Sul, Univ Hosp Res Ctr CPE HCPA, Canc Res Lab, Porto Alegre, RS, Brazil; [Goldani, Marcelo Z.] Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil; [Goldani, Marcelo Z.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Foss, Anna M.] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Social & Math Epidemiol Res Grp, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of Southampton; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; University of London; London School of Hygiene & Tropical Medicine	Vanni, T (corresponding author), Hosp Clin Porto Alegre, Natl Inst Sci & Technol Translat Med, Porto Alegre, RS, Brazil.	taziovanni@gmail.com	Sanchez-Garcia, Ruben J/AAI-5391-2021; Schwartsmann, Gilberto/G-4256-2016; Goldani, Marcelo Zubaran/U-8596-2019; Vanni, Tazio P./B-7925-2018; Roesler, Rafael/U-9261-2019	Schwartsmann, Gilberto/0000-0002-7850-1644; Sanchez-Garcia, Ruben/0000-0001-6479-3028; Roesler, Rafael/0000-0001-6016-2261				Ambos TC, 2009, J INT MANAG, V15, P1, DOI 10.1016/j.intman.2008.02.002; [Anonymous], 2009, INT AAAI C WEBL SOC; [Anonymous], 6 DEGREES SEPARATION; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; BIERBAUM EG, 1995, J AM SOC INFORM SCI, V46, P530, DOI 10.1002/(SICI)1097-4571(199508)46:7<530::AID-ASI6>3.0.CO;2-C; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Breschi S, 2010, RES POLICY, V39, P14, DOI 10.1016/j.respol.2009.11.004; Burt RS, 2004, AM J SOCIOL, V110, P349, DOI 10.1086/421787; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; De Nooy W., 2011, EXPLORATORY SOCIAL N, V2; De Vuyst H, 2012, BRIT J CANCER, V107, P1624, DOI 10.1038/bjc.2012.441; De Vuyst H, 2008, EUR J CANCER PREV, V17, P545, DOI 10.1097/CEJ.0b013e3282f75ea1; Denny LA, 2012, VACCINE, V30, pF168, DOI 10.1016/j.vaccine.2012.06.045; Easley D, 2010, NETWORKS CROWDS MARK; Falagas ME, 2006, AIDS RES HUM RETROV, V22, P1199, DOI 10.1089/aid.2006.22.1199; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Guan P, 2013, INT J CANCER, V132, P248, DOI 10.1002/ijc.27663; Latapy M, 2008, THEOR COMPUT SCI, V407, P458, DOI 10.1016/j.tcs.2008.07.017; Long JC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001434; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Moodley JR, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-135; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Onyancha OB, 2004, LIBR INFORM SCI RES, V26, P434, DOI 10.1016/j.lisr.2004.04.005; Page L, 1999, PAGERANK CITATION RA, DOI DOI 10.1109/IISWC.2012.6402911; Palefsky JM, 2003, CURR OPIN ONCOL, V15, P382, DOI 10.1097/00001622-200309000-00007; Rochon PA, 2004, CAN MED ASSOC J, V170, P1673, DOI 10.1503/cmaj.1031006; Rosas SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017428; SENGUPTA IN, 1991, SCIENTOMETRICS, V20, P297, DOI 10.1007/BF02018160; SMALL H, 1994, SCIENTOMETRICS, V30, P229, DOI 10.1007/BF02017225; SMALL H, 1989, COMMUN RES, V16, P642, DOI 10.1177/009365089016005006; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010; The Royal Society, 2011, KNOWL NETW NAT GLOB; Thijs J, 2010, SOCIOL EDUC, V83, P333, DOI 10.1177/0038040710383521; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; Uddin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057546; Vanni T, 2012, INT J CANCER, V131, pE96, DOI 10.1002/ijc.26472; Vasconcellos AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045569; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Yu Q, 2013, INT J CARDIOL, V167, P631, DOI 10.1016/j.ijcard.2012.09.134	45	34	36	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93376	10.1371/journal.pone.0093376	http://dx.doi.org/10.1371/journal.pone.0093376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0TC	24682041	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000333678100046
J	Benelli, G; Benvenuti, S; Desneux, N; Canale, A				Benelli, Giovanni; Benvenuti, Stefano; Desneux, Nicolas; Canale, Angelo			Cephalaria transsylvanica-Based Flower Strips as Potential Food Source for Bees during Dry Periods in European Mediterranean Basin Countries	PLOS ONE			English	Article							SOWN WILDFLOWER STRIPS; SOIL TEXTURE; NATIVE BEES; POLLINATION; CONSERVATION; HABITAT; WEED; BIODIVERSITY; ENHANCEMENT; DIVERSITY	The introduction of sown wildflower strips favours the establishment of pollinator communities, with special reference to social Apoidea. Here, we evaluated the late summer flowering Cephalaria transsylvanica as suitable species for strips providing food for pollinators in paucity periods. C. transsylvanica showed no particular requirements in terms of seed germination and growth during summer. This plant had an excellent potential of self-seeding and competitiveness towards weed competitors. C. transsylvanica prevented from entomophilous pollination showed inbreeding depression, with a decrease in seed-set and accumulation of seed energy reserves. However, C. transsylvanica did not appear to be vulnerable in terms of pollination biology since it had a wide range of pollinators including bees, hoverflies and Lepidoptera. C. transsylvanica was visited mainly by honeybees and bumblebees and these latter pollinators increased their visits on C. transsylvanica flowers during early autumn. This plant may be useful as an abundant source of pollen during food paucity periods, such as autumn. We proposed C. transsylvanica for incorporation into flower strips to be planted in non-cropped farmlands in intensively managed agricultural areas as well as in proximity of beehives. The latter option may facilitate the honeybees collecting pollen and nectar for the colony, thereby ensuring robustness to overcome the winter season.	[Benelli, Giovanni; Canale, Angelo] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Pisa, Italy; [Benvenuti, Stefano] Univ Pisa, Dept Agr Food & Environm, Agron & Agroecosyst Management Sect, Pisa, Italy; [Desneux, Nicolas] French Natl Inst Agr Res INRA, Sophia Antipolis, France	University of Pisa; University of Pisa; INRAE	Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Pisa, Italy.	g.benelli@sssup.it; angelo.canale@unipi.it	Desneux, Nicolas/J-6262-2013; Benelli, Giovanni/A-9100-2013	Benelli, Giovanni/0000-0001-8971-6010	Italian Ministry of Education, University and Research (MIUR)	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	Funds were achieved by the Italian Ministry of Education, University and Research (MIUR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; [Anonymous], 1973, GEOBOTANICAL FDN MID; Aviron S, 2011, RESTOR ECOL, V19, P500, DOI 10.1111/j.1526-100X.2010.00649.x; Baker HG, 1983, POLLEN BIOL IMPLICAT, P43; Basteri G, 2010, ACTA HORTIC, V881, P585; Benedek P, 1969, Z ANG ENTOMOL, V63, P186; Benvenuti S, 2003, AGRON J, V95, P191, DOI 10.2134/agronj2003.0191; Benvenuti S, 2007, SEED SCI RES, V17, P211, DOI 10.1017/S0960258507782752; Blake RJ, 2011, PEST MANAG SCI, V67, P377, DOI 10.1002/ps.2136; Bosch J, 1997, OECOLOGIA, V109, P583, DOI 10.1007/s004420050120; Bretzel F, 2009, ACTA OECOL, V35, P657, DOI 10.1016/j.actao.2009.06.008; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Canale A, 2014, PLANT BIOSYST, V148, P889, DOI 10.1080/11263504.2013.863810; Canale A, 2010, REDIA, V93, P95; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Corbet SA, 2003, APIDOLOGIE, V34, P1, DOI 10.1051/apido:2002049; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Decourtye A, 2010, APIDOLOGIE, V41, P264, DOI 10.1051/apido/2010024; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Fabian Y, 2013, J ANIM ECOL, V82, P1203, DOI 10.1111/1365-2656.12103; Freitas BM, 2009, APIDOLOGIE, V40, P332, DOI 10.1051/apido/2009012; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Graves SD, 2003, BIOL CONSERV, V110, P413, DOI 10.1016/S0006-3207(02)00233-1; Haaland C, 2011, IMPORTANCE OF BIOLOGICAL INTERACTIONS IN THE STUDY OF BIODIVERSITY, P155; Haaland C, 2011, J INSECT CONSERV, V15, P301, DOI 10.1007/s10841-010-9353-8; Haaland C, 2011, INSECT CONSERV DIVER, V4, P60, DOI 10.1111/j.1752-4598.2010.00098.x; HEDRICK PW, 1992, ECOL APPL, V2, P30, DOI 10.2307/1941887; Hitchmough J, 2004, LANDSCAPE URBAN PLAN, V66, P75, DOI 10.1016/S0169-2046(03)00096-3; ISTA, 1999, SEED SCI TECHNOL, V31, P1; Jacobs JH, 2009, ANN BOT-LONDON, V104, P1397, DOI 10.1093/aob/mcp236; JENNERSTEN O, 1984, OECOLOGIA, V63, P80, DOI 10.1007/BF00379789; Jennings JA, 2002, AGRON J, V94, P1104, DOI 10.2134/agronj2002.1104; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Katzourakis A, 2001, J EVOLUTION BIOL, V14, P219, DOI 10.1046/j.1420-9101.2001.00278.x; Kayce P, 2010, REC NAT PROD, V4, P141; KIRMIZIGUL S, 1995, PHYTOCHEMISTRY, V39, P1171, DOI 10.1016/0031-9422(95)00106-H; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Korpela EL, 2011, AGR ECOSYST ENVIRON, V179, P18; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Ma MH, 2002, AGR ECOSYST ENVIRON, V89, P137, DOI 10.1016/S0167-8809(01)00325-5; MARSHALL EJP, 1995, LANDSCAPE URBAN PLAN, V31, P205, DOI 10.1016/0169-2046(94)01047-C; Nicholls CI, 2013, AGRON SUSTAIN DEV, V33, P257, DOI 10.1007/s13593-012-0092-y; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Ollerton J, 2003, ANN BOT-LONDON, V92, P807, DOI 10.1093/aob/mcg206; Ollerton J, 2007, TAXON, V56, P717, DOI 10.2307/25065856; Ozkok Tuylu A, 2007, HACETTEPE J BIOL CHE, V35, P31; Pesson P., 1984, P97; Pignatti S, 1982, FLORA ITALIA; Pisciotta S, 2011, PLANT BIOSYST, V145, P141, DOI 10.1080/11263504.2010.540779; POTTS S, 2010, STRAD, V121, P25; Ricciardelli G., 2000, FIORI API FLORA VISI; SCHUHMACHER H, 1982, ENTOMOL GEN, V7, P327; Steffan-Dewenter I, 1997, OECOLOGIA, V109, P294, DOI 10.1007/s004420050087; Vange V, 2002, BIOL CONSERV, V108, P59, DOI 10.1016/S0006-3207(02)00090-3; VANTREUREN R, 1994, J EVOLUTION BIOL, V7, P287, DOI 10.1046/j.1420-9101.1994.7030287.x; Wratten SD, 2012, AGR ECOSYST ENVIRON, V159, P112, DOI 10.1016/j.agee.2012.06.020	58	22	22	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93153	10.1371/journal.pone.0093153	http://dx.doi.org/10.1371/journal.pone.0093153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676345	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677500083
J	Browne, S; Macdonald, S; May, CR; Macleod, U; Mair, FS				Browne, Susan; Macdonald, Sara; May, Carl R.; Macleod, Una; Mair, Frances S.			Patient, Carer and Professional Perspectives on Barriers and Facilitators to Quality Care in Advanced Heart Failure	PLOS ONE			English	Article							NORMALIZATION PROCESS THEORY; PALLIATIVE CARE; EUROPEAN-SOCIETY; COMMUNITY; PEOPLE; CANCER; ASSOCIATION; PREVALENCE; DIAGNOSIS; SURVIVAL	Background: Those with advanced heart failure (HF) experience high levels of morbidity and mortality, similar to common cancers. However, there remains evidence of inequity of access to palliative care services compared to people with cancer. This study examines patient, carer, and professional perspectives on current management of advanced HF and barriers and facilitators to improved care. Methods: Qualitative study involving semi-structured interviews and focus groups with advanced HF patients (n = 30), carers (n = 20), and professionals (n = 65). Data analysed using Normalisation Process Theory (NPT) as the underpinning conceptual framework. Findings: Uncertainty is ubiquitous in accounts from advanced HF patients and their caregivers. This uncertainty relates to understanding of the implications of their diagnosis, appropriate treatments, and when and how to seek effective help. Health professionals agree this is a major problem but feel they lack knowledge, opportunities, or adequate support to improve the situation. Fragmented care with lack of coordination and poor communication makes life difficult. Poor understanding of the condition extends to the wider circle of carers and means that requests for help may not be perceived as legitimate, and those with advanced HF are not prioritised for social and financial supports. Patient and caregiver accounts of emergency care are uniformly poor. Managing polypharmacy and enduring concomitant side effects is a major burden, and the potential for rationalisation exists. This study has potential limitations because it was undertaken within a single geographical location within the United Kingdom. Conclusions: Little progress is being made to improve care experiences for those with advanced HF. Even in the terminal stages, patients and caregivers are heavily and unnecessarily burdened by health care services that are poorly coordinated and offer fragmented care. There is evidence that these poor experiences could be improved to a large extent by simple organisational rather than complex clinical mechanisms.	[Browne, Susan; Macdonald, Sara; Mair, Frances S.] Univ Glasgow, Inst Hlth & Wellbeing MVLS, Gen Practice & Primary Care, Glasgow, Lanark, Scotland; [May, Carl R.] Univ Southampton, Fac Hlth Sci, Southampton, Hants, England; [Macleod, Una] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Glasgow; University of Southampton; University of Hull; University of York - UK	Mair, FS (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing MVLS, Gen Practice & Primary Care, Glasgow, Lanark, Scotland.	Frances.Mair@glasgow.ac.uk	Macdonald, Sara/D-3340-2018; Morris, Josephine D./F-3366-2018	Macdonald, Sara/0000-0002-5380-6943; Morris, Josephine D./0000-0001-9404-5602; Browne, Susan/0000-0003-1785-1429; Mair, Frances/0000-0001-9780-1135; May, Carl/0000-0002-0451-2690	Marie Curie Cancer Care; British Heart Foundation; NHS Greater Glasgow and Clyde	Marie Curie Cancer Care; British Heart Foundation(British Heart Foundation); NHS Greater Glasgow and Clyde	This work was funded by the Caring Together programme (http://www.mariecurie.org.uk/caring), a partnership between Marie Curie Cancer Care, British Heart Foundation, and NHS Greater Glasgow and Clyde. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler ED, 2009, CIRCULATION, V120, P2597, DOI 10.1161/CIRCULATIONAHA.109.869123; Allen LA, 2012, CIRCULATION, V125, P1928, DOI 10.1161/CIR.0b013e31824f2173; Barclay S., 2011, BRITISH JOURNAL OF G, V61, P582; Barnes S, 2006, J PAIN SYMPTOM MANAG, V32, P208, DOI 10.1016/j.jpainsymman.2006.04.005; Beattie JM, 2007, IMPLANTABLE CARDIOVE; Dev S, 2012, AM HEART J, V164, P313, DOI 10.1016/j.ahj.2012.05.023; Gadoud A, 2013, PALLIATIVE MED, V27, P822, DOI 10.1177/0269216313494960; Gallacher K, 2011, ANN FAM MED, V9, P235, DOI 10.1370/afm.1249; Haga K, 2012, HEART, V98, P579, DOI 10.1136/heartjnl-2011-301021; Hogg KJ, 2012, HEART, V98, P523, DOI 10.1136/heartjnl-2012-301753; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jaarsma T, 2009, EUR J HEART FAIL, V11, P433, DOI 10.1093/eurjhf/hfp041; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; LeMond L, 2011, PROG CARDIOVASC DIS, V54, P168, DOI 10.1016/j.pcad.2011.03.012; Low J, 2011, J CARD FAIL, V17, P231, DOI 10.1016/j.cardfail.2010.10.003; May C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2803; May C, 2009, SOCIOLOGY, V43, P535, DOI 10.1177/0038038509103208; May CR, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-29; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Metzger M, 2013, HEART LUNG, V42, P112, DOI 10.1016/j.hrtlng.2012.11.002; Momen Natalie C, 2011, Curr Opin Support Palliat Care, V5, P312, DOI 10.1097/SPC.0b013e32834b8c4d; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Nordgren Lena, 2003, Eur J Cardiovasc Nurs, V2, P213; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Rogers AE, 2000, BMJ-BRIT MED J, V321, P605, DOI 10.1136/bmj.321.7261.605; Shah AB, 2013, REV CARDIOVASC MED, V14, P41, DOI 10.3909/ricm0635; SIGN, 2007, GUID 95 MAN CHRON HE; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007; Stewart S, 2001, EUR J HEART FAIL, V3, P315, DOI 10.1016/S1388-9842(00)00141-0; Stuart B, 2007, J PALLIAT MED, V10, P210, DOI 10.1089/jpm.2006.9988; Walke LM, 2006, J PAIN SYMPTOM MANAG, V31, P31, DOI 10.1016/j.jpainsymman.2005.05.014	32	64	66	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93288	10.1371/journal.pone.0093288	http://dx.doi.org/10.1371/journal.pone.0093288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676421	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000333677500104
J	Markey, FB; Ruezinsky, W; Tyagi, S; Batish, M				Markey, Fatu Badiane; Ruezinsky, William; Tyagi, Sanjay; Batish, Mona			Fusion FISH Imaging: Single-Molecule Detection of Gene Fusion Transcripts In Situ	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; NEUROECTODERMAL TUMOR; RNA DETECTION; HUMAN CANCER; CHROMOSOME; FAMILY; CELLS; TRANSLOCATIONS; ABERRATIONS; EXPRESSION	Double-stranded DNA breaks occur on a regular basis in the human genome as a consequence of genotoxic stress and errors during replication. Usually these breaks are rapidly and faithfully repaired, but occasionally different chromosomes, or different regions of the same chromosome, are fused to each other. Some of these aberrant chromosomal translocations yield functional recombinant genes, which have been implicated as the cause of a number of lymphomas, leukemias, sarcomas, and solid tumors. Reliable methods are needed for the in situ detection of the transcripts encoded by these recombinant genes. We have developed just such a method, utilizing single-molecule fluorescence in situ hybridization (sm-FISH), in which approximately 50 short fluorescent probes bind to adjacent sites on the same mRNA molecule, rendering each target mRNA molecule visible as a diffraction-limited spot in a fluorescence microscope. Utilizing this method, gene fusion transcripts are detected with two differently colored probe sets, each specific for one of the two recombinant segments of a target mRNA; enabling the fusion transcripts to be seen in the microscope as distinct spots that fluoresce in both colors. We demonstrate this method by detecting the BCR-ABL fusion transcripts that occur in chronic myeloid leukemia cells, and by detecting the EWSR1-FLI1 fusion transcripts that occur in Ewing's sarcoma cells. This technology should pave the way for accurate in situ typing of many cancers that are associated with, or caused by, fusion transcripts.	[Markey, Fatu Badiane; Ruezinsky, William; Batish, Mona] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07102 USA; [Tyagi, Sanjay] Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Batish, M (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07102 USA.	batishmo@njms.rutgers.edu	Batish, Mona/AAG-8296-2019	Batish, Mona/0000-0001-9039-6149; Tyagi, Sanjay/0000-0001-7303-5827	US National Institutes of Health (NIH) [5DP5OD-0121605]; NIH [AI-106036]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106036] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012160] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Rutgers University receives royalties from the sale of pre-labeled single-molecule FISH probes by Biosearch Technologies Inc., which markets them as Stellaris probes. A fraction of these proceeds is distributed to Sanjay Tyagi's laboratory for research and to him personally. Funding for this study was provided from the US National Institutes of Health (NIH) Director's Early Independence Award (5DP5OD-0121605) to MB, and from NIH grant AI-106036 to ST. The funders had no role in study design, data collection and analysis, decision to publish, or in preparation of the manuscript.	Batish M, 2012, P NATL ACAD SCI USA, V109, P4645, DOI 10.1073/pnas.1111226109; Batish M, 2011, METHODS MOL BIOL, V714, P3, DOI 10.1007/978-1-61779-005-8_1; Battich N, 2013, NAT METHODS, V10, P1127, DOI 10.1038/nmeth.2657; Branford S, 2006, METH MOLEC MED, V125, P69; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Chinnaiyan AM, 2010, PROG MOL BIOL TRANSL, V95, P55, DOI 10.1016/B978-0-12-385071-3.00004-6; Drexler HG, 2000, LEUKEMIA, V14, P1533, DOI 10.1038/sj.leu.2401878; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Evans CH, 2012, CLIN CANCER RES, V18, P5341, DOI 10.1158/1078-0432.CCR-12-1985; Folpe AL, 2000, AM J SURG PATHOL, V24, P1657, DOI 10.1097/00000478-200012000-00010; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gamberi G, 2011, J MOL DIAGN, V13, P313, DOI 10.1016/j.jmoldx.2011.01.004; Jabbour E, 2007, CANCER-AM CANCER SOC, V109, P2171, DOI 10.1002/cncr.22661; Le Deley MC, 2010, J CLIN ONCOL, V28, P1982, DOI 10.1200/JCO.2009.23.3585; Leiserson MDM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003054; Lyubimova A, 2013, NAT PROTOC, V8, P1743, DOI 10.1038/nprot.2013.109; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Rabbitts TH, 2009, CELL, V137, P391, DOI 10.1016/j.cell.2009.04.034; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Semrau S, 2014, CELL REP, V6, P18, DOI 10.1016/j.celrep.2013.12.002; Shaffer SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075120; Sinnamon JR, 2014, RNA, V20, P260, DOI 10.1261/rna.041905.113; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Steine EJ, 2011, J CLIN INVEST, V121, P1748, DOI 10.1172/JCI43169; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2011, SCI TRANSL MED, V3; Tsugita M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077416; Vargas DY, 2011, CELL, V147, P1054, DOI 10.1016/j.cell.2011.10.024	35	26	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93488	10.1371/journal.pone.0093488	http://dx.doi.org/10.1371/journal.pone.0093488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675777	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500130
J	Meng, HW; Pagano, JM; White, BS; Toyoda, Y; Min, IM; Craighead, HG; Shalloway, D; Lis, JT; Xiao, K; Jin, MM				Meng, Hsien-Wei; Pagano, John M.; White, Brian S.; Toyoda, Yoshiko; Min, Irene M.; Craighead, Harold G.; Shalloway, David; Lis, John T.; Xiao, Kai; Jin, Moonsoo M.			Discovering Aptamers by Cell-SELEX against Human Soluble Growth Factors Ectopically Expressed on Yeast Cell Surface	PLOS ONE			English	Article							HEPARIN-BINDING DOMAIN; DNA APTAMERS; RNA; VEGF; SELECTION; DISEASE; CANCER; RECEPTORS; THERAPY; ANTIBODIES	SELEX, the process of selecting aptamers, is often hampered by the difficulty of preparing target molecules in their native forms and by a lack of a simple yet quantitative assay for monitoring enrichment and affinity of reactive aptamers. In this study, we sought to discover DNA aptamers against human serum markers for potential therapeutic and diagnostic applications. To circumvent soluble expression and immobilization for performing SELEX, we ectopically expressed soluble growth factors on the surface of yeast cells to enable cell-SELEX and devised a flow cytometry-based method to quantitatively monitor progressive enrichment of specific aptamers. High-throughput sequencing of selected pools revealed that the emergence of highly enriched sequences concurred with the increase in the percentage of reactive aptamers shown by flow cytometry. Particularly, selected DNA aptamers against VEGF were specific and of high affinity (K-D = similar to 1 nM) and demonstrated a potent inhibition of capillary tube formation of endothelial cells, comparable to the effect of a clinically approved anti-VEGF antibody drug, bevacizumab. Considering the fact that many mammalian secretory proteins have been functionally expressed in yeast, the strategy of implementing cell-SELEX and quantitative binding assay can be extended to discover aptamers against a broad array of soluble antigens.	[Meng, Hsien-Wei; Toyoda, Yoshiko; Jin, Moonsoo M.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA; [Meng, Hsien-Wei] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Pagano, John M.; White, Brian S.; Shalloway, David; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Craighead, Harold G.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Xiao, Kai; Jin, Moonsoo M.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Min, Irene M.] Dongguk Univ, Dept Biomed Engn, Seoul, South Korea	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Dongguk University	Jin, MM (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.	moj2005@med.cornell.edu	Toyoda, Yoshiko/AAP-8180-2021; Min, Irene/AAQ-4186-2021	Min, Irene/0000-0002-1057-4804	National Institutes of Health [R01 GM090320]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM090320. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027051; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Avci-Adali M, 2010, MOLECULES, V15, P1, DOI 10.3390/molecules15010001; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Cho M, 2010, P NATL ACAD SCI USA, V107, P15373, DOI 10.1073/pnas.1009331107; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Gu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030680; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hasegawa H, 2008, BIOTECHNOL LETT, V30, P829, DOI 10.1007/s10529-007-9629-6; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Hu XB, 2010, P NATL ACAD SCI USA, V107, P6252, DOI 10.1073/pnas.0914358107; Kaur H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031196; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Krilleke D, 2007, J BIOL CHEM, V282, P28045, DOI 10.1074/jbc.M700319200; Krilleke D, 2009, BIOCHEM SOC T, V37, P1201, DOI 10.1042/BST0371201; KRUEGER JG, 1990, J INVEST DERMATOL, V94, pS135, DOI 10.1111/1523-1747.ep12876121; Latuhppe DR, 2013, ANAL GHEM; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Ordas I, 2012, CLIN PHARMACOL THER, V91, P635, DOI 10.1038/clpt.2011.328; Ozer A, 2013, NUCL ACIDS RES; Pagano JM, 2011, RNA, V17, P14, DOI 10.1261/rna.2428111; Patel DJ, 1997, J MOL BIOL, V272, P645, DOI 10.1006/jmbi.1997.1281; Potty ASR, 2009, BIOPOLYMERS, V91, P145, DOI 10.1002/bip.21097; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Trikha M, 2003, CLIN CANCER RES, V9, P4653; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wecker M, 1996, RNA, V2, P982; Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u; Zearfoss N Ruth, 2012, Methods Mol Biol, V941, P181, DOI 10.1007/978-1-62703-113-4_14	38	3	3	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93052	10.1371/journal.pone.0093052	http://dx.doi.org/10.1371/journal.pone.0093052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675636	gold, Green Submitted, Green Published			2022-12-25	WOS:000333677500066
J	Mitchell, SN; Rigden, DJ; Dowd, AJ; Lu, F; Wilding, CS; Weetman, D; Dadzie, S; Jenkins, AM; Regna, K; Boko, P; Djogbenou, L; Muskavitch, MAT; Ranson, H; Paine, MJI; Mayans, O; Donnelly, MJ				Mitchell, Sara N.; Rigden, Daniel J.; Dowd, Andrew J.; Lu, Fang; Wilding, Craig S.; Weetman, David; Dadzie, Samuel; Jenkins, Adam M.; Regna, Kimberly; Boko, Pelagie; Djogbenou, Luc; Muskavitch, Marc A. T.; Ranson, Hilary; Paine, Mark J. I.; Mayans, Olga; Donnelly, Martin J.			Metabolic and Target-Site Mechanisms Combine to Confer Strong DDT Resistance in Anopheles gambiae	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; PROTEIN STABILITY CHANGES; AMINO-ACID SUBSTITUTION; INSECTICIDE RESISTANCE; MALARIA VECTOR; KDR MUTATION; WEB SERVER; IDENTIFICATION; POPULATIONS; INHIBITION	The development of resistance to insecticides has become a classic exemplar of evolution occurring within human time scales. In this study we demonstrate how resistance to DDT in the major African malaria vector Anopheles gambiae is a result of both target-site resistance mechanisms that have introgressed between incipient species (the M-and S-molecular forms) and allelic variants in a DDT-detoxifying enzyme. Sequencing of the detoxification enzyme, Gste2, from DDT resistant and susceptible strains of An. gambiae, revealed a non-synonymous polymorphism (I114T), proximal to the DDT binding domain, which segregated with strain phenotype. Recombinant protein expression and DDT metabolism analysis revealed that the proteins from the susceptible strain lost activity at higher DDT concentrations, characteristic of substrate inhibition. The effect of I114T on GSTE2 protein structure was explored through X-ray crystallography. The amino acid exchange in the DDT-resistant strain introduced a hydroxyl group nearby the hydrophobic DDT-binding region. The exchange does not result in structural alterations but is predicted to facilitate local dynamics and enzyme activity. Expression of both wild-type and 114T alleles the allele in Drosophila conferred an increase in DDT tolerance. The 114T mutation was significantly associated with DDT resistance in wild caught M-form populations and acts in concert with target-site mutations in the voltage gated sodium channel (Vgsc-1575Y and Vgsc-1014F) to confer extreme levels of DDT resistance in wild caught An. gambiae.	[Mitchell, Sara N.; Dowd, Andrew J.; Wilding, Craig S.; Weetman, David; Dadzie, Samuel; Boko, Pelagie; Ranson, Hilary; Paine, Mark J. I.; Donnelly, Martin J.] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Rigden, Daniel J.; Lu, Fang; Mayans, Olga] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Dadzie, Samuel] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Jenkins, Adam M.; Regna, Kimberly; Muskavitch, Marc A. T.] Boston Coll, Chestnut Hill, MA 02167 USA; [Djogbenou, Luc] Univ Dabomey Calavi, Inst Reg Sante Publ Ouidah, Cotonou, Benin; [Muskavitch, Marc A. T.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Donnelly, Martin J.] Wellcome Trust Sanger Inst, Malaria Programme, Cambridge, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool; University of Ghana; Boston College; University of Abomey Calavi; Harvard University; Harvard T.H. Chan School of Public Health; Wellcome Trust Sanger Institute	Mayans, O (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	olga.mayans@liv.ac.uk; m.j.donnelly@liv.ac.uk	Paine, Mark John Ingraham/O-7450-2019; Weetman, David/M-1261-2014; Mitchell, Sara/AAB-5536-2020; Wilding, Craig S/C-5500-2012; Mitchell, Sara/I-3104-2014	Paine, Mark John Ingraham/0000-0003-2061-7713; Weetman, David/0000-0002-5820-1388; Wilding, Craig S/0000-0001-5818-2706; Dowd, Andrew/0000-0001-7936-7531; Donnelly, Martin/0000-0001-5218-1497; DJOGBENOU, Salako Luc/0000-0002-7381-6321; Dadzie, Dr Samuel Kweku/0000-0002-4105-1010; Rigden, Daniel/0000-0002-7565-8937; Ranson, Hilary/0000-0003-2332-8247; Mitchell, Sara/0000-0002-7926-1881; Mayans, Olga/0000-0001-6876-8532	Biotechnology and Biological Sciences Research Council; Innovative Vector Control Consortium; National Institute of Allergy and Infectious Diseases [R01AI082734]; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR) [A70588]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082734] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Innovative Vector Control Consortium; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR)(World Health Organization); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a Biotechnology and Biological Sciences Research Council studentship (to S.N.M.), by the Innovative Vector Control Consortium and the National Institute of Allergy and Infectious Diseases Grant R01AI082734. Funding for the mosquito collections from Burkina Faso was provided by UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR), Grant A70588. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amenya DA, 2008, INSECT MOL BIOL, V17, P19, DOI 10.1111/j.1365-2583.2008.00776.x; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-232; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Claudianos C, 1999, INSECT BIOCHEM MOLEC, V29, P675, DOI 10.1016/S0965-1748(99)00035-1; Daborn PJ, 2012, INSECT BIOCHEM MOLEC, V42, P918, DOI 10.1016/j.ibmb.2012.09.003; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Ding YC, 2005, BIOCHEM J, V387, P879, DOI 10.1042/BJ20041850; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Donnelly MJ, 2000, INSECT MOL BIOL, V9, P357, DOI 10.1046/j.1365-2583.2000.00197.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hood G.M., 2010, POPTOOLS VERSION 3 2; JAENICKE R, 1991, EUR J BIOCHEM, V202, P715, DOI 10.1111/j.1432-1033.1991.tb16426.x; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Le Goff G, 2003, INSECT BIOCHEM MOLEC, V33, P701, DOI 10.1016/S0965-1748(03)00064-X; Lin Y, 2001, DRUG METAB DISPOS, V29, P368; Lones C, 2012, P NATL ACAD SCI USA, V109, P6614; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; McCoy AJ, 2007, J APPL CRYSTALLOGRAP, V40; Merz A, 2000, BIOCHEMISTRY-US, V39, P880, DOI 10.1021/bi992333i; Mitchell SN, 2012, P NATL ACAD SCI USA, V109, P6147, DOI 10.1073/pnas.1203452109; Mosca R, 2008, NUCLEIC ACIDS RES, V36, pW42, DOI 10.1093/nar/gkn197; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; PRAPANTHADARA L, 1995, B ENTOMOL RES, V85, P267, DOI 10.1017/S0007485300034350; PRAPANTHADARA LA, 1993, PESTIC BIOCHEM PHYS, V47, P119, DOI 10.1006/pest.1993.1070; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; R Core Team, 2012, R LANG ENV STAT COMP; Ranson H, 2000, INSECT MOL BIOL, V9, P499, DOI 10.1046/j.1365-2583.2000.00214.x; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Reimer L, 2008, J MED ENTOMOL, V45, P260, DOI 10.1603/0022-2585(2008)45[260:RBKMAR]2.0.CO;2; Schlee S, 2009, BIOCHEMISTRY-US, V48, P5199, DOI 10.1021/bi802335s; Smith DT, 2011, J EVOLUTION BIOL, V24, P1351, DOI 10.1111/j.1420-9101.2011.02271.x; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Vincent F, 2005, J BIOL CHEM, V280, P19649, DOI 10.1074/jbc.M502131200; Wang YJ, 2008, J STRUCT BIOL, V164, P228, DOI 10.1016/j.jsb.2008.08.003; Weetman D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013140; Weill M, 2000, INSECT MOL BIOL, V9, P451, DOI 10.1046/j.1365-2583.2000.00206.x; WHO, 2012, TEST PROC INS RES MO; Wilkins EE, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-91	51	64	65	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92662	10.1371/journal.pone.0092662	http://dx.doi.org/10.1371/journal.pone.0092662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675797	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000333677500032
J	Newman, MR; Sykes, PJ; Blyth, BJ; Bezak, E; Lawrence, MD; Morel, KL; Ormsby, RJ				Newman, Michelle R.; Sykes, Pamela J.; Blyth, Benjamin J.; Bezak, Eva; Lawrence, Mark D.; Morel, Katherine L.; Ormsby, Rebecca J.			A Single Whole-Body Low Dose X-Irradiation Does Not Affect L1, B1 and IAP Repeat Element DNA Methylation Longitudinally	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; ADAPTIVE RESPONSE; LINE-1 HYPOMETHYLATION; GENE-EXPRESSION; NEOPLASTIC TRANSFORMATION; CHROMOSOMAL INVERSIONS; EPIGENETIC VARIATIONS; HISTONE MODIFICATIONS; IONIZING-RADIATION; POSSIBLE MECHANISM	The low dose radioadaptive response has been shown to be protective against high doses of radiation as well as aging-induced genomic instability. We hypothesised that a single whole-body exposure of low dose radiation would induce a radioadaptive response thereby reducing or abrogating aging-related changes in repeat element DNA methylation in mice. Following sham or 10 mGy X-irradiation, serial peripheral blood sampling was performed and differences in Long Interspersed Nucleic Element 1 (L1), B1 and Intracisternal-A-Particle (IAP) repeat element methylation between samples were assessed using high resolution melt analysis of PCR amplicons. By 420 days post-irradiation, neither radiation-or aging-related changes in the methylation of peripheral blood, spleen or liver L1, B1 and IAP elements were observed. Analysis of the spleen and liver tissues of cohorts of untreated aging mice showed that the 17-19 month age group exhibited higher repeat element methylation than younger or older mice, with no overall decline in methylation detected with age. This is the first temporal analysis of the effect of low dose radiation on repeat element methylation in mouse peripheral blood and the first to examine the long term effect of this dose on repeat element methylation in a radiosensitive tissue (spleen) and a tissue fundamental to the aging process (liver). Our data indicate that the methylation of murine DNA repeat elements can fluctuate with age, but unlike human studies, do not demonstrate an overall aging-related decline. Furthermore, our results indicate that a low dose of ionising radiation does not induce detectable changes to murine repeat element DNA methylation in the tissues and at the time-points examined in this study. This radiation dose is relevant to human diagnostic radiation exposures and suggests that a dose of 10 mGy X-rays, unlike high dose radiation, does not cause significant short or long term changes to repeat element or global DNA methylation.	[Newman, Michelle R.; Sykes, Pamela J.; Blyth, Benjamin J.; Lawrence, Mark D.; Morel, Katherine L.; Ormsby, Rebecca J.] Flinders Univ & Med Ctr, Flinders Ctr Innovat Canc, Bedford Pk, SA, Australia; [Bezak, Eva] Royal Adelaide Hosp, Dept Med Phys, Adelaide, SA 5000, Australia	Flinders University South Australia; Royal Adelaide Hospital	Sykes, PJ (corresponding author), Flinders Univ & Med Ctr, Flinders Ctr Innovat Canc, Bedford Pk, SA, Australia.	pam.sykes@flinders.edu.au	Bezak, Eva/Q-6309-2017; Bezak, Eva/S-4231-2019	Bezak, Eva/0000-0002-1315-1735; Bezak, Eva/0000-0002-1315-1735; Lawrence, Mark/0000-0003-4078-8691; Sykes, Pam/0000-0001-9239-7639; Ormsby, Rebecca/0000-0002-4256-7481; Morel, Katherine/0000-0002-7968-4032; Blyth, Benjamin/0000-0003-4754-6249	Low Dose Radiation Research Program, Biological and Environmental Research, U.S. Department of Energy [DE-FG02-05ER64104]; Flinders Medical Centre/Flinders Centre for Innovation in Cancer Research Grant; Flinders Medical Centre Foundation; BHP Billiton Low Dose Radiation Research Scholarship	Low Dose Radiation Research Program, Biological and Environmental Research, U.S. Department of Energy(United States Department of Energy (DOE)); Flinders Medical Centre/Flinders Centre for Innovation in Cancer Research Grant; Flinders Medical Centre Foundation; BHP Billiton Low Dose Radiation Research Scholarship	This work was supported by the Low Dose Radiation Research Program, Biological and Environmental Research, U.S. Department of Energy (DE-FG02-05ER64104); the Flinders Medical Centre/Flinders Centre for Innovation in Cancer Research Grant; and the Flinders Medical Centre Foundation and BHP Billiton Low Dose Radiation Research Scholarship (to M.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalsteinsson BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046705; Akagi K, 2008, GENOME RES, V18, P869, DOI 10.1101/gr.075770.107; Aukett R J, 2005, Phys Med Biol, V50, P2739, DOI 10.1088/0031-9155/50/12/001; Azzam EI, 1996, RADIAT RES, V146, P369, DOI 10.2307/3579298; AZZAM EI, 1994, RADIAT RES, V138, pS28, DOI 10.2307/3578755; Baccarelli A, 2010, EPIDEMIOLOGY, V21, P819, DOI 10.1097/EDE.0b013e3181f20457; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Barbot W, 2002, NUCLEIC ACIDS RES, V30, P2365, DOI 10.1093/nar/30.11.2365; Beetstra S, 2005, MUTAT RES-FUND MOL M, V578, P317, DOI 10.1016/j.mrfmmm.2005.05.012; Belgnaoui SM, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-13; Bollati V, 2011, BRAIN BEHAV IMMUN, V25, P1078, DOI 10.1016/j.bbi.2011.01.017; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Broome EJ, 2002, RADIAT RES, V158, P181, DOI 10.1667/0033-7587(2002)158[0181:DRFATL]2.0.CO;2; Calvanese V, 2009, AGEING RES REV, V8, P268, DOI 10.1016/j.arr.2009.03.004; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; CovielloMcLaughlin GM, 1997, NUCLEIC ACIDS RES, V25, P3051, DOI 10.1093/nar/25.15.3051; Danam RP, 1999, MOL CARCINOGEN, V24, P85, DOI 10.1002/(SICI)1098-2744(199902)24:2<85::AID-MC2>3.0.CO;2-C; Daskalos A, 2009, INT J CANCER, V124, P81, DOI 10.1002/ijc.23849; Day TK, 2007, INT J RADIAT BIOL, V83, P523, DOI 10.1080/09553000701420582; Day TK, 2007, RADIAT RES, V167, P682, DOI 10.1667/RR0764.1; Day TK, 2006, RADIAT RES, V166, P757, DOI 10.1667/RR0689.1; de Andrade A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-617; Drissi R, 2011, CANCER PREV RES, V4, P1973, DOI 10.1158/1940-6207.CAPR-11-0069; Edwards LJ, 2000, PEDIATR PULM, V30, P330, DOI 10.1002/1099-0496(200010)30:4<330::AID-PPUL10>3.0.CO;2-D; Ekram MB, 2012, EPIGENETICS-US, V7, P370, DOI 10.4161/epi.19462; El-Maarri O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016252; Elmore E, 2008, RADIAT RES, V169, P311, DOI 10.1667/RR1199.1; Fahrner JA, 2002, CANCER RES, V62, P7213; Feinendegen LE, 1999, HUM EXP TOXICOL, V18, P426, DOI 10.1191/096032799678840309; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Filkowski JN, 2010, CARCINOGENESIS, V31, P1110, DOI 10.1093/carcin/bgp300; Gadhia PK, 1998, MUTAGENESIS, V13, P151; GAUBATZ JW, 1991, MECH AGEING DEV, V57, P71, DOI 10.1016/0047-6374(91)90025-U; Gentilini D, 2013, AGE, V35, P1961, DOI 10.1007/s11357-012-9463-1; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Giotopoulos G, 2006, EXP HEMATOL, V34, P1462, DOI 10.1016/j.exphem.2006.06.008; Goetz W, 2011, RADIAT RES, V175, P575, DOI 10.1667/RR2390.1; Gonzalo S, 2010, J APPL PHYSIOL, V109, P586, DOI 10.1152/japplphysiol.00238.2010; Hagan CR, 2003, NAT GENET, V35, P219, DOI 10.1038/ng1259; Hashimoto S, 1999, RADIAT RES, V151, P717, DOI 10.2307/3580211; Hooker AM, 2004, RADIAT RES, V162, P447, DOI 10.1667/RR3228; Horie K, 2002, J RADIAT RES, V43, P353, DOI 10.1269/jrr.43.353; Hunter Richard G, 2013, Mob Genet Elements, V3, pe24555; Hunter RG, 2009, P NATL ACAD SCI USA, V106, P20912, DOI 10.1073/pnas.0911143106; Igarashi S, 2010, CLIN CANCER RES, V16, P5114, DOI 10.1158/1078-0432.CCR-10-0581; Ina Y, 2005, RADIAT RES, V163, P153, DOI 10.1667/RR3289; Iyer R, 2002, RADIAT RES, V157, P3, DOI 10.1667/0033-7587(2002)157[0003:APIIIT]2.0.CO;2; Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009; Johansson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067378; Kato K, 2011, J RADIAT RES, V52, P293, DOI 10.1269/jrr.10142; Kim K-c, 2010, BR J NUTR, V104, P1; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Klevenhagen SC, 1996, PHYS MED BIOL, V41, P2605, DOI 10.1088/0031-9155/41/12/002; Koturbash I, 2005, BIOCHEM BIOPH RES CO, V337, P526, DOI 10.1016/j.bbrc.2005.09.084; Kovalchuk O, 2004, MUTAT RES-FUND MOL M, V550, P59, DOI 10.1016/j.mrfmmm.2004.02.007; Kovalchuk O, 2004, MUTAT RES-FUND MOL M, V548, P75, DOI 10.1016/j.mrfmmm.2003.12.016; Kumar A, 2011, INT J RADIAT BIOL, V87, P1086, DOI 10.3109/09553002.2011.605417; Lange NE, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001231; Li W, 2004, EXP HEMATOL, V32, P1088, DOI 10.1016/j.exphem.2004.07.015; Lin CH, 2001, CANCER RES, V61, P4238; LINDOP PJ, 1962, BRIT J RADIOL, V35, P23, DOI 10.1259/0007-1285-35-409-23; Liu L, 2011, CLIN EPIGENETICS, V2, P349, DOI 10.1007/s13148-011-0042-6; LORENZ E, 1955, J NATL CANCER I, V15, P1049; MAYSHOOPES L, 1986, DEV GENET, V7, P65, DOI 10.1002/dvg.1020070202; Meischl C, 2000, EUR J HUM GENET, V8, P697, DOI 10.1038/sj.ejhg.5200523; Mitchel REJ, 2008, RADIAT RES, V170, P765, DOI 10.1667/RR1414.1; Mitchel REJ, 2004, RADIAT RES, V162, P20, DOI 10.1667/RR3190; Mitchel REJ, 2003, RADIAT RES, V159, P320, DOI 10.1667/0033-7587(2003)159[0320:LDORIT]2.0.CO;2; Mizugaki M, 1997, CLIN EXP IMMUNOL, V110, P265; Nakagawachi T, 2003, ONCOGENE, V22, P8835, DOI 10.1038/sj.onc.1207183; Newman MR, 2012, EPIGENETICS-US, V7, P92, DOI 10.4161/epi.7.1.18815; Nomura T, 2013, RADIAT RES, V179, P717, DOI 10.1667/RR2977.1; Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Pogribny I, 2004, BIOCHEM BIOPH RES CO, V320, P1253, DOI 10.1016/j.bbrc.2004.06.081; Pogribny IP, 2010, EPIGENETICS OF AGING, P11, DOI 10.1007/978-1-4419-0639-7_2; Pogrlbny I, 2005, MOL CANCER RES, V3, P553, DOI 10.1158/1541-7786.MCR-05-0074; Raiche J, 2004, BIOCHEM BIOPH RES CO, V325, P39, DOI 10.1016/j.bbrc.2004.10.002; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Saito K, 2010, CLIN CANCER RES, V16, P2418, DOI 10.1158/1078-0432.CCR-09-2819; Sakai Kazuo, 2006, Dose-Response, V4, P327, DOI 10.2203/dose-response.06-115.Sakai; SASAKI S, 1991, J RADIAT RES, V32, P73, DOI 10.1269/jrr.32.SUPPLEMENT2_73; SHADLEY JD, 1987, MUTAGENESIS, V2, P95, DOI 10.1093/mutage/2.2.95; Shuryak I, 2010, JNCI-J NATL CANCER I, V102, P1628, DOI 10.1093/jnci/djq346; SILINI G, 1974, EXP GERONTOL, V9, P99, DOI 10.1016/0531-5565(74)90038-2; SINGHAL RP, 1987, MECH AGEING DEV, V41, P199, DOI 10.1016/0047-6374(87)90040-6; St Laurent G, 2010, MECH AGEING DEV, V131, P299, DOI 10.1016/j.mad.2010.03.008; Stach D, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng002; Steegenga WT, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-38; Stoilov LM, 2007, MUTAGENESIS, V22, P117, DOI 10.1093/mutage/gel061; Tawa R, 1998, J RADIAT RES, V39, P271, DOI 10.1269/jrr.39.271; Ugwu A, 2009, J BIOMED RES, V1, P61; Wang GJ, 2000, TOXICOL SCI, V53, P369, DOI 10.1093/toxsci/53.2.369; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; WOLFF S, 1988, INT J RADIAT BIOL, V53, P39, DOI 10.1080/09553008814550401; Wolff S, 1998, ENVIRON HEALTH PERSP, V106, P277, DOI 10.2307/3433927; Wu HC, 2012, CANCER EPIDEM BIOMAR, V21, P1314, DOI 10.1158/1055-9965.EPI-12-0300; Wu HC, 2011, EPIGENETICS-US, V6, P76, DOI 10.4161/epi.6.1.13391; YOSHIDA N, 1993, J RADIAT RES, V34, P269, DOI 10.1269/jrr.34.269; Zaichkina S. I., 2006, International Journal of Low Radiation, V2, P1, DOI 10.1504/IJLR.2006.007890; Zeng GX, 2006, MUTAT RES-FUND MOL M, V602, P65, DOI 10.1016/j.mrfmmm.2006.08.002	106	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93016	10.1371/journal.pone.0093016	http://dx.doi.org/10.1371/journal.pone.0093016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676381	Green Published, Green Accepted, gold			2022-12-25	WOS:000333677500065
J	Ristau, T; Paun, C; Ersoy, L; Hahn, M; Lechanteur, Y; Hoyng, C; de Jong, EK; Daha, MR; Kirchhof, B; den Hollander, AI; Fauser, S				Ristau, Tina; Paun, Constantin; Ersoy, Lebriz; Hahn, Moritz; Lechanteur, Yara; Hoyng, Carel; de Jong, Eiko K.; Daha, Mohamed R.; Kirchhof, Bernd; den Hollander, Anneke I.; Fauser, Sascha			Impact of the Common Genetic Associations of Age-Related Macular Degeneration upon Systemic Complement Component C3d Levels	PLOS ONE			English	Article							FACTOR-H POLYMORPHISM; ALTERNATIVE PATHWAY; HAPLOTYPE RECONSTRUCTION; RISK; VARIANT; ACTIVATION; RECOGNITION; DRUSEN	Age-related macular degeneration (AMD) is a common condition that leads to severe vision loss and dysregulation of the complement system is thought to be associated with the disease. To investigate associations of polymorphisms in AMD susceptibility genes with systemic complement activation, 2655 individuals were genotyped for 32 single nucleotide polymorphisms (SNPs) in or near 23 AMD associated risk genes. Component 3 (C3) and its catabolic fragment C3d were measured in serum and AMD staging was performed using multimodal imaging. The C3d/C3 ratio was calculated and associations with environmental factors, SNPs and various haplotypes of complement factor H (CFH) genes and complement factor B (CFB) genes were analyzed. Linear models were built to measure the influence of genetic variants on the C3d/C3 ratio. The study cohort included 1387 patients with AMD and 1268 controls. Higher C3d/C3 ratios were found for current smoker (p = 0.002), higher age (p = 1.56x10(-7)), AMD phenotype (p = 1.15x10(-11)) and the two SNPs in the C3 gene rs6795735 (p = 0.04) and rs2230199 (p = 0.04). Lower C3d/C3 ratios were found for diabetes (p = 2.87x10(-6)), higher body mass index (p = 1.00x10(-13)), the SNPs rs1410996 (p = 0.0001), rs800292 (p = 0.003), rs12144939 (p = 4.60x10(-6)) in CFH, rs4151667 (p = 1.01x10(-5)) in CFB and individual haplotypes in CFH and CFB. The linear model revealed a corrected R-square of 0.063 including age, smoking status, gender, and genetic polymorphisms explaining 6.3% of the C3d/C3 ratio. After adding the AMD status the corrected R-square was 0.067. In conclusion, none of the evaluated genetic polymorphisms showed an association with increased systemic complement activation apart from two SNPs in the C3 gene. Major genetic and non-genetic factors for AMD were not associated with systemic complement activation.	[Ristau, Tina; Ersoy, Lebriz; Kirchhof, Bernd; Fauser, Sascha] Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany; [Paun, Constantin; Lechanteur, Yara; Hoyng, Carel; de Jong, Eiko K.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Hahn, Moritz] Univ Cologne, Inst Med Stat Informat & Epidemiol, D-50931 Cologne, Germany; [Daha, Mohamed R.] Leiden Univ Nijmegen, Med Ctr, Dept Nephrol, Leiden, Netherlands	University of Cologne; Radboud University Nijmegen; University of Cologne	Fauser, S (corresponding author), Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany.	sascha.fauser@uk-koeln.de	Hollander, Anneke den/N-4911-2014; Lechanteur, Yara/ABB-6875-2020; de Jong, Eiko/P-3407-2015; Lehtimäki, Terho/AAD-1094-2022; Hoyng, C.B./H-8050-2014	Lechanteur, Yara/0000-0003-0951-4625; de Jong, Eiko/0000-0001-6520-0407; Lehtimäki, Terho/0000-0002-2555-4427; 	Retinovit Foundation, Germany	Retinovit Foundation, Germany	This work was supported by the Retinovit Foundation, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hawkins JR, 2002, HUM MUTAT, V19, P543, DOI 10.1002/humu.10060; Hecker LA, 2010, HUM MOL GENET, V19, P209, DOI 10.1093/hmg/ddp472; Johnson PT, 2006, P NATL ACAD SCI USA, V103, P17456, DOI 10.1073/pnas.0606234103; Khandhadia S, 2012, IMMUNOBIOLOGY, V217, P127, DOI 10.1016/j.imbio.2011.07.019; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; SCHREIBER RD, 1978, P NATL ACAD SCI USA, V75, P3948, DOI 10.1073/pnas.75.8.3948; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Smailhodzic D, 2012, OPHTHALMOLOGY, V119, P339, DOI 10.1016/j.ophtha.2011.07.056; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zipfel PF, 2008, VACCINE, V26, pI67, DOI 10.1016/j.vaccine.2008.11.015	22	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93459	10.1371/journal.pone.0093459	http://dx.doi.org/10.1371/journal.pone.0093459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675670	gold, Green Submitted, Green Published			2022-12-25	WOS:000333677500126
J	Bhaskaracharya, A; Phuong, DU; Jalilian, I; Spildrejorde, M; Skarratt, KK; Fuller, SJ; Sluyter, R; Stokes, L				Bhaskaracharya, Archana; Phuong Dao-Ung; Jalilian, Iman; Spildrejorde, Mari; Skarratt, Kristen K.; Fuller, Stephen J.; Sluyter, Ronald; Stokes, Leanne			Probenecid Blocks Human P2X7 Receptor-Induced Dye Uptake via a Pannexin-1 Independent Mechanism	PLOS ONE			English	Article							HUMAN P2X(7) RECEPTOR; INTERLEUKIN-1-BETA RELEASE; INFLAMMASOME ACTIVATION; HUMAN MONOCYTES; ATP RELEASE; POLYMORPHISM; MACROPHAGES; SECRETION; TRANSPORT; IL-1-BETA	P2X7 is a ligand-gated ion channel which is activated by ATP and displays secondary permeability characteristics. The mechanism of development of the secondary permeability pathway is currently unclear, although a role for the hemichannel protein pannexin-1 has been suggested. In this study we investigated the role of pannexin-1 in P2X7-induced dye uptake and ATP-induced IL-1 beta secretion from human monocytes. We found no pharmacological evidence for involvement of pannexin-1 in P2X7-mediated dye uptake in transfected HEK-293 cells with no inhibition seen for carbenoxolone and the pannexin-1 mimetic inhibitory peptide, (10)Panx1. However, we found that probenecid inhibited P2X7-induced cationic and anionic dye uptake in stably transfected human P2X7 HEK-293 cells. An IC50 value of 203 mM was calculated for blockade of ATP-induced responses at human P2X7. Probenecid also reduced dye uptake and IL-1 beta secretion from human CD14(+) monocytes whereas carbenoxolone and (10)Panx1 showed no inhibitory effect. Patch clamp and calcium indicator experiments revealed that probenecid directly blocks the human P2X7 receptor.	[Bhaskaracharya, Archana; Phuong Dao-Ung; Skarratt, Kristen K.; Fuller, Stephen J.; Stokes, Leanne] Univ Sydney, Nepean Hosp, Sydney Med Sch Nepean, Penrith, NSW, Australia; [Jalilian, Iman; Spildrejorde, Mari; Sluyter, Ronald] Univ Wollongong, Sch Biol Sci, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Stokes, Leanne] RMIT Univ, Sch Med Sci, Hlth Innovat Res Inst, Melbourne, Vic, Australia	Nepean Hospital; University of Sydney; University of Wollongong; Royal Melbourne Institute of Technology (RMIT)	Stokes, L (corresponding author), Univ Sydney, Nepean Hosp, Sydney Med Sch Nepean, Penrith, NSW, Australia.	leanne.stokes@rmit.edu.au	Skarratt, Kristy/AAN-1479-2020; Fuller, Stephen/W-6646-2019; Sluyter, Ronald/B-5798-2009	Fuller, Stephen/0000-0003-4637-7391; Sluyter, Ronald/0000-0003-4909-686X; Spildrejorde, Mari/0000-0002-3890-9477; Skarratt, Kristy/0000-0003-4971-2773; Stokes, Leanne/0000-0003-4013-6781	National Health and Medical Research Council of Australia [ID632687]; Nepean Medical Research Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Nepean Medical Research Foundation	This work was supported by a project grant from the National Health and Medical Research Council of Australia (LS, ID632687) and the Nepean Medical Research Foundation (LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto AVP, 2013, N-S ARCH PHARMACOL, V386, P775, DOI 10.1007/s00210-013-0868-x; Bang SS, 2007, NEUROSCI LETT, V425, P120, DOI 10.1016/j.neulet.2007.08.035; Bartlett R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/271813; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; DIVIRGILIO F, 1988, J IMMUNOL, V140, P915; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Gadeock S, 2012, PURINERG SIGNAL, V8, P669, DOI 10.1007/s11302-012-9320-9; Greene TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020123; Hanley PJ, 2012, J BIOL CHEM, V287, P10650, DOI 10.1074/jbc.M111.332676; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Kingsbury SR, 2011, J INFLAMM RES, V4, P39, DOI 10.2147/JIR.S11330; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; Marques-Da-Silva C, 2011, BRIT J PHARMACOL, V163, P912, DOI 10.1111/j.1476-5381.2011.01254.x; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2010, IMMUNOL REV, V233, P218, DOI 10.1111/j.0105-2896.2009.00860.x; McClenaghan C, 2012, ASSAY DRUG DEV TECHN, V10, P533, DOI 10.1089/adt.2012.447; Michel AD, 2006, BRIT J PHARMACOL, V149, P948, DOI 10.1038/sj.bjp.0706938; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Pupovac A, 2013, PURINERG SIGNAL, V9, P609, DOI 10.1007/s11302-013-9371-6; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Riteau N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.144; RochRamel F, 1997, J PHARMACOL EXP THER, V280, P839; Schachter J, 2008, J CELL SCI, V121, P3261, DOI 10.1242/jcs.029991; Shemon AN, 2004, BRIT J PHARMACOL, V142, P1015, DOI 10.1038/sj.bjp.0705868; Shemon AN, 2008, BIOCHEM BIOPH RES CO, V365, P515, DOI 10.1016/j.bbrc.2007.11.008; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Sluyter R, 2004, GENES IMMUN, V5, P588, DOI 10.1038/sj.gene.6364127; Sluyter R, 2004, J IMMUNOL, V172, P3399, DOI 10.4049/jimmunol.172.6.3399; STEINBERG TH, 1987, J CELL BIOL, V105, P2695, DOI 10.1083/jcb.105.6.2695; Stokes L, 2010, FASEB J, V24, P2916, DOI 10.1096/fj.09-150862; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Tao JH, 2013, SEMIN ARTHRITIS RHEU, V43, P376, DOI 10.1016/j.semarthrit.2013.04.007; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x	37	56	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93058	10.1371/journal.pone.0093058	http://dx.doi.org/10.1371/journal.pone.0093058			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671093	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000333677000109
J	Schorr, GS; Falcone, EA; Moretti, DJ; Andrews, RD				Schorr, Gregory S.; Falcone, Erin A.; Moretti, David J.; Andrews, Russel D.			First Long-Term Behavioral Records from Cuvier's Beaked Whales (Ziphius cavirostris) Reveal Record-Breaking Dives	PLOS ONE			English	Article							MESOPLODON-DENSIROSTRIS; DIVING BEHAVIOR; STRANDINGS	Cuvier's beaked whales (Ziphius cavirostris) are known as extreme divers, though behavioral data from this difficult-to-study species have been limited. They are also the species most often stranded in association with Mid-Frequency Active (MFA) sonar use, a relationship that remains poorly understood. We used satellite-linked tags to record the diving behavior and locations of eight Ziphius off the Southern California coast for periods up to three months. The effort resulted in 3732 hr of dive data with associated regional movements - the first dataset of its kind for any beaked whale - and included dives to 2992 m depth and lasting 137.5 min, both new mammalian dive records. Deep dives had a group mean depth of 1401 m (s.d. = 137.8, n = 1142) and duration of 67.4 min (s.d. = 6.9). The group mean time between deep dives was 102.3 min (s.d. = 30.8, n = 783). While the previously described stereotypic pattern of deep and shallow dives was apparent, there was considerable inter-and intra-individual variability in most parameters. There was significant diel behavioral variation, including increased time near the surface and decreased shallow diving at night. However, maximum depth and the proportion of time spent on deep dives (presumed foraging), varied little from day to night. Surprisingly, tagged whales were present within an MFA sonar training range for 38% of days locations were received, and though comprehensive records of sonar use during tag deployments were not available, we discuss the effects frequent acoustic disturbance may have had on the observed behaviors. These data better characterize the true behavioral range of this species, and suggest caution should be exercised when drawing conclusions about behavior using short-term datasets.	[Schorr, Gregory S.; Falcone, Erin A.] Cascadia Res Collect, Olympia, WA 98501 USA; [Moretti, David J.] Naval Undersea Warfare Ctr, Newport, RI USA; [Andrews, Russel D.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Andrews, Russel D.] Alaska SeaLife Ctr, Seward, AK USA	United States Department of Defense; United States Navy; US Navy Naval Sea Systems Command; University of Alaska System; University of Alaska Fairbanks	Schorr, GS (corresponding author), Cascadia Res Collect, Olympia, WA 98501 USA.	gschorr@cascadiaresearch.org		Andrews, Russel/0000-0002-4545-137X	United States Navy (N45) via the Naval Postgraduate School [N00244-10-1-0050]; Wildlife Computers; Office of Naval Research [N000140811203]; Alaska SeaLife Center; National Oceanic and Atmospheric Administration/Northwest Fisheries Science Center; United States Navy (N45) via the Living Marine Resources program	United States Navy (N45) via the Naval Postgraduate School; Wildlife Computers; Office of Naval Research(Office of Naval Research); Alaska SeaLife Center; National Oceanic and Atmospheric Administration/Northwest Fisheries Science Center; United States Navy (N45) via the Living Marine Resources program	Field work was funded by a grant to Cascadia Research Collective from the United States Navy (N45) via the Naval Postgraduate School (Grant Number N00244-10-1-0050) (http://www.nps.edu/). Development of the Mk10-A LIMPET tag was funded by Wildlife Computers and the Office of Naval Research (Grant Number N000140811203) with additional support from the Alaska SeaLife Center and National Oceanic and Atmospheric Administration/Northwest Fisheries Science Center. Marine Mammal Monitoring on Navy Ranges (M3R) is funded by the United States Navy (N45) via the Living Marine Resources program (http://www.lmr.navy.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RD, 2008, POLAR BIOL, V31, P1461, DOI 10.1007/s00300-008-0487-z; [Anonymous], 2009, TAKING IMPORTING MAR; [Anonymous], 2008, SO CALIFORNIA RANGE; Baird RW, 2008, MAR MAMMAL SCI, V24, P630, DOI 10.1111/j.1748-7692.2008.00211.x; Baird RW, 2006, CAN J ZOOL, V84, P1120, DOI 10.1139/Z06-095; Brandt MJ, 2011, MAR ECOL PROG SER, V421, P205, DOI 10.3354/meps08888; Carretta J, 2012, US PACIFIC MARINE MA; Costa DP, 2010, INTEGR COMP BIOL, V50, P1018, DOI 10.1093/icb/icq054; Cox TM, 2006, J CETACEAN RES MANAG, P177; D'Amico Angela, 2009, Aquatic Mammals, V35, P452, DOI 10.1578/AM.35.4.2009.452; DeRuiter SL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0223; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Falcone EA, 2009, MAR BIOL, V156, P2631, DOI 10.1007/s00227-009-1289-8; Filadelfo Ronald, 2009, Aquatic Mammals, V35, P445, DOI 10.1578/AM.35.4.2009.445; HINDELL MA, 1992, CAN J ZOOL, V70, P370, DOI 10.1139/z92-055; Hooker SK, 2009, RESP PHYSIOL NEUROBI, V167, P235, DOI 10.1016/j.resp.2009.04.023; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; McGlatchie S, 2013, REGIONAL FISHERIES O; Moretti D., 2006, J ACOUSTICAL SOC AM, V119, P3374, DOI [10.1121/1.4786579, DOI 10.1121/1.4786579]; Morton AB, 2002, ICES J MAR SCI, V59, P71, DOI 10.1006/jmsc.2001.1136; Schorr Gregory S., 2010, Endangered Species Research, V10, P203, DOI 10.3354/esr00229; Soto NA, 2006, MAR MAMMAL SCI, V22, P690, DOI 10.1111/j.1748-7692.2006.00044.x; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Wildlife Computers, 2012, WILDL COMP MK10 TAG; Wildlife Computers, 2013, WILDL COMP DAT AN PR; Zimmer WMX, 2007, MAR MAMMAL SCI, V23, P888, DOI 10.1111/j.1748-7692.2007.00152.x	27	191	195	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92633	10.1371/journal.pone.0092633	http://dx.doi.org/10.1371/journal.pone.0092633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670984	gold, Green Published			2022-12-25	WOS:000333677000060
J	Yang, FY; Ko, CE; Huang, SY; Chung, IF; Chen, GS				Yang, Feng-Yi; Ko, Chia-En; Huang, Sheng-Yao; Chung, I-Fang; Chen, Gin-Shin			Pharmacokinetic Changes Induced by Focused Ultrasound in Glioma-Bearing Rats as Measured by Dynamic Contrast-Enhanced MRI	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GLIOBLASTOMA-MULTIFORME; LIPOSOMAL DOXORUBICIN; MOLECULAR DELIVERY; PERMEABILITY; DISRUPTION; MODEL; TRACER; IMAGES; AGENTS	Focused ultrasound (FUS) combined with microbubbles has been shown to be a noninvasive and targeted drug delivery technique for brain tumor treatment. The purpose of this study was to measure the kinetics of Gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA) in glioma-bearing rats in the presence of FUS-induced blood-brain barrier disruption (BBB-D) by magnetic resonance imaging (MRI). A total of ten glioma-bearing rats (9-12 weeks, 290-340 g) were used in this study. Using dynamic contrast-enhanced (DCE)-MRI, the spatial permeability of FUS-induced BBB-D was evaluated and the kinetic parameters were calculated by a general kinetic model (GKM). The results demonstrate that the mean K-trans of the sonicated tumor (0.128 +/- 0.019 at 20 min and 0.103 +/- 0.023 at 24 h after sonication, respectively) was significantly higher than (2.46-fold at 20 min and 1.78-fold at 24 h) that of the contralateral (non-sonicated) tumor (0.052 +/- 0.019 at 20 min and 0.058 +/- 0.012 at 24 h after sonication, respectively). In addition, the transfer constant K-trans in the sonicated tumor correlated strongly with tissue EB extravasation (R = 0.95), which suggests that DCE-MRI may reflect drug accumulation in the brain. Histological observations showed no macroscopic damage except for a few small erythrocyte extravasations. The current study demonstrates that DCE-MRI can monitor the dynamics of the FUS-induced BBB-D process and constitutes a useful tool for quantifying BBB permeability in tumors.	[Yang, Feng-Yi; Ko, Chia-En] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Yang, Feng-Yi] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan; [Huang, Sheng-Yao; Chung, I-Fang] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chen, Gin-Shin] Natl Hlth Res Inst, Div Med Engn Res, Zhunan, Miaoli County, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan	Yang, FY (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	fyyang@ym.edu.tw	Chen, Gin-Shin/E-3988-2010	Chen, Gin-Shin/0000-0003-3368-7470; Huang, Sheng-Yao/0000-0002-3241-430X				Bilgen M, 2001, MAGN RESON MED, V46, P1099, DOI 10.1002/mrm.1305; Black Keith L, 2004, Cancer Control, V11, P165; Choi JJ, 2007, PHYS MED BIOL, V52, P5509, DOI 10.1088/0031-9155/52/18/004; GOLDSTEIN EJ, 1984, PHYSIOL CHEM PHYS, V16, P97; Hsieh CH, 2005, J NUCL MED, V46, P1858; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Hynynen K, 2008, ADV DRUG DELIVER REV, V60, P1209, DOI 10.1016/j.addr.2008.03.010; Kroll RA, 1998, NEUROSURGERY, V42, P1083, DOI 10.1097/00006123-199805000-00082; Liu YY, 2006, J CONTROL RELEASE, V114, P89, DOI 10.1016/j.jconrel.2006.05.018; Marty B, 2012, J CEREBR BLOOD F MET, V32, P1948, DOI 10.1038/jcbfm.2012.100; Neuwelt EA, 1999, NEUROSURGERY, V44, P604, DOI 10.1097/00006123-199903000-00095; Park J, 2012, J CONTROL RELEASE, V162, P134, DOI 10.1016/j.jconrel.2012.06.012; Peruzzo D, 2011, COMPUT METH PROG BIO, V104, pE148, DOI 10.1016/j.cmpb.2011.02.012; Simpson NE, 1999, MAGN RESON MED, V42, P42, DOI 10.1002/(SICI)1522-2594(199907)42:1<42::AID-MRM8>3.0.CO;2-Z; Su MY, 1996, MAGNET RESON MED, V36, P868, DOI 10.1002/mrm.1910360609; Su MY, 1998, MAGN RESON MED, V39, P259, DOI 10.1002/mrm.1910390213; Tartis MS, 2008, J CONTROL RELEASE, V131, P160, DOI 10.1016/j.jconrel.2008.07.030; Thomas DL, 2006, MAGN RESON MED, V55, P943, DOI 10.1002/mrm.20823; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Vlachos F, 2010, PHYS MED BIOL, V55, P5451, DOI 10.1088/0031-9155/55/18/012; Vlachos F, 2011, MAGN RESON MED, V66, P821, DOI 10.1002/mrm.22848; Yang FY, 2013, ULTRASOUND MED BIOL, V39, P620, DOI 10.1016/j.ultrasmedbio.2012.11.027; Yang FY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045468; Yang FY, 2012, J CONTROL RELEASE, V160, P652, DOI 10.1016/j.jconrel.2012.02.023; Yang FY, 2012, INT J NANOMED, V7, P965, DOI 10.2147/IJN.S29229; Yang FY, 2012, INT J NANOMED, V7, P723, DOI 10.2147/IJN.S28503; Yang FY, 2011, IEEE T ULTRASON FERR, V58, P964, DOI 10.1109/TUFFC.2011.1897; Yang FY, 2011, J NUCL MED, V52, P478, DOI 10.2967/jnumed.110.083071; Yang FY, 2011, J CONTROL RELEASE, V150, P111, DOI 10.1016/j.jconrel.2010.10.038; Yang FY, 2010, J MAGN RESON IMAGING, V32, P593, DOI 10.1002/jmri.22297	31	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92910	10.1371/journal.pone.0092910	http://dx.doi.org/10.1371/journal.pone.0092910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670992	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000091
J	Cardador, L; De Caceres, M; Bota, G; Giralt, D; Casas, F; Arroyo, B; Mougeot, F; Cantero-Martinez, C; Moncunill, J; Butler, SJ; Brotons, L				Cardador, Laura; De Caceres, Miquel; Bota, Gerard; Giralt, David; Casas, Fabian; Arroyo, Beatriz; Mougeot, Francois; Cantero-Martinez, Carlos; Moncunill, Judit; Butler, Simon J.; Brotons, Lluis			A Resource-Based Modelling Framework to Assess Habitat Suitability for Steppe Birds in Semiarid Mediterranean Agricultural Systems	PLOS ONE			English	Article							CURLEW BURHINUS-OEDICNEMUS; PARTRIDGE ALECTORIS-RUFA; BUSTARDS TETRAX-TETRAX; FARMLAND BIRDS; SET-ASIDE; SPECIES DISTRIBUTION; VEGETATION STRUCTURE; RANGING BEHAVIOR; LESSER KESTREL; SELECTION	European agriculture is undergoing widespread changes that are likely to have profound impacts on farmland biodiversity. The development of tools that allow an assessment of the potential biodiversity effects of different land-use alternatives before changes occur is fundamental to guiding management decisions. In this study, we develop a resource-based model framework to estimate habitat suitability for target species, according to simple information on species' key resource requirements (diet, foraging habitat and nesting site), and examine whether it can be used to link land-use and local species' distribution. We take as a study case four steppe bird species in a lowland area of the north-eastern Iberian Peninsula. We also compare the performance of our resource-based approach to that obtained through habitat-based models relating species' occurrence and land-cover variables. Further, we use our resource-based approach to predict the effects that change in farming systems can have on farmland bird habitat suitability and compare these predictions with those obtained using the habitat-based models. Habitat suitability estimates generated by our resource-based models performed similarly (and better for one study species) than habitat based-models when predicting current species distribution. Moderate prediction success was achieved for three out of four species considered by resource-based models and for two of four by habitat-based models. Although, there is potential for improving the performance of resource-based models, they provide a structure for using available knowledge of the functional links between agricultural practices, provision of key resources and the response of organisms to predict potential effects of changing land-uses in a variety of context or the impacts of changes such as altered management practices that are not easily incorporated into habitat-based models.	[Cardador, Laura; De Caceres, Miquel; Bota, Gerard; Giralt, David; Brotons, Lluis] Forest Sci Ctr Catalonia CTFC, Solsona, Catalonia, Spain; [Casas, Fabian; Mougeot, Francois] CSIC, EEZA, La Canada De San Urbano, Almeria, Spain; [Arroyo, Beatriz] CSIC UCLM JCCM, Inst Invest Recursos Cineget IREC, Ciudad Real, Spain; [Cantero-Martinez, Carlos; Moncunill, Judit] Univ Lleida UDL, Dept Prod Vegetal & Ciencia Forestal, Lleida, Spain; [Butler, Simon J.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [De Caceres, Miquel; Brotons, Lluis] CREAF, Bellaterra, Catalonia, Spain	Centre Tecnologic Forestal de Catalunya (CTFC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Universitat de Lleida; University of East Anglia; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF)	Cardador, L (corresponding author), Forest Sci Ctr Catalonia CTFC, Solsona, Catalonia, Spain.	laura.cardador@ctfc.cat	Cantero-Martinez, Carlos/D-3231-2013; De Caceres, Miquel/I-1279-2016; Casas, Fabian/Y-3021-2018; Giralt, David/ABG-6410-2020; Mougeot, Francois/B-1894-2009; Arroyo, Beatriz/A-3504-2013; Cardador, Laura/K-4412-2014; Mougeot, Francois/Y-9569-2019; Casas, Fabian/AAE-9846-2020; Brotons, Lluís/D-1570-2009; Butler, Simon/H-1703-2011	Cantero-Martinez, Carlos/0000-0002-6984-2025; De Caceres, Miquel/0000-0001-7132-2080; Casas, Fabian/0000-0003-3662-6585; Giralt, David/0000-0001-9712-1957; Mougeot, Francois/0000-0002-5819-6275; Arroyo, Beatriz/0000-0002-4657-6609; Cardador, Laura/0000-0003-2548-8578; Mougeot, Francois/0000-0002-5819-6275; Casas, Fabian/0000-0003-3662-6585; Brotons, Lluís/0000-0002-4826-4457; Bota Cabau, Gerard/0000-0001-9020-7272; Butler, Simon/0000-0002-5111-5639	Project "Steppeahead"; Fundacion General del Consejo Superior de Investigaciones Cientificas from Spain (FGCSIC); Banco Santander; JAE-Doc contract; CSIC; European Social Fund (ESF); FGCSIC; Infraestructures.cat (Generalitat de Catalunya); Aigues del Segarra-Garrigues SA; BBSRC [BB/F011911/1] Funding Source: UKRI; NERC [NE/I020350/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F011911/1] Funding Source: researchfish; Natural Environment Research Council [NE/I020350/1] Funding Source: researchfish	Project "Steppeahead"; Fundacion General del Consejo Superior de Investigaciones Cientificas from Spain (FGCSIC); Banco Santander; JAE-Doc contract; CSIC; European Social Fund (ESF)(European Social Fund (ESF)); FGCSIC; Infraestructures.cat (Generalitat de Catalunya); Aigues del Segarra-Garrigues SA; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the Project "Steppeahead" funded by Fundacion General del Consejo Superior de Investigaciones Cientificas from Spain (FGCSIC) and Banco Santander. F. C. was supported by a JAE-Doc contract financed by CSIC and the European Social Fund (ESF). L. C. was supported by a postdoctoral contract funded by FGCSIC and Banco Santander. FARMDINDIS project, funded by Infraestructures.cat (Generalitat de Catalunya) and Aigues del Segarra-Garrigues SA, provided data on field censuses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAT JA, 1986, BIRD STUDY, V33, P71, DOI 10.1080/00063658609476898; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; Bouma J, 1998, AGR ECOSYST ENVIRON, V67, P103, DOI 10.1016/S0167-8809(97)00109-6; Brotons L, 2004, BIODIVERS CONSERV, V13, P1039, DOI 10.1023/B:BIOC.0000014468.71368.35; Brotons L, 2007, DIVERS DISTRIB, V13, P276, DOI 10.1111/j.1472-4642.2007.00339.x; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Buenestado FJ, 2008, AGR ECOSYST ENVIRON, V126, P158, DOI 10.1016/j.agee.2008.01.020; Burfield IJ., 2005, ECOLOGY CONSERVATION, P119, DOI DOI 10.1111/OIK.01758; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Butler SJ, 2007, SCIENCE, V315, P381, DOI 10.1126/science.1136607; Butler SJ, 2010, AGR ECOSYST ENVIRON, V137, P348, DOI 10.1016/j.agee.2010.03.005; Butler SJ, 2013, AGR ECOSYST ENVIRON, V164, P200, DOI 10.1016/j.agee.2012.11.001; Cantero C., 2012, SISTEMAS AGRICOLAS P; Cardador L, 2011, ANIM CONSERV, V14, P382, DOI 10.1111/j.1469-1795.2011.00449.x; Casas F, 2010, ENVIRON CONSERV, V37, P177, DOI 10.1017/S0376892910000299; Catry I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058320; Catry I, 2012, J APPL ECOL, V49, P99, DOI 10.1111/j.1365-2664.2011.02071.x; Cramp S., 1994, BIRDS W PALEARCTIC; Dettki H, 2003, AMBIO, V32, P549, DOI 10.1639/0044-7447(2003)032[0549:MHSFMI]2.0.CO;2; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Estrada A, 2012, BIOL CONSERV, V152, P37, DOI 10.1016/j.biocon.2012.03.031; Estrada J., 2004, ATLES DELS OCELLS NI; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Fortuna Miguel Angel, 2002, Ardeola, V49, P59; Gillings S, 2010, IBIS, V152, P713, DOI 10.1111/j.1474-919X.2010.01058.x; Graf RF, 2006, ECOGRAPHY, V29, P319, DOI 10.1111/j.2006.0906-7590.04328.x; Green RE, 2000, J ZOOL, V250, P161, DOI 10.1111/j.1469-7998.2000.tb01067.x; GREEN RE, 1984, IBIS, V126, P332, DOI 10.1111/j.1474-919X.1984.tb00254.x; Henle K, 2008, AGR ECOSYST ENVIRON, V124, P60, DOI 10.1016/j.agee.2007.09.005; Herkert JR, 2009, CONSERV BIOL, V23, P1036, DOI 10.1111/j.1523-1739.2009.01234.x; Holland JM, 2006, ANN APPL BIOL, V148, P49, DOI 10.1111/j.1744-7348.2006.00039.x; Homem de Brito P, 1996, CONSERVATION STEPPE; Jiguet F, 2000, BEHAV PROCESS, V51, P63, DOI 10.1016/S0376-6357(00)00119-4; Jiguet F, 2002, BIRD STUDY, V49, P105, DOI 10.1080/00063650209461253; Joseph LN, 2006, CONSERV BIOL, V20, P1679, DOI 10.1111/j.1523-1739.2006.00529.x; Kleijn D, 2005, CONSERV BIOL, V19, P963, DOI 10.1111/j.1523-1739.2005.00603.x; Koks BJ, 2007, IBIS, V149, P575, DOI 10.1111/j.1474-919X.2007.00683.x; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Martinez C., 2011, ENCICLOPEDIA VIRTUAL; Mcmahon BJ, 2010, BIRD STUDY, V57, P289, DOI 10.1080/00063651003749680; Morales MB, 2008, ACTA OECOL, V34, P345, DOI 10.1016/j.actao.2008.06.009; Morales M. B., 2009, ADAPTACION EVOLUCION; Moreira F, 1999, BIRD STUDY, V46, P309, DOI 10.1080/00063659909461144; Morgado R, 2010, ACTA OECOL, V36, P63, DOI 10.1016/j.actao.2009.10.002; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Ponjoan A, 2012, BEHAV PROCESS, V91, P35, DOI 10.1016/j.beproc.2012.05.005; RANDS MRW, 1988, ORNIS SCAND, V19, P35, DOI 10.2307/3676525; Ribeiro PF, 2014, AGR ECOSYST ENVIRON, V183, P138, DOI 10.1016/j.agee.2013.11.002; RICCI J C, 1990, Gibier Faune Sauvage, V7, P231; Robertson MP, 2003, ECOL MODEL, V164, P153, DOI 10.1016/S0304-3800(03)00028-0; Rueda Ma Jesus, 1993, Ecologia (Madrid), V7, P429; RUEDA MJ, 1993, B MENS ONC, V184, P2; Sanza MA, 2012, J ORNITHOL, V153, P525, DOI 10.1007/s10336-011-0773-3; Sarda-Palomera F, 2012, IBIS, V154, P703, DOI 10.1111/j.1474-919X.2012.01254.x; Silva JP, 2007, BIOL CONSERV, V139, P186, DOI 10.1016/j.biocon.2007.06.013; Suarez F, 2009, ALONDRAS ESPANA PENI; Sutherland WJ, 2012, PHILOS T R SOC B, V367, P322, DOI 10.1098/rstb.2011.0181; Swets K. A., 1988, SCIENCE, V240, P1285; Tella JL, 1998, CONSERV BIOL, V12, P593, DOI 10.1046/j.1523-1739.1998.96288.x; Van Dyck H, 2012, EVOL APPL, V5, P144, DOI 10.1111/j.1752-4571.2011.00230.x; Vargas J.M., 1996, TROFEO, V317, P23; Vizeu Pinheiro M.F., 1977, Boletin Estac cent Ecol, V6, P105; Wade ASI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064552; Whittingham MJ, 2006, J APPL ECOL, V43, P640, DOI 10.1111/j.1365-2664.2006.01186.x; Wilson JD, 2005, IBIS, V147, P453, DOI 10.1111/j.1474-919x.2005.00440.x; Wilson MW, 2012, IBIS, V154, P578, DOI 10.1111/j.1474-919X.2012.01236.x; Wright HL, 2012, CONSERV LETT, V5, P11, DOI 10.1111/j.1755-263X.2011.00208.x	70	22	22	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92790	10.1371/journal.pone.0092790	http://dx.doi.org/10.1371/journal.pone.0092790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667825	Green Published, Green Accepted, gold			2022-12-25	WOS:000333675600075
J	Sarsero, JP; Holloway, TP; Li, LL; Finkelstein, DI; Ioannou, PA				Sarsero, Joseph P.; Holloway, Timothy P.; Li, Lingli; Finkelstein, David I.; Ioannou, Panos A.			Rescue of the Friedreich Ataxia Knockout Mutation in Transgenic Mice Containing an FXN-EGFP Genomic Reporter	PLOS ONE			English	Article							REPEAT EXPANSION; TRIPLET-REPEAT; FRATAXIN GENE; SACCHAROMYCES-CEREVISIAE; EPIGENETIC CHANGES; IRON ACCUMULATION; YEAST FRATAXIN; MOUSE MODELS; DNA; TRANSCRIPTION	Friedreich ataxia (FRDA) is an autosomal recessive disorder characterized by neurodegeneration and cardiomyopathy. The presence of a GAA trinucleotide repeat expansion in the first intron of the FXN gene results in the inhibition of gene expression and an insufficiency of the mitochondrial protein frataxin. We previously generated BAC-based transgenic mice containing an FXN-EGFP genomic reporter construct in which the EGFP gene is fused in-frame immediately following the final codon of exon 5a of the human FXN gene. These transgenic mice were mated with mice heterozygous for a knockout mutation of the murine Fxn gene, to generate mice homozygous for the Fxn knockout mutation and hemizygous or homozygous for the human transgene. Rescue of the embryonic lethality that is associated with homozygosity for the Fxn knockout mutation was observed. Rescue mice displayed normal behavioral and histological parameters with normal viability, fertility and life span and without any signs of aberrant phenotype. Immunoblotting demonstrated the production of full-length frataxin-EGFP fusion protein that appears to act as a bifunctional hybrid protein. This study shows frataxin replacement may be a viable therapeutic option. Further, these mice should provide a useful resource for the study of human FXN gene expression, frataxin function, the evaluation of pharmacologic inducers of FXN expression in a whole-animal model and provide a useful source of cells for stem cell transplantation studies.	[Sarsero, Joseph P.; Holloway, Timothy P.; Li, Lingli; Ioannou, Panos A.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Sarsero, Joseph P.; Ioannou, Panos A.] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Finkelstein, David I.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Sarsero, JP (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	joe@sarsero.com	Finkelstein, David/B-9617-2009	Finkelstein, David/0000-0002-8167-4917	Muscular Dystrophy Association (USA) [3657, 3725]; Friedreich's Ataxia Research Alliance (USA); Brockhoff Foundation (Australia); Seek A Miracle (USA); Victorian Government's Operational Infrastructure Support Program	Muscular Dystrophy Association (USA)(Muscular Dystrophy Association); Friedreich's Ataxia Research Alliance (USA); Brockhoff Foundation (Australia); Seek A Miracle (USA); Victorian Government's Operational Infrastructure Support Program	This work was supported by the Muscular Dystrophy Association (USA) (grants 3657, 3725), the Friedreich's Ataxia Research Alliance (USA), the Brockhoff Foundation (Australia), Seek A Miracle (USA) and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Al-Mahdawi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074956; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Buck NE, 2012, BIOCHEM BIOPH RES CO, V427, P30, DOI 10.1016/j.bbrc.2012.08.134; Castaldo I, 2008, J MED GENET, V45, P808, DOI 10.1136/jmg.2008.058594; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Cossee M, 2000, HUM MOL GENET, V9, P1219, DOI 10.1093/hmg/9.8.1219; Delatycki MB, 1999, ANN NEUROL, V45, P673, DOI 10.1002/1531-8249(199905)45:5<673::AID-ANA20>3.3.CO;2-H; Evans-Galea MV, 2012, ANN NEUROL, V71, P487, DOI 10.1002/ana.22671; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hogan B, 1994, MANIPULATING MOUSE E; Koeppen AH, 2007, ACTA NEUROPATHOL, V114, P163, DOI 10.1007/s00401-007-0220-y; Koeppen AH, 2009, ACTA NEUROPATHOL, V118, P763, DOI 10.1007/s00401-009-0589-x; Li LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055940; Narayanan K, 1999, GENE THER, V6, P442, DOI 10.1038/sj.gt.3300901; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Pandolfo M, 2006, METH MOLEC MED, V126, P197; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Puspasari N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022001; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Sarsero JP, 2005, MAMM GENOME, V16, P228, DOI 10.1007/s00335-004-3021-9; Sarsero JP, 2004, MAMM GENOME, V15, P370, DOI 10.1007/s00335-004-3019-3; Sarsero JP, 2003, J GENE MED, V5, P72, DOI 10.1002/jgm.320; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Turner BJ, 2003, J NEUROSCI RES, V74, P605, DOI 10.1002/jnr.10796; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i	35	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93307	10.1371/journal.pone.0093307	http://dx.doi.org/10.1371/journal.pone.0093307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667739	Green Published, gold			2022-12-25	WOS:000333675600169
J	Tsoli, M; Schweiger, M; Vanniasinghe, AS; Painter, A; Zechner, R; Clarke, S; Robertson, G				Tsoli, Maria; Schweiger, Martina; Vanniasinghe, Anne S.; Painter, Arran; Zechner, Rudolf; Clarke, Stephen; Robertson, Graham			Depletion of White Adipose Tissue in Cancer Cachexia Syndrome Is Associated with Inflammatory Signaling and Disrupted Circadian Regulation	PLOS ONE			English	Article							LIPID-METABOLISM; PALLIATIVE CARE; WEIGHT-LOSS; FOOD-INTAKE; IN-VITRO; FAT; LIPOLYSIS; MUSCLE; INTERLEUKIN-6; CLOCK	Involuntary weight loss in patients with cancer is the hallmark of cancer cachexia. The etiology of cachexia is multifactorial involving loss of skeletal muscle and adipose tissue associated with high systemic levels of acute phase proteins and inflammatory cytokines. While muscle wasting overtly impacts on cancer patient quality of life, loss of lipid depots represents a sustained energy imbalance. In this study fat depletion was examined in Colon-26 model of cancer cachexia, which is a widely used rodent model of this syndrome. We investigated diurnal expression of circadian rhythm regulators as well as key mediators of energy metabolism and cytokine signaling. Mice bearing the C26 tumour exhibited reduced adipose mass, elevated adipose tissue lipolysis and a 5-fold increase in plasma levels of free fatty acids. These changes were associated with activated IL-6 signaling in WAT through a 3-fold increase in phosphorylated STAT3 and high SOCS3 gene expression levels. In addition perturbations in circadian regulation of lipid metabolism were also observed. Lipid catabolism did not appear to be influenced by the classical PKA pathway activating the lipase HSL. ATGL protein levels were elevated 2-fold in cachectic mice while 4-fold increase phosphorylated ACC and a 2-fold decrease in phosphorylated 4EBP1 was observed indicating that lipid metabolism is modulated by the ATGL & AMPK/mTOR pathways. This study provides evidence for activation of cytokine signaling and concomitant alterations in circadian rhythm and regulators of lipid metabolism in WAT of cachectic animals.	[Tsoli, Maria; Vanniasinghe, Anne S.] Childrens Canc Inst Med Res, Randwick, NSW, Australia; [Schweiger, Martina; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, Graz, Austria; [Tsoli, Maria; Vanniasinghe, Anne S.; Painter, Arran; Robertson, Graham] Concord Repatriat Gen Hosp, Anzac Res Inst, Canc Pharmacol Unit, Concord West, NSW, Australia; [Clarke, Stephen] Univ Sydney, Royal N Shore Hosp, Northern Clin Sch, St Leonards, NSW 2065, Australia; [Robertson, Graham] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Children's Cancer Institute; Children's Medical Research Institute - Australia; University of Graz; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; Royal North Shore Hospital; University of Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Robertson, G (corresponding author), Concord Repatriat Gen Hosp, Anzac Res Inst, Canc Pharmacol Unit, Concord West, NSW, Australia.	g.robertson@garvan.org.au	Tsoli, Maria/P-3941-2018; Research Institute, ANZAC/CAE-9030-2022	Tsoli, Maria/0000-0003-1155-0510; Zechner, Rudolf/0000-0001-5483-1182; Clarke, Stephen/0000-0001-5817-1222; Schweiger, Martina/0000-0002-3419-1007	Cancer Institute NSW translational program grant for colorectal cancer; Austrian Science Fund (FWF) [Z 136, F 3002] Funding Source: researchfish	Cancer Institute NSW translational program grant for colorectal cancer; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by a Cancer Institute NSW translational program grant for colorectal cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Argiles JM, 2004, CURR DRUG TARGETS, V5, P265, DOI 10.2174/1389450043490505; Arner P, 2011, SCIENCE, V333, P163, DOI 10.1126/science.1209418; Barnea M, 2010, OBESITY, V18, P230, DOI 10.1038/oby.2009.276; Batista ML, 2012, J ENDOCRINOL, V215, P363, DOI 10.1530/JOE-12-0307; Bertile F, 2011, J NUTR BIOCHEM, V22, P372, DOI 10.1016/j.jnutbio.2010.03.005; Bing C, 2006, BRIT J CANCER, V95, P1028, DOI 10.1038/sj.bjc.6603360; Blum D, 2011, CRIT REV ONCOL HEMAT, V80, P114, DOI 10.1016/j.critrevonc.2010.10.004; Bonetto A, 2012, AM J PHYSIOL-ENDOC M, V303, pE410, DOI 10.1152/ajpendo.00039.2012; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Bruera E, 1997, BRIT MED J, V315, P1219, DOI 10.1136/bmj.315.7117.1219; Cao DX, 2010, CANCER SCI, V101, P1639, DOI 10.1111/j.1349-7006.2010.01582.x; Carson JA, 2010, EXERC SPORT SCI REV, V38, P168, DOI 10.1097/JES.0b013e3181f44f11; Dahlman I, 2010, BRIT J CANCER, V102, P1541, DOI 10.1038/sj.bjc.6605665; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Fearon KCH, 2011, NEW ENGL J MED, V365, P565, DOI 10.1056/NEJMcibr1106880; Fouladiun M, 2005, CANCER-AM CANCER SOC, V103, P2189, DOI 10.1002/cncr.21013; Franck N, 2011, J CLIN ENDOCR METAB, V96, pE413, DOI 10.1210/jc.2009-2534; Froy O, 2011, CLIN SCI, V120, P65, DOI 10.1042/CS20100327; Gomez-Abellan P, 2008, INT J OBESITY, V32, P121, DOI 10.1038/sj.ijo.0803689; Haugen F., 2011, Archives of Physiology and Biochemistry, V117, P78, DOI 10.3109/13813455.2011.560609; Johnston JD, 2009, OBES REV, V10, P52, DOI 10.1111/j.1467-789X.2009.00665.x; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karatsoreos IN, 2011, P NATL ACAD SCI USA, V108, P1657, DOI 10.1073/pnas.1018375108; Kelly M, 2004, BIOCHEM BIOPH RES CO, V320, P449, DOI 10.1016/j.bbrc.2004.05.188; Lee SJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-2; Loboda A, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-7; Murphy KT, 2012, DIS MODEL MECH, V5, P533, DOI 10.1242/dmm.008839; Palesty JA, 2003, DIGEST DIS, V21, P198, DOI 10.1159/000073337; Petersen EW, 2005, AM J PHYSIOL-ENDOC M, V288, pE155, DOI 10.1152/ajpendo.00257.2004; Richards CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041883; Ryden M, 2008, CANCER-AM CANCER SOC, V113, P1695, DOI 10.1002/cncr.23802; Ryden M, 2007, CLIN NUTR, V26, P1, DOI 10.1016/j.clnu.2006.09.009; Sahar S, 2012, TRENDS ENDOCRIN MET, V23, P1, DOI 10.1016/j.tem.2011.10.005; Soliman GA, 2010, LIPIDS, V45, P1089, DOI 10.1007/s11745-010-3488-y; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; STRASSMANN G, 1993, J CLIN INVEST, V92, P2152, DOI 10.1172/JCI116816; STRASSMANN G, 1992, J CLIN INVEST, V89, P1681, DOI 10.1172/JCI115767; Tsoli M, 2012, CANCER RES, V72, P4372, DOI 10.1158/0008-5472.CAN-11-3536; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; Wallenius K, 2002, BIOCHEM BIOPH RES CO, V293, P560, DOI 10.1016/S0006-291X(02)00230-9; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	48	57	59	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92966	10.1371/journal.pone.0092966	http://dx.doi.org/10.1371/journal.pone.0092966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667661	Green Submitted, Green Published, gold			2022-12-25	WOS:000333675600110
J	Wonkam, A; Bitoungui, VJN; Vorster, AA; Ramesar, R; Cooper, RS; Tayo, B; Lettre, G; Ngogang, J				Wonkam, Ambroise; Bitoungui, Valentina J. Ngo; Vorster, Anna A.; Ramesar, Raj; Cooper, Richard S.; Tayo, Bamidele; Lettre, Guillaume; Ngogang, Jeanne			Association of Variants at BCL11A and HBS1L-MYB with Hemoglobin F and Hospitalization Rates among Sickle Cell Patients in Cameroon	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ACUTE CHEST SYNDROME; FETAL-HEMOGLOBIN; GENETIC-VARIATION; BETA-THALASSEMIA; ANEMIA PATIENTS; RISK-FACTORS; DISEASE; POPULATION; HAPLOTYPES	Background: Genetic variation at loci influencing adult levels of HbF have been shown to modify the clinical course of sickle cell disease (SCD). Data on this important aspect of SCD have not yet been reported from West Africa. We investigated the relationship between HbF levels and the relevant genetic loci in 610 patients with SCD (98% HbSS homozygotes) from Cameroon, and compared the results to a well-characterized African-American cohort. Methods and Findings: Socio-demographic and clinical features were collected and medical records reviewed. Only patients >5 years old, who had not received a blood transfusion or treatment with hydroxyurea were included. Hemoglobin electrophoresis and a full blood count were conducted upon arrival at the hospital. RFLP-PCR was used to describe the HBB gene haplotypes. SNaPshot PCR, Capillary electrophoresis and cycle sequencing were used for the genotyping of 10 selected SNPs. Genetic analysis was performed with PLINK software and statistical models in the statistical package R. Allele frequencies of relevant variants at BCL11A were similar to those detected in African Americans; although the relationships with Hb F were significant (p < .001), they explained substantially less of the variance in HbF than was observed among African Americans (similar to 2% vs 10%). SNPs in HBS1L-MYB region (HMIP) likewise had a significant impact on HbF, however, we did not find an association between HbF and the variations in HBB cluster and OR51B5/6 locus on chromosome 11p, due in part to the virtual absence of the Senegal and Indian Arab haplotypes. We also found evidence that selected SNPs in HBS1L-MYB region (HMIP) and BCL11A affect both other hematological indices and rates of hospitalization. Conclusions: This study has confirmed the associations of SNPs in BCL11A and HBS1L-MYB and fetal haemoglobin in Cameroonian SCA patients; hematological indices and hospitalization rates were also associated with specific allelic variants.	[Wonkam, Ambroise; Vorster, Anna A.; Ramesar, Raj] Univ Cape Town, Div Human Genet, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Bitoungui, Valentina J. Ngo; Ngogang, Jeanne] Univ Yaounde I, Fac Med & Biomed Sci, Dept Microbiol Parasitol & Haematol, Yaounde, Cameroon; [Ramesar, Raj] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, UCT MRC Human Genet Res Unit,Div Human Genet, ZA-7925 Cape Town, South Africa; [Cooper, Richard S.; Tayo, Bamidele] Loyola Univ Chicago, Stritch Sch Med, Dept Publ Hlth Sci, Maywood, IL USA; [Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lettre, Guillaume] Univ Montreal, Montreal, PQ, Canada	University of Cape Town; University of Yaounde I; University of Cape Town; Loyola University Chicago; Universite de Montreal; Universite de Montreal	Wonkam, A (corresponding author), Univ Cape Town, Div Human Genet, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa.	ambroise.wonkam@uct.ac.za	Wonkam, Ambroise/AFU-6901-2022; Ramesar, Raj S/I-6941-2015	Ramesar, Raj S/0000-0001-5688-1634	National Health Laboratory Services (NHLS), South Africa; University of Cape Town (UCT) Research Committee; Carnegie Research Development Grant, South Africa; Third World Academy of Sciences (TWAS)	National Health Laboratory Services (NHLS), South Africa; University of Cape Town (UCT) Research Committee; Carnegie Research Development Grant, South Africa; Third World Academy of Sciences (TWAS)	The molecular experiments of the study were funded by the National Health Laboratory Services (NHLS), South Africa; the University of Cape Town (UCT) Research Committee and Carnegie Research Development Grant, South Africa. The students' bursaries were supported by the Third World Academy of Sciences (TWAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae HT, 2012, BLOOD, V120, P1961, DOI 10.1182/blood-2012-06-432849; Bartolucci P, 2012, CURR OPIN HEMATOL, V19, P149, DOI 10.1097/MOH.0b013e328351c35f; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bean CJ, 2013, BRIT J HAEMATOL, V163, P268, DOI 10.1111/bjh.12507; Creary LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004218; Elderdery AY, 2012, INT J LAB HEMATOL, V34, P262, DOI 10.1111/j.1751-553X.2011.01388.x; Farrell JJ, 2011, BLOOD, V117, P4935, DOI 10.1182/blood-2010-11-317081; Galarneau G, 2013, BLOOD, V122, P434, DOI 10.1182/blood-2013-01-478776; Garner C, 2000, BLOOD, V95, P342; Grosse SD, 2011, AM J PREV MED, V41, pS398, DOI 10.1016/j.amepre.2011.09.013; Hanchard N, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-52; LABIE D, 1985, P NATL ACAD SCI USA, V82, P2111, DOI 10.1073/pnas.82.7.2111; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Makani J, 2011, BLOOD, V117, P1390, DOI 10.1182/blood-2010-08-302703; Menzel S, 2007, BLOOD, V110, P3624, DOI 10.1182/blood-2007-05-093419; Njamnshi AK, 2006, J NEUROL SCI, V250, P79, DOI 10.1016/j.jns.2006.07.003; Ondei LS, 2007, GENET MOL RES, V6, P453; Pati N, 2004, J BIOCHEM BIOPH METH, V60, P1, DOI 10.1016/j.jbbm.2003.11.005; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; Platt OS, 2008, NEW ENGL J MED, V358, P1362, DOI 10.1056/NEJMct0708272; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ruffieux N, 2013, CHILD NEUROPSYCHOL, V19, P143, DOI 10.1080/09297049.2011.640932; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Solovieff N, 2010, BLOOD, V115, P1815, DOI 10.1182/blood-2009-08-239517; STEINBERG MH, 1984, BLOOD, V63, P1353; Steinberg MH, 1998, AM J HEMATOL, V59, P121, DOI 10.1002/(SICI)1096-8652(199810)59:2<121::AID-AJH4>3.0.CO;2-#; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Thein SL, 2009, BRIT J HAEMATOL, V145, P455, DOI 10.1111/j.1365-2141.2009.07650.x; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704; Wonkam A, 2013, J GENETIC COUNSELING; World Bank, 2010, 48373CM WORLD BANK, P1; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053	35	67	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92506	10.1371/journal.pone.0092506	http://dx.doi.org/10.1371/journal.pone.0092506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667352	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600044
J	An, X; Gong, HL; McLoughlin, N; Yang, YP; Wang, W				An, Xu; Gong, Hongliang; McLoughlin, Niall; Yang, Yupeng; Wang, Wei			The Mechanism for Processing Random-Dot Motion at Various Speeds in Early Visual Cortices	PLOS ONE			English	Article							SPATIAL-FREQUENCY SELECTIVITY; COMPLEX CELLS; RECEPTIVE-FIELDS; FUNCTIONAL ARCHITECTURE; DIRECTION SELECTIVITY; CONTRAST SENSITIVITY; STRIATE CORTEX; ORIENTATION SELECTIVITY; AREAS 17; CAT	All moving objects generate sequential retinotopic activations representing a series of discrete locations in space and time (motion trajectory). How direction-selective neurons in mammalian early visual cortices process motion trajectory remains to be clarified. Using single-cell recording and optical imaging of intrinsic signals along with mathematical simulation, we studied response properties of cat visual areas 17 and 18 to random dots moving at various speeds. We found that, the motion trajectory at low speed was encoded primarily as a direction signal by groups of neurons preferring that motion direction. Above certain transition speeds, the motion trajectory is perceived as a spatial orientation representing the motion axis of the moving dots. In both areas studied, above these speeds, other groups of direction-selective neurons with perpendicular direction preferences were activated to encode the motion trajectory as motion-axis information. This applied to both simple and complex neurons. The average transition speed for switching between encoding motion direction and axis was about 31 degrees/s in area 18 and 15 degrees/s in area 17. A spatio-temporal energy model predicted the transition speeds accurately in both areas, but not the direction-selective indexes to random-dot stimuli in area 18. In addition, above transition speeds, the change of direction preferences of population responses recorded by optical imaging can be revealed using vector maximum but not vector summation method. Together, this combined processing of motion direction and axis by neurons with orthogonal direction preferences associated with speed may serve as a common principle of early visual motion processing.	[An, Xu; Yang, Yupeng] Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Sch Life Sci, Hefei 230026, Peoples R China; [An, Xu; Gong, Hongliang; Wang, Wei] Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China; [An, Xu; Gong, Hongliang; Wang, Wei] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai, Peoples R China; [McLoughlin, Niall] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Manchester	Yang, YP (corresponding author), Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Sch Life Sci, Hefei 230026, Peoples R China.	yangyp@ustc.edu.cn; w.wang@ion.ac.cn	An, Xu/HIK-2020-2022; Yang, Yupeng/G-5107-2018	An, Xu/0000-0003-3386-5521; Yang, Yupeng/0000-0002-9473-9994; McLoughlin, Niall/0000-0002-0138-4312	National '973' Program [2011CBA00400, 2009CB941303]; Fundamental Research Funds for the Central Universities [WK2070000007]	National '973' Program(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National '973' Program 2011CBA00400, 2009CB941303, and the Fundamental Research Funds for the Central Universities (WK2070000007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; An X, 2012, J NEUROSCI, V32, P13363, DOI 10.1523/JNEUROSCI.1900-12.2012; Apthorp D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2339; Bair W, 2005, CURR OPIN NEUROBIOL, V15, P459, DOI 10.1016/j.conb.2005.07.006; Baker TI, 2005, J NEUROPHYSIOL, V94, P775, DOI 10.1152/jn.01093.2004; Basole A, 2003, NATURE, V423, P986, DOI 10.1038/nature01721; Basole A, 2006, PROG BRAIN RES, V154, P121, DOI 10.1016/S0079-6123(06)54006-3; BISTI S, 1974, J PHYSIOL-LONDON, V241, P201, DOI 10.1113/jphysiol.1974.sp010649; BISTI S, 1985, J PHYSIOL-LONDON, V359, P259, DOI 10.1113/jphysiol.1985.sp015584; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bonhoeffer Tobias, 1996, P55; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Borst A, 2011, NEURON, V71, P974, DOI 10.1016/j.neuron.2011.08.031; BRADDICK OJ, 1980, PHILOS T ROY SOC B, V290, P137, DOI 10.1098/rstb.1980.0087; Bradley DC, 2008, NAT REV NEUROSCI, V9, P686, DOI 10.1038/nrn2472; Burr D, 2011, VISION RES, V51, P1431, DOI 10.1016/j.visres.2011.02.008; Burr DC, 2002, J NEUROSCI, V22, P8661; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V198, P237, DOI 10.1113/jphysiol.1968.sp008604; CAMPBELL FW, 1973, J PHYSIOL-LONDON, V229, P719, DOI 10.1113/jphysiol.1973.sp010163; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; CASANOVA C, 1995, J NEUROPHYSIOL, V74, P1271, DOI 10.1152/jn.1995.74.3.1271; Chance FS, 1998, J NEUROSCI, V18, P4785; Chen Y, 2009, J VISION, V9, DOI 10.1167/9.9.12; CROOK JM, 1990, EXP BRAIN RES, V80, P545; De Valois RL, 2000, VISION RES, V40, P3685, DOI 10.1016/S0042-6989(00)00210-8; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Dreher B, 1996, CEREB CORTEX, V6, P585, DOI 10.1093/cercor/6.4.585; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Felsen G, 2005, NAT NEUROSCI, V8, P1643, DOI 10.1038/nn1608; FERSTER D, 1990, VISUAL NEUROSCI, V4, P115, DOI 10.1017/S0952523800002285; Fournier J, 2011, NAT NEUROSCI, V14, P1053, DOI 10.1038/nn.2861; FREUND TF, 1985, J COMP NEUROL, V242, P263, DOI 10.1002/cne.902420208; Gardner JL, 1999, VISUAL NEUROSCI, V16, P1115, DOI 10.1017/S0952523899166112; Geisler WS, 1999, NATURE, V400, P65, DOI 10.1038/21886; Geisler WS, 2001, VISUAL NEUROSCI, V18, P501, DOI 10.1017/S0952523801184014; Grabska-Barwinska A, 2012, J NEUROSCI METH, V203, P1, DOI 10.1016/j.jneumeth.2011.08.026; Gur M, 2005, CEREB CORTEX, V15, P1207, DOI 10.1093/cercor/bhi003; HAMMOND P, 1978, EXP BRAIN RES, V31, P341; HAMMOND P, 1983, J PHYSIOL-LONDON, V342, P35, DOI 10.1113/jphysiol.1983.sp014838; HAMMOND P, 1980, NEUROSCI LETT, V19, P309, DOI 10.1016/0304-3940(80)90279-7; HAMMOND P, 1978, J PHYSIOL-LONDON, V285, P479, DOI 10.1113/jphysiol.1978.sp012584; Hedges JH, 2011, CURR BIOL, V21, P2023, DOI 10.1016/j.cub.2011.10.049; HEGGELUND P, 1978, EXP BRAIN RES, V32, P197; Hua TM, 2006, NEUROBIOL AGING, V27, P155, DOI 10.1016/j.neurobiolaging.2004.11.012; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUMPHREY AL, 1985, J COMP NEUROL, V233, P190, DOI 10.1002/cne.902330204; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; Jancke D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-14-j0005.2000; Kisvarday ZF, 2001, CEREB CORTEX, V11, P636, DOI 10.1093/cercor/11.7.636; Kourtzi Z, 2008, TRENDS COGN SCI, V12, P230, DOI 10.1016/j.tics.2008.02.013; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; Lu HDD, 2010, NEURON, V68, P1002, DOI 10.1016/j.neuron.2010.11.020; Mante V, 2005, J NEUROPHYSIOL, V94, P788, DOI 10.1152/jn.01094.2004; MARR D, 1981, PROC R SOC SER B-BIO, V211, P151, DOI 10.1098/rspb.1981.0001; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; MORRONE MC, 1986, J NEUROPHYSIOL, V56, P969, DOI 10.1152/jn.1986.56.4.969; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; NAKAYAMA K, 1985, PERCEPTION, V14, P225, DOI 10.1068/p140225; NAKAYAMA K, 1981, VISION RES, V21, P427, DOI 10.1016/0042-6989(81)90089-4; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Pan YX, 2012, J NEUROSCI, V32, P6760, DOI 10.1523/JNEUROSCI.6140-11.2012; PAYNE BR, 1993, CEREB CORTEX, V3, P1, DOI 10.1093/cercor/3.1.1; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; RAMACHANDRAN VS, 1986, SCI AM, V254, P102, DOI 10.1038/scientificamerican0686-102; Rao SC, 1997, J COMP NEUROL, V387, P358; Reichardt W., 1961, S PRINC SENS COMM, P303; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; ROSE D, 1974, EXP BRAIN RES, V20, P1; SAUL AB, 1992, VISUAL NEUROSCI, V8, P365, DOI 10.1017/S0952523800005101; SCANNELL JW, 1995, J NEUROSCI, V15, P1463; Schiessl I, 2008, NEUROIMAGE, V39, P634, DOI 10.1016/j.neuroimage.2007.09.022; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; Shmuel A, 1996, J NEUROSCI, V16, P6945; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; SKOTTUN BC, 1988, J NEUROPHYSIOL, V59, P1719, DOI 10.1152/jn.1988.59.6.1719; SKOTTUN BC, 1991, VISION RES, V31, P43, DOI 10.1016/0042-6989(91)90071-C; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SKOTTUN BC, 1994, VISUAL NEUROSCI, V11, P885, DOI 10.1017/S0952523800003849; STONE J, 1973, J NEUROPHYSIOL, V36, P551, DOI 10.1152/jn.1973.36.3.551; Swindale NV, 2003, CEREB CORTEX, V13, P225, DOI 10.1093/cercor/13.3.225; Tani T, 2012, EUR J NEUROSCI, V35, P44, DOI 10.1111/j.1460-9568.2011.07954.x; TOLHURST DJ, 1981, PROC R SOC SER B-BIO, V213, P183, DOI 10.1098/rspb.1981.0061; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; TUSA RJ, 1978, J COMP NEUROL, V177, P213, DOI 10.1002/cne.901770204; VANESSEN DC, 1994, NEURON, V13, P1, DOI 10.1016/0896-6273(94)90455-3; WATKINS DW, 1974, EXP BRAIN RES, V19, P433; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; WORGOTTER F, 1991, EXP BRAIN RES, V83, P665; WORGOTTER F, 1989, EXP BRAIN RES, V76, P307; WORGOTTER F, 1991, EXP BRAIN RES, V83, P656; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452; Zhan CA, 2008, CEREB CORTEX, V18, P1029, DOI 10.1093/cercor/bhm139; Zhan CA, 2006, CEREB CORTEX, V16, P896, DOI 10.1093/cercor/bhj033; Zhang J, 2004, SOC NEUROSCI, V648, P6	104	13	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93115	10.1371/journal.pone.0093115	http://dx.doi.org/10.1371/journal.pone.0093115			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682033	gold, Green Published, Green Submitted			2022-12-25	WOS:000333678100025
J	Burlaud-Gaillard, J; Sellin, C; Georgeault, S; Uzbekov, R; Lebos, C; Guillaume, JM; Roingeard, P				Burlaud-Gaillard, Julien; Sellin, Caroline; Georgeault, Sonia; Uzbekov, Rustem; Lebos, Claude; Guillaume, Jean-Marc; Roingeard, Philippe			Correlative Scanning-Transmission Electron Microscopy Reveals that a Chimeric Flavivirus Is Released as Individual Particles in Secretory Vesicles	PLOS ONE			English	Article							INFECTED-CELLS; DENGUE VIRUS; REPLICATION; LIGHT	The intracellular morphogenesis of flaviviruses has been well described, but flavivirus release from the host cell remains poorly documented. We took advantage of the optimized production of an attenuated chimeric yellow fever/dengue virus for vaccine purposes to study this phenomenon by microscopic approaches. Scanning electron microscopy (SEM) showed the release of numerous viral particles at the cell surface through a short-lived process. For transmission electron microscopy (TEM) studies of the intracellular ultrastructure of the small number of cells releasing viral particles at a given time, we developed a new correlative microscopy method: CSEMTEM (for correlative scanning electron microscopy transmission electron microscopy). CSEMTEM analysis suggested that chimeric flavivirus particles were released as individual particles, in small exocytosis vesicles, via a regulated secretory pathway. Our morphological findings provide new insight into interactions between flaviviruses and cells and demonstrate that CSEMTEM is a useful new method, complementary to SEM observations of biological events by intracellular TEM investigations.	[Burlaud-Gaillard, Julien; Georgeault, Sonia; Uzbekov, Rustem; Lebos, Claude; Roingeard, Philippe] Univ Tours, PPF ASB, Plate Forme RIO Microscopies, Tours, France; [Burlaud-Gaillard, Julien; Georgeault, Sonia; Uzbekov, Rustem; Lebos, Claude; Roingeard, Philippe] CHRU Tours, Tours, France; [Sellin, Caroline; Guillaume, Jean-Marc] Sanofi Pasteur, Dept Bioproc, Upstream Platform, Marcy Letoile, France; [Roingeard, Philippe] Univ Tours, INSERM, U966, Tours, France	Universite de Tours; CHU Tours; Sanofi-Aventis; Sanofi France; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Roingeard, P (corresponding author), Univ Tours, PPF ASB, Plate Forme RIO Microscopies, Tours, France.	roingeard@med.univ-tours.fr			Francois Rabelais University, Loire Valley, France	Francois Rabelais University, Loire Valley, France	This work was supported by the Francois Rabelais University, Loire Valley, France. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTH OM, 1992, MEM I OSWALDO CRUZ, V87, P565, DOI 10.1590/S0074-02761992000400017; Barth OM, 2000, ATLAS DENGUE VIRUSES; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blanchard E, 2002, J VIROL, V76, P4073, DOI 10.1128/JVI.76.8.4073-4079.2002; Chen ZN, 2011, MICROBES INFECT, V13, P143, DOI 10.1016/j.micinf.2010.10.011; Chu JJH, 2002, J GEN VIROL, V83, P2427, DOI 10.1099/0022-1317-83-10-2427; Depla M, 2010, CELL MOL LIFE SCI, V67, P3151, DOI 10.1007/s00018-010-0373-z; DEUBEL V, 1981, AM J TROP MED HYG, V30, P1071, DOI 10.4269/ajtmh.1981.30.1071; Ferraris P, 2013, CELL MOL LIFE SCI, V70, P1297, DOI 10.1007/s00018-012-1213-0; Ferraris P, 2010, J GEN VIROL, V91, P2230, DOI 10.1099/vir.0.022186-0; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; GRAY EW, 1987, J GEN VIROL, V68, P2339, DOI 10.1099/0022-1317-68-9-2339; Guizetti J, 2010, METHOD CELL BIOL, V96, P591, DOI 10.1016/S0091-679X(10)96024-X; Guy B, 2010, HUM VACCINES, V6, P696, DOI [10.4161/hv.6.9.12739, 10.4161.hv.6.9.12739]; HASE T, 1987, ARCH VIROL, V92, P273, DOI 10.1007/BF01317484; KO KK, 1979, ARCH VIROL, V62, P41, DOI 10.1007/BF01314902; Kolotuev I, 2010, BIOL CELL, V102, P121, DOI 10.1042/BC20090096; Macovei A, 2006, BIOCHEM BIOPH RES CO, V346, P1083, DOI 10.1016/j.bbrc.2006.06.023; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Mironov AA, 2012, METHOD ENZYMOL, V504, P201, DOI 10.1016/B978-0-12-391857-4.00010-0; Muller-Reichert T, 2007, METHOD CELL BIOL, V79, P101, DOI 10.1016/S0091-679X(06)79004-5; Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264	27	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93573	10.1371/journal.pone.0093573	http://dx.doi.org/10.1371/journal.pone.0093573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681578	Green Published, Green Submitted, gold			2022-12-25	WOS:000333678100053
J	Coyan, FC; Abderemane-Ali, F; Amarouch, MY; Piron, J; Mordel, J; Nicolas, CS; Steenman, M; Merot, J; Marionneau, C; Thomas, A; Brasseur, R; Baro, I; Loussouarn, G				Coyan, Fabien C.; Abderemane-Ali, Fayal; Amarouch, Mohamed Yassine; Piron, Julien; Mordel, Jerome; Nicolas, Celine S.; Steenman, Marja; Merot, Jean; Marionneau, Celine; Thomas, Annick; Brasseur, Robert; Baro, Isabelle; Loussouarn, Gildas			A Long QT Mutation Substitutes Cholesterol for Phosphatidylinositol-4,5-Bisphosphate in KCNQ1 Channel Regulation	PLOS ONE			English	Article							PROTEIN-KINASE-A; K+ CHANNEL; ION CHANNELS; POTASSIUM CHANNELS; I-KS; MEMBRANE CHOLESTEROL; VOLTAGE-SENSOR; PIP2; 4,5-BISPHOSPHATE; ATP	Introduction: Phosphatidylinositol-4,5-bisphosphate (PIP2) is a cofactor necessary for the activity of KCNQ1 channels. Some Long QT mutations of KCNQ1, including R243H, R539W and R555C have been shown to decrease KCNQ1 interaction with PIP2. A previous study suggested that R539W is paradoxically less sensitive to intracellular magnesium inhibition than the WT channel, despite a decreased interaction with PIP2. In the present study, we confirm this peculiar behavior of R539W and suggest a molecular mechanism underlying it. Methods and Results: COS-7 cells were transfected with WT or mutated KCNE1-KCNQ1 channel, and patch-clamp recordings were performed in giant-patch, permeabilized-patch or ruptured-patch configuration. Similar to other channels with a decreased PIP2 affinity, we observed that the R243H and R555C mutations lead to an accelerated current rundown when membrane PIP2 levels are decreasing. As opposed to R243H and R555C mutants, R539W is not more but rather less sensitive to PIP2 decrease than the WT channel. A molecular model of a fragment of the KCNQ1 C-terminus and the membrane bilayer suggested that a potential novel interaction of R539W with cholesterol stabilizes the channel opening and hence prevents rundown upon PIP2 depletion. We then carried out the same rundown experiments under cholesterol depletion and observed an accelerated R539W rundown that is consistent with this model. Conclusions: We show for the first time that a mutation may shift the channel interaction with PIP2 to a preference for cholesterol. This de novo interaction wanes the sensitivity to PIP2 variations, showing that a mutated channel with a decreased affinity to PIP2 could paradoxically present a slowed current rundown compared to the WT channel. This suggests that caution is required when using measurements of current rundown as an indicator to compare WT and mutant channel PIP2 sensitivity.	[Coyan, Fabien C.; Abderemane-Ali, Fayal; Amarouch, Mohamed Yassine; Piron, Julien; Mordel, Jerome; Nicolas, Celine S.; Steenman, Marja; Merot, Jean; Marionneau, Celine; Baro, Isabelle; Loussouarn, Gildas] Inst Natl Sante & Rech Med, Inst Thorax, Nantes, France; [Coyan, Fabien C.; Abderemane-Ali, Fayal; Amarouch, Mohamed Yassine; Piron, Julien; Mordel, Jerome; Nicolas, Celine S.; Steenman, Marja; Merot, Jean; Marionneau, Celine; Baro, Isabelle; Loussouarn, Gildas] Ctr Natl Rech Sci, Unite Mixte Rech 6291, Nantes, France; [Coyan, Fabien C.; Abderemane-Ali, Fayal; Amarouch, Mohamed Yassine; Piron, Julien; Mordel, Jerome; Nicolas, Celine S.; Merot, Jean; Marionneau, Celine; Baro, Isabelle; Loussouarn, Gildas] Univ Nantes, Unite Format & Rech Med, Nantes, France; [Thomas, Annick] Ctr Natl Rech Sci, Inst Pharmacol & Biol Struct, Toulouse, France; [Brasseur, Robert] Univ Liege, Ctr Biophys Mol Numer, Gembloux, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Liege	Loussouarn, G (corresponding author), Inst Natl Sante & Rech Med, Inst Thorax, Nantes, France.	gildas.loussouarn@inserm.fr	MEROT, Jean/D-5741-2015; Baró, Isabelle/ABH-5667-2020; Marionneau, Céline/D-4011-2015; Loussouarn, Gildas/ABH-6043-2020; Steenman, Marja/S-8433-2019; Baró, Isabelle/D-3604-2015; Steenman, Marja/D-3618-2015; Loussouarn, Gildas/D-3590-2015	Baró, Isabelle/0000-0003-4850-4171; Marionneau, Céline/0000-0003-0962-9756; Loussouarn, Gildas/0000-0001-8007-5931; Steenman, Marja/0000-0003-4547-4448; Baró, Isabelle/0000-0003-4850-4171; Steenman, Marja/0000-0003-4547-4448; Loussouarn, Gildas/0000-0001-8007-5931; Nicolas, Celine/0000-0002-5285-5946; Amarouch, Mohamed Yassine/0000-0002-0523-1348	Agence Nationale de la Recherche [ANR-05-JCJC-0160-01]; AFMTelethon; Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; Fondation d'entreprise Genavie; Association Francaise contre les Myopathies; INSERM (poste d'accueil); French Ministere de la Recherche	Agence Nationale de la Recherche(French National Research Agency (ANR)); AFMTelethon(Association Francaise contre les Myopathies); Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; Fondation d'entreprise Genavie; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); INSERM (poste d'accueil)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministere de la Recherche(Ministry of Research, France)	This work was supported by the Agence Nationale de la Recherche (ANR-05-JCJC-0160-01), the AFMTelethon, and a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (GL). FCC and FA-A were recipients of a grant from the French Ministere de la Recherche. FA-A was supported by the Fondation d'entreprise Genavie. JP was supported by the Association Francaise contre les Myopathies. CSN was supported by the INSERM (poste d'accueil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderemane-Ali F, 2012, J BIOL CHEM, V287, P36158, DOI 10.1074/jbc.M112.382085; Atger VM, 1997, J CLIN INVEST, V99, P773, DOI 10.1172/JCI119223; Balijepalli RC, 2007, CHANNELS, V1, P263, DOI 10.4161/chan.4946; Bian JS, 2001, CIRC RES, V89, P1168, DOI 10.1161/hh2401.101375; BRASSEUR R, 1991, J BIOL CHEM, V266, P16120; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; Carozzi AJ, 2002, J BIOL CHEM, V277, P17944, DOI 10.1074/jbc.M110879200; Chouabe C, 2000, CARDIOVASC RES, V45, P971, DOI 10.1016/S0008-6363(99)00411-3; Coyan FC, 2013, CHANNELS, V7, P415, DOI 10.4161/chan.26683; Donger C, 1997, CIRCULATION, V96, P2778, DOI 10.1161/01.CIR.96.9.2778; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Ducarme P, 1998, PROTEINS, V30, P357, DOI 10.1002/(SICI)1097-0134(19980301)30:4<357::AID-PROT3>3.0.CO;2-G; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Gasque G, 2005, FEBS LETT, V579, P5129, DOI 10.1016/j.febslet.2005.08.022; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hibino H, 2007, EUR J NEUROSCI, V26, P2539, DOI 10.1111/j.1460-9568.2007.05876.x; Hihara T, 2013, HUM EXP TOXICOL, V32, P1028, DOI 10.1177/0960327112474848; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Jalili T, 1999, CARDIOVASC RES, V44, P5, DOI 10.1016/S0008-6363(99)00211-4; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Li Y, 2013, P NATL ACAD SCI USA, V110, P18922, DOI 10.1073/pnas.1315649110; Li Y, 2011, P NATL ACAD SCI USA, V108, P9095, DOI 10.1073/pnas.1100872108; Liou HH, 1999, P NATL ACAD SCI USA, V96, P5820, DOI 10.1073/pnas.96.10.5820; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Logothetis DE, 2010, PFLUG ARCH EUR J PHY, V460, P321, DOI 10.1007/s00424-010-0828-y; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lopes CMB, 2007, CHANNELS, V1, P124, DOI 10.4161/chan.4322; Loussouarn G, 2003, EMBO J, V22, P5412, DOI 10.1093/emboj/cdg526; Loussouarn G, 2001, J BIOL CHEM, V276, P29098, DOI 10.1074/jbc.M102365200; Loussouarn Gildas, 2006, V337, P167; Matavel A, 2010, CHANNELS, V4, P3, DOI 10.4161/chan.4.1.10227; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; Nakamura H, 2007, CIRCULATION, V116, P2913, DOI 10.1161/CIRCULATIONAHA.107.702407; Napolitano C, INHERITED ARRHYTHMIA; Nicolas CS, 2008, CARDIOVASC RES, V79, P427, DOI 10.1093/cvr/cvn085; Park KH, 2005, CIRC RES, V96, P730, DOI 10.1161/01.RES.0000161451.04649.a8; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Piron J, 2010, J PHYSIOL-LONDON, V588, P3471, DOI 10.1113/jphysiol.2010.195313; Rodriguez N, 2010, BIOPHYS J, V99, P1110, DOI 10.1016/j.bpj.2010.06.013; Rodriguez-Menchaca AA, 2012, P NATL ACAD SCI USA, V109, pE2399, DOI 10.1073/pnas.1207901109; Rohacs T, 2002, METHOD ENZYMOL, V345, P71; Roura-Ferrer M, 2010, J CELL PHYSIOL, V225, P692, DOI 10.1002/jcp.22265; Santiago J, 2001, J BIOL CHEM, V276, P46523, DOI 10.1074/jbc.M104563200; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Sillen L, 1964, STABILITY CONSTANTS; Singh DK, 2009, J BIOL CHEM, V284, P30727, DOI 10.1074/jbc.M109.011221; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Taniguchi T, 2012, J CARDIOVASC PHARM, V59, P377, DOI 10.1097/FJC.0b013e318245e0c5; Thomas A, 2006, PROTEINS, V65, P889, DOI 10.1002/prot.21151; Varga A, 2007, EUR J PHARMACOL, V562, P130, DOI 10.1016/j.ejphar.2007.02.003; WALSH KB, 1988, SCIENCE, V242, P67, DOI 10.1126/science.2845575; Wang WY, 1998, J BIOL CHEM, V273, P34069, DOI 10.1074/jbc.273.51.34069; Wiener R, 2008, J BIOL CHEM, V283, P5815, DOI 10.1074/jbc.M707541200; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200; Yarbrough TL, 2002, CIRC RES, V90, P443, DOI 10.1161/hh0402.105177; Yasuda Y, 2005, BRIT J PHARMACOL, V145, P156, DOI 10.1038/sj.bjp.0706191; YAZAWA K, 1990, J PHYSIOL-LONDON, V421, P135, DOI 10.1113/jphysiol.1990.sp017937; Zaydman MA, 2013, P NATL ACAD SCI USA, V110, P13180, DOI 10.1073/pnas.1305167110; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	61	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93255	10.1371/journal.pone.0093255	http://dx.doi.org/10.1371/journal.pone.0093255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24681627	gold, Green Published, Green Submitted			2022-12-25	WOS:000333678100035
J	Liang, GX; Malmuthuge, N; McFadden, TB; Bao, H; Griebel, PJ; Stothard, P; Guan, LL				Liang, Guanxiang; Malmuthuge, Nilusha; McFadden, Thomas B.; Bao, Hua; Griebel, Philip J.; Stothard, Paul; Guan, Le Luo			Potential Regulatory Role of MicroRNAs in the Development of Bovine Gastrointestinal Tract during Early Life	PLOS ONE			English	Article							GUT MICROBIOTA; IMMUNE-SYSTEM; MAST-CELLS; EXPRESSION; BACTERIA; TISSUES; EPITHELIUM; PHENOTYPE; INTESTINE; TARGETS	This study aimed to investigate the potential regulatory role of miRNAs in the development of gastrointestinal tract (GIT) during the early life of dairy calves. Rumen and small intestinal (mid-jejunum and ileum) tissue samples were collected from newborn (30 min after birth; n = 3), 7-day-old (n = 6), 21-day-old (n = 6), and 42-day-old (n = 6) dairy calves. The miRNA profiling was performed using Illumina RNA-sequencing and the temporal and regional differentially expressed miRNAs were further validated using qRT-PCR. Analysis of 16S rRNA gene copy numbers was used to quantify total bacteria, Bifidobacterium and Lactobacillus species. The expression of miR-143 was abundant in all three gut regions, at all time points and it targets genes involved primarily in the proliferation of connective tissue cells and muscle cells, suggesting a role in regulating rapid tissue development during the early life of calves. The expression of miR-146, miR-191, miR-33, miR-7, miR-99/100, miR-486, miR-145, miR-196 and miR-211 displayed significant temporal differences (FDR <0.05), while miR-192/215, miR-194, miR-196, miR-205 and miR-31 revealed significant regional differences (FDR <0.05). The expression levels of miR-15/16, miR-29 and miR-196 were positively correlated with the copy numbers of 16S rRNA gene of Bifidobacterium or Lactobacillus species or both (P<0.05). Functional analysis using Ingenuity Pathway Analysis identified the above mentioned differentially expressed miRNAs as potential regulators of gut tissue cell proliferation and differentiation. The bacterial density-associated miRNAs were identified as modulators of the development of lymphoid tissues (miR-196), maturation of dendritic cells (miR-29) and development of immune cells (miR-15/16). The present study revealed temporal and regional changes in miRNA expression and a correlation between miRNA expression and microbial population in the GIT during the early life, which provides further evidence for another mechanism by which host-microbial interactions play a role in regulating gut development.	[Liang, Guanxiang; Malmuthuge, Nilusha; Bao, Hua; Stothard, Paul; Guan, Le Luo] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [McFadden, Thomas B.] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Griebel, Philip J.] Univ Saskatchewan, Saskatoon, SK, Canada; [Griebel, Philip J.] Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada	University of Alberta; University of Missouri System; University of Missouri Columbia; University of Saskatchewan; University of Saskatchewan	Guan, LL (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	lguan@ualberta.ca	Liang, Guanxiang/C-7108-2018; Liang, Guanxiang/CAG-8838-2022; Malmuthuge, Nilusha/N-2215-2019	Liang, Guanxiang/0000-0002-7367-2516; 	Alberta Livestock and Meat Agency (Edmonton, Alberta, Canada) [2011F129R]	Alberta Livestock and Meat Agency (Edmonton, Alberta, Canada)	This project was funded by Alberta Livestock and Meat Agency (Edmonton, Alberta, Canada) (2011F129R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bao H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-609; Benjamini Y, 1995, J R STAT SOC B, V57; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Chew R, 2008, GASTROINTESTINAL SYS; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Cristino AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019350; Dalmasso G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019293, 10.1371/journal.pone.0023806]; De Winter BY, 2012, BBA-MOL BASIS DIS, V1822, P66, DOI 10.1016/j.bbadis.2011.03.016; Enright AJ, 2004, GENOME BIOL, V5; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; Hausser J, 2013, GENOME RES; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jin WW, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-90; Jost T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044595; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li M, 2009, J APPL MICROBIOL, V107, P1924, DOI 10.1111/j.1365-2672.2009.04376.x; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Macfarlane S, 2007, J APPL MICROBIOL, V102, P1187, DOI 10.1111/j.1365-2672.2007.03287.x; Malmuthuge N, 2012, FEMS MICROBIOL ECOL, V79, P337, DOI 10.1111/j.1574-6941.2011.01220.x; Masotti A, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00137; McLeod KR, 2007, J ANIM SCI, V85, P2256, DOI 10.2527/jas.2006-359; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; North TE, 2004, STEM CELLS, V22, P158, DOI 10.1634/stemcells.22-2-158; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Playford RJ, 2000, AM J CLIN NUTR, V72, P5; Popovic R, 2009, BLOOD, V113, P3314, DOI 10.1182/blood-2008-04-154310; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SHELDRAKE RF, 1985, J DAIRY RES, V52, P599, DOI 10.1017/S0022029900024560; Song Lin, 2006, Birth Defects Research, V78, P140, DOI 10.1002/bdrc.20070; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; van Baarlen P, 2013, TRENDS IMMUNOL, V34, P208, DOI 10.1016/j.it.2013.01.005; Walter J, 2001, APPL ENVIRON MICROB, V67, P7; Wang XB, 2010, J BIOL CHEM, V285, P23239, DOI 10.1074/jbc.M109.084673; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhou R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002702	60	71	77	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92592	10.1371/journal.pone.0092592	http://dx.doi.org/10.1371/journal.pone.0092592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682221	gold, Green Published, Green Submitted			2022-12-25	WOS:000333678100010
J	Zhu, Q; Gu, LW; Wang, YM; Jia, L; Zhao, ZM; Peng, SQ; Lei, LS				Zhu, Qing; Gu, Liwei; Wang, Yimei; Jia, Li; Zhao, Zengming; Peng, Shuangqing; Lei, Linsheng			The Role of Alpha-1 and Alpha-2 Adrenoceptors in Restraint Stress-Induced Liver Injury in Mice	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; IMMOBILIZATION STRESS; INDUCED ELEVATION; OXIDATIVE STRESS; ANTIOXIDANT; DISEASE; RATS; APOPTOSIS; BLOCKADE; HEPATOTOXICITY	Acute stress affects cellular integrity in many tissues including the liver, but its underlying mechanism is still unclear. The aim of the present study was to investigate the potential involvement of catecholamines and adrenoceptors in the regulation of acute restraint stress-induced liver injury. Restraint was achieved by placing mice in restraint tubes. Mice were treated with either an alpha-l antagonist, prazosin, an alpha-2 antagonist, yohimbine, a beta-l antagonist, betaxolol, a beta-2 antagonist, ICI 118551, or a central and peripheral catecholamine depleting agent, reserpine, and followed by restraint stress. Assessment of liver injury (serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), hepatic total GSH, GSSG and GSH/GSSG ratio), histopathology and of apoptosis, by TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling) assay and western blotting, was performed. Three hours of restraint stress resulted in liver injury, as indexed by elevated serum transaminase levels, decreased hepatic total GSH levels and GSH/GSSG ratio, increased hepatic GSSG levels as well as enhanced hepatocytes apoptosis. Either reserpine or prazosin or yohimbine was found to attenuate liver injury. Furthermore, prazosin and yohimbine protected against restraint-induced hepatocytes apoptosis through attenuating the activation of caspases-9 and -3 and reducing the Bax/Bcl-2 ratio. These results suggest that alpha-1 and alpha-2 adrenoceptors mediate restraint-induced liver oxidative injury through caspase-9 and Bcl-2 family of apoptotic regulatory proteins.	[Zhu, Qing; Lei, Linsheng] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Zhu, Qing; Wang, Yimei; Jia, Li; Zhao, Zengming; Peng, Shuangqing] Acad Mil Med Sci, Evaluat & Res Ctr Toxicol, Inst Dis Control & Prevent, Beijing, Peoples R China; [Gu, Liwei] China Acad Chinese Med Sci, Inst Chinese Mat Med, Qinghaosu Artemisinin Res Ctr, Beijing, Peoples R China	Southern Medical University - China; Academy of Military Medical Sciences - China; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS	Peng, SQ (corresponding author), Acad Mil Med Sci, Evaluat & Res Ctr Toxicol, Inst Dis Control & Prevent, Beijing, Peoples R China.	pengsq@hotmail.com; lls@smu.edu.cn			National Natural Science Foundation of China [81273602]; National Key Research and Development Programs on Fundamental Sciences (973 Project) [2011CB503803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Programs on Fundamental Sciences (973 Project)(National Basic Research Program of China)	This project was supported by the National Natural Science Foundation of China (No. 81273602) and the National Key Research and Development Programs on Fundamental Sciences (973 Project) (No. 2011CB503803). The funders who supported this project had a role in data collection.	Adamekova E, 2003, NEOPLASMA, V50, P428; Ahmet I, 2004, CIRCULATION, V110, P1083, DOI 10.1161/01.CIR.0000139844.15045.F9; Bemeur C, 2010, METAB BRAIN DIS, V25, P23, DOI 10.1007/s11011-010-9186-x; Black PH, 2002, BRAIN BEHAV IMMUN, V16, P622, DOI 10.1016/S0889-1591(02)00021-1; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Castrejon-Sosa M, 2002, LIFE SCI, V71, P2469, DOI 10.1016/S0024-3205(02)02041-6; Chida Y, 2004, NEUROIMMUNOMODULAT, V11, P419, DOI 10.1159/000080153; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; FELDMAN S, 1995, NEUROSCI BIOBEHAV R, V19, P235, DOI 10.1016/0149-7634(94)00062-6; Fernandez G, 2000, CELL STRESS CHAPERON, V5, P306, DOI 10.1379/1466-1268(2000)005<0306:ISICFA>2.0.CO;2; Forray MI, 2004, BRAIN RES REV, V47, P145, DOI 10.1016/j.brainresrev.2004.07.011; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kvetnansky R, 1995, ANN NY ACAD SCI, V771, P131, DOI 10.1111/j.1749-6632.1995.tb44676.x; Kwak HB, 2006, FASEB J, V20, P791, DOI 10.1096/fj.05-5116fje; Ma S, 2005, J NEUROENDOCRINOL, V17, P22, DOI 10.1111/j.1365-2826.2005.01279.x; Martini D, 2011, J NEUROCHEM, V119, P1317, DOI 10.1111/j.1471-4159.2011.07530.x; Mastorakos G, 2005, HORM METAB RES, V37, P577, DOI 10.1055/s-2005-870426; Mastorakos George, 2005, Hormones (Athens), V4, P73; Nichols WG, 2008, ANTIMICROB AGENTS CH, V52, P858, DOI 10.1128/AAC.00821-07; Nukina H, 1998, NEUROIMMUNOMODULAT, V5, P323, DOI 10.1159/000026352; Ohta Y, 2007, REDOX REP, V12, P139, DOI 10.1179/135100007X200218; Oishi K, 2002, SCAND J CLIN LAB INV, V62, P115, DOI 10.1080/003655102753611735; Olfe Jakob, 2010, BMC Physiology, V10, P2, DOI 10.1186/1472-6793-10-2; Panuganti SD, 2006, J PHARMACOL EXP THER, V318, P26, DOI 10.1124/jpet.106.100933; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Reyes TM, 1997, BRAIN RES, V769, P29, DOI 10.1016/S0006-8993(97)00687-2; Rogoz Z, 2010, PHARMACOL REP, V62, P1191; Sahin E, 2007, COMP BIOCHEM PHYS C, V144, P342, DOI 10.1016/j.cbpc.2006.10.009; SALAS M, 1980, PATHOL RES PRACT, V167, P217, DOI 10.1016/S0344-0338(80)80052-5; Salim SA-R, 2012, AFRICAN J PHARM PHAR, V6; Sanchez O, 2002, CELL STRESS CHAPERON, V7, P36, DOI 10.1379/1466-1268(2002)007<0036:ASITII>2.0.CO;2; Sanchez O, 2007, AM J PHYSIOL-REG I, V293, pR1908, DOI 10.1152/ajpregu.00113.2007; Stojanovich L, 2008, AUTOIMMUN REV, V7, P209, DOI 10.1016/j.autrev.2007.11.007; Stone EA, 1996, PHARMACOL BIOCHEM BE, V55, P215, DOI 10.1016/S0091-3057(96)00070-6; SWAROOP A, 1983, BIOCHEM J, V214, P745, DOI 10.1042/bj2140745; von Montfort C, 2008, AM J PHYSIOL-GASTR L, V294, pG1227, DOI 10.1152/ajpgi.00050.2008; Wang P, 2000, BBA-MOL BASIS DIS, V1535, P36, DOI 10.1016/S0925-4439(00)00080-6; Weng D, 2007, TOXICOLOGY, V232, P15, DOI 10.1016/j.tox.2006.12.010; Yang LJ, 2012, NEUROSCI LETT, V511, P95, DOI 10.1016/j.neulet.2012.01.046; Zaidi S M Kashif R, 2005, Drugs R D, V6, P157, DOI 10.2165/00126839-200506030-00004; Zaidi SMKR, 2003, J NUTR BIOCHEM, V14, P633, DOI 10.1016/S0955-2863(03)00117-7; Zhu RZ, 2012, HEPATOL RES, V42, P741, DOI 10.1111/j.1872-034X.2012.00996.x; Zubidat AE, 2008, PHYSIOL BEHAV, V93, P243, DOI 10.1016/j.physbeh.2007.08.024	44	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92125	10.1371/journal.pone.0092125	http://dx.doi.org/10.1371/journal.pone.0092125			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682087	Green Published, Green Submitted, gold			2022-12-25	WOS:000333678100006
J	Hyung, D; Lee, C; Kim, JH; Yoo, D; Seo, YS; Jeong, SC; Lee, JH; Chung, Y; Jung, KH; Cook, DR; Choi, HK				Hyung, Daejin; Lee, Chaeyoung; Kim, Jin-Hyun; Yoo, Dongwoon; Seo, Young-Su; Jeong, Soon-Chun; Lee, Jai-Heon; Chung, Youngsoo; Jung, Ki-Hong; Cook, Douglas R.; Choi, Hong-Kyu			Cross-Family Translational Genomics of Abiotic Stress-Responsive Genes between Arabidopsis and Medicago truncatula	PLOS ONE			English	Article							2C PROTEIN PHOSPHATASES; ABSCISIC-ACID; KINASE SOS2; LEGUME; EXPRESSION; ABA; IDENTIFICATION; EVOLUTION; NETWORK; SALT	Cross-species translation of genomic information may play a pivotal role in applying biological knowledge gained from relatively simple model system to other less studied, but related, genomes. The information of abiotic stress (ABS)-responsive genes in Arabidopsis was identified and translated into the legume model system, Medicago truncatula. Various data resources, such as TAIR/AtGI DB, expression profiles and literatures, were used to build a genome-wide list of ABS genes. tBlastX/BlastP similarity search tools and manual inspection of alignments were used to identify orthologous genes between the two genomes. A total of 1,377 genes were finally collected and classified into 18 functional criteria of gene ontology (GO). The data analysis according to the expression cues showed that there was substantial level of interaction among three major types (i.e., drought, salinity and cold stress) of abiotic stresses. In an attempt to translate the ABS genes between these two species, genomic locations for each gene were mapped using an in-house-developed comparative analysis platform. The comparative analysis revealed that fragmental colinearity, represented by only 37 synteny blocks, existed between Arabidopsis and M. truncatula. Based on the combination of E-value and alignment remarks, estimated translation rate was 60.2% for this cross-family translation. As a prelude of the functional comparative genomic approaches, in-silico gene network/interactome analyses were conducted to predict key components in the ABS responses, and one of the sub-networks was integrated with corresponding comparative map. The results demonstrated that core members of the sub-network were well aligned with previously reported ABS regulatory networks. Taken together, the results indicate that network-based integrative approaches of comparative and functional genomics are important to interpret and translate genomic information for complex traits such as abiotic stresses.	[Hyung, Daejin] Dong A Univ, Dept Comp Sci, Pusan, South Korea; [Lee, Chaeyoung; Kim, Jin-Hyun] Dong A Univ, Dept Med Biosci, Pusan, South Korea; [Yoo, Dongwoon; Lee, Jai-Heon; Chung, Youngsoo; Choi, Hong-Kyu] Dong A Univ, Dept Genet Engn, Pusan, South Korea; [Seo, Young-Su] Busan Natl Univ, Dept Microbiol, Pusan, South Korea; [Jeong, Soon-Chun] Korea Res Inst Biosci & Biotechnol, Bioevaluat Ctr, Cheongwon, South Korea; [Jung, Ki-Hong] Kyung Hee Univ, Dept Plant Mol Syst Biotechnol, Yongin, South Korea; [Jung, Ki-Hong] Kyung Hee Univ, Grad Sch Biotechnol, Yongin, South Korea; [Cook, Douglas R.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	Dong A University; Dong A University; Dong A University; Pusan National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Kyung Hee University; Kyung Hee University; University of California System; University of California Davis	Choi, HK (corresponding author), Dong A Univ, Dept Genet Engn, Pusan, South Korea.	hkchoi@dau.ac.kr	Jung, Ki Hong/L-5570-2019	Jung, Ki Hong/0000-0003-0427-5901; Jeong, Soon-Chun/0000-0003-0223-1155	Next-Generation BioGreen21 Program, Rural Development Administration [PJ009089, PJ008124]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology, Republic of Korea [NRF-2010-0023585]	Next-Generation BioGreen21 Program, Rural Development Administration; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was conducted within the framework of the Next-Generation BioGreen21 Program (PJ009089, PJ008124), Rural Development Administration and the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (NRF-2010-0023585), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Berardini TZ, 2004, PLANT PHYSIOL, V135, P745, DOI 10.1104/pp.104.040071; Bies-Etheve N, 1999, PLANT MOL BIOL, V40, P1045, DOI 10.1023/A:1006252512202; Bordat A, 2011, G3-GENES GENOM GENET, V1, P93, DOI 10.1534/g3.111.000349; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Brendel V, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews1005; Cannon SB, 2009, PLANT PHYSIOL, V151, P970, DOI 10.1104/pp.109.144659; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Cheong YH, 2007, PLANT J, V52, P223, DOI 10.1111/j.1365-313X.2007.03236.x; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Choi HI, 2005, PLANT PHYSIOL, V139, P1750, DOI 10.1104/pp.105.069757; Choi HK, 2004, P NATL ACAD SCI USA, V101, P15289, DOI 10.1073/pnas.0402251101; Choi HK, 2006, MOL GENET GENOMICS, V276, P56, DOI 10.1007/s00438-006-0118-8; Choi HK, 2013, MOL PLANT MICROBE IN, V26, P643, DOI 10.1094/MPMI-09-12-0217-R; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Conte MG, 2008, NUCLEIC ACIDS RES, V36, pD991, DOI 10.1093/nar/gkm934; Doyle JJ, 2003, PLANT PHYSIOL, V131, P900, DOI 10.1104/pp.102.018150; FINKELSTEIN RR, 1994, PLANT J, V5, P765, DOI 10.1046/j.1365-313X.1994.5060765.x; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Gale MD, 1998, SCIENCE, V282, P656, DOI 10.1126/science.282.5389.656; Garcia ME, 2008, PLANT MOL BIOL, V67, P643, DOI 10.1007/s11103-008-9344-2; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Hirsch AM, 2001, PLANT PHYSIOL, V127, P1484, DOI 10.1104/pp.010866; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jensen MK, 2010, BIOCHEM J, V426, P183, DOI 10.1042/BJ20091234; Juul T, 2010, J BIOL CHEM, V285, P21411, DOI 10.1074/jbc.M110.103564; Kim W, 2013, PLANT CELL PHYSIOL, V54, P555, DOI 10.1093/pcp/pct017; Krysan PJ, 1996, P NATL ACAD SCI USA, V93, P8145, DOI 10.1073/pnas.93.15.8145; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Liu H, 2001, GENOME RES, V11, P2020, DOI 10.1101/gr.194501; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Michard E, 2005, PLANT J, V44, P783, DOI 10.1111/j.1365-313X.2005.02566.x; Movahedi S, 2011, PLANT PHYSIOL, V156, P1316, DOI 10.1104/pp.111.177865; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Ohta M, 2003, P NATL ACAD SCI USA, V100, P11771, DOI 10.1073/pnas.2034853100; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Ramon M, 2007, PLANT MOL BIOL, V63, P195, DOI 10.1007/s11103-006-9082-2; Ren XL, 2013, PLANT J, V74, P258, DOI 10.1111/tpj.12123; Rohde A, 2000, PLANT CELL, V12, P35, DOI 10.1105/tpc.12.1.35; Sanchez DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017094; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Tripathi V, 2009, PLANT J, V58, P778, DOI 10.1111/j.1365-313X.2009.03812.x; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Verslues PE, 2006, J EXP BOT, V57, P201, DOI 10.1093/jxb/erj026; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Wang Y, 2013, ANNU REV PLANT BIOL, V64, P451, DOI 10.1146/annurev-arplant-050312-120153; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Young ND, 2009, CURR OPIN PLANT BIOL, V12, P193, DOI 10.1016/j.pbi.2008.11.005; Zhang WX, 2005, BIOINFORMATICS, V21, P3074, DOI 10.1093/bioinformatics/bti490; Zhu HY, 2003, PLANT PHYSIOL, V131, P1018, DOI 10.1104/pp.102.016436; Zhu HY, 2002, MOL PLANT MICROBE IN, V15, P529, DOI 10.1094/MPMI.2002.15.6.529	66	14	15	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e91721	10.1371/journal.pone.0091721	http://dx.doi.org/10.1371/journal.pone.0091721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675968	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500016
J	Kim, MH; Kim, SH; Yang, WM				Kim, Mi Hye; Kim, Sung-Hoon; Yang, Woong Mo			Beneficial Effects of Astragaloside IV for Hair Loss via Inhibition of Fas/Fas L-Mediated Apoptotic Signaling	PLOS ONE			English	Article							CELL-DEATH; GROWTH; KERATINOCYTES; PROTEINS	Apoptosis with premature termination of hair follicle growth induces several types of hair loss and is one of the crucial factors of hair loss. Astragaloside IV, which is a major component of Astragalus membranaceus, is a cycloartane triterpene saponin. Although an anti-apoptotic effect of Astragaloside IV has been reported, its effects against hair loss have not been investigated. To explore the underlying mechanisms of Astragaloside IV on apoptotic signaling in hair follicle, the dorsal skin of depilated C57BL/6 mice was topically treated with 1 and 100 mu M Astragaloside IV for 14 days. In Astragaloside IV-treated group, TUNEL-positive cells were reduced. We found that Astragaloside IV blocked the procaspase-8, resulting in the inhibition of caspase-3 and procaspase-9 activities. The changes were accompanied with down-regulation of Bax and p53, and up-regulation of Bcl-2 and Bcl-(xL) by Astragaloside IV treatment. In addition, activation of NF-kappa B and phosphorylation of IkB-alpha were inhibited, along with decreases in three MAPKs: ERK, SAPK/JNK and p38 by Astragaloside IV. The expressions of KGF, p21, TNF-alpha and IL-1 beta, which are keratinocyte terminal differentiation markers associated with catagen, were modulated by treatment with Astragaloside IV. These results demonstrated that Astragaloside IV is concerned with blocking the Fas/Fas L-mediated apoptotic pathway, which would be an alternative therapy for hair loss.	[Kim, Mi Hye; Yang, Woong Mo] Kyung Hee Univ, Coll Korean Med, Seoul, South Korea; [Kim, Mi Hye; Yang, Woong Mo] Kyung Hee Univ, Inst Korean Med, Seoul, South Korea; [Kim, Sung-Hoon] Kyung Hee Univ, Coll Korean Med, Canc Prevent Mat Dev Res Ctr, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University	Yang, WM (corresponding author), Kyung Hee Univ, Coll Korean Med, Seoul, South Korea.	wmyang@khu.ac.kr	Yang, Woong Mo/AAH-9185-2020	kim, sunghoon/0000-0002-1570-3230; Yang, Woong Mo/0000-0001-5308-2386	National Research Foundation of Korea; Korea government [MEST] [2012 0005755]	National Research Foundation of Korea(National Research Foundation of Korea); Korea government [MEST](Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea grant funded by the Korea government [MEST] (No. 2012-0005755). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botchkarev VA, 2001, AM J PATHOL, V158, P1913, DOI 10.1016/S0002-9440(10)64659-7; Botchkareva NV, 2006, J INVEST DERMATOL, V126, P258, DOI 10.1038/sj.jid.5700007; Cho YS, 2008, BBA-MOL CELL RES, V1783, P323, DOI 10.1016/j.bbamcr.2007.11.017; Gafter-Gvili A, 2003, AM J PHYSIOL-CELL PH, V284, pC1593, DOI 10.1152/ajpcell.00537.2002; Gui DK, 2013, APOPTOSIS, V18, P409, DOI 10.1007/s10495-013-0801-2; Gui DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039824; Ipaktchi K, 2006, SHOCK, V26, P201, DOI 10.1097/01.shk.0000225739.13796.f2; Kim SH, 2009, TOXICOL IN VITRO, V23, P1215, DOI 10.1016/j.tiv.2009.07.036; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Luanpitpong S, 2011, APOPTOSIS, V16, P769, DOI 10.1007/s10495-011-0609-x; Martin SS, 2004, BBA-MOL CELL RES, V1692, P145, DOI 10.1016/j.bbamcr.2004.02.008; Park S, 2011, J ETHNOPHARMACOL, V138, P340, DOI 10.1016/j.jep.2011.08.013; Philpott MP, 1996, BRIT J DERMATOL, V135, P942, DOI 10.1046/j.1365-2133.1996.d01-1099.x; Qi WW, 2014, CELL STRESS CHAPERON, V19, P105, DOI 10.1007/s12192-013-0438-7; Saxena N, 2013, TOXICOL SCI, V135, P103, DOI 10.1093/toxsci/kft139; Schultz DR, 2003, SEMIN ARTHRITIS RHEU, V32, P345, DOI 10.1053/sarh.2003.50005; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Sredni B, 2003, FASEB J, V17, P400, DOI 10.1096/fj.03-0552fje; Van Neste D, 2004, MICRON, V35, P193, DOI 10.1016/j.micron.2003.11.006; Zhang ZG, 2012, MOL CELL BIOCHEM, V364, P209, DOI 10.1007/s11010-011-1219-1; Zhao MM, 2013, BIOL PHARM BULL, V36, P515, DOI 10.1248/bpb.b12-00655	21	22	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92984	10.1371/journal.pone.0092984	http://dx.doi.org/10.1371/journal.pone.0092984			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676213	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677500061
J	Lee, KY; Chan, KYY; Tsang, KS; Chen, YC; Kung, HF; Ng, PC; Li, CK; Leung, KT; Li, K				Lee, King Yiu; Chan, Kathy Yuen Yee; Tsang, Kam Sze; Chen, Yang Chao; Kung, Hsiang-fu; Pak Cheung Ng; Li, Chi Kong; Kam Tong Leung; Li, Karen			Ubiquitous Expression of MAKORIN-2 in Normal and Malignant Hematopoietic Cells and Its Growth Promoting Activity	PLOS ONE			English	Article							STEM/PROGENITOR CELLS; ANTISENSE; GENES; RING; IDENTIFICATION; TRANSCRIPTION; DOWNSTREAM; PROTEINS; CLONING; MKRN1	Makorin-2 (MKRN2) is a highly conserved protein and yet its functions are largely unknown. We investigated the expression levels of MKRN2 and RAF1 in normal and malignant hematopoietic cells, and leukemia cell lines. We also attempted to delineate the role of MKRN2 in umbilical cord blood CD34(+) stem/progenitor cells and K562 cell line by over-expression and inhibition of MKRN2 through lentivirus transduction and shRNA nucleofection, respectively. Our results provided the first evidence on the ubiquitous expression of MKRN2 in normal hematopoietic cells, embryonic stem cell lines, primary leukemia and leukemic cell lines of myeloid, lymphoid, erythroid and megakaryocytic lineages. The expression levels of MKRN2 were generally higher in primary leukemia samples compared with those in age-matched normal BM cells. In all leukemia subtypes, there was no significant correlation between expression levels of MKRN2 and RAF1. sh-MKRN2-silenced CD34(+) cells had a significantly lower proliferation capacity and decreased levels of the early stem/progenitor subpopulation (CFU-GEMM) compared with control cultures. Over-expression of MKRN2 in K562 cells increased cell proliferation. Our results indicated possible roles of MKRN2 in normal and malignant hematopoiesis.	[Lee, King Yiu; Chan, Kathy Yuen Yee; Pak Cheung Ng; Li, Chi Kong; Kam Tong Leung; Li, Karen] Chinese Univ Hong Kong, Dept Paediat, Hong Kong, Hong Kong, Peoples R China; [Tsang, Kam Sze] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Chen, Yang Chao; Kung, Hsiang-fu] Chinese Univ Hong Kong, Ctr Emerging Infect Dis, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Li, K (corresponding author), Chinese Univ Hong Kong, Dept Paediat, Hong Kong, Hong Kong, Peoples R China.	lipang@cuhk.edu.hk	Leung, Kam Tong/I-8569-2017; Li, Chi-kong/J-8456-2013; Chan, Kathy/AAE-8538-2021; Chen, Yangchao/AAG-2127-2019	Leung, Kam Tong/0000-0002-7695-2513; Li, Chi-kong/0000-0002-2810-5758; Chan, Kathy/0000-0002-6501-9592; Chen, Yangchao/0000-0002-0249-3414	Research Grant Council of Hong Kong [470507, 2041293]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	This project was supported by the Earmarked Grant 470507 and Direct Grant 2041293 of the Research Grant Council of Hong Kong to The Chinese University of Hong Kong. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YC, 2007, HEPATOLOGY, V46, P200, DOI 10.1002/hep.21668; Cheung WKC, 2010, BIOCHEM BIOPH RES CO, V394, P18, DOI 10.1016/j.bbrc.2010.02.041; Demidenko ZN, 2005, CANCER BIOL THER, V4, P484, DOI 10.4161/cbt.4.4.1702; Du ZW, 2001, BIOCHEM BIOPH RES CO, V282, P701, DOI 10.1006/bbrc.2001.4636; Gray TA, 2000, GENOMICS, V66, P76, DOI 10.1006/geno.2000.6199; Gray TA, 2001, GENOMICS, V77, P119, DOI 10.1006/geno.2001.6627; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; Ko A, 2012, JNCI-J NATL CANCER I, V104, P1660, DOI 10.1093/jnci/djs424; KRYSTAL GW, 1990, MOL CELL BIOL, V10, P4180, DOI 10.1128/MCB.10.8.4180; Lee KY, 2011, STEM CELLS DEV, V20, P31, DOI 10.1089/scd.2010.0196; Leung KT, 2011, BLOOD, V117, P1840, DOI 10.1182/blood-2010-04-281329; Li K, 2000, CELL TRANSPLANT, V9, P125, DOI 10.1177/096368970000900115; Mao M, 1998, P NATL ACAD SCI USA, V95, P8175, DOI 10.1073/pnas.95.14.8175; MUSZYNSKI KW, 1995, J EXP MED, V181, P2189, DOI 10.1084/jem.181.6.2189; Omwancha J, 2006, ENDOCRINE, V29, P363, DOI 10.1385/ENDO:29:2:363; Salvatico J, 2010, MOL CELL BIOCHEM, V342, P241, DOI 10.1007/s11010-010-0490-x; Stork PJS, 2005, BLOOD, V106, P2952, DOI 10.1182/blood-2005-03-1062; Yang PH, 2008, J BIOL CHEM, V283, P8486, DOI 10.1074/jbc.M704768200; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Yoshida Noriyuki, 2003, Hum Cell, V16, P65, DOI 10.1111/j.1749-0774.2003.tb00132.x; Zhang QH, 2000, GENOME RES, V10, P1546, DOI 10.1101/gr.140200	23	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92706	10.1371/journal.pone.0092706	http://dx.doi.org/10.1371/journal.pone.0092706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675897	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500034
J	Xue, XB; Zou, LF; Ma, WX; Liu, ZY; Chen, GY				Xue, Xiao-bo; Zou, Li-fang; Ma, Wen-xiu; Liu, Zhi-yang; Chen, Gong-you			Identification of 17 HrpX-Regulated Proteins Including Two Novel Type III Effectors, XOC_3956 and XOC_1550, in Xanthomonas oryzae pv. oryzicola	PLOS ONE			English	Article							HYPERSENSITIVE RESPONSE; SECRETION SYSTEM; GENOME SEQUENCE; RALSTONIA-SOLANACEARUM; BACTERIAL-BLIGHT; FULL VIRULENCE; CAMPESTRIS; GENE; EXPRESSION; HOST	The function of some hypothetical proteins, possibly regulated by key hrp regulators, in the pathogenicity of phytopathogenic bacteria remains largely unknown. In the present study, in silicon microarray data demonstrated that the expression of 17 HrpX-regulated protein (Xrp) genes of X. oryzae pv. oryzicola (Xoc), which causes bacterial leaf streak in rice, were either positively or negatively regulated by HrpX or/and HrpG. Bioinformatics analysis demonstrated that five Xrps possess a putative type III secretion (T3S) signal in the first 50 N-terminal amino acids, six xrp genes contain a PIP-box-like sequence (TTCGB-N-X-TTCGB, 9 <= X <= 25) in the promoter regions, and two Xrps have both motifs. Twelve Xrps are widely conserved in Xanthomonas spp., whereas four are specific for X. oryzae (Xrp6) or Xoc (Xrp8, Xrp14 and Xrp17). In addition to the regulation by HrpG/HrpX, some of the 17 genes were also modulated by another hrp regulator HrpD6. Mutagenesis of these 17 genes indicated that five Xrps (Xrp1, Xrp2, Xrp5, Xrp8 and Xrp14) were required for full virulence and bacterial growth in planta. Immunoblotting assays and fusion with N-terminally truncated AvrXa10 indicated that Xrp3 and Xrp5 were secreted and translocated into rice cells through the type-III secretion system (T3S), suggesting they are novel T3S effectors. Our results suggest that Xoc exploits an orchestra of proteins that are regulated by HrpG, HrpX and HrpD6, and these proteins facilitate both infection and metabolism.	[Xue, Xiao-bo; Zou, Li-fang; Ma, Wen-xiu; Liu, Zhi-yang; Chen, Gong-you] Shanghai Jiao Tong Univ, Sch Agr & Biol, Key Lab Urban South, Minist Agr, Shanghai 200030, Peoples R China; [Zou, Li-fang; Chen, Gong-you] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China	Ministry of Agriculture & Rural Affairs; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, GY (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Key Lab Urban South, Minist Agr, Shanghai 200030, Peoples R China.	gyouchen@sjtu.edu.cn	CHEN, Gongyou/AAA-9694-2019	CHEN, Gongyou/0000-0003-1979-2880	State Key Basic Research and Development Project of China [20112CB114003]; Natural Science Foundation of China [31230059]; Special Fund for Agro-Scientific Research in the Public Interest of China [201303015]	State Key Basic Research and Development Project of China(State Key Development Program for Basic Research of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest of China	This work was supported by the State Key Basic Research and Development Project of China (20112CB114003), the Natural Science Foundation of China (31230059), and the Special Fund for Agro-Scientific Research in the Public Interest of China (201303015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Alfano JR, 1997, J BACTERIOL, V179, P5655, DOI 10.1128/jb.179.18.5655-5662.1997; Axtell MJ, 2003, MOL MICROBIOL, V49, P1537, DOI 10.1046/j.1365-2958.2003.03666.x; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11; Brito B, 1999, MOL MICROBIOL, V31, P237, DOI 10.1046/j.1365-2958.1999.01165.x; Buttner D, 2002, EMBO J, V21, P5313, DOI 10.1093/emboj/cdf536; Casper-Lindley C, 2002, P NATL ACAD SCI USA, V99, P8336, DOI 10.1073/pnas.122220299; Chao NX, 2008, MOL PLANT MICROBE IN, V21, P411, DOI 10.1094/MPMI-21-4-0411; Chen Gong-you, 2005, Chinese Journal of Rice Science, V19, P291; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cui YP, 2013, MOL PLANT PATHOL, V14, P678, DOI 10.1111/mpp.12039; Cunnac S, 2004, MOL MICROBIOL, V53, P115, DOI 10.1111/j.1365-2958.2004.04118.x; Furutani A, 2006, FEMS MICROBIOL LETT, V259, P133, DOI 10.1111/j.1574-6968.2006.00265.x; Furutani A, 2004, J BACTERIOL, V186, P1374, DOI 10.1128/JB.186.5.1374-1380.2004; Furutani A, 2009, MOL PLANT MICROBE IN, V22, P96, DOI 10.1094/MPMI-22-1-0096; Furutani Ayako, 2003, Journal of General Plant Pathology, V69, P271, DOI 10.1007/s10327-003-0042-2; Guo W, 2012, APPL ENVIRON MICROB, V78, P5672, DOI 10.1128/AEM.07997-11; Guo YP, 2011, MOL PLANT MICROBE IN, V24, P649, DOI 10.1094/MPMI-09-10-0209; Hilaire E, 2001, MOL PLANT MICROBE IN, V14, P1411, DOI 10.1094/MPMI.2001.14.12.1411; Hotson A, 2004, CURR OPIN PLANT BIOL, V7, P384, DOI 10.1016/j.pbi.2004.05.003; Hotson A, 2003, MOL MICROBIOL, V50, P377, DOI 10.1046/j.1365-2958.2003.03730.x; Huang DL, 2009, MOL PLANT MICROBE IN, V22, P321, DOI 10.1094/MPMI-22-3-0321; Jiang Jia, 2009, Wei Sheng Wu Xue Bao, V49, P1018; Jiang W, 2009, MOL PLANT MICROBE IN, V22, P1401, DOI 10.1094/MPMI-22-11-1401; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KAMDAR HV, 1993, J BACTERIOL, V175, P2017, DOI 10.1128/JB.175.7.2017-2025.1993; Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006; Kim JG, 2009, PLANT CELL, V21, P1305, DOI 10.1105/tpc.108.063123; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Li YR, 2011, MOL PLANT MICROBE IN, V24, P1086, DOI 10.1094/MPMI-09-10-0205; Li YR, 2011, APPL ENVIRON MICROB, V77, P3809, DOI 10.1128/AEM.02849-10; Lian HL, 2011, GENE DEV, V25, P1023, DOI 10.1101/gad.2025111; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Martin T., 1992, GUS protocols: using the GUS gene as a reporter of gene expression., P23; Mcnally RR, 2012, MOL PLANT PATHOL, V13, P160, DOI 10.1111/j.1364-3703.2011.00738.x; Mukaihara T, 2010, MOL PLANT MICROBE IN, V23, P251, DOI 10.1094/MPMI-23-3-0251; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Noel L, 2002, J BACTERIOL, V184, P1340, DOI 10.1128/JB.184.5.1340-1348.2002; Ochiai H, 2005, JARQ-JPN AGR RES Q, V39, P275, DOI 10.6090/jarq.39.275; OKU T, 1995, DNA SEQUENCE, V5, P245, DOI 10.3109/10425179509030974; Ou S.H., 1985, RICE DIS IRRI; Pieretti I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-616; Qian GL, 2013, J PROTEOME RES, V12, P3327, DOI 10.1021/pr4001543; Robin GP, 2013, J PROTEOMICS; Roden J, 2004, MOL PLANT MICROBE IN, V17, P633, DOI 10.1094/MPMI.2004.17.6.633; Roden JA, 2004, P NATL ACAD SCI USA, V101, P16624, DOI 10.1073/pnas.0407383101; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Sambrook J., 2001, MOL CLONING LAB MANU; Schechter LM, 2006, MOL PLANT MICROBE IN, V19, P1180, DOI 10.1094/MPMI-19-1180; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Scholze H, 2011, CURR OPIN MICROBIOL, V14, P47, DOI 10.1016/j.mib.2010.12.001; Seo YS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-99; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Shen YP, 2012, J INTEGR AGR, V11, P600, DOI 10.1016/S2095-3119(12)60047-1; Song CF, 2010, MOL PLANT MICROBE IN, V23, P893, DOI 10.1094/MPMI-23-7-0893; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Stushnoff C, 2010, J EXP BOT, V61, P1225, DOI 10.1093/jxb/erp394; Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x; Thieme F, 2007, MOL PLANT MICROBE IN, V20, P1250, DOI 10.1094/MPMI-20-10-1250; Tsuge S, 2006, J BACTERIOL, V188, P4158, DOI 10.1128/JB.00006-06; Turner PE, 2004, GENETICS, V167, P9, DOI 10.1534/genetics.167.1.9; Venkatesh B, 2006, J BACTERIOL, V188, P3088, DOI 10.1128/JB.188.8.3088-3098.2006; Wang YinPeng, 2009, Acta Phytopathologica Sinica, V39, P392; Wei K, 2007, J BACTERIOL, V189, P2055, DOI 10.1128/JB.01331-06; Wengelnik K, 1996, J BACTERIOL, V178, P3462, DOI 10.1128/jb.178.12.3462-3469.1996; White FF, 2009, MOL PLANT PATHOL, V10, P749, DOI 10.1111/j.1364-3703.2009.00590.x; Xiao You-lun, 2007, Weishengwu Xuebao, V47, P396; Yamazaki A, 2008, J GEN PLANT PATHOL, V74, P138, DOI 10.1007/s10327-008-0075-7; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang SS, 2008, RES MICROBIOL, V159, P569, DOI 10.1016/j.resmic.2008.06.010; Zou LF, 2006, APPL ENVIRON MICROB, V72, P6212, DOI 10.1128/AEM.00511-06; Zou LF, 2011, AGR SCI CHINA, V10, P1139, DOI 10.1016/S1671-2927(11)60104-1	76	9	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93205	10.1371/journal.pone.0093205	http://dx.doi.org/10.1371/journal.pone.0093205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675748	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677500088
J	Zeng, P; Zhao, Y; Zhang, LW; Huang, SP; Chen, F				Zeng, Ping; Zhao, Yang; Zhang, Liwei; Huang, Shuiping; Chen, Feng			Rare Variants Detection with Kernel Machine Learning Based on Likelihood Ratio Test	PLOS ONE			English	Article							DISEASE ASSOCIATION; GENOMIC SIMILARITY; GENETIC PATHWAY; REGRESSION; COMMON; COMPONENTS; MODELS; SUSCEPTIBILITY; INFERENCE	This paper mainly utilizes likelihood-based tests to detect rare variants associated with a continuous phenotype under the framework of kernel machine learning. Both the likelihood ratio test (LRT) and the restricted likelihood ratio test (ReLRT) are investigated. The relationship between the kernel machine learning and the mixed effects model is discussed. By using the eigenvalue representation of LRT and ReLRT, their exact finite sample distributions are obtained in a simulation manner. Numerical studies are performed to evaluate the performance of the proposed approaches under the contexts of standard mixed effects model and kernel machine learning. The results have shown that the LRT and ReLRT can control the type I error correctly at the given alpha level. The LRT and ReLRT consistently outperform the SKAT, regardless of the sample size and the proportion of the negative causal rare variants, and suffer from fewer power reductions compared to the SKAT when both positive and negative effects of rare variants are present. The LRT and ReLRT performed under the context of kernel machine learning have slightly higher powers than those performed under the context of standard mixed effects model. We use the Genetic Analysis Workshop 17 exome sequencing SNP data as an illustrative example. Some interesting results are observed from the analysis. Finally, we give the discussion.	[Zeng, Ping; Zhao, Yang; Zhang, Liwei; Chen, Feng] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Zeng, Ping; Huang, Shuiping] Xuzhou Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Xuzhou, Jiangsu, Peoples R China	Nanjing Medical University; Xuzhou Medical University	Chen, F (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	fengchen@njmu.edu.cn	zhao, yang/GXF-4424-2022	Zeng, Ping/0000-0003-2710-3440; Chen, Feng/0000-0002-2699-7190	National Natural Science Foundation of China [81072389, 81373102]; Research Found for the Doctoral Program of Higher Education of China [20113234110002]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [10KJA330034]; College Philosophy and Social Science Foundation from Education Department of Jiangsu Province of China [2013SJB790059, 2013SJD790032]; Research Foundation from Xuzhou Medical College [2012KJ02]; Research and Innovation Project for College Graduates of Jiangsu Province of China [CXLX13_574]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Found for the Doctoral Program of Higher Education of China; Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); College Philosophy and Social Science Foundation from Education Department of Jiangsu Province of China; Research Foundation from Xuzhou Medical College; Research and Innovation Project for College Graduates of Jiangsu Province of China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Natural Science Foundation of China (No. 81072389, 81373102), Research Found for the Doctoral Program of Higher Education of China (No. 20113234110002), Key Grant of Natural Science Foundation of the Jiangsu Higher Education Institutions of China (No. 10KJA330034), College Philosophy and Social Science Foundation from Education Department of Jiangsu Province of China (No. 2013SJB790059, 2013SJD790032), Research Foundation from Xuzhou Medical College (No. 2012KJ02), Research and Innovation Project for College Graduates of Jiangsu Province of China (No. CXLX13_574), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy Laura, 2011, BMC Proc, V5 Suppl 9, pS2, DOI 10.1186/1753-6561-5-S9-S2; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Bacanu SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042530; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bowes J, 2010, HUM GENET, V128, P627, DOI 10.1007/s00439-010-0889-1; Chen Z, 2003, BIOMETRICS, V59, P762, DOI 10.1111/j.0006-341X.2003.00089.x; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Claeskens G, 2004, J R STAT SOC B, V66, P909, DOI 10.1111/j.1467-9868.2004.05421.x; CORBEIL RR, 1976, TECHNOMETRICS, V18, P31, DOI 10.2307/1267913; Crainiceanu CM, 2004, J ROY STAT SOC B, V66, P165, DOI 10.1111/j.1467-9868.2004.00438.x; Cristianini N, 2000, INTRO SUPPORT VECTOR; Davies RB, 1980, J ROYAL STAT SOC C, V29, P323, DOI DOI 10.2307/2346911; Duchesne P, 2010, COMPUT STAT DATA AN, V54, P858, DOI 10.1016/j.csda.2009.11.025; Feng T, 2010, HUM GENET, V128, P269, DOI 10.1007/s00439-010-0849-9; Ghosh Saurabh, 2011, BMC Proc, V5 Suppl 9, pS1, DOI 10.1186/1753-6561-5-S9-S1; Gianola D, 2008, GENETICS, V178, P2289, DOI 10.1534/genetics.107.084285; Greven S, 2008, J COMPUT GRAPH STAT, V17, P870, DOI 10.1198/106186008X386599; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; HARVILLE DA, 1974, BIOMETRIKA, V61, P383, DOI 10.2307/2334370; Hofmann T, 2008, ANN STAT, V36, P1171, DOI 10.1214/009053607000000677; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; KIMELDORF G, 1971, J MATH ANAL APPL, V33, P82, DOI 10.1016/0022-247X(71)90184-3; Kuo BS, 1999, ECONOMET THEOR, V15, P24; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Lin XH, 1997, BIOMETRIKA, V84, P309, DOI 10.1093/biomet/84.2.309; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Liu D, 2007, BIOMETRICS, V63, P1079, DOI 10.1111/j.1541-0420.2007.00799.x; Liu DW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-292; Liu H, 2009, COMPUT STAT DATA AN, V53, P853, DOI 10.1016/j.csda.2008.11.025; Madsen B.E., 2009, PLOS GENET, V5; Mallick BK, 2005, J R STAT SOC B, V67, P219, DOI 10.1111/j.1467-9868.2005.00498.x; Masson E, 2008, HUM GENET, V123, P83, DOI 10.1007/s00439-007-0459-3; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Peng G, 2013, P NATL ACAD SCI USA, V110, P3985, DOI 10.1073/pnas.1222158110; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; R Core Team, 2021, R LANG ENV STAT COMP; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schaid DJ, 2010, HUM HERED, V70, P109, DOI 10.1159/000312641; Schaid DJ, 2010, HUM HERED, V70, P132, DOI 10.1159/000312643; Scheipl F, 2008, COMPUT STAT DATA AN, V52, P3283, DOI 10.1016/j.csda.2007.10.022; Scholkopf B., 2001, LEARNING KERNELS; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Smith G, 2013, ANN CLIN BIOCHEM, V50, P83, DOI 10.1258/acb.2012.012103; STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455; Verbeke G, 2003, BIOMETRICS, V59, P254, DOI 10.1111/1541-0420.00032; Verbeke G, 2009, SPRINGER SER STAT, P1; Wahba G, 1999, ADVANCES IN KERNEL METHODS, P69; Wahba G., 1990, SPLINE MODELS OBSERV; Wu MC, 2013, GENET EPIDEMIOL, V37, P267, DOI 10.1002/gepi.21715; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yu L, 2013, HUM GENET, V132, P285, DOI 10.1007/s00439-012-1249-0; Zhan HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044173; Zuo LJ, 2013, J HUM GENET, V58, P178, DOI 10.1038/jhg.2012.153	69	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93355	10.1371/journal.pone.0093355	http://dx.doi.org/10.1371/journal.pone.0093355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675868	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500112
J	Johnston, NN; Bradley, JE; Otter, KA				Johnston, Naira N.; Bradley, James E.; Otter, Ken A.			Increased Flight Altitudes among Migrating Golden Eagles Suggest Turbine Avoidance at a Rocky Mountain Wind Installation	PLOS ONE			English	Article							RED-TAILED HAWKS; BIRD MIGRATION; WEATHER; MORTALITY; BEHAVIOR; RISK; RAPTORS; HABITAT; FARMS; MODEL	Potential wind-energy development in the eastern Rocky Mountain foothills of British Columbia, Canada, raises concerns due to its overlap with a golden eagle (Aquila chrysaetos) migration corridor. The Dokie 1 Wind Energy Project is the first development in this area and stands as a model for other projects in the area because of regional consistency in topographic orientation and weather patterns. We visually tracked golden eagles over three fall migration seasons (2009-2011), one pre-and two post-construction, to document eagle flight behaviour in relation to a ridge-top wind energy development. We estimated three-dimensional positions of eagles in space as they migrated through our study site. Flight tracks were then incorporated into GIS to ascertain flight altitudes for eagles that flew over the ridge-top area (or turbine string). Individual flight paths were designated to a category of collision-risk based on flight altitude (e. g. flights within rotor-swept height; <= 150 m above ground) and wind speed (winds sufficient for the spinning of turbines; >6.8 km/h at ground level). Eagles were less likely to fly over the ridge-top area within rotor-swept height (risk zone) as wind speed increased, but were more likely to make such crosses under headwinds and tailwinds compared to western crosswinds. Most importantly, we observed a smaller proportion of flights within the risk zone at wind speeds sufficient for the spinning of turbines (higher-risk flights) during post-construction compared to pre-construction, suggesting that eagles showed detection and avoidance of turbines during migration.	[Johnston, Naira N.; Bradley, James E.; Otter, Ken A.] Univ No British Columbia, Prince George, BC V2L 5P2, Canada	University of Northern British Columbia	Johnston, NN (corresponding author), Univ No British Columbia, Prince George, BC V2L 5P2, Canada.	johnstn@alumni.unbc.ca			Natural Sciences and Research Engineering Council of Canada (NSERC) Industrial Postgraduate Scholarships program; NSERC Strategic Project Grant; Environment Canada; Stantec Consulting Ltd.; Dokie General Partnership	Natural Sciences and Research Engineering Council of Canada (NSERC) Industrial Postgraduate Scholarships program(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Strategic Project Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada(CGIAR); Stantec Consulting Ltd.; Dokie General Partnership	Natural Sciences and Research Engineering Council of Canada (NSERC) Industrial Postgraduate Scholarships program: http://www.nserc-crsng.gc.ca/students-etudiants/pg-cs/ips-besii_eng.asp; NSERC Strategic Project Grant: http://www.nserc-crsng.gc.ca/professors-professeurs/rpp-pp/spg-sps_eng.asp; Environment Canada; and, through partnership through Stantec Consulting Ltd. and the Dokie General Partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1996, INTRO CATEGORICAL DA; Ainslie B, 2014, INT J BIOMETEOROL, V58, P17, DOI 10.1007/s00484-012-0620-0; Alerstam T, 1990, BIRD MIGRATION PHYSL, P331, DOI [DOI 10.1007/978-3-642-74542-3_22., 10.1007/978-3-642-74542-3_22]; Band W, 2007, BIRDS WIND FARMS RIS, P49; Barrios L, 2004, J APPL ECOL, V41, P72, DOI 10.1111/j.1365-2664.2004.00876.x; Barrios Luis, 2007, P229; Batschelet E, 1981, CIRCULAR STAT BIOL; De Lucas M, 2004, BIODIVERS CONSERV, V13, P395, DOI 10.1023/B:BIOC.0000006507.22024.93; de Lucas M, 2012, BIOL CONSERV, V147, P184, DOI 10.1016/j.biocon.2011.12.029; de Lucas Manuela, 2007, P219; Desholm M, 2005, BIOL LETTERS, V1, P296, DOI 10.1098/rsbl.2005.0336; Drewitt AL, 2008, ANN NY ACAD SCI, V1134, P233, DOI 10.1196/annals.1439.015; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; Ferrer M, 2012, J APPL ECOL, V49, P38, DOI 10.1111/j.1365-2664.2011.02054.x; Fox AD, 2006, IBIS, V148, P129, DOI 10.1111/j.1474-919X.2006.00510.x; Garvin JC, 2011, J APPL ECOL, V48, P199, DOI 10.1111/j.1365-2664.2010.01912.x; Goodale W, 2009, BRI200918; Harmata AR, 2000, AM MIDL NAT, V143, P30, DOI 10.1674/0003-0031(2000)143[0030:PRATOB]2.0.CO;2; Hoover SL, 2005, J WILDLIFE MANAGE, V69, P150, DOI 10.2193/0022-541X(2005)069<0150:BORHIA>2.0.CO;2; Hunt G, 1995, NRELSR50026092; Hunt G, 2002, 50002043F CAL EN COM; Johnson Gregory D., 2007, P241; Johnston NN, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00608-080212; Kerlinger P., 1989, Current Ornithology, V6, P109; Langston R.W.H., 2003, WIND FARMS BIRDS ANA; Lanzone MJ, 2012, BIOL LETTERS, V8, P710, DOI 10.1098/rsbl.2012.0359; Larsen JK, 2007, J APPL ECOL, V44, P516, DOI 10.1111/j.1365-2664.2007.01303.x; LIECHTI F, 1994, J THEOR BIOL, V170, P219, DOI 10.1006/jtbi.1994.1181; Liguori J., 2004, BIRDING, V36, P278; Mandel JT, 2011, ECOL APPL, V21, P2258, DOI 10.1890/10-1651.1; Maransky B, 1997, WILSON BULL, V109, P246; Martin GR, 2012, IBIS, V154, P626, DOI 10.1111/j.1474-919X.2012.01227.x; McIntyre CL, 2008, AUK, V125, P214, DOI 10.1525/auk.2008.125.1.214; McIsaac H. P., 2001, P NAT AV WIND POW PL, P59; Niles LJ, 1996, CONDOR, V98, P382, DOI 10.2307/1369156; Nygard T, 2010, BOU P CLIMATE CHANGE; Orloff S., 1992, WIND TURBINE EFFECTS; Pagel JE, 2013, J RAPTOR RES, V47, P311, DOI 10.3356/JRR-12-00019.1; Percival Steve, 2005, British Birds, V98, P194; Pomeroy A, 2009, 2009 WILDLIFE MONITO; RICHARDSON WJ, 1978, OIKOS, V30, P224, DOI 10.2307/3543482; Shamoun-Baranes J, 2003, BOUND-LAY METEOROL, V107, P673, DOI 10.1023/A:1022824008388; Sherrington Peter, 2003, Bird Trends, V9, P34; Smallwood KS, 2009, J WILDLIFE MANAGE, V73, P1082, DOI 10.2193/2008-555; Smallwood KS, 2004, DEV METHODS REDUCE B; Smallwood KS, 2009, CEC5002009065; Sparr Reto, 2000, Technical Soaring, V24, P49; Thelander Carl G., 2007, P25; Whiteman CD, 2000, MOUNTAIN METEROLOGY; Yates RE, 2001, J RAPTOR RES, V35, P81; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/; Zuur AF, 2009, MIXED EFFECTS MODELS, P264	52	27	27	4	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93030	10.1371/journal.pone.0093030	http://dx.doi.org/10.1371/journal.pone.0093030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671199	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677000103
J	Lehner, K; Santarelli, F; Vasold, R; Penning, R; Sidoroff, A; Konig, B; Landthaler, M; Baumler, W				Lehner, Karin; Santarelli, Francesco; Vasold, Rudolf; Penning, Randolph; Sidoroff, Alexis; Koenig, Burkhard; Landthaler, Michael; Baeumler, Wolfgang			Black Tattoos Entail Substantial Uptake of Genotoxicpolycyclic Aromatic Hydrocarbons (PAH) in Human Skin and Regional Lymph Nodes	PLOS ONE			English	Article							DIESEL EXHAUST PARTICLES; GENE-EXPRESSION; DNA-ADDUCTS; CANCER; ACTIVATION; CELLS; INKS; CARCINOGENS; METABOLISM; EXPOSURE	Hundreds of millions of people worldwide have tattoos, which predominantly contain black inks consisting of soot products like Carbon Black or polycyclic aromatic hydrocarbons (PAH). We recently found up to 200 mu g/g of PAH in commercial black inks. After skin tattooing, a substantial part of the ink and PAH should be transported to other anatomical sites like the regional lymph nodes. To allow a first estimation of health risk, we aimed to extract and quantify the amount of PAH in black tattooed skin and the regional lymph nodes of pre-existing tattoos. Firstly, we established an extraction method by using HPLC - DAD technology that enables the quantification of PAH concentrations in human tissue. After that, 16 specimens of human tattooed skin and corresponding regional lymph nodes were included in the study. All skin specimen and lymph nodes appeared deep black. The specimens were digested and tested for 20 different PAH at the same time. PAH were found in twelve of the 16 tattooed skin specimens and in eleven regional lymph nodes. The PAH concentration ranged from 0.1-0.6 mu g/cm(2) in the tattooed skin and 0.1-11.8 mu g/g in the lymph nodes. Two major conclusions can be drawn from the present results. Firstly, PAH in black inks stay partially in skin or can be found in the regional lymph nodes. Secondly, the major part of tattooed PAH had disappeared from skin or might be found in other organs than skin and lymph nodes. Thus, beside inhalation and ingestion, tattooing has proven to be an additional, direct and effective route of PAH uptake into the human body.	[Lehner, Karin; Santarelli, Francesco; Landthaler, Michael; Baeumler, Wolfgang] Univ Regensburg, Dept Dermatol, D-93053 Regensburg, Germany; [Vasold, Rudolf; Koenig, Burkhard] Univ Regensburg, Dept Organ Chem, D-93053 Regensburg, Germany; [Penning, Randolph] Univ Munich, Dept Forens Med, Munich, Germany; [Sidoroff, Alexis] Univ Innsbruck, Dept Dermatol & Venereol, A-6020 Innsbruck, Austria	University of Regensburg; University of Regensburg; University of Munich; University of Innsbruck	Baumler, W (corresponding author), Univ Regensburg, Dept Dermatol, D-93053 Regensburg, Germany.	baeumler.wolfgang@klinik.uni-regensburg.de	Koenig, Burkhard/A-1362-2009; Koenig, Burkhard/GRX-2026-2022; Koenig, Burkhard/O-8172-2019	Koenig, Burkhard/0000-0002-6131-4850; Koenig, Burkhard/0000-0002-6131-4850; Koenig, Burkhard/0000-0002-6131-4850	Deutsche Forschungsgemeinschaft (DFG) [BA 1741/3-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG, grant BA 1741/3-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akintobi AM, 2007, TOXICOL APPL PHARM, V220, P9, DOI 10.1016/j.taap.2006.12.002; Benford D, 2010, FOOD CHEM TOXICOL, V48, pS42, DOI 10.1016/j.fct.2009.09.039; BICKERS DR, 1978, J CLIN INVEST, V62, P1061, DOI 10.1172/JCI109211; BIZUB D, 1986, P NATL ACAD SCI USA, V83, P6048, DOI 10.1073/pnas.83.16.6048; Bosetti C, 2007, ANN ONCOL, V18, P431, DOI 10.1093/annonc/mdl172; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Burchiel SW, 2001, CLIN IMMUNOL, V98, P2, DOI 10.1006/clim.2000.4934; Buters JTM, 1999, P NATL ACAD SCI USA, V96, P1977, DOI 10.1073/pnas.96.5.1977; Davila DR, 1996, TOXICOL APPL PHARM, V139, P333, DOI 10.1006/taap.1996.0173; EC-SCF, 2002, POL AR HYDR OCC FOOD; Engel E, 2010, EXP DERMATOL, V19, P54, DOI 10.1111/j.1600-0625.2009.00925.x; GELBOIN HV, 1980, PHYSIOL REV, V60, P1107, DOI 10.1152/physrev.1980.60.4.1107; Gerde P, 2001, CARCINOGENESIS, V22, P741, DOI 10.1093/carcin/22.5.741; Haftka JJH, 2009, SAR QSAR ENVIRON RES, V20, P221, DOI 10.1080/10629360902949336; [IARC] International Agency for Research on Cancer, 2005, IARC MONOGRAPHS EVAL; IARC (International Agency for Research on Cancer), 2006, IARC MON, V92; Jira W, 2008, FOOD ADDIT CONTAM A, V25, P704, DOI 10.1080/02652030701697769; Kaur RR, 2009, J COSMET DERMATOL-US, V8, P295, DOI 10.1111/j.1473-2165.2009.00469.x; Klugl I, 2010, DERMATOLOGY, V221, P43, DOI 10.1159/000292627; Kluger N, 2012, LANCET ONCOL, V13, pE161, DOI 10.1016/S1470-2045(11)70340-0; KOREEDA M, 1978, SCIENCE, V199, P778, DOI 10.1126/science.622566; Laumann AE, 2006, J AM ACAD DERMATOL, V55, P413, DOI 10.1016/j.jaad.2006.03.026; Lehner K, 2011, J EUR ACAD DERMATOL; Lehner K, 2011, CONTACT DERMATITIS, V65, P231, DOI 10.1111/j.1600-0536.2011.01947.x; Lewtas J, 2007, MUTAT RES-REV MUTAT, V636, P95, DOI 10.1016/j.mrrev.2007.08.003; Matikainen T, 2001, NAT GENET, V28, P355, DOI 10.1038/ng575; Melendez-Colon VJ, 1999, CARCINOGENESIS, V20, P1885, DOI 10.1093/carcin/20.10.1885; Moraitis AG, 2013, ENDOCR PRACT, V19, pE50, DOI 10.4158/EP12092.CR; Nel AE, 1998, J ALLERGY CLIN IMMUN, V102, P539, DOI 10.1016/S0091-6749(98)70269-6; NEWMAN MJ, 1988, J CLIN INVEST, V82, P145, DOI 10.1172/JCI113563; Penning TM, 1999, CHEM RES TOXICOL, V12, P1, DOI 10.1021/tx980143n; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Pratt MM, 2011, INT J ENV RES PUB HE, V8, P2675, DOI 10.3390/ijerph8072675; Regensburger J, 2010, EXP DERMATOL, V19, pE275, DOI 10.1111/j.1600-0625.2010.01068.x; Ren AG, 2011, P NATL ACAD SCI USA, V108, P12770, DOI 10.1073/pnas.1105209108; Schlager A, 2008, BREAST J, V14, P299, DOI 10.1111/j.1524-4741.2008.00578.x; Shimada T, 2004, CANCER SCI, V95, P1, DOI 10.1111/j.1349-7006.2004.tb03162.x; Solhaug A, 2004, CARCINOGENESIS, V25, P809, DOI 10.1093/carcin/bgh069; Tsien A, 1997, TOXICOL APPL PHARM, V142, P256, DOI 10.1006/taap.1996.8063; van Grevenynghe J, 2003, J IMMUNOL, V170, P2374, DOI 10.4049/jimmunol.170.5.2374; Varga E, 2011, J CUTAN PATHOL	41	24	24	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92787	10.1371/journal.pone.0092787	http://dx.doi.org/10.1371/journal.pone.0092787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670978	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000075
J	Peng, J; Yang, H; Jiang, H; Lin, YX; Lu, CD; Xu, YW; Zeng, J				Peng, Jin; Yang, Hao; Jiang, Hua; Lin, Yi-xiao; Lu, Charles Damien; Xu, Ya-wei; Zeng, Jun			The Origin of Novel Avian Influenza A (H7N9) and Mutation Dynamics for Its Human-To-Human Transmissible Capacity	PLOS ONE			English	Article							ERROR CATASTROPHE; HUMAN INFECTION; VIRUS; RIBAVIRIN	In February 2013, H7N9 (A/H7N9/2013_China), a novel avian influenza virus, broke out in eastern China and caused human death. It is a global priority to discover its origin and the point in time at which it will become transmittable between humans. We present here an interdisciplinary method to track the origin of H7N9 virus in China and to establish an evolutionary dynamics model for its human-to-human transmission via mutations. After comparing influenza viruses from China since 1983, we established an A/H7N9/2013_China virus evolutionary phylogenetic tree and found that the human instances of virus infection were of avian origin and clustered into an independent line. Comparing hemagglutinin (HA) and neuraminidase (NA) gene sequences of A/H7N9/2013_China viruses with all human-to-human, avian, and swine influenza viruses in China in the past 30 years, we found that A/H7N9/2013_China viruses originated from Baer's Pochard H7N1 virus of Hu Nan Province 2010 (HA gene, EPI: 370846, similarity with H7N9 is 95.5%) and duck influenza viruses of Nanchang city 2000 (NA gene, EPI: 387555, similarity with H7N9 is 97%) through genetic re-assortment. HA and NA gene sequence comparison indicated that A/H7N9/2013_China virus was not similar to human-to-human transmittable influenza viruses. To simulate the evolution dynamics required for human-to-human transmission mutations of H7N9 virus, we employed the Markov model. The result of this calculation indicated that the virus would acquire properties for human-to-human transmission in 11.3 years (95% confidence interval (CI): 11.2-11.3, HA gene).	[Peng, Jin; Yang, Hao; Jiang, Hua; Lin, Yi-xiao; Lu, Charles Damien; Xu, Ya-wei; Zeng, Jun] Sichuan Acad Med Sci, Metabol & Multidisciplinary Lab Trauma Res, Inst Emergency & Disaster Med, Sichuan Prov Peoples Hosp,Dept Computat Math & Bi, Chengdu, Sichuan Provinc, Peoples R China; [Jiang, Hua; Zeng, Jun] Sichuan Acad Med Sci, Ctr Emergency Med, Sichuan Prov Peoples Hosp, Chengdu, Sichuan Provinc, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Jiang, H (corresponding author), Sichuan Acad Med Sci, Metabol & Multidisciplinary Lab Trauma Res, Inst Emergency & Disaster Med, Sichuan Prov Peoples Hosp,Dept Computat Math & Bi, Chengdu, Sichuan Provinc, Peoples R China.	cdjianghua@gmail.com; zengjun@medmail.com.cn	Jiang, Hua/ABE-5811-2021	Jiang, Hua/0000-0003-1465-0170	Sichuan Provincial Department of Science and Technology [2011SZ0139, 2011SZ0336, 2012SZ0181]; Chengdu Municipality Department of Science and Technology [12PPYB181SF-002]; Medical Research Grants of Sichuan Department of Health [100552, 100553, 110162]	Sichuan Provincial Department of Science and Technology; Chengdu Municipality Department of Science and Technology; Medical Research Grants of Sichuan Department of Health	This work was supported by the Sichuan Provincial Department of Science and Technology (Science and Technology Support Program, grants No.2011SZ0139, No.2011SZ0336, and No.2012SZ0181; http://www.scst.gov.cn/info/). This work was also supported by the Chengdu Municipality Department of Science and Technology (Grant No. 12PPYB181SF-002; http://www.cdst.gov.cn/). JZ and HJ are recipients of Medical Research Grants of Sichuan Department of Health (Grants No. 100552, No. 100553, and No. 110162; http://www.scwst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bull JJ, 2005, PLOS COMPUT BIOL, V1, P450, DOI 10.1371/journal.pcbi.0010061; Butler D, 2013, NATURE, V496, P145, DOI 10.1038/496145a; Cai B, 2012, ZHONG HUA JI ZHEN YI, V21, P887; Chang JT, 1996, MATH BIOSCI, V137, P51, DOI 10.1016/S0025-5564(96)00075-2; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Graci JD, 2002, VIROLOGY, V298, P175, DOI 10.1006/viro.2002.1487; Hayes DP, 2010, MED HYPOTHESES, V74, P831, DOI 10.1016/j.mehy.2009.12.002; Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Liu SL, 2011, WETLAND SCI MANAGEME, V7, P44; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; National Health and Family Planning Commission of China, 2013, EP INF H7N9 MAY 13; Norris J. R., 1998, MARKOV CHAINS; Potter CW, 2011, J INFECTION, V63, P252, DOI 10.1016/j.jinf.2011.04.013; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Takekawa JY, 2010, AVIAN DIS, V54, P466, DOI 10.1637/8914-043009-Reg.1; Wilks S, 2012, VACCINE, V30, P4369, DOI 10.1016/j.vaccine.2012.02.076; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yeung JWK, 2006, MED HYPOTHESES, V67, P1016, DOI 10.1016/j.mehy.2006.03.048; Zhao X, 1994, ZHE JIANG LIN YE KE, V5, P26; Zhao X. M., 2006, BIRD MIGRATION BIRD; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	24	20	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93094	10.1371/journal.pone.0093094	http://dx.doi.org/10.1371/journal.pone.0093094			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671138	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677000112
J	Sun, H; Zhang, SX; Zhang, AH; Yan, GL; Wu, XH; Han, Y; Wang, XJ				Sun, Hui; Zhang, Shuxiang; Zhang, Aihua; Yan, Guangli; Wu, Xiuhong; Han, Ying; Wang, Xijun			Metabolomic Analysis of Diet-Induced Type 2 Diabetes Using UPLC/MS Integrated with Pattern Recognition Approach	PLOS ONE			English	Article							RAT MODEL; SERUM	Metabolomics represents an emerging discipline concerned with comprehensive assessment of small molecule endogenous metabolites in biological systems and provides a powerful approach insight into the mechanisms of diseases. Type 2 diabetes (T2D), called the burden of the 21st century, is growing with an epidemic rate. However, its precise molecular mechanism has not been comprehensively explored. In this study, we applied urinary metabolomics based on the UPLC/MS integrated with pattern recognition approaches to discover differentiating metabolites, to characterize and explore metabolic pathway disruption in an experimental model for high-fat-diet induced T2D. Six differentiating urinary metabolites were found in the negative mode, and two (2-(4-hydroxy-3-methoxy-phenyl) acetaldehyde sulfate, 2-phenylethanol glucuronide) of which were identified involving the key metabolic pathways linked to pentose and glucuronate interconversions, starch, sucrose metabolism and tyrosine metabolism. Our study provides new insight into pathophysiologic mechanisms and may enhance the understanding of T2D pathogenesis.	[Sun, Hui; Zhang, Shuxiang; Zhang, Aihua; Yan, Guangli; Wu, Xiuhong; Han, Ying; Wang, Xijun] Heilongjiang Univ Chinese Med, Dept Pharmaceut Anal, Key Lab Metabol & Chinmed, Natl TCM Key Lab Serum Pharmacochem, Harbin, Peoples R China	Heilongjiang University of Chinese Medicine	Wang, XJ (corresponding author), Heilongjiang Univ Chinese Med, Dept Pharmaceut Anal, Key Lab Metabol & Chinmed, Natl TCM Key Lab Serum Pharmacochem, Harbin, Peoples R China.	xijunwangls@126.com	Wang, Xijun/C-4477-2014	Wang, Xijun/0000-0002-0949-3492	Key Program of Natural Science Foundation of State [90709019]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2011BAI03B03, 2011BAI03B06, 2011BAI03B08]; Key Science and Technology Program of Heilongjiang Province, China [GC06C501, GA08C303, GA06C30101]; Foundation of Heilongjiang University of Chinese Medicine [201209]; National Key Subject of Drug Innovation [2009ZX09502-005]	Key Program of Natural Science Foundation of State(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Key Science and Technology Program of Heilongjiang Province, China; Foundation of Heilongjiang University of Chinese Medicine; National Key Subject of Drug Innovation	This work was supported by grants from the Key Program of Natural Science Foundation of State (Grant No. 90709019), National Key Technology Research and Development Program of the Ministry of Science and Technology of China (Grant No. 2011BAI03B03, 2011BAI03B06, 2011BAI03B08), Key Science and Technology Program of Heilongjiang Province, China (Grant No. GC06C501, GA08C303, GA06C30101), Foundation of Heilongjiang University of Chinese Medicine (Grant No. 201209), and National Key Subject of Drug Innovation (Grant No. 2009ZX09502-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2005, WORLD J GASTROENTERO, V11, P3675, DOI 10.3748/wjg.v11.i24.3675; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Gjesing AP, 2012, EUR J CLIN INVEST, V42, P579, DOI 10.1111/j.1365-2362.2012.02678.x; Gregory JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063544; Jung Y, 2011, ANALYST, V136, P4222, DOI 10.1039/c1an15403f; Mihalik SJ, 2012, DIABETES CARE, V35, P605, DOI [10.2337/dc11-1577, 10.2337/DC11-1577]; Miura D, 2012, J PROTEOMICS, V75, P5052, DOI 10.1016/j.jprot.2012.02.011; Ng DPK, 2012, DIABETOLOGIA, V55, P499, DOI 10.1007/s00125-011-2339-6; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rosengren AH, 2010, SCIENCE, V327, P217, DOI 10.1126/science.1176827; Skappak C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065035; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Thwe AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065349; Ugarte M, 2012, GENOME MED, V4, DOI 10.1186/gm334; van Vliet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064545; Wang XJ, 2013, HEPATOLOGY, V57, P2072, DOI 10.1002/hep.26130; Wang XJ, 2012, ANALYST, V137, P4703, DOI 10.1039/c2an35891c; Wang XJ, 2012, MOL CELL PROTEOMICS, V11, P370, DOI 10.1074/mcp.M111.016006; Wang XJ, 2012, J PROTEOME RES, V11, P1284, DOI 10.1021/pr200963e; Wang XJ, 2012, J PROTEOMICS, V75, P1411, DOI 10.1016/j.jprot.2011.11.011; Zhang AH, 2014, J PHYSIOL BIOCHEM, V70, P117, DOI 10.1007/s13105-013-0286-z; Zhang AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064381; Zhang AH, 2012, ANAL BIOANAL CHEM, V404, P1239, DOI 10.1007/s00216-012-6117-1; Zhang AH, 2012, ANALYST, V137, P293, DOI 10.1039/c1an15605e; Zhang SX, 2010, J PHARMACEUT BIOMED, V53, P1011, DOI 10.1016/j.jpba.2010.06.033; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065880	28	22	23	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93384	10.1371/journal.pone.0093384	http://dx.doi.org/10.1371/journal.pone.0093384			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671089	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677000139
J	Flaven-Pouchon, J; Garcia, T; Abed-Vieillard, D; Farine, JP; Ferveur, JF; Everaerts, C				Flaven-Pouchon, Justin; Garcia, Thibault; Abed-Vieillard, Dehbia; Farine, Jean-Pierre; Ferveur, Jean-Francois; Everaerts, Claude			Transient and Permanent Experience with Fatty Acids Changes Drosophila melanogaster Preference and Fitness	PLOS ONE			English	Article							ENVIRONMENT INTERACTIONS; OVIPOSITION BEHAVIOR; FEEDING EXPERIENCE; SITE SELECTION; PREGNANT RATS; HOST; CHOICE; METHYLATION; ADAPTATION; EXPOSURE	Food and host-preference relies on genetic adaptation and sensory experience. In vertebrates, experience with food-related cues during early development can change adult preference. This is also true in holometabolous insects, which undergo a drastic nervous system remodelling during their complete metamorphosis, but remains uncertain in Drosophila melanogaster. We have conditioned D. melanogaster with oleic (C18:1) and stearic (C18:0) acids, two common dietary fatty acids, respectively preferred by larvae and adult. Wild-type individuals exposed either during a transient period of development-from embryo to adult-or more permanently-during one to ten generation cycles-were affected by such conditioning. In particular, the oviposition preference of females exposed to each fatty acid during larval development was affected without cross-effect indicating the specificity of each substance. Permanent exposure to each fatty acid also drastically changed oviposition preference as well as major fitness traits (development duration, sex-ratio, fecundity, adult lethality). This suggests that D. melanogaster ability to adapt to new food sources is determined by its genetic and sensory plasticity both of which may explain the success of this generalist-diet species.	[Flaven-Pouchon, Justin; Garcia, Thibault; Abed-Vieillard, Dehbia; Farine, Jean-Pierre; Ferveur, Jean-Francois; Everaerts, Claude] Univ Bourgogne, UMR INRA 1324, UMR CNRS 6265, Ctr Sci Gout & Alimentat, Dijon, France	INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Ferveur, JF (corresponding author), Univ Bourgogne, UMR INRA 1324, UMR CNRS 6265, Ctr Sci Gout & Alimentat, Dijon, France.	Jean-Francois.ferveur@u-bourgogne.fr; claude.everaerts@u-bourgogne.fr			Centre National de la Recherche Scientifique (INSB); Burgundy Regional Council (PARI); French Ministry of Research and Higher Education	Centre National de la Recherche Scientifique (INSB)(Centre National de la Recherche Scientifique (CNRS)); Burgundy Regional Council (PARI)(Region Bourgogne-Franche-Comte); French Ministry of Research and Higher Education	This work was funded in part by the Centre National de la Recherche Scientifique (INSB), the Burgundy Regional Council (PARI), and the French Ministry of Research and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinsoft, 2012, XLSTAT 2012 DAT AN S; Akhtar Y, 2003, J CHEM ECOL, V29, P1853, DOI 10.1023/A:1024802328458; ALLOWAY TM, 1972, ANNU REV ENTOMOL, V17, P43, DOI 10.1146/annurev.en.17.010172.000355; Anderson P, 2013, ANIM BEHAV, V85, P1169, DOI 10.1016/j.anbehav.2013.03.002; Ashburner M., 1989, DROSOPHILA LAB HDB; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Barron AB, 2000, ENTOMOL EXP APPL, V94, P159, DOI 10.1023/A:1003998715018; Barron AB, 1999, ANIM BEHAV, V58, P621, DOI 10.1006/anbe.1999.1169; Barron AB, 2001, J INSECT BEHAV, V14, P725, DOI 10.1023/A:1013033332535; Barrozo RB, 2004, CHEM SENSES, V29, P833, DOI 10.1093/chemse/bjh249; Blackiston DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001736; Bosch OJ, 2000, CHEM SENSES, V25, P323, DOI 10.1093/oxfordjournals.chemse.a014042; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Burns JG, 2012, P NATL ACAD SCI USA, V109, P17239, DOI 10.1073/pnas.1121265109; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; Colomb J, 2007, ANIM BEHAV, V73, P587, DOI 10.1016/j.anbehav.2006.04.016; Davis JM, 2008, Q REV BIOL, V83, P363, DOI 10.1086/592851; Fougeron AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026899; Fricke C, 2007, EVOLUTION, V61, P440, DOI 10.1111/j.1558-5646.2007.00038.x; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Grishkevich V, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.19; Gutierrez-Ibanez C, 2007, NATURWISSENSCHAFTEN, V94, P595, DOI 10.1007/s00114-007-0233-3; HERSHBERGER WA, 1967, ANIM BEHAV, V15, P259, DOI 10.1016/0003-3472(67)90008-5; HIRSCH HVB, 1995, ANIM BEHAV, V50, P1211, DOI 10.1016/0003-3472(95)80038-7; HOFFMANN AA, 1988, J INSECT PHYSIOL, V34, P197, DOI 10.1016/0022-1910(88)90050-9; Hussein N, 2009, LIPIDS, V44, P685, DOI 10.1007/s11745-009-3318-2; Ingleby FC, 2013, J EVOLUTION BIOL, V26, P94, DOI 10.1111/jeb.12030; JAENIKE J, 1988, Journal of Insect Behavior, V1, P3, DOI 10.1007/BF01052500; JAENIKE J, 1983, OECOLOGIA, V58, P320, DOI 10.1007/BF00385230; JAENIKE J, 1982, AM NAT, V119, P784, DOI 10.1086/283955; KAROWE DN, 1989, OECOLOGIA, V78, P106, DOI 10.1007/BF00377204; Kent CF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000609; King-Jones K, 2005, CELL, V121, P773, DOI 10.1016/j.cell.2005.03.030; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Kruidhof HM, 2013, OIKOS, V122, P1094, DOI 10.1111/j.1600-0706.2012.00142.x; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; MANNING A, 1967, NATURE, V216, P338, DOI 10.1038/216338a0; Martel V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025658; Milo R, 2007, P NATL ACAD SCI USA, V104, P16998, DOI 10.1073/pnas.0707673104; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Montmayeur J-P, 2010, FAT DECTECTION TASTE; Mullens BA, 2009, PEST MANAG SCI, V65, P1360, DOI 10.1002/ps.1823; Peralta Quesada PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053229; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; PHILLIPS WM, 1977, ENTOMOL EXP APPL, V21, P71, DOI 10.1007/BF00300343; PROKOPY RJ, 1982, SCIENCE, V218, P76, DOI 10.1126/science.218.4567.76; Radziute S, 2013, ENTOMOL EXP APPL, V146, P286, DOI 10.1111/eea.12028; Reaume CJ, 2006, CURR BIOL, V16, pR623, DOI 10.1016/j.cub.2006.07.042; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Schaal B, 2004, CLIN PERINATOL, V31, P261, DOI 10.1016/j.clp.2004.04.003; Shikano I, 2009, ANIM BEHAV, V77, P247, DOI 10.1016/j.anbehav.2008.08.033; SKINNER WA, 1970, EXPERIENTIA, V26, P728, DOI 10.1007/BF02232510; Smallegange RC, 2009, J CHEM ECOL, V35, P933, DOI 10.1007/s10886-009-9668-7; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Svetec N, 2005, CURR BIOL, V15, pR790, DOI 10.1016/j.cub.2005.09.034; Thorpe WH, 1939, PROC R SOC SER B-BIO, V127, P424, DOI 10.1098/rspb.1939.0032; Tremmel M, 2013, BEHAV ECOL, V24, P386, DOI 10.1093/beheco/ars175; VET LEM, 1983, NETH J ZOOL, V33, P225, DOI 10.1163/002829683X00101; Yach D, 2006, NAT MED, V12, P367, DOI 10.1038/nm0306-367a; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842	62	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92352	10.1371/journal.pone.0092352	http://dx.doi.org/10.1371/journal.pone.0092352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667657	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600033
J	Negro, F; Yavuz, US; Farina, D				Negro, Francesco; Yavuz, Utku S.; Farina, Dario			Limitations of the Spike-Triggered Averaging for Estimating Motor Unit Twitch Force: A Theoretical Analysis	PLOS ONE			English	Article							ORDERLY RECRUITMENT; DORSAL INTEROSSEUS; DISCHARGE RATE; MUSCLE; SYNCHRONIZATION; STIMULATION; CONTRACTION; MICROSTIMULATION; THRESHOLD; MASSETER	Contractile properties of human motor units provide information on the force capacity and fatigability of muscles. The spike-triggered averaging technique (STA) is a conventional method used to estimate the twitch waveform of single motor units in vivo by averaging the joint force signal. Several limitations of this technique have been previously discussed in an empirical way, using simulated and experimental data. In this study, we provide a theoretical analysis of this technique in the frequency domain and describe its intrinsic limitations. By analyzing the analytical expression of STA, first we show that a certain degree of correlation between the motor unit activities prevents an accurate estimation of the twitch force, even from relatively long recordings. Second, we show that the quality of the twitch estimates by STA is highly related to the relative variability of the inter-spike intervals of motor unit action potentials. Interestingly, if this variability is extremely high, correct estimates could be obtained even for high discharge rates. However, for physiological inter-spike interval variability and discharge rate, the technique performs with relatively low estimation accuracy and high estimation variance. Finally, we show that the selection of the triggers that are most distant from the previous and next, which is often suggested, is not an effective way for improving STA estimates and in some cases can even be detrimental. These results show the intrinsic limitations of the STA technique and provide a theoretical framework for the design of new methods for the measurement of motor unit force twitch.	[Negro, Francesco; Yavuz, Utku S.; Farina, Dario] Univ Gottingen, Dept Neurorehabil Engn, Bernstein Focus Neurotechnol Gottingen, Bernstein Ctr Computat Neurosci, D-37073 Gottingen, Germany; [Yavuz, Utku S.] Univ Gottingen, Dept Orthob, Bernstein Focus Neurotechnol Gottingen, Bernstein Ctr Computat Neurosci, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Negro, F (corresponding author), Univ Gottingen, Dept Neurorehabil Engn, Bernstein Focus Neurotechnol Gottingen, Bernstein Ctr Computat Neurosci, D-37073 Gottingen, Germany.	negro.francesco@bccn.uni-goettingen.de	Negro, Francesco/K-1345-2013; Negro, Francesco/H-4471-2019; Farina, Dario/AAB-2648-2019	Negro, Francesco/0000-0002-9094-8932; Negro, Francesco/0000-0002-9094-8932; Yavuz, Utku Sukru/0000-0002-6968-8064	European Research Council Advanced Grant DEMOVE [267888]	European Research Council Advanced Grant DEMOVE	The authors acknowledge financial support by the European Research Council Advanced Grant DEMOVE (contract #267888) (DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen S, 1983, BIOMEDICAL ENG IEEE, P742; [Anonymous], 2004, INTRO HARMONIC ANAL, DOI DOI 10.1017/CBO9781139165372; BURKE RE, 1967, J PHYSIOL-LONDON, V193, P141, DOI 10.1113/jphysiol.1967.sp008348; CALANCIE B, 1986, MUSCLE NERVE, V9, P78, DOI 10.1002/mus.880090113; Carpentier A, 2001, J PHYSIOL-LONDON, V534, P903, DOI 10.1111/j.1469-7793.2001.00903.x; Celichowski J, 2008, J BIOMECH, V41, P3448, DOI 10.1016/j.jbiomech.2008.09.013; Cescon C, 2004, MED BIOL ENG COMPUT, V42, P496, DOI 10.1007/BF02350990; COGGSHALL JC, 1973, KYBERNETIK, V13, P30, DOI 10.1007/BF00289108; Cox DR., 1977, THEORY STOCHASTIC PR; DATTA AK, 1990, J PHYSIOL-LONDON, V422, P397, DOI 10.1113/jphysiol.1990.sp017991; Dideriksen JL, 2012, J NEUROPHYSIOL, V107, P3357, DOI 10.1152/jn.00938.2011; Drzymala-Celichowska H, 2010, J ELECTROMYOGR KINES, V20, P599, DOI 10.1016/j.jelekin.2010.01.006; FUGLEVAND AJ, 1993, J NEUROPHYSIOL, V70, P2470, DOI 10.1152/jn.1993.70.6.2470; GOLDBERG LJ, 1977, J NEUROPHYSIOL, V40, P879, DOI 10.1152/jn.1977.40.4.879; Gossen ER, 2003, J PHYSIOL-LONDON, V552, P657, DOI 10.1113/jphysiol.2003.048132; Gossen ER, 2003, J NEUROSCI METH, V126, P155, DOI 10.1016/S0165-0270(03)00077-3; Heckman C, 2012, COMPREHENSIVE PHYSL; Heckman C, 2004, HAND CLIN N, V4, P119; Keen DA, 2004, J NEUROPHYSIOL, V91, P2515, DOI 10.1152/jn.01178.2003; Keen DA, 2012, J NEUROPHYSIOL, V108, P3264, DOI 10.1152/jn.01154.2011; KOSSEV A, 1994, ELECTROEN CLIN NEURO, V93, P100, DOI 10.1016/0168-5597(94)90072-8; Kutch JJ, 2007, J COMPUT NEUROSCI, V22, P347, DOI 10.1007/s10827-007-0023-0; Kutch JJ, 2010, J NEUROPHYSIOL, V103, P3535, DOI 10.1152/jn.00956.2009; LIM KY, 1995, MUSCLE NERVE, V18, P165, DOI 10.1002/mus.880180204; MILNERBR.HS, 1973, J PHYSIOL-LONDON, V230, P359, DOI 10.1113/jphysiol.1973.sp010192; Moritz CT, 2005, J NEUROPHYSIOL, V93, P2449, DOI 10.1152/jn.01122.2004; Negro F, 2010, 40 ANN M SOC NEUR NE; Negro F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044894; NORDSTROM MA, 1989, MUSCLE NERVE, V12, P556, DOI 10.1002/mus.880120706; NORDSTROM MA, 1992, J PHYSIOL-LONDON, V453, P547, DOI 10.1113/jphysiol.1992.sp019244; Raikova R, 2010, J BIOMECH, V43, P1546, DOI 10.1016/j.jbiomech.2010.01.034; Roatta S, 2008, J PHYSIOL-LONDON, V586, P5561, DOI 10.1113/jphysiol.2008.160770; STEIN RB, 1972, BRAIN RES, V40, P187, DOI 10.1016/0006-8993(72)90126-6; STEPHENS JA, 1977, BRAIN RES, V125, P91, DOI 10.1016/0006-8993(77)90361-4; Suresh N, 2012, IEEE ENG MED BIO, P3604, DOI 10.1109/EMBC.2012.6346746; Taylor AM, 2002, J NEUROPHYSIOL, V88, P265, DOI 10.1152/jn.2002.88.1.265; THOMAS CK, 1990, J NEUROPHYSIOL, V64, P1347, DOI 10.1152/jn.1990.64.4.1347; William R, 1978, EXPT NEUROLOGY, V61, P31; YEMM R, 1977, J PHYSIOL-LONDON, V265, P163, DOI 10.1113/jphysiol.1977.sp011710	39	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92390	10.1371/journal.pone.0092390	http://dx.doi.org/10.1371/journal.pone.0092390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667744	Green Submitted, Green Published, gold			2022-12-25	WOS:000333675600035
J	Palanisamy, AP; Cheng, G; Sutter, AG; Liu, J; Lewin, DN; Chao, J; Chavin, K				Palanisamy, Arun P.; Cheng, Gang; Sutter, Alton G.; Liu, John; Lewin, David N.; Chao, Julie; Chavin, Kenneth			Adenovirus-Mediated eNOS Expression Augments Liver Injury after Ischemia/Reperfusion in Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ISCHEMIA-REPERFUSION INJURY; CYTOCHROME-C; INDUCED APOPTOSIS; MITOCHONDRIAL RESPIRATION; TYROSINE NITRATION; GENE-TRANSFER; CELL-LINE; PIG-LIVER; RAT-LIVER	Hepatic ischemia/reperfusion (l/R) injury continues to be a critical problem. The role of nitric oxide in liver I/R injury is still controversial. This study examines the effect of endothelial nitric oxide synthase (eNOS) over-expression on hepatic function following I/R. Adenovirus expressing human eNOS (Ad-eNOS) was administered by tail vein injection into C57BL/6 mice. Control mice received either adenovirus expressing LacZ or vehicle only. Sixty minutes of total hepatic ischemia was performed 3 days after adenovirus treatment, and mice were sacrificed after 6 or 24 hrs of reperfusion to assess hepatic injury. eNOS over expression caused increased liver injury as evidenced by elevated AST and ALT levels and decreased hepatic ATP content. While necrosis was not pervasive in any group, TUNEL demonstrated significantly increased apoptosis in Ad-eNOS infected livers. Western blotting demonstrated increased levels of protein nitration and upregulation of the proapoptotic proteins bax and p53. Our data suggest that over-expression of eNOS is detrimental in the setting of hepatic I/R.	[Palanisamy, Arun P.; Cheng, Gang; Sutter, Alton G.; Liu, John; Chavin, Kenneth] Med Univ S Carolina, Dept Surg, Div Transplant Surg, Charleston, SC 29425 USA; [Lewin, David N.; Chao, Julie] Med Univ S Carolina, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Chavin, K (corresponding author), Med Univ S Carolina, Dept Surg, Div Transplant Surg, Charleston, SC 29425 USA.	chavinkd@musc.edu	Sutter, Alton/GWV-3369-2022; Palanisamy, Arun/I-7712-2019; Palanisamy, Arun/L-2019-2014	Palanisamy, Arun/0000-0002-7793-0682; Palanisamy, Arun/0000-0002-7793-0682				Alexander B, 1998, NUTRITION, V14, P376, DOI 10.1016/S0899-9007(97)00492-9; Alexander HS, 1998, J VIROL METHODS, V74, P9, DOI 10.1016/S0166-0934(98)00062-7; Bal-Price A, 2000, J NEUROCHEM, V75, P1455, DOI 10.1046/j.1471-4159.2000.0751455.x; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Cassina A, 1996, ARCH BIOCHEM BIOPHYS, V328, P309, DOI 10.1006/abbi.1996.0178; Chatterjee PK, 2002, KIDNEY INT, V61, P862, DOI 10.1046/j.1523-1755.2002.00234.x; Cheng G, 2002, DEV DYNAM, V223, P119, DOI 10.1002/dvdy.1244; Cheng G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075980; Clemens MG, 1999, HEPATOLOGY, V30, P1, DOI 10.1002/hep.510300148; Cottart CH, 1999, HEPATOLOGY, V29, P809, DOI 10.1002/hep.510290317; DENICOLA A, 1995, FREE RADICAL BIO MED, V19, P11, DOI 10.1016/0891-5849(94)00239-G; Dhar DK, 1998, HEPATOLOGY, V28, P782, DOI 10.1002/hep.510280327; Elibol B, 2001, NEUROSCIENCE, V105, P79, DOI 10.1016/S0306-4522(01)00159-2; Evans ZP, 2012, AM J PHYSIOL-GASTR L, V302, pG336, DOI 10.1152/ajpgi.00049.2011; Farmer D. G., 2000, TRANSPLANT REV, V14, P106, DOI DOI 10.1053/TR.2000.4651; Farzaneh-Far R, 2001, LIVER, V21, P161, DOI 10.1034/j.1600-0676.2001.021003161.x; Gogvadze V, 2001, J BIOL CHEM, V276, P19066, DOI 10.1074/jbc.M100614200; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gujral JS, 2001, HEPATOLOGY, V33, P397, DOI 10.1053/jhep.2001.22002; Hines IN, 2002, MOL CELL BIOCHEM, V234, P229, DOI 10.1023/A:1015952926016; Hortelano S, 1997, FEBS LETT, V410, P373, DOI 10.1016/S0014-5793(97)00623-6; Hortelano S, 1999, FASEB J, V13, P2311, DOI 10.1096/fasebj.13.15.2311; Ilan Y, 1999, SEMIN LIVER DIS, V19, P49, DOI 10.1055/s-2007-1007097; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; JAESCHKE H, 1992, LIFE SCI, V50, P1797, DOI 10.1016/0024-3205(92)90064-V; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kawachi S, 2000, BIOCHEM BIOPH RES CO, V276, P851, DOI 10.1006/bbrc.2000.3559; Kobayashi H, 1995, J SURG RES, V59, P772, DOI 10.1006/jsre.1995.1238; LANCASTER JR, 1990, P NATL ACAD SCI USA, V87, P1223, DOI 10.1073/pnas.87.3.1223; Lin KT, 1998, AM J PHYSIOL-CELL PH, V274, pC855, DOI 10.1152/ajpcell.1998.274.4.C855; Ling H, 1999, AM J PHYSIOL-RENAL, V277, pF383; Lizasoain I, 1996, BIOCHEM J, V314, P877, DOI 10.1042/bj3140877; MA TT, 1995, GASTROENTEROLOGY, V108, P463, DOI 10.1016/0016-5085(95)90075-6; Meguro M, 2003, TRANSPLANTATION, V75, P703, DOI 10.1097/01.TP.0000053400.42842.5C; Meguro M, 2002, TRANSPLANTATION, V73, P1439, DOI 10.1097/00007890-200205150-00013; Messmer UK, 1996, BIOCHEM J, V319, P299, DOI 10.1042/bj3190299; MESSMER UK, 1994, FEBS LETT, V355, P23; Nutt LK, 2002, J BIOL CHEM, V277, P9219, DOI 10.1074/jbc.M106817200; Palanisamy AP, 2013, METAB SYNDR RELAT DI; Peralta C, 1997, HEPATOLOGY, V25, P934, DOI 10.1002/hep.510250424; Pryor WA, 1995, AM J PHYSL, V268; Ricciardi R, 2001, TRANSPLANTATION, V71, P193, DOI 10.1097/00007890-200101270-00004; SCHWEIZER M, 1994, BIOCHEM BIOPH RES CO, V204, P169, DOI 10.1006/bbrc.1994.2441; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; SHAW P, 1992, P NATL ACAD SCI USA, V89, P4495, DOI 10.1073/pnas.89.10.4495; Shimamura T, 1999, J AM COLL SURGEONS, V188, P43, DOI 10.1016/S1072-7515(98)00259-2; Smith RS, 2002, ARTERIOSCL THROM VAS, V22, P1279, DOI 10.1161/01.ATV.0000026613.18742.67; Stadler J, 1991, AM J PHYSL, V260; Stuehr DJ, 1999, BIOCH BIOPHYSICA ACT, V5; Sullivan DE, 1997, HUM GENE THER, V8, P1195, DOI 10.1089/hum.1997.8.10-1195; TAKEHARA Y, 1995, ARCH BIOCHEM BIOPHYS, V323, P27, DOI 10.1006/abbi.1995.0005; Tzeng E, 1998, SURGERY, V124, P278, DOI 10.1067/msy.1998.90569; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Wang Y, 1998, SHOCK, V10, P20, DOI 10.1097/00024382-199807000-00004; Wu B, 2002, FREE RADICAL BIO MED, V33, P649, DOI 10.1016/S0891-5849(02)00917-6; Zhou S, 2013, J SURG RES	58	10	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93304	10.1371/journal.pone.0093304	http://dx.doi.org/10.1371/journal.pone.0093304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667691	Green Published, Green Submitted, gold			2022-12-25	WOS:000333675600168
J	Jude, JG; Spencer, GJ; Huang, X; Somerville, TDD; Jones, DR; Divecha, N; Somervaille, TCP				Jude, J. G.; Spencer, G. J.; Huang, X.; Somerville, T. D. D.; Jones, D. R.; Divecha, N.; Somervaille, T. C. P.			A targeted knockdown screen of genes coding for phosphoinositide modulators identifies PIP4K2A as required for acute myeloid leukemia cell proliferation and survival	ONCOGENE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; BREAST-CANCER; PTDINS5P; EXPRESSION; KINASE; INHIBITION; APOPTOSIS; PATHWAY; RATHER	Given the importance of deregulated phosphoinositide (PI) signaling in leukemic hematopoiesis, genes coding for proteins that regulate PI metabolism may have significant and as yet unappreciated roles in leukemia. We performed a targeted knockdown (KD) screen of PI modulator genes in human acute myeloid leukemia (AML) cells and identified candidates required to sustain proliferation or prevent apoptosis. One of these, the lipid kinase phosphatidylinositol-5-phosphate 4-kinase, type II, alpha (PIP4K2A) regulates cellular levels of phosphatidylinositol-5-phosphate (Ptslns5P) and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5) P-2). We found PIP4K2A to be essential for the clonogenic and leukemia-initiating potential of human AML cells, and for the clonogenic potential of murine MLL-AF9 AML cells. Importantly, PIP4K2A is also required for the clonogenic potential of primary human AML cells. Its KD results in accumulation of the cyclin-dependent kinase inhibitors CDKN1A and CDKN1B, G1 cell cycle arrest and apoptosis. Both CDKN1A accumulation and apoptosis were partially dependent on activation of the mTOR pathway. Critically, however, PIP4K2A KD in normal hematopoietic stem and progenitor cells, both murine and human, did not adversely impact either clonogenic or multilineage differentiation potential, indicating a selective dependency that we suggest may be the consequence of the regulation of different transcriptional programs in normal versus malignant cells. Thus, PIP4K2A is a novel candidate therapeutic target in myeloid malignancy.	[Jude, J. G.; Divecha, N.] Univ Manchester, Canc Res UK Manchester Inst, Inositide Lab, Manchester, Lancs, England; [Jude, J. G.; Spencer, G. J.; Huang, X.; Somerville, T. D. D.; Somervaille, T. C. P.] Univ Manchester, Canc Res UK Manchester Inst, Leukaemia Biol Lab, Manchester, Lancs, England	Cancer Research UK; University of Manchester; Cancer Research UK; University of Manchester	Divecha, N (corresponding author), Canc Res UK Manchester Inst, Manchester M20 4BX, Lancs, England.	nullin.divecha@cruk.manchester.ac.uk; tim.somervaille@cruk.manchester.ac.uk	Huang, Xu/N-5609-2019	Huang, Xu/0000-0001-6706-199X; Jude, Julian/0000-0002-9091-9867; divecha, nullin/0000-0001-9695-6039; Somervaille, Tim/0000-0002-9188-4379	Cancer Research UK [C5759/A12328]; Cancer Research UK [19280] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	We thank Morgan Blaylock, Jeff Barry, Michael Hughes, Gail Bruder, Angela Cooke and Yaoyong Li for technical support. This work was supported by Cancer Research UK grant number C5759/A12328.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bertagnolo V, 2006, INT J ONCOL, V28, P863; Bertagnolo V, 2007, CARCINOGENESIS, V28, P1638, DOI 10.1093/carcin/bgm078; Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Davis MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054127; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Emerling BM, 2013, CELL, V155, P844, DOI 10.1016/j.cell.2013.09.057; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Halstead JR, 2001, CURR BIOL, V11, P386, DOI 10.1016/S0960-9822(01)00121-X; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Huang X, 2014, LEUKEMIA, V28, P1081, DOI 10.1038/leu.2013.316; Jones DR, 2006, MOL CELL, V23, P685, DOI 10.1016/j.molcel.2006.07.014; Jones DR, 2013, NAT PROTOC, V8, P1058, DOI 10.1038/nprot.2013.040; Jones DR, 2013, FASEB J, V27, P1644, DOI 10.1096/fj.12-218842; Keune WJ, 2013, CANCER RES, V73, P6913, DOI 10.1158/0008-5472.CAN-13-0424; Keune WJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003223; Kubota Y, 2004, LEUKEMIA, V18, P1438, DOI 10.1038/sj.leu.2403402; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; LING LE, 1989, J BIOL CHEM, V264, P5080; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Migliorini G, 2013, BLOOD, V122, P3298, DOI 10.1182/blood-2013-03-491316; Min YH, 2003, LEUKEMIA, V17, P995, DOI 10.1038/sj.leu.2402874; Myhre S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014002; Ndamukong I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013396; Polak R, 2012, BLOOD, V119, P911, DOI 10.1182/blood-2011-07-366203; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Sarkes D, 2010, BIOCHEM J, V428, P375, DOI 10.1042/BJ20100129; Schulze H, 2006, BLOOD, V107, P3868, DOI 10.1182/blood-2005-07-2755; Somervaille TCP, 2003, BRIT J HAEMATOL, V120, P876, DOI 10.1046/j.1365-2141.2003.04204.x; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Szczepanek J, 2012, J APPL GENET, V53, P83, DOI 10.1007/s13353-011-0073-x; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Vergez F, 2012, CURR TOP MICROBIOL, V362, P163, DOI 10.1007/978-94-007-5025-8_8; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Wilcox A, 2008, FEBS LETT, V582, P1391, DOI 10.1016/j.febslet.2008.03.022; Wiseman DH, 2014, ONCOGENE, V33, P3091, DOI 10.1038/onc.2013.269; Wouters BJ, 2007, BLOOD, V109, P389, DOI 10.1182/blood-2006-08-042325; Xu H, 2013, JNCI-J NATL CANCER I, V105, P733, DOI 10.1093/jnci/djt042; Xu Q, 2003, BLOOD, V102, P972, DOI 10.1182/blood-2002-11-3429; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang L, 2007, CLIN CANCER RES, V13, P5314, DOI 10.1158/1078-0432.CCR-06-2660; Zhao S, 2004, LEUKEMIA, V18, P267, DOI 10.1038/sj.leu.2403220	51	39	42	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 5	2015	34	10					1253	1262		10.1038/onc.2014.77	http://dx.doi.org/10.1038/onc.2014.77			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CC9JX	24681948	Green Accepted			2022-12-25	WOS:000350687100005
J	Dixon, EV; Claridge, JK; Harvey, DJ; Baruah, K; Yu, XJ; Vesiljevic, S; Mattick, S; Pritchard, LK; Krishna, B; Scanlan, CN; Schnell, JR; Higgins, MK; Zitzmann, N; Crispin, M				Dixon, Emma V.; Claridge, Jolyon K.; Harvey, David J.; Baruah, Kavitha; Yu, Xiaojie; Vesiljevic, Snezana; Mattick, Susan; Pritchard, Laura K.; Krishna, Benjamin; Scanlan, Christopher N.; Schnell, Jason R.; Higgins, Matthew K.; Zitzmann, Nicole; Crispin, Max			Fragments of Bacterial Endoglycosidase S and Immunoglobulin G Reveal Subdomains of Each That Contribute to Deglycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody; Antibody engineering; Enzyme Mechanism; Glycoprotein; Glycosylation	LASER-DESORPTION IONIZATION; N-LINKED GLYCANS; STREPTOCOCCUS-PYOGENES; PROTEIN-PRODUCTION; IGG; ENDOS; RECOGNITION; SPEB; SYSTEM; GLYCOSYLATION	Background: Endoglycosidase S (EndoS) is an immune evasion factor from Streptococcus pyogenes that impedes IgG effector functions by deglycosylation. Results: Analysis of fragments of enzyme and substrate identify components of each that contribute to catalysis. Conclusion: Regions outside of the catalytic domain of EndoS contribute to IgG deglycosylation, and catalysis does not require all antibody subunits. Significance: Engineering of EndoS specificity requires consideration of both catalytic and non-catalytic regions. Endoglycosidase S (EndoS) is a glycoside-hydrolase secreted by the bacterium Streptococcus pyogenes. EndoS preferentially hydrolyzes the N-linked glycans from the Fc region of IgG during infection. This hydrolysis impedes Fc functionality and contributes to the immune evasion strategy of S. pyogenes. Here, we investigate the mechanism of human serum IgG deactivation by EndoS. We expressed fragments of IgG1 and demonstrated that EndoS was catalytically active against all of them including the isolated CH2 domain of the Fc domain. Similarly, we sought to investigate which domains within EndoS could contribute to activity. Bioinformatics analysis of the domain organization of EndoS confirmed the previous predictions of a chitinase domain and leucine-rich repeat but also revealed a putative carbohydrate binding module (CBM) followed by a C-terminal region. Using expressed fragments of EndoS, circular dichroism of the isolated CBM, and a CBM-C-terminal region fusion revealed folded domains dominated by sheet and helical structure, respectively. Nuclear magnetic resonance analysis of the CBM with monosaccharides was suggestive of carbohydrate binding functionality. Functional analysis of truncations of EndoS revealed that, whereas the C-terminal of EndoS is dispensable for activity, its deletion impedes the hydrolysis of IgG glycans.	[Dixon, Emma V.; Harvey, David J.; Baruah, Kavitha; Yu, Xiaojie; Vesiljevic, Snezana; Mattick, Susan; Pritchard, Laura K.; Krishna, Benjamin; Scanlan, Christopher N.; Zitzmann, Nicole; Crispin, Max] Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England; [Claridge, Jolyon K.; Schnell, Jason R.; Higgins, Matthew K.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Harvey, David J.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Oxford; University of Oxford; University of Warwick	Crispin, M (corresponding author), Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, South Parks Rd, Oxford OX1 3QU, England.	emma.dixon@msdtc.ox.ac.uk; max.crispin@bioch.ox.ac.uk	yu, xiaojie/GSI-9676-2022; Harvey, David/A-5579-2013; Crispin, Max/AAG-4098-2020	Crispin, Max/0000-0002-1072-2694; Harvey, David/0000-0003-0544-771X; Krishna, Benjamin/0000-0003-0919-2961; Higgins, Matthew/0000-0002-2870-1955	Medical Research Council, UK; Oxford Glycobiology Endowment; Medical Research Council [MC_PC_12020] Funding Source: researchfish; MRC [MC_PC_12020] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Glycobiology Endowment; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Confidence in Concept grant (to M. C. and C.N.S.) from the Medical Research Council, UK, and by a Oxford Glycobiology Endowment.	Abbott DW, 2009, J BIOL CHEM, V284, P11676, DOI 10.1074/jbc.M809663200; Allhorn M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-3; Anumula KR, 2012, J IMMUNOL METHODS, V382, P167, DOI 10.1016/j.jim.2012.05.022; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Baruah K, 2012, J MOL BIOL, V420, P1, DOI 10.1016/j.jmb.2012.04.002; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BORNSEN KO, 1995, RAPID COMMUN MASS SP, V9, P1031, DOI 10.1002/rcm.1290091112; Borrok MJ, 2012, ACS CHEM BIOL, V7, P1596, DOI 10.1021/cb300130k; Bowden TA, 2012, J AM CHEM SOC, V134, P17554, DOI 10.1021/ja306068g; Collin M, 2002, INFECT IMMUN, V70, P6646, DOI 10.1128/IAI.70.12.6646-6651.2002; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Collin M., 2012, ISBT SCI SERIES, V7, P142; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Crispin M, 2013, P NATL ACAD SCI USA, V110, P10059, DOI 10.1073/pnas.1307776110; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Ficko-Blean E, 2012, CURR OPIN STRUC BIOL, V22, P570, DOI 10.1016/j.sbi.2012.07.009; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goodfellow JJ, 2012, J AM CHEM SOC, V134, P8030, DOI 10.1021/ja301334b; Harvey DJ, 2008, ANAL BIOCHEM, V376, P44, DOI 10.1016/j.ab.2008.01.025; Harvey DJ, 2013, ELECTROPHORESIS, V34, P2368, DOI 10.1002/elps.201200669; Harvey DJ, 2009, PROTEOMICS, V9, P3796, DOI 10.1002/pmic.200900096; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Lood C, 2012, ARTHRITIS RHEUM-US, V64, P2698, DOI 10.1002/art.34454; Lund J, 2000, EUR J BIOCHEM, V267, P7246, DOI 10.1046/j.1432-1327.2000.01839.x; Nandakumar KS, 2007, EUR J IMMUNOL, V37, P2973, DOI 10.1002/eji.200737581; Nandakumar KS, 2007, ARTHRITIS RHEUM-US, V56, P3253, DOI 10.1002/art.22930; Nandakumar KS, 2013, P NATL ACAD SCI USA, V110, P10252, DOI 10.1073/pnas.1301480110; Newstead SL, 2005, ACTA CRYSTALLOGR D, V61, P1483, DOI 10.1107/S0907444905026132; Nimmerjahn F, 2010, IMMUNOL REV, V236, P265, DOI 10.1111/j.1600-065X.2010.00910.x; NOSE M, 1983, P NATL ACAD SCI-BIOL, V80, P6632, DOI 10.1073/pnas.80.21.6632; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Sjogren J, 2013, BIOCHEM J, V455, P107, DOI 10.1042/BJ20130126; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; von Pawel-Rammingen U, 2003, CURR OPIN MICROBIOL, V6, P50, DOI 10.1016/S1369-5274(03)00003-1; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Yang R, 2010, NEPHROL DIAL TRANSPL, V25, P2479, DOI 10.1093/ndt/gfq115; Yu XJ, 2013, J AM CHEM SOC, V135, P9723, DOI 10.1021/ja4014375	49	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13876	13889		10.1074/jbc.M113.532812	http://dx.doi.org/10.1074/jbc.M113.532812			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24668806	Green Published, hybrid			2022-12-25	WOS:000335984600020
J	Abdoli, G; Bottai, M; Moradi, T				Abdoli, Gholamreza; Bottai, Matteo; Moradi, Tahereh			Cancer Mortality by Country of Birth, Sex, and Socioeconomic Position in Sweden, 1961-2009	PLOS ONE			English	Article							NEW-SOUTH-WALES; AFRICAN MIGRANTS; PROSTATE-CANCER; ASIAN MIGRANTS; CASE-FATALITY; SWEDISH-BORN; IMMIGRANTS; ENGLAND; WOMEN; RISK	In 2010, cancer deaths accounted for more than 15% of all deaths worldwide, and this fraction is estimated to rise in the coming years. Increased cancer mortality has been observed in immigrant populations, but a comprehensive analysis by country of birth has not been conducted. We followed all individuals living in Sweden between 1961 and 2009 (7,109,327 men and 6,958,714 women), and calculated crude cancer mortality rates and age-standardized rates (ASRs) using the world population for standardization. We observed a downward trend in all-site ASRs over the past two decades in men regardless of country of birth but no such trend was found in women. All-site cancer mortality increased with decreasing levels of education regardless of sex and country of birth (p for trend <0.001). We also compared cancer mortality rates among foreign-born (13.9%) and Sweden-born (86.1%) individuals and determined the effect of education level and sex estimated by mortality rate ratios (MRRs) using multivariable Poisson regression. All-site cancer mortality was slightly higher among foreign-born than Sweden-born men (MRR = 1.05, 95% confidence interval 1.04-1.07), but similar mortality risks was found among foreign-born and Sweden-born women. Men born in Angola, Laos, and Cambodia had the highest cancer mortality risk. Women born in all countries except Iceland, Denmark, and Mexico had a similar or smaller risk than women born in Sweden. Cancer-specific mortality analysis showed an increased risk for cervical and lung cancer in both sexes but a decreased risk for colon, breast, and prostate cancer mortality among foreign-born compared with Sweden-born individuals. Further studies are required to fully understand the causes of the observed inequalities in mortality across levels of education and countries of birth.	[Abdoli, Gholamreza; Moradi, Tahereh] Karolinska Inst, Inst Environm Med, Div Epidemiol, S-10401 Stockholm, Sweden; [Abdoli, Gholamreza] Kermanshah Univ Med Sci, Dept Biostat & Epidemiol, Kermanshah, Iran; [Bottai, Matteo] Karolinska Inst, Inst Environm Med, Biostat Unit, S-10401 Stockholm, Sweden; [Moradi, Tahereh] Healthcare Provis, Ctr Epidemiol & Social Med, Stockholm, Sweden	Karolinska Institutet; Kermanshah University of Medical Sciences; Karolinska Institutet	Abdoli, G (corresponding author), Karolinska Inst, Inst Environm Med, Div Epidemiol, S-10401 Stockholm, Sweden.	gholamreza.abdoli@ki.se	Abdoli, Gholamreza/B-5529-2018	Abdoli, Gholamreza/0000-0001-6972-4646	Kermanshah University of Medical Sciences, Kermanshah, Iran; department of environmental Medicine, Karolinska Institutet, Sweden	Kermanshah University of Medical Sciences, Kermanshah, Iran; department of environmental Medicine, Karolinska Institutet, Sweden	Gholamreza Abdoli doctoral studies are partially supported by The Kermanshah University of Medical Sciences, Kermanshah, Iran(http://www.kumc.ac.ir/home-en.html)and department of environmental Medicine, Karolinska Institutet, Sweden(URL:http://ki.se/ki/jsp/polopoly.jsp?d=1666&I=en). No additional external funding received for this study. "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azerkan F, 2012, INT J CANCER, V130, P937, DOI 10.1002/ijc.26084; BALZI D, 1995, CANCER CAUSE CONTROL, V6, P68, DOI 10.1007/BF00051682; Beiki O, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3086; Beiki O, 2009, INT J CANCER, V124, P1941, DOI 10.1002/ijc.24138; Borne Y, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-20; Bos V, 2004, INT J EPIDEMIOL, V33, P1112, DOI 10.1093/ije/dyh189; BOUCHARDY C, 1994, INT J CANCER, V58, P638, DOI 10.1002/ijc.2910580504; Bouchardy C, 1996, INT J EPIDEMIOL, V25, P5, DOI 10.1093/ije/25.1.5; BOUCHARDY C, 1995, CANCER CAUSE CONTROL, V6, P539, DOI 10.1007/BF00054163; Fernandez E, 1999, BRIT J CANCER, V79, P684, DOI 10.1038/sj.bjc.6690108; GEDDES M, 1991, CANCER CAUSE CONTROL, V2, P133, DOI 10.1007/BF00053133; GRULICH AE, 1992, BRIT J CANCER, V66, P905, DOI 10.1038/bjc.1992.383; Harding S, 2009, EUR J CANCER, V45, P2168, DOI 10.1016/j.ejca.2009.02.029; Ito S, 2008, EUR J PUBLIC HEALTH, V18, P466, DOI 10.1093/eurpub/ckn052; Johansson LA, 2009, J CLIN EPIDEMIOL, V62, P1202, DOI 10.1016/j.jclinepi.2009.01.010; KHLAT M, 1995, CANCER CAUSE CONTROL, V6, P525, DOI 10.1007/BF00054161; Kyobutungi C, 2006, EUR J CANCER, V42, P2577, DOI 10.1016/j.ejca.2006.03.032; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MALLIN K, 1988, INT J CANCER, V41, P670, DOI 10.1002/ijc.2910410506; MATOS EL, 1991, INT J CANCER, V49, P805, DOI 10.1002/ijc.2910490602; McCredie M, 1999, BRIT J CANCER, V79, P1277, DOI 10.1038/sj.bjc.6690205; Moradi Tahereh, 2006, Lakartidningen, V103, P137; Nasseri K, 2011, J IMMIGR MINOR HEALT, V13, P361, DOI 10.1007/s10903-009-9270-7; Ott JJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-110; Public health in Stockholm County, 2007, PUBL HLTH STOCKH CON; Puigpinos R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-35; Razum O, 1998, TROP MED INT HEALTH, V3, P297, DOI 10.1046/j.1365-3156.1998.00233.x; Regidor E, 2008, ANN EPIDEMIOL, V18, P605, DOI 10.1016/j.annepidem.2008.04.007; Ronellenfitsch U, 2009, EUR J GASTROEN HEPAT, V21, P319, DOI 10.1097/MEG.0b013e3283155220; ROSENWAIKE I, 1986, INT J EPIDEMIOL, V15, P30, DOI 10.1093/ije/15.1.30; ROSENWAIKE I, 1988, PUBLIC HEALTH REP, V103, P195; Seeff LC, 2003, CANCER DETECT PREV, V27, P203, DOI 10.1016/S0361-090X(03)00062-X; Singh GK, 2001, AM J PUBLIC HEALTH, V91, P392, DOI 10.2105/AJPH.91.3.392; Smith D, 1996, AUST NZ J PUBL HEAL, V20, P129, DOI 10.1111/j.1753-6405.1996.tb01806.x; Socialstyrelsen, 2010, CAUS DEATH SWED 2010; Spallek J, 2012, EUR J EPIDEMIOL, V27, P915, DOI 10.1007/s10654-012-9746-y; Statistics Sweden, 2006, HIST POP REG; Stirbu I, 2006, INT J CANCER, V119, P2665, DOI 10.1002/ijc.22200; SWERDLOW AJ, 1995, BRIT J CANCER, V72, P1312, DOI 10.1038/bjc.1995.507; SWERDLOW AJ, 1991, INT J EPIDEMIOL, V20, P13, DOI 10.1093/ije/20.1.13; Talback M, 2003, ACTA ONCOL, V42, P637, DOI 10.1080/02841860310013391; Torres-Cintron Mariela, 2012, Prev Chronic Dis, V9, pE15; United Nations Department of Economic and Social Affairs Population Division, 2009, TRENDS INT MIGR STOC; Uthman OA, 2013, J EPIDEMIOL IN PRESS, V67; WANG ZJ, 1989, INT J EPIDEMIOL, V18, P17, DOI 10.1093/ije/18.1.17; Weires M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-340; Wild SH, 2006, BRIT J CANCER, V94, P1079, DOI 10.1038/sj.bjc.6603031; Winkler V, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.9135; Winkler V, 2009, CANCER CAUSE CONTROL, V20, P1873, DOI 10.1007/s10552-009-9381-4; World Health Organization, CANCER; World Health Organization, 2022, CANCER; Yang D, 2012, EUR J PREV CARDIOL, V19, P1304, DOI 10.1177/1741826711425340	52	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93174	10.1371/journal.pone.0093174	http://dx.doi.org/10.1371/journal.pone.0093174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0TC	24682217	Green Published, Green Submitted, gold			2022-12-25	WOS:000333678100030
J	McCormick, N; Lacaille, D; Bhole, V; Avina-Zubieta, JA				McCormick, Natalie; Lacaille, Diane; Bhole, Vidula; Avina-Zubieta, J. Antonio			Validity of Myocardial Infarction Diagnoses in Administrative Databases: A Systematic Review	PLOS ONE			English	Review							CORONARY-HEART-DISEASE; POSITIVE PREDICTIVE-VALUE; HOSPITAL DISCHARGE REGISTER; 1ST NATIONS POPULATION; CARDIOVASCULAR-DISEASE; RHEUMATOID-ARTHRITIS; LUPUS-ERYTHEMATOSUS; MORTALITY STATISTICS; EUROPEAN-SOCIETY; CODING ACCURACY	Background: Though administrative databases are increasingly being used for research related to myocardial infarction (MI), the validity of MI diagnoses in these databases has never been synthesized on a large scale. Objective: To conduct the first systematic review of studies reporting on the validity of diagnostic codes for identifying MI in administrative data. Methods: MEDLINE and EMBASE were searched (inception to November 2010) for studies: (a) Using administrative data to identify MI; or (b) Evaluating the validity of MI codes in administrative data; and (c) Reporting validation statistics (sensitivity, specificity, positive predictive value (PPV), negative predictive value, or Kappa scores) for MI, or data sufficient for their calculation. Additonal articles were located by handsearch (up to February 2011) of original papers. Data were extracted by two independent reviewers; article quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies tool. Results: Thirty studies published from 1984-2010 were included; most assessed codes from the International Classification of Diseases (ICD)-9 th revision. Sensitivity and specificity of hospitalization data for identifying MI in most [>= 50%] studies was >= 86%, and PPV in most studies was >= 93%. The PPV was higher in the more-recent studies, and lower when criteria that do not incorporate cardiac troponin levels (such as the MONICA) were employed as the gold standard. MI as a cause-of-death on death certificates also demonstrated lower accuracy, with maximum PPV of 60% (for definite MI). Conclusions: Hospitalization data has higher validity and hence can be used to identify MI, but the accuracy of MI as a cause-of-death on death certificates is suboptimal, and more studies are needed on the validity of ICD-10 codes. When using administrative data for research purposes, authors should recognize these factors and avoid using vital statistics data if hospitalization data is not available to confirm deaths from MI.	[McCormick, Natalie] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [McCormick, Natalie; Lacaille, Diane; Bhole, Vidula; Avina-Zubieta, J. Antonio] Arthrit Res Ctr Canada, Richmond, BC, Canada; [Lacaille, Diane; Bhole, Vidula; Avina-Zubieta, J. Antonio] Univ British Columbia, Dept Med, Div Rheumatol, Vancouver, BC, Canada; [Lacaille, Diane; Avina-Zubieta, J. Antonio] CANRAD Network, Cardiovasc Comm, Richmond, BC, Canada; EpiSolut Consultancy Serv, Thana, India	University of British Columbia; University of British Columbia	Avina-Zubieta, JA (corresponding author), Arthrit Res Ctr Canada, Richmond, BC, Canada.	azubieta@arthritisresearch.ca		McCormick, Natalie/0000-0002-4147-8348	Canadian Arthritis Network; Arthritis Society of Canada	Canadian Arthritis Network; Arthritis Society of Canada	This study was funded in part by the Canadian Arthritis Network (http://www.arthritisnetwork.ca). JAAZ held a salary award from the Canadian Arthritis Network and The Arthritis Society of Canada. He is currently the British Columbia Lupus Society Scholar. DL holds the Mary Pack Chair in Arthritis Research from UBC and The Arthritis Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainla T, 2006, SCAND J PUBLIC HEALT, V34, P327, DOI 10.1080/14034940500242019; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; [Anonymous], 1989, Can J Public Health, V80, P412; [Anonymous], 1992, Can J Cardiol, V8, P253; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Barber C, 2013, ARTHRIT CARE RES, V65, P1343, DOI 10.1002/acr.21959; Barchielli A, 2012, J EPIDEMIOL COMMUN H, V66, P462, DOI 10.1136/jech.2010.110908; Barnabe C, 2012, ARTHRIT CARE RES, V64, P1715, DOI 10.1002/acr.21743; Barnabe C, 2012, ARTHRIT CARE RES, V64, P138, DOI 10.1002/acr.20656; BEAGLEHOLE R, 1987, AUST NZ J MED, V17, P43, DOI 10.1111/j.1445-5994.1987.tb05048.x; Bernatsky S, 2007, RHEUMATOLOGY, V46, P1814, DOI 10.1093/rheumatology/kem233; Bernatsky S, 2011, RHEUMATOL INT, V31, P549, DOI 10.1007/s00296-010-1591-2; Bernatsky S, 2013, J RHEUMATOL, V40, P66, DOI 10.3899/jrheum.120835; BOYLE CA, 1995, AUST NZ J MED, V25, P316, DOI 10.1111/j.1445-5994.1995.tb01896.x; Chen GM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-5; De Henauw S, 1998, J EPIDEMIOL COMMUN H, V52, P513, DOI 10.1136/jech.52.8.513; De Vera MA, 2010, ANN RHEUM DIS, V69, P1162, DOI 10.1136/ard.2009.122770; Fischer LM, 2004, AM J CARDIOL, V93, P198, DOI 10.1016/j.amjcard.2003.09.037; Gonzalez A, 2008, ANN RHEUM DIS, V67, P64, DOI 10.1136/ard.2006.059980; Hammar N, 2001, INT J EPIDEMIOL, V30, pS30, DOI 10.1093/ije/30.suppl_1.S30; Health statistics and informatics department World Health Organization, 2011, CAUS DEATH 2008 SUMM; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; Heisler CA, 2009, J AM COLL SURGEONS, V209, P119, DOI 10.1016/j.jamcollsurg.2009.03.017; Henderson T, 2006, MED CARE, V44, P1011, DOI 10.1097/01.mlr.0000228018.48783.34; Hudson M, 2013, J CLIN EPIDEMIOL, V66, P278, DOI 10.1016/j.jclinepi.2012.10.004; Humphries KH, 2000, J CLIN EPIDEMIOL, V53, P343, DOI 10.1016/S0895-4356(99)00188-2; Ingelsson E, 2005, EUR J HEART FAIL, V7, P787, DOI 10.1016/j.ejheart.2004.12.007; JACKSON R, 1988, NEW ZEAL MED J, V101, P658; Kavsak PA, 2006, AM HEART J, V152, P118, DOI 10.1016/j.ahj.2005.09.022; KENNEDY GT, 1984, AM J CARDIOL, V53, P1000, DOI 10.1016/0002-9149(84)90625-8; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kontos MC, 2003, AM HEART J, V146, P446, DOI 10.1016/S0002-8703(03)00245-X; Kopec JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P929, DOI 10.1002/art.23827; Kramer MS, 1988, CLIN EPIDEMIOLOGY BI, P236; Kuo CF, 2013, RHEUMATOLOGY, V52, P111, DOI 10.1093/rheumatology/kes169; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733; Levy AR, 1999, CAN J CARDIOL, V15, P1277; LINDBLAD U, 1993, SCAND J SOC MED, V21, P3, DOI 10.1177/140349489302100102; LOWEL H, 1991, J CLIN EPIDEMIOL, V44, P249, DOI 10.1016/0895-4356(91)90036-9; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Mahonen M, 1997, EUR J EPIDEMIOL, V13, P403, DOI 10.1023/A:1007306110822; Mahonen M, 1999, J CLIN EPIDEMIOL, V52, P157, DOI 10.1016/S0895-4356(98)00145-0; McCarthy EP, 2000, MED CARE, V38, P868, DOI 10.1097/00005650-200008000-00010; Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38; Merry AHH, 2009, EUR J EPIDEMIOL, V24, P237, DOI 10.1007/s10654-009-9335-x; Office of Cardiovascular Diseases World Health Organization, 1999, MONICA MAN COR EV RE; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; PALOMAKI P, 1994, J CLIN EPIDEMIOL, V47, P659, DOI 10.1016/0895-4356(94)90213-5; Parikh NI, 2009, CIRCULATION, V119, P1203, DOI 10.1161/CIRCULATIONAHA.108.825364; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Pladevall M, 1996, INT J EPIDEMIOL, V25, P948, DOI 10.1093/ije/25.5.948; Rahman MM, 2013, ARTHRIT CARE RES, V65, P1951, DOI 10.1002/acr.22092; Rapola JM, 1997, EUR J EPIDEMIOL, V13, P133, DOI 10.1023/A:1007380408729; Rawson NSB, 1995, STAT MED, V14, P2627, DOI 10.1002/sim.4780142404; Roger VL, 2010, CIRCULATION, V121, P863, DOI 10.1161/CIRCULATIONAHA.109.897249; Rosamond WD, 2004, AM J EPIDEMIOL, V160, P1137, DOI 10.1093/aje/kwh341; Salomaa V, 2005, EUR HEART J, V26, P1719, DOI 10.1093/eurheartj/ehi185; Salomaa V, 2006, EUROPREVENT ANN C EU; Scherrer JF, 2010, AM HEART J, V159, P772, DOI 10.1016/j.ahj.2010.02.033; Soedamah-Muthu SS, 2006, DIABETES CARE, V29, P798, DOI 10.2337/diacare.29.04.06.dc05-1433; Solomon DH, 2006, ARTHRITIS RHEUM-US, V54, P3790, DOI 10.1002/art.22255; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; VANWALRAVEN C, 1990, CAN J CARDIOL, V6, P383; Varas-Lorenzo C, 2008, PHARMACOEPIDEM DR S, V17, P842, DOI 10.1002/pds.1619; Varas-Lorenzo C, 2007, ATHEROSCLEROSIS, V192, P376, DOI 10.1016/j.atherosclerosis.2006.05.019; Wahl PM, 2010, PHARMACOEPIDEM DR S, V19, P596, DOI 10.1002/pds.1924; Watson DJ, 2003, J RHEUMATOL, V30, P1196; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Widdifield J, 2013, ARTHRIT CARE RES, V65, P1490, DOI 10.1002/acr.21993	71	171	175	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e92286	10.1371/journal.pone.0092286	http://dx.doi.org/10.1371/journal.pone.0092286			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0TC	24682186	gold, Green Published, Green Submitted			2022-12-25	WOS:000333678100008
J	Diawara, MR; Hue, C; Wilder, SP; Venteclef, N; Aron-Wisnewsky, J; Scott, J; Clement, K; Gauguier, D; Calderari, S				Diawara, Malika R.; Hue, Christophe; Wilder, Steven P.; Venteclef, Nicolas; Aron-Wisnewsky, Judith; Scott, James; Clement, Karine; Gauguier, Dominique; Calderari, Sophie			Adaptive Expression of MicroRNA-125a in Adipose Tissue in Response to Obesity in Mice and Men	PLOS ONE			English	Article							INSULIN TARGET TISSUES; SPONTANEOUS RAT MODEL; 3T3-L1 ADIPOCYTES; GLUCOSE; RESISTANCE; CELLS; SENSITIVITY; METABOLISM; ACTIVATION; PROFILES	MicroRNAs are emerging as new mediators in the regulation of adipose tissue biology and the development of obesity. An important role of microRNA-125a has been suggested in the pathogenesis of insulin resistance (IR). Here, we characterized the function of microRNA-125a in adipose tissue in a context of experimentally-induced IR and obesity in mice and in obese patients. We showed time dependent overexpression of the microRNA in adipose tissue of BALB/c and C57BL/6J mice in response to high fat diet (HFD) feeding. MicroRNA-125a expression was downregulated in vitro in insulin resistant 3T3-L1 adipocytes and ex vivo in adipose tissue of obese patients. In vitro modulation of microRNA-125a expression in 3T3-L1 adipocytes did not affect glucose uptake. Gene set enrichment analysis (GSEA) identified significantly altered expression patterns of predicted microRNA-125a gene targets in transcriptomic datasets of adipose tissue from HFD-fed mice and obese patients. Among genes that contributed to global enrichment of altered expression of microRNA-125a targets, Thyrotroph embryonic factor (Tef), Mannan-binding lectin serine peptidase 1, Reticulon 2 and Ubiquitin-conjugating enzyme E2L3 were significantly differentially expressed in adipose tissue in these groups. We showed that Tef expression is reduced in adipose tissue of obese patients following gastric bypass surgery. Our findings indicate that microRNA-125a expression in adipose tissue adapts to IR and may play a role in the development of obesity in mice and obese subjects through uncoupled regulation of the expression of microRNA-125a and its targets.	[Diawara, Malika R.; Hue, Christophe; Venteclef, Nicolas; Aron-Wisnewsky, Judith; Clement, Karine; Gauguier, Dominique; Calderari, Sophie] Univ Paris 06, Cordeliers Res Ctr, INSERM, UMRS 872, Paris, France; [Diawara, Malika R.; Hue, Christophe; Venteclef, Nicolas; Aron-Wisnewsky, Judith; Clement, Karine; Gauguier, Dominique; Calderari, Sophie] Univ Paris 06, Pitie Salpetriere Hosp, ICAN, Inst Cardiometab & Nutr, Paris, France; [Wilder, Steven P.; Gauguier, Dominique] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Scott, James] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Oxford; Wellcome Centre for Human Genetics; Imperial College London	Calderari, S (corresponding author), Univ Paris 06, Cordeliers Res Ctr, INSERM, UMRS 872, Paris, France.	sophie.calderari@crc.jussieu.fr	Venteclef, Nicolas/K-8484-2017; ARON-WISNEWSKY, judith/AAH-7608-2020; Clément, karine/R-1120-2017; Gauguier, Dominique/G-2190-2016	Gauguier, Dominique/0000-0001-6156-9530; Wilder, Steven/0000-0001-8049-2559; Calderari, Sophie/0000-0002-9669-681X; Venteclef, Nicolas/0000-0002-6313-1214	Wellcome Functional Genomics Initiative BAIR (Biological Atlas of IR) [066786]; European Community [LSHG-CT-2006-037683]; Societe Francophone du Diabete; Institute of Cardiometabolism and Nutrition (ICAN) [ANR-10-IAHU-05]; Wellcome Senior Fellowship in Basic Biomedical Science [057733]; Ile de France region (CORDDIM); The Direction of Clinical Research (CRC) [PHRC 02076]; The Direction of Clinical Research (CRC) (CRC FIBROTA)	Wellcome Functional Genomics Initiative BAIR (Biological Atlas of IR); European Community(European Commission); Societe Francophone du Diabete; Institute of Cardiometabolism and Nutrition (ICAN); Wellcome Senior Fellowship in Basic Biomedical Science; Ile de France region (CORDDIM)(Region Ile-de-France); The Direction of Clinical Research (CRC); The Direction of Clinical Research (CRC) (CRC FIBROTA)	This work was supported by grants from the Wellcome Functional Genomics Initiative BAIR (Biological Atlas of IR) (066786), the European Community's Sixth Framework Programme under the grant agreement LSHG-CT-2006-037683 (FGENTCARD), the Societe Francophone du Diabete, the Institute of Cardiometabolism and Nutrition (ICAN, ANR-10-IAHU-05) and a Wellcome Senior Fellowship in Basic Biomedical Science (057733) to D. Gauguier. M. Diawara is supported by a PhD studentship from the Ile de France region (CORDDIM). The Direction of Clinical Research (CRC) promoted and supported clinical investigations (PHRC 02076 and CRC FIBROTA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bengestrate L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021305; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carrano AC, 2009, NATURE, V460, P396, DOI 10.1038/nature08130; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Dalmas E, 2011, AM J CLIN NUTR, V94, P450, DOI 10.3945/ajcn.111.013771; Dirksen C, 2012, DIABETOLOGIA, V55, P1890, DOI 10.1007/s00125-012-2556-7; Fearnside JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001668; Fernandez-Valverde SL, 2011, DIABETES, V60, P1825, DOI 10.2337/db11-0171; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Gachon F, 2011, P NATL ACAD SCI USA, V108, P4794, DOI 10.1073/pnas.1002862108; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Gunaratne PH, 2010, METHODS MOL BIOL, V667, P297, DOI 10.1007/978-1-60761-811-9_20; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Herrera BM, 2010, DIABETOLOGIA, V53, P1099, DOI 10.1007/s00125-010-1667-2; Herrera BM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-54; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ikemoto T, 2009, DIABETES, V58, P2802, DOI 10.2337/db09-0756; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kallio P, 2009, INT J OBESITY, V33, P80, DOI 10.1038/ijo.2008.196; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Ling HY, 2009, CLIN EXP PHARMACOL P, V36, pe32, DOI 10.1111/j.1440-1681.2009.05207.x; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; Nugent C, 2001, MOL ENDOCRINOL, V15, P1729, DOI 10.1210/me.15.10.1729; Oskowitz AZ, 2008, P NATL ACAD SCI USA, V105, P18372, DOI 10.1073/pnas.0809807105; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; PORTHA B, 1991, DIABETES, V40, P486, DOI 10.2337/diabetes.40.4.486; Potenza N, 2013, MOL GENET GENOMICS; Ross SA, 2000, BIOCHEM BIOPH RES CO, V273, P1033, DOI 10.1006/bbrc.2000.3082; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun YM, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-6; Thomson MJ, 1997, J BIOL CHEM, V272, P7759, DOI 10.1074/jbc.272.12.7759; Toye AA, 2007, DIABETOLOGIA, V50, P1867, DOI 10.1007/s00125-007-0738-5; West DB, 1998, AM J CLIN NUTR, V67, p505S, DOI 10.1093/ajcn/67.3.505S; Wilder SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-63	39	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e91375	10.1371/journal.pone.0091375	http://dx.doi.org/10.1371/journal.pone.0091375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675842	gold, Green Published, Green Submitted			2022-12-25	WOS:000333677500014
J	Dubelman, S; Fischer, J; Zapata, F; Huizinga, K; Jiang, CJ; Uffman, J; Levine, S; Carson, D				Dubelman, Samuel; Fischer, Joshua; Zapata, Fatima; Huizinga, Kristin; Jiang, Changjian; Uffman, Joshua; Levine, Steven; Carson, David			Environmental Fate of Double-Stranded RNA in Agricultural Soils	PLOS ONE			English	Article							CRY1AB PROTEIN; DNA; DEGRADATION; PERSISTENCE; BIOASSAY; SEAWATER; CROPS	A laboratory soil degradation study was conducted to determine the biodegradation potential of a DvSnf7 dsRNA transcript derived from a Monsanto genetically modified (GM) maize product that confers resistance to corn rootworm (CRW; Diabrotica spp.). This study provides new information to improve the environmental assessment of dsRNAs that become pesticidal through an RNAi process. Three agricultural soils differing in their physicochemical characteristics were obtained from the U. S., Illinois (IL; silt loam), Missouri (MO; loamy sand) and North Dakota (ND; clay loam), and exposed to the target dsRNA by incorporating insect-protected maize biomass and purified (in vitro-transcribed) DvSnf7 RNA into soil. The GM and control (non-GM maize) materials were added to each soil and incubated at ca. 22 degrees C for 48 hours (h). Samples were collected at 12 time intervals during the incubation period, extracted, and analyzed using QuantiGene molecular analysis and insect bioassay methods. The DT50 (half-life) values for DvSnf7 RNA in IL, MO, and ND soils were 19, 28, and 15 h based on QuantiGene, and 18, 29, and 14 h based on insect bioassay, respectively. Furthermore, the DT90 (time to 90% degradation) values for DvSnf7 RNA in all three soils were <35 h. These results indicate that DvSnf7 RNA was degraded and biological activity was undetectable within approximately 2 days after application to soil, regardless of texture, pH, clay content and other soil differences. Furthermore, soil-incorporated DvSnf7 RNA was non-detectable in soil after 48 h, as measured by QuantiGene, at levels ranging more than two orders of magnitude (0.3, 1.5, 7.5 and 37.5 mu g RNA/g soil). Results from this study indicate that the DvSnf7 dsRNA is unlikely to persist or accumulate in the environment. Furthermore, the rapid degradation of DvSnf7 dsRNA provides a basis to define relevant exposure scenarios for future RNA-based agricultural products.	[Dubelman, Samuel; Fischer, Joshua; Zapata, Fatima; Huizinga, Kristin; Jiang, Changjian; Uffman, Joshua; Levine, Steven; Carson, David] Monsanto Co, Regulatory Div, St Louis, MO 63167 USA	Monsanto	Dubelman, S (corresponding author), Monsanto Co, Regulatory Div, St Louis, MO 63167 USA.	samuel.dubelman@monsanto.com			Monsanto Company	Monsanto Company	Monsanto Company funded this study. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Armstrong TA, 2013, J AGR FOOD CHEM, V61, P12557, DOI 10.1021/jf4031458; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Auer C, 2009, TRENDS BIOTECHNOL, V27, P644, DOI 10.1016/j.tibtech.2009.08.005; Badea EM, 2010, ROM BIOTECH LETT, V15, P55; Blum SAE, 1997, SYST APPL MICROBIOL, V20, P513, DOI 10.1016/S0723-2020(97)80021-5; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; CARSON DB, 1990, AM SOC TEST MATER, V1096, P48, DOI 10.1520/STP20098S; CRIPE CR, 1990, AM SOC TEST MATER, V1096, P29, DOI 10.1520/STP20097S; Dancer D, 2010, J FOOD PROTECT, V73, P2123, DOI 10.4315/0362-028X-73.11.2123; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DONEGAN KK, 1995, APPL SOIL ECOL, V2, P111, DOI 10.1016/0929-1393(94)00043-7; Dubelman S, 2005, ENVIRON ENTOMOL, V34, P915, DOI 10.1603/0046-225X-34.4.915; England LS, 1998, WORLD J MICROB BIOT, V14, P163, DOI 10.1023/A:1008865609698; England LS, 2003, RIV BIOL-BIOL FORUM, V96, P317; GLEDHILL WE, 1991, CHEMOSPHERE, V22, P873, DOI 10.1016/0045-6535(91)90245-9; GREAVES M P, 1970, Soil Biology and Biochemistry, V2, P257, DOI 10.1016/0038-0717(70)90032-5; GREEN PJ, 1994, ANNU REV PLANT PHYS, V45, P421, DOI 10.1146/annurev.pp.45.060194.002225; Gruber H, 2012, TRANSGENIC RES, V21, P77, DOI 10.1007/s11248-011-9509-7; Gulden RH, 2005, J AGR FOOD CHEM, V53, P5858, DOI 10.1021/jf0504667; Head G, 2002, ENVIRON ENTOMOL, V31, P30, DOI 10.1603/0046-225X-31.1.30; Herman RA, 2002, J AGR FOOD CHEM, V50, P7076, DOI 10.1021/jf025630u; Icoz I, 2008, SOIL BIOL BIOCHEM, V40, P559, DOI 10.1016/j.soilbio.2007.11.002; Iida T, 2006, CURR BIOL, V16, P1459, DOI 10.1016/j.cub.2006.05.061; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Keown H., 2004, New Zealand Natural Sciences, V29, P13; Levy-Booth DJ, 2008, J AGR FOOD CHEM, V56, P6339, DOI 10.1021/jf800767g; Levy-Booth DJ, 2007, SOIL BIOL BIOCHEM, V39, P2977, DOI 10.1016/j.soilbio.2007.06.020; Lundgren JG, 2013, BIOSCIENCE, V63, P657, DOI 10.1525/bio.2013.63.8.8; Miller SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047431; NOVITSKY JA, 1986, APPL ENVIRON MICROB, V52, P504, DOI 10.1128/AEM.52.3.504-509.1986; Palm CJ, 1996, CAN J MICROBIOL, V42, P1258, DOI 10.1139/m96-163; Pietramellara G, 2007, BIOL FERT SOILS, V43, P731, DOI 10.1007/s00374-008-0345-8; Pote J, 2005, CHEMOSPHERE, V61, P677, DOI 10.1016/j.chemosphere.2005.03.030; Ramaseshadri P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054270; Sims SR, 1996, ENVIRON ENTOMOL, V25, P659, DOI 10.1093/ee/25.3.659; Sims SR, 1997, J AGR FOOD CHEM, V45, P1502, DOI 10.1021/jf960647w; TSAI YL, 1995, APPL ENVIRON MICROB, V61, P363, DOI 10.1128/AEM.61.1.363-366.1995; US EPA, 1998, FED REGISTER; VANEWIJK PH, 1993, ECOTOX ENVIRON SAFE, V25, P25, DOI 10.1006/eesa.1993.1003	39	90	99	6	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93155	10.1371/journal.pone.0093155	http://dx.doi.org/10.1371/journal.pone.0093155			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676387	Green Submitted, gold, Green Published			2022-12-25	WOS:000333677500084
J	Saitou, T; Kajiwara, K; Oneyama, C; Suzuki, T; Okada, M				Saitou, Takashi; Kajiwara, Kentaro; Oneyama, Chitose; Suzuki, Takashi; Okada, Masato			Roles of Raft-Anchored Adaptor Cbp/PAG1 in Spatial Regulation of c-Src Kinase	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASE; FOCAL ADHESION KINASE; FAMILY KINASES; SCAFFOLD PROTEINS; ACTIVATION; CSK; LYN; TRANSFORMATION; BINDING; CANCER	The tyrosine kinase c-Src is upregulated in numerous human cancers, implying a role for c-Src in cancer progression. Previously, we have shown that sequestration of activated c-Src into lipid rafts via a transmembrane adaptor, Cbp/PAG1, efficiently suppresses c-Src-induced cell transformation in Csk-deficient cells, suggesting that the transforming activity of c-Src is spatially regulated via Cbp in lipid rafts. To dissect the molecular mechanisms of the Cbp-mediated regulation of c-Src, a combined analysis was performed that included mathematical modeling and in vitro experiments in a c-Src-or Cbpinducible system. c-Src activity was first determined as a function of c-Src or Cbp levels, using focal adhesion kinase (FAK) as a crucial c-Src substrate. Based on these experimental data, two mathematical models were constructed, the sequestration model and the ternary model. The computational analysis showed that both models supported our proposal that raft localization of Cbp is crucial for the suppression of c-Src function, but the ternary model, which includes a ternary complex consisting of Cbp, c-Src, and FAK, also predicted that c-Src function is dependent on the lipid-raft volume. Experimental analysis revealed that c-Src activity is elevated when lipid rafts are disrupted and the ternary complex forms in non-raft membranes, indicating that the ternary model accurately represents the system. Moreover, the ternary model predicted that, if Cbp enhances the interaction between c-Src and FAK, Cbp could promote c-Src function when lipid rafts are disrupted. These findings underscore the crucial role of lipid rafts in the Cbp-mediated negative regulation of c-Src-transforming activity, and explain the positive role of Cbp in c-Src regulation under particular conditions where lipid rafts are perturbed.	[Saitou, Takashi] Ehime Univ, Grad Sch Med, Dept Mol Med Pathogenesis, Toon, Ehime, Japan; [Kajiwara, Kentaro; Oneyama, Chitose; Okada, Masato] Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 565, Japan; [Suzuki, Takashi] Osaka Univ, Grad Sch Engn Sci, Dept Syst Innovat, Div Math Sci, Toyonaka, Osaka 560, Japan; [Suzuki, Takashi] JST, CREST, Chiyoda Ku, Tokyo, Japan	Ehime University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Saitou, T (corresponding author), Ehime Univ, Grad Sch Med, Dept Mol Med Pathogenesis, Toon, Ehime, Japan.	t-saito@m.ehime-u.ac.jp; kajiwara@biken.osaka-u.ac.jp	Saitou, Takshi/AAF-2355-2019	Saitou, Takashi/0000-0003-0532-8112; Kajiwara, Kentaro/0000-0001-7574-4010	Japan Science Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST)	Japan Science Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST)	This work was supported by the Japan Science Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arold ST, 2011, CURR OPIN STRUC BIOL, V21, P808, DOI 10.1016/j.sbi.2011.09.008; Barua D, 2012, J IMMUNOL, V189, P646, DOI 10.4049/jimmunol.1102003; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Fuss H, 2008, BIOPHYS J, V94, P1995, DOI 10.1529/biophysj.107.115022; Fuss H, 2007, J COMPUT BIOL, V14, P1185, DOI 10.1089/cmb.2007.0095; Fuss H, 2006, BIOINFORMATICS, V22, pE158, DOI 10.1093/bioinformatics/btl201; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Ingley E, 2006, J BIOL CHEM, V281, P31920, DOI 10.1074/jbc.M602637200; Inoue K, 2009, GENE THER, V16, P1383, DOI 10.1038/gt.2009.105; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; Kaimachnikov NP, 2009, FEBS J, V276, P4102, DOI 10.1111/j.1742-4658.2009.07117.x; Kajiwara K, 2013, BIOCHEM J, V458, P81; Kanou T, 2011, MOL CANCER RES, V9, P103, DOI 10.1158/1541-7786.MCR-10-0340; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; OKADA M, 1991, J BIOL CHEM, V266, P24249; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Oneyama C, 2008, GENES CELLS, V13, P1, DOI 10.1111/j.1365-2443.2007.01145.x; Oneyama C, 2009, MOL CELL BIOL, V29, P6462, DOI 10.1128/MCB.00941-09; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Shima T, 2003, P NATL ACAD SCI USA, V100, P14897, DOI 10.1073/pnas.2432139100; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Solheim SA, 2008, FEBS J, V275, P4863, DOI 10.1111/j.1742-4658.2008.06626.x; Solheim SA, 2008, J BIOL CHEM, V283, P2773, DOI 10.1074/jbc.M705215200; Stites EC, 2007, SCIENCE, V318, P463, DOI 10.1126/science.1144642; Suzuki K, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.195362; Takeuchi S, 2000, J BIOL CHEM, V275, P29183, DOI 10.1074/jbc.C000326200; Tauzin S, 2008, BLOOD, V111, P2310, DOI 10.1182/blood-2007-05-090985; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Tomar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044041; Wang WQ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-49; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	50	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93470	10.1371/journal.pone.0093470	http://dx.doi.org/10.1371/journal.pone.0093470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675741	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677500128
J	Tamboli, IY; Heo, D; Rebeck, GW				Tamboli, Irfan Y.; Heo, Dongeun; Rebeck, G. William			Extracellular Proteolysis of Apolipoprotein E (apoE) by Secreted Serine Neuronal Protease	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AMYLOID-BETA-PROTEIN; ALZHEIMERS-DISEASE; A-BETA; NEUTROPHIL SUPEROXIDE; BRAIN; INFLAMMATION; ALPHA-1-ANTICHYMOTRYPSIN; IDENTIFICATION; GLYCOSYLATION	Under normal conditions, brain apolipoprotein E (apoE) is secreted and lipidated by astrocytes, then taken up by neurons via receptor mediated endocytosis. Free apoE is either degraded in intraneuronal lysosomal compartments or released. Here we identified a novel way by which apoE undergoes proteolysis in the extracellular space via a secreted neuronal protease. We show that apoE is cleaved in neuronal conditioned media by a secreted serine protease. This apoE cleavage was inhibited by PMSF and alpha 1-antichymotrypsin, but not neuroserpin-1 or inhibitors of thrombin and cathepsin G, supporting its identity as a chymotrypsin like protease. In addition, apoE incubation with purified chymotrypsin produced a similar pattern of apoE fragments. Analysis of apoE fragments by mass spectrometry showed cleavages occuring at the C-terminal side of apoE tryptophan residues, further supporting our identification of cleavage by chymotrypsin like protease. Hippocampal neurons were more efficient in mediating this apoE cleavage than cortical neurons. Proteolysis of apoE4 generated higher levels of low molecular weight fragments compared to apoE3. Primary glial cultures released an inhibitor of this proteolytic activity. Together, these studies reveal novel mechanism by which apoE can be regulated and therefore could be useful in designing apoE directed AD therapeutic approaches.	[Tamboli, Irfan Y.; Heo, Dongeun; Rebeck, G. William] Georgetown Univ, Dept Neurosci, Washington, DC 20057 USA	Georgetown University	Rebeck, GW (corresponding author), Georgetown Univ, Dept Neurosci, Washington, DC 20057 USA.	gwr2@georgetown.edu	Rebeck, George William/J-2192-2012	Rebeck, George William/0000-0001-6276-248X	National Institute of Aging, Bethesda, MD, USA [R01 AG035379, P01 AG030128-01]; NATIONAL INSTITUTE ON AGING [P01AG030128, R01AG035379] Funding Source: NIH RePORTER	National Institute of Aging, Bethesda, MD, USA; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research was funded by two grants [R01 AG035379 -National Institute of Aging (Rebeck) P01 AG030128-01 -National Institute of Aging ( Rebeck)] from National Institute of Aging, Bethesda, MD 20892, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham CR, 2001, NEUROBIOL AGING, V22, P931, DOI 10.1016/S0197-4580(01)00302-5; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Aizawa Y, 1997, BRAIN RES, V768, P208, DOI 10.1016/S0006-8993(97)00640-9; Baker C, 2007, FRONT BIOSCI, V12, P2821, DOI 10.2741/2275; Belinson H, 2009, J ALZHEIMERS DIS, V17, P469, DOI 10.3233/JAD-2009-1065; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Cho HS, 2001, J NEUROPATH EXP NEUR, V60, P342, DOI 10.1093/jnen/60.4.342; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Czirr E, 2012, J CLIN INVEST, V122, P1156, DOI 10.1172/JCI58656; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Elliott DA, 2011, NEUROBIOL AGING, V32, P257, DOI 10.1016/j.neurobiolaging.2009.02.006; Ghosal K, 2013, NEURODEGENER DIS, V12, P51, DOI 10.1159/000341299; Gorodkiewicz E, 2011, MICROCHIM ACTA, V173, P407, DOI 10.1007/s00604-011-0569-4; GREGG RE, 1986, J CLIN INVEST, V78, P815, DOI 10.1172/JCI112645; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Hawkes CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041636; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; Hyman BT, 2000, ARCH NEUROL-CHICAGO, V57, P646, DOI 10.1001/archneur.57.5.646; Irizarry MC, 2000, ACTA NEUROPATHOL, V100, P451, DOI 10.1007/s004010000263; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jones PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014586; Kanemaru K, 1996, NEUROBIOL AGING, V17, P767; KILPATRICK L, 1991, J IMMUNOL, V146, P2388; Kim J, 2012, J EXP MED, V209, P2149, DOI 10.1084/jem.20121274; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kline A, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt135; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Leduc Valerie, 2011, Int J Alzheimers Dis, V2011, P974361, DOI 10.4061/2011/974361; Lee CJ, 2011, BRIT J CLIN PHARMACO, V72, P581, DOI 10.1111/j.1365-2125.2011.03916.x; Lee Y, 2010, MOL CELL PROTEOMICS, V9, P1968, DOI 10.1074/mcp.M900430-MCP200; Licastro F, 1999, AM J PATHOL, V155, P869, DOI 10.1016/S0002-9440(10)65186-3; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mahley RW, 2012, J MED CHEM, V55, P8997, DOI 10.1021/jm3008618; Mandrekar-Colucci S, 2010, CNS NEUROL DISORD-DR, V9, P156, DOI 10.2174/187152710791012071; Marques MA, 2004, J MOL NEUROSCI, V24, P73, DOI 10.1385/JMN:24:1:073; Masters CL, 1998, BRIT MED J, V316, P446, DOI 10.1136/bmj.316.7129.446; Minami SS, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-16; Miranda E, 2006, CELL MOL LIFE SCI, V63, P709, DOI 10.1007/s00018-005-5077-4; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Nakamura T, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-35; Pocivavsek A, 2009, GLIA, V57, P444, DOI 10.1002/glia.20772; Porcellini E, 2008, CURR PHARM DESIGN, V14, P2659, DOI 10.2174/138161208786264151; Potter H, 2001, NEUROBIOL AGING, V22, P923, DOI 10.1016/S0197-4580(01)00308-6; REBECK GW, 1993, NEURON, V11, P575; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Sadowski MJ, 2006, P NATL ACAD SCI USA, V103, P18787, DOI 10.1073/pnas.0604011103; SCHUSTER MG, 1992, J BIOL CHEM, V267, P5056; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Shuvaev VV, 1999, BBA-MOL BASIS DIS, V1454, P296, DOI 10.1016/S0925-4439(99)00047-2; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011; Tai Leon M, 2011, Int J Alzheimers Dis, V2011, P810981, DOI 10.4061/2011/810981; Tamboli IY, 2008, J NEUROSCI, V28, P12097, DOI 10.1523/JNEUROSCI.2635-08.2008; Tanzi RE, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006296; Terwel D, 2011, J NEUROSCI, V31, P7049, DOI 10.1523/JNEUROSCI.6546-10.2011; Thal DR, 2005, ACTA NEUROPATHOL, V110, P459, DOI 10.1007/s00401-005-1053-1; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Tomomura A, 2002, NEUROSCI LETT, V317, P17, DOI 10.1016/S0304-3940(01)02409-0; Utter S, 2008, J NEUROPATH EXP NEUR, V67, P842, DOI 10.1097/NEN.0b013e3181836a71; Vance JE, 2010, BBA-MOL CELL BIOL L, V1801, P806, DOI 10.1016/j.bbalip.2010.02.007; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Vitek MP, 2012, NEURODEGENER DIS, V10, P122, DOI 10.1159/000334914; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; Weisgraber KH, 1996, FASEB J, V10, P1485, DOI 10.1096/fasebj.10.13.8940294; WERNETTEHAMMOND ME, 1989, J BIOL CHEM, V264, P9094; Wildsmith KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038013; WISNIEWSKI T, 1995, LANCET, V345, P956, DOI 10.1016/S0140-6736(95)90701-7; Yoshida S, 1999, INT J MOL MED, V3, P405; Zhou W, 2006, NEUROSCIENCE, V143, P689, DOI 10.1016/j.neuroscience.2006.08.019; Zhu YG, 2012, GLIA, V60, P559, DOI 10.1002/glia.22289; Zlokovic BV, 2013, JAMA NEUROL, V70, P440, DOI 10.1001/jamaneurol.2013.2152	77	26	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93120	10.1371/journal.pone.0093120	http://dx.doi.org/10.1371/journal.pone.0093120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675880	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677500074
J	Bhardwaj, AR; Joshi, G; Pandey, R; Kukreja, B; Goel, S; Jagannath, A; Kumar, A; Katiyar-Agarwal, S; Agarwal, M				Bhardwaj, Ankur R.; Joshi, Gopal; Pandey, Ritu; Kukreja, Bharti; Goel, Shailendra; Jagannath, Arun; Kumar, Amar; Katiyar-Agarwal, Surekha; Agarwal, Manu			A Genome-Wide Perspective of miRNAome in Response to High Temperature, Salinity and Drought Stresses in Brassica juncea (Czern) L.	PLOS ONE			English	Article							SMALL RNAS; SUPEROXIDE-DISMUTASE; TARGET GENES; COMPUTATIONAL IDENTIFICATION; COPPER CHAPERONE; INNATE IMMUNITY; MICRORNAS; ARABIDOPSIS; NAPUS; EXPRESSION	Micro RNAs (miRNAs) are involved in diverse biological processes including adaptive response towards abiotic stresses. To unravel small RNAs and more specifically miRNAs that can potentially regulate determinants of abiotic stress tolerance, next generation sequencing of B. juncea seedlings subjected to high temperature, high salt and drought conditions was carried out. With the help of UEA sRNA workbench software package, 51 conserved miRNAs belonging to 30 miRNA families were identified. As there was limited genomic information available for B. juncea, we generated and assembled its genome sequence at a low coverage. Using the generated sequence and other publically available Brassica genomic/transcriptomic resources as mapping reference, 126 novel (not reported in any plant species) were discovered for the first time in B. juncea. Further analysis also revealed existence of 32 and 37 star sequences for conserved and novel miRNAs, respectively. The expression of selected conserved and novel miRNAs under conditions of different abiotic stresses was revalidated through universal TaqMan based real time PCR. Putative targets of identified conserved and novel miRNAs were predicted in B. rapa to gain insights into functional roles manifested by B. juncea miRNAs. Furthermore, SPL2-like, ARF17-like and a NAC domain containing protein were experimentally validated as targets of miR156, miR160 and miR164 respectively. Investigation of gene ontologies linked with targets of known and novel miRNAs forecasted their involvement in various biological functions.	[Bhardwaj, Ankur R.; Joshi, Gopal; Kukreja, Bharti; Goel, Shailendra; Jagannath, Arun; Kumar, Amar; Agarwal, Manu] Univ Delhi, Dept Bot, Delhi 110007, India; [Pandey, Ritu; Katiyar-Agarwal, Surekha] Univ Delhi, Dept Plant Mol Biol, Delhi 110007, India	University of Delhi; University of Delhi	Katiyar-Agarwal, S (corresponding author), Univ Delhi, Dept Plant Mol Biol, South Campus, Delhi 110007, India.	katiyars@south.du.ac.in; agarwalm71@gmail.com		Joshi, Gopal/0000-0002-6238-9926; Goel, Shailendra/0000-0002-8731-8892; AGARWAL, MANU/0000-0003-4241-5055	Department of Biotechnology (DBT), Delhi, India [BT/PR628/AGR/36/674/20111]; University of Delhi, Delhi, India; DBT, India; Council of Scientific and Industrial research (CSIR), India; DBT-funded High-Throughput Sequencing Facility at University of Delhi South Campus, University of Delhi, New Delhi, India	Department of Biotechnology (DBT), Delhi, India(Department of Biotechnology (DBT) India); University of Delhi, Delhi, India(University of Delhi); DBT, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); DBT-funded High-Throughput Sequencing Facility at University of Delhi South Campus, University of Delhi, New Delhi, India	The work was financially supported by grant from the Department of Biotechnology (DBT), Delhi, India (grant No. BT/PR628/AGR/36/674/20111. The support from University of Delhi, Delhi, India is also duly acknowledged. ARB, GJ and BK arc supported by DBT, India. RP is thankful for research fellowship from Council of Scientific and Industrial research (CSIR), India and DBT, India. Deep sequencing was carried out by DBT-funded High-Throughput Sequencing Facility at University of Delhi South Campus, University of Delhi, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2010, INDIAN J AGR SCI, V80, P1043; Aung K, 2006, PLANT PHYSIOL, V141, P1000, DOI 10.1104/pp.106.078063; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Beauclair L, 2010, PLANT J, V62, P454, DOI 10.1111/j.1365-313X.2010.04162.x; Benhassaine-Kesri G, 2002, PHYSIOL PLANTARUM, V115, P221, DOI 10.1034/j.1399-3054.2002.1150207.x; Bhuiyan NH, 2007, J EXP BOT, V58, P4203, DOI 10.1093/jxb/erm278; Chen XM, 2012, CURR OPIN GENET DEV, V22, P361, DOI 10.1016/j.gde.2012.04.004; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chu CC, 2005, PLANT PHYSIOL, V139, P425, DOI 10.1104/pp.105.065284; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dalal M, 2009, J BIOTECHNOL, V139, P137, DOI 10.1016/j.jbiotec.2008.09.014; Dhandapani V, 2011, MOL CELLS, V32, P21, DOI 10.1007/s10059-011-2313-7; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Ghuge SA, 2011, ARCH AGRON SOIL SCI, V57, P127, DOI 10.1080/03650340903296793; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Han YJ, 2012, PLANT CELL REP, V31, P1677, DOI 10.1007/s00299-012-1280-6; Herr AJ, 2005, FEBS LETT, V579, P5879, DOI 10.1016/j.febslet.2005.08.040; Huang SQ, 2010, PLANT BIOTECHNOL J, V8, P887, DOI 10.1111/j.1467-7652.2010.00517.x; Jamil M, 2007, Pak J Biol Sci, V10, P910, DOI 10.3923/pjbs.2007.910.914; Jia XY, 2009, J PLANT PHYSIOL, V166, P2046, DOI 10.1016/j.jplph.2009.06.011; Jia XY, 2009, PLANT MOL BIOL, V71, P51, DOI 10.1007/s11103-009-9508-8; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim B, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-218; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Korbes AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050663; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; Li T, 2011, NUCLEIC ACIDS RES, V39, P2821, DOI 10.1093/nar/gkq1047; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li Y, 2010, PLANT PHYSIOL, V152, P2222, DOI 10.1104/pp.109.151803; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Manavella PA, 2013, PLANT PHYSIOL, V161, P805, DOI 10.1104/pp.112.207068; Miyoshi K, 2010, MOL GENET GENOMICS, V284, P95, DOI 10.1007/s00438-010-0556-1; Moldovan D, 2010, J EXP BOT, V61, P165, DOI 10.1093/jxb/erp296; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Palmieri MC, 2010, PLANT PHYSIOL, V152, P1514, DOI 10.1104/pp.109.152579; Pant BD, 2009, PLANT PHYSIOL, V150, P1541, DOI 10.1104/pp.109.139139; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Poethig RS, 2009, CURR OPIN GENET DEV, V19, P374, DOI 10.1016/j.gde.2009.06.001; Pradhan AK, 2003, THEOR APPL GENET, V106, P607, DOI 10.1007/s00122-002-1083-1; Purty Ram Singh, 2008, Physiology and Molecular Biology of Plants, V14, P39, DOI 10.1007/s12298-008-0004-4; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rogers K, 2013, PLANT CELL, V25, P2383, DOI 10.1105/tpc.113.113159; Rogers SO., 1994, PLANT MOL BIOL, V1, P183, DOI 10.1007/978-94-011-0511-8_12; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047810; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Song JB, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-210; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Srivastava S, 2013, J EXP BOT, V64, P303, DOI 10.1093/jxb/ers333; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Wang FD, 2012, MOL GENET GENOMICS, V287, P555, DOI 10.1007/s00438-012-0699-3; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang JY, 2012, GENE, V505, P300, DOI 10.1016/j.gene.2012.06.002; Wang PT, 2011, CHINESE SCI BULL, V56, P3538, DOI 10.1007/s11434-011-4802-7; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie FL, 2007, FEBS LETT, V581, P1464, DOI 10.1016/j.febslet.2007.02.074; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Xu MY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-421; Yadava SK, 2012, THEOR APPL GENET, V125, P1553, DOI 10.1007/s00122-012-1934-3; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; Yang JH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-9; Young LW, 2004, J EXP BOT, V55, P485, DOI 10.1093/jxb/erh038; Youssefi A., 2011, American-Eurasian Journal of Agricultural & Environmental Sciences, V11, P406; Yu X, 2012, J EXP BOT, V63, P1025, DOI 10.1093/jxb/err337; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang JZ, 2012, MOL BIOTECHNOL, V51, P44, DOI 10.1007/s12033-011-9439-x; Zhang WX, 2011, PLANT MOL BIOL, V75, P93, DOI 10.1007/s11103-010-9710-8; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666; Zhou ZS, 2012, J EXP BOT, V63, P4597, DOI 10.1093/jxb/ers136; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295	93	39	46	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92456	10.1371/journal.pone.0092456	http://dx.doi.org/10.1371/journal.pone.0092456			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671003	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000046
J	Brault, G; Shareck, F; Hurtubise, Y; Lepine, F; Doucet, N				Brault, Guillaume; Shareck, Francois; Hurtubise, Yves; Lepine, Francois; Doucet, Nicolas			Short-Chain Flavor Ester Synthesis in Organic Media by an E-coli Whole-Cell Biocatalyst Expressing a Newly Characterized Heterologous Lipase	PLOS ONE			English	Article							BIODIESEL PRODUCTION; IMMOBILIZED LIPASE; ENZYMATIC PRODUCTION; SOLVENT-FREE; ESTERIFICATION; SUBSTRATE; DISPLAY; ENZYMES; SURFACE; SYSTEM	Short-chain aliphatic esters are small volatile molecules that produce fruity and pleasant aromas and flavors. Most of these esters are artificially produced or extracted from natural sources at high cost. It is, however, possible to 'naturally' produce these molecules using biocatalysts such as lipases and esterases. A gene coding for a newly uncovered lipase was isolated from a previous metagenomic study and cloned into E. coli BL21 (DE3) for overexpression using the pET16b plasmid. Using this recombinant strain as a whole-cell biocatalyst, short chain esters were efficiently synthesized by transesterification and esterification reactions in organic media. The recombinant lipase (LipIAF5-2) showed good affinity toward glyceryl trioctanoate and the highest conversion yields were obtained for the transesterification of glyceryl triacetate with methanol. Using a simple cetyl-trimethylammonium bromide pretreatment increased the synthetic activity by a six-fold factor and the whole-cell biocatalyst showed the highest activity at 40 degrees C with a relatively high water content of 10% (w/w). The whole-cell biocatalyst showed excellent tolerance to alcohol and short-chain fatty acid denaturation. Substrate affinity was equally effective with all primary alcohols tested as acyl acceptors, with a slight preference for methanol. The best transesterification conversion of 50 mmol glyceryl triacetate into isoamyl acetate (banana fragrance) provided near 100% yield after 24 hours using 10% biocatalyst loading (w/w) in a fluidized bed reactor, allowing recycling of the biocatalyst up to five times. These results show promising potential for an industrial approach aimed at the biosynthesis of short-chain esters, namely for natural flavor and fragrance production in micro-aqueous media.	[Brault, Guillaume; Shareck, Francois; Lepine, Francois; Doucet, Nicolas] Univ Quebec, INRS Inst Armand Frappier, Laval, PQ, Canada; [Hurtubise, Yves] Innu Sci Canada Inc, Trois Rivieres, PQ, Canada; [Doucet, Nicolas] PROTEO, Quebec City, PQ, Canada; [Doucet, Nicolas] GRASP, Quebec City, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS)	Doucet, N (corresponding author), Univ Quebec, INRS Inst Armand Frappier, Laval, PQ, Canada.	nicolas.doucet@iaf.inrs.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) Collaborative Research and Development grant; NSERC Discovery grant [RGPIN 402623-2011]; Innu-Science Canada; BMP Innovation scholarship from NSERC; Fonds de Recherche du Quebec - Nature et Technologies; "Fonds de Recherche Quebec - Sante'' Research Scholar Junior 1 Career Award	Natural Sciences and Engineering Research Council of Canada (NSERC) Collaborative Research and Development grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Innu-Science Canada; BMP Innovation scholarship from NSERC; Fonds de Recherche du Quebec - Nature et Technologies; "Fonds de Recherche Quebec - Sante'' Research Scholar Junior 1 Career Award	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Collaborative Research and Development grant (awarded to FS) and NSERC Discovery grant RGPIN 402623-2011 (awarded to ND), as well as private funding from Innu-Science Canada. GB was the recipient of a BMP Innovation scholarship from NSERC and the Fonds de Recherche du Quebec - Nature et Technologies. ND is also supported by a "Fonds de Recherche Quebec - Sante'' Research Scholar Junior 1 Career Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas H, 2003, ENZYME MICROB TECH, V32, P589, DOI 10.1016/S0141-0229(03)00022-X; Balcao VM, 1996, ENZYME MICROB TECH, V18, P392, DOI 10.1016/0141-0229(95)00125-5; Ban K, 2002, J MOL CATAL B-ENZYM, V17, P157, DOI 10.1016/S1381-1177(02)00023-1; Ban K, 2001, BIOCHEM ENG J, V8, P39, DOI 10.1016/S1369-703X(00)00133-9; Becker S, 2005, FEBS LETT, V579, P1177, DOI 10.1016/j.febslet.2004.12.087; Berger RG, 2009, BIOTECHNOL LETT, V31, P1651, DOI 10.1007/s10529-009-0083-5; Brault G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032041; Canovas M, 2005, ENZYME MICROB TECH, V37, P300, DOI 10.1016/j.enzmictec.2004.07.023; Chen JP, 2010, APPL BIOCHEM BIOTECH, V161, P181, DOI 10.1007/s12010-009-8776-8; Cote A, 2008, ENZYME MICROB TECH, V42, P381, DOI 10.1016/j.enzmictec.2008.01.009; Cote A, 2010, J IND MICROBIOL BIOT, V37, P883, DOI 10.1007/s10295-010-0735-4; Dubal S.A., 2008, ADV BIOTECHNOL, V3, P20; Fjerbaek L, 2009, BIOTECHNOL BIOENG, V102, P1298, DOI 10.1002/bit.22256; Fontanille P, 2003, APPL MICROBIOL BIOT, V60, P534, DOI 10.1007/s00253-002-1164-8; Fukuda H, 2008, TRENDS BIOTECHNOL, V26, P668, DOI 10.1016/j.tibtech.2008.08.001; Gao B, 2009, J BIOTECHNOL, V139, P169, DOI 10.1016/j.jbiotec.2008.10.004; Glogauer A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-54; Hama S, 2008, APPL MICROBIOL BIOT, V81, P637, DOI 10.1007/s00253-008-1689-6; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; Hills G, 2003, EUR J LIPID SCI TECH, V105, P601, DOI 10.1002/ejlt.200300853; Ishige T, 2005, CURR OPIN CHEM BIOL, V9, P174, DOI 10.1016/j.cbpa.2005.02.001; Jaeger KE, 1998, TRENDS BIOTECHNOL, V16, P396, DOI 10.1016/S0167-7799(98)01195-0; Jin Z, 2012, J BIOTECHNOL, V159, P108, DOI 10.1016/j.jbiotec.2012.02.013; Kennedy J, 2011, J APPL MICROBIOL, V111, P787, DOI 10.1111/j.1365-2672.2011.05106.x; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Krings U, 1998, APPL MICROBIOL BIOT, V49, P1, DOI 10.1007/s002530051129; Krings U, 2008, BIOTECHNOL LETT, V30, P1347, DOI 10.1007/s10529-008-9690-9; Krishna SH, 2001, J BIOTECHNOL, V87, P193, DOI 10.1016/S0168-1656(00)00432-6; Lee SH, 2004, APPL ENVIRON MICROB, V70, P5074, DOI 10.1128/AEM.70.9.5074-5080.2004; Li AT, 2012, BIORESOURCE TECHNOL, V114, P725, DOI 10.1016/j.biortech.2012.03.034; Li W, 2008, BIOCHEM ENG J, V41, P111, DOI 10.1016/j.bej.2008.04.003; Longo MA, 2006, FOOD TECHNOL BIOTECH, V44, P335; Lorenz P, 2005, NAT REV MICROBIOL, V3, P510, DOI 10.1038/nrmicro1161; Mahapatra P, 2009, J MOL CATAL B-ENZYM, V60, P57, DOI 10.1016/j.molcatb.2009.03.010; Matsumoto M, 2001, J CHEM TECHNOL BIOT, V76, P1070, DOI 10.1002/jctb.491; Matsumoto T, 2001, APPL MICROBIOL BIOT, V57, P515; Meilleur C, 2009, J IND MICROBIOL BIOT, V36, P853, DOI 10.1007/s10295-009-0562-7; Pagot Y, 1997, LETT APPL MICROBIOL, V25, P113, DOI 10.1046/j.1472-765X.1997.00182.x; Paiva AL, 2000, ENZYME MICROB TECH, V27, P187, DOI 10.1016/S0141-0229(00)00206-4; Palomo JM, 2003, BIOMACROMOLECULES, V4, P1, DOI 10.1021/bm025729+; Ranganathan SV, 2008, BIORESOURCE TECHNOL, V99, P3975, DOI 10.1016/j.biortech.2007.04.060; Romero MD, 2007, J BIOTECHNOL, V127, P269, DOI 10.1016/j.jbiotec.2006.07.009; Saponjic S, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue6-fulltext-8; Schrader J, 2004, BIOTECHNOL LETT, V26, P463, DOI 10.1023/B:BILE.0000019576.80594.0e; Schreier P., 1997, BIOTECHNOLOGY AROMA, P51; Serra S, 2005, TRENDS BIOTECHNOL, V23, P193, DOI 10.1016/j.tibtech.2005.02.003; Sharma D, 2011, BIO-TECHNOL, V10, P23, DOI [10.3923/biotech.2011.23.40, DOI 10.3923/BI0TECH.2011.23.40, DOI 10.3923/BIOTECH.2011.23.40]; Vandamme EJ, 2002, J CHEM TECHNOL BIOT, V77, P1323, DOI 10.1002/jctb.722; Xu Y, 2012, J BIOTECHNOL, V162, P407, DOI 10.1016/j.jbiotec.2012.05.017; Yan JY, 2012, BIORESOURCE TECHNOL, V123, P332, DOI 10.1016/j.biortech.2012.07.103; YANG B, 1994, ENZYME MICROB TECH, V16, P577, DOI 10.1016/0141-0229(94)90122-8; Zheng GW, 2010, J BIOTECHNOL, V150, P108, DOI 10.1016/j.jbiotec.2010.07.007	52	38	42	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e91872	10.1371/journal.pone.0091872	http://dx.doi.org/10.1371/journal.pone.0091872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670408	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000028
J	Morris, RG; TenEyck, M; Barnes, JC; Kovandzic, TV				Morris, Robert G.; TenEyck, Michael; Barnes, J. C.; Kovandzic, Tomislav V.			The Effect of Medical Marijuana Laws on Crime: Evidence from State Panel Data, 1990-2006	PLOS ONE			English	Article							JUVENILE DETENTION CENTER; VIOLENT BEHAVIOR; DRUG-USE; USE LEAD; ALCOHOL; ASSOCIATION; AGGRESSION; CANNABIS; INVOLVEMENT; AMERICAN	Background: Debate has surrounded the legalization of marijuana for medical purposes for decades. Some have argued medical marijuana legalization (MML) poses a threat to public health and safety, perhaps also affecting crime rates. In recent years, some U.S. states have legalized marijuana for medical purposes, reigniting political and public interest in the impact of marijuana legalization on a range of outcomes. Methods: Relying on U.S. state panel data, we analyzed the association between state MML and state crime rates for all Part I offenses collected by the FBI. Findings: Results did not indicate a crime exacerbating effect of MML on any of the Part I offenses. Alternatively, state MML may be correlated with a reduction in homicide and assault rates, net of other covariates. Conclusions: These findings run counter to arguments suggesting the legalization of marijuana for medical purposes poses a danger to public health in terms of exposure to violent crime and property crimes.	[Morris, Robert G.; TenEyck, Michael; Barnes, J. C.; Kovandzic, Tomislav V.] Univ Texas Dallas, Program Criminol, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas	Morris, RG (corresponding author), Univ Texas Dallas, Program Criminol, Richardson, TX 75083 USA.	morris@utdallas.edu		Barnes, J.C./0000-0001-6932-5397				Allison PD, 2009, FIXED EFFECTS REGRES; Anderson DM, 2013, J LAW ECON, V56, P333, DOI 10.1086/668812; Arseneault L, 2000, ARCH GEN PSYCHIAT, V57, P979, DOI 10.1001/archpsyc.57.10.979; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Boden JM, 2012, DRUG ALCOHOL DEPEN, V122, P135, DOI 10.1016/j.drugalcdep.2011.09.023; Brady SS, 2008, J ADOLESCENT HEALTH, V43, P285, DOI 10.1016/j.jadohealth.2008.02.007; Bureau of Justice Statistics, 2008, DEATHS CUST REP PROG; Cleveland HH, 2008, DEV PSYCHOPATHOL, V20, P615, DOI 10.1017/S0954579408000308; DEMBO R, 1987, J PSYCHOACTIVE DRUGS, V19, P47, DOI 10.1080/02791072.1987.10472379; DEMBO R, 1987, J PSYCHOACTIVE DRUGS, V19, P361, DOI 10.1080/02791072.1987.10472424; DESIMONE J, 1998, E EC J, V0024; DiNardo J, 2001, J HEALTH ECON, V20, P991, DOI 10.1016/S0167-6296(01)00102-3; Freisthler B, 2013, AM J COMMUN PSYCHOL, V51, P278, DOI 10.1007/s10464-012-9542-6; Green KM, 2010, DRUG ALCOHOL DEPEN, V112, P117, DOI 10.1016/j.drugalcdep.2010.05.018; Harris AWF, 2010, AUST NZ J PSYCHIAT, V44, P85, DOI 10.3109/00048670903270423; Jacobs EA, 2004, PEDIATRICS, V113, P1825; Johnson Kevin, 2013, US TODAY; Kepple NJ, 2012, J STUD ALCOHOL DRUGS, V73, P523, DOI 10.15288/jsad.2012.73.523; Keyes KM, 2011, ADDICTION, V106, P1790, DOI 10.1111/j.1360-0443.2011.03485.x; KOVANDZIC TV, 2009, CRIMINOLOGY PUBLIC P, V0008; Levinthal C.F., 2008, DRUGS SOC CRIMINAL J; Monshouwer K, 2006, BRIT J PSYCHIAT, V188, P148, DOI 10.1192/bjp.188.2.148; Moore TM, 2005, AGGRESS VIOLENT BEH, V10, P171, DOI 10.1016/j.avb.2003.10.002; Niveau G, 2003, MED SCI LAW, V43, P115, DOI 10.1258/rsmmsl.43.2.115; O'Brien PK, 2013, DEVIANT BEHAV, V34, P423, DOI 10.1080/01639625.2012.735608; Ostrowsky MK, 2011, J DRUG EDUC, V41, P369, DOI 10.2190/DE.41.4.c; Pedersen W, 2010, ADDICTION, V105, P109, DOI 10.1111/j.1360-0443.2009.02719.x; Reingle JM, 2012, J INTERPERS VIOLENCE, V27, P1562, DOI 10.1177/0886260511425787; Scribner R, 1999, J STUD ALCOHOL, V60, P310, DOI 10.15288/jsa.1999.60.310; Swartout KM, 2010, J INTERPERS VIOLENCE, V25, P1716, DOI 10.1177/0886260509354586; Wooldridge JM, 2013, INTRO ECONOMETRICS M, V5th	31	64	64	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92816	10.1371/journal.pone.0092816	http://dx.doi.org/10.1371/journal.pone.0092816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24671103	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677000080
J	Lyall, R; Ingle, RA; Illing, N				Lyall, Rafe; Ingle, Robert A.; Illing, Nicola			The Window of Desiccation Tolerance Shown by Early-Stage Germinating Seedlings Remains Open in the Resurrection Plant, Xerophyta viscosa	PLOS ONE			English	Article							GENTIAN AXILLARY BUDS; SEED DORMANCY; INDUCTION; MATURATION; PRECULTURE; MECHANISMS; EVOLUTION; SURVIVAL; SUCROSE	Resurrection plants are renowned for their vegetative desiccation tolerance (DT). While DT in vegetative tissues is rare in angiosperms, it is ubiquitous in mature orthodox seeds. During germination, seedlings gradually lose DT until they pass a point of no return, after which they can no longer survive dehydration. Here we investigate whether seedlings of the resurrection plant Xerophyta viscosa ever lose the capacity to establish DT. Seedlings from different stages of germination were dehydrated for 48 hours and assessed for their ability to recover upon rehydration. While a transient decline in the ability of X. viscosa seedlings to survive dehydration was observed, at no point during germination was the ability to re-establish DT completely lost in all seedlings. Pre-treatment of seedlings with PEG or sucrose reduced this transient decline, and improved the survival rate at all stages of germination. Additionally, we observed that the trait of poikilochlorophylly (or loss of chlorophyll) observed in adult X. viscosa leaves can be induced throughout seedling development. These results suggest that the window of DT seen in germinating orthodox seeds remains open in X. viscosa seedlings and that vegetative DT in Xerophyta species may have evolved from the ability to retain this program through to adulthood.	[Lyall, Rafe; Ingle, Robert A.; Illing, Nicola] Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, South Africa	University of Cape Town	Illing, N (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, South Africa.	Nicola.Illing@uct.ac.za	Ingle, Robert A/C-5599-2008	Ingle, Robert A/0000-0002-8362-3777; Lyall, Rafe/0000-0003-3353-4212	National Research Foundation of South Africa; University of Cape Town	National Research Foundation of South Africa(National Research Foundation - South Africa); University of Cape Town	This research was supported by incentive funding from the National Research Foundation of South Africa (http://www.nrf.ac.za/index.php), and the University of Cape Town. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud S, 2002, PLANT PHYSIOL BIOCH, V40, P151, DOI 10.1016/S0981-9428(01)01350-X; Berjak P, 2006, SEED SCI RES, V16, P1, DOI 10.1079/SSR2005236; Bewley J. D., 1992, Water and life: comparative analysis of water relationships at the organismic, cellular and molecular level., P141; BEWLEY J. D, 2013, SEEDS, V3, DOI [DOI 10.1007/978-1-4614-4693-4_1, 10.1017/S0960258513000287]; BEWLEY JD, 1979, ANNU REV PLANT PHYS, V30, P195, DOI 10.1146/annurev.pp.30.060179.001211; BRUGGINK T, 1995, SEED SCI RES, V5, P1, DOI 10.1017/S096025850000252X; Buitink J, 2003, SEED SCI RES, V13, P273, DOI 10.1079/SSR2003145; Buitink J, 2008, CR BIOL, V331, P788, DOI 10.1016/j.crvi.2008.08.002; Buitink J, 2006, PLANT J, V47, P735, DOI 10.1111/j.1365-313X.2006.02822.x; Cuming AC, 1999, SEED PROTEINS, P753; Emery D.E., 1988, ICSID REV, V29, P451; EVENARI M., 1971, NEGEV CHALLENGE DESE; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; FRIEDMAN J, 1981, OECOLOGIA, V51, P400, DOI 10.1007/BF00540912; Gaff DF, 2013, FUNCT PLANT BIOL, V40, P315, DOI 10.1071/FP12321; Gibson SI, 2005, CURR OPIN PLANT BIOL, V8, P93, DOI 10.1016/j.pbi.2004.11.003; Gray A, 1887, ELEMENTS BOT BEGINNE; Gutterman Yitzchak, 2000, Plant Species Biology, V15, P113, DOI 10.1046/j.1442-1984.2000.00032.x; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Huang ZY, 2004, PLANT SOIL, V259, P231, DOI 10.1023/B:PLSO.0000020971.66784.fc; Illing N, 2005, INTEGR COMP BIOL, V45, P771, DOI 10.1093/icb/45.5.771; Ingle RA, 2007, PLANT CELL ENVIRON, V30, P435, DOI 10.1111/j.1365-3040.2006.01631.x; Kermode Allison R., 2002, P149, DOI 10.1079/9780851995342.0149; KERMODE AR, 1990, CRIT REV PLANT SCI, V9, P155, DOI 10.1080/07352689009382286; LEPRINCE O, 1990, PLANT CELL ENVIRON, V13, P539, DOI 10.1111/j.1365-3040.1990.tb01070.x; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Maia J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029123; MEURS C, 1992, PLANT PHYSIOL, V98, P1484, DOI 10.1104/pp.98.4.1484; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Mundree S.G., 2000, PLANT TOLERANCE ABIO, P201; Negbi M, 1962, P MADRID S UNESCO, P249; Oliver M. J., 1996, Horticultural Reviews, V18, P171, DOI 10.1002/9780470650608.ch3; Oliver MJ, 2000, PLANT ECOL, V151, P85, DOI 10.1023/A:1026550808557; SARANGA Y, 1990, Hortscience, V25, P1088; Sarkar A, 2009, PLANT STEM CELLS; SENARATNA T, 1989, PLANT SCI, V65, P253, DOI 10.1016/0168-9452(89)90072-1; Suzuki M, 2005, PLANT CELL TISS ORG, V83, P115, DOI 10.1007/s11240-005-4854-y; Suzuki M, 1998, PLANT SCI, V135, P69, DOI 10.1016/S0168-9452(98)00054-5; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Vertucci C. W., 1995, SEED DEV GERMINATION, P237, DOI 10.1201/9780203740071-10; Vicente-Carbajosa J, 2005, INT J DEV BIOL, V49, P645, DOI 10.1387/ijdb.052046jc; Vieira CV, 2010, PLANT GROWTH REGUL, V62, P257, DOI 10.1007/s10725-010-9496-3	42	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93093	10.1371/journal.pone.0093093	http://dx.doi.org/10.1371/journal.pone.0093093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667896	gold, Green Published, Green Submitted			2022-12-25	WOS:000333675600137
J	Lamke, JP; Daniels, JK; Dorfel, D; Gaebler, M; Rahman, RA; Hummel, F; Erk, S; Walter, H				Lamke, Jan-Peter; Daniels, Judith K.; Doerfel, Denise; Gaebler, Michael; Rahman, Rasha Abdel; Hummel, Falk; Erk, Susanne; Walter, Henrik			The Impact of Stimulus Valence and Emotion Regulation on Sustained Brain Activation: Task-Rest Switching in Emotion	PLOS ONE			English	Article							DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; FMRI DATA; STATE; AMYGDALA; RESPONSES; EXPERIENCE; ATTENTION; MIND	Task-rest interactions, defined as the modulation of brain activation during fixation periods depending on the preceding stimulation and experimental manipulation, have been described repeatedly for different cognitively demanding tasks in various regions across the brain. However, task-rest interactions in emotive paradigms have received considerably less attention. In this study, we therefore investigated task-rest interactions evoked by the induction and instructed regulation of negative emotion. Whole-brain, functional MRI data were acquired from 55 healthy participants. Two-level general linear model statistics were computed to test for differences between conditions, separately for stimulation and for fixation periods, as well as for interactions between stimulation and fixation (task-rest interactions). Results showed that the regulation of negative emotion led to reverse task-rest interactions (decreased activation during stimulation but increased activation during fixation) in the amygdala as well as in visual cortex regions and to concordant task-rest interactions (increased activation during both, stimulation and fixation) in the dorsolateral prefrontal cortex as well as in a number of brain regions at the intersection of the default mode and the dorsal attention networks. Thus, this first whole-brain investigation of task-rest interactions following the induction and regulation of negative emotion identified a widespread specific modulation of brain activation in regions subserving emotion generation and regulation as well as regions implicated in attention and default mode.	[Lamke, Jan-Peter; Daniels, Judith K.; Doerfel, Denise; Gaebler, Michael; Erk, Susanne; Walter, Henrik] Charite, Div Mind & Brain Res, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Lamke, Jan-Peter; Gaebler, Michael; Rahman, Rasha Abdel] Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany; [Daniels, Judith K.] Univ Magdeburg, Clin Psychosomat Med & Psychotherapy, D-39106 Magdeburg, Germany; [Gaebler, Michael] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Rahman, Rasha Abdel; Walter, Henrik] Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany; [Hummel, Falk] Univ Bonn, Dept Psychiat & Psychotherapy, Div Med Psychol, Bonn, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Otto von Guericke University; Max Planck Society; Humboldt University of Berlin; University of Bonn	Daniels, JK (corresponding author), Charite, Div Mind & Brain Res, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany.	judith.daniels@charite.de; henrik.walter@charite.de	Dörfel, Denise/AAR-6523-2021; Walter, Henrik/O-2612-2013; Gaebler, Michael/C-1923-2014; Rahman, Rasha Abdel/J-4687-2015	Dörfel, Denise/0000-0002-5632-419X; Gaebler, Michael/0000-0002-4442-5778; Rahman, Rasha Abdel/0000-0002-8438-1570; Daniels, Judith/0000-0001-6304-2310; Walter, Henrik/0000-0002-9403-6121; Erk, Susanne/0000-0003-0961-3543	VW-foundation [II/84051]	VW-foundation(Volkswagen)	The work of Jan-Peter Lamke, Judith K. Daniels, and Michael Gaebler was supported by a VW-foundation grant (no. II/84051) to Henrik Walter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Anderson JS, 2011, BRAIN CONNECT, V1, P147, DOI 10.1089/brain.2011.0007; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J., 1997, CLIN MRI DEV MR, V7, P26; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bzdok D, 2012, HUMAN BRAIN MAPPING; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Daniels JK, 2013, PSYCHOL TRAUMA-US, V5, P142, DOI 10.1037/a0026946; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Eldaief MC, 2012, SOC COGN AFFECT NEUR, V7, P380, DOI 10.1093/scan/nsr003; Erk S, 2010, J NEUROSCI, V30, P15726, DOI 10.1523/JNEUROSCI.1856-10.2010; Eryilmaz H, 2011, NEUROIMAGE, V54, P2481, DOI 10.1016/j.neuroimage.2010.10.021; Evers EAT, 2012, BRAIN CONNECT, V2, P102, DOI 10.1089/brain.2011.0060; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Friston KJ, 2005, NEUROIMAGE, V24, P244, DOI 10.1016/j.neuroimage.2004.08.055; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Hamm AO, 1993, PSYCHOL RUNDSCHAU; Harrison BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001794; He BJ, 2013, J NEUROSCI, V33, P4672, DOI 10.1523/JNEUROSCI.2922-12.2013; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Koenigsberg HW, 2010, NEUROPSYCHOLOGIA, V48, P1813, DOI 10.1016/j.neuropsychologia.2010.03.002; Lang PJ, 2008, INT AFFECTIVE PICTUR; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Mcrae K, 2008, GROUP PROCESS INTERG, V11, P143, DOI 10.1177/1368430207088035; Mullinger KJ, 2013, P NATL ACAD SCI USA, V110, P13636, DOI 10.1073/pnas.1221287110; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nolen-Hoeksema S, 2012, ANNU REV CLIN PSYCHO, V8, P161, DOI 10.1146/annurev-clinpsy-032511-143109; Northoff G, 2010, TRENDS NEUROSCI, V33, P277, DOI 10.1016/j.tins.2010.02.006; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pitroda S, 2008, NEUROSCI LETT, V443, P72, DOI 10.1016/j.neulet.2008.07.050; Posner J, 2005, DEV PSYCHOPATHOL, V17, P715, DOI 10.1017/S0954579405050340; Pyka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007198; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Schardt DM, 2010, NEUROIMAGE, V53, P943, DOI 10.1016/j.neuroimage.2009.11.078; Schneider F, 2008, NEUROSCIENCE, V157, P120, DOI 10.1016/j.neuroscience.2008.08.014; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Tomasi D, 2011, CEREB CORTEX, V21, P2003, DOI 10.1093/cercor/bhq268; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Marle HJF, 2010, NEUROIMAGE, V53, P348, DOI 10.1016/j.neuroimage.2010.05.070; Veer IM, 2011, NEUROIMAGE, V57, P1534, DOI 10.1016/j.neuroimage.2011.05.074; Walter H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006726; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Zong XP, 2011, NEUROIMAGE, V57, P391, DOI 10.1016/j.neuroimage.2011.04.067	54	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2014	9	3							e93098	10.1371/journal.pone.0093098	http://dx.doi.org/10.1371/journal.pone.0093098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0TC	24682003	Green Published, gold			2022-12-25	WOS:000333678100024
J	Ma, JQ; Yao, MZ; Ma, CL; Wang, XC; Jin, JQ; Wang, XM; Chen, L				Ma, Jian-Qiang; Yao, Ming-Zhe; Ma, Chun-Lei; Wang, Xin-Chao; Jin, Ji-Qiang; Wang, Xue-Min; Chen, Liang			Construction of a SSR-Based Genetic Map and Identification of QTLs for Catechins Content in Tea Plant (Camellia sinensis)	PLOS ONE			English	Article							MARKER-ASSISTED SELECTION; QUANTITATIVE TRAIT LOCI; EXPRESSED SEQUENCE TAGS; MICROSATELLITE MARKERS; LINKAGE MAP; SEGREGATION DISTORTION; GREEN TEA; AFLP; TRANSFERABILITY; AMPLIFICATION	Catechins are the most important bioactive compounds in tea, and have been demonstrated to possess a wide variety of pharmacological activities. To characterize quantitative trait loci (QTLs) for catechins content in the tender shoots of tea plant, we constructed a moderately saturated genetic map using 406 simple sequence repeat (SSR) markers, based on a pseudo-testcross population of 183 individuals derived from an intraspecific cross of two Camellia sinensis varieties with diverse catechins composition. The map consisted of fifteen linkage groups (LGs), corresponding to the haploid chromosome number of tea plant (2n = 2x = 30). The total map length was 1,143.5 cM, with an average locus spacing of 2.9 cM. A total of 25 QTLs associated with catechins content were identified over two measurement years. Of these, nine stable QTLs were validated across years, and clustered into four main chromosome regions on LG03, LG11, LG12 and LG15. The population variability explained by each QTL was predominantly at moderate-to-high levels and ranged from 2.4% to 71.0%, with an average of 17.7%. The total number of QTL for each trait varied from four to eight, while the total population variability explained by all QTLs for a trait ranged between 38.4% and 79.7%. This is the first report on the identification of QTL for catechins content in tea plant. The results of this study provide a foundation for further cloning and functional characterization of catechin QTLs for utilization in improvement of tea plant.	[Ma, Jian-Qiang; Yao, Ming-Zhe; Ma, Chun-Lei; Wang, Xin-Chao; Jin, Ji-Qiang; Wang, Xue-Min; Chen, Liang] Chinese Acad Agr Sci TRICAAS, Natl Ctr Tea Improvement, Tea Res Inst, Key Lab Tea Plant Biol & Resources Utilizat,Minis, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS	Chen, L (corresponding author), Chinese Acad Agr Sci TRICAAS, Natl Ctr Tea Improvement, Tea Res Inst, Key Lab Tea Plant Biol & Resources Utilizat,Minis, Hangzhou, Zhejiang, Peoples R China.	liangchen@mail.tricaas.com	Wang, Xinchao/I-5745-2019; Chen, Liang/R-4438-2019; MINGZHE, YAO/AAH-7748-2021	Wang, Xinchao/0000-0002-5224-6286; Chen, Liang/0000-0002-7507-3947; 	Earmarked Fund for China Agriculture Research System [CARS-23]; Science and Technology Major Project for New Crop Varieties Breeding of Zhejiang Province [2012C12905-6]; National Natural Science Foundation of China [31170624, 31100504, 30901159]	Earmarked Fund for China Agriculture Research System; Science and Technology Major Project for New Crop Varieties Breeding of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported in part by the Earmarked Fund for China Agriculture Research System (CARS-23) to Liang Chen, the Science and Technology Major Project for New Crop Varieties Breeding of Zhejiang Province (2012C12905-6), National Natural Science Foundation of China (31170624, 31100504, 30901159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheit KV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-380; [Anonymous], 2005, 145022 ISO; Bali S, 2013, MOL BREEDING, V32, P735, DOI 10.1007/s11032-013-9902-4; Barchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043740; Basu A, 2007, NUTR REV, V65, P361, DOI 10.1111/j.1753-4887.2007.tb00314.x; Behrend A, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-64; Bradeen JM, 2001, GENOME, V44, P111, DOI 10.1139/gen-44-1-111; Charters YM, 1996, THEOR APPL GENET, V92, P442, DOI 10.1007/BF00223691; Chen X, 2010, GENETICS, V186, P1053, DOI 10.1534/genetics.110.120311; Chen ZY, 2010, CONSERV GENET, V11, P1163, DOI 10.1007/s10592-009-9908-y; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Ferreira A, 2006, GENET MOL BIOL, V29, P187, DOI 10.1590/S1415-47572006000100033; Foolad MR, 2012, CRIT REV PLANT SCI, V31, P93, DOI 10.1080/07352689.2011.616057; Freeman S, 2004, MOL ECOL NOTES, V4, P324, DOI 10.1111/j.1471-8286.2004.00682.x; Frenkel O, 2012, PLANT PATHOL, V61, P106, DOI 10.1111/j.1365-3059.2011.02502.x; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Gupta PK, 2000, EUPHYTICA, V113, P163, DOI 10.1023/A:1003910819967; Hackett CA, 2000, HEREDITY, V85, P346, DOI 10.1046/j.1365-2540.2000.00769.x; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; Hu CY, 2013, EUPHYTICA, V191, P141, DOI 10.1007/s10681-013-0908-0; Huang FuPing, 2006, Journal of Tea Science, V26, P171; Huang JianAn, 2005, Journal of Tea Science, V25, P7; Hung CY, 2008, CONSERV GENET, V9, P779, DOI 10.1007/s10592-007-9391-2; International Tea Committee, 2012, ANN B STAT 2012, P50; Isemura T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041304; Jin JiQiang, 2006, Journal of Tea Science, V26, P17; Kamunya SM, 2010, TREE GENET GENOMES, V6, P915, DOI 10.1007/s11295-010-0301-2; Kenis K, 2005, MOL BREEDING, V15, P205, DOI 10.1007/s11032-004-5592-2; Knott SA, 1997, THEOR APPL GENET, V94, P810, DOI 10.1007/s001220050482; Kumawat G, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-84; Li XH, 2011, THEOR APPL GENET, V123, P667, DOI 10.1007/s00122-011-1617-5; Ma JQ, 2012, SCI HORTIC-AMSTERDAM, V134, P167, DOI 10.1016/j.scienta.2011.10.029; Ma JQ, 2010, AM J BOT, V97, pE153, DOI 10.3732/ajb.1000376; Mano Y, 2005, PLANT BREEDING, V124, P432, DOI 10.1111/j.1439-0523.2005.01128.x; Miura K, 2011, TRENDS PLANT SCI, V16, P319, DOI 10.1016/j.tplants.2011.02.009; Ota S, 1999, BREED RES, V1, P16; Pang YZ, 2013, PLANT PHYSIOL, V161, P1103, DOI 10.1104/pp.112.212050; Petroli CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044684; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; Rabbi I, 2012, THEOR APPL GENET, V125, P329, DOI 10.1007/s00122-012-1836-4; Saravanan M, 2005, PHYTOCHEMISTRY, V66, P561, DOI 10.1016/j.phytochem.2004.06.024; Schramm Laura, 2013, J Carcinog Mutagen, V4, P1000142; Sharma H, 2011, AM J BOT, V98, pE133, DOI 10.3732/ajb.1000525; Sharma RK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-53; Sibov ST, 2003, HEREDITAS, V139, P96, DOI 10.1111/j.1601-5223.2003.01666.x; Tanaka J., 2006, J REMOTE SENS SOC JP, V2006, P1, DOI [10.5979/cha.2006.1, DOI 10.5979/CHA.2006.1]; Tanaka JI, 1995, J JPN BREED, V45, P198; Taniguchi F, 2012, BREEDING SCI, V62, P263, DOI 10.1270/jsbbs.62.263; Taniguchi F, 2012, BREEDING SCI, V62, P186, DOI 10.1270/jsbbs.62.186; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tounekti T, 2013, CRIT REV PLANT SCI, V32, P192, DOI 10.1080/07352689.2012.747384; Van Ooijen J. W., 2006, JIONMAP 4 SOFTWARE C; van Ooijen JW, 2002, MAPQTL 4 0 SOFTWARE; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vogl C, 2000, GENETICS, V155, P1439; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Vuong QV, 2011, FOOD REV INT, V27, P227, DOI 10.1080/87559129.2011.563397; Wallace JG, 2014, HEREDITY, V112, P30, DOI 10.1038/hdy.2013.6; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang HF, 2000, TRENDS FOOD SCI TECH, V11, P152, DOI 10.1016/S0924-2244(00)00061-3; Wang XC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-415; Weinreb O, 2009, GENES NUTR, V4, P283, DOI 10.1007/s12263-009-0143-4; Wu HL, 2013, PLANT MOL BIOL REP, V31, P524, DOI 10.1007/s11105-012-0519-2; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yang JB, 2009, CONSERV GENET, V10, P1621, DOI 10.1007/s10592-009-9814-3; Yao MZ, 2012, TREE GENET GENOMES, V8, P205, DOI 10.1007/s11295-011-0433-z; Yin TM, 2004, THEOR APPL GENET, V109, P451, DOI 10.1007/s00122-004-1653-5; Yu ZN, 2003, BIOL BULL-US, V204, P327, DOI 10.2307/1543603; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006; Zhan HM, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-97; Zhao LP, 2008, CONSERV GENET, V9, P1327, DOI 10.1007/s10592-007-9476-y; Zhou YanHua, 2011, Scientia Silvae Sinicae, V47, P59	77	55	64	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e93131	10.1371/journal.pone.0093131	http://dx.doi.org/10.1371/journal.pone.0093131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676054	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677500078
J	Mancini, M; Lanzillo, R; Liuzzi, R; Di Donato, O; Ragucci, M; Monti, S; Salvatore, E; Morra, VB; Salvatore, M				Mancini, Marcello; Lanzillo, Roberta; Liuzzi, Raffaele; Di Donato, Orlando; Ragucci, Monica; Monti, Serena; Salvatore, Elena; Morra, Vincenzo Brescia; Salvatore, Marco			Internal Jugular Vein Blood Flow in Multiple Sclerosis Patients and Matched Controls	PLOS ONE			English	Article							CEREBROSPINAL VENOUS INSUFFICIENCY; PERFUSION; IMPAIRMENT; DISABILITY; ABNORMALITIES; LEUKOARAIOSIS; INCOMPETENCE; LESIONS; VALVE	The aim of the study was to investigate the Internal Jugular Veins dynamics using contrast enhanced ultrasonography in Multiple Sclerosis patients, clinically isolated syndrome patients and healthy controls. Contrast enhanced ultrasonography imaging of the Internal Jugular Vein was performed in fifty-eight patients with Multiple Sclerosis, seven clinically isolated syndrome patients and in thirteen healthy controls. Time-intensity curves were quantified using a semi-automated method and compared with clinical disease outcomes. Wash-out parameters were calculated and six Time-intensity curves shapes were created. Significantly reduction of wash-out rate in Internal Jugular Veins was detected in Multiple Sclerosis patients compared to healthy controls [22.2% (2.7%-65.9%) vs. 33.4% (16.2%-76.8%); P<0.005]. Internal Jugular Vein enhancement was heterogeneous in patients with Multiple Sclerosis and consisted of slow wash-out Time-intensity curves shapes, compared with almost only one type of Time-intensity curves shape in control subjects that correspond to fast enhancement and fast wash-out. The vein wash-in parameters were similar in Multiple Sclerosis group compared with controls. A significant correlation was found between Internal Jugular Vein wash-out and level of disability (R = -0.402, p<0.05). Contrast enhanced ultrasonography of the Internal Jugular Vein with time intensity curve analysis revealed alterations of cerebral venous outflow in Multiple Sclerosis patients, however mechanisms that determine this condition remains unclear.	[Mancini, Marcello; Liuzzi, Raffaele] IBB, Italian Natl Res Council CNR, Naples, Italy; [Mancini, Marcello; Ragucci, Monica] IRCCS, SDN Fdn, Inst Diagnost & Nucl Dev, Naples, Italy; [Lanzillo, Roberta; Morra, Vincenzo Brescia] Univ Naples Federico II, Sch Med, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy; [Di Donato, Orlando; Salvatore, Elena; Salvatore, Marco] Univ Naples Federico II, Sch Med, Dept Adv Biomed Sci, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Istituto di Neuroscienze (IN-CNR); IRCCS Fondazione Pascale; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); University of Naples Federico II; University of Naples Federico II	Mancini, M (corresponding author), IBB, Italian Natl Res Council CNR, Naples, Italy.	marcello.mancini58@gmail.com	Liuzzi, Raffaele/AIC-0886-2022; Monti, Serena/C-1062-2015; Salvatore, Marco/K-8083-2016; Lanzillo, Roberta/AFA-8874-2022	Liuzzi, Raffaele/0000-0002-2350-6691; Monti, Serena/0000-0002-8777-7837; Salvatore, Marco/0000-0001-9734-7702; SALVATORE, Elena/0000-0003-1493-5133; Lanzillo, Roberta/0000-0001-6388-8180	Italian Ministry for Education University and Research in the framework of PRIN [2010XE5L2R_004]	Italian Ministry for Education University and Research in the framework of PRIN(Ministry of Education, Universities and Research (MIUR))	This work was supported by a research grant from the Italian Ministry for Education University and Research in the framework of PRIN (2010XE5L2R_004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN IV, 1981, NEUROPATH APPL NEURO, V7, P169, DOI 10.1111/j.1365-2990.1981.tb00087.x; Bateman GA, 2002, NEURORADIOLOGY, V44, P740, DOI 10.1007/s00234-002-0812-0; Beggs C, 2013, PHLEBOLOGY; Chung CP, 2011, ANN NEUROL, V69, P553, DOI 10.1002/ana.22276; Chung CP, 2010, MED HYPOTHESES, V75, P85, DOI 10.1016/j.mehy.2010.01.042; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dawson JW, 1916, EDINBURGH MED J, V17, DOI [10.1007/978-3-319-02735-7, DOI 10.1007/978-3-319-02735-7]; Delorme Stefan, 2006, Cancer Imaging, V6, P148, DOI 10.1102/1470-7330.2006.0023; Denislic M, 2013, PHLEBOLOGY, V28, P353, DOI 10.1258/phleb.2012.012065; Digre Kathleen B, 2002, Curr Pain Headache Rep, V6, P217, DOI 10.1007/s11916-002-0038-1; Doepp F, 2008, CEPHALALGIA, V28, P182, DOI 10.1111/j.1468-2982.2007.01484.x; Doepp F, 2008, J CLIN ULTRASOUND, V36, P480, DOI 10.1002/jcu.20470; Dolic K, 2012, AM J NEURORADIOL, V33, P16, DOI 10.3174/ajnr.A2877; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Frydrychowski AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048245; Gaitan MI, 2013, NEUROLOGY, V80, P145, DOI 10.1212/WNL.0b013e31827b916f; Garaci FG, 2012, RADIOLOGY, V265, P233, DOI 10.1148/radiol.12112245; Ge YL, 2005, AM J NEURORADIOL, V26, P1539; Ge YL, 2012, J CEREBR BLOOD F MET, V32, P403, DOI 10.1038/jcbfm.2011.191; Gianesini S, 2014, PHLEBOLOGY, V29, P632, DOI 10.1177/0268355513489549; Gosselink R, 1999, EUR RESPIR J, V13, P449, DOI 10.1183/09031936.99.13244999; Haacke EM, 2012, J VASC INTERV RADIOL, V23, P60, DOI 10.1016/j.jvir.2011.09.027; Haufschild T, 2001, J NEURO-OPHTHALMOL, V21, P37, DOI 10.1097/00041327-200103000-00011; Inglese M, 2008, J CEREBR BLOOD F MET, V28, P164, DOI 10.1038/sj.jcbfm.9600504; Inglese M, 2007, ARCH NEUROL-CHICAGO, V64, P196, DOI 10.1001/archneur.64.2.196; Jayaraman MV, 2012, AM J NEURORADIOL, V33, P1247, DOI 10.3174/ajnr.A2953; Kilsdonk ID, 2012, NEUROIMAG CLIN N AM, V22, P135, DOI 10.1016/j.nic.2012.02.010; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lanzillo R, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-20; Law M, 2004, RADIOLOGY, V231, P645, DOI 10.1148/radiol.2313030996; Mancini M, 2012, RADIOLOGY, V262, P947, DOI 10.1148/radiol.11111239; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Putnam TJ, 1937, ARCH NEURO PSYCHIATR, V38, P1, DOI 10.1001/archneurpsyc.1937.02260190011001; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Schaller B, 2004, BRAIN RES REV, V46, P243, DOI 10.1016/j.brainresrev.2004.04.005; Sinnecker T, 2013, MULT SCLER J, V19, P316, DOI 10.1177/1352458512451941; Sun X, 1998, Ann Nucl Med, V12, P89; Valdueza JM, 2000, LANCET, V355, P200; Varga AW, 2009, J NEUROL SCI, V282, P28, DOI 10.1016/j.jns.2008.12.036; Veroux P, 2013, J VASC INTERV RADIOL, V24, P1790, DOI 10.1016/j.jvir.2013.08.024; WAKEFIELD AJ, 1994, J CLIN PATHOL, V47, P129, DOI 10.1136/jcp.47.2.129; Weinstock-Guttman B, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-26; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2012, J VASC SURG, V56, P677, DOI 10.1016/j.jvs.2012.01.074; Zamboni P, 2009, J NEUROL SCI, V282, P21, DOI 10.1016/j.jns.2008.11.027; Zivadinov R, 2011, NEUROLOGY, V77, P138, DOI 10.1212/WNL.0b013e318212a901	46	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92730	10.1371/journal.pone.0092730	http://dx.doi.org/10.1371/journal.pone.0092730			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675965	gold, Green Submitted, Green Published			2022-12-25	WOS:000333677500035
J	Vincent, AG; Sundqvist, MK; Wardle, DA; Giesler, R				Vincent, Andrea G.; Sundqvist, Maja K.; Wardle, David A.; Giesler, Reiner			Bioavailable Soil Phosphorus Decreases with Increasing Elevation in a Subarctic Tundra Landscape	PLOS ONE			English	Article							NITROGEN MINERALIZATION; HEDLEY FRACTIONATION; ORGANIC PHOSPHORUS; LITTER DECOMPOSITION; PHOSPHATE SORPTION; IRON ACCUMULATION; MOUNT KINABALU; BOREAL FORESTS; RAIN-FORESTS; ALUMINUM	Phosphorus (P) is an important macronutrient in arctic and subarctic tundra and its bioavailability is regulated by the mineralization of organic P. Temperature is likely to be an important control on P bioavailability, although effects may differ across contrasting plant communities with different soil properties. We used an elevational gradient in northern Sweden that included both heath and meadow vegetation types at all elevations to study the effects of temperature, soil P sorption capacity and oxalate-extractable aluminium (Al-ox) and iron (Fe-ox) on the concentration of different soil P fractions. We hypothesized that the concentration of labile P fractions would decrease with increasing elevation (and thus declining temperature), but would be lower in meadow than in heath, given that N to P ratios in meadow foliage are higher. As expected, labile P in the form of Resin-P declined sharply with elevation for both vegetation types. Meadow soils did not have lower concentrations of Resin-P than heath soils, but they did have 2-fold and 1.5-fold higher concentrations of NaOH-extractable organic P and Residual P, respectively. Further, meadow soils had 3-fold higher concentrations of Al-ox + Feox and a 20% higher P sorption index than did heath soils. Additionally, Resin-P expressed as a proportion of total soil P for the meadow was on average half that in the heath. Declining Resin-P concentrations with elevation were best explained by an associated 2.5-3.0 degrees C decline in temperature. In contrast, the lower P availability in meadow relative to heath soils may be associated with impaired organic P mineralization, as indicated by a higher accumulation of organic P and P sorption capacity. Our results indicate that predicted temperature increases in the arctic over the next century may influence P availability and biogeochemistry, with consequences for key ecosystem processes limited by P, such as primary productivity.	[Vincent, Andrea G.; Giesler, Reiner] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Vincent, Andrea G.; Sundqvist, Maja K.; Wardle, David A.] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden; [Giesler, Reiner] Umea Univ, Climate Impacts Res Ctr, Dept Ecol & Environm Sci, Umea, Sweden	Umea University; Swedish University of Agricultural Sciences; Umea University	Vincent, AG (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden.	vincent.andrea@gmail.com	Vincent, Andrea G./C-3989-2013; Wardle, David A./F-6031-2011; Sundqvist, Maja/C-6100-2015	Wardle, David A./0000-0002-0476-7335; Sundqvist, Maja/0000-0001-5947-839X; Vincent, Andrea G./0000-0002-4301-0351	Wallenberg Scholars award; Centre for Environmental Research in Umea (CMF) [0632292]	Wallenberg Scholars award; Centre for Environmental Research in Umea (CMF)	This project was funded by a Wallenberg Scholars award to DAW (http://www.wallenberg.com/kaw/) and a grant from the Centre for Environmental Research in Umea (CMF) to DAW and RG (grant number 0632292; http://www8.umu.se/cmf/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achat DL, 2013, BIOGEOSCIENCES, V10, P733, DOI 10.5194/bg-10-733-2013; [Anonymous], 2005, ARCTIC CLIMATE IMPAC; BACHE BW, 1971, J SOIL SCI, V22, P289, DOI 10.1111/j.1365-2389.1971.tb01617.x; Binkley D, 2000, FOREST ECOL MANAG, V128, P241, DOI 10.1016/S0378-1127(99)00138-3; Bjork RG, 2007, PLANT SOIL, V294, P247, DOI 10.1007/s11104-007-9250-4; Brady NC., 1999, NATURE PROPERTIES SO; Bragazza L, 2013, NAT CLIM CHANGE, V3, P273, DOI [10.1038/nclimate1781, 10.1038/NCLIMATE1781]; Buurman P, 1996, MANUAL SOIL WATER AN; Celi L, 1999, SOIL SCI, V164, P574, DOI 10.1097/00010694-199908000-00005; Celi L., 2005, Organic phosphorus in the environment, P113, DOI 10.1079/9780851998220.0113; CHAPIN FS, 1978, OIKOS, V31, P189, DOI 10.2307/3543562; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Condron LM, 2011, J SOIL SEDIMENT, V11, P830, DOI 10.1007/s11368-011-0363-2; CROSS AF, 1995, GEODERMA, V64, P197, DOI 10.1016/0016-7061(94)00023-4; Dell'Olio LA, 2008, SOIL SCI, V173, P119, DOI [10.1097/ss.0b013e31815d8eb7, 10.1097/SS.0b013e31815d8eb7]; Dieter D, 2010, CATENA, V82, P118, DOI 10.1016/j.catena.2010.05.010; Eskelinen A, 2009, OECOLOGIA, V161, P113, DOI 10.1007/s00442-009-1362-5; Frossard E, 2000, J ENVIRON QUAL, V29, P15, DOI 10.2134/jeq2000.00472425002900010003x; Fukami T, 2005, P ROY SOC B-BIOL SCI, V272, P2105, DOI 10.1098/rspb.2005.3277; Gerke J, 2010, SOIL SCI, V175, P417, DOI 10.1097/SS.0b013e3181f1b4dd; GIBLIN AE, 1991, ECOL MONOGR, V61, P415, DOI 10.2307/2937049; Giesler R, 2005, SOIL SCI SOC AM J, V69, P77; Giesler R, 2004, ECOSYSTEMS, V7, P208, DOI 10.1007/s10021-003-0223-z; Giesler R, 2002, ECOSYSTEMS, V5, P300, DOI 10.1007/s10021-001-0073-5; Giesler R, 2012, BIOGEOCHEMISTRY, V108, P429, DOI 10.1007/s10533-011-9609-8; Girardin CAJ, 2013, GLOBAL BIOGEOCHEM CY, V27, P252, DOI 10.1029/2011GB004082; GUZMAN G, 1994, PLANT SOIL, V159, P219, DOI 10.1007/BF00009284; HEDLEY MJ, 1994, PLANT SOIL, V158, P53, DOI 10.1007/BF00007917; HEDLEY MJ, 1982, SOIL SCI SOC AM J, V46, P970, DOI 10.2136/sssaj1982.03615995004600050017x; Hoch G, 2012, GLOBAL ECOL BIOGEOGR, V21, P861, DOI 10.1111/j.1466-8238.2011.00731.x; Jansson M, 2008, ECOSYSTEMS, V11, P367, DOI 10.1007/s10021-008-9127-2; Jenny H, 1994, FACTORS SOIL FORMATI, P104; Johnson AH, 2003, OECOLOGIA, V135, P487, DOI 10.1007/s00442-002-1164-5; Jonasson S, 1999, ECOLOGY, V80, P1828, DOI 10.1890/0012-9658(1999)080[1828:RIMAPT]2.0.CO;2; JONASSON S, 1993, OECOLOGIA, V95, P179, DOI 10.1007/BF00323488; Kang J, 2009, SOIL SCI SOC AM J, V73, P360, DOI 10.2136/sssaj2008.0113; Kardol P, 2010, ECOLOGY, V91, P767, DOI 10.1890/09-0135.1; Karlsson J, 2005, GLOBAL CHANGE BIOL, V11, P710, DOI 10.1111/j.1365-2486.2005.00945.x; Kitayama K, 1998, ECOL RES, V13, P301, DOI 10.1046/j.1440-1703.1998.00264.x; Kitayama K, 2000, OECOLOGIA, V123, P342, DOI 10.1007/s004420051020; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kohler J, 2006, POLAR RES, V25, P91, DOI 10.1111/j.1751-8369.2006.tb00026.x; Lagerstrom A, 2009, BIOGEOCHEMISTRY, V95, P199, DOI 10.1007/s10533-009-9331-y; LITAOR MI, 1992, CATENA, V19, P1, DOI 10.1016/0341-8162(92)90013-2; LIU LX, 1992, CAN J SOIL SCI, V72, P159, DOI 10.4141/cjss92-015; MCBRIDE M, 1989, SOIL SCI SOC AM J, V53, P1668, DOI 10.2136/sssaj1989.03615995005300060009x; MCKEAGUE JA, 1966, CAN J SOIL SCI, V46, P13, DOI 10.4141/cjss66-003; Milbau A, 2013, NEW PHYTOL, V197, P1002, DOI 10.1111/nph.12054; Nadelhoffer KJ, 2002, PLANT SOIL, V242, P107, DOI 10.1023/A:1019646124768; Nieminen M, 1996, SCAND J FOREST RES, V11, P321, DOI 10.1080/02827589609382942; OGNALAGA M, 1994, SOIL SCI SOC AM J, V58, P332, DOI 10.2136/sssaj1994.03615995005800020011x; Quinn GP, 2002, EXPT DESIGN DATA ANA, DOI DOI 10.1017/CBO9780511806384; RICHARDSON CJ, 1985, SCIENCE, V228, P1424, DOI 10.1126/science.228.4706.1424; Rui YC, 2012, PLANT SOIL, V357, P73, DOI 10.1007/s11104-012-1132-8; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; SAGGAR S, 1990, FERT RES, V24, P173, DOI 10.1007/BF01073586; Salinas N, 2011, NEW PHYTOL, V189, P967, DOI 10.1111/j.1469-8137.2010.03521.x; Schimel JP, 2004, SOIL BIOL BIOCHEM, V36, P217, DOI 10.1016/j.soilbio.2003.09.008; Schmidt IK, 2002, PLANT SOIL, V242, P93, DOI 10.1023/A:1019642007929; SHAVER GR, 1995, ECOGRAPHY, V18, P259, DOI 10.1111/j.1600-0587.1995.tb00129.x; SIBBESEN E, 1978, PLANT SOIL, V50, P305, DOI 10.1007/BF02107180; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; STARK S, 2007, NUTR CYCLING TERREST, P309, DOI DOI 10.1007/978-3-540-68027-7_11; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Sundqvist MK, 2012, FUNCT ECOL, V26, P1090, DOI 10.1111/j.1365-2435.2012.02034.x; Sundqvist MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027056; Sundqvist MK, 2011, OIKOS, V120, P128, DOI 10.1111/j.1600-0706.2010.18811.x; Sundqvist MK, 2013, ANN REV ECO IN PRESS; SVEINBJORNSSON B, 1995, ARCTIC ALPINE RES, V27, P29, DOI 10.2307/1552065; Tiessen H., 1993, SOIL SAMPLING METHOD, P75, DOI [10.1201/9781420005271.ch25, DOI 10.1201/9781420005271.CH25]; Turner BL, 2004, SOIL BIOL BIOCHEM, V36, P815, DOI 10.1016/j.soilbio.2004.01.011; Vestergren J, 2012, ENVIRON SCI TECHNOL, V46, P3950, DOI 10.1021/es204016h; Vincent AG, 2013, PLANT SOIL, V367, P149, DOI 10.1007/s11104-013-1731-z; Vincent AG, 2012, BIOGEOCHEMISTRY, V108, P485, DOI 10.1007/s10533-011-9612-0; VITOUSEK PM, 1994, ECOLOGY, V75, P418, DOI 10.2307/1939545; VITOUSEK PM, 1988, OECOLOGIA, V77, P565, DOI 10.1007/BF00377275; Wallenstein MD, 2009, GLOBAL CHANGE BIOL, V15, P1631, DOI 10.1111/j.1365-2486.2008.01819.x; Wang SJ, 2009, SOIL BIOL BIOCHEM, V41, P891, DOI 10.1016/j.soilbio.2008.12.016; Wardle DA, 2008, OIKOS, V117, P93, DOI 10.1111/j.2007.0030-1299.16130.x; Weintraub MN, 2011, SOIL BIOL, V26, P295, DOI 10.1007/978-3-642-15271-9_12; Yang X, 2011, BIOGEOSCIENCES, V8, P2907, DOI 10.5194/bg-8-2907-2011; Zar J.H., 1996, BIOSTAT ANAL, V5th	82	39	44	9	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92942	10.1371/journal.pone.0092942	http://dx.doi.org/10.1371/journal.pone.0092942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24676035	Green Published, gold, Green Submitted			2022-12-25	WOS:000333677500058
J	Bonnet, X; Brischoux, F; Bonnet, C; Plichon, P; Fauvel, T				Bonnet, Xavier; Brischoux, Francois; Bonnet, Christophe; Plichon, Patrice; Fauvel, Thomas			Coastal Nurseries and Their Importance for Conservation of Sea Kraits	PLOS ONE			English	Article							CORAL-REEFS; SNAKES; POPULATIONS; DECLINE; SERPENTES; MORTALITY; ECOLOGY; HABITAT; ELAPIDAE; SURVIVAL	Destruction and pollution of coral reefs threaten these marine biodiversity hot stops which shelter more than two thirds of sea snake species. Notably, in many coral reef ecosystems of the Western Pacific Ocean, large populations of sea kraits (amphibious sea snakes) have drastically declined during the past three decades. Protecting remaining healthy populations is thus essential. In New Caledonia, coral reefs shelter numerous sea krait colonies spread throughout an immense lagoon (24,000 km(2)). Sea kraits feed on coral fish but lay their eggs on land. However, ecological information on reproduction and juveniles is extremely fragmentary, precluding protection of key habitats for reproduction. Our 10 years mark recapture study on Yellow sea kraits (L. saintgironsi >8,700 individuals marked) revealed that most neonates aggregate in highly localized coastal sites, where they feed and grow during several months before dispersal. Hundreds of females emigrate seasonally from remote populations (>50 km away) to lay their eggs in these coastal nurseries, and then return home. Protecting these nurseries is a priority to maintain recruitment rate, and to retain sea krait populations in the future.	[Bonnet, Xavier; Brischoux, Francois; Fauvel, Thomas] CNRS, Ctr Etud Biol Chize, Unite Mixte Rech 7372, Villiers En Bois, France; [Bonnet, Xavier; Brischoux, Francois; Fauvel, Thomas] Univ La Rochelle, Villiers En Bois, France; [Bonnet, Christophe] Ctr Hosp Terr Gaston Bourret, Noumea, New Caledonia; [Plichon, Patrice] Direct Environm, Noumea, Province Sud, New Caledonia; [Fauvel, Thomas] Univ Paris 06, Paris, France	Centre National de la Recherche Scientifique (CNRS); La Rochelle Universite; UDICE-French Research Universities; Sorbonne Universite	Bonnet, X (corresponding author), CNRS, Ctr Etud Biol Chize, Unite Mixte Rech 7372, Villiers En Bois, France.	bonnet@cebc.cnrs.fr		Bonnet, Xavier/0000-0001-6150-8199	Province Sud [C.283-11]	Province Sud	The Province Sud (convention C.283-11) provided a financial support to this study that covered part of the field equipment (< 20%) and boat transportation expenses (80%). This study did not receive any other specific funding (e.g. no funding for salary, general functioning, logistic), and thus this study essentially relied on the participation of unpaid volunteers (e.g. Christophe Bonnet) and on the personal involvement of researchers (CNRS employees, XB, TF, FB) and marine rangers (Province Sud employees, PP). The funders played a limited role in study design and data collection. Indeed, the Province Sud issued permits (see ethical statements) to perform surveys in several Natural Reserves (e.g. Signal Island). Yet, the main study site of this study is not a Natural Reserve and thus, no specific permit was required to perform surveys (note that sea kraits are not protected in New Caledonia). Thus funders had no role in most of the study design and data collection; and they played no role at all in analysis, decision to publish, or preparation of the manuscript.	Ackerman R.A., 1991, P193, DOI 10.1017/CBO9780511585739.013; Bacolod P.T., 1983, Philippine Scientist, V20, P39; BACOLOD P T, 1984, Philippine Scientist, V21, P155; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Bonnet X, 2005, BIOL J LINN SOC, V85, P433, DOI 10.1111/j.1095-8312.2005.00505.x; Bonnet X, 1999, BIOL CONSERV, V89, P39, DOI 10.1016/S0006-3207(98)00140-2; BONNET X, 2012, INTEGR COMP BIOL, V52, P1; Bonnet X, 2014, SCI TOTAL ENVIRON, V470, P876, DOI 10.1016/j.scitotenv.2013.10.027; Bonnet X, 2010, CORAL REEFS, V29, P379, DOI 10.1007/s00338-010-0588-3; Bonnet X, 2009, ENVIRON CONSERV, V36, P62, DOI 10.1017/S0376892909005451; Breininger DR, 2012, ANIM CONSERV, V15, P361, DOI 10.1111/j.1469-1795.2012.00524.x; Brischoux F., 2009, ZOOLOGIA NEOCALEDONI, V7, P37; Brischoux F, 2007, MAR ECOL PROG SER, V350, P145, DOI 10.3354/meps07133; Brischoux F, 2011, AUSTRAL ECOL, V36, P46, DOI 10.1111/j.1442-9993.2010.02115.x; Brischoux F, 2009, OIKOS, V118, P145, DOI 10.1111/j.1600-0706.2008.17011.x; Brischoux F, 2009, BIODIVERS CONSERV, V18, P2473, DOI 10.1007/s10531-009-9602-x; Brooks SE, 2010, BIOL CONSERV, V143, P2127, DOI 10.1016/j.biocon.2010.05.023; Cogger HG, 2006, REC AUST MUS, V58, P245, DOI 10.3853/j.0067-1975.58.2006.1452; Delmas V, 2008, PHYSIOL BIOCHEM ZOOL, V81, P345, DOI 10.1086/529459; Elfes CT, 2013, HERPETOL CONSERV BIO, V8, P37; Fauvel T, 2012, AMPHIBIA-REPTILIA, V33, P365, DOI 10.1163/15685381-00002839; Fitzgerald LA, 2000, WILDLIFE SOC B, V28, P235; Goiran C, 2013, CORAL REEFS, V32, P281, DOI 10.1007/s00338-012-0977-x; GRAVES BM, 1995, HERPETOLOGICAL MONOGRAPHS, NO 9, 1995, P102; Guinea M. L., 2007, DEWHA FINAL REP SURV, P1; Heatwole H, 1997, WILDLIFE SOC B, V25, P766; HEATWOLE H, 1999, AUSTR NATURAL HIST S; HERRE AWCT, 1949, COPEIA, P282; Hibbitts TJ, 2009, SOUTHWEST NAT, V54, P461, DOI 10.1894/GC-195.1; Ineich I, 2007, MAR BIOL, V151, P793, DOI 10.1007/s00227-006-0527-6; Lane A, 2011, MOL PHYLOGENET EVOL, V59, P567, DOI 10.1016/j.ympev.2011.03.005; Lowenborg K, 2012, BIODIVERS CONSERV, V21, P2477, DOI 10.1007/s10531-012-0308-0; Luiselli L, 2012, BIOTROPICA, V44, P569, DOI 10.1111/j.1744-7429.2011.00842.x; Lukoschek V, 2013, BIOL CONSERV, V166, P191, DOI 10.1016/j.biocon.2013.07.004; Milton DA, 2001, BIOL CONSERV, V101, P281, DOI 10.1016/S0006-3207(00)00232-9; Natusch DJD, 2012, BIODIVERS CONSERV, V21, P2899, DOI 10.1007/s10531-012-0345-8; Packard G.C., 1988, Biology of Reptilia, V16, P523; Pike DA, 2008, BIOL LETTERS, V4, P704, DOI 10.1098/rsbl.2008.0359; Pike DA, 2008, ECOLOGY, V89, P607, DOI 10.1890/06-2162.1; Rasmussen AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027373; Reading CJ, 2010, BIOL LETTERS, V6, P777, DOI 10.1098/rsbl.2010.0373; SAINT GIRONS H., 1964, TERRE VIE, V111, P185; Santos X, 2009, ACTA HERPETOL, V4, P161; Sasaki K, 2012, J HERPETOL, V46, P689, DOI 10.1670/11-023; Shetty S, 2002, CONSERV BIOL, V16, P1422, DOI 10.1046/j.1523-1739.2002.00515.x; Shine R, 2003, J ZOOL, V259, P261, DOI 10.1017/S0952836902003242; Shine R, 1997, ECOLOGY, V78, P2559; Shine Richard, 2009, P172; TU MC, 1990, J HERPETOL, V24, P119, DOI 10.2307/1564218; Wilkinson C, 2006, CONSERV BIOL SER, P3; Winne CT, 2007, COPEIA, P507, DOI 10.1643/0045-8511(2007)2007[507:EDOAPP]2.0.CO;2; *WRI, 2011, REEFS RISK REVISITED; 2012, SCIENCE, V335, P150	53	11	12	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e90246	10.1371/journal.pone.0090246	http://dx.doi.org/10.1371/journal.pone.0090246			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24670985	Green Published, gold			2022-12-25	WOS:000333677000007
J	Keenan, K; Grundy, E; Kenward, MG; Leon, DA				Keenan, Katherine; Grundy, Emily; Kenward, Michael G.; Leon, David A.			Women's Risk of Repeat Abortions Is Strongly Associated with Alcohol Consumption: A Longitudinal Analysis of a Russian National Panel Study, 1994-2009	PLOS ONE			English	Article							ST-PETERSBURG; UNINTENDED PREGNANCY; SUBSTANCE USE; CONDOM USE; DRUG-USE; OUTCOMES; HEALTH; TRENDS; DRINKING; PATTERNS	Abortion rates in Russia, particularly repeat abortions, are among the highest in the world, and abortion complications make a substantial contribution to the country's high maternal mortality rate. Russia also has a very high rate of hazardous alcohol use. However, the association between alcohol use and abortion in Russia remains unexplored. We investigated the longitudinal predictors of first and repeat abortion, focussing on women's alcohol use as a risk factor. Follow-up data from 2,623 women of reproductive age (16-44 years) was extracted from 14 waves of the Russian Longitudinal Monitoring Survey (RLMS), a nationally representative panel study covering the period 1994-2009. We used discrete time hazard models to estimate the probability of having a first and repeat abortion by social, demographic and health characteristics at the preceding study wave. Having a first abortion was associated with demographic factors such as age and parity, whereas repeat abortions were associated with low education and alcohol use. After adjustment for demographic and socioeconomic factors, the risk of having a repeat abortion increased significantly as women's drinking frequency increased (P<0.001), and binge drinking women were significantly more likely to have a repeat abortion than non-drinkers (OR 2.28, 95% CI 1.62-3.20). This association was not accounted for by contraceptive use or a higher risk of pregnancy. Therefore the determinants of first and repeat abortion in Russia between 1994-2009 were different. Women who had repeat abortions were distinguished by their heavier and more frequent alcohol use. The mechanism for the association is not well understood but could be explained by unmeasured personality factors, such as risk taking, or social non-conformity increasing the risk of unplanned pregnancy. Heavy or frequent drinkers constitute a particularly high risk group for repeat abortion, who could be targeted in prevention efforts.	[Keenan, Katherine; Kenward, Michael G.; Leon, David A.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Grundy, Emily] Univ London London Sch Econ & Polit Sci, Dept Social Policy, London WC2A 2AE, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School Economics & Political Science	Keenan, K (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	Katherine.keenan@lshtm.ac.uk	Leon, David A/G-2195-2010; Grundy, Emily/AAC-3260-2019	Leon, David A/0000-0001-9747-1762; Grundy, Emily/0000-0002-9633-1116; Keenan, Katherine/0000-0002-9670-1607	United Kingdom Economic and Social Research Council PhD Studentship	United Kingdom Economic and Social Research Council PhD Studentship	KK was funded by a United Kingdom Economic and Social Research Council PhD Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala N, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-28; Abdala N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-676; Alexandrova YN, 1999, CANCER LETT, V145, P43, DOI 10.1016/S0304-3835(99)00218-9; Asamoah BO, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-10; Bobak M, 2004, J EPIDEMIOL COMMUN H, V58, P238, DOI 10.1136/jech.2003.011825; Carpenter J. R., 2013, MULTIPLE IMPUTATION; Centers for Disease Control and Prevention ORC Macro, 2003, REPR MAT CHILD HLTH; Charles VE, 2008, CONTRACEPTION, V78, P436, DOI 10.1016/j.contraception.2008.07.005; David PH, 2007, HEALTH POLICY PLANN, V22, P83, DOI 10.1093/heapol/czm003; Denisov BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049986; Dianov MA, 2011, ZDRAVOOKHRANENIYE RO; England & Wales Department of Health, 2012, AB STAT ENGL WAL 201; Fahrmeir L, 1998, ENCY BIOSTATISTICS, V2; Gerber TP, 2008, STUD FAMILY PLANN, V39, P1, DOI 10.1111/j.1728-4465.2008.00147.x; Hagenaars A. J., 1996, POVERTY STAT LATE 19; Higher School of Economics, 1992, DEM; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Horga M, 2006, PREVENTING UNSAFE AB, P209; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Klemetti R, 2012, HUM REPROD, V27, P3315, DOI 10.1093/humrep/des294; Leon DA, 2009, ADDICTION, V104, P1630, DOI 10.1111/j.1360-0443.2009.02655.x; Martino SC, 2006, PERSPECT SEX REPRO H, V38, P66, DOI 10.1363/3806606; MENSCH B, 1992, DEMOGRAPHY, V29, P409, DOI 10.2307/2061826; Naimi TS, 2003, PEDIATRICS, V111, P1136; Oliveras E, 2005, J BIOSOC SCI, V37, P585, DOI 10.1017/S0021932004006960; Perlman F, 2009, PERSPECT SEX REPRO H, V41, P40, DOI [10.1363/4104009, 10.1111/j.1931-2393.2009.4114009.x]; Philipov D, 2004, EUR J POPUL, V20, P95, DOI 10.1023/B:EUJP.0000034499.24658.7a; Pietila I, 2008, SOCIOL HEALTH ILL, V30, P1070, DOI 10.1111/j.1467-9566.2008.01106.x; Prager SW, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.007; Reardon DC, 2004, AM J DRUG ALCOHOL AB, V30, P369, DOI 10.1081/ADA-120037383; Regushevskaya E, 2009, EUR J CONTRACEP REPR, V14, P176, DOI 10.1080/13625180902916038; Sedgh G, 2012, LANCET, V379, P625, DOI 10.1016/S0140-6736(11)61786-8; Shuper PA, 2010, ALCOHOL ALCOHOLISM, V45, P159, DOI 10.1093/alcalc/agp091; UNICEF, 2012, TRANSMONEE 2012 DAT; WHO, 2011, GLOB STAT REP ALC 20	35	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e90356	10.1371/journal.pone.0090356	http://dx.doi.org/10.1371/journal.pone.0090356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE0SR	24671000	Green Accepted, gold, Green Published			2022-12-25	WOS:000333677000008
J	Kovacs, S; Hawes, SE; Maley, SN; Mosites, E; Wong, L; Stergachis, A				Kovacs, Stephanie; Hawes, Stephen E.; Maley, Stephen N.; Mosites, Emily; Wong, Ling; Stergachis, Andy			Technologies for Detecting Falsified and Substandard Drugs in Low and Middle-Income Countries	PLOS ONE			English	Article							COUNTERFEIT DRUGS; QUALITY; IDENTIFICATION; SPECTROMETRY; SPECTROSCOPY; ARTESUNATE; PRODUCTS; TABLETS	Falsified and substandard drugs are a global health problem, particularly in low-and middle-income countries (LMIC) that have weak pharmacovigilance and drug regulatory systems. Poor quality medicines have important health consequences, including the potential for treatment failure, development of antimicrobial resistance, and serious adverse drug reactions, increasing healthcare costs and undermining the public's confidence in healthcare systems. This article presents a review of the methods employed for the analysis of pharmaceutical formulations. Technologies for detecting substandard and falsified drugs were identified primarily through literature reviews. Key-informant interviews with experts augmented our methods when warranted. In order to aid comparisons, technologies were assigned a suitability score for use in LMIC ranging from 0-8. Scores measured the need for electricity, need for sample preparation, need for reagents, portability, level of training required, and speed of analysis. Technologies with higher scores were deemed the most feasible in LMICs. We categorized technologies that cost $10,000 USD or less as low cost, $10,000-100,000 USD as medium cost and those greater than $100,000 USD as high cost technologies (all prices are 2013 USD). This search strategy yielded information on 42 unique technologies. Five technologies were deemed both low cost and had feasibility scores between 6-8, and an additional four technologies had medium cost and high feasibility. Twelve technologies were deemed portable and therefore could be used in the field. Many technologies can aid in the detection of substandard and falsified drugs that vary from the simplest of checklists for packaging to the most complex mass spectrometry analyses. Although there is no single technology that can serve all the requirements of detecting falsified and substandard drugs, there is an opportunity to bifurcate the technologies into specific niches to address specific sections within the workflow process of detecting products.	[Kovacs, Stephanie; Hawes, Stephen E.; Maley, Stephen N.; Mosites, Emily; Stergachis, Andy] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Wong, Ling] Bill & Melinda Gates Fdn, Seattle, WA USA; [Stergachis, Andy] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Stergachis, Andy] Univ Washington, Global Med Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Bill & Melinda Gates Foundation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kovacs, S (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	kovacs2@uw.edu		Mosites, Emily/0000-0002-2968-9564	Strategic Analysis and Research Training Program (START); Bill and Melinda Gates Foundation	Strategic Analysis and Research Training Program (START); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was funded by the Strategic Analysis and Research Training Program (START) funded by the Bill and Melinda Gates Foundation. The funders role was limited to the design of the original project. The funders had no role in decision to publish or preparation of the manuscript.	Almuzaini T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002923; [Anonymous], QUALITY ANTIMALARIAL; [Anonymous], 2013, COUNT PROBL FALS SUB; Bate R, 2012, RES REP TROP MED, V3, P57, DOI 10.2147/RRTM.S33108; Bate R, 2009, AFR J PHARM PHARMACO, V3, P165; Davison Mark, 2011, PHARM ANTICOUNTERFEI; Deconinck E, 2013, J CHROMATOGR SCI, V51, P791, DOI 10.1093/chromsci/bmt006; Felton LA, 2011, DRUG DEV IND PHARM, V37, P88, DOI 10.3109/03639045.2010.492397; Fernandes RD, 2012, J PHARMACEUT BIOMED, V66, P85, DOI 10.1016/j.jpba.2012.03.004; Fernandez FM, 2011, ANALYST, V136, P3073, DOI 10.1039/c0an00627k; Food and Drug Administration, 1995, GUID IND IMM REL SOL; GPHF, GPHF MIN PROT COUNT; Green MD, 2001, TROP MED INT HEALTH, V6, P980, DOI 10.1046/j.1365-3156.2001.00793.x; Green MD, 2007, J PHARMACEUT BIOMED, V43, P105, DOI 10.1016/j.jpba.2006.06.047; Harris GA, 2012, ANALYST, V137, P3039, DOI 10.1039/c2an35431d; Harris GA, 2011, ANAL CHEM, V83, P1908, DOI 10.1021/ac102246h; Holzgrabe U, 2011, J PHARMACEUT BIOMED, V55, P679, DOI 10.1016/j.jpba.2010.12.017; Hostetler DM, 2012, ANAL METHODS-UK, V4, P3392, DOI 10.1039/c2ay25443c; Hu CQ, 2006, J PHARMACEUT BIOMED, V40, P68, DOI 10.1016/j.jpba.2005.06.026; KAINE LA, 1994, J CHROMATOGR A, V674, P255, DOI 10.1016/0021-9673(94)85231-6; Kaur H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003403; KENYON AS, 1995, J AOAC INT, V78, P41; Lal R, 2010, AAPS J, V12, P716, DOI 10.1208/s12248-010-9232-y; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2700, 10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136]; Marini RD, 2010, J PHARMACEUT BIOMED, V53, P1278, DOI 10.1016/j.jpba.2010.07.026; Martino R, 2010, ANAL BIOANAL CHEM, V398, P77, DOI 10.1007/s00216-010-3748-y; Maurin JK, 2007, J PHARMACEUT BIOMED, V43, P1514, DOI 10.1016/j.jpba.2006.10.033; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; Newton PN, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001139; Poole C, 2021, GAS CHROMATOGRAPHY; Roll Back Malaria, 2012, GLOB MAL ACT PLAN; Santamaria-Fernandez R, 2009, SCI JUSTICE, V49, P102, DOI 10.1016/j.scijus.2008.12.003; Sherma J, 2007, ACTA CHROMATOGR, V19, P5; Stanton C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000431; Stein MJ, 2012, ANAL CHEM, V84, P1572, DOI 10.1021/ac2028134; Storme-Paris I, 2010, ANAL CHIM ACTA, V658, P163, DOI 10.1016/j.aca.2009.11.005; Twohig M, 2010, DRUG TEST ANAL, V2, P45, DOI 10.1002/dta.115; USP, 2013, PQM PROM QUAL MED DE; Weaver AA, 2013, ANAL CHEM, V85, P6453, DOI 10.1021/ac400989p; WHO, 2011, SURV QUAL SEL ANT ME; Wilkinson N, 2012, BRIEFCASE ENCOUNTER; World Health Organization, TOOL VIS INSP; World Health Organization, 2012, SPUR FALS LAB FALS C	43	82	84	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e90601	10.1371/journal.pone.0090601	http://dx.doi.org/10.1371/journal.pone.0090601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671033	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000009
J	Peano, C; Chiaramonte, F; Motta, S; Pietrelli, A; Jaillon, S; Rossi, E; Consolandi, C; Champion, OL; Michell, SL; Freddi, L; Falciola, L; Basilico, F; Garlanda, C; Mauri, P; De Bellis, G; Landini, P				Peano, Clelia; Chiaramonte, Fabrizio; Motta, Sara; Pietrelli, Alessandro; Jaillon, Sebastien; Rossi, Elio; Consolandi, Clarissa; Champion, Olivia L.; Michell, Stephen L.; Freddi, Luca; Falciola, Luigi; Basilico, Fabrizio; Garlanda, Cecilia; Mauri, Pierluigi; De Bellis, Gianluca; Landini, Paolo			Gene and Protein Expression in Response to Different Growth Temperatures and Oxygen Availability in Burkholderia thailandensis	PLOS ONE			English	Article							RNA DEGRADOSOME COMPOSITION; ESCHERICHIA-COLI; CAPSULAR POLYSACCHARIDE; VIRULENCE GENES; PSEUDOMALLEI; IDENTIFICATION; ADAPTATION; INFECTION; FLAGELLA; MALLEI	Burkholderia thailandensis, although normally avirulent for mammals, can infect macrophages in vitro and has occasionally been reported to cause pneumonia in humans. It is therefore used as a model organism for the human pathogen B. pseudomallei, to which it is closely related phylogenetically. We characterized the B. thailandensis clinical isolate CDC2721121 (BtCDC272) at the genome level and studied its response to environmental cues associated with human host colonization, namely, temperature and oxygen limitation. Effects of the different growth conditions on BtCDC272 were studied through whole genome transcription studies and analysis of proteins associated with the bacterial cell surface. We found that growth at 37 degrees C, compared to 28 degrees C, negatively affected cell motility and flagella production through a mechanism involving regulation of the flagellin-encoding fliC gene at the mRNA stability level. Growth in oxygen-limiting conditions, in contrast, stimulated various processes linked to virulence, such as lipopolysaccharide production and expression of genes encoding protein secretion systems. Consistent with these observations, BtCDC272 grown in oxygen limitation was more resistant to phagocytosis and strongly induced the production of inflammatory cytokines from murine macrophages. Our results suggest that, while temperature sensing is important for regulation of B. thailandensis cell motility, oxygen limitation has a deeper impact on its physiology and constitutes a crucial environmental signal for the production of virulence factors.	[Peano, Clelia; Motta, Sara; Pietrelli, Alessandro; Consolandi, Clarissa; Basilico, Fabrizio; Mauri, Pierluigi; De Bellis, Gianluca] CNR, Inst Biomed Technol, Milan, Italy; [Chiaramonte, Fabrizio; Rossi, Elio; Freddi, Luca; Landini, Paolo] Univ Milan, Dept Biosci, Milan, Italy; [Jaillon, Sebastien; Garlanda, Cecilia] Humanitas Clin & Res Ctr Inst, Milan, Italy; [Champion, Olivia L.; Michell, Stephen L.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Falciola, Luigi] Univ Milan, Dept Chem, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milan; University of Exeter; University of Milan	Landini, P (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	paolo.landini@unimi.it	Freddi, Luca/ABG-1801-2020; Rossi, Elio/N-4802-2015; Pietrelli, Alessandro/J-4389-2016; Peano, Clelia/C-4015-2018; JAILLON, Sebastien/A-7537-2015; Mauri, Pietro Luigi/AAC-3095-2019; Garlanda, Cecilia/K-4601-2016; De Bellis, Gianluca/H-9725-2013; MOTTA, SARA/P-9635-2018; Landini, Paolo/B-7859-2017; Falciola, Luigi/Q-2256-2016	Rossi, Elio/0000-0002-2042-608X; Pietrelli, Alessandro/0000-0003-0241-8542; Peano, Clelia/0000-0001-7055-3629; JAILLON, Sebastien/0000-0002-5600-855X; Mauri, Pietro Luigi/0000-0003-4364-0393; Garlanda, Cecilia/0000-0002-1510-7703; De Bellis, Gianluca/0000-0002-1622-4477; MOTTA, SARA/0000-0001-8421-6287; Landini, Paolo/0000-0003-0999-426X; Falciola, Luigi/0000-0002-2031-239X; Freddi, Luca/0000-0002-3395-4113	Fondazione CARIPLO (Progetto Vaccini) [2009-3577]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [FIRB RBLA039LSF]	Fondazione CARIPLO (Progetto Vaccini)(Fondazione Cariplo); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by Fondazione CARIPLO (Progetto Vaccini, contract number 2009-3577) and by Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (project FIRB RBLA039LSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Braaten RO, 2000, AQUACULT ENG, V23, P295, DOI 10.1016/S0144-8609(00)00059-5; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Burtnick MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076767; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Chua KL, 2003, INFECT IMMUN, V71, P1622, DOI 10.1128/IAI.71.4.1622-1629.2003; Chuaygud T, 2008, T ROY SOC TROP MED H, V102, P140; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Comunian C, 2011, PROTEOMICS, V11, P2320, DOI 10.1002/pmic.201000479; CONDON C, 1995, MICROBIOL REV, V59, P623, DOI 10.1128/MMBR.59.4.623-645.1995; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fisher NA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-117; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Glass MB, 2006, J CLIN MICROBIOL, V44, P4601, DOI 10.1128/JCM.01585-06; Gualdi L, 2007, J BACTERIOL, V189, P8034, DOI 10.1128/JB.00900-07; Hamad MA, 2011, ANTIMICROB AGENTS CH, V55, P3313, DOI 10.1128/AAC.00953-10; Jensen PO, 2007, MICROBIOL-SGM, V153, P1329, DOI 10.1099/mic.0.2006/003863-0; Kamp HD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002153; Kim HS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-174; Lacqua A, 2006, APPL ENVIRON MICROB, V72, P956, DOI 10.1128/AEM.72.1.956-959.2006; Lertpatanasuwan N, 1999, CLIN INFECT DIS, V28, P927, DOI 10.1086/517253; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loferer H, 1997, MOL MICROBIOL, V26, P11, DOI 10.1046/j.1365-2958.1997.5231883.x; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; MASKELL JP, 1991, J MED MICROBIOL, V34, P253, DOI 10.1099/00222615-34-5-253; Mauri P, 2005, FASEB J, V19, P1125, DOI 10.1096/fj.04-3000fje; Mauri P, 2008, METHOD ENZYMOL, V447, P99, DOI 10.1016/S0076-6879(08)02206-4; Moalli F, 2010, BLOOD, V116, P5170, DOI 10.1182/blood-2009-12-258376; Nachin L, 2005, J BACTERIOL, V187, P6265, DOI 10.1128/JB.187.18.6265-6272.2005; O'Quinn AL, 2001, CELL MICROBIOL, V3, P381, DOI 10.1046/j.1462-5822.2001.00118.x; Ooi WF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003795; Palma CA, 2010, J AM CHEM SOC, V132, P17880, DOI 10.1021/ja107882e; Peano Clelia, 2013, Microb Inform Exp, V3, P1, DOI 10.1186/2042-5783-3-1; Pessi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072939; Pilatova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049745; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Regonesi ME, 2006, BIOCHIMIE, V88, P151, DOI 10.1016/j.biochi.2005.07.012; Sass AM, 2013, ISME J, V7, P1568, DOI 10.1038/ismej.2013.36; Schell MA, 2011, J PROTEOME RES, V10, P2417, DOI 10.1021/pr1012398; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Sim BMQ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r89; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smith MD, 1997, INFECT IMMUN, V65, P4319, DOI 10.1128/IAI.65.10.4319-4321.1997; Soini J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-30; Tomich M, 2002, INFECT IMMUN, V70, P1799, DOI 10.1128/IAI.70.4.1799-1806.2002; Wand ME, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-11; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524; Yu YT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-46; Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6	54	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93009	10.1371/journal.pone.0093009	http://dx.doi.org/10.1371/journal.pone.0093009			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671187	Green Published, Green Submitted, gold			2022-12-25	WOS:000333677000100
J	Wang, ZK; Gao, JN; Song, HY; Wu, XM; Sun, Y; Qi, J; Yu, HY; Wang, ZG; Zhang, QQ				Wang, Zhongkai; Gao, Jinning; Song, Huayu; Wu, Xiaomeng; Sun, Yan; Qi, Jie; Yu, Haiyang; Wang, Zhigang; Zhang, Quanqi			Sexually Dimorphic Expression of vasa Isoforms in the Tongue Sole (Cynoglossus semilaevis)	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; GREEN FLUORESCENT PROTEIN; INITIATION-FACTOR 4A; GENOME-WIDE ANALYSIS; DEAD-BOX PROTEINS; TRANSLATION INITIATION; RNA HELICASE; DIFFERENTIAL EXPRESSION; CRYSTAL-STRUCTURE; HOMOLOG GENE	The vasa gene encodes an ATP-dependent RNA helicase of the DEAD box protein family that functions in a broad range of molecular events involving duplex RNA. In most species, the germline specific expression of vasa becomes a molecular marker widely used in the visualization and labeling of primordial germ cells (PGCs) and a tool in surrogate broodstock production through PGC transplantation. The vasa gene from tongue sole (Cynoglossus semilaevis) was characterized to promote the development of genetic breeding techniques in this species. Three C. semilaevis vasa transcripts were isolated, namely vas-l, vas-m, and vas-s. Quantitative real-time PCR results showed that C. semilaevis vasa transcripts were prevalently expressed in gonads, with very weak expression of vas-s in other tissues. Embryonic development expression profiles revealed the onset of zygotic transcription of vasa mRNAs and the maternal deposit of the three transcripts. The genetic ZW female juvenile fish was discriminated from genetic ZZ males by a pair of female specific primers. Only the expression of vas-s can be observed in both sexes during early gonadal differentiation. Before PGCs started mitosis, there was sexually dimorphic expression of vas-s with the ovary showing higher levels and downward trend. The results demonstrated the benefits of vasa as a germline specific marker for PGCs during embryonic development and gonadal differentiation. This study lays the groundwork for further application of C. semilaevis PGCs in fish breeding.	[Wang, Zhongkai; Gao, Jinning; Song, Huayu; Wu, Xiaomeng; Sun, Yan; Qi, Jie; Yu, Haiyang; Wang, Zhigang; Zhang, Quanqi] Ocean Univ China, Key Lab Marine Genet & Breeding MGB, Minist Educ, Coll Marine Life Sci, Qingdao, Peoples R China	Ocean University of China	Zhang, QQ (corresponding author), Ocean Univ China, Key Lab Marine Genet & Breeding MGB, Minist Educ, Coll Marine Life Sci, Qingdao, Peoples R China.	qzhang@ouc.edu.cn		wang, zhongkai/0000-0001-8909-7790	National High-Tech Research and Development Program [2012AA10A402]; National Natural Science Foundation of China [31172385]	National High-Tech Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High-Tech Research and Development Program (2012AA10A402) and the National Natural Science Foundation of China (31172385). The URL is http://www.863.gov.cn and http://www.nsfc.gov.cn/Portal0/default152.htm, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4; Blazquez M, 2011, GEN COMP ENDOCR, V170, P322, DOI 10.1016/j.ygcen.2010.10.007; BLUM S, 1992, P NATL ACAD SCI USA, V89, P7664, DOI 10.1073/pnas.89.16.7664; Cao MX, 2012, COMP BIOCHEM PHYS A, V162, P163, DOI 10.1016/j.cbpa.2012.02.007; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Chen SL, 2014, NAT GENET, V46, P253, DOI 10.1038/ng.2890; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; Fairchild EA, 2007, J WORLD AQUACULT SOC, V38, P114, DOI 10.1111/j.1749-7345.2006.00079.x; Feng ZF, 2011, AQUACULTURE, V314, P202, DOI 10.1016/j.aquaculture.2011.02.017; Fujimura K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029477; Fujimura M, 2000, DEV GENES EVOL, V210, P64, DOI 10.1007/s004270050012; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Gao JN, 2013, GENE, V531, P411, DOI 10.1016/j.gene.2013.08.030; Gavis ER, 1996, DEVELOPMENT, V122, P2791; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; Herpin A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-3; Ikenishi K, 2000, DEV GROWTH DIFFER, V42, P95; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kobayashi T, 2003, FISH PHYSIOL BIOCHEM, V28, P479, DOI 10.1023/B:FISH.0000030634.37486.fa; Kobayashi T, 2002, MECH DEVELOP, V111, P167, DOI 10.1016/S0925-4773(01)00613-X; Kobayashi T, 2000, MECH DEVELOP, V99, P139, DOI 10.1016/S0925-4773(00)00464-0; Kobayashi T, 2007, MOL REPROD DEV, V74, P207, DOI 10.1002/mrd.20577; KOMIYA T, 1994, DEV BIOL, V162, P354, DOI 10.1006/dbio.1994.1093; Krovel AV, 2004, DEV BIOL, V271, P190, DOI 10.1016/j.ydbio.2004.04.004; Krovel AV, 2002, MECH DEVELOP, V116, P141, DOI 10.1016/S0925-4773(02)00154-5; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lin F, 2012, MOL REPROD DEV, V79, P803, DOI 10.1002/mrd.22120; [马学坤 MA Xuekun], 2006, [海洋水产研究, Marine Fisheries Research], V27, P55; Mallam AL, 2012, NATURE, V490, P121, DOI 10.1038/nature11402; Markussen FH, 1997, COLD SPRING HARB SYM, V62, P13; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Mochizuki K, 2001, DEV GENES EVOL, V211, P299, DOI 10.1007/s004270100156; Nagasawa K, 2008, FISHERIES SCI, V75, P71; Okutsu T, 2006, P NATL ACAD SCI USA, V103, P2725, DOI 10.1073/pnas.0509218103; Olsen LC, 1997, MECH DEVELOP, V66, P95, DOI 10.1016/S0925-4773(97)00099-3; Pacchiarini T, 2013, REPROD FERT DEVELOP, V25, P646, DOI 10.1071/RD11240; PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Pugh GE, 1999, J MOL BIOL, V292, P771, DOI 10.1006/jmbi.1999.3112; Raghuveer K, 2010, COMP BIOCHEM PHYS A, V157, P79, DOI 10.1016/j.cbpa.2010.04.017; Rocak S, 2005, NUCLEIC ACIDS RES, V33, P999, DOI 10.1093/nar/gki244; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; ROZEN F, 1989, MOL CELL BIOL, V9, P4061, DOI 10.1128/MCB.9.9.4061; Saito T, 2008, BIOL REPROD, V78, P159, DOI 10.1095/biolreprod.107.060038; Saito T, 2010, INT J DEV BIOL, V54, P1481, DOI 10.1387/ijdb.103111ts; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHUPBACH T, 1986, DEV BIOL, V113, P443, DOI 10.1016/0012-1606(86)90179-X; Schwer B, 2000, EMBO J, V19, P6582, DOI 10.1093/emboj/19.23.6582; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101; Shibata N, 1999, DEV BIOL, V206, P73, DOI 10.1006/dbio.1998.9130; Shinomiya A, 2000, DEV GROWTH DIFFER, V42, P317; Siddiqui NU, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r11; Takeuchi Y, 2003, BIOL REPROD, V69, P1142, DOI 10.1095/biolreprod.103.017624; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka M, 2001, P NATL ACAD SCI USA, V98, P2544, DOI 10.1073/pnas.041315498; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Thomsen S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r93; Tomancak P, 1998, DEVELOPMENT, V125, P1723; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30; Wang XB, 2013, AQUACULTURE, V388, P49, DOI 10.1016/j.aquaculture.2013.01.024; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Wu XM, 2014, COMP BIOCHEM PHYS B, V167, P41, DOI 10.1016/j.cbpb.2013.06.004; Xu HY, 2005, DEV DYNAM, V233, P872, DOI 10.1002/dvdy.20410; Yang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064799, 10.1371/journal.pone.0064058]; Yang Q, 2007, MOL CELL, V28, P253, DOI 10.1016/j.molcel.2007.08.016; Yang QS, 2006, NAT STRUCT MOL BIOL, V13, P981, DOI 10.1038/nsmb1165; Yoon C, 1997, DEVELOPMENT, V124, P3157; Yoshizaki G, 2000, INT J DEV BIOL, V44, P323; Yoshizaki G, 2000, MOL REPROD DEV, V55, P364, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;364::AID-MRD2&gt;3.0.CO;2-8	75	6	8	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e93380	10.1371/journal.pone.0093380	http://dx.doi.org/10.1371/journal.pone.0093380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	24671276	gold, Green Submitted, Green Published			2022-12-25	WOS:000333677000137
J	Ioacara, S; Guja, C; Ionescu-Tirgoviste, C; Fica, S; Roden, M				Ioacara, Sorin; Guja, Cristian; Ionescu-Tirgoviste, Constantin; Fica, Simona; Roden, Michael			Cancer Specific Mortality in Insulin-Treated Type 2 Diabetes Patients	PLOS ONE			English	Article							RISK; GLARGINE; ANALOGS; MALIGNANCIES; COHORT	Aims: To test the hypothesis that cumulative exposure to insulin and long-acting insulin analogs might be associated with cancer mortality in diabetes patients. Methods: All consecutive diabetes patients aged over 40 years, residing in a major urban area were screened at their first diabetes outpatient visit between 01/01/2001-12/31/2008 (n = 79869). Exclusion criteria were insulin treatment at screening, no insulin treatment until 12/31/2008, less than 6 months of glucose-lowering treatment alone before insulin initiation, insulin prescription before glargine became available, age <40/>= 80 years at first insulin prescription, and <6 months of insulin exposure. A total 4990 subjects were followed-up for death based on death certificate, until 12/31/2011. Adjusted time-dependent competing risk regression analysis, with daily updates of treatment modalities was performed. Results are expressed for every 10,000 IU of cumulative dose or one year of cumulative time exposure to insulin. Results: Mean baseline age was 62 +/- 9 years, and follow-up 4.7 +/- 1.9 years. Glargine cumulative dose was associated with lower cancer mortality risk (subhazard ratio, SHR: 0.94 (95%CI 0.89-0.99, p = 0.033)). Cumulative exposure limited to that attained one year prior to death revealed lower SHRs for cumulative time (0.94 (95%CI 0.89-0.99, p = 0.018)) and cumulative dose of glargine (0.92 (95%CI 0.86-0.98, p = 0.014)). Glargine cumulative time and cumulative dose were significant predictors for lower pancreatic and breast cancer mortality, but not for deaths from lung, colorectal, female genital, liver, and urinary tract cancer. No increased hazards were found for any other subtypes of insulins. Conclusions: The cumulative dose exposure to insulin glargine was associated with a lower risk of cancer mortality in general, and of breast and pancreatic cancer in particular. This effect remained even after additional "fixed" cohort or propensity score analyses.	[Ioacara, Sorin; Fica, Simona] Elias Hosp, Bucharest, Romania; [Ioacara, Sorin; Guja, Cristian; Ionescu-Tirgoviste, Constantin; Fica, Simona] Carol Davila Univ Med & Pharm, Bucharest, Romania; [Guja, Cristian; Ionescu-Tirgoviste, Constantin] N Paulescu Natl Inst Diabet Nutr & Metab Dis, Bucharest, Romania; [Roden, Michael] Univ Dusseldorf, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Roden, Michael] German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany	Carol Davila University of Medicine & Pharmacy; Heinrich Heine University Dusseldorf; Deutsches Diabetes-Zentrum (DDZ)	Ioacara, S (corresponding author), Elias Hosp, Bucharest, Romania.	drsorin@yahoo.com	Guja, Cristian/K-2334-2019; Roden, Michael/AAD-3843-2019; Ioacara, Sorin/AAO-9210-2021	Ioacara, Sorin/0000-0001-5663-3593				Blin P, 2012, DIABETOLOGIA, V55, P644, DOI 10.1007/s00125-011-2429-5; Carstensen B, 2012, DIABETOLOGIA, V55, P948, DOI 10.1007/s00125-011-2381-4; Colhoun HM, 2012, DIABETOLOGIA, V55, P2929, DOI 10.1007/s00125-012-2668-0; Colhoun HM, 2009, DIABETOLOGIA, V52, P1755, DOI 10.1007/s00125-009-1453-1; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Home PD, 2009, DIABETOLOGIA, V52, P2499, DOI 10.1007/s00125-009-1530-5; Ioacara S, 2011, DIABETES RES CLIN PR, V92, P400, DOI 10.1016/j.diabres.2011.03.022; Johnson JA, 2011, DIABETOLOGIA, V54, P2263, DOI 10.1007/s00125-011-2242-1; Jonasson JM, 2009, DIABETOLOGIA, V52, P1745, DOI 10.1007/s00125-009-1444-2; Mannucci E, 2010, DIABETES CARE, V33, P1997, DOI 10.2337/dc10-0476; Morden NE, 2011, DIABETES CARE, V34, P1965, DOI 10.2337/dc11-0699; Renehan AG, 2012, DIABETOLOGIA, V55, P7, DOI 10.1007/s00125-011-2352-9; Rosenstock J, 2009, DIABETOLOGIA, V52, P1971, DOI 10.1007/s00125-009-1452-2; Ruiter R, 2012, DIABETOLOGIA, V55, P51, DOI 10.1007/s00125-011-2312-4; Stefansdottir G, 2011, DIABETOLOGIA, V54, P1608, DOI 10.1007/s00125-011-2104-x; Suissa S, 2011, DIABETOLOGIA, V54, P2254, DOI 10.1007/s00125-011-2190-9; van Staa TP, 2012, DIABETOLOGIA, V55, P654, DOI 10.1007/s00125-011-2390-3; WHO Collaborating Centre for Drug statistics Methodology, 2012, ATC DDD IND	22	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93132	10.1371/journal.pone.0093132	http://dx.doi.org/10.1371/journal.pone.0093132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667573	gold, Green Published, Green Submitted			2022-12-25	WOS:000333675600146
J	Koyama, N; Nishida, Y; Ishii, T; Yoshida, T; Furukawa, Y; Narahara, H				Koyama, Naoko; Nishida, Yoshihiro; Ishii, Terukazu; Yoshida, Toshie; Furukawa, Yuichi; Narahara, Hisashi			Telmisartan Induces Growth Inhibition, DNA Double-Strand Breaks and Apoptosis in Human Endometrial Cancer Cells	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; PROSTATE-CANCER; ESTROGEN-RECEPTOR; CROSS-TALK; X-RAY; PROLIFERATION; CARCINOMA; BLOCKER; DAMAGE; LIGAND	Telmisartan, an angiotensin II receptor type 1 blocker, is often used as an antihypertension drug, and it has also been characterized as a peroxisome proliferator-activated receptor-gamma (PPAR gamma) ligand. The purpose of this study was to elucidate the antitumor effects of telmisartan on endometrial cancer cells. We treated three endometrial cancer cell lines with various concentrations of telmisartan, and we investigated the effects of the telmisartan on the cell proliferation, apoptosis, and their related measurements in vitro. We also administered telmisartan to nude mice with experimental tumors to determine its in vivo effects and toxicity. All three endometrial cancer cell lines were sensitive to the growth-inhibitory effect of telmisartan. The induction of apoptosis was confirmed in concert with the altered expression of genes and proteins related to the apoptosis. We also observed that DNA double-strand breaks (DSBs) were induced in HHUA (human endometrial cancer) cells by telmisartan treatment. In addition, experiments in nude mice showed that telmisartan significantly inhibited human endometrial tumor growth, without toxic side effects. Our results suggest that telmisartan might be a new therapeutic option for the treatment of endometrial cancers.	[Koyama, Naoko; Nishida, Yoshihiro; Ishii, Terukazu; Yoshida, Toshie; Furukawa, Yuichi; Narahara, Hisashi] Oita Univ, Fac Med, Dept Obstet & Gynecol, Oita 87011, Japan	Oita University	Nishida, Y (corresponding author), Oita Univ, Fac Med, Dept Obstet & Gynecol, Oita 87011, Japan.	ynishida@oita-u.ac.jp			Oita University	Oita University(Oita University)	This study was supported by a Research Fund at the Discretion of the President, Oita University (HN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57; Benson SC, 2008, J HYPERTENS, V26, P973, DOI 10.1097/HJH.0b013e3282f56ba5; Berstein LM, 2004, J CANCER RES CLIN, V130, P687, DOI 10.1007/s00432-004-0587-2; Boisvert M, 2008, VIROLOGY, V380, P1, DOI 10.1016/j.virol.2008.07.023; Chen L, 2013, UPTODATE; Chen Y, 2001, CANCER RES, V61, P6437; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; Doyle MC, 2013, BIOCHEM BIOPH RES CO, V431, P472, DOI 10.1016/j.bbrc.2013.01.036; Evans T, 2011, BRIT J CANCER, V104, P1505, DOI 10.1038/bjc.2011.68; Funao K, 2008, ONCOL REP, V20, P295, DOI 10.3892/or_00000006; Funao K, 2009, MOL MED REP, V2, P193, DOI 10.3892/mmr_00000083; Ghous Z, 2008, ANTICANCER RES, V28, P3757; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Hardwick JM, 2012, TRENDS CELL BIOL, V22, P318, DOI 10.1016/j.tcb.2012.03.005; Hu FB, 2003, J WOMEN HEALTH GEN-B, V12, P163, DOI 10.1089/154099903321576565; Ishiguro H, 2007, PROSTATE, V67, P924, DOI 10.1002/pros.20571; Isobe A, 2008, HUM REPROD, V23, P440, DOI 10.1093/humrep/dem247; KELLER H, 1995, MOL ENDOCRINOL, V9, P794, DOI 10.1210/me.9.7.794; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kociecka B, 2010, EUR J PHARMACOL, V628, P51, DOI 10.1016/j.ejphar.2009.11.043; Koike M, 2013, J VET MED SCI, V75, P415, DOI 10.1292/jvms.12-0333; Matsuyama M, 2010, EXP THER MED, V1, P301, DOI 10.3892/etm_00000046; Nishida M, 1996, Hum Cell, V9, P109; Nishida M, 1985, Nihon Sanka Fujinka Gakkai Zasshi, V37, P1103; Nishida Masato, 2002, Hum Cell, V15, P104, DOI 10.1111/j.1749-0774.2002.tb00105.x; Nusuetrong P, 2012, J TOXICOL SCI, V37, P803, DOI 10.2131/jts.37.803; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Obel Jennifer C, 2006, Clin Adv Hematol Oncol, V4, P459; Ota K, 2006, CLIN CANCER RES, V12, P4200, DOI 10.1158/1078-0432.CCR-05-1833; Plesca D, 2008, METHOD ENZYMOL, V446, P107, DOI 10.1016/S0076-6879(08)01606-6; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Rimon G, 1997, J NEUROSCI RES, V48, P563, DOI 10.1002/(SICI)1097-4547(19970615)48:6<563::AID-JNR9>3.0.CO;2-8; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Uemura H, 2003, MOL CANCER THER, V2, P1139; Vale CL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003915.pub4; Wang L, 2012, CHINESE MED J-PEKING, V125, P2200, DOI 10.3760/cma.j.issn.0366-6999.2012.12.021; Wang TT, 2006, CRIT REV ONCOL HEMAT, V58, P1, DOI 10.1016/j.critrevonc.2005.08.011; Wang X, 2002, MOL CELL ENDOCRINOL, V194, P123, DOI 10.1016/S0303-7207(02)00154-5; Xin B, 2007, CANCER, V110, P791, DOI 10.1002/cncr.22854; Yamamoto K, 2009, HYPERTENSION, V54, P1353, DOI 10.1161/HYPERTENSIONAHA.109.138750; Yang YC, 2007, INT J GYNECOL CANCER, V17, P418, DOI 10.1111/j.1525-1438.2006.00866.x; You H, 2013, J HUAZHONG U SCI-MED, V33, P43, DOI 10.1007/s11596-013-1069-z	44	39	42	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93050	10.1371/journal.pone.0093050	http://dx.doi.org/10.1371/journal.pone.0093050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667764	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600132
J	Lin, GG; Andrejeva, G; Te Fong, ACW; Hill, DK; Orton, MR; Parkes, HG; Koh, DM; Robinson, SP; Leach, MO; Eykyn, TR; Chung, YL				Lin, Gigin; Andrejeva, Gabriela; Te Fong, Anne-Christine Wong; Hill, Deborah K.; Orton, Matthew R.; Parkes, Harry G.; Koh, Dow-Mu; Robinson, Simon P.; Leach, Martin O.; Eykyn, Thomas R.; Chung, Yuen-Li			Reduced Warburg Effect in Cancer Cells Undergoing Autophagy: Steady-State H-1-MRS and Real-Time Hyperpolarized C-13-MRS Studies	PLOS ONE			English	Article							TUMOR RESPONSE; BREAST; PYRUVATE; LACTATE; INHIBITOR; INDUCTION; PROSTATE; RECOVERY; SURVIVAL; BRAIN	Autophagy is a highly regulated, energy dependent cellular process where proteins, organelles and cytoplasm are sequestered in autophagosomes and digested to sustain cellular homeostasis. We hypothesized that during autophagy induced in cancer cells by i) starvation through serum and amino acid deprivation or ii) treatment with PI-103, a class I PI3K/mTOR inhibitor, glycolytic metabolism would be affected, reducing flux to lactate, and that this effect may be reversible. We probed metabolism during autophagy in colorectal HT29 and HCT116 Bax knock-out cells using hyperpolarized C-13-magnetic resonance spectroscopy (MRS) and steady-state H-1-MRS. 24 hr PI103-treatment or starvation caused significant reduction in the apparent forward rate constant (k(PL)) for pyruvate to lactate exchange compared with controls in HT29 (100 mu M PI-103: 82%, p = 0.05) and HCT116 Bax-ko cells (10 mu M PI-103: 53%, p = 0.05; 20 mu M PI-103: 42%, p<0.0001; starvation: 52%, p<0.001), associated with reduced lactate excretion and intracellular lactate in all cases, and unchanged lactate dehydrogenase (LDH) activity and increased NAD+/NADH ratio following PI103 treatment or decreased LDH activity and unchanged NAD+/NADH ratio following starvation. After 48 hr recovery from PI103 treatment, k(PL) remained below control levels in HT29 cells (74%, p = 0.02), and increased above treated values, but remained below 24 hr vehicle-treated control levels in HCT116 Bax-ko cells (65%, p = 0.004) both were accompanied by sustained reduction in lactate excretion, recovery of NAD+/NADH ratio and intracellular lactate. Following recovery from starvation, k(PL) was significantly higher than 24 hr vehicle-treated controls (140%, p = 0.05), associated with increased LDH activity and total cellular NAD(H). Changes in k(PL) and cellular and excreted lactate provided measureable indicators of the major metabolic processes accompanying starvation-and drug-induced autophagy. The changes are reversible, returning towards and exceeding control values on cellular recovery, which potentially identifies resistance. k(PL) (hyperpolarized C-13-MRS) and lactate (H-1-MRS) provide useful biomarkers for the autophagic process, enabling non-invasive monitoring of the Warburg effect.	[Lin, Gigin; Andrejeva, Gabriela; Te Fong, Anne-Christine Wong; Hill, Deborah K.; Orton, Matthew R.; Parkes, Harry G.; Koh, Dow-Mu; Robinson, Simon P.; Leach, Martin O.; Eykyn, Thomas R.; Chung, Yuen-Li] Canc Res UK, Sutton, Surrey, England; [Lin, Gigin; Andrejeva, Gabriela; Te Fong, Anne-Christine Wong; Hill, Deborah K.; Orton, Matthew R.; Parkes, Harry G.; Koh, Dow-Mu; Robinson, Simon P.; Leach, Martin O.; Eykyn, Thomas R.; Chung, Yuen-Li] Inst Canc Res, Div Radiotherapy & Imaging, EPSRC Canc Imaging Ctr, Sutton, Surrey, England; [Lin, Gigin; Andrejeva, Gabriela; Te Fong, Anne-Christine Wong; Hill, Deborah K.; Orton, Matthew R.; Parkes, Harry G.; Koh, Dow-Mu; Robinson, Simon P.; Leach, Martin O.; Eykyn, Thomas R.; Chung, Yuen-Li] Royal Marsden Hosp, Sutton, Surrey, England; [Lin, Gigin] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan; [Eykyn, Thomas R.] St Thomas Hosp, Rayne Inst, Kings Coll London, Div Imaging Sci & Biomed Engn, London SE1 7EH, England	Cancer Research UK; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Chang Gung Memorial Hospital; Chang Gung University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Leach, MO (corresponding author), Canc Res UK, Sutton, Surrey, England.	Martin.Leach@icr.ac.uk; ylichung@icr.ac.uk	Eykyn, Thomas/J-3284-2016; Lin, Gigin/A-2676-2017; Chung, Yuen-Li/K-2269-2019; leach, martin o/C-2248-2008; Parkes, Harold G/I-7412-2012	Eykyn, Thomas/0000-0003-1768-3808; Lin, Gigin/0000-0001-7246-1058; Chung, Yuen-Li/0000-0003-0807-1658; leach, martin o/0000-0002-0756-5368; Hill, Deborah/0000-0002-6441-5489; Robinson, Simon/0000-0003-4101-7274; Andrejeva, Gabriela/0000-0002-3508-7682; Koh, Dow-Mu/0000-0001-7654-8011; Parkes, Harold/0000-0003-4981-864X	Cancer Research UK; EPSRC Cancer Imaging Centre; MRC; Department of Health (England) [C1060/A10334]; NHS; Chang Gung Medical Foundation (Taiwan) [CMRPG370443, CMRPG3B1922]; EPSRC [EP/H046526/1] Funding Source: UKRI; Cancer Research UK [16464] Funding Source: researchfish; Engineering and Physical Sciences Research Council [GR/S23612/01, EP/H046526/1] Funding Source: researchfish; Medical Research Council [1100738] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10162] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); EPSRC Cancer Imaging Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (England); NHS; Chang Gung Medical Foundation (Taiwan); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors acknowledge the support received from the Cancer Research UK and EPSRC Cancer Imaging Centre in association with the MRC and Department of Health (England) grant C1060/A10334, also NHS funding to the NIHR Biomedical Research Centre, MRC-funded studentship, also Chang Gung Medical Foundation (Taiwan) grants CMRPG370443 and CMRPG3B1922. MOL is an NIHR Senior Investigator. The authors also thank Alice Warley at the King's College London Centre for Ultrastructural Imaging (CUI) for assistance with electron microscopy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; BOARD M, 1990, BIOCHEM J, V265, P503, DOI 10.1042/bj2650503; Bohndiek SE, 2010, MOL CANCER THER, V9, P3278, DOI 10.1158/1535-7163.MCT-10-0706; Christensen CE, 2013, J BIOL CHEM, DOI [10.1074/jbc.M113.498626, DOI 10.1074/JBC.M113.498626.32.SANTIDRIAN]; Crowley LC, 2011, AM J HEMATOL, V86, P38, DOI 10.1002/ajh.21914; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; Day SE, 2011, MAGN RESON MED, V65, P557, DOI 10.1002/mrm.22698; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris T, 2009, P NATL ACAD SCI USA, V106, P18131, DOI 10.1073/pnas.0909049106; Hill DK, 2013, NMR BIOMED, V26, P1321, DOI 10.1002/nbm.2957; Hill DK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071996, 10.1371/journal.pone.0074627]; HOURI JJ, 1995, BIOCHEM J, V309, P521, DOI 10.1042/bj3090521; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Kwock L, 2006, LANCET ONCOL, V7, P859, DOI 10.1016/S1470-2045(06)70905-6; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lodi A, 2013, NMR BIOMED, V26, P299, DOI 10.1002/nbm.2848; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Nishida K, 2009, CELL DEATH DIFFER, V16, P31, DOI 10.1038/cdd.2008.163; O'Donovan TR, 2011, AUTOPHAGY, V7, P509, DOI 10.4161/auto.7.5.15066; Park I, 2011, J MAGN RESON IMAGING, V33, P1284, DOI 10.1002/jmri.22563; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Rosenfeldt MT, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001306; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Sitter B, 2002, NMR BIOMED, V15, P327, DOI 10.1002/nbm.775; Tyagi RK, 1996, MAGN RESON MED, V35, P194, DOI 10.1002/mrm.1910350210; Ward CS, 2010, CANCER RES, V70, P1296, DOI 10.1158/0008-5472.CAN-09-2251; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Witney TH, 2011, J BIOL CHEM, V286, P24572, DOI 10.1074/jbc.M111.237727; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	36	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92645	10.1371/journal.pone.0092645	http://dx.doi.org/10.1371/journal.pone.0092645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667972	Green Submitted, Green Published, gold			2022-12-25	WOS:000333675600059
J	Morignat, E; Perrin, JB; Gay, E; Vinard, JL; Calavas, D; Henaux, V				Morignat, Eric; Perrin, Jean-Baptiste; Gay, Emilie; Vinard, Jean-Luc; Calavas, Didier; Henaux, Viviane			Assessment of the Impact of the 2003 and 2006 Heat Waves on Cattle Mortality in France	PLOS ONE			English	Article							EXCESS MORTALITY; TEMPERATURES; EXTREMES	Objectives: While several studies have highlighted and quantified human mortality during the major heat waves that struck Western Europe in 2003 and 2006, the impact on farm animals has been overlooked. The aim of this study was to assess the effect of these two events on cattle mortality in France, one of the most severely impacted countries. Methods: Poisson regressions were used to model the national baseline for cattle mortality between 2004 and 2005 and predict the weekly number of expected deaths in 2003 and 2006 for the whole cattle population and by subpopulation based on age and type of production. Observed and estimated values were compared to identify and quantify excess mortality. The same approach was used at a departmental scale (a French department being an administrative and territorial division) to assess the spatio-temporal evolution of the mortality pattern. Results: Overall, the models estimated relative excess mortality of 24% [95% confidence interval: 22-25%] for the two-week heat wave of 2003, and 12% [11-14%] for the three-week heat wave of 2006. In 2003, most cattle subpopulations were impacted during the heat wave and some in the following weeks too. In 2006, cattle subpopulations were impacted for a limited time only, with no excess mortality at the beginning or after the heat wave. No marked differences in cattle mortality were found among the different subpopulations by age and type of production. The implications of these results for risk prevention are discussed.	[Morignat, Eric; Gay, Emilie; Vinard, Jean-Luc; Calavas, Didier; Henaux, Viviane] Agence Natl Securite Sanit Alimentat Environm & T, Unite Epidemiol Lab Lyon, Lyon, France; [Perrin, Jean-Baptiste] Bur Sante Anim, Direct Gen Alimentat DGAI, Paris, France		Morignat, E (corresponding author), Agence Natl Securite Sanit Alimentat Environm & T, Unite Epidemiol Lab Lyon, Lyon, France.	eric.morignat@anses.fr						Bessemoulin P., 2004, METEOROLOGIE, V46, P25; Crescio MI, 2010, PREV VET MED, V97, P191, DOI 10.1016/j.prevetmed.2010.09.004; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331; Fouillet A, 2008, INT J EPIDEMIOL, V37, P309, DOI 10.1093/ije/dym253; Fouillet A, 2006, INT ARCH OCC ENV HEA, V80, P16, DOI 10.1007/s00420-006-0089-4; Fouillet A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-114; Frich P, 2002, CLIMATE RES, V19, P193, DOI 10.3354/cr019193; Hahn GL, 1999, J ANIM SCI, V77, P10; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Nardone A, 2010, LIVEST SCI, V130, P57, DOI 10.1016/j.livsci.2010.02.011; Perrin JB, 2011, INRA PROD ANIM, V24, P235; Perrin JB, 2010, EPIDEMICS-NETH, V2, P207, DOI 10.1016/j.epidem.2010.10.002; Poumadere M, 2005, RISK ANAL, V25, P1483, DOI 10.1111/j.1539-6924.2005.00694.x; R Core Team, 2012, R LANG ENV STAT COMP; Rey G, 2007, INT ARCH OCC ENV HEA, V80, P615, DOI 10.1007/s00420-007-0173-4; Sahai H, 1996, STAT EPIDEMIOLOGY ME; Schneider M, 2007, BEH, P22; Silanikove N, 2000, LIVEST PROD SCI, V67, P1, DOI 10.1016/S0301-6226(00)00162-7; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Ung A., 2013, BEH, V11, P99; Wilson EB, 1931, P NATL ACAD SCI USA, V17, P684, DOI 10.1073/pnas.17.12.684	23	33	33	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93176	10.1371/journal.pone.0093176	http://dx.doi.org/10.1371/journal.pone.0093176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667835	Green Submitted, gold, Green Published			2022-12-25	WOS:000333675600153
J	Pereira, S; Malard, V; Ravanat, JL; Davin, AH; Armengaud, J; Foray, N; Adam-Guillermin, C				Pereira, Sandrine; Malard, Veronique; Ravanat, Jean-Luc; Davin, Anne-Helene; Armengaud, Jean; Foray, Nicolas; Adam-Guillermin, Christelle			Low Doses of Gamma-Irradiation Induce an Early Bystander Effect in Zebrafish Cells Which Is Sufficient to Radioprotect Cells	PLOS ONE			English	Article							MEDIATED INTERCELLULAR COMMUNICATION; C3H 10T(1)/(2) CELLS; DOUBLE-STRAND BREAKS; ADAPTIVE RESPONSE; GLIOMA-CELLS; HUMAN FIBROBLASTS; ALPHA-PARTICLES; RADIOADAPTIVE RESPONSE; MAMMALIAN-CELLS; NITRIC-OXIDE	The term "bystander effect'' is used to describe an effect in which cells that have not been exposed to radiation are affected by irradiated cells though various intracellular signaling mechanisms. In this study we analyzed the kinetics and mechanisms of bystander effect and radioadaptation in embryonic zebrafish cells (ZF4) exposed to chronic low dose of gamma rays. ZF4 cells were irradiated for 4 hours with total doses of gamma irradiation ranging from 0.01-0.1 Gy. In two experimental conditions, the transfer of irradiated cells or culture medium from irradiated cells results in the occurrence of DNA double strand breaks in non-irradiated cells (assessed by the number of gamma-H2AX foci) that are repaired at 24 hours post-irradiation whatever the dose. At low total irradiation doses the bystander effect observed does not affect DNA repair mechanisms in targeted and bystander cells. An increase in global methylation of ZF4 cells was observed in irradiated cells and bystander cells compared to control cells. We observed that pre-irradiated cells which are then irradiated for a second time with the same doses contained significantly less gamma-H2AX foci than in 24 h gamma-irradiated control cells. We also showed that bystander cells that have been in contact with the pre-irradiated cells and then irradiated alone present less gamma-H2AX foci compared to the control cells. This radioadaptation effect is significantly more pronounced at the highest doses. To determine the factors involved in the early events of the bystander effect, we performed an extensive comparative proteomic study of the ZF4 secretomes upon irradiation. In the experimental conditions assayed here, we showed that the early events of bystander effect are probably not due to the secretion of specific proteins neither the oxidation of these secreted proteins. These results suggest that early bystander effect may be due probably to a combination of multiple factors.	[Pereira, Sandrine; Adam-Guillermin, Christelle] Inst Radioprotect & Surete Nucl, PRP Environm SERIS, Lab Ecotoxicol Radionucleides, Cadarache, St Paul Lez Dur, France; [Pereira, Sandrine; Foray, Nicolas] CRCL UMR INSERM 1052 CNRS 5286, Equipe Radiobiol, Lyon, France; [Malard, Veronique; Davin, Anne-Helene; Armengaud, Jean] CEA, DSV, IBEB, Lab Biochim Syst Perturb, Bagnols Sur Ceze, France; [Ravanat, Jean-Luc] CEA Grenoble, INAC Scib UMR CEA UJF E3, Lab Les Acides Nucl, F-38054 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Pereira, S (corresponding author), Inst Radioprotect & Surete Nucl, PRP Environm SERIS, Lab Ecotoxicol Radionucleides, Cadarache, St Paul Lez Dur, France.	sandrine.pereira@ymail.com	malard, veronique/AAF-6253-2020; Ravanat, Jean-Luc/E-3452-2018; Foray, Nicolas/Q-2363-2019; malard, veronique/AAY-1670-2021; Foray, Nicolas/I-4755-2018	Ravanat, Jean-Luc/0000-0002-7123-6358; Foray, Nicolas/0000-0002-1282-1303; malard, veronique/0000-0002-0020-0518; Foray, Nicolas/0000-0002-1282-1303; ARMENGAUD, Jean/0000-0003-1589-445X; Adam-Guillermin, christelle/0000-0002-8833-0762	European Union programme STAR (Strategy for Allied Radioecology) [Fission-2010-3.5.1-269672]; Institute for Radioprotection and Nuclear Safety (IRSN); National Institute for Medical Research (INSERM)	European Union programme STAR (Strategy for Allied Radioecology); Institute for Radioprotection and Nuclear Safety (IRSN); National Institute for Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This research was supported by the European Union programme STAR (Strategy for Allied Radioecology) (Fission-2010-3.5.1-269672). S. Pereira is a postdoctoral fellow funded by the Institute for Radioprotection and Nuclear Safety (IRSN) and the National Institute for Medical Research (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengaud J, 2012, EXPERT REV PROTEOMIC, V9, P561, DOI [10.1586/epr.12.52, 10.1586/EPR.12.52]; Azzam EI, 2003, ONCOGENE, V22, P7050, DOI 10.1038/sj.onc.1206961; Azzam EI, 1998, RADIAT RES, V150, P497, DOI 10.2307/3579865; Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; Azzam EI, 2000, CANCER RES, V60, P2623; Barcellos-Hoff MH, 2001, RADIAT RES, V156, P618, DOI 10.1667/0033-7587(2001)156[0618:ESTTMA]2.0.CO;2; Belyakov OV, 2002, RADIAT PROT DOSIM, V99, P249, DOI 10.1093/oxfordjournals.rpd.a006775; Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Burdak-Rothkamm S, 2009, EUR J PHARMACOL, V625, P151, DOI 10.1016/j.ejphar.2009.09.068; Choi VWY, 2013, ENVIRON SCI TECHNOL, V47, P6368, DOI 10.1021/es401171h; Choi VWY, 2012, ENVIRON SCI TECHNOL, V46, P226, DOI 10.1021/es2016928; Choi VWY, 2010, ENVIRON SCI TECHNOL, V44, P8829, DOI 10.1021/es101535f; Clair G, 2010, MOL CELL PROTEOMICS, V9, P1486, DOI 10.1074/mcp.M000027-MCP201; Dickey JS, 2009, CARCINOGENESIS, V30, P1686, DOI 10.1093/carcin/bgp192; Dupierris V, 2009, BIOINFORMATICS, V25, P1980, DOI 10.1093/bioinformatics/btp301; Foray N, 2003, EMBO J, V22, P2860, DOI 10.1093/emboj/cdg274; Gerashchenko BI, 2003, CYTOM PART A, V56A, P71, DOI 10.1002/cyto.a.10092; Gilbin R, 2008, J ENVIRON RADIOACTIV, V99, P134, DOI 10.1016/j.jenvrad.2007.07.004; Herok R, 2010, INT J RADIAT ONCOL, V77, P244, DOI 10.1016/j.ijrobp.2009.11.033; Hu BR, 2006, CARCINOGENESIS, V27, P245, DOI 10.1093/carcin/bgi224; Ilnytskyy Y, 2011, MUTAT RES-FUND MOL M, V714, P113, DOI 10.1016/j.mrfmmm.2011.06.014; Jarvis RB, 2003, MUTAT RES-GEN TOX EN, V541, P63, DOI 10.1016/S1383-5718(03)00182-7; Kashino G, 2004, MUTAT RES-FUND MOL M, V556, P209, DOI 10.1016/j.mrfmmm.2004.08.009; Kovalchuk O, 2003, MUTAT RES-FUND MOL M, V529, P13, DOI 10.1016/S0027-5107(03)00103-9; Liu CS, 2012, AQUAT TOXICOL, V118, P108, DOI 10.1016/j.aquatox.2012.04.001; Lyng FM, 2002, RADIAT RES, V157, P365, DOI 10.1667/0033-7587(2002)157[0365:IOAICE]2.0.CO;2; Maguire P, 2005, RADIAT RES, V163, P384, DOI 10.1667/RR3325; Malard V, 2012, J PROTEOMICS, V75, P1043, DOI 10.1016/j.jprot.2011.10.025; Mitchell SA, 2004, INT J RADIAT BIOL, V80, P465, DOI 10.1080/09553000410001725116; Mothersill C, 1997, INT J RADIAT BIOL, V72, P597, DOI 10.1080/095530097143095; Mothersill C, 2006, RADIAT RES, V165, P26, DOI 10.1667/RR3488.1; Mothersill C, 2004, RADIAT RES, V161, P256, DOI 10.1667/RR3136; Mothersill C, 2004, NAT REV CANCER, V4, P158, DOI 10.1038/nrc1277; Mothersill C, 2009, INT J RADIAT BIOL, V85, P909, DOI 10.3109/09553000903105452; Ojima Mitsuaki, 2001, Physiological Chemistry and Physics and Medical NMR, V33, P41; Ojima M, 2011, RADIAT PROT DOSIM, V146, P276, DOI 10.1093/rpd/ncr169; OLIVIERI G, 1984, SCIENCE, V223, P594, DOI 10.1126/science.6695170; Pereira S, 2011, ENVIRON TOXICOL CHEM, V30, P2831, DOI 10.1002/etc.695; Postiglione I, 2010, MED ONCOL, V27, P495, DOI 10.1007/s12032-009-9241-9; Prise KM, 2005, LANCET ONCOL, V6, P520, DOI 10.1016/S1470-2045(05)70246-1; Raiche J, 2004, BIOCHEM BIOPH RES CO, V325, P39, DOI 10.1016/j.bbrc.2004.10.002; Ravanat JL, 2002, CARCINOGENESIS, V23, P1911, DOI 10.1093/carcin/23.11.1911; Ryan LA, 2008, J ENVIRON RADIOACTIV, V99, P739, DOI 10.1016/j.jenvrad.2007.10.001; Sawant SG, 2001, RADIAT RES, V156, P177, DOI 10.1667/0033-7587(2001)156[0177:ARATBE]2.0.CO;2; Shao C, 2008, ONCOGENE, V27, P434, DOI 10.1038/sj.onc.1210653; Shao C, 2005, INT J CANCER, V116, P45, DOI 10.1002/ijc.21003; Shao C, 2003, CANCER RES, V63, P8437; Shao CL, 2004, P NATL ACAD SCI USA, V101, P13495, DOI 10.1073/pnas.0404930101; Shao CL, 2003, RADIAT RES, V160, P318, DOI 10.1667/RR3044; Smith RW, 2007, PROTEOMICS, V7, P4171, DOI 10.1002/pmic.200700573; Smith RW, 2013, INT J RADIAT BIOL, V89, P225, DOI 10.3109/09553002.2013.754558; Smith RW, 2011, BBA-PROTEINS PROTEOM, V1814, P290, DOI 10.1016/j.bbapap.2010.11.002; Sokolov MV, 2005, ONCOGENE, V24, P7257, DOI 10.1038/sj.onc.1208886; Tawa R, 1998, J RADIAT RES, V39, P271, DOI 10.1269/jrr.39.271; Yang HY, 2005, ONCOGENE, V24, P2096, DOI 10.1038/sj.onc.1208439; Yasuda T, 2006, J RADIAT RES, V47, P295, DOI 10.1269/jrr.0617; Zhou HN, 2000, P NATL ACAD SCI USA, V97, P2099, DOI 10.1073/pnas.030420797	57	43	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e92974	10.1371/journal.pone.0092974	http://dx.doi.org/10.1371/journal.pone.0092974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667817	Green Published, gold			2022-12-25	WOS:000333675600115
J	Zheng, WJ; Hou, YJ; Yao, W				Zheng, Weijiang; Hou, Yanjun; Yao, Wen			Lactulose Increases Equol Production and Improves Liver Antioxidant Status in Barrows Treated with Daidzein	PLOS ONE			English	Article							IN-VITRO FERMENTATION; DIVERSITY ANALYSIS; IDENTIFICATION; QUANTITATION; ISOFLAVONES; POPULATIONS; METABOLISM; BACTERIA; CULTURE; LIGNANS	Equol, one of the intestinal microflora metabolites of daidzein, has gained much attention for having greater bioactivity than its precursor (daidzein and daidzin) and seeming to be promoted by hydrogen gas. The effects of lactulose on the equol-producing capacity and liver antioxidant status of barrows treated with daidzein were investigated in this study. Male castrated piglets (barrows) of Landrace x Duroc, aged 40 days, were randomly divided into the following three groups: control group (C, n = 12, fed an isoflavones-free basic diet), daidzein group (D, n = 12, fed an isoflavones-free basic diet with 50 mg/kg of daidzein supplementation) and daidzein+lactulose group (D+L, n = 12, fed an isoflavones-free basic diet with 1% of lactulose and 50 mg/kg of daidzein supplementation). After 20 days, the profile of short-chain fatty acids in the colon digesta showed that lactulose significantly increased the fermented capacity in the gastrointestinal tract of the barrows. First-void urinary equol concentrations were significantly higher in the D+L group than in the D group (3.13 +/- 0.93 compared to 2.11 +/- 0.82 mu g/ml, respectively). Furthermore, fecal equol levels were also significantly higher in the D+L group than in the D group (12.00 +/- 2.68 compared to 10.00 +/- 2.26 mu g/g, respectively). The population of bacteroidetes and the percentage of bacteroidetes to bacteria in feces were higher in the D+L group than in the D group. The DGGE profiles results indicate that lactulose might shift the pathways of hydrogen utilization, and changing the profiles of SRB in feces. Moreover, the D+L group had weak enhancement of T-SOD and CuZn-SOD activities in the livers of barrows treated with daidzein.	[Zheng, Weijiang; Hou, Yanjun; Yao, Wen] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Yao, Wen] Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs	Yao, W (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	yaowen67jp@njau.edu.cn		Zheng, Weijiang/0000-0002-1725-2488	Ph.D. Programs Foundation of Ministry of Education of China [B0201100681]; Scientific Research Foundation for Returned Overseas Chinese Scholars [G0201100315]; Special Fund for Agro-scientific Research in the Public Interest [201003011]	Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Scientific Research Foundation for Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Special Fund for Agro-scientific Research in the Public Interest	This study was funded by Ph.D. Programs Foundation of Ministry of Education of China (B0201100681), Scientific Research Foundation for Returned Overseas Chinese Scholars (G0201100315) and the Special Fund for Agro-scientific Research in the Public Interest (201003011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blay M, 2010, J PHARMACEUT BIOMED, V51, P382, DOI 10.1016/j.jpba.2009.03.028; Bolca S, 2007, J NUTR, V137, P2242, DOI 10.1093/jn/137.10.2242; Bolca S, 2010, ANAEROBE, V16, P247, DOI 10.1016/j.anaerobe.2010.03.002; Bowey E, 2003, FOOD CHEM TOXICOL, V41, P631, DOI 10.1016/S0278-6915(02)00324-1; Cheng YF, 2009, LETT APPL MICROBIOL, V48, P585, DOI 10.1111/j.1472-765X.2009.02583.x; Choi EJ, 2009, J FOOD SCI, V74, pH65, DOI 10.1111/j.1750-3841.2008.01039.x; Decroos K, 2005, ARCH MICROBIOL, V183, P45, DOI 10.1007/s00203-004-0747-4; Denman SE, 2007, FEMS MICROBIOL ECOL, V62, P313, DOI 10.1111/j.1574-6941.2007.00394.x; Deplancke B, 2000, APPL ENVIRON MICROB, V66, P2166, DOI 10.1128/AEM.66.5.2166-2174.2000; FLORENT C, 1985, J CLIN INVEST, V75, P608, DOI 10.1172/JCI111738; GIBSON GR, 1990, GUT, V31, P679, DOI 10.1136/gut.31.6.679; HANE BG, 1993, ELECTROPHORESIS, V14, P967, DOI 10.1002/elps.11501401154; Jin JS, 2010, INT J SYST EVOL MICR, V60, P1721, DOI 10.1099/ijs.0.016774-0; Konstantinov SR, 2003, FEMS MICROBIOL ECOL, V43, P225, DOI 10.1111/j.1574-6941.2003.tb01062.x; Lane D.J., 1991, NUCL ACID TECHNIQUES, DOI [10.1099/ijs.0.060731-0, DOI 10.1099/ijs.0.060731-0]; Layton A, 2006, APPL ENVIRON MICROB, V72, P4214, DOI 10.1128/AEM.01036-05; Mao SY, 2007, ANIM FEED SCI TECH, V136, P154, DOI 10.1016/j.anifeedsci.2006.09.012; Maubach J, 2003, J CHROMATOGR B, V784, P137, DOI 10.1016/S1570-0232(02)00789-4; Minamida K, 2008, INT J SYST EVOL MICR, V58, P1238, DOI 10.1099/ijs.0.64894-0; Minamida K, 2006, J BIOSCI BIOENG, V102, P247, DOI 10.1263/jbb.102.247; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Nubel U, 1996, J BACTERIOL, V178, P5636; Possemiers S, 2007, FEMS MICROBIOL ECOL, V61, P372, DOI 10.1111/j.1574-6941.2007.00330.x; Rimbach G, 2003, XENOBIOTICA, V33, P913, DOI 10.1080/0049825031000150444; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; SETCHELL KDR, 1984, AM J CLIN NUTR, V40, P569, DOI 10.1093/ajcn/40.3.569; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Setchell KDR, 2010, J NUTR, V140, p1363S, DOI 10.3945/jn.109.119784; Shannon-Weaver, 1963, MATH THEOR COMM; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Tousen Y, 2012, J NUTR SCI, V1, DOI 10.1017/jns.2012.14; Tousen Y, 2011, METABOLISM, V60, P1425, DOI 10.1016/j.metabol.2011.02.009; Ueno T., 2002, ANN NUTR METAB, V45, P114; Wang XL, 2007, ARCH MICROBIOL, V187, P155, DOI 10.1007/s00203-006-0183-8; Wei XJ, 2011, ANIMAL, V5, P320, DOI 10.1017/S1751731110001771; XU X, 1994, J NUTR, V124, P825, DOI 10.1093/jn/124.6.825; Yu ZT, 2008, FEMS MICROBIOL LETT, V282, P73, DOI 10.1111/j.1574-6968.2008.01108.x; Zhang Xun, 2012, Weishengwu Xuebao, V52, P866; Zheng WJ, 2014, ANAEROBE, V25, P47, DOI 10.1016/j.anaerobe.2013.11.011; Zhu WY, 2003, ANAEROBE, V9, P175, DOI 10.1016/S1075-9964(03)00083-0	41	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e93163	10.1371/journal.pone.0093163	http://dx.doi.org/10.1371/journal.pone.0093163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667812	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600152
J	Zhang, B; Chen, SY; He, XY; Liu, WJ; Zhao, Q; Zhao, L; Tian, CJ				Zhang, Bin; Chen, Shengyun; He, Xingyuan; Liu, Wenjie; Zhao, Qian; Zhao, Lin; Tian, Chunjie			Responses of Soil Microbial Communities to Experimental Warming in Alpine Grasslands on the Qinghai-Tibet Plateau	PLOS ONE			English	Article							CLIMATE-CHANGE MANIPULATIONS; CARBON-CYCLE FEEDBACK; DYNAMICS; BACTERIA; FUNGI; MICROORGANISMS; TEMPERATURE; MOISTURE; LITTER; GROWTH	Global surface temperature is predicted to increase by at least 1.5 degrees C by the end of this century. However, the response of soil microbial communities to global warming is still poorly understood, especially in high-elevation grasslands. We therefore conducted an experiment on three types of alpine grasslands on the Qinghai-Tibet Plateau to study the effect of experimental warming on abundance and composition of soil microbial communities at 0-10 and 10-20 cm depths. Plots were passively warmed for 3 years using open-top chambers and compared to adjacent control plots at ambient temperature. Soil microbial communities were assessed using phospholipid fatty acid (PLFA) analysis. We found that 3 years of experimental warming consistently and significantly increased microbial biomass at the 0-10 cm soil depth of alpine swamp meadow (ASM) and alpine steppe (AS) grasslands, and at both the 0-10 and 10-20 cm soil depths of alpine meadow (AM) grasslands, due primarily to the changes in soil temperature, moisture, and plant coverage. Soil microbial community composition was also significantly affected by warming at the 0-10 cm soil depth of ASM and AM and at the 10-20 cm soil depth of AM. Warming significantly decreased the ratio of fungi to bacteria and thus induced a community shift towards bacteria at the 0-10 cm soil depth of ASM and AM. While the ratio of arbuscular mycorrhizal fungi to saprotrophic fungi (AMF/SF) was significantly decreased by warming at the 0-10 cm soil depth of ASM, it was increased at the 0-10 cm soil depth of AM. These results indicate that warming had a strong influence on soil microbial communities in the studied high-elevation grasslands and that the effect was dependent on grassland type.	[Zhang, Bin; He, Xingyuan; Tian, Chunjie] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China; [Chen, Shengyun; Liu, Wenjie; Zhao, Qian; Zhao, Lin] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, State Key Lab Cryospher Sci, Lanzhou, Peoples R China; [Zhao, Lin] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Observat & Res Stn Qinghai Tibet Plateau, Golmud, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Tian, CJ (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China.	tiancj@iga.ac.cn	Cai, Guanjing/GZK-7070-2022; Zhang, Bangzhou/CAG-9625-2022; Zhao, Lin/M-9536-2018	Zhao, Lin/0000-0003-0245-8413	National Basic Research Program of China (973 program) [2013CBA01807]; Science Foundation of Chinese Academy of Sciences [KZZD-EW-TZ-16]; National Natural Science Foundation of China [Y4E1041001, 40901040]; Natural Science Foundation of Jilin Province [20130101080JC]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Science Foundation of Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province	This work was financially supported by the National Basic Research Program of China (973 program, 2013CBA01807, http://www.973.gov.cn/Default_3.aspx), the Science Foundation of Chinese Academy of Sciences (KZZD-EW-TZ-16, http://www.cas.cn/), the National Natural Science Foundation of China (Y4E1041001,40901040, http://www.nsfc.gov.cn/) and the Natural Science Foundation of Jilin Province (20130101080JC, http://kjt.jl.gov.cn/kjt/4/tindex.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP; [Anonymous], 2013, CLIM CHANG 2013 PHYS; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Berg N, 2008, SOIL BIOL BIOCHEM, V40, P2686, DOI 10.1016/j.soilbio.2008.07.019; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; [陈生云 Chen Shengyun], 2012, [冰川冻土, Journal of Glaciology and Geocryology], V34, P1142; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Crowther TW, 2012, ISME J, V6, P1992, DOI 10.1038/ismej.2012.53; Deslippe JR, 2012, FEMS MICROBIOL ECOL, V82, P303, DOI 10.1111/j.1574-6941.2012.01350.x; Eklof JS, 2012, ECOL LETT, V15, P864, DOI 10.1111/j.1461-0248.2012.01810.x; Frey SD, 2008, SOIL BIOL BIOCHEM, V40, P2904, DOI 10.1016/j.soilbio.2008.07.020; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Grimm NB, 2013, FRONT ECOL ENVIRON, V11, P474, DOI 10.1890/120282; Guo DL, 2012, INT J CLIMATOL, V32, P1775, DOI 10.1002/joc.2388; Haugwitz MS, 2014, PLANT SOIL, V374, P211, DOI 10.1007/s11104-013-1855-1; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Posada RH, 2012, FUNGAL BIOL-UK, V116, P747, DOI 10.1016/j.funbio.2012.04.003; Institute of Soil Sciences Chinese Academy of Sciences, 1978, PHYS CHEM AN METH SO, P7; IUSS Working Group WRB, 2006, WORLD REFERENCE BASE, V103; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Jackson RB, 2007, ECOLOGY, V88, P1343, DOI 10.1890/06-1882; KIEFT TL, 1994, APPL ENVIRON MICROB, V60, P3292, DOI 10.1128/AEM.60.9.3292-3299.1994; Klein JA, 2005, GLOBAL CHANGE BIOL, V11, P1440, DOI 10.1111/j.1365-2486.2005.00994.x; Liang C, 2012, APPL SOIL ECOL, V54, P24, DOI 10.1016/j.apsoil.2011.11.015; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Liu WJ, 2014, ENV RES LET IN PRESS; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Luo CY, 2010, GLOBAL CHANGE BIOL, V16, P1606, DOI 10.1111/j.1365-2486.2009.02026.x; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Margesin R, 2009, FEMS MICROBIOL ECOL, V67, P208, DOI 10.1111/j.1574-6941.2008.00620.x; Marion GM, 1997, GLOB CHANGE BIOL, V3, P20, DOI 10.1111/j.1365-2486.1997.gcb136.x; Mille-Lindblom C, 2006, OIKOS, V113, P233, DOI 10.1111/j.2006.0030-1299.14337.x; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Rinnan R, 2007, GLOBAL CHANGE BIOL, V13, P28, DOI 10.1111/j.1365-2486.2006.01263.x; Rousk J, 2011, FEMS MICROBIOL ECOL, V78, P17, DOI 10.1111/j.1574-6941.2011.01106.x; Sheik CS, 2011, ISME J, V5, P1692, DOI 10.1038/ismej.2011.32; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; Wen Z, 2014, ENVIRON EARTH SCI, V71, P1195, DOI 10.1007/s12665-013-2523-8; Wixon DL, 2013, SOIL BIOL BIOCHEM, V57, P769, DOI 10.1016/j.soilbio.2012.08.016; Yergeau E, 2012, ISME J, V6, P692, DOI 10.1038/ismej.2011.124; Yuan YL, 2014, FEMS MICROBIOL ECOL, V87, P121, DOI 10.1111/1574-6941.12197; Zhang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066184; Zhang B, 2012, SOIL TILL RES, V124, P153, DOI 10.1016/j.still.2012.05.011; Zhang NL, 2013, OECOLOGIA, V173, P1125, DOI 10.1007/s00442-013-2685-9; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078616; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	51	64	80	11	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103859	10.1371/journal.pone.0103859	http://dx.doi.org/10.1371/journal.pone.0103859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	24675867	Green Submitted, Green Published, gold			2022-12-25	WOS:000339819800091
J	Okudela, K; Katayama, A; Woo, T; Mitsui, H; Suzuki, T; Tateishi, Y; Umeda, S; Tajiri, M; Masuda, M; Nagahara, N; Kitamura, H; Ohashi, K				Okudela, Koji; Katayama, Akira; Woo, Tetsukan; Mitsui, Hideaki; Suzuki, Takehisa; Tateishi, Yoko; Umeda, Shigeaki; Tajiri, Michihiko; Masuda, Munetaka; Nagahara, Noriyuki; Kitamura, Hitoshi; Ohashi, Kenichi			Proteome Analysis for Downstream Targets of Oncogenic KRAS - the Potential Participation of CLIC4 in Carcinogenesis in the Lung	PLOS ONE			English	Article							CHLORIDE CHANNEL PROTEIN; EMBRYONIC FIBROBLAST CELLS; H-RAS; K-RAS; BREAST-CANCER; EXPRESSION; TRANSFORMATION; MUTATIONS; THERAPY; ADENOCARCINOMAS	This study investigated the proteome modulated by oncogenic KRAS in immortalized airway epithelial cells. Chloride intracellular channel protein 4 (CLIC4), S100 proteins (S100A2 and S100A11), tropomyosin 2, cathepsin L1, integrins alpha 3, eukaryotic elongation factor 1, vimentin, and others were discriminated. We here focused on CLIC4 to investigate its potential involvement in carcinogenesis in the lung because previous studies suggested that some chloride channels and chloride channel regulators could function as tumor suppressors. CILC4 protein levels were reduced in some lung cancer cell lines. The restoration of CLIC4 in lung cancer cell lines in which CLIC4 expression was reduced attenuated their growth activity. The immunohistochemical expression of the CLIC4 protein was weaker in primary lung cancer cells than in non-tumorous airway epithelial cells and was occasionally undetectable in some tumors. CLIC4 protein levels were significantly lower in a subtype of mucinous ADC than in others, and were also significantly lower in KRAS-mutated ADC than in EGFR-mutated ADC. These results suggest that the alteration in CLIC4 could be involved in restrictedly the development of a specific fraction of lung adenocarcinomas. The potential benefit of the proteome modulated by oncogenic KRAS to lung cancer research has been demonstrated.	[Okudela, Koji; Mitsui, Hideaki; Suzuki, Takehisa; Tateishi, Yoko; Umeda, Shigeaki; Kitamura, Hitoshi; Ohashi, Kenichi] Yokohama City Univ, Grad Sch Med, Dept Pathol, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Katayama, Akira] Nippon Med Univ, Dept Biochem Cell Biol, Bunkyo Ku, Tokyo, Japan; [Woo, Tetsukan; Masuda, Munetaka] Yokohama City Univ, Grad Sch Med, Dept Surgey, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Tajiri, Michihiko] Kanagawa Prefectural Cardiovasc & Resp Ctr Hosp, Div Gen Thorac Surg, Kanazawa Ku, Yokohama, Kanagawa, Japan; [Nagahara, Noriyuki] Nippon Med Univ, Dept Enviromental Med, Bunkyo Ku, Tokyo, Japan	Yokohama City University; Yokohama City University; Kanagawa Cardiovascular & Respiratory Center	Okudela, K (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Pathol, Kanazawa Ku, 3-9 Future, Yokohama, Kanagawa 232, Japan.	kojixok@yokohama-cu.ac.jp	Amano, Tatsuya/E-7367-2010; Katayama, Naoki/O-2734-2018	Amano, Tatsuya/0000-0001-6576-3410; Katayama, Naoki/0000-0002-1136-442X; Naoe, Shoji/0000-0002-0605-4187	Japanese Ministry of Education, Culture, Sports, and Science (Tokyo Japan); Yokohama Medical Facility (Yokohama, Japan)	Japanese Ministry of Education, Culture, Sports, and Science (Tokyo Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokohama Medical Facility (Yokohama, Japan)	This study was funded by The Japanese Ministry of Education, Culture, Sports, and Science (Tokyo Japan) and the Yokohama Medical Facility (Yokohama, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckley JR, 2004, J BIOL CHEM, V279, P41634, DOI 10.1074/jbc.M408334200; Bustin SA, 2001, DNA CELL BIOL, V20, P331, DOI 10.1089/10445490152122442; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Deshusses JMP, 2003, PROTEOMICS, V3, P1418, DOI 10.1002/pmic.200300492; Fernandez-Salas E, 2002, MOL CELL BIOL, V22, P3610, DOI 10.1128/MCB.22.11.3610-3620.2002; Ferreira L, 2012, ELECTROPHORESIS, V33, P1385, DOI 10.1002/elps.201100606; Finberg KE, 2007, J MOL DIAGN, V9, P320, DOI 10.2353/jmoldx.2007.060182; Gruber AD, 1999, CANCER RES, V59, P5488; Hoffman PC, 2002, LUNG CANCER-J IASLC, V38, P65, DOI 10.1016/S0169-5002(02)00144-7; Ikonomou G, 2012, J PROTEOMICS, V75, P5356, DOI 10.1016/j.jprot.2012.06.038; Ji H, 2008, ELECTROPHORESIS, V29, P2660, DOI 10.1002/elps.200800015; Jin BF, 2006, J PROTEOME RES, V5, P2815, DOI 10.1021/pr060283f; Kim S, 2008, PROTEOMICS, V8, P3082, DOI 10.1002/pmic.200800106; Li DF, 2006, PROTEIN PEPTIDE LETT, V13, P641, DOI 10.2174/092986606777145742; Maeshima A, 2002, VIRCHOWS ARCH, V440, P598, DOI 10.1007/s00428-002-0629-6; Marchetti A, 1996, J PATHOL, V179, P254, DOI 10.1002/(SICI)1096-9896(199607)179:3<254::AID-PATH589>3.0.CO;2-J; Mathias RA, 2009, J PROTEOME RES, V8, P2827, DOI 10.1021/pr8010974; Okudela K, 2010, PATHOL INT, V60, P651, DOI 10.1111/j.1440-1827.2010.02580.x; Okudela K, 2009, AM J PATHOL, V175, P2646, DOI 10.2353/ajpath.2009.080571; Okudela K, 2009, AM J PATHOL, V175, P867, DOI 10.2353/ajpath.2009.080489; Padmakumar VC, 2012, AM J PATHOL, V181, P74, DOI 10.1016/j.ajpath.2012.03.025; Park JW, 2006, PROTEOMICS, V6, P2433, DOI 10.1002/pmic.200500688; Park JW, 2006, PROTEOMICS, V6, P1175, DOI 10.1002/pmic.200500405; Proutski I, 2002, BIOCHEM BIOPH RES CO, V297, P317, DOI 10.1016/S0006-291X(02)02199-X; Rusch M, 2011, ANGEW CHEM INT EDIT, V50, P9838, DOI 10.1002/anie.201102967; Shiio Y, 2006, J BIOL CHEM, V281, P2750, DOI 10.1074/jbc.M509349200; Shukla A, 2013, ONCOGENE; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Sudhir PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020199; Suh KS, 2012, CARCINOGENESIS, V33, P986, DOI 10.1093/carcin/bgs115; Suh KS, 2005, J INVEST DERM SYMP P, V10, P105, DOI 10.1111/j.1087-0024.2005.200402.x; Suh KS, 2007, J CELL SCI, V120, P2631, DOI 10.1242/jcs.002741; Suh KS, 2007, CLIN CANCER RES, V13, P121, DOI 10.1158/1078-0432.CCR-06-1562; Travis WD., 2004, TRAVIS WB WHO CLASSI; Wang J, 2008, J PROTEOME RES, V7, P3879, DOI 10.1021/pr8001645; Woo T, 2009, LUNG CANCER, V65, P355, DOI 10.1016/j.lungcan.2008.11.020; Yao Q, 2009, ONCOL REP, V22, P541, DOI 10.3892/or_00000469; Yazawa T, 1999, J PATHOL, V187, P191, DOI 10.1002/(SICI)1096-9896(199901)187:2<191::AID-PATH206>3.0.CO;2-3; Zhan Xianquan, 2003, Pituitary, V6, P189, DOI 10.1023/B:PITU.0000023426.99808.40	39	49	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87193	10.1371/journal.pone.0087193	http://dx.doi.org/10.1371/journal.pone.0087193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24503901	Green Published, Green Submitted, gold			2022-12-25	WOS:000330631800020
J	Lin, H; Qu, YLW; Geng, ZX; Li, C; Wu, HP; Dong, N; Liu, ZG; Li, W				Lin, Hui; Qu, Yangluowa; Geng, Zhixin; Li, Cheng; Wu, Huping; Dong, Nuo; Liu, Zuguo; Li, Wei			Air Exposure Induced Characteristics of Dry Eye in Conjunctival Tissue Culture	PLOS ONE			English	Article							CORNEAL EPITHELIAL-CELLS; OCULAR SURFACE EPITHELIUM; FLOW-CYTOMETRIC ANALYSIS; MUCIN GENE-EXPRESSION; KERATOCONJUNCTIVITIS SICCA; SQUAMOUS METAPLASIA; LACRIMAL GLAND; MATRIX METALLOPROTEINASES; BENZALKONIUM CHLORIDE; INFLAMMATORY MARKERS	There are several animal models illustrating dry eye pathophysiology. Current study would like to establish an ex vivo tissue culture model for characterizing dry eye. Human conjunctival explants were cultured under airlift or submerged conditions for up to 2 weeks, and only airlifted conjunctival cultures underwent increased epithelial stratification. Starting on day 4, the suprabasal cells displayed decreased K19 expression whereas K10 keratin became evident in airlift group. Pax6 nuclear expression attenuated already at 2 days, while its perinuclear and cytoplasmic expression gradually increased. MUC5AC and MUC19 expression dramatically decreased whereas the full thickness MUC4 and MUC16 expression pattern disappeared soon after initiating the airlift condition. Real time PCR showed K16, K10 and MUC16 gene up-regulated while K19, MUC5AC, MUC19 and MUC4 down-regulated on day 8 and day 14. On day 2 was the appearance of apoptotic epithelial and stromal cells appeared. The Wnt signaling pathway was transiently activated from day 2 to day 10. The inflammatory mediators IL-1 beta, TNF-alpha, and MMP-9 were detected in the conditioned media after 6 to 8 days. In conclusion, airlifted conjunctival tissue cultures demonstrated Wnt signaling pathway activation, coupled with squamous metaplasia, mucin pattern alteration, apoptosis and upregulation of proinflammatory cytokine expression. These changes mimic the pathohistological alterations described in dry eye. This correspondence suggests that insight into the pathophysiology of dry eye may be aided through the use of airlifted conjunctival tissue cultures.	[Lin, Hui; Qu, Yangluowa; Geng, Zhixin; Li, Cheng; Liu, Zuguo; Li, Wei] Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China; [Geng, Zhixin; Wu, Huping; Dong, Nuo; Liu, Zuguo; Li, Wei] Xiamen Univ, Affiliated Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China; [Lin, Hui; Qu, Yangluowa; Li, Cheng; Liu, Zuguo; Li, Wei] Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Liu, ZG (corresponding author), Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China.	zuguoliu@xmu.edu.cn; wei1018@gmail.com	Li, Wei/P-8985-2015; Lin, Hui/N-6947-2018	Li, Wei/0000-0001-7458-2590; 	Chinese National Key Scientific Research Project [2013CB967003]; National Natural Science Foundation of China (NSFC) [81270977, 81000403, U1205025, 81270978]	Chinese National Key Scientific Research Project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research described was supported in part by the grants from Chinese National Key Scientific Research Project (2013CB967003 [to WL]), the National Natural Science Foundation of China (NSFC, No. 81270977 [to WL], 81000403 [to HL], U1205025 [to ZL], 81270978 [to ZL]). The funders had no role in study design, data collection and analysis.	Acera A, 2008, OPHTHALMIC RES, V40, P315, DOI 10.1159/000150445; Afonso AA, 1999, INVEST OPHTH VIS SCI, V40, P2506; Barabino S, 2005, INVEST OPHTH VIS SCI, V46, P2766, DOI 10.1167/iovs.04-1326; Barabino S, 2004, INVEST OPHTH VIS SCI, V45, P1641, DOI 10.1167/iovs.03-1055; Brignole F, 2000, INVEST OPHTH VIS SCI, V41, P1356; Caffery B, 2008, MOL VIS, V14, P2547; Chen W, 2008, INVEST OPHTH VIS SCI, V49, P1386, DOI 10.1167/iovs.07-0744; Chen Y, 2004, AM J RESP CELL MOL, V30, P155, DOI 10.1165/rcmb.2003-0103OC; Chikama T, 2008, AM J PATHOL, V172, P638, DOI 10.2353/ajpath.2008.070897; Corrales RM, 2011, INVEST OPHTH VIS SCI, V52, P8363, DOI 10.1167/iovs.11-7655; Dogru M, 2008, ALLERGY, V63, P1324, DOI 10.1111/j.1398-9995.2008.01781.x; Dong N, 2009, INVEST OPHTHALMOL VI; Dursun D, 2002, INVEST OPHTH VIS SCI, V43, P632; Espana EM, 2003, INVEST OPHTH VIS SCI, V44, P5130, DOI 10.1167/iovs.03-0584; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fini ME, 1996, AM J PATHOL, V149, P1287; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Guo ZJ, 2000, EXP EYE RES, V71, P23, DOI 10.1006/exer.2000.0855; JESTER JV, 1989, INVEST OPHTH VIS SCI, V30, P936; Jones DT, 1998, ADV EXP MED BIOL, V438, P533; KASWAN R, 1994, ADV EXP MED BIOL, V350, P583; KASWAN RL, 1989, ARCH OPHTHALMOL-CHIC, V107, P1210, DOI 10.1001/archopht.1989.01070020276038; Kawakita T, 2008, J CELL MOL MED, V12, P1303, DOI 10.1111/j.1582-4934.2008.00297.x; Koroma BM, 1997, INVEST OPHTH VIS SCI, V38, P108; Li DQ, 2001, EXP EYE RES, V73, P449, DOI 10.1006/exer.2001.1054; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; Li W, 2008, INVEST OPHTH VIS SCI, V49, P154, DOI 10.1167/iovs.07-0883; Li WM, 2003, DEVELOPMENT, V130, P6143, DOI 10.1242/dev.00820; Lin ZR, 2011, MOL VIS, V17, P257; LIU SH, 1987, INVEST OPHTH VIS SCI, V28, P270; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Ma X, 2009, INVEST OPHTH VIS SCI, V50, P2716, DOI 10.1167/iovs.08-2139; Maas-Szabowski N, 2001, J INVEST DERMATOL, V116, P816, DOI 10.1046/j.1523-1747.2001.01349.x; Mantelli F, 2008, CURR OPIN ALLERGY CL, V8, P477, DOI 10.1097/ACI.0b013e32830e6b04; Marko CK, 2013, AM J PATHOL, V183, P35, DOI 10.1016/j.ajpath.2013.03.017; Miyoshi K, 2002, P NATL ACAD SCI USA, V99, P219, DOI 10.1073/pnas.012414099; Mukhopadhyay M, 2006, DEVELOPMENT, V133, P2149, DOI 10.1242/dev.02381; Murube J, 2003, EUR J OPHTHALMOL, V13, P115, DOI 10.1177/112067210301300201; Paulsen F, 2008, ANN ANAT, V190, P59, DOI 10.1016/j.aanat.2007.05.001; Pearton DJ, 2005, P NATL ACAD SCI USA, V102, P3714, DOI 10.1073/pnas.0500344102; Pflugfelder SC, 2005, AM J PATHOL, V166, P61, DOI 10.1016/S0002-9440(10)62232-8; Pisella PJ, 2000, OPHTHALMOLOGY, V107, P1841, DOI 10.1016/S0161-6420(00)00347-X; Pitz S, 2002, PROG RETIN EYE RES, V21, P241, DOI 10.1016/S1350-9462(01)00025-8; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; SCHERMER A, 1989, DIFFERENTIATION, V42, P103, DOI 10.1111/j.1432-0436.1989.tb00611.x; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; Song XJ, 2003, INVEST OPHTH VIS SCI, V44, P4223, DOI 10.1167/iovs.02-1319; Tei M, 2000, INVEST OPHTH VIS SCI, V41, P82; Tsubota K, 2003, EXP EYE RES, V76, P233, DOI 10.1016/S0014-4835(02)00279-8; Wang BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002186; Xiong C, 2008, INVEST OPHTH VIS SCI, V49, P1850, DOI 10.1167/iovs.07-0720; Yeh S, 2003, INVEST OPHTH VIS SCI, V44, P124, DOI 10.1167/iovs.02-0581; Yu DF, 2008, EXP EYE RES, V86, P403, DOI 10.1016/j.exer.2007.11.013; 2007, OCUL SURF, V5, P93; 2007, OCUL SURF, V5, P179	56	25	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87368	10.1371/journal.pone.0087368	http://dx.doi.org/10.1371/journal.pone.0087368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24671174	Green Published, gold, Green Submitted			2022-12-25	WOS:000330621900100
J	Zhang, BZ; Cai, GJ; Wang, HT; Li, D; Yang, XJ; An, XL; Zheng, XW; Tian, Y; Zheng, W; Zheng, TL				Zhang, Bangzhou; Cai, Guanjing; Wang, Haitao; Li, Dong; Yang, Xujun; An, Xinli; Zheng, Xiaowei; Tian, Yun; Zheng, Wei; Zheng, Tianling			Streptomyces alboflavus RPS and Its Novel and High Algicidal Activity against Harmful Algal Bloom Species Phaeocystis globosa	PLOS ONE			English	Article							TOXIC DINOFLAGELLATE; MICROCYSTIS-AERUGINOSA; POPULATION-DYNAMICS; MARINE; BACTERIUM; IDENTIFICATION; CYANOBACTERIA; ACTINOMYCETE; MECHANISMS; COMPOUND	Phaeocystis globosa blooms have frequently occurred along coastal waters and exerted serious impacts on ecological environments by releasing toxic hemolytic substances, forming nuisance foam, and causing oxygen depletion. An actinomycete strain RPS with high algicidal activity against P. globosa was isolated and identified as Streptomyces alboflavus, based on morphology, physiological and biochemical characteristics, and 16S rDNA sequence analysis. RPS lysed 95% of P. globosa within 48 h by releasing an extracellular active substance into the growth medium. The activity of RPS supernatant was sensitive to temperature at and above 50 degrees C and insensitive to pH from 3 to 11. The molecular weight of the active substance was between 100 Da and 1000 Da, and approximately 90% of it was extracted by ethyl acetate. It was presumed that the active component efficiently inhibited the movement of P. globosa, caused the flagella to fall off the algae, and finally lysed the algal cells. RPS showed a wide target range against harmful algae. S. alboflavus RPS with high algicidal activity and such novel features of temperature and pH sensitivity, low molecular weight, algicidal process, and target range possesses great potential in the biological control of P. globosa blooms.	[Zheng, Wei] Xiamen Univ, Sch Life Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Zheng, W (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.	jedi@xmu.edu.cn; microzh@xmu.edu.cn	Cai, Guanjing/GZK-7070-2022; Zhang, Bangzhou/CAG-9625-2022; Zhao, Lin/M-9536-2018	Zhao, Lin/0000-0003-0245-8413	National Natural Science Foundation of China [40930847, 41376119]; Public Science and Technology Research Funds Projects of Ocean [201305016]; Special Fund for Ph.D. Programs in the University [20120121130001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Science and Technology Research Funds Projects of Ocean; Special Fund for Ph.D. Programs in the University	This work was supported by the National Natural Science Foundation of China (40930847, 41376119) (http://www.nsfc.gov.cn/publish/portal0/default.htm), the Public Science and Technology Research Funds Projects of Ocean (201305016) (http://www.soa.gov.cn/), and the Special Fund for Ph.D. Programs in the University (20120121130001) (http://www.cutech.edu.cn/cn/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actinomycete Classification Group of CAS, 1975, MAN STREPT ID, P13; Amin SA, 2012, MICROBIOL MOL BIOL R, V76, P667, DOI 10.1128/MMBR.00007-12; Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; Anderson DM, 2009, OCEAN COAST MANAGE, V52, P342, DOI 10.1016/j.ocecoaman.2009.04.006; Arnoux P, 2009, PLANT CELL, V21, P2036, DOI 10.1105/tpc.109.068007; Bai SJJ, 2011, CURR MICROBIOL, V62, P1774, DOI 10.1007/s00284-011-9927-z; Banin E, 2001, APPL ENVIRON MICROB, V67, P1536, DOI 10.1128/AEM.67.4.1536-1541.2001; Baudoux AC, 2005, VIROLOGY, V341, P80, DOI 10.1016/j.virol.2005.07.002; Blauw AN, 2010, J MARINE SYST, V83, P115, DOI 10.1016/j.jmarsys.2010.05.003; Cai WW, 2011, APPL ENVIRON MICROB, V77, P7837, DOI 10.1128/AEM.05783-11; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; Hai DN, 2010, J MARINE SYST, V83, P253, DOI 10.1016/j.jmarsys.2010.04.015; Fei XG, 2004, HYDROBIOLOGIA, V512, P145, DOI 10.1023/B:HYDR.0000020320.68331.ce; Gumbo RJ, 2008, AFR J BIOTECHNOL, V7, P4765; Guo ZY, 2009, J ANTIBIOT, V62, P201, DOI 10.1038/ja.2009.15; Jeong HJ, 2008, HARMFUL ALGAE, V7, P368, DOI 10.1016/j.hal.2007.12.004; Jessup DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004550; Kodama M, 2006, ECOL STU AN, V189, P243, DOI 10.1007/978-3-540-32210-8_19; Kodani S, 2002, J APPL PHYCOL, V14, P109, DOI 10.1023/A:1019533414018; Kong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057654; Lamy D, 2009, AQUAT MICROB ECOL, V58, P95, DOI 10.3354/ame01359; Lee SO, 2000, APPL ENVIRON MICROB, V66, P4334, DOI 10.1128/AEM.66.10.4334-4339.2000; Lee SW, 2013, J HAZARD MATER, V263, P20, DOI 10.1016/j.jhazmat.2013.08.017; Lee YJ, 2008, HARMFUL ALGAE, V7, P154, DOI 10.1016/j.hal.2007.06.004; Li FM, 2005, APPL ENVIRON MICROB, V71, P6545, DOI 10.1128/AEM.71.11.6545-6553.2005; Li L, 2013, ENVIRON SCI TECHNOL, V47, P4555, DOI 10.1021/es305234d; Li PN, 2011, ENVIRON SCI TECHNOL, V45, P4521, DOI 10.1021/es200057g; LISS PS, 1994, J MARINE SYST, V5, P41, DOI 10.1016/0924-7963(94)90015-9; Manset KJV, 2013, J ENVIRON SCI MANAG, P11; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; Mayali X, 2002, HARMFUL ALGAE, V1, P277, DOI 10.1016/S1568-9883(02)00032-X; Meuser D, 1999, FEBS LETT, V462, P447, DOI 10.1016/S0014-5793(99)01579-3; Monchy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039924; Nakashima T, 2006, AQUAT MICROB ECOL, V45, P255, DOI 10.3354/ame045255; Nayak BB, 2000, WORLD J MICROB BIOT, V16, P99, DOI 10.1023/A:1008934406780; Ni LX, 2012, CHEMOSPHERE, V88, P1051, DOI 10.1016/j.chemosphere.2012.05.009; Nishitarumizu S, 2011, FISHERIES SCI, P1; Orton JH, 1923, NATURE, V111, P773, DOI 10.1038/111773a0; Ozaki K, 2008, CHEMOSPHERE, V71, P1531, DOI 10.1016/j.chemosphere.2007.11.052; Paul C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021032; Peng XC, 2005, J INTEGR PLANT BIOL, V47, P165, DOI 10.1111/j.1744-7909.2005.00039.x; Peperzak L, 2008, J SEA RES, V60, P220, DOI 10.1016/j.seares.2008.06.001; Qi YZ, 2004, HYDROBIOLOGIA, V512, P209, DOI 10.1023/B:HYDR.0000020329.06666.8c; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Schoemann V, 2005, J SEA RES, V53, P43, DOI 10.1016/j.seares.2004.01.008; Seong Kyeong Ah, 2011, Ocean Science Journal, V46, P105, DOI 10.1007/s12601-011-0010-2; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Skerratt JH, 2002, MAR ECOL PROG SER, V244, P1, DOI 10.3354/meps244001; Su RQ, 2007, HARMFUL ALGAE, V6, P799, DOI 10.1016/j.hal.2007.04.004; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Wang BX, 2010, LETT APPL MICROBIOL, V51, P552, DOI 10.1111/j.1472-765X.2010.02936.x; Wang BX, 2012, HARMFUL ALGAE, V13, P83, DOI 10.1016/j.hal.2011.10.006; Wang XL, 2005, HARMFUL ALGAE, V4, P433, DOI 10.1016/j.hal.2004.06.001; Yamamoto Y, 1998, J APPL PHYCOL, V10, P391, DOI 10.1023/A:1008077414808; Yan Rong-jun, 2011, Huanjing Kexue, V32, P225; Yang CY, 2012, HARMFUL ALGAE, V20, P132, DOI 10.1016/j.hal.2012.09.002; Yoshikawa K, 2000, APPL ENVIRON MICROB, V66, P718, DOI 10.1128/AEM.66.2.718-722.2000; Zhang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063018; Zhang SJ, 2012, ENVIRON SCI TECHNOL, V46, P8764, DOI 10.1021/es301000m; Zheng XW, 2013, APPL MICROBIOL BIOT, V97, P9207, DOI 10.1007/s00253-012-4617-8; Zhou LH, 2007, HARMFUL ALGAE, V6, P354, DOI 10.1016/j.hal.2006.10.002	62	64	80	11	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92907	10.1371/journal.pone.0092907	http://dx.doi.org/10.1371/journal.pone.0092907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675867	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677500054
J	Peng, Z; Wang, CX; Fang, EH; Lu, XM; Wang, GB; Tong, Q				Peng, Zhao; Wang, Chenxiao; Fang, Erhu; Lu, Xiaoming; Wang, Guobin; Tong, Qiang			Co-Delivery of Doxorubicin and SATB1 shRNA by Thermosensitive Magnetic Cationic Liposomes for Gastric Cancer Therapy	PLOS ONE			English	Article							OVERCOME DRUG-RESISTANCE; IN-VITRO; TEMPERATURE; GENE; RNA; ADENOCARCINOMA; NANOPARTICLES; EXPRESSION; RELEASE; CELLS	In previous a study, we had developed a novel thermosensitive magnetic delivery system based on liposomes. This study aimed to evaluate the efficiency of this system for the co-delivery of both drugs and genes to the same cell and its antitumor effects on gastric cancer. Doxorubicin (DOX) and SATB1 shRNA vector were loaded into the co-delivery system, and in vitro DOX thermosensitive release activity, targeted gene silencing efficiency, targeted cellular uptake, in vitro cytotoxicity, as well as in vivo anti-tumor activity were determined. The results showed that this co-delivery system had desirable targeted delivery efficacy, DOX thermosensitive release and SATB1 gene silencing. Moreover, the co-delivery of DOX and SATB1 shRNA exhibited enhanced activity to inhibit gastric cancer cell growth in vitro and in vivo, compared to single delivery. In conclusion, the novel thermosensitive magnetic drug and gene co-delivery system has promising application in combined chemotherapy and gene therapy for gastric cancer.	[Peng, Zhao; Wang, Chenxiao; Fang, Erhu; Lu, Xiaoming; Wang, Guobin; Tong, Qiang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Wang, GB (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	guobinwang1954@gmail.com; qiangtong@hust.edu.cn	Li, Yilin/AAW-9533-2021		National Natural Science Foundation of China [81172186]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81172186). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Alberts SR, 2003, ANN ONCOL, V14, P31, DOI 10.1093/annonc/mdg726; Alexiou C, 2000, CANCER RES, V60, P6641; Chen J, 2013, DRUG DEV IND PHARM, V39, P197, DOI 10.3109/03639045.2012.668912; Chen YC, 2010, J BIOL CHEM, V285, P22639, DOI 10.1074/jbc.M110.125906; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GABER MH, 1995, PHARMACEUT RES, V12, P1407, DOI 10.1023/A:1016206631006; Heger Z, 2013, INT J MOL SCI, V14, P21629, DOI 10.3390/ijms141121629; Huang B, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-8; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Juergen S, 2012, FUNDAMENTALS APPL CO, P291; Kohwi-Shigematsu T, 2013, SEMIN CANCER BIOL, V23, P72, DOI 10.1016/j.semcancer.2012.06.009; Kono K, 2004, METHODS ENZYMOL, V387, P73; Li Wei, 2011, Zhonghua Wei Chang Wai Ke Za Zhi, V14, P432; Liu CX, 2013, BIOMATERIALS, V34, P2547, DOI 10.1016/j.biomaterials.2012.12.038; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; Mir R, 2012, CURR DRUG TARGETS, V13, P1603, DOI 10.2174/138945012803530008; Mykhaylyk O, 2010, METHODS MOL BIOL, V605, P487, DOI 10.1007/978-1-60327-360-2_34; Park SC, 2013, GUT LIVER, V7, P385, DOI 10.5009/gnl.2013.7.4.385; Patani N, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-18; Pradhan P, 2010, J CONTROL RELEASE, V142, P108, DOI 10.1016/j.jconrel.2009.10.002; Pradhan P, 2010, METHODS MOL BIOL, V605, P279, DOI 10.1007/978-1-60327-360-2_19; Shen JA, 2012, BIOMATERIALS, V33, P8613, DOI 10.1016/j.biomaterials.2012.08.007; Shim G, 2011, J CONTROL RELEASE, V155, P60, DOI 10.1016/j.jconrel.2010.10.017; Skeel R, 2011, HDB CANC CHEMOTHERAP; Stebbing J, 2002, CANCER TREAT REV, V28, P121, DOI 10.1053/ctrv.2002.0262; Ta T, 2013, J CONTROL RELEASE, V169, P112, DOI 10.1016/j.jconrel.2013.03.036; Takahashi Tsunehiro, 2013, Cancers (Basel), V5, P48, DOI 10.3390/cancers5010048; Torchilin Vladimir P, 2010, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-00477-3_1; Wang CM, 2011, BIOCHEM BIOPH RES CO, V410, P537, DOI 10.1016/j.bbrc.2011.06.019; Xiao YL, 2012, NANOSCALE, V4, P7185, DOI 10.1039/c2nr31853a; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047902; Zhao F, 2014, BIOMATERIALS, V35, P1050, DOI 10.1016/j.biomaterials.2013.10.044; Zheng XL, 2009, INT J PHARMACEUT, V366, P211, DOI 10.1016/j.ijpharm.2008.09.019; Zhou Lai-Yong, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P534; Zhu XD, 2010, ONCOL LETT, V1, P407, DOI 10.3892/ol_00000071	39	136	146	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92924	10.1371/journal.pone.0092924	http://dx.doi.org/10.1371/journal.pone.0092924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24416238	Green Submitted, Green Published, gold			2022-12-25	WOS:000333677500056
J	Peng, Z; Zhu, Y; Wang, QQ; Gao, J; Li, YL; Li, YY; Ge, S; Shen, L				Peng, Zhi; Zhu, Yan; Wang, Qianqian; Gao, Jing; Li, Yilin; Li, Yanyan; Ge, Sai; Shen, Lin			Prognostic Significance of MET Amplification and Expression in Gastric Cancer: A Systematic Review with Meta-Analysis	PLOS ONE			English	Review							HEPATOCYTE GROWTH-FACTOR; C-MET; FACTOR-RECEPTOR; POOR-PROGNOSIS; E-CADHERIN; GENE; OVEREXPRESSION; MARKER; CARCINOMA; P53	Background and Aims: MET, the hepatocyte growth factor receptor, is a receptor tyrosine kinase overexpressed and activated in a subset of gastric cancer. Several studies investigated the relationship between MET amplification and expression with the clinical outcome in patients with gastric cancer, but yielded conflicting results. We performed a systematic review and meta-analysis to determine the influence of MET amplification and expression on prognosis in gastric cancer. Methods: MEDLINE and EMBASE were searched for studies that explored the association between MET amplification and expression with survival in patients with gastric cancer up to 1 April, 2013. Data of individual hazard ratios (HRs) and 95% confidence intervals (CIs) for meta-analyses were extracted from the publications and combined in pooled HRs. Results: Fourteen studies involving 2,258 patients with gastric cancer were included. It was suggested that MET overexpression had an unfavorable impact on survival of patients with gastric cancer, with HRs (95% CIs) of 2.57 (95% CI: 1.97-3.35) overall, 2.82 (95% CI: 1.86-4.27) among studies using amplification for measure scale of MET and 2.42 (95% CI: 1.66-3.54) for expression. The magnitude of association was reduced whereas remained statistically significant in high quality studies or in larger sample size studies and corresponding HRs were 2.18(1.76, 2.70) and 2.35(1.93, 2.87), respectively, without significant heterogeneity. Conclusion: The findings from present study indicated that higher MET gene amplification and expression in gastric cancer was an indicator of poor prognosis.	[Peng, Zhi; Zhu, Yan; Gao, Jing; Li, Yilin; Li, Yanyan; Ge, Sai; Shen, Lin] Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol,Key Lab Carcinogenesi, Beijing 100871, Peoples R China; [Wang, Qianqian] Peking Univ, Clin Med Coll 4, Beijing Jishuitan Hosp, Dept Epidemiol, Beijing 100871, Peoples R China	Peking University; Peking University	Shen, L (corresponding author), Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol,Key Lab Carcinogenesi, Beijing 100871, Peoples R China.	lin100@medmail.com.cn	Li, Yilin/AAW-9533-2021		National Natural Science Foundation of China [81172110]; National High Technology Research and Development Program [2006AA 02A 402-B02, 2012AA 02A 504]; China Postdoctoral Scientific Fund [2013M530494]; Beijing Municipal Science & Technology Commission Program "Exploring the utilization of molecular markers in the individual treatment of gastric cancer based on the clinical research cohort''	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program(National High Technology Research and Development Program of China); China Postdoctoral Scientific Fund; Beijing Municipal Science & Technology Commission Program "Exploring the utilization of molecular markers in the individual treatment of gastric cancer based on the clinical research cohort''	This work was supported by National Natural Science Foundation of China (No. 81172110), National High Technology Research and Development Program (No. 2006AA 02A 402-B02, 2012AA 02A 504), China Postdoctoral Scientific Fund (2013M530494) and Beijing Municipal Science & Technology Commission Program "Exploring the utilization of molecular markers in the individual treatment of gastric cancer based on the clinical research cohort''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya H, 2010, INVEST CLIN, V51, P369; Asaoka Y, 2011, EXPERT OPIN INV DRUG, V20, P595, DOI 10.1517/13543784.2011.566863; Bamias A, 2010, CANCER CHEMOTH PHARM, V65, P1009, DOI 10.1007/s00280-010-1256-6; Bang YJ, 2010, LANCET, V376, P1302; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Catenacci DVT, 2011, CANCER BIOL THER, V12, P9, DOI 10.4161/cbt.12.1.15747; de Graeff P, 2009, BRIT J CANCER, V101, P149, DOI 10.1038/sj.bjc.6605112; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Drebber U, 2008, ONCOL REP, V19, P1477; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Ge SH, 2011, CHINESE J CANCER RES, V23, P153, DOI 10.1007/s11670-011-0153-9; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; Graziano F, 2011, J CLIN ONCOL, V29, P4789, DOI 10.1200/JCO.2011.36.7706; Hayes DF, 1996, JNCI-J NATL CANCER I, V88, P1456, DOI 10.1093/jnci/88.20.1456; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang TJ, 2001, ACTA ONCOL, V40, P638; Janjigian YY, 2011, CANCER EPIDEM BIOMAR, V20, P1021, DOI 10.1158/1055-9965.EPI-10-1080; Jatoi Ismail, 2010, Curr Probl Surg, V47, P750, DOI 10.1067/j.cpsurg.2010.06.002; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kubicka S, 2002, DIGEST DIS SCI, V47, P114, DOI 10.1023/A:1013275706401; KUNIYASU H, 1992, BIOCHEM BIOPH RES CO, V189, P227, DOI 10.1016/0006-291X(92)91548-5; Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237; Lee J, 2011, ONCOL REP, V25, P1517, DOI 10.3892/or.2011.1219; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; Li Y, 2012, J SURG ONCOL, V106, P304, DOI 10.1002/jso.23008; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Meert AP, 2002, EUR RESPIR J, V20, P975, DOI 10.1183/09031936.02.00296502; Moher David, 2009, BMJ, V339, pb2535, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Nakajima M, 1999, CANCER, V85, P1894; Oldenhuis CNAM, 2008, EUR J CANCER, V44, P946, DOI 10.1016/j.ejca.2008.03.006; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Shi J, 2012, INT J MOL SCI, V13, P4714, DOI 10.3390/ijms13044714; Sierra J Rafael, 2011, Ther Adv Med Oncol, V3, pS21, DOI 10.1177/1758834011422557; Smith RA, 2011, BRIT J CANCER, V104, P1440, DOI 10.1038/bjc.2011.110; Taniguchi K, 1998, CANCER, V82, P2112, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2112::AID-CNCR5>3.3.CO;2-U; Toiyama Y, 2012, INT J CANCER, V130, P2912, DOI 10.1002/ijc.26330; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Tsugawa K, 1998, ONCOLOGY-BASEL, V55, P475, DOI 10.1159/000011898; Wu H, 2009, CONSERV GENET RESOUR, V1, P1, DOI 10.1007/s12686-009-9000-4; Yonemura Y, 1996, INT J ONCOL, V8, P555; Yonemura Y, 1997, ONCOL REP, V4, P743; Zhao J, 2011, HISTOL HISTOPATHOL, V26, P1111, DOI 10.14670/HH-26.1111; Zhuang X, 2000, Zhonghua Bing Li Xue Za Zhi, V29, P409	44	136	146	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84502	10.1371/journal.pone.0084502	http://dx.doi.org/10.1371/journal.pone.0084502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24416238	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500132
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24941042	gold, Green Published, Green Submitted			2022-12-25	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon R. T., 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/NCLIMATE1958, 10.1038/nclimate1958]; R Core Team, 2021, R LANG ENV STAT COMP; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24941042	Green Published, gold, Green Accepted			2022-12-25	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000343943100017
